[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

WO2002083876A2 - Secretory molecules - Google Patents

Secretory molecules Download PDF

Info

Publication number
WO2002083876A2
WO2002083876A2 PCT/US2002/009921 US0209921W WO02083876A2 WO 2002083876 A2 WO2002083876 A2 WO 2002083876A2 US 0209921 W US0209921 W US 0209921W WO 02083876 A2 WO02083876 A2 WO 02083876A2
Authority
WO
WIPO (PCT)
Prior art keywords
2001mar30
polynucleotide
2001may17
sequence
2001jun22
Prior art date
Application number
PCT/US2002/009921
Other languages
French (fr)
Other versions
WO2002083876A3 (en
Inventor
Abel Daffo
Anissa L. Jones
Alanna-Phung B. Tran
Christopher R. Dahl
Darryl Gietzen
Joyce Chinn
Gerard E. Dufour
Jennifer L. Jackson
Jimmy Y. Yu
Olivia Tuason
Pierre E. Yap
Stefan R. Amshey
Sean C. Daughtery
Tam C. Dam
Tommy F. Liu
Duy-Viet An Nguyen
Yael Kleefeld
Edward H. Gerstin, Jr.
Careyna H. Peralta
Marie H. David
Samantha A. Lewis
Alice J. Chen
Scott R. Panzer
Bernard Harris
Vincent Z. Mullahy-Flores
Rakesh Marwaha
Audrey Lo
Ruth Y. Lan
Michael E. Urashka
Original Assignee
Incyte Genomics, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Incyte Genomics, Inc. filed Critical Incyte Genomics, Inc.
Priority to EP02739118A priority Critical patent/EP1409504A2/en
Priority to CA002447212A priority patent/CA2447212A1/en
Priority to AU2002311791A priority patent/AU2002311791A1/en
Publication of WO2002083876A2 publication Critical patent/WO2002083876A2/en
Publication of WO2002083876A3 publication Critical patent/WO2002083876A3/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Definitions

  • the present invention relates to secretory molecules and to the use of these sequences in the diagnosis, study, prevention, and treatment of diseases associated with, as well as effects of exogenous compounds on, the expression of secretory molecules.
  • Protein transport is mediated by a signal peptide located at the amino terminus of the protein to be transported or secreted.
  • the signal peptide is comprised of about ten to twenty hydrophobic amino acids which target the nascent protein from the riboso e to a particular membrane bound compartment such as the endoplasmic reticulum (ER).
  • ER endoplasmic reticulum
  • Proteins targeted to the ER may either proceed through the secretory pathway or remain in any of the secretory organelles such as the ER, Golgi apparatus, or lysosomes. Proteins that transit through the secretory pathway are either secreted into the extracellular space or retained in the plasma membrane.
  • Proteins that are retained in the plasma membrane contain one or more transmembrane domains, each comprised of about 20 hydrophobic amino acid residues.
  • Proteins that are secreted from the cell are generally synthesized as inactive precursors that are activated by post-translational processing events during transit through the secretory pathway. Such events include glycosylation, proteolysis, and removal of the signal peptide by a signal peptidase.
  • Other events that may occur during protein transport include chaperone-dependent unfolding and folding of he nascent protein and interaction of the protein with a receptor or pore complex. Examples of secretory proteins with amino terminal signal peptides are discussed below and include proteins with important roles in cell-to-cell signaling.
  • G-protein coupled receptors comprise a superfamily of integral membrane proteins which transduce extracellular signals. Not all GPCRs contain N-terminal signal peptides.
  • GPCRs include receptors for biogenic amines such as dopamine, epinephrine, histamine, glutamate (metabotropic-type), acetylcholine (muscarinic-type), and serotonin; for lipid mediators of inflammation such as prostaglandins, platelet activating factor, and leukotrienes; for peptide hormones such as calcitonin, C5a anaphylatoxin, follicle stimulating hormone, gonadotropin releasing hormone, neurokinin, oxytocin, and thrombin; and for sensory signal mediators such as retinal photopigments and olfactory stimulatory molecules.
  • biogenic amines such as dopamine, epinephrine, histamine, glutamate (metabotropic-type), acetylcholine (muscarinic-type), and serotonin
  • lipid mediators of inflammation such as prostaglandins, platelet activating factor, and leukotrienes
  • the structure of these highly conserved receptors consists of seven hydrophobic transmembrane regions, cysteine disulfide bridges between the second and third extracellular loops, an extracellular N-terminus, and a cytoplasmic C-terminus.
  • the N-terminus interacts with ligands
  • the disulfide bridges interact with agonists and antagonists
  • the large third intracellular loop interacts with G proteins to activate second messengers such as cyclic AMP, phospholipase C, inositol triphosphate, or ion channels.
  • receptors include cell surface antigens identified on leukocytic cells of he immune system. These antigens have been identified using systematic, monoclonal antibody (mAb)- based "shot gun” techniques. These techniques have resulted in the production of hundreds of mAbs directed against unknown cell surface leukocytic antigens. These antigens have been grouped into "clusters of differentiation” based on common immunocytochemical localization patterns in various differentiated and undifferentiated leukocytic cell types. Antigens in a given cluster are presumed to identify a single cell surface protein and are assigned a "cluster of differentiation" or "CD” designation.
  • CD antigens Some of the genes encoding proteins identified by CD antigens have been cloned and verified by standard molecular biology techniques. CD antigens have been characterized as both transmembrane proteins and cell surface proteins anchored to the plasma membrane via covalent attachment to fatty acid-containing glycolipids such as glycosylphosphatidylinositol (GPI). (Reviewed in Barclay, A.N. et al. (1995) The Leucocyte Antigen Facts Book, Academic Press, San Diego CA, pp. 17-20.)
  • GPI glycosylphosphatidylinositol
  • MPs Matrix proteins
  • the expression and balance of MPs may be perturbed by biochemical changes that result from congenital, epigenetic, or infectious diseases.
  • MPs affect leukocyte migration, proliferation, differentiation, and activation in the immune response.
  • MPs are frequently characterized by the presence of one or more domains which may include collagen-like domains, EGF-like domains, immunoglobulin-like domains, and fibronectin-like domains, hi addition, MPs may be heavily glycosylated and may contain an Arginine-Glycine- Aspartate (RGD) tripeptide motif which may play a role in adhesive interactions.
  • MPs include extracellular proteins such as fibronectin, collagen, galectin, vitronectin and its proteolytic derivative somatomedin B; and cell adhesion receptors such as cell adhesion molecules (CAMs), cadherins, and integrins.
  • Cytokines are secreted by hematopoietic cells in response to injury or infection. Interleukins, neurotrophins, growth factors, interferons, and chemokines all define cytokine families that work in conjunction with cellular receptors to regulate cell proliferation and differentiation. In addition, cytokines effect activities such as leukocyte migration and function, hematopoietic cell proliferation, temperature regulation, acute response to infection, tissue remodeling, and apoptosis.
  • Chemokines are small chemoattractant cytokines involved in inflammation, leukocyte proliferation and migration, angiogenesis and angiostasis, regulation of hematopoiesis, HIV infectivity, and stimulation of cytokine secretion.
  • Chemokines generally contain 70-100 amino acids and are subdivided into four subfamilies based on the presence of conserved cysteine-based motifs. (Ca ⁇ lard, R. and Gearing, A. (1994) The Cytokine Facts Book, Academic Press, New York NY, pp. 181-190, 210-213, 223-227.)
  • Growth and differentiation factors are secreted proteins which function in intercellular communication. Some factors require oligomerization or association with MPs for activity. Complex interactions among these factors and their receptors trigger intracellular signal transduction pathways that stimulate or inhibit cell division, cell differentiation, cell signaling, and cell motility. Most growth and differentiation factors act on cells in their local environment (paracrine signaling).
  • the first class includes the large polypeptide growth factors such as epidermal growth factor, fibroblast growth factor, transforming growth factor, insulin-like growth factor, and platelet-derived growth factor.
  • the second class includes the hematopoietic growth factors such as the colony stimulating factors (CSFs).
  • CSFs colony stimulating factors
  • Hematopoietic growth factors stimulate the proliferation and differentiation of blood cells such as B-lymphocytes, T- lymphocytes, erythrocytes, platelets, eosinophils, basophils, neutrophils, macrophages, and their stem cell precursors.
  • the third class includes small peptide factors such as bombesin, vasopressin, oxytocin, endothelin, transferrin, angiotensin H, vasoactive intestinal peptide, and bradykinin which function as hormones to regulate cellular functions other than proliferation.
  • Growth and differentiation factors play critical roles in neoplastic transformation of cells in vitro and in tumor progression in vivo. Inappropriate expression of growth factors by tumor cells may contribute to vascularization and metastasis of tumors. During hematopoiesis, growth factor misregulation can result in anemias, leukemias, and lymphomas. Certain growth factors such as interferon are cytotoxic to tumor cells both in vivo and in vitro. Moreover, some growth factors and growth factor receptors are related both structurally and functionally to oncoproteins. In addition, growth factors affect transcriptional regulation of both proto-oncogenes and oncosuppressor genes. (Reviewed in Pimentel, E. (1994) Handbook of Growth Factors.
  • Proteolytic enzymes or proteases either activate or deactivate proteins byhydrolyzing peptide bonds.
  • Proteases are found in the cytosol, in membrane-bound compartments, and in the extracellular space. The major families are the zinc, serine, cysteine, thiol, and carboxyl proteases.
  • Ion channels, ion pumps, and transport proteins mediate the transport of molecules across cellular membranes.
  • Transport can occur by a passive, concentration-dependent mechanism or can be linked to an energy source such as ATP hydrolysis.
  • Symporters and antiporters transport ions and small molecules such as amino acids, glucose, and drugs.
  • Symporters transport molecules and ions unidirectionally, and antiporters transport molecules and ions bidirectionally.
  • Transporter superfamilies include facilitative transporters and active ATP-binding cassette transporters which are involved in multiple-drug resistance and the targeting of antigenic peptides to MHC Class I molecules. These . transporters bind to a specific ion or other molecule and undergo a conformational change in order to transfer the ion or molecule across the membrane.
  • Ion channels are formed by transmembrane proteins which create a lined passageway across the membrane through which water and ions, such as Na + , K + , Ca 2+ , and CI", enter and exit the cell.
  • chloride channels are involved in the regulation of the membrane electric potential as well as absorption and secretion of ions across the membrane. Chloride channels also regulate the internal pH of membrane-bound organelles.
  • Ion pumps are ATPases which actively maintain membrane gradients. Ion pumps are classified as P, V, or F according to their structure and function. All have one or more binding sites for ATP in their cytosolic domains.
  • the P-class ion pumps include Ca 2+ ATPase and NaVK + ATPase and function in transporting H + , Na + , K + , and Ca 2+ ions.
  • P-class pumps consist of two ⁇ and two ⁇ transmembrane subunits.
  • the V- and F-class ion pumps have similar structures but transport only H + .
  • F class H + pumps mediate transport across the membranes of mitochondria and chloroplasts, while V- class H + pumps regulate acidity inside lysosomes, endosomes, and plant vacuoles.
  • the proteins in this family contain a highly conserved, large transmembrane domain comprised of 12 ⁇ -helices, and several weakly conserved, cytoplasmic and exoplasmic domains. (Pessin, J.E. and Bell, G.I. (1992) Annu. Rev. Physiol. 54:911-930.)
  • Amino acid transport is mediated by Na + dependent amino acid transporters. These transporters are involved in gastrointestinal and renal uptake of dietary and cellular amino acids and in neuronal reuptake of neurotransmitters. Transport of cationic amino acids is mediated by the system y+ family and the cationic amino acid transporter (CAT) family. Members ofthe CAT family share a high degree of sequence homology, and each contains 12-14 putative transmembrane domains. (Ito, K. and Groudine, M. (1997) J. Biol. Chem. 272:26780-26786.)
  • Hormones are secreted molecules that travel through the circulation and bind to specific receptors on the surface of, or within, target cells. Although they have diverse biochemical 5 compositions and mechanisms of action, hormones can be grouped into two categories.
  • One category includes small lipophilic hormones that diffuse through the plasma membrane of target cells, bind to cytosolic or nuclear receptors, and form a complex that alters gene expression. Examples of these molecules include retinoic acid, thyroxine, and the cholesterol-derived steroid hormones such as progesterone, estrogen, testosterone, cortisol, and aldosterone.
  • the second category includes l o hydrophilic hormones that function by binding to cell surface receptors that transduce signals across the plasma membrane.
  • hormones include amino acid derivatives such as catecholamines and peptide hormones such as glucagon, insulin, gastrin, secretin, cholecystokinin, adrenocorticotropic hormone, follicle stimulating hormone, luteinizing hormone, thyroid stimulating hormone, and vasopressin.
  • catecholamines amino acid derivatives
  • peptide hormones such as glucagon, insulin, gastrin, secretin, cholecystokinin, adrenocorticotropic hormone, follicle stimulating hormone, luteinizing hormone, thyroid stimulating hormone, and vasopressin.
  • Neuropeptides and vasomediators comprise a large family of endogenous signaling molecules. Included in this family are neuropeptides and neuropeptide hormones such as bombesin, neuropeptide Y, neurotensin, neuromedin N, melanocortins, opioids, galanin, somatostatin, tachykinins, urotensin II and related peptides involved in smooth muscle stimulation, vasopressin, vasoactive
  • NP/VMs can transduce signals directly, modulate the activity or release of other neurotransmitters and hormones, and act as catalytic enzymes in cascades. The effects of NP/VMs range from extremely brief to long-lasting. (Reviewed in Martin, CR. et al. (1985) Endocrine Physiology, Oxford University Press,
  • Embodiments ofthe invention relate to nucleic acid sequences comprising human polynucleotides encoding secretory polypeptides that can contain signal peptides and/or transmembrane domains.
  • human polynucleotides as presented in the Sequence Listing uniquely identify partial or full length genes encoding structural, functional, and regulatory polypeptides involved in cell signaling.
  • An embodiment of the invention provides an isolated polynucleotide selected from the group consisting of a) a polynucleotide comprising a polynucleotide sequence selected from the group consisting of SEQ ID NO:l-567; b) a polynucleotide comprising a naturally occurring polynucleotide sequence at least 90% identical to a polynucleotide sequence selected from the group consisting of SEQ ID NO:l-567; c) a polynucleotide complementary to the polynucleotide of a); d) a polynucleotide complementary to the polynucleotide of b); and e) an RNA equivalent of a) through d).
  • the polynucleotide comprises a polynucleotide sequence selected from the group consisting of SEQ ID NO:l-567.
  • the polynucleotide comprises at least 30 contiguous nucleotides of a polynucleotide selected from the group consisting of a) a polynucleotide comprising a polynucleotide sequence selected from the group consisting of SEQ ID NO:l-567; b) a polynucleotide comprising a naturally occurring polynucleotide comprising a polynucleotide sequence at least 90% identical to a polynucleotide sequence selected from the group consisting of SEQ ID NO: 1-567; c) a polynucleotide complementary to the polynucleotide of a); d) a polynucleotide complementary to the polynucleotide of b); and e) an RNA equivalent of a) through d
  • the polynucleotide comprises at least 60 contiguous nucleotides of a polynucleotide selected from the group consisting of a) a polynucleotide comprising a polynucleotide sequence selected from the group consisting of SEQ ID NO:l-567; b) a polynucleotide comprising a naturally occurring polynucleotide comprising a polynucleotide sequence at least 90% identical to a polynucleotide sequence selected from the group consisting of SEQ ID NO:l-567; c) a polynucleotide complementary to the polynucleotide of a); d) a polynucleotide complementary to the polynucleotide of b); and e) an RNA equivalent of a) through d).
  • compositions for the detection of expression of secretory polynucleotides comprising at least one isolated polynucleotide comprising a polynucleotide selected from the group consisting of a) a polynucleotide comprising a polynucleotide sequence selected from the group consisting of SEQ ID NO:l-567; b) a polynucleotide comprising a naturally occurring polynucleotide sequence at least 90% identical to a polynucleotide sequence selected from the group consisting of SEQ ID NO: 1-567; c) a polynucleotide complementary to the polynucleotide of a); d) a polynucleotide complementary to the polynucleotide of b); and e) an RNA equivalent of a) through d); and a detectable label.
  • An embodiment of the invention also provides a method for detecting a target polynucleotide in a sample, said target polynucleotide having a polynucleotide sequence of a polyneucleotide selected from the group consisting of a) a polynucleotide comprising a polynucleotide sequence of a polynucleotide selected from the group consisting of SEQ ID NO: 1-567; b) a polynucleotide comprising a naturally occurring polynucleotide sequence at least 90% identical to a polynucleotide sequence selected from the group consisting of SEQ ID NO:l-567; c) a polynucleotide complementary to the polynucleotide of a); d) a polynucleotide complementary to the polynucleotide of b); and e) an RNA equivalent of a) through d).
  • the method comprises a) amplifying said target polynucleotide or fragment thereof using polymerase chain reaction amplification, and b) detecting the presence or absence of said amplified target polynucleotide or fragment thereof, and, optionally, if present, the amount thereof.
  • Another embodiment also provides a method for detecting a target polynucleotide in a sample, said target polynucleotide having a polynucleotide sequence of a polynucleotide selected from the group consisting of a) a polynucleotide comprising a polynucleotide sequence selected from the group consisting of SEQ ID NO:l-567; b) a polynucleotide comprising a naturally occurring polynucleotide sequence at least 90% identical to a polynucleotide sequence selected from the group consisting of SEQ ID NO:l-567; c) a polynucleotide complementary to the polynucleotide of a); d) a polynucleotide complementary to the polynucleotide of b); and e) an RNA equivalent of a) through d).
  • the method comprises a) hybridizing the sample with a probe comprising at least 20 contiguous nucleotides comprising a sequence complementary to said target polynucleotide in the sample, and which probe specifically hybridizes to said target polynucleotide, under conditions whereby a hybridization complex is formed between said probe and said target polynucleotide, and b) detecting the presence or absence of said hybridization complex, and, optionally, if present, the amount thereof.
  • the invention provides a composition comprising a target polynucleotide ofthe method, wherein said probe comprises at least 30 contiguous nucleotides.
  • the invention provides a composition comprising a target polynucleotide ofthe method, wherein said probe comprises at least 60 contiguous nucleotides.
  • Another embodiment provides a recombinant polynucleotide comprising a promoter sequence operably linked to an isolated polynucleotide selected from the group consisting of a) a polynucleotide comprising a polynucleotide sequence selected from the group consisting of SEQ ID NO: 1-567; b) a polynucleotide comprising a naturally occurring polynucleotide sequence at least 90% identical to a polynucleotide sequence selected from the group consisting of SEQ ID NO: 1-567; c) a polynucleotide complementary to the polynucleotide of a); d) a polynucleotide complementary to the polynucleotide of b); and e) an RNA equivalent of a) through d).
  • the invention provides a cell transformed with the recombinant polynucleotide.
  • the invention provides a transgenic organism comprising the recombin
  • Yet another embodiment provides a method for producing a secretory polypeptide, the method comprising a) culturing a cell under conditions suitable for expression ofthe secretory polypeptide, wherein said cell is transformed with a recombinant polynucleotide, said recombinant polynucleotide comprising an isolated polynucleotide selected from the group consisting of i) a polynucleotide comprising a polynucleotide sequence selected from the group consisting of SEQ ID NO:l-567; ii) a polynucleotide comprising a naturally occurring polynucleotide sequence at least 90% identical to a polynucleotide sequence selected from the group consisting of SEQ ID NO:l-567; iii) a polynucleotide 5 complementary to the polynucleotide of i); iv) a polynucleotide complementary to the polynucleotide of ii);
  • Still another embodiment provides an isolated secretory polypeptide (SPTM) encoded by at 0 least one polynucleotide comprising a polynucleotide sequence selected from the group consisting of SEQ ID NO: 1-567.
  • SPTM secretory polypeptide
  • the invention further provides a method of screening for a test compound that specifically binds to the polypeptide having an amino acid sequence selected from the group consisting of SEQ ID NO:568-1146.
  • the method comprises a) combining the polypeptide having an amino acid sequence selected from the group consisting of SEQ ID NO:568-1146 with at least one test compound 5 under suitable conditions, and b) detecting binding of the polypeptide having an amino acid sequence selected from the group consisting of SEQ ID NO:568-1146 to the test compound, thereby identifying a compound that specifically binds to the polypeptide having an amino acid sequence selected from the group consisting of SEQ ID NO:568-1146.
  • Still yet another embodiment provides a microarray wherein at least one element of the o microarray is an isolated polynucleotide comprising at least 30 contiguous nucleotides of a polynucleotide selected from the group consisting of a) a polynucleotide comprising a polynucleotide sequence selected from the group consisting of SEQ ID NO: 1-567; b) a polynucleotide comprising a naturally occurring polynucleotide sequence at least 90% identical to a polynucleotide sequence selected from the group consisting of SEQ ID NO: 1-567; c) a polynucleotide complementary to the 5 polynucleotide of a); d) a polynucleotide complementary to the polynucleotide of b); and e) an RNA equivalent of a) through d).
  • the invention also provides a method for generating a transcript image of a sample which contains polynucleotides.
  • the method comprises a) labeling the polynucleotides of he sample, b) contacting the elements of the microarray with the labeled polynucleotides of the sample under conditions suitable for the formation of a hybridization complex, and c) quantifying the o expression of the polynucleotides in the sample.
  • Still yet another embodiment provides a method for screening a compound for effectiveness in altering expression of a target polynucleotide, wherein said target polynucleotide comprises a polynucleotide selected from the group consisting of a) a polynucleotide comprising a polynucleotide sequence selected from the group consisting of SEQ ID NO:l-567; b) a polynucleotide comprising a naturally occurring polynucleotide sequence at least 90% identical to a polynucleotide sequence selected from the group consisting of SEQ ID NO: 1-567; c) a polynucleotide complementary to the polynucleotide of a); d) a polynucleotide complementary to the polynucleotide of b); and e) an RNA equivalent of a) through d).
  • a target polynucleotide comprises a polynucleotide selected from the group consisting of
  • the method comprises a) exposing a sample comprising the target 5 polynucleotide to a compound, b) detecting altered expression of the target polynucleotide, and c) comparing the expression ofthe target polynucleotide in the presence of varying amounts ofthe compound and in the absence of the compound.
  • Another embodiment provides a method for assessing toxicity of a test compound, said method comprising a) treating a biological sample containing nucleic acids with the test compound; b) l o hybridizing the nucleic acids of the treated biological sample with a probe comprising at least 20 contiguous nucleotides of a polynucleotide selected from the group consisting of i) a polynucleotide comprising a polynucleotide sequence selected from the group consisting of SEQ ID NO:l-567; ii) a polynucleotide comprising a naturally occurring polynucleotide sequence at least 90% identical to a polynucleotide sequence selected from the group consisting of SEQ ID NO:l-567; iii) a polynucleotide
  • Hybridization occurs under conditions whereby a specific hybridization complex is formed between said probe and a target polynucleotide in the biological sample, said target polynucleotide comprising a polynucleotide sequence of a polynucleotide selected from the group consisting of i) a polynucleotide comprising a polynucleotide sequence
  • the target polynucleotide comprises a polynucleotide sequence of a
  • Another embodiment provides an isolated polypeptide selected from the group consisting of a) a polypeptide comprising an amino acid sequence selected from the group consisting of SEQ ID NO:568-1146, b) a polypeptide comprising a naturally occurring amino acid sequence at least 90% identical to an amino acid sequence selected from the group consisting of SEQ ID NO:568-1146, c) a biologically active fragment of a polypeptide having an amino acid sequence selected from the group consisting of SEQ ID NO:568-1146, and d) an immunogenic fragment of a polypeptide having an amino acid sequence selected from the group consisting of SEQ ID NO:568-1146.
  • the invention provides an isolated polypeptide comprising an amino acid sequence selected from the group consisting of SEQ ID NO:568-1146.
  • Still another embodiment provides an isolated polynucleotide encoding a polypeptide selected from the group consisting of a) a polypeptide comprising an amino acid sequence selected from the group consisting of SEQ ID NO:568-l 146, b) a polypeptide comprising a naturally occurring amino acid sequence at least 90% identical to an amino acid sequence selected from the group consisting of SEQ ID NO:568-1146, c) a biologically active fragment of a polypeptide having an amino acid sequence selected from the group consisting of SEQ ID NO:568-l 146, and d) an immunogenic fragment of a polypeptide having an amino acid sequence selected from the group consisting of SEQ ID NO:568-1146.
  • the polynucleotide encodes a polypeptide comprising an amino acid sequence selected from the group consisting of SEQ ID NO:568-1146.
  • the polynucleotide comprises a polynucleotide sequence selected from the group consisting of SEQ ID NO:l-567.
  • Another embodiment provides an isolated antibody which specifically binds to a polypeptide selected from the group consisting of a) a polypeptide comprising an amino acid sequence selected from the group consisting of SEQ ID NO:568-1146, b) a polypeptide comprising a naturally occurring amino acid sequence at least 90% identical to an amino acid sequence selected from the group consisting of SEQ ID NO:568-l 146, c) a biologically active fragment of a polypeptide having an amino acid sequence selected from the group consisting of SEQ ID NO:568-1146, and d) an immunogenic fragment of a polypeptide having an amino acid sequence selected from the group consisting of SEQ ID NO.568-1146.
  • compositions comprising a polypeptide selected from the group consisting of a) a polypeptide comprising an amino acid sequence selected from the group consisting of SEQ ID NO:568-1146, b) a polypeptide comprising a naturally occurring amino acid sequence at least 90% identical to an amino acid sequence selected from the group consisting of SEQ ID NO:568-1146, c) a biologically active fragment of a polypeptide having an amino acid sequence selected from the group consisting of SEQ ID NO:568-l 146, and d) an immunogenic fragment of a polypeptide having an amino acid sequence selected from the group consisting of SEQ TD NO:568-l 146, and a pharmaceutically acceptable excipient.
  • the composition comprises a polypeptide having an amino acid sequence selected from the group consisting of SEQ ID NO:568-1146.
  • Another embodiment provides a method of treating a disease or condition associated with decreased expression of functional SPTM, comprising administering to a patient in need of such treatment the composition.
  • Another embodiment provides a method for screening a compound for effectiveness as an agonist of a polypeptide selected from the group consisting of a) a polypeptide comprising an amino acid sequence selected from the group consisting of SEQ ID NO:568-1146, b) a polypeptide comprising a naturally occurring amino acid sequence at least 90% identical to an amino acid sequence 5 selected from the group consisting of SEQ ID NO:568-l 146, c) a biologically active fragment of a polypeptide having an amino acid sequence selected from the group consisting of SEQ ID NO:568- 1146, and d) an immunogenic fragment of a polypeptide having an amino acid sequence selected from the group consisting of SEQ ID NO:568-l 146.
  • the method comprises a) exposing a sample comprising the polypeptide to a compound, and b) detecting agonist activity in the sample.
  • the invention provides a composition comprising an agonist compound identified by the method and a pharmaceutically acceptable excipient.
  • the invention provides a method of treating a disease or condition associated with decreased expression of functional SPTM, comprising administering to a patient in need of such treatment the composition.
  • Another embodiment provides a method for screening a compound for effectiveness as an antagonist of a polypeptide selected from the group consisting of a) a polypeptide comprising an amino acid sequence selected from the group consisting of SEQ ID NO:568-1146, b) a polypeptide comprising a naturally occurring amino acid sequence at least 90% identical to an amino acid sequence selected from the group consisting of SEQ ID NO:568-l 146, c) a biologically active fragment of a o polypeptide having an amino acid sequence selected from the group consisting of SEQ ID NO:568-
  • the method comprises a) exposing a sample comprising the polypeptide to a compound, and b) detecting antagonist activity in the sample.
  • the invention provides a composition comprising an antagonist compound identified by the 5 method and a pharmaceutically acceptable excipient.
  • the invention provides a method of treating a disease or condition associated with overexpression of functional SPTM, comprising administering to a patient in need of such treatment the composition.
  • Another embodiment provides a method of screening for a compound that modulates the activity of a polypeptide selected from the group consisting of a) a polypeptide comprising an amino o acid sequence selected from the group consisting of SEQ ID NO.568-1146, b) a polypeptide comprising a naturally occurring amino acid sequence at least 90% identical to an amino acid sequence selected from the group consisting of SEQ ID NO:568-1146, c) a biologically active fragment of a polypeptide having an amino acid sequence selected from the group consisting of SEQ ID NO.568- 1146, and d) an immunogenic fragment of a polypeptide having an amino acid sequence selected from 5 the group consisting of SEQ ID NO:568-l 146.
  • the method comprises a) combining the polypeptide with at least one test compound under conditions permissive for the activity ofthe polypeptide, b) assessing the activity of the polypeptide in the presence of the test compound, and c) comparing the activity of the polypeptide in the presence of the test compound with the activity of the polypeptide in the absence ofthe test compound, wherein a change in the activity of he polypeptide in the presence of the test compound is indicative of a compound that modulates the activity of the polypeptide.
  • Table 1 shows the sequence identification numbers (SEQ ID NO:s) and template identification numbers (template IDs) co ⁇ esponding to the polynucleotides of the present invention, along with the sequence identification numbers (SEQ ID NO:s) and open reading frame identification numbers (ORF IDs) co ⁇ esponding to polypeptides encoded by the template ID.
  • Table 2 shows the sequence identification numbers (SEQ ID NO:s) and template identification numbers (template IDs) corresponding to the polynucleotides ofthe present invention, along with polynucleotide segments of each template sequence as defined by the indicated “start” and “stop” nucleotide positions.
  • the reading frames of the polynucleotide segments are shown, and the polypeptides encoded by the polynucleotide segments constitute either signal peptide (SP) or transmembrane (TM) domains, as indicated.
  • SP signal peptide
  • TM transmembrane
  • Table 3 shows the sequence identification numbers and template identification numbers
  • template IDs co ⁇ esponding to the polynucleotides ofthe present invention, along with component sequence identification spans corresponding to each template.
  • the component sequences, which were used to assemble the template sequences, are defined by the spans indicating the nucleotide positions along each template.
  • Table 4 shows the tissue distribution profiles for the templates of the invention.
  • Table 5 shows the sequence identification numbers (SEQ ID NO:s) corresponding to the polypeptides of the present invention, along with the reading frames used to obtain the polypeptide segments, the lengths ofthe polypeptide segments, the "start” and “stop” nucleotide positions ofthe polynucleotide sequences used to define the encoded polypeptide segments, the GenBank hits (GI Numbers), probability scores, and functional annotations co ⁇ esponding to the GenBank hits.
  • Table 6 summarizes the bioinformatics tools which are useful for analysis ofthe polynucleotides of the present invention.
  • the first column of Table 6 lists analytical tools, programs, and algorithms, the second column provides brief descriptions thereof, the third column presents appropriate references, all of which are incorporated by reference herein in their entirety, and the fourth column presents, where applicable, the scores, probability values, and other parameters used to evaluate the strength of a match between two sequences (the higher the score, the greater the homology between two sequences).
  • sptm refers to a nucleic acid sequence
  • SPTM amino acid sequence encoded by sptm
  • a “full-length” sptm refers to a nucleic acid sequence containing the entire coding region of a gene endogenously expressed in human tissue.
  • adjuvants are materials such as Freund's adjuvant, mineral gels (aluminum hydroxide), and surface active substances (lysolecithin, pluronic polyols, polyanions, peptides, oil emulsions, keyhole limpet hemocyanin, and dinitrophenol) which maybe administered to increase a host's immunological response.
  • Alleles refers to an alternative form of a nucleic acid sequence. Alleles result from a “mutation,” a change or an alternative reading of the genetic code. Any given gene may have none, one, or many allelic forms. Mutations which give rise to alleles include deletions, additions, or substitutions of nucleotides. Each of these changes may occur alone, or in combination with the others, one or more times in a given nucleic acid sequence.
  • the present invention encompasses allelic sptm.
  • allelic variant is an alternative form of the gene encoding SPTM. Allelic variants may result from at least one mutation in the nucleic acid sequence and may result in altered mRNAs or in polypeptides whose structure or function may or may not be altered. A gene may have none, one, or many allelic variants of its naturally occurring form. Common mutational changes which give rise to allelic variants are generally ascribed to natural deletions, additions, or substitutions of nucleotides. Each of these types of changes may occur alone, or in combination with the others, one or more times in a given sequence.
  • altered nucleic acid sequences encoding SPTM include those sequences with deletions, 5 insertions, or substitutions of different nucleotides, resulting in a polypeptide the same as SPTM or a polypeptide with at least one functional characteristic of SPTM. Included within this definition are polymorphisms which may or may not be readily detectable using a particular oligonucleotide probe of the polynucleotide encoding SPTM, and improper or unexpected hybridization to allelic variants, with a locus other than the normal chromosomal locus for the polynucleotide sequence encoding SPTM.
  • the 0 encoded protein may also be "altered,” and may contain deletions, insertions, or substitutions of amino acid residues which produce a silent change and result in a functionally equivalent SPTM.
  • Deliberate amino acid substitutions may be made on the basis of similarity in polarity, charge, solubility, hydrophobicity, hydrophilicity, and/or the amphipathic nature ofthe residues, as long as the biological or immunological activity of SPTM is retained.
  • negatively charged amino acids may 5 include aspartic acid and glutamic acid
  • positively charged amino acids may include lysine and arginine.
  • Amino acids with uncharged polar side chains having similar hydrophilicity values may include: asparagine and glutamine; and serine and threonine.
  • Amino acids with uncharged side chains having similar hydrophilicity values may include: leucine, isoleucine, and valine; glycine and alanine; and phenylalanine and tyrosine.
  • Amino acid sequence refers to a peptide, a polypeptide, or a protein of either natural or synthetic origin. The amino acid sequence is not limited to the complete, endogenous amino acid sequence and may be a fragment, epitope, variant, or derivative of a protein expressed by a nucleic acid sequence.
  • Amplification refers to the production of additional copies of a sequence and is carried out 5 using polymerase chain reaction (PCR) technologies well known in the art.
  • PCR polymerase chain reaction
  • Antibody refers to intact molecules as well as to fragments thereof, such as Fab, F(ab') 2 , and Fv fragments, which are capable of binding the epitopic determinant.
  • Antibodies that bind SPTM polypeptides can be prepared using intact polypeptides or using fragments containing small peptides of interest as the immunizing antigen.
  • the polypeptide or peptide used to immunize an animal e.g., a o mouse, a rat, or a rabbit
  • an animal e.g., a o mouse, a rat, or a rabbit
  • Commonly used carriers that are chemically coupled to peptides include bovine serum albumin, thyroglobulin, and keyhole limpet hemocyanin (KLH). The coupled peptide is then used to immunize the animal.
  • aptamer refers to a nucleic acid or oligonucleotide molecule that binds to a 5 specific molecular target.
  • Aptamers are derived from an in vitro evolutionary process (e.g. , SELEX (Systematic Evolution of Ligands by Exponential Enrichment), described in U.S. Patent No. 5,270,163), which selects for target-specific aptamer sequences from large combinatorial libraries.
  • Aptamer compositions may be double-stranded or single-stranded, and may include deoxyribonucleotides, ribonucleotides, nucleotide derivatives, or other nucleotide-like molecules.
  • the nucleotide components of an aptamer may have modified sugar groups (e.g., the 2 -OH group of a ribonucleotide maybe replaced by 2 -F or 2 -NH-,), which may improve a desired property, e.g., resistance to nucleases or longer lifetime in blood.
  • Aptamers may be conjugated to other molecules, e.g., a high molecular weight carrier to slow clearance ofthe aptamer from the circulatory system.
  • Aptamers maybe specifically cross-linked to their cognate ligands, e.g., by photo-activation of a cross-linker. (See, e.g., Brody, E.N. and L. Gold (2000) J. Biotechnol. 74:5-13.)
  • introduction refers to an aptamer which is expressed in vivo.
  • a vaccinia virus-based RNA expression system has been used to express specific RNA aptamers at high levels in the cytoplasm of leukocytes (Blind, M. et al. (1999) Proc. Natl Acad. Sci. USA 96:3606-3610).
  • spiegelmer refers to an aptamer which includes L-DNA, L-RNA, or other left- handed nucleotide derivatives or nucleotide-like molecules. Aptamers containing left-handed nucleotides are resistant to degradation by naturally occurring enzymes, which normally act on substrates containing right-handed nucleotides.
  • Antisense sequence refers to a sequence capable of specifically hybridizing to a target sequence.
  • the antisense sequence may include DNA, RNA, or any nucleic acid mimic or analog such as peptide nucleic acid (PNA); oligonucleotides having modified backbone linkages such as phosphorothioates, methylphosphonates, or benzylphosphonates; oligonucleotides having modified sugar groups such as 2'-methoxyethyl sugars or 2'-methoxyethoxy sugars; or oligonucleotides having modified base.
  • PNA peptide nucleic acid
  • Antisense technology refers to any technology which relies on the specific hybridization of an antisense sequence to a target sequence.
  • a 'bin is a portion of computer memory space used by a computer program for storage of data, and bounded in such a manner that data stored in a bin may be retrieved by the program.
  • Bioly active refers to an amino acid sequence having a structural, regulatory, or biochemical function of a naturally occu ⁇ ing amino acid sequence.
  • “Clone joining” is a process for combining gene bins based upon the bins' containing sequence information from the same clone. The sequences may assemble into a primary gene transcript as well as one or more splice variants.
  • Component sequence is a nucleic acid sequence selected by a computer program such as PHRED and used to assemble a consensus or template sequence from one or more component sequences.
  • a "consensus sequence” or “template sequence” is a nucleic acid sequence which has been assembled from overlapping sequences, using a computer program for fragment assembly such as the GELVIEW fragment assembly system (Genetics Computer Group (GCG), Madison WI) or using a relational database management system (RDMS).
  • GELVIEW fragment assembly system Genetics Computer Group (GCG), Madison WI
  • RDMS relational database management system
  • Constant amino acid substitutions are those substitutions that, when made, least interfere with the properties of the original protein, i. e. , the structure and especially the function of the protein is conserved and not significantly changed by such substitutions.
  • the table below shows amino acids which maybe substituted for an original amino acid in a protein and which are regarded as conservative substitutions.
  • Conservative substitutions generally maintain (a) the structure of the polypeptide backbone in the area of the substitution, for example, as a beta sheet or alpha helical conformation, (b) the charge or hydrophobicity of the molecule at the target site, or (c) the bulk of the side chain.
  • “Deletion” refers to a change in either a nucleic or amino acid sequence in which at least one nucleotide or amino acid residue, respectively, is absent.
  • “Derivative” refers to the chemical modification of a nucleic acid sequence, such as by replacement of hydrogen by an alkyl, acyl, amino, hydroxyl, or other group.
  • “Differential expression” refers to increased or upregulated; or decreased, downregulated, or absent gene or protein expression, determined by comparing at least two different samples. Such comparisons maybe carried out between, for example, a treated and an untreated sample, or a diseased and a normal sample. 5
  • element and “a ⁇ ay element” refer to a polynucleotide, polypeptide, or other chemical compound having a unique and defined position on a microa ⁇ ay.
  • modulate refers to a change in the activity of SPTM. For example, modulation may cause an increase or a decrease in protein activity, binding characteristics, or any other biological, functional, or immunological properties of SPTM.
  • E-value refers to the statistical probability that a match between two sequences occurred by chance.
  • Exon shuffling refers to the recombination of different coding regions (exons). Since an exon may represent a structural or functional domain ofthe encoded protein, new proteins may be assembled through the novel reassortment of stable substructures, thus allowing acceleration of the 5 evolution of new protein functions.
  • a “fragment” is a unique portion of sptm or SPTM which is identical in sequence to but shorter in length than the parent sequence.
  • a fragment may comprise up to the entire length of the defined sequence, minus one nucleotide/amino acid residue.
  • a fragment may comprise from 10 to 1000 contiguous amino acid residues or nucleotides.
  • a fragment used as a probe, primer, 0 antigen, therapeutic molecule, or for other purposes maybe at least 5, 10, 15, 16, 20, 25, 30, 40, 50, 60, 75, 100, 150, 250 or at least 500 contiguous amino acid residues or nucleotides in length. Fragments may be preferentially selected from certain regions of a molecule.
  • a polypeptide fragment may comprise a certain length of contiguous amino acids selected from the first 250 or 500 amino acids (or first 25% or 50%) of a polypeptide as shown in a certain defined sequence.
  • these lengths are exemplary, and any length that is supported by the specification, including the Sequence Listing and the figures, maybe encompassed by the present embodiments.
  • a fragment of sptm comprises a region of unique polynucleotide sequence that specifically identifies sptm, for example, as distinct from any other sequence in the same genome.
  • a fragment of sptm is useful, for example, in hybridization and amplification technologies and in analogous methods o that distinguish sptm from related polynucleotide sequences.
  • the precise length of a fragment of sptm and the region of sptm to which the fragment co ⁇ esponds are routinely determinable by one of ordinary skill in the art based on the intended purpose for the fragment.
  • a fragment of SPTM is encoded by a fragment of sptm.
  • a fragment of SPTM comprises a region of unique amino acid sequence that specifically identifies SPTM.
  • a fragment of 5 SPTM is useful as an immunogenic peptide for the development of antibodies that specifically recognize SPTM.
  • the precise length of a fragment of SPTM and the region of SPTM to which the fragment co ⁇ esponds are routinely determinable by one of ordinary skill in the art based on the intended purpose for the fragment.
  • a “full length” nucleotide sequence is one containing at least a start site for translation to a protein sequence, followed by an open reading frame and a stop site, and encoding a "full length” polypeptide.
  • “Hit” refers to a sequence whose annotation will be used to describe a given template. Criteria for selecting the top hit are as follows: if the template has one or more exact nucleic acid matches, the top hit is the exact match with highest percent identity. If the template has no exact matches but has significant protein hits, the top hit is the protein hit with the lowest E-value. If the template has no significant protein hits, but does have significant non-exact nucleotide hits, the top hit is the nucleotide hit with the lowest E-value.
  • Homology refers to sequence similarity either between a reference nucleic acid sequence and at least a fragment of an sptm or between a reference amino acid sequence and a fragment of an SPTM.
  • Hybridization refers to the process by which a strand of nucleotides anneals with a complementary strand through base pairing. Specific hybridization is an indication that two nucleic acid sequences share a high degree of identity. Specific hybridization complexes form under defined annealing conditions, and remain hybridized after the "washing" step.
  • the defined hybridization conditions include the annealing conditions and the washing step(s), the latter of which is particularly important in determining the stringency of the hybridization process, with more stringent conditions allowing less non-specific binding, i.e., binding between pairs of nucleic acid probes that are not perfectly matched.
  • Permissive conditions for annealing of nucleic acid sequences are routinely determinable and maybe consistent among hybridization experiments, whereas wash conditions may be varied among experiments to achieve the desired stringency.
  • stringency of hybridization is expressed with reference to the temperature under which the wash step is carried out.
  • wash temperatures are selected to be about 5°C to 20°C lower than the thermal melting point (T, for the specific sequence at a defined ionic strength and pH.
  • T m is the temperature (under defined ionic strength and pH) at which 50% of the target sequence hybridizes to a perfectly matched probe.
  • High stringency conditions for hybridization between polynucleotides ofthe present invention include wash conditions of 68°C in the presence of about 0.2 x SSC and about 0.1 % SDS, for 1 hour. Alternatively, temperatures of about 65°C, 60°C, or 55°C may be used. SSC concentration may be varied from about 0.2 to 2 x SSC, with SDS being present at about 0.1%.
  • blocking reagents are used to block non-specific hybridization. Such blocking reagents include, for instance, denatured salmon sperm DNA at about 100-200 ⁇ g/ml. Useful variations on these conditions will be readily apparent to those skilled in the art.
  • Hybridization, particularly under high stringency conditions may be suggestive of evolutionary similarity between the nucleotides. Such similarity is strongly indicative of a similar role for the nucleotides and their resultant proteins.
  • RNA:DNA hybridizations may also be used under particular circumstances, such as RNA:DNA hybridizations. Appropriate hybridization conditions are routinely determinable by one of ordinary skill in the art.
  • Immunologically active or “immunogenic” describes the potential for a natural, recombinant, or synthetic peptide, epitope, polypeptide, or protein to induce antibody production in appropriate animals, cells, or cell lines.
  • Immunogenic response can refer to conditions associated with inflammation, trauma, immune disorders, or infectious or genetic disease, etc. These conditions can be characterized by expression of various factors, e.g., cytokines, chemokines, and other signaling molecules, which may affect cellular and systemic defense systems.
  • An "immunogenic fragment” is a polypeptide or oligopeptide fragment of SPTM which is capable of eliciting an immune response when introduced into a living organism, for example, a mammal.
  • the term “immunogenic fragment” also includes any polypeptide or oligopeptide fragment of SPTM which is useful in any of the antibody production methods disclosed herein or known in the art.
  • “Insertion” or “addition” refers to a change in either a nucleic or amino acid sequence in which at least one nucleotide or residue, respectively, is added to the sequence.
  • Labeling refers to the covalent or noncovalent joining of a polynucleotide, polypeptide, or antibody with a reporter molecule capable of producing a detectable or measurable signal.
  • “Microarray” is any a ⁇ angement of nucleic acids, amino acids, antibodies, etc., on a substrate.
  • the substrate maybe a solid support such as beads, glass, paper, nitrocellulose, nylon, or an appropriate membrane.
  • Linkers are short stretches of nucleotide sequence which maybe added to a vector or an sptm to create restriction endonuclease sites to facilitate cloning.
  • Polylinkers are engineered to incorporate multiple restriction enzyme sites and to provide for the use of enzymes which leave 5' or 3' overhangs (e.g., BamHI, EcoRI, and Hindlll) and those which provide blunt ends (e.g., EcoRV, SnaBI, and Stul).
  • Nucleic acid sequence refers to the specific order of nucleotides joined by phosphodiester bonds in a linear, polymeric arrangement. Depending on the number of nucleotides, the nucleic acid sequence can be considered an oligomer, oligonucleotide, or polynucleotide.
  • the nucleic acid can be DNA, RNA, or any nucleic acid analog, such as PNA, may be of genomic or synthetic origin, may be either double-stranded or single-stranded, and can represent either the sense or antisense (complementary) strand.
  • Oligomers refers to a nucleic acid sequence of at least about 6 nucleotides and as many as about 60 nucleotides, preferably about 15 to 40 nucleotides, and most preferably between about 20 and 30 nucleotides, that may be used in hybridization or amplification technologies. Oligomers may be used as, e.g., primers for PCR, and are usually chemically synthesized.
  • "Operably linked” refers to the situation in which a first nucleic acid sequence is placed in a functional relationship with the second nucleic acid sequence. For instance, a promoter is operably linked to a coding sequence if the promoter affects the transcription or expression of the coding sequence.
  • PNA protein nucleic acid
  • PNA refers to a DNA mimic in which nucleotide bases are attached to a pseudopeptide backbone to increase stability.
  • PNAs also designated antigene agents, can prevent gene expression by targeting complementary messenger RNA.
  • percent identity and % identity refer to the percentage of residue matches between at least two polynucleotide sequences aligned using a standardized algorithm. Such an algorithm may insert, in a standardized and reproducible way, gaps in the sequences being compared in order to optimize alignment between two sequences, and therefore achieve a more meaningful comparison ofthe two sequences.
  • NCBI National Center for Biotechnology Information
  • BLAST Basic Local Alignment Search Tool
  • NCBI National Center for Biotechnology Information
  • BLAST Basic Local Alignment Search Tool
  • the BLAST software suite includes various sequence analysis programs including "BLASTN,” that is used to determine alignment between a known polynucleotide sequence and other sequences on a variety of databases.
  • BLAST 2 Sequences are used for direct pairwise comparison of two nucleotide sequences.
  • "BLAST 2 Sequences” can be accessed and used interactively at http://www.ncbi.nlm.nih.gov/gorf/bl2/.
  • the "BLAST 2 Sequences” tool can be used for both BLASTN and BLASTP (discussed below).
  • BLAST programs are commonly used with gap and other parameters set to default settings. For example, to compare two nucleotide sequences, one may use BLASTN with the "BLAST 2 Sequences" tool Version 2.0.9 (May-07-1999) set at default parameters. Such default parameters maybe, for example:
  • Percent identity may be measured over the length of an entire defined sequence, for example, as defined by a particular SEQ ID number, or may be measured over a shorter length, for example, over the length of a fragment taken from a larger, defined sequence, for instance, a fragment of at least 20, at least 30, at least 40, at least 50, at least 70, at least 100, or at least 200 contiguous nucleotides.
  • Such lengths are exemplary only, and it is understood that any fragment length supported by the sequences shown herein, in figures or Sequence Listings, may be used to describe a length over which percentage identity may be measured.
  • Nucleic acid sequences that do not show a high degree of identity may nevertheless encode similar amino acid sequences due to the degeneracy of the genetic code. It is understood that changes in nucleic acid sequence can be made using this degeneracy to produce multiple nucleic acid sequences that all encode substantially the same protein.
  • the phrases "percent identity” and "% identity”, as applied to polypeptide sequences refer to the percentage of residue matches between at least two polypeptide sequences aligned using a standardized algorithm. Methods of polypeptide sequence alignment are well-known. Some alignment methods take into account conservative amino acid substitutions. Such conservative substitutions, explained in more detail above, generally preserve the hydrophobicity and acidity of the substituted residue, thus preserving the structure (and therefore function) ofthe folded polypeptide.
  • NCBI BLAST software suite may be used.
  • BLAST 2 Sequences Version 2.0.9 (May-07-1999) with BLASTP set at default parameters.
  • BLASTP default parameters
  • Percent identity may be measured over the length of an entire defined polypeptide sequence, for example, as defined by a particular SEQ ID number, or may be measured over a shorter length, for example, over the length of a fragment taken from a larger, defined polypeptide sequence, for instance, a fragment of at least 15, at least 20, at least 30, at least 40, at least 50, at least 70 or at least 150 contiguous residues.
  • Such lengths are exemplary only, and it is understood that any fragment length supported by the sequences shown herein, in figures or Sequence Listings, may be used to describe a length over which percentage identity may be measured.
  • Probe refers to sptm or fragments thereof, which are used to detect identical, allelic or related nucleic acid sequences. Probes are isolated oligonucleotides or polynucleotides attached to a detectable label or reporter molecule. Typical labels include radioactive isotopes, ligands, chemiluminescent agents, and enzymes.
  • Primer pairs are short nucleic acids, usually DNA 5 oligonucleotides, which may be annealed to a target polynucleotide by complementary base-pairing. The primer may then be extended along the target DNA strand by a DNA polymerase enzyme. Primer pairs can be used for amplification (and identification) of a nucleic acid sequence, e.g., by the polymerase chain reaction (PCR).
  • PCR polymerase chain reaction
  • Probes and primers as used in the present invention typically comprise at least 15 contiguous 0 nucleotides of a known sequence. In order to enhance specificity, longer probes and primers may also be employed, such as probes and primers that comprise at least 20, 30, 40, 50, 60, 70, 80, 90, 100, or at least 150 consecutive nucleotides of the disclosed nucleic acid sequences. Probes and primers maybe considerably longer than these examples, and it is understood that any length supported by the specification, including the figures and Sequence Listing, maybe used. 5 Methods for preparing and using probes and primers are described in the references, for example Sambrook et al., 1989, Molecular Cloning: A Laboratory Manual, 2 nd ed., vol.
  • PCR primer pairs can be o derived from a known sequence, for example, by using computer programs intended for that purpose such as Primer (Version 0.5, 1991, Whitehead Institute for Biomedical Research, Cambridge MA).
  • Oligonucleotides for use as primers are selected using software known in the art for such purpose. For example, OLIGO 4.06 software is useful for the selection of PCR primer pairs of up to 100 nucleotides each, and for the analysis of oligonucleotides and larger polynucleotides of up to 5,000 5 nucleotides from an input polynucleotide sequence of up to 32 kilobases. Similar primer selection programs have incorporated additional features for expanded capabilities. For example, the PrimOU primer selection program (available to the public from the Genome Center at University of Texas South West Medical Center, Dallas TX) is capable of choosing specific primers from megabase sequences and is thus useful for designing primers on a genome- wide scope. The Primer3 primer o selection program (available to the public from the Whitehead Institute/MIT Center for Genome
  • Primer3 is useful, in particular, for the selection of oligonucleotides for microarrays.
  • the source code for the latter two primer selection programs may also be obtained from their respective sources and modified to meet the user's specific needs.
  • the 5 PrimeGen program (available to the public from the UK Human Genome Mapping Project Resource Centre, Cambridge UK) designs primers based on multiple sequence alignments, thereby allowing selection of primers that hybridize to either the most conserved or least conserved regions of aligned nucleic acid sequences.
  • this program is useful for identification of both unique and conserved oligonucleotides and polynucleotide fragments.
  • the oligonucleotides and polynucleotide fragments identified by any of the above selection methods are useful in hybridization technologies, for example, as PCR or sequencing primers, microa ⁇ ay elements, or specific probes to identify fully or partially complementary polynucleotides in a sample of nucleic acids. Methods of oligonucleotide selection are not limited to those described above.
  • “Purified” refers to molecules, either polynucleotides or polypeptides that are isolated or separated from their natural environment and are at least about 60% free, preferably at least about 75% free, and most preferably at least about 90% free from other compounds with which they are naturally associated.
  • a "recombinant nucleic acid” is a sequence that is not naturally occurring or has a sequence that is made by an artificial combination of two or more otherwise separated segments of sequence. This artificial combination is often accomplished by chemical synthesis or, more commonly, by the artificial manipulation of isolated segments of nucleic acids, e.g., by genetic engineering techniques such as those described in Sambrook, supra.
  • the term recombinant includes nucleic acids that have been altered solely by addition, substitution, or deletion of a portion ofthe nucleic acid.
  • a recombinant nucleic acid may include a nucleic acid sequence operably linked to a promoter sequence. Such a recombinant nucleic acid may be part of a vector that is used, for example, to transform a cell.
  • such recombinant nucleic acids may be part of a viral vector, e.g., based on a vaccinia virus, that could be use to vaccinate a mammal wherein the recombinant nucleic acid is expressed, inducing a protective immunological response in the mammal.
  • Regulatory element refers to a nucleic acid sequence from nontranslated regions of a gene, and includes enhancers, promoters, introns, and 3 ' untranslated regions, which interact with host proteins to carry out or regulate transcription or translation.
  • Reporter molecules are chemical or biochemical moieties used for labeling a nucleic acid, an amino acid, or an antibody. They include radionuclides; enzymes; fluorescent, chemiluminescent, or chromogenic agents; substrates; cofactors; inhibitors; magnetic particles; and other moieties known in the art.
  • RNA equivalent in reference to a DNA sequence, is composed ofthe same linear sequence of nucleotides as the reference DNA sequence with the exception that all occu ⁇ ences of the nitrogenous base thymine are replaced with uracil, and the sugar backbone is composed of ribose instead of deoxyribose. "Sample” is used in its broadest sense.
  • Samples may contain nucleic or amino acids, antibodies, or other materials, and maybe derived from any source (e.g., bodily fluids including, but not limited to, saliva, blood, and urine; chromosome(s), organelles, or membranes isolated from a cell; genomic DNA, RNA, or cDNA in solution or bound to a substrate; and cleared cells or tissues or blots or imprints from such cells or tissues).
  • source e.g., bodily fluids including, but not limited to, saliva, blood, and urine; chromosome(s), organelles, or membranes isolated from a cell; genomic DNA, RNA, or cDNA in solution or bound to a substrate; and cleared cells or tissues or blots or imprints from such cells or tissues).
  • Specific binding or “specifically binding” refers to the interaction between a protein or peptide and its agonist, antibody, antagonist, or other binding partner. The interaction is dependent upon the presence of a particular structure of the protein, e.g., the antigenic dete ⁇ ninant or epitope, recognized by the binding molecule. For example, if an antibody is specific for epitope "A,” the presence of a polypeptide containing epitope A, or the presence of free unlabeled A, in a reaction containing free labeled A and the antibody will reduce the amount of labeled A that binds to the antibody.
  • Substitution refers to the replacement of at least one nucleotide or amino acid by a different nucleotide or amino acid.
  • Substrate refers to any suitable rigid or semi-rigid support including, e.g., membranes, filters, chips, slides, wafers, fibers, magnetic or nonmagnetic beads, gels, tubing, plates, polymers, microparticles or capillaries.
  • the substrate can have a variety of surface forms, such as wells, trenches, pins, channels and pores, to which polynucleotides or polypeptides are bound.
  • a “transcript image” refers to the collective pattern of gene expression by a particular tissue or cell type under given conditions at a given time.
  • Transformation refers to a process by which exogenous DNA enters a recipient cell. Transformation may occur under natural or artificial conditions using various methods well known in the art. Transformation may rely on any known method for the insertion of foreign nucleic acid sequences into a prokaryotic or eukaryotic host cell. The method is selected based on the host cell being transformed.
  • Transformants include stably transformed cells in which the inserted DNA is capable of replication either as an autonomously replicating plasmid or as part of the host chromosome, as well as cells which transiently express inserted DNA or RNA.
  • a "transgenic organism,” as used herein, is any organism, including but not limited to animals and plants, in which one or more of the cells of the organism contains heterologous nucleic acid introduced by way of human intervention, such as by transgenic techniques well known in the art.
  • the nucleic acid is introduced into the cell, directly or indirectly by introduction into a precursor of the cell, by way of deliberate genetic manipulation, such as by microinjection or by infection with a recombinant virus.
  • the term genetic manipulation does not include classical cross-breeding, or in vitro fertilization, but rather is directed to the introduction of a recombinant DNA molecule.
  • the transgenic organisms contemplated in accordance with the present invention include bacteria, cyanobacteria, fungi, and plants and animals.
  • the isolated DNA ofthe present invention can be introduced into the host by methods known in the art, for example infection, transfection, transformation or transconjugation. Techniques for transferring the DNA ofthe present invention into such organisms 5 are widely known and provided in references such as Sambrook et al. (1989), supra.
  • a "variant" of a particular nucleic acid sequence is defined as a nucleic acid sequence having at least 25% sequence identity to the particular nucleic acid sequence over a certain length of one of the nucleic acid sequences using BLASTN with the "BLAST 2 Sequences" tool Version 2.0.9 (May- 07-1999) set at default parameters.
  • Such a pair of nucleic acids may show, for example, at least 30%, 0 at least 50%, at least 60%, at least 70%, at least 80%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, or at least 99% or greater sequence identity over a certain defined length.
  • the variant may result in "conservative" amino acid changes which do not affect structural and/or chemical properties.
  • a variant may be described as, for example, an "allelic” (as defined above), “splice,” “species,” or “polymorphic” 5 variant.
  • a splice variant may have significant identity to a reference molecule, but will generally have a greater or lesser number of polynucleotides due to alternate splicing of exons during mRNA processing.
  • the co ⁇ esponding polypeptide may possess additional functional domains or lack domains that are present in the reference molecule.
  • Species variants are polynucleotide sequences that vary from one species to another. The resulting polypeptides generally will have significant amino acid o identity relative to each other.
  • a polymorphic variant is a variation in the polynucleotide sequence of a particular gene between individuals of a given species.
  • Polymorphic variants also may encompass "single nucleotide polymorphisms" (SNPs) in which the polynucleotide sequence varies by one base. The presence of SNPs may be indicative of, for example, a certain population, a disease state, or a propensity for a disease state. 5
  • variants of the polynucleotides of the present invention may be generated through recombinant methods.
  • One possible method is a DNA shuffling technique such as MOLECULARBREEDING (Maxygen Inc., Santa Clara CA; described in U.S.
  • DNA shuffling is a process by which a library of gene variants is produced using PCR-mediated recombination of gene fragments. The library is then subjected to selection or screening procedures that identify those gene variants with the desired properties.
  • prefe ⁇ ed variants may then be pooled and further subjected to recursive rounds of DNA shuffling and 5 selection/screening.
  • genetic diversity is created through "artificial" breeding and rapid molecular evolution. For example, fragments of a single gene containing random point mutations may be recombined, screened, and then reshuffled until the desired properties are optimized.
  • fragments of a given gene maybe recombined with fragments of homologous genes in the same gene family, either from the same or different species, thereby maximizing the genetic diversity of multiple naturally occurring genes in a directed and controllable manner.
  • a "variant" of a particular polypeptide sequence is defined as a polypeptide sequence having at least 40% sequence identity to the particular polypeptide sequence over a certain length of one of the polypeptide sequences using BLASTP with the "BLAST 2 Sequences" tool Version 2.0.9 (May- 07-1999) set at default parameters.
  • Such a pair of polypeptides may show, for example, at least 50%, at least 60%, at least 70%, at least 80%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, or at least 99% or greater sequence identity over a certain defined length of one of the polypeptides.
  • cDNA sequences derived from human tissues and cell lines were aligned based on nucleotide sequence identity and assembled into "consensus" or "template” sequences which are designated by the template identification numbers (template IDs) in column 2 of Table 2.
  • template IDs template identification numbers
  • SEQ ID NO:s sequence identification numbers co ⁇ esponding to the template IDs are shown in column 1.
  • Segments ofthe template sequences are defined by the "start” and “stop” nucleotide positions listed in columns 3 and 4. These segments, when translated in the reading frames indicated in column 5, have similarity to signal peptide (SP) or transmembrane (TM) domain consensus sequences, as indicated in column 6.
  • the invention incorporates the nucleic acid sequences of these templates as disclosed in the Sequence Listing and the use of these sequences in the diagnosis and treatment of disease states characterized by defects in cell signaling.
  • the invention further utilizes these sequences in hybridization and amplification technologies, and in particular, in technologies which assess gene expression patterns correlated with specific cells or tissues and their responses in vivo or in vitro to pharmaceutical agents, toxins, and other treatments. In this manner, the sequences ofthe present invention are used to develop a transcript image for a particular cell or tissue.
  • cDNA was isolated from libraries constructed using RNA derived from normal and diseased human tissues and cell lines.
  • the human tissues and cell lines used for cDNA library construction were selected from a broad range of sources to provide a diverse population of cDNAs representative of gene transcription throughout the human body. Descriptions of the human tissues and cell lines used for cDNA library construction are provided in the LIEESEQ database (Incyte Genomics, Inc. (Incyte), Palo Alto CA).
  • Human tissues were broadly selected from, for example, cardiovascular, dermatologic, endocrine, gastrointestinal, hematopoietic/immune system, musculoskeletal, neural, reproductive, and urologic sources.
  • Cell lines used for cDNA library construction were derived from, for example, leukemic cells, teratocarcinomas, neuroepitheliomas, cervical carcinoma, lung fibroblasts, and endothelial cells.
  • Such cell lines include, for example, THP-1, Jurkat, HUVEC, hNT2, WI38, HeLa, and other cell lines commonly used and available from public depositories (American Type Culture Collection, Manassas VA).
  • cell lines Prior to mRNA isolation, cell lines were untreated, treated with a pharmaceutical agent such as 0 5 -aza-2'-deoxycytidine, treated with an activating agent such as lipopolysaccharide in the case of leukocytic cell lines, or, in the case of endothelial cell lines, subjected to shear stress.
  • a pharmaceutical agent such as 0 5 -aza-2'-deoxycytidine
  • an activating agent such as lipopolysaccharide in the case of leukocytic cell lines, or, in the case of endothelial cell lines, subjected to shear stress.
  • Chain termination reaction products may be electrophoresed on urea- polyacrylamide gels and detected either by autoradiography (for radioisotope-labeled nucleotides) or by fluorescence (for fluorophore-labeled nucleotides).
  • Automated methods for mechanized reaction 5 preparation, sequencing, and analysis using fluorescence detection methods have been developed.
  • Machines used to prepare cDNAs for sequencing can include the MICROLAB 2200 liquid transfer system (Hamilton Company (Hamilton), Reno NV), Peltier thermal cycler (PTC200; MJ Research, Inc. (MJ Research), Watertown MA), and ABI CATALYST 800 thermal cycler (Applied Biosystems). Sequencing can be carried out using, for example, the ABI 373 or 377 (Applied o Biosystems) or MEGABACE 1000 (Molecular Dynamics, Inc. (Molecular Dynamics), Sunnyvale
  • CA DNA sequencing systems, or other automated and manual sequencing systems well known in the art.
  • nucleotide sequences of he Sequence Listing have been prepared by current, state-of- the-art, automated methods and, as such, may contain occasional sequencing errors or unidentified 5 nucleotides. Such unidentified nucleotides are designated by an N. These infrequent unidentified bases do not represent a hindrance to practicing the invention for those skilled in the art.
  • Several methods employing standard recombinant techniques maybe used to co ⁇ ect errors and complete the missing sequence information. (See, e.g., those described in Ausubel, F.M. et al. (1997) Short Protocols in Molecular Biology, John Wiley & Sons, New York NY; and Sambrook, J. et al. (1989) Molecular Cloning, A Laboratory Manual, Cold Spring Harbor Press, Plainview NY.)
  • Human polynucleotide sequences may be assembled using programs or algorithms well known in the art. Sequences to be assembled are related, wholly or in part, and may be derived from a single or many different transcripts. Assembly of the sequences can be performed using such programs as PHRAP (Phils Revised Assembly Program) and the GELVIEW fragment assembly system (GCG), or other methods known in the art.
  • PHRAP Phils Revised Assembly Program
  • GCG GELVIEW fragment assembly system
  • cDNA sequences are used as "component" sequences that are assembled into “template” or “consensus” sequences as follows. Sequence chromatograms are processed, verified, and quality scores are obtained using PHRED. Raw sequences are edited using an editing pathway known as Block 1 (See, e.g., the LIEESEQ Assembled User Guide, Incyte Genomics, Palo Alto, CA). A series of BLAST comparisons is performed and low-information segments and repetitive elements (e.g., dinucleotide repeats, Alu repeats, etc.) are replaced by "n's", or masked, to prevent spurious matches. Mitochondrial and ribosomal RNA sequences are also removed.
  • Block 1 See, e.g., the LIEESEQ Assembled User Guide, Incyte Genomics, Palo Alto, CA).
  • a series of BLAST comparisons is performed and low-information segments and repetitive elements (e.g., dinucleotide
  • the processed sequences are then loaded into a relational database management system (ROMS) which assigns edited sequences to existing templates, if available.
  • RDMS relational database management system
  • a process is initiated which modifies existing templates or creates new templates from works in progress (i.e., nonfinal assembled sequences) containing queued sequences or the sequences themselves.
  • the templates can be merged into bins. If multiple templates exist in one bin, the bin can be split and the templates reannotated.
  • bins are "clone joined" based upon clone information. Clone joining occurs when the 5' sequence of one clone is present in one bin and the 3' sequence from the same clone is present in a different bin, indicating that the two bins should be merged into a single bin. Only bins which share at least two different clones are merged.
  • a resultant template sequence may contain either a partial or a full length open reading frame, or all or part of a genetic regulatory element. This variation is due in part to the fact that the full length cDNAs of many genes are several hundred, and sometimes several thousand, bases in length. With current technology, cDNAs comprising the coding regions of large genes cannot be cloned because of vector limitations, incomplete reverse transcription of the mRNA, or incomplete "second strand" synthesis. Template sequences maybe extended to include additional contiguous sequences derived from the parent RNA transcript using a variety of methods known to those of skill in the art. Extension may thus be used to achieve the full length coding sequence of a gene.
  • the cDNA sequences are analyzed using a variety of programs and algorithms which are well known in the art. (See, e.g., Ausubel, 1997, supra. Chapter 7.7; Meyers, R.A. (Ed.) (1995) Molecular Biology and Biotechnolo y, Wiley VCH, New York NY, pp. 856-853; and Table 6.) These analyses comprise both reading frame determinations, e.g., based on triplet codon periodicity for 0 particular organisms (Fickett, J.W. (1982) Nucleic Acids Res. 10:5303-5318); analyses of potential start and stop codons; and homology searches.
  • BLAST Basic Local Alignment Search Tool
  • BLAST is especially useful in determining exact matches and comparing two sequence fragments of arbitrary but equal lengths, whose alignment is locally maximal and for which the alignment score meets or exceeds a threshold or cutoff score set by the user (Karlin, S. et al. (1988) Proc. Natl. Acad. Sci. USA 85:841-845).
  • GenBank e.g., GenBank
  • SwissProt e.g., GenBank
  • BLOCKS e.g., GenBank
  • PFAM e.g., PFAM
  • other databases e.g., GenBank, SwissProt, BLOCKS, PFAM and other databases maybe o searched for sequences containing regions of homology to a query sptm or SPTM of the present invention.
  • Protein hierarchies can be assigned to the putative encoded polypeptide based on, e.g., motif, BLAST, or biological analysis. Methods for assigning these hierarchies are described, for example, in o "Database System Employing Protein Function Hierarchies for Viewing Biomolecular Sequence
  • the sptm ofthe present invention maybe used for a variety of diagnostic and therapeutic 5 purposes.
  • an sptm maybe used to diagnose a particular condition, disease, or disorder associated with cell signaling.
  • Such conditions, diseases, and disorders include, but are not limited to, a cell proliferative disorder such as actinic keratosis, arteriosclerosis, atherosclerosis, bursitis, cirrhosis, hepatitis, mixed connective tissue disease (MCTD), myelofibrosis, paroxysmal nocturnal hemoglobinuria, polycythemia vera, psoriasis, primary thrombocythemia, and cancers including 5 adenocarcinoma, leukemia, lymphoma, melanoma, myeloma, sarcoma, teratocarcinoma, and, in particular, a cancer ofthe adrenal gland, bladder, bone, bone marrow, brain, breast, cervix, gall bladder
  • the sptm can be used to detect the presence of, or to quantify the amount of, an sptm- related polynucleotide in a sample. This information is then compared to information obtained from appropriate reference samples, and a diagnosis is established.
  • a polynucleotide complementary to a given sptm can inhibit or inactivate a therapeutically relevant gene related to the sptm.
  • the expression of sptm may be routinely assessed by hybridization-based methods to determine, for example, the tissue-specificity, disease-specificity, or developmental stage-specificity of sptm expression.
  • the level of expression of sptm may be compared among different cell types or tissues, among diseased and normal cell types or tissues, among cell types or tissues at different developmental stages, or among cell types or tissues undergoing various treatments.
  • This type of analysis is useful, for example, to assess the relative levels of sptm expression in fully or partially differentiated cells or tissues, to determine if changes in sptm expression levels are co ⁇ elated with the development or progression of specific disease states, and to assess the response of a cell or tissue to a specific therapy, for example, in pharmacological or toxicological studies.
  • Methods for the analysis of sptm expression are based on hybridization and amplification technologies and include membrane-based procedures such as northern blot analysis, high-throughput procedures that utilize, for example, microarrays, and PCR-based procedures.
  • the sptm, their fragments, or complementary sequences may be used to identify the presence of and/or to determine the degree of similarity between two (or more) nucleic acid sequences.
  • the sptm may be hybridized to naturally occurring or recombinant nucleic acid sequences under appropriately selected temperatures and salt concentrations.
  • Hybridization with a probe based on the nucleic acid sequence of at least one of he sptm allows for the detection of nucleic acid sequences, including genomic sequences, which are identical or related to the sptm ofthe Sequence Listing.
  • Probes may be selected from non-conserved or unique regions of at least one of the polynucleotides of SEQ ID NO:l-567 and tested for their ability to identify or amplify the target nucleic acid sequence using standard protocols.
  • Polynucleotide sequences that are capable of hybridizing, in particular, to those shown in SEQ ID NO: 1 -567 and fragments thereof, can be identified using various conditions of stringency. (See, e.g., Wahl, G.M. and S.L. Berger (1987) Methods Enzymol. 152:399-407; Kimmel, A.R. (1987) Methods Enzymol. 152:507-511.) Hybridization conditions are discussed in "Definitions.”
  • a probe for use in Southern or northern hybridization may be derived from a fragment of an sptm sequence, or its complement, that is up to several hundred nucleotides in length and is either 5 single-stranded or double-stranded. Such probes may be hybridized in solution to biological materials such as plasmids, bacterial, yeast, or human artificial chromosomes, cleared or sectioned tissues, or to artificial substrates containing sptm. Microa ⁇ ays are particularly suitable for identifying the presence of and detecting the level of expression for multiple genes of interest by examining gene expression co ⁇ elated with, e.g., various stages of development, treatment with a drug or compound, or disease 0 progression.
  • An array analogous to a dot or slot blot may be used to arrange and link polynucleotides to the surface of a substrate using one or more ofthe following: mechanical (vacuum), chemical, thermal, or UV bonding procedures.
  • mechanical (vacuum), chemical, thermal, or UV bonding procedures Such an a ⁇ ay may contain any number of sptm and may be produced by hand or by using available devices, materials, and machines.
  • Microa ⁇ ays may be prepared, used, and analyzed using methods known in the art. (See, e.g., 5 Brennan, T.M. et al. (1995) U.S. Patent No. 5,474,796; Schena, M. et al. (1996) Proc. Natl. Acad.
  • Probes may be labeled by either PCR or enzymatic techniques using a variety of o commercially available reporter molecules.
  • commercial kits are available for radioactive and chencdluminescent labeling (Amersham Pharmacia Biotech) and for alkaline phosphatase labeling (Life Technologies).
  • sptm may be cloned into commercially available vectors for the production of RNA probes.
  • Such probes may be transcribed in the presence of at least one labeled nucleotide (e.g., 32 P-ATP, Amersham Pharmacia Biotech).
  • polynucleotides of SEQ ID NO: 1-567 or suitable fragments thereof can be used to isolate full length cDNA sequences utilizing hybridization and/or amplification procedures well known in the art, e.g., cDNA library screening, PCR amplification, etc.
  • the molecular cloning of such full length cDNA sequences may employ the method of cDNA library screening with probes using the hybridization, stringency, washing, and probing strategies described above and in Ausubel, supra, o Chapters 3, 5, and 6. These procedures may also be employed with genomic libraries to isolate genomic sequences of sptm in order to analyze, e.g., regulatory elements.
  • Gene identification and mapping are important in the investigation and treatment of almost all 5 conditions, diseases, and disorders. Cancer, cardiovascular disease, Alzheimer's disease, arthritis, diabetes, and mental illnesses are of particular interest. Each of these conditions is more complex than the single gene defects of sickle cell anemia or cystic fibrosis, with select groups of genes being predictive of predisposition for a particular condition, disease, or disorder.
  • cardiovascular disease may result from malfunctioning receptor molecules that fail to clear cholesterol from the bloodstream, and diabetes may result when a particular individual's immune system is activated by an infection and attacks the insulin-producing cells of the pancreas.
  • Alzheimer's disease has been linked to a gene on chromosome 21; other studies predict a different gene and location.
  • Mapping of disease genes is a complex and reiterative process and generally proceeds from genetic linkage analysis to physical mapping.
  • a genetic linkage map traces parts of chromosomes that are inherited in the same pattern as the condition.
  • Statistics link the inheritance of particular conditions to particular regions of chromosomes, as defined by RFLP or other markers.
  • RFLP Radio Resource Linearity
  • markers and their locations are known from previous studies. More often, however, the markers are simply stretches of DNA that differ among individuals. Examples of genetic linkage maps can be found in various scientific journals or at the Online Mendelian Inheritance in Man (OMIM) World Wide Web site.
  • sptm sequences may be used to generate hybridization probes useful in chromosomal mapping of naturally occurring genomic sequences. Either coding or noncoding sequences of sptm may be used, and in some instances, noncoding sequences may be preferable over coding sequences. For example, conservation of an sptm coding sequence among members of a multi-gene family may potentially cause undesired cross hybridization during chromosomal mapping.
  • sequences may be mapped to a particular chromosome, to a specific region of a chromosome, or to artificial chromosome constructions, e.g., human artificial chromosomes (HACs), yeast artificial chromosomes (YACs), bacterial artificial chromosomes (BACs), bacterial PI constructions, or single chromosome cDNA libraries.
  • HACs human artificial chromosomes
  • YACs yeast artificial chromosomes
  • BACs bacterial artificial chromosomes
  • bacterial PI constructions or single chromosome cDNA libraries.
  • Fluorescent in situ hybridization may be co ⁇ elated with other physical chromosome mapping techniques and genetic map data.
  • Co ⁇ elation between the location of sptm on a physical chromosomal map and a specific disorder, or a predisposition to a specific disorder may help define the region of DNA associated with that disorder.
  • the sptm sequences may also be used to detect polymorphisms that are genetically linked to the inheritance of a particular condition, disease, or disorder.
  • In situ hybridization of chromosomal preparations and genetic mapping techniques such as linkage analysis using established chromosomal markers, maybe used for extending existing genetic maps.
  • any sequences mapping to that area may represent associated or regulatory genes for further investigation.
  • the nucleotide sequences ofthe subject 0 invention may also be used to detect differences in chromosomal architecture due to translocation, inversion, etc., among normal, carrier, or affected individuals.
  • a disease-associated gene is mapped to a chromosomal region, the gene is cloned in order to identify mutations or other alterations (e.g., translocations or inversions) that maybe co ⁇ elated with disease.
  • This process includes a physical map of the chromosomal region containing 5 the disease-gene of interest along with associated markers. A physical map is necessary for determining the nucleotide sequence of and order of marker genes on a particular chromosomal region. Physical mapping techniques are well known in the art and involve the generation of overlapping sets of cloned DNA fragments from a particular organelle, chromosome, or genome. These clones are analyzed to reconstruct and catalog their order. Once the position of a marker is o determined, the DNA from that region is obtained by consulting the catalog and selecting clones from that region. The gene of interest is located through positional cloning techniques using hybridization or similar methods.
  • embodiments of sptm described herein can be configured to be used to design probes useful in diagnostic assays known to those skilled in the art. Such assays can be configured to be used to diagnose, detect, confirm or quantitate conditions, disorders, or diseases associated with abnormal levels of sptm expression. Labeled probes developed from sptm sequences are added to a sample under hybridizing conditions of desired stringency. In some instances, sptm, or o fragments or oligonucleotides derived from sptm, may be used as primers in amplification steps prior to hybridization. The amount of hybridization complex formed is quantified and compared with standards for a selected cell or tissue type.
  • Indication of the presence of the condition, disorder, or disease can be determined by variation of the amount of sptm expression from the assay standard.
  • the amount of variation indicative of the condition can be above or below the standard, can be selected by the 5 medical practioner, can be determined from known patient populations and/or amounts known in the medical arts and/or associated standards organizations or regulations (e.g. CLIA).
  • Examples of qualitative or quantitative diagnostic assays or methods may include but are not limited to northern, dot blot, or other membrane or dip-stick based technologies or multiple-sample format technologies such as PCR, enzyme-linked immunosorbent assay (ELISA)-like, pin, chip-based assays and the like.
  • the probes described above may also be used to monitor the progress of conditions, disorders, or diseases associated with abnormal levels of sptm expression, or to evaluate the efficacy of a particular therapeutic treatment.
  • the candidate probe maybe identified from the sptm that are specific to a given human tissue and have not been observed in GenBank or other genome databases. Such a probe may be used in animal studies, preclinical tests, clinical trials, or in monitoring the 0 treatment of an individual patient.
  • standard expression is established by methods well known in the art for use as a basis of comparison, samples from patients affected by the disorder or disease are combined with the probe to evaluate any deviation from the standard profile, and a therapeutic agent is administered and effects are monitored to generate a treatment profile.
  • Efficacy is evaluated by determining whether the expression progresses toward or returns to the standard 5 normal pattern. Treatment profiles may be generated over a period of several days or several months. Statistical methods well known to those skilled in the art may be use to determine the significance of such therapeutic agents.
  • the polynucleotides are also useful for identifying individuals from minute biological samples, for example, by matching the RFLP pattern of a sample's DNA to that of an individual's DNA.
  • the o polynucleotides of the present invention can also be used to detenriine the actual base-by-base DNA sequence of selected portions of an individual's genome. These sequences can be used to prepare PCR primers for amplifying and isolating such selected DNA, which can then be sequenced. Using this technique, an individual can be identified through a unique set of DNA sequences. Once a unique ID database is established for an individual, positive identification of that individual can be made from 5 extremely small tissue samples.
  • oligonucleotide primers derived from the sptm of the invention maybe used to detect single nucleotide polymorphisms (SNPs).
  • SNPs are substitutions, insertions and deletions that are a frequent cause of inherited or acquired genetic disease in humans.
  • Methods of SNP detection include, but are not limited to, single-stranded conformation polymorphism (SSCP) and o fluorescent SSCP (fSSCP) methods.
  • SSCP single-stranded conformation polymorphism
  • fSSCP o fluorescent SSCP
  • oligonucleotide primers derived from sptm are used to amplify DNA using the polymerase chain reaction (PCR).
  • the DNA may be derived, for example, from diseased or normal tissue, biopsy samples, bodily fluids, and the like.
  • SNPs in the DNA cause differences in the secondary and tertiary structures of PCR products in single-stranded form, and these differences are detectable using gel electrophoresis in non-denaturing gels.
  • the 5 oligonucleotide primers are fluorescently labeled, which allows detection of the amplimers in high- throughput equipment such as DNA sequencing machines.
  • sequence database analysis methods termed in silico SNP (isSNP) are capable of identifying polymorphisms by comparing the sequences of individual overlapping DNA fragments which assemble into a common consensus sequence.
  • SNPs maybe detected and characterized by mass spectrometry using, for example, the high throughput MASSARRAY system (Sequenom, Inc., San Diego CA).
  • DNA-based identification techniques can be used in forensic technology. DNA sequences taken from very small biological samples such as tissues, e.g., hair or skin, or body fluids, e.g., blood, saliva, semen, etc., can be amplified using, e.g., PCR, to identify individuals. (See, e.g., Erlich, H.
  • polynucleotides ofthe present invention can be used as polymorphic markers.
  • reagents can comprise, for example, DNA probes or primers prepared from the sequences of the present invention that are specific for particular tissues. Panels of such reagents can identify tissue by species and/or by organ type. In a similar fashion, these reagents can be used to screen tissue cultures for contamination.
  • polynucleotides of the present invention can also be used as molecular weight markers on nucleic acid gels or Southern blots, as diagnostic probes for the presence of a specific mRNA in a particular cell type, in the creation of subtracted cDNA libraries which aid in the discovery of novel polynucleotides, in selection and synthesis of oligomers for attachment to an array or other support, and as an antigen to elicit an immune response.
  • the polynucleotides encoding SPTM or their mammalian homologs may be "knocked out" in an animal model system using homologous recombination in embryonic stem (ES) cells.
  • ES embryonic stem
  • Such techniques are well known in the art and are useful for the generation of animal models of human disease.
  • mouse ES cells such as the mouse 129/SvJ cell line, are derived from the early mouse embryo and grown in culture.
  • the ES cells are transformed with a vector containing the gene of interest disrupted by a marker gene, e.g., the neomycin phosphotransferase gene (neo; Capecchi, M.R. (1989) Science 244:1288-1292).
  • a marker gene e.g., the neomycin phosphotransferase gene (neo; Capecchi, M.R. (1989) Science 244:1288-1292).
  • the vector integrates into the co ⁇ esponding region ofthe host genome by homologous recombination.
  • homologous recombination takes place using the Cre-loxP system to knockout a gene of interest in a tissue- or developmental stage-specific manner (Marth, J.D. (1996) Clin. Invest. 97:1999-2002; Wagner, K.U. et al. (1997) Nucleic Acids Res. 25:4323-4330).
  • Transformed ES cells are identified and microinjected into mouse cellblastocysts such as those from the C57BL/6 mouse strain.
  • the blastocysts are surgically transferred to pseudopregnant dams, and the resulting chimeric progeny are genotyped and bred to produce heterozygous or homozygous strains.
  • Transgenic animals thus generated maybe tested with potential therapeutic or toxic agents.
  • the polynucleotides encoding SPTM may also be manipulated in vitro in ES cells derived from human blastocysts. Human ES cells have the potential to differentiate into at least eight separate cell lineages including endoderm, mesoderm, and ectodermal cell types.
  • the polynucleotides encoding SPTM of the invention can also be used to create "knockin" humanized animals (pigs) or transgenic animals (mice or rats) to model human disease. With knockin technology, a region of sptm is injected into animal ES cells, and the injected sequence integrates into the animal cell genome. Transformed cells are injected into blastulae, and the blastulae are implanted as described above.
  • Transgenic progeny or inbred lines are studied and treated with potential 5 pharmaceutical agents to obtain info ⁇ nation on treatment of a human disease.
  • a mammal inbred to overexpress sptm resulting, e.g., in the secretion of SPTM in its milk, may also serve as a convenient source of that protein (Janne, J. et al. (1998) Biotechnol. Annu. Rev. 4:55-74).
  • Screening Assays o SPTM encoded by polynucleotides of the present invention may be used to screen for molecules that bind to or are bound by the encoded polypeptides.
  • the binding of the polypeptide and the molecule may activate (agonist), increase, inhibit (antagonist), or decrease activity of the polypeptide or the bound molecule.
  • Examples of such molecules include antibodies, oligonucleotides, proteins (e.g., receptors), or small molecules.
  • the molecule is closely related to the natural ligand of the polypeptide, e.g., a ligand or fragment thereof, a natural substrate, or a structural or functional mimetic.
  • the molecule can be closely related to the natural receptor to which the polypeptide binds, or to at least a fragment ofthe receptor, e.g., the active site. In either case, the molecule can be rationally designed using known techniques.
  • the screening for these molecules involves producing appropriate cells which express the polypeptide, either as a secreted protein or on the cell membrane. Preferred cells include cells from mammals, yeast, Drosophila. or E. coli.
  • Cells expressing the polypeptide or cell membrane fractions which contain the expressed polypeptide are then contacted with a test compound and binding, stimulation, or inhibition of activity of either the polypeptide or the molecule is analyzed.
  • An assay may simply test binding of a candidate compound to the polypeptide, wherein binding is detected by a fluorophore, radioisotope, enzyme conjugate, or other detectable label. Alternatively, the assay may assess binding in the presence of a labeled competitor.
  • the assay can be carried out using cell-free preparations, polypeptide/molecule affixed to a solid support, chemical libraries, or natural product mixtures.
  • the assay may also simply 5 comprise the steps of mixing a candidate compound with a solution containing a polypeptide, measuring polypeptide/molecule activity or binding, and comparing the polypeptide/molecule activity or binding to a standard.
  • an ELISA assay using, e.g., a monoclonal or polyclonal antibody can measure polypeptide level in a sample.
  • the antibody can measure polypeptide level by either binding, directly 0 or indirectly, to the polypeptide or by competing with the polypeptide for a substrate.
  • All of the above assays can be used in a diagnostic or prognostic context.
  • the molecules discovered using these assays can be used to treat disease or to bring about a particular result in a patient (e.g., blood vessel growth) by activating or inhibiting the polypeptide/molecule.
  • the assays can discover agents which may inhibit or enhance the production of the polypeptide from 5 suitably manipulated cells or tissues.
  • a transcript image represents the global pattern of gene expression by a particular tissue or cell o type. Global gene expression patterns are analyzed by quantifying the number of expressed genes and their relative abundance under given conditions and at a given time. (See Seilhamer et al, "Comparative Gene Transcript Analysis," U.S. Patent Number 5,840,484, expressly incorporated by reference herein.)
  • a transcript image may be generated by hybridizing the polynucleotides of the present invention or their complements to the totality of transcripts or reverse transcripts of a 5 particular tissue or cell type.
  • the hybridization takes place in high-throughput format, wherein the polynucleotides of the present invention or their complements comprise a subset of a plurality of elements on a microarray.
  • the resultant transcript image would provide a profile of gene activity pertaining to cell signaling.
  • Transcript images which profile sptm expression may be generated using transcripts isolated o from tissues, cell lines, biopsies, or other biological samples.
  • the transcript image may thus reflect sptm expression in vivo, as in the case of a tissue or biopsy sample, or in vitro, as in the case of a cell line.
  • Transcript images which profile sptm expression may also be used in conjunction with in vitro model systems and preclinical evaluation of pharmaceuticals, as well as toxicological testing of 5 industrial and naturally-occurring environmental compounds. All compounds induce characteristic gene expression patterns, frequently termed molecular fingerprints or toxicant signatures, which are indicative of mechanisms of action and toxicity (Nuwaysir, E. F. et al. (1999) Mol. Carcinog. 24:153- 159; Steiner, S. and Anderson, N. L. (2000) Toxicol. Lett. 112-113:467-71, expressly incorporated by reference herein). If a test compound has a signature similar to that of a compound with known toxicity, it is likely to share those toxic properties.
  • the toxicity of a test compound is assessed by treating a biological sample containing nucleic acids with the test compound.
  • Nucleic acids that are expressed in the treated biological sample are hybridized with one or more probes specific to the polynucleotides ofthe present invention, so that transcript levels co ⁇ esponding to the polynucleotides of the present invention may be quantified.
  • the transcript levels in the treated biological sample are compared with levels in an untreated biological sample. Differences in the transcript levels between the two samples are indicative of a toxic response caused by the test compound in the treated sample.
  • proteome refers to the global pattern of protein expression in a particular tissue or cell type.
  • proteome expression patterns, or profiles are analyzed by quantifying the number of expressed proteins and their relative abundance under given conditions and at a given time.
  • a profile of a cell's proteome may thus be generated by separating and analyzing the polypeptides of a particular tissue or cell type.
  • the separation is achieved using two-dimensional gel electrophoresis, in which proteins from a sample are separated by isoelectric focusing in the first dimension, and then according to molecular weight by sodium dodecyl sulfate slab gel electrophoresis in the second dimension (Steiner and Anderson, supra).
  • the proteins are visualized in the gel as discrete and uniquely positioned spots, typically by staining the gel with an agent such as Coomassie Blue or silver or fluorescent stains.
  • the optical density of each protein spot is generally proportional to the level of the protein in the sample.
  • the optical densities of equivalently positioned protein spots from different samples for example, from biological samples either treated or untreated with a test compound or therapeutic agent, are compared to identify any changes in protein spot density related to the treatment.
  • - 5 spots are partially sequenced using, for example, standard methods employing chemical or enzymatic cleavage followed by mass spectrometry.
  • the identity of the protein in a spot may be determined by comparing its partial sequence, preferably of at least 5 contiguous amino acid residues, to the polypeptide sequences of the present invention. In some cases, further sequence data may be obtained for definitive protein identification.
  • a proteomic profile may also be generated using antibodies specific for SPTM to quantify the levels of SPTM expression. In one embodiment, the antibodies are used as elements on a microa ⁇ ay, and protein expression levels are quantified by exposing the microarray to the sample and detecting the levels of protein bound to each array element (Lueking, A. et al. (1999) Anal. Biochem.
  • Detection may be performed by a variety 5 of methods known in the art, for example, by reacting the proteins in the sample with a thiol- or amino- reactive fluorescent compound and detecting the amount of fluorescence bound at each a ⁇ ay element.
  • Toxicant signatures at the proteome level are also useful for toxicological screening, and should be analyzed in parallel with toxicant signatures at the transcript level. There is a poor 0 co ⁇ elation between transcript and protein abundances for some proteins in some tissues (Anderson, N. L. and Seilhamer, J. (1997) Electrophoresis 18:533-537), so proteome toxicant signatures maybe useful in the analysis of compounds which do not significantly affect the transcript image, but which alter the proteomic profile. In addition, the analysis of transcripts in body fluids is difficult, due to rapid degradation of mRNA, so proteomic profiling may be more reliable and informative in such cases. 5 In another embodiment, the toxicity of a test compound is assessed by treating a biological sample containing proteins with the test compound.
  • Proteins that are expressed in the treated biological sample are separated so that the amount of each protein can be quantified.
  • the amount of each protein is compared to the amount of the co ⁇ esponding protein in an untreated biological sample. A difference in the amount of protein between the two samples is indicative of a toxic response to the o test compound in the treated sample.
  • Individual proteins are identified by sequencing the amino acid residues of the individual proteins and comparing these partial sequences to the SPTM encoded by polynucleotides of the present invention.
  • the toxicity of a test compound is assessed by treating a biological sample containing proteins with the test compound. Proteins from the biological sample are incubated 5 with antibodies specific to the SPTM encoded by polynucleotides of the present invention. The amount of protein recognized by the antibodies is quantified. The amount of protein in the treated biological sample is compared with the amount in an untreated biological sample. A difference in the amount of protein between the two samples is indicative of a toxic response to the test compound in the treated sample. Transcript images may be used to profile sptm expression in distinct tissue types. This process can be used to determine cell signaling activity in a particular tissue type relative to this activity in a different tissue type.
  • Transcript images may be used to generate a profile of sptm expression characteristic of diseased tissue. Transcript images of tissues before and after treatment may be used for diagnostic purposes, to monitor the progression of disease, and to monitor the efficacy of drug treatments for diseases which affect cell signaling activity.
  • Transcript images of cell lines can be used to assess cell signaling activity and/or to identify cell lines that lack or misregulate this activity. Such cell lines may then be treated with pharmaceutical agents, and a transcript image following treatment may indicate the efficacy of these agents in restoring desired levels of this activity. A similar approach may be used to assess the toxicity of pharmaceutical agents as reflected by undesirable changes in cell signaling activity. Candidate pharmaceutical agents maybe evaluated by comparing their associated transcript images with those of pharmaceutical agents of known effectiveness.
  • Antisense Molecules The polynucleotides of the present invention are useful in antisense technology. Antisense technology or therapy relies on the modulation of expression of a target protein through the specific binding of an antisense sequence to a target sequence encoding the target protein or directing its expression.
  • Antisense technology or therapy relies on the modulation of expression of a target protein through the specific binding of an antisense sequence to a target sequence encoding the target protein or directing its expression.
  • Agrawal, S., ed. 1996 Antisense Therapeutics, Humana Press Inc., Totawa NJ; Alama, A. et al. (1997) Pharmacol. Res. 36(3):171-178; Crooke, S.T. (1997) Adv. Pharmacol. 40:1-49; Sharma, H.W. and R.
  • An antisense sequence is a polynucleotide sequence capable of specifically hybridizing to at least a portion of the target sequence. Antisense sequences bind to cellular mRNA and/or genomic DNA, affecting translation and/or transcription. Antisense sequences can be DNA, RNA, or nucleic acid mimics and analogs. (See, e.g., Rossi, J.J. et al. (1991) Antisense Res. Dev. l(3):285-288; Lee, R. et al.
  • the binding which results in modulation of expression occurs through hybridization or binding of complementary base pairs.
  • Antisense sequences can also bind to DNA duplexes through specific interactions in the major groove of the double helix.
  • the polynucleotides of the present invention and fragments thereof can be used as antisense sequences to modify the expression of the polypeptide encoded by sptm.
  • antisense sequences can be produced ex vivo, such as by using any of the ABI nucleic acid synthesizer series (Applied Biosystems) or other automated systems known in the art. Antisense sequences can also be produced biologically, such as by transforming an appropriate host cell with an expression vector containing the 5 sequence of interest. (See, e.g., Agrawal, supra.)
  • Antisense sequences can be delivered intracellularly in the form of an expression plasmid which, upon transcription, produces a sequence complementary to at least a portion of the cellular sequence encoding the target protein.
  • Antisense sequences can also be introduced intracellularly through the use of viral vectors, such as retrovirus and adeno-associated virus vectors.
  • expression 0 In order to express a biologically active SPTM, the nucleotide sequences encoding SPTM or fragments thereof maybe inserted into an appropriate expression vector, i.e., a vector which contains the necessary elements for transcriptional and translational control of the inserted coding sequence in a suitable host.
  • an appropriate expression vector i.e., a vector which contains the necessary elements for transcriptional and translational control of the inserted coding sequence in a suitable host.
  • Methods which are well known to those skilled in the art may be used to construct expression vectors containing sequences encoding SPTM and appropriate transcriptional and 5 translational control elements. These methods include in vitro recombinant DNA techniques, synthetic techniques, and in vivo genetic recombination. (See, e.g., Sambrook, supra, Chapters 4, 8, 16, and 17; and Ausubel, supra, Chapters 9, 10, 13, and 16.)
  • a variety of expression vector/host systems may be utilized to contain and express sequences encoding SPTM. These include, but are not limited to, microorganisms such as bacteria transformed o with recombinant bacteriophage, plasmid, or cosmid DNA expression vectors; yeast transformed with yeast expression vectors; insect cell systems infected with viral expression vectors (e.g., baculovirus); plant cell systems transformed with viral expression vectors (e.g., cauliflower mosaic virus, CaMV, or tobacco mosaic virus, TMV) or with bacterial expression vectors (e.g., Ti or pBR322 plasmids); or animal (mammalian) cell systems.
  • microorganisms such as bacteria transformed o with recombinant bacteriophage, plasmid, or cosmid DNA expression vectors; yeast transformed with yeast expression vectors; insect cell systems infected with viral expression vectors (e.g., baculovirus); plant cell systems transformed with viral expression vectors (e.g., cauliflower
  • Expression vectors derived from retroviruses, adeno viruses, or herpes or vaccinia viruses, or from various bacterial plasmids maybe used for delivery of nucleotide sequences to the targeted organ, tissue, or cell population.
  • sequences encoding SPTM can be transformed into cell lines using expression vectors which may contain viral origins of replication and/or endogenous expression elements and a selectable marker gene on the same or on a separate vector. Any number of selection systems may be used to recover transformed cell lines.
  • the polynucleotides encoding SPTM of the invention may be used for somatic or germline gene therapy.
  • Gene therapy may be performed to (i) co ⁇ ect a genetic deficiency (e.g., in the cases of severe combined immunodeficiency (SCID)-Xl disease characterized by X-linked inheritance (Cavazzana-Calvo, M. et al. (2000) Science 288:669-672), severe combined immunodeficiency syndrome associated with an inherited adenosine deaminase (ADA) deficiency (Blaese, R.M. et al. (1995) Science 270:475-480; Bordignon, C et al.
  • SCID severe combined immunodeficiency
  • ADA adenosine deaminase
  • sptm hepatitis B or C virus
  • fungal parasites such as Candida albicans and Paracoccidioides brasiliensis
  • protozoan parasites such as Plasmodium falciparum and Trypanosoma cruzi
  • diseases or disorders caused by deficiencies in sptm are treated by constructing mammalian expression vectors comprising sptm and introducing these vectors by mechanical means into sptm-deficient cells.
  • Mechanical transfer technologies for use with cells in vivo or ex vitro include (i) direct D ⁇ A microinjection into individual cells, (ii) ballistic gold particle delivery, (iii) liposome-mediated transfection, (iv) receptor-mediated gene transfer, and (v) the use of D ⁇ A transposons (Morgan, R.A. and Anderson, W.F. (1993) Annu. Rev. Biochem. 62:191- 217; Ivies, Z. (1997) Cell 91:501-510; Boulay, J-L. and Recipon, H (1998) Curr. Opin. Biotechnol. 9:445-450).
  • Expression vectors that may be effective for the expression of sptm include, but are not limited to, the PCD ⁇ A 3.1, EPITAG, PRCCMV2, PREP, PVAX vectors (Invitrogen, Carlsbad CA), PCMV-SCRIPT, PCMV-TAG, PEGSH/PERV (Stratagene, La Jolla CA), and PTET-OFF, PTET-O ⁇ , PTRE2, PTRE2-LUC, PTK-HYG (Clontech, Palo Alto CA).
  • the sptm of the invention maybe expressed using (i) a constitutively active promoter, (e.g., from cytomegalovirus (CMV), Rous sarcoma virus (RSV), SV40 virus, thymidine kinase (TK), or ⁇ -actin genes), (ii) an inducible promoter (e.g., the tetracycline-regulated promoter (Gossen, M. and Bujard, H. (1992) Proc. ⁇ atl. Acad. Sci. U.S.A. 89:5547-5551; Gossen, M. et al., (1995) Science 268:1766-1769; Rossi, F.M.V. and Blau, H.M.
  • a constitutively active promoter e.g., from cytomegalovirus (CMV), Rous sarcoma virus (RSV), SV40 virus, thymidine kinase (TK), or ⁇ -actin
  • TRANSFECTION KIT available from Invitrogen
  • transformation is performed using the calcium phosphate method (Graham, F.L. and Eb, A J. (1973) Virology 52:456-467), or by electroporation (Neumann, E. et al. (1982) EMBO J. 1 :841-845).
  • the introduction of DNA to primary cells involves modification of these standardized mammalian transfection protocols.
  • diseases or disorders caused by genetic defects with respect to sptm expression are treated by constructing a retiovirus vector consisting of (i) sptm under the control of an independent promoter or the retrovirus long terminal repeat (LTR) promoter, (ii) appropriate RNA packaging signals, and (iii) a Rev-responsive element (RRE) along with additional retrovirus cw-acting RNA sequences and coding sequences required for efficient vector propagation.
  • Retrovirus vectors e.g., PFB and PFBNEO
  • Retrovirus vectors are commercially available (Stratagene) and are based on published data (Riviere, I. et al. (1995) Proc. Natl. Acad. Sci. U.S.A.
  • the vector is propagated in an appropriate vector producing cell line (VPCL) that expresses an envelope gene with a tropism for receptors on the target cells or a promiscuous envelope protein such as VSVg (Armentano, D. et al. (1987) J. Virol. 61:1647-1650; Bender, M.A. et al. (1987) J. Virol. 61:1639-1646; Adam, M.A. and Miller, A.D. (1988) J. Virol. 62:3802-3806; Dull, T. et al. (1998) J. Virol. 72:8463-8471; Zufferey, R. et al. (1998) J.
  • VPCL vector producing cell line
  • U.S. Patent Number 5,910,434 to Rigg discloses a method for obtaining retrovirus packaging cell lines and is hereby incorporated by reference. Propagation of retrovirus vectors, transduction of a population of cells (e.g., CD4 + T-cells), and the return of transduced cells to a patient are procedures well known to persons skilled in the art of gene therapy and have been well documented (Ranga, U. et al. (1997) J. Virol. 71:7020-7029; Bauer, G. et al.
  • an adenovirus-based gene therapy delivery system is used to deliver sptm to cells which have one or more genetic abnormalities with respect to the expression of sptm.
  • the construction and packaging of adenovirus-based vectors are well known to those with ordinary skill in the art. Replication defective adenovirus vectors have proven to be versatile for importing genes encoding immunoregulatory proteins into intact islets in the pancreas (Csete, M.E. et al. (1995) Transplantation 27 :263-268). Potentially useful adenoviral vectors are described in U.S. Patent Number 5,707,618 to Armentano ("Adenovirus vectors for gene therapy”), hereby incorporated by reference.
  • herpes-based, gene therapy delivery system is used to deliver sptm to target cells which have one or more genetic abnormalities with respect to the expression of sptm.
  • HSV herpes simplex virus
  • herpes-based vectors are well known to those with ordinary skill in the art.
  • a replication-competent herpes simplex virus (HSV) type 1-based vector has been used to deliver a reporter gene to the eyes of primates (Liu, X. et al. (1999) Exp. Eye Res.l69:385-395).
  • the construction of a HSV-1 virus vector has also been disclosed in detail in U.S. Patent Number 5,804,413 to DeLuca ("Herpes simplex virus strains for gene transfer"), which is hereby incorporated by reference.
  • Patent Number 5,804,413 teaches the use of recombinant HSV d92 which consists of a genome containing at least one exogenous gene to be transferred to a cell under the control of the appropriate promoter for purposes including human gene therapy. Also taught by this patent are the construction and use of recombinant HSV strains deleted for ICP4, ICP27 and ICP22. For HSV vectors, see also Goins, W. F. et al. 1999 J. Virol. 73:519-532 and Xu, H. et al., (1994) Dev. Biol. 163:152-161, hereby incorporated by reference.
  • herpesvirus sequences The manipulation of cloned herpesvirus sequences, the generation of recombinant virus following the transfection of multiple plasmids containing different segments of the large herpesvirus genomes, the growth and propagation of herpesvirus, and the infection of cells with herpesvirus are techniques well known to those of ordinary skill in the art.
  • an alphavirus (positive, single-stranded RNA virus) vector is used to deliver sptm to target cells.
  • SFV Semliki Forest Virus
  • SFV Semliki Forest Virus
  • alphavirus infection is typically associated with cell lysis within a few days
  • BHK-21 hamster normal kidney cells
  • SIN Sindbis virus
  • the ability to establish a persistent infection in hamster normal kidney cells (BHK-21) with a variant of Sindbis virus (SIN) indicates that the lytic replication of alphaviruses can be altered to suit the needs of the gene therapy application (Dryga, S.A. et al. (1997) Virology 228:74-83).
  • the wide host range of alphaviruses will allow the introduction of sptm into a variety of cell types.
  • the specific transduction of a subset of cells in a population may require the sorting of cells prior to transduction.
  • the methods of manipulating infectious cDNA clones of alphaviruses, performing alphavirus cDNA and RNA transfections, and performing alphavirus infections, are well known to those with ordinary skill in the art.
  • Anti-SPTM antibodies may be used to analyze protein expression levels. Such antibodies include, but are not limited to, polyclonal, monoclonal, chimeric, single chain, and Fab fragments. For descriptions of and protocols of antibody technologies, see, e.g., Pound J.D. (1998) Immunochemical Protocols, Humana Press, Totowa, NJ.
  • amino acid sequence encoded by the sptm of the Sequence Listing may be analyzed by appropriate software (e.g., LASERGENE NAVIGATOR software, DNASTAR) to determine 5 regions of high immunogenicity.
  • appropriate software e.g., LASERGENE NAVIGATOR software, DNASTAR
  • the optimal sequences for immunization are selected from the C- terminus, the N-terminus, and those intervening, hydrophilic regions of the polypeptide which are likely to be exposed to the external environment when the polypeptide is in its natural conformation. Analysis used to select appropriate epitopes is also described by Ausubel (1997, supra. Chapter 11.7). Peptides used for antibody induction do not need to have biological activity; however, they should be o antigenic.
  • Peptides used to induce specific antibodies may have an amino acid sequence consisting of at least five amino acids, preferably at least 10 amino acids, and most preferably at least 15 amino acids.
  • a peptide which mimics an antigenic fragment of the natural polypeptide may be fused with another protein such as keyhole limpet hemocyanin (KLH; Sigma, St. Louis MO) for antibody production.
  • KLH keyhole limpet hemocyanin
  • a peptide encompassing ah antigenic region may be expressed from an sptm, synthesized 5 as described above, or purified from human cells.
  • mice, goats, and rabbits may be immunized by injection with a peptide.
  • various adjuvants maybe used to increase immunological response.
  • peptides about 15 residues in length maybe synthesized using an ABI 431 A 0 ' peptide synthesizer (Applied Biosystems) using frnoc-chemistry and coupled to KLH (Sigma) by reaction with M-maleimidobenzoyl-N-hydroxysuccinimide ester (Ausubel, 1995, supra).
  • Rabbits are immunized with the peptide-KLH complex in complete Freund's adjuvant.
  • the resulting antisera are tested for antipeptide activity by binding the peptide to plastic, blocking with 1% bovine serum albumin (BSA), reacting with rabbit antisera, washing, and reacting with radioiodinated goat anti-rabbit IgG.
  • BSA bovine serum albumin
  • Antisera with antipeptide activity are tested for anti-SPTM activity using protocols well known in the art, including ELISA, radioimmunoassay (RIA), and immunoblotting.
  • isolated and purified peptide may be used to immunize mice (about 100 ⁇ g of peptide) or rabbits (about 1 mg of peptide). Subsequently, the peptide is radioiodinated and used to screen the immunized animals' B-lymphocytes for production of antipeptide antibodies. Positive o cells are then used to produce hybridomas using standard techniques. About 20 mg of peptide is sufficient for labeling and screening several thousand clones. Hybridomas of interest are detected by screening with radioiodinated peptide to identify those fusions producing peptide-specific monoclonal antibody.
  • wells of a multi-well plate (FAST, Becton-Dickinson, Palo Alto, CA) are coated with affinity-purified, specific rabbit-anti-mouse (or suitable anti-species IgG) antibodies at 5 10 mg/ml.
  • the coated wells are blocked with 1% BSA and washed and exposed to supematants from hybridomas. After incubation, the wells are exposed to radiolabeled peptide at 1 mg/ml.
  • Clones producing antibodies bind a quantity of labeled peptide that is detectable above background. Such clones are expanded and subjected to 2 cycles of cloning. Cloned hybridomas are injected into pristane-treated mice to produce ascites, and monoclonal antibody is purified from the ascitic fluid by affinity chromatography on protein A (Amersham Pharmacia Biotech). Several procedures for the production of monoclonal antibodies, including in vitro production, are described in Pound (supra). Monoclonal antibodies with antipeptide activity are tested for anti-SPTM activity using protocols well known in the art, including ELISA, RIA, and immunoblotting.
  • Antibody fragments containing specific binding sites for an epitope may also be generated.
  • such fragments include, but are not limited to, the Ffab ⁇ fragments produced by pepsin digestion ofthe antibody molecule, and the Fab fragments generated by reducing the disulfide bridges ofthe F(ab')2 fragments.
  • construction of Fab expression libraries in filamentous bacteriophage allows rapid and easy identification of monoclonal fragments with desired specificity (Pound, supra, Chaps. 45-47).
  • Antibodies generated against polypeptide encoded by spt can be used to purify and characterize full-length SPTM protein and its activity, binding partners, etc.
  • Anti-SPTM antibodies may be used in assays to quantify the amount of SPTM found in a particular human cell. Such assays include methods utilizing the antibody and a label to detect expression level under normal or disease conditions.
  • the peptides and antibodies of the invention may be used with or without modification or labeled by joining them, either covalently or noncovalently, with a reporter molecule.
  • Protocols for detecting and measuring protein expression using either polyclonal or monoclonal antibodies are well known in the art. Examples include ELISA, RIA, and fluorescent activated cell sorting (FACS). Such immunoassays typically involve the formation of complexes between the SPTM and its specific antibody and the measurement of such complexes. These and other assays are described in Pound (supra).
  • RNA was purchased from CLONTECH Laboratories, Inc. (Palo Alto CA) or isolated from various tissues. Some tissues were homogenized and lysed in guanidinium isothiocyanate, while others were homogenized and lysed in phenol or in a suitable mixture of denaturants, such as TRIZOL (Life Technologies), a monophasic solution of phenol and guanidine isothiocyanate. The resulting lysates were centrifuged over CsCl cushions or extracted with chloroform. RNA was precipitated with either isopropanol or sodium acetate and ethanol, or by other routine methods. Phenol extraction and precipitation of RNA were repeated as necessary to increase RNA purity.
  • RNA was treated with DNase.
  • poly(A+) RNA was isolated using oligo d(T)-coupled paramagnetic particles (Promega Corporation (Promega), Madison WI), OLIGOTEX latex particles (QIAGEN, Inc. (QIAGEN), Valencia CA), or an OLIGOTEX mRNA purification kit (QIAGEN).
  • RNA was isolated directly from tissue lysates using other RNA isolation kits, e.g., the POLY(A)PURE mRNA purification kit (Ambion, Inc., Austin TX).
  • Stratagene was provided with RNA and constructed the co ⁇ esponding cDNA libraries. Otherwise, cDNA was synthesized and cDNA libraries were constructed with the UNIZAP vector system (Stratagene Cloning Systems, Inc. (Stratagene), La Jolla CA) or SUPERSCRIPT plasmid system (Life Technologies), using the recommended procedures or similar methods known in the art. (See, e.g., Ausubel, 1997, supra, Chapters 5.1 through 6.6.) Reverse transcription was initiated using oligo d(T) or random primers. Synthetic oligonucleotide adapters were ligated to double stranded cDNA, and the cDNA was digested with the appropriate restriction enzyme or enzymes.
  • the cDNA was size-selected (300-1000 bp) using SEPHACRYL S1000, SEPHAROSE CL2B, or SEPHAROSE CL4B column chromatography (Amersham Pharmacia Biotech) or preparative agarose gel electrophoresis.
  • cDNAs were ligated into compatible restriction enzyme sites of the polylinker of a suitable plasmid, e.g., PBLUESCRTPT plasmid (Stratagene), PSPORT1 plasmid (Life Technologies), PCDNA2.1 plasmid (Invitrogen, Carlsbad CA), PBK-CMV plasmid (Stratagene), PCR2-TOPOTA plasmid (Invitrogen), PCMV-ICIS plasmid (Stratagene), pIGEN (Incyte Genomics, Palo Alto CA), pRARE (Incyte Genomics), or pINCY (Incyte Genomics), or derivatives thereof.
  • Recombinant plasmids were transformed into competent E. coli cells including XLl-Blue, XLl-BlueMRF, or SOLR from Stratagene or DH5 ⁇ , DH10B, or ElectroMAX DH10B from Life Technologies.
  • Plasmids were recovered from host cells by in vivo excision using the UNIZAP vector system
  • Plasmids were purified using at least one of the following: the Magic or WIZARD Minipreps DNA purification system (Promega); the AGTC Miniprep purification kit (Edge BioSystems, Gaithersburg MD); and the QIAWELL 8, QIAWELL 8 Plus, and QIAWELL 8 Ultra plasmid purification systems or the R.E.A.L. PREP 96 plasmid purification kit (QIAGEN). Following 0 precipitation, plasmids were resuspended in 0.1 ml of distilled water and stored, with or without lyophilization, at 4°C
  • plasmid DNA was amplified from host cell lysates using direct link PCR in a high-throughput format.
  • Host cell lysis and thermal cycling steps were carried out in a single reaction mixture. Samples were processed and stored in 5 384-well plates, and the concentration of amplified plasmid DNA was quantified fluorometrically using PICOGREEN dye (Molecular Probes, Inc. (Molecular Probes), Eugene OR) and a FLUOROSKAN II fluorescence scanner (Labsystems Oy . Helsinki, Finland).
  • cDNA sequencing reactions were processed using standard methods or high-throughput instrumentation such as the ABI CATALYST 800 thermal cycler (Applied Biosystems) or the PTC- 200 thermal cycler (MJ Research) in conjunction with the HYDRA microdispenser (Robbins Scientific Corp., Sunnyvale CA) or the MICROLAB 2200 liquid transfer system (Hamilton).
  • cDNA sequencing reactions were prepared using reagents provided by Amersham Pharmacia Biotech or 5 supplied in ABI sequencing kits such as the ABI PRISM BIGDYE Terminator cycle sequencing ready reaction kit (Applied Biosystems).
  • Electrophoretic separation of cDNA sequencing reactions and detection of labeled polynucleotides were carried out using the MEGABACE 1000 DNA sequencing system (Molecular Dynamics); the ABI PRISM 373 or 377 sequencing system (Applied Biosystems) in conjunction with standard ABI protocols and base calling software; or other sequence o analysis systems known in the art. Reading frames within the cDNA sequences were identified using standard methods (reviewed in Ausubel, 1997, supra, Chapter 7.7). Some of the cDNA sequences were selected for extension using the techniques disclosed in Example VHL
  • sequences from chromatograms were subject to PHRED analysis and assigned a quality score.
  • the sequences having at least a required quality score were subject to various preprocessing editing pathways to eliminate, e.g., low quality 3 ' ends, vector and linker sequences, polyA tails, Alu repeats, mitochondrial and ribosomal sequences, bacterial contamination sequences, and sequences smaller than 50 base pairs.
  • low-information sequences and repetitive 5 elements e.g., dinucleotide repeats, Alu repeats, etc.
  • sequences were then subject to assembly procedures in which the sequences were assigned to gene bins (bins). Each sequence could only belong to one bin. Sequences in each gene bin were assembled to produce consensus sequences (templates). Subsequent new sequences were 0 added to existing bins using BLASTN (v.1.4 WashU) and CROSSMATCH. Candidate pairs were identified as all BLAST hits having a quality score greater than or equal to 150. Alignments of at least 82% local identity were accepted into the bin. The component sequences from each bin were assembled using a version of PHRAP. Bins with several overlapping component sequences were assembled using DEEP PHRAP.
  • each assembled template 5 was determined based on the number and orientation of its component sequences. Template sequences as disclosed in the sequence listing co ⁇ espond to sense strand sequences (the "forward" reading frames), to the best determination. The complementary (antisense) strands are inherently disclosed herein.
  • the component sequences which were used to assemble each template consensus sequence are listed in Table 3 by their positions along the template nucleotide sequences. o Bins were compared against each other and those having local similarity of at least 82% were combined and reassembled. Reassembled bins having templates of insufficient overlap (less than 95% local identity) were re-split.
  • Assembled templates were also subject to analysis by ST ⁇ TCHER/EXON MAPPER algorithms which analyze the probabilities of the presence of splice variants, alternatively spliced exons, splice junctions, differential expression of alternative spliced 5 genes across tissue types or disease states, etc. These resulting bins were subject to several rounds of the above assembly procedures.
  • bins were clone joined based upon clone information. If the 5' sequence of one clone was present in one bin and the 3' sequence from the same clone was present in a different bin, it was likely that the two bins actually o belonged together in a single bin. The resulting combined bins underwent assembly procedures to regenerate the consensus sequences.
  • the template sequences were further analyzed by translating each template in all three forward reading frames and searching each translation against the Pfam database of hidden Markov model-based protein families and domains using the HMMER software package (available to the public from Washington University School of Medicine, St. Louis MO). (See also World Wide Web site http://pfam.wustl.edu/for detailed descriptions of Pfam protein domains and families.)
  • the template sequences were translated in all three forward reading frames, and each translation was searched against hidden Markov models for signal peptides using the HMMER software package. Construction of hidden Markov models and their usage in sequence analysis has been described. (See, for example, Eddy, S.R. (1996) Curr. Opin. Str. Biol. 6:361-365.) Only those signal peptide hits with a cutoff score of 11 bits or greater are reported. A cutoff score of 11 bits or greater corresponds to at least about 91-94% true-positives in signal peptide prediction.
  • Template sequences were also translated in all three forward reading frames, and each translation was searched against TMHMMER, a program that uses a hidden Markov model (HMM) to delineate transmembrane segments on protein sequences and determine orientation (Sonnhammer, E.L. et al. (1998) Proc. Sixth Intl. Conf. On Intelligent Systems for Mol. Biol., Glasgow et al., eds., The Am. Assoc. for Artificial Intelligence (AAAI) Press, Menlo Park, CA, and MIT Press, Cambridge, MA, pp. 175-182.) Regions of templates which, when translated, contain similarity to signal peptide or transmembrane consensus sequences are reported in Table 2.
  • HMM hidden Markov model
  • Template sequences are further analyzed using the bioinformatics tools listed in Table 6, or using sequence analysis software known in the art such as MACDNASIS PRO software (Hitachi Software Engineering, South San Francisco CA) and LASERGENE software (DNASTAR). Template sequences may be further queried against public databases such as the GenBank rodent, mammalian, vertebrate, prokaryote, and eukaryote databases.
  • polypeptide sequences were translated to derive the corresponding longest open reading frame as presented by the polypeptide sequences as reported in Table 5.
  • a polypeptide of the invention may begin at any of the methionine residues within the full length translated polypeptide.
  • Polypeptide sequences were subsequently analyzed by querying against the GenBank protein database (GENPEPT, (GenBank version 128)).
  • Full length polynucleotide sequences are also analyzed using MACDNASIS PRO software (Hitachi Software Engineering, South San Francisco CA) and LASERGENE software (DNASTAR).
  • Polynucleotide and polypeptide sequence alignments are generated using default parameters specified by the CLUSTAL algorithm as incorporated into the MEGALIGN multisequence alignment program (DNASTAR), which also calculates the percent identity between aligned sequences.
  • Table 5 shows sequences with homology to the polypeptides of the invention as identified by BLAST analysis against the GenBank protein (GENPEPT) database.
  • Column 1 shows the polypeptide sequence identification number (SEQ ID NO:) for the polypeptide segments of the invention.
  • Column 2 shows the reading frame used in the translation of the polynucleotide sequences encoding the polypeptide segments.
  • Column 3 shows the length of the translated polypeptide segments.
  • Columns 4 and 5 show the start and stop nucleotide positions of the polynucleotide sequences encoding the polypeptide segments.
  • Column 6 shows the GenBank identification number (GI Number) of the nearest GenBank homolog.
  • Column 7 shows the probability score for the match between each polypeptide and its GenBank homolog.
  • Column 8 shows the annotation ofthe GenBank homolog.
  • Northern analysis is a laboratory technique used to detect the presence of a transcript of a gene and involves the hybridization of a labeled nucleotide sequence to a membrane on which RNAs from a particular cell type or tissue have been bound. (See, e.g., Sambrook, supra, ch. 7; Ausubel, 1995, supra, ch. 4 and 16.)
  • the product score takes into account both the degree of similarity between two sequences and the length ofthe sequence match.
  • the product score is a normalized value between 0 and 100, and is calculated as follows: the BLAST score is multiplied by the percent nucleotide identity and the product is divided by (5 times the length of the shorter of the two sequences).
  • the BLAST score is calculated by assigning a score of +5 for every base that matches in a high-scoring segment pair (HSP), and -4 for every mismatch. Two sequences may share more than one HSP (separated by gaps). If there is more than one HSP, then the pair with the highest BLAST score is used to calculate the product score.
  • the product score represents a balance between fractional overlap and quality in a BLAST alignment.
  • a product score of 100 is produced only for 100% identity over the entire length of the shorter of the two sequences being compared.
  • a product score of 70 is produced either by 100% identity and 70% overlap at one end, or by 88% identity and 100% overlap at the other.
  • a product score of 50 is produced either by 100% identity and 50% overlap at one end, or 79% identity and 100% overlap.
  • polynucleotide sequences encoding SPTM are analyzed with respect to the tissue sources from which they were derived.
  • Polynucleotide sequences encoding SPTM were assembled, at least in part, with overlapping Incyte cDNA sequences.
  • Each cDNA sequence is derived from a cDNA library constructed from a human tissue.
  • Each human tissue is classified into one of the following organ/tissue categories: cardiovascular system; connective tissue; digestive system; embryonic structures; endocrine system; exocrine glands; genitalia, female; genitalia, male; germ cells; hemic and immune system; liver; musculoskeletal system; nervous system; pancreas; respiratory system; sense organs; skin; stomatognathic system; unclassified/mixed; or urinary tract.
  • the number of libraries in each category for each polynucleotide sequence encoding SPTM is counted and divided by the total number of libraries across all categories for each polynucleotide sequence encoding SPTM.
  • each human tissue is classified into one of the following disease/condition categories: cancer, cell line, developmental, inflammation, neurological, trauma, cardiovascular, pooled, and other, and the number of libraries in each category for each polynucleotide sequence encoding SPTM is counted and divided by the total number of libraries across all categories for each polynucleotide sequence encoding SPTM. The resulting percentages reflect the tissue-specific and disease-specific expression of cDNA encoding SPTM. Percentage values of tissue-specific expression are reported in . cDNA sequences and cDNA library/tissue information are found in the LEPESEQ GOLD database (Incyte Genomics, Palo Alto CA). VI. Tissue Distribution Profiling
  • a tissue distribution profile is determined for each template by compiling the cDNA library tissue classifications of its component cDNA sequences.
  • Each component sequence is derived from a cDNA library constructed from a human tissue.
  • Each human tissue is classified into one of the 5 following categories: cardiovascular system; connective tissue; digestive system; embryonic structures; endocrine system; exocrine glands; genitalia, female; genitalia, male; germ cells; hemic and immune system; liver; musculoskeletal system; nervous system; pancreas; respiratory system; sense organs; skin; stomatognathic system; unclassified/mixed; or urinary tract.
  • Template sequences, component sequences, and cDNA library/tissue information are found in the LIFESEQ GOLD 0 database (Incyte Genomics, Palo Alto CA). shows the tissue distribution profile for the templates of the invention. For each template, the three most frequently observed tissue categories are shown in column 2, along with the percentage of component sequences belonging to each category. Only tissue categories with percentage values of ⁇ 10% are shown. A tissue distribution of "widely distributed" in column 2 indicates percentage values 5 of ⁇ 10% in all tissue categories.
  • Transcript images are generated as described in Seilhamer et al., "Comparative Gene Transcript Analysis," U.S. Patent Number 5,840,484, incorporated herein by reference. 0
  • Oligonucleotide primers designed using an sptm ofthe Sequence Listing are used to extend the nucleic acid sequence.
  • One primer is synthesized to initiate 5' extension of the template, and the other primer, to initiate 3' extension ofthe template.
  • the initial primers maybe designed using OLIGO 5 4.06 software (National Biosciences, Inc. (National Biosciences), Plymouth MN), or another appropriate program, to be about 22 to 30 nucleotides in length, to have a GC content of about 50% or more, and to anneal to the target sequence at temperatures of about 68 °C to about 72 °C. Any stretch of nucleotides which would result in hairpin structures and primer-primer dimerizations are avoided.
  • Selected human cDNA libraries are used to extend the sequence. If more than one o extension is necessary or desired, additional or nested sets of primers are designed.
  • PCR is performed in 96-well plates using the PTC-200 thermal cycler (MJ Research).
  • the reaction mix contains DNA template, 200 nmol of each primer, reaction buffer containing Mg 2+ , (NH ⁇ SO.*., and ⁇ - mercaptoethanol, Taq DNA polymerase (Amersham Pharmacia Biotech), ELONGASE enzyme (Life 5 Technologies), and Pfu DNA polymerase (Stratagene), with the following parameters for primer pair PCI A and PCI B: Step 1: 94°C, 3 min; Step 2: 94°C, 15 sec; Step 3: 60°C, 1 min; Step 4: 68 °C, 2 min; Step 5: Steps 2, 3, and 4 repeated 20 times; Step 6: 68°C, 5 min; Step 7: storage at 4°C
  • the parameters for primer pair T7 and SK+ are as follows: Step 1: 94 °C, 3 min; Step 2: 94°C, 15
  • the concentration of DNA in each well is determined by dispensing 100 ⁇ l PICOGREEN quantitation reagent (0.25% (v/v); Molecular Probes) dissolved in IX Tris-EDTA (TE) and 0.5 ⁇ l of undiluted PCR product into each well of an opaque fluorimeter plate (Corning Incorporated (Corning), Corning NY), allowing the DNA to bind to the reagent.
  • the plate is scanned in a ELUOROSKAN II (Labsystems Oy) to measure the fluorescence ofthe sample and to quantify the concentration of
  • a 5 ⁇ l to 10 ⁇ l aliquot ofthe reaction mixture is analyzed by electrophoresis on a 1 % agarose mini-gel to determine which reactions are successful in extending the sequence.
  • the extended nucleotides are desalted and concentrated, transfe ⁇ ed to 384-well plates, digested with CviJI cholera virus endonuclease (Molecular Biology Research, Madison WI), and sonicated or sheared prior to religation into pUC 18 vector (Amersham Pharmacia Biotech).
  • CviJI cholera virus endonuclease Molecular Biology Research, Madison WI
  • sonicated or sheared prior to religation into pUC 18 vector
  • the digested nucleotides are separated on low concentration (0.6 to 0.8%) agarose gels, fragments are excised, and agar digested with AGAR ACE (Promega).
  • Extended clones are religated using T4 ligase (New England Biolabs, Inc., Beverly MA) into pUC 18 vector (Amersham Pharmacia Biotech), treated with Pfu DNA polymerase (Stratagene) to fill-in restriction site overhangs, and transfected into competent E. coli cells. Transformed cells are selected on antibiotic-containing media, individual colonies are picked and cultured overnight at 37 °C in 384-well plates in LB/2x carbenicillin liquid media.
  • the cells are lysed, and DNA is amplified by PCR using Taq DNA polymerase (Amersham Pharmacia Biotech) and Pfu DNA polymerase (Stratagene) with the following parameters: Step 1: 94°C, 3 min; Step 2: 94°C, 15 sec; Step 3: 60°C, 1 min; Step 4: 72°C, 2 min; Step 5: steps 2, 3, and 4 repeated 29 times; Step 6: 72 °C, 5 min; Step 7: storage at 4°C DNA is quantified by PICOGREEN reagent (Molecular Probes) as described above. Samples with low DNA recoveries are reamplified using the same conditions as described above.
  • Samples are diluted with 20% dimethysulfoxide (1:2, v/v), and sequenced using DYENAMIC energy transfer sequencing primers and the DYENAMIC DIRECT kit (Amersham Pharmacia Biotech) or the ABI PRISM BIGDYE Terminator cycle sequencing ready reaction kit (Applied Biosystems).
  • the sptm is used to obtain regulatory sequences (promoters, introns, and enhancers) using the procedure above, oligonucleotides designed for such extension, and an appropriate genomic library.
  • Hybridization probes derived from the sptm of the Sequence Listing are employed for screening cDNAs, mRNAs, or genomic DNA.
  • the labeling of probe nucleotides between 100 and 1000 nucleotides in length is specifically described, but essentially the same procedure may be used with larger cDNA fragments.
  • Probe sequences are labeled at room temperature for 30 minutes using a T4 polynucleotide kinase, ⁇ 32 P-ATP, and 0.5X One-Phor-All Plus (Amersham Pharmacia Biotech) buffer and purified using a ProbeQuant G-50 Microcolumn (Amersham Pharmacia Biotech).
  • the probe mixture is diluted to 10 7 dpm/ ⁇ g/ml hybridization buffer and used in a typical membrane-based hybridization analysis.
  • the DNA is digested with a restriction endonuclease such as Eco RV and is electrophoresed through a 0.7% agarose gel.
  • the DNA fragments are transferred from the agarose to nylon membrane (NYTRAN Plus, Schleicher & Schuell, Inc., Keene NH) using procedures specified by the manufacturer of the membrane.
  • Prehybridization is carried out for three or more hours at 68 °C, and hybridization is carried out overnight at 68 °C
  • blots are sequentially washed at room temperature under increasingly stringent conditions, up to 0.
  • RNA lx saline sodium citrate (SSC) and 0.5% sodium dodecyl sulfate. After the blots are placed in a PHOSPHORIMAGER cassette (Molecular Dynamics) or are exposed to autoradiography film, hybridization patterns of standard and experimental lanes are compared. Essentially the same procedure is employed when screening RNA.
  • the cDNA sequences which were used to assemble SEQ ID NO:l-567 are compared with sequences from the Incyte LIFESEQ database and public domain databases using BLAST and other implementations of the Smith- Waterman algorithm. Sequences from these databases that match SEQ ID NO: 1-567 are assembled into clusters of contiguous and overlapping sequences using assembly algorithms such as PHRAP (Table 6). Radiation hybrid and genetic mapping data available from public resources such as the Stanford Human Genome Center (SHGC), Whitehead Institute for Genome Research (WIGR), and Genethon are used to determine if any ofthe clustered sequences have been previously mapped.
  • SHGC Stanford Human Genome Center
  • WIGR Whitehead Institute for Genome Research
  • Genethon Genethon
  • a mapped sequence in a cluster will result in the assignment of all sequences of that cluster, including its particular SEQ ID NO:, to that map location.
  • the genetic map locations of SEQ ID NO:l-567 are described as ranges, or intervals, of human chromosomes.
  • the map position of an interval, in centiMorgans, is measured relative to the terminus ofthe chromosome's p-arm.
  • centiMorgan (cM) is a unit of measurement based on recombination frequencies between chromosomal markers.
  • cM is roughly equivalent to 1 megabase (Mb) of DNA in humans, although this can vary widely due to hot and cold spots of recombination.
  • Mb megabase
  • the cM distances are based on genetic markers mapped by Genethon which provide boundaries for radiation hybrid markers whose sequences were included in each ofthe clusters.
  • Total RNA is isolated from tissue samples using the guanidinium thiocyanate method and polyA + RNA is purified using the oligo (dT) cellulose method.
  • Each polyA + RNA sample is reverse transcribed using MMLV reverse-transcriptase, 0.05 pg/ ⁇ l oligo-dT primer (21mer), IX first strand buffer, 0.03 units/ ⁇ l RNase inhibitor, 500 ⁇ M dATP, 500 ⁇ M dGTP, 500 ⁇ M dTTP, 40 ⁇ M dCTP, 40 0 ⁇ M dCTP-Cy3 (BDS) or dCTP-Cy5 (Amersham Pharmacia Biotech).
  • the reverse transcription reaction is performed in a 25 ml volume containing 200 ng polyA + RNA with GEMBRIGHT kits (Incyte).
  • Specific control polyA + RNAs are synthesized by in vitro transcription from non-coding yeast genomic DNA (W. Lei, unpublished).
  • the control mRNAs at 0.002 ng, 0.02 ng, 0.2 ng, and 2 ng are diluted into reverse transcription reaction at ratios of 1:100,000, 1:10,000, 5 1:1000, 1:100 (w/w) to sample mRNA respectively.
  • the control mRNAs are diluted into reverse transcription reaction at ratios of 1:3, 3:1, 1:10, 10:1, 1:25, 25:1 (w/w) to sample mRNA differential expression patterns.
  • each reaction sample (one with Cy3 and another with Cy5 labeling) is treated with 2.5 ml of 0.5M sodium hydroxide and incubated for 20 minutes at 85° C to the stop the reaction and degrade the RNA.
  • Probes are purified using two o successive CHROMA SPIN 30 gel filtration spin columns (CLONTECH Laboratories, Inc.
  • reaction samples are ethanol precipitated using 1 ml of glycogen (1 mg/ml), 60 ml sodium acetate, and 300 ml of 100% ethanol.
  • the probe is then dried to completion using a SpeedVAC (Savant Instruments Inc., Holbrook NY) and resuspended in 14 ⁇ l 5X SSC/0.2% SDS. 5
  • Sequences of the present invention are used to generate a ⁇ ay elements.
  • Each a ⁇ ay element is amplified from bacterial cells containing vectors with cloned cDNA inserts.
  • PCR amplification uses primers complementary to the vector sequences flanking the cDNA insert.
  • Array elements are o amplified in thirty cycles of PCR from an initial quantity of 1-2 ng to a final quantity greater than 5 ⁇ g.
  • Amplified a ⁇ ay elements are then purified using SEPHACRYL-400 (Amersham Pharmacia Biotech).
  • Purified a ⁇ ay elements are immobilized on polymer-coated glass slides.
  • Glass microscope slides (Corning) are cleaned by ultrasound in 0.1% SDS and acetone, with extensive distilled water washes between and after treatments.
  • Glass slides are etched in 4% hydrofluoric acid (VWR 5 Scientific Products Corporation (VWR), West Chester, PA), washed extensively in distilled water, and coated with 0.05% aminopropyl silane (Sigma) in 95% ethanol. Coated slides are cured in a 110°C oven.
  • Array elements are applied to the coated glass substrate using a procedure described in US Patent No. 5,807,522, incorporated herein by reference.
  • 1 ⁇ l of the a ⁇ ay element DNA, at an average 5 concentration of 100 ng/ ⁇ l, is loaded into the open capillary printing element by a high-speed robotic apparatus.
  • the apparatus then deposits about 5 nl of a ⁇ ay element sample per slide.
  • Microarrays are UV-crosslinked using a STRATALINKER UN-crosslihker (Stratagene). Microa ⁇ ays are washed at room temperature once in 0.2% SDS and three times in distilled water. Non-specific binding sites are blocked by incubation of microarrays in 0.2% casein in phosphate o buffered saline (PBS) (Tropix, Inc., Bedford, MA) for 30 minutes at 60° C followed by washes in 0.2% SDS and distilled water as before.
  • PBS phosphate o buffered saline
  • Hybridization reactions contain 9 ⁇ l of probe mixture consisting of 0.2 ⁇ g each of Cy3 and Cy5 5 labeled cDNA synthesis products in 5X SSC, 0.2% SDS hybridization buffer.
  • the probe mixture is heated to 65° C for 5 minutes and is aliquoted onto the microarray surface and covered with an 1.8 cm 2 coverslip.
  • the arrays are transfe ⁇ ed to a waterproof chamber having a cavity just slightly larger than a microscope slide.
  • the chamber is kept at 100% humidity internally by the addition of 140 ⁇ l of 5x SSC in a co er of the chamber.
  • the chamber containing the arrays is incubated for about 6.5 0 hours at 60° C.
  • the arrays are washed for 10 min at 45°C in a first wash buffer (IX SSC, 0.1% SDS), three times for 10 minutes each at 45° C in a second wash buffer (0.1X SSC), and dried.
  • Reporter-labeled hybridization complexes are detected with a microscope equipped with an 5 Innova 70 mixed gas 10 W laser (Coherent, Inc., Santa Clara CA) capable of generating spectral lines at 488 nm for excitation of Cy3 and at 632 nm for excitation of Cy5.
  • the excitation laser light is focused on the a ⁇ ay using a 20X microscope objective (Nikon, Inc., Melville NY).
  • the slide containing the a ⁇ ay is placed on a computer-controlled X-Y stage on the microscope and raster- scanned past the objective.
  • the 1.8 cm x 1.8 cm array used in the present example is scanned with a o resolution of 20 micrometers.
  • a mixed gas multiline laser excites the two fluorophores sequentially. Emitted light is split, based on wavelength, into two photomultiplier tube detectors (PMT R1477, Hamamatsu Photonics Systems, Bridgewater NJ) co ⁇ esponding to the two fluorophores. Appropriate filters positioned between the array and the photomultiplier tubes are used to filter the signals.
  • the 5 emission maxima of the fluorophores used are 565 nm for Cy3 and 650 nm for Cy5. Each a ⁇ ay is typically scanned twice, one scan per fluorophore using the appropriate filters at the laser source, although the apparatus is capable of recording the spectra from both fluorophores simultaneously.
  • the sensitivity of the scans is typically calibrated using the signal intensity generated by a cDNA control species added to the probe mix at a known concentration.
  • a specific location on the 5 a ⁇ ay contains a complementary DNA sequence, allowing the intensity of the signal at that location to be co ⁇ elated with a weight ratio of hybridizing species of 1:100,000.
  • the calibration is done by labeling samples ofthe calibrating cDNA with the two fluorophores and adding i o identical amounts of each to the hybridization mixture.
  • the output ofthe photomultiplier tube is digitized using a 12-bit RTT-835H analog-to-digital (A/D) conversion board (Analog Devices, Inc., Norwood, MA) installed in an IBM-compatible PC computer.
  • the digitized data are displayed as an image where the signal intensity is mapped using a linear 20-color transformation to a pseudocolor scale ranging from blue (low signal) to red (high 15 signal).
  • the data is also analyzed quantitatively. Where two different fluorophores are excited and measured simultaneously, the data are first co ⁇ ected for optical crosstalk (due to overlapping emission spectra) between the fluorophores using each fluorophore's emission spectrum.
  • a grid is superimposed over the fluorescence signal image such that the signal from each spot is centered in each element of the grid.
  • the fluorescence signal within each element is then
  • the software used for signal analysis is the GEMTOOLS gene expression analysis program (Incyte).
  • Sequences complementary to the sptm are used to detect, decrease, or inhibit expression of 25 the naturally occurring nucleotide.
  • the use of oligonucleotides comprising from about 15 to 30 base pairs is typical in the art. However, smaller or larger sequence fragments can also be used.
  • Appropriate oligonucleotides are designed from the sptm using OLIGO 4.06 software (National Biosciences) or other appropriate programs and are synthesized using methods standard in the art or ordered from a commercial supplier. To inhibit transcription, a complementary oligonucleotide is
  • a complementary oligonucleotide is designed to prevent ribosomal binding and processing ofthe transcript.
  • SPTM expression and purification of SPTM is accomplished using bacterial or virus-based expression systems.
  • cDNA is subcloned into an appropriate vector containing an antibiotic resistance gene and an inducible promoter that directs high levels of cDNA transcription.
  • promoters include, but are not limited to, the trp-lac (tad) hybrid promoter and the T5 or T7 bacteriophage promoter in conjunction with the lac operator regulatory element.
  • Recombinant vectors are transformed into suitable bacterial hosts, e.g., BL21(DE3).
  • Antibiotic resistant bacteria express SPTM upon induction with isopropyl beta-D- thiogalactopyranoside (IPTG).
  • SPTM in eukaryotic cells is achieved by infecting insect or mammalian cell lines with recombinant Autographica californica nuclear polyhedrosis virus (AcMNPV), commonly known as baculovirus.
  • AcMNPV Autographica californica nuclear polyhedrosis virus
  • the nonessential polyhedrin gene of baculovirus is replaced with cDNA encoding SPTM by either homologous recombination or bacterial-mediated transposition involving transfer plasmid intermediates. Viral infectivity is maintained and the strong polyhedrin promoter drives high levels of cDNA transcription.
  • Recombinant baculovirus is used to infect Spodoptera frugiperda (Sf9) insect cells in most cases, or human hepatocytes, in some cases. Infection of the latter requires additional genetic modifications to baculovirus. (See e.g., Engelhard, supra; and Sandig, supra.)
  • SPTM is synthesized as a fusion protein with, e.g., glutathione S- transferase (GST) or a peptide epitope tag, such as FLAG or 6-His, permitting rapid, single-step, affinity-based purification of recombinant fusion protein from crude cell lysates.
  • GST glutathione S- transferase
  • a peptide epitope tag such as FLAG or 6-His
  • FLAG an 8-amino acid peptide
  • 6-His a stretch of six consecutive histidine residues, enables purification on metal-chelate resins (QIAGEN). Methods for protein expression and purification are discussed in Ausubel (1995, supra. Chapters 10 and 16). Purified SPTM obtained by these methods can be used directly in the following activity assay.
  • XIV. Demonstration of SPTM Activity An assay for SPTM activity measures the expression of SPTM on the cell surface.
  • cDNA encoding SPTM is subcloned into an appropriate mammalian expression vector suitable for high levels of cDNA expression.
  • the resulting construct is transfected into a nonhuman cell line such as NTH3T3.
  • Cell surface proteins are labeled with biotin using methods known in the art.
  • Immunoprecipitations are performed using SPTM-specific antibodies, and immunoprecipitated samples are analyzed using SDS-PAGE and immunoblotting techniques. The ratio of labeled immunoprecipitant to unlabeled immunoprecipitant is proportional to the amount of SPTM expressed on the cell surface.
  • an assay for SPTM activity measures the amount of SPTM in secretory, membrane-bound organelles.
  • Transfected cells as described above are harvested and lysed.
  • the lysate is fractionated using methods known to those of skill in the art, for example, sucrose gradient ultracentrifugation. Such methods allow the isolation of subcellular components such as the Golgi apparatus, ER, small membrane-bound vesicles, and other secretory organelles.
  • Immunoprecipitations from fractionated and total cell lysates are performed using SPTM-specific antibodies, and immunoprecipitated samples are analyzed using SDS-PAGE and immunoblotting techniques.
  • the concentration of SPTM in secretory organelles relative to SPTM in total cell lysate is proportional to the amount of SPTM in transit through the secretory pathway.
  • SPTM function is assessed by expressing sptm at physiologically elevated levels in mammalian cell culture systems.
  • cDNA is subcloned into a mammalian expression vector containing a strong promoter that drives high levels of cDNA expression.
  • Vectors of choice include pCMV SPORT (Life Technologies) and pCR3.1 (Invitrogen Corporation, Carlsbad CA), both of which contain the cytomegalovirus promoter.
  • 5-10 ⁇ g of recombinant vector are transiently transfected into a human cell line, preferably of endothelial or hematopoietic origin, using either liposome formulations or electroporation.
  • 1-2 ⁇ g of an additional plasmid containing sequences encoding a marker protein are co-transfected.
  • marker protein provides a means to distinguish transfected cells from nontransfected cells and is a reliable predictor of cDNA expression from the recombinant vector.
  • Marker proteins of choice include, e.g., Green Fluorescent Protein (GFP; CLONTECH), CD64, or a CD64-GFP fusion protein.
  • FCM Flow cytometry
  • FCM detects and quantifies the uptake of fluorescent molecules that diagnose events preceding or coincident with cell death. These events include changes in nuclear DNA content as measured by staining of DNA with propidium iodide; changes in cell size and granularity as measured by forward light scatter and 90 degree side light scatter; down-regulation of DNA synthesis as measured by decrease in bromodeoxyuridine uptake; alterations in expression of cell surface and intracellular proteins as measured by reactivity with specific antibodies; and alterations in plasma membrane composition as measured by the binding of fluorescein-conjugated Annexin V protein to the cell surface. Methods in flow cytometry are discussed in Ormerod, M. G. (1994) Flow Cytometry. Oxford, New York NY.
  • the influence of SPTM on gene expression can be assessed using highly purified populations of cells transfected with sequences encoding SPTM and either CD64 or CD64-GFP.
  • CD64 and CD64-GFP are expressed on the surface of transfected cells and bind to conserved regions of human immunoglobulin G (IgG).
  • Transfected cells are efficiently separated from nontransfected cells using magnetic beads coated with either human IgG or antibody against CD64 (DYNAL, Inc., Lake Success NY).
  • mRNA can be purified from the cells using methods well known by those of skill in the art. Expression of mRNA encoding SPTM and other genes of interest can be analyzed by northern analysis or microarray techniques.
  • SPTM substantially purified using polyacrylamide gel electrophoresis (PAGE; see, e.g., Harrington, M.G. (1990) Methods Enzymol. 182:488-495), or other purification techniques, can be used to immunize rabbits and to produce antibodies using standard protocols.
  • PAGE polyacrylamide gel electrophoresis
  • the SPTM amino acid sequence is analyzed using LASERGENE software
  • peptides 15 residues in length are synthesized using an ABI 431 A peptide synthesizer (Applied Biosystems) using fmoc-chemistry and coupled to KLH (Sigma) by reaction with N-maleiimdobenzoyl-N-hydroxysuccinimide ester (MBS) to increase immunogenicity.
  • Rabbits are immunized with the peptide-KLH complex in complete Freund's adjuvant. Resulting antisera are tested for antipeptide activity by, for example, binding the peptide to plastic, blocking with 1% BSA, reacting with rabbit antisera, washing, and reacting with radioiodinated goat anti-rabbit IgG. Antisera with antipeptide activity are tested for anti-SPTM activity using protocols well known in the art, including ELISA, RIA, and immunoblotting.
  • Naturally occurring or recombinant SPTM is substantially purified by immunoaffinity chromatography using antibodies specific for SPTM.
  • An knmunoaffinity column is constructed by covalently coupling anti-SPTM antibody to an activated chromatographic resin, such as CNBr-activated SEPHAROSE (Amersham Pharmacia Biotech). After the coupling, the resin is blocked and washed according to the manufacturer's instructions. Media containing SPTM are passed over the immunoaffinity column, and the column is washed under conditions that allow the preferential absorbance of SPTM (e.g., high ionic strength buffers in the presence of detergent).
  • the column is eluted under conditions that disrupt antibody/SPTM binding (e.g., a buffer of pH 2 to pH 3, or a high concentration of a chaotrope, such as urea or thiocyanate ion), and SPTM is collected.
  • disrupt antibody/SPTM binding e.g., a buffer of pH 2 to pH 3, or a high concentration of a chaotrope, such as urea or thiocyanate ion
  • SPTM or biologically active fragments thereof, are labeled with 125 I Bolton-Hunter reagent.
  • Bolton-Hunter reagent See, e.g., Bolton, A.E. and W.M. Hunter (1973) Biochem. J. 133:529-539.
  • Candidate molecules previously arrayed in the wells of a multi-well plate are incubated with the labeled SPTM, washed, and any wells with labeled SPTM complex are assayed. Data obtained using different concentrations of SPTM are used to calculate values for the number, affinity, and association of SPTM with the candidate molecules.
  • molecules interacting with SPTM are analyzed using the yeast two-hybrid system as described in Fields, S. and O. Song (1989) Nature 340:245-246, or using commercially available kits based on the two-hybrid system, such as the MATCHMAKER system (CLONTECH).
  • SPTM may also be used in the PATHCALLTNG process (CuraGen Corp., New Haven CT) which employs the yeast two-hybrid system in a high-throughput manner to determine all interactions between the proteins encoded by two large libraries of genes (Nandabalan, K. et al. (2000) U.S. Patent No. 6,057,101).
  • LG:1138554.16:2001MAR30 1 227 forward 3 TM Non-Cytbsolic 3 LG:1138554.16:2001MAR30 228 250 forward 3 TM Transmembrane 3 LG: 1138554.16.-2001MAR30 251 256 forward 3 TM Cytosolic 3 LG:1138554.16:2001MAR30 257 279 forward 3 TM Transmembrane 3 LG:1138554.16:2001MAR30 280 293 forward 3 TM Non-Cytosolic 3 LG:1138554.16:2001MAR30 294 316 forward 3 TM Transmembrane
  • LG:1397614.15:2001MAR30 1 forward 1 TM Cytosolic 5 LG:1397614.15:2001MAR30 2 21 forward 1 TM Transmembrane 5 LG: 1397614.15:2001MAR30 22 35 forward 1 TM Non-Cytosolic 5 LG:1397614.15:2001MAR30 36 58 forward 1 TM Transmembrane 5 LG:1397614.15:2001MAR30 59 193 forward 1 TM Cytosolic 5 LG: 1397614.15:2001MAR30 194 216 forward 1 TM Transmembrane 5 LG:1397614.15:2001MAR30 217 225 forward 1 TM Non-Cytosolic 5 LG:1397614.15:2001MAR30 226 243 forward 1 TM Transmembrane TABLE 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The invention provides purified secretory polynucleotides (sptm). Also encompassed are the polypeptides (SPTM) encoded by sptm. The invention also provides for the use of sptm, or complements, oligonucleotides, or fragments thereof in diagnostic assays. The invention further provides for vectors and host cells containing sptm for the expression of SPTM. The invention additionally provides for the use of isolated and purified SPTMto induce antibodies and to screen libraries of compounds and the use of anti-SPTM antibodies in diagnostic assays. Also provided are microarrays containing sptm and methods of use.

Description

SECRETORY MOLECULES
TECHNICAL FIELD The present invention relates to secretory molecules and to the use of these sequences in the diagnosis, study, prevention, and treatment of diseases associated with, as well as effects of exogenous compounds on, the expression of secretory molecules.
BACKGROUND OF THE INVENTION Both protein transport and secretion are involved in cellular function. Protein transport is mediated by a signal peptide located at the amino terminus of the protein to be transported or secreted. The signal peptide is comprised of about ten to twenty hydrophobic amino acids which target the nascent protein from the riboso e to a particular membrane bound compartment such as the endoplasmic reticulum (ER). Proteins targeted to the ER may either proceed through the secretory pathway or remain in any of the secretory organelles such as the ER, Golgi apparatus, or lysosomes. Proteins that transit through the secretory pathway are either secreted into the extracellular space or retained in the plasma membrane. Proteins that are retained in the plasma membrane contain one or more transmembrane domains, each comprised of about 20 hydrophobic amino acid residues. Proteins that are secreted from the cell are generally synthesized as inactive precursors that are activated by post-translational processing events during transit through the secretory pathway. Such events include glycosylation, proteolysis, and removal of the signal peptide by a signal peptidase. Other events that may occur during protein transport include chaperone-dependent unfolding and folding of he nascent protein and interaction of the protein with a receptor or pore complex. Examples of secretory proteins with amino terminal signal peptides are discussed below and include proteins with important roles in cell-to-cell signaling. Such proteins include transmembrane receptors and cell surface markers, extracellular matrix molecules, cytokines, hormones, growth and differentiation factors, neuropeptides, vasomediators, ion channels, transporters/pumps, and proteases. (Reviewed in Alberts, B. et al. (1994) Molecular Biology of The Cell. Garland Publishing, New York NY, pp. 557-560, 582-592.) G-protein coupled receptors (GPCRs) comprise a superfamily of integral membrane proteins which transduce extracellular signals. Not all GPCRs contain N-terminal signal peptides. GPCRs include receptors for biogenic amines such as dopamine, epinephrine, histamine, glutamate (metabotropic-type), acetylcholine (muscarinic-type), and serotonin; for lipid mediators of inflammation such as prostaglandins, platelet activating factor, and leukotrienes; for peptide hormones such as calcitonin, C5a anaphylatoxin, follicle stimulating hormone, gonadotropin releasing hormone, neurokinin, oxytocin, and thrombin; and for sensory signal mediators such as retinal photopigments and olfactory stimulatory molecules. The structure of these highly conserved receptors consists of seven hydrophobic transmembrane regions, cysteine disulfide bridges between the second and third extracellular loops, an extracellular N-terminus, and a cytoplasmic C-terminus. The N-terminus interacts with ligands, the disulfide bridges interact with agonists and antagonists, and the large third intracellular loop interacts with G proteins to activate second messengers such as cyclic AMP, phospholipase C, inositol triphosphate, or ion channels. (Reviewed in Watson, S. and Arkinstall, S. (1994) The G-protein Linked Receptor Facts Book. Academic Press, San Diego CA, pp. 2-6; and Bolander, F.F. (1994) Molecular Endocrinology, Academic Press, San Diego CA, pp. 162-176.) Other types of receptors include cell surface antigens identified on leukocytic cells of he immune system. These antigens have been identified using systematic, monoclonal antibody (mAb)- based "shot gun" techniques. These techniques have resulted in the production of hundreds of mAbs directed against unknown cell surface leukocytic antigens. These antigens have been grouped into "clusters of differentiation" based on common immunocytochemical localization patterns in various differentiated and undifferentiated leukocytic cell types. Antigens in a given cluster are presumed to identify a single cell surface protein and are assigned a "cluster of differentiation" or "CD" designation. Some of the genes encoding proteins identified by CD antigens have been cloned and verified by standard molecular biology techniques. CD antigens have been characterized as both transmembrane proteins and cell surface proteins anchored to the plasma membrane via covalent attachment to fatty acid-containing glycolipids such as glycosylphosphatidylinositol (GPI). (Reviewed in Barclay, A.N. et al. (1995) The Leucocyte Antigen Facts Book, Academic Press, San Diego CA, pp. 17-20.)
Matrix proteins (MPs) are transmembrane and extracellular proteins which function in formation, growth, remodeling, and maintenance of tissues and as important mediators and regulators of the inflammatory response. The expression and balance of MPs may be perturbed by biochemical changes that result from congenital, epigenetic, or infectious diseases. In addition, MPs affect leukocyte migration, proliferation, differentiation, and activation in the immune response. MPs are frequently characterized by the presence of one or more domains which may include collagen-like domains, EGF-like domains, immunoglobulin-like domains, and fibronectin-like domains, hi addition, MPs may be heavily glycosylated and may contain an Arginine-Glycine- Aspartate (RGD) tripeptide motif which may play a role in adhesive interactions. MPs include extracellular proteins such as fibronectin, collagen, galectin, vitronectin and its proteolytic derivative somatomedin B; and cell adhesion receptors such as cell adhesion molecules (CAMs), cadherins, and integrins. (Reviewed in Ayad, S. et al. (1994) The Extracellular Matrix Facts Book, Academic Press, San Diego CA, pp. 2- 16; Ruoslahti, E. (1997) Kidney Int. 51:1413-1417; Sjaastad, M.D. and Nelson, WJ. (1997) BioEssays 19:47-55.)
Cytokines are secreted by hematopoietic cells in response to injury or infection. Interleukins, neurotrophins, growth factors, interferons, and chemokines all define cytokine families that work in conjunction with cellular receptors to regulate cell proliferation and differentiation. In addition, cytokines effect activities such as leukocyte migration and function, hematopoietic cell proliferation, temperature regulation, acute response to infection, tissue remodeling, and apoptosis.
Chemokines, in particular, are small chemoattractant cytokines involved in inflammation, leukocyte proliferation and migration, angiogenesis and angiostasis, regulation of hematopoiesis, HIV infectivity, and stimulation of cytokine secretion. Chemokines generally contain 70-100 amino acids and are subdivided into four subfamilies based on the presence of conserved cysteine-based motifs. (Caϊlard, R. and Gearing, A. (1994) The Cytokine Facts Book, Academic Press, New York NY, pp. 181-190, 210-213, 223-227.)
Growth and differentiation factors are secreted proteins which function in intercellular communication. Some factors require oligomerization or association with MPs for activity. Complex interactions among these factors and their receptors trigger intracellular signal transduction pathways that stimulate or inhibit cell division, cell differentiation, cell signaling, and cell motility. Most growth and differentiation factors act on cells in their local environment (paracrine signaling). There are three broad classes of growth and differentiation factors. The first class includes the large polypeptide growth factors such as epidermal growth factor, fibroblast growth factor, transforming growth factor, insulin-like growth factor, and platelet-derived growth factor. The second class includes the hematopoietic growth factors such as the colony stimulating factors (CSFs). Hematopoietic growth factors stimulate the proliferation and differentiation of blood cells such as B-lymphocytes, T- lymphocytes, erythrocytes, platelets, eosinophils, basophils, neutrophils, macrophages, and their stem cell precursors. The third class includes small peptide factors such as bombesin, vasopressin, oxytocin, endothelin, transferrin, angiotensin H, vasoactive intestinal peptide, and bradykinin which function as hormones to regulate cellular functions other than proliferation.
Growth and differentiation factors play critical roles in neoplastic transformation of cells in vitro and in tumor progression in vivo. Inappropriate expression of growth factors by tumor cells may contribute to vascularization and metastasis of tumors. During hematopoiesis, growth factor misregulation can result in anemias, leukemias, and lymphomas. Certain growth factors such as interferon are cytotoxic to tumor cells both in vivo and in vitro. Moreover, some growth factors and growth factor receptors are related both structurally and functionally to oncoproteins. In addition, growth factors affect transcriptional regulation of both proto-oncogenes and oncosuppressor genes. (Reviewed in Pimentel, E. (1994) Handbook of Growth Factors. CRC Press, Ann Arbor MI, pp. 1-9.) Proteolytic enzymes or proteases either activate or deactivate proteins byhydrolyzing peptide bonds. Proteases are found in the cytosol, in membrane-bound compartments, and in the extracellular space. The major families are the zinc, serine, cysteine, thiol, and carboxyl proteases.
Ion channels, ion pumps, and transport proteins mediate the transport of molecules across cellular membranes. Transport can occur by a passive, concentration-dependent mechanism or can be linked to an energy source such as ATP hydrolysis. Symporters and antiporters transport ions and small molecules such as amino acids, glucose, and drugs. Symporters transport molecules and ions unidirectionally, and antiporters transport molecules and ions bidirectionally. Transporter superfamilies include facilitative transporters and active ATP-binding cassette transporters which are involved in multiple-drug resistance and the targeting of antigenic peptides to MHC Class I molecules. These . transporters bind to a specific ion or other molecule and undergo a conformational change in order to transfer the ion or molecule across the membrane. (Reviewed in Alberts, B. et al. (1994) Molecular Biology of The Cell. Garland Publishing, New York NY, pp. 523-546.)
Ion channels are formed by transmembrane proteins which create a lined passageway across the membrane through which water and ions, such as Na+, K+, Ca2+, and CI", enter and exit the cell. For example, chloride channels are involved in the regulation of the membrane electric potential as well as absorption and secretion of ions across the membrane. Chloride channels also regulate the internal pH of membrane-bound organelles.
Ion pumps are ATPases which actively maintain membrane gradients. Ion pumps are classified as P, V, or F according to their structure and function. All have one or more binding sites for ATP in their cytosolic domains. The P-class ion pumps include Ca2+ ATPase and NaVK+ ATPase and function in transporting H+, Na+, K+, and Ca2+ ions. P-class pumps consist of two α and two β transmembrane subunits. The V- and F-class ion pumps have similar structures but transport only H+. F class H+ pumps mediate transport across the membranes of mitochondria and chloroplasts, while V- class H+ pumps regulate acidity inside lysosomes, endosomes, and plant vacuoles.
A family of structurally related intrinsic membrane proteins known as facilitative glucose transporters catalyze the movement of glucose and other selected sugars across the plasma membrane. The proteins in this family contain a highly conserved, large transmembrane domain comprised of 12 α-helices, and several weakly conserved, cytoplasmic and exoplasmic domains. (Pessin, J.E. and Bell, G.I. (1992) Annu. Rev. Physiol. 54:911-930.)
Amino acid transport is mediated by Na+ dependent amino acid transporters. These transporters are involved in gastrointestinal and renal uptake of dietary and cellular amino acids and in neuronal reuptake of neurotransmitters. Transport of cationic amino acids is mediated by the system y+ family and the cationic amino acid transporter (CAT) family. Members ofthe CAT family share a high degree of sequence homology, and each contains 12-14 putative transmembrane domains. (Ito, K. and Groudine, M. (1997) J. Biol. Chem. 272:26780-26786.)
Hormones are secreted molecules that travel through the circulation and bind to specific receptors on the surface of, or within, target cells. Although they have diverse biochemical 5 compositions and mechanisms of action, hormones can be grouped into two categories. One category includes small lipophilic hormones that diffuse through the plasma membrane of target cells, bind to cytosolic or nuclear receptors, and form a complex that alters gene expression. Examples of these molecules include retinoic acid, thyroxine, and the cholesterol-derived steroid hormones such as progesterone, estrogen, testosterone, cortisol, and aldosterone. The second category includes l o hydrophilic hormones that function by binding to cell surface receptors that transduce signals across the plasma membrane. Examples of such hormones include amino acid derivatives such as catecholamines and peptide hormones such as glucagon, insulin, gastrin, secretin, cholecystokinin, adrenocorticotropic hormone, follicle stimulating hormone, luteinizing hormone, thyroid stimulating hormone, and vasopressin. (See, for example, Lodish et al. (1995) Molecular Cell Biology, Scientific
15 American Books Inc., New York NY, pp. 856-864.)
Neuropeptides and vasomediators (NP/VM) comprise a large family of endogenous signaling molecules. Included in this family are neuropeptides and neuropeptide hormones such as bombesin, neuropeptide Y, neurotensin, neuromedin N, melanocortins, opioids, galanin, somatostatin, tachykinins, urotensin II and related peptides involved in smooth muscle stimulation, vasopressin, vasoactive
20 intestinal peptide, and circulatory system-borne signaling molecules such as angiotensin, complement, calcitonin, endothelins, formyl-methionyl peptides, glucagon, cholecystokinin and gastrin. NP/VMs can transduce signals directly, modulate the activity or release of other neurotransmitters and hormones, and act as catalytic enzymes in cascades. The effects of NP/VMs range from extremely brief to long-lasting. (Reviewed in Martin, CR. et al. (1985) Endocrine Physiology, Oxford University Press,
25 New York, NY, pp. 57-62.)
The discovery of new secretory molecules provide new compositions which are useful in the diagnosis, study, prevention, and treatment of diseases associated with, as well as effects of exogenous compounds on, cell signaling and the expression of secretory molecules.
3 o SUMMARY OF THE INVENTION
Embodiments ofthe invention relate to nucleic acid sequences comprising human polynucleotides encoding secretory polypeptides that can contain signal peptides and/or transmembrane domains. These human polynucleotides (sptm) as presented in the Sequence Listing uniquely identify partial or full length genes encoding structural, functional, and regulatory polypeptides involved in cell signaling.
An embodiment of the invention provides an isolated polynucleotide selected from the group consisting of a) a polynucleotide comprising a polynucleotide sequence selected from the group consisting of SEQ ID NO:l-567; b) a polynucleotide comprising a naturally occurring polynucleotide sequence at least 90% identical to a polynucleotide sequence selected from the group consisting of SEQ ID NO:l-567; c) a polynucleotide complementary to the polynucleotide of a); d) a polynucleotide complementary to the polynucleotide of b); and e) an RNA equivalent of a) through d). In one alternative, the polynucleotide comprises a polynucleotide sequence selected from the group consisting of SEQ ID NO:l-567. In another alternative, the polynucleotide comprises at least 30 contiguous nucleotides of a polynucleotide selected from the group consisting of a) a polynucleotide comprising a polynucleotide sequence selected from the group consisting of SEQ ID NO:l-567; b) a polynucleotide comprising a naturally occurring polynucleotide comprising a polynucleotide sequence at least 90% identical to a polynucleotide sequence selected from the group consisting of SEQ ID NO: 1-567; c) a polynucleotide complementary to the polynucleotide of a); d) a polynucleotide complementary to the polynucleotide of b); and e) an RNA equivalent of a) through d). In another alternative, the polynucleotide comprises at least 60 contiguous nucleotides of a polynucleotide selected from the group consisting of a) a polynucleotide comprising a polynucleotide sequence selected from the group consisting of SEQ ID NO:l-567; b) a polynucleotide comprising a naturally occurring polynucleotide comprising a polynucleotide sequence at least 90% identical to a polynucleotide sequence selected from the group consisting of SEQ ID NO:l-567; c) a polynucleotide complementary to the polynucleotide of a); d) a polynucleotide complementary to the polynucleotide of b); and e) an RNA equivalent of a) through d). Another embodiment provides a composition for the detection of expression of secretory polynucleotides comprising at least one isolated polynucleotide comprising a polynucleotide selected from the group consisting of a) a polynucleotide comprising a polynucleotide sequence selected from the group consisting of SEQ ID NO:l-567; b) a polynucleotide comprising a naturally occurring polynucleotide sequence at least 90% identical to a polynucleotide sequence selected from the group consisting of SEQ ID NO: 1-567; c) a polynucleotide complementary to the polynucleotide of a); d) a polynucleotide complementary to the polynucleotide of b); and e) an RNA equivalent of a) through d); and a detectable label. An embodiment of the invention also provides a method for detecting a target polynucleotide in a sample, said target polynucleotide having a polynucleotide sequence of a polyneucleotide selected from the group consisting of a) a polynucleotide comprising a polynucleotide sequence of a polynucleotide selected from the group consisting of SEQ ID NO: 1-567; b) a polynucleotide comprising a naturally occurring polynucleotide sequence at least 90% identical to a polynucleotide sequence selected from the group consisting of SEQ ID NO:l-567; c) a polynucleotide complementary to the polynucleotide of a); d) a polynucleotide complementary to the polynucleotide of b); and e) an RNA equivalent of a) through d). The method comprises a) amplifying said target polynucleotide or fragment thereof using polymerase chain reaction amplification, and b) detecting the presence or absence of said amplified target polynucleotide or fragment thereof, and, optionally, if present, the amount thereof.
Another embodiment also provides a method for detecting a target polynucleotide in a sample, said target polynucleotide having a polynucleotide sequence of a polynucleotide selected from the group consisting of a) a polynucleotide comprising a polynucleotide sequence selected from the group consisting of SEQ ID NO:l-567; b) a polynucleotide comprising a naturally occurring polynucleotide sequence at least 90% identical to a polynucleotide sequence selected from the group consisting of SEQ ID NO:l-567; c) a polynucleotide complementary to the polynucleotide of a); d) a polynucleotide complementary to the polynucleotide of b); and e) an RNA equivalent of a) through d). The method comprises a) hybridizing the sample with a probe comprising at least 20 contiguous nucleotides comprising a sequence complementary to said target polynucleotide in the sample, and which probe specifically hybridizes to said target polynucleotide, under conditions whereby a hybridization complex is formed between said probe and said target polynucleotide, and b) detecting the presence or absence of said hybridization complex, and, optionally, if present, the amount thereof. In an alternative embodiment, the invention provides a composition comprising a target polynucleotide ofthe method, wherein said probe comprises at least 30 contiguous nucleotides. In an alternative embodiment, the invention provides a composition comprising a target polynucleotide ofthe method, wherein said probe comprises at least 60 contiguous nucleotides.
Another embodiment provides a recombinant polynucleotide comprising a promoter sequence operably linked to an isolated polynucleotide selected from the group consisting of a) a polynucleotide comprising a polynucleotide sequence selected from the group consisting of SEQ ID NO: 1-567; b) a polynucleotide comprising a naturally occurring polynucleotide sequence at least 90% identical to a polynucleotide sequence selected from the group consisting of SEQ ID NO: 1-567; c) a polynucleotide complementary to the polynucleotide of a); d) a polynucleotide complementary to the polynucleotide of b); and e) an RNA equivalent of a) through d). In an alternative embodiment, the invention provides a cell transformed with the recombinant polynucleotide. In another alternative, the invention provides a transgenic organism comprising the recombinant polynucleotide.
Yet another embodiment provides a method for producing a secretory polypeptide, the method comprising a) culturing a cell under conditions suitable for expression ofthe secretory polypeptide, wherein said cell is transformed with a recombinant polynucleotide, said recombinant polynucleotide comprising an isolated polynucleotide selected from the group consisting of i) a polynucleotide comprising a polynucleotide sequence selected from the group consisting of SEQ ID NO:l-567; ii) a polynucleotide comprising a naturally occurring polynucleotide sequence at least 90% identical to a polynucleotide sequence selected from the group consisting of SEQ ID NO:l-567; iii) a polynucleotide 5 complementary to the polynucleotide of i); iv) a polynucleotide complementary to the polynucleotide of ii); and v) an RNA equivalent of i) through iv), and b) recovering the secretory polypeptide so expressed. The invention additionally provides a method wherein the polypeptide has an amino acid sequence selected from the group consisting of SEQ ID NO:568-l 146.
Still another embodiment provides an isolated secretory polypeptide (SPTM) encoded by at 0 least one polynucleotide comprising a polynucleotide sequence selected from the group consisting of SEQ ID NO: 1-567. The invention further provides a method of screening for a test compound that specifically binds to the polypeptide having an amino acid sequence selected from the group consisting of SEQ ID NO:568-1146. The method comprises a) combining the polypeptide having an amino acid sequence selected from the group consisting of SEQ ID NO:568-1146 with at least one test compound 5 under suitable conditions, and b) detecting binding of the polypeptide having an amino acid sequence selected from the group consisting of SEQ ID NO:568-1146 to the test compound, thereby identifying a compound that specifically binds to the polypeptide having an amino acid sequence selected from the group consisting of SEQ ID NO:568-1146.
Still yet another embodiment provides a microarray wherein at least one element of the o microarray is an isolated polynucleotide comprising at least 30 contiguous nucleotides of a polynucleotide selected from the group consisting of a) a polynucleotide comprising a polynucleotide sequence selected from the group consisting of SEQ ID NO: 1-567; b) a polynucleotide comprising a naturally occurring polynucleotide sequence at least 90% identical to a polynucleotide sequence selected from the group consisting of SEQ ID NO: 1-567; c) a polynucleotide complementary to the 5 polynucleotide of a); d) a polynucleotide complementary to the polynucleotide of b); and e) an RNA equivalent of a) through d). The invention also provides a method for generating a transcript image of a sample which contains polynucleotides. The method comprises a) labeling the polynucleotides of he sample, b) contacting the elements of the microarray with the labeled polynucleotides of the sample under conditions suitable for the formation of a hybridization complex, and c) quantifying the o expression of the polynucleotides in the sample.
Still yet another embodiment provides a method for screening a compound for effectiveness in altering expression of a target polynucleotide, wherein said target polynucleotide comprises a polynucleotide selected from the group consisting of a) a polynucleotide comprising a polynucleotide sequence selected from the group consisting of SEQ ID NO:l-567; b) a polynucleotide comprising a naturally occurring polynucleotide sequence at least 90% identical to a polynucleotide sequence selected from the group consisting of SEQ ID NO: 1-567; c) a polynucleotide complementary to the polynucleotide of a); d) a polynucleotide complementary to the polynucleotide of b); and e) an RNA equivalent of a) through d). The method comprises a) exposing a sample comprising the target 5 polynucleotide to a compound, b) detecting altered expression of the target polynucleotide, and c) comparing the expression ofthe target polynucleotide in the presence of varying amounts ofthe compound and in the absence of the compound.
Another embodiment provides a method for assessing toxicity of a test compound, said method comprising a) treating a biological sample containing nucleic acids with the test compound; b) l o hybridizing the nucleic acids of the treated biological sample with a probe comprising at least 20 contiguous nucleotides of a polynucleotide selected from the group consisting of i) a polynucleotide comprising a polynucleotide sequence selected from the group consisting of SEQ ID NO:l-567; ii) a polynucleotide comprising a naturally occurring polynucleotide sequence at least 90% identical to a polynucleotide sequence selected from the group consisting of SEQ ID NO:l-567; iii) a polynucleotide
15 complementary to the polynucleotide of i); iv) a polynucleotide complementary to the polynucleotide of ii); and v) an RNA equivalent of i) through iv). Hybridization occurs under conditions whereby a specific hybridization complex is formed between said probe and a target polynucleotide in the biological sample, said target polynucleotide comprising a polynucleotide sequence of a polynucleotide selected from the group consisting of i) a polynucleotide comprising a polynucleotide sequence
20 selected from the group consisting of SEQ ID NO:l-567; ii) a polynucleotide comprising a naturally occurring polynucleotide sequence at least 90% identical to a polynucleotide sequence selected from the group consisting of SEQ ID NO:l-567; iii) a polynucleotide complementary to the polynucleotide of i); iv) a polynucleotide complementary to the polynucleotide of ii); and v) an RNA equivalent of i) through iv), and alternatively, the target polynucleotide comprises a polynucleotide sequence of a
25 fragment of a polynucleotide selected from the group consisting of i-v above; c) quantifying the amount of hybridization complex; and d) comparing the amount of hybridization complex in the treated biological sample with the amount of hybridization complex in an untreated biological sample, wherein a difference in the amount of hybridization complex in the treated biological sample is indicative of toxicity of the test compound.
3 o Another embodiment provides an isolated polypeptide selected from the group consisting of a) a polypeptide comprising an amino acid sequence selected from the group consisting of SEQ ID NO:568-1146, b) a polypeptide comprising a naturally occurring amino acid sequence at least 90% identical to an amino acid sequence selected from the group consisting of SEQ ID NO:568-1146, c) a biologically active fragment of a polypeptide having an amino acid sequence selected from the group consisting of SEQ ID NO:568-1146, and d) an immunogenic fragment of a polypeptide having an amino acid sequence selected from the group consisting of SEQ ID NO:568-1146. In an alternative embodiment, the invention provides an isolated polypeptide comprising an amino acid sequence selected from the group consisting of SEQ ID NO:568-1146. Still another embodiment provides an isolated polynucleotide encoding a polypeptide selected from the group consisting of a) a polypeptide comprising an amino acid sequence selected from the group consisting of SEQ ID NO:568-l 146, b) a polypeptide comprising a naturally occurring amino acid sequence at least 90% identical to an amino acid sequence selected from the group consisting of SEQ ID NO:568-1146, c) a biologically active fragment of a polypeptide having an amino acid sequence selected from the group consisting of SEQ ID NO:568-l 146, and d) an immunogenic fragment of a polypeptide having an amino acid sequence selected from the group consisting of SEQ ID NO:568-1146. In one alternative, the polynucleotide encodes a polypeptide comprising an amino acid sequence selected from the group consisting of SEQ ID NO:568-1146. In another alternative, the polynucleotide comprises a polynucleotide sequence selected from the group consisting of SEQ ID NO:l-567.
Another embodiment provides an isolated antibody which specifically binds to a polypeptide selected from the group consisting of a) a polypeptide comprising an amino acid sequence selected from the group consisting of SEQ ID NO:568-1146, b) a polypeptide comprising a naturally occurring amino acid sequence at least 90% identical to an amino acid sequence selected from the group consisting of SEQ ID NO:568-l 146, c) a biologically active fragment of a polypeptide having an amino acid sequence selected from the group consisting of SEQ ID NO:568-1146, and d) an immunogenic fragment of a polypeptide having an amino acid sequence selected from the group consisting of SEQ ID NO.568-1146.
Another embodiment provides a composition comprising a polypeptide selected from the group consisting of a) a polypeptide comprising an amino acid sequence selected from the group consisting of SEQ ID NO:568-1146, b) a polypeptide comprising a naturally occurring amino acid sequence at least 90% identical to an amino acid sequence selected from the group consisting of SEQ ID NO:568-1146, c) a biologically active fragment of a polypeptide having an amino acid sequence selected from the group consisting of SEQ ID NO:568-l 146, and d) an immunogenic fragment of a polypeptide having an amino acid sequence selected from the group consisting of SEQ TD NO:568-l 146, and a pharmaceutically acceptable excipient. In an embodiment, the composition comprises a polypeptide having an amino acid sequence selected from the group consisting of SEQ ID NO:568-1146. Another embodiment provides a method of treating a disease or condition associated with decreased expression of functional SPTM, comprising administering to a patient in need of such treatment the composition. Another embodiment provides a method for screening a compound for effectiveness as an agonist of a polypeptide selected from the group consisting of a) a polypeptide comprising an amino acid sequence selected from the group consisting of SEQ ID NO:568-1146, b) a polypeptide comprising a naturally occurring amino acid sequence at least 90% identical to an amino acid sequence 5 selected from the group consisting of SEQ ID NO:568-l 146, c) a biologically active fragment of a polypeptide having an amino acid sequence selected from the group consisting of SEQ ID NO:568- 1146, and d) an immunogenic fragment of a polypeptide having an amino acid sequence selected from the group consisting of SEQ ID NO:568-l 146. The method comprises a) exposing a sample comprising the polypeptide to a compound, and b) detecting agonist activity in the sample. In an 0 alternative embodiment, the invention provides a composition comprising an agonist compound identified by the method and a pharmaceutically acceptable excipient. In another alternative embodiment, the invention provides a method of treating a disease or condition associated with decreased expression of functional SPTM, comprising administering to a patient in need of such treatment the composition. 5 Another embodiment provides a method for screening a compound for effectiveness as an antagonist of a polypeptide selected from the group consisting of a) a polypeptide comprising an amino acid sequence selected from the group consisting of SEQ ID NO:568-1146, b) a polypeptide comprising a naturally occurring amino acid sequence at least 90% identical to an amino acid sequence selected from the group consisting of SEQ ID NO:568-l 146, c) a biologically active fragment of a o polypeptide having an amino acid sequence selected from the group consisting of SEQ ID NO:568-
1146, and d) an immunogenic fragment of a polypeptide having an amino acid sequence selected from the group consisting of SEQ ID NO:568-1146. The method comprises a) exposing a sample comprising the polypeptide to a compound, and b) detecting antagonist activity in the sample. In an alternative, the invention provides a composition comprising an antagonist compound identified by the 5 method and a pharmaceutically acceptable excipient. In another alternative, the invention provides a method of treating a disease or condition associated with overexpression of functional SPTM, comprising administering to a patient in need of such treatment the composition.
Another embodiment provides a method of screening for a compound that modulates the activity of a polypeptide selected from the group consisting of a) a polypeptide comprising an amino o acid sequence selected from the group consisting of SEQ ID NO.568-1146, b) a polypeptide comprising a naturally occurring amino acid sequence at least 90% identical to an amino acid sequence selected from the group consisting of SEQ ID NO:568-1146, c) a biologically active fragment of a polypeptide having an amino acid sequence selected from the group consisting of SEQ ID NO.568- 1146, and d) an immunogenic fragment of a polypeptide having an amino acid sequence selected from 5 the group consisting of SEQ ID NO:568-l 146. The method comprises a) combining the polypeptide with at least one test compound under conditions permissive for the activity ofthe polypeptide, b) assessing the activity of the polypeptide in the presence of the test compound, and c) comparing the activity of the polypeptide in the presence of the test compound with the activity of the polypeptide in the absence ofthe test compound, wherein a change in the activity of he polypeptide in the presence of the test compound is indicative of a compound that modulates the activity of the polypeptide.
DESCRIPTION OF THE TABLES
Table 1 shows the sequence identification numbers (SEQ ID NO:s) and template identification numbers (template IDs) coπesponding to the polynucleotides of the present invention, along with the sequence identification numbers (SEQ ID NO:s) and open reading frame identification numbers (ORF IDs) coπesponding to polypeptides encoded by the template ID.
Table 2 shows the sequence identification numbers (SEQ ID NO:s) and template identification numbers (template IDs) corresponding to the polynucleotides ofthe present invention, along with polynucleotide segments of each template sequence as defined by the indicated "start" and "stop" nucleotide positions. The reading frames of the polynucleotide segments are shown, and the polypeptides encoded by the polynucleotide segments constitute either signal peptide (SP) or transmembrane (TM) domains, as indicated. For TM domains, the membrane topology of the encoded polypeptide sequence is indicated as being transmembrane or on the cytosolic or non-cytosolic side of the cell membrane or organelle. Table 3 shows the sequence identification numbers and template identification numbers
(template IDs) coπesponding to the polynucleotides ofthe present invention, along with component sequence identification spans corresponding to each template. The component sequences, which were used to assemble the template sequences, are defined by the spans indicating the nucleotide positions along each template. Table 4 shows the tissue distribution profiles for the templates of the invention.
Table 5 shows the sequence identification numbers (SEQ ID NO:s) corresponding to the polypeptides of the present invention, along with the reading frames used to obtain the polypeptide segments, the lengths ofthe polypeptide segments, the "start" and "stop" nucleotide positions ofthe polynucleotide sequences used to define the encoded polypeptide segments, the GenBank hits (GI Numbers), probability scores, and functional annotations coπesponding to the GenBank hits.
Table 6 summarizes the bioinformatics tools which are useful for analysis ofthe polynucleotides of the present invention. The first column of Table 6 lists analytical tools, programs, and algorithms, the second column provides brief descriptions thereof, the third column presents appropriate references, all of which are incorporated by reference herein in their entirety, and the fourth column presents, where applicable, the scores, probability values, and other parameters used to evaluate the strength of a match between two sequences (the higher the score, the greater the homology between two sequences).
DETAILED DESCRIPTION OF THE INVENTION Before the nucleic acid sequences and methods are presented, it is to be understood that this invention is not limited to the particular machines, methods, and materials described. Although particular embodiments are described, machines, methods, and materials similar or equivalent to these embodiments may be used to practice the invention. The prefeπed machines, methods, and materials set forth are not intended to limit the scope of the invention which is limited only by the appended claims.
The singular forms "a", "an", and "the" include plural reference unless the context clearly dictates otherwise. All technical and scientific terms have the meanings commonly understood by one of ordinary skill in the art. All publications are incorporated by reference for the purpose of describing and disclosing the cell lines, vectors, and methodologies which are presented and which might be used in connection with the invention. Nothing in the specification is to be construed as an admission that the invention is not entitled to antedate such disclosure by virtue of prior invention.
Definitions
As used herein, the lower case "sptm" refers to a nucleic acid sequence, while the upper case "SPTM" refers to an amino acid sequence encoded by sptm. A "full-length" sptm refers to a nucleic acid sequence containing the entire coding region of a gene endogenously expressed in human tissue. "Adjuvants" are materials such as Freund's adjuvant, mineral gels (aluminum hydroxide), and surface active substances (lysolecithin, pluronic polyols, polyanions, peptides, oil emulsions, keyhole limpet hemocyanin, and dinitrophenol) which maybe administered to increase a host's immunological response.
"Allele" refers to an alternative form of a nucleic acid sequence. Alleles result from a "mutation," a change or an alternative reading of the genetic code. Any given gene may have none, one, or many allelic forms. Mutations which give rise to alleles include deletions, additions, or substitutions of nucleotides. Each of these changes may occur alone, or in combination with the others, one or more times in a given nucleic acid sequence. The present invention encompasses allelic sptm.
An "allelic variant" is an alternative form of the gene encoding SPTM. Allelic variants may result from at least one mutation in the nucleic acid sequence and may result in altered mRNAs or in polypeptides whose structure or function may or may not be altered. A gene may have none, one, or many allelic variants of its naturally occurring form. Common mutational changes which give rise to allelic variants are generally ascribed to natural deletions, additions, or substitutions of nucleotides. Each of these types of changes may occur alone, or in combination with the others, one or more times in a given sequence.
"Altered" nucleic acid sequences encoding SPTM include those sequences with deletions, 5 insertions, or substitutions of different nucleotides, resulting in a polypeptide the same as SPTM or a polypeptide with at least one functional characteristic of SPTM. Included within this definition are polymorphisms which may or may not be readily detectable using a particular oligonucleotide probe of the polynucleotide encoding SPTM, and improper or unexpected hybridization to allelic variants, with a locus other than the normal chromosomal locus for the polynucleotide sequence encoding SPTM. The 0 encoded protein may also be "altered," and may contain deletions, insertions, or substitutions of amino acid residues which produce a silent change and result in a functionally equivalent SPTM. Deliberate amino acid substitutions may be made on the basis of similarity in polarity, charge, solubility, hydrophobicity, hydrophilicity, and/or the amphipathic nature ofthe residues, as long as the biological or immunological activity of SPTM is retained. For example, negatively charged amino acids may 5 include aspartic acid and glutamic acid, and positively charged amino acids may include lysine and arginine. Amino acids with uncharged polar side chains having similar hydrophilicity values may include: asparagine and glutamine; and serine and threonine. Amino acids with uncharged side chains having similar hydrophilicity values may include: leucine, isoleucine, and valine; glycine and alanine; and phenylalanine and tyrosine. 0 "Amino acid sequence" refers to a peptide, a polypeptide, or a protein of either natural or synthetic origin. The amino acid sequence is not limited to the complete, endogenous amino acid sequence and may be a fragment, epitope, variant, or derivative of a protein expressed by a nucleic acid sequence.
"Amplification" refers to the production of additional copies of a sequence and is carried out 5 using polymerase chain reaction (PCR) technologies well known in the art.
"Antibody" refers to intact molecules as well as to fragments thereof, such as Fab, F(ab')2, and Fv fragments, which are capable of binding the epitopic determinant. Antibodies that bind SPTM polypeptides can be prepared using intact polypeptides or using fragments containing small peptides of interest as the immunizing antigen. The polypeptide or peptide used to immunize an animal (e.g., a o mouse, a rat, or a rabbit) can be derived from the translation of RNA, or synthesized chemically, and can be conjugated to a carrier protein if desired. Commonly used carriers that are chemically coupled to peptides include bovine serum albumin, thyroglobulin, and keyhole limpet hemocyanin (KLH). The coupled peptide is then used to immunize the animal.
The term "aptamer" refers to a nucleic acid or oligonucleotide molecule that binds to a 5 specific molecular target. Aptamers are derived from an in vitro evolutionary process (e.g. , SELEX (Systematic Evolution of Ligands by Exponential Enrichment), described in U.S. Patent No. 5,270,163), which selects for target-specific aptamer sequences from large combinatorial libraries. Aptamer compositions may be double-stranded or single-stranded, and may include deoxyribonucleotides, ribonucleotides, nucleotide derivatives, or other nucleotide-like molecules. The nucleotide components of an aptamer may have modified sugar groups (e.g., the 2 -OH group of a ribonucleotide maybe replaced by 2 -F or 2 -NH-,), which may improve a desired property, e.g., resistance to nucleases or longer lifetime in blood. Aptamers may be conjugated to other molecules, e.g., a high molecular weight carrier to slow clearance ofthe aptamer from the circulatory system. Aptamers maybe specifically cross-linked to their cognate ligands, e.g., by photo-activation of a cross-linker. (See, e.g., Brody, E.N. and L. Gold (2000) J. Biotechnol. 74:5-13.)
The term "intramer" refers to an aptamer which is expressed in vivo. For example, a vaccinia virus-based RNA expression system has been used to express specific RNA aptamers at high levels in the cytoplasm of leukocytes (Blind, M. et al. (1999) Proc. Natl Acad. Sci. USA 96:3606-3610).
The term "spiegelmer" refers to an aptamer which includes L-DNA, L-RNA, or other left- handed nucleotide derivatives or nucleotide-like molecules. Aptamers containing left-handed nucleotides are resistant to degradation by naturally occurring enzymes, which normally act on substrates containing right-handed nucleotides.
"Antisense sequence" refers to a sequence capable of specifically hybridizing to a target sequence. The antisense sequence may include DNA, RNA, or any nucleic acid mimic or analog such as peptide nucleic acid (PNA); oligonucleotides having modified backbone linkages such as phosphorothioates, methylphosphonates, or benzylphosphonates; oligonucleotides having modified sugar groups such as 2'-methoxyethyl sugars or 2'-methoxyethoxy sugars; or oligonucleotides having modified base.
"Antisense technology" refers to any technology which relies on the specific hybridization of an antisense sequence to a target sequence.
A 'bin" is a portion of computer memory space used by a computer program for storage of data, and bounded in such a manner that data stored in a bin may be retrieved by the program.
"Biologically active" refers to an amino acid sequence having a structural, regulatory, or biochemical function of a naturally occuπing amino acid sequence. "Clone joining" is a process for combining gene bins based upon the bins' containing sequence information from the same clone. The sequences may assemble into a primary gene transcript as well as one or more splice variants.
"Complementary" describes the relationship between two single-stranded nucleic acid sequences that anneal by base-pairing (5'-A-G-T-3' pairs with its complement 3 -T-C-A-5'). A "component sequence" is a nucleic acid sequence selected by a computer program such as PHRED and used to assemble a consensus or template sequence from one or more component sequences.
A "consensus sequence" or "template sequence" is a nucleic acid sequence which has been assembled from overlapping sequences, using a computer program for fragment assembly such as the GELVIEW fragment assembly system (Genetics Computer Group (GCG), Madison WI) or using a relational database management system (RDMS).
"Conservative amino acid substitutions" are those substitutions that, when made, least interfere with the properties of the original protein, i. e. , the structure and especially the function of the protein is conserved and not significantly changed by such substitutions. The table below shows amino acids which maybe substituted for an original amino acid in a protein and which are regarded as conservative substitutions.
Original Residue Conservative Substitution
Ala Gly, Ser Arg His, Lys
Asn Asp, Gin, His
Asp Asn, Glu
Cys Ala, Ser
Gin Asn, Glu, His Glu Asp, Gin, His
Gly Ala
His Asn, Arg, Gin, Glu lie Leu, Val
Leu lie, Val Lys Arg, Gin, Glu
Met Leu, Be
Phe His, Met, Leu, Trp, Tyr
Ser Cys, Thr
Thr Ser, Val Trp Phe, Tyr
Tyr His, Phe, Trp Val De, Leu, Thr
Conservative substitutions generally maintain (a) the structure of the polypeptide backbone in the area of the substitution, for example, as a beta sheet or alpha helical conformation, (b) the charge or hydrophobicity of the molecule at the target site, or (c) the bulk of the side chain.
"Deletion" refers to a change in either a nucleic or amino acid sequence in which at least one nucleotide or amino acid residue, respectively, is absent. "Derivative" refers to the chemical modification of a nucleic acid sequence, such as by replacement of hydrogen by an alkyl, acyl, amino, hydroxyl, or other group. "Differential expression" refers to increased or upregulated; or decreased, downregulated, or absent gene or protein expression, determined by comparing at least two different samples. Such comparisons maybe carried out between, for example, a treated and an untreated sample, or a diseased and a normal sample. 5 The terms "element" and "aπay element" refer to a polynucleotide, polypeptide, or other chemical compound having a unique and defined position on a microaπay.
The term "modulate" refers to a change in the activity of SPTM. For example, modulation may cause an increase or a decrease in protein activity, binding characteristics, or any other biological, functional, or immunological properties of SPTM. 0 "E-value" refers to the statistical probability that a match between two sequences occurred by chance.
"Exon shuffling" refers to the recombination of different coding regions (exons). Since an exon may represent a structural or functional domain ofthe encoded protein, new proteins may be assembled through the novel reassortment of stable substructures, thus allowing acceleration of the 5 evolution of new protein functions.
A "fragment" is a unique portion of sptm or SPTM which is identical in sequence to but shorter in length than the parent sequence. A fragment may comprise up to the entire length of the defined sequence, minus one nucleotide/amino acid residue. For example, a fragment may comprise from 10 to 1000 contiguous amino acid residues or nucleotides. A fragment used as a probe, primer, 0 antigen, therapeutic molecule, or for other purposes, maybe at least 5, 10, 15, 16, 20, 25, 30, 40, 50, 60, 75, 100, 150, 250 or at least 500 contiguous amino acid residues or nucleotides in length. Fragments may be preferentially selected from certain regions of a molecule. For example, a polypeptide fragment may comprise a certain length of contiguous amino acids selected from the first 250 or 500 amino acids (or first 25% or 50%) of a polypeptide as shown in a certain defined sequence. Clearly 5 these lengths are exemplary, and any length that is supported by the specification, including the Sequence Listing and the figures, maybe encompassed by the present embodiments.
A fragment of sptm comprises a region of unique polynucleotide sequence that specifically identifies sptm, for example, as distinct from any other sequence in the same genome. A fragment of sptm is useful, for example, in hybridization and amplification technologies and in analogous methods o that distinguish sptm from related polynucleotide sequences. The precise length of a fragment of sptm and the region of sptm to which the fragment coπesponds are routinely determinable by one of ordinary skill in the art based on the intended purpose for the fragment.
A fragment of SPTM is encoded by a fragment of sptm. A fragment of SPTM comprises a region of unique amino acid sequence that specifically identifies SPTM. For example, a fragment of 5 SPTM is useful as an immunogenic peptide for the development of antibodies that specifically recognize SPTM. The precise length of a fragment of SPTM and the region of SPTM to which the fragment coπesponds are routinely determinable by one of ordinary skill in the art based on the intended purpose for the fragment.
A "full length" nucleotide sequence is one containing at least a start site for translation to a protein sequence, followed by an open reading frame and a stop site, and encoding a "full length" polypeptide.
"Hit" refers to a sequence whose annotation will be used to describe a given template. Criteria for selecting the top hit are as follows: if the template has one or more exact nucleic acid matches, the top hit is the exact match with highest percent identity. If the template has no exact matches but has significant protein hits, the top hit is the protein hit with the lowest E-value. If the template has no significant protein hits, but does have significant non-exact nucleotide hits, the top hit is the nucleotide hit with the lowest E-value.
"Homology" refers to sequence similarity either between a reference nucleic acid sequence and at least a fragment of an sptm or between a reference amino acid sequence and a fragment of an SPTM.
"Hybridization" refers to the process by which a strand of nucleotides anneals with a complementary strand through base pairing. Specific hybridization is an indication that two nucleic acid sequences share a high degree of identity. Specific hybridization complexes form under defined annealing conditions, and remain hybridized after the "washing" step. The defined hybridization conditions include the annealing conditions and the washing step(s), the latter of which is particularly important in determining the stringency of the hybridization process, with more stringent conditions allowing less non-specific binding, i.e., binding between pairs of nucleic acid probes that are not perfectly matched. Permissive conditions for annealing of nucleic acid sequences are routinely determinable and maybe consistent among hybridization experiments, whereas wash conditions may be varied among experiments to achieve the desired stringency.
Generally, stringency of hybridization is expressed with reference to the temperature under which the wash step is carried out. Generally, such wash temperatures are selected to be about 5°C to 20°C lower than the thermal melting point (T, for the specific sequence at a defined ionic strength and pH. The Tm is the temperature (under defined ionic strength and pH) at which 50% of the target sequence hybridizes to a perfectly matched probe. An equation for calculating Tm and conditions for nucleic acid hybridization is well known and can be found in Sambrook et al., 1989, Molecular Cloning: A Laboratory Manual, 2nd ed., vol. 1-3, Cold Spring Harbor Press, Plainview NY; specifically see volume 2, chapter 9.
High stringency conditions for hybridization between polynucleotides ofthe present invention include wash conditions of 68°C in the presence of about 0.2 x SSC and about 0.1 % SDS, for 1 hour. Alternatively, temperatures of about 65°C, 60°C, or 55°C may be used. SSC concentration may be varied from about 0.2 to 2 x SSC, with SDS being present at about 0.1%. Typically, blocking reagents are used to block non-specific hybridization. Such blocking reagents include, for instance, denatured salmon sperm DNA at about 100-200 μg/ml. Useful variations on these conditions will be readily apparent to those skilled in the art. Hybridization, particularly under high stringency conditions, may be suggestive of evolutionary similarity between the nucleotides. Such similarity is strongly indicative of a similar role for the nucleotides and their resultant proteins.
Other parameters, such as temperature, salt concentration, and detergent concentration may be varied to achieve the desired stringency. Denaturants, such as formamide at a concentration of about 35-50% v/v, may also be used under particular circumstances, such as RNA:DNA hybridizations. Appropriate hybridization conditions are routinely determinable by one of ordinary skill in the art.
"Immunologically active" or "immunogenic" describes the potential for a natural, recombinant, or synthetic peptide, epitope, polypeptide, or protein to induce antibody production in appropriate animals, cells, or cell lines.
"Immune response" can refer to conditions associated with inflammation, trauma, immune disorders, or infectious or genetic disease, etc. These conditions can be characterized by expression of various factors, e.g., cytokines, chemokines, and other signaling molecules, which may affect cellular and systemic defense systems. An "immunogenic fragment" is a polypeptide or oligopeptide fragment of SPTM which is capable of eliciting an immune response when introduced into a living organism, for example, a mammal. The term "immunogenic fragment" also includes any polypeptide or oligopeptide fragment of SPTM which is useful in any of the antibody production methods disclosed herein or known in the art. "Insertion" or "addition" refers to a change in either a nucleic or amino acid sequence in which at least one nucleotide or residue, respectively, is added to the sequence.
"Labeling" refers to the covalent or noncovalent joining of a polynucleotide, polypeptide, or antibody with a reporter molecule capable of producing a detectable or measurable signal.
"Microarray" is any aπangement of nucleic acids, amino acids, antibodies, etc., on a substrate. The substrate maybe a solid support such as beads, glass, paper, nitrocellulose, nylon, or an appropriate membrane.
"Linkers" are short stretches of nucleotide sequence which maybe added to a vector or an sptm to create restriction endonuclease sites to facilitate cloning. "Polylinkers" are engineered to incorporate multiple restriction enzyme sites and to provide for the use of enzymes which leave 5' or 3' overhangs (e.g., BamHI, EcoRI, and Hindlll) and those which provide blunt ends (e.g., EcoRV, SnaBI, and Stul).
"Naturally occurring" refers to an endogenous polynucleotide or polypeptide that maybe isolated from viruses or prokaryotic or eukaryotic cells. "Nucleic acid sequence" refers to the specific order of nucleotides joined by phosphodiester bonds in a linear, polymeric arrangement. Depending on the number of nucleotides, the nucleic acid sequence can be considered an oligomer, oligonucleotide, or polynucleotide. The nucleic acid can be DNA, RNA, or any nucleic acid analog, such as PNA, may be of genomic or synthetic origin, may be either double-stranded or single-stranded, and can represent either the sense or antisense (complementary) strand.
"Oligomer" refers to a nucleic acid sequence of at least about 6 nucleotides and as many as about 60 nucleotides, preferably about 15 to 40 nucleotides, and most preferably between about 20 and 30 nucleotides, that may be used in hybridization or amplification technologies. Oligomers may be used as, e.g., primers for PCR, and are usually chemically synthesized. "Operably linked" refers to the situation in which a first nucleic acid sequence is placed in a functional relationship with the second nucleic acid sequence. For instance, a promoter is operably linked to a coding sequence if the promoter affects the transcription or expression of the coding sequence. Generally, operably linked DNA sequences may be in close proximity or contiguous and, where necessary to join two protein coding regions, in the same reading frame. "Peptide nucleic acid" (PNA) refers to a DNA mimic in which nucleotide bases are attached to a pseudopeptide backbone to increase stability. PNAs, also designated antigene agents, can prevent gene expression by targeting complementary messenger RNA.
The phrases "percent identity" and "% identity", as applied to polynucleotide sequences, refer to the percentage of residue matches between at least two polynucleotide sequences aligned using a standardized algorithm. Such an algorithm may insert, in a standardized and reproducible way, gaps in the sequences being compared in order to optimize alignment between two sequences, and therefore achieve a more meaningful comparison ofthe two sequences.
Percent identity between polynucleotide sequences maybe determined using the default parameters of he CLUSTAL V algorithm as incorporated into the MEGALIGN version 3.12e sequence alignment program. This program is part of the LASERGENE software package, a suite of molecular biological analysis programs (DNASTAR, Madison WI). CLUSTAL V is described in Higgins, D.G. and Sharp, P.M. (1989) CABIOS 5:151-153 and inHggins, D.G. et al. (1992) CABIOS 8:189-191. For pairwise alignments of polynucleotide sequences, the default parameters are set as follows: Ktuple=2, gap penalty=5, window=4, and "diagonals saved"=4. The "weighted" residue weight table is selected as the default. Percent identity is reported by CLUSTAL V as the "percent similarity" between aligned polynucleotide sequence pairs.
Alternatively, a suite of commonly used and freely available sequence comparison algorithms is provided by the National Center for Biotechnology Information (NCBI) Basic Local Alignment Search Tool (BLAST) (Altschul, S.F. et al. (1990) J. Mol. Biol. 215:403-410), which is available from several sources, including the NCBI, Bethesda, MD, and on the Internet at http://www.ncbi.nlm.nih.gov/BLAST/. The BLAST software suite includes various sequence analysis programs including "BLASTN," that is used to determine alignment between a known polynucleotide sequence and other sequences on a variety of databases. Also available is a tool called "BLAST 2 Sequences" that is used for direct pairwise comparison of two nucleotide sequences. "BLAST 2 Sequences" can be accessed and used interactively at http://www.ncbi.nlm.nih.gov/gorf/bl2/. The "BLAST 2 Sequences" tool can be used for both BLASTN and BLASTP (discussed below). BLAST programs are commonly used with gap and other parameters set to default settings. For example, to compare two nucleotide sequences, one may use BLASTN with the "BLAST 2 Sequences" tool Version 2.0.9 (May-07-1999) set at default parameters. Such default parameters maybe, for example:
Matrix: BLOSUM62
Reward for match: 1
Penalty for mismatch: -2 Open Gap: 5 and Extension Gap: 2 penalties
Gap x drop-off: 50
Expect: 10
Word Size: 11
Filter: on Percent identity may be measured over the length of an entire defined sequence, for example, as defined by a particular SEQ ID number, or may be measured over a shorter length, for example, over the length of a fragment taken from a larger, defined sequence, for instance, a fragment of at least 20, at least 30, at least 40, at least 50, at least 70, at least 100, or at least 200 contiguous nucleotides. Such lengths are exemplary only, and it is understood that any fragment length supported by the sequences shown herein, in figures or Sequence Listings, may be used to describe a length over which percentage identity may be measured.
Nucleic acid sequences that do not show a high degree of identity may nevertheless encode similar amino acid sequences due to the degeneracy of the genetic code. It is understood that changes in nucleic acid sequence can be made using this degeneracy to produce multiple nucleic acid sequences that all encode substantially the same protein. The phrases "percent identity" and "% identity", as applied to polypeptide sequences, refer to the percentage of residue matches between at least two polypeptide sequences aligned using a standardized algorithm. Methods of polypeptide sequence alignment are well-known. Some alignment methods take into account conservative amino acid substitutions. Such conservative substitutions, explained in more detail above, generally preserve the hydrophobicity and acidity of the substituted residue, thus preserving the structure (and therefore function) ofthe folded polypeptide.
Percent identity between polypeptide sequences may be determined using the default parameters ofthe CLUSTAL V algorithm as incorporated into the MEGALIGN version 3.12e sequence alignment program (described and referenced above). For pairwise alignments of polypeptide sequences using CLUSTAL V, the default parameters are set as follows: Ktuple=l, gap penalty=3, window=5, and "diagonals saved"=5. The PAM250 matrix is selected as the default residue weight table. As with polynucleotide alignments, the percent identity is reported by CLUSTAL V as the "percent similarity" between aligned polypeptide sequence pairs.
Alternatively the NCBI BLAST software suite may be used. For example, for a pairwise comparison of two polypeptide sequences, one may use the "BLAST 2 Sequences" tool Version 2.0.9 (May-07-1999) with BLASTP set at default parameters. Such default parameters may be, for example:
Matrix: BLOSUM62
Open Gap: 11 and Extension Gap: 1 penalty Gap x drop-off: 50
Expect: 10
Word Size: 3
Filter: on
Percent identity may be measured over the length of an entire defined polypeptide sequence, for example, as defined by a particular SEQ ID number, or may be measured over a shorter length, for example, over the length of a fragment taken from a larger, defined polypeptide sequence, for instance, a fragment of at least 15, at least 20, at least 30, at least 40, at least 50, at least 70 or at least 150 contiguous residues. Such lengths are exemplary only, and it is understood that any fragment length supported by the sequences shown herein, in figures or Sequence Listings, may be used to describe a length over which percentage identity may be measured.
"Post-translational modification" of an SPTM may involve lipidation, glycosylation, phosphorylation, acetylation, racemization, proteolytic cleavage, and other modifications known in the art. These processes may occur synthetically or biochemically. Biochemical modifications will vary by cell type depending on the enzymatic milieu and the SPTM. "Probe" refers to sptm or fragments thereof, which are used to detect identical, allelic or related nucleic acid sequences. Probes are isolated oligonucleotides or polynucleotides attached to a detectable label or reporter molecule. Typical labels include radioactive isotopes, ligands, chemiluminescent agents, and enzymes. "Primers" are short nucleic acids, usually DNA 5 oligonucleotides, which may be annealed to a target polynucleotide by complementary base-pairing. The primer may then be extended along the target DNA strand by a DNA polymerase enzyme. Primer pairs can be used for amplification (and identification) of a nucleic acid sequence, e.g., by the polymerase chain reaction (PCR).
Probes and primers as used in the present invention typically comprise at least 15 contiguous 0 nucleotides of a known sequence. In order to enhance specificity, longer probes and primers may also be employed, such as probes and primers that comprise at least 20, 30, 40, 50, 60, 70, 80, 90, 100, or at least 150 consecutive nucleotides of the disclosed nucleic acid sequences. Probes and primers maybe considerably longer than these examples, and it is understood that any length supported by the specification, including the figures and Sequence Listing, maybe used. 5 Methods for preparing and using probes and primers are described in the references, for example Sambrook et al., 1989, Molecular Cloning: A Laboratory Manual, 2nd ed., vol. 1-3, Cold Spring Harbor Press, Plainview NY; Ausubel et al.,1987, Cuπent Protocols in Molecular Biology, Greene Publ. Assoc. & Wiley-Intersciences, New York NY; Tunis et al., 1990, PCR Protocols, A Guide to Methods and Applications, Academic Press, San Diego CA. PCR primer pairs can be o derived from a known sequence, for example, by using computer programs intended for that purpose such as Primer (Version 0.5, 1991, Whitehead Institute for Biomedical Research, Cambridge MA).
Oligonucleotides for use as primers are selected using software known in the art for such purpose. For example, OLIGO 4.06 software is useful for the selection of PCR primer pairs of up to 100 nucleotides each, and for the analysis of oligonucleotides and larger polynucleotides of up to 5,000 5 nucleotides from an input polynucleotide sequence of up to 32 kilobases. Similar primer selection programs have incorporated additional features for expanded capabilities. For example, the PrimOU primer selection program (available to the public from the Genome Center at University of Texas South West Medical Center, Dallas TX) is capable of choosing specific primers from megabase sequences and is thus useful for designing primers on a genome- wide scope. The Primer3 primer o selection program (available to the public from the Whitehead Institute/MIT Center for Genome
Research, Cambridge MA) allows the user to input a "misprinting library," in which sequences to avoid as primer binding sites are user-specified. Primer3 is useful, in particular, for the selection of oligonucleotides for microarrays. (The source code for the latter two primer selection programs may also be obtained from their respective sources and modified to meet the user's specific needs.) The 5 PrimeGen program (available to the public from the UK Human Genome Mapping Project Resource Centre, Cambridge UK) designs primers based on multiple sequence alignments, thereby allowing selection of primers that hybridize to either the most conserved or least conserved regions of aligned nucleic acid sequences. Hence, this program is useful for identification of both unique and conserved oligonucleotides and polynucleotide fragments. The oligonucleotides and polynucleotide fragments identified by any of the above selection methods are useful in hybridization technologies, for example, as PCR or sequencing primers, microaπay elements, or specific probes to identify fully or partially complementary polynucleotides in a sample of nucleic acids. Methods of oligonucleotide selection are not limited to those described above.
"Purified" refers to molecules, either polynucleotides or polypeptides that are isolated or separated from their natural environment and are at least about 60% free, preferably at least about 75% free, and most preferably at least about 90% free from other compounds with which they are naturally associated.
A "recombinant nucleic acid" is a sequence that is not naturally occurring or has a sequence that is made by an artificial combination of two or more otherwise separated segments of sequence. This artificial combination is often accomplished by chemical synthesis or, more commonly, by the artificial manipulation of isolated segments of nucleic acids, e.g., by genetic engineering techniques such as those described in Sambrook, supra. The term recombinant includes nucleic acids that have been altered solely by addition, substitution, or deletion of a portion ofthe nucleic acid. Frequently, a recombinant nucleic acid may include a nucleic acid sequence operably linked to a promoter sequence. Such a recombinant nucleic acid may be part of a vector that is used, for example, to transform a cell.
Alternatively, such recombinant nucleic acids may be part of a viral vector, e.g., based on a vaccinia virus, that could be use to vaccinate a mammal wherein the recombinant nucleic acid is expressed, inducing a protective immunological response in the mammal.
"Regulatory element" refers to a nucleic acid sequence from nontranslated regions of a gene, and includes enhancers, promoters, introns, and 3 ' untranslated regions, which interact with host proteins to carry out or regulate transcription or translation.
"Reporter" molecules are chemical or biochemical moieties used for labeling a nucleic acid, an amino acid, or an antibody. They include radionuclides; enzymes; fluorescent, chemiluminescent, or chromogenic agents; substrates; cofactors; inhibitors; magnetic particles; and other moieties known in the art.
An "RNA equivalent," in reference to a DNA sequence, is composed ofthe same linear sequence of nucleotides as the reference DNA sequence with the exception that all occuπences of the nitrogenous base thymine are replaced with uracil, and the sugar backbone is composed of ribose instead of deoxyribose. "Sample" is used in its broadest sense. Samples may contain nucleic or amino acids, antibodies, or other materials, and maybe derived from any source (e.g., bodily fluids including, but not limited to, saliva, blood, and urine; chromosome(s), organelles, or membranes isolated from a cell; genomic DNA, RNA, or cDNA in solution or bound to a substrate; and cleared cells or tissues or blots or imprints from such cells or tissues).
"Specific binding" or "specifically binding" refers to the interaction between a protein or peptide and its agonist, antibody, antagonist, or other binding partner. The interaction is dependent upon the presence of a particular structure of the protein, e.g., the antigenic deteπninant or epitope, recognized by the binding molecule. For example, if an antibody is specific for epitope "A," the presence of a polypeptide containing epitope A, or the presence of free unlabeled A, in a reaction containing free labeled A and the antibody will reduce the amount of labeled A that binds to the antibody.
"Substitution" refers to the replacement of at least one nucleotide or amino acid by a different nucleotide or amino acid. "Substrate" refers to any suitable rigid or semi-rigid support including, e.g., membranes, filters, chips, slides, wafers, fibers, magnetic or nonmagnetic beads, gels, tubing, plates, polymers, microparticles or capillaries. The substrate can have a variety of surface forms, such as wells, trenches, pins, channels and pores, to which polynucleotides or polypeptides are bound.
A "transcript image" refers to the collective pattern of gene expression by a particular tissue or cell type under given conditions at a given time.
"Transformation" refers to a process by which exogenous DNA enters a recipient cell. Transformation may occur under natural or artificial conditions using various methods well known in the art. Transformation may rely on any known method for the insertion of foreign nucleic acid sequences into a prokaryotic or eukaryotic host cell. The method is selected based on the host cell being transformed.
"Transformants" include stably transformed cells in which the inserted DNA is capable of replication either as an autonomously replicating plasmid or as part of the host chromosome, as well as cells which transiently express inserted DNA or RNA.
A "transgenic organism," as used herein, is any organism, including but not limited to animals and plants, in which one or more of the cells of the organism contains heterologous nucleic acid introduced by way of human intervention, such as by transgenic techniques well known in the art. The nucleic acid is introduced into the cell, directly or indirectly by introduction into a precursor of the cell, by way of deliberate genetic manipulation, such as by microinjection or by infection with a recombinant virus. The term genetic manipulation does not include classical cross-breeding, or in vitro fertilization, but rather is directed to the introduction of a recombinant DNA molecule. The transgenic organisms contemplated in accordance with the present invention include bacteria, cyanobacteria, fungi, and plants and animals. The isolated DNA ofthe present invention can be introduced into the host by methods known in the art, for example infection, transfection, transformation or transconjugation. Techniques for transferring the DNA ofthe present invention into such organisms 5 are widely known and provided in references such as Sambrook et al. (1989), supra.
A "variant" of a particular nucleic acid sequence is defined as a nucleic acid sequence having at least 25% sequence identity to the particular nucleic acid sequence over a certain length of one of the nucleic acid sequences using BLASTN with the "BLAST 2 Sequences" tool Version 2.0.9 (May- 07-1999) set at default parameters. Such a pair of nucleic acids may show, for example, at least 30%, 0 at least 50%, at least 60%, at least 70%, at least 80%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, or at least 99% or greater sequence identity over a certain defined length. The variant may result in "conservative" amino acid changes which do not affect structural and/or chemical properties. A variant may be described as, for example, an "allelic" (as defined above), "splice," "species," or "polymorphic" 5 variant. A splice variant may have significant identity to a reference molecule, but will generally have a greater or lesser number of polynucleotides due to alternate splicing of exons during mRNA processing. The coπesponding polypeptide may possess additional functional domains or lack domains that are present in the reference molecule. Species variants are polynucleotide sequences that vary from one species to another. The resulting polypeptides generally will have significant amino acid o identity relative to each other. A polymorphic variant is a variation in the polynucleotide sequence of a particular gene between individuals of a given species. Polymorphic variants also may encompass "single nucleotide polymorphisms" (SNPs) in which the polynucleotide sequence varies by one base. The presence of SNPs may be indicative of, for example, a certain population, a disease state, or a propensity for a disease state. 5 In an alternative, variants of the polynucleotides of the present invention may be generated through recombinant methods. One possible method is a DNA shuffling technique such as MOLECULARBREEDING (Maxygen Inc., Santa Clara CA; described in U.S. Patent Number 5,837,458; Chang, C-C. et al. (1999) Nat. Biotechnol. 17:793-797; Christians, F.C et al. (1999) Nat. Biotechnol. 17:259-264; and Crameri, A. et al. (1996) Nat. Biotechnol. 14:315-319) to alter or improve o the biological properties of SPTM, such as its biological or enzymatic activity or its ability to bind to other molecules or compounds. DNA shuffling is a process by which a library of gene variants is produced using PCR-mediated recombination of gene fragments. The library is then subjected to selection or screening procedures that identify those gene variants with the desired properties. These prefeπed variants may then be pooled and further subjected to recursive rounds of DNA shuffling and 5 selection/screening. Thus, genetic diversity is created through "artificial" breeding and rapid molecular evolution. For example, fragments of a single gene containing random point mutations may be recombined, screened, and then reshuffled until the desired properties are optimized. Alternatively, fragments of a given gene maybe recombined with fragments of homologous genes in the same gene family, either from the same or different species, thereby maximizing the genetic diversity of multiple naturally occurring genes in a directed and controllable manner.
A "variant" of a particular polypeptide sequence is defined as a polypeptide sequence having at least 40% sequence identity to the particular polypeptide sequence over a certain length of one of the polypeptide sequences using BLASTP with the "BLAST 2 Sequences" tool Version 2.0.9 (May- 07-1999) set at default parameters. Such a pair of polypeptides may show, for example, at least 50%, at least 60%, at least 70%, at least 80%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, or at least 99% or greater sequence identity over a certain defined length of one of the polypeptides.
THE INVENTION In a particular embodiment, cDNA sequences derived from human tissues and cell lines were aligned based on nucleotide sequence identity and assembled into "consensus" or "template" sequences which are designated by the template identification numbers (template IDs) in column 2 of Table 2. The sequence identification numbers (SEQ ID NO:s) coπesponding to the template IDs are shown in column 1. Segments ofthe template sequences are defined by the "start" and "stop" nucleotide positions listed in columns 3 and 4. These segments, when translated in the reading frames indicated in column 5, have similarity to signal peptide (SP) or transmembrane (TM) domain consensus sequences, as indicated in column 6.
The invention incorporates the nucleic acid sequences of these templates as disclosed in the Sequence Listing and the use of these sequences in the diagnosis and treatment of disease states characterized by defects in cell signaling. The invention further utilizes these sequences in hybridization and amplification technologies, and in particular, in technologies which assess gene expression patterns correlated with specific cells or tissues and their responses in vivo or in vitro to pharmaceutical agents, toxins, and other treatments. In this manner, the sequences ofthe present invention are used to develop a transcript image for a particular cell or tissue.
Derivation of Nucleic Acid Sequences cDNA was isolated from libraries constructed using RNA derived from normal and diseased human tissues and cell lines. The human tissues and cell lines used for cDNA library construction were selected from a broad range of sources to provide a diverse population of cDNAs representative of gene transcription throughout the human body. Descriptions of the human tissues and cell lines used for cDNA library construction are provided in the LIEESEQ database (Incyte Genomics, Inc. (Incyte), Palo Alto CA). Human tissues were broadly selected from, for example, cardiovascular, dermatologic, endocrine, gastrointestinal, hematopoietic/immune system, musculoskeletal, neural, reproductive, and urologic sources. 5 Cell lines used for cDNA library construction were derived from, for example, leukemic cells, teratocarcinomas, neuroepitheliomas, cervical carcinoma, lung fibroblasts, and endothelial cells. Such cell lines include, for example, THP-1, Jurkat, HUVEC, hNT2, WI38, HeLa, and other cell lines commonly used and available from public depositories (American Type Culture Collection, Manassas VA). Prior to mRNA isolation, cell lines were untreated, treated with a pharmaceutical agent such as 0 5 -aza-2'-deoxycytidine, treated with an activating agent such as lipopolysaccharide in the case of leukocytic cell lines, or, in the case of endothelial cell lines, subjected to shear stress.
Sequencing of the cDNAs
Methods for DNA sequencing are well known in the art. Conventional enzymatic methods 5 employ the Klenow fragment of DNA polymerase I, SEQUENASE DNA polymerase (U.S.
Biochemical Corporation, Cleveland OH), Taq polymerase (Applied Biosystems, Foster City CA), thermostable T7 polymerase (Amersham Pharmacia Biotech, Inc. (Amersham Pharmacia Biotech), Piscataway NJ), or combinations of polymerases and proofreading exonucleases such as those found in the ELONGASE amplification system (Life Technologies Inc. (Life Technologies), Gaithersburg o MD), to extend the nucleic acid sequence from an oligonucleotide primer annealed to the DNA template of interest. Methods have been developed for the use of both single-stranded and double- stranded templates. Chain termination reaction products may be electrophoresed on urea- polyacrylamide gels and detected either by autoradiography (for radioisotope-labeled nucleotides) or by fluorescence (for fluorophore-labeled nucleotides). Automated methods for mechanized reaction 5 preparation, sequencing, and analysis using fluorescence detection methods have been developed. Machines used to prepare cDNAs for sequencing can include the MICROLAB 2200 liquid transfer system (Hamilton Company (Hamilton), Reno NV), Peltier thermal cycler (PTC200; MJ Research, Inc. (MJ Research), Watertown MA), and ABI CATALYST 800 thermal cycler (Applied Biosystems). Sequencing can be carried out using, for example, the ABI 373 or 377 (Applied o Biosystems) or MEGABACE 1000 (Molecular Dynamics, Inc. (Molecular Dynamics), Sunnyvale
CA) DNA sequencing systems, or other automated and manual sequencing systems well known in the art.
The nucleotide sequences of he Sequence Listing have been prepared by current, state-of- the-art, automated methods and, as such, may contain occasional sequencing errors or unidentified 5 nucleotides. Such unidentified nucleotides are designated by an N. These infrequent unidentified bases do not represent a hindrance to practicing the invention for those skilled in the art. Several methods employing standard recombinant techniques maybe used to coπect errors and complete the missing sequence information. (See, e.g., those described in Ausubel, F.M. et al. (1997) Short Protocols in Molecular Biology, John Wiley & Sons, New York NY; and Sambrook, J. et al. (1989) Molecular Cloning, A Laboratory Manual, Cold Spring Harbor Press, Plainview NY.)
Assembly of cDNA Sequences
Human polynucleotide sequences may be assembled using programs or algorithms well known in the art. Sequences to be assembled are related, wholly or in part, and may be derived from a single or many different transcripts. Assembly of the sequences can be performed using such programs as PHRAP (Phils Revised Assembly Program) and the GELVIEW fragment assembly system (GCG), or other methods known in the art.
Alternatively, cDNA sequences are used as "component" sequences that are assembled into "template" or "consensus" sequences as follows. Sequence chromatograms are processed, verified, and quality scores are obtained using PHRED. Raw sequences are edited using an editing pathway known as Block 1 (See, e.g., the LIEESEQ Assembled User Guide, Incyte Genomics, Palo Alto, CA). A series of BLAST comparisons is performed and low-information segments and repetitive elements (e.g., dinucleotide repeats, Alu repeats, etc.) are replaced by "n's", or masked, to prevent spurious matches. Mitochondrial and ribosomal RNA sequences are also removed. The processed sequences are then loaded into a relational database management system (ROMS) which assigns edited sequences to existing templates, if available. When additional sequences are added into the RDMS, a process is initiated which modifies existing templates or creates new templates from works in progress (i.e., nonfinal assembled sequences) containing queued sequences or the sequences themselves. After the new sequences have been assigned to templates, the templates can be merged into bins. If multiple templates exist in one bin, the bin can be split and the templates reannotated.
Once gene bins have been generated based upon sequence alignments, bins are "clone joined" based upon clone information. Clone joining occurs when the 5' sequence of one clone is present in one bin and the 3' sequence from the same clone is present in a different bin, indicating that the two bins should be merged into a single bin. Only bins which share at least two different clones are merged.
A resultant template sequence may contain either a partial or a full length open reading frame, or all or part of a genetic regulatory element. This variation is due in part to the fact that the full length cDNAs of many genes are several hundred, and sometimes several thousand, bases in length. With current technology, cDNAs comprising the coding regions of large genes cannot be cloned because of vector limitations, incomplete reverse transcription of the mRNA, or incomplete "second strand" synthesis. Template sequences maybe extended to include additional contiguous sequences derived from the parent RNA transcript using a variety of methods known to those of skill in the art. Extension may thus be used to achieve the full length coding sequence of a gene.
Analysis of the cDNA Sequences
The cDNA sequences are analyzed using a variety of programs and algorithms which are well known in the art. (See, e.g., Ausubel, 1997, supra. Chapter 7.7; Meyers, R.A. (Ed.) (1995) Molecular Biology and Biotechnolo y, Wiley VCH, New York NY, pp. 856-853; and Table 6.) These analyses comprise both reading frame determinations, e.g., based on triplet codon periodicity for 0 particular organisms (Fickett, J.W. (1982) Nucleic Acids Res. 10:5303-5318); analyses of potential start and stop codons; and homology searches.
Computer programs known to those of skill in the art for performing computer-assisted searches for amino acid and nucleic acid sequence similarity, include, for example, Basic Local Alignment Search Tool (BLAST; Altschul, S.F. (1993) J. Mol. Evol. 36:290-300; Altschul, S.F. et al. 5 (1990) J. Mol. Biol. 215:403-410). BLAST is especially useful in determining exact matches and comparing two sequence fragments of arbitrary but equal lengths, whose alignment is locally maximal and for which the alignment score meets or exceeds a threshold or cutoff score set by the user (Karlin, S. et al. (1988) Proc. Natl. Acad. Sci. USA 85:841-845). Using an appropriate search tool (e.g., BLAST or HMM), GenBank, SwissProt, BLOCKS, PFAM and other databases maybe o searched for sequences containing regions of homology to a query sptm or SPTM of the present invention.
Other approaches to the identification, assembly, storage, and display of nucleotide and polypeptide sequences are provided in "Relational Database for Storing Biomolecule Infoπnation," U.S.S.N. 08/947,845, filed October 9, 1997; "Project-Based Full-Length Biomolecular Sequence 5 Database," U.S. Patent Number 5,953,727; and "Relational Database and System for Storing
Information Relating to Biomolecular Sequences," U.S.S.N. 09/034,807, filed March 4, 1998, all of which are incorporated by reference herein in their entirety.
Protein hierarchies can be assigned to the putative encoded polypeptide based on, e.g., motif, BLAST, or biological analysis. Methods for assigning these hierarchies are described, for example, in o "Database System Employing Protein Function Hierarchies for Viewing Biomolecular Sequence
Data," U.S. Patent Number 6,023,659, incorporated herein by reference.
Human Secretory Sequences
The sptm ofthe present invention maybe used for a variety of diagnostic and therapeutic 5 purposes. For example, an sptm maybe used to diagnose a particular condition, disease, or disorder associated with cell signaling. Such conditions, diseases, and disorders include, but are not limited to, a cell proliferative disorder such as actinic keratosis, arteriosclerosis, atherosclerosis, bursitis, cirrhosis, hepatitis, mixed connective tissue disease (MCTD), myelofibrosis, paroxysmal nocturnal hemoglobinuria, polycythemia vera, psoriasis, primary thrombocythemia, and cancers including 5 adenocarcinoma, leukemia, lymphoma, melanoma, myeloma, sarcoma, teratocarcinoma, and, in particular, a cancer ofthe adrenal gland, bladder, bone, bone marrow, brain, breast, cervix, gall bladder, ganglia, gastrointestinal tract, heart, kidney, liver, lung, muscle, ovary, pancreas, parathyroid, penis, prostate, salivary glands, skin, spleen, testis, thymus, thyroid, and uterus; an immune system disorder such as such as inflammation, actinic keratosis, acquired immunodeficiency syndrome 0 (AIDS), Addison's disease, adult respiratory distress syndrome, allergies, ankylosing spondylitis, amyloidosis, anemia, arteriosclerosis, asthma, atherosclerosis, autoimmune hemolytic anemia, autoimmune thyroiditis, bronchitis, bursitis, cholecystitis, ciπhosis, contact dermatitis, Crohn's disease, atopic dermatitis, dermatomyositis, diabetes mellitus, emphysema, erythroblastosis fetalis, erythema nodosum, atrophic gastritis, glomerulonephritis, Goodpasture's syndrome, gout, Graves' disease, 5 Hashimoto's thyroiditis, paroxysmal nocturnal hemoglobinuria, hepatitis, hypereosinophilia, irritable bowel syndrome, episodic lymphopenia with lymphoeytotoxins, mixed connective tissue disease (MCTD), multiple sclerosis, myasthenia gravis, myocardial or pericardial inflammation, myelofibrosis, osteoarthritis, osteoporosis, pancreatitis, polycythemia vera, polymyositis, psoriasis, Reiter's syndrome, rheumatoid arthritis, scleroderma, Sjogren's syndrome, systemic anaphylaxis, systemic lupus o erythematosus, systemic sclerosis, primary thrombocythemia, thrombocytopenic purpura, ulcerative colitis, uveitis, Werner syndrome, complications of cancer, hemodialysis, and extracorporeal circulation, trauma, and hematopoietic cancer including lymphoma, leukemia, and myeloma; and a neurological disorder such as epilepsy, ischemic cerebrovascular disease, stroke, cerebral neoplasms, Alzheimer's disease, Pick's disease, Huntington's disease, dementia, Parkinson's disease and other 5 extrapyramidal disorders, amyotiophic lateral sclerosis and other motor neuron disorders, progressive neural muscular atrophy, retinitis pigmentosa, hereditary ataxias, multiple sclerosis and other demyelinating diseases, bacterial and viral meningitis, brain abscess, subdural empyema, epidural abscess, suppurative intracranial thrombophlebitis, myelitis and radiculitis, viral central nervous system disease, prion diseases including kuru, Creutzfeldt- Jakob disease, and Gerstmann-Straussler-Scheinker o syndrome, fatal familial insomnia, nutritional and metabolic diseases of the nervous system, neurofibromatosis, tuberous sclerosis, cerebelloretinal hemangioblastomatosis, encephalotrigeminal syndrome, mental retardation and other developmental disorder of the central nervous system, cerebral palsy, a neuroskeletal disorder, an autonomic nervous system disorder, a cranial nerve disorder, a spinal cord disease, muscular dystrophy and other neuromuscular disorder, a peripheral nervous 5 system disorder, dermatomyositis and polymyositis, inherited, metabolic, endocrine, and toxic myopathy, myasthenia gravis, periodic paralysis, a mental disorder including mood, anxiety, and schizophrenic disorder, seasonal affective disorder (SAD), akathesia, amnesia, catatonia, diabetic neuropathy, tardive dyskinesia, dystonias, paranoid psychoses, postherpetic neuralgia, and Tourette's disorder. The sptm can be used to detect the presence of, or to quantify the amount of, an sptm- related polynucleotide in a sample. This information is then compared to information obtained from appropriate reference samples, and a diagnosis is established. Alternatively, a polynucleotide complementary to a given sptm can inhibit or inactivate a therapeutically relevant gene related to the sptm.
Analysis of sptm Expression Patterns
The expression of sptm may be routinely assessed by hybridization-based methods to determine, for example, the tissue-specificity, disease-specificity, or developmental stage-specificity of sptm expression. For example, the level of expression of sptm may be compared among different cell types or tissues, among diseased and normal cell types or tissues, among cell types or tissues at different developmental stages, or among cell types or tissues undergoing various treatments. This type of analysis is useful, for example, to assess the relative levels of sptm expression in fully or partially differentiated cells or tissues, to determine if changes in sptm expression levels are coπelated with the development or progression of specific disease states, and to assess the response of a cell or tissue to a specific therapy, for example, in pharmacological or toxicological studies. Methods for the analysis of sptm expression are based on hybridization and amplification technologies and include membrane-based procedures such as northern blot analysis, high-throughput procedures that utilize, for example, microarrays, and PCR-based procedures.
Hybridization and Genetic Analysis The sptm, their fragments, or complementary sequences, may be used to identify the presence of and/or to determine the degree of similarity between two (or more) nucleic acid sequences. The sptm may be hybridized to naturally occurring or recombinant nucleic acid sequences under appropriately selected temperatures and salt concentrations. Hybridization with a probe based on the nucleic acid sequence of at least one of he sptm allows for the detection of nucleic acid sequences, including genomic sequences, which are identical or related to the sptm ofthe Sequence Listing.
Probes may be selected from non-conserved or unique regions of at least one of the polynucleotides of SEQ ID NO:l-567 and tested for their ability to identify or amplify the target nucleic acid sequence using standard protocols.
Polynucleotide sequences that are capable of hybridizing, in particular, to those shown in SEQ ID NO: 1 -567 and fragments thereof, can be identified using various conditions of stringency. (See, e.g., Wahl, G.M. and S.L. Berger (1987) Methods Enzymol. 152:399-407; Kimmel, A.R. (1987) Methods Enzymol. 152:507-511.) Hybridization conditions are discussed in "Definitions."
A probe for use in Southern or northern hybridization may be derived from a fragment of an sptm sequence, or its complement, that is up to several hundred nucleotides in length and is either 5 single-stranded or double-stranded. Such probes may be hybridized in solution to biological materials such as plasmids, bacterial, yeast, or human artificial chromosomes, cleared or sectioned tissues, or to artificial substrates containing sptm. Microaπays are particularly suitable for identifying the presence of and detecting the level of expression for multiple genes of interest by examining gene expression coπelated with, e.g., various stages of development, treatment with a drug or compound, or disease 0 progression. An array analogous to a dot or slot blot may be used to arrange and link polynucleotides to the surface of a substrate using one or more ofthe following: mechanical (vacuum), chemical, thermal, or UV bonding procedures. Such an aπay may contain any number of sptm and may be produced by hand or by using available devices, materials, and machines.
Microaπays may be prepared, used, and analyzed using methods known in the art. (See, e.g., 5 Brennan, T.M. et al. (1995) U.S. Patent No. 5,474,796; Schena, M. et al. (1996) Proc. Natl. Acad.
Sci. USA 93:10614-10619; Baldeschweiler et al. (1995) PCT application WO95/251116; Shalon, D. et al. (1995) PCT application WO95/35505; Heller, R.A. et al. (1997) Proc. Natl. Acad. Sci. USA 94:2150-2155; and Heller, MJ. et al. (1997) U.S. Patent No. 5,605,662.)
Probes may be labeled by either PCR or enzymatic techniques using a variety of o commercially available reporter molecules. For example, commercial kits are available for radioactive and chencdluminescent labeling (Amersham Pharmacia Biotech) and for alkaline phosphatase labeling (Life Technologies). Alternatively, sptm may be cloned into commercially available vectors for the production of RNA probes. Such probes may be transcribed in the presence of at least one labeled nucleotide (e.g., 32P-ATP, Amersham Pharmacia Biotech). 5 Additionally the polynucleotides of SEQ ID NO: 1-567 or suitable fragments thereof can be used to isolate full length cDNA sequences utilizing hybridization and/or amplification procedures well known in the art, e.g., cDNA library screening, PCR amplification, etc. The molecular cloning of such full length cDNA sequences may employ the method of cDNA library screening with probes using the hybridization, stringency, washing, and probing strategies described above and in Ausubel, supra, o Chapters 3, 5, and 6. These procedures may also be employed with genomic libraries to isolate genomic sequences of sptm in order to analyze, e.g., regulatory elements.
Genetic Mapping
Gene identification and mapping are important in the investigation and treatment of almost all 5 conditions, diseases, and disorders. Cancer, cardiovascular disease, Alzheimer's disease, arthritis, diabetes, and mental illnesses are of particular interest. Each of these conditions is more complex than the single gene defects of sickle cell anemia or cystic fibrosis, with select groups of genes being predictive of predisposition for a particular condition, disease, or disorder. For example, cardiovascular disease may result from malfunctioning receptor molecules that fail to clear cholesterol from the bloodstream, and diabetes may result when a particular individual's immune system is activated by an infection and attacks the insulin-producing cells of the pancreas. In some studies, Alzheimer's disease has been linked to a gene on chromosome 21; other studies predict a different gene and location. Mapping of disease genes is a complex and reiterative process and generally proceeds from genetic linkage analysis to physical mapping. As a condition is noted among members of a family, a genetic linkage map traces parts of chromosomes that are inherited in the same pattern as the condition. Statistics link the inheritance of particular conditions to particular regions of chromosomes, as defined by RFLP or other markers. (See, for example, Lander, E. S. and Botstein, D. (1986) Proc. Natl. Acad. Sci. USA 83:7353-7357.) Occasionally, genetic markers and their locations are known from previous studies. More often, however, the markers are simply stretches of DNA that differ among individuals. Examples of genetic linkage maps can be found in various scientific journals or at the Online Mendelian Inheritance in Man (OMIM) World Wide Web site.
In another embodiment of the invention, sptm sequences may be used to generate hybridization probes useful in chromosomal mapping of naturally occurring genomic sequences. Either coding or noncoding sequences of sptm may be used, and in some instances, noncoding sequences may be preferable over coding sequences. For example, conservation of an sptm coding sequence among members of a multi-gene family may potentially cause undesired cross hybridization during chromosomal mapping. The sequences may be mapped to a particular chromosome, to a specific region of a chromosome, or to artificial chromosome constructions, e.g., human artificial chromosomes (HACs), yeast artificial chromosomes (YACs), bacterial artificial chromosomes (BACs), bacterial PI constructions, or single chromosome cDNA libraries. (See, e.g., Harrington, J.J. et al. (1997) Nat. Genet. 15:345-355; Price, CM. (1993) Blood Rev. 7:127-134; and Trask, BJ. (1991) Trends Genet. 7:149-154.)
Fluorescent in situ hybridization (FISH) may be coπelated with other physical chromosome mapping techniques and genetic map data. (See, e.g., Meyers, supra, pp. 965-968.) Coπelation between the location of sptm on a physical chromosomal map and a specific disorder, or a predisposition to a specific disorder, may help define the region of DNA associated with that disorder. The sptm sequences may also be used to detect polymorphisms that are genetically linked to the inheritance of a particular condition, disease, or disorder. In situ hybridization of chromosomal preparations and genetic mapping techniques, such as linkage analysis using established chromosomal markers, maybe used for extending existing genetic maps. Often the placement of a gene on the chromosome of another mammalian species, such as mouse, may reveal associated markers even if the number or arm of the coπesponding human chromosome is not known. These new marker sequences can be mapped to human chromosomes 5 and may provide valuable information to investigators searching for disease genes using positional cloning or other gene discovery techniques. Once a disease or syndrome has been crudely correlated by genetic linkage with a particular genomic region, e.g., ataxia-telangiectasia to llq22-23, any sequences mapping to that area may represent associated or regulatory genes for further investigation. (See, e.g., Gatti, R.A. et al. (1988) Nature 336:577-580.) The nucleotide sequences ofthe subject 0 invention may also be used to detect differences in chromosomal architecture due to translocation, inversion, etc., among normal, carrier, or affected individuals.
Once a disease-associated gene is mapped to a chromosomal region, the gene is cloned in order to identify mutations or other alterations (e.g., translocations or inversions) that maybe coπelated with disease. This process includes a physical map of the chromosomal region containing 5 the disease-gene of interest along with associated markers. A physical map is necessary for determining the nucleotide sequence of and order of marker genes on a particular chromosomal region. Physical mapping techniques are well known in the art and involve the generation of overlapping sets of cloned DNA fragments from a particular organelle, chromosome, or genome. These clones are analyzed to reconstruct and catalog their order. Once the position of a marker is o determined, the DNA from that region is obtained by consulting the catalog and selecting clones from that region. The gene of interest is located through positional cloning techniques using hybridization or similar methods.
Diagnostic Uses 5 In various embodiments, embodiments of sptm described herein can be configured to be used to design probes useful in diagnostic assays known to those skilled in the art. Such assays can be configured to be used to diagnose, detect, confirm or quantitate conditions, disorders, or diseases associated with abnormal levels of sptm expression. Labeled probes developed from sptm sequences are added to a sample under hybridizing conditions of desired stringency. In some instances, sptm, or o fragments or oligonucleotides derived from sptm, may be used as primers in amplification steps prior to hybridization. The amount of hybridization complex formed is quantified and compared with standards for a selected cell or tissue type. Indication of the presence of the condition, disorder, or disease can be determined by variation of the amount of sptm expression from the assay standard. The amount of variation indicative of the condition can be above or below the standard, can be selected by the 5 medical practioner, can be determined from known patient populations and/or amounts known in the medical arts and/or associated standards organizations or regulations (e.g. CLIA). Examples of qualitative or quantitative diagnostic assays or methods may include but are not limited to northern, dot blot, or other membrane or dip-stick based technologies or multiple-sample format technologies such as PCR, enzyme-linked immunosorbent assay (ELISA)-like, pin, chip-based assays and the like. 5 The probes described above may also be used to monitor the progress of conditions, disorders, or diseases associated with abnormal levels of sptm expression, or to evaluate the efficacy of a particular therapeutic treatment. The candidate probe maybe identified from the sptm that are specific to a given human tissue and have not been observed in GenBank or other genome databases. Such a probe may be used in animal studies, preclinical tests, clinical trials, or in monitoring the 0 treatment of an individual patient. In a typical process, standard expression is established by methods well known in the art for use as a basis of comparison, samples from patients affected by the disorder or disease are combined with the probe to evaluate any deviation from the standard profile, and a therapeutic agent is administered and effects are monitored to generate a treatment profile. Efficacy is evaluated by determining whether the expression progresses toward or returns to the standard 5 normal pattern. Treatment profiles may be generated over a period of several days or several months. Statistical methods well known to those skilled in the art may be use to determine the significance of such therapeutic agents.
The polynucleotides are also useful for identifying individuals from minute biological samples,, for example, by matching the RFLP pattern of a sample's DNA to that of an individual's DNA. The o polynucleotides of the present invention can also be used to detenriine the actual base-by-base DNA sequence of selected portions of an individual's genome. These sequences can be used to prepare PCR primers for amplifying and isolating such selected DNA, which can then be sequenced. Using this technique, an individual can be identified through a unique set of DNA sequences. Once a unique ID database is established for an individual, positive identification of that individual can be made from 5 extremely small tissue samples.
In a particular aspect, oligonucleotide primers derived from the sptm of the invention maybe used to detect single nucleotide polymorphisms (SNPs). SNPs are substitutions, insertions and deletions that are a frequent cause of inherited or acquired genetic disease in humans. Methods of SNP detection include, but are not limited to, single-stranded conformation polymorphism (SSCP) and o fluorescent SSCP (fSSCP) methods. In SSCP, oligonucleotide primers derived from sptm are used to amplify DNA using the polymerase chain reaction (PCR). The DNA may be derived, for example, from diseased or normal tissue, biopsy samples, bodily fluids, and the like. SNPs in the DNA cause differences in the secondary and tertiary structures of PCR products in single-stranded form, and these differences are detectable using gel electrophoresis in non-denaturing gels. In fSCCP, the 5 oligonucleotide primers are fluorescently labeled, which allows detection of the amplimers in high- throughput equipment such as DNA sequencing machines. Additionally, sequence database analysis methods, termed in silico SNP (isSNP), are capable of identifying polymorphisms by comparing the sequences of individual overlapping DNA fragments which assemble into a common consensus sequence. These computer-based methods filter out sequence variations due to laboratory preparation of DNA and sequencing eπors using statistical models and automated analyses of DNA sequence chromatograms. In the alternative, SNPs maybe detected and characterized by mass spectrometry using, for example, the high throughput MASSARRAY system (Sequenom, Inc., San Diego CA). DNA-based identification techniques can be used in forensic technology. DNA sequences taken from very small biological samples such as tissues, e.g., hair or skin, or body fluids, e.g., blood, saliva, semen, etc., can be amplified using, e.g., PCR, to identify individuals. (See, e.g., Erlich, H.
(1992) PCR Technology, Freeman and Co., New York, NY). Similarly, polynucleotides ofthe present invention can be used as polymorphic markers.
There is also a need for reagents capable of identifying the source of a particular tissue.
Appropriate reagents can comprise, for example, DNA probes or primers prepared from the sequences of the present invention that are specific for particular tissues. Panels of such reagents can identify tissue by species and/or by organ type. In a similar fashion, these reagents can be used to screen tissue cultures for contamination.
The polynucleotides of the present invention can also be used as molecular weight markers on nucleic acid gels or Southern blots, as diagnostic probes for the presence of a specific mRNA in a particular cell type, in the creation of subtracted cDNA libraries which aid in the discovery of novel polynucleotides, in selection and synthesis of oligomers for attachment to an array or other support, and as an antigen to elicit an immune response.
Disease Model Systems Using sptm The polynucleotides encoding SPTM or their mammalian homologs may be "knocked out" in an animal model system using homologous recombination in embryonic stem (ES) cells. Such techniques are well known in the art and are useful for the generation of animal models of human disease. (See, e.g., U.S. Patent Number 5,175,383 and U.S. Patent Number 5,767,337.) For example, mouse ES cells, such as the mouse 129/SvJ cell line, are derived from the early mouse embryo and grown in culture. The ES cells are transformed with a vector containing the gene of interest disrupted by a marker gene, e.g., the neomycin phosphotransferase gene (neo; Capecchi, M.R. (1989) Science 244:1288-1292). The vector integrates into the coπesponding region ofthe host genome by homologous recombination. Alternatively, homologous recombination takes place using the Cre-loxP system to knockout a gene of interest in a tissue- or developmental stage-specific manner (Marth, J.D. (1996) Clin. Invest. 97:1999-2002; Wagner, K.U. et al. (1997) Nucleic Acids Res. 25:4323-4330). Transformed ES cells are identified and microinjected into mouse cellblastocysts such as those from the C57BL/6 mouse strain. The blastocysts are surgically transferred to pseudopregnant dams, and the resulting chimeric progeny are genotyped and bred to produce heterozygous or homozygous strains. Transgenic animals thus generated maybe tested with potential therapeutic or toxic agents. 5 The polynucleotides encoding SPTM may also be manipulated in vitro in ES cells derived from human blastocysts. Human ES cells have the potential to differentiate into at least eight separate cell lineages including endoderm, mesoderm, and ectodermal cell types. These cell lineages differentiate into, for example, neural cells, hematopoietic lineages, and cardiomyocytes (Thomson, J.A. et al. (1998) Science 282:1145-1147). 0 The polynucleotides encoding SPTM of the invention can also be used to create "knockin" humanized animals (pigs) or transgenic animals (mice or rats) to model human disease. With knockin technology, a region of sptm is injected into animal ES cells, and the injected sequence integrates into the animal cell genome. Transformed cells are injected into blastulae, and the blastulae are implanted as described above. Transgenic progeny or inbred lines are studied and treated with potential 5 pharmaceutical agents to obtain infoπnation on treatment of a human disease. Alternatively, a mammal inbred to overexpress sptm, resulting, e.g., in the secretion of SPTM in its milk, may also serve as a convenient source of that protein (Janne, J. et al. (1998) Biotechnol. Annu. Rev. 4:55-74).
Screening Assays o SPTM encoded by polynucleotides of the present invention may be used to screen for molecules that bind to or are bound by the encoded polypeptides. The binding of the polypeptide and the molecule may activate (agonist), increase, inhibit (antagonist), or decrease activity of the polypeptide or the bound molecule. Examples of such molecules include antibodies, oligonucleotides, proteins (e.g., receptors), or small molecules. 5 Preferably, the molecule is closely related to the natural ligand of the polypeptide, e.g., a ligand or fragment thereof, a natural substrate, or a structural or functional mimetic. (See, Coligan et al., (1991) Cuπent Protocols in Immunologv 1(2): Chapter 5.) Similarly, the molecule can be closely related to the natural receptor to which the polypeptide binds, or to at least a fragment ofthe receptor, e.g., the active site. In either case, the molecule can be rationally designed using known techniques. o Preferably, the screening for these molecules involves producing appropriate cells which express the polypeptide, either as a secreted protein or on the cell membrane. Preferred cells include cells from mammals, yeast, Drosophila. or E. coli. Cells expressing the polypeptide or cell membrane fractions which contain the expressed polypeptide are then contacted with a test compound and binding, stimulation, or inhibition of activity of either the polypeptide or the molecule is analyzed. 5 An assay may simply test binding of a candidate compound to the polypeptide, wherein binding is detected by a fluorophore, radioisotope, enzyme conjugate, or other detectable label. Alternatively, the assay may assess binding in the presence of a labeled competitor.
Additionally, the assay can be carried out using cell-free preparations, polypeptide/molecule affixed to a solid support, chemical libraries, or natural product mixtures. The assay may also simply 5 comprise the steps of mixing a candidate compound with a solution containing a polypeptide, measuring polypeptide/molecule activity or binding, and comparing the polypeptide/molecule activity or binding to a standard.
Preferably, an ELISA assay using, e.g., a monoclonal or polyclonal antibody, can measure polypeptide level in a sample. The antibody can measure polypeptide level by either binding, directly 0 or indirectly, to the polypeptide or by competing with the polypeptide for a substrate.
All of the above assays can be used in a diagnostic or prognostic context. The molecules discovered using these assays can be used to treat disease or to bring about a particular result in a patient (e.g., blood vessel growth) by activating or inhibiting the polypeptide/molecule. Moreover, the assays can discover agents which may inhibit or enhance the production of the polypeptide from 5 suitably manipulated cells or tissues.
Transcript Imaging and Toxicological Testing
Another embodiment relates to the use of sptm to develop a transcript image of a tissue or cell type. A transcript image represents the global pattern of gene expression by a particular tissue or cell o type. Global gene expression patterns are analyzed by quantifying the number of expressed genes and their relative abundance under given conditions and at a given time. (See Seilhamer et al, "Comparative Gene Transcript Analysis," U.S. Patent Number 5,840,484, expressly incorporated by reference herein.) Thus a transcript image may be generated by hybridizing the polynucleotides of the present invention or their complements to the totality of transcripts or reverse transcripts of a 5 particular tissue or cell type. In an embodiment, the hybridization takes place in high-throughput format, wherein the polynucleotides of the present invention or their complements comprise a subset of a plurality of elements on a microarray. The resultant transcript image would provide a profile of gene activity pertaining to cell signaling.
Transcript images which profile sptm expression may be generated using transcripts isolated o from tissues, cell lines, biopsies, or other biological samples. The transcript image may thus reflect sptm expression in vivo, as in the case of a tissue or biopsy sample, or in vitro, as in the case of a cell line.
Transcript images which profile sptm expression may also be used in conjunction with in vitro model systems and preclinical evaluation of pharmaceuticals, as well as toxicological testing of 5 industrial and naturally-occurring environmental compounds. All compounds induce characteristic gene expression patterns, frequently termed molecular fingerprints or toxicant signatures, which are indicative of mechanisms of action and toxicity (Nuwaysir, E. F. et al. (1999) Mol. Carcinog. 24:153- 159; Steiner, S. and Anderson, N. L. (2000) Toxicol. Lett. 112-113:467-71, expressly incorporated by reference herein). If a test compound has a signature similar to that of a compound with known toxicity, it is likely to share those toxic properties. These fingerprints or signatures are most useful and refined when they contain expression information from a large number of genes and gene families. Ideally, a genome-wide measurement of expression provides the highest quality signature. Even genes whose expression is not altered by any tested compounds are important as well, as the levels of expression of these genes are used to normalize the rest of the expression data. The normalization procedure is useful for comparison of expression data after treatment with different compounds. While the assignment of gene function to elements of a toxicant signature aids in interpretation of toxicity mechanisms, knowledge of gene function is not necessary for the statistical matching of signatures which leads to prediction of toxicity. (See, for example, Press Release 00-02 from the National Institute of Environmental Health Sciences, released February 29, 2000, available at http://www.niehs.nih.gov/oc/news/toxchip.htm.) Therefore, it is important and desirable in toxicological screening using toxicant signatures to include all expressed gene sequences.
In an embodiment, the toxicity of a test compound is assessed by treating a biological sample containing nucleic acids with the test compound. Nucleic acids that are expressed in the treated biological sample are hybridized with one or more probes specific to the polynucleotides ofthe present invention, so that transcript levels coπesponding to the polynucleotides of the present invention may be quantified. The transcript levels in the treated biological sample are compared with levels in an untreated biological sample. Differences in the transcript levels between the two samples are indicative of a toxic response caused by the test compound in the treated sample.
Another particular embodiment relates to the use of SPTM encoded by polynucleotides ofthe present invention to analyze the proteome of a tissue or cell type. The term proteome refers to the global pattern of protein expression in a particular tissue or cell type. Each protein component of a proteome can be subjected individually to further analysis. Proteome expression patterns, or profiles, are analyzed by quantifying the number of expressed proteins and their relative abundance under given conditions and at a given time. A profile of a cell's proteome may thus be generated by separating and analyzing the polypeptides of a particular tissue or cell type. In one embodiment, the separation is achieved using two-dimensional gel electrophoresis, in which proteins from a sample are separated by isoelectric focusing in the first dimension, and then according to molecular weight by sodium dodecyl sulfate slab gel electrophoresis in the second dimension (Steiner and Anderson, supra). The proteins are visualized in the gel as discrete and uniquely positioned spots, typically by staining the gel with an agent such as Coomassie Blue or silver or fluorescent stains. The optical density of each protein spot is generally proportional to the level of the protein in the sample. The optical densities of equivalently positioned protein spots from different samples, for example, from biological samples either treated or untreated with a test compound or therapeutic agent, are compared to identify any changes in protein spot density related to the treatment. The proteins in the
- 5 spots are partially sequenced using, for example, standard methods employing chemical or enzymatic cleavage followed by mass spectrometry. The identity of the protein in a spot may be determined by comparing its partial sequence, preferably of at least 5 contiguous amino acid residues, to the polypeptide sequences of the present invention. In some cases, further sequence data may be obtained for definitive protein identification. 0 A proteomic profile may also be generated using antibodies specific for SPTM to quantify the levels of SPTM expression. In one embodiment, the antibodies are used as elements on a microaπay, and protein expression levels are quantified by exposing the microarray to the sample and detecting the levels of protein bound to each array element (Lueking, A. et al. (1999) Anal. Biochem. 270:103- 11 ; Mendoze, L. G. et al. (1999) Biotechniques 27:778-88). Detection may be performed by a variety 5 of methods known in the art, for example, by reacting the proteins in the sample with a thiol- or amino- reactive fluorescent compound and detecting the amount of fluorescence bound at each aπay element.
Toxicant signatures at the proteome level are also useful for toxicological screening, and should be analyzed in parallel with toxicant signatures at the transcript level. There is a poor 0 coπelation between transcript and protein abundances for some proteins in some tissues (Anderson, N. L. and Seilhamer, J. (1997) Electrophoresis 18:533-537), so proteome toxicant signatures maybe useful in the analysis of compounds which do not significantly affect the transcript image, but which alter the proteomic profile. In addition, the analysis of transcripts in body fluids is difficult, due to rapid degradation of mRNA, so proteomic profiling may be more reliable and informative in such cases. 5 In another embodiment, the toxicity of a test compound is assessed by treating a biological sample containing proteins with the test compound. Proteins that are expressed in the treated biological sample are separated so that the amount of each protein can be quantified. The amount of each protein is compared to the amount of the coπesponding protein in an untreated biological sample. A difference in the amount of protein between the two samples is indicative of a toxic response to the o test compound in the treated sample. Individual proteins are identified by sequencing the amino acid residues of the individual proteins and comparing these partial sequences to the SPTM encoded by polynucleotides of the present invention.
In another embodiment, the toxicity of a test compound is assessed by treating a biological sample containing proteins with the test compound. Proteins from the biological sample are incubated 5 with antibodies specific to the SPTM encoded by polynucleotides of the present invention. The amount of protein recognized by the antibodies is quantified. The amount of protein in the treated biological sample is compared with the amount in an untreated biological sample. A difference in the amount of protein between the two samples is indicative of a toxic response to the test compound in the treated sample. Transcript images may be used to profile sptm expression in distinct tissue types. This process can be used to determine cell signaling activity in a particular tissue type relative to this activity in a different tissue type. Transcript images may be used to generate a profile of sptm expression characteristic of diseased tissue. Transcript images of tissues before and after treatment may be used for diagnostic purposes, to monitor the progression of disease, and to monitor the efficacy of drug treatments for diseases which affect cell signaling activity.
Transcript images of cell lines can be used to assess cell signaling activity and/or to identify cell lines that lack or misregulate this activity. Such cell lines may then be treated with pharmaceutical agents, and a transcript image following treatment may indicate the efficacy of these agents in restoring desired levels of this activity. A similar approach may be used to assess the toxicity of pharmaceutical agents as reflected by undesirable changes in cell signaling activity. Candidate pharmaceutical agents maybe evaluated by comparing their associated transcript images with those of pharmaceutical agents of known effectiveness.
Antisense Molecules The polynucleotides of the present invention are useful in antisense technology. Antisense technology or therapy relies on the modulation of expression of a target protein through the specific binding of an antisense sequence to a target sequence encoding the target protein or directing its expression. (See, e.g., Agrawal, S., ed. (1996) Antisense Therapeutics, Humana Press Inc., Totawa NJ; Alama, A. et al. (1997) Pharmacol. Res. 36(3):171-178; Crooke, S.T. (1997) Adv. Pharmacol. 40:1-49; Sharma, H.W. and R. Narayanan (1995) Bioessays 17(12):1055-1063; and Lavrosky, Y. et al. (1997) Biochem. Mol. Med. 62(l):ll-22.) An antisense sequence is a polynucleotide sequence capable of specifically hybridizing to at least a portion of the target sequence. Antisense sequences bind to cellular mRNA and/or genomic DNA, affecting translation and/or transcription. Antisense sequences can be DNA, RNA, or nucleic acid mimics and analogs. (See, e.g., Rossi, J.J. et al. (1991) Antisense Res. Dev. l(3):285-288; Lee, R. et al. (1998) Biochemistry 37(3):900-1010; Pardridge, W.M. et al. (1995) Proc. Natl. Acad. Sci. USA 92(12):5592-5596; and Nielsen, P. E. and Haaima, G. (1997) Chem. Soc. Rev. 96:73-78.) Typically, the binding which results in modulation of expression occurs through hybridization or binding of complementary base pairs. Antisense sequences can also bind to DNA duplexes through specific interactions in the major groove of the double helix. The polynucleotides of the present invention and fragments thereof can be used as antisense sequences to modify the expression of the polypeptide encoded by sptm. The antisense sequences can be produced ex vivo, such as by using any of the ABI nucleic acid synthesizer series (Applied Biosystems) or other automated systems known in the art. Antisense sequences can also be produced biologically, such as by transforming an appropriate host cell with an expression vector containing the 5 sequence of interest. (See, e.g., Agrawal, supra.)
In therapeutic use, any gene delivery system suitable for introduction of the antisense sequences into appropriate target cells can be used. Antisense sequences can be delivered intracellularly in the form of an expression plasmid which, upon transcription, produces a sequence complementary to at least a portion of the cellular sequence encoding the target protein. (See, e.g., 0 Slater, J.E., et al. (1998) J. Allergy Clin. Immunol. 102(3):469-475; and Scanlon, K.J., et al. (1995) 9(13):1288-1296.) Antisense sequences can also be introduced intracellularly through the use of viral vectors, such as retrovirus and adeno-associated virus vectors. (See, e.g., Miller, A.D. (1990) Blood 76:271; Ausubel, F.M. et al. (1995) Cuπent Protocols in Molecular Biology, John Wiley & Sons, New York NY; Uckert, W. and W. Walther (1994) Pharmacol. Ther. 63(3):323-347.) Other gene delivery 5 mechanisms include liposome-derived systems, artificial viral envelopes, and other systems known in the art. (See, e.g., Rossi, JJ. (1995) Br. Med. Bull. 51(l):217-225; Boado, RJ. et al. (1998) J. Pharm. Sci. 87(11):1308-1315; and Morris, M.C. et al. (1997) Nucleic Acids Res. 25(14):2730-2736.)
Expression 0 In order to express a biologically active SPTM, the nucleotide sequences encoding SPTM or fragments thereof maybe inserted into an appropriate expression vector, i.e., a vector which contains the necessary elements for transcriptional and translational control of the inserted coding sequence in a suitable host. Methods which are well known to those skilled in the art may be used to construct expression vectors containing sequences encoding SPTM and appropriate transcriptional and 5 translational control elements. These methods include in vitro recombinant DNA techniques, synthetic techniques, and in vivo genetic recombination. (See, e.g., Sambrook, supra, Chapters 4, 8, 16, and 17; and Ausubel, supra, Chapters 9, 10, 13, and 16.)
A variety of expression vector/host systems may be utilized to contain and express sequences encoding SPTM. These include, but are not limited to, microorganisms such as bacteria transformed o with recombinant bacteriophage, plasmid, or cosmid DNA expression vectors; yeast transformed with yeast expression vectors; insect cell systems infected with viral expression vectors (e.g., baculovirus); plant cell systems transformed with viral expression vectors (e.g., cauliflower mosaic virus, CaMV, or tobacco mosaic virus, TMV) or with bacterial expression vectors (e.g., Ti or pBR322 plasmids); or animal (mammalian) cell systems. (See, e.g., Sambrook, supra; Ausubel, 1995, supra, Van Heeke, G. 5 and S.M. Schuster (1989) J. Biol. Chem. 264:5503-5509; Bitter, G.A. et al. (1987) Methods Enzymol. 153:516-544; Scorer, CA. et al. (1994) Bio/Technology 12:181-184; Engelhard, E.K. et al. (1994) Proc. Natl. Acad. Sci. USA 91:3224-3227; Sandig, V. et al. (1996) Hum. Gene Ther. 7:1937-1945; Takamatsu, N. (1987) EMBO J. 6:307-311; Coruzzi, G. et al. (1984) EMBO J. 3:1671-1680; Broglie, R. et al. (1984) Science 224:838-843; Winter, J. et al. (1991) Results Probl. Cell Differ. 17:85-105; The McGraw Hill Yearbook of Science and Technology (1992) McGraw Hill, New York NY, pp. 191-196; Logan, J. and T. Shenk (1984) Proc. Natl. Acad. Sci. USA 81:3655-3659; and Harrington, J.J. et al. (1997) Nat. Genet. 15:345-355.) Expression vectors derived from retroviruses, adeno viruses, or herpes or vaccinia viruses, or from various bacterial plasmids, maybe used for delivery of nucleotide sequences to the targeted organ, tissue, or cell population. (See, e.g., Di Nicola, M. et al. (1998) Cancer Gen. Ther. 5(6):350-356; Yu, M. et al., (1993) Proc. Natl. Acad. Sci. USA
90(13):6340-6344; Buller, R.M. et al. (1985) Nature 317(6040):813-815; McGregor, D.P. et al. (1994) Mol. Immunol. 31(3):219-226; and Nerma, I.M. and Ν. Somia (1997) Nature 389:239-242.) The invention is not limited by the host cell employed.
For long term production of recombinant proteins in mammalian systems, stable expression of SPTM in cell lines is preferred. For example, sequences encoding SPTM can be transformed into cell lines using expression vectors which may contain viral origins of replication and/or endogenous expression elements and a selectable marker gene on the same or on a separate vector. Any number of selection systems may be used to recover transformed cell lines. (See, e.g., Wigler, M. et al. (1977) Cell 11:223-232; Lowy, I. et al. (1980) Cell 22:817-823.; Wigler, M. et al. (1980) Proc. Natl. Acad. Sci. USA 77:3567-3570; Colbere-Garapin, F. et al. (1981) J. Mol. Biol. 150:1-14; Hartman, S.C. and R.CMulligan (1988) Proc. Natl. Acad. Sci. USA 85:8047-8051; Rhodes, CA. (1995) Methods Mol. Biol. 55:121-131.)
Therapeutic Uses of sptm The polynucleotides encoding SPTM of the invention may be used for somatic or germline gene therapy. Gene therapy may be performed to (i) coπect a genetic deficiency (e.g., in the cases of severe combined immunodeficiency (SCID)-Xl disease characterized by X-linked inheritance (Cavazzana-Calvo, M. et al. (2000) Science 288:669-672), severe combined immunodeficiency syndrome associated with an inherited adenosine deaminase (ADA) deficiency (Blaese, R.M. et al. (1995) Science 270:475-480; Bordignon, C et al. (1995) Science 270:470-475), cystic fibrosis (Zabner, J. et al. (1993) Cell 75:207-216; Crystal, R.G. et al. (1995) Hum. Gene Therapy 6:643-666; Crystal, R.G. et al. (1995) Hum. Gene Therapy 6:667-703), thalassemias, familial hypercholesterolemia, and hemophilia resulting from Factor VDI or Factor IX deficiencies (Crystal, R.G. (1995) Science 270:404-410; Verma. I.M. and Somia, N. (1997) Nature 389:239-242)), (ii) express a conditionally lethal gene product (e.g., in the case of cancers which result from unregulated cell proliferation), or (iii) express a protein which affords protection against intracellular parasites (e.g., against human retroviruses, such as human immunodeficiency virus (HJN) (Baltimore, D. (1988) Nature 335:395- 396; Poeschla, E. et al. (1996) Proc. Natl. Acad. Sci. USA. 93:11395-11399), hepatitis B or C virus (HBN, HCV); fungal parasites, such as Candida albicans and Paracoccidioides brasiliensis; and protozoan parasites such as Plasmodium falciparum and Trypanosoma cruzi). In the case where a genetic deficiency in sptm expression or regulation causes disease, the expression of sptm from an appropriate population of transduced cells may alleviate the clinical manifestations caused by the genetic deficiency.
In a further embodiment of the invention, diseases or disorders caused by deficiencies in sptm are treated by constructing mammalian expression vectors comprising sptm and introducing these vectors by mechanical means into sptm-deficient cells. Mechanical transfer technologies for use with cells in vivo or ex vitro include (i) direct DΝA microinjection into individual cells, (ii) ballistic gold particle delivery, (iii) liposome-mediated transfection, (iv) receptor-mediated gene transfer, and (v) the use of DΝA transposons (Morgan, R.A. and Anderson, W.F. (1993) Annu. Rev. Biochem. 62:191- 217; Ivies, Z. (1997) Cell 91:501-510; Boulay, J-L. and Recipon, H (1998) Curr. Opin. Biotechnol. 9:445-450).
Expression vectors that may be effective for the expression of sptm include, but are not limited to, the PCDΝA 3.1, EPITAG, PRCCMV2, PREP, PVAX vectors (Invitrogen, Carlsbad CA), PCMV-SCRIPT, PCMV-TAG, PEGSH/PERV (Stratagene, La Jolla CA), and PTET-OFF, PTET-OΝ, PTRE2, PTRE2-LUC, PTK-HYG (Clontech, Palo Alto CA). The sptm of the invention maybe expressed using (i) a constitutively active promoter, (e.g., from cytomegalovirus (CMV), Rous sarcoma virus (RSV), SV40 virus, thymidine kinase (TK), or β-actin genes), (ii) an inducible promoter (e.g., the tetracycline-regulated promoter (Gossen, M. and Bujard, H. (1992) Proc. Νatl. Acad. Sci. U.S.A. 89:5547-5551; Gossen, M. et al., (1995) Science 268:1766-1769; Rossi, F.M.V. and Blau, H.M. (1998) Cuπ. Opin. Biotechnol. 9:451-456), commercially available in the T-REX plasmid (Invitrogen); the ecdysone-inducible promoter (available in the plasmids PVGRXR and PIΝD; Invitrogen); the FK506/rapamycin inducible promoter; or the RU486/mifepristone inducible promoter (Rossi, F.M.V. and Blau, H.M. supra), or (iii) a tissue-specific promoter or the native promoter of the endogenous gene encoding SPTM from a normal individual. Commercially available liposome transformation kits (e.g. , the PERFECT LIPID
TRANSFECTION KIT, available from Invitrogen) allow one with ordinary skill in the art to deliver polynucleotides to target cells in culture and require minimal effort to optimize experimental parameters. In the alternative, transformation is performed using the calcium phosphate method (Graham, F.L. and Eb, A J. (1973) Virology 52:456-467), or by electroporation (Neumann, E. et al. (1982) EMBO J. 1 :841-845). The introduction of DNA to primary cells involves modification of these standardized mammalian transfection protocols.
In another embodiment of the invention, diseases or disorders caused by genetic defects with respect to sptm expression are treated by constructing a retiovirus vector consisting of (i) sptm under the control of an independent promoter or the retrovirus long terminal repeat (LTR) promoter, (ii) appropriate RNA packaging signals, and (iii) a Rev-responsive element (RRE) along with additional retrovirus cw-acting RNA sequences and coding sequences required for efficient vector propagation. Retrovirus vectors (e.g., PFB and PFBNEO) are commercially available (Stratagene) and are based on published data (Riviere, I. et al. (1995) Proc. Natl. Acad. Sci. U.S.A. 92:6733-6737), incorporated by reference herein. The vector is propagated in an appropriate vector producing cell line (VPCL) that expresses an envelope gene with a tropism for receptors on the target cells or a promiscuous envelope protein such as VSVg (Armentano, D. et al. (1987) J. Virol. 61:1647-1650; Bender, M.A. et al. (1987) J. Virol. 61:1639-1646; Adam, M.A. and Miller, A.D. (1988) J. Virol. 62:3802-3806; Dull, T. et al. (1998) J. Virol. 72:8463-8471; Zufferey, R. et al. (1998) J. Virol. 72:9873-9880). U.S. Patent Number 5,910,434 to Rigg ("Method for obtaining retrovirus packaging cell lines producing high transducing efficiency retroviral supernatant") discloses a method for obtaining retrovirus packaging cell lines and is hereby incorporated by reference. Propagation of retrovirus vectors, transduction of a population of cells (e.g., CD4+ T-cells), and the return of transduced cells to a patient are procedures well known to persons skilled in the art of gene therapy and have been well documented (Ranga, U. et al. (1997) J. Virol. 71:7020-7029; Bauer, G. et al. (1997) Blood 89:2259-2267; Bonyhadi, M.L. (1997) J. Virol. 71:4707-4716; Ranga, U. et al. (1998) Proc. Natl. Acad. Sci. U.S.A. 95:1201-1206; Su, L. (1997) Blood 89:2283-2290).
In the alternative, an adenovirus-based gene therapy delivery system is used to deliver sptm to cells which have one or more genetic abnormalities with respect to the expression of sptm. The construction and packaging of adenovirus-based vectors are well known to those with ordinary skill in the art. Replication defective adenovirus vectors have proven to be versatile for importing genes encoding immunoregulatory proteins into intact islets in the pancreas (Csete, M.E. et al. (1995) Transplantation 27 :263-268). Potentially useful adenoviral vectors are described in U.S. Patent Number 5,707,618 to Armentano ("Adenovirus vectors for gene therapy"), hereby incorporated by reference. For adenoviral vectors, see also Antinozzi, P.A. et al. (1999) Annu. Rev. Nutr. 19:511-544 and Verma, I.M. and Somia, N. (1997) Nature 18:389:239-242, both incorporated by reference herein. In another alternative, a herpes-based, gene therapy delivery system is used to deliver sptm to target cells which have one or more genetic abnormalities with respect to the expression of sptm. The use of herpes simplex virus (HSV)-based vectors may be especially valuable for introducing sptm to cells ofthe central nervous system, for which HSV has a tropism. The construction and packaging of herpes-based vectors are well known to those with ordinary skill in the art. A replication-competent herpes simplex virus (HSV) type 1-based vector has been used to deliver a reporter gene to the eyes of primates (Liu, X. et al. (1999) Exp. Eye Res.l69:385-395). The construction of a HSV-1 virus vector has also been disclosed in detail in U.S. Patent Number 5,804,413 to DeLuca ("Herpes simplex virus strains for gene transfer"), which is hereby incorporated by reference. U.S. Patent Number 5,804,413 teaches the use of recombinant HSV d92 which consists of a genome containing at least one exogenous gene to be transferred to a cell under the control of the appropriate promoter for purposes including human gene therapy. Also taught by this patent are the construction and use of recombinant HSV strains deleted for ICP4, ICP27 and ICP22. For HSV vectors, see also Goins, W. F. et al. 1999 J. Virol. 73:519-532 and Xu, H. et al., (1994) Dev. Biol. 163:152-161, hereby incorporated by reference. The manipulation of cloned herpesvirus sequences, the generation of recombinant virus following the transfection of multiple plasmids containing different segments of the large herpesvirus genomes, the growth and propagation of herpesvirus, and the infection of cells with herpesvirus are techniques well known to those of ordinary skill in the art.
In another alternative, an alphavirus (positive, single-stranded RNA virus) vector is used to deliver sptm to target cells. The biology of the prototypic alphavirus, Semliki Forest Virus (SFV), has been studied extensively and gene transfer vectors have been based on the SFV genome (Garoff, H. and Li, K-J. (1998) Cuπ. Opin. Biotech. 9:464-469). During alphavirus RNA replication, a subgenomic RNA is generated that normally encodes the viral capsid proteins. This subgenomic RNA replicates to higher levels than the full-length genomic RNA, resulting in the overproduction of capsid proteins relative to the viral proteins with enzymatic activity (e.g., protease and polymerase).
Similarly, inserting sptm into the alphavirus genome in place ofthe capsid-coding region results in the production of a large number of sptm RNAs and the synthesis of high levels of SPTM in vector transduced cells. While alphavirus infection is typically associated with cell lysis within a few days, the ability to establish a persistent infection in hamster normal kidney cells (BHK-21) with a variant of Sindbis virus (SIN) indicates that the lytic replication of alphaviruses can be altered to suit the needs of the gene therapy application (Dryga, S.A. et al. (1997) Virology 228:74-83). The wide host range of alphaviruses will allow the introduction of sptm into a variety of cell types. The specific transduction of a subset of cells in a population may require the sorting of cells prior to transduction. The methods of manipulating infectious cDNA clones of alphaviruses, performing alphavirus cDNA and RNA transfections, and performing alphavirus infections, are well known to those with ordinary skill in the art.
Antibodies
Anti-SPTM antibodies may be used to analyze protein expression levels. Such antibodies include, but are not limited to, polyclonal, monoclonal, chimeric, single chain, and Fab fragments. For descriptions of and protocols of antibody technologies, see, e.g., Pound J.D. (1998) Immunochemical Protocols, Humana Press, Totowa, NJ.
The amino acid sequence encoded by the sptm of the Sequence Listing may be analyzed by appropriate software (e.g., LASERGENE NAVIGATOR software, DNASTAR) to determine 5 regions of high immunogenicity. The optimal sequences for immunization are selected from the C- terminus, the N-terminus, and those intervening, hydrophilic regions of the polypeptide which are likely to be exposed to the external environment when the polypeptide is in its natural conformation. Analysis used to select appropriate epitopes is also described by Ausubel (1997, supra. Chapter 11.7). Peptides used for antibody induction do not need to have biological activity; however, they should be o antigenic. Peptides used to induce specific antibodies may have an amino acid sequence consisting of at least five amino acids, preferably at least 10 amino acids, and most preferably at least 15 amino acids. A peptide which mimics an antigenic fragment of the natural polypeptide may be fused with another protein such as keyhole limpet hemocyanin (KLH; Sigma, St. Louis MO) for antibody production. A peptide encompassing ah antigenic region may be expressed from an sptm, synthesized 5 as described above, or purified from human cells.
Procedures well known in the art may be used for the production of antibodies. Various hosts including mice, goats, and rabbits, may be immunized by injection with a peptide. Depending on the host species, various adjuvants maybe used to increase immunological response.
In one procedure, peptides about 15 residues in length maybe synthesized using an ABI 431 A 0 ' peptide synthesizer (Applied Biosystems) using frnoc-chemistry and coupled to KLH (Sigma) by reaction with M-maleimidobenzoyl-N-hydroxysuccinimide ester (Ausubel, 1995, supra). Rabbits are immunized with the peptide-KLH complex in complete Freund's adjuvant. The resulting antisera are tested for antipeptide activity by binding the peptide to plastic, blocking with 1% bovine serum albumin (BSA), reacting with rabbit antisera, washing, and reacting with radioiodinated goat anti-rabbit IgG. 5 Antisera with antipeptide activity are tested for anti-SPTM activity using protocols well known in the art, including ELISA, radioimmunoassay (RIA), and immunoblotting.
In another procedure, isolated and purified peptide maybe used to immunize mice (about 100 μg of peptide) or rabbits (about 1 mg of peptide). Subsequently, the peptide is radioiodinated and used to screen the immunized animals' B-lymphocytes for production of antipeptide antibodies. Positive o cells are then used to produce hybridomas using standard techniques. About 20 mg of peptide is sufficient for labeling and screening several thousand clones. Hybridomas of interest are detected by screening with radioiodinated peptide to identify those fusions producing peptide-specific monoclonal antibody. In a typical protocol, wells of a multi-well plate (FAST, Becton-Dickinson, Palo Alto, CA) are coated with affinity-purified, specific rabbit-anti-mouse (or suitable anti-species IgG) antibodies at 5 10 mg/ml. The coated wells are blocked with 1% BSA and washed and exposed to supematants from hybridomas. After incubation, the wells are exposed to radiolabeled peptide at 1 mg/ml.
Clones producing antibodies bind a quantity of labeled peptide that is detectable above background. Such clones are expanded and subjected to 2 cycles of cloning. Cloned hybridomas are injected into pristane-treated mice to produce ascites, and monoclonal antibody is purified from the ascitic fluid by affinity chromatography on protein A (Amersham Pharmacia Biotech). Several procedures for the production of monoclonal antibodies, including in vitro production, are described in Pound (supra). Monoclonal antibodies with antipeptide activity are tested for anti-SPTM activity using protocols well known in the art, including ELISA, RIA, and immunoblotting.
Antibody fragments containing specific binding sites for an epitope may also be generated. For example, such fragments include, but are not limited to, the Ffab^ fragments produced by pepsin digestion ofthe antibody molecule, and the Fab fragments generated by reducing the disulfide bridges ofthe F(ab')2 fragments. Alternatively, construction of Fab expression libraries in filamentous bacteriophage allows rapid and easy identification of monoclonal fragments with desired specificity (Pound, supra, Chaps. 45-47). Antibodies generated against polypeptide encoded by spt can be used to purify and characterize full-length SPTM protein and its activity, binding partners, etc.
Assays Using Antibodies
Anti-SPTM antibodies may be used in assays to quantify the amount of SPTM found in a particular human cell. Such assays include methods utilizing the antibody and a label to detect expression level under normal or disease conditions. The peptides and antibodies of the invention may be used with or without modification or labeled by joining them, either covalently or noncovalently, with a reporter molecule.
Protocols for detecting and measuring protein expression using either polyclonal or monoclonal antibodies are well known in the art. Examples include ELISA, RIA, and fluorescent activated cell sorting (FACS). Such immunoassays typically involve the formation of complexes between the SPTM and its specific antibody and the measurement of such complexes. These and other assays are described in Pound (supra).
Without further elaboration, it is believed that one skilled in the art can, using the preceding description, utilize the present invention to its fullest extent. The following embodiments are, therefore, to be construed as merely illustrative, and not limitative of the remainder of the disclosure in any way whatsoever.
Without further elaboration, it is believed that one skilled in the art can, using the preceding description, utilize the present invention to its fullest extent. The following embodiments are, therefore, to be construed as merely illustrative, and not limitative of the remainder ofthe disclosure in any way whatsoever. The disclosures of all patents, applications, and publications mentioned above and below, . including U.S. Application Ser. No. 60/280,067, U.S. Application Ser. No. 60/280,068, U.S. Application Ser. No.60/291,280, U.S. Application Ser. No. 60/291,849, U.S. Application Ser. No. 60/291,829, U.S. Application Ser. No. 60/299,428, U.S. Application Ser. No. 60/300,001, and U.S. Application Ser. No. 60/299,776, are hereby expressly incorporated by reference herein.
EXAMPLES I. Construction of cDNA Libraries
RNA was purchased from CLONTECH Laboratories, Inc. (Palo Alto CA) or isolated from various tissues. Some tissues were homogenized and lysed in guanidinium isothiocyanate, while others were homogenized and lysed in phenol or in a suitable mixture of denaturants, such as TRIZOL (Life Technologies), a monophasic solution of phenol and guanidine isothiocyanate. The resulting lysates were centrifuged over CsCl cushions or extracted with chloroform. RNA was precipitated with either isopropanol or sodium acetate and ethanol, or by other routine methods. Phenol extraction and precipitation of RNA were repeated as necessary to increase RNA purity. In most cases, RNA was treated with DNase. For most libraries, poly(A+) RNA was isolated using oligo d(T)-coupled paramagnetic particles (Promega Corporation (Promega), Madison WI), OLIGOTEX latex particles (QIAGEN, Inc. (QIAGEN), Valencia CA), or an OLIGOTEX mRNA purification kit (QIAGEN). Alternatively, RNA was isolated directly from tissue lysates using other RNA isolation kits, e.g., the POLY(A)PURE mRNA purification kit (Ambion, Inc., Austin TX).
In some cases, Stratagene was provided with RNA and constructed the coπesponding cDNA libraries. Otherwise, cDNA was synthesized and cDNA libraries were constructed with the UNIZAP vector system (Stratagene Cloning Systems, Inc. (Stratagene), La Jolla CA) or SUPERSCRIPT plasmid system (Life Technologies), using the recommended procedures or similar methods known in the art. (See, e.g., Ausubel, 1997, supra, Chapters 5.1 through 6.6.) Reverse transcription was initiated using oligo d(T) or random primers. Synthetic oligonucleotide adapters were ligated to double stranded cDNA, and the cDNA was digested with the appropriate restriction enzyme or enzymes. For most libraries, the cDNA was size-selected (300-1000 bp) using SEPHACRYL S1000, SEPHAROSE CL2B, or SEPHAROSE CL4B column chromatography (Amersham Pharmacia Biotech) or preparative agarose gel electrophoresis. cDNAs were ligated into compatible restriction enzyme sites of the polylinker of a suitable plasmid, e.g., PBLUESCRTPT plasmid (Stratagene), PSPORT1 plasmid (Life Technologies), PCDNA2.1 plasmid (Invitrogen, Carlsbad CA), PBK-CMV plasmid (Stratagene), PCR2-TOPOTA plasmid (Invitrogen), PCMV-ICIS plasmid (Stratagene), pIGEN (Incyte Genomics, Palo Alto CA), pRARE (Incyte Genomics), or pINCY (Incyte Genomics), or derivatives thereof. Recombinant plasmids were transformed into competent E. coli cells including XLl-Blue, XLl-BlueMRF, or SOLR from Stratagene or DH5α, DH10B, or ElectroMAX DH10B from Life Technologies.
II. Isolation of cDNA Clones
5 Plasmids were recovered from host cells by in vivo excision using the UNIZAP vector system
(Stratagene) or by cell lysis. Plasmids were purified using at least one of the following: the Magic or WIZARD Minipreps DNA purification system (Promega); the AGTC Miniprep purification kit (Edge BioSystems, Gaithersburg MD); and the QIAWELL 8, QIAWELL 8 Plus, and QIAWELL 8 Ultra plasmid purification systems or the R.E.A.L. PREP 96 plasmid purification kit (QIAGEN). Following 0 precipitation, plasmids were resuspended in 0.1 ml of distilled water and stored, with or without lyophilization, at 4°C
Alternatively, plasmid DNA was amplified from host cell lysates using direct link PCR in a high-throughput format. (Rao, V.B. (1994) Anal. Biochem. 216:1-14.) Host cell lysis and thermal cycling steps were carried out in a single reaction mixture. Samples were processed and stored in 5 384-well plates, and the concentration of amplified plasmid DNA was quantified fluorometrically using PICOGREEN dye (Molecular Probes, Inc. (Molecular Probes), Eugene OR) and a FLUOROSKAN II fluorescence scanner (Labsystems Oy. Helsinki, Finland).
III. Sequencing and Analysis o cDNA sequencing reactions were processed using standard methods or high-throughput instrumentation such as the ABI CATALYST 800 thermal cycler (Applied Biosystems) or the PTC- 200 thermal cycler (MJ Research) in conjunction with the HYDRA microdispenser (Robbins Scientific Corp., Sunnyvale CA) or the MICROLAB 2200 liquid transfer system (Hamilton). cDNA sequencing reactions were prepared using reagents provided by Amersham Pharmacia Biotech or 5 supplied in ABI sequencing kits such as the ABI PRISM BIGDYE Terminator cycle sequencing ready reaction kit (Applied Biosystems). Electrophoretic separation of cDNA sequencing reactions and detection of labeled polynucleotides were carried out using the MEGABACE 1000 DNA sequencing system (Molecular Dynamics); the ABI PRISM 373 or 377 sequencing system (Applied Biosystems) in conjunction with standard ABI protocols and base calling software; or other sequence o analysis systems known in the art. Reading frames within the cDNA sequences were identified using standard methods (reviewed in Ausubel, 1997, supra, Chapter 7.7). Some of the cDNA sequences were selected for extension using the techniques disclosed in Example VHL
IV. Assembly and Analysis of Sequences 5 Component sequences from chromatograms were subject to PHRED analysis and assigned a quality score. The sequences having at least a required quality score were subject to various preprocessing editing pathways to eliminate, e.g., low quality 3 ' ends, vector and linker sequences, polyA tails, Alu repeats, mitochondrial and ribosomal sequences, bacterial contamination sequences, and sequences smaller than 50 base pairs. In particular, low-information sequences and repetitive 5 elements (e.g., dinucleotide repeats, Alu repeats, etc.) were replaced by "n's", or masked, to prevent spurious matches.
Processed sequences were then subject to assembly procedures in which the sequences were assigned to gene bins (bins). Each sequence could only belong to one bin. Sequences in each gene bin were assembled to produce consensus sequences (templates). Subsequent new sequences were 0 added to existing bins using BLASTN (v.1.4 WashU) and CROSSMATCH. Candidate pairs were identified as all BLAST hits having a quality score greater than or equal to 150. Alignments of at least 82% local identity were accepted into the bin. The component sequences from each bin were assembled using a version of PHRAP. Bins with several overlapping component sequences were assembled using DEEP PHRAP. The orientation (sense or antisense) of each assembled template 5 was determined based on the number and orientation of its component sequences. Template sequences as disclosed in the sequence listing coπespond to sense strand sequences (the "forward" reading frames), to the best determination. The complementary (antisense) strands are inherently disclosed herein. The component sequences which were used to assemble each template consensus sequence are listed in Table 3 by their positions along the template nucleotide sequences. o Bins were compared against each other and those having local similarity of at least 82% were combined and reassembled. Reassembled bins having templates of insufficient overlap (less than 95% local identity) were re-split. Assembled templates were also subject to analysis by STΓTCHER/EXON MAPPER algorithms which analyze the probabilities of the presence of splice variants, alternatively spliced exons, splice junctions, differential expression of alternative spliced 5 genes across tissue types or disease states, etc. These resulting bins were subject to several rounds of the above assembly procedures.
Once gene bins were generated based upon sequence alignments, bins were clone joined based upon clone information. If the 5' sequence of one clone was present in one bin and the 3' sequence from the same clone was present in a different bin, it was likely that the two bins actually o belonged together in a single bin. The resulting combined bins underwent assembly procedures to regenerate the consensus sequences.
The final assembled templates were subsequently annotated using the following procedure. Template sequences were analyzed using BLASTN (v2.0, NCBI) versus gbpri (GenBank version 128). "Hits" were defined as an exact match having from 95% local identity over 200 base pairs 5 through 100% local identity over 100 base pairs, or a homolog match having an E-value, i.e. a probability score, of <1 x 10"8. The hits were subject to frameshift FASTx versus GENPEPT (GenBank version 128). (See Table 6). In this analysis, a homolog match was defined as having an E-value of < 1 x 10"8. The assembly method used above was described in "System and Methods for Analyzing Biomolecular Sequences," U.S.S.N. 09/276,534, filed March 25, 1999, and the L1FESEQ Gold user manual (Incyte) both incorporated by reference herein.
Following assembly, template sequences were subjected to motif, BLAST, and functional analyses, and categorized in protein hierarchies using methods described in, e.g., "Database System Employing Protein Function Hierarchies for Viewing Biomolecular Sequence Data," U.S. Patent Number 6,023,659; "Relational Database for Storing Biomolecule Information," U.S.S.N. 08/947,845, filed October 9, 1997; "Project-Based Full-Length Biomolecular Sequence Database," U.S. Patent Number 5,953,727; and "Relational Database and System for Storing Information Relating to Biomolecular Sequences," U.S.S.N. 09/034,807, filed March 4, 1998, all of which are incorporated by reference herein.
The template sequences were further analyzed by translating each template in all three forward reading frames and searching each translation against the Pfam database of hidden Markov model-based protein families and domains using the HMMER software package (available to the public from Washington University School of Medicine, St. Louis MO). (See also World Wide Web site http://pfam.wustl.edu/for detailed descriptions of Pfam protein domains and families.)
Additionally, the template sequences were translated in all three forward reading frames, and each translation was searched against hidden Markov models for signal peptides using the HMMER software package. Construction of hidden Markov models and their usage in sequence analysis has been described. (See, for example, Eddy, S.R. (1996) Curr. Opin. Str. Biol. 6:361-365.) Only those signal peptide hits with a cutoff score of 11 bits or greater are reported. A cutoff score of 11 bits or greater corresponds to at least about 91-94% true-positives in signal peptide prediction. Template sequences were also translated in all three forward reading frames, and each translation was searched against TMHMMER, a program that uses a hidden Markov model (HMM) to delineate transmembrane segments on protein sequences and determine orientation (Sonnhammer, E.L. et al. (1998) Proc. Sixth Intl. Conf. On Intelligent Systems for Mol. Biol., Glasgow et al., eds., The Am. Assoc. for Artificial Intelligence (AAAI) Press, Menlo Park, CA, and MIT Press, Cambridge, MA, pp. 175-182.) Regions of templates which, when translated, contain similarity to signal peptide or transmembrane consensus sequences are reported in Table 2.
Template sequences are further analyzed using the bioinformatics tools listed in Table 6, or using sequence analysis software known in the art such as MACDNASIS PRO software (Hitachi Software Engineering, South San Francisco CA) and LASERGENE software (DNASTAR). Template sequences may be further queried against public databases such as the GenBank rodent, mammalian, vertebrate, prokaryote, and eukaryote databases.
The template sequences were translated to derive the corresponding longest open reading frame as presented by the polypeptide sequences as reported in Table 5. Alternatively, a polypeptide of the invention may begin at any of the methionine residues within the full length translated polypeptide. Polypeptide sequences were subsequently analyzed by querying against the GenBank protein database (GENPEPT, (GenBank version 128)). Full length polynucleotide sequences are also analyzed using MACDNASIS PRO software (Hitachi Software Engineering, South San Francisco CA) and LASERGENE software (DNASTAR). Polynucleotide and polypeptide sequence alignments are generated using default parameters specified by the CLUSTAL algorithm as incorporated into the MEGALIGN multisequence alignment program (DNASTAR), which also calculates the percent identity between aligned sequences.
Table 5 shows sequences with homology to the polypeptides of the invention as identified by BLAST analysis against the GenBank protein (GENPEPT) database. Column 1 shows the polypeptide sequence identification number (SEQ ID NO:) for the polypeptide segments of the invention. Column 2 shows the reading frame used in the translation of the polynucleotide sequences encoding the polypeptide segments. Column 3 shows the length of the translated polypeptide segments. Columns 4 and 5 show the start and stop nucleotide positions of the polynucleotide sequences encoding the polypeptide segments. Column 6 shows the GenBank identification number (GI Number) of the nearest GenBank homolog. Column 7 shows the probability score for the match between each polypeptide and its GenBank homolog. Column 8 shows the annotation ofthe GenBank homolog.
V. Analysis of Polynucleotide Expression
Northern analysis is a laboratory technique used to detect the presence of a transcript of a gene and involves the hybridization of a labeled nucleotide sequence to a membrane on which RNAs from a particular cell type or tissue have been bound. (See, e.g., Sambrook, supra, ch. 7; Ausubel, 1995, supra, ch. 4 and 16.)
Analogous computer techniques applying BLAST were used to search for identical or related molecules in cDNA databases such as GenBank or LDFESEQ (Incyte Genomics). This analysis is much faster than multiple membrane-based hybridizations. In addition, the sensitivity of the computer search can be modified to determine whether any particular match is categorized as exact or similar. The basis of the search is the product score, which is defined as: BLAST Score x Percent Identity
5 x minimum {length(Seq. 1), length(Seq. 2)}
The product score takes into account both the degree of similarity between two sequences and the length ofthe sequence match. The product score is a normalized value between 0 and 100, and is calculated as follows: the BLAST score is multiplied by the percent nucleotide identity and the product is divided by (5 times the length of the shorter of the two sequences). The BLAST score is calculated by assigning a score of +5 for every base that matches in a high-scoring segment pair (HSP), and -4 for every mismatch. Two sequences may share more than one HSP (separated by gaps). If there is more than one HSP, then the pair with the highest BLAST score is used to calculate the product score. The product score represents a balance between fractional overlap and quality in a BLAST alignment. For example, a product score of 100 is produced only for 100% identity over the entire length of the shorter of the two sequences being compared. A product score of 70 is produced either by 100% identity and 70% overlap at one end, or by 88% identity and 100% overlap at the other. A product score of 50 is produced either by 100% identity and 50% overlap at one end, or 79% identity and 100% overlap.
Alternatively, polynucleotide sequences encoding SPTM are analyzed with respect to the tissue sources from which they were derived. Polynucleotide sequences encoding SPTM were assembled, at least in part, with overlapping Incyte cDNA sequences. Each cDNA sequence is derived from a cDNA library constructed from a human tissue. Each human tissue is classified into one of the following organ/tissue categories: cardiovascular system; connective tissue; digestive system; embryonic structures; endocrine system; exocrine glands; genitalia, female; genitalia, male; germ cells; hemic and immune system; liver; musculoskeletal system; nervous system; pancreas; respiratory system; sense organs; skin; stomatognathic system; unclassified/mixed; or urinary tract. The number of libraries in each category for each polynucleotide sequence encoding SPTM is counted and divided by the total number of libraries across all categories for each polynucleotide sequence encoding SPTM. Similarly, each human tissue is classified into one of the following disease/condition categories: cancer, cell line, developmental, inflammation, neurological, trauma, cardiovascular, pooled, and other, and the number of libraries in each category for each polynucleotide sequence encoding SPTM is counted and divided by the total number of libraries across all categories for each polynucleotide sequence encoding SPTM. The resulting percentages reflect the tissue-specific and disease-specific expression of cDNA encoding SPTM. Percentage values of tissue-specific expression are reported in . cDNA sequences and cDNA library/tissue information are found in the LEPESEQ GOLD database (Incyte Genomics, Palo Alto CA). VI. Tissue Distribution Profiling
A tissue distribution profile is determined for each template by compiling the cDNA library tissue classifications of its component cDNA sequences. Each component sequence, is derived from a cDNA library constructed from a human tissue. Each human tissue is classified into one of the 5 following categories: cardiovascular system; connective tissue; digestive system; embryonic structures; endocrine system; exocrine glands; genitalia, female; genitalia, male; germ cells; hemic and immune system; liver; musculoskeletal system; nervous system; pancreas; respiratory system; sense organs; skin; stomatognathic system; unclassified/mixed; or urinary tract. Template sequences, component sequences, and cDNA library/tissue information are found in the LIFESEQ GOLD 0 database (Incyte Genomics, Palo Alto CA). shows the tissue distribution profile for the templates of the invention. For each template, the three most frequently observed tissue categories are shown in column 2, along with the percentage of component sequences belonging to each category. Only tissue categories with percentage values of ≥ 10% are shown. A tissue distribution of "widely distributed" in column 2 indicates percentage values 5 of <10% in all tissue categories.
VII. Transcript Image Analysis
Transcript images are generated as described in Seilhamer et al., "Comparative Gene Transcript Analysis," U.S. Patent Number 5,840,484, incorporated herein by reference. 0
VIII. Extension of Polynucleotide Sequences and Isolation of a Full-length cDNA
Oligonucleotide primers designed using an sptm ofthe Sequence Listing are used to extend the nucleic acid sequence. One primer is synthesized to initiate 5' extension of the template, and the other primer, to initiate 3' extension ofthe template. The initial primers maybe designed using OLIGO 5 4.06 software (National Biosciences, Inc. (National Biosciences), Plymouth MN), or another appropriate program, to be about 22 to 30 nucleotides in length, to have a GC content of about 50% or more, and to anneal to the target sequence at temperatures of about 68 °C to about 72 °C. Any stretch of nucleotides which would result in hairpin structures and primer-primer dimerizations are avoided. Selected human cDNA libraries are used to extend the sequence. If more than one o extension is necessary or desired, additional or nested sets of primers are designed.
High fidelity amplification is obtained by PCR using methods well known in the art. PCR is performed in 96-well plates using the PTC-200 thermal cycler (MJ Research). The reaction mix contains DNA template, 200 nmol of each primer, reaction buffer containing Mg2+, (NH^SO.*., and β- mercaptoethanol, Taq DNA polymerase (Amersham Pharmacia Biotech), ELONGASE enzyme (Life 5 Technologies), and Pfu DNA polymerase (Stratagene), with the following parameters for primer pair PCI A and PCI B: Step 1: 94°C, 3 min; Step 2: 94°C, 15 sec; Step 3: 60°C, 1 min; Step 4: 68 °C, 2 min; Step 5: Steps 2, 3, and 4 repeated 20 times; Step 6: 68°C, 5 min; Step 7: storage at 4°C In the alternative, the parameters for primer pair T7 and SK+ are as follows: Step 1: 94 °C, 3 min; Step 2: 94°C, 15 sec; Step 3: 57°C, 1 min; Step 4: 68°C, 2 min; Step 5: Steps 2, 3, and 4 repeated 20 times; Step 6: 68 °C, 5 min; Step 7 : storage at 4 °C.
The concentration of DNA in each well is determined by dispensing 100 μl PICOGREEN quantitation reagent (0.25% (v/v); Molecular Probes) dissolved in IX Tris-EDTA (TE) and 0.5 μl of undiluted PCR product into each well of an opaque fluorimeter plate (Corning Incorporated (Corning), Corning NY), allowing the DNA to bind to the reagent. The plate is scanned in a ELUOROSKAN II (Labsystems Oy) to measure the fluorescence ofthe sample and to quantify the concentration of
DNA. A 5 μl to 10 μl aliquot ofthe reaction mixture is analyzed by electrophoresis on a 1 % agarose mini-gel to determine which reactions are successful in extending the sequence.
The extended nucleotides are desalted and concentrated, transfeπed to 384-well plates, digested with CviJI cholera virus endonuclease (Molecular Biology Research, Madison WI), and sonicated or sheared prior to religation into pUC 18 vector (Amersham Pharmacia Biotech). For shotgun sequencing, the digested nucleotides are separated on low concentration (0.6 to 0.8%) agarose gels, fragments are excised, and agar digested with AGAR ACE (Promega). Extended clones are religated using T4 ligase (New England Biolabs, Inc., Beverly MA) into pUC 18 vector (Amersham Pharmacia Biotech), treated with Pfu DNA polymerase (Stratagene) to fill-in restriction site overhangs, and transfected into competent E. coli cells. Transformed cells are selected on antibiotic-containing media, individual colonies are picked and cultured overnight at 37 °C in 384-well plates in LB/2x carbenicillin liquid media.
The cells are lysed, and DNA is amplified by PCR using Taq DNA polymerase (Amersham Pharmacia Biotech) and Pfu DNA polymerase (Stratagene) with the following parameters: Step 1: 94°C, 3 min; Step 2: 94°C, 15 sec; Step 3: 60°C, 1 min; Step 4: 72°C, 2 min; Step 5: steps 2, 3, and 4 repeated 29 times; Step 6: 72 °C, 5 min; Step 7: storage at 4°C DNA is quantified by PICOGREEN reagent (Molecular Probes) as described above. Samples with low DNA recoveries are reamplified using the same conditions as described above. Samples are diluted with 20% dimethysulfoxide (1:2, v/v), and sequenced using DYENAMIC energy transfer sequencing primers and the DYENAMIC DIRECT kit (Amersham Pharmacia Biotech) or the ABI PRISM BIGDYE Terminator cycle sequencing ready reaction kit (Applied Biosystems).
In like manner, the sptm is used to obtain regulatory sequences (promoters, introns, and enhancers) using the procedure above, oligonucleotides designed for such extension, and an appropriate genomic library. IX. Labeling of Probes and Southern Hybridization Analyses
Hybridization probes derived from the sptm of the Sequence Listing are employed for screening cDNAs, mRNAs, or genomic DNA. The labeling of probe nucleotides between 100 and 1000 nucleotides in length is specifically described, but essentially the same procedure may be used with larger cDNA fragments. Probe sequences are labeled at room temperature for 30 minutes using a T4 polynucleotide kinase, γ32P-ATP, and 0.5X One-Phor-All Plus (Amersham Pharmacia Biotech) buffer and purified using a ProbeQuant G-50 Microcolumn (Amersham Pharmacia Biotech). The probe mixture is diluted to 107 dpm/μg/ml hybridization buffer and used in a typical membrane-based hybridization analysis. The DNA is digested with a restriction endonuclease such as Eco RV and is electrophoresed through a 0.7% agarose gel. The DNA fragments are transferred from the agarose to nylon membrane (NYTRAN Plus, Schleicher & Schuell, Inc., Keene NH) using procedures specified by the manufacturer of the membrane. Prehybridization is carried out for three or more hours at 68 °C, and hybridization is carried out overnight at 68 °C To remove non-specific signals, blots are sequentially washed at room temperature under increasingly stringent conditions, up to 0. lx saline sodium citrate (SSC) and 0.5% sodium dodecyl sulfate. After the blots are placed in a PHOSPHORIMAGER cassette (Molecular Dynamics) or are exposed to autoradiography film, hybridization patterns of standard and experimental lanes are compared. Essentially the same procedure is employed when screening RNA.
X. Chromosome Mapping of sptm
The cDNA sequences which were used to assemble SEQ ID NO:l-567 are compared with sequences from the Incyte LIFESEQ database and public domain databases using BLAST and other implementations of the Smith- Waterman algorithm. Sequences from these databases that match SEQ ID NO: 1-567 are assembled into clusters of contiguous and overlapping sequences using assembly algorithms such as PHRAP (Table 6). Radiation hybrid and genetic mapping data available from public resources such as the Stanford Human Genome Center (SHGC), Whitehead Institute for Genome Research (WIGR), and Genethon are used to determine if any ofthe clustered sequences have been previously mapped. Inclusion of a mapped sequence in a cluster will result in the assignment of all sequences of that cluster, including its particular SEQ ID NO:, to that map location. The genetic map locations of SEQ ID NO:l-567 are described as ranges, or intervals, of human chromosomes. The map position of an interval, in centiMorgans, is measured relative to the terminus ofthe chromosome's p-arm. (The centiMorgan (cM) is a unit of measurement based on recombination frequencies between chromosomal markers. On average, 1 cM is roughly equivalent to 1 megabase (Mb) of DNA in humans, although this can vary widely due to hot and cold spots of recombination.) The cM distances are based on genetic markers mapped by Genethon which provide boundaries for radiation hybrid markers whose sequences were included in each ofthe clusters.
XI. Microarray Analysis
5 Probe Preparation from Tissue or Cell Samples
Total RNA is isolated from tissue samples using the guanidinium thiocyanate method and polyA+ RNA is purified using the oligo (dT) cellulose method. Each polyA+ RNA sample is reverse transcribed using MMLV reverse-transcriptase, 0.05 pg/μl oligo-dT primer (21mer), IX first strand buffer, 0.03 units/μl RNase inhibitor, 500 μM dATP, 500 μM dGTP, 500 μM dTTP, 40 μM dCTP, 40 0 μM dCTP-Cy3 (BDS) or dCTP-Cy5 (Amersham Pharmacia Biotech). The reverse transcription reaction is performed in a 25 ml volume containing 200 ng polyA+ RNA with GEMBRIGHT kits (Incyte). Specific control polyA+ RNAs are synthesized by in vitro transcription from non-coding yeast genomic DNA (W. Lei, unpublished). As quantitative controls, the control mRNAs at 0.002 ng, 0.02 ng, 0.2 ng, and 2 ng are diluted into reverse transcription reaction at ratios of 1:100,000, 1:10,000, 5 1:1000, 1:100 (w/w) to sample mRNA respectively. The control mRNAs are diluted into reverse transcription reaction at ratios of 1:3, 3:1, 1:10, 10:1, 1:25, 25:1 (w/w) to sample mRNA differential expression patterns. After incubation at 37° C for 2 hr, each reaction sample (one with Cy3 and another with Cy5 labeling) is treated with 2.5 ml of 0.5M sodium hydroxide and incubated for 20 minutes at 85° C to the stop the reaction and degrade the RNA. Probes are purified using two o successive CHROMA SPIN 30 gel filtration spin columns (CLONTECH Laboratories, Inc.
(CLONTECH), Palo Alto CA) and after combining, both reaction samples are ethanol precipitated using 1 ml of glycogen (1 mg/ml), 60 ml sodium acetate, and 300 ml of 100% ethanol. The probe is then dried to completion using a SpeedVAC (Savant Instruments Inc., Holbrook NY) and resuspended in 14 μl 5X SSC/0.2% SDS. 5
Microarray Preparation
Sequences of the present invention are used to generate aπay elements. Each aπay element is amplified from bacterial cells containing vectors with cloned cDNA inserts. PCR amplification uses primers complementary to the vector sequences flanking the cDNA insert. Array elements are o amplified in thirty cycles of PCR from an initial quantity of 1-2 ng to a final quantity greater than 5 μg.
Amplified aπay elements are then purified using SEPHACRYL-400 (Amersham Pharmacia Biotech).
Purified aπay elements are immobilized on polymer-coated glass slides. Glass microscope slides (Corning) are cleaned by ultrasound in 0.1% SDS and acetone, with extensive distilled water washes between and after treatments. Glass slides are etched in 4% hydrofluoric acid (VWR 5 Scientific Products Corporation (VWR), West Chester, PA), washed extensively in distilled water, and coated with 0.05% aminopropyl silane (Sigma) in 95% ethanol. Coated slides are cured in a 110°C oven.
Array elements are applied to the coated glass substrate using a procedure described in US Patent No. 5,807,522, incorporated herein by reference. 1 μl of the aπay element DNA, at an average 5 concentration of 100 ng/μl, is loaded into the open capillary printing element by a high-speed robotic apparatus. The apparatus then deposits about 5 nl of aπay element sample per slide.
Microarrays are UV-crosslinked using a STRATALINKER UN-crosslihker (Stratagene). Microaπays are washed at room temperature once in 0.2% SDS and three times in distilled water. Non-specific binding sites are blocked by incubation of microarrays in 0.2% casein in phosphate o buffered saline (PBS) (Tropix, Inc., Bedford, MA) for 30 minutes at 60° C followed by washes in 0.2% SDS and distilled water as before.
Hybridization
Hybridization reactions contain 9 μl of probe mixture consisting of 0.2 μg each of Cy3 and Cy5 5 labeled cDNA synthesis products in 5X SSC, 0.2% SDS hybridization buffer. The probe mixture is heated to 65° C for 5 minutes and is aliquoted onto the microarray surface and covered with an 1.8 cm2 coverslip. The arrays are transfeπed to a waterproof chamber having a cavity just slightly larger than a microscope slide. The chamber is kept at 100% humidity internally by the addition of 140 μl of 5x SSC in a co er of the chamber. The chamber containing the arrays is incubated for about 6.5 0 hours at 60° C. The arrays are washed for 10 min at 45°C in a first wash buffer (IX SSC, 0.1% SDS), three times for 10 minutes each at 45° C in a second wash buffer (0.1X SSC), and dried.
Detection
Reporter-labeled hybridization complexes are detected with a microscope equipped with an 5 Innova 70 mixed gas 10 W laser (Coherent, Inc., Santa Clara CA) capable of generating spectral lines at 488 nm for excitation of Cy3 and at 632 nm for excitation of Cy5. The excitation laser light is focused on the aπay using a 20X microscope objective (Nikon, Inc., Melville NY). The slide containing the aπay is placed on a computer-controlled X-Y stage on the microscope and raster- scanned past the objective. The 1.8 cm x 1.8 cm array used in the present example is scanned with a o resolution of 20 micrometers.
In two separate scans, a mixed gas multiline laser excites the two fluorophores sequentially. Emitted light is split, based on wavelength, into two photomultiplier tube detectors (PMT R1477, Hamamatsu Photonics Systems, Bridgewater NJ) coπesponding to the two fluorophores. Appropriate filters positioned between the array and the photomultiplier tubes are used to filter the signals. The 5 emission maxima of the fluorophores used are 565 nm for Cy3 and 650 nm for Cy5. Each aπay is typically scanned twice, one scan per fluorophore using the appropriate filters at the laser source, although the apparatus is capable of recording the spectra from both fluorophores simultaneously. The sensitivity of the scans is typically calibrated using the signal intensity generated by a cDNA control species added to the probe mix at a known concentration. A specific location on the 5 aπay contains a complementary DNA sequence, allowing the intensity of the signal at that location to be coπelated with a weight ratio of hybridizing species of 1:100,000. When two probes from different sources (e.g., representing test and control cells), each labeled with a different fluorophore, are hybridized to a single aπay for the purpose of identifying genes that are differentially expressed, the calibration is done by labeling samples ofthe calibrating cDNA with the two fluorophores and adding i o identical amounts of each to the hybridization mixture.
The output ofthe photomultiplier tube is digitized using a 12-bit RTT-835H analog-to-digital (A/D) conversion board (Analog Devices, Inc., Norwood, MA) installed in an IBM-compatible PC computer. The digitized data are displayed as an image where the signal intensity is mapped using a linear 20-color transformation to a pseudocolor scale ranging from blue (low signal) to red (high 15 signal). The data is also analyzed quantitatively. Where two different fluorophores are excited and measured simultaneously, the data are first coπected for optical crosstalk (due to overlapping emission spectra) between the fluorophores using each fluorophore's emission spectrum.
A grid is superimposed over the fluorescence signal image such that the signal from each spot is centered in each element of the grid. The fluorescence signal within each element is then
2 o integrated to obtain a numerical value coπesponding to the average intensity of the signal. The software used for signal analysis is the GEMTOOLS gene expression analysis program (Incyte).
XII. Complementary Nucleic Acids
Sequences complementary to the sptm are used to detect, decrease, or inhibit expression of 25 the naturally occurring nucleotide. The use of oligonucleotides comprising from about 15 to 30 base pairs is typical in the art. However, smaller or larger sequence fragments can also be used. Appropriate oligonucleotides are designed from the sptm using OLIGO 4.06 software (National Biosciences) or other appropriate programs and are synthesized using methods standard in the art or ordered from a commercial supplier. To inhibit transcription, a complementary oligonucleotide is
3 o designed from the most unique 5' sequence and used to prevent transcription factor binding to the promoter sequence. To inhibit translation, a complementary oligonucleotide is designed to prevent ribosomal binding and processing ofthe transcript.
XIII. Expression of SPTM
35 Expression and purification of SPTM is accomplished using bacterial or virus-based expression systems. For expression of SPTM in bacteria, cDNA is subcloned into an appropriate vector containing an antibiotic resistance gene and an inducible promoter that directs high levels of cDNA transcription. Examples of such promoters include, but are not limited to, the trp-lac (tad) hybrid promoter and the T5 or T7 bacteriophage promoter in conjunction with the lac operator regulatory element. Recombinant vectors are transformed into suitable bacterial hosts, e.g., BL21(DE3). Antibiotic resistant bacteria express SPTM upon induction with isopropyl beta-D- thiogalactopyranoside (IPTG). Expression of SPTM in eukaryotic cells is achieved by infecting insect or mammalian cell lines with recombinant Autographica californica nuclear polyhedrosis virus (AcMNPV), commonly known as baculovirus. The nonessential polyhedrin gene of baculovirus is replaced with cDNA encoding SPTM by either homologous recombination or bacterial-mediated transposition involving transfer plasmid intermediates. Viral infectivity is maintained and the strong polyhedrin promoter drives high levels of cDNA transcription. Recombinant baculovirus is used to infect Spodoptera frugiperda (Sf9) insect cells in most cases, or human hepatocytes, in some cases. Infection of the latter requires additional genetic modifications to baculovirus. (See e.g., Engelhard, supra; and Sandig, supra.)
In most expression systems, SPTM is synthesized as a fusion protein with, e.g., glutathione S- transferase (GST) or a peptide epitope tag, such as FLAG or 6-His, permitting rapid, single-step, affinity-based purification of recombinant fusion protein from crude cell lysates. GST, a 26-kilodalton enzyme from Schistosoma japonicum, enables the purification of fusion proteins on immobilized glutathione under conditions that maintain protein activity and antigenicity (Amersham Pharmacia Biotech). Following purification, the GST moiety can be proteolytically cleaved from SPTM at specifically engineered sites. FLAG, an 8-amino acid peptide, enables immunoaffinity purification using commercially available monoclonal and polyclonal anti-FLAG antibodies (Eastman Kodak Company, Rochester NY). 6-His, a stretch of six consecutive histidine residues, enables purification on metal-chelate resins (QIAGEN). Methods for protein expression and purification are discussed in Ausubel (1995, supra. Chapters 10 and 16). Purified SPTM obtained by these methods can be used directly in the following activity assay.
XIV. Demonstration of SPTM Activity An assay for SPTM activity measures the expression of SPTM on the cell surface. cDNA encoding SPTM is subcloned into an appropriate mammalian expression vector suitable for high levels of cDNA expression. The resulting construct is transfected into a nonhuman cell line such as NTH3T3. Cell surface proteins are labeled with biotin using methods known in the art. Immunoprecipitations are performed using SPTM-specific antibodies, and immunoprecipitated samples are analyzed using SDS-PAGE and immunoblotting techniques. The ratio of labeled immunoprecipitant to unlabeled immunoprecipitant is proportional to the amount of SPTM expressed on the cell surface.
Alternatively, an assay for SPTM activity measures the amount of SPTM in secretory, membrane-bound organelles. Transfected cells as described above are harvested and lysed. The lysate is fractionated using methods known to those of skill in the art, for example, sucrose gradient ultracentrifugation. Such methods allow the isolation of subcellular components such as the Golgi apparatus, ER, small membrane-bound vesicles, and other secretory organelles. Immunoprecipitations from fractionated and total cell lysates are performed using SPTM-specific antibodies, and immunoprecipitated samples are analyzed using SDS-PAGE and immunoblotting techniques. The concentration of SPTM in secretory organelles relative to SPTM in total cell lysate is proportional to the amount of SPTM in transit through the secretory pathway.
XV. Functional Assays
SPTM function is assessed by expressing sptm at physiologically elevated levels in mammalian cell culture systems. cDNA is subcloned into a mammalian expression vector containing a strong promoter that drives high levels of cDNA expression. Vectors of choice include pCMV SPORT (Life Technologies) and pCR3.1 (Invitrogen Corporation, Carlsbad CA), both of which contain the cytomegalovirus promoter. 5-10 μg of recombinant vector are transiently transfected into a human cell line, preferably of endothelial or hematopoietic origin, using either liposome formulations or electroporation. 1-2 μg of an additional plasmid containing sequences encoding a marker protein are co-transfected.
Expression of a marker protein provides a means to distinguish transfected cells from nontransfected cells and is a reliable predictor of cDNA expression from the recombinant vector. Marker proteins of choice include, e.g., Green Fluorescent Protein (GFP; CLONTECH), CD64, or a CD64-GFP fusion protein. Flow cytometry (FCM), an automated laser optics-based technique, is used to identify transfected cells expressing GFP or CD64-GFP and to evaluate the apoptotic state of the cells and other cellular properties.
FCM detects and quantifies the uptake of fluorescent molecules that diagnose events preceding or coincident with cell death. These events include changes in nuclear DNA content as measured by staining of DNA with propidium iodide; changes in cell size and granularity as measured by forward light scatter and 90 degree side light scatter; down-regulation of DNA synthesis as measured by decrease in bromodeoxyuridine uptake; alterations in expression of cell surface and intracellular proteins as measured by reactivity with specific antibodies; and alterations in plasma membrane composition as measured by the binding of fluorescein-conjugated Annexin V protein to the cell surface. Methods in flow cytometry are discussed in Ormerod, M. G. (1994) Flow Cytometry. Oxford, New York NY.
The influence of SPTM on gene expression can be assessed using highly purified populations of cells transfected with sequences encoding SPTM and either CD64 or CD64-GFP. CD64 and CD64-GFP are expressed on the surface of transfected cells and bind to conserved regions of human immunoglobulin G (IgG). Transfected cells are efficiently separated from nontransfected cells using magnetic beads coated with either human IgG or antibody against CD64 (DYNAL, Inc., Lake Success NY). mRNA can be purified from the cells using methods well known by those of skill in the art. Expression of mRNA encoding SPTM and other genes of interest can be analyzed by northern analysis or microarray techniques.
XVI. Production of Antibodies
SPTM substantially purified using polyacrylamide gel electrophoresis (PAGE; see, e.g., Harrington, M.G. (1990) Methods Enzymol. 182:488-495), or other purification techniques, can be used to immunize rabbits and to produce antibodies using standard protocols. Alternatively, the SPTM amino acid sequence is analyzed using LASERGENE software
(DNASTAR) to determine regions of high immunogenicity, and a corresponding peptide is synthesized and used to raise antibodies by means known to those of skill in the art. Methods for selection of appropriate epitopes, such as those near the C-terminus or in hydrophilic regions are well described in the art. (See, e.g., Ausubel, 1995, supra. Chapter 11.) Typically, peptides 15 residues in length are synthesized using an ABI 431 A peptide synthesizer (Applied Biosystems) using fmoc-chemistry and coupled to KLH (Sigma) by reaction with N-maleiimdobenzoyl-N-hydroxysuccinimide ester (MBS) to increase immunogenicity. (See, e.g., Ausubel, supra.) Rabbits are immunized with the peptide-KLH complex in complete Freund's adjuvant. Resulting antisera are tested for antipeptide activity by, for example, binding the peptide to plastic, blocking with 1% BSA, reacting with rabbit antisera, washing, and reacting with radioiodinated goat anti-rabbit IgG. Antisera with antipeptide activity are tested for anti-SPTM activity using protocols well known in the art, including ELISA, RIA, and immunoblotting.
XVII. Purification of Naturally Occurring SPTM Using Specific Antibodies Naturally occurring or recombinant SPTM is substantially purified by immunoaffinity chromatography using antibodies specific for SPTM. An knmunoaffinity column is constructed by covalently coupling anti-SPTM antibody to an activated chromatographic resin, such as CNBr-activated SEPHAROSE (Amersham Pharmacia Biotech). After the coupling, the resin is blocked and washed according to the manufacturer's instructions. Media containing SPTM are passed over the immunoaffinity column, and the column is washed under conditions that allow the preferential absorbance of SPTM (e.g., high ionic strength buffers in the presence of detergent). The column is eluted under conditions that disrupt antibody/SPTM binding (e.g., a buffer of pH 2 to pH 3, or a high concentration of a chaotrope, such as urea or thiocyanate ion), and SPTM is collected.
XVIII. Identification of Molecules Which Interact with SPTM
SPTM, or biologically active fragments thereof, are labeled with 125I Bolton-Hunter reagent. (See, e.g., Bolton, A.E. and W.M. Hunter (1973) Biochem. J. 133:529-539.) Candidate molecules previously arrayed in the wells of a multi-well plate are incubated with the labeled SPTM, washed, and any wells with labeled SPTM complex are assayed. Data obtained using different concentrations of SPTM are used to calculate values for the number, affinity, and association of SPTM with the candidate molecules.
Alternatively, molecules interacting with SPTM are analyzed using the yeast two-hybrid system as described in Fields, S. and O. Song (1989) Nature 340:245-246, or using commercially available kits based on the two-hybrid system, such as the MATCHMAKER system (CLONTECH).
SPTM may also be used in the PATHCALLTNG process (CuraGen Corp., New Haven CT) which employs the yeast two-hybrid system in a high-throughput manner to determine all interactions between the proteins encoded by two large libraries of genes (Nandabalan, K. et al. (2000) U.S. Patent No. 6,057,101).
All publications and patents mentioned in the above specification are herein incorporated by reference. Various modifications and variations ofthe described method and system of the invention will be apparent to those skilled in the art without departing from the scope and spirit of the invention. Although the invention has been described in connection with specific embodiments, it should be understood that the invention as claimed should not be unduly limited to such specific embodiments. Indeed, various modifications of the above-described modes for caπying out the invention which are obvious to those skilled in the field of molecular biology or related fields are intended to be within the scope of the following claims. TABLE 1
ID NO: Template ID SEQ ID NO: ORF ID
1 LG:1041015.22:2001MAR30 568 LG: 1041015.22.orfl :2001MAR30
2 LG: 106877.10:2001MAR30 569 LG:106877.10.orf3:2001MAR30
3 LG:1138554.16:2001MAR30 570 LG:1138554.16.orf2:2001MAR30
4 LG: 1383277.7:2001MAR30 571 LG:1383277.7.orf3:2001MAR30
5 LG:1397614.15:2001MAR30 572 LG:1397614.15.orfl:2001MAR30
6 LG:1399315.8:2001MAR30 573 LG:1399315.8.orfl:2001MAR30
7 LG:198782.1:2001MAR30 574 LG: 198782.1.orf2a:2001MAR30
7 LG: 198782.1:2001MAR30 575 LG: 198782.1.orf2b:2001M AR30
7 LG: 198782.1.2001MAR30 576 LG:198782.1.orf3:2001MAR30
8 LG:236046.1:2001MAR30 577 LG:236046.1.orf2:2001MAR30
9 LG:332122.6:2001MAR30 578 LG:332122.6.orf3:2001MAR30
10 LG:345320.16:2001MAR30 579 LG:345320.16.orfl:2001MAR30
11 LG:350827.10:2001MAR30 580 LG:350827.10.orf3:2001MAR30
12 LG:399901.5:2001MAR30 581 LG:399901.5.orf3:2001MAR30
13 LG:404563.1:2001MAR30 582 LG:404563.1.orf2:2001MAR30
14 LG:977812.15:2001MAR30 583 LG:977812.15.orf2:2001MAR30
15 LG:983810.1:2001MAR30 584 LG:983810.1.orfl :2001MAR30
16 LG:984488.1:2001MAR30 585 LG:984488.1.orfl :2001MAR30
17 LG:011606.1:2001MAR30 586 LG:011606.1. orfl :2001MAR30
18 LG. 25465.5.-2001MAR30 587 LG:025465.5.orf 1 :2001MAR30
19 LG:025724.10:2001MAR30 588 LG:025724.10.orf3:2001MAR30
20 LG: 1095426.1 :2001MAR30 589 LG:1095426.1.orf3:2001MAR30
21 LG:1132418.1:2001MAR30 590 LG:1132418. l.orf2:2001MAR30
22 LG:1377900.14:2001MAR30 591 LG:1377900.14.orf3:2001MAR30
23 LG:1383812.1 :2001MAR30 592 LG:1383812.1.orf2:2001MAR30
24 LG: 1468687. L2001MAR30 593 LG: 1468687.1.orf3:2001MAR30
25 LG:1505513.1:2001MAR30 594 LG:1505513.1.orfl:2001MAR30
26 LG:178823.9:2001MAR30 595 LG:178823.9.orf2:2001MAR30
27 LG:198342.3:2001MAR30 596 LG: 198342.3.orf3 :2001 MAR30
28 LG:210672.1:2001MAR30 597 LG:210672.1.orfl :2001MAR30
29 LG:212823.8:2001MAR30 598 LG:212823.8.orfl:2001MAR30
30 LG:220495.9:2001MAR30 599 LG:220495.9.orf2:2001MAR30
31 LG:238262.1 :2001MAR30 600 LG:238262.1.orf3:2001MAR30
32 LG:239410.21:2001MAR30 601 LG:239410.21.orf2:2001MAR30
33 LG:245854.7:2001MAR30 602 LG:245854.7.orf3:2001MAR30
34 LG:294697.1 :2001MAR30 603 LG:294697.1.orf3:2001MAR30
35 LG.-345884.1 :2001MAR30 604 LG:345884.1.orfl :2001MAR30
36 LG:400095.15:2001MAR30 605 LG:400095.15. orf 1 :2001MAR30
37 LG:402180.1:2001MAR30 606 LG:402180.1.orf3:2001MAR30
38 LG:403401.1:2001MAR30 607 LG:403401.1.orf3:2001MAR30
39 LG:411327.29:2001MAR30 608 LG:41 1327.29.orfl:2001MAR30
40 LG:417464.10:2001MAR30 609 LG:417464.10.orf2:2001MAR30
41 LG:481997.1 :2001MAR30 610 LG:481997.1.orfl :2001MAR30
42 LG:979304.7:2001MAR30 611 LG:979304.7.orO:2001MAR30
43 LG:997964.1:2001MAR30 612 LG:997964.1.orf3:2001MAR30
44 LG.-998845.1 :2001MAR30 613 LG:998845.1.orf2:2001MAR30
45 LG:000014.1 :2001MAR30 614 LG:000014.1.orfl :2001MAR30
46 LG:000290.9:2001 MAR30 615 LG:000290.9.orfl :2001MAR30
47 LG:001923.1 :2001MAR30 616 LG :001923.1.orf3a:2001 MAR30
47 LG:001923.1:2001MAR30 617 LG:001923.1.orf3b:2001MAR30
48 LG:008606.21 :2001MAR30 618 LG:008606.21.orf3:2001MAR30
49 LG:009699.32:2001MAR30 619 LG:009699.32.orf3:2001MAR30
50 LG:016723.6:2001MAR30 620 LG:016723.6.orfl :2001MAR30
51 LG:017126.5:2001 MAR30 621 LG:017 I26.5.orf2:2001MAR30 . TABLE 1
SEQ ID NO: Template ID SEQ ID NO: ORF ID
52 LG:019362.10:2001MAR30 622 LG:019362.10.orfl:2001MAR30
53 LG:022183.1:2001MAR30 623 LG:022183.1.orf2:2001MAR30
54 LG:028493.1:2001MAR30 624 LG:028493.1.orf3:2001MAR30
55 LG:034197.1:2001MAR30 625 LG:034197.1.orf2:2001MAR30
56 LG:054096.31 :200 IM AR30 626 LG:054096.31.orfl :2001MAR30
57 LG:054807.3:2001MAR30 627 LG:054807.3.orf2:2001MAR30
58 LG:065873.12:2001MAR30 628 LG:065873.12.orf2:2001MAR30
59 LG:083814.6:2001MAR30 629 LG:083814.6.orfl:2001MAR30
59 LG:083814.6:2001MAR30 630 LG:083814.6.orf2:2001MAR30
60 LG:093477.1:2001MAR30 631 LG:093477.1.orf3:2001MAR30
61 LG:099572.12:2001MAR30 632 LG:099572.12.orf 1 :2001MAR30
62 LG:100396.31:2001MAR30 633 LG:100396.31.orf3:2001MAR30
63 LG: 1026903.5 :2001MAR30 634 LG:1026903.5.orf2:2001MAR30
63 LG: 1026903.5 :2001MAR30 635 LG:1026903.5.orf3:2001MAR30
64 LG:1060168.6:2001MAR30 636 LG:1060168.6.orfl:2001MAR30
65 LG:1086906.41:2001MAR30 637 LG: 1086906.41.orfl :2001MAR30
66 LG: 1089326.18 :2001 MAR30 638 LG: 1089326.18.orf2:2001MAR30
67 LG:1090862.32:2001MAR30 639 LG:1090862.32.orf3:2001MAR30
68 LG:1091941.41:2001MAR30 640 LG:1091941.41.orf3:2001MAR30
69 LG:1093386.8:2001MAR30 641 LG:1093386.8.orf2:2001MAR30
70 LG:1094187.33:2001MAR30 642 LG:1094187.33.orf3:2001MAR30
71 LG:1098692.18:2001MAR30 643 LG:1098692.18.orf2:2001MAR30
72 LG:1173104.22:2001MAR30 644 LG:1173104.22.orf3:2001MAR30
73 LG: 1215335.7:2001MAR30 645 LG:1215335.7.orfl:2001MAR30
74 LG:1256753.1:2001MAR30 646 LG: 1256753. l.orf2:2001MAR30
75 LG: 1326702.10:2001 MAR30 647 LG:1326702.10.orf2:2001MAR30
76 LG:1327239.15:2001MAR30 648 LG:1327239.15.orf2:2001MAR30
77 LG:1327867.15:2001MAR30 649 LG:1327867.15.orf2:2001MAR30
78 LG:1383232.1:2001MAR30 650 LG: 1383232.1. orf 1:2001MAR30
79 LG:1383368.40:2001MAR30 651 LG:1383368.40.orf2:2001MAR30
80 LG.-1384477.1:2001MAR30 652 LG:1384477.1.orf2:2001MAR30
81 LG: 1390822.1 :2001MAR30 653 LG: 1390822.1. orf L2001MAR30
82 LG:1398274.13:2001MAR30 654 LG:1398274.13.orf3:2001MAR30
83 LG: 1398646.1:2001 M AR30 655 LG:1398646.1.orf2:2001MAR30
84 LG:1398905.1:2001MAR30 656 LG:1398905.1.orfl:2001MAR30
84 LG: 1398905.1 :2001MAR30 657 LG: 1398905. l.orf2:2001MAR30
85 LG: 1399785.1:2001MAR30 658 LG:1399785.1.orfl:2001MAR30
86 LG:1446193.10:2001MAR30 659 LG:1446193.10.orfl:2001MAR30
87 LG: 1446210.8:2001MAR30 660 LG: 1446210.8.orf 1 :2001MAR30
88 LG:1450054.6:2001MAR30 661 LG:1450054.6.orf2:2001MAR30
89 LG: 1452516.4:2001 M AR30 662 LG: 1452516.4.orf3:2001MAR30
90 LG:1455293.7:2001MAR30 663 LG:1455293.7.orf2:2001MAR30
91 LG:1498113.1:2001MAR30 664 LG:1498113.1.orfl:2001MAR30
92 LG: 1500042.1:2001MAR30 665 LG: 1500042.1.orfl :2001MAR30
93 LG: 1500434.4:2001 MAR30 666 LG:1500434.4.orf3:2001MAR30
94 LG:1501102.4:2001MAR30 667 LG:1501102.4.orf3:2001MAR30
95 LG:1501768.2:2001MAR30 668 LG:1501768.2.orfl:2001MAR30
96 LG:1502155.6:2001MAR30 669 LG:1502155.6.orfl:2001MAR30
97 LG: 1512304.2:2001 MAR30 670 LG:1512304.2.orf3:2001MAR30
98 LG:1512931.11 :2001MAR30 671 LG:1512931.11.orf3:2001MAR30
99 LG: 155076.18:2001MAR30 672 LG:155076.18.orf3:2001MAR30
100 LG:159111.41:2001MAR30 673 LG:15911 1.41.orf3:2001MAR30
101 LG: 170604.1 :2001 MAR30 674 LG: 170604. l .orf3:2001MAR30
102 LG:190477.4:2001MAR30 675 LG:190477.4.orf3:2001MAR30 TABLE 1
SEQ ID NO: Template ID SEQ ID NO: ORF ID
103 LG:198087.8:2001MAR30 676 LG:198087.8.orf2:2001MAR30
104 LG:198743.2:2001MAR30 677 LG:198743.2.orf3:2001MAR30
105 LG: 199194.1.-2001MAR30 678 LG:199194.1.orf2:2001MAR30
106 LG:200727.6:2001MAR30 679 LG:200727.6.orf2:2001MAR30
107 LG:201572.20:2001MAR30 680 LG:201572.20.orfl:2001MAR30
108 LG:201669.25:2001MAR30 681 LG:201669.25.orf3:2001MAR30
109 LG:208588.4:2001MAR30 682 LG:208588.4.orf 1 :2001MAR30
110 LG:210412.29:2001MAR30 683 LG:210412.29.orfl:2001MAR30
111 LG:215051.15:2001MAR30' 684 LG:215051.15.orfl:2001MAR30
112 LG:215475.21:2001MAR30 685 LG:215475.21. orf L2001MAR30
113 LG:224523.1:2001MAR30 686 LG:224523.1.orfl:2001MAR30
114 LG:228186.1:2001MAR30 687 LG:228186.1.orf2:2001MAR30
115 LG:233138.2:2001MAR30 688 LG:233138.2.orf2:2001MAR30
116 LG:234811.10:2001MAR30 689 LG:234811.10.orf2:2001MAR30
117 LG:236092.1:2001MAR30 690 LG:236092.1.orf2:2001MAR30
118 LG:236098.12:2001MAR30 691 LG:236098.12.orfl:2001MAR30
119 LG:236697.15:2001MAR30 692 LG:236697.15.orfl:2001MAR30
120 LG:237503.21:2001MAR30 693 LG:237503.21.orf3:2001MAR30
121 LG:238023J:2001MAR30 694 LG:238023.7.orf2:2001MAR30
122 LG:238209.1:2001MAR30 695 LG:238209.1.orf2:2001MAR30
123 LG:238456.10:2001MAR30 696 LG:238456.10.orf3:2001MAR30
124 LG:239245.1:2001MAR30 697 LG.-239245.1.orf3:2001MAR30
125 LG:239579.8:2001MAR30 698 LG:239579.8.orf3:2001MAR30
126 LG:239601.22:2001MAR30 699 LG:239601.22.orf 1 :2001MAR30
126 LG:239601.22:2001MAR30 700 LG:239601.22.orf3:2001MAR30
127 LG:240121.1:2001MAR30 701 LG:240121.1.orf3:2001MAR30
128 LG:241110.2:2001MAR30 702 LG:241110.2.orB:2001MAR30
129 LG:244948.4:2001MAR30 ' 703 LG:244948.4.orf3:2001MAR30
130 LG:245378.6:2001MAR30 704 LG:245378.6.orf3:2001MAR30
131 LG:248203.9:2001MAR30 705 LG:248203.9.orf 1 :2001MAR30
132 LG:249247.1:2001MAR30 706 LG:249247.1.orf3:2001MAR30
133 LG:267153.16:2001MAR30 707 LG:267153.16.orf2:2001MAR30
134 LG:291759.5:2001MAR30 708 LG:291759.5.orf2:2001MAR30
135 LG:298102.1:2001MAR30 709 LG:298102.1. orf 2001MAR30
136 LG:308891.1:2001MAR30 710 LG:308891.1.orf2:2001MAR30
137 LG:312668.4:2001MAR30 711 LG:312668.4.orfl:2001MAR30
138 LG:331642.6:2001MAR30 712 LG:331642.6.orf2:2001MAR30
139 LG:331851.12:2001MAR30 713 LG:331851.12.orf3:2001MAR30
140 LG:332414.5:2001MAR30 714 LG:332414.5.orf2:2001MAR30
141 LG:332730.12:2001MAR30 715 LG:332730.12.orf2:2001MAR30
142 LG:333062.22:2001MAR30 716 LG:333062.22.orf2:2001MAR30
143 LG:335705.2:2001MAR30 717 LG:335705.2.orf2:2001MAR30
144 LG:337930.16:2001MAR30 718 LG:337930.16.orf2:2001MAR30
145 LG:346481.15:2001MAR30 719 LG:346481.15.orfl :2001MAR30
146 LG:349164.1:2001MAR30 720 LG:349164.1.orf3:2001MAR30
147 LG:350957.5:2001MAR30 721 LG:350957.5.orfl :2001MAR30
148 LG:383512.8:2001MAR30 722 LG:383512.8.orfl :2001MAR30
149 LG:401163.10:2001MAR30 723 LG:401163.10.orfl:2001MAR30
150 LG:402133.1:2001MAR30 724 LG:402133.1.orfl :2001MAR30
151 LG:405820.1:2001MAR30 725 LG:405820.1.orf2:2001 MAR30
152 LG:405846.1:2001MAR30 726 LG:405846.1.orf3:2001MAR30
153 LG:407401.2:2001MAR30 727 LG:407401.2.orf2:2001MAR30
154 LG:408448.10:2001MAR30 728 LG:408448.10.orf3:2001MAR30
155 LG:408854.13:2001MAR30 729 LG:408854.13.orf2:2001MAR30 TABLE 1
SEQ ID NO: Template ID SEQ ID NO: ORF ID
156 LG:411150.14:2001MAR30 730 LG:411150.14.orf2:2001MAR30
157 LG:411466.1:2001MAR30 731 LG:411466.1.orf2:2001MAR30
158 LG:413969.68:2001MAR30 732 LG:413969.68.orfl :2001MAR30
159 LG:419641.35:2001MAR30 733 LG:419641.35.orfl:2001MAR30
160 LG:428206J:2001MAR30 734 LG:428206.7.orf2:2001MAR30
161 LG:430059.1:2001MAR30 735 LG:430059.1.orf3:2001MAR30
162 LG:448040.3:2001MAR30 736 LG:448040.3.orf2:2001 MAR30
163 LG:451274.1:2001MAR30 737 LG:451274.1.orf3:2001MAR30
164 LG:456110.1:2001MAR30 738 LG:456110.1. orf 2001MAR30
165 LG:456954.1:2001MAR30 739 LG:456954.1.orf3 :2001MAR30
166 LG:474942.12:2001MAR30 740 LG:474942.12.orf3:2001MAR30
167 LG:475119.14:2001MAR30 741 LG:475119.14.orfl:2001MAR30
168 LG:479908J7:2001MAR30 742 LG:479908.77.orf3:2001MAR30
169 LG:480127.47:2001MAR30 743 LG:480127.47.orf3:2001MAR30
170 LG:481154.12:2001MAR30 744 LG:481154.12.orf 1 :2001MAR30
171 LG:481414.6:2001MAR30 745 LG:481414.6.orf2:2001MAR30
172 LG:481941.1:2001MAR30 746 LG:481941.1.orf3:2001MAR30
173 LG:887216.4:2001MAR30 747 LG:887216.4.orf3:2001MAR30
174 LG:899402.3:2001MAR30 748 LG:899402.3.orf 1 :2001MAR30
175 LG:899894.2:2001MAR30 749 LG:899894.2.orf3:2001MAR30
176 LG:977908.1:2001MAR30 750 LG:977908.1.orf3:2001MAR30
177 LG:977929.1:2001MAR30 751 LG:977929.1.orfl:2001MAR30
178 LG:978008.14:2001MAR30 752 LG:978008.14.orf3:2001MAR30
179 LG:979054.18:2001MAR30 • 753 LG:979054.18.orfl:2001MAR30
180 LG:979185.10:2001MAR30 754 LG:979185.10.orfl:2001MAR30
181 LG:983654.1:2001MAR30 755 LG:983654.1.orf2:2001MAR30
182 LG:985092.12:2001MAR30 756 LG:985092.12.orf3:2001MAR30
183 LG:987396.8:2001MAR30 757 LG:987396.8.orf2:2001MAR30
184 LG:987418.10:2001MAR30 758 LG:987418.10.orf2:2001MAR30
184 LG:987418.10:2001MAR30 759 LG:987418.10.orf3:2001MAR30
185 LG:997203.25:2001MAR30 760 LG:997203.25.orf3:2001MAR30
186 LG:997477.8:2001MAR30 761 LG:997477.8.orf3:2001MAR30
187 LG:998855.4:2001MAR30 762 LG:998855.4.orfl :2001MAR30
188 LG:999093.1:2001MAR30 763 LG:999093.1.orf2:2001MAR30
189 LG:999183.1:2001MAR30 764 LG:999183.1.orf3:2001MAR30
190 LI: 1032972.1:2001MAY17 765 LI:1032972.1.orfl :2001MAY17
191 LI:170666.6:2001MAY17 766 LI:170666.6.orf2:2001MAY17
192 LI:197048.10:2001MAY17 767 LI:197048.10.orf3:2001MAY17
193 LI:228655.5:2001MAY17 768 LI:228655.5.orf3:2001MAY17
194 LI:229789.6:2001MAY17 769 LI:229789.6.orf3:2001MAY17
195 LI:231500.8:2001MAY17 770 LI:231500.8.orfl:2001MAY17
196 LI:253851.26:2001MAY17 771 L 253851.26.orf3:2001 MAY17
197 LL373302.1.2001MAY17 772 LI:373302.1.orfl :2001MAY17
198 LI:405707.12:2001MAY17 773 LI:405707.12.orf2:2001MAY17
199 LI:411441.8:2001MAY17 774 LI:411441.8.orf3:2001MAY17
200 LI:758193.3:2001MAY17 775 LI:758193.3.orf2:2001MAY17
201 LI:1028562.3:2001MAY17 776 LI:1028562.3.orf2:2001MAY17
202 LI:104650J:2001MAY17 777 LI:104650.7.orf3:2001MAY17
203 LI:1094557.4:2001MAY17 778 LI:1094557.4.orf3:2001MAY17
204 LI:1143528.4:2001MAY17 779 LI:1143528.4.orf2:2001MAY17
205 LI:1172210J:2001MAY17 780 LI:1172210.7.orf2:2001MAY17
206 LI:1178659.14:2001MAY17 781 LI: 1178659.14.orf 1 :2001 MAY17
207 LI: 1983726.3:2001MAY17 782 LI:1983726.3.orf3:2001MAY17
208 LI:2051495.3:2001MAY17 783 LI:2051495.3.orf2:2001MAY17 TABLE 1
SEQ ID NO: Template ID SEQ ID NO: ORF ID
209 LI:2117629.1:2001MAY17 784 LI:2117629.1.orf3:2001MAY17
210 LI:2118007.3.2001MAY17 785 LI:2118007.3.orf3:2001MAY17
211 LI:2118292.9:2001MAY17 786 LI:2118292.9.orf 1 :2001 MAY 17
212 LI:2118733.7:2001MAY17 787 LI:2118733.7.orfl :2001MAY17
213 LI:212702.3:2001MAY17 788 LI:212702.3. orf 1 :2001MAY17
214 ' LI:2207871.10:2001MAY17 789 LI:2207871.10.orf2:2001MAY17
215 LI:2207876.5:2001MAY17 790 LI:2207876.5.orfl :2001MAY17
215 LI:2207876.5:2001MAY17 791 LI:2207876.5.orf2:2001MAY17
216 LI:2208743.1:2001MAY17 792 L 2208743.1.orf3 :2001 MAY 17
217 LI:2208744.1:2001MAY17 793 LI:2208744.1.orf2:2001MAY17
218 LI:230905.3:2001MAY17 794 LI:230905.3.orf2:2001MAY17
219 LI:235233.95:2001MAY17 795 LI:235233.95.orf3:2001MAY17
220 LI:235359.24:2001MAY17 796 LI:235359.24.orf3:2001MAY17
221 LI:238365.6:2001MAY17 797 LI:238365.6.orf2:2001MAY17
222 LI:260259.23:2001MAY17 798 LI:260259.23.orf2:2001MAY17
223 LI:321069.2:2001MAY17 799 LI:321069.2.orfl:2001MAY17
224 LI:331499.8:2001MAY17 800 LI:331499.8.orfl:2001MAY17
225 LI:332176.8:2001MAY17 801 LI:332176.8.orf2:2001MAY17
226 LI:333952.7:2001MAY17 802 LI:333952J.orfl:2001MAY17
227 LI:338428.2:2001MAY17 803 LI:338428.2.orf3:2001MAY17
228 LI:343869.2:2001MAY17 804 LI:343869.2.orf3:2001MAY17
229 LI:363532.1:2001MAY17 805 LI:363532.1.orfl:2001MAY17
230 LI:398153.37:2001MAY17 806 LI:398153.37.orf3:2001MAY17
231 LI:416650.1:2001MAY17 807 LI:416650.1.orf3:2001MAY17
232 LI:444767.32:2001MAY17 . 808 LI:444767.32.orf2:2001MAY17
233 LI:759073.1:2001MAY17 809 , L 759073.1.orfl :200 IM AY 17
234 LI:759902.4:2001MAY17 810 LI:759902.4.orf3 :2001 MAY 17
235 LI:762268.1:2001MAY17 811 LI:762268.1.orfl:2001MAY17
236 L 813699.1.2001MAY17 812 LI:813699.1.orf3:2001MAY17
237 LI:024142.16:2001MAY17 813 LI:024142.16.orf2:2001MAY17
238 LI: 1018424.4:2001MAY17 814 LI:1018424.4.orf2:2001MAY17
239 LI:1085250.6:2001MAY17 815 LI: 1085250.6.orf 1 :2001 MAY 17
240 LI:179233.63:2001MAY17 816 LI:179233.63.orf2:2001MAY17
241 LI:2207125.3:2001MAY17 817 LI:2207125.3.orf3:2001MAY17
242 LI:235153.44:2001MAY17 818 LI:235153.44.orfl :2001MAY17
243 LI:007101.10:2001MAY17 819 LI:007101.10.orfl :2001MAY17
244 LI:008541.2:2001MAY17 820 LI:008541.2.orf3:2001MAY17
245 LI:009658.13:2001MAY17 821 LI.O09658.13.orf 1 :2001 MAY 17
246 LI:020012.14:2001MAY17 822 LI:020012.14.orf3:2001MAY17
247 LI:020691.1:2001MAY17 823 LI:020691.1.orfl:2001MAY17
248 LI:021188.12:2001MAY17 824 LI:021188.12.orf2:2001MAY17
249 LI:021324.4:2001MAY17 825 LI:021324.4.orf3:2001MAY17
250 LI:021834.15:2001MAY17 826 LI:021834.15.orfl :2001MAY17
251 LI:024841.1:2001MAY17 827 L 024841.1. orf 1 :2001 MAY 17
252 LI:025724.12:2001MAY17 828 LI:025724.12.orf2:2001MAY17
253 LI:029328.2:2001MAY17 829 LI:029328.2.orf2:2001 MAY 17
254 LI:032171.5:2001MAY17 830 LI:032171.5.orf2:2001MAY17
255 LI:035055.1:2001MAY17 831 L 035055.1.orf2a:2001 MAY 17
255 LI:035055.1:2001MAY17 832 LI:035055.1.orf2b:2001MAY17
256 LI:036747.17:2001MAY17 833 LI:03674J17.orf2:2001MAY17
257 LI:044301.2:2001MAY17 834 LI:044301.2.orf3:2001MAY17
258 LI:061585.10:2001MAY17 835 LI:061585.10.orf3:2001MAY17
259 LI:066742.21:2001MAY17 836 LL066742.21.orf2:2001 M A Y 17
260 LI:075492.206:2001MAY17 837 LI:075492.206.orf2:2001 MAY 17 TABLE 1
SEQ ID NO: Template ID SEQ ID N( ORF ID
261 L 090782.3.2001MAY17 838 LI:090782.3.orfl:2001MAY17
262 LI:1031308.1:2001MAY17 839 LI:1031308.1.orf2:2001MAY17
263 LI:1054377.1 :2001MAY17 840 LI:1054377.1.orf2:2001MAY17
264 LI:1072074.10:2001MAY17 841 LI:1072074.10.orf2:2001MAY17
265 LI:1072889.15:2001MAY17 842 LI:1072889.15.orf3:2001MAY17
266 LI: 1077480.1.2001MAY17 843 LI:1077480.1.orf3:2001MAY17
267 LI:1079555.1:2001MAY17 844 LI:1079555.1.orf2:2001MAY17
268 LI:1084992.28:2001MAY17 845 LI:1084992.28.orf2:2001MAY17
269 LI:1085472.5:2001MAY17 846 LI:1085472.5. orf 2001MAY 17
270 LI:1086800.7:2001MAY17 847 LI:1086800.7.orf2:2001MAY17
271 LI:1089871.9:2001MAY17 848 LI:1089871.9.orf2:2001MAY17
272 LI:110297.6:2001MAY17 849 LI:110297.6.orf2:2001MAY17
273 LI:1143463.8:2001MAY17 850 LI:1143463.8.orfl:2001MAY17
274 LI:1144466.1:2001MAY17 851 LI:1144466. l.orf2:2001MAY17
275 LT.l 170624.2:2001MAY17 852 LI:1170624.2.orf2:2001MAY17
276 LI:1171602.39:2001MAY17 853 LI:1171602.39.orf2:2001MAY17
277 LI:1182361.3:2001MAY17 854 LI:1182361.3.orfl:2001MAY17
278 LI:1188194.15:2001MAY17 855 LI:1188194.15.orfl:2001MAY17
279 LI:1189195J:2001MAY17 856 LI:1189195.7.orf3:2001MAY17
280 LI:1190092.13:2001MAY17 857 LI:1190092.13.orf3:2001MAY17
281 LI:1190318.4:2001MAY17 858 LI:1190318.4.orf2:2001MAY17
282 LI:144233.1:2001MAY17 859 LI:144233.1.orf3:2001MAY17
283 LI:154608.1:2001MAY17 860 LI: 154608. l.orf2:2001MAY17
284 LI: 170101. 2001MAY17 861 LI:170101.1.orf2:2001MAY17
285 LI:180043.1:2001MAY17 862 LI:180043.1.orfl:2001MAY17
286 LI:193050.1:2001MAY17 863 LI:193050.1.orf2:2001MAY17
287 LI:197477.31:2001MAY17 864 , LI:197477.31.orfl:2001MAY17
288 LI:199639.12:2001MAY17 865 LI:199639.12.orfl:2001MAY17
" 289 LI:200058.6:2001MAY17 866 * ' LI:200058.6.orf3:2001MAY17
290 LI:201374.23:2001MAY17 867 LI:201374.23.orf2:2001MAY17
291 LI:201824.1:2001MAY17 868 LI:201824.1.orf2:2001MAY17
292 LI:201989.11:2001MAY17 869 LI:201989.11.orf2:2001MAY17
293 LI:2035159.1 :2001MAY17 870 LI:2035159.1.orf3:2001MAY17
294 LI:204818.10:2001MAY17 871 LI:204818.10.orfl:2001MAY17
295 LI:2048337.1:2001MAY17 872 LI:2048337.1.orf3:2001MAY17
296 LI:2049697.4:2001MAY17 873 LI:2049697.4.orf3:2001MAY 17
297 LI:2050808.19:2001MAY17 874 LI:2050808.19.orf2:2001MAY17
298 LI:209773.25:2001MAY17 875 LI:209773.25.orf3:2001MAY17
299 LI:2117881.32:2001MAY17 876 LI:2117881.32.orf2:2001MAY17
300 LI:2118140.9:2001MAY17 877 LI:2118140.9.orfl:2001MAY17
301 LI:2118151.15:2001MAY17 878 LI:2118151.15.orf2:2001MAY17
302 LI:2118324.9:2001MAY17 879 LI:2118324.9.orf2:2001MAY17
303 LI.-2118368.12:2001MAY17 880 LI:2118368.12.orf2:2001MAY17
304 LI:2119448.5:2001MAY17 881 LI:2119448.5.orf3:2001MAY17
305 LI:212023J:2001MAY17 882 LI:212023J.orf2:2001MAY17
306 LI:2120556.1 :2001MAY17 883 LI:2120556.1.orf2:2001MAY17
307 LI:2121577.3:2001MAY17 884 LI:2121577.3.orf3:2001MAY17
308 LI:2123395.11:2001MAY17 885 LI:2123395.11.orf3:2001MAY17
309 LI:2123452.9:2001MAY17 886 LI:2123452.9.orf2:2001MAY17
310 LI:2164109.1:2001MAY17 887 LI:2164109.1.orf3:2001MAY17
311 LI:2168320.1:2001MAY17 888 LI:2168320.1.orfl:2001MAY17
312 LI:2173577.1 :2001MAY17 889 LI:2173577.1.orfl:2001MAY17
313 LL2179256. 2001MAY17 890 LI.-2179256.1.orfl :2001 MAY 17
314 LL2180388. L2001MAY17 891 LI:2180388.1.orfl:2001MAY 17 TABLE 1
SEQ ID NO: Template ID SEQ ID NO: ORF ID
315 LI:2199713.8:2001MAY17 892 LI:2199713.8.orfl:2001MAY17
316 LI:2200587.2:2001MAY17 893 LI:2200587.2.orfl:2001MAY17
317 LI:2200761.12:2001MAY17 894 LI:2200761.12.orf2:2001MAY17
318 LI:2203624.1:2001MAY17 895 LI:2203624.1.orf2:2001MAY17
319 LI:220495.9:2001MAY17 896 LI:220495.9.orf2:2001MAY17
320 LI:2205532.1:2001MAY17 897 LI:2205532.1.orf3:2001MAY17
321 LI:2206277.1:2001MAY17 898 LI:2206277.1.orf3:2001MAY17
322 LI:2207765.8:2001MAY17 899 LI:2207765.8.orf3:2001MAY17
323 LI:2208404.4:2001MAY17 900 LI:2208404.4.orf2:2001MAY17
324 LI:2208715.3:2001MAY17 901 LI:2208715.3.orfl:2001MAY17
325 LI:2208766.2:2001MAY17 902 LI:2208766.2.orf3:2001MAY17
326 LI:2209636.3:2001MAY17 903 LI:2209636.3.orfl:2001MAY17
327 LI:221864.68:2001MAY17 904 LI:221864.68.orfl:2001MAY17
328 LI:229267.1:2001MAY17 905 LI:229267.1.orf3:2001MAY17
329 LI:229648.2:2001MAY17 906 LI:229648.2.orfl:2001MAY17
330 LI:231016.1:2001MAY17 907 LI:231016.1.orf3:2001MAY17
331 LI:231140.5:2001MAY17 908 LI:231140.5.orfl:2001MAY17
332 LI:231695.14:2001MAY17 909 LI.-231695.14.orf3:2001MAY17
333 LI:232846.24:2001MAY17 910 LI:232846.24.orf3:2001MAY17
334 LI:233411.11:2001MAY17 911 L 233411.1 l.orf3:2001MAY17
335 LI:233545.13:2001MAY17 912 LI:233545.13.orf3:2001MAY17
336 LI:234671.101:2001MAY17 913 LI:234671.101.orf3:2001MAY17
337 LI:236098.14:2001MAY17 914 LI:236098.14.orf3:2001MAY17
338 LI:236196.15:2001MAY17 915 LI:236196.15.orfl:2001MAY17
339 LI:237086.1:2001MAY17 916 LI:237086.1.orf2:2001MAY17
340 LI:238585.30:2001MAY17 917 LI:238585.30.orf2:2001MAY17
341 LI:238672.6:2001MAY17 918 LI:238672.6.orf2:2001MAY17
342 LI:239579.9:2001MAY17 919 LI:239579.9.orf2:2001MAY17
343 LI:239720.1:2001MAY17 920 • LI:239720.1.orf3:2001MAY17
344 * LI:240037.6:2001MAY17 921 LI:240037.6.orf2:2001MAY17
345 LI:243900.7:2001MAY17 922 LI:243900J.orf3:2001MAY17
346 LI:244378.1:2001MAY17 923 LI:244378.1.orf2:2001MAY17
347 LI:245500.3:2001MAY17 924 LI:245500.3.orf 1 :2001MAY17
348 LI:245982.24:2001MAY17 925 LI:245982.24.orf2:2001MAY17
349 LI:246054.1:2001MAY17 926 LI:246054.1.orf3:2001MAY17
350 LI:256051.229:2001MAY17 927 LI:256051.229.orf3:2001MAY17
351 LI:260629.7:2001MAY17 928 LI:260629.7.orfl:2001MAY17
352 LI:272723.1:2001MAY17 929 LI:272723.1.orf3a:2001MAY17
352 LI:272723.1:2001MAY17 930 LI:272723.1.orf3b:2001MAY17
353 LI:272766.1:2001MAY17 931 LL272766.1.orf2:2001MAY 17
354 LI:275726.1:2001MAY17 932 LI:275726.1.orf2:2001MAY17
355 LI:276815.1:2001MAY17 933 LI:276815.1.orf2:2001MAY17
356 LI:283562.5:2001MAY17 934 LI:283562.5.orf3:2001MAY17
357 LI:289066.15:2001MAY17 935 LI:289066.15.orf3:2001MAY17
358 LI:331040.17:2001MAY17 936 LI:331040.17.orfl:2001MAY17
359 LI:332414.5:2001MAY17 937 LI:332414.5.orfl:2001MAY17
360 LI:332730.16:2001MAY17 938 LI:332730.16.orf2:2001MAY17
361 LI:333849.21:2001MAY17 939 LI:333849.21.orf3:2001MAY17
362 LI:337038.15:2001MAY17 940 LI:337038.15.orfl:2001MAY17
363 LI:337606.6:2001MAY17 941 LI:337606.6.orf2:2001MAY17
364 LI:338032.10:2001MAY17 942 LI:338032.10.orf2:2001MAY17
365 LI:339265.16:2001MAY17 943 LI:339265.16.orf3:2001MAY17
366 LI:344646.4:2001MAY17 944 LI:344646.4.orf3:2001MAY17
367 LI:347393.7:2001MAY17 945 LI:347393.7.orf2:2001MAY17 , TABLE 1
SEQ ID NO: Template ID SEQ ID NO ORF ID
368 LI:348107.36:2001MAY17 946 LI:348107.36.orf3:2001MAY17
369 LL351120.6.2001MAY17 947 L 351 120.6.orf3:2001MAY17
370 LI:358762.41:2001MAY17 948 LI:358762.41.orf3:2001MAY17
371 LI:363003.48:2001MAY17 949 LI:363003.48.orf2:2001MAY17
372 LT.370899.6:2001MAY17 '950 LI:370899.6.orfl:2001MAY17
373 LI:376470.1:2001MAY17 951 LI:376470.1.orf2:2001MAY17
374 LI:400961.18:2001MAY17 952 LI:400961.18.orfl:2001MAY17
375 LI:404482.20:2001MAY17 953 LI:404482.20.orf3:2001MAY17
376 LI:405985.1:2001MAY17 954 LI:405985.1.orf2:2001MAY17
377 LI:406389.1:2001MAY17 955 LI:406389.1.orf2:2001MAY17
378 LI:406833.1:2001MAY17 956 LI:406833.1.orf2:2001MAY17
379 LI:407921.3:2001MAY17 957 LI:407921.3.orfl:2001MAY17
380 LI:409078.54:2001MAY17 958 LI:409078.54.orf3:2001MAY17
381 LI:423601.6:2001MAY17 959 LI:423601.6.orf3:2001MAY17
382 LI:425024.5:2001MAY17 960 LI:425024.5.orfl:2001MAY17
383 LI:427909.29:2001MAY17 961 LI:427909.29.orfl:2001MAY17
384 LI:428198.20:2001MAY17 962 LI:428198.20.orf3:2001MAY17
385 LI:429738.6:2001MAY17 963 LI:429738.6.orf3:2001MAY17
386 LI:449437.1:2001MAY17 964 LI:449437.1.orfl:2001MAY17
387 LI:459269.25:2001MAY17 965 LI:459269.25.orfl:2001MAY17
388 LI:464206.1:2001MAY17 966 LI:464206.1.orf3:2001MAY17
389 LI:465821.2:2001MAY17 967 LI:465821.2.orfl:2001MAY17
390 LI:474414.28:2001MAY17 968 LI:474414.28.orfl:2001MAY17
391 LI:474435.14:2001MAY17 969 LI:474435.14.orf2:2001MAY17
392 LI:474458.11:2001MAY17 970 LI:474458.11.orf3:2001MAY17
393 LI:477127.18:2001MAY17 971 LI:477127.18.orf3:2001MAY17
394 LI:480375.55:2001MAY17 972 LI:480375.55.orf3:2001MAY17
395 LI:480467.24:2001MAY17 973 LI:480467.24.orf2:2001MAY17
396 LI:480587.1:2001MAY17 974 LI:480587.1.orf3:2001MAY17
397 LI:480798.13:2001MAY17 975 LI:480798.13.orf2:2001MAY17
398 LI:481203.14:2001MAY17 976 LI:481203.14.orfl:2001MAY17
399 LI:481237.11:2001MAY17 977 LL481237.11.orfl :2001MAY 17
400 LI:481368.12:2001MAY17 978 LI:481368.12.orf3:2001MAY17
401 LI:482301.8:2001MAY17 979 LI:482301.8.orf3:2001MAY17
402 LI:482482.29:2001MAY17 980 H:482482.29.orfl:2001MAY17
403 LI:758877.26:2001MAY17 981 LI:758877.26.orf3:2001MAY17
404 LI:791042.1:2001MAY17 982 LI:791042.1.orf3:2001MAY17
405 LI:808999.26:2001MAY17 983 LI:808999.26.orf3:2001MAY17
406 LI:815715.10:2001MAY17 984 LI:815715.10.orfl:2001MAY17
407 LI:902980.16:2001MAY17 985 LI:902980.16.orf3:2001MAY17
408 LI:903196.25:2001MAY17 986 LI:903196.25.orf2:2001MAY17
409 LI:903914.10:2001MAY17 987 LI:903914.10.orf2:2001MAY17
410 LG:006764.2:2001JUN22 ' 988 LG:006764.2.orf2:2001JUN22
411 LG:014704.8:2001JUN22 989 LG:014704.8.orf3:2001JUN22
412 LG: 1447607.7:2001JU 22 990 LG: 1447607.7.orf 1 :2001 JUN22
413 LG:1455032.3:2001JUN22 991 LG:1455032.3.orf2:2001JUN22
414 LG:1501898.18:2001JUN22 992 LG:1501898.18.orfl:2001JUN22
415 LG:1502692.5:2001JUN22 993 LG: 1502692.5.orf2:2001 JUN22
416 LG:208949.8:2001JUN22 994 LG:208949.8.orf2:2001JUN22
417 LG:240501.10:2001 JUN22 995 LG:240501.10.orf3:2001JUN22
418 LG:329228.27:2001JUN22 996 LG:329228.27.orf2:2001JUN22
419 LG:337056.11:2001 JUN22 997 LG:337056.1 l.orf2:2001 JUN22
420 LG:346663.9:2001JUN22 998 LG:346663.9.orf3:2001JUN22
421 LG:7685586.2:2001JUN22 999 LG:7685586.2.orf3:2001JUN22 TABLE 1
SEQ ID NO: Template ID SEQ ID NO: ORF ID
422 LG:407730.13:2001JUN22 1000 LG:407730.13.orf 1 :2001 JU 22
423 LG:025465.5:2001JUN22 1001 LG:025465.5.orf3:2001JUN22
424 LG:054509.14:2001 JUN22 1002 LG:054509.14.orf3:2001JUN22
425 LG: 1067876.1:2001 JUN22 1003 LG:1067876.1.orfl:2001JUN22
426 LG:1327699.55:2001JUN22 1004 LG:1327699.55.orf3:2001JUN22
427 LG: 1482904.10:2001JUN22 1005 LG:1482904.10.orf3:2001JUN22
428 LG:222317.4:2001JUN22 1006 LG:222317.4.orf2:2001JUN22
429 LG:332701.3:2001 JUN22 1007 LG:332701.3.orfl :2001 JUN22
430 LG:369881.5:2001JUN22 1008 LG:369881.5.orf 1 :2001 JUN22
431 LG:404381.2:2001 JUN22 1009 LG:404381.2.orf2:2001JUN22
432 LG:405709.2:2001JUN22 1010 LG:405709.2.or 2:2001JUN22
433 LG:406664.17:2001JUN22 1011 LG:406664.17.orf3:2001JUN22
434 LG:7670681.1:2001JUN22 1012 LGJ670681.1.orfl :2001 JUN22
435 LG:7687404.1:2001 JUN22 1013 LG:7687404.1.orf2:2001JUN22
436 LG:7690030.24:2001JU 22 1014 LG:7690030.24.orf3:2001JUN22
437 LG:7690229.3:2001JUN22 1015 LG:7690229.3.orfl:2001JUN22
438 LG:7690533.16:2001JUN22 1016 LG:7690533.16.orf3:2001IUN22
439 LG:7691131.2:2001JUN22 1017 LG:7691131.2.orf3:2001JUN22
440 LG:7692559.6:2001JUN22 1018 LG:7692559.6.orf3:2001JUN22
441 LG:7684866.10:2001 JUN22 1019 LG:7684866.10.orf2:2001JUN22
442 LG:002106.5:2001JUN22 1020 LG:002106.5.orfl:2001JUN22
443 LG:004064.1:2001 JUN22 1021 LG:004064.1.or 2:2001 JUN22
444 LG:007916.8:2001JUN22 1022 LG:007916.8.orf2:2001JUN22
445 LG:014719.14:2001JUN22 1023 LG:014719.14.orf3:2001JUN22
446 LG:021763.31:2001JUN22 1024 LG:021763.31.orf3:2001JUN22
447 LG:025397.1 :2001JUN22 1025 LG:025397.1.orβ:2001JUN22
448 LG:029880.20:2001JUN22 1026 LG:029880.20.orf2:2001 JUN22
449 LG:040422.37:2001JUN22 1027 LG:040422.37.orf 1 :2001 JUN22
450 LG:065935.11:2001JUN22 1028 LG:065935.11.orf2:2001JUN22
451 LG:074381.1:2001JUN22 1029 LG:074381.1.orf2:2001JUN22
452 LG:083814.6:2001JUN22 1030 LG:083814.6.orf3:2001JUN22
453 LG:090985.1:2001 JUN22 1031 LG:090985.1.orf2:2001JUN22
454 LG:093750.2:2001JUN22 1032 LG:093750.2.orI3:2001JUN22
455 LG:1013708.26:2001JUN22 1033 LG:1013708.26.orfl:2001JUN22
456 LG: 1022283.8:2001 JUN22 1034 LG:1022283.8.orfl:2001JUN22
457 LG:1034386.1 :2001JUN22 1035 LG:1034386.1.orO:2001JUN22
458 LG:1045617.36:2001JUN22 1036 LG:1045617.36.orfl:2001JUN22
459 LG: 1063303.1 :2001 JUN22 1037 LG:1063303.1.orfl:2001JUN22
460 LG: 1094200.1 :2001 JUN22 1038 LG:1094200.1.orfl:2001JU 22
461 LG: 1099249.19:2001 JUN22 1039 LG:1099249.19.orf3:2001JUN22
462 LG: 110667.1:2001 JUN22 1040 LG: 110667.1.orf 1 :2001 JUN22
463 LG: 1132386.20:2001 JUN22 1041 LG:1132386.20.orf2:2001JUN22
464 LG: 116015.2:2001 JUN22 1042 LG: 116015.2.orf 1 :2001JUN22
465 LG: 1173104.15:2001 JUN22 1043 LG:1173104.15.orf3:2001JUN22
466 LG:1285109.14:2001JUN22 1044 LG:1285109.14.orf3:2001JUN22
467 LG:131477.1 1 :2001JUN22 1045 LG.-131477.1 l.orf3:2001JUN22
468 LG: 1333618.1 :2001 JUN22 1046 LG: 1333618. l.orf2:2001JUN22
469 LG: 1347760.16:2001 JUN22 1047 LG: 1347760.16.orf 1 :2001 JUN22
470 LG:1383039.369:2001 JUN22 1048 LG:1383039.369.orf3:2001JUN22
471 LG:1383313.3:2001JUN22 1049 LG:1383313.3.orf3:2001JUN22
472 LG:1384075.8:2001JUN22 1050 LG:1384075.8.orf2:2001JUN22
473 LG:1384155.1 :2001JUN22 1051 LG:1384155.1.orfl:2001JUN22
474 LG: 1385280.12:2001 JUN22 1052 LG:1385280.12.orf3:2001JUN22
475 LG:1390535.25:2001JUN22 1053 LG: 1390535.25.orf3:2001JUN22 TABLE 1
SEQ ID NO: Template ID SEQ ID NO: ORF ID
476 LG:1397047.1:2001JUN22 1054 LG:1397047.1.orf3:2001JUN22
477 LG:1398646.15:2001JUN22 1055 LG: 1398646.15.orf2:2001JUN22
478 LG: 1446193.10:2001JUN22 1056 LG: 1446193.10.orfl:2001JUN22
479 LG:1446405.14:2001JUN22 1057 LG:1446405.14.orf2:2001JUN22
480 LG:1448148.1:2001JUN22 1058 LG:1448148.1.orfl:2001JUN22
481 LG: 1452619.13:2001 JUN22 1059 LG: 1452619.13.orfl:2001JUN22
482 LG: 1452783.22:2001 JUN22 1060 LG:1452783.22.orf3:2001JUN22
483 LG:1453417.5:2001JUN22 1061 LG:1453417.5.orf3:2001JUN22
484 LG: 1455222.23:2001 JUN22 1062 LG:1455222.23.orfl:2001JUN22
485 LG:149121.8:2001JUN22 1063 LG:149121.8.orfl:2001JUN22
486 LG:1500175.18:2001JUN22 1064 LG:1500175.18.orf3:2001JUN22
487 LG: 1500434.6:2001 JUN22 1065 LG: 1500434.6.orf2:2001 JUN22
488 LG:1501550.19:2001JUN22 1066 LG:1501550.19.orfl:2001JUN22
489 LG: 1501923.26:2001 JUN22 1067 LG:1501923.26.orf2:2001JUN22
490 LG: 150960.9:2001 JUN22 1068 LG:150960.9.orf2:2001JUN22
491 LG: 182744.29:2001JUN22 1069 LG:182744.29.orfl:2001JUN22
492 LG:197166.1:2001JUN22 1070 LG:197166.1.orfl:2001JUN22
493 LG:197455.5:2001JUN22 1071 LG:197455.5.orf2:2001JUN22
494 LG: 198251.8 :2001JUN22 1072 LG:198251.8.or 2:2001JUN22
495 LG:200149.3:2001JUN22 1073 LG:200149.3.orfl:2001JUN22
496 LG:203483.3:2001JUN22 1074 LG:203483.3.orf2:2001JUN22
497 LG:209701J:2001JUN22 1075 LG:209701.7.orfl:2001JUN22
498 LG:210614.1:200UUN22 1076 LG:210614.1.orfl:2001JUN22
499 • LG:210672.1:200UUN22 1077 LG:210672.1.orfl :2001 JUN22
500 LG:215051.10:2001 JUN22 1078 LG:215051.10.orf3:2001JUN22
501 LG:218989.3:2001JUN22 1079 LG:218989.3.orf2:2001JUN22
502 LG:228107.11:2001JUN22 1080 LG:228107.11.orf3:2001JUN22
503 LG:231016.1:2001JUN22 1081 LG:231016.1.orf2:2001JUN22
504 LG:235943.60:2001JUN22 1082 LG:235943.60.orfl:2001JUN22
505 LG:235970.14:2001JUN22 1083 LG:235970.14.orf2:2001JUN22
506 LG:236697.15:2001 JUN22 1084 LG:236697.15.orfl:2001JUN22
507 LG:238576.3:2001JUN22 1085 LG:238576.3.orf2:2001JUN22
508 LG:238602.2:2001JUN22 1086 LG:238602.2.orfl:2001JUN22
509 LG:241291.46:2001JUN22 1087 LG:241291.46.orfl:2001JUN22
510 LG:241742.1:2001 JUN22 1088 LG:241742.1.orf3:2001JUN22
511 LG:244520.33:2001JUN22 1089 LG:244520.33.orf2:2001JUN22
512 LG:247556.1:2001JUN22 1090 LG:247556.1.orfl :2001 JUN22
513 LG:247792.5:2001JUN22 1091 LG:247792.5.orf3:2001JUN22
514 LG:253580.6:2001JUN22 1092 LG:253580.6.orf3:2001JUN22
515 LG:291759.5:2001JUN22 1093 LG:291759.5.orf3:2001JUN22
516 LG:298226.1:2001JUN22 1094 LG:298226.1.orfl :2001 JUN22
517 LG:306342.1:2001JUN22 1095 LG:306342.1.orf2:2001 JUN22
518 LG:327144.5:2001JUN22 1096 LG:327144.5.orf2:2001JUN22
519 LG:331499.8:2001JUN22 1097 LG:331499.8.orf3:2001JUN22
520 LG:331582.12:2001JUN22 1098 LG:331582.12.orf2:2001JUN22
521 LG:333017.12:2001 JUN22 1099 LG:333017.12.orf2:2001JUN22
522 LG:334438.8:2001JUN22 1100 LG:334438.8.orf2:2001JUN22
523 LG:337835.7:2001IUN22 1101 LG:337835.7.orf3:2001JUN22
524 LG:346536.12:2001 JUN22 1102 LG:346536.12.orf2:2001 JUN22
525 LG:348117.5:2001JUN22 1103 LG:348117.5.orfl:2001JUN22
526 LG:350407.22:2001JUN22 1104 LG:350407.22.orf3:2001JUN22
527 LG:373219.13:2001JUN22 1105 LG:373219.13.orf2:2001JUN22
528 LG:375048.15 :2001 JUN22 1106 LG:375048.15.orf3:2001JUN22
529 LG:400114.3:2001 JUN22 1107 LG:400114.3.orf3:2001 JUN22 TABLE 1
SEQ ID NO: Template ID SEQ ID NO: ORF ID
530 LG.400652.1:2001 JUN22 1108 LG:400652.1.orfl:2001JUN22
531 LG:401313.10:2001JUN22 1109 LG:401313.10.orfl:2001JUN22
532 LG-.406389.1:2001 JUN22 1110 LG:406389.1.όrf2:2001JUN22
533 LG:406595.2:2001 JUN22 l l l l LG:406595.2.orfl:2001JUN22
534 LG:410628.21:2001JUN22 1112 LG:410628.21.orf2:2001JUN22
535 LG:413583.15:2001JUN22 1113 LG:413583.15.orf3:2001JUN22
536 LG:419641.35:2001JUN22 1114 LG:419641.35.orf3:2001JUN22
537 LG:420759.4:2001JUN22 1115 LG:420759.4.orf 1 :2001 JUN22 538. LG:425448.18:2001 JUN22 1116 LG:425448.18.orfl:2001JUN22
539 LG:435717.5:2001JUN22 1117 LG:435717.5.orfl:2001JUN22
540 LG:441159.31:2001JUN22 1118 LG:441159.31.orfl:2001JUN22
541 LG:461375.2:2001JUN22 1119 LG:461375.2.orfl:2001JUN22
542 LG:474674.34:2001JUN22 1120 LG:474674.34.orf3:2001JUN22
543 LG:481414.8:2001JUN22 1121 LG:481414.8.orfl:2001JUN22
544 LG:7669276.1:2001 JUN22 1122 LG:7669276.1.orf2:2001JUN22
545 LG.7677848.1:2001 JUN22 1123 LG:7677848.1.orf3:2001JUN22
546 LG:7684981.3:2001JUN22 1124 LG:7684981.3.orf3:2001JUN22
547 LG:7685048.6:2001JUN22 1125 LG:7685048.6.orf2:2001JUN22
548 LG-.7688302.1:2001 JUN22 1126 LG:7688302.1.orf3:2001JUN22
549 LG:7690463.3:2001JUN22 1127 LG:7690463.3.orfl:2001JUN22
550 LG:7691479.5:2001JUN22 1128 LG:7691479.5.orfl:2001JUN22
551 LG:7691527.4:2001 JUN22 1129 LG:7691527.4.orfl:2001JUN22
552 LG:7691663.1:2001JUN22 1130 LG:7691663.1.orf2:2001JUN22
553 LG:7691854.1:2001JUN22 1131 LG:7691854.1.orf2:2001 JUN22
554 LG:7692235.2:2001JUN22 1132 LG:7692235.2.orf2:2001JUN22
555 LG:7692239.1:2001 JUN22 1133 LG:7692239.1.orfl:2001JUN22
556 LG:7692575.1:2001JUN22 1134 LG:7692575.1.orfl:2001JUN22
557 LG:7692742.1:2001 JUN22 1135 LG:7692742.1.orf 1:2001 JUN22
558 LGJ693942.1:2001 JUN22 1136 LG:7693942.1.orf3:2001JUN22
559 LG:899248.22:2001JUN22 1137 LG:899248.22.orfl:2001JUN22
560 LG:979051.25:2001JUN22 1138 LG:979051.25.orf2:2001JUN22
561 LG:979054.18:2001 JUN22 1139 LG:979054.18.orf2:2001JUN22
562 LG:979415.1:2001JUN22 1140 LG:979415.1.orfl:2001JUN22
562 LG:979415.1:2001 JUN22 1141 LG:979415.1.orf3:2001 JUN22
563 LG:980685.1:2001JUN22 1142 LG:980685.1.orf3:2001JUN22
564 LG:981272.6:2001JUN22 1143 LG:981272.6.orfl:2001JUN22
565 LG:982723.4:2001JUN22 1144 LG:982723.4.orf3:2001JUN22
566 LG:982915.8:2001JUN22 1145 LG:982915.8.orf2:2001JUN22
567 LG:987785.10:2001 JUN22 1146 LG:987785.10.orf2:2001JUN22
TABLE 2
SEQ D NO: Template ID Start Stop Frame Domain Type Topology
LG: 1041015.22:2001MAR30 1 19 forward 1 TM Non-Cytosolic LG:1041015.22:2001MAR30 20 42 forward 1 TM Transmembrane LG:1041015.22:2001MAR30 43 54 forward 1 TM Cytosolic LG:1041015.22:2001MAR30 55 77 forward 1 TM Transmembrane LG:1041015.22:2001MAR30 78 290 forward 1 TM Non-Cytosolic LG:1041015.22:2001MAR30 1 60 forward 2 TM Cytosolic LG:1041015.22:2001MAR30 61 83 forward 2 TM Transmembrane LG:1041015.22:2001MAR30 84 290 forward 2 TM Non-Cytosolic 2 LG:106877.10:2001MAR30 1 78 forward 1 TM Non-Cytosolic
2 LG:106877.10:2001MAR30 79 101 forward 1 TM Transmembrane
2 LG:106877.10:2001MAR30 102 127 forward 1 TM Cytosolic
2 LG:106877.10:2001MAR30 128 150 forward 1 TM Transmembrane
2 LG:106877.10:2001MAR30 151 952 forward 1 TM Non-Cytosolic
2 LG: 106877.10.2001MAR30 1 71 forward 3 TM Non-Cytosolic
2 LG:106877.10:2001MAR30 72 94 forward 3 TM Transmembrane
2 LG:106877.10:2001MAR30 95 177 forward 3 TM Cytosolic
2 LG: 106877.10:2001MAR30 178 200 forward 3 TM Transmembrane
2 LG:106877.10:2001MAR30 201 742 forward 3 TM Non-Cytosolic
2 LG:106877.10:2001MAR30 743 765 forward 3 TM Transmembrane
2 LG:106877.10:2001MAR30 766 952 forward 3 TM Cytosolic
3 LG:1138554.16:2001MAR30 1 227 forward 3 TM Non-Cytbsolic 3 LG:1138554.16:2001MAR30 228 250 forward 3 TM Transmembrane 3 LG: 1138554.16.-2001MAR30 251 256 forward 3 TM Cytosolic 3 LG:1138554.16:2001MAR30 257 279 forward 3 TM Transmembrane 3 LG:1138554.16:2001MAR30 280 293 forward 3 TM Non-Cytosolic 3 LG:1138554.16:2001MAR30 294 316 forward 3 TM Transmembrane
3 LG:1138554.16:2001MAR30 317 332 forward 3 TM Cytosolic
4 LG:1383277.7:2001MAR30 1 44 forward 1 TM Cytosolic 4 LG:1383277J:2001MAR30 45 67 forward 1 TM Transmembrane 4 LG:1383277J:2001MAR30 68 155 forward 1 TM Non-Cytosolic 4 LG:1383277J:2001MAR30 156 178 forward 1 , TM Transmembrane 4 LG:1383277J:2001MAR30 179 198 forward 1 TM Cytosolic 4 LG:1383277.7:2001MAR3O 199 218 forward 1 TM Transmembrane 4 LG:1383277J:2001MAR30 219 221 forward 1 TM Non-Cytosolic 4 LG:1383277.7:2001MAR30 1 52 forward 2 TM Non-Cytosolic 4 LG:1383277.7:2001MAR30 53 75 forward 2 TM Transmembrane 4 LG:1383277.7:2001MAR30 76 221 forward 2 TM Cytosolic 4 LG:1383277.7:2001MAR30 1 67 forward 3 TM Cytosolic 4 LG:1383277.7:2001MAR30 68 90 forward 3 TM Transmembrane 4 LG:1383277.7:2001MAR30 91 93 forward 3 TM Non-Cytosolic 4 LG:1383277.7:2001MAR30 94 113 forward 3 TM Transmembrane 4 LG:1383277.7:2001MAR30 114 153 forward 3 TM Cytosolic 4 LG:1383277.7:2001MAR30 154 176 forward 3 TM Transmembrane 4 LG:1383277.7:2001MAR30 177 198 forward 3 TM Non-Cytosolic 4 LG:1383277.7:2001MAR30 199 218 forward 3 TM Transmembrane
4 LG:1383277.7:2001MAR30 219 220 forward 3 TM Cytosolic
5 LG:1397614.15:2001MAR30 1 1 forward 1 TM Cytosolic 5 LG:1397614.15:2001MAR30 2 21 forward 1 TM Transmembrane 5 LG: 1397614.15:2001MAR30 22 35 forward 1 TM Non-Cytosolic 5 LG:1397614.15:2001MAR30 36 58 forward 1 TM Transmembrane 5 LG:1397614.15:2001MAR30 59 193 forward 1 TM Cytosolic 5 LG: 1397614.15:2001MAR30 194 216 forward 1 TM Transmembrane 5 LG:1397614.15:2001MAR30 217 225 forward 1 TM Non-Cytosolic 5 LG:1397614.15:2001MAR30 226 243 forward 1 TM Transmembrane TABLE 2
SEQ D NO: Template ID Start Stop Frame Domain Type Topology
5 LG: 1397614.15:2001MAR30 244 259 forward 1 TM Cytosolic
5 LG:1397614.15:2001MAR30 260 282 forward 1 TM Transmembrane
5 LG: 1397614.15.-2001MAR30 283 458 forward 1 TM Non-Cytosolic
5 LG:1397614.15:2001MAR30 459 481 forward 1 TM Transmembrane
5 LG: 1397614.15:2001MAR30 482 534 forward 1 TM Cytosolic
5 LG:1397614.15:2001MAR30 535 557 forward 1 TM Transmembrane
5 LG:1397614.15:2001MAR30 558 566 forward 1 TM Non-Cytosolic
5 LG:1397614.15:2001MAR30 567 589 forward 1 TM Transmembrane
5 LG:1397614.15:2001MAR30 590 644 forward 1 TM Cytosolic 5 LG:1397614.15:2001MAR30 1 43 forward 2 TM Non-Cytosolic
5 LG:1397614.15:2001MAR30 44 66 forward 2 TM Transmembrane
5 LG:1397614.15:2001MAR30 67 97 forward 2 TM Cytosolic
5 LG:1397614.15:2001MAR30 98 120 forward 2 TM Transmembrane
5 LG: 1397614.15.2001MAR30 121 195 forward 2 TM Non-Cytosolic
5 LG:1397614.15:2001MAR30 196 218 forward 2 TM Transmembrane
5 LG:1397614.15:2001MAR30 219 260 forward 2 TM Cytosolic
5 LG:1397614.15:2001MAR30 261 283 forward 2 TM Transmembrane
5 LG:1397614.15:2001MAR30 284 342 forward 2 TM Non-Cytosolic
5 LG:1397614.15:2001MAR30 343 365 forward 2 TM Transmembrane
5 LG:1397614.15:2001MAR30 366 457 forward 2 TM Cytosolic
5 LG:1397614.15:2001MAR30 458 480 forward 2 TM Transmembrane
5 LG:1397614.15:2001MAR30 481 499 forward 2 TM Non-Cytosolic
5 LG: 1397614.15.-2001MAR30 500 522 forward 2 TM Transmembrane
5 LG:1397614.15:2001MAR30 523 644 forward 2 TM Cytosolic
5 LG:1397614.15:2001MAR30 1 1 forward 3 TM Cytosolic
5 LG:1397614.15:2001MAR30' 2 19 forward 3 TM Transmembrane
5 LG:1397614.15:2001MAR30 20 33 forward 3 TM Non-Cytosolic
5 LG:1397614.15:2001MAR30 34 56 forward 3 TM Transmembrane
5 LG:1397614.15:2001MAR30 57 195 forward 3 TM Cytosolic
5 LG:1397614.15:2001MAR30 196 218 forward 3 TM Transmembrane
5 LG:1397614.15:2001MAR30 219 263 forward 3 TM Non-Cytosolic
5 LG:1397614.15:2001MAR30 264 286 forward 3 TM Transmembrane
5 LG:1397614.15:2001MAR30 287 292 forward 3 TM Cytosolic
5 LG:1397614.15:2001MAR30 293 315 forward 3 TM Transmembrane
5 LG:1397614.15:2001MAR30 316 324 forward 3 TM Non-Cytosolic
5 LG:1397614.15:2001MAR30 325 347 forward 3 TM Transmembrane
5 LG:1397614.15:2001MAR30 348 396 forward 3 TM Cytosolic
5 LG:1397614.15:2001MAR30 397 416 forward 3 TM Transmembrane
5 LG:1397614.15:2001MAR30 417 457 forward 3 TM ' Non-Cytosolic
5 LG: 1397614.15:2001MAR30 458 480 forward 3 TM Transmembrane
5 LG:1397614.15:2001MAR30 481 533 forward 3 TM Cytosolic
5 LG:1397614.15:2001MAR30 534 556 forward 3 TM Transmembrane
5 LG:1397614.15:2001MAR30 557 565 forward 3 TM Non-Cytosolic
5 LG:1397614.15:2001MAR30 566 588 forward 3 TM Transmembrane
5 LG:1397614.15:2001MAR30 589 644 forward 3 TM Cytosolic 6- LG:1399315.8:2001MAR30 1 612 forward 2 TM Non-Cytosolic
6 LG:1399315.8:2001MAR30 613 635 forward 2 TM Transmembrane 6 LG:1399315.8:2001MAR30 636 742 forward 2 TM Cytosolic 6 LG:1399315.8:2001MAR30 743 760 forward 2 TM Transmembrane 6 LG:1399315.8:2001MAR30 761 987 forward 2 TM Non-Cytosolic 6 LG:1399315.8:2001MAR30 1 243 forward 3 TM Non-Cytosolic 6 LG:1399315.8:2001MAR30 244 261 forward 3 TM Transmembrane 6 LG:1399315.8:2001MAR30 262 292 forward 3 TM Cytosolic 6 LG:1399315.8:2001MAR30 293 315 forward 3 TM Transmembrane TABLE 2
SEQ D NO: Template ID Start Stop Frame Domain Type Topology
6 LG:1399315.8:2001MAR30 316 986 forward 3 TM Non-Cytosolic
7 LG: 198782. 2001MAR30 1 735 forward 1 TM Non-Cytosolic 7 LG: 198782. L2001MAR30 736 758 forward 1 TM Transmembrane 7 LG:198782.1 :2001MAR30 759 770 forward 1 TM Cytosolic 7 LG:198782. L2001MAR30 771 793 forward 1 TM Transmembrane 7 LG: 198782. L2001MAR30 794 851 forward 1 TM Non-Cytosolic 7 LG: 198782. L2001MAR30 1 27 forward 2 TM Non-Cytosolic 7 LG:198782.1:2001MAR30 28 50 forward 2 TM Transmembrane 7 LG:198782.1:2001MAR30 51 377 forward 2 TM Cytosolic 7 LG:198782.1:2001MAR30 378 400 forward 2 TM Transmembrane 7 LG: 198782.1 :2001MAR30 401 404 forward 2 TM Non-Cytosolic 7 LG: 198782. L2001MAR30 405 424 forward 2 TM Transmembrane 7 LG:198782. L.2001MAR30 425 769 forward 2 TM Cytosolic 7 LG:198782.1:2001MAR30 770 792 forward 2 TM Transmembrane 7 LG:198782.1:2001MAR30 793 801 forward 2 TM Non-Cytosolic
J LG:198782.1:2001MAR30 802 819 forward 2 TM Transmembrane
7 LG:198782.1:2001MAR30 820 850 forward 2 TM Cytosolic
7 LG:198782.1:2001MAR30 1 33 forward 3 TM Non-Cytosolic
7 LG: 198782. L2001MAR30 34 51 forward 3 TM Transmembrane
7 LG:198782.1:2001MAR30 52 380 forward 3 TM Cytosolic
7 LG:198782.1 :2001MAR30 381 403 forward 3 TM Transmembrane
7 LG: 198782. L.2001MAR30 404 406 forward 3 TM Non-Cytosolic
7 LG: 198782. L2001MAR30 407 424 forward 3 TM Transmembrane
7 LG: 198782. L2001MAR30 425 436 forward 3 TM Cytosolic
7 LG: 198782. 2001MAR30 437 459 forward 3 TM Transmembrane
7 LG: 198782. 2001MAR30 460 541 forward 3 TM Non-Cytosolic
7 LG:198782. L2001MAR30 542 564 forward 3 TM Transmembrane
7 LG:198782. l:2001MAR30 565 770 forward 3 TM Cytosolic
7 LG:198782. L2001MAR30 771 793 forward 3 TM Transmembrane
7 LG:198782.1:2001MAR30 794 802 forward 3 TM Non-Cytosolic
7 LG:198782. 2001MAR30 803 822 forward 3 TM Transmembrane
7 LG:198782. L2001MAR30 823 850 forward 3 TM Cytosolic
8 LG:236046.1:2001MAR30 1 160 forward 1 TM Non-Cytosolic 8 LG:236046.1 :2001MAR30 161 183 forward 1 TM Transmembrane 8 LG:236046.1:2001MAR30 184 203 forward 1 TM Cytosolic 8 LG:236046.1 :2001MAR30 204 226 forward 1 TM Transmembrane 8 LG:236046.1 :2001MAR30 227 235 forward 1 TM Non-Cytosolic 8 LG:236046.1:2001MAR30 236 253 forward 1 TM Transmembrane 8 LG:236046.1:2001MAR30 254 273 forward 1 TM Cytosolic 8 LG:236046.1:2001MAR30 274 296 forward 1 TM Transmembrane 8 LG:236046.1:2001MAR30 297 367 forward 1 TM Non-Cytosolic 8 LG:236046.1:2001MAR30 368 390 forward 1 TM Transmembrane 8 LG:236046.1 :2001MAR30 391 396 forward 1 TM Cytosolic 8 LG:236046.1:2001MAR30 397 416 forward 1 TM Transmembrane
8 LG:236046.1:2001MAR30 417 848 forward 1 TM Non-Cytosolic
9 LG:332122.6:2001MAR30 1 389 forward 1 TM Non-Cytosolic 9 LG:332122.6:2001MAR30 390 412 forward 1 TM Transmembrane 9 LG:332122.6:2001MAR30 413 447 forward 1 TM Cytosolic 9 LG:332122.6:2001MAR30 448 470 forward 1 TM Transmembrane 9 LG:332122.6:2001MAR30 471 557 forward 1 TM Non-Cytosolic 9 LG:332122.6:2001MAR30 558 575 forward 1 TM Transmembrane 9 LG:332122.6:2001MAR30 576 655 forward 1 TM Cytosolic 9 LG:332122.6:2001MAR30 656 678 forward 1 TM Transmembrane 9 LG:332122.6:2001MAR30 679 681 forward 1 TM Non-Cytosolic TABLE 2
SEQ D NO: Template ID Start Stop Frame Domain Type Topology
9 LG:332122.6:2001MAR30 682 701 forward 1 TM Transmembrane
9 LG:332122.6:2001MAR30 702 758 forward 1 TM Cytosolic
9 LG:332122.6:2001MAR30 759 778 forward 1 TM Transmembrane
9 LG:332122.6:2001MAR30 779 797 forward 1 TM Non-Cytosolic
9 LG:332122.6:2001MAR30 798 817 forward 1 TM Transmembrane
9 LG:332122.6:2001MAR30 818 837 forward 1 TM Cytosolic
9 LG:332122.6:2001MAR30 1 66 forward 2 TM Cytosolic
9 LG:332122.6:2001MAR30 67 84 forward 2 TM Transmembrane
9 LG:332122.6:2001MAR30 85 120 forward 2 TM Non-Cytosolic
9 LG:332122.6:2001MAR30 121 140 forward 2 TM Transmembrane
9 LG:332122.6:2001MAR30 141 235 forward 2 TM Cytosolic
9 LG:332122.6:2001MAR30 236 255 forward 2 TM Transmembrane
9 LG:332122.6:2001MAR30 256 269 forward 2 TM Non-Cytosolic
9 LG:332122.6:2001MAR30 270 289 forward 2 TM Transmembrane
9 LG:332122.6:2001MAR30 290 347 forward 2 TM Cytosolic
9 LG:332122.6:2001MAR30 348 370 forward 2 TM Transmembrane
9 LG:332122.6:2001MAR30 371 396 forward 2 TM Non-Cytosolic
9 LG:332122.6:2001MAR30 397 419 forward 2 TM Transmembrane
9 LG:332122.6:2001MAR30 420 431 forward 2 TM Cytosolic
9 LG:332122.6:2001MAR30 432 451 forward 2 TM Transmembrane
9 LG:332122.6:2001MAR30 452 465 forward 2 TM Non-Cytosolic
9 LG:332122.6:2001MAR30 466 488 forward 2 TM Transmembrane
9 LG:332122.6:2001MAR30 489 554 forward 2 TM Cytosolic
9 LG:332122.6:2001MAR30 555 574 forward 2 TM Transmembrane
9 LG:332122.6:2001MAR30 ' 575 837 forward 2 TM Non-Cytosolic
9 LG:332122.6:2001MAR30 1 231 forward 3 TM Cytosolic
9 LG:332122.6:2001MAR30 232 254 forward 3 TM Transmembrane
9 LG:332122.6:2001MAR30 255 -268' forward 3 TM Non-Cytosolic
9 LG:332122.6:2001MAR30 269 286 forward 3 TM Transmembrane
9 LG:332122.6:2001MAR30 287 328 forward 3 TM Cytosolic
9 LG:332122.6:2001MAR30 329 351 forward 3 TM Transmembrane
9 LG:332122.6:2001MAR30 352 393 forward 3 TM Non-Cytosolic
9 LG:332122.6:2001MAR30 394 416 forward 3 TM Transmembrane
9 LG:332122.6:2001MAR30 417 428 forward 3 TM Cytosolic
9 LG:332122.6:2001MAR30 429 451 forward 3 TM Transmembrane
9 LG:332122.6:2001MAR30 452 836 forward 3 TM Non-Cytosolic
10 LG:345320.16:2001MAR30 1 82 forward 1 TM Cytosolic 10 LG:345320.16:2001MAR30 83 105 forward 1 TM Transmembrane 10 LG:345320.16:2001MAR30 106 114 forward 1 TM Non-Cytosolic 10 LG:345320.16:2001MAR30 115 137 forward 1 TM Transmembrane 10 LG:345320.16:2001MAR30 138 290 forward 1 TM Cytosolic 10 LG:345320.16:2001MAR30 291 313 forward 1 TM Transmembrane 10 LG:345320.16:2001MAR30 314 327 forward 1 TM Non-Cytosolic 10 LG:345320.16:2001MAR30 328 350 forward 1 TM Transmembrane 10 LG:345320.16:2001MAR30 351 424 forward 1 TM Cytosolic 10 LG:345320.16:2001MAR30 425 447 forward 1 TM Transmembrane 10 LG:345320.16:2001MAR30 448 764 forward 1 TM Non-Cytosolic 10 LG:345320.16:2001MAR30 1 98 forward 2 TM Cytosolic 10 LG:345320.16:2001MAR30 99 121 forward 2 TM Transmembrane 10 LG:345320.16:2001MAR30 122 159 forward 2 TM Non-Cytosolic 10 LG:345320.16:2001MAR30 160 182 forward 2 TM Transmembrane 10 LG:345320.16:2001MAR30 183 188 forward 2 TM Cytosolic 10 LG:345320.16:2001MAR30 189 21 1 forward 2 TM Transmembrane 10 LG:345320.16:2001MAR30 212 331 forward 2 TM Non-Cytosolic TABLE 2
SEQ D NO: Template ID Start Stop Frame Domain Type Topology
5 LG:1397614.15:2001MAR30 244 259 forward 1 TM Cytosolic
5 LG:1397614.15:2001MAR30 260 282 forward 1 TM Transmembrane
5 LG:1397614.15:2001MAR30 283 458 forward 1 TM Non-Cytosolic
5 LG:1397614.15:2001MAR30 459 481 forward 1 TM Transmembrane
5 LG:1397614.15:2001MAR30 482 534 forward 1 TM Cytosolic
5 LG:1397614.15:2001MAR30 535 557 forward 1 TM Transmembfane
5 LG:1397614.15:2001MAR30 558 566 forward 1 TM Non-Cytosolic
5 LG:1397614.15:2001MAR30 567 589 forward 1 TM Transmembrane
5 LG:1397614.15:2001MAR30 590 644 forward 1 TM Cytosolic
5 LG:1397614.15:2001MAR30 1 43 forward 2 TM Non-Cytosolic
5 LG:1397614.15.-2001MAR30 44 66 forward 2 TM Transmembrane
5 LG:1397614.15:2001MAR30 67 97 forward 2 TM Cytosolic
5 LG:1397614.15:2001MAR30 98 120 forward 2 TM Transmembrane
5 LG:1397614.15:2001MAR30 121 195 forward 2 TM Non-Cytosolic
5 LG:1397614.15:2001MAR30 196 218 forward 2 TM Transmembrane
5 LG:1397614.15.-2001MAR30 219 260 forward 2 TM Cytosolic
5 LG:1397614.15:2001MAR30 261 283 forward 2 TM Transmembrane
5 LG:1397614.15:2001MAR30 284 342 forward 2 TM Non-Cytosolic
5 LG:1397614.15:2001MAR30 343 365 forward 2 TM Transmembrane
5 LG:1397614.15:2001MAR30 366 457 forward 2 TM Cytosolic
5 LG:1397614.15:2001MAR30 458 480 forward 2 TM Transmembrane
5 LG:1397614.15:2001MAR30 481 499 forward 2 TM Non-Cytosolic
5 LG:1397614.15:2001MAR30 500 522 forward 2 TM Transmembrane
5 LG:1397614.15:2001MAR30 523 644 forward 2 TM Cytosolic
5 LG:1397614.15:2001MAR30 1 1 forward 3 TM Cytosolic
5 LG:1397614.15:2001MAR30 2 19 forward 3 TM Transmembrane
5 LG:1397614.15:2001MAR30 20 33 forward 3 TM Non-Cytosolic
5 LG: 1397614.15.-2001MAR30 34 56 forward 3 TM Transmembrane
5 LG:1397614.15:2001MAR30 57 195 forward 3 TM Cytosolic
5 LG:1397614.15:2001MAR30 196 218 forward 3 TM Transmembrane
5 LG:1397614.15:2001MAR30 219 263 forward 3 TM Non-Cytosolic
5 LG:1397614.15:2001MAR30 264 286 forward 3 TM Transmembrane
5 LG:1397614.15:2001MAR30 287 292 forward 3 TM Cytosolic
5 LG:1397614.15:2001MAR30 293 315 forward 3 TM Transmembrane
5 LG:1397614.15:2001MAR30 316 324 forward 3 TM Non-Cytosolic
5 LG:1397614.15:2001MAR30 325 347 forward 3 TM Transmembrane
. 5 LG:1397614.15:2001MAR30 348 396 forward 3 TM Cytosolic
5 LG:1397614.15:2001MAR30 397 416 forward 3 TM Transmembrane
5 LG:1397614.15:2001MAR30 417 457 forward 3 TM Non-Cytosolic
5 LG:1397614.15:2001MAR30 458 480 forward 3 TM Transmembrane
5 LG:1397614.15:2001MAR30 481 533 forward 3 TM Cytosolic
5 LG:1397614.15.-2001MAR30 534 556 forward 3 TM Transmembrane
5 LG:1397614.15:2001MAR30 557 565 forward 3 TM Non-Cytosolic
5 LG:1397614.15:2001MAR30 566 588 forward 3 TM Transmembrane
5 LG:1397614.15:2001MAR30 589 644 forward 3 TM Cytosolic
6 LG:1399315.8:2001MAR30 1 612 forward 2 TM Non-Cytosolic 6 LG:1399315.8:2001MAR30 613 635 forward 2 TM Transmembrane 6 LG: 1399315.8:2001MAR30 636 742 forward 2 TM Cytosolic 6 LG:1399315.8:2001MAR30 743 760 forward 2 TM Transmembrane 6 LG:1399315.8:2001MAR30 761 987 forward 2 TM Non-Cytosolic 6 LG:1399315.8:2001MAR30 1 243 forward 3 TM Non-Cytosolic 6 LG:1399315.8:2001MAR30 244 261 forward 3 TM Transmembrane 6 LG:1399315.8:2001MAR30 262 292 forward 3 TM Cytosolic 6 LG:1399315.8:2001MAR30 293 315 forward 3 TM Transmembrane TAB] JE 2
SEQ D NO: Template ID Start Stop Frame Domain Type Topology
6 LG:1399315.8:2001MAR30 316 986 forward 3 TM Non-Cytosolic
7 LG: 198782. L2001MAR30 1 735 forward 1 TM Non-Cytosolic 7 LG:198782.1:2001MAR30 736 758 forward 1 TM Transmembrane 7 LG: 198782. L2001MAR30 759 770 forward 1 TM Cytosolic 7 LG:198782.1:2001MAR30 771 793 forward 1 TM Transmembrane 7 LG:198782.1:2001MAR30 794 851 forward 1 TM Non-Cytosolic 7 LG: 198782. 2001MAR30 1 27 forward 2 TM Non-Cytosolic 7 LG: 198782. 2001MAR30 28 50 forward 2 TM Transmembrane 7 LG: 198782. L2001MAR30 51 377 forward 2 TM Cytosolic 7 LG:198782. L2001MAR30 378 400 forward 2 TM Transmembrane 7 LG: 198782. L2001MAR30 401 404 forward 2 TM Non-Cytosolic 7 LG: 198782. 2001MAR30 405 424 forward 2 TM Transmembrane 7 LG:198782.1:2001MAR30 425 769 forward 2 TM Cytosolic 7 LG: 198782. L2001MAR30 770 792 forward 2 TM Transmembrane 7 LG:198782.1:2001MAR30 793 801 forward 2 TM Non-Cytosolic 7 LG: 198782. L2001MAR30 802 819 forward 2 TM Transmembrane 7 LG:198782.1.-2001MAR30 820 850 forward 2 TM Cytosolic 7 LG: 198782. L2001MAR30 1 33 forward 3 TM Non-Cytosolic 7 LG:198782.1.-2001MAR30 34 51 forward 3 TM Transmembrane 7 LG: 198782.1.2001MAR30 52 380 forward 3 TM Cytosolic 7 LG:198782.1.2001MAR30 381 403 forward 3 TM Transmembrane 7 LG: 198782. L2001MAR30 404 406 forward 3 TM Non-Cytosolic 7 LG: 198782. L2001MAR30 407 . 424 forward 3 TM Transmembrane 7 LG: 198782.1:2001MAR30 425 436 forward 3 TM Cytosolic 7 LG: 198782. L2001MAR30 437 459 forward 3 TM Transmembrane 7 LG: 198782. L2001MAR30 460 541 forward 3 TM. Non-Cytosolic 7 LG:198782.1:2001MAR30 542 564 forward 3 TM Transmembrane 7 LG: 198782. 2001MAR30 565 770 forward 3 ' TM Cytosolic 7 LG:198782.1:2001MAR30 771 793 forward 3 TM Transmembrane 7 LG: 198782. L2001MAR30 794 802 forward 3 TM Non-Cytosolic 7 LG: 198782. 2001MAR30 803 822 forward 3 TM Transmembrane
7 LG: 198782. L2001MAR30 823 850 forward 3 TM Cytosolic
8 LG:236046.1:2001MAR30 1 160 forward 1 TM Non-Cytosolic 8 LG:236046.1:2001MAR30 161 183 forward 1 TM Transmembrane 8 LG:236046.1:2001MAR30 184 203 forward 1 TM Cytosolic 8 LG:236046.1:2001MAR30 204 226 forward 1 TM Transmembrane 8 LG:236046.1:2001MAR30 227 235 forward 1 TM Non-Cytosolic 8 LG:236046.1:2001MAR30 236 253 forward 1 TM Transmembrane 8 LG:236046.1:2001MAR30 254 273 forward 1 TM Cytosolic 8 LG:236046.1:2001MAR30 274 296 forward 1 TM Transmembrane 8 LG:236046.1:2001MAR30 297 367 forward 1 TM Non-Cytosolic 8 LG:236046.1:2001MAR30 368 390 forward 1 TM Transmembrane 8 LG:236046.1:2001MAR30 391 396 forward 1 TM Cytosolic 8 LG:236046.1:2001MAR30 397 416 forward 1 TM Transmembrane
8 LG:236046.1:2001MAR30 417 848 forward 1 TM Non-Cytosolic
9 LG:332122.6:2001MAR30 1 389 forward 1 TM Non-Cytosolic 9 LG:332122.6:2001MAR30 390 412 forward 1 TM Transmembrane 9 LG:332122.6:2001MAR30 413 447 forward 1 TM Cytosolic 9 LG:332122.6:2001MAR30 448 470 forward 1 TM Transmembrane 9 LG:332122.6:2001MAR30 471 557 forward 1 TM Non-Cytosolic 9 LG:332122.6:2001MAR30 558 575 forward 1 TM Transmembrane 9 LG:332122.6:2001MAR30 576 655 forward 1 TM Cytosolic 9 LG:332122.6:2001MAR30 656 678 forward 1 TM Transmembrane 9 LG:332122.6:2001MAR30 679 681 forward 1 TM Non-Cytosolic TABLE 2
SEQ D NO: Template ID Start Stop Frame Domain Type Topology
9 LG:332122.6:2001MAR30 682 701 forward 1 TM Transmembrane
9 LG:332122.6:2001MAR30 702 758 forward 1 TM Cytosolic
9 LG:332122.6:2001MAR30 759 778 forward 1 TM Transmembrane
9 LG:332122.6:2001MAR30 779 797 forward 1 TM Non-Cytosolic
9 LG:332122.6:2001MAR30 798 817 forward 1 TM Transmembrane
9 LG:332122.6:2001MAR30 818 837 forward 1 TM Cytosolic
9 LG:332122.6:2001MAR30 1 66 forward 2 TM Cytosolic
9 LG:332122.6:2001MAR30 67 84 forward 2 TM Transmembrane
9 LG:332122.6:2001MAR30 85 120 forward 2 TM Non-Cytosolic
9 LG:332122.6:2001MAR30 121 140 forward 2 TM Transmembrane
9 LG:332122.6:2001MAR30 141 235 forward 2 TM Cytosolic
9 LG:332122.6:2001MAR30 236 255 forward 2 TM Transmembrane
9 LG:332122.6:2001MAR30 256 269 forward 2 TM Non-Cytosolic
9 LG:332122.6:2001MAR30 270 289 forward 2 TM Transmembrane
9 LG:332122.6:2001MAR30 290 347 forward 2 TM Cytosolic
9 LG:332122.6:2001MAR30 348 370 forward 2 TM Transmembrane
9 LG:332122.6:2001MAR30 371 396 forward 2 TM Non-Cytosolic
9 LG:332122.6:2001MAR30 397 419 forward 2 TM Transmembrane
9 LG:332122.6:2001MAR30 420 431 forward 2 TM Cytosolic
9 LG:332122.6:2001MAR30 432 451 forward 2 TM Transmembrane
9 LG:332122.6:2001MAR30 452 465 forward 2 TM Non-Cytosolic
9 LG:332122.6:2001MAR30 466 488 forward 2 TM Transmembrane
9 LG:332122.6:2001MAR30 489 554 forward 2 TM Cytosolic
9 LG:332122.6:2001MAR30 555 574 forward 2 TM Transmembrane
9 LG:332122.6:2001MAR30 575 837 forward 2 TM Non-Cytosolic
9 LG:332122.6:2001MAR30 1 231 forward 3 TM Cytosolic
9 LG:332122.6:2001MAR30 232 254 forward 3 TM Transmembrane
9 LG:332122.6:2001MAR30 255 268 forward 3 TM Non-Cytosolic
9 LG:332122.6:2001MAR30 269 286 forward 3 TM Transmembrane
9 LG:332122.6:2001MAR30 287 328 forward 3 TM Cytosolic
9 LG:332122.6:2001MAR30 329 351 forward 3 TM Transmembrane
9 LG:332122.6:2001MAR30 352 393 forward 3 TM Non-Cytosolic
9 LG:332122.6:2001MAR30 394 416 forward 3 TM Transmembrane
9 LG:332122.6:2001MAR30 417 428 forward 3 TM Cytosolic
9 LG:332122.6:2001MAR30 429 451 forward 3 TM Transmembrane
9 LG:332122.6:2001MAR30 452 836 forward 3 TM Non-Cytosolic
10 LG:345320.16:2001MAR30 1 82 forward 1 TM Cytosolic 10 LG:345320.16:2001MAR30 83 105 forward 1 TM Transmembrane 10 LG:345320.16:2001MAR30 106 114 forward 1 TM Non-Cytosolic 10 LG:345320.16:2001MAR30 115 137 forward 1 TM Transmembrane 10 LG:345320.16:2001MAR30 138 290 forward 1 TM Cytosolic 10 LG:345320.16:2001MAR30 291 313 forward 1 TM Transmembrane 10 LG:345320.16:2001MAR30 314 327 forward 1 TM Non-Cytosolic 10 LG:345320.16:2001MAR30 328 350 forward 1 TM Transmembrane 10 LG:345320.16:2001MAR30 351 424 forward 1 TM Cytosolic 10 LG:345320.16:2001MAR30 425 447 forward 1 TM Transmembrane 10 LG:345320.16:2001MAR30 448 764 forward 1 TM Non-Cytosolic 10 LG:345320.16:2001MAR30 1 98 forward 2 TM Cytosolic 10 LG:345320.16:2001MAR30 99 121 forward 2 TM Transmembrane 10 LG:345320.16:2001MAR30 122 159 forward 2 TM Non-Cytosolic 10 LG:345320.16:2001MAR30 160 182 forward 2 TM Transmembrane 10 LG:345320.16:2001MAR30 183 188 forward 2 TM Cytosolic 10 LG:345320.16:2001MAR30 189 211 forward 2 TM Transmembrane 10 LG:345320.16:2001MAR30 212 331 forward 2 TM Non-Cytosolic TABLE 2
SEQ D NO Template ID Start Stop Frame Domain Type Topology
10 LG:345320.16:2001MAR30 332 354 forward 2 TM Transmembrane
10 LG:345320.16:2001MAR30 355 447 forward 2 TM Cytosolic
10 LG:345320.16:2001MAR30 448 470 forward 2 TM Transmembrane
10 LG:345320.16:2001MAR30 471 764 forward 2 TM Non-Cytosolic
10 LG:345320.16:2001MAR30 1 88 forward 3 TM Cytosolic
10 LG:345320.16:2001MAR30 89 111 forward 3 TM Transmembrane
10 LG:345320.16:2001MAR30 112 114 forward 3 TM Non-Cytosolic
10 LG:345320.16:2001MAR30 115 137 forward 3 TM Transmembrane
10 LG:345320.16:2001MAR30 138 172 forward 3 TM Cytosolic
10 LG:345320.16:2001MAR30 173 195 forward 3 TM Transmembrane
10 LG:345320.16:2001MAR30 196 330 forward 3 TM Non-Cytosolic
10 LG:345320.16:2001MAR30 331 353 forward 3 TM Transmembrane
10 LG:345320.16:2001MAR30 354 438 forward 3 TM Cytosolic
10 LG.-345320.16:2001MAR30 439 461 forward 3 TM Transmembrane
10 LG:345320.16:2001MAR30 462 764 forward 3 TM Non-Cytosolic
11 LG:350827.10:2001MAR30 1 9 forward 2 TM Non-Cytosolic
11 LG:350827.10:2001MAR30 10 32 forward 2 TM Transmembrane
11 LG:350827.10:2001MAR30 33 82 forward 2 TM Cytosolic
11 LG:350827.10:2001MAR30 83 105 forward 2 TM Transmembrane
11 LG:350827.10:2001MAR30 106 109 forward 2 TM Non-Cytosolic
11 LG:350827.10:2001MAR30 110 129 forward 2 TM Transmembrane
11 LG:350827.10:2001MAR30 130 149 forward 2 TM Cytosolic
11 LG:350827.10:2001MAR30 150 172 forward 2 TM Transmembrane
11 LG:350827.10:2001MAR30 173 181 forward 2 TM Non-Cytosolic
11 LG:350827.10:2001MAR30 182 204 forward 2 TM Transmembrane
11 LG:350827.10:2001MAR30 205 273 forward 2 TM Cytosolic
11 LG:350827.10:2001MAR30 274 296 forward 2 TM Transmembrane
11 LG:350827.10:2001MAR30 297 352 forward 2 TM Non-Cytosolic
11 LG:350827.10:2001MAR30 1 9 forward 3 TM Non-Cytosolic
11 LG:350827.10:2001MAR30 10 32 forward 3 TM Transmembrane
11 LG.-350827.10.-2001MAR30 33 140 forward 3 TM Cytosolic
11 LG:350827.10:2001MAR30 141 163 forward 3 TM Transmembrane
11 LG:350827.10:2001MAR30 164 177 forward 3 TM Non-Cytosolic
11 LG:350827.10:2001MAR30 178 197 forward 3 TM Transmembrane
11 LG:350827.10:2001MAR30 198 351 forward 3 TM Cytosolic
12 LG:399901.5:2001MAR30 1 308 forward 1 TM Non-Cytosolic
12 LG:399901.5:2001MAR30 309 331 forward 1 TM Transmembrane
12 LG:399901.5:2001MAR30 332 343 forward 1 TM Cytosolic
12 LG:399901.5:2001MAR30 344 366 forward 1 TM Transmembrane
12 LG:399901.5:2001MAR30 367 376 forward 1 TM Non-Cytosolic
13 LG:404563.1:2001MAR30 1 351 forward 1 TM Non-Cytosolic
13 LG:404563.1:2001MAR30 352 374 forward 1 TM Transmembrane
13 LG:404563.1:2001MAR30 375 662 forward 1 TM Cytosolic
13 LG:404563.1:2001MAR30 663 685 forward 1 TM Transmembrane
13 LG:404563.1 :2001MAR30 686 1 103 forward 1 TM Non-Cytosolic
13 LG:404563.1:2001MAR30 1 33 forward 2 TM Cytosolic
13 LG:404563.1:2001MAR30 34 51 forward 2 TM Transmembrane
13 LG:404563.1:2001MAR30 52 894 forward 2 TM Non-Cytosolic
13 LG:404563.1:2001MAR30 895 917 forward 2 TM Transmembrane
13 LG:404563.1:2001MAR30 918 999 forward 2 TM Cytosolic
13 LG:404563.1:2001MAR30 1000 1022 forward 2 TM Transmembrane
13 LG:404563.1:2001MAR30 1023 1 102 forward 2 TM Non-Cytosolic
13 LG:404563.1:2001MAR30 1 896 forward 3 TM Non-Cytosolic
13 LG:404563.1 :2001MAR30 897 919 forward 3 TM Transmembrane TABLE 2
SEQ D NO: Template ID Start Stop Frame Domain Type Topology
13 LG:404563.1:2001MAR30 920 996 forward 3 TM Cytosolic
13 LG:404563.1:2001MAR30 997 1014 forward 3 TM Transmembrane
13 LG:404563.1:2001MAR30 1015 1102 forward 3 TM Non-Cytosolic
14 LG:977812.15:2001MAR30 1 23 forward 1 TM Cytosolic 14 LG:977812.15:2001MAR30 24 43 forward 1 TM Transmembrane 14 LG:977812.15:2001MAR30 44 52 forward 1 TM Non-Cytosolic 14 LG:977812.15:2001MAR30 53 75 forward 1 TM Transmembrane
* 14 LG:977812.15:2001MAR30 76 94 forward 1 TM Cytosolic
14 LG:977812.15:2001MAR30 95 112 forward 1 TM Transmembrane
14 LG:977812.15:2001MAR30 113 115 forward 1 TM Non-Cytosolic
14 LG:977812.15:2001MAR30 116 138 forward 1 TM Transmembrane
14 LG:977812.15:2001MAR30 139 158 forward 1 TM Cytosolic
14 LG:977812.15:2001MAR30 159 177 forward 1 TM Transmembrane
14 LG:977812.15:2001MAR30 178 210 forward 1 TM Non-Cytosolic
14 LG:977812.15:2001MAR30 211 228 forward 1 TM Transmembrane
14 LG:977812.15:2001MAR30 229 247 forward 1 TM Cytosolic
14 LG:977812.15:2001MAR30 248 270 forward 1 TM Transmembrane
14 LG:977812.15:2001MAR30 271 284 forward 1 TM Non-Cytosolic
14 LG:977812.15:2001MAR30 285 307 forward 1 TM Transmembrane
14 LG:977812.15:2001MAR30 308 339 forward 1 TM Cytosolic
14 LG:977812.15:2001MAR30 340 357 forward 1 TM Transmembrane
14 LG:977812.15:2001MAR30 358 446 forward 1 TM Non-Cytosolic
14 LG:977812.15:2001MAR30 447 466 forward 1 TM Transmembrane
14 LG:977812.15:2001MAR30 467 482 forward 1 TM Cytosolic
14 LG:977812.15:2001MAR30 1 89 forward 2 TM Non-Cytosolic
14 LG:977812.15:2001MAR30 90 107 forward 2 TM Transmembrane
14 LG:977812.15:2001MAR30 108 113 forward 2 TM Cytosolic
14 LG:977812.15:2001MAR30 114 136 forward 2 TM Transmembrane
14 LG:977812.15:2001MAR30 137 150 forward 2 TM Non-Cytosolic
14 LG:977812.15:2001MAR30 151 173 forward 2 TM Transmembrane
14 LG:977812.15:2001MAR30 174 259 forward 2 TM Cytosolic
14 LG:977812.15:2001MAR30 260 282 forward 2 TM Transmembrane
14 LG:977812.15:2001MAR30 283 333 forward 2 TM Non-Cytosolic
14 LG:977812.15:2001MAR30 334 356 forward 2 TM Transmembrane
14 LG:977812.15:2001MAR30 357 417 forward 2 TM Cytosolic
14 LG:977812.15:2001MAR30 418 440 forward 2 TM Transmembrane
14 LG:977812.15:2001MAR30 441 449 forward 2 TM Non-Cytosolic
14 LG:977812.15:2001MAR30 450 467 forward 2 TM Transmembrane
14 LG:977812.15:2001MAR30 468 481 forward 2 TM Cytosolic
14 LG:977812.15:2001MAR30 1 93 forward 3 TM Cytosolic
14 LG:977812.15:2001MAR30 94 116 forward 3 TM Transmembrane
14 LG:977812.15:2001MAR30 117 125 forward 3 TM Non-Cytosolic
14 LG:977812.15:2001MAR30 126 148 forward 3 TM Transmembrane
14 LG:977812.15:2001MAR30 149 154 forward 3 TM Cytosolic
14 LG:977812.15:2001MAR30 155 174 forward 3 TM Transmembrane
14 LG:977812.15:2001MAR30 175 209 forward 3 TM Non-Cytosolic
14 LG:977812.15:2001MAR30 210 227 forward 3 TM Transmembrane
14 LG:977812.15:2001MAR30 228 246 forward 3 TM Cytosolic
14 LG:977812.15:2001MAR30 247 269 forward 3 TM Transmembrane
14 LG:977812.15:2001MAR30 270 283 forward 3 TM Non-Cytosolic
14 LG:977812.15:2001MAR30 284 306 forward 3 TM Transmembrane
14 LG:977812.15:2001MAR30 307 337 forward 3 TM Cytosolic
14 LG:977812.15:2001MAR30 338 355 forward 3 TM Transmembrane
14 LG:977812.15:2001MAR30 356 381 forward 3 TM Non-Cytosolic TABLE 2
SEQ D NO Template ID Start Stop Frame Domain Type Topology
14 LG:977812.15:2001MAR30 382 404 forward 3 TM Transmembrane
14 LG:977812.15:2001MAR30 405 446 forward 3 TM Cytosolic
14 LG:977812.15:2001MAR30 447 469 forward 3 TM Transmembrane
14 LG:977812.15:2001MAR30 470 481 forward 3 TM Non-Cytosolic
15 LG.983810.1 2001MAR30 1 86 forward 1 TM Non-Cytosolic
15 LG:983810.1 2001MAR30 87 109 forward 1 TM Transmembrane
15 LG.983810.1 2001MAR30 110 115 forward 1 TM Cytosolic
15 LG.-983810.1 2001MAR30 116 138 forward 1 TM Transmembrane
15 LG.983810.1 2001MAR30 139 380 forward 1 TM Non-Cytosolic
15 LG.983810.1 2001MAR30 381 403 forward 1 TM Transmembrane
15 LG.983810.1 2001MAR30 404 451 forward 1 TM Cytosolic
15 LG.983810.1 2001MAR30 452 474 forward 1 TM Transmembrane
15 LG:983810.1 2001MAR30 475 493 forward 1 TM Non-Cytosolic
15 LG:983810.1 2001MAR30 494 516 forward 1 TM Transmembrane
15 LG.983810.1 2001MAR30 517 528 forward 1 TM Cytosolic
15 LG:983810.1 2001MAR30 529 551 forward 1 TM Transmembrane
15 LG:983810.1 2001MAR30 552 615 forward 1 TM Non-Cytosolic
15 LG:983810.1 2001MAR30 616 638 forward 1 TM Transmembrane
15 LG:983810.1 2001MAR30 639 650 forward 1 TM Cytosolic
15 LG:983810.1 2001MAR30 651 673 forward 1 TM Transmembrane
15 LG:983810.1 2001MAR30 674 773 forward 1 TM Non-Cytosolic
15 LG:983810.1 2001MAR30 1 93 forward 2 TM Cytosolic
15 LG:983810.1 2001MAR30 94 116 forward 2 TM Transmembrane
15 LG:983810.1 2001MAR30 117 331 forward 2 TM Non-Cytosolic
15 LG:983810.1 2001MAR30 332 351 forward 2 TM Transmembrane
15 LG:983810.1 2001MAR30 352 455 forward 2 TM Cytosolic
15 LG:983810.1 2001MAR30 456 478 forward 2 TM Transmembrane
15 LG.-983810.1 2001MAR30 479 521 forward 2 TM Non-Cytosolic
15 LG:983810.1 2001MAR30 522 541 forward 2 TM Transmembrane
15 LG.-983810.1 2001MAR30 542 553 forward 2 TM Cytosolic
15 LG:983810.1 2001MAR30 554 571 forward 2 TM Transmembrane
15 LG:983810.1 2001MAR30 572 613 forward 2 TM Non-Cytosolic
15 LG:983810.1 2001MAR30 614 636 forward 2 TM Transmembrane
15 LG:983810.1 2001MAR30 637 642 forward 2 TM Cytosolic
15 LG:983810.1 2001MAR30 643 665 forward 2 TM Transmembrane
15 LG:983810.1 2001MAR30 666 684 forward 2 TM Non-Cytosolic
15 LG:983810.1 2001MAR30 685 707 forward 2 TM Transmembrane
15 LG:983810.1 2001MAR30 708 772 forward 2 TM Cytosolic
15 LG:983810.1 .2001MAR30 1 94 forward 3 TM Non-Cytosolic
15 LG:983810.1 2001MAR30 95 117 forward 3 TM Transmembrane
15 LG.983810.1 2001MAR30 118 123 forward 3 TM Cytosolic
15 LG:983810.1 2001MAR30 124 146 forward 3 TM Transmembrane
15 LG.983810.1 2001MAR30 147 772 forward 3 TM Non-Cytosolic
16 LG:984488.1 2001MAR30 1 12 forward 1 TM Cytosolic
16 LG:984488.1 2O01MAR3O 13 35 forward 1 TM Transmembrane
16 LG:984488.1 :2001MAR30 36 54 forward 1 TM Non-Cytosolic
16 LG:984488.1 2001MAR30 55 77 forward 1 TM Transmembrane
16 LG:984488.1 :2001MAR30 78 218 forward 1 TM Cytosolic
16 LG:984488.1 2001MAR30 1 14 forward 3 TM Non-Cytosolic
16 LG:984488.1 :2001MAR30 15 37 forward 3 TM Transmembrane
16 LG-.984488.1 :2001MAR30 38 218 forward 3 TM Cytosolic
17 LG:01 1606.1 :2001MAR30 1 92 forward 3 TM Cytosolic
17 LG:01 1606.1 :2001MAR30 93 115 forward 3 TM Transmembrane
17 LG:01 1606.1 :2001MAR3O 116 129 forward 3 TM Non-Cytosolic TABLE 2
SEQ D NO: Template ID Start Stop Frame Domain Type Topology
17 LG:011606.1:2001MAR30 130 152 forward 3 TM Transmembrane
17 LG:011606.1 :2001MAR30 153 400 forward 3 TM Cytosolic
18 LG:025465.5:2001MAR30 1 374 forward 2 TM Non-Cytosolic
18 LG:025465.5:2001MAR30 375 397 forward 2 TM Transmembrane
18 LG:025465.5:2001MAR30 398 453 forward 2 TM Cytosolic
18 LG:025465.5:2001MAR30 454 476 forward 2 TM Transmembrane
18 LG:025465.5:2001MAR30 477 661 forward 2 TM Non-Cytosolic
19 LG.O25724.10.-2001MAR30 1 92 forward 1 TM Non-Cytosolic
19 LG:025724.10:2001MAR30 93 115 forward 1 TM Transmembrane
19 LG:025724.10:2001MAR30 116 403 forward 1 TM Cytosolic
19 LG:025724.10:2001MAR30 404 426 forward 1 TM Transmembrane
19 LG:025724.10:2001MAR30 427 638 forward 1 TM Non-Cytosolic
19 LG:025724.10:2001MAR30 639 656 forward 1 TM Transmembrane
19 LG:025724.10:2001MAR30 657 662 forward 1 TM Cytosolic
19 LG:025724.10:2001MAR30 663 685 forward 1 TM Transmembrane
19 LG:025724.10:2001MAR30 686 694 forward 1 TM Non-Cytosolic
19 LG:025724.10:2001MAR30 695 717 forward 1 TM Transmembrane
19 LG:025724.10:2001MAR30 718 728 forward 1 TM Cytosolic
19 LG:025724.10:2001MAR30 729 748 forward 1 TM Transmembrane
19 LG:025724.10:2001MAR30 749 762 forward 1 TM Non-Cytosolic
19 LG:025724.10:2001MAR30 763 785 forward 1 TM Transmembrane
19 LG:025724.10:2001MAR30 786 805 forward 1 TM Cytosolic
19 LG:025724.10:2001MAR30 806 828 forward 1 TM Transmembrane
19 LG:025724.10:2001MAR30 829 831 forward 1 TM Non-Cytosolic
19 LG:025724.10:2001MAR30 832 854 forward 1 TM Transmembrane
19 LG:025724.10:2001MAR30 855 860 forward 1 TM Cytosolic
19 LG:025724.10:2001MAR30 861 883 forward 1 TM Transmembrane
19 LG:025724.10:2001MAR30 884 929 forward 1 TM Non-Cytosolic
19 LG:025724.10:2001MAR30 930 952 forward 1 TM Transmembrane
19 LG:025724.10:2001MAR30 953 993 forward 1 TM Cytosolic
19 LG:025724.10:2001MAR30 994 1016 forward 1 TM Transmembrane
19 LG:025724.10:2001MAR30 1017 1151 forward 1 TM Non-Cytosolic
19 LG:025724.10:2001MAR30 1 683 forward 2 TM Non-Cytosolic
19 LG:025724.10:2001MAR30 684 703 forward 2 TM Transmembrane
19 LG:025724.10:2001MAR30 704 714 forward 2 TM Cytosolic
19 LG:025724.10:2001MAR30 715 732 forward 2 TM Transmembrane
19 LG:025724.10:2001MAR30 733 746 forward 2 TM Non-Cytosolic
19 LG:025724.10:2001MAR30 747 769 forward 2 TM Transmembrane
19 LG:025724.10:2001MAR30 770 845 forward 2 TM Cytosolic
19 LG:025724.10:2001MAR30 846 868 forward 2 TM Transmembrane
19 LG.-025724.10.-2001MAR30 869 934 forward 2 TM Non-Cytosolic
19 LG:025724.10:2001MAR30 935 957 forward 2 TM Transmembrane
19 LG:025724.10:2001MAR30 958 968 forward 2 TM Cytosolic
19 LG:025724.10:2001MAR30 969 991 forward 2 TM Transmembrane
19 LG:025724.10:2001MAR30 992 1024 forward 2 TM Non-Cytosolic
19 LG:025724.10:2001MAR30 1025 1047 forward 2 TM Transmembrane
19 LG:025724.10:2001MAR30 1048 1151 forward 2 TM Cytosolic
19 LG:025724.10:2001MAR30 1 9 forward 3 TM Non-Cytosolic
19 LG.-025724.10:2001MAR30 10 28 forward 3 TM Transmembrane
19 LG:025724.10:2001MAR30 29 74 forward 3 TM Cytosolic
19 LG:025724.10:2001MAR30 75 97 forward 3 TM Transmembrane
19 LG:025724.10:2001MAR30 98 396 forward 3 TM Non-Cytosolic
19 LG:025724.10:2001MAR30 397 419 forward 3 TM Transmembrane
19 LG:025724.10:2001MAR30 420 635 forward 3 TM Cytosolic TABLE 2
SEQ D NO: Template ID Start Stop Frame Domain Type Topology
19 LG:025724.10:2001MAR30 636 653 forward 3 TM Transmembrane
19 LG:025724.10:2001MAR30 654 680 forward 3 TM Non-Cytosolic
19 LG:025724.10:2001MAR30 681 703 forward 3 TM Transmembrane
19 LG.025724.10:2001MAR30 704 871 forward 3 TM Cytosolic
19 LG:025724.10:2001MAR30 872 889 forward 3 TM Transmembrane
19 LG.O25724.10:2001MAR30 890 968 forward 3 TM Non-Cytosolic
19 LG:025724.10:2001MAR30 969 991 forward 3 TM Transmembrane
19 LG:025724.10:2001MAR30 992 1083 forward 3 TM Cytosolic
19 LG:025724.10:2001MAR30 1084 1106 forward 3 TM Transmembrane
19 LG:025724.10:2001MAR30 1107 1115 forward 3 TM Non-Cytosolic
19 LG:025724.10:2001MAR30 1116 1135 forward 3 TM Transmembrane
19 LG:025724.10:2001MAR30 1136 1151 forward 3 TM Cytosolic
20 LG:1095426.1:2001MAR30 1 168 forward 1 TM Non-Cytosolic 20 LG:1095426.1:2001MAR30 169 191 forward 1 TM Transmembrane 20 LG:1095426.1:2001MAR30 192 202 forward 1 TM Cytosolic 20 LG:1095426.1:2001MAR30 203 225 forward 1 TM Transmembrane 20 LG: 1095426.1:2001MAR30 226 883 forward 1 TM Non-Cytosolic 20 LG:1095426.1:2001MAR30 1 119 forward 3 TM Cytosolic 20 LG:1095426.1:2001MAR30 120 142 forward 3 TM Transmembrane
20 LG: 1095426.1:2001MAR30 143 882 forward 3 TM Non-Cytosolic
21 LG:1132418.1:2001MAR30 1 141 forward 3 TM Cytosolic 21 LG:1132418.1:2001MAR30 142 164 forward 3 TM Transmembrane
21 LG:1132418.1:2001MAR30 165 260 forward 3 TM Non-Cytosolic
22 LG: 1377900.14.-2001MAR30 1 157 forward 1 TM Cytosolic 22 LG:1377900.14:2001MAR30 158 180 forward 1 TM Transmembrane 22 LG: 1377900.14:2001MAR30 181 199 forward 1 TM Non-Cytosolic 22 LG:1377900.14:2001MAR30 200 222 forward 1 TM Transmembrane
22 LG: 1377900.14:2001MAR30 223 230 forward 1 TM Cytosolic
23 LG:1383812.1:2001MAR30 1 83 forward 2 TM Non-Cytosolic 23 LG:1383812.1:2001MAR30 84 106 forward 2 TM Transmembrane 23 LG:1383812.1:2001MAR30 107 125 forward 2 TM Cytosolic 23 LG:1383812.1:2001MAR30 126 143 forward 2 TM Transmembrane 23 LG:1383812.1:2001MAR30 144 152 forward 2 TM Non-Cytosolic 23 LG:1383812.1:2001MAR30 153 170 forward 2 TM Transmembrane 23 LG:1383812.1:2001MAR30 171 176 forward 2 TM Cytosolic 23 LG:1383812.1:2001MAR30 177 196 forward 2 TM Transmembrane 23 LG:1383812.1:2001MAR30 197 200 forward 2 TM Non-Cytosolic 23 LG:1383812.1:2001MAR30 201 218 forward 2 TM Transmembrane 23 LG:1383812.1:2001MAR30 219 224 forward 2 TM Cytosolic 23 LG:1383812.1 :2001MAR30 225 247 forward 2 TM Transmembrane
23 LG:1383812.1:2001MAR30 248 732 forward 2 TM Non-Cytosolic
24 LG: 1468687. 2001MAR30 1 48 forward 1 TM Non-Cytosolic 24 LG: 1468687.1:2001MAR30 49 71 forward 1 TM Transmembrane
24 LG: 1468687.1 :2001MAR30 72 152 forward 1 TM Cytosolic
25 LG:1505513.1 :2001MAR30 1 14 forward 1 TM Non-Cytosolic 25 LG: 1505513.1 :2001MAR30 15 37 forward 1 TM Transmembrane 25 LG:1505513.1:2001MAR30 38 110 forward 1 TM Cytosolic 25 LG:1505513.1 :2001MAR30 111 133 forward 1 TM Transmembrane 25 LG:1505513.1:2001MAR30 134 152 forward 1 TM Non-Cytosolic 25 LG:1505513.1:2001MAR30 153 172 forward 1 TM Transmembrane 25 LG: 1505513. 2001MAR30 173 344 forward 1 TM Cytosolic 25 LG:1505513.1:2001MAR30 1 12 forward 2 TM Cytosolic 25 LG: 1505513. L2001MAR30 13 35 forward 2 TM Transmembrane 25 LG:1505513.1:2001MAR30 36 49 forward 2 TM Non-Cytosolic TABLE 2
SEQ D NO: Template ID Start Stop Frame Domain Type Topology
25 LG:1505513.1:2001MAR30 50 72 forward 2 TM Transmembrane
25 LG:1505513.1:2001MAR30 73 110 forward 2 TM Cytosolic
25 LG:1505513.1:2001MAR30 111 133 forward 2 TM Transmembrane
25 LG: 1505513. 2001MAR30 134 343 forward 2 TM Non-Cytosolic
25 LG: 1505513. L2001MAR30 1 14 forward 3 TM Non-Cytosolic
25 LG:1505513.1:2001MAR30 15 37 forward 3 TM Transmembrane
25 LG:1505513.1:2001MAR30 38 108 forward 3 TM Cytosolic
25 LG:1505513.1:2001MAR30 109 126 forward 3 TM Transmembrane
25 LG:1505513.1:2001MAR30 127 343 forward 3 TM Non-Cytosolic
26 ' LG:178823.9:2001MAR30 1 262 forward 1 TM Non-Cytosolic 26 LG:178823.9:2001MAR30 263 281 forward 1 TM Transmembrane 26 LG:178823.9:2001MAR30 282 292 forward 1 TM Cytosolic 26 LG:178823.9:2001MAR30 293 312 forward 1 TM Transmembrane 26 LG:178823.9:2001MAR30 313 316 forward 1 TM Non-Cytosolic 26 LG:178823.9:2001MAR30 317 334 forward 1 TM Transmembrane 26 LG:178823.9:2001MAR30 335 346 forward 1 TM Cytosolic 26 LG:178823.9:2001MAR30 347 369 forward 1 TM Transmembrane 26 LG:178823.9:2001MAR30 370 398 forward 1 TM Non-Cytosolic 26 LG:178823.9:2001MAR30 1 90 forward 2 TM Cytosolic 26 LG:178823.9:2001MAR30 91 113 forward 2 TM Transmembrane 26 LG:178823.9:2001MAR30 114 127 forward 2 TM Non-Cytosolic 26 LG:178823.9:2001MAR30 128 150 forward 2 TM Transmembrane 26 LG:178823.9:2001MAR30 151 296 forward 2 TM Cytosolic 26 LG:178823.9:2001MAR30 297 319 forward 2 TM Transmembrane 26 LG:178823.9:2001MAR30 320 333 forward 2 TM Non-Cytosolic 26 LG:178823.9:2001MAR30 334 351 ' forward 2 TM Transmembrane
26 LG:178823.9:2001MAR30 352 398 forward 2 TM Cytosolic
27 LG:198342.3:2001MAR30 1 1418 forward 3 TM Non-Cytosolic 27 LG:198342.3:2001MAR30 1419 1441 forward 3 TM Transmembrane 27 LG:198342.3:2001MAR30 1442 1545 forward 3 TM Cytosolic 27 LG:198342.3:2001MAR30 1546 1568 forward 3 TM Transmembrane
27 LG:198342.3:2001MAR30 1569 1597 forward 3 TM Non-Cytosolic
28 LG:210672.1:2001MAR30 1 397 forward 1 TM Cytosolic 28 LG:210672.1:2001MAR30 398 420 forward 1 TM Transmembrane 28 LG:210672.1:2001MAR30 421 468 forward 1 TM Non-Cytosolic 28 LG:210672.1:2001MAR30 469 491 forward 1 TM Transmembrane 28 LG:210672.1:2001MAR30 492 585 forward 1 TM Cytosolic 28 LG:210672.1:2001MAR30 1 76 forward 2 TM Cytosolic 28 LG:210672.1:2001MAR30 77 99 forward 2 TM Transmembrane 28 LG:210672.1:2001MAR30 100 102 forward 2 TM Non-Cytosolic 28 LG:210672.1:2001MAR30 103 125 forward 2 TM Transmembrane 28 LG:210672.1:2001MAR30 126 402 forward 2 TM Cytosolic 28 LG:210672.1:2001MAR30 403 425 forward 2 TM Transmembrane
28 LG:210672.1:2001MAR30 426 585 forward 2 TM Non-Cytosolic
29 LG:212823.8:2001MAR30 1 58 forward 1 TM Non-Cytosolic 29 LG:212823.8:2001MAR30 59 81 forward 1 TM Transmembrane 29 LG:212823.8:2001MAR30 82 100 forward 1 TM Cytosolic 29 LG:212823.8:2001MAR30 101 123 forward 1 TM Transmembrane 29 LG:212823.8:2001MAR30 124 569 forward 1 TM Non-Cytosolic 29 LG:212823.8:2001MAR30 570 588 forward 1 TM Transmembrane 29 LG:212823.8:2001MAR30 589 594 forward 1 TM Cytosolic 29 LG:212823.8:2001MAR30 595 617 forward 1 TM Transmembrane 29 LG:212823.8:2001MAR30 618 835 forward 1 TM Non-Cytosolic 29 LG:212823.8:2001MAR30 1 37 forward 2 TM Cytosolic TABLE 2
SEQ D NO: Template ID Start Stop Frame Domain Type Topology
29 LG:212823.8:2001MAR30 38 60 forward 2 TM Transmembrane
29 LG:212823.8:2001MAR30 61 64 forward 2 TM Non-Cytosolic
29 LG:212823.8:2001MAR30 65 82 forward 2 TM Transmembrane
29 LG:212823.8:2001MAR30 83 88 forward 2 TM Cytosolic
29 LG:212823.8:2001MAR30 89 111 forward 2 TM Transmembrane
29 LG:212823.8:2001MAR30 112 835 forward 2 TM Non-Cytosolic
29 LG:212823.8:2001MAR30 1 9 forward 3 TM Non-Cytosolic
29 LG:212823.8:2001MAR30 10 32 forward 3 TM Transmembrane
29 LG:212823.8:2001MAR30 33 51 forward 3 TM Cytosolic
29 LG:212823.8:2001MAR30 52 74 forward 3 TM Transmembrane
29 LG:212823.8:2001MAR30 75 587 forward 3 TM Non-Cytosolic
29 LG:212823.8:2001MAR30 588 610 forward 3 TM Transmembrane
29 LG:212823.8:2001MAR30 611 834 forward 3 TM Cytosolic
30 LG:220495.9:2001MAR30 1 14 forward 1 TM Non-Cytosolic 30 LG:220495.9:2001MAR30 15 37 forward 1 TM Transmembrane 30 LG:220495.9:2001MAR30 38 446 forward 1 TM Cytosolic 30 LG:220495.9:2001MAR30 447 465 forward 1 TM Transmembrane 30 LG:220495.9:2001MAR30 466 484 forward 1 TM Non-Cytosolic 30 LG:220495.9:2001MAR30 485 507 forward 1 TM Transmembrane 30 LG:220495.9:2001MAR30 508 567 forward 1 TM Cytosolic 30 LG:220495.9:2001MAR30 568 590 forward 1 TM Transmembrane 30 LG:220495.9:2001MAR30 591 599 forward 1 TM Non-Cytosolic 30 LG:220495.9:2001MAR30 600 622 forward 1 TM Transmembrane 30 LG:220495.9:2001MAR30 623 737 forward 1 TM Cytosolic 30 LG:220495.9:2001MAR30 1 40 forward 2 TM Non-Cytosolic 30 LG:220495.9:2001MAR30 41 63 forward 2 TM Transmembrane 30 LG:220495.9:2001MAR30 64 163 forward 2 TM Cytosolic 30 LG:220495.9:2001MAR30 164 183 forward 2 TM Transmembrane 30 LG:220495.9:2001MAR30 184 192 forward 2 TM Non-Cytosolic 30 LG:220495.9:2001MAR30 193 210 forward 2 TM Transmembrane 30 LG:220495.9:2001MAR30 211 247 forward 2 TM Cytosolic 30 LG:220495.9:2001MAR30 248 270 forward 2 TM Transmembrane 30 LG:220495.9:2001MAR30 271 284 forward 2 TM Non-Cytosolic 30 LG:220495.9:2001MAR30 285 307 forward 2 TM Transmembrane 30 LG:220495.9:2001MAR30 308 486 forward 2 TM Cytosolic 30 LG:220495.9:2001MAR30 487 509 forward 2 TM Transmembrane
30 LG:220495.9:2001MAR30 510 737 forward 2 TM Non-Cytosolic
31 LG:238262.1 :2001MAR30 1 327 forward 1 TM Cytosolic 31 LG:238262.1:2001MAR30 328 350 forward 1 TM Transmembrane 31 LG:238262.1 :2001MAR30 351 369 forward 1 TM Non-Cytosolic 31 LG:238262.1 :2001MAR30 370 392 forward 1 TM Transmembrane 31 LG:238262.1:2001MAR30 393 405 forward 1 TM Cytosolic 31 LG:238262.1:2001MAR30 1 334 forward 3 TM Non-Cytosolic 31 LG:238262.1:2001MAR30 335 357 forward 3 TM Transmembrane
31 LG:238262.1 :2001MAR30 358 404 forward 3 TM Cytosolic
32 LG:239410.21:2001MAR30 1 816 forward 1 TM Non-Cytosolic 32 LG:239410.21:2001MAR30 817 834 forward 1 TM Transmembrane 32 LG:239410.21:2001MAR30 835 963 forward 1 TM Cytosolic 32 LG:239410.21:2001MAR30 1 139 forward 2 TM Non-Cytosolic 32 • LG:239 10.21 :2001MAR30 140 162 forward 2 TM Transmembrane 32 LG:239410.21:2001MAR30 163 163 forward 2 TM Cytosolic 32 LG:239410.21 :2001MAR30 164 186 forward 2 TM Transmembrane 32 LG:239410.21 :2001MAR30 187 219 forward 2 TM Non-Cytosolic 32 LG:239410.21:2001MAR30 220 242 forward 2 TM Transmembrane TABLE 2
SEQ D NO Template ID Start Stop Frame Domain Type Topology
32 LG:239410.21:2001MAR30 243 267 forward 2 TM Cytosolic
32 LG:239410.21:2001MAR30 268 290 forward 2 TM Transmembrane
32 LG:239410.21:2001MAR30 291 365 forward 2 TM Non-Cytosolic
32 LG:239410.21:2001MAR30 366 388 forward 2 TM Transmembrane
32 LG:239410.21:2001MAR30 389 408 forward 2 TM Cytosolic
32 LG:239410.21:2001MAR30 409 431 forward 2 TM Transmembrane
32 LG:239410.21 :2001MAR30 432 470 forward 2 TM Non-Cytosolic
32 LG:239410.21:2001MAR30 471 493 forward 2 TM Transmembrane
32 LG:239410.21:2001MAR30 494 508 forward 2 TM Cytosolic
32 LG:239410.21:2001MAR30 509 531 forward 2 TM Transmembrane
32 LG:239410.21:2001MAR30 532 550 forward 2 TM Non-Cytosolic
32 LG:239410.21:2001MAR30 551 573 forward 2 TM Transmembrane
32 LG:239410.21:2001MAR30 574 963 forward 2 TM Cytosolic
33 LG:245854J:2001MAR30 1 68 forward 3 TM Cytosolic
33 LG:245854.7:2001MAR30 69 88 forward 3 TM Transmembrane
33 LG:245854J:2001MAR30 89 1346 forward 3 TM Non-Cytosolic
34 LG:294697.1:2001MAR30 1 61 forward 1 TM Cytosolic
34 LG:294697.1:2001MAR30 62 84 forward 1 TM Transmembrane
34 LG:294697.1:2001MAR30 85 225 forward 1 TM Non-Cytosolic
34 LG:294697.1:2001MAR30 1 85 forward 3 TM Cytosolic
34 LG:294697.1:2001MAR30 86 105 forward 3 TM Transmembrane
34 LG:294697.1:2001MAR30 106 178 forward 3 TM Non-Cytosolic
34 LG:294697.1:2001MAR30 179 201 forward 3 TM Transmembrane
34 LG:294697.1:2001MAR30 202 224 forward 3 TM Cytosolic
35 LG:345884.1:2001MAR30 1 28 forward 1 TM Cytosolic
35 LG:345884.1 :2001MAR30 29 51 forward 1 TM Transmembrane
35 LG:345884.1:2001MAR30 52 192 forward 1 TM Non-Cytosolic
36 LG:400095.15:2001MAR30 1 970 forward 1 TM Non-Cytosolic
36 LG:400095.15:2001MAR30 971 993 forward 1 TM Transmembrane
36 LG:400095.15:2001MAR30 994 997 forward 1 TM Cytosolic
36 LG:400095.15:2001MAR30 998 1015 forward 1 TM Transmembrane
36 LG:400095.15:2001MAR30 1016 1018 forward 1 TM Non-Cytosolic
36 LG:400095.15:2001MAR30 1019 1036 forward 1 TM Transmembrane
36 LG:400095.15:2001MAR30 1037 1062 forward 1 TM Cytosolic
37 LG.402180.1 2001MAR30 1 162 forward 1 TM Cytosolic
37 LG:402180.1 2001MAR30 163 185 forward 1 TM Transmembrane
37 LG.402180.1 2001MAR30 186 204 forward 1 TM Non-Cytosolic
37 LG:402180.1 2001MAR30 205 227 forward 1 TM Transmembrane
37 LG:402180.1 2001MAR30 228 283 forward 1 TM Cytosolic
37 LG.402180.1 2001MAR30 284 306 forward 1 TM Transmembrane
37 LG:402180.1 2001MAR30 307 325 forward 1 TM Non-Cytosolic
37 LG:402180.1 2001MAR30 326 348 forward 1 TM Transmembrane
37 LG.402180.1 2001MAR30 349 560 forward 1 TM Cytosolic
37 LG.402180.1 2001MAR30 561 583 forward 1 TM Transmembrane
37 LG:402180.1 2001MAR30 584 614 forward 1 TM Non-Cytosolic
37 LG.402180.1 2001MAR30 615 637 forward 1 TM Transmembrane
37 LG:402180.1 2001MAR30 638 658 forward 1 TM Cytosolic
37 LG:402180.1 2001MAR30 1 318 forward 2 TM Non-Cytosolic
37 LG:402180.1 2001MAR30 319 341 forward 2 TM Transmembrane
37 LG:402180.1 2001MAR30 342 562 forward 2 TM Cytosolic
37 LG:402180.1 2001MAR30 563 585 forward 2 TM Transmembrane
37 LG:402180.1 2001MAR30 586 658 forward 2 TM Non-Cytosolic
38 LG.403401.1 2001MAR30 1 176 forward 1 TM Cytosolic
38 LG.-403401.1 2001MAR30 177 199 forward 1 TM Transmembrane TABLE 2
Q D NO Template ID Start Stop Frame Domain Type Topology
38 LG.403401.1 2001MAR30 200 218 forward 1 TM Non-Cytosolic
38 LG.403401.1 2001MAR30 219 238 forward 1 TM Transmembrane
38 LG:403401.1 20Q1MAR30 239 250 forward 1 TM Cytosolic
38 LG.403401.1 2001MAR30 251 273 forward 1 TM Transmembrane
38 LG.403401.1 2001MAR30 274 350 forward 1 * TM Non-Cytosolic
38 LG.403401.1 2001MAR30 1 14 forward 2 TM Non-Cytosolic
38 LG.403401.1 2001MAR30 15 37 forward 2 TM Transmembrane
38 LG.403401.1 2001MAR30 38 176 forward 2 TM Cytosolic
38 LG.403401.1 2001MAR30 177 199 forward 2 TM Transmembrane
38 LG.403401.1 2001MAR30 200 213 forward 2 TM Non-Cytosolic
38 LG.403401.1 2001MAR30 214 236 forward 2 TM Transmembrane
38 LG.403401.1 2001MAR30 237 350 forward 2 TM Cytosolic
38 LG:403401.1 2001MAR30 1 138 forward 3 TM Cytosolic
38 LG:403401.1 2001MAR30 139 161 forward 3 TM Transmembrane
38 LG:403401.1 2001MAR30 162 192 forward 3 TM Non-Cytosolic
38 LG:403401.1 2001MAR30 193 215 forward 3 TM Transmembrane
38 LG:403401.1 2001MAR30 216 226 forward 3 TM ( Cytosolic
38 LG:403401.1 2001MAR30 227 249 forward 3 TM Transmembrane
38 LG:403401.1 2001MAR30 250 350 forward 3 TM Non-Cytosolic
39 LG:411327.29:2001MAR30 1 97 forward 1 TM Cytosolic
39 LG:411327.29:2001MAR30 98 120 forward 1 TM Transmembrane
39 LG:411327.29:2001MAR30 121 371 forward 1 TM Non-Cytosolic
40 LG:417464.10:2001MAR30 1 19 forward 1 TM Non-Cytosolic
40 LG:417464.10:2001MAR30 20 42 forward 1 TM Transmembrane
40 LG:417464.10:2001MAR30 43 298 forward 1 TM Cytosolic
40 LG:417464.10:2001MAR30 299 321 forward 1 TM Transmembrane
40 LG:417464.10.-2001MAR30 322 340 forward 1 TM Non-Cytosolic
40 LG:417464.10:2001MAR30 341 363 forward 1 TM Transmembrane
40 LG:417464.10:2001MAR30 364 418 forward 1 TM Cytosolic
40 LG:417464.10:2001MAR30 1 287 forward 2 TM Non-Cytosolic
40 LG:417464.10:2001MAR30 288 310 forward 2 TM Transmembrane
40 LG:417464.10:2001MAR30 311 330 forward 2 TM Cytosolic
40 LG:417464.10:2001MAR30 331 353 forward 2 TM Transmembrane
40 LG:417464.10:2001MAR30 354 367 forward 2 TM Non-Cytosolic
40 LG:417464.10:2001MAR30 368 390 forward 2 TM Transmembrane
40 LG:417464.10:2001MAR30 391 418 forward 2 TM Cytosolic
40 LG:417464.10:2001MAR30 1 1 forward 3 TM Cytosolic
40 LG:417464.10:2001MAR30 2 24 forward 3 TM Transmembrane
40 LG:417464.10:2001MAR30 25 95 forward 3 TM Non-Cytosolic
40 LG:417464.10:2001MAR30 96 118 forward 3 TM Transmembrane
40 LG:417464.10:2001MAR30 119 328 forward 3 TM Cytosolic
40 LG:417464.10:2001MAR30 329 351 forward 3 TM Transmembrane
40 LG:417464.10:2001MAR30 352 417 forward 3 TM Non-Cytosolic
41 LG:481997.1 2001MAR30 1 82 forward 1 TM Cytosolic
41 LG.481997.1 :2001MAR30 83 105 forward 1 TM Transmembrane
41 LG:481997.1 2001MAR30 106 152 forward 1 TM Non-Cytosolic
41 LG:481997.1 :2001MAR30 153 175 forward 1 TM Transmembrane
41 LG:481997.1 2001MAR30 176 253 forward 1 TM Cytosolic
41 LG:481997.1 2001MAR30 254 276 forward 1 TM Transmembrane
41 LG.481997.1 2001MAR30 277 279 forward 1 TM Non-Cytosolic
41 LG:481997.1 2001MAR30 280 302 forward 1 TM Transmembrane
41 LG:481997.1 :2001MAR30 303 383 forward 1 TM Cytosolic
41 LG:481997.1 :2001MAR30 1 81 forward 3 TM Cytosolic
41 LG:481997.1 :2001MAR30 82 104 forward 3 TM Transmembrane TABLE 2
SEQ D NO: Template ID Start Stop Frame Domain Type Topology
41 LG:481997.1:2001MAR30 105 382 forward 3 TM Non-Cytosolic
42 LG:979304.7:2001MAR30 1 319 forward 2 TM Non-Cytosolic
42 LG:979304.7:2001MAR30 320 342 forward 2 TM Transmembrane
42 LG:979304.7:2001 MAR30 343 354 forward 2 TM Cytosolic
42 LG:979304.7:2001MAR30 355 377 forward 2 TM Transmembrane
42 LG:979304.7:2001MAR30 378 391 forward 2 TM Non-Cytosolic
42 LG:979304.7:2001MAR30 392 414 forward 2 TM Transmembrane
42 LG:979304.7:2001MAR30 415 426 forward 2 TM Cytosolic
43 LG:997964.1:2001MAR30 21 110 forward 3 SP
43 LG:997964.1 :2001MAR30 1 356 forward 3 TM Cytosolic
43 LG:997964.1:2001MAR30 357 379 forward 3 TM Transmembrane
43 LG:997964.1:2001MAR30 380 1082 forward 3 TM Non-Cytosolic
44 LG:998845.1 :2001MAR30 1 66 forward 2 TM Non-Cytosolic
44 LG:998845.1:2001MAR30 67 89 forward 2 TM Transmembrane
44 LG:998845.1:2001MAR30 90 281 forward 2 TM Cytosolic
44 LG:998845.1:2001MAR30 1 67 forward 3 TM Non-Cytosolic
44 LG:998845.1:2001MAR30 68 90 forward 3 TM Transmembrane
44 LG:998845.1:2001MAR30 91 102 forward 3 TM Cytosolic
44 LG:998845.1:2001MAR30 103 125 forward 3 TM Transmembrane
44 LG:998845.1:2001MAR30 126 185 forward 3 TM Non-Cytosolic
44 LG:998845.1:2001MAR30 186 208 forward 3 TM Transmembrane
44 LG:998845.1:2001MAR30 209 281 forward 3 TM Cytosolic
45 LG:000014.1:2001MAR30 1 92 forward 1 TM Cytosolic
45 LG:000014.1:2001MAR30 93 115 forward 1 TM Transmembrane
45 LG:000014.1:2001MAR30 116 156 forward 1 TM Non-Cytosolic
45 LG:000014.1 :2001MAR30 157 179 forward 1 TM Transmembrane
45 LG:000014.1:2001MAR30 180 198 forward 1 TM Cytosolic
45 LG.O00014.1 :2001MAR30 199 221 forward 1 TM Transmembrane
45 LG:000014.1 :2001MAR30 222 300 forward 1 TM Non-Cytosolic
45 LG:000014.1:2001MAR30 301 323 forward 1 TM Transmembrane
45 LG:000014.1:2001MAR30 324 327 forward 1 TM Cytosolic
45 LG:000014.1 :2001MAR30 328 347 forward 1 TM Transmembrane
45 LG:000014.1:2001MAR30 348 363 forward 1 TM Non-Cytosolic
45 LG:000014.1:2001MAR30 1 183 forward 2 TM Non-Cytosolic
45 LG:000014.1:2001MAR30 184 206 forward 2 TM Transmembrane
45 LG. 00014.1 :2001MAR30 207 276 forward 2 TM Cytosolic
45 LG:000014.1:2001MAR30 277 296 forward 2 TM Transmembrane
45 LG:000014.1 :2001MAR30 297 363 forward 2 TM Non-Cytosolic
45 LG:000014.1:2001MAR30 1 94 forward 3 TM Cytosolic
45 LG:000014.1:2001MAR30 95 117 forward 3 TM Transmembrane
45 LG:000014.1 :2001MAR30 118 120 forward 3 TM Non-Cytosolic
45 LG:000014.1:2001MAR30 121 140 forward 3 TM Transmembrane
45 LG:000014.1:2001MAR30 141 160 forward 3 TM Cytosolic
45 LG:000014.1:2001MAR30 161 183 forward 3 TM Transmembrane
45 LG:000014.1:2001MAR30 184 363 forward 3 TM Non-Cytosolic
46 LG:000290.9:2001MAR30 1 559 forward 2 TM Non-Cytosolic
46 LG:000290.9:2001MAR30 560 582 forward 2 TM Transmembrane
46 LG:000290.9:2001MAR30 583 617 forward 2 TM Cytosolic
47 LG:001923.1:2001MAR30 1 109 forward 1 TM Cytosolic
47 LG:001923.1:2001MAR30 110 132 forward 1 TM Transmembrane
47 LG.O01923.1 :2001MAR30 133 141 forward 1 TM Non-Cytosolic
47 LG:001923.1 :2001MAR30 142 164 forward 1 TM Transmembrane
47 LG:001923.1:2001MAR30 165 176 forward 1 TM Cytosolic
47 LG.-001923.1 :2001MAR30 177 199 forward 1 TM Transmembrane TABLE 2
SEQ D NO Template ID Start Stop Frame Domain Type Topology
47 LG:001923.1 2001MAR30 200 265 forward 1 TM Non-Cytosolic
47 LG:001923.1 2001MAR30 266 288 forward 1 TM Transmembrane
47 LG:001923.1 2001MAR30 289 461 forward 1 TM Cytosolic
47 LG:001923.1 2001MAR30 462 484 forward 1 TM Transmembrane
47 LG.-001923.1 2001MAR30 485 503 forward 1 TM Non-Cytosolic
47 LG:001923.1 2001MAR30 504 526 forward 1 TM Transmembrane
47 LG:001923.1 2001MAR30 527 532 forward 1 TM Cytosolic
47 LG:001923.1 2001MAR30 533 555 forward 1 TM Transmembrane
47 LG:001923.1 2001MAR30 556 590 forward 1 TM Non-Cytosolic
47 LG:001923.1 2001MAR30 1 135 forward 3 TM Non-Cytosolic
47 LG:001923.1 2001MAR30 136 158 forward 3 TM Transmembrane
47 LG:001923.1 2001MAR30 159 164 forward 3 TM Cytosolic
47 LG:001923.1 2001MAR30 165 187 forward 3 TM Transmembrane
47 LG.O01923.1 2001MAR30 188 201 forward 3 TM Non-Cytosolic
47 LG:001923.1 2001MAR30 202 221 forward 3 TM Transmembrane
47 LG:001923.1 2001MAR30 222 241 forward 3 TM Cytosolic
47 LG:001923.1 2001MAR30 242 264 forward 3 TM Transmembrane
47 LG:001923.1 2001MAR30 265 589 forward 3 TM Non-Cytosolic
48 LG:008606.21:2001MAR30 1 160 forward 1 TM Cytosolic
48 LG:008606.21:2001MAR30 161 183 forward 1 TM Transmembrane
48 LG:008606.21:2001MAR30 184 202 forward 1 TM Non-Cytosolic
48 LG:008606.21 :2001MAR30 203 225 forward 1 TM Transmembrane
48 LG:008606.21:2001MAR30 226 401 forward 1 TM Cytosolic
48 LG:008606.21:2001MAR30 402 424 forward 1 TM Transmembrane
48 LG:008606.21:2001MAR30 425 443 forward 1 TM Non-Cytosolic
48 LG:008606.21:2001MAR30 444 466 forward 1 TM Transmembrane
48 LG:008606.21:2001MAR30 467 668 forward 1 TM Cytosolic
48 LG:008606.21:2001MAR30 1 404 forward 2 TM Non-Cytosolic
48 LG:008606.21:2001MAR30 405 427 forward 2 TM Transmembrane
48 LG:008606.21:2001MAR30 428 439 forward 2 TM Cytosolic
48 LG:008606.21:2001MAR30 440 462 forward 2 TM Transmembrane
48 LG:008606.21:2001MAR30 463 667 forward 2 TM Non-Cytosolic
48 LG:008606.21:2001MAR30 1 169 forward 3 TM Cytosolic
48 LG:008606.21:2001MAR30 170 192 forward 3 TM Transmembrane
48 LG:008606.21:2001MAR30 193 201 forward 3 TM Non-Cytosolic
48 LG.O08606.21.-2001MAR30 202 224 forward 3 TM Transmembrane
48 LG:008606.21:2001MAR30 225 230 forward 3 TM Cytosolic
48 LG:008606.21 :2001MAR30 231 253 forward 3 TM Transmembrane
48 LG:008606.21:2001MAR30 254 410 forward 3 TM Non-Cytosolic
48 LG:008606.21 :2001MAR30 411 433 forward 3 TM Transmembrane
48 LG:008606.21:2001MAR30 434 439 forward 3 TM Cytosolic
48 LG:008606.21:2001MAR30 440 462 forward 3 TM Transmembrane
48 LG:008606.21:2001MAR30 463 667 forward 3 TM Non-Cytosolic
49 LG:009699.32:2001MAR30 1 6 forward 1 TM Cytosolic
49 LG:009699.32:2001MAR30 7 25 forward 1 TM Transmembrane
49 LG:009699.32:2001MAR30 26 127 forward 1 TM Non-Cytosolic
49 LG:009699.32:2001MAR30 128 150 forward 1 TM Transmembrane
49 LG:009699.32:2001MAR30 151 180 forward 1 TM Cytosolic
49 LG:009699.32:2001MAR30 1 128 forward 2 TM Non-Cytosolic
49 LG:009699.32:2001MAR30 129 151 forward 2 TM Transmembrane
49 LG:009699.32:2001MAR30 152 180 forward 2 TM Cytosolic
50 LG:016723.6:2001MAR30 1 187 forward 1 TM Cytosolic
50 LG:016723.6:2001MAR30 188 205 forward 1 TM Transmembrane
50 LG.O16723.6 2001MAR30 206 276 forward 1 TM Non-Cytosolic TABLE 2
SEQ D NO: Template ID Start Stop Frame Domain Type Topology
51 LG:017126.5:2001MAR30 1 310 forward 1 TM Cytosolic
51 LG:017126.5:2001MAR30 311 333 forward 1 TM Transmembrane
51 LG:017126.5:2001MAR30 334 360 forward 1 TM Non-Cytosolic
51 LG:017126.5:2001MAR30 361 383 forward 1 ' TM Transmembrane
51 LG.O17126.5.-2001MAR30 384 413 forward 1 TM Cytosolic
51 LG.O17126.5. -2001MAR30 414 433 forward 1 TM Transmembrane
51 LG:017126.5:2001MAR30 434 952 forward 1 TM Non-Cytosolic
52 LG:019362.10:2001MAR30 1 20 forward 1 TM Cytosolic 52 LG:019362.10:2001MAR30 21 40 forward 1 TM Transmembrane 52 ' LG:019362.10:2001MAR30 41 49 forward 1 TM Non-Cytosolic 52 LG:019362.10:2001MAR30 50 72 forward 1 TM Transmembrane 52 LG:019362.10:2001MAR30 73 304 forward 1 TM Cytosolic 52 LG:019362.10:2001MAR30 305 323 forward 1 TM Transmembrane 52 LG:019362.10:2001MAR30 324 337 forward 1 ' TM Non-Cytosolic 52 LG:019362.10:2001MAR30 338 357 forward 1 TM Transmembrane 52 LG:019362.10:2001MAR30 358 377 forward 1 TM Cytosolic 52 LG:019362.10:2001MAR30 378 400 forward 1 TM Transmembrane 52 LG:019362.10:2001MAR30 401 494 forward 1 TM Non-Cytosolic 52 LG:019362.10:2001MAR30 495 514 forward 1 TM Transmembrane 52 LG:019362.10:2001MAR30 515 534 forward 1 TM Cytosolic 52 LG:019362.10:2001MAR30 535 557 forward 1 TM Transmembrane 52 LG:019362.10:2001MAR30 558 572 forward 1 TM Non-Cytosolic 52 LG:019362.10:2001MAR30 1 47 forward 2 TM Non-Cytosolic 52 LG:019362.10:2001MAR30 48 70 forward 2 TM Transmembrane 52 LG:019362.10:2001MAR30 71 377 forward 2 TM Cytosolic 52 LG:019362.10:2001MAR30 378 397 forward 2 TM Transmembrane 52 LG:019362.10:2001MAR30 398 463 forward 2 TM Non-Cytosolic 52 LG:019362.10:2001MAR30 464 483 forward 2 TM Transmembrane 52 LG:019362.10:2001MAR30 484 495 forward 2 TM Cytosolic 52 LG:019362.10:2001MAR30 496 518 forward 2 TM Transmembrane 52 LG:019362.10:2001MAR30 519 546 forward 2 TM Non-Cytosolic 52 LG:019362.10:2001MAR30 547 569 forward 2 TM Transmembrane
52 LG:019362.10:2001MAR30 570 571 forward 2 TM Cytosolic
53 LG:022183.1:2001MAR30 1 19 forward 2 TM Cytosolic 53 LG:022183.1:2001MAR30 20 42 forward 2 TM Transmembrane
53 LG:022183.1 :2001MAR30 43 272 forward 2 TM Non-Cytosolic
54 LG:028493.1 :2001MAR30 1 521 forward 3 TM Non-Cytosolic 54 LG:028493.1 :2001MAR30 522 544 forward 3 TM Transmembrane
54 LG:028493.1:2001MAR30 545 689 forward 3 TM Cytosolic
55 LG:034197.1 :2001MAR30 1 12 forward 3 TM Cytosolic 55 LG:034197.1:2001MAR30 13 35 forward 3 TM Transmembrane 55 LG:034197.1:2001MAR30 36 139 forward 3 TM Non-Cytosolic 55 LG:034197.1:2001MAR30 140 162 forward 3 TM Transmembrane
55 LG:034197.1 :2001MAR30 163 192 forward 3 TM Cytosolic
56 LG:054096.31:2001MAR30 1 723 forward 1 TM Non-Cytosolic 56 LG:054096.31 :2001MAR30 724 746 forward 1 TM Transmembrane 56 LG:054096.31:2001MAR30 747 752 forward 1 TM Cytosolic 56 LG:054096.31:2001MAR30 753 775 forward 1 TM Transmembrane 56 LG:054096.31:2001MAR30 776 789 forward 1 TM Non-Cytosolic 56 LG:054096.31:2001MAR30 790 812 forward 1 TM Transmembrane
56 LG:054096.31:2001MAR30 813 844 forward 1 TM Cytosolic
57 LG:054807.3:2001MAR30 1 253 forward 1 TM Non-Cytosolic 57 LG:054807.3:2001MAR30 254 276 forward 1 TM Transmembrane 57 LG:054807.3:2001MAR30 277 330 forward 1 TM Cytosolic TABLE 2
SEQ D NO: Template ID Start Stop Frame Domain Type Topology
57 LG:054807.3:2001MAR30 331 350 forward 1 TM Transmembrane
57 LG:054807.3:2001MAR30 351 353 forward 1 TM Non-Cytosolic
57 LG:054807.3:2001MAR30 354 373 forward 1 TM Transmembrane
57 LG:054807.3:2001MAR30 374 385 forward 1 TM Cytosolic
57 LG:054807.3:2001MAR30 386 408 forward 1 TM Transmembrane
57 LG:054807.3:2001MAR30 409 458 forward 1 TM Non-Cytosolic
57 LG:054807.3:2001MAR30 459 481 forward 1 TM Transmembrane
57 LG:054807.3:2001MAR30 482 551 forward 1 TM Cytosolic
57 LG:054807.3:2001MAR30 552 574 forward 1 TM Transmembrane
57 LG:054807.3:2001MAR30 575 577 forward 1 TM Non-Cytosolic
57 LG:054807.3:2001MAR30 578 600 forward 1 TM Transmembrane
57 LG:054807.3:2001MAR30 601 694 forward 1 TM Cytosolic
57 LG:054807.3:2001MAR30 695 717 forward 1 TM Transmembrane
57 LG:054807.3:2001MAR30 718 815 forward 1 TM Non-Cytosolic
57 LG:054807.3 :2001MAR30 1 426 forward 2 TM Non-Cytosolic
57 LG:054807.3:2001MAR30 427 449 forward 2 TM Transmembrane
57 LG:054807.3:2001MAR30 450 461 forward 2 TM Cytosolic
57 LG:054807.3:2001MAR30 462 484 forward 2 TM Transmembrane
57 LG:054807.3:2001MAR30 485 692 forward 2 TM Non-Cytosolic
57 LG:054807.3:2001MAR30 693 710 forward 2 TM Transmembrane
57 LG:054807.3:2001MAR30 711 751 forward 2 TM Cytosolic
57 LG.O54807.3.-2001MAR30 752 774 forward 2 TM Transmembrane
57 LG:054807.3:2001MAR30 775 788 forward 2 TM Non-Cytosolic
57 LG:054807.3:2001MAR30 789 808 forward 2 TM Transmembrane
57 LG:054807.3:2001MAR30 809 814 forward 2 TM Cytosolic
57 LG:054807.3:2001MAR30 1 177 forward 3 TM Cytosolic
57 LG:054807.3:2001MAR30 178 197 forward 3 TM Transmembrane
57 LG:054807.3:2001MAR30 198 247 forward 3 TM Non-Cytosolic
57 LG:054807.3:2001MAR30 248 270 forward 3 TM Transmembrane
57 LG:054807.3:2001MAR30 271 327 forward 3 TM Cytosolic
57 LG:054807.3:2001MAR30 328 350 forward 3 TM Transmembrane
57 LG:054807.3:2001MAR30 351 433 forward 3 TM Non-Cytosolic
57 LG:054807.3:2001MAR30 434 456 forward 3 TM Transmembrane
57 LG:054807.3:2001MAR30 457 462 forward 3 TM Cytosolic
57 LG:054807.3:2001MAR30 463 485 forward 3 TM Transmembrane
57 LG:054807.3:2001MAR30 486 489 forward 3 TM Non-Cytosolic
57 LG:054807.3:2001MAR30 490 512 forward 3 TM Transmembrane
57 LG:054807.3:2001MAR3O 513 550 forward 3 TM Cytosolic
57 LG:054807.3:2001MAR30 551 573 forward 3 TM Transmembrane
57 LG:054807.3:2001MAR30 574 576 forward 3 TM Non-Cytosolic
57 LG:054807.3:2001MAR30 577 596 forward 3 TM Transmembrane
57 LG:054807.3:2001MAR30 597 692 forward 3 TM Cytosolic
57 LG:054807.3:2001MAR30 693 712 forward 3 TM Transmembrane
57 LG:054807.3:2001MAR30 713 814 forward 3 TM Non-Cytosolic
58 LG:065873.12:2001MAR30 1 38 forward 1 TM Cytosolic
58 LG.-065873.12:2001MAR30 39 58 forward 1 TM Transmembrane
58 LG:065873.12:2001MAR30 59 925 forward 1 TM Non-Cytosolic
58 LG:065873.12:2001MAR30 1 19 forward 3 TM Cytosolic
58 LG:065873.12:2001MAR30 20 42 forward 3 TM Transmembrane
58 LG:065873.12:2001MAR30 43 867 forward 3 TM Non-Cytosolic
58 LG:065873.12:2001MAR30 868 890 forward 3 TM Transmembrane
58 LG:065873.12:2001MAR30 891 924 forward 3 TM Cytosolic
59 LG:083814.6:2,001MAR30 1 660 forward 1 TM Non-Cytosolic
59 LG:083814.6:2001MAR30 661 680 forward 1 TM Transmembrane TABLE 2
SEQ D NO: Template ID Start Stop Frame Domain Type Topology
59 LG:083814.6:2001MAR30 681 714 forward 1 TM Cytosolic
59 LG:083814.6:2001MAR30 715 733 forward 1 TM Transmembrane
59 LG. 83814.6.-2001MAR30 734 741 forward 1 TM Non-Cytosolic
59 LG:083814.6:2001MAR30 1 681 forward 3 TM Non-Cytosolic
59 LG:083814.6:2001MAR30 682 701 forward 3 TM Transmembrane
59 LG:083814.6:2001MAR30 702 712 forward 3 TM Cytosolic
59 LG:083814.6:2001MAR30 713 730 forward 3 TM Transmembrane
59 LG:083814.6:2001MAR30 731 740 forward 3 TM Non-Cytosolic
60 LG:093477.1:2001MAR30 1 12 forward 2 TM Cytosolic 60 LG:093477.1:2001MAR30 13 35 forward 2 TM Transmembrane 60 LG:093477.1:2001MAR30 36 291 forward 2 TM Non-Cytosolic 60 LG:093477.1:2001MAR30 1 6 forward 3 TM Cytosolic 60 LG:093477.1:2001MAR30 7 29 forward 3 TM Transmembrane
60 LG:093477.1:2001MAR30 30 291 forward 3 TM Non-Cytosolic
61 LG:099572.12:2001MAR30 1 803 forward 2 TM Non-Cytosolic 61 LG:099572.12:2001MAR30 804 826 forward 2 TM Transmembrane 61 LG:099572.12:2001MAR30 827 960 forward 2 TM Cytosolic 61 LG:099572.12:2001MAR30 961 975 forward 2 TM Transmembrane 61 LG:099572.12:2001MAR30 976 984 forward 2 TM Non-Cytosolic 61 LG:099572.12:2001MAR30 985 1007 forward 2 TM Transmembrane 61 LG:099572.12:2001MAR30 1008 1043 forward 2 TM Cytosolic 61 LG:099572.12:2001MAR30 1044 1066 forward 2 TM Transmembrane 61 LG:099572.12:2001MAR30 1067 1510 forward 2 TM Non-Cytosolic 61 LG:099572.12:2001MAR30 1511 1533 forward 2 TM Transmembrane 61 LG:099572.12:2001MAR30 1534 1546 forward 2 TM Cytosolic 61 LG:099572.12:2001MAR30 1 1008 forward 3 TM Non-Cytosolic 61 LG.O99572.12.-2001MAR30 1009 1031 forward 3 TM Transmembrane 61 LG:099572.12:2001MAR30 1032 1089 ' forward 3 TM Cytosolic 61 LG:099572.12:2001MAR30 1090 1112 ' forward 3 TM Transmembrane
61 LG:099572.12:2001MAR30 1113 1546 forward 3 TM Non-Cytosolic
62 LG:100396.31:2001MAR30 1 247 forward 1 TM Non-Cytosolic 62 LG:100396.31:2001MAR30 248 265 forward 1 TM Transmembrane 62 LG: 100396.3 2001MAR30 266 318 forward 1 TM Cytosolic 62 LG: 100396.3 L2001MAR30 319 338 forward 1 TM Transmembrane 62 LG: 100396.3 L2001MAR30 339 373 forward 1 TM Non-Cytosolic 62 LG: 100396.3 L2001MAR30 374 393 forward 1 TM Transmembrane 62 LG: 100396.31:2001MAR30 394 394 forward 1 TM Cytosolic 62 LG:100396.31:2001MAR30 1 361 forward 2 TM Non-Cytosolic 62 LG: 100396.3 L2001MAR30 362 393 forward 2 TM Transmembrane
62 LG: 100396.3 2001MAR30 394 394 forward 2 TM Cytosolic
63 LG:1026903.5:2001MAR30 1 84 forward 1 TM Cytosolic 63 LG:1026903.5:2001MAR30 85 107 forward 1 TM Transmembrane
63 LG: 1026903.5:2001MAR30 108 452 forward 1 TM Non-Cytosolic
64 LG:1060168.6:2001MAR30 1 147 forward 1 ' TM Cytosolic
65 LG: 1086906.41 :2001MAR30 1 417 forward 2 TM Non-Cytosolic 65 LG:1086906.41 :2001MAR30 418 435 forward 2 TM Transmembrane 65 LG:1086906.41 :2001MAR30 436 551 forward 2 TM Cytosolic 65 LG:1086906.41 :2001MAR30 1 412 forward 3 TM Non-Cytosolic 65 LG: 1086906.41. -2001MAR30 413 435 forward 3 TM Transmembrane
65 LG:1086906.41 :2001MAR30 436 551 forward 3 TM Cytosolic
66 LG: 1089326.18:2001MAR30 1 73 forward 2 TM Cytosolic 66 LG: 1089326.18:2001MAR30 74 96 forward 2 TM Transmembrane
66 LG: 1089326.18:2001MAR30 97 807 forward 2 TM Non-Cytosolic
67 LG: 1090862.32:2001MAR30 1 47 forward 3 TM Cytosolic TABLE 2
SEQ D NO: Template ID Start Stop Frame Domain Type Topology
67 LG: 1090862.32:2001MAR30 48 70 forward 3 TM Transmembrane
67 LG: 1090862.32:2001MAR30 71 568 forward 3 TM Non-Cytosolic
68 LG:1091941.41:2001MAR30 1 6 forward 1 TM Cytosolic
68 LG: 1091941.41 :2001MAR30 7 29 forward 1 TM Transmembrane
68 LG:1091941.41:2001MAR30 30 260 forward 1 • TM Non-Cytosolic
69 LG:1093386.8:2001MAR30 1 22 forward 1 TM Non-Cytosolic
69 LG:1093386.8:2001MAR30 23 42 forward 1 TM Transmembrane
69 LG:1093386.8:2001MAR30 43 254 forward 1 TM Cytosolic
69 LG:1093386.8:2001MAR30 255 274 forward 1 TM Transmembrane
69 LG:1093386.8:2001MAR30 275 612 forward 1 TM Non-Cytosolic
69 LG:1093386.8:2001MAR30 613 635 forward 1 TM Transmembrane
69 LG:1093386.8:2001MAR30 636 647 forward 1 TM Cytosolic
69 LG:1093386.8:2001MAR30 648 670 forward 1 TM Transmembrane
69 LG:1093386.8:2001MAR30 671 680 forward 1 TM Non-Cytosolic
69 LG:1093386.8:2001MAR30 1 123 forward 2 TM Non-Cytosolic
69 LG: 1093386.8:2001MAR30 124 146 forward 2 TM Transmembrane
69 LG:1093386.8:2001MAR30 147 597 forward 2 TM Cytosolic
69 LG:1093386.8:2001MAR30 598 620 forward 2 TM Transmembrane
69 LG:1093386.8:2001MAR30 621 642 forward 2 TM Non-Cytosolic
69 LG:1093386.8:2001MAR30 643 665 forward 2 TM Transmembrane
69 LG: 1093386.8-.2001MAR30 666 679 forward 2 TM Cytosolic
69 LG:1093386.8:2001MAR30 1 252 forward 3 TM Non-Cytosolic
69 LG:1093386.8:2001MAR30 253 275 forward 3 TM Transmembrane
69 LG:1093386.8:2001MAR30 276 294 forward 3 TM Cytosolic
69 LG: 1093386.8-.2001MAR30 295 317 forward 3 TM Transmembrane
69 LG:1093386.8:2001MAR30 318 596 forward 3 TM Non-Cytosolic
69 LG:1093386.8:2001MAR30 597 619 forward 3 TM Transmembrane
69 LG:1093386.8:2001MAR30 620 639 forward 3 TM Cytosolic
69 LG: 1093386.8:2001MAR30 640 662 forward 3 TM Transmembrane
69 LG:1093386.8:2001MAR30 663 679 forward 3 TM Non-Cytosolic
70 LG:1094187.33:2001MAR30 1 128 forward 1 TM Cytosolic
70 LG: 1094187.33:2001MAR30 129 151 forward 1 TM Transmembrane
70 LG:1094187.33:2001MAR30 152 154 forward 1 TM Non-Cytosolic
70 LG:1094187.33:2001MAR30 155 177 forward 1 TM Transmembrane
70 LG:1094187.33:2001MAR30 178 373 forward 1 TM Cytosolic
70 LG: 1094187.33:2001MAR30 374 396 forward 1 TM Transmembrane
70 LG: 1094187.33:2001MAR30 397 415 forward 1 TM Non-Cytosolic
70 LG: 1094187.33:2001MAR30 416 438 forward 1 TM Transmembrane
70 LG: 1094187.33:2001MAR30 439 472 forward 1 TM Cytosolic
70 LG: 1094187.33.-2001MAR30 1 126 forward 2 TM Cytosolic
70 LG:1094187.33:2001MAR30 127 149 forward 2 TM Transmembrane
70 LG:1094187.33:2001MAR30 150 181 forward 2 TM Non-Cytosolic
70 LG:1094187.33:2001MAR30 182 199 forward 2 TM Transmembrane
70 LG: 1094187.33:2001MAR30 200 372 forward 2 TM Cytosolic
70 LG:1094187.33:2001MAR30 373 395 forward 2 TM Transmembrane
70 LG: 1094187.33:2001MAR30 396 421 forward 2 TM Non-Cytosolic
70 LG: 1094187.33:2001MAR30 422 444 forward 2 TM Transmembrane
70 LG:1094187.33:2001MAR30 445 471 forward 2 TM Cytosolic
70 LG:1094187.33:2001MAR30 1 129 forward 3 TM Non-Cytosolic
70 LG:1094187.33:2001MAR30 130 149 forward 3 TM Transmembrane
70 LG:1094187.33:2001MAR30 150 150 forward 3 TM Cytosolic
70 LG:1094187.33:2001MAR30 151 170 forward 3 TM Transmembrane
70 LG:1094187.33:2001MAR30 171 179 forward 3 TM Non-Cytosolic
70 LG: 1094187.33:2001MAR30 180 197 forward 3 TM Transmembrane TABLE 2
SEQ D NO: Template ID - Start Stop Frame Domain Type Topology
70 LG:1094187.33:2001MAR30 198 355 forward 3 TM Cytosolic
70 LG:1094187.33:2001MAR30 356 375 forward 3 TM Transmembrane
70 LG:1094187.33:2001MAR30 376 404 forward 3 TM Non-Cytosolic
70 LG:1094187.33:2001MAR30 405 427 forward 3 TM Transmembrane
70 LG:1094187.33:2001MAR30 428 439 forward.3 TM Cytosolic
70 LG:1094187.33:2001MAR30 440 462 forward 3 TM Transmembrane
70 LG:1094187.33:2001MAR30 463 471 forward 3 TM Non-Cytosolic
71 LG:1098692.18:2001MAR30 1 37 forward 2 TM Non-Cytosolic 71 LG: 1098692.18:2001MAR30 38 57 forward 2 TM Transmembrane 71 LG:1098692.18:2001MAR30 58 124 forward 2 TM Cytosolic 71 LG:1098692.18:2001MAR30 125 147 forward 2 TM Transmembrane 71 LG:1098692.18:2001MAR30 148 176 forward 2 TM Non-Cytosolic 71 LG: 1098692.18:2001MAR30 177 199 forward 2 TM Transmembrane 71 LG:1098692.18:2001MAR30 200 211 forward 2 TM Cytosolic 71 LG:1098692.18:2001MAR30 212 231 forward 2 TM Transmembrane 71 LG:1098692.18:2001MAR30 232 250 forward 2 TM Non-Cytosolic 71 LG:1098692.18:2001MAR30 251 273 forward 2 TM Transmembrane
71 LG: 1098692.18:2001MAR30 274 588 forward 2 TM Cytosolic
72 LG:1173104.22:2001MAR30 1 180 forward 1 TM Non-Cytosolic 72 LG:1173104.22:2001MAR30 181 203 forward 1 TM Transmembrane 72 LG:1173104.22:2001MAR30 204 265 forward 1 TM Cytosolic 72 LG: 1173104.22:2001MAR30 266 288 forward 1 TM Transmembrane 72 LG:1173104.22:2001MAR30 289 297 forward 1 TM Non-Cytosolic 72 LG:1173104.22:2001MAR30 298 320 forward 1 TM Transmembrane 72 LG:1173104.22:2001MAR30 321 389 forward 1 TM Cytosolic 72 LG:1173104.22:2001MAR30 1 265 forward 2 TM Cytosolic 72 LG:1173104.22:2001MAR30 266 285 forward 2 TM Transmembrane 72 LG:1173104.22:2001MAR30 286 299 forward 2 TM Non-Cytosolic 72 LG:1173104.22:2001MAR30 300 322 forward 2 TM Transmembrane 72 LG:1173104.22:2001MAR30 323 389 forward 2 TM Cytosolic 72 LG: 1173104.22:2001MAR30 1 267 forward 3 TM Non-Cytosolic 72 LG:1173104.22:2001MAR30 268 290 forward 3 TM Transmembrane 72 LG:1173104.22:2001MAR30 291 296 forward 3 TM Cytosolic 72 LG:1173104.22:2001MAR30 297 319 forward 3 TM Transmembrane
72 LG:1173104.22:2001MAR30 320 388 forward 3 TM Non-Cytosolic
73 LG:1215335.7:2001MAR30 1 971 forward 1 TM Non-Cytosolic 73 LG:1215335.7:2001MAR30 972 994 forward 1 TM Transmembrane 73 LG:1215335.7:2001MAR30 995 1050 forward 1 TM Cytosolic 73 LG: 1215335.7:2001MAR30 1 160 forward 2 TM Non-Cytosolic 73 LG: 1215335.7:2001MAR30 161 183 forward 2 TM Transmembrane 73 LG:1215335.7:2001MAR30 184 467 forward 2 TM Cytosolic 73 LG:1215335J:2001MAR30 468 490 forward 2 TM Transmembrane
73 LG:1215335J:2001MAR30 491 1050 forward 2 TM Non-Cytosolic
74 LG: 1256753.1:2001MAR30 1 10 forward 1 TM Cytosolic 74 LG: 1256753.1-.2001MAR30 11 33 forward 1 TM Transmembrane 74 LG: 1256753.1:2001MAR30 34 614 forward 1 TM Non-Cytosolic 74 LG: 1256753.1:2001MAR30 615 637 forward 1 TM Transmembrane 74 LG: 1256753.1 :2001MAR30 638 669 forward 1 TM Cytosolic 74 LG: 1256753.1 :2001MAR30 1 573 forward 2 TM Cytosolic 74 LG: 1256753.1.-2001MAR30 574 596 forward 2 TM Transmembrane 74 LG: 1256753.1:2001MAR30 597 615 forward 2 TM Non-Cytosolic 74 LG: 1256753.1 :2001MAR30 616 638 forward 2 TM Transmembrane 74 LG: 1256753.1 :2001MAR30 639 669 forward 2 TM Cytosolic 74 LG: 1256753.1:2001MAR30 1 45 forward 3 TM Non-Cytosolic TABLE 2
SEQ D NO Template ID Start Stop Frame Domain Type Topology
74 LG: 1256753.1 :2001MAR30 46 68 forward 3 TM Transmembrane
74 LG:1256753.1:2001MAR30 69 74 forward 3 TM Cytosolic
74 LG:1256753.1:2001MAR30 75 97 forward 3 TM Transmembrane
74 LG:1256753.1:2001MAR30 98 503 forward 3 TM Non-Cytosolic
74 LG:1256753.1:2001MAR30 504 523 forward 3 TM Transmembrane
74 LG:1256753.1:2001MAR30 524 669 forward 3 TM Cytosolic
75 LG:1326702.10:2001MAR30 1 2173 forward 1 TM Non-Cytosolic
75 LG:1326702.10:2001MAR30 2174 2196 forward 1 TM Transmembrane
75 LG: 1326702.10:2001MAR30 2197 2202 forward 1 TM Cytosolic
75 LG:1326702.10:2001MAR30 2203 2225 forward 1 TM Transmembrane
75 LG: 1326702.10:2001MAR30 2226 2234 forward 1 TM Non-Cytosolic
75 LG: 1326702.10:2001MAR30 2235 2257 forward 1 TM Transmembrane
75 LG:1326702.10:2001MAR30 2258 2258 forward 1 TM Cytosolic
75 LG:1326702.10:2001MAR30 1 2174 forward 2 TM Non-Cytosolic
75 LG: 1326702.10:2001MAR30 2175 2197 forward 2 TM Transmembrane
75 LG:1326702.10:2001MAR30 2198 2209 forward 2 TM Cytosolic
75 LG:1326702.10:2001MAR30 2210 2232 forward 2 TM Transmembrane
75 LG: 1326702.10:2001MAR30 2233 2257 forward 2 TM Non-Cytosolic
75 LG: 1326702.10:2001MAR30 1 ' 1425 forward 3 TM Non-Cytosolic
75 LG:1326702.10:2001MAR30 1426 1448 forward 3 TM Transmembrane
75 LG:1326702.10:2001MAR30 1449 1521 forward 3 TM Cytosolic
75 LG:1326702.10:2001MAR30 1522 1541 forward 3 TM Transmembrane
75 LG: 1326702.10:2001MAR30 1542 1608 forward 3 TM Non-Cytosolic
75 LG:1326702.10:2001MAR30 1609 1631 forward 3 TM Transmembrane
75 LG: 1326702.10:2001MAR30 1632 2174 forward 3 TM Cytosolic
75 LG: 1326702.10:2001MAR30 2175 2197 forward 3 TM Transmembrane
75 LG: 1326702.10:2001MAR30 2198 2211 forward 3 TM Non-Cytosolic
75 LG: 1326702.10:2001MAR30 2212 2234 forward 3 TM Transmembrane
75 LG:1326702.10:2001MAR30 2235 2257 forward 3 TM Cytosolic
76 LG:1327239.15:2001MAR30 1 59 forward 1 TM Cytosolic
76 LG:1327239.15:2001MAR30 60 82 forward 1 TM Transmembrane
76 LG: 1327239.15:2001MAR30 83 253 forward 1 TM Non-Cytosolic
76 LG:1327239.15:2001MAR30 254 276 forward 1 TM Transmembrane
76 LG:1327239.15:2001MAR30 277 287 forward 1 TM Cytosolic
76 LG: 1327239.15:2001MAR30 288 310 forward 1 TM Transmembrane
76 LG:1327239.15:2001MAR30 311 499 forward 1 TM Non-Cytosolic
76 LG:1327239.15:2001MAR30 1 60 forward 2 TM Cytosolic
76 LG:1327239.15:2001MAR30 61 83 forward 2 TM Transmembrane
76 LG:1327239.15:2001MAR30 84 120 forward 2 TM Non-Cytosolic
76 LG: 1327239.15:2001MAR30 121 143 forward 2 TM Transmembrane
76 LG:1327239.15:2001MAR30 144 155 forward 2 TM Cytosolic
76 LG: 1327239.15:2001MAR30 156 178 forward 2 TM Transmembrane
76 LG: 1327239.15:2001MAR30 179 499 forward 2 TM Non-Cytosolic
76 LG.T 327239.15:2001MAR30 1 33 forward 3 TM Cytosolic
76 LG:1327239.15:2001MAR30 34 56 forward 3 TM Transmembrane
76 LG: 1327239.15:2001MAR30 57 60 forward 3 TM Non-Cytosolic
76 LG:1327239.15:2001MAR30 61 83 forward 3 TM Transmembrane
76 LG: 1327239.15 :2001MAR30 84 190 forward 3 TM Cytosolic
76 LG:1327239.15:2001MAR30 191 213 forward 3 TM Transmembrane
76 LG: 1327239.15:2001MAR30 214 254 forward 3 TM Non-Cytosolic
76 LG: 1327239.15:2001MAR30 255 277 forward 3 TM Transmembrane
76 LG: 1327239.15:2001MAR30 278 468 forward 3 TM Cytosolic
76 LG: 1327239.15:2001MAR30 469 491 forward 3 TM Transmembrane
76 LG: 1327239.15:2001MAR30 492 499 forward 3 TM Non-Cytosolic IOC ) TABLE 2
SEQ D NO: Template ID Start Stop Frame Domain Type Topology
77 LG:1327867.15:2001MAR30 1 508 forward 1 TM Non-Cytosolic
77 LG:1327867.15:2001MAR30 509 528 forward 1 TM Transmembrane
77 LG:1327867.15:2001MAR30 529 548 forward 1 TM Cytosolic
77 LG:1327867.15:2001MAR30 549 571 forward 1 TM Transmembrane
77 LG:1327867.15:2001MAR30 572 575 forward 1 TM Non-Cytosolic
77 LG:1327867.15:2001MAR30 576 593 forward 1 TM Transmembrane
77 LG:1327867.15:2001MAR30 594 706 forward 1 TM Cytosolic
77 LG:1327867.15:2001MAR30 707 729 forward 1 TM Transmembrane
77 LG:1327867.15:2001MAR30 730 774 forward 1 TM Non-Cytosolic 77 ' LG:1327867.15:2001MAR30 775 797 forward 1 TM Transmembrane
77 LG:1327867.15:2001MAR30 798 803 forward 1 TM Cytosolic
77 LG:1327867.15:2001MAR30 804 826 forward 1 TM Transmembrane
77 LG:1327867.15.-2001MAR30 827 851 forward 1 TM Non-Cytosolic
77 LG:1327867.15:2001MAR30 852 874 forward 1 TM Transmembrane
77 LG: 1327867.15:2001MAR30 875 893 forward 1 TM Cytosolic
77 LG:1327867.15:2001MAR30 894 916 forward 1 TM Transmembrane
77 LG:1327867.15-.2001MAR30 917 930 forward 1 TM Non-Cytosolic
77 LG:1327867.15:2001MAR30 931 953 forward 1 TM Transmembrane
77 LG: 1327867.15 :2001MAR30 954 1158 forward 1 TM Cytosolic
77 LG:1327867.15:2001MAR30 1159 1181 forward 1 TM Transmembrane
77 LG:1327867.15:2001MAR30 1182 1212 forward 1 TM Non-Cytosolic
77 LG:1327867.15:2001MAR30 1 450 forward 2 TM Non-Cytosolic
77 LG.T 327867.15:2001MAR30 451 473 forward 2 TM Transmembrane
7.7 LG:1327867.15:2001MAR30 474 477 forward 2 TM Cytosolic
77 LG:1327867.15:2001MAR30 478 496 forward 2 TM Transmembrane
77 LG:1327867.15:2001MAR30 497 505 forward 2 TM Non-Cytosolic
77 LG:1327867.15:2001MAR30 506 528 forward 2 TM Transmembrane
77 LG:1327867.15:2001MAR30 529 548 forward 2 TM ' Cytosolic
77 LG:1327867.15:2001MAR30 549 571 forward 2 TM Transmembrane
77 LG:1327867.15:2001MAR30 572 574 forward 2 TM Non-Cytosolic.
77 LG:1327867.15:2001MAR30 575 593 forward 2 TM Transmembrane
77 LG: 1327867.15 :2001MAR30 594 718 forward 2 TM Cytosolic
77 LG:1327867.15:2001MAR30 719 741 forward 2 TM Transmembrane
77 LG:1327867.15:2001MAR30 742 760 forward 2 TM Non-Cytosolic
77 LG:1327867.15:2001MAR30 761 783 forward 2 TM Transmembrane
77 LG: 1327867.15:2001MAR30 784 789 forward 2 TM Cytosolic
77 LG: 1327867.15:2001MAR30 790 812 forward 2 TM Transmembrane
77 LG:1327867.15:2001MAR30 813 854 forward 2 TM Non-Cytosolic
77 LG: 1327867.15:2001MAR30 855 877 forward 2 TM Transmembrane
77 LG:1327867.15.-2001MAR30 878 897 forward 2 TM Cytosolic
77 LG:1327867.15:2001MAR30 898 920 forward 2 TM Transmembrane
77 LG: 1327867.15:2001MAR30 921 934 forward 2 TM Non-Cytosolic
77 LG:1327867.15:2001MAR30 935 952 forward 2 TM Transmembrane
77 LG: 1327867.15:2001MAR30 953 1211 forward 2 TM Cytosolic
77 LG: 1327867.15.2001MAR30 1 447 forward 3 TM Non-Cytosolic
77 LG: 1327867.15:2001MAR30 448 470 forward 3 TM Transmembrane
77 LG: 1327867.15:2001MAR30 471 548 forward 3 TM Cytosolic
77 LG:1327867.15.2001MAR30 549 571 forward 3 TM Transmembrane
77 LG: 1327867.15:2001MAR30 572 574 forward 3 TM Non-Cytosolic
77 LG: 1327867.15:2001MAR30 575 .592 forward 3 TM Transmembrane
77 LG:1327867.15:2001MAR30 593 771 forward 3 TM Cytosolic
77 LG: 1327867.15:2001MAR30 772 794 forward 3 TM Transmembrane
77 LG: 1327867.15:2001MAR30 795 798 forward 3 TM Non-Cytosolic
77 LG: 1327867.15:2001MAR30 799 821 forward 3 TM Transmembrane TABLE 2
SEQ D NO: Template ID Start Stop Frame Domain Type Topology
77 LG: 1327867.15:2001MAR30 822 833 forward 3 TM Cytosolic
77 LG:1327867.15:2001MAR30 834 856 forward 3 TM Transmembrane
77 LG:1327867.15:2001MAR30 857 1174 forward 3 TM Non-Cytosolic
77 LG: 1327867.15 :2001MAR30 1175 1197 forward 3 TM Transmembrane
77 LG: 1327867.15:2001 MAR30 1198 1211 forward 3 TM Cytosolic
78 LG: 1383232.1 :2001MAR30 1 20 forward 1 TM Cytosolic
78 LG:1383232.1:2001MAR30 21 43 forward 1 TM Transmembrane
78 LG: 1383232.1:2001MAR30 44 754 forward 1 TM Non-Cytosolic
78 LG:1383232.1:2001MAR30 755 777 forward 1 TM Transmembrane
78 LG: 1383232. 2001MAR30 778 788 forward 1 TM Cytosolic
78 LG: 1383232.1 :2001MAR30 1 14 forward 2 TM Non-Cytosolic
78 LG: 1383232.1.2001MAR30 15 34 forward 2 TM Transmembrane
78 LG:1383232.1:2001MAR30 35 71 forward 2 TM Cytosolic
78 LG:1383232.1:2001MAR30 72 94 forward 2 TM Transmembrane
78 LG:1383232.1:2001MAR30 95 113 forward 2 TM Non-Cytosolic
78 LG: 1383232.1 :2001MAR30 114 136 forward 2 TM Transmembrane
78 LG:1383232.1:2001MAR30 137 190 forward 2 TM Cytosolic
78 LG:1383232.1:2001MAR30 191 213 forward 2 TM Transmembrane
78 LG: 1383232.1 :2001MAR30 214 401 forward 2 TM Non-Cytosolic
78 LG:1383232.1:2001MAR30 402 424 forward 2 TM Transmembrane
78 LG: 1383232.1 :2001MAR30 425 604 forward 2 TM Cytosolic
78 LG: 1383232.1 :2001MAR30 605 627 forward 2 TM Transmembrane
78 LG: 1383232.1 :2001MAR30 628 720 forward 2 TM Non-Cytosolic
78 LG:1383232.1:2001MAR30 721 743 forward 2 TM Transmembrane
78 LG:1383232.1:2001MAR30 744 749 forward 2 TM Cytosolic
78 LG: 1383232.1 :2001MAR30 750 769 forward 2 TM Transmembrane
78 LG:1383232.1:2001MAR30 770 787 forward 2 TM Non-Cytosolic
78 LG: 1383232. L2001MAR30 1 405 forward 3 TM Non-Cytosolic
78 LG: 1383232.1:2001MAR30 406 428 forward 3 TM Transmembrane
78 LG:1383232.1:2001MAR30 429 480 forward 3 TM Cytosolic
78 LG:1383232.1 :2001MAR30 481 503 forward 3 TM Transmembrane
78 LG: 1383232.1 :2001MAR30 504 699 forward 3 TM Non-Cytosolic
78 LG:1383232.1:2001MAR30 700 722 forward 3 TM Transmembrane
78 LG: 1383232.1 :2001MAR30 723 728 forward 3 TM Cytosolic
78 LG:1383232. L2001MAR30 729 747 forward 3 TM Transmembrane
78 LG: 1383232.1 :2001MAR30 748 756 forward 3 TM Non-Cytosolic
78 LG:1383232. L2001MAR30 757 776 forward 3 TM Transmembrane
78 LG:1383232.1.2001MAR30 111 787 forward 3 TM Cytosolic
79 LG:1383368.40:2001MAR30 1 393 forward 1 TM Cytosolic
79 LG:1383368.40:2001MAR30 394 416 forward 1 TM Transmembrane
79 LG:1383368.40:2001MAR30 417 482 forward 1 TM Non-Cytosolic
79 LG:1383368.40:2001MAR30 483 500 forward 1 TM Transmembrane
79 LG: 1383368.40:2001MAR30 501 574 forward 1 TM Cytosolic
79 LG.T 383368.40:2001MAR30 575 597 forward 1 TM Transmembrane
79 LG: 1383368.40-.2001MAR30 598 695 forward 1 TM Non-Cytosolic
79 LG: 1383368.40:2001MAR30 696 718 forward 1 TM Transmembrane
79 LG:1383368.40:2001MAR30 719 753 forward 1 TM Cytosolic
79 LG: 1383368.40:2001MAR30 754 776 forward 1 TM Transmembrane
79 LG: 1383368.40-.2001MAR30 111 795 forward 1 TM Non-Cytosolic
79 LG: 1383368.40:2001MAR30 196 818 forward 1 TM Transmembrane
79 LG: 1383368.40.-2001MAR30 819 838 forward 1 TM Cytosolic
79 LG: 1383368.40:2001MAR30 839 861 forward 1 TM Transmembrane
79 LG: 1383368.40:2001MAR30 862 922 forward 1 TM Non-Cytosolic
79 LG: 1383368.40:2001MAR30 923 945 forward 1 TM Transmembrane TABLE 2
SEQ D NO: Template ID Start Stop Frame Domain Type Topology
79 LG:1383368.40:2001MAR30 946 1030 forward 1 TM Cytosolic
79 LG:1383368.40:2001MAR30 1031 1050 forward 1 TM Transmembrane
79 LG:1383368.40:2001MAR30 1051 1077 forward 1 TM Non-Cytosolic
79 LG:1383368.40:2001MAR30 1078 1100 forward 1 TM Transmembrane
79 LG:1383368.40:2001MAR30 1101 1112 forward 1 TM Cytosolic
79 LG: 1383368.40:2001MAR30 1 398 forward 2 TM Non-Cytosolic
79 LG:1383368.40:2001MAR30 399 421 forward 2 TM Transmembrane
79 LG:1383368.40:2001MAR30 422 578 forward 2 TM Cytosolic
79 LG:1383368.40:2001MAR30 579 601 forward 2 TM Transmembrane
79 LG:1383368.40:2001MAR30 602 604 forward 2 TM Non-Cytosolic
79 LG:1383368.40:2001MAR30 605 627 forward 2 TM Transmembrane
79 LG:1383368.40:2001MAR30 628 704 forward 2 TM Cytosolic
79 LG:1383368.40:2001MAR30 705 724 forward 2 TM Transmembrane
79 LG:1383368.40:2001MAR30 725 733 forward 2 TM Non-Cytosolic
79 LG:1383368.40:2001MAR30 734 756 forward 2 TM Transmembrane
79 LG:1383368.40:2001MAR30 757 767 forward 2 TM Cytosolic
79 LG:1383368.40:2001MAR30 768 790 forward 2 TM Transmembrane
79 LG:1383368.40:2001MAR30 791 804 forward 2 TM Non-Cytosolic
79 LG:1383368.40:2001MAR30 805 823 forward 2 TM Transmembrane
79 LG:1383368.40:2001MAR30 824 829 forward 2 TM Cytosolic
79 LG:1383368.40:2001MAR30 830 847 forward 2 TM Transmembrane
79 LG:1383368.40:2001MAR30 848 856 forward 2 TM Non-Cytosolic
79 LG:1383368.40:2001MAR30 857 879 forward 2 TM Transmembrane
79 LG:1383368.40:2001MAR30 880 1005 forward 2 TM Cytosolic
79 LG:1383368.40:2001MAR30 1006 1028 forward 2 TM Transmembrane
79 LG:1383368.40:2001MAR30 1029 1032 forward 2 TM Non-Cytosolic
79 LG:1383368.40:2001MAR30 1033 1052 forward 2 TM Transmembrane
79 LG:1383368.40:2001MAR30 1053 1077 forward 2 TM Cytosolic
79 LG:1383368.40:2001MAR30 1078 1100 forward 2 TM Transmembrane
79 LG:1383368.40:2001MAR30 1101 1112 forward 2 TM Non-Cytosolic
79 LG:1383368.40:2001MAR30 1 129 forward 3 TM Cytosolic
79 LG:1383368.40:2001MAR30 130 152 forward 3 TM Transmembrane
79 LG:1383368.40:2001MAR30 153 396 forward 3 TM Non-Cytosolic
79 LG:1383368.40:2001MAR30 397 419 forward 3 TM Transmembrane
79 LG:1383368.40:2001MAR30 420 443 forward 3 TM Cytosolic
79 LG:1383368.40:2001MAR30 444 466 forward 3 TM Transmembrane
79 LG:1383368.40:2001MAR30 467 485 forward 3 TM Non-Cytosolic
79 LG:1383368.40:2001MAR30 486 508 forward 3 TM Transmembrane
79 LG: 1383368.40:2001MAR30 509 574 forward 3 TM Cytosolic
79 LG:1383368.40:2001MAR30 575 597 forward 3 TM Transmembrane
79 LG:1383368.40:2001MAR30 598 611 forward 3 TM Non-Cytosolic
79 LG:1383368.40:2001MAR30 612 631 forward 3 TM Transmembrane
79 LG:1383368.40:2001MAR30 632 855 forward 3 TM Cytosolic
79 LG:1383368.40:2001MAR30 856 878 forward 3 TM Transmembrane
79 LG:1383368.40:2001MAR30 879 913 forward 3 TM Non-Cytosolic
79 LG:1383368.40:2001MAR30 914 936 forward 3 TM Transmembrane
79 LG:1383368.40:2001MAR30 937 1002 forward 3 TM Cytosolic
79 LG:1383368.40:2001MAR30 1003 1025 forward 3 TM Transmembrane
79 LG:1383368.40:2001MAR30 1026 1081 forward 3 TM Non-Cytosolic
79 LG: 1383368.40:2001MAR30 1082 1 104 forward 3 TM Transmembrane
79 LG.T383368.40:2001MAR30 1105 l l l l forward 3 TM Cytosolic
80 LG:1384477.1:2001MAR30 1 77 forward 1 TM Non-Cytosolic 80 LG:1384477. L2001MAR30 78 100 forward 1 TM Transmembrane 80 LG:1384477.1:2001MAR30 101 1 12 forward 1 TM Cytosolic TABLE 2
SEQ D NO- Template ID Start Stop Frame Domain Type Topology
80 LG: 1384477.1:2001MAR30 113 135 forward 1 TM Transmembrane
80 LG:1384477.1:2001MAR30 136 601 forward 1 TM Non-Cytosolic
80 LG:1384477.1:2001MAR30 602 624 forward 1 TM Transmembrane
80 LG: 1384477.1 :2O01MAR30 625 639 forward 1 TM Cytosolic
80 LG:1384477.1:2001MAR30 1 127 forward 2 • TM Cytosolic
80 LG.T384477.1 :2001MAR30 128 150 forward 2 TM Transmembrane
80 LG: 1384477.1 :2001MAR30 151 639 forward 2 TM Non-Cytosolic
80 LG:1384477.1:2001MAR30 1 62 forward 3 TM Cytosolic
80 LG:1384477. 2001MAR30 63 80 forward 3 TM Transmembrane
80 LG: 1384477.1 :2001MAR30 81 639 forward 3 TM Non-Cytosolic
81 LG: 1390822.1 :2001MAR30 1 550 forward 1 TM Non-Cytosolic
81 LG:1390822.1:2001MAR30 551 573 forward 1 TM Transmembrane
81 LG: 1390822.1 :2001MAR30 574 744 forward 1 TM Cytosolic
81 LG:1390822.1:2001MAR30 745 767 forward 1 TM Transmembrane
81 LG:1390822.1:2001MAR30 768 776 forward 1 TM Non-Cytosolic
81 LG:1390822.1:2001MAR30 111 799 forward 1 TM Transmembrane
81 LG:1390822.1:2001MAR30 800 811 forward 1 TM Cytosolic
81 LG: 1390822.1 :2001MAR30 812 834 forward 1 TM Transmembrane
81 LG:1390822.1:2001MAR30 835 921 forward 1 TM Non-Cytosolic
81 LG: 1390822.1 :2001MAR30 922 944 forward 1 TM Transmembrane
81 LG:1390822.1:2001MAR30 945 977 forward 1 TM Cytosolic
81 LG:1390822.1:2001MAR30 978 1000 forward 1 TM Transmembrane
81 LG: 1390822.1 :2001MAR30 1001 1049 forward 1 TM Non-Cytosolic
81 LG: 1390822.1:2001MAR30 1050 1067 forward 1 TM Transmembrane
81 LG:1390822.1:2001MAR30 1068 1102 forward 1 TM Cytosolic
81 LG: 1390822.1 :2001MAR30 1103 1125 forward 1 TM Transmembrane
81 LG: 1390822.1 :2001MAR30 1126 1134 forward 1 TM Non-Cytosolic
81 LG: 1390822.1 :2001MAR30 ' 1135 1157 forward 1 TM Transmembrane
81 LG: 1390822.1 :2001MAR30 1158 1236 forward 1 TM Cytosolic
81 LG:1390822.1:2001MAR30 1 549 forward 3 TM Non-Cytosolic
81 LG: 1390822.1 :2001MAR30 550 572 forward 3 TM Transmembrane
81 LG: 1390822.1 :2001MAR30 573 765 forward 3 TM Cytosolic
81 LG:1390822. L2001MAR30 766 788 forward 3 TM Transmembrane
81 LG:1390822.1:2001MAR30 789 816 forward 3 TM Non-Cytosolic
81 LG:1390822. L2001MAR30 817 839 forward 3 TM Transmembrane
81 LG: 1390822.1:2001MAR30 840 910 forward 3 TM Cytosolic
81 LG: 1390822.1 :2001MAR30 911 933 forward 3 TM Transmembrane
81 LG: 1390822. L2001MAR30 934 1049 forward 3 TM Non-Cytosolic
81 LG: 1390822.1 :2001MAR30 1050 1067 forward 3 TM Transmembrane
81 LG: 1390822.1:2001MAR30 1068 1097 forward 3 TM Cytosolic
81 LG: 1390822.1 :2001MAR30 1098 1120 forward 3 TM Transmembrane
81 LG: 1390822. 2001MAR30 1121 1236 forward 3 TM Non-Cytosolic
82 LG: 1398274.13:2001MAR30 1 9 forward 1 TM Non-Cytosolic
82 LG: 1398274.13:2001MAR30 10 32 forward 1 TM Transmembrane
82 LG: 1398274.13:2001MAR30 33 36 forward 1 TM Cytosolic
82 LG: 1398274.13:2001MAR30 37 54 forward 1 TM Transmembrane
82 LG: 1398274.13:2001MAR30 55 901 forward 1 TM Non-Cytosolic
82 LG: 1398274.13:2001MAR30 902 924 forward 1 TM Transmembrane
82 LG: 1398274.13 :2001MAR30 925 973 forward 1 TM Cytosolic
82 LG: 1398274.13:2001MAR30 974 996 forward 1 TM Transmembrane
82 LG:1398274.13:2001MAR30 997 1354 forward 1 TM Non-Cytosolic
82 LG: 1398274.13:2001MAR30 1355 1377 forward 1 TM Transmembrane
82 LG: 1398274.13:2001MAR30 1378 1410 forward 1 TM Cytosolic
82 LG: 1398274.13.2001MAR30 1 4 forward 2 TM Non-Cytosolic TABLE 2
SEQ D NO Template ID Start Stop Frame Domain Type Topology
82 LG: 1398274.13:2001MAR30 5 27 forward 2 TM Transmembrane
82 LG: 1398274.13:2001MAR30 28 33 forward 2 TM Cytosolic
82 LG:1398274.13:2001MAR30 34 56 forward 2 TM Transmembrane
82 LG:1398274.13:2001MAR30 57 498 forward 2 TM Non-Cytosolic
82 LG:1398274.13:2001MAR30 499 516 forward 2 TM Transmembrane
82 LG: 1398274.13:2001MAR30 517 522 forward 2 TM Cytosolic
82 LG: 1398274.13.-2001MAR30 523 545 forward 2 TM Transmembrane
82 LG:1398274.13:2001MAR30 546 891 forward 2 TM Non-Cytosolic
82 LG:1398274.13:2001MAR30 892 914 forward 2 TM Transmembrane
82 LG:1398274.13:2001MAR30 915 934 forward 2 TM Cytosolic
82 LG: 1398274.13 :2001MAR30 935 952 forward 2 TM Transmembrane
82 LG: 1398274.13:2001MAR30 953 961 forward 2 TM Non-Cytosolic
82 LG: 1398274.13:2001MAR30 962 984 forward 2 TM Transmembrane
82 LG:1398274.13:2001MAR30 985 1349 forward 2 TM Cytosolic
82 LG:1398274.13:2001MAR30 1350 1372 forward 2 TM Transmembrane
82 LG:1398274.13:2001MAR30 1373 1410 forward 2 TM Non-Cytosolic
82 LG:1398274.13:2001MAR30 1 236 forward 3 TM Non-Cytosolic
82 LG.T398274.13:2001MAR30 237 259 forward 3 TM Transmembrane
82 LG:1398274.13:2001MAR30 260 353 forward 3 TM Cytosolic
82 LG:1398274.13:2001MAR30 354 376 forward 3 TM Transmembrane
82 LG:1398274.13:2001MAR30 377 390 forward 3 TM Non-Cytosolic
82 LG:1398274.13:2001MAR30 391 413 forward 3 TM Transmembrane
82 LG: 1398274.13:2001MAR30 414 448 forward 3 TM Cytosolic
82 LG: 1398274.13:2001MAR30 449 471 forward 3 TM Transmembrane
82 LG: 1398274.13 :2001MAR30 472 485 forward 3 TM Non-Cytosolic
82 LG:1398274.13:2001MAR30 486 508 forward 3 TM Transmembrane
82 LG:1398274.13:2001MAR30 509 520 forward 3 TM Cytosolic
82 LG: 1398274.13.2001MAR30 521 538 forward 3 TM Transmembrane
82 LG: 1398274.13:2001MAR30 539 754 forward 3 TM Non-Cytosolic
82 LG:1398274.13:2001MAR30 755 774 forward 3 TM Transmembrane
82 LG:1398274.13:2001MAR30 775 802 forward 3 TM Cytosolic
82 LG:1398274.13:2001MAR30 803 825 forward 3 TM Transmembrane
82 LG:1398274.13:2001MAR30 826 839 forward 3 TM Non-Cytosolic
82 LG:1398274.13:2001MAR30 840 862 forward 3 TM Transmembrane
82 LG:1398274.13.2001MAR30 863 894 forward 3 TM Cytosolic
82 LG: 1398274.13 :2001MAR30 895 914 forward 3 TM Transmembrane
82 LG: 1398274.13.2001MAR30 915 1286 forward 3 TM Non-Cytosolic
82 LG:1398274.13:2001MAR30 1287 1309 forward 3 TM Transmembrane
82 LG: 1398274.13:2001MAR30 1310 1320 forward 3 TM Cytosolic
82 LG: 1398274.13:2001MAR30 1321 1343 forward 3 TM Transmembrane
82 LG:1398274.13:2001MAR30 1344 1352 forward 3 TM Non-Cytosolic
82 LG:1398274.13:2001MAR30 1353 1375 forward 3 TM Transmembrane
82 LG: 1398274.13 :2001MAR30 1376 1410 forward 3 TM Cytosolic
83 LG: 1398646.1 2001MAR30 1 6 forward 1 TM Cytosolic
83 LG.T 398646.1 2001MAR30 7 26 forward 1 TM Transmembrane
83 LG: 1398646.1 2001MAR30 27 431 forward 1 TM Non-Cytosolic
83 LG:1398646.1 2001MAR30 432 454 forward 1 TM Transmembrane
83 LG:1398646.1 2001MAR30 455 820 forward 1 TM Cytosolic
83 LGT398646.1 2001MAR30 821 843 forward 1 TM Transmembrane
83 LG: 1398646.1 2001MAR30 844 852 forward I TM Non-Cytosolic
83 LG.T 398646.1 2001MAR30 853 872 forward 1 TM Transmembrane
83 LG: 1398646.1 2001MAR30 873 873 forward 1 TM Cytosolic
83 LG: 1398646.1 2001MAR30 874 891 forward 1 TM Transmembrane
83 LG: 1398646.1 2001MAR30 892 905 forward 1 TM Non-Cytosolic TABLE 2
SEQ D NO: Template ID Start Stop Frame Domain Type Topology
83 LG:1398646.1:2001MAR30 906 928 forward 1 TM Transmembrane
83 LG:1398646.1:2001MAR30 929 1081 forward 1 TM Cytosolic
83 LG: 1398646.1 :2001MAR30 1 867 forward 2 TM Non-Cytosolic
83 LG:1398646. L2001MAR30 868 890 forward 2 TM Transmembrane
83 LG:1398646. 2001MAR30 891 1033 forward 2 TM Cytosolic
83 LG.T398646.1.-2001MAR30 1034 1053 forward 2 TM Transmembrane
83 LG:1398646.1.2001MAR30 1054 1080 forward 2 TM Non-Cytosolic
83 LG:1398646.1.2001MAR30 1 12 forward 3 TM Cytosolic
83 LG:1398646. 2001MAR30 13 35 forward 3 TM Transmembrane
83 LG:1398646. 2001MAR30 36 614 forward 3 TM Non-Cytosolic
83 LG:1398646.1:2001MAR30 615 634 forward 3 TM Transmembrane
83 LG:1398646.1:2001MAR30 635 866 forward 3 TM Cytosolic
83 LG:1398646.1:2001MAR30 867 889 forward 3 TM Transmembrane
83 LG:1398646.1:2001MAR30 890 903 forward 3 TM Non-Cytosolic
83 LG:1398646.1:2001MAR30 904 926 forward 3 TM' Transmembrane
83 LG:1398646.1:2001MAR30 927 1032 forward 3 TM Cytosolic
83 LG:1398646.1:2001MAR30 1033 1055 forward 3 TM Transmembrane
83 LG:1398646.1:2001MAR30 1056 1080 forward 3 TM Non-Cytosolic
84 LG:1398905.1:2001MAR30 1 278 forward 2 TM Non-Cytosolic 84 LG:1398905.1:2001MAR30 279 296 forward 2 TM Transmembrane 84 LG:1398905.1:2001MAR30 297 308 forward 2 TM Cytosolic 84 LG:1398905.1:2001MAR30 309 331 forward 2 TM Transmembrane 84 LG:1398905.1:2001MAR30 332 488 forward 2 TM Non-Cytosolic 84 LG:1398905.1:2001MAR30 1 277 forward 3 TM Non-Cytosolic 84 LG:1398905.1:2001MAR30 278 295 forward 3 TM Transmembrane
84 LG:1398905.1:2001MAR30 296 487 forward 3 TM Cytosolic
85 LG:1399785.1:2001MAR30 1 104 forward 1 TM Non-Cytosolic 85 LG: 1399785. 2001MAR30 105 124 forward 1 TM Transmembrane 85 LG:1399785.1:2001MAR30 125 145 forward 1 TM Cytosolic 85 LG.T399785.1:2001MAR30 146 168 forward 1 TM Transmembrane
85 LG:1399785.1:2001MAR30 169 1902 forward 1 TM Non-Cytosolic
86 LG:1446193.10:2001MAR30 1 941 forward 1 TM Non-Cytosolic 86 LG:1446193.10:2001MAR30 942 961 forward 1 TM Transmembrane
86 LG: 1446193.10:2001MAR30 962 1020 forward 1 TM Cytosolic
87 LG:1446210.8:2001MAR30 1 50 forward 1 TM Cytosolic 87 LG:1446210.8:2001MAR30 51 70 forward 1 TM Transmembrane 87 LG.T446210.8.-2001MAR30 71 74 forward 1 TM Non-Cytosolic 87 LG:1446210.8:2001MAR30 75 97 forward 1 TM Transmembrane 87 LG:1446210.8:2001MAR30 98 117 forward 1 TM Cytosolic 87 LG:1446210.8:2001MAR30 118 140 forward 1 TM Transmembrane 87 LG:1446210.8:2001MAR30 141 159 forward 1 TM Non-Cytosolic 87 LG:1446210.8:2001MAR30 160 182 forward 1 TM Transmembrane 87 LG:1446210.8:2001MAR30 183 333 forward 1 TM Cytosolic 87 LG:1446210.8:2001MAR30 334 356 forward 1 TM Transmembrane 87 LG: 1446210.8:2001MAR30 357 375 forward 1 TM Non-Cytosolic 87 LG:1446210.8:2001MAR30 376 398 forward 1 TM Transmembrane 87 LG:1446210.8:2001MAR30 399 404 forward 1 TM Cytosolic 87 LG:1446210.8:2001MAR30 405 427 forward 1 TM Transmembrane 87 LG:1446210.8:2001MAR30 428 596 forward 1 TM Non-Cytosolic 87 LG:1446210.8:2001MAR30 1 43 forward 2 TM Cytosolic 87 LG:1446210.8:2001MAR30 44 66 forward 2 TM Transmembrane 87 LG:1446210.8:2001MAR30 67 369 forward 2 TM Non-Cytosolic 87 LG:1446210.8:2001MAR30 370 392 forward 2 TM Transmembrane 87 LG:1446210.8:2001MAR30 393 563 forward 2 TM Cytosolic TABLE 2
SEQ D NO: Template ID Start Stop Frame Domain Type Topology
87 LG: 1446210.8:2001MAR30 564 586 forward 2 TM Transmembrane
87 LG:1446210.8:2001MAR30 587 596 forward 2 TM Non-Cytosolic
88 LG:1450054.6:2001MAR30 1 1807 forward 2 TM Non-Cytosolic
88 LG:1450054.6:2001MAR30 1808 1827 forward 2 TM Transmembrane
88 LG:1450054.6:2001MAR30 1828 1865 forward 2 TM Cytosolic
89 LG: 1452516.4:2001MAR30 1 567 forward 3 TM Non-Cytosolic
89 LG: 1452516.4:2001MAR30 568 590 forward 3 TM Transmembrane
89 LG:1452516.4:2001MAR30 591 634 forward 3 TM Cytosolic
90 LG:1455293J:2001MAR30 1 27 forward 1 TM Non-Cytosolic
90 LG:1455293J:2001MAR30 28 46 forward 1 TM Transmembrane
90 LG:1455293J:2001MAR30 47 202 forward 1 TM Cytosolic
90 LG:1455293J:2001MAR30 203 225 forward 1 TM Transmembrane
90 LG:1455293J:2001MAR30 226 544 forward 1 TM Non-Cytosolic
90 LG:1455293J:2001MAR30 1 23 forward 2 TM Non-Cytosolic
90 LG.T455293J:2001MAR30 24 46 forward 2 TM Transmembrane
90 LG:1455293.7:2001MAR30 47 200 forward 2 TM Cytosolic
90 LG:1455293.7:2001MAR30 201 223 forward 2 TM Transmembrane
90 LG:1455293.7:2001MAR30 224 242 forward 2 TM Non-Cytosolic
90 LG:1455293.7:2001MAR30 243 260 forward 2 TM Transmembrane
90 LG: 1455293.7:2001MAR30 261 272 forward 2 TM Cytosolic
90 LG:1455293.7:2001MAR30 273 290 forward 2 TM Transmembrane
90 LG: 1455293.7:2001MAR30 291 485 forward 2 TM Non-Cytosolic
90 LG:1455293.7:2001MAR30 486 505 forward 2 TM Transmembrane
90 LG:1455293.7:2001MAR30 . 506 511 forward 2 TM Cytosolic
90 LG:1455293.7:2001MAR30 512 534 forward 2 TM Transmembrane
90 LG: 1455293.7 :2001MAR30 535 543 forward 2 TM Non-Cytosolic
90 LG:1455293.7:2001MAR30 .1 202 forward 3 TM Cytosolic
90 LG:1455293.7:2001MAR30 ■ 203 225 forward 3 TM Transmembrane
90 LG: 1455293.7:2001MAR30. . 226 262 forward 3 TM Non-Cytosolic
90 LG.T455293.7.-2001MAR30 263 285 forward 3 TM Transmembrane
90 LG: 1455293.7:2001 MAR30 286 305 forward 3 TM Cytosolic
90 LG:1455293.7:2001MAR30 306 328 forward 3 TM Transmembrane
90 LG:1455293.7:2001MAR30 329 401 forward 3 TM Non-Cytosolic
90 LG: 1455293.7:2001MAR30 402 424 forward 3 TM Transmembrane
90 LG:1455293.7:2001MAR30 425 461 forward 3 TM Cytosolic
90 LG: 1455293.7:200 IM AR30 462 484 forward 3 TM Transmembrane
90 LG.T455293.7.-2001MAR30 485 489 forward 3 TM Non-Cytosolic
90 LG:1455293.7:2001MAR30 490 512 forward 3 TM Transmembrane
90 LG:1455293J:2001MAR30 513 543 forward 3 TM Cytosolic
91 LG:1498113.1:2001MAR30 1 216 forward 3 TM Cytosolic
92 LG:1500042.1:2001MAR30 1 4 forward 1 TM Non-Cytosolic
92 LG:1500042.1:2001MAR30 5 27 forward 1 TM Transmembrane
92 LG:1500042.1:2001MAR30 28 31 forward 1 TM Cytosolic
92 LG: 1500042.1 :2001 MAR30 32 54 forward 1 TM Transmembrane
92 LG.T500042.1:2001MAR30 55 68 forward 1 TM Non-Cytosolic
92 LG: 1500042.1.-2001MAR30 69 91 forward 1 TM Transmembrane
92 LG:1500042.1:2001MAR30 92 97 forward 1 TM Cytosolic
92 LG: 1500042.1 :2001 M AR30 98 117 forward 1 TM Transmembrane
92 LG: 1500042.1 :2001 MAR30 118 122 forward 1 TM Non-Cytosolic
92 LG: 1500042.1:2001 M AR30 1 6 forward 2 TM Cytosolic
92 LG: 1500042.1 :2001MAR30 7 29 forward 2 TM Transmembrane
92 LG: 1500042.1 :2001MAR30 30 33 forward 2 TM Non-Cytosolic
92 LG: 1500042.1:2001 MAR30 34 56 forward 2 TM Transmembrane
92 LG: 1500042.1 :2001 M AR30 57 62 forward 2 TM Cytosolic TABLE 2
SEQ D NO: Template ID Start Stop Frame Domain Type Topology
92 LG:1500042.1 :2001MAR30 63 85 forward 2 TM Transmembrane
92 LG:1500042.1:2001MAR30 86 122 forward 2 TM Non-Cytosolic
92 LG:1500042.1 :2001MAR30 1 1 forward 3 TM Cytosolic
92 LG:1500042.1 :2001MAR30 2 24 forward 3 TM Transmembrane
92 LG:1500042.1 :2001MAR30 25 38 forward 3 TM Non-Cytosolic
92 LG:1500042.1:2001MAR30 39 61 forward 3 TM Transmembrane
92 LG:1500042.1:2001MAR30 62 87 forward 3 TM Cytosolic
92 LG: 1500042.1:2001MAR30 88 110 forward 3 TM Transmembrane
92 LG: 1500042.1:2001 MAR30 111 122 forward 3 TM Non-Cytosolic
93 LG: 1500434.4:2001MAR30 1 179 forward 1 TM Non-Cytosolic 93 LG:1500434.4:2001MAR30 180 202 forward 1 TM Transmembrane 93 LG:1500434.4:2001MAR30 203 405 forward 1 TM Cytosolic 93 LG:1500434.4:2001MAR30 406 423 forward 1 TM Transmembrane 93 LG:1500434.4:2001MAR30 424 479 forward 1 TM Non-Cytosolic 93 LG:1500434.4:2001MAR30 480 502 forward 1 TM Transmembrane 93 LG:1500434.4:2001MAR30 503 543 forward 1 TM Cytosolic 93 LG:1500434.4:2001MAR30 544 566 forward 1 TM Transmembrane 93 LG: 1500434.4:2001MAR30 567 593 forward 1 TM Non-Cytosolic 93 LG: 1500434.4:2001MAR30 594 616 forward 1 TM Transmembrane 93 LG:1500434.4:2001MAR30 617 660 forward 1 TM Cytosolic 93 LG:1500434.4:2001MAR30 661 683 forward 1 TM Transmembrane 93 LG:1500434.4:2001MAR30 684 697 forward 1 TM Non-Cytosolic 93 LG:1500434.4:2001MAR30 698 720 forward 1 TM Transmembrane 93 LG:1500434.4:2001MAR30 721 726 forward 1 TM Cytosolic 93 LG:1500434.4:2001MAR30 727 749 forward 1 TM Transmembrane 93 LG:1500434.4:2001MAR30 750 763 forward 1 TM Non-Cytosolic 93 LG: 1500434.4:2001MAR30 764 786 forward 1 TM Transmembrane 93 LG:1500434.4:2001MAR30 787 951 forward 1 TM Cytosolic 93 LG:1500434.4:2001MAR30 952 974 forward 1 TM Transmembrane 93 LG: 1500434.4.-2001MAR30 975 1002 forward 1 TM Non-Cytosolic 93 LG: 1500434.4.-2001MAR30 1003 1025 forward 1 TM Transmembrane 93 LG:1500434.4:2001MAR30 1026 1098 forward 1 TM Cytosolic 93 LG:1500434.4:2001MAR30 1099 1121 forward 1 TM Transmembrane 93 LG:1500434.4:2001MAR30 1122 1135 forward 1 TM Non-Cytosolic 93 LG:1500434.4:2001MAR30 1136 1158 forward 1 TM Transmembrane 93 LG: 1500434.4:2001MAR30 1159 1249 forward 1 TM Cytosolic 93 LG:1500434.4:2001MAR30 1 428 forward 2 TM Non-Cytosolic 93 LG:1500434.4:2001MAR30 429 451 forward 2 TM Transmembrane 93 LG:1500434.4:2001MAR30 452 551 forward 2 TM Cytosolic 93 LG:1500434.4:2001MAR30 552 574 forward 2 TM Transmembrane 93 LG.T500434.4.-2001MAR30 575 588 forward 2 TM Non-Cytosolic 93 LG:1500434.4:2001MAR30 589 611 forward 2 TM Transmembrane 93 LG:1500434.4:2001MAR30 612 696 forward 2 TM Cytosolic 93 LG:1500434.4:2001MAR30 697 719 forward 2 TM Transmembrane 93 LG:1500434.4:2001MAR30 720 733 forward 2 TM Non-Cytosolic 93 LG: 1500434.4:2001MAR30 734 753 forward 2 TM Transmembrane 93 LG: 1500434.4:2001MAR30 754 834 forward 2 TM Cytosolic 93 LG:1500434.4:2001MAR30 835 857 forward 2 TM Transmembrane 93 LG:1500434.4:2001MAR30 858 871 forward 2 TM Non-Cytosolic 93 LG:1500434.4:2001MAR30 872 894 forward 2 TM Transmembrane 93 LG: 1500434.4:2001 MAR30 895 984 forward 2 TM Cytosolic 93 LG: 1500434.4:2001 MAR30 985 1007 forward 2 TM Transmembrane 93 LG:1500434.4:2001MAR30 1008 1096 forward 2 TM Non-Cytosolic 93 LG:1500434.4:2001MAR30 1097 1119 forward 2 TM Transmembrane TABLE 2
SEQ D NO: Template ID Start Stop Frame Domain Type Topology
93 LG:1500434.4:2001MAR30 1120 1145 forward 2 TM Cytosolic
93 LG: 1500434.4:2001MAR30 1146 1168 forward 2 TM Transmembrane
93 LG: 1500434.4:2001MAR30 1169 1172 forward 2 TM Non-Cytosolic
93 LG: 1500434.4:2001MAR30 1173 1195 forward 2 TM Transmembrane
93 LG:1500434.4:2001MAR30 1196 1249 forward 2 TM Cytosolic
93 LG:1500434.4:2001MAR30 1 511 forward 3 TM Non-Cytosolic
93 LG: 1500434.4:2001MAR30 512 531 forward 3 TM Transmembrane
93 LG:1500434.4:2001MAR30 532 551 forward 3 TM Cytosolic
93 LG:1500434.4:2001MAR30 552 574 forward 3 TM Transmembrane
93 LG:1500434.4:2001MAR30 575 610 forward 3 TM Non-Cytosolic
93 LG:1500434.4:2001MAR30 611 633 forward 3 TM Transmembrane
93 LG:1500434.4:2001MAR30 634 655 forward 3 TM Cytosolic
93 LG: 1500434.4.-2001MAR30 656 678 forward 3 TM Transmembrane
93 LG:1500434.4:2001MAR30 679 697 forward 3 TM Non-Cytosolic
93 LG:1500434.4:2001MAR30 698 720 forward 3 TM Transmembrane
93 LG:1500434.4:2001MAR30 721 732 forward 3 TM Cytosolic
93 LG:1500434.4:2001MAR30 733 755 forward 3 TM Transmembrane
93 LG: 1500434.4:2001MAR30 756 963 forward 3 TM Non-Cytosolic
93 LG:1500434.4:2001MAR30 964 986 forward 3 TM Transmembrane
93 LG:1500434.4:2001MAR30 987 998 forward 3 TM Cytosolic
93 LG:1500434.4:2001MAR30 999 1021 forward 3 TM Transmembrane
93 LG:1500434.4:2001MAR30 1022 1060 forward 3 TM Non-Cytosolic
93 LG:1500434.4:2001MAR30 1061 1078 forward 3 TM Transmembrane
93 LG:1500434.4:2001MAR30 1079 1145 forward 3 TM Cytosolic
93 LG:1500434.4:2001MAR30 1146 1168 forward 3 TM Transmembrane
93 LG:1500434.4:2001MAR30 1 169 1171 forward 3 TM * Non-Cytosolic
93 LG:1500434.4:2001MAR30 1172 1189 forward 3 TM Transmembrane
93 LG:1500434.4:2001MAR30 1190 1208 forward 3 TM Cytosolic
93 LG:1500434.4:2001MAR30 1209 1231 forward 3 TM Transmembrane
93 LG:1500434.4:2001MAR30 1232 1249 forward 3 TM Non-Cytosolic
94 LG:1501102.4:2001MAR30 1 45 forward 1 TM Non-Cytosolic
94 LG:1501102.4:2001MAR30 46 68 forward 1 TM Transmembrane
94 LG:1501102.4:2001MAR30 69 98 forward 1 TM Cytosolic
94 LG.-1501102.4:2001MAR30 99 121 forward 1 TM Transmembrane
94 LG:1501102.4:2001MAR30 122 426 forward 1 TM Non-Cytosolic
94 LG:1501102.4:2001MAR30 1 91 forward 3 TM Cytosolic
94 LG:1501102.4:2001MAR30 92 111 forward 3 TM Transmembrane
94 LG:1501102.4:2001MAR30 112 114 forward 3 TM Non-Cytosolic
94 LG:1501102.4:2001MAR30 1 15 134 forward 3 TM Transmembrane
94 LG.T501102.4.-2001MAR30 135 170 forward 3 TM Cytosolic
94 LG:1501102.4:2001MAR30 171 193 forward 3 TM Transmembrane
94 LG:1501102.4:2001MAR30 194 425 forward 3 TM Non-Cytosolic
95 LG:1501768.2:2001MAR30 1 6 forward 1 TM Cytosolic
95 LG:1501768.2:2001MAR30 7 29 forward 1 TM Transmembrane
95 LG: 1501768.2-.2001MAR30 30 85 forward 1 TM Non-Cytosolic
96 LG: 1502155.6:2001MAR30 1 315 forward 2 TM Non-Cytosolic
96 LG:1502155.6:2001MAR30 316 338 forward 2 TM Transmembrane
96 LG:1502155.6:2001MAR30 339 401 forward 2 TM Cytosolic
97 LG:1512304.2:2001MAR30 1 92 forward 1 TM Cytosolic
97 LG:1512304.2:2001MAR30 93 115 forward 1 TM Transmembrane
97 LG:1512304.2:2001MAR30 116 180 forward 1 TM Non-Cytosolic
97 LG:1512304.2:2001MAR30 181 203 forward 1 TM Transmembrane
97 LG:1512304.2:2001MAR30 204 245 forward 1 TM Cytosolic
97 LG:1512304.2:2001MAR30 246 268 forward 1 TM Transmembrane TABLE 2
SEQ D NO: Template ID Start Stop Frame Domain Type Topology
97 LG:1512304.2:2001MAR30 269 278 forward 1 TM Non-Cytosolic
97 LG: 1512304.2:2001MAR30 1 240 forward 2 TM Non-Cytosolic
97 LG:1512304.2:2001MAR30 241 263 forward 2 TM Transmembrane
97 LG:1512304.2:2001MAR30 264 278 forward 2 TM Cytosolic
97 LG:1512304.2:2001MAR30 1 89 forward 3 TM Cytosolic
97 LG:1512304.2:2001MAR30 90 112 forward 3 TM Transmembrane
97 LG:1512304.2:2001MAR30 113 137 forward 3 TM Non-Cytosolic
97 LG:1512304.2:2001MAR30 138 160 forward 3 TM Transmembrane
97 LG:1512304.2:2001MAR30 161 176 forward 3 TM Cytosolic
97 LG:1512304.2:2001MAR30 177 199 forward 3 TM Transmembrane
97 LG: 1512304.2:2001MAR30 200 231 forward 3 TM Non-Cytosolic
97 LG:1512304.2:2001MAR30 232 254 forward 3 TM Transmembrane
97 LG: 1512304.2:2001MAR30 255 277 forward 3 TM Cytosolic
98 LG:1512931.11:2001MAR30 1 260 forward 2 TM Non-Cytosolic
98 LG:1512931.11:2001MAR30 261 280 forward 2 TM Transmembrane
98 LG:1512931.11:2001MAR30 281 296 forward 2 TM Cytosolic
98 LG:1512931.11:2001MAR30 1 260 forward 3 TM Cytosolic
98 LG:1512931.11:2001MAR30 261 283 forward 3 TM Transmembrane
98 LG:1512931.11:2001MAR30 284 296 forward 3 TM Non-Cytosolic
99 LG:155076.18:2001MAR30 1 1165 forward 2 TM Non-Cytosolic
99 LG:155076.18:2001MAR30 1166 1188 forward 2 TM Transmembrane
99 LG: 155076.18:2001MAR30 1189 1194 forward 2 TM Cytosolic
99 LG: 155076.18:2001MAR30 1195 1214 forward 2 TM Transmembrane
99 LG:155076.18:2001MAR30 1215 1590 forward 2 TM Non-Cytosolic
100 LG:159111.41:2001MAR30 1 193 forward 1 TM Non-Cytosolic
100 LG:159111.41:2001MAR30 194 216 forward 1 TM Transmembrane
100 LG:159111.41:2001MAR30 217 351 forward 1 TM Cytosolic
100 LG:159111.41:2001MAR30 352 374 forward 1 TM Transmembrane
100 LG:159111.41:2001MAR30 375 383 forward 1 TM Non-Cytosolic
100 LG:159111.41:2001MAR30 384 406 forward 1 TM Transmembrane
100 LG:159111.41:2001MAR30 407 412 forward 1 TM Cytosolic
100 LG: 159111.41:2001MAR30 413 430 forward 1 TM Transmembrane
100 LG:159111.41:2001MAR30 431 2269 forward 1 TM Non-Cytosolic
100 LG:159111.41:2001MAR30 1 191 forward 3 TM Non-Cytosolic
100 LG:159111.41:2001MAR30 192 214 forward 3 TM Transmembrane
100 LG:159111.41:2001MAR30 215 382 forward 3 TM Cytosolic
100 LG:159111.41:2001MAR30 383 405 forward 3 TM Transmembrane
100 LG:159111.41:2001MAR30 406 2269 forward 3 TM Non-Cytosolic
101 LG: 170604. L2001MAR30 1 240 forward 3 TM Cytosolic
101 LG: 170604. 2001MAR30 241 260 forward 3 TM Transmembrane
101 LG: 170604.1 :2001MAR30 261 262 forward 3 TM Non-Cytosolic
102 LG:190477.4:2001MAR30 1 4 forward 1 TM Non-Cytosolic
102 LG: 190477.4:2001MAR30 5 27 forward 1 TM Transmembrane
102 LG: 190477.4:2001MAR30 28 70 forward 1 TM Cytosolic
102 LG: 190477.4:2001MAR30 71 93 forward 1 TM Transmembrane
102 LG: 190477.4.-2001MAR30 94 124 forward 1 TM Non-Cytosolic
102 LG:190477.4:2001MAR30 125 147 forward 1 TM Transmembrane
102 LG:190477.4:2001MAR30 148 153 forward 1 TM Cytosolic
102 LG: 190477.4:2001MAR30 154 176 forward 1 TM Transmembrane
102 LG:190477.4:2001MAR30 177 207 forward 1 TM Non-Cytosolic
102 LG:190477.4:2001MAR30 208 230 forward 1 TM Transmembrane
102 LG:190477.4:2001MAR30 231 341 forward 1 TM Cytosolic
102 LG: 190477.4:2001MAR30 342 364 forward 1 TM Transmembrane
102 LG: 190477.4:2001MAR30 365 401 forward 1 TM Non-Cytosolic TABLE 2
SEQ D NO: Template ID Start Stop Frame Domain Type Topology
102 LG:190477.4:2001MAR30 402 421 forward 1 TM Transmembrane
102 LG: 190477.4:2001MAR30 422 427 forward 1 TM Cytosolic
102 LG:190477.4:2001MAR30 428 445 forward 1 TM Transmembrane
102 LG:190477.4:2001MAR30 446 449 forward 1 TM Non-Cytosolic
102 LG:190477.4:2001MAR30 450 472 forward, 1 TM Transmembrane
102 LG.T90477.4.-2001MAR30 473 502 forward 1 TM Cytosolic
102 LG.T90477.4.-2001MAR30 503 525 forward 1 TM Transmembrane
102 LG:190477.4:2001MAR30 526 623 forward 1 TM Non-Cytosolic
102 LG: 190477.4:200 IM AR30 624 646 forward 1 TM Transmembrane
102 LG:190477.4:2001MAR30 647 652 forward 1 TM Cytosolic
102 LG:190477.4:2001MAR30 653 672 forward 1 TM Transmembrane
102 LG:190477.4:2001MAR30 673 691 forward 1 TM Non-Cytosolic
102 LG:190477.4:2001MAR30 692 714 forward 1 TM Transmembrane
102 LG:190477.4:2001MAR30 715 720 forward 1 TM Cytosolic
102 LG: 190477.4.-2001MAR30 721 743 forward 1 TM Transmembrane
102 LG: 190477.4:2001MAR30 744 757 forward 1 TM Non-Cytosolic
102 LG:190477.4:2001MAR30 758 780 forward 1 TM Transmembrane
102 LG: 190477.4:2001MAR30 781 827 forward 1 TM Cytosolic
102 LG:190477.4:2001MAR30 1 51 forward 2 TM Cytosolic
102 LG:190477.4:2001MAR30 52 74 forward 2 TM Transmembrane
102 LG:190477.4:2001MAR30 75 83 forward 2 TM Non-Cytosolic
102 LG.T 90477.4.-2001MAR30 84 106 forward 2 TM Transmembrane
102 LG:190477.4:2001MAR30 107 126 forward 2 TM Cytosolic
102 LG:190477.4:2001MAR30 127 149 forward 2 .TM Transmembrane
102 LG:190477.4:2001MAR30 150 579 forward 2 TM Non-Cytosolic
102 LG:190477.4:2001MAR30 580 602 forward 2 TM Transmembrane
102 LG:190477.4:2001MAR30 603 622 forward 2 TM ' Cytosolic
102 LG: 190477.4:2001MAR30 623 645 forward 2 TM Transmembrane
102 LG:190477.4:2001MAR30 646 664 forward 2 TM Non-Cytosolic
102 LG.T 90477.4:2001MAR30 665 682 forward 2 TM Transmembrane
102 LG:190477.4:2001MAR30 683 826 forward 2 TM Cytosolic
102 LG:190477.4:2001MAR30 1 65 forward 3 TM Cytosolic
102 LG:190477.4:2001MAR30 66 83 forward 3 TM Transmembrane
102 LG:190477.4:2001MAR30 84 97 forward 3 TM Non-Cytosolic
102 LG:190477.4:2001MAR30 98 117 forward 3 TM Transmembrane
102 LG:190477.4:2001MAR30 118 123 forward 3 TM Cytosolic
102. LG: 190477.4:2001MAR30 124 146 forward 3 TM Transmembrane
102 LG.T90477.4:2001MAR30 147 206 forward 3 TM Non-Cytosolic
102 LG.T 90477.4:2001MAR30 207 229 forward 3 TM Transmembrane
102 LG:190477.4:2001MAR30 230 283 forward 3 TM Cytosolic
102 LG:190477.4:2001MAR30 284 306 forward 3 TM Transmembrane
102 LG:190477.4:2001MAR30 307 333 forward 3 TM Non-Cytosolic
102 LG:190477.4:2001MAR30 334 356 forward 3 TM Transmembrane
102 LG:190477.4:2001MAR30 357 399 forward 3 TM Cytosolic
102 LG: 190477.4:2001MAR30 400 417 forward 3 TM Transmembrane
102 LG.T90477.4:2001MAR30 418 436 forward 3 TM Non-Cytosolic
102 LG:190477.4:2001MAR30 437 456 forward 3 TM Transmembrane
102 LG: 190477.4:2001MAR30 457 584 forward 3 TM Cytosolic
102 LG:190477.4:2001MAR30 585 607 forward 3 TM Transmembrane
102 LG:190477.4:2001MAR30 . 608 626 forward 3 TM Non-Cytosolic
102 LG:190477.4:2001MAR30 627 649 forward 3 TM Transmembrane
102 LG:190477.4:2001MAR30 650 661 forward 3 TM Cytosolic
102 LG: 190477.4:2001MAR30 662 684 forward 3 TM Transmembrane
102 LG:190477.4:2001MAR30 685 693 forward 3 TM Non-Cytosolic TABLE 2
SEQ D NO: Template ID Start Stop Frame Domain Type Topology
102 LG:190477.4:2001MAR30 694 713 forward 3 TM Transmembrane
102 LG:190477.4:2001MAR30 714 719 forward 3 TM Cytosolic
102 LG: 190477.4:2001MAR30 720 742 forward 3 TM Transmembrane
102 LG:190477.4:2001MAR30 743 756 forward 3 TM Non-Cytosolic
102 LG:190477.4:2001MAR30 757 779 forward 3 TM Transmembrane
102 LG:190477.4:2001MAR30 780 826 forward 3 TM Cytosolic
103 LG:198087.8:2001MAR30 1 312 forward 2 TM Non-Cytosolic
103 LG:198087.8:2001MAR30 313 335 forward 2 TM Transmembrane
103 LG:198087.8:2001MAR30 336 399 forward 2 TM Cytosolic
103 LG:198087.8:2001MAR30 400 419 forward 2 TM Transmembrane
103 LG:198087.8:2001MAR30 420 433 forward 2 TM Non-Cytosolic
103 LG.T98087.8:2001MAR30 434 456 forward 2 TM Transmembrane
103 LG.T98087.8:2001MAR30 457 468 forward 2 TM Cytosolic
103 LG:198087.8:2001MAR30 469 491 forward 2 TM Transmembrane
. 103 LG:198087.8:2001MAR30 492 584 forward 2 TM Non-Cytosolic
103 LG:198087.8:2001MAR30 585 607 forward 2 TM Transmembrane
103 LG:198087.8:2001MAR30 608 781 forward 2 TM Cytosolic
103 LG:198087.8:2001MAR30 782 804 forward 2 TM Transmembrane
103 LG:198087.8:2001MAR30 805 835 forward 2 TM Non-Cytosolic
103 LG:198087.8:2001MAR30 836 858 forward 2 TM Transmembrane
103 LG:198087.8:2001MAR30 859 864 forward 2 TM Cytosolic
103 LG:198087.8:2001MAR30 865 887 forward 2 TM Transmembrane
103 LG:198087.8:2001MAR30 888 997 forward 2 TM Non-Cytosolic
103 LG:198087.8:2001MAR30 998 1017 forward 2 TM Transmembrane
103 LG:198087.8:2001MAR30 1018 1023 forward 2 TM Cytosolic
103 LG:198087.8:2001MAR30 1024 1046 forward 2 TM Transmembrane
103 LG:198087.8:2001MAR30 1047 1055 forward 2 TM Non-Cytosolic
' 103 LG:198087.8:2001MAR30 1056 1073 forward 2 TM Transmembrane
103 LG:198087.8:2001MAR30 1074 1310 forward 2 TM Cytosolic
103 LG:198087.8:2001MAR30 1 405 forward 3 TM Non-Cytosolic
103 LG:198087.8:2001MAR30 406 428 forward 3 TM Transmembrane
103 LG:198087.8:2001MAR30 429 434 forward 3 TM Cytosolic
103 LG.T98087.8.-2001MAR30 435 457 forward 3 TM Transmembrane
103 LG:198087.8:2001MAR30 458 987 forward 3 TM Non-Cytosolic
103 LG:198087.8:2001MAR30 988 1010 forward 3 TM Transmembrane
103 LG:198087.8:2001MAR30 1011 1022 forward 3 TM Cytosolic
103 LG:198087.8:2001MAR30 1023 1040 forward 3 TM Transmembrane
103 LG:198087.8:2001MAR30 1041 1054 forward 3 TM Non-Cytosolic
103 LG:198087.8:2001MAR30 1055 1072 forward 3 TM Transmembrane
103 LG.T98087.8:2001MAR30 1073 1310 forward 3 TM Cytosolic
104 LG:198743.2:2001MAR30 1 1132 forward 1 TM Non-Cytosolic
104 LG: 198743.2:2001MAR30 1133 1152 forward 1 TM Transmembrane
104 LG:198743.2:2001MAR30 1153 1164 forward 1 TM Cytosolic
104 LG:198743.2:2001MAR30 1165 1187 forward 1 TM Transmembrane
104 LG:198743.2:2001MAR30 1 188 1215 forward 1 TM Non-Cytosolic
104 LG: 198743.2:2001MAR30 1 1038 forward 2 TM Non-Cytosolic
104 LG: 198743.2:2001MAR30 1039 1058 forward 2 TM Transmembrane
104 LG:198743.2:2001MAR30 1059 1105 forward 2 TM Cytosolic
104 LG:198743.2:2001MAR30 1106 1 128 forward 2 TM Transmembrane
104 LG:198743.2:2001MAR30 1129 1215 forward 2 TM Non-Cytosolic
104 LG:198743.2:2001MAR30 1 983 forward 3 TM Non-Cytosolic
104 LG:198743.2:2001MAR30 984 1006 forward 3 TM Transmembrane
104 LG: 198743.2:2001MAR30 1007 1012 forward 3 TM Cytosolic
104 LG: 198743.2:2001MAR30 1013 1035 forward 3 TM Transmembrane 111 ; TABLE 2
SEQ D NO: Template ID Start Stop Frame Domain Type Topology
104 LG:198743.2:2001MAR30 1036 1044 forward 3 TM Non-Cytosolic
104 LG:198743.2:2001MAR30 1045 1067 forward 3 TM Transmembrane
104 LG:198743.2:2001MAR30 1068 1214 forward 3 TM Cytosolic
105 LG:199194.1:2001MAR30 1 75 forward 1 TM Cytosolic 105 LG:199194.1:2001MAR30 76 95 forward 1 TM Transmembrane 105 LG:199194.1:2001MAR30 96 1183 forward 1 TM Non-Cytosolic 105 LG: 199194.1:2001MAR30 1 479 forward 3 TM Non-Cytosolic 105 LG: 199194. 2001MAR30 480 502 forward 3 TM Transmembrane 105 LG.T99194. 2001MAR30 503 597 forward 3 TM Cytosolic 105 ' LG:199194.1:2001MAR30 598 617 forward 3 TM Transmembrane 105 LG:199194.1:2001MAR30 618 631 forward 3 TM Non-Cytosolic 105 LG:199194.1:2001MAR30 632 654 forward 3 TM Transmembrane 105 LG: 199194.1 :2001MAR30 655 658 forward 3 TM Cytosolic 105 LG: 199194.1.2001MAR30 659 681 forward 3 TM Transmembrane
105 LG:199194.1:2001MAR30 682 1182 forward 3 TM Non-Cytosolic
106 LG:200727.6:2001MAR30 1 351 forward 2 TM Non-Cytosolic 106 LG:200727.6:2001MAR30 352 374 forward 2 TM Transmembrane
106 LG:200727.6:2001MAR30 375 474 forward 2 TM Cytosolic
107 LG:201572.20:2001MAR30 1 12 forward 1 TM Non-Cytosolic 107 LG:201572.20:2001MAR30 13 35 forward 1 TM Transmembrane 107 LG:201572.20:2001MAR30 36 74 forward 1 TM Cytosolic 107 LG:201572.20:2001MAR30 75 97 forward 1 TM Transmembrane 107 LG:201572.20:2001MAR30 98 185 forward 1 TM Non-Cytosolic 107 LG:201572.20:2001MAR30 186 203 forward 1 TM Transmembrane 107 LG:201572.20:2001MAR30 204 485 forward 1 TM Cytosolic 107 LG:201572.20:2001MAR30 486 508 forward 1 TM Transmembrane 107 LG:201572.20:2001MAR30 509 546 forward 1 TM Non-Cytosolic 107 LG:201572.20:2001MAR30 547 569 forward 1 TM Transmembrane 107 LG:201572.20:2001MAR30 570 589 forward 1 TM Cytosolic 107 LG:201572.20:2001MAR30 590 612 forward 1 TM Transmembrane 107 LG:201572.20:2001MAR30 613 706 forward 1 TM Non-Cytosolic 107 LG:201572.20:2001MAR30 707 729 forward 1 TM Transmembrane 107 LG:201572.20:2001MAR30 730 861 forward 1 TM Cytosolic 107 LG:201572.20:2001MAR30 862 884 forward 1 TM Transmembrane 107 LG:201572.20:2001MAR30 885 898 forward 1 TM Non-Cytosolic 107 LG:201572.20:2001MAR30 899 918 forward 1 TM Transmembrane 107 LG:201572.20:2001MAR30 919 930 forward 1 TM Cytosolic 107 LG:201572.20:2001MAR30 931 948 forward 1 TM Transmembrane 107 LG:201572.20:2001MAR30 949 1215 forward 1 TM Non-Cytosolic 107 LG:201572.20:2001MAR30 1 14 forward 2 TM Non-Cytosolic 107 LG:201572.20:2001MAR30 15 37 forward 2 TM Transmembrane 107 LG:201572.20:2001MAR30 38 234 forward 2 TM Cytosolic 107 LG:201572.20:2001MAR30 235 257 forward 2 TM Transmembrane 107 LG:201572.20:2001MAR30 258 486 forward 2 TM Non-Cytosolic 107 LG:201572.20:2001MAR30 487 505 forward 2 TM Transmembrane 107 LG:201572.20:2001MAR30 506 589 forward 2 TM Cytosolic 107 LG:201572.20:2001MAR30 590 612 forward 2 TM Transmembrane 107 LG:201572.20:2001MAR30 613 703 forward 2 TM Non-Cytosolic 107 LG:201572.20:2001MAR30 704 726 forward 2 TM Transmembrane 107 LG:201572.20:2001MAR30 727 790 forward 2 TM Cytosolic 107 LG:201572.20:2001MAR30 791 813 forward 2 TM Transmembrane 107 LG:201572.20:2001MAR30 814 897 forward 2 TM Non-Cytosolic 107 LG:201572.20:2001MAR30 898 920 forward 2 TM Transmembrane 107 LG:201572.20:2001MAR30 921 938 forward 2 TM Cytosolic TABLE 2
SEQ D NO: Template ID Start Stop Frame Domain Type Topology
107 LG:201572.20:2001MAR30 939 961 forward 2 TM Transmembrane
107 LG:201572.20:2001MAR30 962 964 forward 2 TM Non-Cytosolic
107 LG:201572.20:2001MAR30 965 982 forward 2 TM Transmembrane
107 LG:201572.20:2001MAR30 983 1215 forward 2 TM Cytosolic
107 LG:201572.20:2001MAR30 1 14 forward 3 TM Non-Cytosolic
107 LG:201572.20:2001MAR30 15 37 forward 3 TM Transmembrane
107 LG:201572.20:2001MAR30 38 88 forward 3 TM Cytosolic
107 LG:201572.20:2001MAR30 89 111 forward 3 TM Transmembrane
107 LG:201572.20:2001MAR30 112 180 forward 3 TM Non-Cytosolic
107 LG:201572.20:2001MAR30 181 203 forward 3 TM Transmembrane
107 LG:201572.20:2001MAR30 204 348 forward 3 TM Cytosolic
107 LG:201572.20:2001MAR30 349 368 forward 3 TM Transmembrane
107 LG:201572.20:2001MAR30 369 494 forward 3 TM Non-Cytosolic
107 LG:201572.20:2001MAR30 495 517 forward 3 TM Transmembrane
107 LG:201572.20:2001MAR30 518 523 forward 3 TM Cytosolic
107 LG:201572.20:2001MAR30 524 542 forward 3 TM Transmembrane
107 LG:201572.20:2001MAR30 543 561 forward 3 TM Non-Cytosolic
107 LG:201572.20:2001MAR30 562 584 forward 3 TM Transmembrane
107 LG:201572.20:2001MAR30 585 590 forward 3 TM Cytosolic
107 LG:201572.20:2001MAR30 591 613 forward 3 TM Transmembrane
107 LG:201572.20:2001MAR30 614 808 forward 3 TM Non-Cytosolic
107 LG:201572.20:2001MAR30 809 826 forward 3 TM Transmembrane
107 LG:201572.20:2001MAR30 827 900 forward 3 TM Cytosolic
107 LG:201572.20:2001MAR30 901 918 forward 3 TM Transmembrane
107 LG:201572.20:2001MAR30 919 937 forward 3 TM Non-Cytosolic
107 LG:201572.20:2001MAR30 938 960 forward 3 TM Transmembrane
107 LG:201572.20:2001MAR30 961 1118 forward 3 TM Cytosolic 107 ■ LG:201572.20:2001MAR30 1119 1141 forward 3 TM Transmembrane
107 LG:201572.20:2001MAR30 1142 1214 forward 3 TM Non-Cytosolic
108 LG:201669.25:2001MAR30 1 20 forward 1 TM Cytosolic 108 LG:201669.25:2001MAR30 21 43 forward 1 TM Transmembrane 108 LG:201669.25:2001MAR30 44 1148 forward 1 TM Non-Cytosolic 108 LG:201669.25:2001MAR30 1 195 forward 3 TM Non-Cytosolic 108 LG:201669.25:2001MAR30 196 218 forward 3 TM Transmembrane 108 LG:201669.25:2001MAR30 219 244 forward 3 TM Cytosolic 108 LG:201669.25:2001MAR30 245 267 forward 3 TM Transmembrane 108 LG:201669.25:2001MAR30 268 271 forward 3 TM Non-Cytosolic 108 LG:201669.25:2001MAR30 272 294 forward 3 TM Transmembrane 108 LG:201669.25:2001MAR30 295 320 forward 3 TM Cytosolic 108 LG:201669.25:2001MAR30 321 338 forward 3 TM Transmembrane 108 LG:201669.25:2001MAR30 339 342 forward 3 TM Non-Cytosolic 108 LG:201669.25:2001MAR30 343 360 forward 3 TM Transmembrane 108 LG:201669.25:2001MAR30 361 372 forward 3 TM Cytosolic 108 LG:201669.25:2001MAR30 373 392 forward 3 TM Transmembrane 108 LG:201669.25:2001MAR30 393 436 forward 3 TM Non-Cytosolic 108 LG:201669.25:2001MAR30 437 454 forward 3 TM Transmembrane 108 LG:201669.25:2001MAR30 455 466 forward 3 TM Cytosolic 108 LG:201669.25:2001MAR30 467 489 forward 3 TM Transmembrane
108 LG:201669.25:2001MAR30 490 1147 forward 3 TM Non-Cytosolic
109 LG:208588.4:2001MAR30 1 35 forward 2 TM Cytosolic 109 LG:208588.4:2001MAR30 36 55 forward 2 TM Transmembrane
109 LG:208588.4:2001MAR30 56 93 forward 2 TM Non-Cytosolic
1 10 LG:210412.29:2001MAR30 1 33 forward 1 TM Cytosolic 110 LG:210412.29:2001MAR30 34 56 forward 1 TM Transmembrane TABLE 2
SEQ D NO Template ID Start Stop Frame Domain Type Topology
110 LG:210412.29:2001MAR30 57 373 forward 1 TM Non-Cytosolic
110 LG:210412.29:2001MAR30 1 31 forward 2 TM Non-Cytosolic
110 LG:210412.29:2001MAR30 32 54 forward 2 TM Transmembrane
110 LG:210412.29:2001MAR30 55 134 forward 2 TM Cytosolic
110 LG:210412.29:2001MAR30 135 157 forward 2 TM Transmembrane
110 LG:210412.29:20.01MAR30 158 373 forward 2 TM Non-Cytosolic
110 LG:210412.29:2001MAR30 1 31 forward 3 TM Cytosolic
110 LG:210412.29:2001MAR30 32 51 forward 3 TM Transmembrane
110 LG:210412.29:2001MAR30 52 54 forward 3 TM Non-Cytosolic
110 LG:210412.29:2001MAR30 55 77 forward 3 TM Transmembrane
110 LG:210412.29:2001MAR30 78 372 forward 3 TM Cytosolic
111 LG:215051.15:2001MAR30 1 67 forward 1 TM Non-Cytosolic
111 LG:215051.15:2001MAR30 68 85 forward 1 TM Transmembrane
111 LG:215051.15:2001MAR30 86 167 forward 1 TM Cytosolic
111 LG:215051.15:2001MAR30 168 190 forward 1 TM Transmembrane
111 LG:215051.15:2001MAR30 191 234 forward 1 TM Non-Cytosolic
111 LG:215051.15:2001MAR30 235 254 forward 1 TM Transmembrane
111 LG:215051.15:2001MAR30 255 292 forward 1 TM Cytosolic
111 LG:215051.15:2001MAR30 293 315 forward 1 TM Transmembrane
111 LG:215051.15:2001MAR30 316 329 forward 1 TM Non-Cytosolic
111 LG:215051.15:2001MAR30 330 352 forward 1 TM Transmembrane
111 LG:215051.15:2001MAR30 353 651 forward 1 TM Cytosolic
111 LG:215051.15:2001MAR30 652 674 forward 1 TM Transmembrane
111 LG:215051.15:2001MAR30 > 675 841 forward 1 TM Non-Cytosolic
111 LG:215051.15:2001MAR30 842 864 forward 1 TM Transmembrane n r LG:215051.15:2001MAR30 865 931 forward 1 TM Cytosolic
111 LG:215051.15:2001MAR30 1 167 forward 3 TM Non-Cytosolic
111 LG:215051.15:2001MAR30 ' 168 190 forward 3 TM Transmembrane
111 LG:215051.15:2001MAR30 191 201 forward 3 TM Cytosolic
111 LG:215051.15:2001MAR30 202 224 forward 3 TM Transmembrane
111 LG:215051.15:2001MAR30 225 846 forward 3 TM Non-Cytosolic
111 LG:215051.15:2001MAR30 847 869 forward 3 TM Transmembrane
1 1 1 LG:215051.15:2001MAR30 870 930 forward 3 TM Cytosolic
1 12 LG:215475.21:2001MAR30 1 153 forward 1 TM Cytosolic
112 LG:215475.21:2001MAR30 154 176 forward 1 TM Transmembrane
112 LG:215475.21 :2001MAR30 177 185 forward 1 TM Non-Cytosolic
112 LG:215475.21:2001MAR30 186 208 forward 1 TM Transmembrane
112 LG:215475.21:2001MAR30 209 293 forward 1 TM Cytosolic
112 LG:215475.21 :2001MAR30 294 316 forward 1 TM Transmembrane
112 LG:215475.21:2001MAR30 317 445 forward 1 TM Non-Cytosolic
1 12 LG:215475.21:2001MAR30 446 468 forward 1 TM Transmembrane
112 LG:215475.21:2001MAR30 469 474 forward 1 TM Cytosolic
1 12 LG:215475.21:2001MAR30 475 497 forward 1 TM Transmembrane
112 LG:215475.21:2001MAR30 498 506 forward 1 TM Non-Cytosolic
112 LG:215475.21:2001MAR30 507 529 forward 1 TM Transmembrane
1 12 . LG:215475.21:2001MAR30 530 580 forward 1 TM Cytosolic
112 LG:215475.21:2001MAR30 581 603 forward 1 TM Transmembrane
112 LG:215475.21:2001MAR30 604 622 forward 1 TM Non-Cytosolic
112 LG:215475.21:2001MAR30 623 641 forward 1 TM Transmembrane
1 12 LG:215475.21:2001MAR30 642 647 forward 1 TM Cytosolic
1 12 LG:215475.21:2001MAR30 648 670 forward 1 TM Transmembrane
1 12 LG:215475.21:2001MAR30 671 684 forward 1 TM Non-Cytosolic
1 12 LG:215475.21:2001MAR30 685 707 forward 1 TM Transmembrane
1 12 LG:215475.21:2001MAR30 708 734 forward 1 TM Cytosolic TABLE 2
SEQ D NO: Template ID Start Stop Frame Domain Type Topology
112 LG:215475.21:2001MAR30 735 757 forward 1 TM Transmembrane
112 LG:215475.21:2001MAR30 758 795 forward 1 TM Non-Cytosolic
111 LG:215475.21 :2001MAR30 796 818 forward 1 TM Transmembrane
112 LG:215475.21:2001MAR30 819 922 forward 1 TM Cytosolic
112 LG:215475.21:2001MAR30 923 945 forward 1 TM Transmembrane
112 LG:215475.21:2001MAR30 946 976 forward 1 TM Non-Cytosolic
112 LG:215475.21:2001MAR30 977 999 forward 1 TM Transmembrane
112 LG:215475.21:2001MAR30 1000 1128 forward 1 TM Cytosolic
112 LG:215475.21:2001MAR30 1 142 forward 2 TM Cytosolic
112 LG:215475.21:2001MAR30 143 165 forward 2 TM Transmembrane
112 LG:215475.21:2001MAR30 166 231 forward 2 TM Non-Cytosolic
112 LG:215475.21.-2001MAR30 232 251 forward 2 TM Transmembrane
.112 LG:215475.21:2001MAR30 252 334 forward 2 TM Cytosolic
112 LG:215475.21:2001MAR30 335 357 forward 2 TM Transmembrane
112 LG:215475.21 :2001MAR30 358 664 forward 2 TM Non-Cytosolic
112 LG:215475.21:2001MAR30 665 687 forward 2 TM Transmembrane
112 LG:215475.21 :2001MAR30 688 693 forward 2 TM Cytosolic
112 LG:215475.21:2001MAR30 694 716 forward 2 TM Transmembrane
112 LG:215475.21:2001MAR30 717 730 forward 2 TM Non-Cytosolic
112 LG:215475.21:2001MAR30 731 753 forward 2 TM Transmembrane
112 LG:215475.21:2001MAR30 754 799 forward 2 TM Cytosolic
112 LG:215475.21:2001MAR30 800 822 forward 2 TM Transmembrane
112 LG:215475.21:2001MAR30 823 971 forward 2 TM Non-Cytosolic
112 LG:215475.21 :2001MAR30 972 994 forward 2 TM Transmembrane
112 LG:215475.21:2001MAR30 995 1000 forward 2 ' TM Cytosolic
112 LG:215475.21:2001MAR30 1001 1023 forward 2 TM Transmembrane
112 LG:215475.21:2001MAR30 1024 1128 forward 2 TM Non-Cytosolic
112 LG:215475.21 :2001MAR30 1 589' forward 3 TM Non-Cytosolic
112 LG:215475.21:2001MAR30 590 612 forward 3 TM Transmembrane
112 LG:215475.21:2001MAR30 613 793 forward 3 TM Cytosolic
112 LG:215475.21:2001MAR30 794 816 forward 3 TM Transmembrane
112 LG:215475.21:2001MAR30 817 1127 forward 3 TM Non-Cytosolic
113 LG:224523.1 :2001MAR30 1 19 forward 1 TM Non-Cytosolic
113 LG:224523.1:2001MAR30 20 42 forward 1 TM Transmembrane
113 LG:224523.1:2001MAR30 43 116 forward 1 TM Cytosolic
113 LG:224523.1:2001MAR30 117 134 forward 1 TM Transmembrane
113 LG:224523.1:2001MAR30 135 148 forward 1 TM Non-Cytosolic
113 LG:224523.1:2001MAR30 149 171 forward 1 TM Transmembrane
113 LG:224523.1:2001MAR30 172 213 forward 1 TM Cytosolic
1 13 LG:224523.1:2001MAR30 1 116 forward 2 TM Cytosolic
113 LG:224523.1:2001MAR30 117 139 forward 2 TM Transmembrane
113 LG:224523.1:2001MAR30 140 148 forward 2 TM Non-Cytosolic
113 LG:224523.1:2001MAR30 149 171 forward 2 TM Transmembrane
1 13 LG-.224523.1 :2001MAR30 172 212 forward 2 TM Cytosolic
1 13 LG:224523.1 :2001MAR30 1 115 forward 3 TM Cytosolic
113 LG:224523.1:2001MAR30 116 135 forward 3 TM Transmembrane
113 LG:224523.1:2001MAR30 136 139 forward 3 TM Non-Cytosolic
113 LG:224523.1:2001MAR30 140 162 forward 3 TM Transmembrane
1 13 LG:224523.1:2001MAR30 163 212 forward 3 TM Cytosolic
1 14 LG:228186.1:2001MAR30 1 32 forward 1 TM Non-Cytosolic
114 LG:228186.1:2001MAR30 33 55 forward 1 TM Transmembrane
1 14 LG:228186.1:2001MAR30 56 105 forward 1 TM Cytosolic
1 14 LG:228186.1 :2001MAR30 106 125 forward 1 TM Transmembrane
1 14 LG:228186.1:2001MAR30 126 139 forward 1 TM Non-Cytosolic TABLE 2
SEQ D NO: Template ID Start Stop Frame Domain Type Topology
114 LG:228186.1 :2001MAR30 140 162 forward 1 TM Transmembrane
114 LG:228186.1 :2001MAR30 163 168 forward 1 TM Cytosolic
114 LG:228186.1 :2001MAR30 169 191 forward 1 TM Transmembrane
114 LG:228186.1 :2001MAR30 192 1292 forward 1 TM Non-Cytosolic
114 LG:228186.1:2001MAR30 1293 1315 forward 1 TM Transmembrane
114 LG:228186.1 :2001MAR30 1316 1569 forward 1 TM Cytosolic
114 LG:228186.1 :2001MAR30 1570 1592 forward 1 TM Transmembrane
114 LG:228186.1 :2001MAR30 1593 1723 forward 1 TM Non-Cytosolic
114 LG:228186.1. -2001MAR30 1 6 forward 2 TM Cytosolic
114 LG:228186.1 :2001MAR30 7 25 forward 2 TM Transmembrane
114 LG:228186.1:2001MAR30 26 39 forward 2 TM Non-Cytosolic
114 LG:228186.1:2001MAR30 40 62 forward 2 TM Transmembrane
114 LG:228186.1 :2001MAR30 63 74 forward 2 TM Cytosolic
114 LG:228186.1:2001MAR30 75 92 forward 2 TM Transmembrane
114 LG:228186.1 :2001MAR30 93 106 forward 2 TM Non-Cytosolic
114 LG:228186.1 :2001MAR30 107 126 forward 2 TM Transmembrane
114 LG:228186.1:2001MAR30 127 167 forward 2 TM Cytosolic
114 LG:228186.1:2001MAR30 168 190 forward 2 TM Transmembrane
114 LG:228186.1 :2001MAR30 191 1316 forward 2 TM Non-Cytosolic
114 LG:228186.1:2001MAR30 1317 1339 forward 2 TM Transmembrane
114 LG:228186.1 :2001 MAR30 1340 1449 forward 2 TM Cytosolic
114 LG:228186.1:2001MAR30 1450 1472 forward 2 TM Transmembrane
114 LG:228186.1:2001MAR30 1473 1723 forward 2 TM Non-Cytosolic
114 LG.-228186.1 :2001 MAR30 * . 1 102 forward 3 TM Non-Cytosolic
114 LG:228186.1 :2001MAR30 103 122 forward 3 TM Transmembrane
114 LG:228186.1:2001MAR30 . 123 134 forward 3 TM Cytosolic
114 LG:228186.1:2001MAR30 . 135 157 forward 3 TM Transmembrane
114 LG:228186.1:2001MAR30 158 467* forward 3 TM Non-Cytosolic
114 LG:228186.1:2001MAR30 468 485 forward 3 TM Transmembrane
114 LG:228186.1:2001MAR30 486 589 forward 3 TM Cytosolic
114 LG:228186.1:2001MAR30 590 612 forward 3 TM Transmembrane
114 LG:228186.1:2001MAR30 613 1448 forward 3 TM Non-Cytosolic
114 LG:228186.1:2001MAR30 1449 1471 forward 3 TM Transmembrane
114 LG:228186.1 :2001 MAR30 1472 1594 forward 3 TM Cytosolic
114 LG:228186.1:2001MAR30 1595 1617 forward 3 TM Transmembrane
114 LG:228186.1:2001MAR30 1618 1631 forward 3 TM Non-Cytosolic
114 LG:228186.1:2001MAR30 1632 1651 forward 3 TM Transmembrane
114 LG-.228186.1 :2001 MAR30 1652 1671 forward 3 TM Cytosolic
114 LG:228186.1:2001MAR30 1672 1694 forward 3 TM Transmembrane
114 LG:228186.1:2001MAR30 1695 1722 forward 3 TM Non-Cytosolic
115 LG:233138.2:2001MAR30 1 1464 forward 1 TM Non-Cytosolic
115 LG:233138.2:2001MAR30 1465 1487 forward 1 TM Transmembrane
115 LG:233138.2:2001MAR30 1488 1554 forward 1 TM Cytosolic
115 LG:233138.2:2001MAR30 1 434 forward 2 TM Non-Cytosolic
115 LG:233138.2:2001MAR30 435 457 forward 2 TM Transmembrane
115 LG:233138.2:2001MAR30 458 463 forward 2 TM Cytosolic
115 LG:233138.2:2001MAR30 464 486 forward 2 TM Transmembrane
115 LG:233138.2:2001MAR30 487 1554 forward 2 TM Non-Cytosolic
116 LG.-234811.10:2001MAR30 1 312 forward 1 TM Non-Cytosolic
116 LG:234811.10:2001MAR30 313 335 forward 1 TM Transmembrane
116 LG:234811.10:2001MAR30 336 350 forward 1 TM Cytosolic
116 LG:234811.10:2001 MAR30 1 326 forward 2 TM Non-Cytosolic
116 LG:234811.10:2001MAR30 327 346 forward 2 TM Transmembrane
116 LG:234811.10:2001 MAR30 347 349 forward 2 TM Cytosolic TABLE 2
SEQ D NO: Template ID Start Stop Frame Domain Type Topology
117 LG:236092.1 :2001MAR30 1 114 forward 1 TM Cytosolic
117 LG:236092.1:2001MAR30 115 137 forward 1 TM Transmembrane
117 LG:236092.1 :2001MAR30 138 290 forward 1 TM Non-Cytosolic
117 LG:236092.1 :2001 MAR30 291 313 forward 1 TM Transmembrane
117 LG:236092.1:2001MAR30 314 399 forward 1 TM Cytosolic
117 LG:236092.1:2001MAR30 400 422 forward 1 TM Transmembrane
117 LG:236092.1:2001MAR30 423 441 forward 1 TM Non-Cytosolic
117 LG:236092.1:2001MAR30 442 464 forward 1 TM Transmembrane
117 LG:236092.1:2001MAR30 465 534 forward 1 TM Cytosolic
117 LG:236092.1:2001MAR30 535 557 forward 1 TM Transmembrane
117 LG:236092.1:2001MAR30 558 728 forward 1 TM Non-Cytosolic
117 LG:236092.1:2001MAR30 1 54 forward 2 TM Non-Cytosolic
117 LG:236092.1 :2001 MAR30 55 74 forward 2 TM Transmembrane
117 LG:236092.1:2001MAR30 75 111 forward 2 TM Cytosolic
117 LG:236092.1:2001MAR30 112 134 forward 2 TM Transmembrane
117 LG:236092.1:2001MAR30 135 155 forward 2 TM Non-Cytosolic
117 LG:236092.1:2001MAR30 156 178 forward 2 TM Transmembrane
117 LG:236092.1:2001MAR30 179 416 forward 2 TM Cytosolic
117 LG:236092.1:2001MAR30 417 439 forward 2 TM Transmembrane
117 LG:236092.1:2001MAR30 440 448 forward 2 TM Non-Cytosolic
117 LG:236092.1:2001MAR30 449 471 forward 2 TM Transmembrane
117 LG:236092.1:2001MAR30 472 526 forward 2 TM Cytosolic
117 LG:236092.1:2001MAR30 527 549 forward 2 TM Transmembrane
117 LG:236092.1 :2001MAR30 550 591 forward 2 TM Non-Cytosolic
117 LG:236092.1 :2001MAR30 592 609 forward 2 TM Transmembrane
117 LG:236092.1:2001MAR30 610 728 forward 2 ■TM Cytosolic
117 LG:236092.1:2001MAR30 1 14 forward 3 TM Non-Cytosolic
117 LG:236092.1:2001MAR30 15 37 forward 3 'TM Transmembrane
117 LG:236092.1:2001MAR30 38 57 forward 3 TM Cytosolic
117 LG:236092.1:2001MAR30 58 80 forward 3 TM Transmembrane
117 LG:236092.1:2001MAR30 81 111 forward 3 TM Non-Cytosolic
117 LG:236092.1:2001MAR30 112 131 forward 3 TM Transmembrane
117 LG:236092.1:2001MAR30 132 143 forward 3 TM Cytosolic
117 LG:236092.1 :2001 M AR30 144 166 forward 3 TM Transmembrane
117 LG:236092.1:2001MAR30 167 453 forward 3 TM Non-Cytosolic
117 LG:236092.1:2001MAR30 454 476 forward 3 TM Transmembrane
117 LG:236092.1 :2001MAR30 477 551 forward 3 TM Cytosolic
117 LG:236092.1:2001MAR30 552 574 forward 3 TM Transmembrane
117 LG:236092.1:2001MAR30 575 593 forward 3 TM Non-Cytosolic
117 LG:236092.1:2001MAR30 594 616 forward 3 TM Transmembrane
117 LG:236092.1 :2001 MAR30 617 622 forward 3 TM Cytosolic
117 LG:236092.1:2001MAR30 623 642 forward 3 TM Transmembrane
117 LG:236092.1:2001MAR30 643 673 forward 3 TM Non-Cytosolic
117 LG:236092.1:2001MAR30 674 696 forward 3 TM Transmembrane
117 LG:236092.1:2001MAR30 697 727 forward 3 TM Cytosolic
118 LG:236098.12:2001MAR30 1 437 forward 1 TM Non-Cytosolic
118 LG:236098.12:2001MAR30 438 460 forward 1 TM Transmembrane
118 LG:236098.12:2001MAR30 461 504 forward 1 TM Cytosolic
118 LG:236098.12:2001MAR30 505 526 forward 1 TM Transmembrane
118 LG:236098.12:2001MAR30 527 1270 forward 1 TM Non-Cytosolic
118 LG:236098.12:2001MAR30 1271 1293 forward 1 TM Transmembrane
118 LG:236098.12:2001MAR30 1294 1346 forward 1 TM Cytosolic
118 LG:236098.12:2001MAR30 1347 1369 forward 1 TM Transmembrane
118 LG:236098.12:2001MAR30 1370 1378 forward 1 TM Non-Cytosolic TABI 3 2
SEQ D NO: Template ID Start Stop Frame Domain Type Topology
8 LG:236098.12:2001MAR30 1379 1401 forward 1 TM Transmembrane
8 LG:236098.12:2001MAR30 1402 1421 forward 1 TM Cytosolic
8 LG:236098.12:2001MAR30 1422 1444 forward 1 TM Transmembrane
8 LG:236098.12:2001MAR30 1445 1458 forward 1 TM Non-Cytosolic
8 LG:236098.12:2001MAR30 1459 1481 forward 1 TM Transmembrane
8 LG:236098.12:2001MAR30 1482 1494 forward 1 TM Cytosolic
8 LG:236098.12:2001MAR30 1 400 forward 2 TM Non-Cytosolic
8 LG:236098.12:2001MAR30 401 423 forward 2 TM Transmembrane
8 LG:236098.12:2001MAR30 424 442 forward 2 TM Cytosolic
8 LG:236098.12:2001MAR30 443 460 forward 2 TM Transmembrane
8 LG:236098.12:2001MAR30 461 469 forward 2 TM Non-Cytosolic
8 LG:236098.12:2001MAR30 470 487 forward 2 TM Transmembrane
8 LG:236098.12:2001MAR30 488 499 forward 2 TM Cytosolic
8 LG:236098.12:2001MAR30 500 522 forward 2 TM Transmembrane
8 LG:236098.12:2001MAR30 523 541 forward 2 TM Non-Cytosolic
8 LG:236098.12:2001MAR30 542 564 forward 2 TM Transmembrane
8 LG:236098.12:2001MAR30 565 584 forward 2 TM Cytosolic
8 LG:236098.12:2001MAR30 585 602 forward 2 TM Transmembrane
8 LG:236098.12:2001MAR30 603 616 forward 2 TM Non-Cytosolic
8 LG:236098.12:2001MAR30 617 639 forward 2 TM Transmembrane
8 LG:236098.12:2001MAR30 640 888 forward 2 TM Cytosolic
8 LG:236098.12:2001MAR30 889 911 forward 2 TM Transmembrane
8 LG:236098.12:2001MAR30 912 920 forward 2 TM Non-Cytosolic
8 LG:236098.12:2001MAR30 921 943 forward 2 TM Transmembrane
8 LG:236098.12:2001MAR30 944 963 forward 2 TM Cytosolic
8 LG:236098.12:2001MAR30 964 986 forward 2 TM Transmembrane
8 LG:236098.12:2001MAR30 987 1005 forward 2 TM Non-Cytosolic
8 LG:236098.12:2001MAR30 1006 1028 forward 2 TM Transmembrane
8 LG:236098.12:2001MAR30 1029 1169 forward 2 TM Cytosolic
8 LG:236098.12:2001MAR30 1170 1192 forward 2 TM Transmembrane
8 LG:236098.12:2001MAR30 1193 1494 forward 2 TM Non-Cytosolic
8 LG:236098.12:2001MAR30 1 433 forward 3 TM Non-Cytosolic
8 LG:236098.12:2001MAR30 434 456 forward 3 TM Transmembrane
8 LG:236098.12:2001MAR30 457 492 forward 3 TM Cytosolic
8 LG:236098.12:2001MAR30 493 515 forward 3 TM Transmembrane
8 LG:236098.12:2001MAR30 516 529 forward 3 TM Non-Cytosolic
8 LG:236098.12:2001MAR30 530 552 forward 3 TM Transmembrane
8 LG:236098.12:2001MAR30 553 615 forward 3 TM Cytosolic
8 LG:236098.12:2001MAR30 616 638 forward 3 TM Transmembrane
8 LG:236098.12:2001MAR30 639 759 forward 3 TM Non-Cytosolic
8 LG:236098.12:2001MAR30 760 782 forward 3 TM Transmembrane
8 LG:236098.12:2001MAR30 783 898 forward 3 TM Cytosolic
8 LG:236098.12:2001MAR30 899 921 forward 3 TM Transmembrane
8 LG:236098.12:2001MAR30 922 935 forward 3 TM Non-Cytosolic
8 LG:236098.12:2001MAR30 936 953 forward 3 TM Transmembrane
8 LG:236098.12:2001MAR30 954 957 forward 3 TM Cytosolic
8 LG:236098.12:2001MAR30 958 980 forward 3 TM Transmembrane
8 LG:236098.12:2001MAR30 981 1494 forward 3 TM Non-Cytosolic
9 LG:236697.15:2001MAR30 1 90 forward 1 TM Cytosolic 9 LG:236697.15:2001MAR30 91 113 forward 1 TM Transmembrane 9 LG:236697.15:2001MAR30 114 127 forward 1 TM Non-Cytosolic 9 LG:236697.15:2001MAR30 128 150 forward 1 TM Transmembrane 9 LG:236697.15:2001MAR30 151 219 forward 1 TM Cytosolic 9 LG:236697.15:2001MAR30 220 239 forward 1 TM Transmembrane TABLE 2
SEQ D NO: Template ID Start Stop Frame Domain Type Topology
119 LG:236697.15:2001MAR30 240 258 forward 1 TM Non-Cytosolic
119 LG:236697.15:2001MAR30 259 281 forward 1 TM Transmembrane
119 LG:236697.15:2001MAR30 282 287 forward 1 TM Cytosolic
119 LG:236697.15:2001MAR30 288 307 forward 1 TM Transmembrane
119 LG:236697.15:2001MAR30 308 316 forward 1 TM Non-Cytosolic
119 LG:236697.15:2001MAR30 317 336 forward 1 TM Transmembrane
119 LG:236697.15:2001MAR30 337 524 forward 1 TM Cytosolic
119 LG:236697.15:2001MAR30 525 547 forward 1 TM Transmembrane
119 LG:236697.15:2001MAR30 548 566 forward 1 TM Non-Cytosolic
119 LG:236697.15:2001MAR30 567 589 forward 1 TM Transmembrane
119 LG:236697.15:2001MAR30 590 608 forward 1 TM Cytosolic
119 LG:236697.15:2001MAR30 609 631 forward 1 TM Transmembrane
119 LG:236697.15:2001MAR30 632 673 forward 1 TM Non-Cytosolic
119 LG:236697.15:2001MAR30 1 80 forward 2 TM Non-Cytosolic
119 LG:236697.15:2001MAR30 81 100 forward 2 TM Transmembrane
119 LG:236697.15:2001MAR30 101 251 forward 2 TM Cytosolic
119 LG:236697.15:2001MAR30 252 271 forward 2 TM Transmembrane
119 LG:236697.15:2001MAR30 272 533 forward 2 TM Non-Cytosolic
119 LG:236697.15:2001MAR30 534 556 forward 2 TM Transmembrane
119 LG:236697.15:2001MAR30 557 568 forward 2 TM Cytosolic
119 LG:236697.15:2001MAR30 569 586 forward 2 TM Transmembrane
119 LG:236697.15:2001MAR30 587 600 forward 2 TM Non-Cytosolic
119 LG:236697.15:2001MAR30 601 620 forward 2 TM Transmembrane
119 LG:236697.15:2001MAR30 621 640 forward 2 TM Cytosolic
119 LG:236697.15:2001MAR30 641 663 forward 2 TM Transmembrane
119 LG:236697.15:2001MAR30 664 673 forward 2 TM Non-Cytosolic
119 LG:236697.15:2001MAR30 1 454 forward 3 TM Non-Cytosolic
119 LG:236697.15:2001MAR30 455 477 forward 3 TM Transmembrane
119 LG:236697.15:2001MAR30 478 526 forward 3 TM Cytosolic
119 LG:236697.15:2001MAR30 527 549 forward 3 TM Transmembrane
119 LG:236697.15:2001MAR30 550 563 forward 3 TM Non-Cytosolic
119 LG:236697.15:2001MAR30 564 583 forward 3 TM Transmembrane
119 LG:236697.15:2001MAR30 584 605 forward 3 TM Cytosolic
119 LG:236697.15:2001MAR30 606 628 forward 3 TM Transmembrane
119 LG:236697.15:2001MAR30 629 672 forward 3 TM Non-Cytosolic
120 LG:237503.21:2001MAR30 1 960 forward 1 TM Non-Cytosolic
120 LG:237503.21:2001MAR30 961 983 forward 1 TM Transmembrane
120 LG:237503.21:2001MAR30 984 989 forward 1 TM Cytosolic
120 LG:237503.21:2001MAR30 990 1007 forward 1 TM Transmembrane
120 LG:237503.21:2001MAR30 1008 1072 forward 1 TM Non-Cytosolic
120 LG:237503.21:2001MAR30 1073 1095 forward 1 TM Transmembrane
120 LG:237503.21:2001MAR30 1096 1218 forward 1 TM Cytosolic
120 LG:237503.21:2001MAR30 1 9 forward 2 TM Non-Cytosolic
120 LG:237503.21 :2001MAR30 10 32 forward 2 TM Transmembrane
120 LG:237503.21:2001MAR30 33 44 forward 2 TM Cytosolic
120 LG:237503.21:2001MAR30 45 64 forward 2 TM Transmembrane
120 LG:237503.21:2001MAR30 65 926 forward 2 TM Non-Cytosolic
120 LG:237503.21:2001MAR30 927 949 forward 2 TM Transmembrane
120 LG:237503.21:2001MAR30 950 961 forward 2 TM Cytosolic
120 LG:237503.21:2001MAR30 962 984 forward 2 TM Transmembrane
120 LG:237503.21:2001MAR30 985 1218 forward 2 TM Non-Cytosolic
120 LG:237503.21:2001MAR30 1 115 forward 3 TM Non-Cytosolic
120 LG:237503.21:2001MAR30 116 138 forward 3 TM Transmembrane
120 LG:237503.21 :2001MAR30 139 144 forward 3 TM Cytosolic 12C 1 TABLE 2
SEQ D NO Template ID Start Stop Frame Domain Type Topology
120 LG:237503.21:2001MAR30 145 167 forward 3 TM Transmembrane
120 LG:237503.21 :2001MAR30 168 232 forward 3 TM Non-Cytosolic
120 LG:237503.21:2001MAR30 233 255 forward 3 TM Transmembrane
120 LG:237503.21:2001MAR30 256 465 forward 3 TM Cytosolic
120 LG:237503.21 :2001MAR30 466 488 forward 3 TM Transmembrane
120 LG:237503.21:2001MAR30 489 960 forward 3 TM Non-Cytosolic
120 LG:237503.21:2001MAR30 961 983 forward 3 TM Transmembrane
120 LG:237503.21 :2001MAR30 984 989 forward 3 TM Cytosolic
120 LG:237503.21 :2001MAR30 990 1009 forward 3 TM Transmembrane
120 LG:237503.21 :2001MAR30 1010 1217 forward 3 TM Non-Cytosolic
121 LG:238023.7:2001MAR30 1 753 forward 1 TM Non-Cytosolic
121 LG:238023.7:2001MAR30 754 776 forward 1 TM Transmembrane
121 LG:238023.7:2001MAR30 777 843 forward 1 TM Cytosolic
121 LG:238023.7:2001MAR30 844 866 forward 1 TM Transmembrane
121 LG:238023.7:2001MAR30 867 893 forward 1 TM Non-Cytosolic
121 LG:238023.7:2001MAR30 1 19 forward 2 TM Non-Cytosolic
121 LG:238023.7:2001MAR30 20 42 forward 2 TM Transmembrane
121 LG:238023.7:2001MAR30 43 53 forward 2 TM Cytosolic
121 LG:238023J:2001MAR30 54 76 forward 2 TM Transmembrane
121 LG:238023.7:2001MAR30 77 85 forward 2 TM Non-Cytosolic
121 LG:238023.7:2001MAR30 86 108 forward 2 TM Transmembrane
121 LG:238023J:2001MAR30 109 128 forward 2 TM Cytosolic
121 LG:238023.7:2001MAR30 129 151 forward 2 TM Transmembrane
121 LG:238023.7:2001MAR30 152 597 forward 2 TM Non-Cytosolic
121 LG:238023.7:2001MAR30 598 620 forward 2 TM Transmembrane
121 LG:238023.7:2001MAR30 621 639 forward 2 TM Cytosolic
121 LG:238023.7:2001MAR30 640 659 forward 2 TM Transmembrane
121 LG:238023J:2001MAR30 660 859 forward 2 TM Non-Cytosolic
121 LG:238023.7:2001MAR30 860 882 forward 2 TM Transmembrane
121 LG:238023.7:2001MAR30 883 893 forward 2 TM Cytosolic
122 LG:238209.1:2001MAR30 1 1179 forward 2 TM Non-Cytosolic
122 LG:238209.1:2001MAR30 1180 1202 forward 2 TM Transmembrane
122 LG:238209.1 :2001MAR30 1203 1302 forward 2 TM Cytosolic
122 LG:238209.1:2001MAR30 1 ll ll forward 3 TM Non-Cytosolic
122 LG:238209.1:2001MAR30 1112 1134 forward 3 TM Transmembrane
122 LG:238209.1:2001MAR30 1135 1154 forward 3 TM Cytosolic
122 LG:238209.1:2001MAR30 1155 1172 forward 3 TM Transmembrane
122 LG:238209.1:2001MAR30 1173 1186 forward 3 TM Non-Cytosolic
122 LG:238209.1:2001MAR30 1187 1209 forward 3 TM Transmembrane
122 LG :238209.1 :2001MAR30 1210 1215 forward 3 TM Cytosolic
122 LG:238209.1:2001MAR30 1216 1235 forward 3 TM Transmembrane
122 LG:238209.1:2001MAR30 1236 1268 forward 3 TM Non-Cytosolic
122 LG:238209.1:2001MAR30 1269 1291 forward 3 TM Transmembrane
122 LG:238209.1:2001MAR30 1292 1302 forward 3 TM Cytosolic
123 LG:238456.10:2001MAR30 1 6 forward 3 TM Cytosolic
123 LG:238456.10:2001MAR30 7 29 forward 3 TM Transmembrane
123 LG:238456.10:2001MAR30 30 431 forward 3 TM Non-Cytosolic
124 LG:239245.1:2001MAR30 1 158 forward 1 TM Cytosolic
124 LG:239245.1:2001MAR30 159 181 forward 1 TM Transmembrane
124 LG:239245.1:2001MAR30 182 782 forward 1 TM Non-Cytosolic
124 LG:239245.1:2001MAR30 783 805 forward 1 TM Transmembrane
124 LG:239245.1:2001MAR30 806 842 forward 1 TM Cytosolic
124 LG:239245.1:2001MAR30 1 162 forward 2 TM Non-Cytosolic
124 LG:239245.1:2001MAR30 163 185 forward 2 TM Transmembrane TABLE 2
SEQ D NO: Template ID Start Stop Frame Domain Type Topology
124 LG:239245.1:2001MAR30 186 479 forward 2 TM Cytosolic
124 LG:239245.1 :2001MAR30 480 499 forward 2 TM Transmembrane
124 LG:239245.1:2001MAR30 500 777 forward 2 TM Non-Cytosolic
124 LG:239245.1:2001MAR30 778 800 forward 2 TM Transmembrane
124 LG:239245.1:2001MAR30 801 842 forward 2 * TM Cytosolic
124 LG:239245.1:2001MAR30 1 159 forward 3 TM Cytosolic
124 LG:239245.1:2001MAR30 160 182 forward 3 TM Transmembrane
124 LG:239245.1:2001MAR30 183 475 forward 3 TM Non-Cytosolic
124 LG:239245.1:2001MAR30 476 498 forward 3 TM Transmembrane
124 LG:239245.1:2001MAR30 499 732 forward 3 TM Cytosolic
124 LG:239245.1:2001MAR30 733 752 forward 3 TM Transmembrane
124 LG:239245.1:2001MAR30 753 773 forward 3 TM Non-Cytosolic
124 LG:239245.1:2001MAR30 774 796 forward 3 TM Transmembrane
124 LG:239245.1:2001MAR30 797 842 forward 3 TM Cytosolic
125 LG:239579.8:2001MAR30 1 45 forward 1 TM Non-Cytosolic 125 LG:239579.8:2001MAR30 46 63 forward 1 TM Transmembrane 125 LG:239579.8:2001MAR30 64 210 forward 1 TM Cytosolic 125 LG:239579.8:2001MAR30 211 233 forward 1 TM Transmembrane 125 LG:239579.8:2001MAR30 234 418 forward 1 TM Non-Cytosolic 125 LG:239579.8:2001MAR30 419 441 forward 1 TM Transmembrane 125 LG:239579.8:2001MAR30 442 469 forward 1 TM Cytosolic 125 LG:239579.8:2001MAR30 1 224 forward 2 TM Non-Cytosolic 125 LG:239579.8:2001MAR30 225 247 forward 2 TM Transmembrane 125 LG:239579.8:2001MAR30 248 420 forward 2 TM Cytosolic
, 125 LG:239579.8:2001MAR30 421 443 forward 2 TM ' Transmembrane
125 LG:239579.8:2001MAR30 444 469 forward 2 TM Non-Cytosolic . 125 LG:239579.8:2001MAR30 1 222 forward 3 TM Non-Cytosolic
125 LG:239579.8:2001MAR30 223 245 forward 3 TM Transmembrane
. 125 LG:239579.8:2001MAR30 246 264 forward 3 TM Cytosolic
125 LG:239579.8:2001MAR30 265 287 forward 3 TM Transmembrane
125 LG:239579.8:2001MAR30 288 301 forward 3 TM Non-Cytosolic
125 LG:239579.8:2001MAR30 302 324 forward 3 TM Transmembrane
125 LG:239579.8:2001MAR30 325 418 forward 3 TM Cytosolic
125 LG:239579.8:2001MAR30 419 441 forward 3 TM Transmembrane
125 LG:239579.8:2001MAR30 442 468 forward 3 TM Non-Cytosolic
126 LG:239601.22:2001MAR30 1 105 forward 1 TM Cytosolic 126 LG:239601.22:2001MAR30 106 128 forward 1 TM Transmembrane 126 LG:239601.22:2001MAR30 129 243 forward 1 TM Non-Cytosolic 126 LG:239601.22:2001MAR30 244 266 forward 1 TM Transmembrane 126 LG:239601.22:2001MAR30 267 314 forward 1 TM Cytosolic 126 LG:239601.22:2001MAR30 315 337 forward 1 TM Transmembrane 126 LG:239601.22:2001MAR30 338 346 forward 1 TM Non-Cytosolic 126 LG:239601.22:2001MAR30 347 369 forward 1 TM Transmembrane 126 LG:239601.22:2001MAR30 370 518 forward 1 TM Cytosolic 126 LG:239601.22:2001MAR30 519 541 forward 1 TM Transmembrane 126 LG:239601.22:2001MAR30 542 934 forward 1 TM Non-Cytosolic 126 LG:239601.22:2001MAR30 1 114 forward 2 TM Non-Cytosolic 126 LG:239601.22:2001MAR30 115 137 forward 2 TM Transmembrane 126 LG:239601.22:2001MAR30 138 175 forward 2 TM Cytosolic 126 LG:239601.22:2001MAR30 176 198 forward 2 TM Transmembrane 126 LG:239601.22:2001MAR30 199 248 forward 2 TM Non-Cytosolic 126 LG:239601.22:2001MAR30 249 271 forward 2 TM Transmembrane 126 LG:239601.22:2001MAR30 272 291 forward 2 TM Cytosolic 126 LG:239601.22:2001MAR30 292 314 forward 2 TM Transmembrane TABLE 2
SEQ D NO: Template ID Start Stop Frame Domain Type Topology
126 LG:239601.22:2001MAR30 315 318 forward 2 TM Non-Cytosolic
126 LG:239601.22:2001MAR30 319 341 forward 2 TM Transmembrane
126 LG:239601.22:2001MAR30 342 352 forward 2 TM Cytosolic
126 LG:239601.22:2001MAR30 353 375 forward 2 TM Transmembrane
126 LG:239601.22:2001MAR30 376 933 forward 2 TM Non-Cytosolic
126 LG:239601.22:2001MAR30 1 25 forward 3 TM Non-Cytosolic
126 LG:239601.22:2001MAR30 26 45 forward 3 TM Transmembrane
126 LG:239601.22:2001MAR30 46 109 forward 3 TM Cytosolic
126 LG:239601.22:2001MAR30 110 129 forward 3 TM Transmembrane
126 LG:239601.22:2001MAR30 130 182 forward 3 TM Non-Cytosolic
126 LG:239601.22:2001MAR30 183 205 forward 3 TM Transmembrane
126 LG:239601.22:2001MAR30 206 231 forward 3 TM Cytosolic
126 LG:239601.22:2001MAR30 232 254 forward 3 TM Transmembrane
126 LG:239601.22:2001MAR30 255 268 forward 3 TM Non-Cytosolic
126 LG:239601.22:2001MAR30 269 291 forward 3 TM Transmembrane
126 LG:239601.22:2001MAR30 292 303 forward 3 TM Cytosolic
126 LG:239601.22:2001MAR30 304 326 forward 3 TM Transmembrane
126 LG:239601.22:2001MAR30 327 933 forward 3 TM Non-Cytosolic
127 LG:240121.1:2001MAR30 1 409 forward 1 TM Non-Cytosolic
127 LG:240121.1:2001MAR30 410 432 forward 1 TM Transmembrane
127 LG:240121.1:2001MAR30 433 723 forward 1 TM Cytosolic
127 LG:240121.1:2001MAR30 724 742 forward 1 TM Transmembrane
127 LG:240121.1:2001MAR30 743 756 forward 1 TM Non-Cytosolic
127 LG:240121.1:2001MAR30 757 774 forward 1 TM Transmembrane
127 LG:240121.1:2001MAR30 775 793 forward 1 TM Cytosolic
127 LG:240121.1:2001MAR30 794 816 forward 1 TM Transmembrane
127 LG:240121.1:2001MAR30 817 820 forward 1 TM Non-Cytosolic
127 LG:240121.1:2001MAR30 821 843 forward 1 TM Transmembrane
127 LG:240121.1:2001MAR30 844 898 forward 1 TM Cytosolic
127 LG:240121.1:2001MAR30 1 409 forward 2 TM Non-Cytosolic
127 LG:240121.1:2001MAR30 410 432 forward 2 TM Transmembrane
127 LG:240121.1:2001MAR30 433 729 forward 2 TM Cytosolic
127 LG:240121.1:2001MAR30 730 747 forward 2 TM Transmembrane
127 LG:240121.1:2001MAR30 748 756 forward 2 TM Non-Cytosolic
127 LG:240121.1:2001MAR30 757 774 forward 2 TM Transmembrane
127 LG:240121.1:2001MAR30 775 785 forward 2 TM Cytosolic
127 LG:240121.1:2001MAR30 786 808 forward 2 TM Transmembrane
127 LG:240121.1:2001MAR30 809 827 forward 2 TM Non-Cytosolic
127 LG:240121.1:2001MAR30 828 850 forward 2 TM Transmembrane
127 LG:240121.1:2001MAR30 851 898 forward 2 TM Cytosolic
127 LG:240121.1:2001MAR30 1 405 forward 3 TM Non-Cytosolic
127 LG:240121.1:2001MAR30 406 428 forward 3 TM Transmembrane
127 LG:240121.1:2001MAR30 429 785 forward 3 TM Cytosolic
127 LG:240121.1:2001MAR30 786 808 forward 3 TM Transmembrane
127 LG:240121.1:2001MAR30 809 827 forward 3 TM Non-Cytosolic
127 LG:240121.1:2001MAR30 828 850 forward 3 TM Transmembrane
127 LG:240121.1:2001MAR30 851 897 forward 3 TM Cytosolic
128 LG:241110.2:2001MAR30 1 1348 forward 2 TM Non-Cytosolic
128 LG:241110.2:2001MAR30 1349 1371 forward 2 TM Transmembrane
128 LG:241110.2:2001MAR30 1372 1377 forward 2 TM Cytosolic
128 LG:241110.2:2001MAR30 1378 1400 forward 2 TM Transmembrane
128 LG:241110.2:2001MAR30 1401 2121 forward 2 TM Non-Cytosolic
129 LG:244948.4:2001MAR30 1 309 forward 1 TM Cytosolic
129 LG:244948.4:2001MAR30 310 332 forward 1 TM Transmembrane TABLE 2
SEQ D NO: Template ID Start Stop Frame Domain Type Topology
129 LG:244948.4:2001MAR30 333 336 forward 1 TM Non-Cytosolic
130 LG:245378.6:2001MAR30 1 294 forward 1 TM Cytosolic 130 LG:245378.6:2001MAR30 295 312 forward 1 TM Transmembrane 130 LG:245378.6:2001MAR30 313 321 forward 1 TM Non-Cytosolic 130 LG:245378.6:2001MAR30 322 344 forward 1 TM Transmembrane 130 LG:245378.6:2001MAR30 345 390 forward 1 TM Cytosolic 130 LG:245378.6:2001MAR30 391 413 forward 1 TM Transmembrane 130 LG:245378.6:2001MAR30 414 464 forward 1 TM Non-Cytosolic 130 LG:245378.6:2001MAR30 465 487 forward 1 TM Transmembrane 130 LG:245378.6:2001MAR30 488 574 forward 1 TM Cytosolic 130 LG:245378.6:2001MAR30 575 597 forward 1 TM Transmembrane 130 LG:245378.6:2001MAR30 598 606 forward 1 TM Non-Cytosolic 130 LG:245378.6:2001MAR30 607 629 forward 1 TM Transmembrane 130 LG:245378.6:2001MAR30 630 805 forward 1 TM Cytosolic 130 LG:245378.6:2001MAR30 806 828 forward 1 TM Transmembrane 130 LG:245378.6:2001MAR30 829 842 forward 1 TM Non-Cytosolic 130 LG:245378.6:2001MAR30 843 862 forward 1 TM Transmembrane 130 LG:245378.6:2001MAR30 863 886 forward 1 TM Cytosolic 130 LG:245378.6:2001MAR30 887 909 forward 1 TM Transmembrane 130 LG:245378.6:2001MAR30 910 955 forward 1 TM Non-Cytosolic 130 LG:245378.6:2001MAR30 956 978 forward 1 TM Transmembrane 130 LG:245378.6:2001MAR30 979 989 forward 1 TM Cytosolic 130 LG:245378.6:2001MAR30 990 1009 forward 1 TM Transmembrane 130 LG:245378.6:2001MAR30 1010 1013 forward 1 TM Non-Cytosolic 130 LG:245378.6:2001MAR30 1014 1036 forward 1 TM Transmembrane 130 LG:245378.6:2001MAR30 1037 1070 forward 1 TM Cytosolic 130 LG:245378.6:2001MAR30 1071 1090 forward 1 TM Transmembrane 130 LG:245378.6:2001MAR30 1091 1179 forward 1 TM Non-Cytosolic 130 LG:245378.6:2001MAR30 1180 1202 forward 1 TM Transmembrane 130 LG:245378.6:2001MAR30 1203 1347 forward 1 TM Cytosolic 130 LG:245378.6:2001MAR30 1348 1370 forward 1 TM Transmembrane 130 LG:245378.6:2001MAR30 1371 1412 forward 1 TM Non-Cytosolic 130 LG:245378.6:2001MAR30 1413 1430 forward 1 TM Transmembrane 130 LG:245378.6:2001MAR30 1431 1509 forward 1 TM Cytosolic 130 LG:245378.6:2001MAR30 1510 1532 forward 1 TM Transmembrane 130 LG:245378.6:2001MAR30 1533 1583 forward 1 TM Non-Cytosolic 130 LG:245378.6:2001MAR30 1584 1606 forward 1 TM Transmembrane 130 LG:245378.6:2001MAR30 1607 1683 forward 1 TM Cytosolic 130 LG:245378.6:2001MAR30 1684 1706 forward 1 TM Transmembrane 130 LG:245378.6:2001MAR30 1707 1725 forward 1 TM Non-Cytosolic 130 LG:245378.6:2001MAR30 1726 1748 forward 1 TM Transmembrane 130 LG:245378.6:2001MAR30 1749 1760 forward 1 TM Cytosolic 130 LG:245378.6:2001MAR30 1761 1783 forward 1 TM Transmembrane 130 LG:245378.6:2001MAR30 1784 1796 forward 1 TM Non-Cytosolic 130 LG:245378.6:2001MAR30 1 389 forward 2 TM Non-Cytosolic 130 LG:245378.6:2001MAR30 390 412 forward 2 TM Transmembrane 130 LG:245378.6:2001MAR30 413 473 forward 2 TM Cytosolic 130 LG:245378.6:2001MAR30 474 493 forward 2 TM Transmembrane 130 LG:245378.6:2001MAR30 494 597 forward 2 TM Non-Cytosolic 130 LG:245378.6:2001MAR30 598 620 forward 2 TM Transmembrane 130 LG:245378.6:2001MAR30 621 690 forward 2 TM Cytosolic 130 LG:245378.6:2001MAR30 691 713 forward 2 TM Transmembrane 130 LG:245378.6:2001MAR30 714 839 forward 2 TM Non-Cytosolic 130 LG:245378.6:2001MAR30 840 862 forward 2 TM Transmembrane TABLE 2
SEQ D NO: Template ID Start Stop Frame Domain Type Topology
130 LG:245378.6:2001MAR30 863 874 forward 2 TM Cytosolic
130 LG:245378.6:2001MAR30 875 897 forward 2 TM Transmembrane
130 LG:245378.6:2001MAR30 898 916 forward 2 TM Non-Cytosolic
130 LG:245378.6:2001MAR30 917 939 forward 2 TM Transmembrane
130 LG:245378.6:2001MAR30 940 958 forward 2 TM Cytosolic
130 LG:245378.6:2001MAR30 959 981 forward 2 TM Transmembrane
130 LG:245378.6:2001MAR30 982 1086 forward 2 TM Non-Cytosolic
130 LG:245378.6:2001MAR30 1087 1109 forward 2 TM Transmembrane
130 LG:245378.6:2001MAR30 1110 1257 forward 2 TM Cytosolic
130 LG:245378.6:2001MAR30 1258 1280 forward 2 TM Transmembrane
130 LG:245378.6:2001MAR30 1281 1440 forward 2 TM Non-Cytosolic
130 LG:245378.6:2001MAR30 1441 1463 forward 2 TM Transmembrane
130 LG:245378.6:2001MAR30 1464 1483 forward 2 TM Cytosolic
130 LG:245378.6:2001MAR30 1484 1506 forward 2 TM Transmembrane
130 LG:245378.6:2001MAR30 1507 1580 forward 2 TM Non-Cytosolic
130 LG:245378.6:2001MAR30 1581 1598 forward 2 TM Transmembrane
130 LG:245378.6:2001MAR30 1599 1641 forward 2 TM Cytosolic
130 LG:245378.6:2001MAR30 1642 1664 forward 2 TM Transmembrane
130 LG:245378.6:2001MAR30 1665 1683 forward 2 TM Non-Cytosolic
130 LG:245378.6:2001MAR30 1684 1706 forward 2 TM Transmembrane
130 LG:245378.6:2001MAR30 1707 1722 forward 2 TM Cytosolic
130 LG:245378.6:2001MAR30 1723 1745 forward 2 TM Transmembrane
130 LG:245378.6:2001MAR30 1746 1754 forward 2 TM Non-Cytosolic
130 LG:245378.6:2001MAR30 1755 1777 forward 2 TM Transmembrane
130 LG:245378.6:2001MAR30 1778 1796 forward 2 TM Cytosolic
130 LG:245378.6:2001MAR30 1 78 forward 3 TM Non-Cytosolic
130 LG:245378.6:2001MAR30 79 101 forward 3 TM Transmembrane
130 LG:245378.6:2001MAR30 102 392 forward 3 TM Cytosolic
130 LG:245378.6:2001MAR30 393 415 forward 3 TM Transmembrane
130 LG:245378.6:2001MAR30 416 468 forward 3 TM Non-Cytosolic
130 LG:245378.6:2001MAR30 469 486 forward 3 TM Transmembrane
130 LG:245378.6:2001MAR30 487 569 forward 3 TM Cytosolic
130 LG:245378.6:2001MAR30 570 592 forward 3 TM Transmembrane
130 LG:245378.6:2001MAR30 593 615 forward 3 TM Non-Cytosolic
130 LG:245378.6:2001MAR30 616 638 forward 3 TM Transmembrane
130 LG:245378.6:2001MAR30 639 691 forward 3 TM Cytosolic
130 LG:245378.6:2001MAR30 692 714 forward 3 TM Transmembrane
130 LG:245378.6:2001MAR30 715 728 forward 3 TM Non-Cytosolic
130 LG:245378.6:2001MAR30 729 748 forward 3 TM Transmembrane
130 LG:245378.6:2001MAR30 749 772 forward 3 TM Cytosolic
130 LG:245378.6:2001MAR30 773 795 forward 3 TM Transmembrane
130 LG:245378.6:2001MAR30 796 914 forward 3 TM Non-Cytosolic
130 LG:245378.6:2001MAR30 915 937 forward 3 TM Transmembrane
130 LG:245378.6:2001MAR30 938 957 forward 3 TM Cytosolic
130 LG:245378.6:2001MAR30 958 980 forward 3 TM Transmembrane
130 LG:245378.6:2001MAR30 981 1021 forward 3 TM Non-Cytosolic
130 LG:245378.6:2001MAR30 1022 1044 forward 3 TM Transmembrane
130 LG:245378.6:2001MAR30 1045 1064 forward 3 TM Cytosolic
130 LG:245378.6:2001MAR30 1065 1087 forward 3 TM Transmembrane
130 LG:245378.6:2001MAR30 1088 1096 forward 3 TM Non-Cytosolic
130 LG:245378.6:2001MAR30 1097 1114 forward 3 TM Transmembrane
130 LG:245378.6:2001MAR30 1115 1143 forward 3 TM Cytosolic
130 LG:245378.6:2001MAR30 1144 1166 forward 3 TM Transmembrane
130 LG:245378.6:2001MAR30 1167 1185 forward 3 TM Non-Cytosolic TABLE 2
SEQ D NO: Template ID Start Stop Frame Domain Type Topology
130 LG:245378.6:2001MAR30 1186 1208 forward 3 TM Transmembrane
130 LG:245378.6:2001MAR30 1209 1368 forward 3 TM Cytosolic
130 LG:245378.6:2001MAR30 1369 1391 forward 3 TM Transmembrane
130 LG:245378.6:2001MAR30 1392 1405 forward 3 TM Non-Cytosolic
130 LG:245378.6:2001MAR30 1406 1428 forward 3 TM Transmembrane
130 LG:245378.6:2001MAR30 1429 1440 forward 3 TM Cytosolic
130 LG:245378.6:2001MAR30 1441 1463 forward 3 TM Transmembrane
130 LG:245378.6:2001MAR30 1464 1477 forward 3 TM Non-Cytosolic
130 LG:245378.6:2001MAR30 1478 1500 forward 3 TM Transmembrane
130 LG:245378.6:2001MAR30 1501 1512 forward 3 TM Cytosolic
130 LG:245378.6:2001MAR30 1513 1532 forward 3 TM Transmembrane
130 LG:245378.6:2001MAR30 1533 1572 forward 3 TM Non-Cytosolic
130 LG:245378.6:2001MAR30 1573 1590 forward 3 TM Transmembrane
130 LG:245378.6:2001MAR30 1591 1752 forward 3 TM Cytosolic
130 LG:245378.6:2001MAR30 1753 1775 forward 3 TM Transmembrane
130 LG:245378.6:2001MAR30 1776 1795 forward 3 TM Non-Cytosolic
131 LG:248203.9:2001MAR30 1 197 forward 2 TM Non-Cytosolic
131 LG:248203.9:2001MAR30 198 220 forward 2 TM Transmembrane
131 LG:248203.9:2001MAR30 221 240 forward 2 TM Cytosolic
131 LG:248203.9:2001MAR30 241 263 forward 2 TM Transmembrane
131 LG:248203.9:2001MAR30 264 656 forward 2 TM Non-Cytosolic
131 LG:248203.9:2001MAR30 1 242 forward 3 TM Non-Cytosolic
131 LG:248203.9:2001MAR30 243 265 forward 3 TM Transmembrane
131 LG:248203.9:2001MAR30 266 280 forward 3 TM Cytosolic
131 LG:248203.9:2001MAR30 281 303 forward 3 TM Transmembrane
131 LG:248203.9:2001MAR30 304 656 forward 3 TM Non-Cytosolic
132 LG:249247.1:2001MAR30 1 489 forward 1 TM Non-Cytosolic
132 LG:249247.1:2001MAR30 490 512 forward 1 TM Transmembrane
132 LG:249247.1:2001MAR30 513 579 forward 1 TM Cytosolic
132 LG:249247.1:2001MAR30 580 602 forward 1 TM Transmembrane
132 LG:249247.1 :2001MAR30 603 769 forward 1 TM Non-Cytosolic
132 LG:249247.1:2001MAR30 1 480 forward 3 TM Non-Cytosolic
132 LG:249247.1:2001MAR30 481 503 forward 3 TM Transmembrane
132 LG:249247.1 :2001MAR30 504 532 forward 3 TM Cytosolic
132 LG:249247.1 :2001MAR30 533 555 forward 3 TM Transmembrane
132 LG:249247.1:2001MAR30 556 768 forward 3 TM Non-Cytosolic
133 LG:267153.16:2001MAR30 1 1106 forward 3 TM Non-Cytosolic
133 LG:267153.16:2001MAR30 1107 1129 forward 3 TM Transmembrane
133 LG:267153.16:2001MAR30 1130 1135 forward 3 TM Cytosolic
133 LG:267153.16:2001MAR30 1136 1158 forward 3 TM Transmembrane
133 LG:267153.16:2001MAR30 1159 1190 forward 3 TM Non-Cytosolic
134 LG :291759.5 :2001MAR30 1 16 forward 2 TM Cytosolic
134 LG:291759.5:2001MAR30 17 39 forward 2 TM Transmembrane
134 LG:291759.5:2001MAR30 40 406 forward 2 TM Non-Cytosolic
134 LG:291759.5:2001MAR30 1 4 forward 3 TM Cytosolic
134 LG:291759.5:2001MAR30 5 34 forward 3 TM Transmembrane
134 LG:291759.5:2001MAR30 35 405 forward 3 TM Non-Cytosolic
135 LG:298102.1:2001MAR30 1 52 forward 2 TM Cytosolic
135 LG:298102.1:2001MAR30 53 70 forward 2 TM Transmembrane
135 LG:298102.1:2001MAR30 71 276 forward 2 TM Non-Cytosolic
135 LG:298102.1:2001MAR30 1 9 forward 3 TM Non-Cytosolic
135 LG:298102.1:2001MAR30 10 28 forward 3 TM Transmembrane
135 LG:298102.1:2001MAR30 29 40 forward 3 TM Cytosolic
135 LG:298102.1:2001MAR30 41 63 forward 3 TM Transmembrane TABLE 2
SEQ D NO: Template ID Start Stop Frame Domain Type Topology
135 LG:298102.1:2001MAR30 64 276 forward 3 TM Non-Cytosolic
136 LG:308891.1 :2001MAR30 1 14 forward 2 TM Non-Cytosolic
136 LG:308891.1:2001MAR30 15 37 forward 2 TM Transmembrane
136 LG:308891.1:2001MAR30 38 191 forward 2 TM Cytosolic
136 LG.-308891.1.-2001MAR30 192 214 forward 2 TM Transmembrane
136 LG:308891.1:2001MAR30 215 219 forward 2 TM Non-Cytosolic
137 LG:312668.4:2001MAR30 1 270 forward 3 TM Non-Cytosolic
137 LG:312668.4:2001MAR30 271 293 forward 3 TM Transmembrane
137 LG:312668.4:2001MAR30 294 408 forward 3 TM Cytosolic
137 LG:312668.4:2001MAR30 409 431 forward 3 TM Transmembrane
137 LG:312668.4:2001MAR30 432 625 forward 3 TM Non-Cytosolic
138 LG:331642.6:2001MAR30 1 19 forward 1 TM Cytosolic
138 LG:331642.6:2001MAR30 20 42 forward 1 TM Transmembrane
138 LG:331642.6:2001MAR30 43 630 forward 1 TM Non-Cytosolic
138 LG:331642.6:2001MAR30 1 12 forward 3 TM Cytosolic
138 LG:331642.6:2001MAR30 13 35 forward 3 TM Transmembrane
138 LG:331642.6:2001MAR30 36 65 forward 3 TM Non-Cytosolic
138 LG:331642.6:2001MAR30 66 85 forward 3 TM Transmembrane
138 LG:331642.6:2001MAR30 86 266 forward 3 TM Cytosolic
138 LG:331642.6:2001MAR30 267 289 forward 3 TM Transmembrane
138 LG:331642.6:2001MAR30 290 629 forward 3 TM Non-Cytosolic
139 LG:331851.12:2001MAR30 1 904 forward 2 TM Non-Cytosolic
139 LG:331851.12:2001MAR30 905 927 forward 2 TM Transmembrane
139 LG:331851.12:2001MAR30 928 946 forward 2 TM Cytosolic
139 LG:331851.12:2001MAR30 947 969 forward 2 TM Transmembrane
139 LG:331851.12:2001MAR30 970 2183 forward 2 TM Non-Cytosolic
139 LG:331851.12:2001MAR30 2184 2206 forward 2 TM Transmembrane
139 LG:331851.12:2001MAR30 2207 2218 forward 2 TM Cytosolic
139 LG:331851.12:2001MAR30 1 , 833 forward 3 TM Non-Cytosolic
139 LG:331851.12:2001MAR30 834 856 forward 3 TM Transmembrane
139 LG:331851.12:2001MAR30 857 875 forward 3 TM Cytosolic
139 LG:331851.12:2001MAR30 876 898 forward 3 TM Transmembrane
139 LG:331851.12:2001MAR30 899 902 forward 3 TM Non-Cytosolic
139 LG:331851.12:2001MAR30 903 925 forward 3 TM Transmembrane
139 LG:331851.12:2001MAR30 926 992 forward 3 TM Cytosolic
139 LG:331851.12:2001MAR30 993 1015 forward 3 TM Transmembrane
139 LG:331851.12:2001MAR30 1016 2217 forward 3 TM Non-Cytosolic
140 LG:332414.5:2001MAR30 1 482 forward 2 TM Non-Cytosolic
140 LG:332414.5:2001MAR30 483 505 forward 2 TM Transmembrane
140 LG:332414.5:2001MAR30 506 521 forward 2 TM Cytosolic
140 LG:332414.5:2001MAR30 1 111 forward 3 TM Non-Cytosolic
140 LG:332414.5:2001MAR30 112 134 forward 3 TM Transmembrane
140 LG:332414.5:2001MAR30 135 218 forward 3 TM Cytosolic
140 LG:332414.5:2001MAR30 219 236 forward 3 TM Transmembrane
140 LG:332414.5:2001MAR30 237 250 forward 3 TM Non-Cytosolic
140 LG:332414.5:2001MAR30 251 273 forward 3 TM Transmembrane
140 LG:332414.5:2001MAR30 274 480 forward 3 TM Cytosolic
140 LG:332414.5:2001MAR30 481 503 forward 3 TM Transmembrane
140 LG:332414.5:2001MAR30 504 521 forward 3 TM Non-Cytosolic
141 LG:332730.12:2001MAR30 1 516 forward 1 TM Non-Cytosolic
141 LG:332730.12:2001MAR30 517 539 forward 1 TM Transmembrane
141 LG:332730.12:2001MAR30 540 684 forward 1 TM Cytosolic
141 LG:332730.12:2001MAR30 685 707 forward 1 TM Transmembrane
141 LG:332730.12:2001MAR30 708 710 forward 1 TM Non-Cytosolic TABI B 2
SEQ D NO: Template ID Start Stop Frame Domain Type Topology
141 LG:332730.12:2001MAR30 711 733 forward 1 TM Transmembrane
141 LG:332730.12:2001MAR30 734 739 forward 1 TM Cytosolic
141 LG:332730.12:2001MAR30 740 762 forward 1 TM Transmembrane
141 LG:332730.12:2001MAR30 763 781 forward 1 TM Non-Cytosolic
141 LG:332730.12:2001MAR30 782 804 forward 1 * TM Transmembrane
141 LG:332730.12:2001MAR30 805 1011 forward 1 TM Cytosolic
141 LG:332730.12:2001MAR30 1012 1034 forward 1 TM Transmembrane
141 LG:332730.12:2001MAR30 1035 1043 forward 1 TM Non-Cytosolic
141 LG:332730.12:2001MAR30 1044 1063 forward 1 TM Transmembrane
141 LG:332730.12:2001MAR30 1064 1083 forward 1 TM Cytosolic
141 LG:332730.12:2001MAR30 1084 1106 forward 1 TM Transmembrane
141 LG:332730.12:2001MAR30 1107 1302 forward 1 TM Non-Cytosolic
141 LG:332730.12:2001MAR30 1 526 forward 2 TM Non-Cytosolic
141 LG:332730.12:2001MAR30 527 549 forward 2 TM Transmembrane
141 LG:332730.12:2001MAR30 550 739 forward 2 TM Cytosolic
141 LG:332730.12:2001MAR30 740 762 forward 2 TM Transmembrane
141 LG:332730.12:2001MAR30 763 781 forward 2 TM Non-Cytosolic
141 LG:332730.12:2001MAR30 782 804 forward 2 TM Transmembrane
141 LG:332730.12:2001MAR30 805 891 forward 2 TM Cytosolic
141 LG:332730.12:2001MAR30 892 914 forward 2 TM Transmembrane
141 LG:332730.12:2001MAR30 915 946 forward 2 TM Non-Cytosolic
141 LG:332730.12:2001MAR30 947 969 forward 2 TM Transmembrane
141 LG:332730.12:2001MAR30 970 1001 forward 2 TM Cytosolic
141 LG:332730.12:2001MAR30 1002 1024 forward 2 TM Transmembrane
141 LG:332730.12:2001MAR30 1025 1028 forward 2 TM Non-Cytosolic
141 LG:332730.12:2001MAR30 1029 1048 forward 2 TM Transmembrane
141 LG:332730.12:2001MAR30 1049 1079 forward 2 TM Cytosolic
141 LG:332730.12:2001MAR30 1080 1102 forward 2 TM Transmembrane
141 LG:332730.12:2001MAR30 1103 1301 forward 2 TM Non-Cytosolic
141 LG:332730.12:2001MAR30 1 514 forward 3 TM Non-Cytosolic
141 LG:332730.12:2001MAR30 515 537 forward 3 TM Transmembrane
141 LG:332730.12:2001MAR30 538 738 forward 3 TM Cytosolic
141 LG:332730.12:2001MAR30 739 761 forward 3 TM Transmembrane
141 LG:332730.12:2001MAR30 762 780 forward 3 TM Non-Cytosolic
141 LG:332730.12:2001MAR30 781 803 forward 3 TM Transmembrane
141 LG:332730.12:2001MAR30 804 1094 forward 3 TM Cytosolic
141 LG:332730.12:2001MAR30 1095 11 17 forward 3 TM Transmembrane
141 LG:332730.12:2001MAR30 1 1 18 1 181 forward 3 TM Non-Cytosolic
141 LG:332730.12:2001MAR30 1182 1201 forward 3 TM Transmembrane
141 LG:332730.12:2001MAR30 1202 1212 forward 3 TM Cytosolic
141 LG:332730.12:2001MAR30 1213 1235 forward 3 TM Transmembrane
141 LG:332730.12:2001MAR30 1236 1269 forward 3 TM Non-Cytosolic
141 LG:332730.12:2001MAR30 1270 1287 forward 3 TM Transmembrane
141 LG:332730.12:2001MAR30 1288 1301 forward 3 TM Cytosolic
142 LG:333062.22:2001MAR30 1 14 forward 1 TM Non-Cytosolic 142 LG:333062.22:2001MAR30 15 37 forward 1 TM Transmembrane 142 LG:333062.22:2001MAR30 38 133 forward 1 TM Cytosolic 142 LG:333062.22:2001MAR30 134 151 forward 1 TM Transmembrane 142 LG:333062.22:2001MAR30 152 160 forward 1 TM Non-Cytosolic 142 LG:333062.22:2001MAR30 161 180 forward 1 TM Transmembrane 142 LG:333062.22:2001MAR30 181 229 forward 1 TM Cytosolic 142 LG:333062.22:2001MAR30 1 100 forward 2 TM Non-Cytosolic 142 LG:333062.22:2001MAR30 101 120 forward 2 TM Transmembrane 142 LG:333062.22:2001MAR30 121 204 forward 2 TM Cytosolic TABLE 2
SEQ D NO Template ID Start Stop Frame Domain Type Topology
142 LG:333062.22:2001MAR30 205 227 forward 2 TM Transmembrane
142 LG:333062.22:2001MAR30 228 229 forward 2 TM Non-Cytosolic
143 LG:335705.2:2001MAR30 1 1114 forward 1 TM Non-Cytosolic
143 LG:335705.2:2001MAR30 1115 1137 forward 1 TM Transmembrane
143 LG:335705.2:2001MAR30 1138 1233 forward 1 TM Cytosolic
143 LG:335705.2:2001MAR30 1234 1256 forward 1 TM Transmembrane
143 LG:335705.2:2001MAR30 1257 1747 forward 1 TM Non-Cytosolic
143 LG:335705.2:2001MAR30 1748 1770 forward 1 TM Transmembrane
143 LG:335705.2:2001MAR30 1771 1790 forward 1 TM Cytosolic
143 LG:335705.2:2001MAR30 1 1249 forward 2 TM Non-Cytosolic
143 LG:335705.2:2001MAR30 1250 1272 forward 2 TM Transmembrane
143 LG:335705.2:2001MAR30 1273 1283 forward 2 TM Cytosolic
143 LG:335705.2:2001MAR30 1284 1306 forward 2 TM Transmembrane
143 LG:335705.2:2001MAR30 1307 1315 forward 2 TM Non-Cytosolic
143 LG:335705.2:2001MAR30 1316 1338 forward 2 TM Transmembrane
143 LG:335705.2:2001MAR30 1339 1496 forward 2 TM Cytosolic
143 LG:335705.2:2001MAR30 1497 1514 forward 2 TM Transmembrane
143 LG:335705.2:2001MAR30 1515 1730 forward 2 TM Non-Cytosolic
143 LG:335705.2:2001MAR30 1731 1753 forward 2 TM Transmembrane
143 LG:335705.2:2001MAR30 1754 1790 forward 2 TM Cytosolic
143 LG:335705.2:2001MAR30 1 1248 forward 3 TM Non-Cytosolic
143 LG:335705.2:2001MAR30 1249 1271 forward 3 TM Transmembrane
143 LG:335705.2:2001MAR30 1272 1283 forward 3 TM Cytosolic
143 LG:335705.2:2001MAR30 1284 1306 forward 3 TM Transmembrane
143 LG:335705.2:2001MAR30 1307 1315 forward 3 TM Non-Cytosolic
143 LG:3357O5.2:2001MAR30 1316 1335 forward 3 TM Transmembrane
143 LG:335705.2:2001MAR30 1336 1346 forward 3 TM Cytosolic
143 LG:335705.2:2001MAR30 1347 1366 forward 3 TM Transmembrane
143 LG:335705.2:2001MAR30 1367 1789 forward 3 TM Non-Cytosolic
144 LG:337930.16:2001MAR30 1 12 forward 2 TM Cytosolic
144 LG:337930.16:2001MAR30 13 35 forward 2 TM Transmembrane
144 LG:33793O.16:2001MAR3O 36 645 forward 2 TM Non-Cytosolic
145 LG:346481.15:2001MAR30 1 106 forward 2 TM Non-Cytosolic
. 145 LG.-346481.15:2001MAR30 107 129 forward 2 TM Transmembrane
145 LG:346481.15:2001MAR30 130 161 forward 2 TM Cytosolic
146 LG:349164.1 2001MAR30 1 48 forward 1 TM Cytosolic
146 LG:349164.1 2001MAR30 49 67 forward 1 TM Transmembrane
146 LG:349164.1 2001MAR30 68 76 forward 1 TM Non-Cytosolic
146 LG:349164.1 2001MAR30 77 99 forward 1 TM Transmembrane
146 LG:349164.1 2001MAR30 100 123 forward 1 TM Cytosolic
146 LG:349164.1 2001MAR30 124 146 forward 1 TM Transmembrane
146 LG:349164.1 2001MAR30 147 738 forward 1 TM Non-Cytosolic
146 LG:349164.1 2001MAR30 739 761 forward 1 TM Transmembrane
146 LG:349164.1 2001MAR30 762 807 forward 1 TM Cytosolic
146 LG-.349164.1 2001MAR30 808 830 forward 1 TM Transmembrane
146 LG:349164.1 2001MAR30 , 831 844 forward 1 TM Non-Cytosolic
146 LG:349164.1 2001MAR30 845 867 forward 1 TM Transmembrane
146 LG:349164.1 2001MAR30 868 943 forward 1 TM Cytosolic
146 LG:349164.1 2001MAR30 944 966 forward 1 TM Transmembrane
146 LG:349164.1 2001MAR30 967 973 forward 1 TM Non-Cytosolic
146 LG:349164.1 2001MAR30 1 45 forward 2 TM Cytosolic
146 LG:349164.1 2001MAR30 46 68 forward 2 TM Transmembrane
146 LG:349164.1 2001MAR30 69 124 forward 2 TM Non-Cytosolic
146 LG:349164.1 2001MAR30 125 144 forward 2 TM Transmembrane TABLE 2
SEQ D NO: Template ID Start Stop Frame Domain Type Topology
146 LG:349164.1:2001MAR30 145 150 forward 2 TM Cytosolic
146 LG:349164.1:2001MAR30 151 173 forward 2 TM Transmembrane
146 LG:349164.1 :2001MAR30 174 187 forward 2 TM Non-Cytosolic
146 LG:349164.1:2001MAR30 188 210 forward 2 TM Transmembrane
146 LG:349164.1:2001MAR30 211 389 forward 2 TM Cytosolic
146 LG:349164.1:2001MAR30 390 408 forward 2 TM Transmembrane
146 LG:349164.1 :2001MAR30 409 422 forward 2 TM Non-Cytosolic
146 LG:349164.1 :2001MAR30 423 442 forward 2 TM Transmembrane
146 LG:349164.1:2001MAR30 443 478 forward 2 TM Cytosolic
146 LG:349164.1:2001MAR30 479 496 forward 2 TM Transmembrane
146 LG:349164.1:2001MAR30 497 660 forward 2 TM Non-Cytosolic
146 LG:349164.1:2001MAR30 661 683 forward 2 TM Transmembrane
146 LG:349164.1:2001MAR30 684 695 forward 2 TM Cytosolic
146 LG:349164.1:2001MAR30 696 715 forward 2 TM Transmembrane
146 LG:349164.1:2001MAR30 716 734 forward 2 TM Non-Cytosolic
146 LG:349164.1:2001MAR30 735 757 forward 2 TM Transmembrane
146 LG:349164.1:2001MAR30 758 776 forward 2 TM Cytosolic
146 LG:349164.1:2001MAR30 777 799 forward 2 TM Transmembrane
146 LG:349164.1:2001MAR30 800 824 forward 2 TM Non-Cytosolic
146 LG:349164.1:2001MAR30 825 847 forward 2 TM Transmembrane
146 LG:349164.1 :2001MAR30 848 853 forward 2 TM Cytosolic
146 LG:349164.1 :2001MAR30 854 873 forward 2 TM Transmembrane
146 LG:349164.1:2001MAR30 874 876 forward 2 TM Non-Cytosolic
146 LG:349164.1:2001MAR30 877 899 forward 2 TM Transmembrane
146 LG:349164.1:2001MAR30 900 932 forward 2 TM Cytosolic
146 LG:349164.1:2001MAR30 933 955 forward 2 , TM Transmembrane
146 LG:349164.1:2001MAR30 956 973 forward 2 TM Non-Cytosolic
146 LG:349164.1:2001MAR30 ' 1 663 forward 3 TM Non-Cytosolic
146 LG:349164.1:2001MAR30 664 681 forward 3 TM Transmembrane
146 LG:349164.1:2001MAR30 682 692 forward 3 TM Cytosolic
146 LG:349164.1:2001MAR30 693 715 forward 3 TM Transmembrane
146 LG:349164.1:2001MAR30 716 741 forward 3 TM Non-Cytosolic
146 LG:349164.1:2001MAR30 742 764 forward 3 TM Transmembrane
146 LG:349164.1:2001MAR30 765 776 forward 3 TM Cytosolic
146 LG:349164.1:2001MAR30 111 799 forward 3 TM Transmembrane
146 LG:349164.1 :2001MAR30 800 818 forward 3 TM Non-Cytosolic
146 LG:349164.1:2001MAR30 819 841 forward 3 TM Transmembrane
146 LG:349164.1:2001MAR30 842 852 forward 3 TM Cytosolic
146 LG:349164.1:2001MAR30 853 875 forward 3 TM Transmembrane
146 LG:349164.1:2001MAR30 876 878 forward 3 TM Non-Cytosolic
146 LG:349164.1:2001MAR30 879 898 forward 3 TM Transmembrane
146 LG:349164.1:2001MAR30 899 909 forward 3 TM Cytosolic
146 LG:349164.1:2001MAR30 910 932 forward 3 TM Transmembrane
146 LG:349164.1:2001MAR30 933 941 forward 3 TM Non-Cytosolic
146 LG:349164.1:2001MAR30 942 964 forward 3 TM Transmembrane
146 LG:349164.1:2001MAR30 965 973 forward 3 TM Cytosolic
147 LG:350957.5:2001MAR30 1 71 forward 1 TM Non-Cytosolic
147 LG:350957.5:2001MAR30 72 94 forward 1 TM Transmembrane
147 LG:350957.5:2001MAR30 95 106 forward 1 TM Cytosolic
147 LG:350957.5:2001MAR30 107 129 forward 1 TM Transmembrane
147 LG:350957.5:2001MAR30 130 151 forward 1 TM Non-Cytosolic
147 LG:350957.5:2001MAR30 152 174 forward 1 TM Transmembrane
147 LG:350957.5:2001MAR30 175 238 forward 1 TM Cytosolic
147 LG:350957.5:2001MAR30 239 261 forward 1 TM Transmembrane TABLE 2
SEQ D NO: Template ID Start Stop Frame Domain Type Topology
147 LG:350957.5:2001MAR30 262 286 forward 1 TM Non-Cytosolic
147 LG:350957.5:2001MAR30 287 309 forward 1 TM Transmembrane
147 LG:350957.5:2001MAR30 310 379 forward 1 TM Cytosolic
147 LG.-350957.5 :2001 MAR30 1 18 forward 2 TM Cytosolic
147 LG:350957.5 :2001MAR30 19 41 forward 2 TM Transmembrane
147 LG:350957.5:2001MAR30 42 71 forward 2 TM Non-Cytosolic
147 LG:350957.5:2001MAR30 72 94 forward 2 TM Transmembrane
147 LG:350957.5:2001MAR30 95 151 forward 2 TM Cytosolic
147 LG:350957.5:2001MAR30 152 174 forward 2 TM Transmembrane
147 ' LG:350957.5:2001MAR30 175 212 forward 2 TM Non-Cytosolic
147 LG:350957.5:2001MAR30 213 232 forward 2 TM Transmembrane
147 LG:350957.5:2001MAR30 233 244 forward 2 TM Cytosolic
147 LG:350957.5:2001MAR30 245 262 forward 2 TM Transmembrane
147 LG:350957.5:2001MAR30 263 271 forward 2 TM Non-Cytosolic
147 LG:350957.5:2001MAR30 272 294 forward 2 TM Transmembrane
147 LG:350957.5:2001MAR30 295 298 forward 2 TM Cytosolic
147 LG:350957.5:2001MAR30 299 321 forward 2 TM Transmembrane
147 LG:350957.5:2001MAR30 322 379 forward 2 TM Non-Cytosolic
148 LG:383512.8:2001MAR30 1 833 forward 2 TM Non-Cytosolic
148 LG:383512.8:2001MAR30 834 856 forward 2 TM Transmembrane
148 LG:383512.8:2001MAR30 857 876 forward 2 TM Cytosolic
148 LG:383512.8:2001MAR30 877 899 forward 2 TM Transmembrane
148 LG:383512.8:2001MAR30 900 1052 forward 2 TM Non-Cytosolic
149 LG:401163.10:2001MAR30 1 1167 forward 1 TM Non-Cytosolic
149 LG:401163.10:2001MAR30 1168 1190 forward 1 TM Transmembrane
149 LG:401163.10:2001MAR30 1191 1270 forward 1 TM Cytosolic
149 LG:401163.10:2001MAR30 1271 1290 forward 1 TM Transmembrane
149 ' LG:401163.10:2001MAR30 1291 1492 forward 1 TM Non-Cytosolic
150 ' LG:402133.1 :2001MAR30 1 6 forward 3 TM Cytosolic
150 LG:402133.1:2001MAR30 7 26 forward 3 TM Transmembrane
150 LG:402133.1:2001MAR30 27 68 forward 3 TM Non-Cytosolic
150 LG:402133.1:2001MAR30 69 91 forward 3 TM Transmembrane
150 LG:402133.1:2001MAR30 92 476 forward 3 TM Cytosolic
150 LG:402133.1 :2001MAR30 477 499 forward 3' TM Transmembrane
150 LG:402133.1:2001MAR30 500 543 forward 3 TM Non-Cytosolic
151 LG:405820.1 :2001MAR30 1 242 forward 1 TM Non-Cytosolic
151 LG:405820.1:2001MAR30 243 262 forward 1 TM Transmembrane
151 LG:405820.1 :2001MAR30 263 303 forward 1 TM Cytosolic
152 LG :405846.1 :2001MAR30 1 297 forward 1 TM Non-Cytosolic
152 LG:405846.1 :2001MAR30 298 320 forward 1 TM Transmembrane
152 LG:405846.1:2001MAR30 321 356 forward 1 TM Cytosolic
153 LG:407401.2:2001MAR30 1 542 forward 2 TM Non-Cytosolic
153 LG:407401.2:2001MAR30 543 565 forward 2 TM Transmembrane
153 LG:407401.2:2001MAR30 566 573 forward 2 TM Cytosolic
153 LG:407401.2:2001MAR30 574 591 forward 2 TM Transmembrane
153 LG:407401.2:2001MAR30 592 888 forward 2 TM Non-Cytosolic
154 LG:408448.10:2001MAR30 1 636 forward 1 TM Non-Cytosolic
154 LG:408448.10:2001MAR30 637 659 forward 1 TM Transmembrane
154 LG:408448.10:2001MAR30 660 716 forward 1 TM Cytosolic
154 LG:408448.10:2001MAR30 1 281 forward 2 TM Non-Cytosolic
154 LG:408448.10:2001MAR30 282 304 forward 2 TM Transmembrane
154 LG:408448.10:2001MAR30 305 324 forward 2 TM Cytosolic
154 LG:408448.10:2001MAR30 325 347 forward 2 TM Transmembrane
154 LG :408448.10:2001MAR30 348 715 forward 2 TM Non-Cytosolic TABLE 2
SEQ D NO Template ID Start Stop Frame Domain Type Topology
154 LG:408448.10:2001MAR30 1 281 forward 3 TM Non-Cytosolic
154 LG:408448.10:2001MAR30 282 304 forward 3 TM Transmembrane
154 LG:408448.10:2001MAR30 305 324 forward 3 TM Cytosolic
154 LG:408448.10:2001MAR30 325 347 forward 3 TM Transmembrane
154 LG:408448.10:2001MAR30 348 715 forward 3 TM Non-Cytosolic
155 LG:408854.13:2001MAR30 1 128 forward 1 TM Non-Cytosolic
155 LG:408854.13:2001MAR30 129 148 forward 1 TM Transmembrane
155 LG:408854.13:2001MAR30 149 191 forward 1 TM Cytosolic
155 LG:408854.13:2001MAR30 192 214 forward 1 TM Transmembrane
155 LG:408854.13 :2001MAR30 215 218 forward 1 TM Non-Cytosolic
155 LG:408854.13:2001MAR30 219 238 forward 1 TM Transmembrane
155 LG:408854.13:2001MAR30 239 242 forward 1 TM Cytosolic
155 LG:408854.13:2001MAR30 243 265 forward 1 TM Transmembrane
155 LG:408854.13:2001MAR30 266 305 forward 1 TM Non-Cytosolic
155 LG:408854.13:2001MAR30 306 328 forward 1 TM Transmembrane
155 LG:408854.13:2001MAR30 329 544 forward 1 TM Cytosolic
156 LG.411150.14:2001MAR30 1 676 forward 1 TM Non-Cytosolic
156 LG:411150.14:2001MAR30 677 699 forward 1 TM Transmembrane
156 LG:411150.14-.2001MAR30 700 822 forward 1 TM Cytosolic
156 LG:411150.14:2001MAR30 1 676 forward 2 TM Non-Cytosolic
156 LG:411150.14:2001MAR30 677 699 forward 2 TM Transmembrane
156 LG:411150.14:2001MAR30 700 822 forward 2 TM Cytosolic
156 LG:411150.14:2001MAR30 1 99 forward 3 TM Cytosolic
156 LG:411150.14:2001MAR30 100 117 forward 3 TM Transmembrane
156 LG:411150.14:2001MAR30 118 699 forward 3 TM Non-Cytosolic
156 LG:411150.14:2001MAR30 700 722 forward 3 TM Transmembrane
156 LG:411150.14:2001MAR30 723 733 forward 3 TM Cytosolic
156 LG:411150.14:2001MAR30 734 751 forward 3 TM Transmembrane
156 LG:411150.14:2001MAR30 752 754 forward 3 TM Non-Cytosolic
156 LG:411150.14:2001MAR30 755 777 forward 3 TM Transmembrane
156 LG:411150.14:2001MAR30 778 821 forward 3 TM Cytosolic
157 LG:411466.1 2001MAR30 1 111 forward 1 TM Non-Cytosolic
157 LG:411466.1 2001MAR30 112 134 forward 1 TM Transmembrane
157 LG:411466.1 2001MAR30 135 146 forward 1 TM Cytosolic
157 LG.411466.1 2001MAR30 147 169 forward 1 TM Transmembrane
157 LG:411466.1 2001MAR30 170 188 forward 1 TM Non-Cytosolic
157 LG:411466.1 2001MAR30 189 211 forward 1 TM Transmembrane
157 LG.411466.1 2001MAR30 212 217 forward 1 TM Cytosolic
157 LG:411466.1 2001MAR30 218 240 forward 1 TM Transmembrane
157 LG:411466.1 2001MAR30 241 254 forward 1 TM Non-Cytosolic
157 LG:411466.1 2001MAR30 255 274 forward 1 TM Transmembrane
157 LG:411466.1 2001MAR30 275 333 forward 1 TM Cytosolic
157 LG:411466.1 2001MAR30 334 351 forward 1 TM Transmembrane
157 LG:411466.1 2001MAR30 352 404 forward 1 TM Non-Cytosolic
157 LG:411466.1 2001MAR30 405 427 forward 1 TM Transmembrane
157 LG.411466.1 2001MAR30 428 525 forward 1 TM Cytosolic
157 LG:411466.1 2001MAR30 526 548 forward 1 TM Transmembrane
157 LG:411466.1 2001MAR30 549 918 forward 1 TM Non-Cytosolic
157 LG:411466.1 2001MAR30 1 70 forward 3 TM Cytosolic
157 LG:411466.1 2001MAR30 71 93 forward 3 TM Transmembrane
157 LG:411466.1 2001MAR30 94 110 forward 3 TM Non-Cytosolic
157 LG.411466.1 2001MAR30 11 1 133 forward 3 TM Transmembrane
157 LG:411466.1 2001MAR30 134 145 forward 3 TM Cytosolic
157 LG:411466.1 2001MAR30 146 168 forward 3 TM Transmembrane TABLE 2
SEQ D NO Template ID Start Stop Frame Domain Type Topology
157 LG:411466.1:2001MAR30 169 202 forward 3 TM Non-Cytosolic
157 LG:411466.1:2001MAR30 203 225 forward 3 TM Transmembrane
157 LG:411466.1:2001MAR30 226 231 forward 3 TM Cytosolic
157 LG:411466.1 :2001MAR30 232 254 forward 3 TM Transmembrane
157 LG:411466.1:2001MAR30 255 918 forward 3 TM Non-Cytosolic
158 LG:413969.68:2001MAR30 1 741 forward 2 TM Non-Cytosolic
158 LG:413969.68:2001MAR30 742 764 forward 2 TM Transmembrane
158 LG:413969.68:2001MAR30 765 770 forward 2 TM Cytosolic
158 LG:413969.68:2001MAR30 771 793 forward 2 TM Transmembrane
158 LG:413969.68:2001MAR30 794 807 forward 2 TM Non-Cytosolic
158 LG:413969.68:2001MAR30 808 830. forward 2 TM Transmembrane
158 LG:413969.68:2001MAR30 831 842 forward 2 TM Cytosolic
158 LG:413969.68:2001MAR30 843 865 forward 2 TM Transmembrane
158 LG:413969.68:2001MAR30 866 911 forward 2 TM Non-Cytosolic
159 LG:419641.35:2001MAR30 1 347 forward 1 TM Non-Cytosolic
159 LG:419641.35:2001MAR30 348 370 forward 1 TM Transmembrane
159 LG:419641.35:2001MAR30 371 450 forward 1 TM Cytosolic
159 LG:419641.35:2001MAR30 1 20 forward 2 TM Cytosolic
159 LG:419641.35:2001MAR30 21 40 forward 2 TM Transmembrane
159 LG:419641.35:2001MAR30 41 450 forward 2 TM Non-Cytosolic
159 LG:419641.35:2001MAR30 1 352 forward 3 TM Non-Cytosolic
159 LG:419641.35:2001MAR30 353 370 forward 3 TM Transmembrane
159 LG:419641.35:2001MAR30 371 382 forward 3 TM Cytosolic
159 LG:419641.35:2001MAR30 383 405 forward 3 TM Transmembrane
159 LG:419641.35:2001MAR30 406 424 forward 3 TM Non-Cytosolic
159 LG:419641.35:2001MAR30 425 447 forward 3 TM Transmembrane
159 LG:419641.35:2001MAR30 448 450 forward 3 TM Cytosolic
160 LG:428206.7:2001MAR30 1 367 forward 2 TM Non-Cytosolic
160 LG:428206.7:2001MAR30 368 385 forward 2 TM Transmembrane
160 LG:428206.7:2001MAR30 386 512 forward 2 TM Cytosolic
161 LG:430059.1 :2001MAR30 1 72 forward 1 TM Non-Cytosolic
161 LG:430059.1:2001MAR30 73 95 forward 1 TM Transmembrane
161 LG:430059.1 :2001MAR30 96 106 forward 1 TM Cytosolic
161 LG:430059.1:2001MAR30 107 129 forward 1 TM Transmembrane
161 LG:430059.1 :2001MAR30 130 143 forward 1 TM Non-Cytosolic
161 LG:430059.1 :2001MAR30 144 163 forward 1 TM Transmembrane
161 LG.-430059.1 :2001MAR30 164 583 forward 1 TM Cytosolic
161 LG:430059.1:2001MAR30 584 606 forward 1 TM Transmembrane
161 LG:430059.1:2001MAR30 607 653 forward 1 TM Non-Cytosolic
161 LG:430059.1 :2001MAR30 654 676 forward 1 TM Transmembrane
161 LG:430059.1:2001MAR30 677 783 forward 1 TM Cytosolic
161 LG:430059.1 :2001MAR30 784 806 forward 1 TM Transmembrane
161 LG:430059.1:2001MAR30 807 869 forward 1 TM Non-Cytosolic
161 LG:430059.1 :2001MAR30 870 889 forward 1 TM Transmembrane
161 LG:430059.1:2001MAR30 890 1017 forward 1 TM Cytosolic
161 LG:430059.1 :2001MAR30 1 20 forward 2 TM Cytosolic
161 LG:430059.1:2001MAR30 21 43 forward 2 TM Transmembrane
161 LG:430059.1 :2001MAR30 44 76 forward 2 TM Non-Cytosolic
161 LG:430059.1 :2001MAR30 77 96 forward 2 TM Transmembrane
161 LG:430059.1:2001MAR30 97 102 forward 2 TM Cytosolic
161 LG:430059.1 :2001MAR30 103 122 forward 2 TM Transmembrane
161 LG:430059.1:2001MAR30 123 595 forward 2 TM Non-Cytosolic
161 LG:430059.1:2001MAR30 596 618 forward 2 TM Transmembrane
161 LG:430059.1:2001MAR30 619 645 forward 2 TM Cytosolic TABLE 2
) D NO Template ID Start Stop Frame Domain Type Topology
161 LG:430059.1:2001MAR30 646 668 forward 2 TM Transmembrane
161 LG:430059.1 :2001MAR30 669 671 forward 2 TM Non-Cytosolic
161 LG:430059.1:2001MAR30 672 694 forward 2 TM Transmembrane
161 LG:430059.1 :2001MAR30 695 787 forward 2 TM Cytosolic
161 LG:430059.1:2001MAR30 788 810 forward 2 * TM Transmembrane
161 LG:430059.1:2001MAR30 811 835 forward 2 TM Non-Cytosolic
161 LG:430059.1:2001MAR30 836 858 forward 2 TM Transmembrane
161 LG:430059.1:2001MAR30 859 1017 forward 2 TM Cytosolic
161 LG:430059.1 :2001MAR30 1 75 forward 3 TM Cytosolic
161 LG:430059.1:2001MAR30 76 95 forward 3 TM Transmembrane
161 LG:430059.1:2001MAR30 96 104 forward 3 TM Non-Cytosolic
161 LG:430059.1 :2001MAR30 105 122 forward 3 TM Transmembrane
161 LG:430059.1 :2001MAR30 123 128 forward 3 TM Cytosolic
161 LG:430059.1:2001MAR30 129 151 forward 3 TM Transmembrane
161 LG:430059.1 :2001MAR30 152 190 forward 3 TM Non-Cytosolic
161 LG:430059.1 :2001MAR30 191 213 forward 3 TM Transmembrane
161 LG.-430059.1 :2001MAR30 214 456 forward 3 TM Cytosolic
161 LG:430059.1:2001MAR30 457 479 forward 3 TM Transmembrane
161 LG:430059.1:2001MAR30 480 513 forward 3 TM Non-Cytosolic
161 LG:430059.1 :2001MAR30 514 536 forward 3 TM Transmembrane
161 LG:430059.1 :2001MAR30 537 582 forward 3 TM Cytosolic
161 LG:430059.1 :2001MAR30 583 605 forward 3 TM Transmembrane
161 LG:430059.1:2001MAR30 606 609 forward 3 TM Non-Cytosolic
161 LG:430059.1:2001MAR30 610 632 forward 3 TM Transmembrane
161 LG:430059.1 :2001MAR30 633 651 forward 3 TM Cytosolic
161 LG:430059.1:2001MAR30 652 674 forward 3 TM Transmembrane
161 LG:430059.1:2001MAR30 675 710 forward 3 TM Non-Cytosolic
161 LG:430059.1:2001MAR30 711 733 forward 3 TM Transmembrane
161 LG:430059.1 :2001MAR30 734 737 forward 3 TM Cytosolic
161 LG:430059.1:2001MAR30 738 757 forward 3 TM Transmembrane
161 LG:430059.1:2001MAR30 758 1017 forward 3 TM Non-Cytosolic
162 LG:448040.3:2001MAR30 1 37 forward 1 TM Cytosolic
162 LG:448040.3:2001MAR30 38 57 forward 1 TM Transmembrane
162 LG:448040.3:2001MAR30 58 169 forward 1 TM Non-Cytosolic
162 LG:448040.3:2001MAR30 1 39 forward 2 TM Cytosolic
162 LG:448040.3:2001MAR30 40 62 forward 2 TM Transmembrane
162 LG:448040.3:2001MAR30 63 66 forward 2 TM Non-Cytosolic
162 LG:448040.3:2001MAR30 67 86 forward 2 TM Transmembrane
162 LG:448040.3:2001MAR30 87 168 forward 2 TM Cytosolic
162 LG:448040.3:2001MAR30 1 39 forward 3 TM Cytosolic
162 LG:448040.3:2001MAR30 40 62 forward 3 TM Transmembrane
162 LG:448040.3:2001MAR30 63 168 forward 3 TM Non-Cytosolic
163 LG:451274.1:2001MAR30 1 25 forward 2 TM Non-Cytosolic
163 LG:451274.1:2001MAR30 26 48 forward 2 TM Transmembrane
163 LG:451274.1:2001MAR30 49 54 forward 2 TM Cytosolic
163 LG:451274.1:2001MAR30 55 77 forward 2 TM Transmembrane
163 LG:451274.1:2001MAR30 78 467 forward 2 TM Non-Cytosolic
164 LG:456110.1:2001MAR30 1 103 forward 3 TM Cytosolic
164 LG:456110.1:2001MAR30 104 126 forward 3 TM Transmembrane
164 LG:456110.1:2001MAR30 127 140 forward 3 TM Non-Cytosolic
164 LG:456110.1:2001MAR30 141 160 forward 3 TM Transmembrane
164 LG:456110.1:2001MAR30 161 199 forward 3 TM Cytosolic
165 LG:456954.1:2001MAR30 1 35 forward 1 TM Cytosolic
165 LG:456954.1:2001MAR30 36 58 forward 1 TM Transmembrane TABLE 2
SEQ D NO Template ID Start Stop Frame Domain Type Topology
165 LG:456954.1:2001MAR30 59 102 forward 1 TM Non-Cytosolic
165 LG:456954.1:2001MAR30 103 125 forward 1 TM Transmembrane
165 LG:456954.1:2001MAR30 126 242 forward 1 TM Cytosolic
165 LG:456954.1:2001MAR30 1 38 forward 3 TM Cytosolic
165 LG:456954.1:2001MAR30 39 58 forward 3 TM Transmembrane
165 LG:456954.1:2001MAR30 59 117 forward 3 TM Non-Cytosolic
165 LG:456954.1:2001MAR30 118 140 forward 3 TM Transmembrane
165 LG:456954.1:2001MAR30 141 242 forward 3 TM Cytosolic
166 LG:474942.12:2001MAR30 1 6 forward 1 TM Cytosolic
166 LG:474942.12:2001MAR30 7 29 forward 1 TM Transmembrane
166 LG:474942.12:2001MAR30 30 872 forward 1 TM Non-Cytosolic
166 LG:474942.12:2001MAR30 1 165 forward 3 TM Cytosolic
166 LG:474942.12:2001MAR30 166 188 forward 3 TM Transmembrane
166 LG:474942.12:2001MAR30 189 872 forward 3 TM Non-Cytosolic
167 LG:475119.14:2001MAR30 1 122 forward 1 TM Cytosolic
167 LG:475119.14:2001MAR30 123 145 forward 1 TM Transmembrane
167 LG:475119.14:2001MAR30 146 149 forward 1 TM Non-Cytosolic
167 LG:475119.14:2001MAR30 150 169 forward 1 TM Transmembrane
167 LG:475119.14:2001MAR30 170 181 forward 1 TM Cytosolic
167 LG:475119.14:2001MAR30 182 201 forward 1 TM Transmembrane
167 LG:475119.14:2001MAR30 202 242 forward 1 TM Non-Cytosolic
167 LG:475119.14:2001MAR30 243 265 forward 1 TM Transmembrane
167 LG:475119.14:2001MAR30 266 459 forward 1 TM Cytosolic
168 LG:47990877:2001MAR30 . 1 41 forward 3 TM Cytosolic
168 LG:479908J7:2001MAR30 42 64 forward 3 TM Transmembrane
168 LG:479908J7:2001MAR30 65 150 forward 3 TM Non-Cytosolic
169 LG:480127.47:2001MAR30 1 78 forward 3 TM Non-Cytosolic
169 LG:480127.47:2001MAR30 , 79 101 forward 3 TM Transmembrane
169 LG:480127.47:2001MAR30 102 190 forward 3 TM Cytosolic
170 LG:481154.12:2001MAR30 1 91 forward 3 TM Cytosolic
170 LG:481154.12:2001MAR30 92 111 forward 3 TM Transmembrane
170 LG:481154.12:2001MAR30 112 1082 forward 3 TM Non-Cytosolic
170 LG:481154.12:2001MAR30 1083 1105 forward 3 TM Transmembrane
170 LG:481154.12:2001MAR30 1106 1152 forward 3 TM Cytosolic
171 LG:481414.6:2001MAR30 1 376 forward 1 TM Non-Cytosolic
171 LG:481414.6:2001MAR30 377 399 forward 1 TM Transmembrane
171 LG:481414.6:2001MAR30 400 531 forward 1 TM Cytosolic
171 LG:481414.6:2001MAR30 532 554 forward 1 TM Transmembrane
171 LG:481414.6:2001MAR30 555 877 forward 1 TM Non-Cytosolic
171 LG:481414.6:2001MAR30 1 752 forward 3 TM Non-Cytosolic
171 LG:481414.6:2001MAR30 753 775 forward 3 TM Transmembrane
171 LG:481414.6:2001MAR30 776 781 forward 3 TM Cytosolic
171 LG:481414.6:2001MAR30 782 801 forward 3 TM Transmembrane
171 LG:481414.6:2001MAR30 802 877 forward 3 TM Non-Cytosolic
172 LG:481941.1:2001MAR30 1 19 forward 2 TM Non-Cytosolic
172 LG:481941.1:2001MAR30 20 41 forward 2 TM Transmembrane
172 LG:481941.1:2001MAR30 42 491 forward 2 TM Cytosolic
172 LG:481941.1:2001MAR30 492 514 forward 2 TM Transmembrane
172 LG:481941.1:2001MAR30 515 523 forward 2 TM Non-Cytosolic
172 LG:481941.1:2001MAR30 524 546 forward 2 TM Transmembrane
172 LG:481941.1:2001MAR30 547 759 forward 2 TM Cytosolic
172 LG:481941.1:2001MAR30 760 782 forward 2 TM Transmembrane
172 LG:481941.1:2001MAR30 783 801 forward 2 TM Non-Cytosolic
172 LG:481941.1:2001MAR30 802 824 forward 2 TM Transmembrane TABLE 2
SEQ D NO: Template ID Start Stop Frame Domain Type Topology
172 LG:481941.1 :2001MAR30 825 836 forward 2 TM Cytosolic
172 LG:481941.1:2001MAR30 837 859 forward 2 TM Transmembrane
172 LG:481941.1:2001MAR30 860 1184 forward 2 TM Non-Cytosolic
172 LG:481941.1:2001MAR30 1185 1204 forward 2 TM Transmembrane
172 LG:481941.1:2001MAR30 1205 1263 forward 2 TM Cytosolic
172 LG:481941.1:2001MAR30 1 11 forward 3 TM Cytosolic
172 LG:481941.1:2001MAR30 12 34 forward 3 TM Transmembrane
172 LG:481941.1:2001MAR30 35 1263 forward 3 TM Non-Cytosolic
173 LG:887216.4:2001MAR30 1 248 forward 2 TM Cytosolic
173 LG:887216.4:2001MAR30 249 266 forward 2 TM Transmembrane
173 LG:887216.4:2001MAR30 267 283 forward 2 TM Non-Cytosolic
174 LG:899402.3:2001MAR30 1 754 forward 2 TM Non-Cytosolic
174 LG:899402.3:2001MAR30 755 774 forward 2 TM Transmembrane
174 LG:899402.3:2001MAR30 775 914 forward 2 TM Cytosolic
174 LG:899402.3:2001MAR30 915 937 forward 2 TM Transmembrane
174 LG:899402.3:2001MAR30 938 1020 forward 2 TM Non-Cytosolic
174 LG:899402.3:2001MAR30 1021 1043 forward 2 TM Transmembrane
174 LG:899402.3:2001MAR30 1044 1098 forward 2 TM Cytosolic
174 LG: 899402.3 :2001MAR30 1099 1121 forward 2 TM Transmembrane
174 LG:899402.3:2001MAR30 1122 1784 forward 2 TM Non-Cytosolic
174 LG:899402.3:2001MAR30 1 840 forward 3 TM Non-Cytosolic
174 LG:899402.3:2001MAR30 841 863 forward 3 TM Transmembrane
174 LG:899402.3:2001MAR30 864 875 forward 3 TM Cytosolic
174 LG:899402.3:2001MAR30 876 898 forward 3 TM Transmembrane
174 LG:899402.3:2001MAR30 899 926 forward 3 TM Non-Cytosolic
174 LG:899402.3:2001MAR30 927 949 forward 3 TM Transmembrane
174 LG:899402.3:2001MAR30 950 1136 forward 3 TM Cytosolic
174 LG:899402.3:2001MAR30 1137 1159 forward 3 TM Transmembrane
174 LG:899402.3:2001MAR30 1160 1649 forward 3 TM Non-Cytosolic
174 LG:899402.3:2001MAR30 1650 1672 forward 3 TM Transmembrane
174 LG:899402.3:2001MAR30 1673 1711 forward 3 TM Cytosolic
174 LG:899402.3:2001MAR30 1712 1731 forward 3 TM Transmembrane
174 LG:899402.3:2001MAR30 1732 1761 forward 3 TM Non-Cytosolic
174 LG:899402.3:2001MAR30 1762 1779 forward 3 TM Transmembrane
174 LG:899402.3:2001MAR30 1780 1783 forward 3 TM Cytosolic
175 LG: 899894.2:2001MAR30 1 8 forward 2 TM Cytosolic
175 LG:899894.2:2001MAR30 9 26 forward 2 TM Transmembrane
175 LG:899894.2:2001MAR30 27 35 forward 2 TM Non-Cytosolic
175 LG:899894.2:2001MAR30 36 53 forward 2 TM Transmembrane
175 LG:899894.2:2001MAR30 54 72 forward 2 TM Cytosolic
175 LG:899894.2:2001MAR30 73 95 forward 2 TM Transmembrane
175 LG:899894.2:2001MAR30 96 563 forward 2 TM Non-Cytosolic
175 LG:899894.2:2001MAR30 1 495 forward 3 TM Non-Cytosolic
175 LG:899894.2:2001MAR30 496 518 forward 3 TM Transmembrane
175 LG:899894.2:2001MAR30 519 563 forward 3 TM Cytosolic
176 LG:977908.1:2001MAR30 1 200 forward 1 TM Cytosolic
176 LG:977908.1:2001MAR30 201 223 forward 1 TM Transmembrane
176 LG:977908.1:2001MAR30 224 242 forward 1 TM Non-Cytosolic
176 LG :977908.1 :2001MAR30 243 262 forward 1 TM Transmembrane
176 LG:977908.1:2001MAR30 263 563 forward 1 TM Cytosolic
176 LG-.977908.1 :2001MAR30 564 586 forward 1 TM Transmembrane
176 LG:977908.1:2001MAR30 587 595 forward 1 TM Non-Cytosolic
176 LG:977908.1:2001MAR30 596 618 forward 1 TM Transmembrane
176 LG:977908.1:2001MAR30 619 710 forward 1 TM Cytosolic TABLE 2
SEQ D NO: Template ID Start Stop Frame Domain Type Topology
176 LG:977908.1 :2001MAR30 711 733 forward 1 TM Transmembrane
176 LG:977908.1 :2001MAR30 734 1236 forward 1 TM Non-Cytosolic
176 LG:977908.1 :2001MAR30 1 561 forward 2 TM Non-Cytosolic
176 LG:977908.1 :2001MAR30 562 584 forward 2 TM Transmembrane
176 LG:977908.1 :2001MAR30 585 596 forward 2 TM Cytosolic
176 LG:977908.1:2001MAR30 597 619 forward 2 TM Transmembrane
176 LG:977908.1:2001MAR30 620 1236 forward 2 TM Non-Cytosolic
177 LG:977929.1:2001MAR30 1 688 forward 1 TM Non-Cytosolic
177 LG:977929.1:2001MAR30 689 708 forward 1 TM Transmembrane
177 LG:977929.1:2001MAR30 709 810 forward 1 TM Cytosolic
177 LG:977929.1:2001MAR30 811 828 forward 1 TM Transmembrane
177 LG:977929.1 :2001MAR30 829 837 forward 1 TM Non-Cytosolic
177 LG:977929.1 :2001MAR30 838 860 forward 1 TM Transmembrane
177 LG:977929.1 :2001MAR30 861 890 forward 1 TM Cytosolic
177 LG:977929.1 :2001MAR30 891 913 forward 1 TM Transmembrane
177 LG:977929.1:2001MAR30 914 1006 forward 1 TM Non-Cytosolic
177 LG:977929.1:2001MAR30 1 837 forward 2 TM Non-Cytosolic
177 LG:977929.1:2001MAR30 838 860 forward 2 TM Transmembrane
177 LG:977929.1:2001MAR30 861 1005 forward 2 TM Cytosolic
177 LG:977929.1:2001MAR30 1 776 forward 3 TM Non-Cytosolic
177 LG:977929.1:2001MAR30 777 799 forward 3 TM Transmembrane
177 LG:977929.1:2001MAR30 800 834 forward 3 TM Cytosolic
177 LG:977929.1:2001MAR30 835 857 forward 3 TM Transmembrane
177 LG:977929.1 :2001MAR30 858 889 forward 3 TM Non-Cytosolic
177 LG:977929.1 :2001MAR30 890 912 forward 3 TM Transmembrane
177 LG:977929.1 :2001MAR30 913 924 forward 3 TM Cytosolic
177 LG:977929.1 :2001MAR30 925 947 forward 3 TM Transmembrane
177 LG:977929.1:2001MAR30 948 974 forward 3 TM Non-Cytosolic
177 LG:977929.1 :2001MAR30 975 997 forward 3 TM Transmembrane
177 LG:977929.1:2001MAR30 998 1005 forward 3 TM Cytosolic
178 LG:978008.14:2001MAR30 1 991 forward 2 TM Non-Cytosolic
178 LG:978008.14:2001MAR30 992 1014 forward 2 TM Transmembrane
178 LG:978008.14:2001MAR30 1015 1118 forward 2 TM Cytosolic
178 LG:978008.14:2001MAR30 1119 1136 forward 2 TM Transmembrane
178 LG:978008.14:2001MAR30 1137 1202 forward 2 TM Non-Cytosolic
178 LG:978008.14:2001MAR30 1203 1222 forward 2 TM Transmembrane
178 LG:978008.14:2001MAR30 1223 1431 forward 2 TM Cytosolic
178 LG.-978008.14.-2001MAR30 1432 1449 forward 2 TM Transmembrane
178 LG:978008.14:2001MAR30 1450 1463 forward 2 TM Non-Cytosolic
178 LG:978008.14:2001MAR30 1464 1486 forward 2 TM Transmembrane
178 LG:978008.14:2001MAR30 1487 1499 forward 2 TM Cytosolic
179 LG:979054.18:2001MAR30 1 491 forward 1 TM Non-Cytosolic
179 LG:979054.18 :2001MAR30 492 514 forward 1 TM Transmembrane
179 LG:979054.18 :2001MAR30 515 520 forward 1 TM Cytosolic
179 LG:979054.18:2001MAR30 521 543 forward 1 TM Transmembrane
179 LG:979054.18:2001MAR30 544 1150 forward 1 TM Non-Cytosolic
179 LG:979054.18:2001MAR30 1 490 forward 3 TM Non-Cytosolic
179 LG:979054.18:2001MAR30 491 513 forward 3 TM Transmembrane
179 LG:979054.18:2001MAR30 514 514 forward 3 TM Cytosolic
179 LG:979054.18:2001MAR30 515 537 forward 3 TM Transmembrane
179 LG:979054.18:2001MAR30 538 1149 forward 3 TM Non-Cytosolic
180 LG:979185.10:2001MAR30 1 3 forward 1 TM Non-Cytosolic
180 LG:979185.10:2001MAR30 4 26 forward 1 TM Transmembrane
180 LG:979185.10:2001MAR30 27 277 forward 1 TM Cytosolic TABLE 2
SEQ D NO Template ID Start Stop Frame Domain Type Topology
180 LG:979185.10:2001MAR30 278 300 forward 1 TM Transmembrane
180 LG:979185.10:2001MAR30 301 319 forward 1 TM Non-Cytosolic
180 LG:979185.10:2001MAR30 320 339 forward 1 TM Transmembrane
180 LG:979185.10:2001MAR30 340 533 forward 1 TM Cytosolic
180 LG:979185.10:2001MAR30 1 241 forward 2 TM Non-Cytosolic
180 LG:979185.10:2001MAR30 242 264 forward 2 TM Transmembrane
180 LG:979185.10:2001MAR30 265 276 forward 2 TM Cytosolic
180 LG:979185.10:2001MAR30 277 296 forward 2 TM Transmembrane
180 LG:979185.10:2001MAR30 297 501 forward 2 TM Non-Cytosolic
180 LG:979185.10:2001MAR30 502 524 forward 2 TM Transmembrane
180 LG:979185.10:2001MAR30 525 533 forward 2 TM Cytosolic
180 LG:979185.10:2001MAR30 1 6 forward 3 TM Cytosolic
180 LG:979185.10:2001MAR30 7 24 forward 3 TM Transmembrane
180 LG:979185.10:2001MAR30 25 38 forward 3 TM Non-Cytosolic
180 LG:979185.10:2001MAR30 39 61 forward 3 TM Transmembrane
180 LG:979185.10:2001MAR30 62 241 forward 3 TM Cytosolic
180 LG:979185.10:2001MAR30 242 264 forward 3 TM Transmembrane
180 LG:979185.10:2001MAR30 265 273 forward 3 TM Non-Cytosolic
180 LG:979185.10:2001MAR30 274 296 forward 3 TM Transmembrane
180 LG:979185.10:2001MAR30 297 315 forward 3 TM Cytosolic
180 LG:979185.10:2001MAR30 316 338 forward 3 TM Transmembrane
180 LG:979185.10:2001MAR30 339 362 forward 3 TM Non-Cytosolic
180 LG:979185.10:2001MAR30 363 385 forward 3 TM Transmembrane
180 LG:979185.10:2001MAR30 386 404 forward 3 TM Cytosolic
180 LG:979185.10:2001MAR30 405 427 forward 3 TM Transmembrane
180 LG:979185.10:2001MAR30 428 532 forward 3 TM Non-Cytosolic
181 LG:983654.1:2001MAR30 1 319 forward 2 TM Non-Cytosolic
181 LG:983654.1:2001MAR30 320 342 forward 2 TM Transmembrane
181 LG:983654.1 :2001MAR30 343 348 forward 2 TM Cytosolic
181 LG:983654.1:2001MAR30 349 368 forward 2 TM Transmembrane
181 LG:983654.1:2001MAR30 369 369 forward 2 TM Non-Cytosolic
181 LG:983654.1:2001MAR30 1 237 forward 3 TM Cytosolic
181 LG:983654.1 :2001MAR30 238 255 forward 3 TM Transmembrane
181 LG:983654.1:2001MAR30 256 319 forward 3 TM Non-Cytosolic
181 LG:983654.1 :2001MAR30 320 342 forward 3 TM Transmembrane
181 LG:983654.1:2001MAR30 343 368 forward 3 TM Cytosolic
182 LG:985092.12:2001MAR30 1 118 forward 3 TM Cytosolic
182 LG:985092.12:2001MAR30 119 141 forward 3 TM Transmembrane
182 LG:985092.12:2001MAR30 142 369 forward 3 TM Non-Cytosolic
183 LG:987396.8:2001MAR30 1 132 forward 2 TM Non-Cytosolic
183 LG:987396.8:2001MAR30 133 152 forward 2 TM Transmembrane
183 LG:987396.8:2001MAR30 153 273 forward 2 TM Cytosolic
183 LG:987396.8:2001MAR30 274 296 forward 2 TM Transmembrane
183 LG:987396.8:2001MAR30 297 924 forward 2 TM Non-Cytosolic
183 LG:987396.8:2001MAR30 1 270 forward 3 TM Non-Cytosolic
183 LG:987396.8:2001MAR30 271 293 forward 3 TM Transmembrane
183 LG:987396.8:2001MAR30 294 358 forward 3 TM Cytosolic
183 LG:987396.8:2001MAR30 359 381 forward 3 TM Transmembrane
183 LG:987396.8:2001MAR30 382 924 forward 3 TM Non-Cytosolic
184 LG:987418.10:2001MAR30 1 454 forward 2 TM Non-Cytosolic
184 LG:987418.10:2001MAR30 455 474 forward 2 TM Transmembrane
184 LG:987418.10:2001MAR30 475 479 forward 2 TM Cytosolic
185 LG:997203.25:2001MAR30 1 801 forward 1 TM Non-Cytosolic
185 LG:997203.25:2001MAR30 802 824 forward 1 TM Transmembrane TABLE 2
SEQ D NO: Template ID Start Stop Frame Domain Type Topology
85 LG:997203.25:2001MAR30 825 830 forward 1 TM Cytosolic
85 LG:997203.25:2001MAR30 831 846 forward 1 TM Transmembrane
85 LG:997203.25:2001MAR30 847 855 forward 1 TM Non-Cytosolic
85 LG:997203.25:2001MAR30 856 875 forward 1 TM Transmembrane
85 LG:997203.25:2001MAR30 876 924 forward 1 TM Cytosolic
85 LG:997203.25:2001MAR30 925 947 forward 1 TM Transmembrane
85 LG:997203.25:2001MAR30 948 980 forward 1 TM Non-Cytosolic
85 LG:997203.25:2001MAR30 981 1003 forward 1 TM Transmembrane
85 LG:997203.25:2001MAR30 1004 1292 forward 1 TM Cytosolic
85 LG:997203.25:2001MAR30 1 974 forward 3 TM Non-Cytosolic
85 LG:997203.25:2001MAR30 975 992 forward 3 TM Transmembrane
85 LG:997203.25:2001MAR30 993 1048 forward 3 TM Cytosolic
85 LG:997203.25:2001MAR30 1049 1071 forward 3 TM Transmembrane
85 LG:997203.25:2001MAR30 1072 1291 forward 3 TM Non-Cytosolic
86 LG:997477.8:2001MAR30 1 59 forward 2 TM Non-Cytosolic 86 LG:997477.8:2001MAR30 60 82 forward 2 TM Transmembrane 86 LG:997477.8:2001MAR30 83 275 forward 2 TM Cytosolic 86 LG:997477.8:2001MAR30 276 298 forward 2 TM Transmembrane 86 LG:997477.8:2001MAR30 299 301 forward 2 TM Non-Cytosolic 86 LG:997477.8:2001MAR30 302 324 forward 2 TM Transmembrane
86 LG:997477.8:2001MAR30 325 401 forward 2 TM Cytosolic
87 LG:998855.4:2001MAR30 1 50 forward 1 TM Cytosolic 87 LG:998855.4:2001MAR30 51 73 forward 1 TM Transmembrane
87 LG:998855.4:2001MAR30 74 333 forward 1 TM Non-Cytosolic
88 LG:999093.1:2001MAR30 1 1115 forward 1 TM Non-Cytosolic 88 LG:999093.1:2001MAR30 1116 1138 forward 1 TM Transmembrane 88 LG:999093.1:2001MAR30 1139 1316 forward 1 TM Cytosolic 88 LG:999093.1:2001MAR30 1317 1339 forward 1 TM Transmembrane 88 LG:999093.1:2001MAR30 1340 1554 forward 1 TM Non-Cytosolic 88 LG:999093.1:2001MAR30 1 1073 forward 2 TM Non-Cytosolic 88 LG:999093.1:2001MAR30 1074 1093 forward 2 TM Transmembrane 88 LG:999093.1:2001MAR30 1094 1099 forward 2 TM Cytosolic 88 LG:999093.1:2001MAR30 1100 1119 forward 2 TM Transmembrane 88 LG:999093.1:2001MAR30 1120 1123 forward 2 TM Non-Cytosolic 88 LG:999093.1:2001MAR30 1124 1143 forward 2 TM Transmembrane 88 LG:999093.1:2001MAR30 1144 1163 forward 2 TM Cytosolic 88 LG:999093.1:2001MAR30 1164 1186 forward 2 TM Transmembrane 88 LG:999093.1:2001MAR30 1187 1261 forward 2 TM Non-Cytosolic 88 LG:999093.1:2001MAR30 1262 1284 forward 2 TM Transmembrane 88 LG:999093.1:2001MAR30 1285 1296 forward 2 TM Cytosolic 88 LG:999093.1:2001MAR30 1297 1314 forward 2 TM Transmembrane 88 LG:999093.1:2001MAR30 1315 1318 forward 2 TM Non-Cytosolic 88 LG:999093.1:2001MAR30 1319 1341 forward 2 TM Transmembrane 88 LG:999093.1:2001MAR30 1342 1394 forward 2 TM Cytosolic 88 LG:999093.1:2001MAR30 1395 1417 forward 2 TM Transmembrane 88 LG:999093.1:2001MAR30 1418 1554 forward 2 TM Non-Cytosolic 88 LG:999093.1:2001MAR30 1 422 forward 3 TM Non-Cytosolic 88 LG:999093.1:2001MAR30 423 445 forward 3 TM Transmembrane 88 LG:999093.1:2001MAR30 446 536 forward 3 TM Cytosolic 88 LG:999093.1:2001MAR30 537 559 forward 3 TM Transmembrane 88 LG:999093.1:2001MAR30 560 760 forward 3 TM Non-Cytosolic 88 LG:999093.1:2001MAR30 761 783 forward 3 TM Transmembrane 88 LG:999093.1:2001MAR30 784 1077 forward 3 TM Cytosolic 88 LG:999093.1:2001MAR30 1078 1100 forward 3 TM Transmembrane TABLE 2
SEQ D NO: Template ID Start Stop Frame Domain Type Topology
88 LG:999093.1:2001MAR30 1101 1109 forward 3 TM Non-Cytosolic
88 LG:999093.1 :2001MAR30 1110 1132 forward 3 TM Transmembrane
88 LG:999093.1:2001MAR30 1133 1317 forward 3 TM Cytosolic
88 LG:999093.1:2001MAR30 1318 1340 forward 3 TM Transmembrane
88 LG:999093.1:2001MAR30 1341 1343 forward 3 TM Non-Cytosolic
88 LG:999093.1:2001MAR30 1344 1363 forward 3 TM Transmembrane
88 LG:999093.1:2001MAR30 1364 1375 forward 3 TM Cytosolic
88 LG:999093.1:2001MAR30 1376 1395 forward 3 TM Transmembrane
88 LG:999093.1:2001MAR30 1396 1468 forward 3 TM Non-Cytosolic
88 LG:999093.1:2001MAR30 1469 1488 forward 3 TM Transmembrane
88 LG:999093.1:2001MAR30 1489 1499 forward 3 TM Cytosolic
88 LG:999093.1:2001MAR30 1500 1522 forward 3 TM Transmembrane
88 LG:999093.1:2001MAR30 1523 1553 forward 3 TM Non-Cytosolic
89 LG:999183.1:2001MAR30 1 1406 forward 1 TM Non-Cytosolic 89 LG:999183.1:2001MAR30 1407 1424 forward 1 TM Transmembrane 89 LG:999183.1:2001MAR30 1425 1443 forward 1 TM Cytosolic 89 LG:999183.1:2001MAR30 1444 1463 forward 1 TM Transmembrane 89 LG:999183.1:2001MAR30 1464 1477 forward 1 TM Non-Cytosolic 89 LG:999183.1:2001MAR30 1478 1500 forward 1 TM Transmembrane 89 LG:999183.1:2001MAR30 1501 1615 forward 1 TM Cytosolic 89 LG:999183.1:2001MAR30 1616 1638 forward 1 TM Transmembrane
89 LG:999183.1:2001MAR30 1639 1642 forward 1 TM Non-Cytosolic
90 LI:1032972.1:2001MAY17 1 55 forward 1 TM Cytosolic 90 LI:1032972.1:2001MAY17 56 78 forward 1 TM Transmembrane 90 LI: 1032972.1 :2001MAY17 79 336 forward 1 TM Non-Cytosolic 90 LI:1032972.1:2001MAY17 1 58 forward 2 TM Cytosolic 90 LI:1032972.1:2001MAY17 59 81 forward 2 TM Transmembrane 90 LI: 1032972.1:2001MAY17 82 295 forward 2 TM Non-Cytosolic 90 LI:1032972.1:2001MAY17 296 318 forward 2 TM Transmembrane 90 LI:1032972.1:2001MAY17 319 335 forward 2 TM Cytosolic 90 LT.1032972.1:2001MAY17 1 12 forward 3 TM Non-Cytosolic 90 LI:1032972.1:2001MAY17 13 35 forward 3 TM Transmembrane 90 LI:1032972.1:2001MAY17 36 55 forward 3 TM Cytosolic 90 LI: 1032972.1:2001MAY17 56 78 forward 3 TM Transmembrane
90 LI:1032972.1:2001MAY17 79 335 forward 3 TM Non-Cytosolic
91 LI.T70666.6.-2001MAY17 1 155 forward 3 TM Non-Cytosolic 91 LI:170666.6:2001MAY17 156 178 forward 3 TM Transmembrane
91 LI:170666.6:2001MAY17 179 222 forward 3 TM Cytosolic
92 LI:197048.10:2001MAY17 1 336 forward 1 TM Non-Cytosolic 92 LI:197048.10:2001MAY17 337 359 forward 1 TM Transmembrane 92 LI:197048.10:2001MAY17 360 598 forward 1 TM Cytosolic 92 LI:197048.10:2001MAY17 599 621 forward 1 TM Transmembrane 92 LI:197048.10:2001MAY17 622 640 forward 1 TM Non-Cytosolic 92 LI:197048.10:2001MAY17 641 663 forward 1 TM Transmembrane 92 LI:197048.10:2001MAY17 664 714 forward 1 TM Cytosolic 92 LL197048.10.2001MAY17 715 737 forward 1 TM Transmembrane 92 LI: 197048.10.2001MAY17 738 751 forward 1 TM Non-Cytosolic 92 LI:197048.10:2001MAY17 752 771 forward 1 TM Transmembrane 92 LI: 197048.10:2001MAY17 772 829 forward 1 TM Cytosolic 92 LI: 197048.10:2001MAY17 1 324 forward 2 TM Cytosolic 92 LI:197048.10:2001MAY17 325 347 forward 2 TM Transmembrane 92 LI: 197048.10:2001MAY17 348 361 forward 2 TM Non-Cytosolic 92 LI: 197048.10:2001MAY17 362 384 forward 2 TM Transmembrane 92 LI:197048.10:2001MAY 17 385 488 forward 2 TM Cytosolic
14C TABLE 2
SEQ D NO: Template ID Start Stop Frame Domain Type Topology
192 LI:197048.10:2001MAY17 489 506 forward 2 TM Transmembrane
192 LI:197048.10:2001MAY17 507 509 forward 2 TM Non-Cytosolic
192 LI:197048.10:2001MAY17 510 529 forward 2 TM Transmembrane
192 LI:197048.10:2001MAY17 530 597 forward 2 TM Cytosolic
192 LI:197048.10:2001MAY17 598 620 forward 2 TM Transmembrane
192 LL197048.10:2001MAY17 621 639 forward 2 TM Non-Cytosolic
192 LI:197048.10:2001MAY17 640 662 forward 2 TM Transmembrane
192 LI:197048.10:2001MAY17 663 797 forward 2 TM Cytosolic
192 LI:197048.10:2001MAY17 798 820 forward 2 TM Transmembrane
192 LI: 197048.10:2001MAY17 821 828 forward 2 TM Non-Cytosolic
192 LI:197048.10:2001MAY17 1 376 forward 3 TM Non-Cytosolic
192 LI.T97048.10.2001MAY17 377 399 forward 3 TM Transmembrane
192 LI:197048.10:2001MAY17 400 436 forward 3 TM Cytosolic
192 LI:197048.10:2001MAY17 437 459 forward 3 TM Transmembrane
192 LI:197048.10:2001MAY17 460 488 forward 3 TM Non-Cytosolic
192 LI:197048.10:2001MAY17 489 511 forward 3 TM Transmembrane
192 LI:197048.10:2001MAY17 512 523 forward 3 TM Cytosolic
192 LI:197048.10:2001MAY17 524 546 forward 3 TM Transmembrane
192 LI:197048.10:2001MAY17 547 555 forward 3 TM Non-Cytosolic
192 LT.197048.10:2001MAY17 556 578 forward 3 TM Transmembrane
192 LI:197048.10:2001MAY17 579 597 forward 3 TM Cytosolic
192 LI.T97048.10:2001MAY17 598 617 forward 3 TM Transmembrane
192 LT.l 97048.10:2001MAY 17 618 828 forward 3 TM Non-Cytosolic
193 LI:228655.5:2001MAY17 1 33 forward 1 TM Non-Cytosolic
193 LI:228655.5:2001MAY17 34 56 forward 1 TM Transmembrane
193 LI:228655.5:2001MAY17 57 76 forward 1 TM Cytosolic
193 LI:228655.5:2001MAY17 77 94 forward 1 TM Transmembrane
193 LI:228655.5:2001MAY17 95 108 forward 1 TM Non-Cytosolic
193 LI:228655.5:2001MAY17 109 131 forward 1 TM Transmembrane
193 LI:228655.5:2001MAY17 132 200 forward 1 . TM Cytosolic
193 LI:228655.5:2001MAY17 201 223 forward 1 TM Transmembrane
193 LT.228655.5:2001MAY17 224 237 forward 1 TM Non-Cytosolic
194 LI:229789.6:2001MAY17 1 367 forward 1 TM Non-Cytosolic
194 LI:229789.6:2001MAY17 368 390 forward 1 TM Transmembrane
194 LI:229789.6:2001MAY17 391 394 forward 1 TM Cytosolic
195 LI:231500.8:2001MAY17 1 458 forward 1 TM Non-Cytosolic
195 LI:231500.8:2001MAY17 459 477 forward 1 TM Transmembrane
195 LI:231500.8:2001MAY17 478 481 forward 1 TM Cytosolic '
196 LI:253851.26:2001MAY17 1 6 forward 3 TM Cytosolic
196 LI:253851.26:2001MAY17 7 25 forward 3 TM Transmembrane
196 LI:253851.26:2001MAY17 26 34 forward 3 TM Non-Cytosolic
196 LI:253851.26:2001MAY17 35 57 forward 3 TM Transmembrane
196 LI:253851.26:2001MAY17 58 414 forward 3 TM Cytosolic
196 LI:253851.26:2001MAY17 415 437 forward 3 TM Transmembrane
196 LI:253851.26:2001MAY17 438 477 forward 3 TM Non-Cytosolic
196 LI:253851.26:2001MAY17 478 497 forward 3 TM Transmembrane
196 LI:253851.26:2001MAY17 498 517 forward 3 TM Cytosolic
196 LI:253851.26:2001MAY17 518 537 forward 3 TM Transmembrane
196 LI:253851.26:2001MAY17 538 556 forward 3 TM Non-Cytosolic
196 LI:253851.26:2001MAY17 557 579 forward 3 TM Transmembrane
196 LI:253851.26:2001MAY17 580 748 forward 3 TM Cytosolic
197 LI:373302.1:2001MAY17 1 61 forward 1 TM Non-Cytosolic
197 LI:373302.1:2001MAY17 62 84 forward 1 TM Transmembrane
197 LI:373302.1:2001MAY17 85 104 forward 1 TM Cytosolic TABLE 2
SEQ D NO: : Template ID Start Stop Frame Domain Type Topology
197 LI:373302.1:2001MAY17 105 124 forward 1 TM Transmembrane
197 LI:373302.1:2001MAY17 125 457 forward 1 TM Non-Cytosolic
197 LI:373302.1:2001MAY17 1 110 forward 2 TM Non-Cytosolic
197 LL373302.1.2001MAY17 111 133 forward 2 TM Transmembrane
197 LI:373302.1:2001MAY17 134 161 forward 2 TM Cytosolic
197 LL373302.1:2001 MAY 17 162 184 forward 2 TM Transmembrane
197 LI:373302.1:2001MAY17 185 214 forward 2 TM Non-Cytosolic
197 LI:373302.1:2001MAY17 215 237 forward 2 TM Transmembrane
197 LI:373302.1:2001MAY17 238 395 forward 2 TM Cytosolic
197 LI:373302.1:2001MAY17 396 418 forward 2 TM Transmembrane
197 LI:373302.1:2001MAY17 419 456 forward 2 TM Non-Cytosolic
197 LI:373302.1:2001MAY17 1 98 forward 3 TM Cytosolic
197 LI:373302.1:2001MAY17 99 121 forward 3 TM Transmembrane
197 LI:373302.1:2001MAY17 122 368 forward 3 TM Non-Cytosolic
197 LI:373302.1:2001MAY17 369 391 forward 3 TM Transmembrane
197 LI:373302.1:2001MAY17 392 411 forward 3 TM Cytosolic
197 LI:373302.1:2001MAY17 412 434 forward 3 TM Transmembrane
197 LI:373302.1:2001MAY17 435 456 forward 3 TM Non-Cytosolic
198 LI:405707.12:2001MAY17 1 14 forward 2 TM Non-Cytosolic
198 LI:405707.12:2001MAY17 15 37 forward 2 TM Transmembrane
198 LI:405707.12:2001MAY17 38 128 forward 2 TM Cytosolic
198 LI:405707.12:2001MAY17 129 146 forward 2 TM Transmembrane
198 LI:405707.12:2001MAY17 147 149 forward 2 TM Non-Cytosolic
198 LI:405707.12:2001MAY17 150 172 forward 2 TM Transmembrane
198 LI:405707.12:2001MAY17 173 438 forward 2 TM Cytosolic
199 LI:411441.8:2001MAY17 1 92 forward 3 TM Cytosolic
199 LI:411441.8:2001MAY17 93 115 forward 3 TM Transmembrane
199 LI:411441.8:2001MAY17 116 497 forward 3 TM Non-Cytosolic
200 LI:758193.3:2001MAY17 1 9 forward 1 TM Non-Cytosolic
200 LI:758193.3:2001MAY17 10 32 forward 1 TM Transmembrane
200 LI:758193.3:2001MAY17 33 52 forward 1 TM Cytosolic
200 LI:758193.3:2001MAY17 53 75 forward 1 TM Transmembrane
200 LT.758193.3:2001MAY17 76 99 forward 1 TM Non-Cytosolic
200 LL758193.3.2001MAY17 100 122 forward 1 TM Transmembrane
200 LI:758193.3:2001MAY17 123 214 forward 1 TM Cytosolic
200 LI:758193.3:2001MAY17 215 237 forward 1 TM Transmembrane
200 LI:758193.3:2001MAY17 238 282 forward 1 TM Non-Cytosolic
200 LI:758193.3:2001MAY17 283 305 forward 1 TM Transmembrane
200 LI:758193.3:2001MAY17 306 311 forward 1 TM Cytosolic
200 LI:758193.3:2001MAY17 312 334 forward 1 TM Transmembrane
200 LI:758193.3:2001MAY17 335 343 forward 1 TM Non-Cytosolic
200 LI:758193.3:2001MAY17 344 366 forward 1 TM Transmembrane
200 LL758193.3.2001MAY17 367 415 forward 1 TM Cytosolic
200 LI:758193.3:2001MAY17 416 435 forward 1 TM Transmembrane
200 LI:758193.3:2001MAY17 436 476 forward 1 TM Non-Cytosolic
200 LI:758193.3:2001MAY17 477 499 forward 1 TM Transmembrane
200 LI:758193.3:2001MAY17 500 552 forward 1 TM Cytosolic
200 LI:758193.3:2001MAY17 553 575 forward 1 TM Transmembrane
200 LI:758193.3:2001MAY17 576 584 forward 1 TM Non-Cytosolic
200 LI:758193.3:2001MAY17 585 607 forward 1 TM Transmembrane
200 LI:758193.3:2001MAY17 608 664 forward 1 TM Cytosolic
200 LI:758193.3:2001MAY17 1 20 forward 2 TM Cytosolic
200 LI:758193.3:2001MAY17 21 38 forward 2 TM Transmembrane
200 LI:758193.3:2001MAY17 39 64 forward 2 TM Non-Cytosolic TABLE 2
SEQ D NO: Template ID Start Stop Frame Domain Type Topology
200 LI:758193.3:2001MAY17 65 87 forward 2 TM Transmembrane
200 LI:758193.3:2001MAY17 88 211 forward 2 TM Cytosolic
200 LI:758193.3:2001MAY17 212 234 forward 2 TM Transmembrane
200 LI:758193.3:2001MAY17 235 243 forward 2 TM Non-Cytosolic
200 LI:758193.3:2001MAY17 244 261 forward 2 TM Transmembrane
200 LI:758193.3:2001MAY17 262 277 forward 2 TM Cytosolic
200 LI:758193.3:2001MAY17 278 300 forward 2 TM Transmembrane
200 LI:758193.3:2001MAY17 301 476 forward 2 TM Non-Cytosolic
200 LI:758193.3:2001MAY17 477 499 forward 2 TM Transmembrane 200 ' LI:758193.3:2001MAY17 500 552 forward 2 TM Cytosolic
200 LI:758193.3:2001MAY17 553 575 forward 2 TM Transmembrane
200 LI:758193.3:2001MAY17 576 584 forward 2 TM Non-Cytosolic
200 LI:758193.3:2001MAY17 585 607 forward 2 TM Transmembrane
200 LI:758193.3:2001MAY17 608 664 forward 2 TM Cytosolic
200 LI:758193.3:2001MAY17 1 19 forward 3 TM Cytosolic
200 LI:758193.3:2001MAY17 20 42 forward 3 TM Transmembrane
200 LI:758193.3:2001MAY17 43 56 forward 3 TM Non-Cytosolic
200 LI:758193.3:2001MAY17 57 79 forward 3 TM Transmembrane
200 LI:758193.3:2001MAY17 80 115 forward 3 TM Cytosolic
200 LI:758193.3:2001MAY17 116 138 forward 3 TM Transmembrane
200 LI:758193.3:2001MAY17 139 213 forward 3 TM Non-Cytosolic
200 LI:758193.3:2001MAY17 214 236 forward 3 TM Transmembrane
200 LI:758193.3:2001MAY17 237 278 forward 3 TM Cytosolic
200 LI:758193.3:2001MAY17 279 301 ! forward 3 TM Transmembrane
200 LI:758193.3:2001MAY17 302 360 forward 3 TM Non-Cytosolic
200 LI:758193.3:2001MAY17 361 383 forward 3 TM Transmembrane
200 LI:758193.3:2001MAY17 384 475 forward 3 TM Cytosolic
200 LI:758193.3:2001MAY17 476 498 forward 3 TM Transmembrane
200 LI:758193.3:2001MAY17 499 517 forward 3 TM Non-Cytosolic
200 LI:758193.3:2001MAY17 518 540 forward 3 TM Transmembrane
200 LI:758193.3:2001MAY17 541 664 forward 3 TM Cytosolic
201 LI:1028562.3:2001MAY17 1 6 forward 2 TM Cytosolic 201 LI:1028562.3:2001MAY17 7 24 forward 2 TM Transmembrane 201 LI: 1028562.3.2001MAY17 25 43 forward 2 TM Non-Cytosolic 201 LI:1028562.3:2001MAY17 44 66 forward 2 TM Transmembrane
201 LI:1028562.3:2001MAY17 67 69 forward 2 TM Cytosolic
202 LI:104650J:2001MAY17 1 6 forward 3 TM Cytosolic 202 LI:104650.7:2001MAY17 7 29 forward 3 TM Transmembrane 202 LI:104650.7:2001MAY17 30 38 forward 3 TM Non-Cytosolic 202 LI:104650.7:2001MAY17 39 61 forward 3 TM Transmembrane 202 LI:104650.7:2001MAY17 62 72 forward 3 TM Cytosolic 202 LI:104650J:2001MAY17 73 95 forward 3 TM Transmembrane
202 LI:104650J:2001MAY17 96 265 forward 3 TM Non-Cytosolic
203 LI: 1094557.4:2001MAY17 1 57 forward 1 TM Non-Cytosolic 203 LI:1094557.4:2001MAY17 58 80 forward 1 TM Transmembrane 203 LI:1094557.4:2001MAY17 81 311 forward 1 TM Cytosolic 203 LI:1094557.4:2001MAY17 1 90 forward 3 TM Cytosolic 203 LI:1094557.4:2001MAY17 91 113 forward 3 TM Transmembrane 203 LI:1094557.4:2001MAY17 1 14 127 forward 3 TM Non-Cytosolic 203 LI:1094557.4:2001MAY17 128 147 forward 3 TM Transmembrane
203 LI:1094557.4:2001MAY17 148 310 forward 3 TM Cytosolic
204 LI:1143528.4:2001MAY17 1 302 forward 1 TM Non-Cytosolic 204 LI:1143528.4:2001MAY17 303 325 forward 1 TM Transmembrane 204 LI:1143528.4:2001MAY17 326 331 forward 1 TM Cytosolic TABLE 2
SEQ D NO: Template ID Start Stop Frame Domain Type Topology 204 1143528.4:2001MAY17 1 298 forward 3 TM Non-Cytosolic 204 1143528.4.-2001MAY17 299 321 forward 3 TM Transmembrane 204 1143528.4:2001MAY17 322 330 forward 3 TM Cytosolic 205 1172210.7:2001MAY17 1 582 forward 1 TM Non-Cytosolic 205 1172210J:2001MAY17 583 600 forward 1 TM Transmembrane 205 1172210J:2001MAY17 601 601 forward 1 TM Cytosolic 206 1178659.14.2001MAY17 1 694 forward 1 TM Non-Cytosolic 206 1178659.14:2001MAY17 695 717 forward 1 TM Transmembrane 206 1178659.14:2001MAY17 718 779 forward 1 TM Cytosolic 206 1178659.14:2001MAY17 780 802 forward 1 TM Transmembrane 206 1178659.14.2001MAY17 803 811 forward 1 TM Non-Cytosolic 206 1178659.14.2001MAY17 812 834 forward 1 TM Transmembrane 206 1178659.14.2001MAY17 835 835 forward 1 TM Cytosolic 206 1178659.14:2001MAY17 1 233 forward 2 TM Cytosolic 206 1178659.14:2001MAY17 234 256 forward 2 TM Transmembrane 206 1178659.14:2001MAY17 257 347 forward 2 TM Non-Cytosolic 206 1178659.14.2001MAY17 348 370 forward 2 TM Transmembrane 206 1178659.14.2001MAY17 371 689 forward 2 TM Cytosolic 206 1178659.14.2001MAY17 690 712 forward 2 TM Transmembrane 206 1178659.14:2001MAY17 713 808 forward 2 TM Non-Cytosolic 206 1178659.14:2001MAY17 809 831 forward *2 TM Transmembrane 206 1178659.14:2001MAY17 832 835 forward 2 TM Cytosolic 206 1178659.14:2001MAY17 1 57 forward 3 TM Cytosolic 206 1178659.14.2001MAY17 58 80 forward 3 TM' Transmembrane 206 1178659.14:2001MAY17 81 235 forward 3 TM Non-Cytosolic 206 1178659.14:2001MAY17 236 258 forward 3 TM Transmembrane 206 1178659.14:2001MAY17 259 316 forward 3 TM Cytosolic 206 1178659.14:2001MAY17 317 339 forward 3 TM Transmembrane 206 1178659.14:2001MAY17 340 370 forward 3 TM Non-Cytosolic 206 1178659.14:2001MAY17 371 393 forward 3 TM Transmembrane 206 1178659.14:2001MAY17 394 457 forward 3 TM Cytosolic 206 1178659.14:2001MAY17 458 477 forward 3 TM Transmembrane 206 1178659.14:2001MAY17 478 779 forward 3 TM Non-Cytosolic 206 1178659.14.2001MAY17 780 802 forward 3 TM Transmembrane 206 1178659.14:2001MAY17 803 808 forward 3 TM Cytosolic 206 1178659.14:2001MAY17 809 831 forward 3 TM Transmembrane 206 1178659.14.-2001MAY17 832 835 forward 3 TM Non-Cytosolic 207 1983726.3:2001MAY17 1 95 forward 3 TM Cytosolic 207 1983726.3:2001MAY17 96 118 forward 3 TM Transmembrane 207 1983726.3:2001MAY17 119 151 forward 3 TM Non-Cytosolic 207 1983726.3:2001MAY17 152 174 forward 3 TM Transmembrane 207 1983726.3:2001MAY17 175 186 forward 3 TM Cytosolic 207 1983726.3.-2001MAY17 187 206 forward 3 TM Transmembrane 207 1983726.3:2001MAY17 207 211 forward 3 TM Non-Cytosolic 207 1983726.3:2001MAY17 212 231 forward 3 TM Transmembrane 207 1983726.3:2001MAY17 232 251 forward 3 TM Cytosolic 207 1983726.3:2001MAY17 252 274 forward 3 TM Transmembrane 207 1983726.3:2001MAY17 275 285 forward 3 TM Non-Cytosolic 208 2051495.3:2001MAY17 1 259 forward 1 TM Non-Cytosolic 208 2051495.3:2001MAY17 260 279 forward 1 TM Transmembrane 208 2051495.3:2001MAY17 280 291 forward 1 TM Cytosolic 208 2051495.3:2001MAY17 292 309 forward 1 TM Transmembrane 208 2051495.3:2001MAY17 310 337 forward 1 TM Non-Cytosolic 208 2051495.3:2001MAY17 338 360 forward 1 TM Transmembrane TABLE 2
SEQ D NO: Template ID Start Stop Frame Domain Type Topology
208 LI:2051495.3:2001MAY17 361 527 forward 1 TM Cytosolic
208 LT.2051495.3:2001MAY17 528 550 forward 1 TM Transmembrane
208 LI:2051495.3:2001MAY17 551 706 forward 1 TM Non-Cytosolic
208 LI:2051495.3:2001MAY17 1 320 forward 2 TM Non-Cytosolic
208 LI:2051495.3:2001MAY17 321 343 forward 2 TM Transmembrane
208 LI:2051495.3:2001MAY17 344 515 forward 2 TM Cytosolic
208 LT.2051495.3 :2001MAY17 516 538 forward 2 TM Transmembrane
208 LI:2051495.3:2001MAY17 539 705 forward 2 TM Non-Cytosolic
208 LI:2051495.3:2001MAY17 1 336 forward 3 TM Non-Cytosolic
208 LI:2051495.3:2001MAY17 337 359 forward 3 TM Transmembrane
208 LI:2051495.3:2001MAY17 360 705 forward 3 TM Cytosolic
209 LL2117629.1.2001MAY17 1 320 forward 1 TM Non-Cytosolic
209 LI:2117629.1:2001MAY17 321 343 forward 1 TM Transmembrane
209 LI.2117629.1 :2001MAY 17 344 355 forward 1 TM Cytosolic
209 LI:2117629.1:2001MAY17 356 378 forward 1 TM Transmembrane
209 LI:2117629.1:2001MAY17 379 397 forward 1 TM Non-Cytosolic
209 LI:2117629.1 :2001MAY17 398 416 forward 1 TM Transmembrane
209 LI:2117629.1 :2001MAY17 417 424 forward 1 TM Cytosolic
210 LI.2118007.3:2001MAY17 1 37 forward 3 TM Non-Cytosolic
210 LI:2118007.3:2001MAY17 38 60 forward 3 TM Transmembrane
210 LI:2118007.3:2001MAY17 61 203 forward 3 TM Cytosolic
210 LI:2118007.3:2001MAY17 204 226 forward 3 TM Transmembrane
210 LI:2118007.3:2001MAY17 227 338 forward 3 TM Non-Cytosolic
211 LI:2118292.9:2001MAY17 1 140 forward 1 TM Non-Cytosolic
211 LI:2118292.9:2001MAY17 141 163 forward 1 TM Transmembrane
211 LI:2118292.9:2001MAY17 164 286 forward 1 TM Cytosolic
211 LI:2118292.9:2001MAY17 287 306 forward 1 TM Transmembrane
211 LI:2118292.9:2001MAY17 307 344 forward 1 TM Non-Cytosolic
211 LI:2118292.9:2001MAY17 345 367 forward 1 TM Transmembrane
211 LI:2118292.9:2001MAY17 368 520 forward 1 TM Cytosolic
211 LI:2118292.9:2001MAY17 1 299 forward 2 TM Non-Cytosolic
21 1 LI:2118292.9:2001MAY17 300 319 forward 2 TM Transmembrane
211 LI:2118292.9:2001MAY17 320 418 forward 2 TM Cytosolic
21 1 LI:2118292.9:2001MAY17 419 441 forward 2 TM Transmembrane
21 1 LI:2118292.9:2001MAY17 442 478 forward 2 TM Non-Cytosolic
211 LI:2118292.9:2001MAY17 479 501 forward 2 TM Transmembrane
21 1 LI:2118292.9:2001MAY17 502 520 forward 2 TM Cytosolic
21 1 LL2118292.9:2001MAY17 1 292 forward 3 TM Cytosolic
21 1 LI:2118292.9:2001MAY17 293 312 forward 3 TM Transmembrane
21 1 LI:2118292.9:2001MAY17 313 346 forward 3 TM Non-Cytosolic
21 1 LI:2118292.9:2001MAY17 347 369 forward 3 TM Transmembrane
21 1 LI:2118292.9:2001MAY17 370 452 forward 3 TM Cytosolic
21 1 LI:2118292.9:2001MAY17 453 475 forward 3 TM Transmembrane
211 LI:2118292.9:2001MAY17 476 489 forward 3 TM Non-Cytosolic
21 1 LI:2118292.9:2001MAY17 490 512 forward 3 TM Transmembrane
21 1 LI:2118292.9:2001MAY17 513 519 forward 3 TM Cytosolic
212 LI:2118733J:2001MAY17 1 48 forward 1 TM Non-Cytosolic
212 LI:2118733J:2001MAY17 49 71 forward 1 TM Transmembrane
212 LI:2118733J:2001MAY17 72 195 forward 1 TM Cytosolic
212 LI:2118733J:2001MAY17 196 218 forward 1 TM Transmembrane
212 LI:2118733.7:2001MAY17 219 222 forward 1 TM Non-Cytosolic
212 LI:2118733.7:2001MAY17 223 242 forward 1 TM Transmembrane
212 LI:2118733J:2001MAY17 243 292 forward 1 TM Cytosolic
212 LI:2118733.7:2001MAY17 1 35 forward 2 TM Cytosolic TABLE 2
SEQ D NO: Template ID Start Stop Frame Domain Type Topology
212 LT.2118733.7.2001MAY17 36 58 forward 2 TM Transmembrane
212 LI.2118733J:2001MAY17 59 110 forward 2 TM Non-Cytosolic
212 LI:2118733J:2001MAY17 111 133 forward 2 TM Transmembrane
212 LI:2118733.7:2001MAY17 134 153 forward 2 TM Cytosolic
212 LI:2118733.7:2001MAY17 154 176 forward 2 • TM Transmembrane
212 LI:2118733J:2001MAY17 177 195 forward 2 TM Non-Cytosolic
212 LI:2118733J:2001MAY17 196 218 forward 2 TM Transmembrane
212 LI:2118733.7:2001MAY17 219 291 forward 2 TM Cytosolic
212 LI:2118733J:2001MAY17 1 108 forward 3 TM Cytosolic
212 LI:2118733J:2001MAY17 109 131 forward 3 TM Transmembrane
212 LI:2118733.7:2001MAY17 132 153 forward 3 TM Non-Cytosolic
212 LI:2118733.7:2001MAY17 154 176 forward 3 TM Transmembrane
212 LI:2118733.7:2001MAY17 177 199 forward 3 TM Cytosolic
212 LI:2118733.7:2001MAY17 200 222 forward 3 TM Transmembrane
212 LI:2118733.7:2001MAY17 223 249 forward 3 TM Non-Cytosolic
212 LI:2118733.7:2001MAY17 250 272 forward 3 TM Transmembrane
212 LI:2118733.7:2001MAY17 273 291 forward 3 TM Cytosolic
213 LI:212702.3:2001MAY17 1 615 forward 1 TM Non-Cytosolic 213 LI:212702.3:2001MAY17 616 638 forward 1 TM Transmembrane 213 LI:212702.3:2001MAY17 639 854 forward 1 TM Cytosolic 213 LI:212702.3:2001MAY17 855 874 forward 1 TM Transmembrane 213 LI:212702.3:2001MAY17 875 902 forward 1 TM Non-Cytosolic 213 LI:212702.3:2001MAY17 903 925 forward 1 . TM Transmembrane 213 LI:212702.3:2001MAY17 926 995 forward 1 TM Cytosolic 213 LI:212702.3:2001MAY17 996 1018 forward 1 TM Transmembrane 213 LI:212702.3:2001MAY17 1019 1410 forward 1 TM Non-Cytosolic 213 LI:212702.3:2001MAY17 1 19 forward 2 TM Non-Cytosolic 213 LI:212702.3:2001MAY17 20 42 forward 2 TM Transmembrane 213 LI:212702.3:2001MAY17 43 369 forward 2 TM Cytosolic 213 LT.212702.3:2001MAY17 370 392 forward 2 TM Transmembrane 213 . LI:212702.3:2001MAY17 393 547 forward 2 TM Non-Cytosolic 213 LI:212702.3:2001MAY17 548 570 forward 2 TM Transmembrane 213 LI:212702.3:2001MAY17 571 582 forward 2 TM Cytosolic 213 LI:212702.3:2001MAY17 583' 605 forward 2 TM Transmembrane 213 LI:212702.3:2001MAY17 606 614 forward 2 TM Non-Cytosolic 213 LT.212702.3:2001MAY17 615 637 forward 2 TM Transmembrane 213 LI:212702.3:2001MAY17 638 835 forward 2 TM Cytosolic 213 LT.212702.3:2001MAY17 836 855 forward 2 TM Transmembrane 213 LI:212702.3:2001MAY17 856 1410 forward 2 TM Non-Cytosolic 213 LI:212702.3:2001MAY17 1 19 forward 3 TM Cytosolic 213 LI:212702.3:2001MAY17 20 42 forward 3 TM Transmembrane
213 LI:212702.3:2001MAY17 43 1409 forward 3 TM Non-Cytosolic
214 LI:2207871.10:2001MAY17 1 74 forward 2 TM Cytosolic 214 LI:2207871.10:2001MAY17 75 97 forward 2 TM Transmembrane 214 LI:2207871.10:2001MAY17 98 101 forward 2 TM Non-Cytosolic 214 LI:2207871.10:2001MAY17 102 121 forward 2 TM Transmembrane 214 LI:2207871.10:2001MAY17 122 132 forward 2 TM Cytosolic 214 LI:2207871.10:2001MAY17 133 155 forward 2 TM Transmembrane 214 LI:2207871.10:2001MAY17 156 169 forward 2 TM Non-Cytosolic 214 LI:2207871.10:2001MAY17 170 187 forward 2 TM Transmembrane 214 LL2207871.10:2001 MAY 17 188 193 forward 2 TM Cytosolic 214 LI:2207871.10:2001MAY17 194 216 forward 2 TM Transmembrane
214 LI:2207871.10:2001MAY17 217 629 forward 2 TM Non-Cytosolic
215 LI:2207876.5:2001MAY17 1 63 forward 2 TM Cytosolic TABLE 2
SEQ D NO: Template ID Start Stop Frame Domain Type Topology
216 LI:2208743.1:2001MAY17 1 115 forward 1 TM Non-Cytosolic
216 LI:2208743.1:2001MAY17 116 138 forward 1 TM Transmembrane
216 LI:2208743.1:2001MAY17 139 226 forward 1 TM Cytosolic
216 LI:2208743.1:2001MAY17 227 249 forward 1 TM Transmembrane
216 LI:2208743.1:2001MAY17 250 288 forward 1 TM Non-Cytosolic
217 LI:2208744.1:2001MAY17 1 12 forward 1 TM Cytosolic
217 LI:2208744.1:2001MAY17 13 35 forward 1 TM Transmembrane
217 LI:2208744.1:2001MAY17 36 538 forward 1 TM Non-Cytosolic
218 LI:230905.3:2001MAY17 1 252 forward 2 TM Non-Cytosolic
218 LI:230905.3:2001MAY17 253 275 forward 2 TM Transmembrane
218 LI:230905.3:2001MAY17 276 290 forward 2 TM Cytosolic
218 LT.230905.3:2001MAY17 291 313 forward 2 TM Transmembrane
218 LI:230905.3:2001MAY17 314 327 forward 2 TM Non-Cytosolic
218 LI:230905.3:2001MAY17 328 350 forward 2 TM Transmembrane
218 LT.230905.3:2001MAY17 351 373 forward 2 TM Cytosolic
218 LI:230905.3:2001MAY17 1 4 forward 3 TM Cytosolic
218 LI:230905.3:2001MAY17 5 27 forward 3 TM Transmembrane
218 LI:230905.3:2001MAY17 28 31 forward 3 TM Non-Cytosolic
218 LI:230905.3:2001MAY17 32 54 forward 3 TM Transmembrane
218 LI:230905.3:2001MAY17 55 248 forward 3 TM Cytosolic
218 LI:230905.3:2001MAY17 249 271 forward 3 TM Transmembrane
218 LI:230905.3:2001MAY17 272 285 forward 3 TM Non-Cytosolic
218 LI:230905.3:2001MAY17 286 308 forward 3 TM Transmembrane
218 LI:230905.3:2001MAY17 309 372 forward 3 TM Cytosolic
219 LI:235233.95:2001MAY17 1 19 forward 1 TM Cytosolic
219 LI:235233.95:2001MAY17 20 42 forward 1 TM Transmembrane
219 LI:235233.95:2001MAY17 43 307 forward 1 TM Non-Cytosolic
220 LI:235359.24:2001MAY17 1 149 forward 3 TM Cytosolic
220 LI:235359.24:2001MAY 17 150 172 forward 3 TM Transmembrane
220 LI:235359.24:2001MAY17 173 186 forward 3 TM Non-Cytosolic
220 LI:235359.24:2001MAY17 187 206 forward 3 TM Transmembrane
220 LI:235359.24:2001MAY17 207 335 forward 3 TM Cytosolic
221 LI:238365.6:2001MAY17 1 437 forward 1 TM Non-Cytosolic
221 LI:238365.6:2001MAY17 438 460 forward 1 TM Transmembrane
221 LI:238365.6:2001MAY17 461 465 forward 1 TM Cytosolic
222 LI:260259.23:2001MAY17 1 57 forward 1 TM Cytosolic
222 LI:260259.23:2001MAY17 1 57 forward 2 TM Cytosolic
222 LL260259.23 :2001M A Y 17 1 56 forward 3 TM Cytosolic
223 LL321069.2.2001MAY17 1 181 forward 1 TM Non-Cytosolic
223 LI:321069.2:2001MAY17 182 204 forward 1 TM Transmembrane
223 LI:321069.2:2001MAY17 205 449 forward 1 TM Cytosolic
223 LI:321069.2:2001MAY17 450 469 forward 1 TM Transmembrane
223 LI:321069.2:2001MAY17 470 478 forward 1 TM Non-Cytosolic
223 L 321069.2.2001MAY17 479 501 forward 1 TM Transmembrane
223 LI:321069.2:2001MAY17 502 507 forward 1 TM Cytosolic
223 LI:321069.2:2001MAY17 508 530 forward 1 TM Transmembrane
223 LI:321069.2:2001MAY17 531 631 forward 1 TM Non-Cytosolic
223 LI:321069.2:2001MAY17 632 654 forward 1 TM Transmembrane
223 LI:321069.2:2001MAY17 655 666 forward 1 TM Cytosolic
223 LI:321069.2:2001MAY17 667 689 forward 1 TM Transmembrane
223 LI:321069.2:2001MAY17 690 693 forward 1 TM Non-Cytosolic
223 LI:321069.2:2001MAY 17 694 713 forward 1 TM Transmembrane
223 LI:321069.2:2001MAY17 714 1071 forward 1 TM Cytosolic
223 LI:321069.2:2001MAY17 1072 1094 forward 1 TM Transmembrane 14' TABLE 2
SEQ D NO: Template ID Start Stop Frame Domain Type Topology
223 LI:321069.2:2001MAY17 1095 1103 forward 1 TM Non-Cytosolic
223 LI:321069.2:2001MAY17 1104 1123 forward 1 TM Transmembrane
223 LI:321069.2:2001MAY17 1124 1129 forward 1 TM Cytosolic
223 LI:321069.2:2001MAY17 1130 1152 forward 1 TM Transmembrane
223 LI:321069.2:2001MAY17 1153 1344 forward 1 TM Non-Cytosolic
223 LI:321069.2:2001MAY17 1 630 forward 2 TM Non-Cytosolic
223 LI:321069.2:2001MAY17 631 653 forward 2 TM Transmembrane
223 LI:321069.2:2001MAY17 654 665 forward 2 TM Cytosolic
223 LI:321069.2:2001MAY17 666 688 forward 2 . TM Transmembrane
223 L 321069.2:2001MAY 17 689 702 forward 2 TM Non-Cytosolic
223 LI:321069.2:2001MAY17 703 725 forward 2 TM Transmembrane
223 LI:321069.2:2001MAY17 726 886 forward 2 TM Cytosolic
223 LI:321069.2:2001MAY17 887 909 forward 2 TM Transmembrane
223 LI:321069.2:2001MAY17 910 1343 forward 2 TM Non-Cytosolic
223 LI:321069.2:2001MAY17 1 634 forward 3 TM Non-Cytosolic
223 LI:321069.2:2001MAY17 635 653 forward 3 TM Transmembrane
223 LI:321069.2:2001MAY17 654 664 forward 3 TM Cytosolic
223 LI:321069.2:2001MAY17 665 687 forward 3 TM Transmembrane
223 LI:321069.2:2001MAY17 688 806 forward 3 TM Non-Cytosolic
223 LI:321069.2:2001MAY17 807 829 forward 3 TM Transmembrane
223 LI:321069.2:2001MAY17 830 1078 forward 3 TM Cytosolic
223 LI:321069.2:2001MAY17 1079 1101 forward 3 TM Transmembrane
223 LI:321069.2:2001MAY17 1102 1127 forward 3 TM Non-Cytosolic
223 LI:321069.2:2001MAY17 1128 1150 forward 3 TM Transmembrane
223 LI:321069.2:2001MAY17 1151 1343 forward 3 TM Cytosolic
224 LI:331499.8:2001MAY17 1 480 forward 1 TM Non-Cytosolic
224 LI:331499.8:2001MAY17 481 503 forward 1 TM Transmembrane
224 LI:331499.8:2001MAY17 504 564 forward 1 TM Cytosolic
224 LI:331499.8:2001MAY17 565 584 forward 1 TM Transmembrane
224 LI:331499.8:2001MAY17 585 593 forward 1 TM Non-Cytosolic
224 LI:331499.8:2001MAY17 594 613 forward 1 TM Transmembrane
224 LI:331499.8:2001MAY17 614 614 forward 1 TM Cytosolic
224 LI:331499.8:2001MAY17 1 592 forward 3 TM Non-Cytosolic
224 LI:331499.8:2001MAY17 593 612 forward 3 TM Transmembrane
224 LI:331499.8:2001MAY17 613 613 forward 3 TM Cytosolic
225 LI:332176.8:2001MAY17 1 124 forward 3 TM Non-Cytosolic
225 LI:332176.8:2001MAY17 125 147 forward 3 TM Transmembrane
225 LI:332176.8:2001MAY17 148 238 forward 3 TM Cytosolic
225 LI:332176.8:2001MAY17 239 261 forward 3 TM Transmembrane
225 LI:332176.8:2001MAY17 262 367 forward 3 TM Non-Cytosolic
225 LI:332176.8:2001MAY17 368 390 forward 3 TM Transmembrane
225 LI:332176.8:2001MAY17 391 457 forward 3 TM Cytosolic
226 LI:333952.7:2001MAY17 1 68 forward 1 TM Cytosolic
226 LI:333952J:2001MAY17 69 91 forward 1 TM Transmembrane
226 LI:333952.7:2001MAY17 92 105 forward 1 TM Non-Cytosolic
226 ' LI:333952J:2001MAY17 106 128 forward 1 TM Transmembrane
226 LI:333952J:2001MAY17 129 134 forward 1 TM Cytosolic
226 LI:333952.7:2001MAY17 135 157 forward 1 TM Transmembrane
226 LI:333952J:2001MAY17 158 352 forward 1 TM Non-Cytosolic
227 LI:338428.2:2001MAY17 1 71 forward 3 TM Non-Cytosolic
227 LI:338428.2:2001MAY17 72 94 forward 3 TM Transmembrane
227 LI:338428.2:2001MAY17 95 127 forward 3 TM Cytosolic
228 LI:343869.2:2001MAY 17 1 938 forward 1 TM Non-Cytosolic
228 LI:343869.2:2001MAY17 939 961 forward 1 TM Transmembrane TABLE 2
SEQ D NO: Template ID Start Stop Frame Domain Type Topology
228 LI:343869.2:2001MAY17 962 967 forward 1 TM Cytosolic 228 LI:343869.2:2001MAY17 968 990 forward 1 TM Transmembrane 228 LI:343869.2:2001MAY17 991 1154 forward 1 TM Non-Cytosolic 228 LT.343869.2:2001MAY17 1155 1172 forward 1 TM Transmembrane 228 LI:343869.2:2001MAY17 1173 1183 forward 1 TM Cytosolic 228 LI:343869.2:2001MAY17 1184 1206 forward 1 TM Transmembrane 228 LI:343869.2:2001MAY17 1207 1237 forward 1 TM Non-Cytosolic 228 LI:343869.2:2001MAY17 1238 1260 forward 1 TM Transmembrane 228 LI:343869.2:2001MAY17 1261 1334 forward 1 TM Cytosolic 228 LI:343869.2:2001MAY17 1335 1354 forward 1 TM Transmembrane 228 LI:343869.2:2001MAY17 1355 1363 forward 1 TM Non-Cytosolic 228 LI:343869.2:2001MAY17 1364 1383 forward 1 TM Transmembrane 228 LI:343869.2:2001MAY17 1384 1651 forward 1 TM Cytosolic 228 LI:343869.2:2001MAY17 1 957 forward 3 TM Non-Cytosolic 228 LI:343869.2:2001MAY17 958 980 forward 3 TM Transmembrane 228 LI:343869.2:2001MAY17 981 1126 forward 3 TM Cytosolic 228 LI:343869.2:2001MAY17 1127 1149 forward 3 TM Transmembrane 228 LI:343869.2:2001MAY17 1150 1183 forward 3 TM Non-Cytosolic 228 LI:343869.2:2001MAY17 1184 1206 forward 3 TM Transmembrane 228 LI:343869.2:2001MAY17 1207 1236 forward 3 TM Cytosolic 228 LI:343869.2:2001MAY17 1237 1259 forward 3 TM Transmembrane 228 LI:343869.2:2001MAY17 1260 1650 forward 3 TM Non-Cytosolic 229 LI:363532.1:2001MAY17 1 77 forward 3 TM Non-Cytosolic 229 LI:363532.1:2001MAY17 78 95 forward 3 TM Transmembrane 229 LI:363532.1:2001MAY17 96 189 forward 3 TM Cytosolic 229 LI:363532.1:2001MAY17 190 209 forward 3 TM Transmembrane 229 LI:363532.1:2001MAY17 210 234 forward 3 TM Non-Cytosolic 229 LI:363532.1:2001MAY17 235 257 forward 3 TM Transmembrane 229 LI:363532.1:2001MAY17 258 266 forward 3 TM Cytosolic 230 LI:398153.37:2001MAY17 1 139 forward 2 TM Cytosolic 230 LI:398153.37:2001MAY17 140 162 forward 2 TM Transmembrane 230 LI:398153.37:2001MAY17 163 287 forward 2 TM Non-Cytosolic 231 LI:416650.1:2001MAY17 1 26 forward 1 TM Cytosolic 231 LI:416650.1:2001MAY17 27 49 forward 1 TM Transmembrane 231 LI:416650.1:2001MAY17 50 231 forward 1 TM Non-Cytosolic 231 LT.416650.1:2001MAY17 1 30 forward 3 TM Cytosolic 231 LI:416650.1:2001MAY17 31 53 forward 3 TM Transmembrane 231 LI:416650.1:2001MAY17 54 230 forward 3 TM Non-Cytosolic 232 LI:444767.32:2001MAY17 1 24 forward 1 TM Non-Cytosolic 232 LI:444767.32:2001MAY17 25 47 forward 1 TM Transmembrane 232 LI:444767.32:2001MAY17 48 192 forward 1 TM Cytosolic 232 LL444767.32:2001MAY17 193 215 forward 1 TM Transmembrane 232 LI:444767.32:2001MAY17 216 279 forward 1 TM Non-Cytosolic 232 LI:444767.32:2001MAY17 280 302 forward 1 TM Transmembrane 232 LI:444767.32:2001MAY17 303 440 forward 1 TM Cytosolic 232 LI:444767.32:2001MAY17 441 463 forward 1 TM Transmembrane 232 LI:444767.32:2001MAY17 464 596 forward 1 TM Non-Cytosolic 232 LI:444767.32:2001MAY17 1 12 forward 2 TM Cytosolic 232 LI:444767.32:2001MAY17 13 32 forward 2 TM Transmembrane 232 LI:444767.32:2001MAY17 33 519 forward 2 TM Non-Cytosolic 232 12:444161.32:2001 MA Y 17 520 542 forward 2 TM Transmembrane 232 LI:444767.32:2001MAY17 543 595 forward 2 TM Cytosolic 232 LI:444767.32:2001MAY 17 1 12 forward 3 TM Cytosolic 232 LI-A44161.32:200 IMA Y 17 13 35 forward 3 TM Transmembrane TABLE 2
SEQ D NO: Template ID Start Stop Frame Domain Type Topology
232 LI:444767.32:2001MAY17 36 595 forward 3 TM Non-Cytosolic
233 LI:759073.1:2001MAY17 1 9 forward 1 TM Non-Cytosolic
233 LI:759073.1:2001MAY17 10 32 forward 1 TM Transmembrane
233 LI:759073.1 :2001MAY17 33 210 forward 1 TM Cytosolic
233 LI:759073.1:2001MAY17 211 233 forward 1 TM Transmembrane
233 LI:759073.1:2001MAY17 234 252 forward 1 TM Non-Cytosolic
233 LI:759073.1:2001MAY17 253 270 forward 1 TM Transmembrane
233 LI:759073.1:2001MAY17 271 441 forward 1 TM Cytosolic
233 LI:759073.1:2001MAY17 442 464 forward 1 TM Transmembrane
233 LI:759073.1:2001MAY17 465 574 forward 1 TM Non-Cytosolic
233 LI:759073.1:2001MAY17 1 83 forward 2 TM Cytosolic
233 LTJ59073.1 :2001MAY17 84 106 forward 2 TM Transmembrane
233 LI:759073.1:2001MAY17 107 129 forward 2 TM Non-Cytosolic
233 LI:759073.1:2001MAY17 130 152 forward 2 TM Transmembrane
233 LI:759073.1:2001MAY17 153 156 forward 2 TM Cytosolic
233 LI:759073.1:2001MAY17 157 179 forward 2 TM Transmembrane
233 LI:759073.1:2001MAY17 180 393 forward 2 TM Non-Cytosolic
233 LI:759073.1:2001MAY17 394 416 forward 2 TM Transmembrane
233 LI:759073.1:2001MAY17 417 427 forward 2 TM Cytosolic
233 LI:759073.1:2001MAY17 428 450 forward 2 TM Transmembrane
233 LI:759073.1:2001MAY17 451 574 forward 2 TM Non-Cytosolic
233 LI:759073.1:2001MAY17 1 79 forward 3 TM Cytosolic
233 LI:759073.1:2001MAY17 80 102 forward 3 TM Transmembrane
233 LI:759073.1 :2001MAY17 103 116 forward 3 TM Non-Cytosolic
233 LI:759073.1:2001MAY17 117 139 forward 3 TM Transmembrane
233 LI:759073.1:2001MAY17. 140 150 forward 3 TM Cytosolic
233 LI:759073.1:2001MAY17 151 170 forward 3 TM Transmembrane
233 LI:759073.1:2001MAY17 171 573 forward 3' TM Non-Cytosolic
234 LI:759902.4:2001MAY17 1 3 forward 1 TM Non-Cytosolic
234 LI:759902.4:2001MAY17 4 26 forward 1 TM Transmembrane
234 LI:759902.4:2001MAY17 27 100 forward 1 TM Cytosolic
235 LI:762268.1:2001MAY17 1 49 forward 1 TM Cytosolic
235 LI:762268.1:2001MAY17 50 72 forward 1 TM Transmembrane
235 LI:762268.1:2001MAY17 73 86 forward 1 TM Non-Cytosolic
235 LI:762268.1:2001MAY17 87 109 forward 1 TM Transmembrane
235 LI:762268.1:2001MAY17 110 136 forward 1 TM Cytosolic
235 LI:762268.1:2001MAY17 137 159 forward 1 TM Transmembrane
235 LI:762268.1:2001MAY17 160 594 forward 1 TM ■ Non-Cytosolic
235 LI:762268.1:2001MAY17 1 16 forward 2 TM Cytosolic
235 LI:762268.1:2001MAY17 17 39 forward 2 TM Transmembrane
235 LI:762268.1:2001MAY17 40 48 forward 2 TM Non-Cytosolic
235 LI:762268.1:2001MAY17 49 71 forward 2 TM Transmembrane
235 LI:762268.1:2001MAY17 72 91 forward 2 TM Cytosolic
235 LI:762268.1:2001MAY17 92 111 forward 2 TM Transmembrane
235 LI:762268.1:2001MAY17 112 125 forward 2 TM Non-Cytosolic
235 LI:762268.1:2001MAY17 126 148 forward 2 TM Transmembrane
235 LI:762268.1:2001MAY17 149 167 forward 2 TM Cytosolic
235 LI:762268.1:2001MAY17 168 190 forward 2 TM Transmembrane
235 LI:762268.1:2001MAY17 191 593 forward 2 TM Non-Cytosolic
235 LI:762268.1:2001MAY17 1 45 forward 3 TM Non-Cytosolic
235 LI:762268.1:2001MAY17 46 68 forward 3 TM Transmembrane
235 LI:762268.1:2001MAY17 69 79 forward 3 TM Cytosolic
235 LI:762268.1:2001MAY17 80 102 forward 3 TM Transmembrane
235 LI:762268.1:2001MAY17 103 593 forward 3 TM Non-Cytosolic TABLE 2
SEQ D NO: Template ID Start Stop Frame Domain Type Topology
236 LI:813699.1 :2001MAY17 1 394 forward 2 TM Cytosolic
236 LI:813699.1 :2001MAY17 395 417 forward 2 TM Transmembrane
236 LI: 813699.1 :2001 MAY 17 418 457 forward 2 TM Non-Cytosolic
237 LT.024142.16:2001MAY17 1 49 forward 1 TM Non-Cytosolic
237 LI:024142.16:2001MAY17 50 72 forward 1 TM Transmembrane
237 LI:024142.16:2001MAY17 73 311 forward 1 TM Cytosolic
237 LI:024142.16:2001MAY17 312 334 forward 1 TM Transmembrane
237 LI:024142.16:2001MAY17 335 348 forward 1 TM Non-Cytosolic
237 LI:024142.16:2001MAY17 349 371 forward 1 TM Transmembrane
237 LI:024142.16:2001MAY17 372 377 forward 1 TM Cytosolic
237 LI:024142.16:2001MAY17 378 400 forward 1 TM Transmembrane
237 LI:024142.16:2001MAY17 401 1142 forward 1 TM Non-Cytosolic
237 LI:024142.16:2001MAY17 1 279 forward 2 TM Cytosolic
237 LI:024142.16:2001MAY17 280 299 forward 2 TM Transmembrane
237 LI:024142.16:2001MAY17 300 313 forward 2 TM Non-Cytosolic
237 LI:024142.16:2001MAY17 314 348 forward 2 TM Transmembrane
237 LI:024142.16:2001MAY17 349 360 forward 2 TM Cytosolic
237 LI:024142.16:2001MAY17 361 383 forward 2 TM Transmembrane
237 LI:024142.16:2001MAY17 384 397 forward 2 TM Non-Cytosolic
237 LI:024142.16:2001MAY17 398 420 forward 2 TM Transmembrane
237 LI:024142.16:2001MAY17 421 536 forward 2 TM Cytosolic
237 LI:024142.16:2001MAY17 537 559 forward 2 TM Transmembrane
237 LI:024142.16:2001MAY17 560 586 forward 2 TM Non-Cytosolic
237 LI:024142.16:2001MAY17 587 609 forward 2 TM Transmembrane
237 LI:024142.16:2001MAY17 610 636 forward 2 TM Cytosolic
237 LI:024142.16:2001MAY17 637 659 forward 2 TM Transmembrane
237 LI:024142.16:2001MAY17 660 1141 forward 2 TM Non-Cytosolic
237 LI:024142.16:2001MAY17 1 323 forward 3 TM Non-Cytosolic
237 LI:024142.16:2001MAY17 324 346 forward 3 TM Transmembrane
237 LI:024142.16:2001MAY17 347 352 forward 3 TM Cytosolic
237 LI:024142.16:2001MAY17 353 375 forward 3 TM Transmembrane
237 LI:024142.16:2001MAY17 376 394 forward 3 TM Non-Cytosolic
237 LI:024142.16:2001MAY17 395 414 forward 3 TM Transmembrane
237 LI:024142.16:2001MAY17 415 570 forward 3 TM Cytosolic
237 LI:024142.16:2001MAY17 571 593 forward 3 TM Transmembrane
237 LI:024142.16:2001MAY17 594 1141 forward 3 TM Non-Cytosolic
238 LI:1018424.4:2001MAY17 1 1194 forward 2 TM Non-Cytosolic
238 LI.T018424.4.-2001MAY17 1195 1217 forward 2 TM Transmembrane
238 LI:1018424.4:2001MAY17 1218 1327 forward 2 TM Cytosolic
239 LI:1085250.6:2001MAY17 1 840 forward 1 TM Non-Cytosolic
239 LI:1085250.6:2001MAY17 841 863 forward 1 TM Transmembrane
239 LI:1085250.6:2001MAY17 864 929 forward 1 TM Cytosolic
239 LI:1085250.6:2001MAY17 930 952 forward 1 TM Transmembrane
239 LI:1085250.6:2001MAY17 953 955 forward 1 TM Non-Cytosolic
239 LI:1085250.6:2001MAY17 956 978 forward 1 TM Transmembrane
239 LI: 1085250.6:2001 MAY 17 979 990 forward 1 TM Cytosolic
239 LI:1085250.6:2001MAY17 991 1013 forward 1 TM Transmembrane
239 LI:1085250.6:2001MAY17 1014 1327 forward 1 TM Non-Cytosolic
239 LI: 1085250.6:2001 MAY 17 1328 1350 forward 1 TM Transmembrane
239 LI:1085250.6:2001MAY17 1351 1369 forward 1 TM Cytosolic
239 LI: 1085250.6:2001 MAY 17 1 59 forward 2 TM Cytosolic
239 LI:1085250.6:2001MAY17 60 82 forward 2 TM Transmembrane
239 LI:1085250.6:2001MAY 17 83 515 forward 2 TM Non-Cytosolic
239 LI:1085250.6:2001MAY17 516 538 forward 2 TM Transmembrane TABLE 2
SEQ D NO: Template ID Start Stop Frame Domain Type Topology
239 LI:1085250.6:2001MAY17 539 558 forward 2 TM Cytosolic
239 LI:1085250.6:2001MAY17 559 578 forward 2 TM Transmembrane
239 LI:1085250.6:2001MAY17 579 597 forward 2 TM Non-Cytosolic
239 LI:1085250.6:2001MAY17 598 620 forward 2 TM Transmembrane
239 LI: 1085250.6:2001 MAY 17 621 803 forward 2 • TM Cytosolic
239 LI:1085250.6:2001MAY17 804 826 forward 2 TM Transmembrane
239 LI:1085250.6:2001MAY17 827 835 forward 2 TM Non-Cytosolic
239 LI:1085250.6:2001MAY17 836 858 forward 2 TM Transmembrane
239 LI:1085250.6:2001MAY17 859 878 forward 2 TM Cytosolic
239 LI:1085250.6:2001MAY17 879 901 forward 2 TM Transmembrane
239 LI:1085250.6:2001MAY17 902 910 forward 2 TM Non-Cytosolic
239 LI:1085250.6:2001MAY17 911 933 forward 2 TM Transmembrane
239 LI.T085250.6.-2001MAY17 934 986 forward 2 TM Cytosolic
239 LI:1085250.6:2001MAY17 987 1009 forward 2 TM Transmembrane
239 LI:1085250.6:2001MAY17 1010 1211 forward 2 TM Non-Cytosolic
239 LI:1085250.6:2001MAY17 1212 1234 forward 2 TM Transmembrane
239 LI:1085250.6:2001MAY17 1235 1306 forward 2 TM Cytosolic
239 LI.T085250.6:2001MAY17 1307 1329 forward 2 TM Transmembrane
239 LI:1085250.6:2001MAY17 1330 1338 forward 2 TM Non-Cytosolic
239 LI:1085250.6:2001MAY17 1339 1361 forward 2 TM Transmembrane
239 LI:1085250.6:2001MAY17 1362 1368 forward 2 TM Cytosolic
239 LI:1085250.6:2001MAY17 1 546 forward 3 TM Non-Cytosolic
239 LI:1085250.6:2001MAY17 547 569 forward 3 TM Transmembrane
239 LI:1085250.6:2001MAY17 570 589 forward 3 TM Cytosolic
239 LI:1085250.6:2001MAY17 590 612 forward 3 TM Transmembrane
239 LI: 1085250.6:2001 MAY 17 613 911 forward 3 TM Non-Cytosolic
239 LI:1085250.6:2001MAY17 912 931 forward 3 TM Transmembrane
239 LI.T085250.6:2001MAY17 932 1203 forward 3 TM Cytosolic
239 LI:1085250.6:2001MAY17 1204 1226 forward 3 TM Transmembrane
239 LI:1085250.6:2001MAY17 1227 1240 forward 3 TM Non-Cytosolic
239 LI:1085250.6:2001MAY17 1241 1260 forward 3 TM Transmembrane
239 LI:1085250.6:2001MAY17 1261 1319 forward 3 TM Cytosolic
239 LI:1085250.6:2001MAY17 1320 1342 forward 3 TM Transmembrane
239 LT.1085250.6:2001MAY17 1343 1368 forward 3 TM Non-Cytosolic
240 LI:179233.63:2001MAY17 1 173 forward 1 TM Cytosolic
240 LI:179233.63:2001MAY17 174 196 forward 1 TM Transmembrane
240 LI:179233.63:2001MAY17 197 210 forward 1 TM Non-Cytosolic
240 LI.T79233.63:2001MAY17 211 233 forward 1 TM Transmembrane
240 LI:179233.63:2001MAY17 234 347 forward 1 TM Cytosolic
241 LI:2207125.3:2001MAY17 1 12 forward 1 TM Cytosolic
241 LI:2207125.3:2001MAY17 13 35 forward 1 TM Transmembrane
241 LI:2207125.3:2001MAY17 36 204 forward 1 TM Non-Cytosolic
242 LI:235153.44:2001MAY 17 1 753 forward 2 TM Non-Cytosolic
242 LI:235153.44:2001MAY17 754 776 forward 2 TM Transmembrane
242 LI:235153.44:2001MAY17 111 1029 forward 2 TM Cytosolic
243 LI:007101.10:2001MAY17 1 528 forward 3 TM Non-Cytosolic
243 LI:007101.10:2001MAY17 529 551 forward 3 TM Transmembrane
243 LI:007101.10:2001MAY17 552 694 forward 3 TM Cytosolic
244 LL008541.2:2001 MAY 17 1 79 forward 2 TM Cytosolic
244 LI:008541.2:2001MAY17 80 102 forward 2 TM Transmembrane
244 LI:008541.2:2001MAY17 103 568 forward 2 TM Non-Cytosolic
245 LI:009658.13:2001MAY 17 1 74 forward 1 TM Cytosolic
245 LI:009658.13:2001MAY 17 75 94 forward 1 TM Transmembrane
245 LI:009658.13:2001MAY 17 95 1317 forward 1 TM Non-Cytosolic TABLE 2
SEQ D NO: Template ID Start Stop Frame Domain Type Topology
245 LI:009658.13:2001MAY17 1318 1340 forward 1 TM Transmembrane
245 LI:009658.13:2001MAY17 1341 1362 forward 1 TM Cytosolic
245 LI:009658.13:2001MAY17 1363 1385 forward 1 TM Transmembrane
245 LI:009658.13:2001MAY17 1386 1423 forward 1 TM Non-Cytosolic
245 LI:009658.13:2001MAY17 1 927 forward 2 TM Non-Cytosolic
245 LI:009658.13:2001MAY17 928 950 forward 2 TM Transmembrane
245 LI:009658.13:2001MAY17 951 956 forward 2 TM Cytosolic
245 LI:009658.13:2001MAY17 957 979 forward 2 TM Transmembrane
245 LI:009658.13:2001MAY17 980 1321 forward 2 TM Non-Cytosolic
245 LI:009658.13:2001MAY17 1322 1344 forward 2 TM Transmembrane
245 LI:009658.13:2001MAY17 1345 1364 forward 2 TM Cytosolic
245 LI:009658.13:2001MAY17 1365 1387 forward 2 TM Transmembrane
245 LI:009658.13:2001MAY17 1388 1423 forward 2 TM Non-Cytosolic
245 LI:009658.13:2001MAY17 1 706 forward 3 TM Non-Cytosolic
245 LI:009658.13:2001MAY17 707 729 forward 3 TM Transmembrane
245 LI:009658.13:2001MAY17 730 749 forward 3 TM Cytosolic
245 LI:009658.13:2001MAY17 750 772 forward 3 TM Transmembrane
245 LI:009658.13:2001MAY17 773 791 forward 3 TM Non-Cytosolic
245 LI:009658.13:2001MAY17 792 811 forward 3 TM Transmembrane
245 LI:009658.13:2001MAY17 812 934 forward 3 TM Cytosolic
245 LI:009658.13:2001MAY17 935 957 forward 3 TM Transmembrane
245 LI:009658.13:2001MAY17 958 971 forward 3 TM Non-Cytosolic
245 LI:009658.13:2001MAY17 972 994 forward 3 TM Transmembrane
245 LI:009658.13:2001MAY17 995 1319 forward 3 TM Cytosolic
245 LI:009658.13:2001MAY17 1320 1342 forward 3 TM Transmembrane
245 LI:009658.13:2001MAY17 1343 1356 forward 3 TM Non-Cytosolic
245 LI:009658.13:2001MAY17 1357 1379 forward 3 TM Transmembrane
245 LI:009658.13:2001MAY17 1380 1422 forward 3 TM Cytosolic
246 LI:020012.14:2001MAY17 1 423 forward 1 TM Cytosolic 246 LI:020012.14:2001MAY17 424 446 forward 1 TM Transmembrane 246 LI:020012.14:2001MAY17 447 449 forward 1 TM Non-Cytosolic 246 LI:020012.14:2001MAY17 450 469 forward 1 TM Transmembrane 246 LI:020012.14:2001MAY17 470 884 forward 1 TM Cytosolic 246 LI:020012.14:2001MAY17 885 907 forward 1 TM Transmembrane 246 LI:020012.14:2001MAY17 908 955 forward 1 TM Non-Cytosolic 246 LI:020012.14:2001MAY17 956 978 forward 1 TM Transmembrane 246 LI:020012.14:2001MAY17 979 1013 forward 1 TM Cytosolic 246 LI:020012.14:2001MAY17 1 582 forward 2 TM Non-Cytosolic 246 LI:020012.14:2001MAY17 583 602 forward 2 TM Transmembrane 246 LI:020012.14:2001MAY17 603 614 forward 2 TM Cytosolic 246 LI:020012.14:2001MAY17 615 637 forward 2 TM Transmembrane 246 LI:020012.14:2001MAY17 638 695 forward 2 TM Non-Cytosolic 246 LI:020012.14:2001MAY17 696 718 forward 2 TM Transmembrane 246 LI:020012.14:2001MAY17 719 724 forward 2 TM Cytosolic 246 LI:020012.14:2001MAY17 725 747 forward 2 TM Transmembrane 246 LI:020012.14:2001MAY17 748 761 forward 2 TM Non-Cytosolic 246 LI:020012.14:2001MAY17 762 781 forward 2 TM Transmembrane 246 LI:020012.14:2001MAY17 782 953 forward 2 TM Cytosolic 246 LI:020012.14:2001MAY17 954 976 forward 2 TM Transmembrane 246 LI:020012.14:2001MAY17 977 1012 forward 2 TM Non-Cytosolic 246 LI:020012.14:2001MAY17 1 725 forward 3 TM Non-Cytosolic 246 LI:020012.14:2001MAY17 726 748 forward 3 TM Transmembrane 246 LI:020012.14:2001MAY17 749 760 forward 3 TM Cytosolic 246 LI:020012.14:2001MAY17 761 780 forward 3 TM Transmembrane TABLE 2
SEQ D NO Template ID Start Stop Frame Domain Type Topology
246 LI:020012.14:2001MAY17 781 814 forward 3 TM Non-Cytosolic
246 LI:020012.14:2001MAY17 815 837 forward 3 TM Transmembrane
246 LI.O20012.14.-2001MAY17 838 849 forward 3 TM Cytosolic
246 LI:020012.14:2001MAY17 850 869 forward 3 TM Transmembrane
246 LI:020012.14:2001MAY17 870 883 forward 3 TM Non-Cytosolic
246 LI:020012.14:2001MAY17 884 906 forward 3 TM Transmembrane
246 LI:020012.14:2001MAY17 907 926 forward 3 TM Cytosolic
246 LI:020012.14:2001MAY17 927 946 forward 3 TM Transmembrane
246 LI:020012.14:2001MAY17 947 955 forward 3 TM Non-Cytosolic
246 LI:020012.14:2001MAY17 956 978 forward 3 TM Transmembrane
246 LI:020012.14:2001MAY17 979 1012 forward 3 TM Cytosolic
247 LI:020691.1 2001MAY17 1 19 forward 1 TM Cytosolic
247 LL020691.1 2001MAY17 20 42 forward 1 TM Transmembrane
247 LL020691.1 2001MAY17 43 255 forward 1 TM Non-Cytosolic
247 LL020691.1 2001MAY17 1 12 forward 2 TM Cytosolic
247 LL020691.1 2001MAY17 13 35 forward 2 TM Transmembrane
247 LL020691.1 2001MAY17 36 255 forward 2 TM Non-Cytosolic
248 LI:021188.12:2001MAY17 1 171 forward 3 TM Non-Cytosolic
248 LI:021188.12:2001MAY17 172 194 forward 3 TM Transmembrane
248 LI:021188.12:2001MAY17 195 377 forward 3 TM Cytosolic
249 LI:021324.4:2001MAY17 1 53 forward 1 TM Cytosolic
249 LI:021324.4:2001MAY17 54 76 forward 1 TM Transmembrane
249 LT.021324.4:2001MAY17 77 90 forward 1 TM Non-Cytosolic
249 LI:021324.4:2001MAY17 91 113 forward 1 TM Transmembrane
249 LI:021324.4:2001MAY17 114 227 forward 1 TM Cytosolic
249 LI:021324.4:2001MAY17 228 250 forward 1 TM Transmembrane
249 LI:021324.4:2001MAY17 251 710 forward 1 TM Non-Cytosolic
250 LT.021834.15:2001MAY17 1 552 forward 2 TM Non-Cytosolic
250 LI:021834.15:2001MAY17 553 575 forward 2 TM Transmembrane
250 LI:021834.15:2001MAY17 576 595 forward 2 TM Cytosolic
250 LL021834.15 :2001MAY17 596 618 forward 2 TM Transmembrane
250 LI:021834.15:2001MAY17 619 771 forward 2 TM Non-Cytosolic
251 LL024841.1 2001MAY17 1 752 forward 1 TM Non-Cytosolic
251 LL024841.1 2001MAY17 753 775 forward 1 TM Transmembrane
251 LL024841.1 2001MAY17 776 1017 forward 1 TM Cytosolic
251 LL024841.1 2001MAY17 1018 1040 forward 1 TM Transmembrane
251 LL024841.1 2001MAY17 1041 1054 forward 1 TM Non-Cytosolic
251 LL024841.1 2001MAY17 1055 1077 forward 1 TM Transmembrane
251 LT.024841.1 2001MAY17 1078 1129 forward 1 TM Cytosolic
251 LT.024841.1 2001MAY17 1 748 forward 2 TM Non-Cytosolic
251 LL024841.1 2001MAY17 749 771 forward 2 TM Transmembrane
251 LL024841.1 2001MAY17 772 1015 forward 2 TM Cytosolic
251 LI.024841.1 2001MAY17 1016 1038 forward 2 TM Transmembrane
251 L 024841.1 2001MAY17 1039 1128 forward 2 TM Non-Cytosolic
252 LI:025724.12:2001MAY17 1 446 forward 1 TM Non-Cytosolic
252 LI:025724.12:2001MAY17 447 469 forward 1 TM Transmembrane
252 LI:025724.12:2001MAY17 470 685 forward 1 TM Cytosolic
252 LI:025724.12:2001MAY17 686 703 forward 1 TM Transmembrane
252 LI:025724.12:2001MAY17 704 730 forward 1 TM Non-Cytosolic
252 LI:025724.12:2001MAY17 731 753 forward 1 TM Transmembrane
252 LI:025724.12:2001MAY17 754 895 forward 1 TM Cytosolic
252 LI:025724.12:2001MAY17 896 918 forward 1 TM Transmembrane
252 LI:025724.12:2001MAY17 919 984 forward 1 TM Non-Cytosolic
252 LL025724.1 2:2001MAY17 985 1007 forward 1 TM Transmembrane TABLE 2
SEQ D NO: Template ID Start Stop Frame Domain Type Topology
252 LI:025724.12:2001MAY17 1008 1018 forward 1 TM Cytosolic
252 LI:025724.12:2001MAY17 1019 1041 forward 1 TM Transmembrane
252 LI:025724.12:2001MAY17 1042 1074 forward 1 TM Non-Cytosolic
252 LI:025724.12:2001MAY17 1075 1097 forward 1 TM Transmembrane
252 LI:025724.12:2001MAY17 1098 1201 forward 1 TM Cytosolic
252 LI:025724.12:2001MAY17 1 457 forward 2 TM Non-Cytosolic
252 LI:025724.12:2001MAY17 458 480 forward 2 TM Transmembrane
252 LI:025724.12:2001MAY17 481 695 forward 2 TM Cytosolic
252 LI:025724.12:2001MAY17 696 718 forward 2 TM Transmembrane
252 LI:025724.12:2001MAY17 719 732 forward 2 TM Non-Cytosolic
252 LI:025724.12:2001MAY17 * 733 755 forward 2 TM Transmembrane
252 LI:025724.12:2001MAY17 756 777 forward 2 TM Cytosolic
252 LI:025724.12:2001MAY17 778 797 forward 2 TM Transmembrane
252 LI:025724.12:2001MAY17 798 806 forward 2 TM Non-Cytosolic
252 LI:025724.12:2001MAY17 807 829 forward 2 TM Transmembrane
252 LI:025724.12:2001MAY17 830 921 forward 2 TM Cytosolic
252 LI:025724.12:2001MAY17 922 939 forward 2 TM Transmembrane
252 LI:025724.12:2001MAY17 940 1018 forward 2 TM Non-Cytosolic
252 LI:025724.12:2001MAY17 1019 1041 forward 2 TM Transmembrane
252 LI:025724.12:2001MAY17 1042 1133 forward 2 TM Cytosolic
252 LI:025724.12:2001MAY17 1134 1156 forward 2 TM Transmembrane
252 LI:025724.12:2001MAY17 1157 1165 forward 2 TM Non-Cytosolic
252 LI:025724.12:2001MAY17 1166 1185 forward 2 TM Transmembrane
252 LI:025724.12:2001MAY17 1186 1201 forward 2 TM Cytosolic
252 LI:025724.12:2001MAY17 1 729 forward 3 TM Non-Cytosolic
252 LI:025724.12:2001MAY17 730 752 forward 3 TM Transmembrane
252 LI:025724.12:2001MAY17 753 764 forward 3 TM Cytosolic
252 LI:025724.12:2001MAY17 765 * .,787 forward 3 ■TM Transmembrane
252 LI:025724.12:2001MAY17 788 - 806 forward 3 TM Non-Cytosolic
252 LI:025724.12:2001MAY17 807 829 forward 3 TM Transmembrane
252 LI:025724.12:2001MAY17 830 873 forward 3 TM Cytosolic
252 LI:025724.12:2001MAY17 874 896 forward 3 TM Transmembrane
252 LI:025724.12:2001MAY17 897 910 forward 3 TM Non-Cytosolic
252 LI:025724.12:2001MAY17 911 933 forward 3 TM Transmembrane
252 LI:025724.12:2001MAY17 934 1042 forward 3 TM Cytosolic
252 LI:025724.12:2001MAY17 1043 1065 forward 3 TM Transmembrane
252 LI:025724.12:2001MAY17 1066 1200 forward 3 TM Non-Cytosolic
253 LI:029328.2:2001MAY17 1 714 forward 1 TM Non-Cytosolic
253 LI:029328.2:2001MAY17 715 737 forward 1 TM Transmembrane
253 LI:029328.2:2001MAY17 738 1025 forward 1 TM Cytosolic
253 LI:029328.2:2001MAY17 1026 1043 forward 1 TM Transmembrane
253 LI:029328.2:2001MAY17 1044 1052 forward 1 TM Non-Cytosolic
253 LI:029328.2:2001MAY17 1053 1075 forward 1 TM Transmembrane
253 LI:029328.2:2001MAY17 1076 1179 forward 1 TM Cytosolic
253 LI:029328.2:2001MAY17 1180 1202 forward 1 TM Transmembrane
253 LI:029328.2:2001MAY17 1203 T283 forward 1 TM Non-Cytosolic
253 LI:029328.2:2001MAY17 1284 1306 forward 1 TM Transmembrane
253 LI:029328.2:2001MAY17 1307 1312 forward 1 TM Cytosolic
253 LI:029328.2:2001MAY17 1313 1335 forward 1 TM Transmembrane
253 LI:029328.2:2001MAY17 1336 2000 forward 1 TM Non-Cytosolic
253 LI:029328.2:2001MAY17 1 301 forward 3 TM Non-Cytosolic
253 LI:029328.2:2001MAY17 302 324 forward 3 TM Transmembrane
253 LI:029328.2:2001MAY17 325 365 forward 3 TM Cytosolic
253 LI:029328.2:2001MAY17 366 384 forward 3 TM Transmembrane TABLE 2
SEQ D NO: Template ID Start Stop Frame Domain Type Topology
253 LI:029328.2:2001MAY17 385 1947 forward 3 TM Non-Cytosolic
253 LI:029328.2:2001MAY17 1948 1970 forward 3 TM Transmembrane
253 LI:029328.2:2001MAY17 1971 1999 forward 3 TM Cytosolic
254 LI:032171.5:2001MAY17 1 459 forward 1 TM Non-Cytosolic
254 LI:032171.5:2001MAY17 460 477 forward T TM Transmembrane
254 LI:032171.5:2001MAY17 478 481 forward 1 TM Cytosolic
254 LI:032171.5:2001MAY17 482 504 forward 1 TM Transmembrane
254 LI:032171.5:2001MAY17 505 518 forward 1 TM Non-Cytosolic
254 LI:032171.5:2001MAY17 519 541 forward 1 TM Transmembrane
254 LI:032171.5:2001MAY17 542 553 forward 1 TM Cytosolic
254 LI:032171.5:2001MAY17 554 576 forward 1 TM Transmembrane
254 LI:032171.5:2001MAY17 577 626 forward 1 TM Non-Cytosolic
254 LI:032171.5:2001MAY17 627 649 forward 1 TM Transmembrane
254 LI:032171.5:2001MAY17 650 716 forward 1 TM Cytosolic
254 LI:032171.5:2001MAY17 1 625 forward 2 TM Non-Cytosolic
254 LI:032171.5:2001MAY17 626 648 forward 2 TM Transmembrane
254 LI:032171.5:2001MAY17 649 660 forward 2 TM Cytosolic
254 LI:032171.5:2001MAY17 661 683 forward 2 TM Transmembrane
254 LI:032171.5:2001MAY17 684 686 forward 2 TM Non-Cytosolic
254 LI:032171.5:2001MAY17 687 709 forward 2 TM Transmembrane
254 LI:032171.5:2001MAY17 710 715 forward 2 TM Cytosolic
255 LI:035055.1:2001MAY17 1 489 forward 2 TM Non-Cytosolic
255 LI:035055.1:2001MAY17 490 512 forward 2 TM Transmembrane
255 LI:035055.1:2001MAY17 513 584 forward 2 TM Cytosolic
255 LI:035055.1:2001MAY17 585 607 forward 2 TM Transmembrane
255 LI:035055.1:2001MAY17 608 619 forward 2 TM Non-Cytosolic
255 LI:035055.1:2001MAY17 620 642 forward 2 TM Transmembrane
255 LI:035055.1:2001MAY17 643 673 forward 2 TM Cytosolic
255 LI:035055.1:2001MAY17 1 619 forward 3 TM Non-Cytosolic
255 LI:035055.1:2001MAY17 620 642 forward 3 TM Transmembrane
255 LI:035055.1:2001MAY17 643 673 forward 3 TM Cytosolic
256 LI:036747.17:2001MAY17 1 269 forward 1 TM Cytosolic
256 LI:036747.17:2001MAY17 270 292 forward 1 TM Transmembrane
256 LI:036747.17:2001MAY17 293 325 forward 1 TM Non-Cytosolic
256 LI:036747.17:2001MAY17 326 348 forward 1 TM Transmembrane
256 LI:036747.17:2001MAY17 349 427 forward 1 TM Cytosolic
256 LI:036747.17:2001MAY17 428 450 forward 1 TM Transmembrane
256 LI:036747.17:2001MAY17 451 464 forward 1 TM Non-Cytosolic
256 LI:036747.17:2001MAY17 465 487 forward 1 TM Transmembrane
256 LI:036747.17:2001MAY17 488 499 forward 1 TM Cytosolic
256 LI:036747.17:2001MAY17 500 522 forward 1 TM Transmembrane
256 LI:036747.17:2001MAY17 523 630 forward 1 TM Non-Cytosolic
256 LI:036747.17:2001MAY17 631 653 forward 1 TM Transmembrane
256 LI:036747.17:2001MAY17 654 665 forward 1 TM Cytosolic
256 LI:036747.17:2001MAY17 666 687 forward 1 TM Transmembrane
256 LI:036747.17:2001MAY17 688 762 forward 1 TM Non-Cytosolic
256 LI:036747.17:2001MAY17 763 785 forward 1 TM Transmembrane
256 LI:036747.17:2001MAY17 786 818 forward 1 TM Cytosolic
256 LI:036747.17:2001MAY17 1 269 forward 2 TM Non-Cytosolic
256 LI:036747.17:2001MAY17 270 292 forward 2 TM Transmembrane
256 LI:036747.17:2001MAY17 293 478 forward 2 TM Cytosolic
256 LI:036747.17:2001MAY17 479 501 forward 2 TM Transmembrane
256 LL036747.17.2001MAY17 502 515 forward 2 TM Non-Cytosolic
256 LI:036747.17:2001MAY17 516 535 forward 2 TM Transmembrane TABLE 2
SEQ D NO: Template ID Start Stop Frame Domain Type Topology
256 LI:036747.17:2001MAY17 536 624 forward 2 TM Cytosolic
256 LI:036747.17:2001MAY17 625 647 forward 2 TM Transmembrane
256 LI:036747.17:2001MAY17 648 666 forward 2 TM Non-Cytosolic
256 LI:036747.17:2001MAY17 667 689 forward 2 TM Transmembrane
256 LI:036747.17:2001MAY17 690 709 forward 2 TM Cytosolic
256 LI:036747.17:2001MAY17 710 732 forward 2 TM Transmembrane
256 LI:036747.17:2001MAY17 733 751 forward 2 TM Non-Cytosolic
256 LI:036747.17:2001MAY17 752 774 forward 2 TM Transmembrane
256 LI:036747.17:2001MAY17 775 785 forward 2 TM Cytosolic
256 LI:036747.17:2001MAY17 786 808 forward 2 TM Transmembrane
256 LI:036747.17:2001MAY17 809 817 forward 2 TM Non-Cytosolic
256 LI:036747.17:2001MAY17 1 269 forward 3 TM Non-Cytosolic
256 LI:036747.17:2001MAY17 270 292 forward 3 TM Transmembrane
256 LI:036747.17:2001MAY17 293 399 forward 3 TM Cytosolic
256 LI:036747.17:2001MAY17 400 422 forward 3 TM Transmembrane
256 LI:036747.17:2001MAY17 423 499 forward 3 TM Non-Cytosolic
256 LI:036747.17:2001MAY17 500 522 forward 3 TM Transmembrane
256 LI:036747.17:2001MAY17 523 624 forward 3 TM Cytosolic
256 LI:036747.17:2001MAY17 625 642 forward 3 TM Transmembrane
256 LI:036747.17:2001MAY17 643 677 forward 3 TM Non-Cytosolic
256 LI:036747.17:2001MAY17 678 697 forward 3 TM Transmembrane
256 LI:036747.17:2001MAY17 698 709 forward 3 TM Cytosolic
256 LI:036747.17:2001MAY17 710 732 forward 3 TM Transmembrane
256 LI:036747.17:2001MAY17 733 751 forward 3 TM Non-Cytosolic
256 LI:036747.17:2001MAY17 752 774 forward 3 TM Transmembrane
256 LI:036747.17:2001MAY17 775 780 forward 3 TM Cytosolic
256 LI:036747.17:2001MAY17 781 803 forward 3 TM Transmembrane
256 LI:036747.17:2001MAY17 804 817 forward 3 TM Non-Cytosolic
257 LI:044301.2:2001MAY17 1 965 forward 1 TM Non-Cytosolic
257 LI:044301.2:2001MAY17 966 988 forward 1 TM Transmembrane
257 LI:044301.2:2001MAY17 989 1000 forward 1 TM Cytosolic
258 LI:061585.10:2001MAY17 1 672 forward 1 TM Non-Cytosolic
258 LI:061585.10:2001MAY17 673 695 forward 1 TM Transmembrane
258 LI:061585.10:2001MAY17 696 823 forward 1 TM Cytosolic
258 LI:061585.10:2001MAY17 1 425 forward 2 TM Non-Cytosolic
258 LI:061585.10:2001MAY17 426 445 forward 2 TM Transmembrane
258 LI:061585.10:2001MAY17 446 451 forward 2 TM Cytosolic
258 LI:061585.10:2001MAY17 452 471 forward 2 TM Transmembrane
258 LI:061585.10:2001MAY17 472 680 forward 2 TM Non-Cytosolic
258 LI:061585.10:2001MAY17 681 700 forward 2 TM Transmembrane
258 LI:061585.10:2001MAY17 701 739 forward 2 TM Cytosolic
258 LI:061585.10:2001MAY17 740 762 forward 2 TM Transmembrane
258 LI:061585.10:2001MAY17 763 823 forward 2 TM Non-Cytosolic
258 LI:061585.10:2001MAY17 1 202 forward 3 TM Cytosolic
258 LI:061585.10:2001MAY17 203 225 forward 3 TM Transmembrane
258 LI:061585.10:2001MAY17 226 250 forward 3 TM Non-Cytosolic
258 LI:061585.10:2001MAY17 251 273 forward 3 TM Transmembrane
258 LI:061585.10:2001MAY17 274 277 forward 3 TM Cytosolic
258 LI:061585.10:2001MAY17 278 300 forward 3 TM Transmembrane
258 LI:061585.10:2001MAY17 301 342 forward 3 TM Non-Cytosolic
258 LI:061585.10:2001MAY17 343 365 forward 3 TM Transmembrane
258 LI:061585.10:2001MAY17 366 371 forward 3 TM Cytosolic
258 LI:061585.10:2001MAY17 372 394 forward 3 TM Transmembrane
258 LI:061585.10:2001MAY17 395 822 forward 3 TM Non-Cytosolic TABLE 2
SEQ D NO: Template ID Start Stop Frame Domain Type Topology
259 LI:066742.21:2001MAY17 1 63 forward 1 TM Non-Cytosolic
259 LI:066742.21:2001MAY17 64 86 forward 1 TM Transmembrane
259 LI:066742.21:2001MAY17 87 318 forward 1 TM Cytosolic
259 LI:066742.21:2001MAY17 319 341 forward 1 TM Transmembrane
259 LI:066742.21:2001MAY17 342 355 forward 1 TM Non-Cytosolic
259 LI:066742.21:2001MAY17 356 378 forward 1 TM Transmembrane
259 LL066742.21 :2001MAY17 379 430 forward 1 TM Cytosolic
259 LI:066742.21:2001MAY17 431 450 forward 1 TM Transmembrane
259 LL066742.21 :2001MAY17 451 1022 forward 1 TM Non-Cytosolic
259 LI:066742.21:2001MAY17 1023 1045 forward 1 TM Transmembrane
259 LI:066742.21:2001MAY17 1046 1068 forward 1 TM Cytosolic
259 LI:066742.21:2001MAY17 1069 1091 forward 1 TM Transmembrane
259 LI:066742.21:2001MAY17 1092 1408 forward 1 TM Non-Cytosolic
259 LI:066742.21:2001MAY17 1409 1431 forward 1 TM Transmembrane
259 LI:066742.21:2001MAY17 1432 1437 forward 1 TM Cytosolic
259 LI:066742.21:2001MAY17 1438 1460 forward 1 TM Transmembrane
259 LI:066742.21:2001MAY17 1461 1508 forward 1 TM Non-Cytosolic
259 LI:066742.21:2001MAY17 1509 1531 forward 1 TM Transmembrane
259 LI:066742.21:2001MAY17 1532 1542 forward 1 TM Cytosolic
259 LI:066742.21:2001MAY17 1543 1562 forward 1 TM Transmembrane
259 LI:066742.21:2001MAY17 1563 1583 forward 1 TM Non-Cytosolic
259 LI:066742.21:2001MAY17 1 119 forward 2 TM Cytosolic
259 LI:066742.21:2001MAY17 120 142 forward 2 TM Transmembrane
259 LI:066742.21:2001MAY17 143 146 forward 2 TM Non-Cytosolic
259 LI:066742.21:2001MAY17 147 169 forward 2 TM Transmembrane
259 LI:066742.21:2001MAY17 170 351 forward 2 TM Cytosolic
259 LL066742.21 :2001MAY17 352 374 forward 2 TM Transmembrane
259 LI:066742.21:2001MAY17 375 1202 forward 2 TM Non-Cytosolic
259 LL066742.21 :2001MAY17 1203 1225 forward 2 TM Transmembrane
259 LI:066742.21:2001MAY17 1226 1313 forward 2 TM Cytosolic
259 LI:066742.21:2001MAY17 1314 1336 forward 2 TM Transmembrane
259 LL066742.21 :2001MAY17 1337 1372 forward 2 TM Non-Cytosolic
259 LI:066742.21:2001MAY17 1373 1395 forward 2 TM Transmembrane
259 LI:066742.21:2001MAY17 1396 1582 forward 2 TM Cytosolic
259 LI:066742.21:2001MAY17 1 16 forward 3 TM Cytosolic
259 LL066742.21 :2001MAY17 17 39 forward 3 TM Transmembrane
259 LI:066742.21:2001MAY17 40 53 forward 3 TM Non-Cytosolic
259 LT.066742.21:2001MAY17 54 76 forward 3 TM Transmembrane
259 LI:066742.21:2001MAY17 77 179 forward 3 TM Cytosolic
259 LI:066742.21:2001MAY17 180 202 forward 3 TM Transmembrane
259 LI:066742.21:2001MAY17 203 312 forward 3 TM Non-Cytosolic
259 LI:066742.21:2001MAY17 313 332 forward 3 TM Transmembrane
259 LI:066742.21:2001MAY17 333 351 forward 3 TM Cytosolic
259 LL066742.21 :2001MAY17 352 374 forward 3 TM Transmembrane
259 LI:066742.21:2001MAY17 375 378 forward 3 TM Non-Cytosolic
259 LI. 66742.21.-2001MAY17 379 401 forward 3 TM Transmembrane
259 LI:066742.21:2001MAY17 402 580 forward 3 TM Cytosolic
259 LL066742.21 :2001MAY17 581 598 forward 3 TM Transmembrane
259 LI:066742.21:2001MAY17 599 644 forward 3 TM Non-Cytosolic
259 LI:066742.21:2001MAY17 645 664 forward 3 TM Transmembrane
259 LI:066742.21:2001MAY17 665 717 forward 3 TM Cytosolic
259 LI:066742.21:2001MAY17 718 740 forward 3 TM Transmembrane
259 LI:066742.21:2001MAY17 741 759 forward 3 TM Non-Cytosolic
259 LI:066742.21:2001MAY17 760 782 forward 3 TM Transmembrane TABI -E 2
SEQ D NO: Template ID Start Stop Frame Domain Type Topology
259 LL066742.21 :2001MAY17 783 1168 forward 3 TM Cytosolic
259 LI:066742.21 :2001MAY17 1169 1186 forward 3 TM Transmembrane
259 LI:066742.21:2001MAY17 1187 1200 forward 3 TM Non-Cytosolic
259 LI:066742.21:2001MAY17 1201 1223 forward 3 TM Transmembrane
259 LI:066742.21:2001MAY17 1224 1409 forward 3 TM Cytosolic
259 LI:066742.21:2001MAY17 1410 1432 forward 3 TM Transmembrane
259 LI:066742.21:2001MAY17 1433 1507 forward 3 TM Non-Cytosolic
259 LI:066742.21 :2001MAY17 1508 1527 forward 3 TM Transmembrane
259 LI:066742.21:2001MAY17 1528 1582 forward 3 TM Cytosolic
260 LI:075492.206:2001MAY17 1 14 forward 1 TM Non-Cytosolic
260 LI:075492.206:2001MAY17 15 37 forward 1 TM Transmembrane
260 LI:075492.206:2001MAY17 38 206 forward 1 TM Cytosolic
260 LI:075492.206:2001MAY17 207 229 forward 1 TM Transmembrane
260 LI:075492.206:2001MAY17 230 476 forward 1 TM Non-Cytosolic
260 LI:075492.206:2001MAY17 1 14 forward 2 TM Non-Cytosolic
260 LI:075492.206:2001MAY17 15 34 forward 2 TM Transmembrane
260 LI:075492.206:2001MAY17 35 46 forward 2 TM Cytosolic
260 LI:075492.206:2001MAY17 47 69 forward 2 TM Transmembrane
260 LI:075492.206:2001MAY17 70 476 forward 2 TM Non-Cytosolic
260 LI:075492.206:2001MAY17 1 205 forward 3 TM Cytosolic
260 LI:075492.206:2001MAY17 206 223 forward 3 TM Transmembrane
260 LI:075492.206:2001MAY17 224 475 forward 3 TM Non-Cytosolic
261 LI:090782.3:2001MAY17 1 131 forward 1 TM Non-Cytosolic
261 LI:090782.3:2001MAY17 132 154 forward 1 TM Transmembrane
261 LI:090782.3:2001MAY17 155 339 forward 1 TM Cytosolic
261 LI:090782.3:2001MAY17 340 362 forward 1 TM Transmembrane
261 LI:090782.3:2001MAY17 363 792 forward 1 TM Non-Cytosolic
261 LI:090782.3:2001MAY17 1 417 forward 2 TM Non-Cytosolic
261 LI.O90782.3.-2001MAY17 418 440 forward 2 TM Transmembrane
261 LI:090782.3:2001MAY17 441 451 forward 2 TM Cytosolic
261 LI:090782.3:2001MAY17 452 474 forward 2 TM Transmembrane
261 LI:090782.3:2001MAY17 475 792 forward 2 TM Non-Cytosolic
262 LI:1031308.1:2001MAY17 1 670 forward 1 TM Non-Cytosolic
262 LI:1031308.1:2001MAY17 671 693 forward 1 TM Transmembrane
262 LI:1031308.1:2001MAY17 694 785 forward 1 TM Cytosolic
262 LI: 1031308.1 :2001MAY17 786 808 forward 1 TM Transmembrane
262 LI:1031308.1:2001MAY17 809 848 forward 1 TM Non-Cytosolic
262 LI:1031308.1 :2001MAY17 849 866 forward 1 TM Transmembrane
262 LI:1031308.1:2001MAY17 867 880 forward 1 TM Cytosolic
262 LI:1031308.1:2001MAY17 1 675 forward 2 TM Non-Cytosolic
262 LI:1031308.1:2001MAY17 676 698 forward 2 TM Transmembrane
262 LI:1031308.1 :2001MAY17 699 879 forward 2 TM Cytosolic
262 LI:1031308.1:2001MAY17 1 560 forward 3 TM Non-Cytosolic
262 LLT031308.1.2001MAY17 561 583 forward 3 TM Transmembrane
262 LI: 1031308.1:2001MAY17 584 633 forward 3 TM Cytosolic
262 LI: 1031308.1:2001MAY17 634 656 forward 3 TM Transmembrane
262 LI: 1031308. 2001MAY17 657 670 forward 3 TM Non-Cytosolic
262 LI: 1031308.1:2001MAY17 671 693 forward 3 TM Transmembrane
262 LI: 1031308.1 :2001MAY17 694 879 forward 3 TM Cytosolic
263 LIT 054377. 2001MAY17 1 76 forward 2 TM Cytosolic
263 LIT 054377. L2001MAY17 77 99 forward 2 TM Transmembrane
263 LI: 1054377.1:2001MAY17 100 501 forward 2 TM Non-Cytosolic
264 LI: 1072074.10:2001MAY17 1 38 forward 3 TM Cytosolic
264 LIT 072074.10:2001MAY17 39 58 forward 3 TM Transmembrane TABLE 2
SEQ D NO: Template ID Start Stop Frame Domain Type Topology
264 LI:1072074.10:2001MAY17 59 1024 forward 3 TM Non-Cytosolic
265 LI:1072889.15:2001MAY17 1 67 forward 1 TM Cytosolic
265 LI:1072889.15:2001MAY17 68 87 forward 1 TM Transmembrane
265 LI:1072889.15:2001MAY17 88 91 forward 1 TM Non-Cytosolic
265 LI:1072889.15:2001MAY17 92 111 forward 1 TM Transmembrane
265 LI:1072889.15:2001MAY17 112 310 forward 1 TM Cytosolic
265 LI:1072889.15:2001MAY17 311 333 forward 1 TM Transmembrane
265 LI:1072889.15:2001MAY17 334 627 forward 1 TM Non-Cytosolic
265 LI:1072889.15:2001MAY17 628 650 forward 1 TM Transmembrane
265 LI:1072889.15:2001MAY17 651 662 forward 1 TM Cytosolic
265 LI:1072889.15:2001MAY17 663 685 forward 1 TM Transmembrane
265 LI:1072889.15:2001MAY17 686 694 forward 1 TM Non-Cytosolic
265 LI:1072889.15:2001MAY17 1 19 forward 2 TM Cytosolic
265 LI:1072889.15:2001MAY17 20 42 forward 2 TM Transmembrane
265 LI:1072889.15:2001MAY17 43 51 forward 2 TM Non-Cytosolic
265 LI:1072889.15:2001MAY17 52 74 forward 2 TM Transmembrane
265 LI:1072889.15:2001MAY17 75 94 forward 2 TM Cytosolic
265 LI:1072889.15:2001MAY17 95 117 forward 2 TM Transmembrane
265 LI:1072889.15:2001MAY17 118 139 forward 2 TM Non-Cytosolic
265 LI:1072889.15:2001MAY17 140 162 forward 2 TM Transmembrane
265 LI:1072889.15:2001MAY17 163 272 forward 2 TM Cytosolic
265 LI:1072889.15:2001MAY17 273 295 forward 2 TM Transmembrane
265 LI:1072889.15:2001MAY17 296 520 forward 2 TM Non-Cytosolic
265 LI.T072889.15.2001MAY17 521 543 forward 2 TM Transmembrane
265 LI:1072889.15:2001MAY17 544 612 forward 2 TM Cytosolic
265 LI:1072889.15:2001MAY17 613 635 forward 2 TM Transmembrane
265 LI:1072889.15:2001MAY17 636 657 forward 2 TM Non-Cytosolic
265 LI:1072889.15:2001MAY17 658 680 forward 2 TM Transmembrane
265 LI:1072889.15:2001MAY17 681 694 forward 2 TM Cytosolic
265 LI:1072889.15:2001MAY17 1 38 forward 3 TM Cytosolic
265 LI:1072889.15:2001MAY17 39 61 forward 3 TM Transmembrane
265 LI:1072889.15:2001MAY17 62 92 forward 3 TM Non-Cytosolic
265 LI:1072889.15:2001MAY17 93 115 forward 3 TM Transmembrane
265 LI:1072889.15:2001MAY17 116 266 forward 3 TM Cytosolic
265 LI:1072889.15:2001MAY17 267 289 forward 3 TM Transmembrane
265 LI:1072889.15:2001MAY17 290 611 forward 3 TM Non-Cytosolic
265 LI:1072889.15:2001MAY17 612 634 forward 3 TM Transmembrane
265 LI:1072889.15:2001MAY17 635 654 forward 3 TM Cytosolic
265 LI: 1072889.15:2001MAY17 655 677 forward 3 TM Transmembrane
265 LI:1072889.15:2001MAY17 678 694 forward 3 TM Non-Cytosolic
266 LI:1077480.1:2001MAY17 1 11 forward 1 TM Cytosolic
266 LI:1077480.1.2001MAY17 12 34 forward 1 TM Transmembrane
266 LI: 1077480.1:2001MAY17 35 53 forward 1 TM Non-Cytosolic
266 LI: 1077480.1 :2001MAY17 54 76 forward 1 TM Transmembrane
266 LIT 077480.1.2001MAY17 77 109 forward 1 TM Cytosolic
266 LI:1077480.1 :2001MAY17 110 132 forward 1 TM Transmembrane
266 LI: 1077480.1 :2001MAY17 133 176 forward 1 TM Non-Cytosolic
266 LI: 1077480.1 :2001MAY17 177 199 forward 1 TM Transmembrane
266 LI: 1077480.1 :2001MAY17 200 240 forward 1 TM Cytosolic
266 LI:1077480.1:2001MAY17 241 263 forward 1 TM Transmembrane
266 LIT 077480. L2001MAY17 264 484 forward 1 TM Non-Cytosolic
266 LI: 1077480.1:2001MAY17 1 147 forward 2 TM Cytosolic
266 LI:1077480. L2001MAY17 148 170 forward 2 TM Transmembrane
266 LI: 1077480.1:2001MAY17 171 189 forward 2 TM Non-Cytosolic TABLE 2
SEQ D NO Template ID Start Stop Frame Domain Type Topology
266 LI:1077480.1:2001MAY17 190 207 forward 2 TM Transmembrane
266 LI:1077480.1:2001MAY17 208 251 forward 2 TM Cytosolic
266 LI:1077480.1 :2001MAY17 252 274 forward 2 TM Transmembrane
266 LI:1077480.1:2001MAY17 275 331 forward 2 TM Non-Cytosolic
266 LI:1077480.1 :2001MAY17 332 354 forward 2 TM Transmembrane
266 LI:1077480.1:2001MAY17 355 365 forward 2 TM Cytosolic
266 LI:1077480.1:2001MAY17 366 388 forward 2 TM Transmembrane
266 LI:1077480.1:2001MAY17 389 484 forward 2 TM Non-Cytosolic
266 LI:1077480.1:2001MAY17 1 59 forward 3 TM Cytosolic
266 LI:1077480.1:2001MAY17 60 82 forward 3 TM Transmembrane
266 LI: 1077480. L2001MAY17 83 101 forward 3 TM Non-Cytosolic
266 LI:1077480.1:2001MAY17 102 121 forward 3 TM Transmembrane
266 LI:1077480.1:2001MAY17 122 132 forward 3 TM Cytosolic
266 LI:1077480.1:2001MAY17 133 155 forward 3 TM Transmembrane
266 LI: 1077480. 2001MAY17 156 241 forward 3 TM Non-Cytosolic
266 LI: 1077480.1 :2001MAY17 242 264 forward 3 TM Transmembrane
266 LI:1077480.1:2001MAY17 265 484 forward 3 TM Cytosolic
267 LI:1079555.1:2001MAY17 1 38 forward 2 TM Cytosolic
267 LI:1079555.1:2001MAY17 39 61 forward 2 TM Transmembrane
267 LI: 1079555.1 :2001MAY17 62 444 forward 2 TM Non-Cytosolic
268 LI:1084992.28:2001MAY17 1 68 forward 3 TM Cytosolic
268 LI:1084992.28:2001MAY17 69 91 forward 3 TM Transmembrane
268 LI:1084992.28:2001MAY17 92 263 forward 3 TM Non-Cytosolic
269 LI: 1085472.5 :2001MAY17 1 52 forward 1 TM Cytosolic
269 LI:1085472.5:2001MAY17 53 75 forward 1 TM Transmembrane
269 LI:1085472.5:2001MAY17 76 1590 forward 1 TM Non-Cytosolic
270 LI:1086800.7:2001MAY17 1 84 forward 1 TM Cytosolic
270 LI:1086800.7:2001MAY17 85 107 forward 1 TM Transmembrane
270 LI:1086800.7:2001MAY17 108 140 forward 1 TM Non-Cytosolic
270 LI:1086800.7:2001MAY17 141 163 forward 1 TM Transmembrane
270 LI: 1086800.7 :2001MAY17 164 431 forward 1 TM Cytosolic
270 LI:1086800.7:2001MAY17 432 451 forward 1 TM Transmembrane
270 LI:1086800.7:2001MAY17 452 479 forward 1 TM Non-Cytosolic
270 LI:1086800.7:2001MAY17 480 502 forward 1 TM Transmembrane
270 LI:1086800.7:2001MAY17 503 521 forward 1 TM Cytosolic
270 LI:1086800.7:2001MAY17 522 541 forward 1 TM Transmembrane
270 LI:1086800.7:2001MAY17 542 593 forward 1 TM Non-Cytosolic
270 LI:1086800.7:2001MAY17 594 616 forward 1 TM Transmembrane
270 LI:1086800.7:2001MAY17 617 622 forward 1 TM Cytosolic
270 LI:1086800.7:2001MAY17 623 645 forward 1 TM Transmembrane
270 LI:1086800.7:2001MAY17 646 686 forward 1 TM Non-Cytosolic
270 LI:1086800.7:2001MAY17 687 709 forward 1 TM Transmembrane
270 LI:1086800.7:2001MAY17 710 981 forward 1 TM Cytosolic
270 LI:1086800.7:2001MAY17 982 1004 forward 1 TM Transmembrane
270 LI:1086800.7:2001MAY17 1005 1471 forward 1 TM Non-Cytosolic
270 LI: 1086800.7:2001MAY17 1472 1489 forward 1 TM Transmembrane
270 LI:1086800.7:2001MAY17 1490 1578 forward 1 TM Cytosolic
270 LI: 1086800.7:2001MAY17 1579 1601 forward 1 TM Transmembrane
270 LI: 1086800.7:2001MAY17 1602 1641 forward 1 TM Non-Cytosolic
270 LI:1086800.7:2001MAY17 1642 1664 forward 1 TM Transmembrane
270 LI: 1086800.7:2001MAY17 1665 1671 forward 1 TM Cytosolic
270 LI: 1086800.7:2001MAY17 1 49 forward 2 TM Cytosolic
270 LI: 1086800.7:2001MAY17 50 72 forward 2 TM Transmembrane
270 LI: 1086800.7:2001MAY17 73 86 forward 2 TM Non-Cytosolic TABLE 2
SEQ D NO: Template ID Start Stop Frame Domain Type Topology
270 LI:1086800.7:2001MAY17 87 109 forward 2 TM Transmembrane
270 LI:1086800.7:2001MAY17 110 115 forward 2 TM Cytosolic
270 LI:1086800J:2001MAY17 116 138 forward 2 TM Transmembrane
270 LI:1086800.7:2001MAY17 139 180 forward 2 TM Non-Cytosolic
270 LI:1086800J:2001MAY17 181 203 forward 2 TM Transmembrane
270 LI:1086800J:2001MAY17 204 238 forward 2 TM Cytosolic
270 LT.1086800.7.200IMAY17 239 261 forward 2 TM Transmembrane
270 LI:1086800.7:2001MAY17 262 275 forward 2 TM Non-Cytosolic
270 LI:1086800.7:2001MAY17 276 298 forward 2 TM Transmembrane
270 LI:1086800.7:2001MAY17 299 309 forward 2 TM Cytosolic
270 LI:1086800.7:2001MAY17 310 332 forward 2 TM Transmembrane
270 LI: 1086800.7 :2001MAY17 333 592 forward 2 TM Non-Cytosolic
270 LI:1086800.7:2001MAY17 593 615 forward 2 TM Transmembrane
270 LI:1086800.7:2001MAY17 616 868 forward 2 TM Cytosolic
270 LT.1086800.7:2001MAY17 869 891 forward 2 TM Transmembrane
270 LI:1086800J:2001MAY17 892 905 forward 2 TM Non-Cytosolic
270 LI:1086800.7:2001MAY17 906 928 forward 2 TM Transmembrane
270 LI:1086800.7:2001MAY17 929 1036 forward 2 TM Cytosolic
270 LI:1086800.7:2001MAY17 1037 1059 forward 2 TM Transmembrane
270 LI:1086800.7:2001MAY17 1060 1670 forward 2 TM Non-Cytosolic
270 LI:1086800.7:2001MAY17 1 46 forward 3 TM Cytosolic
270 LI:1086800.7:2001MAY17 47 66 forward 3 TM Transmembrane
270 LI:1086800.7:2001MAY17 67 80 forward 3 TM Non-Cytosolic
270 LI:1086800.7:2001MAY17 81 103 forward 3 TM Transmembrane
270 LI.T086800.7.-2001MAY17 104 233 forward 3 TM Cytosolic
270 LI:1086800.7:2001MAY17 - 234 256 forward 3 TM Transmembrane
270 LI:1086800.7:2001MAY17 ' 257' 275 forward 3 TM Non-Cytosolic
* 270 LI:1086800.7:2001MAY17 ' 276 298 forward 3 1 TM Transmembrane
270 LI:1086800J:2001MAY17 299 388 forward 3 TM Cytosolic
270 LI:1086800.7:2001MAY17 389 411 forward 3 TM Transmembrane
270 LI:1086800.7:2001MAY17 412 584 forward 3 TM Non-Cytosolic
270 LI:1086800.7:2001MAY17 585 607 forward 3 TM Transmembrane
270 LI: 1086800.7:2001MAY17 608 775 forward 3 TM Cytosolic
270 LI:1086800.7:2001MAY17 776 795 forward 3 TM Transmembrane
270 LI:1086800.7:2001MAY17 796 1206 forward 3 TM Non-Cytosolic
270 LI:1086800.7:2001MAY17 1207 1229 forward 3 TM Transmembrane
270 LT.1086800.7:2001MAY17 1230 1262 forward 3 TM Cytosolic
270 LI:10868007:2001MAY17 1263 1285 forward 3 TM Transmembrane
270 LT.1086800J:2001MAY17 1286 1294 forward 3 TM Non-Cytosolic
270 LI:1086800J:2001MAY17 1295 1314 forward 3 TM Transmembrane
270 LI:1086800.7:2001MAY17 1315 1446 forward 3 TM Cytosolic
270 LI: 1086800.7:2001MAY17 1447 1469 forward 3 TM Transmembrane
270 LI: 1086800.7:2001MAY17 1470 1630 forward 3 TM Non-Cytosolic
270 LI:1086800.7:2001MAY17 1631 1653 forward 3 TM Transmembrane
270 LI:1086800.7:2001MAY17 1654 1670 forward 3 TM Cytosolic
271 LI:1089871.9:2001MAY17 1 343 forward 1 TM Non-Cytosolic
271 LI:1089871.9:2001MAY17 344 363 forward 1 TM Transmembrane
271 LI:1089871.9:2001MAY17 364 369 forward 1 TM Cytosolic
271 LI:1089871.9:2001MAY17 370 392 forward 1 TM Transmembrane
271 LI:1089871.9:2001MAY17 393 1441 forward 1 TM Non-Cytosolic
271 LI: 1089871.9:2001MAY17 1442 1464 forward 1 TM Transmembrane
271 LIT 089871.9:2001MAY17 1465 1483 forward 1 TM Cytosolic
271 LIT 089871.9:2001MAY17 1484 1503 forward 1 TM Transmembrane
271 LI: 1089871.9:2001MAY17 1504 1546 forward 1 TM Non-Cytosolic TABLE 2
SEQ D NO Template ID Start Stop Frame Domain Type Topology
271 LI 1089871.9.2001MAY17 1547 1569 forward 1 TM Transmembrane
271 LI- 1089871.9:2001MAY17 1570 1575 forward 1 TM Cytosolic
271 LI 1089871.9:2001MAY17 1576 1598 forward 1 TM Transmembrane
271 LI 1089871.9:2001MAY17 1599 1617 forward 1 TM Non-Cytosolic
271 LI 1089871.9.2001MAY17 1618 1639 forward 1 TM Transmembrane
271 LI 1089871.9:2001MAY17 1640 1753 forward 1 TM Cytosolic
271 LI 1089871.9:2001MAY17 1754 1773 forward 1 TM Transmembrane
271 LI 1089871.9.2001MAY17 1774 1928 forward 1 TM Non-Cytosolic
271 LI 1089871.9.2001MAY17 1 1219 forward 2 TM Non-Cytosolic
271 LI 1089871.9:2001MAY17 1220 1242 forward 2 TM Transmembrane
271 LI 1089871.9:2001MAY17 1243 1408 forward 2 TM Cytosolic
271 LI 1089871.9:2001MAY17 1409 1426 forward 2 TM Transmembrane
271 LI 1089871.9:2001MAY17 1427 1430 forward 2 TM Non-Cytosolic
271 LI 1089871.9.2001MAY17 1431 1448 forward 2 TM Transmembrane
271 LI 1089871.9.2001MAY17 1449 1454 forward 2 TM Cytosolic
271 LI 1089871.9:2001MAY17 1455 1477 forward 2 TM Transmembrane
271 LI 1089871.9:2001MAY17 1478 1481 forward 2 TM Non-Cytosolic
271 LI 1089871.9.2001MAY17 1482 1504 forward 2 TM Transmembrane
271 LI 1089871.9.2001MAY17 1505 1579 forward 2 TM Cytosolic
271 LI 1089871.9.2001MAYT7 1580 1602 forward 2 TM Transmembrane
271 LI 1089871.9:2001MAY17 1603 1673 forward 2 TM Non-Cytosolic
271 LI 1089871.9.2001MAY17 1674 1693 forward 2 TM Transmembrane
271 LI 1089871.9.2001MAYT7 1694 1713 forward 2 TM Cytosolic
271 LI 1089871.9:2001MAY17 1714 1736 forward 2 TM Transmembrane
271 LI 1089871.9:2001MAY17 1737 1759 forward 2 TM Non-Cytosolic
271 LI 1089871.9.2001MAYT7 1760 1782 forward 2 TM Transmembrane
271 LI 1089871.9:2001MAY17 1783 1836 forward 2 TM Cytosolic
271 LI 1089871.9.2001MAY17 1837 1859 forward 2 TM Transmembrane
271 LI 1089871.9.2001MAY17 1860 1862 forward 2 TM Non-Cytosolic
271 LI 1089871.9:2001MAY17 1863 1885 forward 2 TM Transmembrane
271 LI 1089871.9.2001MAY17 1886 1928 forward 2 TM Cytosolic
271 LI 1089871.9.2001MAYT7 1 1382 forward 3 TM Non-Cytosolic
271 LI 1089871.9:2001MAY17 1383 1405 forward 3 TM Transmembrane
271 LI 1089871.9.2001MAY17 1406 1425 forward 3 TM Cytosolic
271 LI 1089871.9:2001MAY17 1426 1448 forward 3 TM Transmembrane
271 LI 1089871.9:2001MAY17 1449 1471 forward 3 TM Non-Cytosolic
271 LI 1089871.9:2001MAY17 1472 1494 forward 3 TM Transmembrane
271 LI 1089871.9:2001MAY17 1495 1571 forward 3 TM Cytosolic
271 LI 1089871.9:2001MAY17 1572 1594 forward 3 TM Transmembrane
271 LI .1089871.9:2001MAY17 1595 1669 forward 3 TM Non-Cytosolic
271 LI 1089871.9:2001MAY17 1670 1687 forward 3 TM Transmembrane
271 LI :1089871.9:2001MAY17 1688 1706 forward 3 TM Cytosolic
271 LI 1089871.9:2001MAY17 1707 1729 forward 3 TM Transmembrane
271 LI 1089871.9:2001MAY17 1730 1748 forward 3 TM Non-Cytosolic
271 LI 1089871.9:2001MAY17 1749 1771 forward 3 TM Transmembrane
271 LI 1089871.9:2001MAY17 1772 1849 forward 3 TM Cytosolic
271 LI : 1089871.9:2001MAY17 1850 1872 forward 3 TM Transmembrane
271 LI 1089871.9:2001MAY17 1873 1881 forward 3 TM Non-Cytosolic
271 LI :1089871.9:2001MAY17 1882 1904 forward 3 TM Transmembrane
271 LI : 1089871.9:2001MAY17 1905 1927 forward 3 TM Cytosolic
272 LI 110297.6:2001MAY17 1 63 forward 1 TM Cytosolic
272 LI : 1 10297.6:2001MAY17 64 86 forward 1 TM Transmembrane
272 LI 1 10297.6:2001MAY17 87 127 forward 1 TM Non-Cytosolic
272 LI : 1 10297.6:2001MAY17 128 145 forward 1 TM Transmembrane TABLE 2
SEQ D NO Template ID Start Stop Frame Domain Type Topology
272 LT.110297.6:2001MAY17 146 156 forward 1 TM Cytosolic
272 LI:110297.6:2001MAY17 157 179 forward 1 TM Transmembrane
272 LI:110297.6:2001MAY17 180 293 forward 1 TM Non-Cytosolic
272 LI:110297.6:2001MAY17 294 311 forward 1 TM Transmembrane
272 LI:110297.6:2001MAY17 312 587 forward 1 * TM Cytosolic
272 LI:110297.6:2001MAY17 588 610 forward 1 TM Transmembrane
272 LI:110297.6:2001MAY17 611 684 forward 1 TM Non-Cytosolic
272 LI:110297.6:2001MAY17 685 702 forward 1 TM Transmembrane
272 LI.T 10297.6.2001MAY17 703 737 forward 1 TM Cytosolic
272 LI:110297.6:2001MAY17 738 760 forward 1 TM Transmembrane
272 LI:110297.6:2001MAY17 761 769 forward 1 TM Non-Cytosolic
272 LIT 10297.6:2001MAY17 770 792 forward 1 TM Transmembrane
272 LI:110297.6:2001MAY17 793 801 forward 1 TM Cytosolic
272 LI:110297.6:2001MAY17 1 735 forward 2 TM Non-Cytosolic
272 LI:110297.6:2001MAY17 736 758 forward 2 TM Transmembrane
272 LI:110297.6:2001MAY17 759 769 forward 2 TM Cytosolic
272 LIT 10297.6:2001MAY17 770 792 forward 2 TM Transmembrane
272 LI:1 10297.6:2001MAY17 793 801 forward 2 TM Non-Cytosolic
272 LI:110297.6:2001MAY17 1 11 forward 3 TM Cytosolic
272 LI:110297.6:2001MAY17 12 29 forward 3 TM Transmembrane
272 LI:1 10297.6:2001MAY17 30 604 forward 3 TM Non-Cytosolic
272 LI:110297.6:2001MAY17 605 627 forward 3 TM Transmembrane
272 LI:110297.6:2001MAY17 628 738 forward 3 TM Cytosolic
272 LI:110297.6:2001MAY17 739 761 forward 3 TM Transmembrane
272 LI:110297.6:2001MAY17 762 775 forward 3 TM Non-Cytosolic
272 LI:110297.6:2001MAY17 776 798 forward 3 TM Transmembrane
272 LI:110297.6:2001MAY17 799 800 forward 3 TM Cytosolic
273 LI:1 143463.8:2001MAY17 1 1373 forward 1 TM Non-Cytosolic
273 LI:1143463.8:2001MAY17 1374 1396 forward 1 TM Transmembrane
273 LI: 1143463.8:2001MAY17 1397 1555 forward 1 TM Cytosolic
273 LI:1 143463.8:2001MAY17 1556 1578 forward 1 TM Transmembrane
273 LI:1 143463.8:2001MAY17 1579 1648 forward 1 TM Non-Cytosolic
273 LI:1 143463.8:2001MAY17 1649 1668 forward 1 TM Transmembrane
273 LI:1 143463.8:2001MAY17 1669 1712 forward 1 TM Cytosolic
273 LI:1 143463.8:2001MAY17 1713 1735 forward 1 TM Transmembrane
273 LI:1 143463.8:2001MAY17 1736 1744 forward 1 TM Non-Cytosolic
273 LI:1 143463.8:2001MAY17 1745 1764 forward 1 TM Transmembrane
273 LI:1143463.8:2001MAY17 1765 1835 forward 1 TM Cytosolic
273 LI:1 143463.8:2001MAY17 1836 1858 forward 1 TM Transmembrane
273 LI:1 143463.8:2001MAY17 1859 1872 forward 1 TM Non-Cytosolic
273 LI:1143463.8':2001MAY17 1873 1892 forward 1 TM Transmembrane
273 LI:1 143463.8:2001MAY17 1893 1912 forward 1 TM Cytosolic
273 LI: 1 143463.8:2001MAY17 1913 1935 forward 1 TM Transmembrane
273 LIT 143463.8-.2001MAY17 1936 1946 forward 1 TM Non-Cytosolic
273 LI. 143463.8:2001MAY17 1 12 forward 2 TM Cytosolic
273 LI: 1 143463.8:2001MAY17 13 35 forward 2 TM Transmembrane
273 LIT 143463.8:2001MAY17 36 721 forward 2 TM Non-Cytosolic
273 LI:1 143463.8:2001MAY17 722 739 forward 2 TM Transmembrane
273 LIT 143463.8:2001MAY17 740 751 forward 2 TM Cytosolic
273 LI: 1 143463.8:2001MAY17 752 774 forward 2 TM Transmembrane
273 LI:1 143463.8:2001MAY17 775 777 forward 2 TM Non-Cytosolic
273 LI: 1 143463.8:2001MAY17 778 797 forward 2 TM Transmembrane
273 LIT 143463.8:2001MAY17 798 837 forward 2 TM Cytosolic
273 LI: 1 143463.8:2001MAY17 838 860 forward 2 TM Transmembrane TABLE 2
SEQ D NO: Template ID Start Stop Frame Domain Type Topology
273 LI:1143463.8:2001MAY17 861 1641 forward 2 TM Non-Cytosolic
273 LI:1143463.8:2001MAY17 1642 1664 forward 2 TM Transmembrane
273 LI:1143463.8:2001MAY17 1665 1690 forward 2 TM Cytosolic
273 LI:1143463.8:2001MAY17 1691 1710 forward 2 TM Transmembrane
273 LI:1143463.8:2001MAY17 1711 1738 forward 2 TM Non-Cytosolic
273 LI:1143463.8:2001MAY17 1739 1761 forward 2 TM Transmembrane
273 LI:1143463.8:2001MAY17 1762 1835 forward 2 TM Cytosolic
273 LI:1143463.8:2001MAY17 1836 1858 forward 2 TM Transmembrane
273 LI:1143463.8:2001MAY17 1859 1877 forward 2 TM Non-Cytosolic
273 LI:1143463.8:2001MAY17 1878 1900 forward 2 TM Transmembrane
273 LI:1143463.8:2001MAY17 1901 1946 forward 2 TM Cytosolic
273 LI:1143463.8:2001MAY17 1 1257 forward 3 TM Non-Cytosolic
273 LI:1143463.8:2001MAY17 1258 1280 forward 3 TM Transmembrane
273 LI:1143463.8:2001MAY17 1281 1381 forward 3 TM Cytosolic
273 LI:1143463.8:2001MAY17 1382 1404 forward 3 TM Transmembrane
273 LI:1143463.8:2001MAY17 1405 1744 forward 3 TM Non-Cytosolic
273 LI:1143463.8:2001MAY17 1745 1767 forward 3 TM Transmembrane
273 LI:1143463.8:2001MAY17 1768 1816 forward 3 TM Cytosolic
273 LI:1143463.8:2001MAY17 1817 1839 forward 3 TM Transmembrane
273 LI:1143463.8:2001MAY17 1840 1848 forward 3 TM Non-Cytosolic
273 LI:1143463.8:2001MAY17 1849 1871 forward 3 TM Transmembrane
273 LI:1143463.8:2001MAY17 1872 1877 forward 3 TM Cytosolic
273 LI:1143463.8:2001MAY17 1878 1897 forward 3 TM Transmembrane
273 LI:1143463.8.2001MAY17 1898 1911 forward 3 TM Non-Cytosolic
273 LI:1143463.8:2001MAY17 1912 1931 forward 3 TM Transmembrane
273 LI:1143463.8:2001MAY17 1932 1946 forward 3 TM Cytosolic
274 LIT 144466.1 :2001MAY17 1 708 forward 1 TM Non-Cytosolic
274 LI:1144466T:2001MAY17 709 728 forward 1 TM Transmembrane
274 LIT 144466. L2001MAY17 729 741 forward 1 TM Cytosolic
274 LIT 144466. T2001MAY17 1 707 forward 3 TM Non-Cytosolic
274 LIT 144466. L2001MAY17 708 727 forward 3 TM Transmembrane
274 LIT 144466.1 :2001MAY17 728 740 forward 3 TM Cytosolic
275 LI:1170624.2:2001MAY17 1 354 forward 1 TM Cytosolic
275 LI:1 170624.2:2001MAY17 355 377 forward 1 TM Transmembrane
275 LI:1170624.2:2001MAY17 378 378 forward 1 TM Non-Cytosolic
275 LI:1 170624.2:2001MAY17 1 356 forward 3 TM Non-Cytosolic
275 LI:1 170624.2:2001MAY17 357 374 forward 3 TM Transmembrane
275 LI:1 170624.2:2001MAY17 375 378 forward 3 TM Cytosolic
276 LIT 171602.39:2001MAY17 1 133 forward 1 TM Non-Cytosolic
276 LI:1171602.39:2001MAY17 134 156 forward 1 TM Transmembrane
276 LI:1 171602.39:2001MAY17 157 234 forward 1 TM Cytosolic
276 LI: 1171602.39:2001MAY17 1 4 forward 2 TM Cytosolic
276 LI:1 171602.39:2001MAY17 5 22 forward 2 TM Transmembrane
276 LIT 171602.39:2001MAY17 23 36 forward 2 TM Non-Cytosolic
276 LI:1 171602.39:2001MAY17 37 59 forward 2 TM Transmembrane
276 LIT 171602.39:2001MAY17 60 234 forward 2 TM Cytosolic
277 LIT 182361.3.2001MAYT7 1 33 forward 1 TM Cytosolic
277 LIT 182361.3:2001MAY17 34 56 forward 1 TM Transmembrane
277 LI 182361.3.2001MAY17 57 245 forward 1 TM Non-Cytosolic
278 LI: 1 188194T5:2001MAY17 1 542 forward 2 TM Non-Cytosolic
278 LI: 1 188194T5:2001MAY17 543 565 forward 2 TM Transmembrane
278 LI: 1 188194T5:2001MAY17 566 585 forward 2 TM Cytosolic
278 LI: 1 188194T5:2001MAY17 586 608 forward 2 TM Transmembrane
278 LI: 1 188194T5:2001MAY17 609 640 forward 2 TM Non-Cytosolic TABLE 2
SEQ D NO: Template ID Start Stop Frame Domain Type Topology
278 LI:1188194.15:2001MAY17 641 659 forward 2 TM Transmembrane
278 LI:1188194T5:2001MAY17 660 662 forward 2 TM Cytosolic
278 LI:1188194T5:2001MAY17 1 538 forward 3 TM Non-Cytosolic
278 LI:1188194.15:2001MAY17 539 561 forward 3 TM Transmembrane
278 LI:1188194.15:2001MAY17 562 634 forward 3 TM Cytosolic
278 LI:1188194T5:2001MAY17 635 657 forward 3 TM Transmembrane
278 LI:1188194.15:2001MAY17 658 662 forward 3 TM Non-Cytosolic
279 LI:1189195.7:2001MAY17 1 426 forward 1 TM Non-Cytosolic
279 LI:1189195.7:2001MAY17 427 445 forward 1 TM Transmembrane
279 LI:1189195.7:2001MAY17 446 457 forward 1 TM Cytosolic
279 LI:1189195J:2001MAY17 458 480 forward 1 TM Transmembrane
279 LI:1189195J:2001MAY17 481 521 forward 1 TM Non-Cytosolic
279 LI:1189195J:2001MAY17 522 539 forward 1 TM Transmembrane
279 LI:1189195.7:2001MAY17 540 567 forward 1 TM Cytosolic
279 LI:1189195J:2001MAY17 568 590 forward 1 TM Transmembrane
279 LI:1189195J:2001MAY17 591 661 forward 1 TM Non-Cytosolic
279 LI:1189195.7:2001MAY17 1 283 forward 2 TM Non-Cytosolic
279 LI:1189195.7:2001MAY17 284 306 forward 2 TM Transmembrane
279 LIT 189195.7:2001MAY17 307 380 forward 2 TM Cytosolic
279 LI:1189195.7:2001MAY17 381 403 forward 2 TM Transmembrane
279 LIT 189195J:2001MAY17 404 422 forward 2 TM Non-Cytosolic
279 LI:1189195.7:2001MAY17 423 445 forward 2 TM Transmembrane
279 LI:1189195.7:2001MAY17 446 457 forward 2 TM Cytosolic
279 LI:1189195.7:2001MAY17 458 480 forward 2 TM Transmembrane
279 LI:1189195.7:2001MAY17 481 489 forward 2 TM Non-Cytosolic
279 LI:1189195.7:2001MAY17 490 509 forward 2 TM Transmembrane
• 279 LI:1189195.7:2001MAY17 510 521 forward 2 TM Cytosolic
279 LI:1189195.7:2001MAY17 522 539 forward 2 TM Transmembrane
279 LI:1189195.7:2001MAY17 540 573 forward 2 TM Non-Cytosolic
279 LI:1189195.7:2001MAY17 574 596 forward 2 TM Transmembrane
279 LI:1189195.7:2001MAY17 597 602 forward 2 TM Cytosolic
279 LI:1189195.7:2001MAY17 603 625 forward 2 TM Transmembrane
279 LI:1189195.7:2001MAY17 626 661 forward 2 TM Non-Cytosolic
279 LI:1189195.7:2001MAY17 1 67 forward 3 TM Cytosolic
279 LI:1189195.7:2001MAY17 68 90 forward 3 TM Transmembrane
279 LIT 189195.7:2001MAY17 91 109 forward 3 TM Non-Cytosolic
279 LI:1189195.7:2001MAY17 110 132 forward 3 TM Transmembrane
279 LI:1189195.7:2001MAY17 133 270 forward 3 TM Cytosolic
279 LI:1189195.7:2001MAY17 271 293 forward 3 TM Transmembrane
279 LI:1189195.7:2001MAY17 294 359 forward 3 TM Non-Cytosolic
279 LI:1189195.7:2001MAY17 360 382 forward 3 TM Transmembrane
279 LI:1189195.7:2001MAY17 383 388 forward 3 TM Cytosolic
279 LI:1189195.7:2001MAY17 389 411 forward 3 TM Transmembrane
279 LI:1189195J:2001MAY17 412 458 forward 3 TM Non-Cytosolic
279 LI:1189195J:2001MAY17 459 481 forward 3 TM Transmembrane
279 LI:1189195.7:2001MAY17 482 517 forward 3 TM Cytosolic
279 LI:1189195.7:2001MAY17 518 537 forward 3 TM Transmembrane
279 LI: 1 189195J:2001MAY17 538 660 forward 3 TM Non-Cytosolic
280 LI:1190092.13:2001MAY17 1 127 forward 1 TM Non-Cytosolic
280 LI: 1190092T3:2001MAY17 128 150 forward 1 TM Transmembrane
280 LIT 190092.13:2001MAY17 151 162 forward 1 TM Cytosolic
280 LIT 190092T3:2001MAY17 1 162 forward 2 TM Cytosolic
281 LI: 1 190318.4:2001MAY17 1 328 forward 1 TM Non-Cytosolic
281 LI: 1 190318.4:2001MAY17 329 351 forward 1 TM Transmembrane TABLE 2
SEQ D NO Template ID Start Stop Frame Domain Type Topology
281 LI:1190318.4:2001MAY17 352 375 forward 1 TM Cytosolic
282 LI: 144233.1 2001MAY17 1 20 forward 1 TM Cytosolic
282 LI: 144233.1 2001MAY17 21 43 forward 1 TM Transmembrane
282 LI: 144233.1 2001MAY17 44 241 forward 1 TM Non-Cytosolic
283 LI: 154608.1 2001MAY17 1 246 forward 1 TM Non-Cytosolic
283 LI: 154608.1 2001MAY17 247 269 forward 1 TM Transmembrane
283 LI: 154608.1 2001MAY17 270 307 forward 1 TM Cytosolic
283 LI: 154608.1 2001MAY17 1 40 forward 2 TM Cytosolic
283 11:154608.1 2001MAY17 41 63 forward 2 TM Transmembrane
283 LIT 54608.1 2001MAY17 64 196 forward 2 TM Non-Cytosolic
283 LI: 154608.1 2001MAY17 197 219 forward 2 TM Transmembrane
283 LI.T54608.1 2001MAY17 220 307 forward 2 TM Cytosolic
283 LI: 154608.1 2001MAY17 1 203 forward 3 TM Non-Cytosolic
283 LIT54608T 2001MAY17 204 226 forward 3 TM Transmembrane
283 LI: 154608.1 2001MAY17 227 245 forward 3 TM Cytosolic
283 LIT 54608.1 2001MAY17 246 268 forward 3 TM Transmembrane
283 LI: 154608.1 2001MAY17 269 306 forward 3 TM Non-Cytosolic
284 LIT70101.1 2001MAY17 1 99 forward 1 TM Cytosolic
284 LIT70101T 2001MAY17 100 122 forward 1 TM Transmembrane
284 LIT70101T 2001MAY17 123 386 forward 1 TM Non-Cytosolic
284 LIT70101T 2001MAY17 1 35 forward 2 TM Non-Cytosolic
284 LIT70101T 2001MAY17 36 58 forward 2 TM Transmembrane
284 LIT 70101.1 2001MAY17 59 99 forward 2 TM Cytosolic
284 LIT70101T 2001MAY17 100 122 forward 2 TM Transmembrane
284 LT.170101.1 2001MAY17 123 136 forward 2 TM Non-Cytosolic
284 LIT70101T 2001MAY17 137 156 forward 2 TM Transmembrane
284 LIT70101T 2001MAY17 157 386 forward 2 TM Cytosolic
284 LT.170101.1 2001MAY17 1 81 forward 3 TM Cytosolic
284 LIT70101T 2001MAY17 82 101 forward 3 TM Transmembrane
284 LI:170101T 2001MAY17 102 110 forward 3 TM Non-Cytosolic
284 LIT70101T 2001MAY17 111 133 forward 3 TM Transmembrane
284 LIT70101T 2001MAY17 134 139 forward 3 TM Cytosolic
284 LIT70101T 2001MAY17 140 157 forward 3 TM Transmembrane
284 LIT70101T 2001MAY17 158 386 forward 3 TM Non-Cytosolic
285 LIT 80043.1 2001MAY17 1 4 forward 1 TM Cytosolic
285 LIT 80043.1 2001MAY17 5 27 forward 1 TM Transmembrane
285 LIT 80043.1 2001MAY17 28 46 forward 1 TM Non-Cytosolic
285 LIT 80043.1 2001MAY17 47 69 forward 1 TM Transmembrane
285 LIT80043T 2001MAY17 70 238 forward 1 TM Cytosolic
285 LIT80043T 2001MAY17 239 261 forward 1 TM Transmembrane
285 LI 80043.1 2001MAY17 262 373 forward 1 TM Non-Cytosolic
285 LIT80043T 2001MAY17 1 208 forward 3 TM Non-Cytosolic
285 LIT 80043.1 2001MAY17 209 228 forward 3 TM Transmembrane
285 LIT 80043.1 2001MAY17 229 373 forward 3 TM Cytosolic
286 LIT93050T 2001MAY17 1 142 forward 1 TM Non-Cytosolic
286 LIT93050T 2001MAY17 143 162 forward 1 TM Transmembrane
286 LIT 93050.1 2001MAY17 163 339 forward 1 TM Cytosolic
286 LIT 93050.1 2001MAY17 340 358 forward 1 TM Transmembrane
286 LIT 93050.1 2001MAY17 359 777 forward 1 TM Non-Cytosolic
286 LIT 93050.1 2001MAY17 1 182 forward 2 TM Non-Cytosolic
286 LIT 93050.1 2001MAY17 183 205 forward 2 TM Transmembrane
286 LIT 93050.1 2001MAY17 206 247 forward 2 TM Cytosolic
286 LIT 93050.1 2001MAY17 248 27O forward 2 TM Transmembrane
286 LIT 93050.1 2001MAY17 271 329 forward 2 TM Non-Cytosolic TABLE 2
SEQ D NO: Template ID Start Stop Frame Domain Type Topology
286 LIT 93050.1 :2001MAY17 330 352 forward 2 TM Transmembrane
286 LIT93050.T.2001MAY17 353 482 forward 2 TM Cytosolic
286 LI:193050T:2001MAY17 483 505 forward 2 TM Transmembrane
286 LIT93050T:2001MAY17 506 536 forward 2 TM Non-Cytosolic
286 LIT93050T:2001MAY17 537 559 forward 2 TM Transmembrane
286 LI: 193050. L2001MAY17 560 684 forward 2 TM Cytosolic
286 LI:193050T:2001MAY17 685 704 forward 2 TM Transmembrane
286 LIT93050.T.2001MAY17 705 734 forward 2 TM Non-Cytosolic
286 LIT 93050. T2001MAY17 735 757 forward 2 TM Transmembrane
286 LIT93050T:2001MAY17 758 777 forward 2 TM Cytosolic
286 LI:193050.1:2001MAY17 1 144 forward 3 TM Cytosolic
286 LI:193050T:2001MAY17 145 167 forward 3 TM Transmembrane
286 LI: 193050. T2001MAY17 168 181 forward 3 TM . Non-Cytosolic
286 LI:193050.1:2001MAY17 182 204 forward 3 TM Transmembrane
286 LL193050.T.2001MAY17 205 255 forward 3 TM Cytosolic
286 LI.T 93050. T2001MAY17 256 278 forward 3 TM Transmembrane
286 LIT93050T:2001MAY17 279 327 forward 3 TM Non-Cytosolic
286 LTT93050T:2001MAY17 328 350 forward 3 TM Transmembrane
286 LI:193050T:2001MAY17 351 419 forward 3 TM Cytosolic
286 LI.T93050.1.2001MAY17 420 439 forward 3 TM Transmembrane
286 LI:193050T:2001MAY17 440 776 forward 3 TM Non-Cytosolic
287 LIT 97477.3 L2001MAY17 1 447 forward 1 TM Non-Cytosolic
287 LI: 197477.3 L2001MAY17 448 470 forward 1 TM Transmembrane
287 LIT 97477.31.2001MAY17 471 500 forward 1 TM Cytosolic
287 LI: 197477.31 :2001MAY17 501 523 forward 1 TM Transmembrane
287 LI:197477.31:2001MAY17 524 ,532 forward 1 TM Non-Cytosolic
287 LI: 197477.31 :2001MAY17 533 550 forward 1 TM Transmembrane
287 LI: 197477.31:2001MAY17 551 655 forward 1 TM Cytosolic
288 LTT99639T2:2001MAY17 1 266 forward 1 TM Non-Cytosolic
288 LI:199639T2:2001MAY17 267 289 forward 1 TM Transmembrane
288 LI: 199639T2.2001MAY17 290 334 forward 1 TM Cytosolic
288 LI:199639T2:2001MAY17 335 357 forward 1 TM Transmembrane
288 LI: 199639.12.2001MAY17 358 360 forward 1 TM Non-Cytosolic
288 LI: 199639T2:2001MAY17 361 383 forward 1 TM Transmembrane
288 LI:199639T2:2001MAY17 384 509 forward 1 TM Cytosolic
288 LIT 99639.12:2001MAY17 510 532 forward 1 TM Transmembrane
288 LI:199639.12:2001MAY17 533 556 forward 1 TM Non-Cytosolic
288 LI: 199639T2:2001MAY17 557 579 forward 1 TM Transmembrane
288 LI:199639.12:2001MAY17 580 585 forward 1 TM Cytosolic
288 LTT99639T2:2001MAY17 586 608 forward 1 TM Transmembrane
288 LI: 199639T2:2001MAY17 609 798 forward 1 TM Non-Cytosolic
288 LI:199639T2:2001MAY17 1 252 forward 2 TM Cytosolic
288 LI: 199639.12:2001MAY17 253 275 forward 2 TM Transmembrane
288 LI: 199639.12.2001MAY17 276 798 forward 2 TM Non-Cytosolic
289 LI:200058.6:2001MAY17 1 101 forward 1 TM Cytosolic
289 LI:200058.6:2001MAY17 102 124 forward 1 TM Transmembrane
289 LI:200058.6:2001MAY17 125 546 forward 1 TM Non-Cytosolic
289 LI:200058.6:2001MAY17 1 402 forward 2 TM Non-Cytosolic
289 LI:200058.6:2001MAY17 403 422 forward 2 TM Transmembrane
289 LI:200058.6:2001MAY17 423 434 forward 2 TM Cytosolic
289 LI:200058.6:2001MAY17 435 454 forward 2 TM Transmembrane
289 LI:200058.6:2001MAY17 455 468 forward 2 TM Non-Cytosolic
289 LI:200058.6:2001MAY17 469 491 forward 2 TM Transmembrane
289 LI:200058.6:2001MAY17 492 546 forward 2 TM Cytosolic TABLE 2
SEQ D NO Template ID Start Stop Frame Domain Type Topology
290 LI:201374.23:2001MAY17 1 177 forward 1 TM Non-Cytosolic
290 LT.201374.23:2001MAY17 178 200 forward 1 TM Transmembrane
290 LI:201374.23:2001MAY17 201 202 forward 1 TM Cytosolic
290 LI:201374.23:2001MAY17 1 58 forward 3 TM Cytosolic
290 LI:201374.23:2001MAY17 59 81 forward 3 TM Transmembrane
290 LI:201374.23:2001MAY17 82 201 forward 3 TM Non-Cytosolic
291 LI.201824.1 2001MAY17 1 488 forward 1 TM Non-Cytosolic
291 LL201824.1 2001MAY17 489 511 forward 1 TM Transmembrane
291 LL201824.1 2001MAY17 512 713 forward 1 TM Cytosolic
291 LL201824.1 2001MAY17 714 736 forward 1 TM Transmembrane
291 LI.201824.1 2001MAY17 737 804 forward 1 TM Non-Cytosolic
291 LL201824.1 2001MAY17 805 824 forward 1 TM Transmembrane
291 LL201824.1 2001MAY17 825 836 forward 1 TM Cytosolic
291 LL201824.1 2001MAY17 837 856 forward 1 TM Transmembrane
291 LT.201824.1 2001MAY17 857 870 forward 1 TM Non-Cytosolic
291 LI.-201824.1 2001MAY17 871 893 forward 1 TM Transmembrane
291 LL201824.1 2001MAY17 894 1218 forward 1 TM Cytosolic
291 LL201824.1 2001MAY17 1219 1249 forward 1 TM Transmembrane
291 LL201824.1 2001MAY17 1250 1253 forward 1 TM Non-Cytosolic
291 LI.-201824.1 2001MAY17 1 143 forward 3 TM Cytosolic
291 LL201824.1 2001MAY17 144 166 forward 3 TM Transmembrane
291 LI.201824.1 2001MAY17 167 199 forward 3 TM Non-Cytosolic
291 LL201824.1 2001MAY17 200 219 forward 3 TM Transmembrane
291 LI.201824.1 2001MAY17 220 231 forward 3 TM Cytosolic
291 LI:201824.1 2001MAY17 232 254 forward 3 TM Transmembrane
291 LI:201824.1 2001MAY17 255 500 forward 3 TM Non-Cytosolic
291 LT201824.1 2001MAY17 501 523 forward 3 TM Transmembrane
291 LI:201824.1 2001MAY17 . '524 529 forward 3 TM Cytosolic
291 LI.201824.1 2001MAY17 '530 549 forward 3 TM Transmembrane
291 LL201824.1 2001MAY17 550 575 forward 3 TM Non-Cytosolic
291 LL201824.1 2001MAY17 576 598 forward 3 TM Transmembrane
291 LL201824.1 2001MAY17 599 692 forward 3 TM Cytosolic
291 LL201824.1 2001MAY17 693 715 forward 3 TM Transmembrane
291 LL201824.1 2001MAY17 716 729 forward 3 TM Non-Cytosolic
291 LL201824.1 2001MAY17 730 752 forward 3 TM Transmembrane
291 LL201824.1 2001MAY17 753 860 forward 3 TM Cytosolic
291 LL201824.1 2001MAY17 861 883 forward 3 TM Transmembrane
291 LL201824.1 2001MAY17 884 1226 forward 3 TM Non-Cytosolic
291 LI:201824.1 2001MAY17 1227 1249 forward 3 TM Transmembrane
291 LT201824.1 2001MAY17 1250 1253 forward 3 TM Cytosolic
292 LI:201989T 1:2001MAY17 1 406 forward 1 TM Non-Cytosolic
292 LI:201989T 1 :2001MAY17 407 429 forward 1 TM Transmembrane
292 LI:201989T 1:2001MAY17 430 443 forward 1 TM Cytosolic
292 LI:201989.1 L2001MAY17 1 400 forward 3 TM Non-Cytosolic
292 LL201989.1 2001MAY17 401 423 forward 3 TM Transmembrane
292 LI:201989.1 L2001MAY17 424 442 forward 3 TM Cytosolic
293 LI:2035159T:2001MAY17 1 52 forward 1 TM Cytosolic
293 LL2035159.1 :2001MAY17 53 72 forward 1 TM Transmembrane
293 LI:2035159T:2001MAY17 73 242 forward 1 TM Non-Cytosolic
293 LI:2035159T :2001MAY17 1 216 forward 2 TM Cytosolic
293 LI:2035159T:2001MAY17 217 236 forward 2 TM Transmembrane
293 LI:2035159T:2001MAY17 237 242 forward 2 TM Non-Cytosolic
294 LI:204818TO:2001MAY17 1 364 forward 1 TM Non-Cytosolic
294 LI.204818.1 0:2001MAY17 365 387 forward 1 TM Transmembrane 16S 1 TABLE 2
SEQ D NO: Template ID Start Stop Frame Domain Type Topology
294 LT.204818.10:2001MAYI7 388 482 forward 1 TM Cytosolic
294 LI:204818T0:2001MAY17 1 229 forward 2 TM Non-Cytosolic
294 LI:204818.10:2001MAY17 230 252 forward 2 TM Transmembrane
294 LI:204818T0:2001MAY17 253 365 forward 2 TM Cytosolic
294 LI:204818T0:2001MAY17 366 388 forward 2 ■ TM Transmembrane
294 LI:204818T0:2001MAY17 389 481 forward 2 TM Non-Cytosolic
295 LI:2048337T :2001MAY17 1 611 forward 2 TM Non-Cytosolic
295 LI:2048337T :2001MAY17 612 634 forward 2 TM Transmembrane
295 LL2048337.T.2001MAY17 635 658 forward 2 TM Cytosolic
295 LI:2048337T:2001MAY17 659 681 forward 2 TM Transmembrane
295 LI:2048337T :2001MAY17 682 709 forward 2 TM Non-Cytosolic
296 LI:2049697.4:2001MAY17 1 390 forward 3 TM Non-Cytosolic
296 LI:2049697.4:2001MAY17 391 413 forward 3 TM Transmembrane
296 LI:2049697.4:2001MAY17 414 698 forward 3 TM Cytosolic
297 LI:2050808T9:2001MAY17 1 105 forward 2 TM, Non-Cytosolic
297 LI:2050808T9:2001MAY17 106 128 forward 2 TM' Transmembrane
297 LI:2050808T9:2001MAY17 129 134 forward 2 TM Cytosolic
297 LI:2050808T9:2001MAY17 135 157 forward 2 TM Transmembrane
297 LI:2050808T9:2001MAY17 158 176 forward 2 TM Non-Cytosolic
297 LI:2050808T9:2001MAY17 177 199 forward 2 TM Transmembrane
297 LI:2050808T9:2001MAY17 200 412 forward 2 TM Cytosolic
298 LI:209773.25:2001MAY17 1 4 forward 1 TM Cytosolic
298 LI:209773.25:2001MAY17 5 27 forward 1 TM Transmembrane
298 LI:209773.25:2001MAY17 28 363 forward 1 TM Non-Cytosolic
298 LI:209773.25:2001MAY17 1 6 forward 3 TM Cytosolic
298 LI:209773.25:2001MAY17 7 ■ 29. forward 3 TM Transmembrane
298 LI:209773.25:2001MAY17 30 362 forward 3 TM Non-Cytosolic
299 LI:2117881.32:2001MAY17 1 177 forward 1 TM Non-Cytosolic
299 LI:2117881.32:2001MAY17 178 200 forward 1 TM Transmembrane
299 LI:2117881.32:2001MAY17 201 386 forward 1 TM Cytosolic
299 LI:21 1788T32:2001MAY17 387 406 forward 1 TM Transmembrane
299 LI:2117881.32:2001MAY17 407 422 forward 1 TM Non-Cytosolic
299 LI:211788T32:2001MAY17 1 288 forward 2 TM Cytosolic
299 LI:211788T32:2001MAY17 289 311 forward 2 TM Transmembrane
299 LI:21 17881.32:2001MAY17 312 325 forward 2 TM Non-Cytosolic
299 LI:2117881.32:2001MAY17 326 348 forward 2 TM Transmembrane
299 LL2117881.32.2001MAYT7 349 422 forward 2 TM Cytosolic
299 LI:21 17881.32:2001MAY17 1 384 forward 3 TM Non-Cytosolic
299 LI:21 17881.32:2001MAY17 385 404 forward 3 TM Transmembrane
299 LI:21 1788T32:2001MAY17 405 422 forward 3 TM Cytosolic
300 LI:21 18140.9:2001MAY17 1 446 forward 1 TM Non-Cytosolic
300 LI:2118140.9:2001MAY17 447 469 forward 1 TM Transmembrane
300 LI:21 18140.9:2001MAY17 470 510 forward 1 TM Cytosolic
300 LI:21 18140.9:2001MAY17 511 533 forward 1 TM Transmembrane
300 LI:21 18140.9:2001MAY17 534 566 forward 1 TM Non-Cytosolic
300 LI:21 18140.9:2001MAY17 1 179 forward 2 TM Non-Cytosolic
300 LI.21 18140.9.2001MAY17 180 202 forward 2 TM Transmembrane
300 LI:21 18140.9:2001MAY17 203 411 forward 2 TM Cytosolic
300 LI:21 18140.9:2001MAY17 412 434 forward 2 TM Transmembrane
300 LI:21 18140.9:2001MAY17 435 443 forward 2 TM Non-Cytosolic
300 LI:21 18140.9:2001MAY17 444 466 forward 2 TM Transmembrane
300 LI:21 18140.9:2001MAY17 467 565 forward 2 TM Cytosolic
300 LI:21 18140.9:2001MAY17 1 201 forward 3 TM Cytosolic
300 LI:21 18140.9:2001MAY17 202 219 forward 3 TM Transmembrane W o σ o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o σ o o o o o o σ
2.
O
Figure imgf000173_0001
o o o o o cu cu Cu cu
Figure imgf000173_0002
OJ OJ OJ OJ OJ OJ
Figure imgf000173_0003
Figure imgf000174_0001
N ( CI M N N t*) N C- N N * N C-t N M N r*l m c<l n n *η m m
O TJ O T3 O O 3 O T_) O O *O T_) 3 TD TJ O O T3 TD T_J T_J O T3 T3 T_ϊ T_) T3 T_J 'O T3 "O T3 D T3 T3 TD TD TD TD TD TD TD TD TD TD TD TD TD TD TD TD TD TD
Sa n a S3 ca is
U-i ,o .o .o ,o .o .o .o .o ,o .o ,o ,o .o ,o o .o cS .o ,o ,o ,o ,o .o ,o ,o ,o .o ,o o ,o ,o ,o ,o .o .o ,o .o .o o
oo CN in tN ι S S S
Figure imgf000174_0002
Figure imgf000174_0003
< * " | (N) ( N N N N (-. N ou o o o o σ o o o o o o o o o o o o o o o o o o o o o o o o o o o o o mcn m<c:n-''> cn cn cn cn cn cn cn cn cn cn cn m
O
Figure imgf000174_0004
TABLE 2
SEQ D NO: Template ID Start Stop Frame Domain Type Topology
303 LI:2118368.12:2001MAY17 1 53 forward 3 TM Cytosolic
303 LI:2118368.12.2001MAY17 54 76 forward 3 TM Transmembrane
303 LI:2118368.12:2001MAY17 77 452 forward 3 TM Non-Cytosolic
304 LI:2119448.5:2001MAY17 1 220 forward 3 TM Cytosolic
304 LI:2119448.5:2001MAY17 221 243 forward 3 TM Transmembrane
304 LI:2119448.5:2001MAY17 244 262 forward 3 TM Non-Cytosolic
304 LI:2119448.5:2001MAY17 263 285 forward 3 TM Transmembrane
304 LI.-2119448.5:2001MAY17 286 393 forward 3 TM Cytosolic
304 LI:2119448.5:2001MAY17 394 416 forward 3 TM Transmembrane
304 LI:2119448.5:2001MAY17 417 1120 forward 3 TM Non-Cytosolic
305 LI:212023.7:2001MAY17 1 69 forward 2 TM Cytosolic
305 LI:212023.7:2001MAY17 70 92 forward 2 TM Transmembrane
305 LI:212023.7:2001MAY17 93 106 forward 2 TM Non-Cytosolic
305 LI:212023.7:2001MAY17 107 129 forward 2 TM Transmembrane
305 LI:212023.7:2001MAY17 130 140 forward 2 TM Cytosolic
305 LI:212023.7:2001MAY17 141 158 forward 2 TM Transmembrane
305 LI:212023.7:2001MAY17 159 172 forward 2 TM Non-Cytosolic
305 LI:212023.7:2001MAY17 173 195 forward 2 TM Transmembrane
305 LI:212023.7:2001MAY17 196 491 forward 2 TM Cytosolic
306 LI:2120556.1:2001MAY17 1 99 forward 3 TM Cytosolic
306 LI:2120556.1:2001MAY17 100 122 forward 3 TM Transmembrane
306 LI:2120556.1:2001MAY17 123 386 forward 3 TM Non-Cytosolic
307 LI:2121577.3:2001MAY17 1 73 forward 1 TM Cytosolic
308 0:2123395.11 :2001MAY17 1 364 forward 1 TM Non-Cytosolic
308 LI:2123395.11:2001MAY17 365 387 forward 1 TM Transmembrane
308 LI:2123395.11:2001MAY17 388 457 forward 1 TM Cytosolic
308 LI:2123395.11:2001MAY17 458 480 forward 1 TM Transmembrane
308 LI:2123395.11:2001MAY17 481 588 forward 1 TM Non-Cytosolic
308 LI:2123395.11:2001MAY17 589 611 forward 1 TM Transmembrane
308 LI:2123395.11:2001MAY17 612 707 forward 1 TM Cytosolic
308 LI:2123395.11:2001MAY17 708 730 forward 1 TM Transmembrane
308 LI:2123395.11:2001MAY17 731 775 forward 1 TM Non-Cytosolic
308 LI:2123395.11:2001MAY17 776 798 forward 1 TM Transmembrane
308 LI:2123395.11:2001MAY17 799 883 forward 1 TM Cytosolic
308 LI:2123395.11:2001MAY17 1 535 forward 2 TM Non-Cytosolic
308 LI:2123395.11:2001MAY17 536 558 forward 2 TM Transmembrane
308 Ll:2123395.11:2001MAY17 559 578 forward 2 TM Cytosolic
308 LI:2123395.11:2001MAY17 579 601 forward 2 TM Transmembrane
308 LI:2123395.11 :2001MAY17 602 665 forward 2 TM Non-Cytosolic
308 LI:2123395.11:2001MAY17 666 688 forward 2 TM Transmembrane
308 LI:2123395.11:2001MAY17 689 707 forward 2 TM Cytosolic
308 LI:2123395.11:2001MAY17 708 730 forward 2 TM Transmembrane
308 LI:2123395.11:2001MAY17 731 749 forward 2 TM Non-Cytosolic
308 LI:2123395.11:2001MAY17 750 772 forward 2 TM Transmembrane
308 1.1:2123395.1 1.2001MAY17 773 882 forward 2 TM Cytosolic
308 LI:2123395.1 1 :2001MAY17 1 369 forward 3 TM Non-Cytosolic
308 LI:2123395.11:2001MAY17 370 392 forward 3 TM Transmembrane
308 LI:2123395.11:2001MAY17 393 437 forward 3 TM Cytosolic
308 LI:2123395.1 1 :2001MAY17 438 460 forward 3 TM Transmembrane
308 LI:2123395.11 :2001MAY17 461 882 forward 3 TM Non-Cytosolic
309 LI:2123452.9:2001MAY17 1 462 forward 1 TM Non-Cytosolic
309 LI:2123452.9:2001MAY17 463 485 forward 1 TM Transmembrane
309 LI:2123452.9-.2001MAY17 486 497 forward 1 TM Cytosolic
309 LI:2123452.9:2001MAY17 498 520 forward 1 TM Transmembrane TABLE 2
SEQ D NO: Template ID Start Stop Frame Domain Type Topology
309 LI:2123452.9:2001MAY17 521 534 forward 1 TM Non-Cytosolic
309 LI:2123452.9:2001MAY17 535 552 forward 1 TM Transmembrane
309 LI:2123452.9:2001MAY17 553 556 forward 1 TM Cytosolic
309 LI:2123452.9:2001MAY17 557 574 forward 1 TM Transmembrane
309 LI:2123452.9:2001MAY17 575 583 forward 1 TM Non-Cytosolic
309 LI:2123452.9:2001MAY17 584 606 forward 1 TM Transmembrane
309 LI:2123452.9:2001MAY17 607 686 forward 1 TM Cytosolic
309 LI:2123452.9:2001MAY17 1 468 forward 2 TM Non-Cytosolic
309 LI:2123452.9:2001MAY17 469 491 forward 2 TM Transmembrane
309 LI:2123452.9:2001MAY17 492 551 forward 2 TM Cytosolic
309 LI:2123452.9:2001MAY17 552 574 forward 2 TM Transmembrane
309 LI:2123452.9:2001MAY17 575 583 forward 2 TM Non-Cytosolic
309 LI:2123452.9:2001MAY17 584 606 forward 2 TM Transmembrane
309 LI:2123452.9:2001MAY17 607 657 forward 2 TM Cytosolic
309 LI:2123452.9:2001MAY17 658 680 forward 2 TM Transmembrane
309 LI:2123452.9:2001MAY17 681 686 forward 2 TM Non-Cytosolic
309 LI:2123452.9:2001MAY17 1 389 forward 3 TM Non-Cytosolic
309 LI:2123452.9:2001MAY17 390 408 forward 3 TM Transmembrane
309 LI:2123452.9:2001MAY17 409 428 forward 3 TM Cytosolic
309 LI:2123452.9:2001MAY17 429 448 forward 3 TM Transmembrane
309 LI:2123452.9:2001MAY17 449 457 forward 3 TM Non-Cytosolic
309 LI:2123452.9:2001MAY17 458 480 forward 3 TM Transmembrane
309 LI:2123452.9:2001MAY17 481 484 forward 3 TM Cytosolic
309 LI:2123452.9:2001MAY17 485 507 forward 3 TM Transmembrane
309 LI:2123452.9:2001MAY17 508 685 forward 3 TM Non-Cytosolic
310 LI:2164109.1 :2001MAY17 1 20 forward 1 TM Cytosolic
310 LI:2164109.1 :2001MAY17 21 43 forward 1 TM Transmembrane
310 LI:2164109.1 :2001MAY17 44 127 forward 1 TM Non-Cytosolic
310 LI:2164109.1 :2001MAY17 128 150 forward 1 TM Transmembrane
310 LT.2164109.1 :2001MAY17 151 154 forward 1 TM Cytosolic
310 LI:2164109.1:2001MAY17 1 12 forward 3 TM Cytosolic
310 0:2164109.1 :2001MAY17 13 35 forward 3 TM Transmembrane
310 0:2164109.1 :2001 MAY 17 36 153 forward 3 TM Non-Cytosolic
311 LI:2168320.1 :2001MAY17 1 9 forward 2 TM Non-Cytosolic
311 0:2168320.1 :2001MAY17 10 32 forward 2 TM Transmembrane
311 0:2168320.1 :2001MAY17 33 38 forward 2 TM Cytosolic
311 0:2168320.1 :2001MAY17 39 61 forward 2 TM Transmembrane
311 0:2168320.1 :2001MAY17 62 123 forward 2 TM Non-Cytosolic
311 0:2168320.1 :2001MAY17 124 146 forward 2 TM Transmembrane
311 0:2168320.1:2001MAY17 147 172 forward 2 TM Cytosolic
311 O:2168320.1 :2001MAY17 1 9 forward 3 TM Non-Cytosolic
311 0:2168320.1 :2001MAY17 10 32 forward 3 TM Transmembrane
311 0:2168320.1 :2001MAY17 33 172 forward 3 TM Cytosolic
312 0:2173577.1 :2001MAY17 1 30 forward 1 TM Non-Cytosolic
312 0:2173577.1 :2001MAY17 31 53 forward 1 TM Transmembrane
312 0:2173577.1 :2001MAY17 54 65 forward 1 TM Cytosolic
312 0:2173577.1 :2001MAY17 66 88 forward 1 TM Transmembrane
312 0:2173577.1 :2001MAY17 89 92 forward 1 TM Non-Cytosolic
312 LI:2173577.1.2001MAY17 93 115 forward 1 TM Transmembrane
312 0:2173577.1 :2001MAY17 116 194 forward 1 TM Cytosolic
312 0:2173577.1 :2001MAY17 1 37 forward 2 TM Cytosolic
312 0:2173577.1 :2001MAY17 38 57 forward 2 TM Transmembrane
312 0:2173577.1:2001MAY17 58 66 forward 2 TM Non-Cytosolic
312 0:2173577.1 :2001MAY17 67 89 forward 2 TM Transmembrane TABLE 2
SEQ D NO: Template ID Start Stop Frame Domain Type Topology
312 LI:2173577.1:2001MAY17 90 193 forward 2 TM Cytosolic
312 LI:2173577.1:2001MAY17 1 43 forward 3 TM Cytosolic
312 LI:2173577.1:2001MAY17 44 66 forward 3 TM Transmembrane
312 LI:2173577.1:2001MAY17 67 75 forward 3 TM Non-Cytosolic
312 LI:2173577.1:2001MAY17 76 98 forward 3 TM Transmembrane
312 LI:2173577.1:2001MAY17 99 193 forward 3 TM Cytosolic
313 LI:2179256.1:2001MAY17 1 41 forward 2 TM Cytosolic
313 LI:2179256.1:2001MAY17 42 64 forward 2 TM Transmembrane
313 LI:2179256.1:2001MAY17 65 210 forward 2 TM Non-Cytosolic
314 LI:2180388.1:2001MAY17 1 118 forward 2 TM Non-Cytosolic
314 LI:2180388.1:2001MAY17 119 141 forward 2 TM Transmembrane
314 O:2180388.1:2001MAY17 142 215 forward 2 TM Cytosolic
315 LI:2199713.8:2001MAY17 1 553 forward 2 TM Non-Cytosolic
315 LI:2199713.8:2001MAY17 554 571 forward 2 TM Transmembrane
315 LI:2199713.8:2001MAY17 572 590 forward 2 TM Cytosolic
316 LI:2200587.2:2001MAY17 1 4 forward 1 TM Cytosolic
316 LI:2200587.2:2001MAY17 5 27 forward 1 TM Transmembrane
316 LI:2200587.2:2001MAY17 28 36 forward 1 TM Non-Cytosolic
316 LI:2200587.2:2001MAY17 37 56 forward 1 TM Transmembrane
316 LI:2200587.2:2001MAY17 57 62 forward 1 TM Cytosolic
316 LI:2200587.2:2001MAY17 63 85 forward 1 TM Transmembrane
316 LI:2200587.2:2001MAY17 86 88 forward 1 TM Non-Cytosolic
316 LI:2200587.2:2001MAY17 89 111 forward 1 TM Transmembrane
316 LI:2200587.2:2001MAY17 112 119 forward 1 TM Cytosolic
316 LI:2200587.2:2001MAY17 120 142 forward 1 TM Transmembrane
316 LI:2200587.2:2001MAY17 143 146 forward 1 TM Non-Cytosolic
316 LI:2200587.2:2001MAY17 147 169 forward 1 TM Transmembrane
316 LI:2200587.2:2001MAY17 170 176 forward 1 TM Cytosolic
316 LI:2200587.2:2001MAY17 1 22 forward 2 TM Non-Cytosolic
316 LI:2200587.2:2001MAY17 23 45 forward 2 TM Transmembrane
316 LI:2200587.2:2001MAY17 46 53 forward 2 TM Cytosolic
316 LI:2200587.2:2001MAY17 54 76 forward 2 TM Transmembrane
316 LI:2200587.2:2001MAY17 77 90 forward 2 TM Non-Cytosolic
316 LI:2200587.2:2001MAY17 91 113 forward 2 TM Transmembrane
316 LI:2200587.2:2001MAY17 114 125 forward 2 TM Cytosolic
316 LI:2200587.2:2001MAY17 126 148 forward 2 TM Transmembrane
316 LI:2200587.2:2001MAY17 149 176 forward 2 TM Non-Cytosolic
316 LI:2200587.2:2001MAY17 1 14 forward 3 TM Non-Cytosolic
316 LI:2200587.2:2001MAY17 15 37 forward 3 TM Transmembrane
316 LI:2200587.2:2001MAY17 38 43 forward 3 TM Cytosolic
316 LI:2200587.2:2001MAY17 44 63 forward 3 TM Transmembrane
316 LI:2200587.2:2001MAY17 64 72 forward 3 TM Non-Cytosolic
316 LI:2200587.2:2001MAY17 73 95 forward 3 TM Transmembrane
316 LI:2200587.2:2001MAY17 96 101 forward 3 TM Cytosolic
316 LI:2200587.2:2001MAY17 102 124 forward 3 TM Transmembrane
316 LI:2200587.2:2001MAY17 125 143 forward 3 TM Non-Cytosolic
316 LI:2200587.2:2001MAY17 144 166 forward 3 TM Transmembrane
316 LI:2200587.2:2001MAY17 167 176 forward 3 TM Cytosolic
317 LI:2200761.12:2001MAY17 1 3 forward 1 TM Non-Cytosolic
317 LI:2200761.12:2001MAY17 4 26 forward 1 TM Transmembrane
317 LI:2200761.12:2001MAY17 27 343 forward 1 TM Cytosolic
317 LI:2200761.12:2001MAY17 344 366 forward 1 TM Transmembrane
317 LI:2200761.12:2001MAY17 367 374 forward 1 TM Non-Cytosolic
317 LI:2200761.12:2001MAY17 1 346 forward 2 TM Non-Cytosolic TABLE 2
SEQ D NO: Template ID Start Stop Frame Domain Type Topology
317 LI:2200761.12:2001MAY17 347 369 forward 2 TM Transmembrane
317 LI:2200761.12:2001MAY17 370 374 forward 2 TM Cytosolic
317 LI:2200761.12:2001MAY17 1 299 forward 3 TM Non-Cytosolic
317 LI:2200761.12:2001MAY17 300 322 forward 3 TM Transmembrane
317 LI:2200761.12:2001MAY17 323 342 forward 3 TM Cytosolic
317 LI:2200761.12:2001MAY17 343 365 forward 3 TM Transmembrane
317 LI:2200761.12:2001MAY17 366 373 forward 3 TM Non-Cytosolic
318 LI:2203624.1:2001MAY17 1 139 forward 1 TM Cytosolic
318 LI:2203624.1:2001MAY17 140 156 forward 1 TM Transmembrane
318 LI:2203624.1:2001MAY17 157 226 forward 1 TM Non-Cytosolic
318 LI:2203624.1:2001MAY17 227 249 forward 1 TM Transmembrane
318 LI:2203624.1:2001MAY17 250 376 forward 1 TM Cytosolic
319 LI:220495.9:2001MAY17 1 40 forward 2 TM Non-Cytosolic
319 LI:220495.9:2001MAY17 41 63 forward 2 TM Transmembrane
319 LI:220495.9:2001MAY17 64 163 forward 2 TM Cytosolic
319 LI:220495.9:2001MAY17 164 183 forward 2 TM Transmembrane
319 LI:220495.9:2001MAY17 184 192 forward 2 TM Non-Cytosolic
319 LI:220495.9:2001MAY17 193 210 forward 2 TM Transmembrane
319 LI:220495.9:2001MAY17 211 247 forward 2 TM Cytosolic
319 LI:220495.9:2001MAY17 248 270 forward 2 TM Transmembrane
319 LI:220495.9:2001MAY17 271 284 forward 2 TM Non-Cytosolic
319 LI:220495.9:2001MAY17 285 307 forward 2 TM Transmembrane
319 LI:220495.9:2001MAY17 308 451 forward 2 TM Cytosolic
319 LI:220495.9:2001MAY17 452 474 forward 2 TM Transmembrane
319 LI:220495.9:2001MAY17 475 931 forward 2 TM Non-Cytosolic
319 LI:220495.9:2001MAY17 932 954 forward 2 TM Transmembrane
319 LI:220495.9:2001MAY17 955 973 forward 2 TM Cytosolic
319 LI:220495.9:2001MAY17 974 996 forward 2 TM Transmembrane
319 LI:220495.9:2001MAY17 997 1034 forward 2 TM Non-Cytosolic
319 LI:220495.9:2001MAY17 1 25 forward 3 TM Non-Cytosolic
319 LI:220495.9:2001MAY17 26 48 forward 3 TM Transmembrane
319 LI:220495.9:2001MAY17 49 453 forward 3 TM Cytosolic
319 LI:220495.9:2001MAY17 454 472 forward 3 TM Transmembrane
319 LI:220495.9:2001MAY17 473 491 forward 3 TM Non-Cytosolic
319 LI:220495.9:2001MAY17 492 514 forward 3 TM Transmembrane
319 LI:220495.9:2001MAY17 515 574 forward 3 TM Cytosolic
319 LI:220495.9:2001MAY17 575 597 forward 3 TM Transmembrane
319 LI:220495.9:2001MAY17 598 606 forward 3 TM Non-Cytosolic
319 LI:220495.9:2001MAY17 607 629 forward 3 TM Transmembrane
319 LI:220495.9:2001MAY17 630 931 forward 3 TM Cytosolic
319 LI:220495.9:2001MAY17 932 954 forward 3 TM Transmembrane
319 LI:220495.9:2001MAY17 955 1033 forward 3 TM Non-Cytosolic
320 LI:2205532.1:2001MAY17 1 28 forward 1 TM Non-Cytosolic
320 LI:2205532.1 :2001MAY17 29 51 forward 1 TM Transmembrane
320 LI:2205532.1 :2001MAY17 52 70 forward 1 TM Cytosolic
320 LI:2205532.1 :2001MAY17 71 90 forward 1 TM Transmembrane
320 LI:2205532.1 :2001MAY17 91 99 forward 1 TM Non-Cytosolic
320 LI:2205532.1:2001MAY17 100 122 forward 1 TM Transmembrane
320 LI:2205532.1 :2001MAY17 123 155 forward 1 TM Cytosolic
320 LI:2205532.1 :2001MAY17 156 178 forward 1 TM Transmembrane
320 LI:2205532.1 :2001MAY17 179 210 forward 1 TM Non-Cytosolic
320 LI:2205532.1 :2001MAY17 211 230 forward 1 TM Transmembrane
320 L 2205532.1 :2001MAY17 231 250 forward 1 TM Cytosolic
320 L 2205532.1 :2001MAY17 251 273 forward 1 TM Transmembrane TABLE 2
SEQ D NO: Template ID Start Stop Frame Domain Type Topology
320 L 2205532.1 -.2001MAY 17 274 367 forward 1 TM Non-Cytosolic
320 11:2205532.1:2001MAY 17 368 390 forward 1 TM Transmembrane
320 LI:2205532.1:2001MAY17 391 407 forward 1 TM Cytosolic
320 LI:2205532.1:2001MAY17 1 30 forward 2 TM Cytosolic
320 LI:2205532.1:2001MAY17 31 53 forward 2 TM Transmembrane
320 LI:2205532.1:2001MAY17 54 96 forward 2 TM Non-Cytosolic
320 LI:2205532.1:2001MAY17 97 119 forward 2 TM Transmembrane
320 LI:2205532.1:2001MAY17 120 243 forward 2 TM Cytosolic
320 LI:2205532.1:2001MAY17 244 266 forward 2 TM Transmembrane
320 LI:2205532.1:2001MAY17 267 275 forward 2 TM Non-Cytosolic
320 LI:2205532.1:2001MAY17 276 293 forward 2 TM Transmembrane
320 LI:2205532.1:2001MAY17 294 406 forward 2 TM Cytosolic
320 LI:2205532.1:2001MAY17 1 35 forward 3 TM Cytosolic
320 LI:2205532.1:2001MAY17 36 58 forward 3 TM Transmembrane
320 LI:2205532.1:2001MAY17 59 82 forward 3 TM Non-Cytosolic
320 LL-2205532.1 :2001MAY17 83 102 forward 3 TM Transmembrane
320 LI:2205532.1:2001MAY17 103 106 forward 3 TM Cytosolic
320 LI:2205532.1:2001MAY17 107 129 forward 3 TM Transmembrane
320 LI:2205532.1:2001MAY17 130 148 forward 3 TM Non-Cytosolic
320 LI:2205532.1:2001MAY17 149 171 forward 3 TM Transmembrane
320 LI:2205532.1:2001MAY17 172 244 forward 3 TM Cytosolic
320 LI:2205532.1:2001MAY17 245 267 forward 3 TM Transmembrane
320 LI:2205532.1:2001MAY17 268 406 forward 3 TM Non-Cytosolic
321 LI:2206277.1:2001MAY17 1 246 forward 1 TM Cytosolic
321 LI:2206277.1:2001MAY17 247 269 forward 1 TM Transmembrane
321 LI:2206277.1:2001MAY17 270 283 forward 1 TM Non-Cytosolic
321 LI:2206277.1:2001MAY17 284 306 forward 1 TM Transmembrane
321 LL.2206277.1 -.2001MAY17 307 367 forward 1 TM Cytosolic
322 LI:2207765.8:2001MAY17 1 6 forward 3 TM Cytosolic
322 LI:2207765.8:2001MAY17 7 29 forward 3 TM Transmembrane
322 LI:2207765.8:2001MAY17 30 384 forward 3 TM Non-Cytosolic
323 LI:2208404.4:2001MAY17 1 44 forward 3 TM Non-Cytosolic
323 LI:2208404.4:2001MAY17 45 64 forward 3 TM Transmembrane
323 LI:2208404.4:2001MAY17 65 114 forward 3 TM Cytosolic
324 LI:2208715.3:2001MAY17 1 237 forward 1 TM Cytosolic
325 LI:2208766.2:2001MAY17 1 28 forward 1 TM Non-Cytosolic
325 LI:2208766.2:2001MAY17 29 48 forward 1 TM Transmembrane
325 LI:2208766.2:2001MAY17 49 272 forward 1 TM Cytosolic
325 LI:2208766.2:2001MAY17 273 295 forward 1 TM Transmembrane
325 LI:2208766.2:2001MAY17 296 309 forward 1 TM Non-Cytosolic
325 LI:2208766.2:2001MAY17 310 332 forward 1 TM Transmembrane
325 LI:2208766.2:2001MAY17 333 369 forward 1 TM Cytosolic
325 LI:2208766.2:2001MAY17 370 387 forward 1 TM Transmembrane
325 LI:2208766.2:2001MAY17 388 396 forward 1 TM Non-Cytosolic
325 LI:2208766.2:2001MAY17 397 419 forward 1 TM Transmembrane
325 LI:2208766.2:2001MAY17 420 535 forward 1 TM Cytosolic
325 LI:2208766.2:2001MAY17 536 558 forward 1 TM Transmembrane
325 LI:2208766.2:2001MAY17 559 577 forward 1 TM Non-Cytosolic
325 LI:2208766.2:2001MAY17 578 597 forward 1 TM Transmembrane
325 LI:2208766.2:2001MAY17 598 731 forward 1 TM Cytosolic
325 LI:2208766.2:2001MAY17 732 751 forward 1 TM Transmembrane
325 LI:2208766.2:2001MAY17 752 779 forward 1 TM Non-Cytosolic
325 LI:2208766.2:2001MAY17 780 802 forward 1 TM Transmembrane
325 LI:2208766.2:2001MAY17 803 835 forward 1 TM Cytosolic TABLE 2
SEQ D NO: Template ID Start Stop Frame Domain Type Topology
325 LI:2208766.2:2001MAY17 1 43 forward 2 TM Non-Cytosolic
325 LI:2208766.2:2001MAY17 44 66 forward 2 TM Transmembrane
325 LI:2208766.2:2001MAY17 67 78 forward 2 TM Cytosolic
325 LI:2208766.2:2001MAY17 79 101 forward 2 TM Transmembrane
325 LI:2208766.2:2001MAY17 102 197 forward 2 TM Non-Cytosolic
325 LI:2208766.2:2001MAY17 198 220 forward 2 TM Transmembrane
325 LI:2208766.2:2001MAY17 221 272 forward 2 TM Cytosolic
325 LI:2208766.2:2001MAY17 273 295 forward 2 TM Transmembrane
325 LI:2208766.2:2001MAY17 296 309 forward 2 TM Non-Cytosolic
325 LI:2208766.2:2001MAY17 310 332 forward 2 TM Transmembrane
325 LI:2208766.2:2001MAY17 333 518 forward 2 TM Cytosolic
325 LI:2208766.2:2001MAY17 519 541 forward 2 TM Transmembrane
325 LI:2208766.2:2001MAY17 542 550 forward 2 TM Non-Cytosolic
325 LI:2208766.2:2001MAY17 551 573 forward 2 TM Transmembrane
325 LI:2208766.2:2001MAY17 574 690 forward 2 TM Cytosolic
325 LI:2208766.2:2001MAY17 691 713 forward 2 TM Transmembrane
325 LI:2208766.2:2001MAY17 714 727 forward 2 TM Non-Cytosolic
325 LI:2208766.2:2001MAY17 728 750 forward 2 TM Transmembrane
325 LI:2208766.2:2001MAY17 751 834 forward 2 TM Cytosolic
325 LI:2208766.2:2001MAY17 1 267 forward 3 TM Non-Cytosolic
325 LI:2208766.2:2001MAY17 268 290 forward 3 TM Transmembrane
325 LI:2208766.2:2001MAY17 291 296 forward 3 TM Cytosolic
325 LI:2208766.2:2001MAY17 297 319 forward 3 TM Transmembrane
325 LI:2208766.2:2001MAY17 320 834 forward 3 TM Non-Cytosolic
326 LI:2209636.3:2001MAY17 1 154 forward 1 TM Cytosolic
326 LI:2209636.3:2001MAY17 155 177 forward 1 TM Transmembrane
326 LI:2209636.3:2001MAY17 178 207 forward 1 TM Non-Cytosolic
326 LI:2209636.3:2001MAY17 ' 208 230 forward 1 TM , Transmembrane
326 LI:2209636.3:2001MAY17 231 375 forward 1 TM Cytosolic
326 LI:2209636.3:2001MAY17 376 395 forward 1 TM Transmembrane
326 LI:2209636.3:2001MAY17 396 443 forward 1 TM Non-Cytosolic
326 LI:2209636.3:2001MAY17 444 466 forward 1 TM Transmembrane
326 LI:2209636.3:2001MAY17 467 472 forward 1 TM Cytosolic
326 LI:2209636.3:2001MAY17 473 495 forward 1 TM Transmembrane
326 LI:2209636.3:2001MAY17 496 498 forward 1 TM Non-Cytosolic
326 LI:2209636.3:2001MAY17 499 521 forward 1 TM Transmembrane
326 LI:2209636.3:2001MAY17 522 527 forward 1 TM Cytosolic
326 LI:2209636.3:2001MAY17 528 550 forward 1 TM Transmembrane
326 LI:2209636.3:2001MAY17 551 616 forward 1 TM Non-Cytosolic
326 LI:2209636.3:2001MAY17 1 20 forward 3 TM Cytosolic
326 LI:2209636.3:2001MAY17 21 43 forward 3 TM Transmembrane
326 LI:2209636.3:2001MAY17 44 196 forward 3 TM Non-Cytosolic
326 LI:2209636.3:2001MAY17 197 219 forward 3 TM Transmembrane
326 LI:2209636.3:2001MAY17 220 319 forward 3 TM Cytosolic
326 LI:2209636.3:2001MAY17 320 342 forward 3 TM Transmembrane
326 LI:2209636.3:2001MAY17 343 425 forward 3 TM Non-Cytosolic
326 LI:2209636.3:2001MAY17 426 448 forward 3 TM Transmembrane
326 LI:2209636.3:2001MAY17 449 467 forward 3 TM Cytosolic
326 LI:2209636.3:2001MAY17 468 490 forward 3 TM Transmembrane
326 LI:2209636.3:2001MAY17 491 499 forward 3 TM Non-Cytosolic
326 LI:2209636.3:2001MAY17 500 522 forward 3 TM Transmembrane
326 LI:2209636.3:2001MAY17 523 616 forward 3 TM Cytosolic
327 LI:221864.68:2001MAY17 1 183 forward 1 TM Cytosolic
328 LI:229267.1 :2001MAY17 1 294 forward 3 TM Non-Cytosolic TABLE 2
SEQ D NO : Template ID Start Stop Frame Domain Type Topology
328 LI:229267.1:2001MAY17 295 317 forward 3 TM Transmembrane
328 LI:229267.1 :2001MAY17 318 570 forward 3 TM Cytosolic
328 LI:229267.1 :2001MAY17 571 593 forward 3 TM Transmembrane
328 LI:229267.1 :2001MAY17 594 927 forward 3 TM Non-Cytosolic
329 LI:229648.2:2001MAY17 1 539 forward 2 TM Non-Cytosolic
329 LI:229648.2:2001MAY17 540 562 forward 2 TM Transmembrane
329 LI:229648.2:2001MAY17 563 751 forward 2 TM Cytosolic
329 LI:229648.2:2001MAY17 752 774 forward 2 TM Transmembrane
329 LI:229648.2:2001MAY17 775 779 forward 2 TM Non-Cytosolic
329 LI:229648.2:2001MAY17 780 802 forward 2 TM Transmembrane
329 LI:229648.2:2001MAY17 803 814 forward 2 TM Cytosolic
329 LI:229648.2:2001MAY17 815 837 forward 2 TM Transmembrane
329 LI:229648.2:2001MAY17 838 846 forward 2 TM Non-Cytosolic
329 LI:229648.2:2001MAY17 847 869 forward 2 TM Transmembrane
329 LI:229648.2:2001MAY17 870 891 forward 2 TM Cytosolic
329 LI:229648.2:2001MAY17 1 657 forward 3 TM Non-Cytosolic
329 LI:229648.2:2001MAY17 658 680 forward 3 TM Transmembrane
329 LI:229648.2:2001MAY17 681 755 forward 3 TM Cytosolic
329 LI:229648.2:2001MAYI7 756 778 forward 3 TM Transmembrane
329 LI:229648.2:2001MAY17 779 833 forward 3 TM Non-Cytosolic
329 LI:229648.2:2001MAY17 834 856 forward 3 TM Transmembrane
329 LI:229648.2:2001MAY17 857 891 forward 3 TM Cytosolic
330 LI:231016.1:2001MAY17 1 14 forward 3 TM Non-Cytosolic
330 LI:231016.1:2001MAY17 > 15 37 forward 3 TM Transmembrane
330 LI:231016.1 :2001MAY17 38 57 forward 3 TM Cytosolic
330 LI:231016.1 :2001MAY17 • " 58 80 forward 3 TM Transmembrane
330 LT.231016.1:2001MAY17 81 84 forward 3 TM Non-Cytosolic
330 Li:231016.1 :2001MAY17 '' 85 107 forward 3 TM Transmembrane
330 LI:231016.1 :2001MAY17 108 201 forward 3 TM Cytosolic
330 LI:231016.1:2001MAY17 202 224 forward 3 TM Transmembrane
330 LI:231016.1:2001MAY17 225 360 forward 3 TM Non-Cytosolic
331 LI:231140.5:2001MAY17 1 146 forward 2 TM Non-Cytosolic
331 LI:231140.5:2001MAY17 147 169 forward 2 TM Transmembrane
331 LI:231140.5:2001MAY17 170 223 forward 2 TM Cytosolic
331 LI:231140.5:2001MAY17 224 246 forward 2 TM Transmembrane
331 LI:231140.5:2001MAY17 247 250 forward 2 TM Non-Cytosolic
331 LI:231140.5:2001MAY17 1 127 forward 3 TM Cytosolic
331 LI:231140.5:2001MAY17 128 150 forward 3 TM Transmembrane
331 LI:231140.5:2001MAY17 151 159 forward 3 TM Non-Cytosolic
331 LI:231140.5:2001MAY17 160 178 forward 3 TM Transmembrane
331 LI:231140.5:2001MAY17 179 249 forward 3 TM Cytosolic
332 LI:231695.14:2001MAY17 1 148 forward 1 TM Non-Cytosolic
332 LI:231695.14:2001MAY17 149 171 forward 1 TM Transmembrane
332 LI:231695.14:2001MAY17 172 212 forward 1 TM Cytosolic
333 LI:232846.24:2001MAY17 1 1167 forward 1 TM Non-Cytosolic
333 LI:232846.24:2001MAY17 1168 1187 forward 1 TM Transmembrane
333 LI:232846.24:2001MAY17 1188 1193 forward 1 TM Cytosolic
333 LI:232846.24:2001 MA Yl 7 1194 1216 forward 1 TM Transmembrane
333 LI:232846.24:2001MAY17 1217 1848 forward 1 TM Non-Cytosolic
333 LI:232846.24:2001MAY17 1 1311 forward 2 TM Non-Cytosolic
333 LI:232846.24:2001MAY17 1312 1334 forward 2 TM Transmembrane
333 LI:232846.24:2001MAY17 1335 1449 forward 2 TM Cytosolic
333 LI:232846.24:2001MAY17 1450 1472 forward 2 TM Transmembrane
333 LI:232846.24:2001MAY17 1473 1848 forward 2 TM Non-Cytosolic TABI _,E 2
SEQ D NO Template ID Start Stop Frame Domain Type Topology
333 LI:232846.24:2001MAY17 1 906 forward 3 TM Non-Cytosolic
333 LI:232846.24:2001MAY17 907 929 forward 3 TM Transmembrane
333 LI:232846.24:2001MAY17 930 1166 forward 3 TM Cytosolic
333 LI:232846.24:2001MAY17 1167 1189 forward 3 TM Transmembrane
333 LI:232846.24:2001MAY17 - 1190 1848 forward 3 TM Non-Cytosolic
334 LI:233411.11:2001MAY17 1 1003 forward 1 TM Non-Cytosolic
334 LI:233411.11:2001MAY17 1004 1026 forward 1 TM Transmembrane
334 LI:233411.11:2001MAY17 1027 1055 forward 1 TM Cytosolic
334 LI:233411.11:2001MAY17 1056 1078 forward 1 TM Transmembrane
334 LI:233411.11:2001MAY17 1079 1092 forward 1 TM Non-Cytosolic
334 LI:233411.11:2001MAY17 1093 1115 forward 1 TM Transmembrane
334 LI:233411.11:2001MAY17 1116 1236 forward 1 TM Cytosolic
334 LI:233411.11:2001MAY17 1 261 forward 2 TM Non-Cytosolic
334 LI:233411.11:2001MAY17 262 284 forward 2 TM Transmembrane
334 LI:233411.11:2001MAY17 285 360 forward 2 TM Cytosolic
334 LI:233411.11:2001MAY17 361 383 forward 2 TM Transmembrane
334 LI:233411.11:2001MAY17 384 1236 forward 2 TM Non-Cytosolic
334 LI:233411.11:2001MAY17 1 345 forward 3 TM Non-Cytosolic
334 LI:233411.11:2001MAY17 346 368 forward 3 TM Transmembrane
334 LI:233411.11:2001MAY17 369 374 forward 3 TM Cytosolic
334 LI:233411.11:2001MAY17 375 397 forward 3 TM Transmembrane
334 LI:233411.11:2001MAY17 398 887 forward 3 TM Non-Cytosolic
334 LI:233411.11:2001MAY17 888 910 forward 3 TM Transmembrane
334 LI:233411.11:2001MAY17 911 922 forward 3 TM Cytosolic
334 LI:233411.11:2001MAY17 923 945 forward 3 TM Transmembrane
334 LI:233411.11:2001MAY17 946 959 forward 3 TM Non-Cytosolic
334 LI:233411.11:2001MAY17 960 982 forward 3 TM Transmembrane
334 LI:233411.11:2001MAY17 983 1050 forward 3 TM Cytosolic
334 LI:233411.11:2001MAY17 > 1051 1073 forward 3 TM Transmembrane
334 LI:233411.11:2001MAY17 1074 1092 forward 3 TM Non-Cytosolic
334 LI:233411.11:2001MAY17 1093 1115 forward 3 TM Transmembrane
334 LI:233411.11:2001MAY17 1116 1126 forward 3 TM Cytosolic
334 LI:233411.11 :2001MAY17 1127 1149 forward 3 TM Transmembrane
334 LI:233411.11 :2001MAY17 1150 1203 forward 3 TM Non-Cytosolic
334 LI:233411.11 :2001MAY17 1204 1223 forward 3 TM Transmembrane
334 LI:233411.11:2001MAY17 1224 1235 forward 3 TM Cytosolic
335 LI:233545.13:2001MAY17 1 506 forward 3 TM Non-Cytosolic
335 LI:233545.13:2001MAY17 507 529 forward 3 TM Transmembrane
335 LI:233545.13:2001MAY17 530 630 forward 3 TM Cytosolic
336 LI:234671.101 :2001MAY17 1 103 forward 1 TM Cytosolic
336 LI:234671.101 :2001MAY17 104 126 forward 1 TM Transmembrane
336 L 234671.101:2001 MAY 17 127 418 forward 1 TM Non-Cytosolic
336 LI:234671.101 :2001MAY17 1 288 forward 2 TM Non-Cytosolic
336 LI:234671.101 :2001MAY17 289 311 forward 2 TM Transmembrane
336 LI:234671.101 :2001MAY17 312 323 forward 2 TM Cytosolic
336 LI:234671.101 :2001MAY17 324 343 forward 2 TM Transmembrane
336 L 234671.101 :2001 MAY 17 344 352 forward 2 TM Non-Cytosolic
336 LI:234671.101:2001 MAY 17 353 375 forward 2 TM Transmembrane
336 LI:234671.101:2001MAY17 376 418 forward 2 TM Cytosolic
337 LI:236098.14:2001MAY17 1 34 forward 1 TM Cytosolic
337 LI:236098.14:2001MAY17 35 57 forward 1 TM Transmembrane
337 LI:236098.14:2001MAY17 58 71 forward 1 TM Non-Cytosolic
337 LI:236098.14:2001MAY17 72 91 forward 1 TM Transmembrane
337 LI:236098.14:2001MAY17 92 97 forward 1 TM Cytosolic TABLE 2
SEQ D NO: Template ID Start Stop Frame Domain Type Topology
337 LI:236098.14:2001MAY17 98 117 forward 1 TM Transmembrane
337 LI:236098.14:2001MAY17 118 127 forward 1 TM Non-Cytosolic
337 LI:236098.14:2001MAY17 128 150 forward 1 TM Transmembrane
337 LI:236098.14:2001MAY17 151 520 forward 1 TM Cytosolic
337 LI:236098.14:2001MAY17 521 543 forward 1 TM Transmembrane
337 LI:236098.14:2001MAY17 544 562 forward 1 TM Non-Cytosolic
337 LI:236098.14:2001MAY17 563 585 forward 1 TM Transmembrane
337 LI:236098.14:2001MAY17 586 591 forward 1 TM Cytosolic
337 LI:236098.14:2001MAY17 592 614 forward 1 TM Transmembrane
337 LI:236098.14:2001MAY17 615 628 forward 1 TM Non-Cytosolic
337 LI:236098.14:2001MAY17 629 651 forward 1 TM Transmembrane
337 LI:236098.14:2001MAY17 652 858 forward 1 TM Cytosolic
337 LI:236098.14:2001MAY17 859 881 forward 1 TM Transmembrane
337 LI:236098.14:2001MAY17 882 900 forward 1 TM Non-Cytosolic
337 LI:236098.14:2001MAY17 901 923 forward 1 TM Transmembrane
337 LI:236098.14:2001MAY17 924 976 forward 1 TM Cytosolic
337 LI:236098.14:2001MAY17 977 999 forward 1 TM Transmembrane
337 LI:236098.14:2001MAY17 1000 1008 forward 1 TM Non-Cytosolic
337 LI:236098.14:2001MAY17 1009 1031 forward 1 TM Transmembrane
337 LI:236098.14:2001MAY17 1032 1051 forward 1 TM Cytosolic
337 LI:236098.14:2001MAY17 1052 1074 forward 1 TM Transmembrane
337 LI:236098.14:2001MAY17 1075 1088 forward 1 TM Non-Cytosolic
337 LI:236098.14:2001MAY17 1089 l l l l forward 1 TM Transmembrane
337 LI:236098.14:2001MAY17 1112 1124 forward 1 TM Cytosolic
337 LI:236098.14:2001MAY17 1 19 forward 2 TM Cytosolic
337 LI:236098.14:2001MAY17 20 39 forward 2 TM Transmembrane
337 LI:236098.14:2001MAY17 40 65 forward 2 TM Non-Cytosolic
337 LI:236098.14:2001MAY17 66 88 forward 2 TM Transmembrane
337 LI:236098.14:2001MAY17 89 133 forward 2 TM Cytosolic
337 0:236098.14:2001MAY17 134 156 forward 2 TM Transmembrane
337 LI:236098.14:2001MAY17 157 170 forward 2 TM Non-Cytosolic
337 LI:236098.14:2001MAY17 171 188 forward 2 TM Transmembrane
337 LI:236098.14:2001MAY17 189 215 forward 2 TM Cytosolic
337 LI:236098.14:2001MAY17 216 235 forward 2 TM Transmembrane
337 LI:236098.14:2001MAY17 236 244 forward 2 TM Non-Cytosolic
337 LI:236098.14:2001MAY17 245 267 forward 2 TM Transmembrane
337 LI:236098.14:2001MAY17 268 518 forward 2 TM Cytosolic
337 LI:236098.14:2001MAY17 519 541 forward 2 TM Transmembrane
337 LI:236098.14:2001MAY17 542 550 forward 2 TM Non-Cytosolic
337 LI:236098.14:2001MAY17 551 573 forward 2 TM Transmembrane
337 LI:236098.14:2001MAY17 574 593 forward 2 TM Cytosolic
337 LI:236098.14:2001MAY17 594 616 forward 2 TM Transmembrane
337 LI:236098.14:2001MAY17 617 635 forward 2 TM Non-Cytosolic
337 LI:236098.14:2001MAY17 636 658 forward 2 TM Transmembrane
337 LI:236098.14:2001MAY17 659 799 forward 2 TM Cytosolic
337 LI:236098.14:2001MAY17 800 822 forward 2 TM Transmembrane
337 LI:236098.14:2001MAY17 823 1124 forward 2 TM Non-Cytosolic
337 LI:236098.14:2001MAY17 1 66 forward 3 TM Cytosolic
337 LI:236098.14:2001MAY17 67 89 forward 3 TM Transmembrane
337 LI:236098.14:2001MAY17 90 159 forward 3 TM Non-Cytosolic
337 LI:236098.14:2001MAY17 160 182 forward 3 TM Transmembrane
337 LI:236098.14:2001MAY17 183 245 forward 3 TM Cytosolic
337 LI:236098.14:2001 MAY 17 246 268 forward 3 TM Transmembrane
337 LI:236098.14:2001MAY17 269 389 forward 3 TM Non-Cytosolic TABLE 2
SEQ D NO: Template ID Start Stop Frame Domain Type Topology
337 LI:236098.14:2001MAY17 390 412 forward 3 TM Transmembrane
337 LI:236098.14:2001MAY17 413 528 forward 3 TM Cytosolic
337 LI:236098.14:2001MAY17 529 551 forward 3 TM Transmembrane
337 LI:236098.14:2001MAY17 552 565 forward 3 TM Non-Cytosolic
337 LI:236098.14:2001MAY17 566 583 forward 3 TM Transmembrane
337 LI:236098.14:2001MAY17 584 587 forward 3 TM Cytosolic
337 LI:236098.14:2001MAY17 588 610 forward 3 TM Transmembrane
337 LI:236098.14:2001MAY17 611 1124 forward 3 TM Non-Cytosolic
338 LI:236196.15:2001MAY17 1 267 forward 1 TM Cytosolic
338 LI:236196.15:2001MAY17 268 287 forward 1 TM Transmembrane
338 LI:236196.15:2001MAY17 288 301 forward 1 TM Non-Cytosolic
338 LI:236196.15:2001MAY17 302 324 forward 1 TM Transmembrane
338 LI:236196.15:2001MAY17 325 328 forward 1 TM Cytosolic
338 LI:236196.15:2001MAY17 329 348 forward 1 TM Transmembrane
338 LI:236196.15:2001MAY17 349 500 forward 1 TM Non-Cytosolic
338 LI:236196.15:2001MAY17 501 523 forward 1 TM Transmembrane
338 LI:236196.15:2001MAY17 524 589 forward 1 TM Cytosolic
338 LI:236196.15:2001MAY17 590 612 forward 1 TM Transmembrane
338 LI:236196.15:2001MAY17 613 613 forward 1 TM Non-Cytosolic
338 LI:236196.15:2001MAY17 1 201 forward 2 TM Cytosolic
338 LI:236196.15:2001MAY17 202 224 forward 2 TM Transmembrane
338 LI:236196.15:2001MAY17 225 261 forward 2 TM Non-Cytosolic
338 LI:236196.15:2001MAY17 262 281 forward 2 TM Transmembrane
338 LI:236196.15:2001MAY17 282 300 forward 2 ' TM Cytosolic
338 LI:236196.15:2001MAY17 301 323 forward 2 TM Transmembrane
338 LI:236196.15:2001MAY17 324 502 forward 2 TM Non-Cytosolic
338 LI:236196.15:2001MAY17 503 525 forward 2 TM Transmembrane
338. LI:236196.15:2001MAY17 526 545 forward 2 TM Cytosolic
338 LI:236196.15:2001MAY17 546 568 forward 2 TM Transmembrane
338 LI:236196.15:2001MAY17 569 613 forward 2 TM Non-Cytosolic
338 LI:236196.15:2001MAY17 1 266 forward 3 TM Cytosolic
338 LI:236196.15:2001MAY17 267 284 forward 3 TM Transmembrane
338 LI:236196.15:2001MAY17 285 293 forward 3 TM Non-Cytosolic
338 LI:236196.15:2001MAY17 294 316 forward 3 TM Transmembrane
338 LI:236196.15:2001MAY17 317 483 forward 3 TM Cytosolic
338 LI:236196.15:2001MAY17 484 506 forward 3 TM Transmembrane
338 LI:236196.15:2001MAY17 507 558 forward 3 TM Non-Cytosolic
338 LI:236196.15:2001MAY17 559 581 forward 3 TM Transmembrane
338 LI:236196.15:2001MAY17 582 613 forward 3 TM Cytosolic
339 LI:237086.1:2001MAY17 1 320 forward 2 TM Non-Cytosolic
339 LI:237086.1:2001MAY17 321 343 forward 2 TM Transmembrane
339 LI:237086.1:2001MAY17 344 379 forward 2 TM Cytosolic
339 LI:237086.1:2001MAY17 1 182 forward 3 TM Non-Cytosolic
339 LI:237086.1:2001MAY17 183 205 forward 3 TM Transmembrane
339 LI:237086.1:2001MAY17 206 358 forward 3 TM Cytosolic
339 LI:237086.1:2001MAY17 359 378 forward 3 TM Transmembrane
339 LI:237086.1:2001MAY17 379 379 forward 3 TM Non-Cytosolic
340 LI:238585.30:2001MAY17 1 108 forward 2 TM Cytosolic
340 LI:238585.30:2001MAY17 109 131 forward 2 TM Transmembrane
340 LI:238585.30:2001MAY17 132 134 forward 2 TM Non-Cytosolic
340 LI:238585.30:2001MAY17 135 157 forward 2 TM Transmembrane
340 LI:238585.30:2001MAY17 158 183 forward 2 TM Cytosolic
340 LI:238585.30:2001MAY17 1 41 forward 3 TM Non-Cytosolic
340 LI:238585.30:2001MAY17 42 64 forward 3 TM Transmembrane TABLE 2
SEQ D NO: Template ID Start Stop Frame Domain Type Topology
340 LI:238585.30:2001MAY17 65 102 forward 3 TM Cytosolic
340 LI:238585.30:2001MAY17 103 125 forward 3 TM Transmembrane
340 LI:238585.30:2001MAY17 126 139 forward 3 TM Non-Cytosolic
340 LI:238585.30:2001MAY17 140 162 forward 3 TM Transmembrane
340 LI:238585.30:2001MAY17 163 183 forward 3 TM Cytosolic
341 LI:238672.6:2001MAY17 1 228 forward 3 TM Non-Cytosolic
341 LI:238672.6:2001MAY 17 229 251 forward 3 TM Transmembrane
341 LI:238672.6:2001MAY17 252 279 forward 3 TM Cytosolic
341 LI:238672.6:2001MAY17 280 301 forward 3 TM Transmembrane
341 LI:238672.6:2001MAY17 302 320 forward 3 TM Non-Cytosolic
341 LI:238672.6:2001MAY17 321 343 forward 3 TM Transmembrane
341 LI:238672.6:2001MAY17 344 373 forward 3 TM Cytosolic
342 LI:239579.9:2001MAY17 1 685 forward 1 TM Non-Cytosolic
342 LI:239579.9:2001MAY17 686 708 forward 1 TM Transmembrane
342 LI:239579.9:2001MAY17 709 736 forward 1 TM Cytosolic
342 LI:239579.9:2001MAY17 1 62 forward 2 TM Cytosolic
342 LI:239579.9:2001MAY17 63 85 forward 2 TM Transmembrane
342 LI:239579.9:2001MAY17 86 491 forward 2 TM Non-Cytosolic
342 LI:239579.9:2001MAY17 492 514 forward 2 TM Transmembrane
342 LI:239579.9:2001MAY17 515 687 forward 2 TM Cytosolic
342 LI:239579.9:2001MAY17 688 710 forward 2 TM Transmembrane
342 LI:239579.9:2001MAY17 711 736 forward 2 TM Non-Cytosolic
342 LI:239579.9:2001MAY17 1 489 forward 3 TM Non-Cytosolic
342 LI:239579.9:2001MAY17 490 512 forward 3 TM Transmembrane
342 LI:239579.9:2001MAY17 513 531 forward 3 TM Cytosolic
342 LI:239579.9:2001MAY17 532 554 forward 3 TM Transmembrane
342 LI:239579.9:2001MAY17 555 568 forward 3 TM Non-Cytosolic
342 LI:239579.9:2001MAY17 569 591 forward 3 TM Transmembrane
342 LI:239579.9:2001MAY17 592 685 forward 3 TM Cytosolic
342 LI:239579.9:2001MAY17 686 708 forward 3 TM Transmembrane
342 LI:239579.9:2001MAY17 709 735 forward 3 TM Non-Cytosolic
343 LI:239720.1:2001MAY17 1 986 forward 2 TM Non-Cytosolic
343 LI:239720.1:2001MAY17 987 1009 forward 2 TM Transmembrane
343 LI:239720.1:2001MAY17 1010 1210 forward 2 TM Cytosolic
344 LI:240037.6:2001MAY17 1 306 forward 3 TM Non-Cytosolic
344 LI:240037.6:2001MAY17 307 329 forward 3 TM Transmembrane
344 LI:240037.6:2001MAY17 330 346 forward 3 TM Cytosolic
345 LI:243900.7:2001MAY17 1 289 forward 2 TM Cytosolic
345 LT.243900.7:2001MAY17 290 309 forward 2 TM Transmembrane
345 LI:243900.7:2001MAY17 310 313 forward 2 TM Non-Cytosolic
345 LI:243900J:2001MAY17 314 336 forward 2 TM Transmembrane
345 LI:243900.7:2001MAY17 337 401 forward 2 TM Cytosolic
345 LI:243900.7:2001MAY17 1 308 forward 3 TM Non-Cytosolic
345 LI:243900.7:2001MAY17 309 331 forward 3 TM Transmembrane
345 LI:243900.7:2001MAY17 332 400 forward 3 TM Cytosolic
346 LI:244378.1:2001MAY17 1 57 forward 1 TM Non-Cytosolic
346 LI:244378.1:2001MAY17 58 75 forward 1 TM Transmembrane
346 LI:244378.1:2001MAY17 76 87 forward 1 TM Cytosolic
346 LI:244378.1:2001MAY17 88 110 forward 1 TM Transmembrane
346 LI:244378.1:2001MAY17 111 119 forward 1 TM Non-Cytosolic
346 LI:244378.1:2001MAY17 120 142 forward 1 TM Transmembrane
346 LI:244378.1:2001MAY17 143 160 forward 1 TM Cytosolic
346 LI:244378.1:2001MAY17 161 178 forward 1 TM Transmembrane
346 LI:244378.1:2001MAY17 179 826 forward 1 TM Non-Cytosolic TABLE 2
SEQ D NO: : Template ID Start Stop Frame Domain Type Topology
346 LI:244378.1:2001MAY17 1 47 forward 2 TM Non-Cytosolic
346 LI:244378.1:2001MAY17 48 70 forward 2 TM Transmembrane
346 LI:244378.1:2001MAY17 71 101 forward 2 TM Cytosolic
346 LI:244378.1:2001MAY17 102 124 forward 2 TM Transmembrane
346 LI:244378.1:2001MAY17 125 258 forward 2 TM Non-Cytosolic
346 LI:244378.1:2001MAY17 259 278 forward 2 TM Transmembrane
346 LI:244378.1:2001MAY17 279 538 forward 2 TM Cytosolic
346 LI:244378.1:2001MAY17 539 561 forward 2 TM Transmembrane
346 LI:244378.1:2001MAY17 562 826 forward 2 TM Non-Cytosolic
346 LI:244378.1:2001MAY17 1 31 forward 3 TM Non-Cytosolic
346 LI:244378.1:2001MAY17 32 54 forward 3 TM Transmembrane
346 LI:244378.1:2001MAY17 55 85 forward 3 TM Cytosolic
346 LI:244378.1:2001MAY17 86 105 forward 3 TM Transmembrane
346 LI:244378.1:2001MAY17 106 825 forward 3 TM Non-Cytosolic
347 LI:245500.3:2001MAY17 1 107 forward 1 TM Cytosolic
347 LI:245500.3:2001MAY17 108 130 forward 1 TM Transmembrane
347 LI:245500.3:2001MAY17 131 144 forward 1 TM Non-Cytosolic
347 LI:245500.3:2001MAY17 145 167 forward 1 TM Transmembrane
347 LI:245500.3:2001MAY17 168 232 forward 1 TM Cytosolic
347 LI:245500.3:2001MAY17 233 255 forward 1 TM Transmembrane
347 LI:245500.3:2001MAY17 256 267 forward 1 TM Non-Cytosolic
347 LI:245500.3 :2001MAY 17 268 290 forward 1 TM Transmembrane
347 LI:245500.3:2001MAY17 291 340 forward 1 TM Cytosolic
347 LI:245500.3:2001MAY17 341 363 forward 1 TM Transmembrane
347 LI:245500.3:2001MAY17 364 372 forward 1 TM Non-Cytosolic
347 LI:245500.3:2001MAY17 373 395 forward 1 TM Transmembrane
347 LI:245500.3:2001MAY17 396 414 forward 1 TM Cytosolic
347 LI:245500.3:2001MAY17 415 437 forward 1 TM Transmembrane
347 LI:245500.3:2001MAY17 438 935 forward 1 TM Non-Cytosolic
347 LI:245500.3:2001MAY17 936 958 forward 1 TM Transmembrane
347 LI:245500.3:2001MAY17 959 1018 forward 1 TM Cytosolic
347 LI:245500.3:2001MAY17 1019 1041 forward 1 TM Transmembrane
347 LI:245500.3:2001MAY17 1042 1052 forward 1 TM Non-Cytosolic
347 LI:245500.3:2001MAY17 1 19 forward 2 TM Cytosolic
347 LI:245500.3:2001MAY17 20 39 forward 2 TM Transmembrane
347 LI:245500.3:2001MAY17 40 48 forward 2 TM Non-Cytosolic
347 LI:245500.3:2001MAY17 49 71 forward 2 TM Transmembrane
347 LI:245500.3:2001MAY17 72 116 forward 2 TM Cytosolic
347 LI:245500.3:2001MAY17 117 136 forward 2 TM Transmembrane
347 LI:245500.3:2001MAY17 137 145 forward 2 TM Non-Cytosolic
347 LI:245500.3:2001MAY17 146 168 forward 2 TM Transmembrane
347 LI:245500.3:2001MAY17 169 243 forward 2 TM Cytosolic
347 LI:245500.3:2001MAY17 244 266 forward 2 TM Transmembrane
347 LI:245500.3:2001MAY17 267 337 forward 2 TM Non-Cytosolic
347 LI:245500.3:2001MAY17 338 360 forward 2 TM Transmembrane
347 LI:245500.3:2001MAY17 361 366 forward 2 TM Cytosolic
347 LI:245500.3:2001MAY17 367 389 forward 2 TM Transmembrane
347 LI:245500.3:2001MAY17 390 392 forward 2 TM Non-Cytosolic
347 LI:245500.3:2001MAY17 393 410 forward 2 TM Transmembrane
347 LI:245500.3:2001MAY17 411 439 forward 2 TM Cytosolic
347 LI:245500.3:2001MAY17 440 459 forward 2 TM Transmembrane
347 LI:245500.3:2001MAY17 460 491 forward 2 TM Non-Cytosolic
347 LI:245500.3:2001MAY 17 492 514 forward 2 TM Transmembrane
347 LI:245500.3:2001MAY17 515 677 forward 2 TM Cytosolic TABLE 2
SEQ D NO: Template ID Start Stop Frame Domain Type Topology
347 LI:245500.3:2001MAY17 678 700 forward 2 TM Transmembrane
347 LI:245500.3:2001MAY17 701 727 forward 2 TM Non-Cytosolic
347 LI:245500.3:2001MAY17 728 750 forward 2 TM Transmembrane
347 LI:245500.3:2001MAY17 751 761 forward 2 TM Cytosolic
347 LI:245500.3:2001MAY17 762 784 forward 2 TM Transmembrane
347 LI:245500.3:2001MAY17 785 803 forward 2 TM Non-Cytosolic
347 LI:245500.3:2001MAY17 804 826 forward 2 TM Transmembrane
347 LI:245500.3:2001MAY17 827 939 forward 2 TM Cytosolic
347 LI:245500.3:2001MAY17 940 959 forward 2 TM Transmembrane
347 LI:245500.3:2001MAY17 960 1052 forward 2 TM Non-Cytosolic
347 LI:245500.3:2001MAY17 1 295 forward 3 TM Non-Cytosolic
347 LI:245500.3:2001MAY17 296 318 forward 3 TM Transmembrane
347 LI:245500.3:2001MAY17 319 329 forward 3 TM Cytosolic
347 LI:245500.3:2001MAY17 330 352 forward 3 TM Transmembrane
347 LI:245500.3:2001MAY17 353 386 forward 3 TM Non-Cytosolic
347 LI:245500.3:2001MAY17 387 409 forward 3 TM Transmembrane
347 LI:245500.3:2001MAY17 410 429 forward 3 TM Cytosolic
347 LI:245500.3:2001MAY17 430 452 forward 3 TM Transmembrane
347 LL245500.3 :2001MAY 17 453 1052 forward 3 TM Non-Cytosolic
348 LI:245982.24:2001MAY17 1 748 forward 3 TM Non-Cytosolic
348 LI:245982.24:2001MAY17 749 771 forward 3 TM Transmembrane
348 LI:245982.24:2001MAY17 772 788 forward 3 TM Cytosolic
349 LI:246054.1:2001MAY17 1 214 forward 1 TM Non-Cytosolic
349 LI:246054.1:2001MAY17 215 237 forward 1 TM Transmembrane
349 LI:246054.1:2001MAY17 238 243 forward 1 TM Cytosolic
349 LL246054.1:2001MAY17 244 266 forward 1 TM Transmembrane
349 LI:246054.1:2001MAY17 267 509 forward 1 TM Non-Cytosolic
349 L 246054.1 :2001MAY 17 510 532 forward 1 TM Transmembrane
349 LI:246054.1:2001MAY17 533 627 forward 1 TM Cytosolic
349 LI:246054.1:2001MAY17 1 257 forward 2 TM Non-Cytosolic
349 LI:246054.1:2001MAY17 258 280 forward 2 TM Transmembrane
349 LI:246054.1:2001MAY17 281 306 forward 2 TM Cytosolic
349 L 246054.1:200 IMAY 17 307 329 forward 2 TM Transmembrane
349 LI:246054.1:2001MAY17 330 627 forward 2 TM Non-Cytosolic
349 LI:246054.1:2001MAY17 1 506 forward 3 TM Non-Cytosolic
349 LI:246054.1:2001MAY17 507 529 forward 3 TM Transmembrane
349 LI:246054.1:2001MAY17 530 597 forward 3 TM Cytosolic
349 LI:246054.1:2001MAY17 598 620 forward 3 TM Transmembrane
349 LI:246054.1:2001MAY17 621 627 forward 3 TM Non-Cytosolic
350 LI:256051.229:2001MAY17 1 229 forward 1 TM Non-Cytosolic
350 LI:256051.229:2001MAY17 230 252 forward 1 TM Transmembrane
350 L 256051.229:200 IMAY 17 253 257 forward 1 TM Cytosolic
350 L 256051.229:200 IMAY 17 1 225 forward 2 TM Cytosolic
350 LL256051.229:200 IMAY 17 226 248 forward 2 TM Transmembrane
350 LL256051.229:2001MAY 17 249 256 forward 2 TM Non-Cytosolic
351 LI:260629J:2001MAY17 1 4 forward 1 TM Cytosolic
351 LI:260629.7:2001MAY17 5 27 forward 1 TM Transmembrane
351 LI:260629.7:2001MAY17 28 48 forward 1 TM Non-Cytosolic
351 LI:260629.7:2001MAY17 1 14 forward 2 TM Non-Cytosolic
351 LI:260629.7:2001MAY17 15 32 forward 2 TM Transmembrane
351 LI:260629J:2001MAY17 33 48 forward 2 TM Cytosolic
352 LI:272723.1:2001MAY17 1 116 forward 2 TM Non-Cytosolic
352 LI:272723.1:2001MAY17 117 139 forward 2 TM Transmembrane
352 LI:272723.1:2001MAY17 140 255 forward 2 TM Cytosolic TABI .E 2
SEQ D NO: Template ID Start Stop Frame Domain Type Topology
352 LI:272723.1:2001MAY17 256 278 forward 2 TM Transmembrane
352 LI:272723.1:2001MAY17 279 287 forward 2 TM Non-Cytosolic
353 LI:272766.1:2001MAY17 1 270 forward 3 TM Non-Cytosolic
353 L 272766.1:200 IMAY 17 271 293 forward 3 TM Transmembrane
353 LI:272766.1:2001MAY17 294 318 forward 3 TM Cytosolic
354 LI:275726.1:2001MAY17 1 197 forward 3 TM Cytosolic
355 LI:276815.1:2001MAY17 1 20 forward 2 TM Cytosolic
355 LI:276815.1:2001MAY17 21 43 forward 2 TM Transmembrane
355 LI:276815.1:2001MAY17 44 199 forward 2 TM Non-Cytosolic
355 LI:276815.1:2001MAY17 1 20 forward 3 TM Cytosolic
355 LI:276815.1:2001MAY17 21 43 forward 3 TM Transmembrane
355 LI:276815.1:2001MAY17 44 198 forward 3 TM Non-Cytosolic
356 LI:283562.5:2001MAY17 1 289 forward 1 TM Cytosolic
356 LI:283562.5:2001MAY17 290 312 forward 1 TM Transmembrane
356 LI:283562.5:2001MAY17 313 1092 forward 1 TM Non-Cytosolic
356 LI:283562.5:2001MAY17 1093 1115 forward 1 TM Transmembrane
356 LI:283562.5:2001MAY17 1116 1125 forward 1 TM Cytosolic
356 LI:283562.5:2001MAY17 1 1091 forward 3 TM Non-Cytosolic
356 LI:283562.5:2001MAY17 1092 1114 forward 3 TM Transmembrane
356 LI:283562.5:2001MAY17 1115 1124 forward 3 TM Cytosolic
357 LI:289066.15:2001MAY17 1 175 forward 1 TM Cytosolic
357 LI:289066.15:2001MAY17 176 198 forward 1 TM Transmembrane
357 LI:289066.15:2001MAY17 199 925 forward 1 TM Non-Cytosolic
357 < LI:289066.15:2001MAY17 926 948 forward 1 TM Transmembrane
357 LI:289066.15:2001MAY17 949 968 forward 1 TM Cytosolic
357 ■ LI:289066.15:2001MAY17 969 991 forward 1 TM Transmembrane
357 LI:289066.15:2001MAY17 992 1022 forward 1 TM Non-Cytosolic
357 LI:289066.15:2001MAY17 1023 1045 forward 1 TM Transmembrane
• ' 357 LI:289066.15:2001MAY17 1046 1083 forward 1 TM Cytosolic
357 LI:289066.15:2001MAY17 1 12 forward 2 TM Cytosolic
357 LI:289066.15:2001MAY17 13 30 forward 2 TM Transmembrane
357 LI:289066.15:2001MAY17 31 39 forward 2 TM Non-Cytosolic
357 LI:289066.15:2001MAY17 40 59 forward 2 TM Transmembrane
357 LI:289066.15:2001MAY17 60 189 forward 2 TM Cytosolic
357 LI:289066.15:2001MAY17 190 212 forward 2 TM Transmembrane
357 LI:289066.15:2001MAY17 213 226 forward 2 TM Non-Cytosolic
357 LI:289066.15:2001MAY17 227 249 forward 2 TM Transmembrane
357 LI:289066.15:2001MAY17 250 303 forward 2 TM Cytosolic
357 LI:289066.15:2001MAY17 304 326 forward 2 TM Transmembrane
357 LI:289066.15:2001MAY17 327 932 forward 2 TM Non-Cytosolic
357 LI:289066.15:2001MAY17 933 955 forward 2 TM Transmembrane
.357 LI:289066.15:2001MAY17 956 975 forward 2 TM Cytosolic
357 LI:289066.15:2001MAY17 976 998 forward 2 TM Transmembrane
357 LI:289066.15:2001MAY17 999 1026 forward 2 TM Non-Cytosolic
357 LI:289066.15:2001MAY17 1027 1049 forward 2 TM Transmembrane
357 LI:289066.15:2001MAY17 1050 1083 forward 2 TM Cytosolic
357 LI:289066.15:2001MAY17 1 90 forward 3 TM Cytosolic
357 L 289066.15 :2001MAY 17 91 113 forward 3 TM Transmembrane
357 LI:289066.15:2001MAY17 114 174 forward 3 TM Non-Cytosolic
357 LI:289066.15:2001MAY17 175 197 forward 3 TM Transmembrane
357 LI:289066.15:2001MAY17 198 220 forward 3 TM Cytosolic
357 LI:289066.15:2001MAY17 221 243 forward 3 TM Transmembrane
357 LI:289066.15:2001MAY17 244 833 forward 3 TM Non-Cytosolic
357 LI:289066.15:2001MAY17 834 856 forward 3 TM Transmembrane TABLE 2
SEQ D NO: : Template ID Start Stop Frame Domain Type Topology
357 LI:289066.15:2001MAY17 857 975 forward 3 TM Cytosolic
357 LI:289066.15:2001MAY17 976 998 forward 3 TM Transmembrane
357 L1:289066.15:2001MAY17 999 1017 forward 3 TM Non-Cytosolic
357 LI:289066.15:2001MAY17 1018 1040 forward 3 TM Transmembrane
357 LI:289066.15:2001MAY17 1041 1083 forward 3 TM Cytosolic
358 LI:331040.17:2001MAY17 1 207 forward 1 TM Non-Cytosolic
358 LI:331040.17:2001MAY17 208 230 forward 1 TM Transmembrane
358 LL331040.17.2001MAY17 231 314 forward 1 TM Cytosolic
358 LI:331040.17:2001MAY17 1 239 forward 3 TM Non-Cytosolic
358 LI:331040.17:2001MAY17 240 262 forward 3 TM Transmembrane
358 LI:331040.17:2001MAY17 263 282 forward 3 TM Cytosolic
358 LI:331040.17:2001MAY17 283 305 forward 3 TM Transmembrane
358 LI:331040.17:2001MAY17 306 313 forward 3 TM Non-Cytosolic
359 LI:332414.5:2001MAY17 1 534 forward 1 TM Non-Cytosolic
359 LI:332414.5:2001MAY17 535 557 forward 1 TM Transmembrane
359 LI:332414.5:2001MAY17 558 574 forward 1 TM Cytosolic
359 LI:332414.5:2001MAY17 1 167 forward 2 TM Cytosolic
359 LI:332414.5:2001MAY17 168 190 forward 2 TM Transmembrane
359 LI:332414.5:2001MAY17 191 574 forward 2 TM Non-Cytosolic
359 LI:332414.5:2001MAY17 1 534 forward 3 TM Non-Cytosolic
359 LI:332414.5:2001MAY17 535 557 forward 3 TM Transmembrane
359 LI:332414.5:2001MAY17 558 573 forward 3 TM Cytosolic
360 LI:332730.16:2001MAY17 1 427 forward 1 TM Cytosolic
360 LI:332730.16:2001MAY17 428 450 forward 1 TM Transmembrane
360 LI:332730.16:2001MAY17 451 963 forward 1 TM Non-Cytosolic
360 LI:332730.16:2001MAY17 964 986 forward 1 TM Transmembrane
360 LI:332730.16:2001MAY17 987 1176 forward 1 TM Cytosolic
360 LI:332730.16:2001MAY17 1177 1199 forward 1 TM Transmembrane
360 LI:332730.16:2001MAY17 1200 1218 forward 1 TM Non-Cytosolic
360 LI:332730.16:2001MAY17 1219 1241 forward 1 TM Transmembrane
360 LI:332730.16:2001MAY17 1242 1328 forward 1 TM Cytosolic
360 LI:332730.16:2001MAY17 1329 1351 forward 1 TM Transmembrane
360 LI:332730.16:2001MAY17 1352 1383 forward 1 TM Non-Cytosolic
360 LI:332730.16:2001MAY17 1384 1406 forward 1 TM Transmembrane
360 LI:332730.16:2001MAY17 1407 1438 forward 1 TM Cytosolic
360 LI:332730.16:2001MAY17 1439 1461 forward 1 TM Transmembrane
360 LI:332730.16:2001MAY17 1462 1465 forward 1 TM Non-Cytosolic
360 LI:332730.16:2001MAY17 1466 1485 forward 1 TM Transmembrane
360 LI:332730.16:2001MAY17 1486 1516 forward 1 TM Cytosolic
360 LI:332730.16:2001MAY17 1517 1539 forward 1 TM Transmembrane
360 LI:332730.16:2001MAY17 1540 1738 forward 1 TM Non-Cytosolic
360 LI:332730.16:2001MAY17 1 951 forward 2 TM Non-Cytosolic
360 LI:332730.16:2001MAY17 952 974 forward 2 TM Transmembrane
360 LI:332730.16:2001MAY17 975 1175 forward 2 TM Cytosolic
360 LI:332730.16:2001MAY17 1176 1198 forward 2 TM Transmembrane
360 LI:332730.16:2001MAY17 1199 1217 forward 2 TM Non-Cytosolic
360 LI:332730.16:2001MAY17 1218 1240 forward 2 TM Transmembrane
360 LI:332730.16:2001MAY17 1241 1531 forward 2 TM Cytosolic
360 LI:332730.16:2001MAY17 1532 1554 forward 2 TM Transmembrane
360 LI:332730.16:2001MAY17 1555 1618 forward 2 TM Non-Cytosolic
360 LI:332730.16:2001MAY17 1619 1638 forward 2 TM Transmembrane
360 LI:332730.16:2001MAY17 1639 1649 forward 2 TM Cytosolic
360 LI:332730.16:2001MAY17 1650 1672 forward 2 TM Transmembrane
360 LI:332730.16:2001MAY17 1673 1706 forward 2 TM Non-Cytosolic TABLE 2
SEQ D NO: Template ID Start Stop Frame Domain Type Topology
360 LI:332730.16:2001MAY17 1707 1724 forward 2 TM Transmembrane
360 LI:332730.16:2001MAY17 1725 1738 forward 2 TM Cytosolic
360 LI:332730.16:2001MAY17 1 952 forward 3 TM Non-Cytosolic
360 LI:332730.16:2001MAY17 $53 975 forward 3 TM Transmembrane
360 LI:332730.16:2001MAY17 976 1120 forward 3 ' TM Cytosolic
360 LI:332730.16:2001MAY17 1121 1143 forward 3 TM Transmembrane
360 LI:332730.16:2001MAY17 1144 1146 forward 3 TM Non-Cytosolic
360 LI:332730.16:2001MAY17 1147 1169 forward 3 TM Transmembrane
360 LI:332730.16:2001MAY17 1170 1175 forward 3 TM Cytosolic
360 LI:332730.16:2001MAY17 1176 1198 forward 3 TM Transmembrane
360 LI:332730.16:2001MAY17 1199 1217 forward 3 TM Non-Cytosolic
360 LI:332730.16:2001MAY17 1218 1240 forward 3 TM Transmembrane
360 LI:332730.16:2001MAY17 1241 1447 forward 3 TM Cytosolic
360 LI:332730.16:2001MAY17 1448 1470 forward 3 TM Transmembrane
360 LI:332730.16:2001MAY17 1471 1479 forward 3 TM Non-Cytosolic
360 LI:332730.16:2001MAY17 1480 1499 forward 3 TM Transmembrane
360 LI:332730.16:2001MAY17 1500 1519 forward 3 TM Cytosolic
360 LI:332730.16:2001MAY17 1520 1542 forward 3 TM Transmembrane
360 LI:332730.16:2001MAY17 1543 1738 forward 3 TM Non-Cytosolic
361 LL333849.21 :2001MAY17 1 188 forward 1 TM Cytosolic
362 LI:337038.15:2001MAY17 1 660 forward 1 TM Non-Cytosolic
362 LI:337038.15:2001MAY17 661 683 forward 1 TM Transmembrane
362 LI:337038.15:2001MAY17 684 793 forward 1 TM Cytosolic
362 LI:337038.15:2001MAY17 794 816 forward 1 TM Transmembrane
362 LI:337038.15:2001MAY17 817 928 forward 1 TM Non-Cytosolic
362 LI:337038.15:2001MAY17' 929 951 forward 1 TM Transmembrane
362 LI:337038.15:2001MAY17 952 957 forward 1 TM Cytosolic
362 LI:337038.15:2001MAY17 958 980 forward 1 TM Transmembrane
362 LI:337038.15:2001MAY17 981 989 forward 1 TM Non-Cytosolic
362 LI:337038.15:2001MAY17 990 1009 forward 1 TM Transmembrane
362 LI:337038.15:2001MAY17 1010 1029 forward 1 TM Cytosolic
362 LI:337038.15:2001MAY17 1030 1052 forward 1 TM Transmembrane
362 LI:337038.15:2001MAY17 1053 1119 forward 1 TM Non-Cytosolic
362 LI:337038.15:2001MAY17 1120 1142 forward 1 TM Transmembrane
362 LI:337038.15:2001MAY17 1143 1174 forward 1 TM Cytosolic
362 LI:337038.15:2001MAY17 1175 1197 forward 1 TM Transmembrane
362 LI:337038.15:2001MAY17 1198 1211 forward 1 TM Non-Cytosolic
362 LI:337038.15:2001MAY17 1212 1231 forward 1 TM Transmembrane
362 LI:337038.15:2001MAY17 1232 1357 forward 1 TM Cytosolic
362 LI:337038.15:2001MAY17 1358 1380 forward 1 TM Transmembrane
362 LI:337038.15:2001MAY17 1381 1394 forward 1 TM Non-Cytosolic
362 LI:337038.15:2001MAY17 1395 1417 forward 1 TM Transmembrane
362 LI:337038.15:2001MAY17 1418 1429 forward 1 TM Cytosolic
362 LI:337038.15:2001MAY17 1430 1452 forward 1 TM Transmembrane
362 LI:337038.15:2001MAY17 1453 1515 forward 1 TM Non-Cytosolic
362 LI:337038.15:2001MAY17 1516 1538 forward 1 TM Transmembrane
362 LI:337038.15:2001MAY17 1539 1550 forward 1 TM Cytosolic
362 LI:337038.15:2001MAY17 1551 1573 forward 1 TM Transmembrane
362 LI:337038.15:2001MAY17 1574 1582 forward 1 TM Non-Cytosolic
362 LI:337038.15:2001MAY17 1583 1601 forward 1 TM Transmembrane
362 LI:337038.15:2001MAY17 1602 1656 forward 1 TM Cytosolic
362 LI:337038.15:2001MAY17 1657 1679 forward 1 TM Transmembrane
362 LI:337038.15:2001MAY17 1680 1698 forward 1 TM Non-Cytosolic
362 LI:337038.15:2001MAY17 1699 1721 forward 1 TM Transmembrane TABLE 2
SEQ D NO: Template ID Start Stop Frame Domain Type Topology
362 LI:337038.15:2001MAY17 1722 1749 forward 1 TM Cytosolic
362 LI:337038.15:2001MAY17 1 660 forward 2 TM Non-Cytosolic
362 LI:337038.15:2001MAY17 661 683 forward 2 TM Transmembrane
362 LI:337038.15:2001MAY17 684 703 forward 2 TM Cytosolic
362 LI:337038.15:2001MAY17 704 721 forward 2 TM Transmembrane
362 LI:337038.15:2001MAY17 722 735 forward 2 TM Non-Cytosolic
362 LI:337038.15:2001MAY17 736 758 forward 2 TM Transmembrane
362 LI:337038.15:2001MAY17 759 764 forward 2 TM Cytosolic
362 LI:337038.15:2001MAY17 765 785 forward 2 TM Transmembrane
362 LI:337038.15:2001MAY17 786 804 forward 2 TM Non-Cytosolic
362 LI:337038.15:2001MAY17 805 827 forward 2 TM Transmembrane
362 LI:337038.15:2001MAY17 828 839 forward 2 TM Cytosolic
362 LI:337038.15:2001MAY17 840 862 forward 2 TM Transmembrane
362 LI:337038.15:2001MAY17 863 935 forward 2 TM Non-Cytosolic
362 LI:337038.15:2001MAY17 936 953 forward 2 TM Transmembrane
362 LI:337038.15:2001MAY17 954 959 forward 2 TM Cytosolic
362 LI:337038.15:2001MAY17 960 982 forward 2 TM Transmembrane
362 LI:337038.15:2001MAY17 983 1027 forward 2 TM Non-Cytosolic
362 LI:337038.15:2001MAY17 1028 1050 forward 2 TM Transmembrane
362 LI:337038.15:2001MAY17 1051 1095 forward 2 TM Cytosolic
362 LI:337038.15:2001MAY17 1096 1118 forward 2 TM Transmembrane
362 LI:337038.15:2001MAY17 1119 1132 forward 2 TM Non-Cytosolic
362 LI:337038.15:2001MAY17 1133 1152 forward 2 TM Transmembrane
362 LI:337038.15:2001MAY17 1153 1325 forward 2 TM Cytosolic
362 LI:337038.15:2001MAY17 1326 1345 forward 2 TM Transmembrane
362 LI:337038.15:2001MAY17 1346 1359 forward 2 TM Non-Cytosolic
362 LI:337038.15:2001MAY17 1360 1382 forward 2 TM Transmembrane
362 LI:337038.15:2001MAY17 1383 1401 forward 2 TM Cytosolic
362 LI:337038.15:2001MAY17 1402 1424 forward 2 TM Transmembrane
362 LI:337038.15:2001MAY17 1425 1438 forward 2 TM Non-Cytosolic
362 LI:337038.15:2001MAY17 1439 1461 forward 2 TM Transmembrane
362 LI:337038.15:2001MAY17 1462 1467 forward 2 TM Cytosolic
362 LI:337038.15:2001MAY17 1468 1487 forward 2 TM Transmembrane
362 LI:337038.15:2001MAY17 1488 1491 forward 2 TM Non-Cytosolic
362 LI:337038.15:2001MAY17 1492 1509 forward 2 TM Transmembrane
362 LI:337038.15:2001MAY17 1510 1515 forward 2 TM Cytosolic
362 LI:337038.15:2001MAY17 1516 1538 forward 2 TM Transmembrane
362 LI:337038.15:2001MAY17 1539 1552 forward 2 TM Non-Cytosolic
362 LI:337038.15:2001MAY17 1553 1575 forward 2 TM Transmembrane
362 LI:337038.15:2001MAY17 1576 1610 forward 2 TM' Cytosolic
362 LI:337038.15:2001MAY17 1611 1633 forward 2 TM Transmembrane
362 LI:337038.15:2001MAY17 1634 1749 forward 2 TM Non-Cytosolic
362 LI:337038.15:2001MAY17 1 206 forward 3 TM Cytosolic
362 LI:337038.15:2001MAY17 207 229 forward 3 TM Transmembrane
362 LI:337038.15:2001MAY17 230 764 forward 3 TM Non-Cytosolic
362 LI:337038.15:2001MAY17 765 787 forward 3 TM Transmembrane
362 LI:337038.15:2001MAY17 788 942 forward 3 TM Cytosolic
362 LI:337038.15:2001MAY17 943 965 forward 3 TM Transmembrane
362 LI:337038.15:2001MAY17 966 1030 forward 3 TM Non-Cytosolic
362 LI:337038.15:2001MAY17 1031 1050 forward 3 TM Transmembrane
362 LI:337038.15:2001MAY17 1051 1172 forward 3 TM Cytosolic
362 LI:337038.15:2001MAY17 1173 1192 forward 3 TM Transmembrane
362 LI:337038.15:2001MAY17 1193 1242 forward 3 TM Non-Cytosolic
362 LI:337038.15:2001MAY17 1243 1265 forward 3 TM Transmembrane TABLE 2
SEQ D NO: Template ID Start Stop Frame Domain Type Topology
362 LI:337O38.15:2001MAY17 1266 1393 forward 3 TM Cytosolic
362 LI:337038.15:2001MAY17 1394 1416 forward 3 TM Transmembrane
362 LI:337038.15:2001MAY17 1417 1430 forward 3 TM Non-Cytosolic
362 LI:337038.15:2001MAY17 1431 1453 forward 3 TM Transmembrane
362 LI:337038.15:2001MAY17 1454 1472 forward 3 TM Cytosolic
362 LI:337038.15:2001MAY17 1473 1495 forward 3 TM Transmembrane
362 LI:337038.15:2001MAY17 1496 1516 forward 3 TM Non-Cytosolic
362 LI:337038.15:2001MAY17 1517 1539 forward 3 TM Transmembrane
362 LI:337038.15:2001MAY17 1540 1551 forward 3 TM Cytosolic
362 LI:337038.15:2001MAY17 1552 1574 forward 3 TM Transmembrane
362 LI:337038.15:2001MAY17 1575 1607 forward 3 TM Non-Cytosolic
362 LI:337038.15:2001MAY17 1608 1630 forward 3 TM Transmembrane
362 LI:337038.15:2001MAY17 1631 1749 forward 3 TM Cytosolic
363 LI:337606.6:2001MAY17 1 73 forward 1 TM Cytosolic
363 LI:337606.6:2001MAY17 74 96 forward 1 TM Transmembrane
363 LI:337606.6:2001MAY17 97 210 forward 1 TM Non-Cytosolic
363 LI:337606.6:2001MAY17 1 168 forward 3 TM Cytosolic
363 LI:337606.6:2001MAY17 169 191 forward 3 TM Transmembrane
363 LI:337606.6:2001MAY17 192 209 forward 3 TM Non-Cytosolic
364 LI:338032.10:2001MAY17 1 4 forward 1 TM Non-Cytosolic
364 LI:338032.10:2001MAY17 5 27 forward 1 TM Transmembrane
364 LI:338032.10:2001MAY17 28 131 forward 1 TM Cytosolic
365 LI:339265.16:2001MAY17 1 1231 forward 1 TM Non-Cytosolic
365 LI:339265.16:2001MAY17 1232 1254 forward 1 TM Transmembrane
365 LI:339265.16:2001MAY17 1255 1274 forward 1 TM Cytosolic
365 LI:339265.16:2001MAY17 1 224 forward 3 TM Non-Cytosolic
365 LI:339265.16:2001MAY17 225 247 forward 3 TM Transmembrane
365 LI:339265.16:2001MAY17 248 341 forward 3 TM Cytosolic
365 LI:339265.16:2001MAY17 342 364 forward 3 TM Transmembrane
365 LI:339265.16:2001MAY17 365 1274 forward 3 TM Non-Cytosolic
366 LI:344646.4:2001MAY17 1 452 forward 1 TM Non-Cytosolic
366 LI:344646.4:2001MAY17 453 475 forward 1 TM Transmembrane
366 LI:344646.4:2001MAY17 476 598 forward 1 TM Cytosolic
366 LI:344646.4:2001MAY17 1 104 forward 2 TM Cytosolic
366 LI:344646.4:2001MAY17 105 127 forward 2 TM Transmembrane
366 LI:344646.4:2001MAY17 128 141 forward 2 TM Non-Cytosolic
366 LI:344646.4:2001MAY17 142 164 forward 2 TM Transmembrane
366 LI:344646.4:2001MAY17 165 250 forward 2 TM Cytosolic
366 LI:344646.4:2001MAY17 251 273 forward 2 TM Transmembrane
366 LI:344646.4:2001MAY17 274 598 forward 2 TM Non-Cytosolic
366 LI:344646.4:2001MAY17 1 289 forward 3 TM Cytosolic
366 LI:344646.4:2001MAY17 290 312 forward 3 TM Transmembrane
366 LI:344646.4:2001MAY17 313 345 forward 3 TM Non-Cytosolic
366 LI:344646.4:2001MAY17 346 365 forward 3 TM Transmembrane
366 LI:344646.4:2001MAY17 366 523 forward 3 TM Cytosolic
366 LI:344646.4:2001MAY17 524 546 forward 3 TM Transmembrane
366 LI:344646.4:2001MAY17 547 598 forward 3 TM Non-Cytosolic
367 LI:347393.7:2001MAY17 1 384 forward 2 TM Non-Cytosolic
367 LI:347393.7:2001MAY17 385 407 forward 2 TM Transmembrane
367 LI:347393.7:2001MAY17 408 449 forward 2 TM Cytosolic
368 LI:348107.36:2001MAY17 1 140 forward 2 TM Non-Cytosolic
368 LI:348107.36:2001MAY17 141 163 forward 2 TM Transmembrane
368 LI:348107.36:2001MAY17 164 166 forward 2 TM Cytosolic
369 LI:351120.6:2001MAY17 1 196 forward 1 TM Non-Cytosolic
Figure imgf000193_0001
N ( M *) N M N C*) r>I N N N N N W -ιi m n n M
TD TD TD TD TD TD TD TD TD TD TD TD TD
Figure imgf000193_0002
,o ,o ,o .o .o ,o ,o ,o ,o tN O 00 T- 1 --a- r-** *-o os t o 'd- t rt •rt *<a- 00 — •< o cs >n f-
O i 00 1 ι 00 o cn cn cn O ( -* cs in co a-* Os ^ tq 00 ' n >*• •** κr> m m K cn cn cn ** in in ui cn cn cn cn 2 in "
<— < c No I o oo tji H
E-i So cn cn cn n. cn -*
Figure imgf000193_0003
Figure imgf000193_0004
TABLE 2
SEQ D NO: Template ID Start Stop Frame Domain Type Topology
370 LI:358762.41:2001MAY17 161 183 forward 2 TM Transmembrane
370 LI:358762.41:2001MAY17 184 216 forward 2 TM Non-Cytosolic
370 LI:358762.41:2001MAY17 217 239 forward 2 TM Transmembrane
370 LI:358762.41:2001MAY17 240 441 forward 2 TM Cytosolic
370 LI:358762.41:2001MAY17 442 464 forward 2 TM Transmembrane
370 LI:358762.41:2001MAY17 465 561 forward 2 TM Non-Cytosolic
370 LI:358762.41:2001MAY17 1 14 forward 3 TM Non-Cytosolic
370 LI:358762.41:2001MAY17 15 37 forward 3 TM Transmembrane
370 LI:358762.41:2001MAY17 38 172 forward 3 TM Cytosolic
370 LI:358762.41:2001MAY17 173 195 forward 3 TM Transmembrane
370 LI:358762.41:2001MAY17 196 209 forward 3 TM Non-Cytosolic
370 LI:358762.41:2001MAY17 210 229 forward 3 TM Transmembrane
370 LI:358762.41:2001MAY17 230 433 forward 3 TM Cytosolic
370 LI:358762.41:2001MAY17 434 453 forward 3 TM Transmembrane
370 LI:358762.41:2001MAY17 454 472 forward 3 TM Non-Cytosolic
370 LI:358762.41:2001MAY17 473 495 forward 3 TM Transmembrane
370 LI:358762.41:2001MAY17 496 560 forward 3 TM Cytosolic
371 LI:363003.48:2001MAY17 1 192 forward 3 TM Non-Cytosolic
371 LI:363003.48:2001MAY17 193 215 forward 3 TM Transmembrane
371 LI:363003.48:2001MAY17 216 256 forward 3 TM Cytosolic
371 LI:363003.48:2001MAY17 257 279 forward 3 TM Transmembrane
371 LI:363003.48:2001MAY17 280 288 forward 3 TM Non-Cytosolic
371 LI:363003.48:2001MAY17 289 311 forward 3 TM Transmembrane
371 LI:363003.48:2001MAY17 312 323 forward 3 TM Cytosolic
371 LI:363003.48:2001MAY17 324 346. forward 3 TM Transmembrane
371 LI:363003.48:2001MAY17 347 347 forward 3 TM Non-Cytosolic
372 LI:370899.6:2001MAY17 1 523 forward 1 TM Non-Cytosolic
372 LI:370899.6:2001MAY17 524 546 forward 1 TM Transmembrane
372 LI:370899.6:2001MAY17 547 579 forward 1 .. TM Cytosolic
372 LI:370899.6:2001MAY17 580 602 forward 1 TM Transmembrane
372 LI:370899.6:2001MAY17 603 621 forward 1 TM Non-Cytosolic
372 LI:370899.6:2001MAY17 622 644 forward 1 TM Transmembrane
372 LI:370899.6:2001MAY17 645 664 forward 1 TM Cytosolic
372 LI:370899.6:2001MAY17 665 687 forward 1 TM Transmembrane
372 LI:370899.6:2001MAY17 688 1216 forward 1 TM Non-Cytosolic
372 LI:370899.6:2001MAY17 1 553 forward 2 TM Non-Cytosolic
372 LI:370899.6:2001MAY17 554 576 forward 2 TM Transmembrane
372 LI:370899.6:2001MAY17 577 617 forward 2 TM Cytosolic
372 LI:370899.6:2001MAY17 618 640 forward 2 TM Transmembrane
372 LI:370899.6:2001MAY17 641 659 forward 2 TM Non-Cytosolic
372 LI:370899.6:2001MAY17 660 682 forward 2 TM Transmembrane
372 LI:370899.6:2001MAY17 683 711 forward 2 TM Cytosolic
372 LI:370899.6:2001MAY17 712 734 forward 2 TM Transmembrane
372 LI:370899.6:2001MAY17 735 1216 forward 2 TM Non-Cytosolic
372 LI:370899.6:2001MAY17 1 522 forward 3 TM Non-Cytosolic
372 LI:370899.6:2001MAY17 523 545 forward 3 TM Transmembrane
372 LI:370899.6:2001MAY17 546 714 forward 3 TM Cytosolic
372 LI:370899.6:2001MAY17 715 737 forward 3 TM Transmembrane
372 LI:370899.6:2001MAY17 738 1215 forward 3 TM Non-Cytosolic
373 LI:376470.1:2001MAY17 1 126 forward 3 TM Cytosolic
373 LI:376470.1:2001MAY17 . 127 149 forward 3 TM Transmembrane
373 LI:376470.1:2001MAY17 150 180 forward 3 TM Non-Cytosolic
374 LI:400961.18:2001MAY17 1 303 forward 1 TM Non-Cytosolic
374 LI:400961.18:2001MAY17 304 326 forward 1 TM Transmembrane TABLE 2
SEQ D NO: Template ID Start Stop Frame Domain Type Topology
374 LI:400961.18:2001MAY17 327 489 forward 1 TM Cytosolic
374 LI:400961.18:2001MAY17 490 512 forward 1 TM Transmembrane
374 LI:400961.18:2001MAY17 513 607 forward 1 TM Non-Cytosolic
374 LI:400961.18:2001MAY17 1 186 forward 3 TM Non-Cytosolic
374 LI:400961.18:2001MAY17 187 206 forward 3 TM Transmembrane
374 LI:400961.18:2001MAY17 207 210 forward 3 TM Cytosolic
374 LI:400961.18:2001MAY17 211 233 forward 3 TM Transmembrane
374 LI:400961.18:2001MAY17 234 606 forward 3 TM Non-Cytosolic
375 LI:404482.20:2001MAY17 1 421 forward 1 TM Non-Cytosolic
375 LI:404482.20:2001MAY17 422 444 forward 1 TM Transmembrane
3.75 LI:404482.20:2001MAY17 445 653 forward 1 TM Cytosolic
375 LI:404482.20:2001MAY17 654 676 forward 1 TM Transmembrane
375 LI:404482.20:2001MAY17 677 719 forward 1 TM Non-Cytosolic
375 LI:404482.20:2001MAY17 720 742 forward 1 TM Transmembrane
375 ■ LI:404482.20:2001MAY17 743 1018 forward 1 TM Cytosolic
375 LI:404482.20:2001MAY17 1019 1038 forward 1 TM Transmembrane
375 LI:404482.20:2001MAY17 1039 1052 forward 1 TM Non-Cytosolic
375 LI:404482.20:2001MAY17 1053 1075 forward 1 TM Transmembrane
375 LI:404482.20:2001MAY17 1076 1081 forward 1 TM Cytosolic
375 LI:404482.20:2001MAY17 1082 1100 forward 1 TM Transmembrane
375 LI:404482.20:2001MAY17 1101 1201 forward 1 TM Non-Cytosolic
375 LI:404482.20:2001MAY17 1 250 forward 2 TM Cytosolic
375 LI:404482.20:2001MAY17 251 273 forward 2 TM Transmembrane
375 LI:404482.20:2001MAY17 274 1041 forward 2 • TM . Non-Cytosolic
375 LI:404482.20:2001MAY17 1042 1061 forward 2 TM Transmembrane
375 LI:404482.20:2001MAY17 1062 1201 forward 2 TM Cytosolic
375 LI:404482.20:2001MAY17 1 930 forward 3 TM Non-Cytosolic
375 LI:404482.20:2001MAY17 931 953 forward 3 TM Transmembrane
375 LI:404482.20:2001MAY17 954 1016 forward 3 TM Cytosolic
375 LI:404482.20:2001MAY17 1017 1039 forward 3 TM Transmembrane
375 LI:404482.20:2001MAY17 1040 1048 forward 3 TM Non-Cytosolic
375 LI:404482.20:2001MAY17 1049 1071 forward 3 TM Transmembrane
375 LI:404482.20:2001MAY17 1072 1102 forward 3 TM Cytosolic
375 LI:404482.20:2001MAY17 1103 1125 forward 3 TM Transmembrane
375 LI:404482.20:2001MAY17 1126 1200 forward 3 TM Non-Cytosolic
376 LI:405985.1:2001MAY17 1 364 forward 1 TM Non-Cytosolic
376 LI:405985.1:2001MAY17 365 387 forward 1 TM Transmembrane
376 LI:405985.1:2001MAY17 388 424 forward 1 TM Cytosolic
376 LI:405985.1:2001MAY17 1 64 forward 2 TM Cytosolic
376 LI:405985.1:2001MAY17 65 87 forward 2 TM Transmembrane
376 LI:405985.1:2001MAY17 88 424 forward 2 TM Non-Cytosolic
377 LI:406389.1:2001MAY17 1 37 forward 2 TM Cytosolic
377 LI:406389.1:2001MAY17 38 60 forward 2 TM Transmembrane
377 LI:406389.1:2001MAY17 61 160 forward 2 TM Non-Cytosolic
377 LI:406389.1:2001MAY17 161 183 forward 2 TM Transmembrane
377 LI:406389.1:2001MAY17 184 199 forward 2 TM Cytosolic
377 LI:406389.1:2001MAY17 200 222 forward 2 TM Transmembrane
377 LI:406389.1:2001MAY17 223 622 forward 2 TM Non-Cytosolic
378 LI:406833.1:2001MAY17 1 448 forward 1 TM Non-Cytosolic
378 LI:406833.1:2001MAY17 449 471 forward 1 TM Transmembrane
378 LI:406833.1:2001MAY17 472 500 forward 1 TM Cytosolic
378 LI:406833.1:2001MAY17 501 523 forward 1 TM Transmembrane
378 LI:406833.1:2001MAY17 524 975 forward 1 TM Non-Cytosolic
378 LI:406833.1:2001MAY17 1 902 forward 2 TM Non-Cytosolic TABLE 2
SEQ D NO: Template ID Start Stop Frame Domain Type Topology
378 LI:406833.1:2001MAY17 903 925 forward 2 TM Transmembrane
378 LI:406833.1:2001MAY17 926 945 forward 2 TM Cytosolic
378 LI:406833.1:2001MAY17 946 968 forward 2 TM Transmembrane
378 LI:406833.1:2001MAY17 969 975 forward 2 TM Non-Cytosolic
378 LI:406833.1:2001MAY17 1 901 forward 3 TM Non-Cytosolic
378 LI:406833.1:2001MAY17 902 924 forward 3 TM Transmembrane
378 LI:406833.1:2001MAY17 925 943 forward 3 TM Cytosolic
378 LI:406833.1:2001MAY17 944 961 forward 3 TM Transmembrane
378 LI:406833.1:2001MAY17 962 975 forward 3 TM Non-Cytosolic
379 LI:407921.3:2001MAY17 1 1805 forward 2 TM Non-Cytosolic
379 LI:407921.3:2001MAY17 1806 1828 forward 2 TM Transmembrane
379 LI:407921.3:2001MAY17 1829 1863 forward 2 TM Cytosolic
380 LI:409078.54:2001MAY17 1 28 forward 3 TM Non-Cytosolic
380 LI:409078.54:2001MAY17 29 51 forward 3 TM Transmembrane
380 LI:409078.54:2001MAY17 52 80 forward 3 TM Cytosolic
380 LI:409078.54:2001MAY17 81 103 forward 3 TM Transmembrane
380 LI:409078.54:2001MAY17 104 1242 forward 3 TM Non-Cytosolic
381 LI:423601.6:2001MAY17 1 314 forward 3 TM Non-Cytosolic
381 LI:423601.6:2001MAY17 315 337 forward 3 TM Transmembrane
381 LI:423601.6:2001MAY17 338 345 forward 3 TM Cytosolic
381 LI:423601.6:2001MAY17 346 364 forward 3 TM Transmembrane
381 LI:423601.6:2001MAY17 365 378 forward 3 TM Non-Cytosolic
381 LI:423601.6:2001MAY17 379 401 forward 3 TM Transmembrane
381 LI:423601.6:2001MAY17 402 414 forward 3 TM Cytosolic
382 LI:425024.5:2001MAY17 1 173 forward 2 TM Non-Cytosolic
382 LI:425024.5:2001MAY17 174 196 forward 2 TM Transmembrane
382 LI:425024.5:2001MAY17 197 215 forward 2 TM Cytosolic
382 LI:425024.5:2001MAY17 216 238 forward 2 TM Transmembrane
382 LL425024.5 :200 IMAY 17 239 242 forward 2 TM Non-Cytosolic
382 LI:425024.5:2001MAY17 243 260 forward 2 TM Transmembrane
382 LI:425024.5:200 IMAY 17 261 266 forward 2 TM Cytosolic
382 LI:425024.5:2001MAY17 267 289 forward 2 TM Transmembrane
382 LI:425024.5:2001MAY17 290 583 forward 2 TM Non-Cytosolic
383 LI:427909.29:2001MAY17 1 252 forward 1 TM Non-Cytosolic
383 LI:427909.29:2001MAY17 253 , 275 forward 1 TM Transmembrane
383 LI:427909.29:2001MAY17 276 463 forward 1 TM Cytosolic
383 LI:427909.29:2001MAY17 464 483 forward 1 TM Transmembrane
383 LI:427909.29:2001MAY17 484 545 forward 1 TM Non-Cytosolic
383 LI:427909.29:2001MAY17 546 568 forward 1 TM Transmembrane
383 LI:427909.29:2001MAY17 569 580 forward 1 TM Cytosolic
383 LI:427909.29:2001MAY17 581 603 forward 1 TM Transmembrane
383 LI:427909.29:2001MAY17 604 617 forward 1 TM Non-Cytosolic
383 LI:427909.29:2001MAY17 618 637 forward 1 TM Transmembrane
383 LI:427909.29:2001MAY17 638 657 forward 1 TM Cytosolic
383 LI:427909.29:2001MAY17 658 680 forward 1 TM Transmembrane
383 LI:427909.29:2001MAY17 681 725 forward 1 TM Non-Cytosolic
383 LI:427909.29:2001MAY17 726 748 forward 1 TM Transmembrane
383 LI:427909.29:2001MAY17 749 780 forward 1 TM Cytosolic
383 LI:427909.29:2001MAY17 781 803 forward 1 TM Transmembrane
383 LI:427909.29:2001MAY17 804 858 forward 1 TM Non-Cytosolic
383 LI:427909.29:2001MAY 17 859 881 forward 1 TM Transmembrane
383 LI:427909.29:2001MAY17 882 1201 forward 1 TM Cytosolic
383 LI:427909.29:2001MAY17 1202 1224 forward 1 TM Transmembrane
383 LI:427909.29:2001MAY17 1225 1255 forward 1 TM Non-Cytosolic TABLE 2
SEQ D NO: Template ID Start Stop Frame Domain Type Topology
383 LI:427909.29:2001MAY17 1 283 forward 2 TM Non-Cytosolic
383 LI:427909.29:2001MAY17 284 306 forward 2 TM Transmembrane
383 LI:427909.29:2001MAY17 307 318 forward 2 TM Cytosolic
383 LI:427909.29:2001MAY17 319 341 forward 2 TM Transmembrane
383 LI:427909.29:2001MAY17 342 460 forward 2 TM Non-Cytosolic
383 LI:427909.29:2001MAY17 461 483 forward 2 TM Transmembrane
383 LI:427909.29:2001MAY17 484 582 forward 2 TM Cytosolic
383 LI:427909.29:2001MAY17 583 605 forward 2 TM Transmembrane
383 LI:427909.29:2001MAY17 606 624 forward 2 TM Non-Cytosolic
383 LI:427909.29:2001MAY17 625 642 forward 2 TM Transmembrane
383 LI:427909.29:2001MAY17 643 662 forward 2 TM Cytosolic
383 LI:427909.29:2001MAY17 663 685 forward 2 TM Transmembrane
383 LI:427909.29:2001MAY17 686 688 forward 2 TM Non-Cytosolic
383 LI:427909.29:2001MAY17 689 711 forward 2 TM Transmembrane
383 LI:427909.29:2001MAY17 712 729 forward 2 TM Cytosolic
383 LI:427909.29:2001MAY17 730 752 forward 2 TM Transmembrane
383 LI:427909.29:2001MAY17 753 780 forward 2 TM Non-Cytosolic
383 LI:427909.29:2001MAY17 781 803 forward 2 TM Transmembrane
383 LI:427909.29:2001MAY17 804 929 forward 2 TM Cytosolic
383 LI:427909.29:2001MAY17 930 949 forward 2 TM Transmembrane
383 LI:427909.29:2001MAY17 950 1254 forward 2 TM Non-Cytosolic
383 LI:427909.29:2001MAY17 1 319 forward 3 TM Cytosolic
383 LI:427909.29:2001MAY17 320 339 forward 3 TM Transmembrane
383 LI:427909.29:2001MAY17 340 622 forward 3 TM Non-Cytosolic
383 LI:427909.29:2001MAY17 623 640 forward 3 TM Transmembrane
383 LI:427909.29:2001MAY17 641 675 forward 3 TM Cytosolic
383 LI:427909.29:2001MAY17 676 698 forward 3 TM Transmembrane
383 LI:427909.29:2001MAY17 699 728 forward 3 TM Non-Cytosolic
383 LI:427909.29:2001MAY17 729 751 forward 3 TM Transmembrane
383 LI:427909.29:2001MAY17 752 833 forward 3 TM Cytosolic
383 LI:427909.29:2001MAY17 834 856 forward 3 TM Transmembrane
383 LI:427909.29:2001MAY17 857 1254 forward 3 TM Non-Cytosolic
384 LI:428198.20:2001MAY17 1 171 forward 2 TM Cytosolic
384 LI:428198.20:2001MAY17 172 194 forward 2 TM Transmembrane
384 LI:428198.20:2001MAY17 195 820 forward 2 TM Non-Cytosolic
384 LI:428198.20:2001MAY17 821 840 forward 2 TM Transmembrane
384 LI:428198.20:2001MAY17 841 860 forward 2 TM Cytosolic
384 LI:428198.20:2001MAY17 861 883 forward 2 TM Transmembrane
384 LI:428198.20:2001MAY17 884 892 forward 2 TM Non-Cytosolic
384 LI:428198.20:2001MAY17 893 915 forward 2 TM Transmembrane
384 LI:428198.20:2001MAY17 916 958 forward 2 TM Cytosolic
384 LI:428198.20:2001MAY17 1 910 forward 3 TM Non-Cytosolic
384 LI:428198.20:2001MAY17 911 933 forward 3 TM Transmembrane
384 LI:428198.20:2001MAY17 934 958 forward 3 TM Cytosolic
385 LI:429738.6:2001MAY17 1 19 forward 1 TM Cytosolic
385 LI:429738.6:2001MAY17 20 42 forward 1 TM Transmembrane
385 LI:429738.6:2001MAY17 43 45 forward 1 TM Non-Cytosolic
385 LI:429738.6:2001MAY17 46 63 forward 1 TM Transmembrane
385 LI:429738.6:2001MAY17 64 343 forward 1 TM Cytosolic
385 LI:429738.6:2001MAY17 344 366 forward 1 TM Transmembrane
385 LI:429738.6:2001MAY17 367 380 forward 1 TM Non-Cytosolic
385 LI:429738.6:2001MAY17 381 403 forward 1 TM Transmembrane
385 LI:429738.6:2001MAY17 404 416 forward 1 TM Cytosolic
385 LI:429738.6:2001MAY17 1 19 forward 2 TM Non-Cytosolic TABI ,E 2
SEQ D NO: Template ID Start Stop Frame Domain Type Topology
385 LI:429738.6:2001MAY17 20 42 forward 2 TM Transmembrane
385 LI:429738.6:2001MAY17 43 336 forward 2 TM Cytosolic
385 LI:429738.6:2001MAY17 337 359 forward 2 TM Transmembrane
385 LI:429738.6:2001MAY17 360 363 forward 2 TM Non-Cytosolic
385 LI:429738.6:2001MAY17 364 386 forward 2 TM Transmembrane
385 LI:429738.6:2001MAY17 387 392 forward 2 TM Cytosolic
385 LI:429738.6:2001MAY17 393 415 forward 2 TM Transmembrane
385 LI:429738.6:2001MAY17 416 416 forward 2 TM Non-Cytosolic
385 LI:429738.6:2001MAY17 1 19 forward 3 TM Cytosolic
385 LI:429738.6:2001MAY17 20 42 forward 3 TM Transmembrane
385 LI:429738.6:2001MAY17 43 333 forward 3 TM Non-Cytosolic
385 LI:429738.6:2001MAY17 334 356 forward 3 TM Transmembrane
385 LI:429738.6:2001MAY17 357 360 forward 3 TM Cytosolic
385 LI:429738.6:2001MAY17 361 383 forward 3 TM Transmembrane
385 LI:429738.6:2001MAY17 384 387 forward 3 TM Non-Cytosolic
385 LI:429738.6:2001MAY17 388 410 forward 3 TM Transmembrane
385 LI:429738.6:2001MAY17 411 415 forward 3 TM Cytosolic
386 LI:449437.1:2001MAY17 1 73 forward 2 TM Cytosolic
386 LI:449437.1:2001MAY17 74 96 forward 2 TM Transmembrane
386 LI:449437.1:2001MAY17 97 115 forward 2 TM Non-Cytosolic
386 LL449437.1:2001MAY17 116 133 forward 2 TM Transmembrane
386 LI:449437.1:2001MAY17 134 237 forward 2 TM Cytosolic
386 LI:449437.1:2001MAY17 238 260 forward 2 TM Transmembrane
386 LI:449437.1:2001MAY17 261 279 forward 2 TM Non-Cytosolic
387 LI:459269.25:2001MAY17 1 326 forward 2 TM Non-Cytosolic
387 LI:459269.25:2001MAY17 327 349 forward 2 TM Transmembrane
387 LI:459269.25:2001MAY17 350 640 forward 2 TM Cytosolic
388 LI:464206.1:2001MAY17 1 80 forward 2 TM Cytosolic
388 LI:464206.1:2001MAY17 81 103 forward 2 TM Transmembrane
388 LI:464206.1:2001MAY17 104 942 forward 2 TM Non-Cytosolic
388 LI:464206.1:2001MAY17 1 694 forward 3 TM Non-Cytosolic
388 LI:464206.1:2001MAY17 695 717 forward 3 TM Transmembrane
388 LI:464206.1:2001MAY17 718 723 forward 3 TM Cytosolic
388 LI:464206.1:2001MAY17 724 746 forward 3 TM Transmembrane
388 LI:464206.1:2001MAY17 747 942 forward 3 TM Non-Cytosolic
389 LI:465821.2:2001MAY17 1 446 forward 1 TM Non-Cytosolic
389 LI:465821.2:2001MAY17 447 466 forward 1 TM Transmembrane
389 LI:465821.2:2001MAY17 467 477 forward 1 TM Cytosolic
389 LI:465821.2:2001MAY17 478 500 forward 1 TM Transmembrane
389 L 465821.2:2001MAY17 501 654 forward 1 TM Non-Cytosolic
389 LI:465821.2:2001MAY17 1 439 forward 2 TM Non-Cytosolic
389 LI:465821.2:2001MAY17 440 459 forward 2 TM Transmembrane
389 LI:465821.2:2001MAY17 460 470 forward 2 TM Cytosolic
389 LI:465821.2:2001MAY17 471 493 forward 2 TM Transmembrane
389 LI:465821.2:2001MAY17 494 653 forward 2 TM Non-Cytosolic
389 LI:465821.2:2001MAY17 1 469 forward 3 TM Non-Cytosolic
389 LI:465821.2:2001MAY17 470 492 forward 3 TM Transmembrane
389 LI:465821.2:2001MAY17 493 653 forward 3 TM Cytosolic
390 LI:474414.28:2001MAY17 1 349 forward 1 TM Non-Cytosolic
390 LI:474414.28:2001MAY17 350 372 forward 1 TM Transmembrane
390 LI:474414.28:2001MAY17 373 391 forward 1 TM Cytosolic
390 LI:474414.28:2001MAY17 392 414 forward 1 TM Transmembrane
390 LI:474414.28:2001MAY17 415 1028 forward 1 TM Non-Cytosolic
390 LI:474414.28:2001MAY17 1029 1051 forward 1 TM Transmembrane TABLE 2
SEQ D NO: Template ID Start Stop Frame Domain Type Topology
390 L 474414.28 :2001 MAY 17 1052 1133 forward 1 TM Cytosolic
390 LI:474414.28:2001MAY17 1134 1156 forward 1 TM Transmembrane
390 LI:474414.28:2001MAY17 1157 1405 forward 1 TM Non-Cytosolic
390 LI:474414.28:2001MAY17 1 12 forward 2 TM Cytosolic
390 LI:474414.28:2001MAY17 13 35 forward 2 TM Transmembrane
390 LI:474414.28:2001MAY17 36 44 forward 2 TM Non-Cytosolic
390 LI:474414.28:2001MAY17 45 67 forward 2 TM Transmembrane
390 LI:474414.28:2001MAY17 68 437 forward 2 TM Cytosolic
390 LI:474414.28:2001MAY17 438 457 forward 2 TM Transmembrane
390 LI:474414.28:2001MAY17 458 466 forward 2 TM Non-Cytosolic
390 LI:474414.28:2001MAY17 467 489 forward 2 TM Transmembrane
390 LI:474414.28:2001MAY17 490 501 forward 2 TM Cytosolic
390 LI:474414.28:2001MAY17 502 521 forward 2 TM Transmembrane
390 LI:474414.28:2001MAY17 522 1405 forward 2 TM Non-Cytosolic
390 LI:474414.28:2001MAY17 1 302 forward 3 TM Non-Cytosolic
390 LI:474414.28:2001MAY17 303 325 forward 3 TM Transmembrane
390 LI:474414.28:2001MAY17 326 345 forward 3 TM Cytosolic
390 LI:474414.28:2001MAY17 346 368 forward 3 TM Transmembrane
390 LI:474414.28:2001MAY17 369 394 forward 3 TM Non-Cytosolic
390 I:474414.28:2001MAY17 395 417 forward 3 TM Transmembrane
390 LI:474414.28:2001MAY17 418 437 forward 3 TM Cytosolic
390 LI:474414.28:2001MAY17 438 455 forward 3 TM Transmembrane
390 LI:474414.28:2001MAY17 456 467 forward 3 TM Non-Cytosolic
390 LI:474414.28:2001MAY17 468 490 forward 3 TM Transmembrane
390 LI:474414.28:2001MAY17 491 496 forward 3 TM Cytosolic
390 LI:474414.28:2001MAY17 497 514 forward 3 TM Transmembrane
390 LI:474414.28:2001MAY17 515 629 forward 3 TM Non-Cytosolic
390 LI:474414.28:2001MAY17 630 652 forward 3 TM Transmembrane
390 LI:474414.28:2001MAY17 653 920 forward 3 TM Cytosolic
390 LI:474414.28:2001MAY17 921 943 forward 3 TM Transmembrane
390 LI:474414.28:2001MAY17 944 1027 forward 3 TM Non-Cytosolic
390 LI:474414.28:2001MAY17 1028 1050 forward 3 TM Transmembrane
390 LI:474414.28:2001MAY17 1051 1259 forward 3 TM Cytosolic
390 LI:474414.28:2001MAY17 1260 1282 forward 3 TM Transmembrane
390 LI:474414.28:2001MAY17 1283 1296 forward 3 TM Non-Cytosolic
390 LI:474414.28:2001MAY17 1297 1316 forward 3 TM Transmembrane
390 LI:474414.28:2001MAY17 1317 1405 forward 3 TM Cytosolic
391 LI:474435.14:2001MAY17 1 137 forward 2 TM Non-Cytosolic
391 LL474435.14:2001MAY17 138 160 forward 2 TM Transmembrane
391 LI:474435.14:2001MAY17 161 180 forward 2 TM Cytosolic
391 LI:474435.14:2001MAY17 181 203 forward 2 TM Transmembrane
391 LI-474435.14:2001MAY17 204 472 forward 2 TM Non-Cytosolic
391 LI:474435.14:2001MAY17 473 495 forward 2 TM Transmembrane
391 LI:474435.14:2001MAY17 496 542 forward 2 TM Cytosolic
391 LI:474435.14:2001MAY17 543 565 forward 2 TM Transmembrane
391 L 474435.14:2001MAY17 566 1160 forward 2 TM Non-Cytosolic
392 LI:474458.11 :2001MAY17 1 3 forward 1 TM Non-Cytosolic
392 LI:474458.11:2001MAY17 4 21 forward 1 TM Transmembrane
392 LI:474458.11 :2001MAY17 22 203 forward 1 TM Cytosolic
392 LI:474458.11 :2001MAY17 204 226 forward 1 TM Transmembrane
392 LI:474458.11:2001MAY17 227 249 forward 1 TM Non-Cytosolic
392 LI:474458.11:2001MAY17 250 269 forward 1 TM Transmembrane
392 LI:474458.11 :2001MAY17 270 275 forward 1 TM Cytosolic
392 LI:474458.11 :2001MAY17 276 298 forward 1 TM Transmembrane TABLE 2
SEQ D NO: Template ID Start Stop Frame Domain Type Topology
392 LI:474458.11:2001MAY17 299 567 forward 1 TM Non-Cytosolic
392 LI:474458.11:2001MAY17 568 590 forward 1 TM Transmembrane
392 LI:474458.11:2001MAY17 591 617 forward 1 TM Cytosolic
392 LI:474458.11 :2001MAY17 618 640 forward 1 TM Transmembrane
392 LI.474458.1 L2001MAY17 641 854 forward 1 TM Non-Cytosolic
392 LI:474458.11:2001MAY17 1 572 forward 2 TM Non-Cytosolic
392 LL474458.1 2001MAY17 573 595 forward 2 TM Transmembrane
392 LI:474458.11:2001MAY17 596 606 forward 2 TM Cytosolic
392 LI:474458.11:2001MAY17 607 629 forward 2 TM Transmembrane
392 LI:474458.11:2001MAY17 630 854 forward 2 TM Non-Cytosolic
392 LI:474458.11:2001MAY17 1 116 forward 3 TM Cytosolic
392 LL474458.il :2001MAY17 117 139 forward 3 TM Transmembrane
392 LI:474458.11:2001MAY17 140 185 forward 3 TM Non-Cytosolic
392 LL474458.11 :2001MAY17 186 208 forward 3 TM Transmembrane
392 LI:474458.11:2001MAY17 209 214 forward 3 TM Cytosolic
392 LI:474458.11:2001MAY17 215 234 forward 3 TM Transmembrane
392 LI:474458.11:2001MAY17 235 248 forward 3 TM Non-Cytosolic
392 LI:474458.11:2001MAY17 249 268 forward 3 TM Transmembrane
392 LI:474458.11:2001MAY17 269 304 forward 3 TM Cytosolic
392 LL474458.il :2001MAY17 305 327 forward 3 TM Transmembrane
392 LL474458.i l :2001MAY17 328 336 forward 3 TM Non-Cytosolic
392 LI:474458.11:2001MAY17 337 359 forward 3 TM Transmembrane
392 LI:474458.11:2001MAY17 360 415 forward 3 TM Cytosolic
392 L 474458.11 :2001MAY17 . 416 433 forward 3 TM Transmembrane
392 LI:474458.11:2001MAY17 , 434 . 567 forward 3 TM Non-Cytosolic
392 LL474458.11 :2001MAY17 568 590 forward 3 TM Transmembrane
392 LL474458.11 :2001MAY17 591 752 forward 3 TM Cytosolic
392 LL474458.i l :2001MAY17 ' 753 775 forward 3 TM Transmembrane
392 LI:474458.11:2001MAY17 . . 776 819 forward 3 TM Non-Cytosolic
392 LI:474458.11:2001MAY17 820 842 forward 3 TM Transmembrane
392 LI:474458.11:2001MAY17 843 854 forward 3 TM Cytosolic
393 LI:477127.18:2001MAY17 1 659 forward 1 TM Non-Cytosolic
393 LI:477127.18:2001MAY17 660 682 forward 1 TM Transmembrane
393 LI:477127.18:2001MAY17 683 752 forward 1 TM Cytosolic
393 LI:477127.18:2001MAY17 753 775 forward 1 TM Transmembrane
393 LI:477127.18:2001MAY17 776 1 102 forward 1 TM Non-Cytosolic
393 LI:477127.18:2001MAY17 1 664 forward 2 TM Non-Cytosolic
393 LI:477127.18:2001MAY17 665 687 forward 2 TM Transmembrane
393 LI:477127.18:2001MAY17 688 750 forward 2 TM Cytosolic
393 LI:477127.18:2001MAY17 751 773 forward 2 TM Transmembrane
393 LI:477127.18:2001MAY17 774 1102 forward 2 TM Non-Cytosolic
393 LI:477127.18:2001MAY17 1 135 forward 3 TM Cytosolic
393 LI:477127.18:2001MAY17 136 158 forward 3 TM Transmembrane
393 LI:477127.18:2001MAY17 159 1102 forward 3 TM Non-Cytosolic
394 LI:480375.55:2001MAY17 1 740 forward 3 TM Non-Cytosolic
394 LI:480375.55:2001MAY17 741 763 forward 3 TM Transmembrane
394 LI:480375.55:2001MAY17 764 805 forward 3 TM Cytosolic
395 LI:480467.24:2001MAY17 1 146 forward 3 TM Cytosolic
395 LI:480467.24:2001MAY17 147 164 forward 3 TM Transmembrane
395 LI:480467.24:2001MAY17 165 191 forward 3 TM Non-Cytosolic
395 LI:480467.24:2001MAY17 192 214 forward 3 TM Transmembrane
395 LI:480467.24:2001MAY17 215 220 forward 3 TM Cytosolic
395 LI:480467.24:2001MAY17 221 238 forward 3 TM Transmembrane
395 LI:480467.24:2001MAY17 239 325 forward 3 TM Non-Cytosolic TABLE 2
SEQ D NO: Template ID Start Stop Frame Domain Type Topology
395 LI:480467.24:2001MAY17 326 343* forward 3 TM Transmembrane
395 LI:480467.24:2001MAY17 344 457 forward 3 TM Cytosolic
396 LI:480587.1:2001MAY17 1 95 forward 1 TM Cytosolic
396 LI:480587.1:2001MAY17 96 118 forward 1 TM Transmembrane
396 LI:480587.1:2001MAY17 119 157 forward 1 TM Non-Cytosolic
396 LI:480587.1:2001MAY17 158 175 forward 1 TM Transmembrane
396 LI:480587.1:2001MAY17 176 238 forward 1 TM Cytosolic
396 LI:480587.1:2001MAY17 239 261 forward 1 TM Transmembrane
396 LI:480587.1:2001MAY17 262 273 forward 1 TM Non-Cytosolic
396 LL480587.1:200 IMAY 17 274 296 forward 1 TM Transmembrane
396 LI:480587.1:2001MAY17 297 308 forward 1 TM Cytosolic
396 LI:480587.1:2001MAY17 309 331 forward 1 TM Transmembrane
396 LI:480587.1:2001MAY17 332 886 forward 1 TM Non-Cytosolic
396 LI:480587.1:2001MAY17 887 909 forward 1 TM Transmembrane
396 LI:480587.1:2001MAY17 910 942 forward 1 TM Cytosolic
396 LI:480587.1:2001MAY17 943 965 forward 1 TM Transmembrane
396 LI:480587.1:2001MAY17 966 1035 forward 1 TM Non-Cytosolic
396 LI:480587.1:2001MAY17 1036 1058 forward 1 TM Transmembrane
396 LI:480587.1:2001MAY17 1059 1070 forward 1 TM Cytosolic
396 LI:480587.1:2001MAY17 1071 1093 forward 1 TM Transmembrane
396 LI:480587.1:2001MAY17 1094 1097 forward 1 TM Non-Cytosolic
396 LI:480587.1:2001MAY17 1098 1120 forward 1 TM Transmembrane
396 LI:480587.1:2001MAY17 1121 1236 forward 1 TM Cytosolic
396 LI:480587.1:2001MAY17 1 275 forward 3 TM Cytosolic
396 LI:480587.1:2001MAY17 276 298 forward 3 TM Transmembrane
396 LI:480587.1:2001MAY17 299 307 forward 3 TM Non-Cytosolic
396 LI:480587.1:2001MAY17 308 330 forward 3 TM Transmembrane
396 LI:480587.1:2001MAY17 331 424 forward 3 TM Cytosolic
396 LI:480587.1:2001MAY17 425 447 forward 3 TM Transmembrane
396 LI:480587.1:2001MAY17 448 938 forward 3 TM Non-Cytosolic
396 LI:480587.1:2001MAY17 939 961 forward 3 TM Transmembrane
396 LI:480587.1:2001MAY17 962 1073 forward 3 TM Cytosolic
396 LI:480587.1:2001MAY17 1074 1096 forward 3 TM Transmembrane
396 LI:480587.1:2001MAY17 1097 1235 forward 3 TM Non-Cytosolic
397 LI:480798.13:2001MAY17 1 392 forward 1 TM Non-Cytosolic
397 LI:480798.13:2001MAY17 393 410 forward 1 TM Transmembrane
397 * LI:480798.13:2001MAY17 411 557 forward 1 TM Cytosolic
397 LI:480798.13:2001MAY17 558 580 forward 1 TM Transmembrane
397 LI:480798.13:2001MAY17 581 678 forward 1 TM Non-Cytosolic
397 LI:480798.13:2001MAY17 679 701 forward 1 TM Transmembrane
397 LI:480798.13:2001MAY17 702 741 forward 1 TM Cytosolic
397 LI:480798.13:2001MAY17 1 362 forward 2 TM Non-Cytosolic
397 LI:480798.13:2001MAY17 363 380 forward 2 TM Transmembrane
397 LI:480798.13:2001MAY17 381 386 forward 2 TM Cytosolic
397 LI:480798.13:2001MAY17 387 409 forward 2 TM Transmembrane
397 LI:480798.13:2001MAY17 410 418 forward 2 TM Non-Cytosolic
397 LI:480798.13:2001MAY17 419 441 forward 2 TM Transmembrane
397 LI:480798.13:2001MAY17 442 ' 670 forward 2 TM Cytosolic
397 LI:480798.13:2001MAY17 671 693 forward 2 TM Transmembrane
397 LI:480798.13:2001MAY17 694 741 forward 2 TM Non-Cytosolic
397 LI:480798.13:2001MAY17 1 360 forward 3 TM Non-Cytosolic
397 LI:480798.13:2001MAY17 361 380 forward 3 TM Transmembrane
397 LI:480798.13:2001MAY17 381 391 forward 3 TM Cytosolic
397 LI:480798.13:2001MAY17 392 41 1 forward 3 TM Transmembrane TABLE 2
SEQ D NO: Template ID Start Stop Frame Domain Type Topology
397 LI:480798.13:2001MAY17 412 420 forward 3 TM Non-Cytosolic
397 LI:480798.13:2001MAY17 421 443 forward 3 TM Transmembrane
397 LI:480798.13:2001MAY17 444 476 forward 3 TM Cytosolic
397 LI:480798.13:2001MAY17 477 499 forward 3 TM Transmembrane
397 LI:480798.13:2001MAY17 500 559 forward 3 TM Non-Cytosolic
397 LI:480798.13:200.1MAY17 560 579 forward 3 TM Transmembrane
397 LI:480798.13:2001MAY17 580 637 forward 3 TM Cytosolic
397 LI:480798.13:2001MAY17 638 656 forward 3 TM Transmembrane
397 LI:480798.13:2001MAY17 657 670 forward 3 TM Non-Cytosolic
397 LI:480798.13:2001MAY17 671 693 forward 3 TM Transmembrane
397 LI:480798.13:2001MAY17 694 740 forward 3 TM Cytosolic
398 LI:481203.14:2001MAY17 1 160 forward 2 TM Cytosolic 398 LI:481203.14:2001MAY17 161 183 forward 2 TM Transmembrane
398 LI:481203.14:2001MAY17 184 1084 forward 2 TM Non-Cytosolic
399 LI:481237.11:2001MAY17 1 711 forward 2 TM Non-Cytosolic 399 LI:481237.11:2001MAY17 712 731 forward 2 TM Transmembrane 399 LI:481237.11:2001MAY17 732 811 forward 2 TM Cytosolic 399 LL481237.il :2001MAY17 812 831 forward 2 TM Transmembrane
399 LI:481237.11:2001MAY17 832 844 forward 2 TM Non-Cytosolic
400 LI:481368.12:2001MAY17 1 15 forward 2 TM Cytosolic 400 LI:481368.12:2001MAY17 16 38 forward 2 TM Transmembrane
400 LI:481368.12:2001MAY17 39 956 forward 2 TM Non-Cytosolic
401 LI:482301.8:2001MAY17 1 358 forward 1 TM Non-Cytosolic 401 LI:482301.8:2001MAY17 359 381 forward 1 TM Transmembrane 401 LI:482301.8:2001MAY17 382 409 forward 1 TM Cytosolic 401 LI:482301.8:2001MAY17 410 432 forward 1 TM Transmembrane 401 LI:482301.8:2001MAY17 433 589 forward 1 TM Non-Cytosolic 401 LI:482301.8:2001MAY17 590 609 forward 1 TM Transmembrane 401 LI:482301.8:2001MAY17 610 626 forward 1 TM Cytosolic 401 LI:482301.8:2001MAY17 1 361 forward 2 TM Non-Cytosolic 401 LI:482301.8:2001MAY17 362 384 forward 2 TM Transmembrane 401 LI:482301.8:2001MAY17 385 536 forward 2 TM Cytosolic 401 LI:482301.8:2001MAY17 537 559 forward 2 TM Transmembrane 401 LI:482301.8:2001MAY17 560 597 forward 2 TM Non-Cytosolic 401 LI:482301.8:2001MAY17 598 620 forward 2 TM Transmembrane 401 LI:482301.8:2001MAY17 621 625 forward 2 TM Cytosolic 401 LI:482301.8:2001MAY17 1 153 forward 3 TM - Non-Cytosolic 401 L 482301.8:2001MAY17 154 176 forward 3 TM Transmembrane 401 LI:482301.8:2001MAY17 177 333 forward 3 TM Cytosolic 401 LI:482301.8:2001MAY17 334 356 forward 3 TM Transmembrane 401 LL482301.8:2001MAY17 357 360 forward 3 TM Non-Cytosolic 401 LI:482301.8:2001MAY17 361 383 forward 3 TM Transmembrane 401 LI:482301.8:2001MAY17 384 387 forward 3 TM Cytosolic 401 LI:482301.8:2001MAY17 388 410 forward 3 TM Transmembrane
401 LI:482301.8:2001MAY17 411 625 forward 3 TM Non-Cytosolic
402 LI:482482.29:2001MAY17 1 168 forward 1 TM Cytosolic 402 LI:482482.29:2001MAY17 169 191 forward 1 TM Transmembrane 402 LI:482482.29:2001MAY17 192 386 forward 1 TM Non-Cytosolic 402 LI:482482.29:2001MAY17 1 119 forward 3 TM Cytosolic 402 LI:482482.29:2001MAY17 120 142 forward 3 TM Transmembrane
402 LI:482482.29:2001MAY17 143 385 forward 3 TM Non-Cytosolic
403 LI:758877.26:2001MAY17 1 201 forward 1 TM Non-Cytosolic 403 LI:758877.26:2001MAY17 202 224 forward 1 TM Transmembrane 403 LI:758877.26:2001MAY17 225 265 forward 1 TM Cytosolic TABLE 2
SEQ D NO. Template ID Start Stop Frame Domain Type Topology
403 LI:758877.26:2001MAY17 266 288 forward 1 TM Transmembrane
403 LL758877.26.2001MAY17 289 711 forward 1 TM Non-Cytosolic
403 LI:758877.26:2001MAY17 1 205 forward 2 TM Cytosolic
403 LTJ58877.26.2001MAY17 206 228 forward 2 TM Transmembrane
403 LI:758877.26:2001MAY17 229 263 forward 2 TM Non-Cytosolic
403 LI:758877.26:2001MAY17 264 286 forward 2 TM Transmembrane
403 LI:758877.26:2001MAY17 287 290 forward 2 TM Cytosolic
403 LI:758877.26:2001MAY17 291 313 forward 2 TM Transmembrane
403 LI:758877.26:2001MAY17 314 327 forward 2 TM Non-Cytosolic
403 LI:758877.26:2001MAY17 328 350 forward 2 TM Transmembrane
403 LI:758877.26:2001MAY17 351 485 forward 2 TM Cytosolic
403 LI:758877.26:2001MAY17 486 508 forward 2 TM Transmembrane
403 LI:758877.26:2001MAY17 509 586 forward 2 TM Non-Cytosolic
403 LI:758877.26:2001MAY17 587 609 forward 2 TM Transmembrane
403 LI:758877.26:2001MAY17 610 711 forward 2 TM Cytosolic
403 LI:758877.26:2001MAY17 1 490 forward 3 TM Non-Cytosolic
403 LI:758877.26:2001MAY17 491 513 forward 3 TM Transmembrane
403 LI:758877.26:2001MAY17 514 571 forward 3 TM Cytosolic
403 LI:758877.26:2001MAY17 572 594 forward 3 TM Transmembrane
403 LI:758877.26:2001MAY17 595 640 forward 3 TM Non-Cytosolic
403 LI:758877.26:2001MAY17 641 663 forward 3 TM Transmembrane
403 LI:758877.26:2001MAY17 664 710 forward 3 TM Cytosolic
404 LI:791042.1:2001MAY17 1 455 forward 3 TM Non-Cytosolic
404 LI:791042.1:2001MAY17 456 478 forward 3 TM Transmembrane
404 LI:791042.1:2001MAY17 479 497 forward 3 TM Cytosolic
404 LI:791042.1:2001MAY17 ' 498 520 forward 3 TM Transmembrane
404 LI:791042.1 :2001MAY17 521 550 forward 3 TM Non-Cytosolic
405 LI:808999.26:2001MAY17 1 1475 forward 3 TM Non-Cytosolic
405 LI:808999.26:2001MAY17 1476 1498 forward 3 TM Transmembrane
405 LI:808999.26:2001MAY17 1499 1523 forward 3 TM Cytosolic
405 LI:808999.26:2001MAY17 1524 1546 forward 3 TM Transmembrane
405 LI:808999.26:2001MAY17 1547 1565 forward 3 TM Non-Cytosolic
405 LI:808999.26:2001MAY17 1566 1588 forward 3 TM Transmembrane
405 LI:808999.26:2001MAY17 1589 1846 forward 3 TM Cytosolic
406 LI:815715.10:2001MAY17 1 355 forward 1 TM Non-Cytosolic
406 LI:815715.10:2001MAY17 356 378 forward 1 TM Transmembrane
406 LI:815715.10:2001MAY17 379 387 forward 1 TM Cytosolic
406 LI:815715.10:2001MAY17 1 14 forward 2 TM Non-Cytosolic
406 LI:815715.10:2001MAY17 15 37 forward 2 TM Transmembrane
406 LI:815715.10:2001MAY17 38 305 forward 2 TM Cytosolic
406 LI:815715.10:2001MAY17 306 328 forward 2 TM Transmembrane
406 LI:815715.10:2001MAY17 329 337 forward 2 TM Non-Cytosolic
406 LI:815715.10:2001MAY17 338 360 forward 2 TM Transmembrane
406 LI:815715.10:2001MAY17 361 366 forward 2 TM Cytosolic
406 LI:815715.10:2001MAY17 367 384 forward 2 TM Transmembrane
406 LI:815715.10:2001MAY17 385 386 forward 2 TM Non-Cytosolic
406 LI:815715.10:2001MAY17 1 92 forward 3 TM Cytosolic
406 LI:815715.10:2001MAY17 93 115 forward 3 TM Transmembrane
406 LI:815715.10:2001MAY17 116 358 forward 3 TM Non-Cytosolic
406 LI:815715.10:2001MAY17 359 381 forward 3 TM Transmembrane
406 LI:815715.10:2001MAY17 382 386 forward 3 TM Cytosolic
407 LI:902980.16:2001MAY17 1 448 forward 1 TM Non-Cytosolic
407 LI:902980.16:2001MAY17 449 471 forward 1 TM Transmembrane
407 LI:902980.16:2001MAY17 472 553 forward 1 TM Cytosolic TABLE 2
SEQ D NO: Template ID Start Stop Frame Domain Type Topology
407 LI:902980.16:2001MAY17 554 576 forward 1 TM Transmembrane
407 LI:902980.16:2001MAY17 577 585 forward 1 TM Non-Cytosolic
407 LI:902980.16:2001MAY17 586 608 forward 1 TM Transmembrane
407 LI:902980.16:2001MAY17 609 655 forward 1 TM Cytosolic
407 LI:902980.16:2001MAY17 656 678 forward 1 TM Transmembrane
407 LI:902980.16:2001MAY17 679 1196 forward 1 TM Non-Cytosolic
407 LI:902980.16:2001MAY17 1 415 forward 2 TM Non-Cytosolic
407 LI:902980.16:2001MAY17 416 438 forward 2 TM Transmembrane
407 LI:902980.16:2001MAY17 439 559 forward 2 TM Cytosolic
407 LI:902980.16:2001MAY17 560 582 forward 2 TM Transmembrane
407 LI:902980.16:2001MAY17 583 596 forward 2 TM Non-Cytosolic
407 LI:902980.16:2001MAY17 597 619 forward 2 TM Transmembrane
407 LI:902980.16:2001MAY17 620 639 forward 2 TM Cytosolic
407 LI:902980.16:2001MAY17 640 662 forward 2 TM Transmembrane
407 LI:902980.16:2001MAY17 663 699 forward 2 TM Non-Cytosolic
407 LI:902980.16:2001MAY17 700 721 forward 2 TM Transmembrane
407 LI:902980.16:2001MAY17 722 816 forward 2 TM Cytosolic
407 LI:902980.16:2001MAY17 817 834 forward 2 TM Transmembrane
407 LI:902980.16:2001MAY17 835 853 forward 2 TM Non-Cytosolic
407 LI:902980.16:2001MAY17 854 876 forward 2 TM Transmembrane
407 LI:902980.16:2001MAY17 877 882 forward 2 TM Cytosolic
407 LI:902980.16:2001MAY17 883 905 forward 2 TM Transmembrane
407 LI:902980.16:2001MAY17 906 1196 forward 2 TM Non-Cytosolic
407 LI:902980.16:2001MAY17 1 558 forward 3 TM Non-Cytosolic
407 LI:902980.16:2001MAY17 559 581 forward 3 TM Transmembrane
407 LI:902980.16:2001MAY17 582 655 forward 3 TM Cytosolic
407 LI:902980.16:2001MAY17 656 678 forward 3 TM Transmembrane
407 LI:902980.16:2001MAY17 679 840 forward 3 TM Non-Cytosolic
407 LI:902980.16:2001MAY17 841 863 forward 3 TM Transmembrane
407 LI:902980.16:2001MAY17 864 869 forward 3 TM Cytosolic
407 LI:902980.16:2001MAY17 870 892 forward 3 TM Transmembrane
407 LI:902980.16:2001MAY17 893 1002 forward 3 TM Non-Cytosolic
407 LI:902980.16:2001MAY17 1003 1025 forward 3 TM Transmembrane
407 LI:902980.16:2001MAY17 1026 1044 forward 3 TM Cytosolic
407 LI:902980.16:2001MAY17 1045 1067 forward 3 TM Transmembrane
407 LI:902980.16:2001MAY17 1068 1196 forward 3 TM Non-Cytosolic
408 LI:903196.25:2001MAY17 1 829 forward 2 TM Non-Cytosolic
408 LI:903196.25:2001MAY17 830 852 forward 2 TM Transmembrane
408 LI:903196.25:2001MAY17 853 864 forward 2 TM Cytosolic
408 LI:903196.25:2001MAY17 865 884 forward 2 TM Transmembrane
408 LI:903196.25:2001MAY17 885 920 forward 2 TM Non-Cytosolic
408 LI:903196.25:2001MAY17 921 943 forward 2 TM Transmembrane
408 LI:903196.25:2001MAY17 944 1224 forward 2 TM Cytosolic
409 LI:903914.10:2001MAY17 1 415 forward 2 TM Non-Cytosolic
409 LI:903914.10:2001MAY17 416 435 forward 2 TM Transmembrane
409 LI:903914.10:2001MAY17 436 664 forward 2 TM Cytosolic
409 LI:903914.10:2001MAY17 665 687 forward 2 TM Transmembrane
409 LI:903914.10:2001MAY17 688 701 forward 2 TM Non-Cytosolic
409 LL903914.10:2001 MAY17 702 724 forward 2 TM Transmembrane
409 L 903914.10:200 IMAY 17 725 743 forward 2 TM Cytosolic
409 LI:903914.10:2001MAY17 744 766 forward 2 TM Transmembrane
409 LI:903914.10:2001MAY17 767 1664 forward 2 TM Non-Cytosolic
409 LI:903914.10:2001MAY17 1 668 forward 3 TM Non-Cytosolic
409 LI:903914.10:2001MAY17 669 691 forward 3 TM Transmembrane TABLE 2
SEQ D NO: Template ID Start Stop Frame Domain Type Topology
409 LL903914.10.2001MAY17 692 841 forward 3 TM Cytosolic
409 LL903914.10.2001MAY17 842 864 forward 3 TM Transmembrane
409 LI:903914.10:2001MAY17 865 1579 forward 3 TM Non-Cytosolic
409 LI:903914.10:2001MAY17 1580 1602 forward 3 TM Transmembrane
409 LI:903914.10:2001MAY17 1603 1663 forward 3 TM Cytosolic
410 LG:006764.2:2001JUN22 1 139 forward 1 TM Cytosolic
410 LG:006764.2:2001JUN22 140 162 forward 1 TM Transmembrane
410 LG:006764.2:2001JUN22 163 181 forward 1 TM Non-Cytosolic
410 LG:006764.2:2001JUN22 182 204 forward 1 TM Transmembrane
410 LG:006764.2:2001JUN22 205 479 forward 1 TM Cytosolic
410 LG:006764.2:2001JUN22 480 502 forward 1 TM Transmembrane
410 LG:006764.2:2001JUN22 503 511 forward 1 TM Non-Cytosolic
410 LG:006764.2:2001JUN22 512 534 forward 1 TM Transmembrane
410 LG:006764.2:2001JUN22 535 539 forward 1 TM Cytosolic
410 LG:006764.2:2001JUN22 1 441 forward 2 TM Non-Cytosolic
410 LG:006764.2:2001JUN22 442 464 forward 2 TM Transmembrane
410 LG:006764.2:2001JUN22 465 484 forward 2 TM Cytosolic
410 LG:006764.2:2001JUN22 485 507 forward 2 TM Transmembrane
410 LG:006764.2:2001JUN22 508 538 forward 2 TM Non-Cytosolic
410 LG:006764.2:2001JUN22 1 86 forward 3 TM Non-Cytosolic
410 LG:006764.2:2001JUN22 87 109 forward 3 TM Transmembrane
410 LG:006764.2:2001JUN22 110 142 forward 3 TM Cytosolic
410 LG:006764.2:2001JUN22 143 165 forward 3 TM Transmembrane
410 LG:006764.2:2001JUN22 166 184 forward 3 TM Non-Cytosolic
410 LG:006764.2:2001JUN22 185 207 forward 3 TM Transmembrane
410 LG:006764.2:2001JUN22 208 472 forward 3 TM Cytosolic
410 LG:006764.2:2001JUN22 473 495 forward 3 TM Transmembrane
410 LG:006764.2:2001JUN22 496 509 forward 3 TM Non-Cytosolic
410 LG:006764.2:2001JUN22 510 532 forward 3 TM Transmembrane
410 LG:006764.2:2001JUN22 533 538 forward 3 TM Cytosolic
411 LG:014704.8:2001JUN22 1 30 forward 1 TM Non-Cytosolic
411 LG:014704.8:2001JUN22 31 53 forward 1 TM Transmembrane
411 LG:014704.8:2001JUN22 54 72 forward 1 TM Cytosolic
411 LG:014704.8:2001JUN22 73 95 forward 1 TM Transmembrane
411 LG:014704.8:2001JUN22 96 467 forward 1 TM Non-Cytosolic
411 LG:014704.8:2001JUN22 468 485 forward 1 TM Transmembrane
411 LG:014704.8:2001JUN22 486 517 forward 1 TM Cytosolic
411 LG:014704.8:2001JUN22 518 540 forward 1 TM Transmembrane
411 LG:014704.8:2001JUN22 541 568 forward 1 TM Non-Cytosolic
411 LG:014704.8:2001JUN22 569 591 forward 1 TM Transmembrane
411 LG:014704.8:2001JUN22 592 647 forward 1 TM Cytosolic
411 LG:014704.8:2001JUN22 1 505 forward 2 TM Non-Cytosolic
411 LG:014704.8:2001JUN22 506 523 forward 2 TM Transmembrane
411 LG:014704.8:2001JUN22 524 560 forward 2 TM Cytosolic
411 LG:014704.8:2001JUN22 561 583 forward 2 TM Transmembrane
411 LG:014704.8:2001JUN22 584 646 forward 2 TM Non-Cytosolic
411 LG:014704.8:2001JUN22 1 133 forward 3 TM Cytosolic
411 LG:014704.8:2001JUN22 134 151 forward 3 TM Transmembrane
411 LG:014704.8:2001JUN22 152 165 forward 3 TM Non-Cytosolic
411 LG:014704.8:2001JUN22 166 184 forward 3 TM Transmembrane
411 LG:014704.8:2001JUN22 185 196 forward 3 TM Cytosolic
411 LG:014704.8:2001JUN22 197 219 forward 3 TM Transmembrane
411 LG:014704.8:2001JUN22 220 233 forward 3 TM Non-Cytosolic
411 LG:014704.8:2001JUN22 234 256 forward 3 TM Transmembrane TABLE 2
SEQ D NO: Template ID Start Stop Frame Domain Type Topology
411 LG:014704.8:2001JUN22 257 305 forward 3 TM Cytosolic
411 LG:014704.8:200UUN22 306 328 forward 3 TM Transmembrane
411 LG:014704.8:2001JUN22 329 350 forward 3 TM Non-Cytosolic
411 LG:014704.8:2001JUN22 351 373 forward 3 TM Transmembrane
411 LG:014704.8:2001JUN22 374 393 forward 3 TM Cytosolic
411 LG:014704.8:2001JUN22 394 413 forward 3 TM Transmembrane
411 LG:014704.8:2001JUN22 414 467 forward 3 TM Non-Cytosolic
411 LG:014704.8:2001JUN22 468 485 forward 3 TM Transmembrane
411 LG:014704.8:2001JUN22 486 491 forward 3 TM Cytosolic
411 LG:014704.8:2001JUN22 492 514 forward 3 TM Transmembrane
411 LG:014704.8:2001JUN22 515 564 forward 3 TM Non-Cytosolic
411 LG:014704.8:2001JUN22 565 584 forward 3 TM Transmembrane
411 LG:014704.8:2001JUN22 585 646 forward 3 TM Cytosolic
412 LG: 1447607.7:2001 JUN22 1 72 forward 1 TM Cytosolic
412 LG: 1447607.7:2001 JUN22 73 95 forward 1 TM Transmembrane
412 LG: 1447607.7:2001 JUN22 96 336 forward 1 TM Non-Cytosolic
412 LG: 1447607.7:2001 JUN22 337 359 forward 1 TM Transmembrane
412 LG: 1447607.7:2001 JUN22 360 406 forward 1 TM Cytosolic
412 LG: 1447607.7:2001 JUN22 407 429 forward 1 TM Transmembrane
412 LG: 1447607.7:2001 JUN22 430 760 forward 1 TM Non-Cytosolic
412 LG: 1447607.7:2001JUN22 1 20 forward 2 TM Cytosolic
412 LG: 1447607.7:2001 JUN22 21 43 forward 2 TM Transmembrane
412 LG: 1447607.7:2001JUN22 44 72 forward 2 TM Non-Cytosolic
412 LG: 1447607.7:2001 JUN22 73 92 forward 2 TM Transmembrane
412 LG:1447607.7:2001JUN22 93 276 forward 2 TM Cytosolic
412 LG: 1447607.7:2001 JUN22 277 299 forward 2 TM Transmembrane
412 LG: 1447607.7:2001 JUN22 300 323 forward 2 TM Non-Cytosolic
412 LG: 1447607.7:2001 JUN22 324 346 forward 2 TM Transmembrane
412 LG:1447607.7:2001JUN22 347 407 forward 2 TM Cytosolic
412 LG: 1447607.7:2001 JUN22 408 430 forward 2 TM Transmembrane
412 LG:1447607.7:2001JUN22 431 449 forward 2 TM Non-Cytosolic
412 LG: 1447607.7:2001 JUN22 450 472 forward 2 TM Transmembrane
412 LG: 1447607.7:2001 JUN22 473 694 forward 2 TM Cytosolic
412 LG: 1447607.7:2001JUN22 695 717 forward 2 TM Transmembrane
412 LG: 1447607.7:2001 JUN22 718 759 forward 2 TM Non-Cytosolic
412 LG: 1447607.7:2001 JUN22 1 19 forward 3 TM Cytosolic
412 LG: 1447607.7:2001JUN22 20 39 forward 3 TM Transmembrane
412 LG:1447607.7:2001JUN22 40 334 forward 3 TM Non-Cytosolic
412 LG: 1447607.7:2001 JUN22 335 357 forward 3 TM Transmembrane
412 LG: 1447607.7:2001 JUN22 358 381 forward 3 TM Cytosolic
412 LG: 1447607.7:2001JUN22 382 404 forward 3 TM Transmembrane
412 LG: 1447607.7:2001 JUN22 405 423 forward 3 TM Non-Cytosolic
412 LG: 1447607.7:2001 JUN22 424 446 forward 3 TM Transmembrane
412 LG:1447607.7:2001JUN22 447 699 forward 3 TM Cytosolic
412 LG: 1447607.7:2001 JUN22 700 722 forward 3 TM Transmembrane
.412 LG:1447607.7:2001JUN22 723 759 forward 3 TM Non-Cytosolic
413 LG: 1455032.3:2001 JUN22 1 151 forward 1 TM Cytosolic
413 LG:1455032.3:2001JUN22 152 174 forward 1 TM Transmembrane
413 LG: 1455032.3:2001JUN22 175 244 forward 1 TM Non-Cytosolic
413 LG:1455032.3:2001JUN22 245 264 forward 1 TM Transmembrane
413 LG:1455032.3:2001JUN22 265 396 forward 1 TM Cytosolic
413 LG: 1455032.3:2001 JUN22 1 134 forward 2 TM Cytosolic
413 LG:1455032.3:2001JUN22 135 157 forward 2 TM Transmembrane
413 LG:1455032.3:2001JUN22 158 166 forward 2 TM Non-Cytosolic TABLE 2
SEQ D NO: Template ID Start Stop Frame Domain Type Topology
413 LG: 1455032.3:2001 JUN22 167 184 forward 2 TM Transmembrane
413 LG: 1455032.3:2001 JUN22 185 396 forward 2 TM Cytosolic
413 LG: 1455032.3:2001 JUN22 1 164 forward 3 TM Cytosolic
413 LG:1455032.3:2001JUN22 165 187 forward 3 TM Transmembrane
413 LG: 1455032.3:2001 JUN22 188 274 forward 3 TM Non-Cytosolic
413 LG:1455032.3:2001JUN22 275 297 forward 3 TM Transmembrane
413 LG: 1455032.3:2001 JUN22 298 395 forward 3 TM Cytosolic
414 LG: 1501898.18:2001 JUN22 1 6 forward 3 TM Cytosolic
414 LG:1501898.18:2001JUN22 7 29 forward 3 TM Transmembrane
414 LG:1501898.18:2001JUN22 30 357 forward 3 TM Non-Cytosolic
415 LG:1502692.5:2001JUN22 1 178 forward 1 TM Non-Cytosolic
415 LG: 1502692.5 :2001 JUN22 179 201 forward 1 TM Transmembrane
415 LG: 1502692.5:2001 JUN22 202 213 forward 1 TM Cytosolic
415 LG:1502692.5:2001JUN22 214 236 forward 1 TM Transmembrane
415 LG:1502692.5:2001JUN22 237 255 forward 1 TM Non-Cytosolic
415 LG:1502692.5:2001JUN22 ' 256 273 forward 1 TM Transmembrane
415 LG:1502692.5:2001JUN22 274 327 forward 1 TM Cytosolic
415 LG: 1502692.5 :2001JUN22 328 347 forward 1 TM Transmembrane
415 LG:1502692.5:2001JUN22 348 359 forward 1 TM Non-Cytosolic
415 LG: 1502692.5:2001 JUN22 1 129 forward 2 TM Cytosolic
415 LG: 1502692.5:2001 JUN22 130 152 forward 2 TM Transmembrane
415 LG:1502692.5:2001JUN22 153 224 forward 2 TM Non-Cytosolic
415 LG: 1502692.5:2001 JUN22 225 247 forward 2 TM Transmembrane
415 LG: 1502692.5:2001 JUN22 248 258 forward 2 TM Cytosolic
415 LG:1502692.5:2001JUN22 259 276 forward 2 TM Transmembrane
- 415 LG:1502692.5:2001JUN22 277 330 forward 2 TM Non-Cytosolic
415 LG:1502692.5:2001JUN22 331 350 forward 2 TM Transmembrane
415 LG:1502692.5:2001JUN22 351 359 forward 2 TM Cytosolic
415 LG: 1502692.5:2001 JUN22 1 44 forward 3 TM Cytosolic
415 LG:1502692.5:2001JUN22 45 67 forward 3 TM Transmembrane
415 LG:1502692.5:2001JUN22 68 166 forward 3 TM Non-Cytosolic
415 LG: 1502692.5:2001 JUN22 167 189 forward 3 TM Transmembrane
415 LG: 1502692.5 :2001 JUN22 190 209 forward 3 TM Cytosolic
415 LG: 1502692.5 :2001 JUN22 210 232 forward 3 TM Transmembrane
415 LG: 1502692.5:2001 JUN22 233 358 forward 3 TM Non-Cytosolic
416 LG:208949.8:2001JUN22 1 177 forward 1 TM Cytosolic
416 LG:208949.8:2001JUN22 178 200 forward 1 TM Transmembrane
416 LG:208949.8:2001JUN22 201 219 forward 1 TM Non-Cytosolic
416 LG:208949.8:2001JUN22 220 237 forward 1 TM Transmembrane
416 LG:208949.8:2001JUN22 238 253 forward 1 TM Cytosolic
416 LG:208949.8:2001JUN22 1 161 forward 2 TM Cytosolic
416 LG:208949.8:2001JUN22 162 184 forward 2 TM Transmembrane
416 LG:208949.8:2001JUN22 185 253 forward 2 TM Non-Cytosolic
416 LG:208949.8:2001JUN22 1 223 forward 3 TM Cytosolic
416 LG:208949.8:2001JUN22 224 246 forward 3 TM Transmembrane
416 LG:208949.8:2001JUN22 247 252 forward 3 TM Non-Cytosolic
417 LG:240501.10:2001 JUN22 1 112 forward 1 TM Cytosolic
417 LG:240501.10:2001JUN22 113 135 forward 1 TM Transmembrane
417 LG:240501.10:2001JUN22 136 138 forward 1 TM Non-Cytosolic
417 LG:240501.10:2001JUN22 139 161 forward 1 TM Transmembrane
417 LG:240501.10:2001JUN22 162 167 forward 1 TM Cytosolic
417 LG:240501.10:2001JUN22 168 185 forward 1 TM Transmembrane
417 LG.240501.10:2001JUN22 186 215 forward 1 TM Non-Cytosolic
417 LG:240501.10:2001JUN22 216 235 forward 1 TM Transmembrane TABLE 2
SEQ D NO: Template ID Start Stop Frame Domain Type Topology
417 LG:240501.10:2001JUN22 236 241 forward 1 TM Cytosolic
417 LG.240501.10:2001JUN22 242 264 forward 1 TM Transmembrane
417 LG:240501.10:2001JUN22 265 267 forward 1 TM Non-Cytosolic
417 LG:240501.10:2001JUN22 268 290 forward 1 TM Transmembrane
417 ' LG:240501.10:2001JUN22 291 413 forward 1 TM Cytosolic
417 LG:240501.10:2001JUN22 1 106 forward 2 TM Cytosolic
417 LG:240501.10:2001JUN22 107 129 forward 2 TM Transmembrane
417 LG:240501.10:2001JUN22 130 138 forward 2 TM Non-Cytosolic
417 LG:240501.10:2001JUN22 139 161 forward 2 TM Transmembrane
417 LG:240501.10:2001JUN22 162 215 forward 2 TM Cytosolic
417 LG:240501.10:2001JUN22 216 233 forward 2 TM Transmembrane
417 LG:240501.10:2001JUN22 234 413 forward 2 TM Non-Cytosolic
417 LG:240501.10:2001JUN22 1 67 forward 3 TM Cytosolic
417 LG:240501.10:2001JUN22 68 90 forward 3 TM Transmembrane
417 LG:240501.10:2001 JUN22 91 109 forward 3 TM Non-Cytosolic
417 LG:240501.10:2001JUN22 no 132 forward 3 TM Transmembrane
417 LG:240501.10:2001 JUN22 133 138 forward 3 TM Cytosolic
417 LG:240501.10:2001JUN22 139 161 forward 3 TM Transmembrane
417 LG:240501.10:2001JUN22 162 215 forward 3 TM Non-Cytosolic
417 LG:240501.10:2001JUN22 216 234 forward 3 TM Transmembrane
417 LG:240501.10:2001 JUN22 235 240 forward 3 TM Cytosolic
417 LG:240501.10:2001JUN22 241 263 forward 3 TM Transmembrane
417 LG:240501.10:2001JUN22 264 322 forward 3 TM Non-Cytosolic
417 . LG:240501.10:2001JUN22 323 345 forward 3 TM Transmembrane
417. LG:240501.10:2001IUN22 346 412 forward 3 TM Cytosolic
. 418 LG:329228.27:2001JUN22 1 261 forward 1 TM Non-Cytosolic
418 LG:329228.27:2001JUN22 262 284 forward 1 TM Transmembrane
418 LG:329228.27:2001JUN22 285 290 forward 1 TM Cytosolic
418 LG:329228.27:2001JUN22 291 313 forward 1 TM Transmembrane
418 LG:329228.27:2001 JUN22 314 509 forward 1 TM Non-Cytosolic
418 LG:329228.27:2001JUN22 1 263 forward 2 TM Cytosolic
418 LG:329228.27:2001 JUN22 264 286 forward 2 TM Transmembrane
418 LG:329228.27:2001JUN22 287 509 forward 2 TM Non-Cytosolic
418 LG:329228.27:2001JUN22 1 220 forward 3 TM Non-Cytosolic
418 LG:329228.27:2001JUN22 221 243 forward 3 TM Transmembrane
418 LG:329228.27:2001JUN22 244 254 forward 3 TM Cytosolic
418 LG:329228.27:2001JUN22 255 274 forward 3 TM Transmembrane
418 LG:329228.27:2001JUN22 275 508 forward 3 TM Non-Cytosolic
419 LG:337056.11:2001JUN22 1 20 forward 2 TM Cytosolic
419 LG:337056.11:2001 JUN22 21 43 forward 2 TM Transmembrane
419 LG:337056.11:2001 JUN22 44 62 forward 2 TM Non-Cytosolic
419 LG:337056.11:2001JUN22 63 85 forward 2 TM Transmembrane
419 LG:337056.11:2001 JUN22 86 131 forward 2 TM Cytosolic
419 LG:337056.11 :2001 JUN22 132 154 forward 2 TM Transmembrane
419 LG:337056.11 :2001 JUN22 155 227 forward 2 TM Non-Cytosolic
420 LG:346663.9:2001JUN22 1 303 forward 1 TM Non-Cytosolic
420 LG:346663.9:2001JUN22 304 326 forward 1 TM Transmembrane
420 LG:346663.9:2001JUN22 327 337 forward 1 TM Cytosolic
420 LG:346663.9:2001JUN22 338 360 forward 1 TM Transmembrane
' 420 LG:346663.9:2001JUN22 361 388 forward 1 TM Non-Cytosolic
420 LG:346663.9:2001JUN22 389 406 forward 1 TM Transmembrane
420 LG:346663.9:2001JUN22 407 417 forward 1 TM Cytosolic
420 LG:346663.9:2001JUN22 418 440 forward 1 TM Transmembrane
420 LG:346663.9:2001JUN22 441 445 forward 1 TM Non-Cytosolic TABLE 2
SEQ D NO: Template ID Start Stop Frame Domain Type Topology
420 LG:346663.9:2001JUN22 1 310 forward 2 TM Non-Cytosolic
420 LG:346663.9:2001JUN22 311 333 forward 2 TM Transmembrane
420 LG:346663.9:2001JUN22 334 445 forward 2 TM . Cytosolic
420 LG:346663.9':2001JUN22 1 302 forward 3 TM Cytosolic
420 LG:346663.9:2001JUN22 303 325 forward 3 TM Transmembrane
420 LG:346663.9:2001JUN22 326 334 forward 3 TM Non-Cytosolic
420 LG:346663.9:2001JUN22 335 357 forward 3 TM Transmembrane
420 LG:346663.9:2001JUN22 358 363 forward 3 ' TM Cytosolic
420 LG:346663.9:2001JUN22 364 386 forward 3 TM Transmembrane
420 LG:346663.9:2001JUN22 387 400 forward 3 TM Non-Cytosolic
420 LG:346663.9:2001JUN22 401 423 forward 3 TM Transmembrane
420 LG:346663.9:2001JUN22 424 445 forward 3 TM Cytosolic
421 LG:7685586.2:2001JUN22 1 152 forward 1 TM Non-Cytosolic
421 LG:7685586.2:2001JUN22 153 175 forward 1 TM Transmembrane
421 LG:7685586.2:2001JUN22 176 195 forward 1 TM Cytosolic
421 LG:7685586.2:2001JUN22 1 142 forward 3 TM Cytosolic
421 LG:7685586.2:2001JUN22 143 165 forward 3 TM Transmembrane
421 LG:7685586.2:2001JUN22 166 194 forward 3 TM Non-Cytosolic
422 LG.-407730.13:2001JUN22 1 14 forward 1 TM Non-Cytosolic
422 LG:407730.13 :2001 JUN22 15 34 forward 1 TM Transmembrane
422 LG:407730.13 :2001 JUN22 35 163 forward 1 TM Cytosolic
422 LG:407730.13:2001JUN22 1 14 forward 3 TM Non-Cytosolic
422 LG:407730.13:2001JUN22 15 37 forward 3 TM Transmembrane
422 LG:407730.13:2001 JUN22 38 162 forward 3 TM Cytosolic
423 LG:025465.5:2001JUN22 1 421 forward 1 TM Non-Cytosolic
423 LG.O25465.5 :2001 JUN22 422 444 forward 1 TM Transmembrane
423 LG:025465.5:2001JUN22 445 500 forward 1 TM Cytosolic
423 LG:025465.5:2001JUN22 501 523 forward 1 TM Transmembrane
423 LG:025465.5:2001JUN22 524 708 forward 1 TM Non-Cytosolic
424 LG:054509.14:2001 JUN22 1 432 forward 1 TM Non-Cytosolic
424 LG:054509.14:2001JUN22 433 455 forward 1 TM Transmembrane
424 LG:054509.14:2001 JUN22 456 567 forward 1 TM Cytosolic
424 LG:054509.14:2001JUN22 568 590 forward 1 TM Transmembrane
424 LG:054509.14:2001 JUN22 591 642 forward 1 TM Non-Cytosolic
424 LG:054509.14:2001JUN22 643 665 forward 1 TM Transmembrane
424 LG:054509.14:2001 JUN22 666 717 forward 1 TM Cytosolic
424 LG:054509.14:2001JUN22 718 740 forward 1 TM Transmembrane
424 LG:054509.14:2001 JUN22 741 752 forward 1 TM Non-Cytosolic
424 LG:054509.14:2001 JUN22 753 775 forward 1 TM Transmembrane
424 LG:054509.14:2001JUN22 776 938 forward 1 TM Cytosolic
424 LG:054509.14:2001 JUN22 939 961 forward 1 TM Transmembrane
424 LG:054509.14:2001 JUN22 962 975 forward 1 TM Non-Cytosolic
424 LG:054509.14:2001JUN22 976 998 forward 1 TM Transmembrane
424 LG:054509.14:2001JUN22 999 1004 forward 1 TM Cytosolic
424 LG:054509.14:2001 JUN22 1005 1027 forward 1 TM Transmembrane
424 LG:054509.14:2001 JUN22 1028 1066 forward 1 TM Non-Cytosolic
424 LG:054509.14:2001JUN22 1067 1089 forward 1 TM Transmembrane
424 LG:054509.14:2001 JUN22 1090 1134 forward 1 TM Cytosolic
424 LG:054509.14:2001JUN22 1 2 forward 2 TM Cytosolic
424 LG:054509.14:2001JUN22 3 20 forward 2 TM Transmembrane
424 LG.O54509.14:2001 JUN22 21 61 forward 2 TM Non-Cytosolic
424 LG:054509.14:2001JUN22 62 84 forward 2 TM Transmembrane
424 LG:054509.14:2001 JUN22 85 90 forward 2 TM Cytosolic
424 LG:054509.14:2001JUN22 91 113 forward 2 TM Transmembrane TABLE 2
SEQ D NO: Template ID Start Stop Frame Domain Type Topology
424 LG:054509.14:2001JUN22 114 188 forward 2 TM Non-Cytosolic
424 LG:054509.14:2001JUN22 189 206 forward 2 TM Transmembrane
424 LG:054509.14:2001JUN22 207 466 forward 2 TM Cytosolic
424 LG:054509.14:2001JUN22 467 489 forward 2 TM Transmembrane
424 LG:054509.14:2001JUN22 490 737 forward 2 TM Non-Cytosolic
424 LG:054509.14:2001JUN22 738 760 forward 2 TM Transmembrane
424 LG:054509.14:2001 JUN22 761 813 forward 2 TM Cytosolic
424 LG:054509.14:2001JUN22 814 833 forward 2 TM Transmembrane
424 LG:054509.14:2001 JUN22 834 842 forward 2 TM Non-Cytosolic
424 LG:054509.14:2001JUN22 843 865 forward 2 TM Transmembrane
424 LG:054509.14:2001 JUN22 866 946 forward 2 TM Cytosolic
424 LG:054509.14:2001 JUN22 947 969 forward 2 TM Transmembrane
424 LG:054509.14:2001JUN22 970 1004 forward 2 TM Non-Cytosolic
424 LG:054509.14:2001 JUN22 1005 1027 forward 2 TM Transmembrane
424 LG:054509.14:2001 JUN22 1028 1066 forward 2 TM Cytosolic
424 LG:054509.14:2001JUN22 1067 1089 forward 2 TM Transmembrane
424 LG:054509.14:2001JUN22 1090 1134 forward 2 TM Non-Cytosolic
424 LG:054509.14:2001 JUN22 1 435 forward 3 TM Non-Cytosolic
424 LG:054509.14:2001 JUN22 436 454 forward 3 TM Transmembrane
424 LG:054509.14:2001JUN22 455 466 forward 3 TM Cytosolic
424 LG:054509.14:2001JUN22 467 489 forward 3 TM Transmembrane
424 LG:054509.14:2001 JUN22 490 503 forward 3 TM Non-Cytosolic
424 LG:054509.14:2001 JUN22 504 523 forward 3 TM Transmembrane
424 LG:054509.14:2001 JUN22 524 717 forward 3 TM Cytosolic
424 LG:054509.14:2001 JUN22 718 740 forward 3 TM Transmembrane
424 LG:054509.14:2001JUN22 741 1133 forward 3 TM Non-Cytosolic
425 LG:1067876.1:2001JUN22 1 105 forward 2 TM Non-Cytosolic
425 LG: 1067876.1 :2001 JUN22 106 128 forward 2 TM Transmembrane
425 LG:1067876.1:2001JUN22 129 215 forward 2 TM Cytosolic
426 LG:1327699.55:2001JUN22 1 32 forward 1 TM Cytosolic
426 LG:1327699.55:2001JUN22 33 55 forward 1 TM Transmembrane
426 LG:1327699.55:2001JUN22 56 64 forward 1 TM Non-Cytosolic
426 LG:1327699.55:2001JUN22 65 87 forward 1 TM Transmembrane
426 LG: 1327699.55 :2001 JUN22 88 90 forward 1 TM Cytosolic
427 LG:1482904.10:2001JUN22 1 323 forward 1 TM Non-Cytosolic
427 LG: 1482904.10:2001 JUN22 324 341 forward 1 TM Transmembrane
427 LG:1482904.10:2001JUN22 342 420 forward 1 TM Cytosolic
427 LG: 1482904.10:2001 JUN22 421 443 forward 1 TM Transmembrane
427 LG: 1482904.10:2001 JUN22 444 849 forward 1 TM Non-Cytosolic
427 LG:1482904.10:2001JUN22 850 869 forward 1 TM Transmembrane
427 LG: 1482904.10:2001 JUN22 870 1015 forward 1 TM Cytosolic
427 LG: 1482904.10:2001 JUN22 1 959 forward 2 TM Non-Cytosolic
427 LG:1482904.10:2001JUN22 960 982 forward 2 TM Transmembrane
427 LG: 1482904.10:2001 JUN22 983 1014 forward 2 TM Cytosolic
427 LG: 1482904.10:2001 JUN22 1 676 forward 3 TM Non-Cytosolic
427 LG:1482904.10:2001JUN22 677 699 forward 3 TM Transmembrane
427 LG:1482904.10:2001JUN22 700 918 forward 3 TM Cytosolic
427 LG:1482904.10:2001JUN22 919 941 forward 3 TM Transmembrane
427 LG: 1482904.10:2001 JUN22 942 960 forward 3 TM Non-Cytosolic
427 LG:1482904.10:2001JUN22 961 983 forward 3 TM Transmembrane
427 LG:1482904.10:2001IUN22 984 1014 forward 3 TM Cytosolic
428 LG:222317.4:2001JUN22 1 4 forward 2 TM Cytosolic
428 LG:222317.4:2001JUN22 5 27 forward 2 TM Transmembrane
428 LG:222317.4:2001JUN22 28 85 forward 2 TM Non-Cytosolic TABLE 2
SEQ D NO: Template ID Start Stop Frame Domain Type Topology
428 LG:222317.4:2001JUN22 1 23 forward 3 TM Non-Cytosolic
428 LG:222317.4:2001JUN22 24 46 forward 3 TM Transmembrane
428 LG:222317.4:2001JUN22 47 84 forward 3 TM Cytosolic
429 LG:332701.3:2001 JUN22 1 1342 forward 1 TM Non-Cytosolic
429 LG:332701.3:2001 JUN22 1343 1365 forward 1 TM Transmembrane
429 LG:332701.3:2001JUN22 1366 1542 forward 1 TM . Cytosolic
429 LG:332701.3:2001 JUN22 1 125 forward 2 TM Non-Cytosolic
429 LG:332701.3:2001 JUN22 126 148 forward 2 TM Transmembrane
429 LG:332701.3:2001 JUN22 149 178 forward 2 TM Cytosolic
429 LG:332701.3:2001JUN22 179 201 forward 2 TM Transmembrane
429 LG:332701.3:2001JUN22 202 224 forward 2 TM Non-Cytosolic
429 LG:332701.3:2001 JUN22 225 247 forward 2 TM Transmembrane
429 LG:332701.3:2001JUN22 248 259 forward 2 TM Cytosolic
429 LG:332701.3:2001 JUN22 260 282 forward 2 TM Transmembrane
429 LG:332701.3:2001JUN22 283 286 forward 2 TM Non-Cytosolic
429 LG:332701.3:2001JUN22 287 309 forward 2 TM Transmembrane
429 LG:332701.3:2001JUN22 310 507 forward 2 TM Cytosolic
429 LG:332701.3:2001JUN22 508 530 forward 2 TM Transmembrane
429 LG:332701.3:2001JUN22 531 983 forward 2 TM Non-Cytosolic
429 LG:332701.3:2001JUN22 984 1006 forward 2 TM Transmembrane
429 LG:332701.3:2001JUN22 1007 1054 forward 2 TM Cytosolic
429 LG:332701.3:2001JUN22 1055 1077 forward 2 TM Transmembrane
429 LG:332701.3:2001JU 22 1078 1541 forward 2 TM Non-Cytosolic
429 LG:332701.3:2001JUN22 1 223 forward 3 TM Non-Cytosolic
429 LG:332701.3:2001JUN22 224 246 forward 3 TM Transmembrane
429 LG:332701.3:2001JUN22 • 247 507 forward 3 ■ TM Cytosolic
429 LG:332701.3:2001JUN22 ' 508 530 forward 3 TM Transmembrane
429 LG:332701.3:2001JUN22 531 1541 forward 3 TM Non-Cytosolic
430 LG:369881.5:2001JUN22 1 311 forward 3 TM Non-Cytosolic
430 LG:369881.5:2001JUN22 312 334 forward 3 TM Transmembrane
430 LG:369881.5:2001JUN22 335 346 forward 3 TM Cytosolic
430 LG:369881.5:2001JUN22 347 369 forward 3 TM Transmembrane
430 LG:369881.5:2001JUN22 370 383 forward 3 TM Non-Cytosolic
430 LG.-369881.5:2001 JUN22 384 406 forward 3 TM Transmembrane
430 LG:369881.5:2001JUN22 407 435 forward 3 TM Cytosolic
431 LG:404381.2:2001JUN22 1 34 forward 2 TM Cytosolic
431 LG:404381.2:2001 JUN22 35 57 forward 2 TM Transmembrane
431 LG:404381.2:2001JUN22 58 66 forward 2 TM Non-Cytosolic
431 LG:404381.2:2001JUN22 67 89 forward 2 TM Transmembrane
431 LG:404381.2:2001 JUN22 90 100 forward 2 TM Cytosolic
431 LG:404381.2:2001JUN22 101 123 forward 2 TM Transmembrane
431 LG:404381.2:2001 JUN22 124 132 forward 2 TM Non-Cytosolic
431 LG:404381.2:2001 JUN22 133 155 forward 2 TM Transmembrane
431 LG:404381.2:2001 JUN22 156 192 forward 2 TM Cytosolic
431 LG:404381.2:2001JUN22 193 215 forward 2 TM Transmembrane
431 LG:404381.2:2001 JUN22 216 271 forward 2 TM Non-Cytosolic
431 LG:404381.2:2001 JUN22 272 294 forward 2 TM Transmembrane
431 LG:404381.2:2001 JUN22 295 302 forward 2 TM Cytosolic
431 LG.404381.2:2001 JUN22 303 325 forward 2 TM Transmembrane
431 LG:404381.2:2001JUN22 326 339 forward 2 TM Non-Cytosolic
431 LG:404381.2:2001JUN22 340 359 forward 2 TM Transmembrane
431 LG:404381.2:2001JUN22 360 466 forward 2 TM Cytosolic
432 LG:405709.2:2001JUN22 1 75 forward 2 TM Cytosolic
432 LG:405709.2:2001JUN22 76 94 forward 2 TM Transmembrane TABLE 2
SEQ D NO: Template ID Start Stop Frame Domain Type Topology
432 LG:405709.2:2001JUN22 95 113 forward 2 TM Non-Cytosolic
432 LG:405709.2:2001JUN22 1 113 forward 3 TM Cytosolic
433 LG:406664.17:2001 JUN22 1 73 forward 1 TM Cytosolic
434 LG:7670681.1:2001JUN22 1 187 forward 2 TM Non-Cytosolic 434 LG:7670681.1 :2001JUN22 188 210 forward 2 TM Transmembrane 434 LG:7670681.1:2001JUN22 211 216 forward 2 TM Cytosolic 434 LG:7670681.1 :2001JUN22 1 37 forward 3 TM Non-Cytosolic 434 LG:7670681.1:2001JUN22 38 60 forward 3 TM Transmembrane
434 LG:7670681.1:2001JUN22 61 215 forward 3 TM Cytosolic
435 LG:7687404.1:2001JUN22 1 114 forward 3 TM Non-Cytosolic 435 LG:7687404.1:2001JUN22 115 137 forward 3 TM Transmembrane 435 LG.7687404.1:2001JUN22 138 225 forward 3 TM Cytosolic 435 LG:7687404.1:2001 JUN22 226 248 forward 3 TM Transmembrane
435 LG:7687404.1:2001JUN22 249 370 forward 3 TM Non-Cytosolic
436 LG:7690030.24:2001JUN22 1 129 forward 1 TM Cytosolic
436 LG:7690030.24:2001JUN22 1 128 forward 2 TM Cytosolic
437 LG:7690229.3:2001JUN22 1 20 forward 3 TM Cytosolic 437 LG:7690229.3:2001JUN22 21 40 forward 3 TM Transmembrane
437 LG:7690229.3:2001JUN22 41 223 forward 3 TM Non-Cytosolic
438 LG:7690533.16:2001 JUN22 1 9 forward 2 TM Non-Cytosolic 438 LG:7690533.16:2001JUN22 10 29 forward 2 TM Transmembrane 438 LG.-7690533.16:2001 JUN22 30 48 forward 2 TM Cytosolic 438 LG:7690533.16:2001JUN22 49 71 forward 2 TM Transmembrane
438 LG:7690533.16:2001JUN22 72 393 ■forward 2 TM Non-Cytosolic
439 LG:7691131.2:2001 JUN22 1 22 forward 1 TM Non-Cytosolic 439 LG:7691131.2:2001JUN22 23 45 - forward 1 TM Transmembrane 439 LG:7691131.2:2001 JUN22 46 331 forward 1 TM Cytosolic 439 LG:7691131.2:2001JUN22 1 101 forward 3 TM Non-Cytosolic 439 LG:7691131.2:2001 JUN22 102 124 forward 3 TM Transmembrane 439 LG:7691131.2:2001JUN22 125 287 forward 3 TM Cytosolic 439 LG:7691131.2:2001JUN22 288 307 forward 3 TM Transmembrane
439 LG:7691131.2:2001 JUN22 308 330 forward 3 TM Non-Cytosolic
440 LG:7692559.6:2001JUN22 1 3 forward 1 TM Non-Cytosolic 440 LG:7692559.6:2001JUN22 4 23 forward 1 TM Transmembrane 440 LG:7692559.6:2001JUN22 24 35 forward 1 TM Cytosolic 440 LG:7692559.6:2001JUN22 36 53 forward 1 TM Transmembrane 440 LG:7692559.6:2001JUN22 54 239 forward 1 TM Non-Cytosolic 440 LG:7692559.6:2001JUN22 1 48 forward 3 TM Non-Cytosolic 440 LG:7692559.6:2001JUN22 49 71 forward 3 TM Transmembrane 440 LG:7692559.6:2001JUN22 72 75 forward 3 TM Cytosolic 440 LG:7692559.6:2001JUN22 76 98 forward 3 TM Transmembrane
440 LG:7692559.6:2001JUN22 99 238 forward 3 TM Non-Cytosolic
441 LG:7684866.10:2001 JUN22 1 56 forward 2 TM Cytosolic 441 LG:7684866.10:2001JUN22 57 79 forward 2 TM Transmembrane 441 LG:7684866.10:2001JUN22 80 93 forward 2 TM Non-Cytosolic 441 LG:7684866.10:2001JUN22 94 116 forward 2 TM Transmembrane
441 LG:7684866.10:2001JUN22 117 170 forward 2 TM Cytosolic
442 LG:002106.5:2001JUN22 1 344 forward 2 TM Non-Cytosolic 442 LG:002106.5 :2001JUN22 345 367 forward 2 TM Transmembrane 442 LG:002106.5:2001JUN22 368 387 forward 2 TM Cytosolic 442 LG:002106.5:2001JUN22 388 410 forward 2 TM Transmembrane 442 LG:002106.5:2001JUN22 411 419 forward 2 TM Non-Cytosolic 442 LG:002106.5:2001JUN22 420 439 forward 2 TM Transmembrane 442 LG:002106.5:2001JUN22 440 548 forward 2 TM Cytosolic TABLE 2
SEQ D NO Template ID Start Stop Frame Domain Type Topology
442 LG:002106.5:200UUN22 1 386 forward 3 TM Non-Cytosolic
442 LG:002106.5:2001JUN22 387 409 forward 3 TM Transmembrane
442 LG:002106.5:2001JUN22 410 420 forward 3 TM Cytosolic
442 LG:002106.5:2001JUN22 421 443 forward 3 TM Transmembrane
442 LG:002106.5:2001JUN22 444 548 forward 3 TM Non-Cytosolic
443 LG:004064.1:2001JUN22 1 20 forward 1 TM Cytosolic
443 LG:004064.1:2001 JUN22 21 43 forward 1 TM Transmembrane
443 LG:004064.1:2001 JUN22 44 335 forward 1 TM Non-Cytosolic
443 LG:004064.1 :2001 JUN22 1 47 forward 2 TM Non-Cytosolic
443 LG:004064.1:2001 JUN22 48 70 forward 2 TM Transmembrane
443 LG:004064.1:2001 JUN22 71 335 forward 2 TM Cytosolic
443 LG:004064.1:2001 JUN22 1 47 forward 3 TM Non-Cytosolic
443 LG:004064.1:2001JUN22 48 70 forward 3 TM Transmembrane
443 LG:004064.1:2001 JUN22 71 208 forward 3 TM Cytosolic
443 LG:004064.1:2001 JUN22 209 228 forward 3 TM Transmembrane
443 LG:004064.1:2001JUN22 229 267 forward 3 TM Non-Cytosolic
443 LG:004064.1:2001JUN22 268 290 forward 3 TM Transmembrane
443 LG:004064.1:2001 JUN22 291 335 forward 3 TM Cytosolic
444 LG:007916.8:2001JUN22 1 159 forward 1 TM Cytosolic
444 LG:007916.8:2001JUN22 160 182 forward 1 TM Transmembrane
444 LG:007916.8:2001JUN22 183 499 forward 1 TM Non-Cytosolic
445 LG:014719.14:2001JUN22 1 913 forward 1 TM Non-Cytosolic
445 LG:014719.14:2001JUN22 914 936 forward 1 TM Transmembrane
445 LG:014719.14:2001JUN22 937 966 forward 1 TM Cytosolic
445 LG:014719.14:2001JUN22 1 915 forward 2 TM Non-Cytosolic
445 LG:014719.14:2001JUN22 916 938 forward 2 TM Transmembrane
445 LG:014719.14:2001JUN22 939 966 forward 2 TM Cytosolic
446 LG:021763.31:2001JUN22 81 170 forward 3 SP
446 LG:021763.31:2001JUN22 1 131 forward 3 TM Non-Cytosolic
446 LG:021763.31:2001JUN22 132 154 forward 3 TM Transmembrane
446 LG:021763.31:2001JUN22 155 233 forward 3 TM Cytosolic
447 LG:025397.1:2001JUN22 1 40 forward 3 TM Cytosolic
447 LG:025397.1:2001JUN22 41 63 forward 3 TM Transmembrane
447 LG. 25397.1 :2001 JUN22 64 77 forward 3 TM Non-Cytosolic
447 LG:025397.1:2001 JUN22 78 100 forward 3 TM Transmembrane
447 LG:025397.1:2001JUN22 101 112 forward 3 TM Cytosolic
447 LG:025397.1:2001JUN22 113 132 forward 3 TM Transmembrane
447 LG:025397.1:2001 JUN22 133 879 forward 3 TM Non-Cytosolic
448 LG:029880.20:2001JUN22 1 399 forward 2 TM Non-Cytosolic
448 LG:029880.20:2001 JUN22 400 422 forward 2 TM Transmembrane
448 LG:029880.20:2001 JUN22 423 434 forward 2 TM Cytosolic
448 LG:029880.20:2001JUN22 435 457 forward 2 TM Transmembrane
448 LG:029880.20:2001JUN22 458 1076 forward 2 TM Non-Cytosolic
448 LG:029880.20:2001 IUN22 1 316 forward 3 TM Non-Cytosolic
448 LG:029880.20:2001JUN22 317 339 forward 3 TM Transmembrane
448 LG:029880.20:2001JUN22 340 565 forward 3 TM Cytosolic
448 LG:029880.20:2001 JUN22 566 588 forward 3 TM Transmembrane
448 LG:029880.20:2001 JUN22 589 1075 forward 3 TM Non-Cytosolic
449 LG:040422.37:2001JUN22 1 344 forward 1 TM Cytosolic
449 LG:040422.37:2001 JUN22 345 367 forward 1 TM Transmembrane
449 LG:040422.37:2001JUN22 368 386 forward 1 TM Non-Cytosolic
449 LG:040422.37:2001JUN22 387 409 forward 1 TM Transmembrane
449 LG:040422.37:2001JUN22 410 447 forward 1 TM Cytosolic
449 LG:040422.37:2001JUN22 448 470 forward 1 TM Transmembrane TABLE 2
SEQ D NO: Template ID Start Stop Frame Domain Type Topology
449 LG:040422.37:2001JUN22 471 542 forward 1 TM Non-Cytosolic
449 LG:040422.37:2001JUN22 543 565 forward 1 TM Transmembrane
449 LG:040422.37:2001JUN22 566 639 forward 1 TM Cytosolic
449 LG:040422.37:2001JUN22 640 662 forward 1 TM Transmembrane
449 LG:040422.37:2001JUN22 663 671 forward 1 TM Non-Cytosolic
449 LG:040422.37:2001JUN22 672 694 forward 1 TM Transmembrane
449 LG:040422.37:2001JUN22 695 747 forward 1 TM Cytosolic
449 LG:040422.37:2001JUN22 748 770 forward 1 TM Transmembrane
449 LG:040422.37:2001JUN22 771 795 forward 1 TM Non-Cytosolic
449 LG:040422.37:2001JUN22 796 814 forward 1 TM Transmembrane
449 LG:040422.37:2001JUN22 815 820 forward 1 TM Cytosolic
449 LG:040422.37:2001JUN22 821 843 forward 1 TM Transmembrane
449 LG:040422.37:2001JUN22 844 1065 forward 1 TM Non-Cytosolic
449 LG:040422.37:2001JUN22 1 640 forward 2 TM Non-Cytosolic
449 LG:040422.37:2001JUN22 641 663 forward 2 TM Transmembrane
449 LG.O40422.37.-2001JUN22 664 674 forward 2 TM Cytosolic
449 LG:040422.37:2001JUN22 675 696 forward 2 TM Transmembrane
449 LG:040422.37:2001JUN22 697 742 forward 2 TM Non-Cytosolic
449 LG:040422.37:2001JUN22 743 765 forward 2 TM Transmembrane
449 LG:040422.37:2001JUN22 766 803 forward 2 TM Cytosolic
449 LG:040422.37:2001JUN22 804 826 forward 2 TM Transmembrane
449 LG:040422.37:2001JUN22 827 925 forward 2 TM Non-Cytosolic
449 LG:040422.37:2001JUN22 926 948 forward 2 TM Transmembrane
449 LG:040422.37:2001JUN22 949 1065 forward 2 TM Cytosolic
449 LG:040422.37:2001JUN22 1 575 forward 3 TM Non-Cytosolic
449 LG:040422.37:2001JUN22 576 598 forward 3 TM Transmembrane
449 LG:040422.37:2001JUN22 599 622 forward 3 TM Cytosolic
449 LG:040422.37:2001JUN22 623 645 forward 3 " TM Transmembrane
449 LG:040422.37:2001JUN22 646 649 forward 3 TM Non-Cytosolic
449 LG:040422.37 :2001 JUN22 650 672 forward 3 TM Transmembrane
449 LG:040422.37:2001JUN22 673 746 forward 3 TM Cytosolic
449 LG:040422.37:2001JUN22 747 769 forward 3 TM Transmembrane
449 LG:040422.37:2001JUN22 770 1064 forward 3 TM Non-Cytosolic
450 LG:065935.11 :2001 JUN22 1 9 forward 1 TM Non-Cytosolic
450 LG:065935.11:2001JUN22 10 27 forward 1 TM Transmembrane
450 LG:065935.11 :2001 JUN22 28 46 forward 1 TM Cytosolic
450 LG:065935.11:2001 JUN22 47 69 forward 1 TM Transmembrane
450 LG:065935.11 :2001 JUN22 70 1451 forward 1 TM Non-Cytosolic
450 LG:065935.11 :2001 JUN22 1 33 forward 2 TM Cytosolic
450 LG:065935.11 :2001 JUN22 34 56 forward 2 TM Transmembrane
450 LG:065935.11:2001JUN22 57 65 forward 2 TM Non-Cytosolic
450 LG. 65935.11:2001 JUN22 66 88 forward 2 TM Transmembrane
450 LG:065935.11 :2001 JUN22 89 312 forward 2 TM Cytosolic
450 LG:065935.11:2001 JUN22 313 335 forward 2 TM Transmembrane
450 LG.065935.11:2001 JUN22 336 370 forward 2 TM Non-Cytosolic
450 LG:065935.11:2001JUN22 371 393 forward 2 TM Transmembrane
450 LG.O65935.11:2001JUN22 394 449 forward 2 TM Cytosolic
450 LG:065935.11:2001 JUN22 450 472 forward 2 TM Transmembrane
450 LG:065935.11 :2001 JUN22 473 498 forward 2 TM Non-Cytosolic
450 LG:065935.11:2001JUN22 499 518 forward 2 TM Transmembrane
450 LG:065935.11:2001JUN22 519 538 forward 2 TM Cytosolic
450 LG:065935.11 :2001 JUN22 539 561 forward 2 TM Transmembrane
450 LG:065935.11:2001 JUN22 562 1450 forward 2 TM Non-Cytosolic
450 LG:065935.11 :2001 JUN22 1 9 forward 3 TM Non-Cytosolic TABLE 2
SEQ D NO: Template ID Start Stop Frame Domain Type Topology
450 LG:065935.11:2001JUN22 10 27 forward 3 TM Transmembrane
450 LG:065935.11 :2001 JUN22 28 39 forward 3 TM Cytosolic
450 LG.065935.11:2001JU 22 40 62 forward 3 TM Transmembrane
450 LG.065935.11:2001 JUN22 63 71 forward 3 TM Non-Cytosolic
450 LG.065935.11:2001 JUN22 72 94 forward 3 TM Transmembrane
450 LG.065935.11:2001 JU 22 95 370 forward 3 TM Cytosolic
450 LG:065935.11:2001 JUN22 371 393 forward 3 TM Transmembrane
450 LG.O65935.11:2001 JU 22 394 1182 forward 3 TM Non-Cytosolic
450 LG:065935.11:2001JUN22 1183 1202 forward 3 TM Transmembrane
450 LG:065935.11:2001JU 22 1203 1395 forward 3 TM Cytosolic
450 LG:065935.11:2001JUN22 1396 1418 forward 3 TM Transmembrane
450 LG:065935.11:2001JUN22 1419 1450 forward 3 TM Non-Cytosolic
451 LG:074381.1:2001JUN22 1 318 forward 2 TM Non-Cytosolic
451 LG:074381.1:2001JUN22 319 341 forward 2 TM Transmembrane
451 LG:074381.1:2001JUN22 342 361 forward 2 TM Cytosolic
451 LG:074381.1:2001JUN22 362 384 forward 2 TM Transmembrane
451 LG.O74381.1:2001 JUN22 385 421 forward 2 TM Non-Cytosolic
451 LG:074381.1:2001JUN22 1 229 forward 3 TM Non-Cytosolic
451 LG:074381.1:2001JUN22 230 252 forward 3 TM Transmembrane
451 LG:074381.1:2001JUN22 253 256 forward 3 TM Cytosolic
451 LG:074381.1:2001JUN22 257 279 forward 3 TM Transmembrane
451 LG:074381.1:2001JUN22 280 317 forward 3 TM Non-Cytosolic
451 LG:074381.1:2001JUN22 318 340 forward 3 TM Transmembrane
451 LG:074381.1:2001JUN22 341 352 forward 3 TM Cytosolic
451 LG.-074381.1. -2001 JUN22 353 375 forward 3 TM Transmembrane
451 LG:074381.1:2001JUN22 376 394 forward 3 TM Non-Cytosolic
451 LG:074381.1:2001JUN22 395 417 forward 3 TM Transmembrane
451 LG:074381.1:2001JUN22 418 421 forward 3 TM Cytosolic
452 LG:083814.6:2001JUN22 1 736 forward 1 TM Non-Cytosolic
452 LG:083814.6:2001 JUN22 737 756 forward 1 TM Transmembrane
452 LG:083814.6:2001 JUN22 757 790 forward 1 TM Cytosolic
452 LG:083814.6:2001JUN22 791 809 forward 1 TM Transmembrane
452 LG:083814.6:2001JUN22 810 817 forward 1 TM Non-Cytosolic
452 LG. 83814.6:2001 JUN22 1 757 forward 3 TM Non-Cytosolic
452 LG:083814.6:2001 JUN22 758 777 forward 3 TM Transmembrane
452 LG:083814.6:2001 JUN22 778 788 forward 3 TM Cytosolic
452 LG:083814.6:2001JUN22 789 806 forward 3 TM Transmembrane
452 LG:083814.6:2001JUN22 807 816 forward 3 TM Non-Cytosolic
453 LG:090985.1:2001 JUN22 1 11 forward 3 TM Cytosolic
453 LG:090985.1:2001JUN22 12 34 forward 3 TM Transmembrane
453 LG:090985.1:2001JUN22 35 37 forward 3 TM Non-Cytosolic
453 LG:090985.1:2001JUN22 38 60 forward 3 TM Transmembrane
453 LG:090985.1:2001JUN22 61 206 forward 3 TM Cytosolic
454 LG:093750.2:2001JUN22 1 392 forward 2 TM Non-Cytosolic
454 LG:093750.2:2001JUN22 393 410 forward 2 TM Transmembrane
454 LG:093750.2:2001JUN22 411 411 forward 2 TM Cytosolic
455 LG:1013708.26:2001JUN22 1 77 forward 1 TM Cytosolic
455 LG:1013708.26:2001JUN22 78 95 forward 1 TM Transmembrane
455 LG:1013708.26:2001JUN22 96 109 forward 1 TM Non-Cytosolic
455 LG:1013708.26:2001JUN22 110 132 forward 1 TM Transmembrane
455 LG: 1013708.26:2001 JUN22 133 147 forward 1 TM Cytosolic
455 LG:1013708.26:2001JUN22 148 170 forward 1 TM Transmembrane
455 LG: 1013708.26:2001 JUN22 171 558 forward 1 TM Non-Cytosolic
455 LG:1013708.26:2001JUN22 1 74 forward 2 TM Cytosolic
21: ! TABLE 2
SEQ D NO: Template ID Start Stop Frame Domain Type Topology
455 LG: 1013708.26:2001 JUN22 75 97 forward 2 TM Transmembrane
455 LG:1013708.26:2001JUN22 98 100 forward 2 TM Non-Cytosolic
455 LG: 1013708.26:2001JUN22 101 120 forward 2 TM Transmembrane
455 LG:1013708.26:2001JUN22 121 369 forward 2 TM Cytosolic
455 LG:1013708.26:2001JUN22 370 392 forward 2 TM Transmembrane
455 LG:1013708.26:2001JUN22 393 558 forward 2 TM Non-Cytosolic
455 LG:1013708.26:2001JUN22 1 77 forward 3 TM Cytosolic
455 LG: 1013708.26:2001 JUN22 78 100 forward 3 TM Transmembrane
455 LG:1013708.26:2001JUN22 101 103 forward 3 TM Non-Cytosolic
455 LG:1013708.26:2001JUN22 104 126 forward 3 TM Transmembrane
455 LG:1013708.26:2001JUN22 127 146 forward 3 TM Cytosolic
455 LG: 1013708.26:2001 JUN22 147 166 forward 3 TM Transmembrane
455 LG: 1013708.26:2001 JUN22 167 557 forward 3 TM Non-Cytosolic
456 LG:1022283.8:2001JUN22 1 1703 forward 1 TM Non-Cytosolic
456 LG:1022283.8:2001JUN22 1704 1726 forward 1 TM Transmembrane
456 LG:1022283.8:2001JUN22 1727 1903 forward 1 TM Cytosolic
456 LG:1022283.8:2001JUN22 1904 1926 forward 1 TM Transmembrane
456 LG: 1022283.8:2001 JUN22 1927 2059 forward 1 TM Non-Cytosolic
456 LG:1022283.8:2001JUN22 2060 2082 forward 1 TM Transmembrane
456 LG:1022283.8:2001JUN22 2083 2182 forward 1 TM Cytosolic
456 LG: 1022283.8:2001 JUN22 2183 2201 forward 1 TM Transmembrane
456 LG: 1022283.8:2001 JUN22 2202 2231 forward 1 TM Non-Cytosolic
456 LG:1022283.8:2001JUN22 2232 2251 forward 1 TM Transmembrane
456 LG:1022283.8:2001JUN22 2252 2390 forward 1 TM Cytosolic
456 LG:1022283.8:2001JUN22 1 1894 forward 2 TM Non-Cytosolic
456 LG:1022283.8:2001JUN22 1895 1917 forward 2 TM Transmembrane
456 LG: 1022283.8:2001 JUN22 1918 2060 forward 2 TM Cytosolic
456 LG: 1022283.8:2001 JUN22 2061 2083 forward 2 TM Transmembrane
456 LG: 1022283.8:2001 JUN22 2084 2173 forward 2 TM Non-Cytosolic
456 LG: 1022283.8:2001 JUN22 2174 2196 forward 2 TM Transmembrane
456 LG:1022283.8:2001JUN22 2197 2207 forward 2 TM Cytosolic
456 LG: 1022283.8:2001 JUN22 2208 2225 forward 2 TM Transmembrane
456 LG:1022283.8:2001JUN22 2226 2229 forward 2 TM Non-Cytosolic
456 LG:1022283.8:2001JUN22 2230 2252 forward 2 TM Transmembrane
456 LG:1022283.8:2001JUN22 2253 2264 forward 2 TM Cytosolic
456 LG:1022283.8:2001JUN22 2265 2284 forward 2 TM Transmembrane
456 LG: 1022283.8:2001 JUN22 2285 2390 forward 2 TM Non-Cytosolic
456 LG: 1022283.8:2001 JUN22 1 1894 forward 3 TM Non-Cytosolic
456 LG:1022283.8:2001JUN22 1895 1917 forward 3 TM Transmembrane
456 LG: 1022283.8:2001 JUN22 1918 2057 forward 3 TM Cytosolic
456 LG:1022283.8:2001JUN22 2058 2077 forward 3 TM Transmembrane
456 LG:1022283.8:2001JU 22 2078 2229 forward 3 TM Non-Cytosolic
456 LG:1022283.8:2001JUN22 2230 2252 forward 3 TM Transmembrane
456 LG: 1022283.8:2001 JUN22 2253 2389 forward 3 TM Cytosolic
457 LG:1034386.1:2001JUN22 1 37 forward 1 TM Non-Cytosolic
457 LG:1034386.1:2001JUN22 38 60 forward 1 TM Transmembrane
457 LG:1034386.1:2001JUN22 61 101 forward 1 TM Cytosolic
457 LG: 1034386.1:2001 JUN22 102 124 forward 1 TM Transmembrane
457 LG:1034386.1:2001JUN22 125 345 forward 1 TM Non-Cytosolic
457 LG:1034386.1:2001JUN22 1 8 forward 2 TM Cytosolic
457 LG:1034386.1:2001JUN22 9 31 forward 2 TM Transmembrane
457 LG:1034386.1:2001JUN22 32 50 forward 2 TM Non-Cytosolic
457 LG:1034386.1:2001JUN22 51 68 forward 2 TM Transmembrane
457 LG:1034386.1:2001JUN22 69 112 forward 2 TM Cytosolic TAB] E 2
SEQ D NO Template ID Start Stop Frame Domain Type Topology
457 LG: 1034386.1 2001JUN22 113 135 forward 2 TM Transmembrane
457 LG: 1034386.1 2001JUN22 136 192 forward 2 TM Non-Cytosolic
457 LG: 1034386.1 2001IUN22 193 215 forward 2 TM Transmembrane
457 LG: 1034386.1 2001JTJN22 216 226 forward 2 TM Cytosolic
457 LG:1034386.1 2001JUN22 227 249 forward 2 TM Transmembrane
457 LG: 1034386.1 2001JUN22 250 345 forward 2 TM Non-Cytosolic
457 LG: 1034386.1 2001JUN22 1 102 forward 3 TM Non-Cytosolic
457 LG:1034386.1 2001JUN22 103 125 forward 3 TM Transmembrane
457 LG: 1034386.1 2001JUN22 126 345 forward 3 TM Cytosolic
458 LG:1045617.36:2001JUN22 1 334 forward 3 TM Non-Cytosolic
458 LG:1045617.36:2001JUN22 335 357 forward 3 TM Transmembrane
458 LG:1045617.36:2001JUN22 358 388 forward 3 TM Cytosolic
459 LG:1063303.1 2001JUN22 1 22 forward 3 TM Non-Cytosolic
459 LG: 1063303.1 2001JUN22 23 45 forward 3 TM Transmembrane
459 LG:1063303.1 2001JUN22 46 51 forward 3 TM Cytosolic
459 LG:1063303.1 2001JUN22 52 74 forward 3 TM Transmembrane
459 LG: 1063303.1 2001JUN22 75 432 forward 3 TM Non-Cytosolic
459 LG: 1063303.1 2001JUN22 433 455 forward 3 TM Transmembrane
459 LG: 1063303.1 2001JUN22 456 575 forward 3 TM Cytosolic
460 LG: 1094200.1 2001JUN22 1 316 forward 1 TM Non-Cytosolic
460 LG: 1094200.1 2001JUN22 317 339 forward 1 TM Transmembrane
460 LG: 1094200.1 2001JUN22 340 372 forward 1 TM Cytosolic
460 LG: 1094200.1 2001JUN22 373 395 forward 1 TM Transmembrane
460 LG: 1094200.1 2001JUN22 396 1061 forward 1 TM Non-Cytosolic
460 LG: 1094200.1 2001JUN22 1 314 forward 2 TM Non-Cytosolic
460 ' LG: 1094200.1 2001JUN22 315 337 forward 2 TM Transmembrane
460 LG: 1094200.1 2001JUN22 338 366 forward 2 TM Cytosolic
460 LG: 1094200.1 2001JUN22 367 389 forward 2 TM Transmembrane
460 ' LG: 1094200.1 2001JUN22 390 392 forward 2 TM Non-Cytosolic
460 LG: 1094200.1 2001JUN22 393 412 forward 2 TM Transmembrane
460 LG: 1094200.1 2001JUN22 413 678 forward 2 TM Cytosolic
460 LG: 1094200.1 2001JUN22 679 701 forward 2 TM Transmembrane
460 LG: 1094200.1 2001JUN22 702 1061 forward 2 TM Non-Cytosolic
460 LG: 1094200.1 2001JUN22 1 380 forward 3 TM Non-Cytosolic
460 LG: 1094200.1 2001JUN22 381 403 forward 3 TM Transmembrane
460 LG: 1094200.1 2001JUN22 404 415 forward 3 TM Cytosolic
460 LG: 1094200.1 2001JUN22 416 438 forward 3 TM Transmembrane
460 LG: 1094200.1 2001JUN22 439 1061 forward 3 TM Non-Cytosolic
461 LG: 1099249.19:2001 JUN22 1 417 forward 1 TM Non-Cytosolic
461 LG:1099249.19:2001JUN22 418 437 forward 1 TM Transmembrane
461 LG: 1099249.19 :2001 JUN22 438 566 forward 1 TM Cytosolic
461 LG: 1099249.19:2001 IUN22 567 589 forward 1 TM Transmembrane
461 LG:1099249.19:2001JUN22 590 615 forward 1 TM Non-Cytosolic
461 LG:1099249.19:2001JUN22 1 538 forward 2 TM Non-Cytosolic
461 LG:1099249.19:2001JUN22 539 557 forward 2 TM Transmembrane
461 LG:1099249.19:2001JUN22 558 569 forward 2 TM Cytosolic
461 LG:1099249.19:2001JUN22 570 592 forward 2 TM Transmembrane
461 LG: 1099249.19:2001 JUN22 593 614 forward 2 TM Non-Cytosolic
461 LG: 1099249.19:2001 JUN22 1 490 forward 3 TM Non-Cytosolic
461 LG:1099249.19:2001JUN22 491 513 forward 3 TM Transmembrane
461 LG:1099249.19:2001JUN22 514 583 forward 3 TM Cytosolic
461 LG:1099249.19:2001JUN22 584 606 forward 3 TM Transmembrane
461 LG:1099249.19:2001JUN22 607 614 forward 3 TM Non-Cytosolic
462 LG: 110667.1:2 001JUN22 1 41 forward 2 TM Non-Cytosolic tu
o ε Q
Figure imgf000218_0002
cs o
W CΛ
Figure imgf000218_0003
* <n rt *<--t- __ ; ". -0 *0 --' T tf
Figure imgf000218_0004
(_Λ
cs cs cs cs s s cs CN CS CS CS CN CS CS CS CS CS CS CS CN cs cs cs cs cs cs cs CS CS tN cS CS CS CN CS CS CS CN CS CN t CS CS CS CS CS S CS 2 2 22 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 CS tN CS CS CS s tN tN CS cs cs tN CS cs cs tN CS CS CS s s cs cs cs s cs s s cs
2222 D B 2 2 p D P P P P P P P P P P cs CS CS P P P P P cs s s cs cs cs
Q 2 2 2 22 2 2 2 2 2 22
P P ; . p p p p p o o O [ -1 P P ! ) !") J P P CD ω O O O O a o o o o o o o o o o o o o o rt, rt r> P P P o o o o ca O O O O O o o o o o o o o o o o o o o o o o o o o o o o cs cs cs tN tN CS CS CS cs cs s CS CS CS CS CS CS CS CS CS CS CS o o o o o o o o o o o o o o o o o o o o o o O O o o o O O O O O o o o o o o o o o o o o o o o o ε s cs cs <N o o o o o o o o o o o o o o o o o o o
CS S CS (N cs rS tN S CS S CS S CS CS s (N cs cs s cs. CS cS CS CS cS CS cS CS CS tN CS cs cs s s s CS o o o tN CS cs s CS <N s cs < s cs cs vn VO VO VO VO VO vo vo o KΩ vo1 vo vo vo vo vo vo vo vo s s s s s s cs s cs cs cs cs cs cs cs cs s s
1- 1 r» c-» r*- r~ oo oo oo oo oo oo oo oo oo oo oo oo oo oo oo oo oo oo oo oo oo oo oo oo oo oo oo oo in in i in in m in in in in in in in in
KΩ VO SO co co co co CO O CO CO O co CO CO co co co co co co co co co co co co
■O VO *o s CS CS CS ( s CS (N CS CS CS CS CS CS CS CS CS CS CS o o o o o o o o o o o o o o o o o o o o o o co co co t co co co co co co co co CO CO co co co co co co co co co co co vo vo vo vo vo vo vo vo VO vo vo vo vo o vo
SO 000000000000000000000000000000000000000000000000000000 t~- rtl J J J rtJ rtl rtl J rtl rtl iJ rtl rtl rtl rtl rtl rtl rt. rtl rtl rtl rtl rtl rtl rtl J υ " "
2 ϊ ^ (N CN CS cS co i'O t-o co co cπ co co co co co co co co cn co co co co co co co co co co co co co co c^ o Q VO VO VO VO VO VO VO VO VO VO VO VO VO VO VO VO VO VD VO VO VD VO VO VO VO VO VO VO VO VO VO VO VO VO VO VO VO VO VO VO VO VO VO VO VO VO VO σ ^ ■■•■ -*** **** ***** -***- *** **** *** -**** **** **-** ^
O ra
TABI _E 2
SEQ D NO: Template ID Start Stop Frame Domain Type Topology
464 LG:116015.2:2001 JUN22 470 489 forward 2 TM Cytosolic
464 LG:116015.2:2001 JUN22 490 512 forward 2 TM Transmembrane
464 LG:116015.2:2001 JUN22 513 539 forward 2 TM Non-Cytosolic
464 LG:116015.2:2001 JUN22 540 562 forward 2 TM Transmembrane
464 LG:116015.2:2001 JUN22 563 760 forward 2 TM Cytosolic
464 LG:116015.2:2001JUN22 761 783 forward 2 TM Transmembrane
464 LG:116015.2:2001 JUN22 784 1062 forward 2 TM Non-Cytosolic
464 LG:116015.2:2001 JUN22 1 442 forward 3 TM Non-Cytosolic
464 LG:116015.2:2001 JUN22 443 465 forward 3 TM Transmembrane
464 LG:116015.2:2001 JUN22 466 543 forward 3 TM Cytosolic
464 LG:116015.2:2001JUN22 544 561 forward 3 TM Transmembrane
464 LG:116015.2:2001 JUN22 562 1062 forward 3 TM Non-Cytosolic
465 LG:1173104.15:2001 JUN22 1 295 forward 1 TM Non-Cytosolic
465 LG:1173104.15:2001JUN22 296 318 forward 1 TM Transmembrane
465 LG:1173104.15:2001JUN22 319 324 forward 1 TM Cytosolic
465 LG:1173104.15:2001JUN22 325 347 forward 1 TM Transmembrane
465 LG:1173104.15:2001JUN22 348 516 forward 1 TM Non-Cytosolic
465 LG: 1173104.15:2001 JUN22 1 296 forward 2 TM Cytosolic
465 LG:1173104.15:2001JUN22 297 319 forward 2 TM Transmembrane
465 LG:1173104.15:2001JUN22 320 328 forward 2 TM Non-Cytosolic
465 LG:1173104.15:2001JUN22 329 348 forward 2 TM Transmembrane
465 LG:1173104.15:2001JUN22 349 516 forward 2 TM Cytosolic
465 LG:1173104.15:2001JUN22 1 209 forward 3 TM Cytosolic
465 LG:1173104.15:2001JUN22 210 232 forward 3 TM Transmembrane
465 LG: 1173104.15.2001JUN22 233 305 forward 3 TM Non-Cytosolic
465 LG:1173104.15:2001JUN22 ' 306 323 forward 3 TM Transmembrane
465 LG:1173104.15:2001JUN22 324 329 forward 3 TM Cytosolic
465 LG: 1173104.15:2001 JUN22 330 352 forward 3 TM Transmembrane
465 LG:1173104.15:2001JUN22 353 516 forward 3 TM Non-Cytosolic
466 LG:1285109.14:2001JUN22 1 4 forward 1 TM Cytosolic
466 LG: 1285109.14:2001 JUN22 5 27 forward 1 TM Transmembrane
466 LG:1285109.14:2001JUN22 28 483 forward 1 TM Non-Cytosolic
466 LG: 1285109.14:2001JUN22 1 6 forward 3 TM Cytosolic
466 LG:1285109.14:2001JUN22 7 29 forward 3 TM Transmembrane
466 LG: 1285109.14:2001 JUN22 30 61 forward 3 TM Non-Cytosolic
466 LG:1285109.14:2001JUN22 62 84 forward 3 TM Transmembrane
466 LG:1285109.14:2001JUN22 85 427 forward 3 TM Cytosolic
466 LG: 1285109.14:2001 JUN22 428 450 forward 3 TM Transmembrane
466 LG:1285109.14:2001JUN22 451 459 forward 3 TM Non-Cytosolic
466 LG:1285109.14:2001JUN22 460 479 forward 3 TM Transmembrane
466 LG:1285109.14:2001JUN22 480 483 forward 3 TM Cytosolic
467 LG:131477.11:2001JUN22 1 1781 forward 1 TM Non-Cytosolic
467 LG: 131477.11:2001 JUN22 1782 1804 forward 1 TM Transmembrane
467 LG: 131477.11:2001JUN22 1805 1830 forward 1 TM Cytosolic
467 LG:131477.11:2001JUN22 1831 1849 forward 1 TM Transmembrane
467 LG:131477.11:2001JUN22 1850 1858 forward 1 TM Non-Cytosolic
467 LG:131477.11:2001JUN22 1859 1881 forward 1 TM Transmembrane
467 LG:131477.11:2001JUN22 1882 1892 forward 1 TM Cytosolic
467 LG: 131477.11:2001JUN22 1893 1915 forward 1 TM Transmembrane
467 LG: 131477.11:2001 JUN22 1916 1916 forward 1 TM Non-Cytosolic
468 LG:1333618.1:2001JUN22 1 15 forward 1 TM Cytosolic
468 LG:1333618.1:2001JUN22 16 35 forward 1 TM Transmembrane
468 LG:1333618.1:2001JUN22 36 200 forward 1 TM Non-Cytosolic
468 LG:1333618.1:2001JUN22 201 223 forward 1 TM Transmembrane TABLE 2
SEQ D NO Template ID Start Stop Frame Domain Type Topology
468 LG:1333618.1 2001JUN22 224 338 forward 1 TM Cytosolic
468 LG-.1333618.1 2001JUN22 339 357 forward 1 TM Transmembrane
468 LG.-1333618.1 2001JUN22 358 360 forward 1 TM Non-Cytosolic
468 LG:1333618.1 2001JUN22 1 19 forward 2 TM Cytosolic
468 LG:1333618.1 2001JUN22 20 39 forward 2 TM Transmembrane
468 LG-.1333618.1 2001JUN22 40 270 forward 2 TM Non-Cytosolic
468 LG:1333618.1 2001JUN22 271 293 forward 2 TM Transmembrane
468 LG: 1333618.1 2001JUN22 294 305 forward 2 TM Cytosolic
468 LG:1333618.1 2001JUN22 306 328 forward 2 TM Transmembrane
468 LG:1333618.1 2001JUN22 329 337 forward 2 TM Non-Cytosolic
468 LG:1333618.1 2001JUN22 338 357 forward 2 TM Transmembrane
468 LG:1333618.1 2001JUN22 358 360 forward 2 TM Cytosolic
468 LG:1333618.1 2001JUN22 1 19 forward 3 TM Non-Cytosolic
468 LG:1333618.1 2001JUN22 20 42 forward 3 TM Transmembrane
468 LG:1333618.1 2001JUN22 43 196 forward 3 TM Cytosolic
468 LG:1333618.1 2001JUN22 197 216 forward 3 TM Transmembrane
468 LG:1333618.1 2001JUN22 217 277 forward 3 TM Non-Cytosolic
468 LG:1333618.1 2001JUN22 278 300 forward 3 TM Transmembrane
468 LG:1333618.1 2001JUN22 301 359 forward 3 TM Cytosolic
469 LG:1347760.16:2001JUN22 1 9 forward 2 TM Non-Cytosolic
469 LG:1347760.16:2001JUN22 10 32 forward 2 TM Transmembrane
469 LG: 1347760.16:2001 JUN22 33 44 forward 2 TM Cytosolic
469 LG: 1347760.16:2001 JUN22 45 67 forward 2 TM Transmembrane
469 LG:1347760.16:2001JUN22 68 823 forward 2 TM Non-Cytosolic
470 LG: 1383039.369:2001 JUN22 1 165 forward 1 TM Cytosolic
470 LG: 1383039.369:2001 JUN22 166 188 forward 1 TM Transmembrane
470 LG:1383039.369:2001JUN22 189 202 forward 1 TM Non-Cytosolic
470 LG: 1383039.369:2001 JUN22 203 225 forward 1 TM Transmembrane
470 LG:1383039.369:2001JUN22 226 383 forward 1 TM Cytosolic
471 LG: 1383313.3:2001 JUN22 1 1068 forward 2 TM Non-Cytosolic
471 LG:1383313.3:2001JUN22 1069 1091 forward 2 TM Transmembrane
471 LG:1383313.3:2001JUN22 1092 1116 forward 2 TM Cytosolic
472 LG:1384075.8:2001JUN22 1 59 forward 2 TM Non-Cytosolic
472 LG: 1384075.8:2001 JUN22 60 82 forward 2 TM Transmembrane
472 LG:1384075.8:2001JUN22 83 101 forward 2 TM Cytosolic
472 LG:1384075.8:2001JUN22 102 124 forward 2 TM Transmembrane
472 LG:1384075.8:2001JUN22 125 127 forward 2 TM Non-Cytosolic
472 LG: 1384075.8:2001 JUN22 128 150 forward 2 TM Transmembrane
472 LG:1384075.8:2001JU 22 151 158 forward 2 TM Cytosolic
472 LG:1384075.8:2001JUN22 159 178 forward 2 TM Transmembrane
472 LG:1384075.8:2001JUN22 179 192 forward 2 TM Non-Cytosolic
472 LG: 1384075.8:2001 JUN22 193 215 forward 2 TM Transmembrane
472 LG:1384075.8:2001JUN22 216 221 forward 2 TM Cytosolic
472 LG:1384075.8:2001JUN22 222 244 forward 2 TM Transmembrane
472 LG:1384075.8:2001JUN22 245 258 forward 2 TM Non-Cytosolic
472 LG: 1384075.8:2001 JUN22 259 281 forward 2 TM Transmembrane
472 LG:1384075.8:2001JUN22 282 293 forward 2 TM Cytosolic
472 LG:1384075.8:2001JUN22 294 316 forward 2 TM Transmembrane
472 LG:1384075.8:2001JUN22 317 773 forward 2 TM Non-Cytosolic
472 LG:1384075.8:2001JUN22 774 796 forward 2 TM Transmembrane
472 LG:1384075.8:2001JUN22 797 813 forward 2 TM Cytosolic
472 LG:1384075.8:2001JUN22 1 773 forward 3 TM Non-Cytosolic
472 LG: 1384075.8:2001 JUN22 774 796 forward 3 TM Transmembrane
472 LG: 1384075.8 :2001JUN22 797 812 forward 3 TM Cytosolic TABLE 2
SEQ D NO: Template ID Start Stop Frame Domain Type Topology
473 LG:1384155.1 :2001JUN22 1 12 forward 2 TM Cytosolic 473 LG:1384155.1 :2001JUN22 13 35 forward 2 TM Transmembrane 473* LG:1384155.1 :2001JUN22 36 461 forward 2 TM Non-Cytosolic 474 LG:1385280.12:2001JUN22 1 9 forward 3 TM Non-Cytosolic 474 LG:1385280.12:2001JUN22 10 32 forward 3 TM Transmembrane 474 LG: 1385280.12:2001 JUN22 33 278 forward 3 TM Cytosolic 475 LG:1390535.25:2001JUN22 1 42 forward 3 TM Cytosolic 475 LG:1390535.25:2001JUN22 43 60 forward 3 TM Transmembrane 475 LG:1390535.25:2001JUN22 61 89 forward 3 TM Non-Cytosolic 475 LG:1390535.25:2001JUN22 90 112 forward 3 TM Transmembrane 475 LG:1390535.25:2001JUN22 113 151 forward 3 TM Cytosolic 476 LG:1397047.1 2001JUN22 1 75 forward 3 TM Cytosolic 476 LG: 1397047.1 2001JUN22 76 98 forward 3 TM Transmembrane 476 LG: 1397047.1 2001JUN22 99 101 forward 3 TM Non-Cytosolic 476 LG:1397047.1 2001JUN22 102 124 forward 3 TM Transmembrane 476 LG: 1397047.1 2001JUN22 125 248 forward 3 TM Cytosolic 476 LG: 1397047.1 2001JUN22 249 266 forward 3 TM Transmembrane 476 LG:1397047.1 2001JUN22 267 507 forward 3 TM Non-Cytosolic 477 LG:1398646.15:2001JUN22 1 63 forward 1 TM Non-Cytosolic 477 LG:1398646.15:2001JUN22 64 86 forward 1 TM Transmembrane 477 LG:1398646.15:2001JUN22 87 287 forward 1 TM Cytosolic 477 LG:1398646.15:2001JUN22 288 310 forward 1 TM Transmembrane 477 LG:1398646.15:2001JUN22 311 329 forward 1 TM Non-Cytosolic 477 LG: 1398646.15:2001 JUN22 330 352 forward 1 TM Transmembrane 477 LG: 1398646.15:2001 JUN22 353 372 forward 1 TM Cytosolic 477 LG:1398646.15:2001JUN22 373 395 forward 1 TM Transmembrane 477 LG:1398646.15:2001JUN22 396 748 forward 1 TM Non-Cytosolic 477 LG:1398646.15:2001JUN22 1 67 forward 2 TM Cytosolic 477 LG:1398646.15:2001JUN22 68 90 forward 2 TM Transmembrane 477 LG:1398646.15:2001JUN22 91 334 forward 2 TM Non-Cytosolic 477 LG: 1398646.15 :2001 JUN22 335 357 forward 2 TM Transmembrane 477 LG:1398646.15:2001JUN22 358 500 forward 2 TM Cytosolic 477 LG:1398646.15:2001JUN22 501 520 forward 2 TM Transmembrane 477 LG: 1398646.15:2001 JUN22 521 601 forward 2 TM Non-Cytosolic 477 LG: 1398646.15:2001 JUN22 602 624 forward 2 TM Transmembrane 477 LG:1398646.15:2001JUN22 625 748 forward 2 TM Cytosolic 477 LG:1398646.15:2001JUN22 1 290 forward 3 TM Non-Cytosolic 477 LG:1398646.15:2001JUN22 291 313 forward 3 TM Transmembrane 477 LG:1398646.15:2001JUN22 314 333 forward 3 TM Cytosolic 477 LG:1398646.15:2001JUN22 334 356 forward 3 TM Transmembrane 477 LG: 1398646.15:2001 JUN22 357 370 forward 3 TM Non-Cytosolic 477 LG:1398646.15:2001JUN22 371 393 forward 3 TM Transmembrane 477 LG:1398646.15:2001JUN22 394 499 forward 3 TM Cytosolic 477 LG: 1398646.15:2001 JUN22 500 522 forward 3 TM Transmembrane 477 LG:1398646.15:2001JUN22 523 536 forward 3 TM Non-Cytosolic 477 LG:1398646.15:2001JUN22 537 559 forward 3 TM Transmembrane 477 LG: 1398646.15 :2001JUN22 560 651 forward 3 TM Cytosolic 477 LG:1398646.15:2001JUN22 652 674 forward 3 TM Transmembrane 477 LG: 1398646.15:2001JUN22 675 677 forward 3 TM Non-Cytosolic 477 LG:1398646.15:2001JUN22 678 697 forward 3 TM Transmembrane 477 LG:1398646.15:2001JUN22 698 748 forward 3 TM Cytosolic 478 LG:1446193.10:2001JUN22 1 941 forward 1 TM Non-Cytosolic 478 LG: 1446193.10:2001 JUN22 942 961 forward 1 TM Transmembrane 478 LG:1446193.10:2001JUN22 962 1036 forward 1 TM Cytosolic TABI .E 2
SEQ D NO Template ID Start Stop Frame Domain Type Topology
478 LG:1446193.10:2001 JUN22 1037 1059 forward 1 TM Transmembrane
478 LG:1446193.10:2001JUN22 1060 1073 forward 1 TM Non-Cytosolic
478 LG:1446193.10:2001JUN22 1074 1096 forward 1 TM Transmembrane
478 LG:1446193.10:2001IUN22 1097 1171 forward 1 TM Cytosolic
478 LG:1446193.10:2001JUN22 1172 1194 forward 1 TM Transmembrane
478 LG:1446193.10:2001JUN22 1195 1371 forward 1 TM Non-Cytosolic
478 LG:1446193.10:2001JUN22 1 1034 forward 2 TM Non-Cytosolic
478 LG:1446193.10:2001JUN22 1035 1057 forward 2 TM Transmembrane
478 LG:1446193.10:2001JUN22 1058 1069 forward 2 TM Cytosolic
478 LG:1446193.10:2001IUN22 1070 1087 forward 2 TM Transmembrane
478 LG:1446193.10:2001JUN22 1088 1371 forward 2 TM Non-Cytosolic
479 LG:1446405.14:2001JUN22 1 3161 forward 1 TM Non-Cytosolic
479 LG:1446405.14:2001JUN22 3162 3184 forward 1 TM Transmembrane
479 LG:1446405.14:2001JUN22 3185 3232 forward 1 TM Cytosolic
479 LG:1446405.14:2001JUN22 3233 3255 forward 1 TM Transmembrane
479 LG: 1446405.14:2001 JUN22 3256 3290 forward 1 TM Non-Cytosolic
479 LG:1446405.14:2001JUN22 3291 3313 forward 1 TM Transmembrane
479 LG:1446405.14:2001JUN22 3314 3410 forward 1 TM Cytosolic
479 LG:1446405.14:2001JUN22 3411 3433 forward 1 TM Transmembrane
479 LG:1446405.14:2001JU 22 3434 3447 forward 1 TM Non-Cytosolic
479 LG:1446405.14:2001JUN22 1 3409 forward 2 TM Non-Cytosolic
479 LG: 1446405.14:2001 JUN22 3410 3432 forward 2 TM Transmembrane
479 LG:1446405.14:2001JUN22 3433 3447 forward 2 TM Cytosolic
479 LG:1446405.14:2001JUN22 1 3127 forward 3 TM Non-Cytosolic
479 LG:1446405.14:2001JUN22 3128 3150 forward 3 TM Transmembrane
479 LG:1446405.14:2001JUN22 3151 3162 forward 3 TM Cytosolic
479 LG:1446405.14:2001JUN22 3163 3185 forward 3 TM Transmembrane
479 LG:1446405.14:2001JUN22 3186 3230 forward 3 TM Non-Cytosolic
479 LG:1446405.14:2001JUN22 3231 3264 forward 3 TM Transmembrane
479 LG:1446405.14:2001JUN22 3265 3283 forward 3 TM Cytosolic
479 LG:1446405.14:2001JUN22 3284 3306 forward 3 TM Transmembrane
479 LG:1446405.14:2001JUN22 3307 3328 forward 3 TM Non-Cytosolic
479 LG:1446405.14:2001JUN22 3329 3351 forward 3 TM Transmembrane
479 LG:1446405.14:2001JUN22 3352 3394 forward 3 TM Cytosolic
479 LG:1446405.14:2001JUN22 3395 3417 forward 3 TM Transmembrane
479 LG:1446405.14:2001JUN22 3418 3426 forward 3 TM Non-Cytosolic
479 LG:1446405.14:2001JUN22 3427 3444 forward 3 TM Transmembrane
479 LG:1446405.14:2001JUN22 3445 3446 forward 3 TM Cytosolic
480 LG:1448148.1:2001JUN22 1 139 forward 2 TM Cytosolic
480 LG:1448148.1:2001JUN22 140 162 forward 2 TM Transmembrane
480 LG: 1448148.1:2001JUN22 163 538 forward 2 TM Non-Cytosolic
480 LG:1448148.1:2001JUN22 539 561 forward 2 TM Transmembrane
480 LG:1448148.1:2001JUN22 562 577 forward 2 TM Cytosolic
481 LG:1452619.13:2001JUN22 1 12 forward 2 TM Cytosolic
481 LG:1452619.13:2001IUN22 13 35 forward 2 TM Transmembrane
481 LG:1452619.13:2001JUN22 36 76 forward 2 TM Non-Cytosolic
481 LG:1452619.13:2001JUN22 77 99 forward 2 TM Transmembrane
481 LG:1452619.13:2001JUN22 100 105 forward 2 TM Cytosolic
481 LG:1452619.13:2001JUN22 106 128 forward 2 TM Transmembrane
481 LG:1452619.13:2001JUN22 129 363 forward 2 TM Non-Cytosolic
482 LG:1452783.22:2001JUN22 1 85 forward 3 TM Cytosolic
482 LG:1452783.22:2001IUN22 86 108 forward 3 TM Transmembrane
482 LG:1452783.22:2001JUN22 109 2326 forward 3 TM Non-Cytosolic
483 LG:1453417.5:2001JUN22 1 18 forward 1 TM Cytosolic TABLE 2
SEQ D NO: Template ID Start Stop Frame Domain Type Topology
483 LG:1453417.5:2001JUN22 19 41 forward 1 TM Transmembrane
483 LG: 1453417.5:2001 JUN22 42 1206 forward 1 TM Non-Cytosolic
483 LG:1453417.5:2001JUN22 1 88 forward 3 TM Non-Cytosolic
483 LG:1453417.5:2001JUN22 89 111 forward 3 TM Transmembrane
483 LG:1453417.5:2001JUN22 112 117 forward 3 TM Cytosolic
483 LG: 1453417.5:2001 JUN22 118 140 forward 3 TM Transmembrane
483 LG:1453417.5:2001JUN22 141 1206 forward 3 TM Non-Cytosolic
484 LG: 1455222.23:2001 JUN22 1 207 forward 2 TM Cytosolic
484 LG: 1455222.23:2001 JUN22 208 230 forward 2 TM Transmembrane
484 LG: 1455222.23:2001 JUN22 231 596 forward 2 TM Non-Cytosolic
485 LG:149121.8:2001JUN22 1 142 forward 1 TM Non-Cytosolic
485 LG:149121.8:2001JUN22 143 160 forward 1 TM Transmembrane
485 LG:149121.8:2001JUN22 161 179 forward 1 TM Cytosolic
485 LG:149121.8:2001IUN22 180 202 forward 1 TM Transmembrane
485 LG:149121.8:2001JUN22 203 205 forward 1 TM Non-Cytosolic
485 LG:149121.8:2001JUN22 206 228 forward 1 TM Transmembrane
485 LG:149121.8:2001JUN22 229 240 forward 1 TM Cytosolic
485 LG:149121.8:2001JUN22 241 263 forward 1 TM Transmembrane
485 LG:149121.8:2001JUN22 264 293 forward 1 TM Non-Cytosolic
485 LG:149121.8:2001JUN22 294 311 forward 1 TM Transmembrane
485 LG:149121.8:2001JUN22 312 339 forward 1 TM Cytosolic
485 LG:149121.8:2001JUN22 340 362 forward 1 TM Transmembrane
485 LG:149121.8:2001JUN22 363 463 forward 1 TM Non-Cytosolic
485 LG:149121.8:2001IUN22 464 486 forward 1 TM Transmembrane
485 LG:149121.8:2001JUN22 487 559 forward 1 TM Cytosolic
485 LG:149121.8:2001JUN22 560 577 forward 1 TM Transmembrane
485 LG:149121.8:2001JUN22 578 586 forward 1 TM Non-Cytosolic
485 LG:149121.8:2001JUN22 587 609 forward 1 TM Transmembrane
485 LG:149121.8:2001JUN22 610 831 forward 1 TM Cytosolic
485 LG:149121.8:2001JUN22 832 854 forward 1 TM Transmembrane
485 LG:149121.8:2001JUN22 855 868 forward 1 TM Non-Cytosolic
485 LG:149121.8:2001JUN22 869 891 forward 1 TM Transmembrane
485 LG:149121.8:2001JUN22 892 978 forward 1 TM Cytosolic
485 LG: 149121.8:2001 JUN22 979 998 forward 1 TM Transmembrane
485 LG:149121.8:2001JUN22 999 1129 forward 1 TM Non-Cytosolic
485 LG:149121.8:2001JUN22 1130 1152 forward 1 TM Transmembrane
485 LG:149121.8:2001JUN22 1153 1300 forward 1 TM Cytosolic
485 LG:149121.8:2001JUN22 1301 1323 forward 1 TM Transmembrane
485 LG: 149121.8:2001 JUN22 1324 1332 forward 1 TM Non-Cytosolic
485 LG:149121.8:2001JUN22 1 142 forward 2 TM Cytosolic
485 LG:149121.8:2001JUN22 143 165 forward 2 TM Transmembrane
485 LG:149121.8:2001JUN22 166 197 forward 2 TM Non-Cytosolic
485 LG:149121.8:2001IUN22 198 220 forward 2 TM Transmembrane
485 LG:149121.8:2001JUN22 221 466 forward 2 TM Cytosolic
485 LG:149121.8:2001JUN22 467 489 forward 2 TM Transmembrane
485 LG:149121.8:2001IUN22 490 627 forward 2 TM Non-Cytosolic
485 LG:149121.8:2001IUN22 628 650 forward 2 TM Transmembrane
485 LG:149121.8:2001IUN22 651 656 forward 2 TM Cytosolic
485 LG:149121.8:2001JUN22 657 679 forward 2 TM Transmembrane
485 LG:149121.8:2001IUN22 680 1304 forward 2 TM Non-Cytosolic
485 LG:149121.8:2001JUN22 1305 1327 forward 2 TM Transmembrane
485 LG:149121.8:2001JUN22 1328 1332 forward 2 TM Cytosolic
485 LG:149121.8:2001JUN22 1 899 forward 3 TM Non-Cytosolic
485 LG:149121.8:2001JUN22 900 922 forward 3 TM Transmembrane TABLE 2
SEQ D NO: Template ID Start Stop Frame Domain Type Topology
485 LG:149121.8:2001JUN22 923 973 forward 3 TM Cytosolic
485 LG:149121.8:2001JUN22 974 996 forward 3 TM Transmembrane
485 LG:149121.8:2001JUN22 997 1000 forward 3 TM Non-Cytosolic
485 LG:149121.8:2001JUN22 1001 1023 forward 3 TM Transmembrane
485 LG:149121.8:2001JUN22 1024 1043 forward 3 TM Cytosolic
485 LG: 149121.8:2001 JUN22 1044 1066 forward 3 TM Transmembrane
485 LG: 149121.8:2001 JUN22 1067 1331 forward 3 TM Non-Cytosolic
486 LG:1500175.18:2001JUN22 1 534 forward 1 TM Non-Cytosolic
486 LG:1500175.18:2001JUN22 535 557 forward 1 TM Transmembrane
486 LG:1500175.18:2001JUN22 558 576 forward 1 TM Cytosolic
486 LG: 1500175.18:2001 JUN22 577 599 forward 1 TM Transmembrane
486 LG:1500175.18:2001JUN22 600 608 forward 1 TM Non-Cytosolic
486 LG:1500175.18:2001JUN22 609 631 forward 1 TM Transmembrane
486 LG:1500175.18:2001JUN22 632 642 forward 1 TM Cytosolic
486 LG:1500175.18:2001JUN22 1 576 forward 2 TM Non-Cytosolic
486 LG:1500175.18:2001JUN22 577 599 forward 2 TM Transmembrane
486 LG:1500175.18:2001JUN22 600 611 forward 2 TM Cytosolic
486 LG:1500175.18:2001JUN22 612 631 forward 2 TM Transmembrane
486 LG:1500175.18:2001JUN22 632 642 forward 2 TM Non-Cytosolic
486 LG:1500175.18:2001JUN22 1 540 forward 3 TM Non-Cytosolic
486 LG:1500175.18:2001JUN22 541 563 forward 3 TM Transmembrane
486 LG:1500175.18:2001JUN22 564 569 forward 3 TM Cytosolic
486 LG:1500175.18:2001JUN22 570 592 forward 3 TM Transmembrane
486 LG:1500175.18:2001JUN22 593 641 forward 3 TM Non-Cytosolic
487 LG: 1500434.6:2001 JUN22 1 431 forward 1 TM Non-Cytosolic
487 LG:1500434.6:2001JUN22 432 454 forward 1 TM Transmembrane
487 LG:1500434.6:2001JUN22 455 515 forward 1 TM Cytosolic
487 LG: 1500434.6:2001 JUN22 516 535 forward 1 TM Transmembrane
487 LG: 1500434.6:2001 JUN22 536 549 forward 1 TM Non-Cytosolic
487 LG: 1500434.6:2001 JUN22 550 572 forward 1 TM Transmembrane
487 LG: 1500434.6:2001 JUN22 573 576 forward 1 TM Cytosolic
487 LG: 1500434.6:2001 JUN22 577 599 forward 1 TM Transmembrane
487 LG: 1500434.6:2001 JUN22 600 626 forward 1 TM Non-Cytosolic
487 LG:1500434.6:2001JUN22 627 649 forward 1 TM Transmembrane
487 LG: 1500434.6:2001 JUN22 650 693 forward 1 TM Cytosolic
487 LG: 1500434.6:2001 JUN22 694 716 forward 1 TM Transmembrane
487 LG:1500434.6:2001JUN22 717 730 forward 1 TM Non-Cytosolic
487 LG: 1500434.6:2001 JUN22 731 753 forward 1 TM Transmembrane
487 LG: 1500434.6:2001 JUN22 754 759 forward 1 TM Cytosolic
487 LG: 1500434.6:2001JUN22 760 782 forward 1 TM Transmembrane
487 LG: 1500434.6:2001 JUN22 783 796 forward 1 TM Non-Cytosolic
487 LG: 1500434.6:2001 JUN22 797 819 forward 1 TM Transmembrane
487 LG: 1500434.6:2001 JUN22 820 984 forward 1 TM Cytosolic
487 LG: 1500434.6:2001 JUN22 985 1007 forward 1 TM Transmembrane
487 LG: 1500434.6:2001 JUN22 1008 1035 forward 1 TM Non-Cytosolic
487 LG: 1500434.6:2001 JUN22 1036 1058 forward 1 TM Transmembrane
487 LG: 1500434.6:2001 JUN22 1059 1131 forward 1 TM Cytosolic
487 LG: 1500434.6:2001 JUN22 1132 1154 forward 1 TM Transmembrane
487 LG: 1500434.6:2001 JUN22 1155 1168 forward 1 TM Non-Cytosolic
487 LG:1500434.6:2001JUN22 1169 1191 forward 1 TM Transmembrane
487 LG: 1500434.6:2001 JUN22 1192 1282 forward 1 TM Cytosolic
487 LG:1500434.6:2001JUN22 1 461 forward 2 TM Non-Cytosolic
487 LG:1500434.6:2001JUN22 462 484 forward 2 TM Transmembrane
487 LG: 1500434.6:2001 JUN22 485 584 forward 2 TM Cytosolic TABLE 2
SEQ D NO: Template ID Start Stop Frame Domain Type Topology
487 LG: 1500434.6:2001 JUN22 585 607 forward 2 TM Transmembrane
487 LG:1500434.6:2001JUN22 608 621 forward 2 TM Non-Cytosolic
487 LG: 1500434.6:2001 JUN22 622 644 forward 2 TM Transmembrane
487 LG: 1500434.6:2001 JUN22 645 729 forward 2 TM Cytosolic
487 LG: 1500434.6:2001 JUN22 730 752 forward 2 TM Transmembrane
487 LG: 1500434.6:2001 JUN22 753 766 forward 2 TM Non-Cytosolic
487 LG: 1500434.6:2001 JUN22 767 786 forward 2 TM Transmembrane
487 LG:1500434.6:2001JUN22 787 867 forward 2 TM Cytosolic
487 LG: 1500434.6:2001 JUN22 868 890 forward 2 TM Transmembrane
487 LG: 1500434.6:2001 JUN22 891 904 forward 2 TM Non-Cytosolic
487 LG: 1500434.6:2001 JUN22 905 927 forward 2 TM Transmembrane
487 LG: 1500434.6:2001 JUN22 928 1017 forward 2 TM Cytosolic
487 LG: 1500434.6:2001 JUN22 1018 1040 forward 2 TM Transmembrane
487 LG: 1500434.6:2001 JUN22 1041 1129 forward 2 TM Non-Cytosolic
487 LG: 1500434.6:2001 JUN22 1130 1152 forward 2 TM Transmembrane
487 LG: 1500434.6:2001 JUN22 1153 1178 forward 2 TM Cytosolic
487 LG: 1500434.6:2001 JUN22 1179 1201 forward 2 TM Transmembrane
487 LG: 1500434.6:2001 JUN22 1202 1205 forward 2 TM Non-Cytosolic
487 LG: 1500434.6:2001 JUN22 1206 1228 forward 2 TM Transmembrane
487 LG: 1500434.6:2001 JUN22 1229 1282 forward 2 TM Cytosolic
487 LG: 1500434.6:2001 JUN22 1 211 forward 3 TM Non-Cytosolic
487 LG:1500434.6:2001JUN22 212 234 forward 3 TM Transmembrane
487 LG: 1500434.6:2001 JUN22 235 515 forward 3 TM Cytosolic
487 LG: 1500434.6:2001 JUN22 516 535 forward 3 TM Transmembrane
487 LG: 1500434.6:2001 JUN22 536 544 forward 3 TM Non-Cytosolic
' 487 LG:1500434.6:2001JUN22 545 564 forward 3 TM Transmembrane
' 487 LG: 1500434.6:2001 JUN22 565 584 forward 3 TM Cytosolic
487 LG: 1500434.6:2001 JUN22 585 607 forward 3 TM Transmembrane
487 LG: 1500434.6:2001 JUN22 608 643 forward 3 TM Non-Cytosolic
487 LG: 1500434.6:2001 JUN22 644 666 forward 3 TM Transmembrane
487 LG: 1500434.6:2001 JUN22 667 688 forward 3 TM Cytosolic
487 LG: 1500434.6:2001 JUN22 689 711 forward 3 TM Transmembrane
487 LG: 1500434.6:2001JUN22 712 730 forward 3 TM Non-Cytosolic
487 LG: 1500434.6:2001 JUN22 731 753 forward 3 TM Transmembrane
487 LG: 1500434.6:2001 JUN22 754 765 forward 3 TM Cytosolic
487 LG: 1500434.6:2001 JUN22 766 788 forward 3 TM Transmembrane
487 LG:1500434.6:2001JUN22 789 996 forward 3 TM Non-Cytosolic
487 LG: 1500434.6:2001 JUN22 997 1019 forward 3 TM Transmembrane
487 LG: 1500434.6:2001 JUN22 1020 1031 forward 3 TM i Cytosolic
487 LG: 1500434.6:2001 JUN22 1032 1054 forward 3 TM Transmembrane
487 LG: 1500434.6:2001 JUN22 1055 1093 forward 3 TM Non-Cytosolic
487 LG: 1500434.6:2001 JUN22 1094 l l l l forward 3 TM Transmembrane
487 LG: 1500434.6:2001 JUN22 1112 1178 forward 3 TM Cytosolic
487 LG: 1500434.6:2001 JUN22 1179 1201 forward 3 TM Transmembrane
487 LG: 1500434.6:2001 JUN22 1202 1204 forward 3 TM Non-Cytosolic
487 LG: 1500434.6:2001 JUN22 1205 1222 forward 3 TM Transmembrane
487 LG:1500434.6:2001JUN22 1223 1241 forward 3 TM Cytosolic
487 LG: 1500434.6:2001 JUN22 1242 1264 forward 3 TM Transmembrane
487 LG: 1500434.6:2001 JUN22 1265 1282 forward 3 TM Non-Cytosolic
488 LG:1501550.19:2001JUN22 1 920 forward 1 TM Non-Cytosolic
488 LG:1501550.19:2001JUN22 921 943 forward 1 TM Transmembrane
488 LG: 1501550.19:2001 JUN22 944 1068 forward 1 TM Cytosolic
488 LG: 1501550.19:2001 JUN22 1069 1086 forward 1 TM Transmembrane
488 LG:1501550.19:2001JUN22 1087 1110 forward 1 'TM Non-Cytosolic TABLE 2
SEQ D NO: Template ID Start Stop Frame Domain Type Topology
488 LG:1501550.19:2001JUN22 l l l l 1133 forward 1 TM Transmembrane
488 LG:1501550.19:2001JUN22 1134 1212 forward 1 TM Cytosolic
488 LG: 1501550.19:2001 JUN22 1213 1230 forward 1 TM Transmembrane
488 LG:1501550.19:2001JUN22 1231 1627 forward 1 TM Non-Cytosolic
488 LG: 1501550.19:2001 JUN22 1 1083 forward 3 TM Non-Cytosolic
488 LG:1501550.19:2001JUN22 1084 1106 forward 3 TM Transmembrane
488 LG:1501550.19:2001JUN22 1107 1211 forward 3 TM Cytosolic
488 LG:1501550.19:2001JUN22 1212 1234 forward 3 TM Transmembrane
488 LG:1501550.19:2001JUN22 1235 1238 forward 3 TM Non-Cytosolic
488 LG:1501550.19:2001JUN22 1239 1261 forward 3 TM Transmembrane
488 LG:1501550.19:2001JUN22 1262 1281 forward 3 TM Cytosolic
488 LG: 1501550.19:2001 JUN22 1282 1304 forward 3 TM Transmembrane
488 LG: 1501550.19:2001 JUN22 1305 1357 forward 3 TM Non-Cytosolic
488 LG: 1501550.19:2001 JUN22 1358 1375 forward 3 TM Transmembrane
488 LG:1501550.19:2001JUN22 1376 1626 forward 3 TM Cytosolic
489 LG:1501923.26:2001JUN22 1 12 forward 1 TM Non-Cytosolic
489 LG:1501923.26:2001JUN22 13 30 forward 1 TM Transmembrane
489 LG:1501923.26:2001JUN22 31 204 forward 1 TM Cytosolic
490 LG:150960.9:2001JUN22 1 215 forward 3 TM Cytosolic
490 LG: 150960.9:2001 JUN22 216 238 forward 3 TM Transmembrane
490 LG: 150960.9:2001 JUN22 239 257 forward 3 TM Non-Cytosolic
490 LG:150960.9:2001JUN22 258 277 forward 3 TM Transmembrane
490 LG: 150960.9:2001 JUN22 278 297 forward 3 TM Cytosolic
490 LG: 150960.9:2001 JUN22 298 320 forward 3 TM Transmembrane
490 LG: 150960.9:2001 JUN22 321 323 forward 3 TM Non-Cytosolic
490 LG: 150960.9:2001 JUN22 324 346 forward 3 TM Transmembrane
490 LG: 150960.9:2001 JUN22 347 474 forward 3 TM Cytosolic
490 LG:150960.9:2001JUN22 475 497 forward 3 TM Transmembrane
490 ' LG: 150960.9:2001 JUN22 498 521 forward 3 TM Non-Cytosolic
490 LG: 150960.9:2001 JUN22 522 544 forward 3 TM Transmembrane
490 LG: 150960.9:2001 JUN22 545 550 forward 3 TM Cytosolic
490 LG: 150960.9:2001 JUN22 551 573 forward 3 TM Transmembrane
490 LG: 150960.9:2001 JUN22 574 763 forward 3 TM Non-Cytosolic
491 LG: 182744.29:2001JUN22 • 1 193 forward 1 TM Non-Cytosolic
491 LG:182744.29:2001 JUN22 194 216 forward 1 TM Transmembrane
491 LG:182744.29:2001 JUN22 217 389 forward 1 TM Cytosolic
491 LG: 182744.29:2001 JUN22 390 409 forward 1 TM Transmembrane
491 LG: 182744.29:2001 JUN22 410 719 forward 1 TM Non-Cytosolic
491 LG:182744.29:2001 JUN22 1 151 forward 2 TM Non-Cytosolic
491 LG:182744.29:2001 JUN22 152 174 forward 2 TM Transmembrane
491 LG:182744.29:2001 JUN22 175 193 forward 2 TM Cytosolic
491 LG: 182744.29:2001 JUN22 194 216 forward 2 TM Transmembrane
491 LG:182744.29:2001JUN22 217 719 forward 2 TM Non-Cytosolic
491 LG:182744.29:2001 JUN22 1 65 forward 3 TM Cytosolic
491 LG:182744.29:2001JUN22 66 85 forward 3 TM Transmembrane
491 LG:182744.29:2001JUN22 86 718 forward 3 TM Non-Cytosolic
492 LG:197166.1:2001JUN22 1 14 forward 3 TM Non-Cytosolic
492 LG:197166.1:2001JUN22 15 37 forward 3 TM Transmembrane
492 LG:197166.1:2001JUN22 38 84 forward 3 TM Cytosolic
493 LG: 197455.5:2001 JUN22 1 202 forward 3 TM Non-Cytosolic
493 LG:197455.5:2001JUN22 203 225 forward 3 TM Transmembrane
493 LG:197455.5:2001JUN22 226 237 forward 3 TM Cytosolic
493 LG: 197455.5:2001 JUN22 238 260 forward 3 TM Transmembrane
493 LG: 197455.5:2001 JUN22 261 316 forward 3 TM Non-Cytosolic TABLE 2 D NO: Template ID Start Stop Frame Domain Type Topology 93 LG:197455.5:2001JUN22 317 336 forward 3 TM Transmembrane 93 LG: 197455.5:2001 JUN22 337 379 forward 3 TM Cytosolic 94 LG:198251.8:2001JUN22 1 286 forward 1 TM Cytosolic 94 LG:198251.8:2001JUN22 287 309 forward 1 TM Transmembrane 94 LG:198251.8:2001JUN22 310 328 forward 1 TM Non-Cytosolic 94 LG:198251.8:2001JUN22 329 346 forward 1 TM Transmembrane 94 LG:198251.8:2001JUN22 347 507 forward 1 TM Cytosolic 94 LG:198251.8:2001JUN22 508 530 forward 1 TM Transmembrane 94 LG:198251.8:2001JUN22 531 539 forward 1 TM Non-Cytosolic 94 LG:198251.8:2001JUN22 540 559 forward 1 TM Transmembrane 94 LG: 198251.8:2001 JUN22 560 596 forward 1 TM Cytosolic 94 LG:198251.8:2001JUN22 1 78 forward 2 TM Non-Cytosolic 94 LG: 198251.8:2001 JUN22 79 101 forward 2 TM Transmembrane 94 LG:198251.8:2001JUN22 102 315 forward 2 TM Cytosolic 94 LG:198251.8:2001JUN22 316 338 forward 2 TM Transmembrane 94 LG:198251.8:2001JUN22 339 517 forward 2 TM Non-Cytosolic 94 LG:198251.8:2001JUN22 518 540 forward 2 TM Transmembrane 94 LG:198251.8:2001JUN22 541 596 forward 2 TM Cytosolic 94 LG:198251.8:2001JUN22 1 77 forward 3 TM Non-Cytosolic 94 LG:198251.8:2001JUN22 78 100 forward 3 TM Transmembrane 94 LG:198251.8:2001JUN22 101 270 forward 3 TM Cytosolic 94 LG:198251.8:2001JUN22 271 293 forward 3 TM Transmembrane 94 LG:198251.8:2001JUN22 294 307 forward 3 TM Non-Cytosolic 94 LG:198251.8:2001JUN22 308 330 forward 3 TM Transmembrane 94 LG:198251.8:2001JUN22 331 506 forward 3 TM Cytosolic 94 LG:198251.8:2001JUN22 507 529 forward 3 TM Transmembrane 94 LG:198251.8:2001JUN22 530 595 forward 3 TM Non-Cytosolic 95 LG:200149.3:2001JUN22 1 395 forward 1 TM Non-Cytosolic 95 LG:200149.3:2001JUN22 396 418 forward 1 TM Transmembrane 95 LG:200149.3:2001JUN22 419 605 forward 1 TM Cytosolic 95 LG:200149.3 :2001JUN22 606 628 forward 1 TM Transmembrane 95 LG:200149.3:2001JUN22 629 642 forward 1 TM Non-Cytosolic 95 LG:200149.3:2001JUN22 643 665 forward 1 TM Transmembrane 95 LG:200149.3:2001JUN22 666 723 forward 1 TM Cytosolic 95 LG:200149.3:2001JUN22 724 746 forward 1 TM Transmembrane 95 LG:200149.3:2001JUN22 747 824 forward 1 TM Non-Cytosolic 95 LG:200149.3:2001JUN22 825 844 forward 1 TM Transmembrane 95 LG:200149.3:2001JUN22 845 850 forward 1 TM Cytosolic 95 LG:200149.3:2001JUN22 851 873 forward 1 TM Transmembrane 95 LG:200149.3:2001JUN22 874 1372 forward 1 TM Non-Cytosolic 95 LG:200149.3 :2001 JUN22 1 405 forward 2 TM Non-Cytosolic 95 LG:200149.3:2001JUN22 406 428 forward 2 TM Transmembrane 95 LG:200149.3:2001JUN22 429 605 forward 2 TM Cytosolic 95 LG:200149.3:2001JUN22 606 628 forward 2 TM Transmembrane 95 LG:200149.3:2001JUN22 629 647 forward 2 TM Non-Cytosolic 95 LG:200149.3:2001JUN22 648 665 forward 2 TM Transmembrane 95 LG:200149.3:2001JUN22 666 719 forward 2 TM Cytosolic 95 LG:200149.3:2001JUN22 720 742 forward 2 TM Transmembrane 95 LG:200149.3:2001JUN22 743 819 forward 2 TM Non-Cytosolic 95 LG:200149.3:2001JUN22 820 842 forward 2 TM Transmembrane 95 LG:200149.3:2001JUN22 843 1268 forward 2 TM Cytosolic 95 LG:200149.3:2001JUN22 1269 1291 forward 2 TM Transmembrane 95 LG:200149.3:2001JUN22 1292 1305 forward 2 TM Non-Cytosolic 95 LG:200149.3:2001JUN22 1306 1328 forward 2 TM Transmembrane TABLE 2
SEQ D NO: Template ID Start Stop Frame Domain Type Topology
495 LG:200149.3:2001JUN22 1329 1339 forward 2 TM Cytosolic
495 LG:200149.3:2001JUN22 1340 1362 forward 2 TM Transmembrane
495 LG:200149.3:2001IUN22 1363 1372 forward 2 TM Non-Cytosolic
495 LG:200149.3:2001JUN22 1 495 forward 3 TM Non-Cytosolic
495 LG:200149.3:2001JUN22 496 515 forward 3 TM Transmembrane
495 LG:200149.3:2001JUN22 516 575 forward 3 TM Cytosolic
495 LG:200149.3:2001JUN22 576 595 forward 3 TM Transmembrane
495 LG:200149.3:2001JUN22 596 604 forward 3 TM Non-Cytosolic
495 LG:200149.3:2001JUN22 605 627 forward 3 TM Transmembrane
495 LG:200149.3:2001JUN22 628 643 forward 3 TM Cytosolic
495 . LG:200149.3:2001JUN22 644 666 forward 3 TM Transmembrane
495 LG:200149.3:2001JUN22 667 1371 forward 3 TM Non-Cytosolic
' 496 LG:203483.3:2001JUN22 1 568 forward 2 TM Non-Cytosolic
496 LG:203483.3:2001JUN22 569 591 forward 2 TM Transmembrane
496 LG:203483.3:2001JUN22 592 634 forward 2 TM Cytosolic
497 LG:209701.7:2001JUN22 1 163 forward 1 TM Non-Cytosolic
497 LG:209701.7:2001JUN22 164 183 forward 1 TM Transmembrane
497 LG:209701J:2001JUN22 184 195 forward 1 TM Cytosolic
497 LG:209701.7:2001 JUN22 196 218 forward 1 TM Transmembrane
497 LG:209701.7:2001JUN22 219 260 forward 1 TM Non-Cytosolic
497 LG:209701.7:2001JUN22 261 283 forward 1 TM Transmembrane
497 LG:209701.7:2001JUN22 284 316 forward 1 TM Cytosolic
497 LG:209701.7:2001JUN22 317 339 forward 1 TM Transmembrane
497 LG:209701.7:2001JUN22 > 340 343 forward 1 TM Non-Cytosolic
497 LG:209701.7:2001JUN22 344 366 forward 1 TM Transmembrane
497 LG:209701.7:2001JUN22 ■ 367 477 forward 1 TM Cytosolic
497 LG:209701.7:2001JUN22 478 500 forward 1 TM Transmembrane
497 LG:209701.7:2001JUN22 501 511 forward 1 TM Non-Cytosolic
497 LG:209701.7:2001JUN22 1 42 forward 2 TM Cytosolic"
497 LG:209701.7:2001JUN22 43 65 forward 2 TM Transmembrane
497 LG:209701.7:2001JUN22 66 68 forward 2 TM Non-Cytosolic
497 LG:209701.7:2001JUN22 69 91 forward 2 TM Transmembrane
497 LG:209701.7:2001 JUN22 92 209 forward 2 TM Cytosolic
497 LG:209701.7:2001JUN22 210 232 forward 2 TM Transmembrane
497 LG:209701.7:2001JUN22 233 510 forward 2 TM Non-Cytosolic
497 LG:209701.7:2001JUN22 1 225 forward 3 TM Non-Cytosolic
497 LG:209701.7:2001JUN22 226 248 forward 3 TM Transmembrane
497 LG:209701.7:2001 JUN22 249 260 forward 3 TM Cytosolic
497 LG:209701.7:2001 JUN22 261 283 forward 3 TM Transmembrane
497 LG:209701.7:2001JUN22 284 510 forward 3 TM Non-Cytosolic
498 LG:210614.1:2001JUN22 1 77 forward 1 TM Non-Cytosolic
498 LG:210614.1:2001JUN22 78 100 forward 1 TM Transmembrane
498 LG:210614.1:2001JUN22 101 135 forward 1 TM Cytosolic
498 LG:210614.1:2001JUN22 136 158 forward 1 TM Transmembrane
498 LG:210614.1:2001JUN22 159 392 forward 1 TM Non-Cytosolic
498 LG:210614.1:2001JUN22 1 134 forward 2 TM Cytosolic
498 LG:210614.1:2001JUN22 135 157 forward 2 TM Transmembrane
498 LG:210614.1:2001JUN22 158 392 forward 2 TM Non-Cytosolic
499 LG:210672.1:2001 JUN22 1 397 forward 1 TM Cytosolic
499 LG:210672.1:2001JUN22 398 420 forward 1 TM Transmembrane
499 LG:210672.1:2001 JUN22 421 468 forward 1 TM Non-Cytosolic
499 LG:210672.1:2001JUN22 469 491 forward 1 TM Transmembrane
499 LG:210672.1:2001JUN22 492 524 forward 1 TM Cytosolic
499 LG:210672.1:2001JUN22 525 547 forward 1 TM Transmembrane TABLE 2
SEQ D NO: Template ID Start Stop Frame Domain Type Topology
499 LG:210672.1:2001JUN22 548 794 forward 1 TM Non-Cytosolic
499 LG:210672.1:2001JUN22 1 76 forward 2 TM Cytosolic
499 LG:210672.1 :2001JUN22 77 99 forward 2 TM Transmembrane
499 LG.210672.1:2001 JU 22 100 102 forward 2 TM Non-Cytosolic
499 LG:210672.1:2001JUN22 103 125 forward 2 TM Transmembrane
499 LG:210672.1:2001JUN22 126 402 forward 2 TM Cytosolic
499 LG:210672.1:2001 JUN22 403 425 forward 2 TM Transmembrane
499 LG:210672.1:2001JUN22 426 794 forward 2 TM Non-Cytosolic
500 LG:215051.10:2001JUN22 1 543 forward 2 TM Non-Cytosolic
500 LG:215051.10:2001JUN22 544 566 forward 2 TM Transmembrane
500 LG:215051.10:2001JUN22 567 729 forward 2 TM Cytosolic
501 LG:218989.3:2001JUN22 1 105 forward 2 TM Cytosolic
501 LG:218989.3:2001JU 22 106 128 forward 2 TM Transmembrane
501 LG:218989.3:2001JUN22 129 218 forward 2 TM Non-Cytosolic
501 LG:218989.3:2001JUN22 219 241 forward 2 TM Transmembrane
501 LG:218989.3:2001JUN22 242 255 forward 2 TM Cytosolic
502 . LG:228107.11:2001JUN22 1 271 forward 1 TM Non-Cytosolic
502 LG:228107.11:2001 JUN22 272 294 forward 1 TM Transmembrane
502 LG:228107.11 :2001JUN22 295 341 forward 1 TM Cytosolic
502 LG:228107.11 :2001JUN22 342 364 forward 1 TM Transmembrane
502 LG:228107.11:2001 JUN22 365 378 forward 1 TM Non-Cytosolic
502 LG:228107.11:2001JUN22 379 401 forward 1 TM Transmembrane
502 LG:228107.11:2001JUN22 402 413 forward 1 TM Cytosolic
502 LG:228107.11:2001 JUN22 ■ 414 436 forward 1 TM Transmembrane
502 LG:228107.11:2001 JUN22 437 476 forward 1 TM Non-Cytosolic
502 LG:228107.11:2001JUN22 ■ . 477 , 496 forward 1 TM Transmembrane
. 502 LG:228107.11:2001 JUN22 497 497 forward 1 TM Cytosolic
502 LG:228107.11 :2001 JUN22 498 520 forward 1 TM Transmembrane
502 LG:228107.11:2001 JUN22 521 550 forward 1 TM Non-Cytosolic
502 LG:228107.11:2001 JUN22 551 570 forward 1 TM Transmembrane
502 LG:228107.11:2001 JUN22 571 702 forward 1 TM Cytosolic
502 LG:228107.11:2001 JUN22 703 725 forward 1 TM Transmembrane
502 LG:228107.11:2001 JUN22 726 781 forward 1 TM Non-Cytosolic
502 LG:228107.11:2001 JUN22 782 801 forward 1 TM Transmembrane
502 LG.-228107.11.-2001JUN22 802 922 forward 1 TM Cytosolic
502 LG:228107.11:2001 JUN22 923 945 forward 1 TM Transmembrane
502 LG:228107.11:2001JUN22 946 964 forward 1 TM Non-Cytosolic
502 LG:228107.11:2001 JUN22 965 984 forward 1 TM Transmembrane
502 LG:228107.11:2001 JUN22 985 1028 forward 1 TM Cytosolic
502 LG:228107.11:2001 JUN22 1 405 forward 2 TM Non-Cytosolic
502 LG:228107.11:2001 JUN22 406 428 forward 2 TM Transmembrane
502 LG:228107.11:2001 JUN22 429 484 forward 2 TM Cytosolic
502 LG:228107.11 :2001 JUN22 485 504 forward 2 TM Transmembrane
502 LG:228107.11:2001 JUN22 505 783 forward 2 TM Non-Cytosolic
502 LG:228107.11:2001 JUN22 784 801 forward 2 TM Transmembrane
502 LG:228107.11:2001JUN22 802 906 forward 2 TM Cytosolic
502 LG:228107.11:2001 JUN22 907 929 forward 2 TM Transmembrane
502 LG:228107.11:2001JUN22 930 938 forward 2 TM Non-Cytosolic
502 LG:228107.11:2001 JUN22 939 961 forward 2 TM Transmembrane
502 LG:228107.11:2001 JUN22 962 967 forward 2 TM Cytosolic
502 LG:228107.11:2001JUN22 968 990 forward 2 TM Transmembrane
502 LG:228107.H:2001JUN22 991 1004 forward 2 TM Non-Cytosolic
502 LG:228107.11:2001JUN22 1005 1027 forward 2 TM Transmembrane
502 LG:228107.11:2001JUN22 1028 1028 forward 2 TM Cytosolic TABLE 2
SEQ D NO: Template ID Start Stop Frame Domain Type Topology
502 LG:228107.11 :2001JUN22 1 471 forward 3 TM Non-Cytosolic
502 LG:228107.11:2001JUN22 472 494 forward 3 TM Transmembrane
502 LG:228107.11:2001JUN22 495 713 forward 3 TM Cytosolic
502 LG:228107.11:2001JUN22 714 733 forward 3 TM Transmembrane
502 LG:228107.11:2001JUN22 734 778 forward 3 TM Non-Cytosolic
502 LG:228107.11:2001JUN22 779 801 forward 3 TM Transmembrane
502 LG:228107.11:2001JUN22 802 900 forward 3 TM Cytosolic
502 LG:228107.11:2001JUN22 901 923 forward 3 TM Transmembrane
502 LG:228107.11:2001JUN22 924 932 forward 3 TM Non-Cytosolic
502 LG.228107.11:2001 JUN22 933 955 forward 3 TM Transmembrane
502 LG:228107.11:2001JUN22 956 1027 forward 3 TM Cytosolic
503 LG:231016.1:2001JUN22 1 4 forward 2 TM Non-Cytosolic
503 LG:231016.1:2001JUN22 5 27 forward 2 TM Transmembrane
503 LG:231016.1:2001JUN22 28 31 forward 2 TM Cytosolic
503 LG:231016.1:2001JUN22 32 54 forward 2 TM Transmembrane
503 LG:231016.1:2001JUN22 55 304 forward 2 TM Non-Cytosolic
504 LG:235943.60:2001JUN22 28 114 forward 1 SP
504 LG:235943.60:2001JUN22 1 14 forward 1 TM Non-Cytosolic
504 LG:235943.60:2001JUN22 15 37 forward 1 TM Transmembrane
504 LG:235943.60:2001JUN22 38 80 forward 1 TM Cytosolic
504 LG:235943.60:2001JUN22 81 103 forward 1 TM Transmembrane
504 LG:235943.60:2001JUN22 104 363 forward 1 TM Non-Cytosolic
505 LG:235970.14:2001JUN22 1 109 forward 1 TM Cytosolic
505 LG:235970.14:2001JUN22 110 129 forward 1 TM Transmembrane
505 LG:235970.14:2001JUN22 130 138 forward 1 TM Non-Cytosolic
505 LG:235970.14:2001JUN22 139 161 forward 1 TM Transmembrane
505 LG:235970.14:2001JUN22 162 438 forward 1 TM Cytosolic
505 LG:235970.14:2001JUN22 439 461 forward 1 TM Transmembrane
505 LG:235970.14:2001JUN22 462 679 forward 1 TM Non-Cytosolic
506 LG:236697.15:2001JUN22 1 534 forward 1 TM Non-Cytosolic
506 LG-.236697.15:2001JUN22 535 557 forward 1 TM Transmembrane
506 LG:236697.15:2001JUN22 558 577 forward 1 TM Cytosolic
506 LG:236697.15:2001JUN22 578 597 forward 1 TM Transmembrane
506 LG:236697.15:2001 JUN22 598 616 forward 1 TM Non-Cytosolic
506 LG:236697.15:2001JUN22 617 639 forward 1 TM Transmembrane
506 LG:236697.15:2001 JUN22 640 682 forward 1 TM Cytosolic
506 LG:236697.15:2001JUN22 1 218 forward 2 TM Non-Cytosolic
506 LG:236697.15:2001 JUN22 219 241 forward 2 TM Transmembrane
506 LG:236697.15:2001JUN22 242 370 forward 2 TM Cytosolic
506 LG:236697.15:2001JUN22 371 388 forward 2 TM Transmembrane
506 LG:236697.15:2001JUN22 389 542 forward 2 TM Non-Cytosolic
506 LG:236697.15:2001 JUN22 543 565 forward 2 TM Transmembrane
506 LG:236697.15:2001JUN22 566 577 forward 2 TM Cytosolic
506 LG:236697.15:2001 JUN22 578 595 forward 2 TM Transmembrane
506 LG:236697.15:2001JUN22 596 609 forward 2 TM Non-Cytosolic
506 LG:236697.15:2001JUN22 610 629 forward 2 TM Transmembrane
506 LG:236697.15:2001JUN22 630 649 forward 2 TM Cytosolic
506 LG:236697.15 :2001 JUN22 650 672 forward 2 TM Transmembrane
506 LG:236697.15:2001JUN22 673 682 forward 2 TM Non-Cytosolic
506 LG:236697.15:2001 JUN22 1 463 forward 3 TM Non-Cytosolic
506 LG.-236697.15:2001 JUN22 464 486 forward 3 TM Transmembrane
506 LG:236697.15:2001JUN22 487 535 forward 3 TM Cytosolic
506 LG:236697.15:2001 JUN22 536 558 forward 3 TM Transmembrane
506 LG:236697.15:2001JUN22 559 572 forward 3 TM Non-Cytosolic TABLE 2
SEQ D NO: Template ID Start Stop Frame Domain Type Topology
506 LG:236697.15:2001JUN22 573 592 forward 3 TM Transmembrane
506 LG:236697.15:2001JUN22 593 614 forward 3 TM Cytosolic
506 LG:236697.15:2001IUN22 615 637 forward 3 TM Transmembrane
506 LG:236697.15:2001JUN22 638 681 forward 3 TM Non-Cytosolic
507 LG:238576.3:2001JUN22 1 36 forward 1 TM Non-Cytosolic
507 LG:238576.3:2001JUN22 37 59 forward 1 TM Transmembrane
507 LG:238576.3:2001JUN22 60 150 forward 1 TM Cytosolic
508 LG:238602.2:2001JUN22 1 139 for ward , 1 TM Cytosolic
508 LG:238602.2:2001JUN22 140 162 forward 1 TM Transmembrane
508 LG:238602.2:2001JUN22 163 183 forward 1 TM Non-Cytosolic
508 LG:238602.2:2001JUN22 184 206 forward 1 TM Transmembrane
508 LG:238602.2:2001JUN22 207 210 forward 1 TM Cytosolic
508 LG:238602.2:2001JUN22 211 233 forward 1 TM Transmembrane
508 LG:238602.2:2001JUN22 234 268 forward 1 TM Non-Cytosolic
508 LG:238602.2:2001JUN22 269 291 forward 1 TM Transmembrane
508 LG:238602.2:2001JUN22 292 402 forward 1 TM Cytosolic
508 LG:238602.2:2001JUN22 403 425 forward 1 TM Transmembrane
508 LG:238602.2:2001JUN22 426 439 forward 1 TM Non-Cytosolic
508 LG:238602.2:2001JUN22 440 462 forward 1 TM Transmembrane
508 LG:238602.2:2001JUN22 463 487 forward 1 TM Cytosolic
508 LG:238602.2:2001JUN22 488 507 forward 1 TM Transmembrane
508 LG:238602.2:2001JUN22 508 892 forward 1 TM Non-Cytosolic
508 LG:238602.2:2001JUN22 1 173 forward 2 TM Cytosolic
508 LG:238602.2:2001JUN22 174 196 forward 2 TM Transmembrane
508 LG:238602.2:2001JUN22 197 210 forward 2 TM Non-Cytosolic
' 508 LG:238602.2:2001JUN22 211 233 forward 2 TM Transmembrane
508 LG:238602.2:2001JUN22 " 234 398 forward 2 TM Cytosolic
508 LG:238602.2:2001JUN22 399 418 forward 2 TM Transmembrane
508 LG:238602.2:2001JUN22 419 437 forward 2 TM Non-Cytosolic
508 LG:238602.2:2001JUN22 438 460 forward 2 TM Transmembrane
508 LG:238602.2:2001JUN22 461 480 forward 2 TM Cytosolic
508 LG:238602.2:2001JUN22 481 503 forward 2 TM Transmembrane
508 LG:238602.2:2001JUN22 504 892 forward 2 TM Non-Cytosolic
508 LG:238602.2:2001JUN22 1 31 forward 3 TM Cytosolic
508 LG:238602.2:2001JUN22 32 49 forward 3 TM Transmembrane
508 LG:238602.2:2001JUN22 50 52 forward 3 TM Non-Cytosolic
508 LG:238602.2:2001JUN22 53 75 forward 3 TM Transmembrane
508 LG:238602.2:2001JUN22 76 160 forward 3 TM Cytosolic
508 LG:238602.2:2001JUN22 161 183 forward 3 TM Transmembrane
508 LG:238602.2:2001JUN22 184 210 forward 3 TM Non-Cytosolic
508 LG:238602.2:2001JUN22 211 233 forward 3 TM Transmembrane
508 LG:238602.2:2001JUN22 234 303 forward 3 TM Cytosolic
508 LG:238602.2:2001JUN22 304 326 forward 3 TM Transmembrane
508 LG:238602.2:2001JUN22 327 356 forward 3 TM Non-Cytosolic
508 LG:238602.2:2001JUN22 . 357 379 forward 3 TM Transmembrane
508 LG:238602.2:2001JUN22 380 395 forward 3 TM Cytosolic
508 LG:238602.2:2001JUN22 396 415 forward 3 TM Transmembrane
508 LG:238602.2:2001JUN22 416 439 forward 3 TM Non-Cytosolic
508 LG:238602.2:2001JUN22 440 462 forward 3 TM Transmembrane
508 LG:238602.2:2001JUN22 463 489 forward 3 TM Cytosolic
508 LG:238602.2:2001JUN22 490 508 forward 3 TM Transmembrane
508 LG:238602.2:2001JUN22 509 891 forward 3 TM Non-Cytosolic
509 LG:241291.46:2001JUN22 1 633 forward 1 TM Non-Cytosolic
509 LG:241291.46:2001JUN22 634 656 forward 1 TM Transmembrane TABLE 2
SEQ D NO: Template ID Start Stop Frame Domain Type Topology
509 LG:241291.46:2001JUN22 657 1032 forward 1 TM Cytosolic
509 LG:241291.46:2001JUN22 1033 1055 forward 1 TM Transmembrane
509 LG:241291.46:2001JUN22 1056 1064 forward 1 TM Non-Cytosolic
509 LG:241291.46:2001JUN22 1065 1084 forward 1 TM Transmembrane
509 LG:241291.46:2001JUN22 1085 1272 forward 1 TM Cytosolic
509 LG:241291.46:2001JUN22 1273 1295 forward 1 TM Transmembrane
509 LG:241291.46:2001JUN22 1296 2007 forward 1 TM Non-Cytosolic
509 LG:241291.46:2001JUN22 2008 2025 forward 1 TM Transmembrane
509 LG:241291.46:2001JUN22 2026 2037 forward 1 TM Cytosolic
509 LG:241291.46:2001JUN22 2038 2060 forward 1 TM Transmembrane
509 LG:241291.46:2001JUN22 2061 2155 forward 1 TM Non-Cytosolic
509 LG:241291.46:2001JUN22 2156 2178 forward 1 TM Transmembrane
509 LG:241291.46:2001JUN22 2179 2190 forward 1 TM Cytosolic
509 LG:241291.46:2001 JUN22 2191 2213 forward 1 TM Transmembrane
509 LG:241291.46:2001 JUN22 2214 2653 forward 1 TM Non-Cytosolic
509 LG:241291.46:2001JUN22 1 2047 forward 2 TM Non-Cytosolic
509 LG:241291.46:2001JUN22 2048 2070 forward 2 TM Transmembrane
509 LG:241291.46:2001JUN22 2071 2162 forward 2 TM Cytosolic
509 LG:241291.46:2001JUN22 2163 2185 forward 2 TM Transmembrane
509 LG:241291.46:2001JUN22 2186 2199 forward 2 TM Non-Cytosolic
509 LG:241291.46:2001JUN22 2200 2222 forward 2 TM Transmembrane
509 LG:241291.46:2001JUN22 2223 2228 forward 2 TM Cytosolic
509 LG:241291.46:2001JUN22 2229 2248 forward 2 TM Transmembrane
509 LG:241291.46:2001JUN22 2249 2262 forward 2 TM Non-Cytosolic
509 LG:241291.46:2001JUN22 2263 2285 forward^ TM Transmembrane
509 LG:241291.46:2001JUN22 2286 2410 forward 2 TM Cytosolic
509 LG:241291.46:2001JUN22 2411 2433 forward 2 TM Transmembrane
509 LG:241291.46:2001JUN22 2434 2447 forward 2 TM Non-Cytosolic
509 LG:241291.46:2001JUN22 2448 2470 forward 2 TM Transmembrane
509 LG:241291.46:2001JUN22 2471 2652 forward 2 TM Cytosolic
509 LG:241291.46:2001JUN22 1 877 forward 3 TM Non-Cytosolic
509 LG:241291.46:2001JUN22 878 897 forward 3 TM Transmembrane
509 LG:241291.46:2001JUN22 898 917 forward 3 TM Cytosolic
509 LG:241291.46:2001JUN22 918 940 forward 3 TM Transmembrane
509 LG:241291.46:2001JUN22 941 1060 forward 3 TM Non-Cytosolic
509 LG:241291.46:2001JUN22 1061 1083 forward 3 TM Transmembrane
509 LG:241291.46:2001JUN22 1084 1103 forward 3 TM Cytosolic
509 LG:241291.46:2001JUN22 1104 1126 forward 3 TM Transmembrane
509 LG:241291.46:2001JUN22 1127 1964 forward 3 TM Non-Cytosolic
509 LG:241291.46:2001JUN22 1965 1984 forward 3 TM Transmembrane
509 LG:241291.46:2001JUN22 1985 1996 forward 3 TM Cytosolic
509 LG:241291.46:2001JUN22 1997 2013 forward 3 TM Transmembrane
509 LG:241291.46:2001JUN22 2014 2022 forward 3 TM Non-Cytosolic
509 LG:241291.46:2001JUN22 2023 2045 forward 3 TM Transmembrane
509 LG:241291.46:2001JUN22 2046 2162 forward 3 TM Cytosolic
509 LG:241291.46:2001JUN22 2163 2185 forward 3 TM Transmembrane
509 LG:241291.46:2001JUN22 2186 2199 forward 3 TM Non-Cytosolic
509 LG:241291.46:2001JUN22 2200 2222 forward 3 TM Transmembrane
509 LG:241291.46:2001JUN22 2223 2563 forward 3 TM Cytosolic
509 LG:241291.46:2001JUN22 2564 2586 forward 3 TM Transmembrane
509 LG:241291.46:2001 JUN22 2587 2610 forward 3 TM Non-Cytosolic
509 LG:241291.46:2001JUN22 2611 2633 forward 3 TM Transmembrane
509 LG:241291.46:2001JUN22 2634 2652 forward 3 TM Cytosolic
510 LG:241742.1:2001JUN22 1 1431 forward 1 TM Non-Cytosolic TABLE 2 Q D NO: : Template ID Start Stop Frame Domain Type Topology
510 LG:241742.1:2001 JUN22 1432 1454 forward 1 TM Transmembrane
510 LG:241742.1:2001JUN22 1455 1783 forward 1 TM Cytosolic
510 LG:241742.1:2001JUN22 1784 1806 forward 1 TM Transmembrane
510 1X3:241742.1:2001 JUN22 1807 1847 forward 1 TM Non-Cytosolic
510 LG:241742.1:2001JUN22 1848 1870 forward 1 TM Transmembrane
* 510 LG:241742.1:2001JUN22 1871 1899 forward 1 TM Cytosolic
510 LG:241742.1:2001 JUN22 1 1018 forward 2 TM Non-Cytosolic
510 LG:241742.1:2001 JUN22 1019 1041 forward 2 TM Transmembrane
510 LG:241742.1:2001JUN22 1042 1133 forward 2 TM Cytosolic
510 LG:241742.1:2001 JUN22 1134 1156 forward 2 TM Transmembrane
510 LG:241742.1:2001JUN22 1157 1899 forward 2 TM Non-Cytosolic
510 LG:241742.1:2001 JUN22 1 1014 forward 3 TM Non-Cytosolic
510 LG:241742.1:2001 JUN22 1015 1037 forward 3 TM Transmembrane
510 LG:241742.1:2001 JUN22 1038 1136 forward 3 TM Cytosolic
510 LG:241742.1:2001 JUN22 1137 1159 forward 3 TM Transmembrane
510 LG:241742.1:2001 JUN22 1160 1898 forward 3 TM Non-Cytosolic
511 LG:244520.33:2001JUN22 1 106 forward 3 TM Non-Cytosolic
511 • LG:244520.33:2001JUN22 107 129 forward 3 TM Transmembrane
511 LG:244520.33:2001JUN22 130 148 forward 3 TM Cytosolic
511 LG:244520.33:2001JUN22 149 168 forward 3 TM Transmembrane
511 LG:244520.33:2001JUN22 169 350 forward 3 TM Non-Cytosolic
512 LG:247556.1:2001JUN22 1 14 forward 1 TM Non-Cytosolic
512 LG:247556.1:2001 JUN22 15 37 forward 1 TM Transmembrane
512 LG:247556.1:2001JUN22 38 80 forward 1 TM Cytosolic
512 LG:247556.1:2001JUN22 1 20 forward 2 TM Cytosolic
512 LG:247556.1:2001 JUN22 21 43 forward 2 TM Transmembrane
512 LG:247556.1:2001JUN22 44 52 forward 2 TM Non-Cytosolic
512 LG:247556.1:2001 JUN22 53 75 forward 2 TM Transmembrane
512 LG:247556.1:2001 JUN22 76 80 forward 2 TM Cytosolic
513 LG:247792.5:2001JUN22 1 472 forward 3 TM Non-Cytosolic
513 LG:247792.5:2001JUN22 473 495 forward 3 TM Transmembrane
513 LG:247792.5:2001JUN22 496 640 forward 3 TM Cytosolic
514 LG:253580.6:2001JUN22 1 687 forward 1 TM Non-Cytosolic
514 LG:253580.6:2001JUN22 688 710 forward 1 TM Transmembrane
514 LG:253580.6:2001JUN22 711 729 forward 1 TM Cytosolic
514 LG:253580.6:2001JUN22 730 752 forward 1 TM Transmembrane
514 LG:253580.6:2001JUN22 753 766 forward 1 TM Non-Cytosolic
514 LG:253580.6:2001JUN22 767 789 forward 1 TM Transmembrane
514 LG:253580.6:2001JUN22 790 801 forward 1 TM Cytosolic
514 LG:253580.6:2001JUN22 802 824 forward 1 TM Transmembrane
514 LG:253580.6:2001JUN22 825 1245 forward 1 TM Non-Cytosolic
514 LG:253580.6:2001JUN22 1246 1268 forward 1 TM Transmembrane
514 LG:253580.6:2001JUN22 1269 1390 forward 1 TM Cytosolic
514 LG:253580.6:2001JUN22 1 213 forward 2 TM Non-Cytosolic
514 LG:253580.6:2001JUN22 214 236 forward 2 TM Transmembrane
514 LG:253580.6:2001JUN22 237 296 forward 2 TM Cytosolic
514 LG:253580.6:2001JUN22 297 319 forward 2 TM Transmembrane
514 LG:253580.6:2001JUN22 320 348 forward 2 TM Non-Cytosolic
514 LG:253580.6:2001JUN22 349 371 forward 2 TM Transmembrane
514 LG:253580.6:2001JUN22 372 377 forward 2 TM Cytosolic
514 LG:253580.6:2001JUN22 378 395 forward 2 TM Transmembrane
514 LG:253580.6:2001JUN22 396 399 forward 2 TM Non-Cytosolic
514 LG:253580.6:2001JUN22 400 422 forward 2 TM Transmembrane
514 LG:253580.6:2001JUN22 423 444 forward 2 TM Cytosolic TABLE 2
SEQ D NO: Template ID Start Stop Frame Domain Type Topology
514 LG:253580.6:2001JUN22 445 467 forward 2 TM Transmembrane
514 LG:253580.6:2001JUN22 468 578 forward 2 TM Non-Cytosolic
514 LG:253580.6:2001JUN22 579 601 forward 2 TM Transmembrane
514 LG:253580.6:2001JUN22 602 613 forward 2 TM Cytosolic
514 LG:253580.6:2001JUN22 614 636 forward 2 TM Transmembrane
514 LG:253580.6:2001JUN22 637 694 forward 2 TM Non-Cytosolic
514 LG:253580.6:2001JUN22 695 717 forward 2 TM Transmembrane
514 LG:253580.6:2001JUN22 718 729 forward 2 TM Cytosolic
514 LG:253580.6:2001JUN22 730 749 forward 2 TM Transmembrane
514 LG:253580.6:2001JUN22 750 763 forward 2 TM Non-Cytosolic
514 LG:253580.6:2001JUN22 764 784 forward 2 TM Transmembrane
514 LG:253580.6:2001JUN22 785 857 forward 2 TM Cytosolic
514 LG:253580.6:2001JUN22 858 880 forward 2 TM Transmembrane
514 LG:253580.6:2001JUN22 881 1390 forward 2 TM Non-Cytosolic
514 LG:253580.6:2001JUN22 1 112 forward 3 TM Cytosolic
514 LG:253580.6:2001JUN22 113 135 forward 3 TM Transmembrane
514 LG:253580.6:2001JUN22 136 211 forward 3 TM Non-Cytosolic
514 LG:253580.6:2001JUN22 212 229 forward 3 TM Transmembrane
514 LG:253580.6:2001JUN22 230 298 forward 3 TM Cytosolic
514 LG:253580.6:2001JUN22 299 321 forward 3 TM Transmembrane
514 LG:253580.6:2001JUN22 322 324 forward 3 TM Non-Cytosolic
514 LG:253580.6:2001JUN22 325 342 forward 3 TM Transmembrane
514 LG:253580.6:2001JUN22 343 348 forward 3 TM Cytosolic
514 LG:253580.6:2001JUN22 349 371 forward 3 . TM Transmembrane
514 LG:253580.6:2001JUN22 372 380 forward 3 TM Non-Cytosolic
514 LG:253580.6:2001JUN22 381 403 forward 3 - TM Transmembrane
514 LG:253580.6:2001JUN22 404 441 forward 3 , TM Cytosolic
514 LG:253580.6:2001JU 22 442 464 forward 3 TM Transmembrane
514 LG:253580.6:2001JUN22 465 577 forward 3 . TM - Non-Cytosolic
514 LG:253580.6:2001JUN22 578 600 forward 3 TM Transmembrane
514 LG:253580.6:2001JUN22 601 606 forward 3 TM Cytosolic
514 LG:253580.6:2001JUN22 607 629 forward 3 TM Transmembrane
514 LG:253580.6:2001JUN22 630 741 forward 3 TM Non-Cytosolic
514 LG:253580.6:2001JUN22 742 764 forward 3 TM Transmembrane
514 LG:253580.6:2001JUN22 765 815 forward 3 TM Cytosolic
514 LG:253580.6:2001JUN22 816 838 forward 3 TM Transmembrane
514 LG:253580.6:2001JUN22 839 857 forward 3 TM Non-Cytosolic
514 LG:253580.6:2001JUN22 858 880 forward 3 TM Transmembrane
514 LG:253580.6:2001JUN22 881 1016 forward 3 TM Cytosolic
514 LG:253580.6:2001JUN22 1017 1039 forward 3 TM Transmembrane
514 LG:253580.6:2001JUN22 1040 1390 forward 3 TM Non-Cytosolic
515 LG:291759.5:2001JUN22 1 119 forward 1 TM Cytosolic
515 LG:291759.5:2001JUN22 120 139 forward 1 TM Transmembrane
515 LG:291759.5:2001JUN22 140 175 forward 1 TM Non-Cytosolic
515 LG:291759.5:2001JUN22 176 198 forward 1 TM Transmembrane
515 LG:291759.5:2001JUN22 199 202 forward 1 TM Cytosolic
515 LG:291759.5:2001JUN22 203 225 forward 1 TM Transmembrane
515 LG:291759.5:2001JUN22 226 588 forward 1 TM Non-Cytosolic
516 LG:298226.1:2001 JUN22 1 9 forward 1 TM Non-Cytosolic
516 LG:298226.1:2001JUN22 10 32 forward 1 TM Transmembrane
516 LG:298226.1:2001 JUN22 33 65 forward 1 TM Cytosolic
516 LG:298226.1:2001 JUN22 66 88 forward 1 TM Transmembrane
516 LG:298226.1:2001 JUN22 89 97 forward 1 TM Non-Cytosolic
516 LG:298226.1:2001 JUN22 98 120 forward 1 TM Transmembrane TABLE 2
SEQ D NO Template ID Start Stop Frame Domain Type Topology
516 LG:298226.1:2001JUN22 121 132 forward 1 TM Cytosolic
516 LG:298226.1 :2001 JUN22 133 155 forward 1 TM Transmembrane
516 LG.298226.1:2001JUN22 156 192 forward 1 TM Non-Cytosolic
516 LG:298226.1:2001JUN22 193 212 forward 1 TM Transmembrane
516 LG:298226.1:2001JUN22 213 362 forward 1 TM Cytosolic
516 LG:298226.1:2001JUN22 363 385 forward 1 TM Transmembrane
516 LG:298226.1:2001 JUN22 386 386 forward 1 TM Non-Cytosolic
516 LG.-298226.1:2001 JUN22 1 4 forward 2 TM Non-Cytosolic
516 LG:298226.1:2001JUN22 5 27 forward 2 TM Transmembrane
516 LG:298226.1:2001 JUN22 28 130 forward 2 TM Cytosolic
516 LG-.298226.1:2001 JUN22 131 153 forward 2 TM Transmembrane
516 LG:298226.1:2001JUN22 154 385 forward 2 TM Non-Cytosolic
516 LG:298226.1:2001JUN22 1 50 forward 3 TM Non-Cytosolic
516 LG:298226.1:2001JUN22 51 73 forward 3 TM Transmembrane
516 LG:298226.1:2001JUN22 74 132 forward 3 TM Cytosolic
516 LG:298226.1:2001 JUN22 133 155 forward 3 TM Transmembrane
516 LG:298226.1:2001 JUN22 156 169 forward 3 TM Non-Cytosolic
516 LG-.298226.1:2001 JUN22 170 192 forward 3 TM Transmembrane
516 LG:298226.1:2001 JUN22 193 385 forward 3 TM Cytosolic
517 LG:306342.1:2001JUN22 1 12 forward 2 TM Cytosolic
517 LG:306342.1:2001 JUN22 13 35 forward 2 TM Transmembrane
517 LG:306342.1:2001JUN22 36 56 forward 2 TM Non-Cytosolic
517 LG:306342.1:2001 JUN22 57 79 forward 2 TM Transmembrane
517 LG:306342.1:2001 JUN22 80 234 forward 2 TM Cytosolic
517 LG:306342.1:2001 JUN22 235 257 forward 2 TM Transmembrane
517 LG:306342.1:2001 JUN22 258 314 forward 2 TM Non-Cytosolic
518 LG:327144.5 :2001JUN22 1 578 forward 1 TM Non-Cytosolic
518 LG:327144.5:2001JUN22 579 601 forward 1 TM Transmembrane
518 LG:327144.5:2001JUN22 602 645 forward 1 TM ' Cytosolic
518 LG:327144.5:2001JUN22 646 668 forward 1 TM Transmembrane
518 LG:327144.5:2001JUN22 669 903 forward 1 TM Non-Cytosolic
518 LG:327144.5:2001JUN22 1 578 forward 3 TM Non-Cytosolic
518 LG:327144.5:2001JUN22 579 601 forward 3 TM Transmembrane
518 LG:327144.5:2001JU 22 602 902 forward 3 TM Cytosolic
519 LG:331499.8:2001JUN22 1 cA9 forward 1 TM Non-Cytosolic
519 LG:331499.8:2001 JUN22 600 622 forward 1 TM Transmembrane
519 LG:331499.8:2001JUN22 623 807 forward 1 TM Cytosolic
520 LG:331582.12:2001JUN22 1 61 forward 1 TM Cytosolic
520 LG:331582.12:2001JUN22 62 84 forward 1 TM Transmembrane
520 LG:331582.12:2001 JUN22 85 743 forward 1 TM Non-Cytosolic
520 LG:331582.12:2001JUN22 744 766 forward 1 TM Transmembrane
520 LG:331582.12:2001JUN22 767 778 forward 1 TM Cytosolic
520 LG:331582.12:2001JUN22 779 801 forward 1 TM Transmembrane
520 LG:331582.12:2001JUN22 802 845 forward 1 TM Non-Cytosolic
520 LG:331582.12:2001JUN22 1 792 forward 2 TM Non-Cytosolic
520 LG:331582.12:2001JUN22 793 815 forward 2 TM Transmembrane
520 LG:331582.12:2001JUN22 816 845 forward 2 TM Cytosolic
521 LG:333017.12:2001JUN22 1 57 forward 3 TM Cytosolic
521 LG:333017.12:2001 JUN22 58 80 forward 3 TM Transmembrane
521 LG:333017.12:2001JUN22 81 185 forward 3 TM Non-Cytosolic
522 LG:334438.8:2001JUN22 1 49 forward 1 TM Non-Cytosolic
522 LG:334438.8:2001JUN22 50 72 forward 1 TM Transmembrane
522 LG:334438.8:2001JUN22 73 136 forward 1 TM Cytosolic
522 LG:334438.8:2001JUN22 137 156 forward 1 TM Transmembrane TABLE 2
SEQ D NO: Template ID Start Stop Frame Domain Type Topology
522 LG:334438.8:2001JUN22 157 160 forward 1 TM Non-Cytosolic
522 LG:334438.8:2001JUN22 161 183 forward 1 TM Transmembrane
522 LG:334438.8:2001JUN22 184 251 forward 1 TM Cytosolic
522 LG:334438.8:2001JUN22 252 269 forward 1 TM Transmembrane
522 LG:334438.S:2001JUN22 270 517 forward 1 TM Non-Cytosolic
522 LG:334438.8:2001JUN22 518 540 forward 1 TM Transmembrane
522 LG:334438.8:2001JUN22 541 562 forward 1 TM Cytosolic
522 LG:334438.8:2001JUN22 1 54 forward 2 TM Non-Cytosolic
522 LG:334438.8:2001JUN22 55 77 forward 2 TM Transmembrane
522 LG:334438.8:2001JUN22 78 144 forward 2 TM Cytosolic
522 LG:334438.8:2001JUN22 145 167 forward 2 TM Transmembrane
522 LG:334438.8:2001JUN22 168 226 forward 2 TM Non-Cytosolic
522 LG:334438.8:2001JUN22 227 249 forward 2 TM Transmembrane
522 LG:334438.8:2001JUN22 250 495 forward 2 TM Cytosolic
522 LG:334438.8:2001JUN22 496 518 forward 2 TM Transmembrane
522 LG:334438.8:2001JUN22 519 561 forward 2 TM Non-Cytosolic
522 LG:334438.8:2001JUN22 1 56 forward 3 TM Cytosolic
522 LG:334438.8:2001JUN22 57 79 forward 3 TM Transmembrane
522 LG:334438.8:2001JUN22 80 561 forward 3 TM Non-Cytosolic
523 LG:337835.7:2001JUN22 1 38 forward 3 TM Cytosolic 523 LG:337835J:2001JUN22 39 61 forward 3 TM Transmembrane
523 LG:337835.7:200UUN22 62 373 forward 3 TM Non-Cytosolic
524 LG:346536.12:200UUN22 1 603 forward 1 TM Non-Cytosolic 524 LG:346536.12:2001 JUN22 604 626 forward 1 TM Transmembrane 524 LG:346536.12:2001JUN22 627 627 forward 1 TM Cytosolic 524 LG:346536.12:2001JUN22 628 647 forward 1 TM Transmembrane 524 LG:346536.12:2001JUN22 648 1188 forward 1 TM Non-Cytosolic 524 LG:346536.12:2001 JUN22 1 1021 forward 3 TM Non-Cytosolic 524 LG:346536.12:2001 JUN22 1022 1044 forward 3 TM Transmembrane
524 LG:346536.12:2001JUN22 1045 1188 forward 3 TM Cytosolic
525 LG:348117.5:2001 JUN22 1 135 forward 1 TM Non-Cytosolic 525 LG:348117.5:2001 JUN22 136 155 forward 1 TM Transmembrane 525 LG:348117.5:2001JUN22 156 274 forward 1 TM Cytosolic 525 LG:348117.5:2001JUN22 275 297 forward 1 TM Transmembrane 525 LG:348117.5:2001JUN22 298 654 forward 1 TM Non-Cytosolic 525 LG:348117.5:2001JUN22 1 251 forward 2 TM Non-Cytosolic 525 LG:348117.5:2001JUN22 252 274 forward 2 TM Transmembrane 525 LG:348117.5:2001JUN22 275 285 forward 2 TM Cytosolic 525 LG:348117.5:2001JUN22 286 308 forward 2 TM Transmembrane 525 LG:348117.5:2001 JUN22 309 653 forward 2 TM Non-Cytosolic 525 LG:348117.5:2001JUN22 1 37 forward 3 TM Non-Cytosolic 525 LG.-348117.5:2001 JUN22 38 60 forward 3 TM Transmembrane 525 LG:348117.5:2001 JUN22 61 296 forward 3 TM Cytosolic 525 LG:348117.5:2001 JUN22 297 319 forward 3 TM Transmembrane
525 LG:348117.5:2001 JUN22 320 653 forward 3 TM Non-Cytosolic
526 LG:350407.22:2001JUN22 1 70 forward 1 TM Cytosolic 526 LG:350407.22:2001JUN22 71 93 forward 1 TM Transmembrane 526 LG:350407.22:2001JUN22 94 102 forward 1 TM Non-Cytosolic 526 LG:350407.22:2001JUN22 103 125 forward 1 TM Transmembrane 526 LG:350407.22:2001JUN22 126 144 forward 1 TM Cytosolic 526 LG:350407.22:2001JUN22 1 85 forward 2 TM Non-Cytosolic 526 LG:350407.22:2001JUN22 86 108 forward 2 TM Transmembrane
526 LG:350407.22:2001JUN22 109 144 forward 2 TM Cytosolic
527 LG:373219.13:2001JUN22 1 23 forward 1 TM Non-Cytosolic TABLE 2
SEQ D NO: Template ID Start Stop Frame Domain Type Topology
527 LG:373219.13:2001JUN22 24 46 forward 1 TM Transmembrane
527 LG:373219.13:2001JUN22 47 100 forward 1 TM Cytosolic
527 LG:373219.13:2001JUN22 101 120 forward 1 TM Transmembrane
527 LG:373219.13:2001JUN22 121 244 forward 1 TM Non-Cytosolic
527 LG:373219.13:2001JUN22 245 267 forward 1 TM Transmembrane
527 LG:373219.13:2001JUN22 268 353 forward 1 TM Cytosolic
527 LG:373219.13:2001JUN22 354 376 forward 1 TM Transmembrane
527 LG:373219.13:2001JUN22 377 413 forward 1 TM Non-Cytosolic
527 LG:373219.13:2001JUN22 414 436 forward 1 TM Transmembrane
527 LG:373219.13:2001JUN22 437 461 forward 1 TM Cytosolic
527 LG:373219.13:2001JUN22 462 484 forward 1 TM Transmembrane
527 LG:373219.13:2001JUN22 485 986 forward 1 TM Non-Cytosolic
527 LG:373219.13:2001JUN22 1 19 forward 2 TM Non-Cytosolic
527 LG:373219.13:2001JUN22 20 42 forward 2 TM Transmembrane
527 LG:373219.13:2001JUN22 43 229 forward 2 TM Cytosolic
527 LG:373219.13:2001JUN22 230 252 forward 2 TM Transmembrane
527 LG:373219.13:2001JUN22 253 280 forward 2 TM Non-Cytosolic
527 LG:373219.13:2001JUN22 281 303 forward 2 TM Transmembrane
527 LG:373219.13:2001JUN22 304 440 forward 2 TM Cytosolic
527 LG:373219.13:2001JUN22 441 460 forward 2 TM Transmembrane
527 LG:373219.13:2001JUN22 461 464 forward 2 TM Non-Cytosolic
527 LG:373219.13:2001JUN22 465 484 forward 2 TM Transmembrane
527 LG:373219.13:2001JUN22 485 636 forward 2 TM Cytosolic
527 LG:373219.13:2001JUN22 637 659 forward 2 TM Transmembrane
527 LG:373219.13:2001JUN22 660 703 forward 2 TM Non-Cytosolic
527 LG:373219.13:2001JUN22 704 723 forward 2 TM Transmembrane
527 LG:373219.13:2001JUN22 724 735 forward 2 TM Cytosolic
527 LG:373219.13:2001JUN22 736 758 forward 2 TM Transmembrane
527 LG:373219.13:2001JUN22 759 875 forward 2 TM Non-Cytosolic
527 LG:373219.13:2001JUN22 876 898 forward 2 TM Transmembrane
527 LG:373219.13:2001JUN22 899 910 forward 2 TM Cytosolic
527 LG:373219.13:2001JUN22 91 1 933 forward 2 TM Transmembrane
527 LG:373219.13:2001JUN22 934 986 forward 2 TM Non-Cytosolic
527 LG:373219.13:2001JUN22 1 19 forward 3 TM ' Cytosolic
527 LG:373219.13:2001JUN22 20 39 forward 3 TM Transmembrane
527 LG:373219.13:2001JUN22 40 43 forward 3 TM Non-Cytosolic
527 LG:373219.13:2001JUN22 44 66 forward 3 TM Transmembrane
527 LG:373219.13:2001JUN22 67 223 forward 3 TM Cytosolic
527 LG:373219.13:2001JUN22 224 246 forward 3 TM Transmembrane
527 LG:373219.13:2001 JUN22 247 275 forward 3 TM Non-Cytosolic
527 LG:373219.13:2001JUN22 276 298 forward 3 TM Transmembrane
527 LG:373219.13:2001JUN22 299 327 forward 3 TM Cytosolic
527 LG:373219.13:2001JUN22 328 347 forward 3 TM Transmembrane
527 LG:373219.13:2001JUN22 348 361 forward 3 TM Non-Cytosolic
527 LG:373219.13:2001JUN22 362 384 forward 3 TM Transmembrane
527 LG:373219.13:2001JUN22 385 404 forward 3 TM Cytosolic
527 LG:373219.13:2001JUN22 405 422 forward 3 TM Transmembrane
527 LG:373219.13:2001JUN22 423 426 forward 3 TM Non-Cytosolic
527 LG:373219.13:2001JUN22 427 449 forward 3 TM Transmembrane
527 LG:373219.13:2001JUN22 450 461 forward 3 TM Cytosolic
527 LG.-373219.13:2001 JUN22 462 484 forward 3 TM Transmembrane
527 LG:373219.13:2001JUN22 485 488 forward 3 TM Non-Cytosolic
527 LG:373219.13:2001JUN22 489 511 forward 3 TM Transmembrane
527 LG:373219.13:2001JUN22 512 515 forward 3 TM Cytosolic TABLE 2
SEQ D NO: Template ID Start Stop Frame Domain Type Topology
527 LG:373219.13:2001JUN22 516 538 forward 3 TM Transmembrane
527 LG:373219.13:2001JUN22 539 577 forward 3 TM Non-Cytosolic
527 LG:373219.13:2001JUN22 578 600 forward 3 TM Transmembrane
527 LG:373219.13:2001JUN22 601 709 forward 3 TM Cytosolic
527 LG:373219.13:2001JUN22 710 732 forward 3 TM Transmembrane
527 LG:373219.13:2001JUN22 733 741 forward 3 TM Non-Cytosolic
527 LG:373219.13:2001JUN22 742 764 forward 3 TM Transmembrane
527 LG:373219.13:2001JUN22 765 873 forward 3 TM Cytosolic
527 LG:373219.13:2001JUN22 874 891 forward 3 TM Transmembrane
527 LG:373219.13:2001JUN22 892 910 forward 3 TM Non-Cytosolic
527 LG:373219.13:2001JUN22 911 933 forward 3 TM Transmembrane
527 LG:373219.13:2001 JUN22 934 985 forward 3 TM Cytosolic
528 LG:375048.15:2001 JUN22 1 891 forward 2 TM Non-Cytosolic
528 LG:375048.15:2001JUN22 892 909 forward 2 TM Transmembrane
528 LG:375048.15:2001JUN22 910 913 forward 2 TM Cytosolic
528 LG:375048.15:2001JUN22 914 936 forward 2 TM Transmembrane
528 LG:375048.15:2001JUN22 937 1309 forward 2 TM Non-Cytosolic
528 LG:375048.15:2001 JUN22 1 117 forward 3 TM Cytosolic
528 LG:375048.15:2001 JUN22 118 135 forward 3 TM Transmembrane
528 LG:375048.15:2001JUN22 136 175 forward 3 TM Non-Cytosolic
528 LG:375048.15:2001JUN22 176 198 forward 3 TM Transmembrane
528 LG:375048.15:2001 JUN22 199 292 forward 3 TM Cytosolic
528 LG:375048.15:2001JUN22 293 315 forward 3 TM Transmembrane
528 LG:375048.15:2001 JUN22 ' 316 334 forward 3 TM Non-Cytosolic
528 LG:375048.15:2001JUN22 335 357 forward 3 TM Transmembrane
528 LG:375048.15:2001JUN22 358 403 forward 3 TM Cytosolic
528 LG:375048.15:2001JUN22 404 423 forward 3 TM Transmembrane
528 LG:375048.15:2001 JUN22 424 1309 forward 3 TM Non-Cytosolic
529 LG:400114.3:2001JUN22 1 541 forward 1 TM Cytosolic
529 LG:400114.3:2001JUN22 542 564 forward 1 TM Transmembrane
529 LG:400114.3:2001 JUN22 565 597 forward 1 TM Non-Cytosolic
529 LG:400114.3:2001 JUN22 598 617 forward 1 TM Transmembrane
529 LG:400114.3:2001 JUN22 618 838 forward 1 TM Cytosolic
529 LG:400114.3:2001 JUN22 839 858 forward 1 TM Transmembrane
529 LG:400114.3:2001 JUN22 859 909 forward 1 TM Non-Cytosolic
529 LG:400114.3:2001 JUN22 910 932 forward 1 TM Transmembrane
529 LG:400114.3:2001 JUN22 933 1083 forward 1 TM Cytosolic
530 LG:400652.1:2001 JUN22 1 11 15 forward 1 TM Non-Cytosolic
530 LG:400652.1:2001 JUN22 1116 1138 forward 1 TM Transmembrane
530 LG:400652.1:2001 JUN22 1139 1264 forward 1 TM Cytosolic
530 LG:400652.1:2001JUN22 1265 1287 forward 1 TM Transmembrane
530 LG:400652.1:2001 JUN22 1288 1301 forward 1 TM Non-Cytosolic
530 LG:400652.1:2001JUN22 1302 1324 forward 1 TM Transmembrane
530 LG:400652.1:2001 JUN22 1325 1351 forward 1 TM Cytosolic
530 LG:400652.1:2001JUN22 1 494 forward 2 TM Non-Cytosolic
530 LG:400652.1:2001 JUN22 495 517 forward 2 TM Transmembrane
530 LG:400652.1:2001 JUN22 518 613 forward 2 TM Cytosolic
530 LG:400652.1:2001JUN22 614 636 forward 2 TM Transmembrane
530 LG:400652.1:2001JUN22 637 1350 forward 2 TM Non-Cytosolic
530 LG:400652.1:2001 JUN22 1 1098 forward 3 TM Non-Cytosolic
530 LG:400652.1:2001JUN22 1099 1 1 16 forward 3 TM Transmembrane
530 LG:400652.1:2001 JUN22 1 1 17 1 120 forward 3 TM Cytosolic
530 LG:400652.1:2001JUN22 1 121 1 143 forward 3 TM Transmembrane
530 LG:400652.1:2001JUN22 1 144 1 157 forward 3 TM Non-Cytosolic TABLE 2
SEQ D NO Template ID Start Stop Frame Domain Type Topology
530 LG:400652.1 :2001 JUN22 1158 1180 forward 3 TM Transmembrane
530 LG:400652.1:2001JUN22 1181 1192 forward 3 TM Cytosolic
530 LG:400652.1:2001 JUN22 1193 1215 forward 3 TM Transmembrane
530 LG.400652.1:2001 JUN22 1216 1350 forward 3 TM Non-Cytosolic
531 LG:401313.10:2001JUN22 1 379 forward 3 TM Non-Cytosolic
531 LG:401313.10:2001IUN22 380 402 forward 3 TM Transmembrane
531 LG:401313.10:2001JUN22 403 408 forward 3 TM Cytosolic
531 LG:401313.10:2001JUN22 409 431 forward 3 TM Transmembrane
531 LG:401313.10:2001JUN22 432 440 forward 3 TM Non-Cytosolic
531 LG:401313.10:2001JUN22 441 463 forward 3 TM Transmembrane
531 LG:401313.10:2001JUN22 464 474 forward 3 TM Cytosolic
532 LG:406389.1:2001 JUN22 1 37 forward 2 TM Cytosolic
532 LG:406389.1:2001 JUN22 38 60 forward 2 TM Transmembrane
532 LG:406389.1:2001 JUN22 61 160 forward 2 TM Non-Cytosolic
532 LG:406389.1:2001 JUN22 161 183 forward 2 TM Transmembrane
532 LG:406389.1:2001 JUN22 184 199 forward 2 TM Cytosolic
532 LG:406389.1:2001 JUN22 200 222 forward 2 TM Transmembrane
532 LG:406389.1:2001 JUN22 223 739 forward 2 TM Non-Cytosolic
533 LG:406595.2:2001JUN22 1 4 forward 1 TM Cytosolic
533 LG:406595.2:2001JUN22 5 27 forward 1 TM Transmembrane
533 LG:406595.2:2001JUN22 28 41 forward 1 TM Non-Cytosolic
533 LG:406595.2:2001JUN22 42 64 forward 1 TM Transmembrane
533 LG:406595.2:2001JUN22 65 99 forward 1 TM Cytosolic
533 LG:406595.2:2001JUN22 100 122 forward 1 TM Transmembrane
533 LG:406595.2:2001JUN22 123 136 forward ,1 TM Non-Cytosolic
533 LG:406595.2:2001JUN22 137 159 forward 1 TM Transmembrane
533 LG:406595.2:2001JUN22 160 170 forward 1 TM Cytosolic
533 LG:406595.2:2001JUN22 171 193 forward 1 TM Transmembrane
533 LG:406595.2:2001JUN22 194 250 forward 1 TM Non-Cytosolic
533 LG:406595.2:2001JUN22 251 273 forward 1 TM Transmembrane
533 LG:406595.2:2001JUN22 274 443 forward 1 TM Cytosolic
533 LG:406595.2:2001JUN22 444 466 forward 1 TM Transmembrane
533 LG:406595.2:2001JUN22 467 485 forward 1 TM Non-Cytosolic
533 LG:406595.2:2001JUN22 486 508 forward 1 TM Transmembrane
533 LG:406595.2:2001JUN22 509 726 forward 1 TM Cytosolic
533 LG:406595.2:2001JUN22 727 749 forward 1 TM Transmembrane
533 LG:406595.2:2001JUN22 750 763 forward 1 TM Non-Cytosolic
533 LG:406595.2:2001JUN22 764 786 forward 1 TM Transmembrane
533 LG:406595.2:2001JUN22 787 894 forward 1 TM Cytosolic
533 LG:406595.2:2001JUN22 895 917 forward 1 TM Transmembrane
533 LG:406595.2:2001JUN22 918 1341 forward 1 TM Non-Cytosolic
533 LG:406595.2:2001JUN22 1 94 forward 2 TM Cytosolic
533 LG:406595.2:2001JUN22 95 117 forward 2 TM Transmembrane
533 LG:406595.2:2001JUN22 118 442 forward 2 TM Non-Cytosolic
533 LG:406595.2:2001JUN22 443 465 forward 2 TM Transmembrane
533 LG:406595.2:2001JUN22 466 633 forward 2 TM Cytosolic
533 LG:406595.2:2001JUN22 634 653 forward 2 TM Transmembrane
533 LG:406595.2:2001JUN22 654 1064 forward 2 TM Non-Cytosolic
533 LG:406595.2:2001JUN22 1065 1087 forward 2 TM Transmembrane
533 LG:406595.2:2001JUN22 1088 1120 forward 2 TM Cytosolic
533 LG:406595.2:2001JUN22 1121 1143 forward 2 TM Transmembrane
533 LG:406595.2:2001JUN22 1144 1152 forward 2 TM Non-Cytosolic
533 LG:406595.2:2001JUN22 1 153 1 172 forward 2 TM Transmembrane
533 LG:406595.2:2001JUN22 1 173 1304 forward 2 TM Cytosolic TABLE 2
SEQ D NO: Template ID Start Stop Frame Domain Type Topology
533 LG:406595.2:2001JUN22 1305 1327 forward 2 TM Transmembrane
533 LG:406595.2:2001JUN22 1328 1341 forward 2 TM Non-Cytosolic
533 LG:406595.2:2001JUN22 1 336 forward 3 TM Non-Cytosolic
533 LG:406595.2:2001JUN22 337 359 forward 3 TM Transmembrane
533 LG:406595.2:2001JUN22 . 360 378 forward 3 TM Cytosolic
533 LG:406595.2:2001JUN22 379 398 forward 3 TM Transmembrane
533 LG:406595.2:2001JUN22 399 450 forward 3 TM Non-Cytosolic
533 LG:406595.2:2001JUN22 451 473 forward 3 TM Transmembrane
533 LG:406595.2:2001 JUN22 474 479 forward 3 TM Cytosolic
533 LG:406595.2:2001JUN22 480 502 forward 3 TM Transmembrane
533 LG:406595.2:2001JUN22 503 543 forward 3 TM Non-Cytosolic
533 LG:406595.2:2001JUN22 544 566 forward 3 TM Transmembrane
533 LG:406595.2:2001JUN22 567 838 forward 3 TM Cytosolic
533 LG:406595.2:2001JUN22 839 861 forward 3 TM Transmembrane
533 LG:406595.2:2001JUN22 862 1340 forward 3 TM Non-Cytosolic
534 LG:410628.21:2001JUN22 1 161 forward 1 TM Cytosolic
534 LG:410628.21:2001 JUN22 162 184 forward 1 TM Transmembrane
534 LG:410628.21:2001JUN22 185 203 forward 1 TM Non-Cytosolic
534 LG:410628.21:2001JUN22 1 8 forward 2 TM Cytosolic
534 LG:410628.21:2001JUN22 9 31 forward 2 TM Transmembrane
534 LG:410628.21:2001JUN22 32 202 forward 2 TM Non-Cytosolic
534 LG:410628.21:2001JUN22 1 21 forward 3 TM Non-Cytosolic
534 LG:410628.21:2001TUN22 22 44 forward 3 TM Transmembrane
534 LG:410628.21:2001 JUN22 45 64 forward 3 TM Cytosolic
534 LG:410628.21:2001JUN22 65 87 , forward 3 TM Transmembrane
534 LG:410628.21:2001JUN22- 88' 91 forward 3 TM Non-Cytosolic
534 LG:410628.21:200UUN22 92 114 forward 3 TM Transmembrane
534 LG:410628.21:2001JUN22 115 202 forward 3 TM Cytosolic
535 LG:413583.15:2001JUN22 1 777 forward 1 TM Non-Cytosolic
535 LG:413583.15:2001JUN22 778 800 forward 1 TM Transmembrane
535 LG:413583.15:2001JUN22 801 834 forward 1 TM Cytosolic
535 LG:413583.15:2001JUN22 835 857 forward 1 TM Transmembrane
535 LG:413583.15:2001JUN22 858 866 forward 1 TM Non-Cytosolic
535 LG:413583.15:2001JUN22 867 889 forward 1 TM Transmembrane
535 LG:413583.15:2001 JUN22 890 1120 forward 1 TM Cytosolic
535 LG:413583.15:2001JUN22 1121 1143 forward 1 TM Transmembrane
535 LG:413583.15:2001JUN22 1144 1145 forward 1 TM Non-Cytosolic
535 LG:413583.15:2001JUN22 1 837 forward 2 TM Non-Cytosolic
535 LG:413583.15:2001JUN22 838 860 forward 2 TM Transmembrane
535 LG:413583.15:2001JUN22 861 871 forward 2 TM Cytosolic
535 LG:413583.15:2001JUN22 872 894 forward 2 TM Transmembrane
535 LG:413583.15:2001JUN22 895 1145 forward 2 TM Non-Cytosolic
535 LG:413583.15:2001 JUN22 1 637 forward 3 TM Non-Cytosolic
535 LG:413583.15:2001JUN22 638 657 forward 3 TM Transmembrane
535 LG:413583.15:2001 JUN22 658 718 forward 3 TM Cytosolic
535 LG:413583.15:2001JUN22 719 741 forward 3 TM Transmembrane
535 LG:413583.15:2001JUN22 742 755 forward 3 TM Non-Cytosolic
535 LG:413583.15:2001JUN22 756 778 forward 3 TM Transmembrane
535 LG:413583.15:2001JUN22 779 831 forward 3 TM Cytosolic
535 LG:413583.15:2001JUN22 832 854 forward 3 TM Transmembrane
535 LG:413583.15:2001 JUN22 855 868 forward 3 TM Non-Cytosolic
535 LG:413583.15:2001JUN22 869 891 forward 3 TM Transmembrane
535 LG:413583.15:2001JUN22 892 1145 forward 3 TM Cytosolic
536 LG:419641.35:2001JUN22 1 530 forward 1 TM Non-Cytosolic TABLE 2
SEQ D NO: Template ID Start Stop Frame Domain Type Topology
536 LG:419641.35:2001JUN22 531 548 forward 1 TM Transmembrane
536 LG:419641.35:2001JUN22 549 668 forward 1 TM Cytosolic
536 LG:419641.35:2001JUN22 669 688 forward 1 TM Transmembrane
536 LG:419641.35:2001JUN22 689 1100 forward 1 TM Non-Cytosolic
536 LG:419641.35:2001JUN22 1 1002 forward 2 TM Non-Cytosolic
536 LG:419641.35:2001JUN22 1003 1020 forward 2 TM Transmembrane
536 LG:419641.35:2001JUN22 1021 1032 forward 2 TM Cytosolic
536 LG:419641.35:2001JUN22 1033 1055 forward 2 TM . Transmembrane
536 LG:419641.35:2001IUN22 1056 1074 forward 2 TM Non-Cytosolic
536 LG:419641.35:2001IUN22 1075 1097 forward 2 TM Transmembrane
536 LG:419641.35:2001JUN22 1098 1100 forward 2 TM Cytosolic
536 LG:419641.35:2001JUN22 1 93 forward 3 TM Cytosolic
" 536 LG:419641.35:2001JUN22 94 116 forward 3 TM Transmembrane
536 LG:419641.35:2001JUN22 117 996 forward 3 TM Non-Cytosolic
536 LG:419641.35:2001JUN22 997 1019 forward 3 TM Transmembrane
536 LG:419641.35:2001JUN22 1020 1099 forward 3 TM Cytosolic
537 LG:420759.4:2001JUN22 1 100 forward 3 TM Cytosolic
537 LG:420759.4:2001IUN22 101 123 forward 3 TM Transmembrane
537 LG:420759.4:2001JUN22 124 125 forward 3 TM Non-Cytosolic
538 LG:425448.18:2001 JUN22 1 355 forward 1 TM Cytosolic
538 LG:425448.18:2001JUN22 356 378 forward 1 TM Transmembrane
538 LG:425448.18:2001JUN22 379 1500 forward 1 TM Non-Cytosolic
539 LG:435717.5:2001JUN22 1 20 forward 1 TM Cytosolic
539 LG:435717.5:2001JUN22 21 43 forward 1 TM Transmembrane
539 LG:435717.5:2001JUN22 44 688 forward 1 TM Non-Cytosolic
539 LG:435717.5:2001IUN22 689 706 forward 1 TM Transmembrane
539 LG:435717.5:2001JUN22 707 712 forward 1 . TM Cytosolic
539 LG:435717.5:2001JUN22 713 732 forward 1 TM Transmembrane
539 LG:435717.5:2001JUN22 733 746 forward 1 TM Non-Cytosolic
539 LG:435717.5:2001IUN22 747 769 forward 1 TM Transmembrane
539 LG:435717.5:2001JU 22 770 789 forward 1 TM Cytosolic
539 LG:435717.5:2001IUN22 1 14 forward 2 TM Non-Cytosolic
539 LG:435717.5:2001JUN22 15 34 forward 2 TM Transmembrane
539 LG:435717.5:2001JUN22 35 71 forward 2 TM Cytosolic
539 LG:435717.5:2001JUN22 72 94 forward 2 TM Transmembrane
539 LG:435717.5:2001JU 22 95 113 forward 2 TM Non-Cytosolic
539 LG:435717.5:2001JUN22 114 136 forward 2 TM Transmembrane
539 LG:435717.5:2001IUN22 137 190 forward 2 TM Cytosolic
539 LG:435717.5:2001JUN22 191 213 forward 2 TM Transmembrane
539 LG:435717.5:2001JUN22 214 401 forward 2 TM Non-Cytosolic
539 LG:435717.5:2001JUN22 402 424 forward 2 TM Transmembrane
539 LG:435717.5:2001JUN22 425 753 forward 2 TM Cytosolic
539 LG:435717.5:2001JUN22 754 776 forward 2 TM Transmembrane
539 LG:435717.5:2001JUN22 777 789 forward 2 TM Non-Cytosolic
539 LG:435717.5:2001IUN22 1 405 forward 3 TM Non-Cytosolic
539 LG:435717.5:2001JUN22 406 428 forward 3 TM Transmembrane
539 LG:435717.5:2001JUN22 429 480 forward 3 TM Cytosolic
539 LG:435717.5:2001JUN22 481 503 forward 3 TM Transmembrane
539 LG:435717.5:2001JUN22 504 720 forward 3 TM Non-Cytosolic
539 LG:435717.5:2001JUN22 721 743 forward 3 TM Transmembrane
539 LG:435717.5:2001 JUN22 744 749 forward 3 TM Cytosolic
539 LG:435717.5:2001JUN22 750 769 forward 3 TM Transmembrane
539 LG:435717.5:2001IUN22 770 788 forward 3 TM Non-Cytosolic
540 LG:441 159.31 :2001JUN22 1 725 forward 1 TM Non-Cytosolic TABLE 2
SEQ D NO: Template ID Start Stop Frame Domain Type Topology
540 LG:441159.31:2001JUN22 726 748 forward 1 TM Transmembrane
540 LG:441159.31:2001 JUN22 749 767 forward 1 TM Cytosolic
540 LG:441159.31:2001JUN22 768 787 forward 1 TM Transmembrane
540 LG.441159.31:2001 JUN22 788 810 forward 1 TM Non-Cytosolic
540 LG:441159.31:2001JUN22 811 833 forward 1 TM Transmembrane
540 LG:441159.31:2001JUN22 834 835 forward 1 TM Cytosolic
540 LG:441159.31:2001JUN22 1 242 forward 2 TM Non-Cytosolic
540 LG:441159.31:2001JUN22 243 265 forward 2 TM Transmembrane
540 LG:441159.31:2001 JUN22 266 618 forward 2 TM Cytosolic
540 LG:441159.31:2001JUN22 619 641 forward 2 TM Transmembrane
540 LG.441159.31:2001JUN22 642 725 forward 2 TM Non-Cytosolic
540 LG:441159.31:2001JUN22 726 748 forward 2 TM Transmembrane
540 LG:441159.31 :2001 JUN22 749 768 forward 2 TM Cytosolic
540 LG.441159.31:2001JUN22 769 788 forward 2 TM Transmembrane
540 LG:441159.31:2001JUN22 789 834 forward 2 TM Non-Cytosolic
540 LG.-441159.31:2001 JUN22 1 459 forward 3 TM Non-Cytosolic
540 LG:441159.31:2001 JUN22 460 482 forward 3 TM Transmembrane
540 LG:441159.31:2001JUN22 483 486 forward 3 TM Cytosolic
540 LG:441159.31:2001JUN22 487 509 forward 3 TM Transmembrane
540 LG:441159.31:2001JUN22 510 722 forward 3 TM Non-Cytosolic
540 LG:441159.31:2001JUN22 723 745 forward 3 TM Transmembrane
540 LG:441159.31:2001JUN22 746 765 forward 3 TM Cytosolic
540 LG:441159.31:2001JUN22 766 788 forward 3 TM Transmembrane
540 LG:441159.31:2001JUN22 789 834 forward 3 TM Non-Cytosolic
541 LG:461375.2:2001JUN22 1 1414 forward 1 TM Non-Cytosolic
541 LG:461375.2:2001JUN22 1415 1437 forward 1 TM Transmembrane
541 LG:461375.2:2001JUN22 1438 1438 forward 1 TM Cytosolic
541 LG:461375.2:2001JUN22 1439 1461 forward 1 TM Transmembrane
541 LG:461375.2:2001JUN22 1462 1613 forward 1 TM Non-Cytosolic
541 LG:461375.2:2001JUN22 1 260 forward 2 TM Non-Cytosolic
541 LG:461375.2:2001JUN22 261 283 forward 2 TM Transmembrane
541 LG:461375.2:2001JUN22 284 303 forward 2 TM Cytosolic
541 LG:461375.2:2001JUN22 304 326 forward 2 TM Transmembrane
541 LG:461375.2:2001JUN22 327 335 forward 2 TM Non-Cytosolic
541 LG:461375.2:2001JUN22 336 358 forward 2 TM Transmembrane
541 LG:461375.2:2001JUN22 359 423 forward 2 TM Cytosolic
541 LG:461375.2:2001JUN22 424 446 forward 2 TM Transmembrane
541 LG:461375.2:2001 JUN22 447 1357 forward 2 TM Non-Cytosolic
541 LG:461375.2:2001JUN22 1358 1380 forward 2 TM Transmembrane
541 LG:461375.2:2001JUN22 1381 1434 forward 2 TM Cytosolic
541 LG:461375.2:2001JUN22 1435 1457 forward 2 TM Transmembrane
541 LG:461375.2:2001JUN22 1458 1547 forward 2 TM Non-Cytosolic
541 LG:461375.2:2001JUN22 1548 1570 forward 2 TM Transmembrane
541 LG:461375.2:2001JUN22 1571 1582 forward 2 TM Cytosolic
541 LG:461375.2:2001JUN22 1583 1605 forward 2 TM Transmembrane
541 LG:461375.2:2001JUN22 1606 1613 forward 2 TM Non-Cytosolic
541 LG:461375.2:2001JUN22 1 1318 forward 3 TM Non-Cytosolic
541 LG:461375.2:2001JUN22 1319 1341 forward 3 TM Transmembrane
541 LG:461375.2:2001JUN22 1342 1440 forward 3 TM Cytosolic
541 LG:461375.2:2001JUN22 1441 1463 forward 3 TM Transmembrane
541 LG:461375.2:2001JUN22 1464 1477 forward 3 TM Non-Cytosolic
541 LG:461375.2:2001JUN22 1478 1500 forward 3 TM Transmembrane
541 LG:461375.2:2001JUN22 1501 1578 forward 3 TM Cytosolic
541 LG:461375.2:2001 JUN22 1579 1598 forward 3 TM Transmembrane TABI JE 2
SEQ D NO: Template ID Start Stop Frame Domain Type Topology
541 LG:461375.2:2001JUN22 1599 1613 forward 3 TM Non-Cytosolic
542 LG:474674.34:2001JUN22 1 4 forward 1 TM Non-Cytosolic 542 LG:474674.34:2001JU 22 5 27 forward 1 TM Transmembrane 542 LG:474674.34:2001JUN22 28 125 forward 1 TM Cytosolic 542 LG:474674.34:2001JUN22 126 / 148 forward 1 TM Transmembrane 542 LG:474674.34:2001JUN22 149 284 forward 1 TM Non-Cytosolic 542 LG:474674.34:2001JUN22 1 14 forward 3 TM Non-Cytosolic 542 LG:474674.34:2001JUN22 15 33 forward 3 TM Transmembrane
542 LG:474674.34:2001JUN22 34 283 forward 3 TM Cytosolic
543 LG:481414.8:2001JUN22 1 857 forward 1 TM Non-Cytosolic 543 LG:481414.8:2001JUN22 858 880 forward 1 TM Transmembrane 543 LG:481414.8:2001JUN22 881 886 forward 1 TM Cytosolic 543 LG:481414.8:2001JUN22 887 906 forward 1 TM Transmembrane 543 LG:481414.8:2001JUN22 907 982 forward 1 TM Non-Cytosolic 543 LG:481414.8:2001JUN22 1 480 forward 2 TM Non-Cytosolic 543 LG:481414.8:2001JUN22 481 503 forward 2 TM Transmembrane 543 LG:481414.8:2001JUN22 504 635 forward 2 TM Cytosolic 543 LG:481414.8:2001JUN22 636 658 forward 2 TM Transmembrane
543 LG:481414.8:2001JUN22 659 981 forward 2 TM Non-Cytosolic
544 LG:7669276.1:2001 JUN22 1 174 forward 2 TM Non-Cytosolic 544 LG:7669276.1:2001 JUN22 175 197 forward 2 TM Transmembrane
544 LG:7669276.1:2001 JUN22 198 202 forward 2 TM Cytosolic
545 LG:7677848.1:2001JUN22 1 9 forward 1 TM Non-Cytosolic 545 LG:7677848.1:2001 JUN22 10 32 forward 1 TM Transmembrane 545 LG:7677848.1:2001 JTJN22 33 62 forward 1 TM Cytosolic 545 LG:7677848.1:2001JUN22 63 85 forward 1 TM Transmembrane
545 LG:7677848.1:2001 JUN22 86 109 forward 1 TM Non-Cytosolic
546 LG:7684981.3:2001 JUN22 1 25 forward 1 TM Cytosolic 546 LG:7684981.3:2001 JUN22 26 48 forward 1 TM Transmembrane 546 LG:7684981.3:2001JUN22 49 128 forward 1 TM Non-Cytosolic 546 LG:7684981.3:2001JUN22 129 151 forward 1 TM Transmembrane 546 LG:7684981.3:2001 JUN22 152 471 forward 1 TM Cytosolic 546 LG:7684981.3:2001JUN22 472 494 forward 1 TM Transmembrane 546 LG:7684981.3:2001JUN22 495 718 forward 1 TM Non-Cytosolic 546 LG:7684981.3:2001JUN22 1 128 forward 2 TM Non-Cytosolic 546 LG:7684981.3:2001 JUN22 129 151 forward 2 TM Transmembrane 546 LG:7684981.3:2001JUN22 152 484 forward 2 TM Cytosolic 546 LG:7684981.3:2001 JUN22 485 507 forward 2 TM Transmembrane 546 LG:7684981.3:2001JUN22 508 718 forward 2 TM' Non-Cytosolic 546 LG.7684981.3:2001 JUN22 1 20 forward 3 TM Cytosolic 546 LG:7684981.3:2001JUN22 21 43 forward 3 TM Transmembrane 546 LG.-7684981.3:2001 JUN22 44 128 forward 3 TM Non-Cytosolic 546 LG-.7684981.3:2001 JUN22 129 151 forward 3 TM Transmembrane 546 LG:7684981.3:2001 JUN22 152 171 forward 3 TM Cytosolic 546 LG:7684981.3:2001JUN22 172 191 forward 3 TM Transmembrane
546 LG:7684981.3:2001 JUN22 192 717 forward 3 TM Non-Cytosolic
547 LG:7685048.6:2001JU 22 1 20 forward 1 TM Cytosolic 547 LG:7685048.6:2001JUN22 21 43 forward 1 TM Transmembrane 547 LG:7685048.6:2001JUN22 44 180 forward 1 TM Non-Cytosolic 547 LG:7685048.6:2001JUN22 1 20 forward 3 TM Cytosolic 547 LG:7685048.6:2001JUN22 21 43 forward 3 TM Transmembrane
547 LG:7685048.6:2001JUN22 44 179 forward 3 TM Non-Cytosolic
548 LG:7688302.1:2001JUN22 1 245 forward 1 TM Cytosolic 548 LG:7688302.1:2001 JUN22 246 268 forward 1 TM Transmembrane TABLE 2
SEQ D NO: Template ID Start Stop Frame Domain Type Topology
548 LG.-7688302.1 :2001 JUN22 269 282 forward 1 TM Non-Cytosolic
548 LG:7688302.1:2001JUN22 283 305 forward 1 TM Transmembrane
548 LGJ688302.1 :2001 JUN22 306 309 forward 1 TM Cytosolic
548 LG:7688302.1:2001JUN22 1 244 forward 3 TM Non-Cytosolic
548 LG:7688302.1:2001JUN22 ' 245 267 forward 3 TM Transmembrane
548 LG:7688302.1:2001JUN22 268 273 forward 3 TM Cytosolic
548 LG:7688302.1:2001 JUN22 274 296 forward 3 TM Transmembrane
548 LG:7688302.1:2001JUN22 297 308 forward 3 TM Non-Cytosolic
549 LG:7690463.3:2001JUN22 1 337 forward 1 TM Non-Cytosolic
549 LG:7690463.3:2001JUN22 338 360 forward 1 TM Transmembrane
549 LG:7690463.3:2001JUN22 361 401 forward 1 TM Cytosolic
549 LG:7690463.3:2001JUN22 1 338 forward 3 TM Non-Cytosolic
549 LG:7690463.3:2001JUN22 339 361 forward 3 TM Transmembrane
549 LG:7690463.3:2001JUN22 362 400 forward 3 TM Cytosolic
550 LG:7691479.5:2001JUN22 1 19 forward 1 TM Non-Cytosolic
550 LG:7691479.5:2001JUN22 20 42 forward 1 TM Transmembrane
550 LG:7691479.5:2001JUN22 43 94 forward 1 TM Cytosolic
550 LG:7691479.5:2001 JUN22 95 117 forward 1 TM Transmembrane
550 LG:7691479.5:2001JUN22 118 199 forward 1 TM Non-Cytosolic
551 LG:7691527.4:2001JUN22 1 38 forward 1 TM Cytosolic
551 LG:7691527.4:2001JUN22 39 56 forward 1 TM Transmembrane
551 LG:7691527.4:2001 JUN22 57 95 forward 1 TM Non-Cytosolic
551 LG:7691527.4:2001JUN22 96 115 forward 1 TM Transmembrane
551 LG:7691527.4:2001JUN22 116 192 forward 1 TM Cytosolic
551 LG.7691527.4:2001 JUN22 1 79 forward 3 TM Cytosolic
551 LG:7691527.4:2001JUN22 80 102 forward 3 TM Transmembrane
551 LG:7691527.4:2001JUN22 103 191 forward 3 TM Non-Cytosolic
552 LG:7691663.1:2001JUN22 1 213 forward 1 TM Non-Cytosolic
552 LG:7691663.1:2001JUN22 214 236 forward 1 TM Transmembrane
552 LG:7691663.1:2001JUN22 237 265 forward 1 TM Cytosolic
552 LG.-7691663.1:2001 JUN22 1 207 forward 3 TM Cytosolic
552 LG:7691663.1:2001JUN22 208 230 forward 3 TM Transmembrane
552 LG:7691663.1:2001JUN22 231 264 forward 3 TM Non-Cytosolic
553 LG:7691854.1:2001 JUN22 1 258 forward 1 TM Cytosolic
553 LG:7691854.1:2001JUN22 259 281 forward 1 TM Transmembrane
553 LG:7691854.1:2001 JUN22 282 298 forward 1 TM Non-Cytosolic
553 LG.7691854. 2001JUN22 1 269 forward 2 TM Non-Cytosolic
553 LG:7691854.1:2001JUN22 270 292 forward 2 TM Transmembrane
553 LG:7691854.1:2001JUN22 293 298 forward 2 TM Cytosolic
553 LG:7691854.1:2001JUN22 1 269 forward 3 TM Non-Cytosolic
553 LG:7691854.1:2001JUN22 270 292 forward 3 TM Transmembrane
553 LG:7691854.1:2001 JUN22 293 298 forward 3 TM Cytosolic
554 LG:7692235.2:2001JUN22 1 134 forward 2 TM Cytosolic
554 LG:7692235.2:2001JUN22 135 154 forward 2 TM Transmembrane
554 LG:7692235.2:2001 JUN22 155 163 forward 2 TM Non-Cytosolic
554 LG:7692235.2:2001JUN22 164 186 forward 2 TM Transmembrane
554 LG:7692235.2:2001JUN22 187 190 forward 2 TM Cytosolic
554 LG:7692235.2:2001JUN22 191 213 forward 2 TM Transmembrane
554 LG:7692235.2:2001JUN22 214 232 forward 2 TM Non-Cytosolic
554 LG:7692235.2:2001JUN22 233 252 forward 2 TM Transmembrane
554 LG:7692235.2:2001JUN22 253 259 forward 2 TM Cytosolic
555 LG:7692239.1:2001JUN22 1 431 forward 1 TM Non-Cytosolic
555 LG:7692239.1:2001JUN22 432 454 forward 1 TM Transmembrane
555 LG:7692239.1:2001JUN22 455 474 forward 1 TM Cytosolic TABLE 2
SEQ D NO: Template ID Start Stop Frame Domain Type Topology
555 LG:7692239.1 :2001JUN22 475 497 forward 1 TM Transmembrane
555 LG:7692239.1:2001JUN22 498 519 forward 1 TM Non-Cytosolic
555 LG:7692239.1 :2001JUN22 520 542 forward 1 TM Transmembrane
555 LG:7692239.1:2001JUN22 543 553 forward 1 TM Cytosolic
555 LG:7692239.1:2001JUN22 1 381 forward 3. TM Cytosolic
555 LG:7692239.1:2001JUN22 382 404 forward 3 TM Transmembrane
555 LG-.7692239.1:2001 JUN22 405 485 forward 3 TM Non-Cytosolic
555 LG.7692239.1:2001 JUN22 486 508 forward 3 TM Transmembrane
555 LG:7692239.1:2001JUN22 509 520 forward 3 TM Cytosolic
555 LG:7692239.1:2001 JUN22 521 543 forward 3 TM Transmembrane
555 LG:7692239.1:2001 JUN22 544 553 forward 3 TM Non-Cytosolic
556 LG:7692575.1:2001JUN22 1 154 forward 1 TM Cytosolic 556 LG:7692575.1:2001JUN22 155 177 forward 1 TM Transmembrane 556 LG:7692575.1:2001JUN22 178 207 forward 1 TM Non-Cytosolic 556 LG:7692575.1:2001JUN22 208 230 forward 1 TM Transmembrane 556 LG:7692575.1:2001JUN22 231 375 forward 1 TM Cytosolic 556 LG:7692575.1:2001JUN22 376 395 forward 1 TM Transmembrane 556 LG:7692575.1:2001JUN22 396 443 forward 1 TM Non-Cytosolic 556 LG:7692575.1:2001 JUN22 444 466 forward 1 TM Transmembrane 556 LG:7692575.1:2001JUN22 467 472 forward 1 TM Cytosolic 556 LG:7692575.1:2001JUN22 473 495 forward 1 TM Transmembrane 556 LG:7692575.1:2001JUN22 496 498 forward 1 TM Non-Cytosolic 556 LG:7692575.1:2001JUN22 499 521 forward 1 TM Transmembrane 556 LG:7692575.1:2001JUN22 522 658 forward 1 TM . Cytosolic 556 LG:7692575.1:2001JUN22 1 522 forward 2 TM Non-Cytosolic 556 LG:7692575.1:2001JUN22 523 545 forward 2 TM Transmembrane 556 LG:7692575.1:2001JUN22 546 658 forward 2 TM Cytosolic 556 LG:7692575.1:2001JUN22 1 20 forward 3 TM Cytosolic 556 LG:7692575.1:2001JUN22 21 43 forward 3 TM Transmembrane 556 LG:7692575.1:2001JUN22 44 196 forward 3 TM Non-Cytosolic 556 LG:7692575.1 :2001JUN22 197 219 forward 3 TM Transmembrane 556 LG:7692575.1:2001 JUN22 220 319 forward 3 TM Cytosolic 556 LG:7692575.1:2001JUN22 320 342 forward 3 TM Transmembrane 556 LG:7692575.1:2001JUN22 343 425 forward 3 TM Non-Cytosolic 556 LG:7692575.1:2001JUN22 426 448 forward 3 TM Transmembrane 556 LG:7692575.1:2001JUN22 449 482 forward 3 TM Cytosolic 556 LG:7692575.1:2001JUN22 483 505 forward 3 TM Transmembrane
556 LG:7692575.1:2001JUN22 506 657 forward 3 TM Non-Cytosolic
557 LG:7692742.1:2001JUN22 1 25 forward 1 TM Non-Cytosolic 557 LG:7692742.1 :2001JUN22 26 45 forward 1 TM Transmembrane 557 LG:7692742.1:2001JUN22 46 56 forward 1 TM Cytosolic 557 LG:7692742.1:2001 JUN22 57 79 forward 1 TM Transmembrane 557 LG:7692742.1:2001JUN22 80 227 forward 1 TM Non-Cytosolic 557 LG:7692742.1:2001JUN22 1 30 forward 3 TM Cytosolic 557 LG:7692742.1:2001JUN22 31 53 forward 3 TM Transmembrane
557 LG:7692742.1:2001JUN22 54 226 forward 3 TM Non-Cytosolic
558 LG:7693942.1:2001 JUN22 1 6 forward 1 TM Cytosolic 558 LG:7693942.1:2001JUN22 7 26 forward 1 TM Transmembrane 558 LG:7693942.1:2001JUN22 27 787 forward 1 TM Non-Cytosolic 558 LG:7693942.1:2001JUN22 1 19 forward 2 TM Non-Cytosolic 558 LG:7693942.1:2001JUN22 20 42 forward 2 TM Transmembrane 558 LG:7693942.1:2001 JUN22 43 372 forward 2 TM Cytosolic 558 LG:7693942.1:2001JUN22 373 395 forward 2 TM Transmembrane 558 LG:7693942.1:2001 JUN22 396 473 forward 2 TM Non-Cytosolic TABLE 2
SEQ D NO Template ID Start Stop Frame Domain Type Topology
558 1X3:7693942.1:2001 JUN22 474 496 forward 2 TM Transmembrane
558 LG.7693942.1:2001 JUN22 497 507 forward 2 TM Cytosolic
558 LG.7693942.1:2001 JUN22 508 530 forward 2 TM Transmembrane
558 LGJ693942.1 :2001 JUN22 531 556 forward 2 TM Non-Cytosolic
558 LGJ693942.1:2001 JUN22 557 579 forward 2 TM Transmembrane
558 LG:7693942.1:2001JUN22 580 787 forward 2 TM Cytosolic
559 LG:899248.22:2001JUN22 1 72 forward 1 TM Cytosolic
559 LG:899248.22:2001JUN22 73 95 forward 1 TM Transmembrane
559 LG:899248.22:2001JUN22 96 986 forward 1 TM Non-Cytosolic
560 LG:979051.25:2001JUN22 1 867 forward 1 TM Non-Cytosolic
560 LG:979051.25:2001 JUN22 868 890 forward 1 TM Transmembrane
560 LG:979051.25:2001JUN22 891 1143 forward 1 TM Cytosolic
560 LG:979051.25:2001JUN22 1144 1166 forward 1 TM Transmembrane
560 LG:979051.25:2001JUN22 1167 1703 forward 1 TM Non-Cytosolic
560 LG:979051.25:2001JUN22 1 40 forward 2 TM Cytosolic
560 LG:979051.25:2001JUN22 41 63 forward 2 TM Transmembrane
560 LG:979051.25:2001JUN22 64 77 forward 2 TM Non-Cytosolic
560 LG:979051.25:2001JUN22 78 100 forward 2 TM Transmembrane
560 LG:979051.25:2001JUN22 101 120 forward 2 TM Cytosolic
560 LG:979051.25:2001JUN22 121 143 forward 2 TM Transmembrane
560 LG:979051.25:2001JUN22 144 911 forward 2 TM Non-Cytosolic
560 LG:979051.25:2001JUN22 912 931 forward 2 TM Transmembrane
560 LG:979051.25:2001JUN22 932 1143 forward 2 TM Cytosolic
560 LG:979051.25:2001JUN22 1 144 1166 forward 2 TM Transmembrane
560 LG:979051.25:2001JUN22 1167 1703 forward 2 TM Non-Cytosolic
561 LG:979054.18:2001 JUN22 1 388 forward 1 TM Non-Cytosolic
561 LG:979054.18:2001JUN22 389 411 forward 1 TM Transmembrane
561 LG:979054.18:2001JUN22 412 412 forward 1 TM Cytosolic
561 LG:979054.18:2001JUN22 413 435 forward 1 TM Transmembrane
561 LG:979054.18:2001JUN22 436 1047 forward 1 TM Non-Cytosolic
561 LG:979054.18:2001JUN22 1 388 forward 2 TM Non-Cytosolic
561 LG:979054.18:2001JUN22 389 411 forward 2 TM Transmembrane
561 LG:979054.18:2001JUN22 412 417 forward 2 TM Cytosolic
561 LG:979054.18:2001JUN22 418 440 forward 2 TM Transmembrane
561 LG:979054.18:2001 JUN22 441 1047 forward 2 TM Non-Cytosolic
562 LG:979415.1 2001JUN22 1 63 forward 1 TM Cytosolic
562 LG:979415.1 2001JUN22 64 86 forward 1 TM Transmembrane
562 LG:979415.1 2001JUN22 87 95 forward 1 TM Non-Cytosolic
562 LG:979415.1 2001JUN22 96 118 forward 1 TM Transmembrane
562 LG:979415.1 2001JUN22 119 278 forward 1 TM Cytosolic
562 LG:979415.1 2001JUN22 279 301 forward 1 TM Transmembrane
562 LG.979415.1 2001JUN22 302 371 forward 1 TM Non-Cytosolic
562 LG:979415.1 2001JUN22 372 394 forward 1 TM Transmembrane
562 LG:979415.1 2001JUN22 395 406 forward 1 TM Cytosolic
562 LG:979415.1 2001JUN22 407 429 forward 1 TM Transmembrane
562 LG.-979415.1 2001JUN22 430 452 forward 1 TM Non-Cytosolic
562 LG:979415.1 2001JUN22 453 472 forward 1 TM Transmembrane
562 LG:979415.1 2001JUN22 473 569 forward 1 TM Cytosolic
562 LG:979415.1 2001JUN22 570 592 forward 1 TM Transmembrane
562 LG:979415.1 2001JUN22 593 1665 forward 1 TM Non-Cytosolic
562 LG:979415.1 2001JUN22 1 20 forward 2 TM Cytosolic
562 LG:979415.1 2001JUN22 21 43 forward 2 TM Transmembrane
562 LG:979415.1 2001JUN22 44 108 forward 2 TM Non-Cytosolic
562 LG.-979415.1 2001JUN22 109 128 forward 2 TM Transmembrane TABLE 2
SEQ D NO: Template ID Start Stop Frame Domain Type Topology
562 LG:979415.1:2001JUN22 129 453 forward 2 TM Cytosolic
562 LG:979415.1:2001JUN22 454 476 forward 2 TM Transmembrane
562 LG:979415.1:2001JUN22 477 1665 forward 2 TM Non-Cytosolic
562 LG:979415.1:2001JU 22 1 20 forward 3 TM Cytosolic
562 LG:979415.1:2001JUN22 21 43 forward 3 TM Transmembrane
562 LG:979415.1:2001JUN22 44 71 forward 3 TM Non-Cytosolic
562 LG:979415.1:2001JUN22 72 91 forward 3 TM Transmembrane
562 LG:979415.1:2001 JUN22 92 157 forward 3 TM Cytosolic
562 LG:979415.1:2001 JUN22 158 177 forward 3 TM Transmembrane
562 LG.-979415.1 :2001 JUN22 178 1665 forward 3 TM Non-Cytosolic
563 LG:980685.1:2001JUN22 1 1193 forward 2 TM Non-Cytosolic
563 LG:980685.1:2001 JUN22 1194 1216 forward 2 TM Transmembrane
563 LG:980685.1:2001JUN22 1217 1228 forward 2 TM Cytosolic
563 LG:980685.1:2001JUN22 1229 1251 forward 2 TM Transmembrane
563 LG:980685.1:2001JUN22 1252 1286 forward 2 TM Non-Cytosolic
563 LG:980685.1 :2001JUN22 1287 1309 forward 2 TM Transmembrane
563 LG:980685.1:2001JUN22 1310 1390 forward 2 TM Cytosolic
563 LG:980685.1 :2001 JUN22 1 587 forward 3 TM Non-Cytosolic
563 LG:980685.1:2001JUN22 588 610 forward 3 TM Transmembrane
563 LG:980685.1:2001 JUN22 611 616 forward 3 TM Cytosolic
563 LG:980685.1:2001JUN22 617 639 forward 3 TM Transmembrane
563 LG:980685.1:2001 JUN22 640 1389 forward 3 TM Non-Cytosolic
564 LG:981272.6:2001 JUN22 1 25 forward 1 TM Cytosolic
564 LG:981272.6:2001 JUN22 26 48 forward 1 TM Transmembrane
564 LG:981272.6:2001JUN22 49 115 forward 1 TM Non-Cytosolic
564 LG:981272.6:2001JUN22 116 138 forward 1 TM Transmembrane
564 LG:981272.6:2001JUN22 ' 139 157 forward 1 " TM Cytosolic
564 LG:981272.6:2001JUN22 158 177 forward 1 TM Transmembrane
564 LG:981272.6:2001JUN22 * 178 448 forward 1 TM Non-Cytosolic
564 LG:981272.6:2001JUN22 449 471 forward 1 TM Transmembrane
564 LG:981272.6:2001JUN22 472 504 forward 1 TM Cytosolic
564 LG:981272.6:2001 JUN22 1 36 forward 2 TM Non-Cytosolic
564 LG:981272.6:2001JUN22 37 59 forward 2 TM Transmembrane
564 LG:981272.6:2001JUN22 60 133 forward 2 TM Cytosolic
564 LG:981272.6:2001JUN22 134 156 forward 2 TM Transmembrane
564 LG:981272.6:2001JUN22 157 504 forward 2 TM Non-Cytosolic
564 LG:981272.6:2001 JUN22 1 40 forward 3 TM Non-Cytosolic
564 LG:981272.6:2001JUN22 41 63 forward 3 TM Transmembrane
564 LG:981272.6:2001 JUN22 64 1 14 forward 3 TM Cytosolic
564 LG:981272.6:2001JUN22 115 137 forward 3 TM Transmembrane
564 LG:981272.6:2001JUN22 138 182 forward 3 TM Non-Cytosolic
564 LG:981272.6:2001JUN22 183 205 forward 3 TM Transmembrane
564 LG:981272.6:2001JUN22 206 442 forward 3 TM Cytosolic
564 LG:981272.6:2001JUN22 443 465 forward 3 TM Transmembrane
564 LG:981272.6:2001JUN22 466 504 forward 3 TM Non-Cytosolic
565 LG:982723.4:2001JUN22 1 1 18 forward 1 TM Cytosolic
565 LG:982723.4:2001JUN22 1 19 141 forward 1 TM Transmembrane
565 LG:982723.4:2001JUN22 142 185 forward 1 TM Non-Cytosolic
565 LG:982723.4:2001JUN22 186 208 forward 1 TM Transmembrane
565 LG:982723.4:2001JUN22 209 363 forward 1 TM Cytosolic
565 LG:982723.4:2001JUN22 364 386 forward 1 TM Transmembrane
565 LG:982723.4:2001JUN22 387 769 forward 1 TM Non-Cytosolic
565 LG:982723.4:2001JUN22 1 1 16 forward 2 TM Cytosolic
565 LG:982723.4:2001JUN22 1 17 139 forward 2 TM Transmembrane TABLE 2
SEQ D NO: Template ID Start Stop Frame Domain Type Topology
565 LG:982723.4:2001JUN22 140 186 forward 2 TM Non-Cytosolic
565 LG:982723.4:2001JUN22 187 209 forward 2 TM Transmembrane
565 LG:982723.4:2001JUN22 210 304 forward 2 TM Cytosolic
565 LG:982723.4:2001JUN22 305 327 forward 2 TM Transmembrane
565 LG:982723.4:2001JUN22 328 362 forward 2 TM Non-Cytosolic
565 LG:982723.4:2001JUN22 363 385 forward 2 TM Transmembrane
565 LG:982723.4:2001JUN22 386 477 forward 2 TM Cytosolic
565 LG:982723.4:2001JUN22 478 497 forward 2 TM Transmembrane
565 LG:982723.4:2001JUN22 498 769 forward 2 TM Non-Cytosolic
565 LG:982723.4:2001JUN22 1 184 forward 3 TM Cytosolic
565 LG:982723.4:2001JUN22 185 207 forward 3 TM Transmembrane
565 LG:982723.4:2001JUN22 . 208 769 forward 3 TM Non-Cytosolic
566 LG:982915.8:2001JUN22 1 2391 forward 2 TM Non-Cytosolic 566 LG:982915.8:2001JUN22 2392 2414 forward 2 TM Transmembrane 566 LG:982915.8:2001JUN22 2415 2420 forward 2 TM Cytosolic 566 LG:982915.8:2001JUN22 2421 2443 forward 2 TM Transmembrane 566 LG:982915.8:2001JUN22 2444 2462 forward 2 TM Non-Cytosolic 566 LG:982915.8:2001JUN22 2463 2485 forward 2 TM Transmembrane 566 LG:982915.8:2001JUN22 2486 2493 forward 2 TM Cytosolic 566 LG:982915.8:2001JUN22 2494 2516 forward 2 TM Transmembrane
566 LG:982915.8:2001JUN22 2517 2527 forward 2 TM Non-Cytosolic
567 LG-.987785.10:2001 JUN22 407 499 forward 2 SP 567 LG:987785.10:2001JUN22 407 499 forward 2 SP 567 LG:987785.10:2001JUN22 1 466 forward 1 TM Non-Cytosolic 567 LG:987785.10:2001JUN22 467 489 forward 1 TM Transmembrane 567 LG:987785.10:2001JUN22 490 687 forward 1 TM Cytosolic 567 LG:987785.10:2001JUN22 688 710 forward 1 TM Transmembrane 567 LG:987785.10:2001JUN22 711 911 forward 1 TM Non-Cytosolic 567 LG:987785.10:2001JUN22 1 338 forward 2 TM Non-Cytosolic 567 LG:987785.10:2001 JUN22 339 361 forward 2 TM Transmembrane 567 LG:987785.10:2001JUN22 362 476 forward 2 TM Cytosolic 567 LG:987785.10:2001JUN22 477 499 forward 2 TM Transmembrane 567 LG:987785.10:2001JUN22 500 911 forward 2 TM Non-Cytosolic 567 LG:987785.10:2001 JUN22 1 466 forward 3 TM Non-Cytosolic 567 LG:987785.10:2001JUN22 467 489 forward 3 TM Transmembrane 567 LG:987785.10:2001JUN22 490 603 forward 3 TM Cytosolic 567 LG:987785.10:2001 JUN22 604 626 forward 3 TM Transmembrane 567 LG:987785.10:2001 JUN22 627 687 forward 3 TM Non-Cytosolic 567 LG:987785.10:2001JUN22 688 710 forward 3 TM Transmembrane 567 LG:987785.10:2001JUN22 711 769 forward 3 TM Cytosolic 567 LG:987785.10:2001JUN22 770 792 forward 3 TM Transmembrane 567 LG.-987785.10:2001 JUN22 793 910 forward 3 , TM Non-Cytosolic Table 3
1/LG: 1041015.22 :2001MAR30 || 394-871; 341-519; 1-520; 204-497; 325-377; 253-374
2/ G:106877.10:200lMAR30 || 1-326; 1-240; 11-536; 11-449; 17-379; 18-590; 70-207; 70-214; 185-764; 225-499; 285-490; 319-788; 319-565; 319-948; 375- 628; 379-908; 475-948; 505-1066; 519-635; 587-1038; 587-727; 620-840; 620- 841; 637-884; 638-1252; 688-1146; 706-1206; 772-1216; 776-1037; 778-910; 797-1089; 797-1229; 803-1090; 834-1459; 847-1139; 847-1107; 855-1057; 943- 1150; 951-1245; 959-1153; 988-1214; 1003-1354; 1008-1263; 1036-1309; 1042-
1305; 1045-1293; 1077-1339 1084-1279 1099-1744; 1127-1401 1133-1698
1133-1381 1172-1402; 1196 1445; 1204-1742; 1207-1365; 1212-1525; 1247-
1775 ; 1232-1451 ; 1275-1381 1305-1534 1306-1917; 1309-1694 1331-1582
1356-1599 1370-1640; 1433 1761; 1446 1930; 1456-1797; 1446 1669; 1468-
1777 ; 1516-2044 ; 1552-1766 1555-1713 1590-1933; 1618-2115 1598-1732
1624-2097 1616-1901; 1681-1929; 1683 2221; 1683-1862; 1760 2250; 1790-
2069 ; 1797-2047 ; 1807-2060 1831-2112 1843-2112; 1848-2071 1856-2108
1884-2139 1912-2208; 1916 2210; 1930-2169; 1938-2209; 1938-2204; 1944-
2063 ; 1945-2215 ; 1948-2157 1957- 2269 1957-2170; 1973-2534 1986-2235
1997-2497 1997-2406; 1997 2229; 1997 2221; 2003-2185; 2012-2284; 2012-
2186 ; 2031-2274 ; 2031-2258 2033- 2342 2044-2258; 2048-2325 2048-2289
2050-2331 2062-2296; 2063 2470; 2073 2627; 2073-2318; 2072-2315; 2073-
2317; 2075-2434; 2075-2280 2075- 2274 2097-2635; 2098-2650 2101-2716
2112-2722 2116-2350; 2137 2649; 2130 2702; 2145-2715; 2145-2381; 2159-
2385; 2172-2409; 2189-2442 2190- 2364 2195-2807; 2215-2693 2215-2707
2215-2614 2215-2432; 2215 2402; 2217 2466; 2220-2467; 2235-2660; 2225-
2708; 2227-2709; 2232-2712 2243- 2713 2245-2548; 2254-2704 2254-2574
2261-2711 2263-2520; 2275 2760; 2280 2722; 2283-2529; 2288-2751; 2288
2755; 2293-2516;.2295-2756 2294- 2751 2301-2540; 2302-255 2301-2550
2305-2760 2306-2750; 2322 2754; 2323 2765; 2323-2571; 2324-2751; ' 2331-
2743; 2332-2750; 2334-2562 2338- 2750 2341-2753; 2341-2750 2342-2750
2344-2747 2346-2753; 2347 2752; 2346 2748; 2351-2751; 2352 ■'2750; 2356
2750; 2366-2753; 2367-2666 2374- 2743 2379-2750; 2386-2749 2389-2628
2392-2750 2394-.2751; 2397 2750; 2401. 2743; 2405-2657; '2429-2742; 2430
2858 ; 2432-2575 ; 2437-2750 2437- 2818 .2452-2750; 2456-2743 2459-2754
.2485-2750 2485-2703 ; 2491 2708; 2495-2798; 2496-2747;' 2502-2748; 2528-
2750 ; 2536-2742 ; 2556-2750 2567-2743 2570-2754; 2589-2750 2634-2755
;2637-2750 2646-2743; 2663-2750; 2662-2776; 2673-2753; 2679-2765; ' 2701-2761''
.3/LG:1138554.16:200lMAR30 II 1-263; 37-270; 90-515; 95-524;* -96-307 ; 95-526; 101-567; 107-591; 112-582 113-296; 136-385; 144-515; 152-412; 159-513; 167-517; 183-499; 185-518 218-486; 218-824; 220-470; 242-859; 253-653; 269-457; 321-511; 320-568 343-899; 359-515; 390-654; 441-960; 478-732; 501-746; 541-999; 560-1003 ; 667-998; 423-862 4/LG: 1383277.7 :2001MAR30 I I 1-94; 10-252; 22-639; 35-636; 85-657; 169-433;
174-632; 190-463 ; 266-604 266-555; 269-567; 336-664; 570-771 5/LG:1397614.15: 2001MAR30 || 1-469; 25-475; 65-327; 142-380; 146-432; 152- 721; 234-464; 241-461; 268-646 271-558; 295-549; 331-456; 335-604; 348- 652; 367-771; 376-654;.393-625 394-654; 423-490; 430-681; 443-707; 454- 728; 488-694; 498-771; 504-772 532-803; 575-825; 578-749; 617-833; 632- 877; 632-946; 639-892; 639-1074; 644-1157; 647-916; 651-902; 660-925; 660- 1214; 660-948; 683-913; 683-992; 702-917; 702-939; 714-1114; 714-1060; 734- 1191; 736-1013; 752-1270; 752-954; 754-874; 769-981; 774-907; 793-1256; 810-1176; 824-1078; 833-1130; 836-1073; 843-1109; 867-1031; 874-1380; 886- 1142; 890-1173; 892-1158; 901-1133; 906-1117; 917-1173; 920-1520; 920-1060; 938-1157; 946-1218; 951-1218; 988-1248; 988-1256; 990-1551; 993-1263; 997- 1233; 996-1521; 996-1510; 996-1236; 1000-1211; 1014-1299; 1020-1473; 1031- 1538; 1043-1289; 1046-1199; 1047-1317; 1051-1237; 1058-1304; 1064-1312; 1064-1304; 1068- 1266; 1088-1351; 1103-1602; 1103-1366; 1131-1368; 1139- 1405; 1173-1389; 1182-1504; 1193-1814; 1195-1408; 1198-1431; 1198-1429; 1218-1750; 1221- 1425; 1228-1488; 1240-1745; 1240-1407; 1242-1744; 1249- 1581; 1250-1513; 1252-1491; 1268-1878; 1270-1540; 1271-1546; 1315-1578; 1323-1898; 1325- 1590; 1326-1571; 1328-1882; 1332-1896; 1335-1594; 1338- Table 3
1940; 1342-1592; 1345-1490; 1373-1590; 1375-1594; 1377-1782; 1380-1651; 1381-1656; 1382-1656; 1385-1624; 1389-1633; 1390-1889; 1400-1623; 1400- 1624; 1400-1640; 1401-1590; 1401-1611; 1412-1683; 1411-1693; 1421-1927; 1425-1707; 1431-1873; 1442-1703; 1443-1571; 1443-1676; 1444-1885; 1446- 1706; 1453-1678; 1451-1925; 1465-1744; 1466-1715; 1465-1921; 1482-1926; 1488-1935; 1491-1757; 1497-1921; 1505-1772; 1514-1921; 1522-1913; 1525- 1781; 1526-1860; 1527-1921; 1529-1930; 1532-1785; 1532-1782; 1537-1929; 1541-1919; 1543-1879; 1547-1899; 1551-1929; 1577-1950; 1587-1819; 1590- 1822; 1593-1865; 1606-1871; 1608-1785; 1619-1931; 1619-1782; 1623-1883; 1624-1924; 1623-1885; 1622-1808; 1632-1886; 1647-1921; 1649-1920; 1658- 1913; 1676-1928; 1688-1915; 1693-1904; 1694-1931; 1699-1921; 1715-1852; 1719-1934; 1719-1921; 1721-1897; 1746-1924; 1770-1925; 1794-1899 6/LG: 1399315.8 :2001MAR30 | | 1-245; 142-220; 157-557; 226-649; 299-738; 302- 595; 325-521; 345-521; 359-728; 367-889; 409-926; 448-533; 472-708; 537- 1033; 540-1056; 595-1052; 633-1092; 638-1095; 643-1093; 654-988; 663-1030; 677-1092; 681-1057; 685-1092; 685-937; 685-932; 704-998; 766-1086; 797-938; 915-1464; 920-1086; 1364-1706; 1547-1827; 1586-1827; 1586-2147; 1754-2296; 1829-2188; 2033-2553; 2044-2592; 2119-2337; 2153-2575; 2204-2661; 2272- 2656; 2312-2680; 2324-2661; 2433-2946; 2526-2664; 2548-2794; 2645-2823; 2722-2962
7/LG:198782.1:2001MAR30 | | 1-571; 1-480; 132-595; 161-433; 248-812; 271- 796; 273-831; 300-838; 324-633; 331-852; 331-591; 331-566; 348-809; 397- 849; 462-547; 469-1150; 478-723; 510-1035; 566-859; 609-997; 624-870; 693- 1189; 694-921; 713-991; 727-1292; 765-1013; 771-1056; 788-1035; 789-1072; 796-1140; 791-1395; 801-1337; 823-1319; 888-1153; 890-1145; 894-1153; 975- 1643; 988-1189; 1046-1296; 1054-1258; 1076-1305; 1086-1642; 1091-1360; 1133-1643; 1133-1376; 1150-1439; 1190-1419; 1209-1515; 1213-1506; 1213-
1409; 1228-1454; 1241-1537 1266-1792 1320- -1502, 1320- -1501, 1320- -1461; 1320-1906; 1323-1590; 1364 1635; 1391 1907; 1423- -1817; 1446- -1691; 1459- 1595; 1461-1614; 1493-1733 1496-1671 1530- -1906, 1545- -1745; 1551- -1717; 1563-1807; 1572-1845; 1591 2256; 1599 1851; 1603- -1860; 1605- -1882; 1616- 2157; 1626-1922; 1656-2197 1656-1882 1675- -2149, 1676 -2104, 1699- -2261; 1699-1974; 1720-2308; 1721 2018; 1777 2018; 1788- -1965; 1810- -1938; 1821- 1937; 1830-2320; 1830-1980 1848-2068 1869 -2167 1880 -2146, 1882 -2138;
1885-2151; 1908-2508; 1916-2121; 1937 2121; 1945- -2519; 1985- -2253; 1992-
2511; 1992-2391; 1992-2247 1992-2232 1995- -2210, 2015- -2345, 2014- -2246; 2032-2324; 2062-2316; 2069 2547; 2070 2546; 2079- -2546; 2105- -2546; 2107- 2546; 2108-2395; 2111-2547 2112-2545 2115- -2546 2119 -2389, 2120 -2499;
2125-2549; 2126-2546; 2127-2551; 2129-2507; 2139-2546; 2146-2425; 2167-
2546; 2176-2508; 2179-2553 2192-2452; 2195-2546; 2209-2511; 2211-2546; 2229-2482; 2251-2547; 2265-2553; 2269- 2539; 2339-2546; 2336-2543; 2369- 2546; 2404-2547; 2405-2546; 2433-2548; 2445-2546; 2492-2546
8/ G:236046.1:200lMAR30 | | 1-271; 1-162; 31-356; 34-526; 43-322; 45-223; 45-163; 44-180; 44-142; 45-174; 44-158; 44-237; 45-353; 45-349; 45-214; 45- 271; 45-115; 45-280; 45-102; 76-308; 89-695; 144-356; 269-350; 324-589; 372-944; 442-735; 522-1063; 551-1100; 556-814; 567-827; 605-851; 618-1139; 641-851; 663-851; 670-851; 686-851; 739-1149; 743-851; 745-1013; 751-1007; 791-1023; 801-1153; 813-1108; 867-1110; 872-1461; 870-1089; 878-1145; 886- 1148; 886-1146; 936-1148; 941-1146; 943-1146; 944-1118; 965-1148; 966-1123; 977-1146; 994-1147; 990-1526; 1026-1146; 1222-1461; 1419-2028; 1447-1710; 1471-1645; 1627-2211; 1723-1952; 1787-2076; 1815-2076; 2108-2546; 2139- 2546; 2170-2546
9/I*G:332122.6:2001MAR30 | 1-271; 1-285; 26-677; 131-687; 154-387; 165-418; 178-759; 189-441; 193-764 255-716; 256-457; 278-676; 284-718; 334-580;
349-543; 410-661; 421-657 429-690; 433-723; 433-734; 433-689; 447-715; 448-726; 521-720; 526-705 530-642; 536-696; 557-853; 556-753; 573-860; 574-810; 585-832; 592-1024; 592-861; 592-848; 592-847; 592-831; : 593-829; 602-866; 621-886; 634-914; 651-718; 664-840; 669-963; 670-988; 688-1184; 700-1172 720-1204; 755-1260; 800-1340; 802-1342; 843-1052; 858-1103; 878- 1158; 895-1322; 908-1205; 939-1194; 946-1378; 972-1385; 970-1386; 985-1403; Table 3
988-1279; 1022-1247; 1038-1330; 1054-1321; 1093-1330; 1100-1368; 1111-1542;
1125-1326; 1134-1330; 1141-1378; 1160-1385 1181-1464; 1182-1378; 1188-
1339; 1197-1553; 1248-1535; 1252-1468; 1318-1553; 1379-1556; 1382-1551;
1463-1952; 1463-1737; 1524-1737; 1552-1837 1586-1737; 1762-1977; 1779-
2116; 1838-2029; 1838-2110; 1880-2146; 1881-2321; 1885-2397; 1888-2062;
1888-2031; 2005-2439; 2005-2245; 2014-2281 2033-2368; 2076-2505; 2122-
2392; 2154-2505; 2173-2434; 2283-2434; 2292-2434; 2323-2434; 2417-2512 10/LG:345320.16:2001MAR30 | | 1-211; 63-371; 82-237; 228-459; 315-906; 322- 583; 322-527; 344-481; 361-607; 363-639; 385-778; 385-545; 390-637; 434- 989; 472-687; 489-989; 496-1159; 499-715; 512-692; 522-760; 566-907; 585- 947; 608-945; 619-947; 630-888; 647-918; 691-1149; 691-930; 692-845; 712- 1021; 714-1020; 718-969; 744-1038; 760-903; 799-1060; 805-1061; 823-1083; 858-1103; 859-938; 869-1127; 877-1152; 886-1144; 936-1164; 1011-1419; 1019-
1424; 1022-1334; 1045-1318; 1061-1364; 1061-1265 1064-1368 1082-1591; 1103-1414; 1106-1360; 1106-1348; 1106-1380; 1107 1354; 1107 1341; 1128- 1369; 1146-1413; 1159-1451; 1160-1368; 1173-1634 1176-1260 1177-1433;
1179-1640; 1180-1628; 1181-1324; 1188-1632; 1196-1636; 1204-1627; 1202-
1578; 1221-1467; 1239-1588; 1237-1366; 1238-1625 1244-1626 1244-1581; 1256-1369; 1259-1630; 1302-1589; 1325-1628; 1342 1636; 1344 1628; 1344- 15.60; 1373-1616; 1389-1625; 1407-1636; 1422-Ϊ626 1461-1628 1470-1626; 1489-1636; 1497-1711; 1498-1993; 1607-1813; 1628 1738; 1647-1870; 1647 1885; 1707-1864; 1736-2027; 1735-2011; 1809-2217 1844-2294 1903-2273; 1912-2238; 1912-2276; 1912-2167; 1923-2276; 1930 2161; 1950-2276; 1953 2291; 1956-2273; 1966-2190; 2018-2273; 2023-2249 2030-2287 2033-2287; 2049-2287; 2108-2268 11/LG: 350827.10 :2001 AR30 | 1-666 193-598; 245-442 259-513 261-509
262- -508 264- -477 265-559; 275-690 272-427; 273-822 275-475 263-374
275- -797 276- -841 275-441; 278-790 267-340; 267-373 280-439 280-611
280- -466 279- -501 280-705; 267-347 302-399; 302-354 280-805 267-359
280- -418 280- -421 280-523; 267-351 280-457; 280-427 283-498 282-480
288- -888 288- -570 289-498; 290-566 293-538; 293-758 294-570 303-497
303- -546 304- -839 311-629; 323-839 342-594; 351-607 357-622 359-834
371- -842 372- -835 375-834; 381-846 381-840; 381-831 384-671 384-570
385- -826 ■ 392- -630 393-502; 395-617 401-875; 402-841 405-839 407-791
410- -834 412- -627 417-834; 418-834 420-839; 426-834 429-839 433-779
435- -834 436- -835 441-730; 441-678 443-831; 445-796 445-686 445-702
445- -648 445- -862 453-840; 463-798 475-841; 475-847 477-830 482-726
488- -750 489- -845 496-767; 496-733 498-754; 502-728 502-756 517-622
517- -734 518- -836 520-773; 522-834 529-831; 564-769 573-829 591-839
596- -699 596- -822 596-761; 614-802 614-855; 614-868 614-728 615-833
649- -839 652- -885 654-1010 655-83** 1; 663-1005; 671-9' 71; 676-8_ 19; 682-835;
701- -831 704- -980 729-839; 739-833 741-834; 741-797 744-968 748-943;
773- -971 776- -836 779-831; 781-856 787-1007 ; 815-10. 57; 821-9*^ 19; 838-1007;
841- -996 845- -100' 7; 845-970 849-95! 5; 856-979 ; 914-10: LO
12/ G:3. 39901 .5:21 301MAR30 | 1-243; 25-569; 25-235; 33-573; 41-495; 83-398;
106- -358 111100-- -447777; 112244--661199;; 124-340; 168-667; 179-291; 203-383; 235-613;
234-511; 235-793; 235-441; 253-497; 258-815; 259-505; 300-452; 361-574; 376-623; 382-671; 393-652; 425-641; 427-806; 479-872; 479-1041; 484-755;
491-1089 490-962 503-763; 530-764; 546-763; 548-762; 582-666; 589-1090; 595-836; 645-1125 645-1025; 664-1088; 676-1128; 680-1080; 686-941; 708- 1127; 724-1125; 732-1120; 732-927; 736-1129; 739-1125; 744-1029; 747-1120; 767-1125; 770-1129; 776-1129; 784-1106; 794-1108; 792-1125; 797-1125; 798- 1125; 804-1120; 804-1039; 804-1129; 818-1088; 821-1125; 827-1125; 833-922; 834-960; 847-1120; 864-1118; 874-1118; 894-1129; 987-1121; 987-1129 13/LG:404563.1:2001MAR30 | | 1-528; 10-307; 336-729; 625-1133; 915-1290; 1000-1259; 1004-1257; 1161-1524; 1235-1570; 1269-1709; 1278-1602; 1310- 1680; 1324-1850; 1337-1935; 1348-1643; 1372-1709; 1426-1711; 1433-1680; 1732-1864; 1732-1993; 1735-1998; 1735-1960; 1735-1977; 1735-1968; 1735- 1971; 1735-2001; 1735-2003; 1766-1957; 1774-2087; 1774-2026; 1815-2242; 1845-2405; 1933-2432; 1947-2181; 1972-2203; 1972-2123; 1972-2202; 1973- Table 3
2074; 1979-2175; 1979-2487; 1999-2392 2065-2272; 2132-2356; 2151-2503
2148-2534; 2152-2534; 2162-2392; 2169 2642; 2173-2537; 2237-2794; 2274
2864; 2302-2578; 2311-2578; 2313-2799 2316-2609; 2319-2524; 2378-2692
2383-2866; 2412-2638; 2414-2463; 2442 2534; 2506-2964; 2504-2631; 2518
3050; 2523-2972; 2528-2969; 2585-2827 2702-2966; 2714-3270; 2889-3313
2908-3307; 2909-3309; 2968-3270; 2991-3309; 2991-3244; 2991-3260; 2991
3208; 3045-3309; 3193-3309
14/LG: 977812.15.2001MAR30 || 1-263 144-238; 145-641; 153-443 162-324
171-434; 171-460; 171-438; 181-324 220-508; 250-539; 355-566 362-827
373-952; 375-637; 375-554; 427-869 432-656; 432-678; 432-872 433-828
453-866; 471-825; 481-865; 481-699 482-826; 524-793; 531-863 539-843
554-866; 573-857; 575-867; 664-927 725-940;.806-1390; 888-1410; 898-1417;
956-1428; 983-1446; 985-1234; 989-1424; 1037-1234; 1051-1368; 1066-1348;
1066-1441; 1066-1399
15/LG: 983810.1.2001MAR30 || 1-337; 1 340; 1- 468; 75-651; 80- -282; 175-669;
175-445; 261-887; 270-712; 361-722; 4 04-684; 407- -727; 529-800; 582-756;
605-686; 638-1215; 681-1220; 701-1243 ; 704-804; 766-1215; 795-1251; 796-
1126; 860-1283; 874-1081; 965-1319; 9 78-1316 J; 982-1316 ; 984- -1316; 991-1243;
1002-1278; 1002-1256; 1002-1322; 1037 -1558; 1370- -1473; 1387- -1925; 1467-
1936; 1478-1974; 1487-1797; 1490-1693. ; 1499- -1923, 1502 -1845 1505- -1965;
1522-1660; 1560-1796; 1562-1815; 1562 -1814; 1564- -1966; 1565- -1968; 1566-
1968; 1719-1946; 1732-2287; 1753-1966 ; 1758- -2140, 1758 -2052 1760- -2037;
1762-2067; 1770-2049; 1775-2184; 1966 -2196; 1966- -2317; 1966- -2254; 1966-
2216; 1966-2272; 2124-2306; 2124-2266 ; 2124- -2308, 2175 -2319 2180- -2314
16/LG:984488.1:2001MAR30 || 1-467; 1 491; 14-234 20-150; 20-224; 21-381;
20-148; 20-70; 21-155; 32-498; 34-510 ; 42-335; 46-228; 52-465; 57- -503; 57-
448; 130-443; 147-509; 147-508; 181-6 56; 194 t-506 217- 511; 255-498
17/LG:011606.1:2001MAR30 || 1-65; 16- 394; 16 .-76; 16-137; 16- -281; 155-428;
155-621; 270-495; 371-773; 371-636; 5 18-773; 542- -701; 629-773; 667-1187;
1048-1441; 1048-1182; 1068-1127; 1068 -1196; 1079- -1202; 1105- -1187; 1110-
1202; 1127-1187; 1127-1182
18/LG: 025465.5 :2001MAR30 || 1-255; 13-572; 20-272; 21-277; 23-268; 25-271;
25-153; 37-271; 42-226; 61-509; 61-276; 66-536; 277-876; 496-985; 496-745;
496-729; 514-867; 642-1073; 667-1123; 777-1215; 780-1066; 781-918; 793-
1090; 791-1171; 857-1091; 912-1431; 919-1124; 918-1479; 1017-1485; 1031-
1482; 1049-1300; 1071-1490; 1120-1479; 1145-1612; 1258-1567; 1313-1553;
1384-1752; 1397-1714; 1464-1646; 1464-1655; 1474-1938; 1475-1658; 1520-
1935; 1522-2035; 1682-1971; 1741-1986; 1812-1883; 1820-1945; 1836-1922
19/LG: 025724.10 :2001MAR30 | | 1-583; 5-527; 385-849; 439-596; 441-894; 507-
971; 507-712; 507-709; 515-956; 517-955; 535-748; 549-824; 574-1080; 619-
899; 619-877; 626-903; 678-1250; 707-872; 754-981; 777-1133; 801-903; 827-
1111; 857-1212; 868-1157; 901-1408; 908-1298; 916-1184; 921-1069; 921-1021;
943-1237; 950-1274; 950-1199; 972-1275; 1021-1228; 1021-1243; 1131-1562;
1147-1600; 1171-1297; 1268-1463; 1275-1601; 1275-1517; 1279-1504; 1281-
1470; 1282-1558; 1293-1542; 1314-1603; 1406-1601; 1437-1601; 1485-1987;
1485-1601; 1487-1601; 1545-1601; 1905-2170; 1907-2041; 1907-2226; 1907-
2180; 1907-1995; 1907-1968; 1907-1964; 1907-2045; 1917-2192; 1917-2175;
1923-2155; 1927-2189; 1936-2199; 1940-2158; 1949-2041; 2088-2290; 2088-
2279; 2110-2345; 2114-2319; 2114-2282; 2125-2359; 2130-2479; 2140-2480;
2146-2313; 2159-2299; 2168-2416; 2169-2433; 2183-2282; 2199-2367; 2263-
2720; 2264-2484; 2287-2532; 2290-2531; 2310-2588; 2312-2558; 2313-2587;
2317-2711; 2322-2564; 2324-2880; 2336-2803; 2336-2458; 2341-2851; 2341-
2613; 2346-2553; 2351-2605; 2355-2632; 2366-2673; 2380-2793; 2378-2606;
2384-2688; 2397-2645; 2400-2630; 2404-2884; 2409-2558; 2413-2699; 2446-
2658; 2451-2734; 2491-2803; 2502-2558; 2552-2694; 2598-2876; 2607-3078;
2610-2856; 2614-2831; 2659-2917; 2741-3192; 2743-3189; 2743-2959; 2756-
3026; 2802-3244; 2826-3246; 2827-3233; 2828-3302; 2829-3402; 2849-3245;
2850-3083; 2887-3134; 2898-3158; 2903-3160; 2904-3295; 2915-3244; 2915-
3202; 2938-3339; 2966-3247; 2969-3331; 2980-3245; 2993-3226; 2994-3386;
3024-3244; 3027-3385; 3028-3277; 3044-3244; 3046-3244; .3054-3244; 3065- Table 3
3242; 3065-3236; 3072-3244; 3083-3307; 3088-3377; 3085-3380; 3092-3444; 3118-3357; 3158-3280; 3153-3455; 3186-3380; 3196-3308; 3204-3416; 3204- 3402; 3205-3432
20/LG:1095426.1:2001MAR30 | | 1-590; 326-790; 335-418; 394-632; 394-900; 445-724; 500-906; 527-737; 542-1132; 542-701; 548-1153; 1024-1206; 1107- 1723; 1129-1722; 1137-1370; 1168-1426; 1182-1387; 1182-1395; 1196-1247; 1236-1528; 1236-1405; 1290-1562; 1302-18.20; 1360-1526; 1395-1739; 1395- 1738; 1435-1625; 1437-2019; 1481-1961; 1561-2040; 1561-1814; 1577-1759; 1634-1897; 1640-2221; 1648-2004; 1656-2258; 1704-1952; 1719-2054; 1766- 2017; 1822-2219; 1941-2531; 1947-2532; 2154-2399; 2173-2548; 2180-2566; 2181-2585; 2215-2585; 2215-2589; 2251-2589; 2273-2593; 2277-2584; 2299- 2497; 2314-2559; 2324-2650; 2326-2642; 2435-2491; 2472-2589; 2495-2549; 2495-2585; 2497-2585; 2510-2567
21/LG:1132418.1:2001MAR30 | | 184-784; 323-724; 1-378
22/LG:1377900.14:200lMAR30 j | 1-597; 15-466; 14-536; 15-418; 15-121; 16- 386; 20-573; 21-433; 24-280; 24-301; 33-455; 29-308; 33-345; 38-277; 56- 262; 66-654; 109-367; 128-398; 183-687; 186-386; 186-395; 190-432; 193-531; 206-456; 222-425; 224-364; 226-690; 230-464; 246-493; 300-621; 368-690; 390-619
23/LG:1383812.1:2001MAR30 | | 1-335; 70-565; 443-1011; 500-1062; 500-998; 500-1228; 653-1102; 762-1343; 822-1252; 822-1076; 926-1467; 926-1319; 929- 1140; 1083-1629; 1241-1700; 1526-2116; 1538-2105; 1612-1873; 1717-2119; 1728-2194; 1812-2199; 1849-2197; 1879-2196; 1905-2185; 1953-2188; 1953- 2184; 1955-2063; 1999-2190; 2093-2184
24/LG: 1468687.1.2001MAR30 1-457 25/LG: 1505513.1.2001 AR30 1-415; 1-382; 1-394; 63-213; 180-628; 205-700; 474-675; 534-1032 26/LG:178823.9:2001MAR30 1-427; 4-258; 15-612; 23-149; 19-186; 25-682;
25-275; 24-679; 27-238; 34-345; 39-228; 45-267; 47-197; 62-570; 52-295; 52-
184 53-612 53-311 53-285 54-340 56-326 57-330; 58-506 58-328 59- 344 57-168 62-624 64-314 63-542 65-289 66-339; 66-208 67-362 70- 330 71-308 71-217 74-324 77-556 78-370 79-325; 79-300 79-317 79- 400 79-283 79-339 79-334 79-277 80-356 81-218; 78-497; 81-195 81- 378 81-335 82-329 82-332 82-399 88-376 84-308; 85-336; 85-288 85- 329 87-407 85-517 87-301 87-329 87-234 87-316 87-270 87-336 87- 339 88-382 88-286 88-361 87-328 88-310 87-363 89-377 89-355 88- 473 90-287 91-366 90-428 91-331 94-674 91-372 92-571 92-585 92- 350 93-227 92-370 75-304 75-311 75-280 95-290 96-328 94-531 96- 341 98-375 98-339 99-370 100-341; 102-342; 102-352; 102-309; 103-346; 103 -362 87-343; 87-326; 87 261; 106-211; 52-178; 112-611; 93-343; 111-401; 113 -396 114-376 114-373 115- -399 114- 399 117- 438 119-688 103-372 125 -493 128-625 130-682 131- 389 132- 391 136- 469 135-249 135-382 135 -360 117-627 139-411 141- 372 142-■467 156- 376 154-427 136-681 137 -455 158-395 164-682 164- -323 168- 681 167- 333 170-430 171-681 176 -457 181-445 172-582 172- -561 196- 401 221- 466 223-682 225-681 234 -687 234-694 236-635 240- 537 244- 465 248- 681 252-681 248-559 234 -683 236-492 241-685 245- 683 264- 535 250- 684 267-531 276-682 281 -688 282-609 284-688 272- •681 273- 680 274- 519 278-554 279-681 298 -641 298-545 284-681 313- 583 309- 653 311- 681 310-549 310-597 316 -417 331-681 335-681 322- 681 337- 681 350- 584 337-686 335-619 335 -637 355-687 355-634 337- 583 355-681 351- 681 373-681 355-586 378 -688 366-581 394-667 375- 681 403-534 405- 686 379-556 389-682 395 -681 460-681 461-688 469- 681 468- 679 468- 681 451-681 472-681 478 -645 484-678 504-684 508- -683 512- 681 542- 681 528-682 528-684 547 -678 548-679 581-682 599- 685 581- 644 602- •688 613-681 599-682 624 -892 637-1038 ; 645-784 648-1099; 938-1190; 941-1191; 973-1195; 973- 1187; 1023-1188
27/LG:198342.3:2001 AR30 || 1-579; 37-610; 69-269; 94-462; 116-317; 116- 444; 122-255; 124-652; 158-401; 172-403; 173-404; 235-467; 279-523; 334- 912; 338-643; 340-720; 340-556; 370-633; 383-654; 387-608; 406-1007; 417- Table 3
587; 483-735; 488-756; 492-1042; 500-579; 508-769; 527-1017; 531-790; 574- 1097; 574-814; 656-933; 656-849; 668-1117; 688-1125; 689-1326; 690-1125; 691-1115; 699-1126; 699-923; 705-1122; 705-1125; 710-1125; 720-1128; 731- 978; 734-1122; 735-1266; 743-1090; 748-1122; 753-1129; 771-1126; 771-1063;
784-1405; 788-1033; 792-1129; 799-1127; 828-1126 848-1086; 873-1135; 877-
1126; 977-1645; 979-1669; 1040-1547; 1043-1263; 1053-1304; 1168-1775; 1186
1483; 1212-1767 1286-1776 1306-1814; 1387-1932 1433-1536; 1470-1707; 1478-2032; 1494 1768; 1533 2092; 1563-2075; 1611-2236; 1638-1964; 1638 1882; 1647-1733 1649-1890 1649-1906; 1670-1931 1678-2139; 1683-1948;
1703-1972; 1711-2254; 1718 2260; 1722-1884; 1726-1981; 1728-1967; 1752
2294; : 1836- -2046 1910-2169 1919-2175; 1932-2172 1934-2169; 1995-2226;
2013- -2288; 2083 2423; 2082-2688; 2085-2416; 2095 2439; 2106-2351; 2106-
2587; : 2106- -2363 2130-2543 2131-2375; 2133-2469 2145-2474; 2145-2369;
2155- -2510; 2211 2829; 2243 2788; 2282-2600; 2393 2847; 2393-2635; 2407-
2707; : 2428- -3052 2430-3057 2463-2935; 2468-2750 2481-2720; 2489-2678;
2489-2677; 2497-2634; 2527 3058; 2540-3152; 2549 2887; 2566-2796; 2569-
2864; 2579-2652 2590-2852 2594-2879; 2596-3180 2596-2863; 2652-2822; 2681-3023; 2685 2944; 2694 3265; 2698-2957; 2711-2973; 2713-2942; 2723 2944; 2731-2932 2734-2947 2744-2994; 2750-2978 2767-3390; 2773-3029;
2779-3052; 2795-3352; 2795 2955; 2803-3368; 2811 3020; 2808-2958; 2810-
3151; 2816-3054 2820-3005 2828-3092; 2859-3104 2874-3478; 2945-3506; 2979-3592; 2985 3276; 3000-3523; 3006-3058; 3006 3227; 3020-3253; 3060- 3272; 3060-3299 3070-3330 3083-3609; 3107-3609 3109-3574; 3136-3421;
3134-3369; 3138-3317; 3155 3710; 3160-3414; 3159 3559; 3166-3597; 3179-
3482; 3178-3458 3178-3609 3187-3419; 3187-3364 3191-3730; 3196-3578; 3231-3505; 3235 3835; 3239 3803; 3246-3502; 3247-3804; 3252-3486; 3261 3532; 3261-3734 3265-3722 3268-3483; 3286-3812 3289-3548; 3290-3523;
3292-3484; 3295-3514; 3300 3862; 3324-3584; 3328-3587; 3332-3603; 3332-
3514; 3338- 3505 3357-3609 3362-3600; 3389-3940 3397-3609; 3405-3609; 3416-3622; 3422 3609; 3429 3997; 3433-3751; 3438-3727; 3444-3968; 3446 3993; 3452-•3815 3450-3609 3450-3555; 3456-3627 3479-3996; 3457-3609; 3463-3514; 3461 3851; 3467-3750; 3467-3812; 3481-3755; 3484-3995; 3487- 3767; 3501- 3744 3510-3609 3497-3945; 3502-3779 3502-3566; 3518-3753; 3513-4001; 3529 3945; 3525-3945; 3537-3945; 3521-3789; 3542-3945; 3549- 3945; 3540- 3965 3553- 4001 3543- -3945; : 3551- -3986 3560-3986; 3611-4003 3624-3945; 3630 3997; 3644 3945; 3649- -3945; 3650 3945; 3650-4007; 3650 3959; 3651-•3995 3655-3945 3658- -3866; : 3658- -3749 3648-4009; 3650-4005 3667-3993; 3666 3911; 3661 3945; 3679- -4005; 3665 4005; 3680-3945; 3706 3986; 3706-3945 3710-•3945 3727- -3979; 3798- -4102 3762-4193; 3756-3972 3756-3995; 3794 3946; 3796 3995; 3802- -4261; 3816 3945; 3819-3995; 3929 4190; 3984-4322 3967-■4254 3997- -4426; 3997- -4499 3997-4246; 3997-4498 3997-4485; 3998 4390; 3998 4187; 3997- -4385; 4006 4435; 4005-4590; 4008 4553; 4015-4471 4018-•4484 4024- -4483; 4024- -4304 4023-4394; 4024-4424 4024-4461; 4024 4453; 4024 4396; 4024- -4383; 4024 4412; 4029-4460; 4029- 4487; 4028-4498 4038-4420 4039- -4245; : 4039- -4511 4041-4229; 4042-4499 4042-4255; 4046 4389; 4051-4612; 4054-4228; 4055-4499; 4060-4380; 4063 4331; 4063-•4283 4063-4190 4064-4356; 4065-4345 4068-4631; 4067-4264;
4071-4190; 4070-4344; 4071-4224; 4083-4322; 4085 4267; 4103-4711; 4140-
4406; 4145-4728 4174-4572 4191-4762; 4212-4443 4213-4460; 4218-4763;
4218-4782; 4220-4463; 42 4501; 4254-4538; 4264 4483; 4283-4749; 4276-
4611; 4284-4510 4291-4766 4294-4546; 4303-4543 4304-4730; 4313-4609; 4313-4753; 4323 4664; 4326-4487; 4336-4763; 4344 4595; 4347-4770; 4358- 4593; 4368-4771 4375-4771 4375-4772; 4380-4762 4381-4662; 4381-4763; 4388-4616; 4420 4762; 4437 4692; 4437-4680; 4439 4669; 4441-4695; 4447- 4708; 4451-4696 4467-4640 4482-4771; 4488-4751 4488-4761; 4487-4763; 4499-4761; 4505 4793; 4507 4660; 4507-4704; 4516 4711; 4520-4676; 4522- 4756; 4527-4763 4534-4766 4535-4771; 4547-4762 4548-4780; 4548-4731;
4549-4768; 4551-4763; 4551 4766; 4555-4710; 4555 4748; 4563-4771; 4582-
4730; 4601-4763 4605-4773 4605-4762; 4612-4756 4613-4763; 4661-4761;
864-1125; 871-1129; 3770-3945 Table 3
28/LG:210672.1:2001MAR30 || 1-266; 16-487; 16-305; 16-309; 16-228; 16-212; 27-214; 123-645; 125-395; 154-788; 154-320; 191-359; 338-877; 391-919; 464- 893; 566-1102; 588-836; 606-855; 1047-1194; 1145-1650; 1145-1253; 1462- 1645; 1489-1757
29/LG: 212823.8 :2001MAR30 || 2067-2506; 2213-2506; 1869-2477; 2220-2452; 1688-2121; 1666-1960; 1875-1945; 220-1804; 1236-1755; 1182-1728; 914-1544; 322-606; 219-606; 48-606; 1-417
30/LG: 220495.9 :2001 AR30 || 1-626; 8-656; 582-816; 582-941; 653-916; 656- 854; 688-1032; 808-1057; 808-1059; 897-1498; 958-1213; 960-1368; 975-1547; 1054-1569; 1057-1602; 1105-1248; 1105-1515; 1127-1539; 1140-1565; 1169- 1345; 1182-1370; 1217-1675; 1256-1530; 1279-1711; 1281-1710; 1291-1697; 1300-1735; 1310-1679; 1344-1718; 1380-1643; 1382-1583; 1399-1573; 1399- 1712; 1399-1671; 1399-1669; 1406-1676; 1498-1712; 1540-1660; 1575-1707; 1597-1837; 1628-1833; 1640-2091; 1748-1961; 1890-2213 31/LG: 238262.1:2001MAR30 || 1-617; 292-773; 318-678; 337-1081; 470-726; 498-1064; 498-683; 498-720; 501-812; 501-788; 507-897; 508-579; 510-800;
510-780 515-748 525-755; 525-792; 530-890; 530-856 530-702; 530-670; 530-666 530-668 530-659; 530-658; 530-637; 530-605 530-589; 530-636 530-596 530-686 530-648; 530-646; 531-690; 531-669 542-800; 547-708 547-604 547-751; 547-720; 547-766; 556-711; 561-1052 560-735; 559-782; 570-1072 : 570-836; 574-1039; 590-1143; 595-735; 598-1180; 599-1021; 601- 718; 602-846; 612-871; 624-815; 620-913; 630-1159; 642-1125; 643-907; 657- 863; 679-1143; 689-914; 689-944; 693-961; 694-1155; 694-1171; 694-899; 710- 1144; 712-957; 715-1135; 727-961; 735-1184; 744-962; 745-1185; 753-1001; 771-1023; 775-1182; 781-1180; 781-1139; 781-1050; 784-1184; 795-1182; 795- 1138; 795-1037; 806-1180; 826-1197; 826-1182; 826-1180; 834-1185; 839-1135; 842-1184; 848-1046; 874-1111; 880-1180; 882-1173; 885-1108; 899-1137; 902- 1131; 915-1177; 919-1142; 929-1185; 938-1180; 944-1187; 945-1184; 954-1112; 961-1171; 969-1178; 1003-1182; 1024-1182; 1029-1184; 1047-1111; 1048-1180; 1048-1179; 1048-1141; 1050-1183; 1108-1183; 1126-1182; 1136-1215 32/LG:239410.21:2001MAR30 || 1-587; 29-569; 33-310; 48-589; 187-433; 210- 553; 388-968; 500-792; 517-758; 524-1099; 532-984; 554-1091; 654-918; 692- 927; 697-975; 767-1054; 774-1043; 777-1066; 790-1057; 803-1326; 803-1010;
819-1049; 855-1402; 858-1441; 877-1116; 879-1103 882-1090; 882-1425; 905-
1504; 944-1118; 953-1240; 959-1208; 988-1466; 999-1238; 1001-1205; 1003
1561; 1024-1233; 1041-1127; 1043-1241; 1049-1310 1054-1636 1071-1337; 1077-1534; 1080-1290; 1083-1599; 1083-1691; 1085 1299; 1106 1241; 1103- 1613; 1126-1601; 1138-1623; 1145-1437; 1147-1726 1157-1721 1168-1474; 1192-1369; 1201-1763; 1216-1505; 1216-1719; 1224 1385; 1223-1455; 122! 1619; 1240-1634; 1240-1501; 1240-1736; 1246-1492 1250-1457 1263-1483 1276-1537; 1286-1381; 1306-1492; 1327-1539; 1331 1611; 1363 1633; 1382 1646; 1407-1622; 1425-1692; 1459-1952; 1565-1805 1567-1942 1567-1805 1678-1908; 1684-1807; 1773-2020; 1773-2030; 1818 2025; 1882 2025; 1889- 2464; 1942-2025; 2334-2602; 2334-2532; 2334-2780 2348-2475 2348-2478
2348-2510; 2357-2580; 2434-2590; 2434-2650; 2434-2884; 2442 2643; 2522-
2818; 2566-28 05; 2633-2890; 2639-2816; 2705-2884; 2724-2884 2727-2884 2732-2884; 2771-2884; 2804-2870; 2811-2884; 2812-2884; 2816-2884; 2823- 2884; 2826-2884 33/LG:245854. 7:2001MAR30 | | 1-571; 13-465; 7-429; 8-255; 18-215; 15-3037; 17-323; 31-650; 32-624; 32-393; 32-608; 32-538; 32-435; 32-596; 32-258; 33- 279; 53-316; 62-219; 55-335; 57-167; 59-628; 62-305; 62-654; 62-628; 62-
598; 62-323; 62-538; 62-586; 62-294; : 105-696; : 111-741; 128-750; 131-745; 133-666; 137-381; 168-397; 169-395; 170-423; 171-734; 189-389; 215-465; 223-504; 231-802; 247-809; 266-925; 271-508; 272-517; 309-579; 314-861; 331-781; 348-849; 363-685; 299-778; 376-960; 309-552; 423-799; 446-668;
444-683; 465- 1071; 464-1097; 482-967; 507-1048; 527-1098; 531-1183; 532- 755; 537-1052 ; 547-818; 547-871; 547-802; 550-1194; 556-1095; 563-800; 576- 924; 579-881; 617-895; 617-998; 627-1053; 639-1270; 643-793; 660-906; 674- 813; 679-973; 684-1293; 696-1277; 695-1152; 736-1238; 775-1021; 819-1068; 840-1396; 842 -llll; 865-1135;' 867-1187; 869-1187; 874-1114; 877-1022; 884- Table 3
1444; 897-1156; 912-1300; 9 11-1447; 90 9-1366 928-1066; 931- -1183; 935-1229; 935-1208; 956-1239; 979-1439; 999-1270 1007 1233; 1026 -1488; 1028-1269; 1029-1266; 1036-1512; 1068-1243; 1068 1479; 1082-1484; 1095- -1478; 1095-
1480 1096-1281 1099-1326 1108-1389 1113-1366; 1151 1357, 1160- -1574; 1176 1429; 1207 1488; 1212 1731; 1223 1484; 1227-1516; 1228- -1451; 1227- 1480 1235-1409 1248-1864 1253-1426 1271-1455; 1277 1388, 1287- -1493;
1289-1714; 1291 1513; 1296-1572; 1308 1478; 1310-1543; 1311- -1825; 1313-
1564 1317-1825 1317-1769 1319-1580 1340-1615; 1342 1545, 1349- -1575;
1361-1591; 1371 1623; 1383 1936; 1388 1713; 1403-1655; 1408- -1583; 1408-
2155 1426-2023 1429-1765 1433-1753 1434-1575; 1439 1839, 1440- -1709; 1446 1682; 1458-1720; 1459 1745; 1484 1743; 1494-1806; 1501- -1747; 1506- 2096 1522-1797 1526-1997 1535-1864 1558 2133; 1563- 1804; 1566- -1779; 1579 1880; 1585 1845; 1589 2186; 1589 2126; 1600-2193; 1601- -2039; 1608- 1821 1610-1799 1617-1932 1617-2121 1629 2186; 1631 1871; 1639- -1926;
1646-1838; 1653-1864; 1658-1917; 1668-1864; 1681-2145; 1696- -2018; 1699-
2009 1703-1864 1705-1974 1705-1864 1718 1853; 1728- 1973; 1731- -1843; 1734 2053; 1739 1972; 1742 2004; 1746 1986; 1771-2032; 1775- -2017; 1791- 2073 1804-2039 1804-2108 1808-2109 1812-2088; 1874- 2181; 1874- -2159;
1881-2070; 1881 2134; 1881 2431; 1881 2119; 1881-2133; 1886- -2304; 1887-
2171 1889-2142 1893-2330 1899-2334 1899 2157; 1905 2164, 1924- -2332; 1933 2357; 1941 2138; 1947 2193; 1957 2227; 1959-2150; 1959- -2237; 1967- 2206 1967-2205 1968-2225 1979-2235 1985 2586; 1987 2581, 1989- -2209;
1994-2250; 1996-2193; 2010 2513; 2015-2244; 2017-2252; 2018- -2277; 2037-
2303 2054-2664 2060-2426 2061-2652 2067 2482; 2079- 2159, 2081- -2346; 2081 2331; 2104-2354; 2109-2312; 2123 2377; 2123-2414; 2126- -2390; 2137- 2369 2139-2238 2146- -2400 2146-2409 2149-2379; 2158 2725, 2168 -2423;
2166-2419; 2166 2395; 2180 2721; 2204 2436; 2204-2414; 2206- -2464; 2206-
2455 2216- 2484 2216- -2428 2220-2475 2220-2667; 2222 2361, 2223- -2743; 2229 2626; 2223 2678; 2225 2656; 2225 2666; 2226-2463; 2241- -2501; 2241- 2526 2259- 2558 2259 -2493 2261-2524 2260 2480; 2264- 2708 2266 -2820; 2270 2893; 2271 2829; 2280 2493; 2282 2584; 2286-2811; 2287- -2549; 2295- 2581 2299- 2544 2304- -2576 2306-2881 2308-2611; 2315- 2613, 2317- -2701; 2320 2518; 2321 2563; 2331 2582; 2333 2607; 2335-2879; 2342- -2920; 2342- 2751 2344- 2610 2344- -2547 2349-2924 2350-2811; 2357- 2612, 2357- -2548; 2359 2912; 2359 2623; 2359 2707; 2360 2929; 2362-2568; 2362- -2579; 2364- 2601 2364-■2543 2366 -2625 2373-2638 2376 2631; 2380- 2626 2383- -2621; 2383 2639; 2401 2959; 2413 2813; 2413 2667; 2413-2701; 2415- -2663; 2420- 3023 2424- 2686 2441- -2619 2442-2570 2448 2680; 2451- 2700, 2453 -2694; 2456 2700; 2458 2669; 2461 2664; 2463 2709; 2467-2719; 2471- -3014; 2471- 2696 2473- 3035 2480- -2739 2495-2883 2490 2728; 2491- 2708 2494 -2746; 2494 2700; 2503-2708; 2509 2899; 2507-2992; 2509-2850; 2510- -2864; 2510- 3000 2510-2698 2512-2713 2519-2662 2520-3037; 2527 2708 2536- -2708; 2541 3032; 2541 2992; 2549 2807; 2557-2708; 2557-2849; 2558- -2800; 2561- 3040 2566-2922 2573-3044 2575-3040 2576 3036; 2577- 2840 2580- -3037; 2581 3032; 2582-3037; 2583-2837; 2583-2971; 2584-2853; 2584- -3037; 2584- 2834 2587-3036 2587-2833 2587-2978 2588 2847; 2589 3148 2593 -3036; 2596 2881; 2596 2858; 2597 3036; 2602-3041; 2603-3037; 2603- -3040; 2606- 3042 2605-3041 2609-3037 2616-3040 2615-3044; 2606 3043 2617 -2886; 2619 3045; 2618 3037; 2620 3037; 2622-3043; 2622-3036; 2624- -2902; 2627- 3037 2627-3032 2628-3037 2631-3039 2631 3037; 2632 3041 2633 -3037; 2634 -3043 ; 2634-3037 ; 2636 3039 ; 2636-3041; 2638-3040; 2638- -3039; 2639- 3035 2640-3037 2643-3035 2643-2878 2647 3037; 2647- 3035 2649 -2987;
2649-3000; 2650 3035; 2653 3037; 2653 2864; 2654-3041; 2654- -3040; 2655-
3037 2656-2901 2661-3037 2653-3043 2714 2934; 2714 2943 2716 -2996; 2724 2940; 2729 3037; 2739 3037; 2738 3039; 2744-3037; 2748- -2896; 2748- 2985 2748-3037 2748-2887 2748-3040 2748 2922; 2749- 3039 2749 -3042; 2750 2988; 2750 3001; 2750-3037; 2752 3019; 2753-3039; 2756- -3039; 2763- 3044 2765-3037 2767-3018 2777-3027 2783-3039; 2778- 2857 2789 -3036; 2794 3035; 2920-3037; 1-96 1-94; 2938 3109; 2987-3582; 3356-3838 ; 3418- 3909 3417-4042 3651-3912 2359-2631 2341-2614; 2555- 2831 2261 -2537; Table 3
2270-2547; 2369-2648; 2348-2634; 2363-2497; 2401-2694; 2359-2674; 2378- 2627; 2276-2522; 2466-2707; 2285-2519; 2384-2618; 2661-2875; 2661-2866; 2450-2644; 1973-2115; 2413-2531; 2035-2152 34/LG:294697.1:2001 AR30 | | 1-387; 1-150; 2-278; 63-675
35/LG:345884.1:2001MAR30 j j 1-315; 7-392; 9-261; 59-265; 192-650; 214-576 36/LG:400095.15:2001 AR30 | | 1-482; 2-494; 11-627; 10-544; 11-577; 11-515; 15-626; 30-405; 35-529; 45-605; 47-557; 58-361; 59-329; 100-376; 107-604; 138-685; 274-529; 284-680; 315-960; 325-723; 423-938; 496-723; 587-861; 672-1251; 694-1262; 746-986; 805-954; 808-1410; 978-1326; 1141-1671; 1155- 1396; 1172-1440; 1259-1725; 1316-1567; 1580-2008; 1623-2034; 1625-1880; 1625-1878; 1684-2200; 1721-2148; 1779-2041; 1823-2453; 1823-2033; 1902- 2082; 1904-2285; 1940-2379; 1941-2167; 2004-2574; 2074-2425; 2098-2700; 2129-2561; 2177-2748; 2227-2751; 2287-2629; 2310-2693; 2362-2799; 2362- 2638; 2378-2692; 2392-2628; 2458-2698; 2550-3123; 2668-3104; 2686-2931; 2711-3151; 2734-3123; 2742-3188; 2789-3187; 2801-3188; 2811-2948; 2861- 3127; 2866-3188; 2911-3172; 2921-3187; 2941-3187; 3025-3187; 3025-3153; 3035-3187; 3041-3187; 3047-3187; 3047-3141; 3047-3134; 3055-3187; 3074-' 3187; 3078-3187
37/LG:402180.1:2001MAR30 | | 1-567; 1-538; 1-684; 188-780; 427-860; 784-936; 784-1075; 793-978; 798-1142; 832-995; 832-988; 845-1351; 915-1351; 953- 1351; 1041-1177; 1285-1941; 1640-1975; 1647-1917; 1654-1929; 1654-1968; 1654-1893
38/LG:403401.1:2001MAR30 | | 717-1052; 592-1050; 630-1049; 729-1049; 848- 1045; 598-1043; 596-1041; 577-1041; 593-1041; 679-1038; 606-1039; 622-1037; 609-1037; 830-1037; 594-1036; 729-1035; 836-1027; 720-1021; 689-999; 729-
998; 608-979; 431-944; 507-926 442-932; 481-895; 390-868; 444-717; 433-
709; 470-705; 390-704; 478-704 367-704; 189-679; 187-648; 113-579; 380-
573; 390-555; 390-499; 378-479 90-262; 92-262; 1-187
39/LG:411327.29:2001MAR30 ) | 1-450; 9-363; 11-630; 9-545; 11-614; 13-461;
20-386; 48-355; 76-463; 78-630; 92-270; 101-356; 127-591; 164-585; 166-426;
221-579 239-383 235-646 282-630; 268-637; 268-582; 288-670 300-576; 327-599 328-527 335-439 326-555; 343-576; 343-805; 369-603 358-630; 378-653 393-665 404-862 417-631; 446-664; 448-716; 451-646; 451-664 453-962 456-663 458-959 506-922; 520-961; 541-967;' 551-925; 559-956 564-791 599-961 637-838 687-952; 697-961; 699-961; 704-966; 711-963 712-925 722-963 722-968 722-925; 725-965; 743-963; 748-963; 840-955 841-929 846-964 848-1113 849-963; 859-959; 871-951; 880-966
40/LG: 417464.10 :2001MAR30 I 1-343; 6-330; 169-665; 160-729; 235-539; 244-
613; 245-689; 353-768; 349-720 ,- 462-681; 462-934; 711-957; 711-948; 727- 1104; 750-1112; 810-1093; 823-1110; 840-1078; 868-1149; 903-1108; 903-1070; 911-1175; 999-1255; 1039-1108 41/LG:481997.1:2001MAR30 || 1- 649; 341-703; 378-710; 378-739; 379-698; 445- 855; 466-776; 541-973; 581-687 ; 592-929; 609-840; '609-839; 685-1141; 696- 1149; 797-1145
42/LG:979304.7:2001 ΛR30 || 1- 479; 51-244; 51-494; 55-708; 129-464; 232- 638; 234-366; 316-574; 348-629 ; 353-467; 353-440; 358-991; 366-606; 455- 725; 526-778; 538-1084; 568-87 6; 587-1099; 620-1162; 646-883; 652-976; 678- 1157; 736-1197; 750-1157; 755- 1245; 832-1281; 833-1161; 868-1200; 867-1207; 867-1177; 878-1206; 886-1268; 903-1211; 934-1122; 976-1205; 1018-1200; 1116-1226
43/LG:997964.1:2001MAR30 || 1- 544; 29-1292; 135-718; 200-439; 311-407; 457- 962; 532-1044; 713-979; 950-1321; 1024-1253; 1041-1608; 1097-1718; 1186- 1477; 1209-1546; 1308-1680; 1316-1746; 1338-1427; 1396-1740; 1472-2119;
1545-1737; 1553-1740 1567-1740; 1597-1723; 1597-1725; 1603-1718; 1640-
1729; 1640-1725; 1643-1725; 1944-2406; 1979-2399; 1979-2049; 1979-2402;
1987-2621; 1989-2409 2001-2230; 2003-2273; 2003-2230; 2003-2182; 2006-
2206; 2006-2220; 2012-2237; 2012-2081; 2013-2193; 2017-2112; 2018-2487;
2033-2367; 2033-2157 2033-2133; 2033-2179; 2033-2131; 2033-2147; 2049-
2551; 2053-2530; 2067-2277; 2088-2261; 2191-2539; 2210-2439; 2214-2474;
2215-2494; 2216-2435 2220-2476; 2220-2482; 2222-2422; 2222-2503; 2234- Table 3
2357; 2234-2312; 2234-2309; 2234-2556; 2234-2412; 2234-2400; 2234-2438
2234-2397; 2234-2366; 2234-2291; 2234-2420; 2234-2338; 2240-2520; 2241
2661; 2246-2460; 2246-2490; 2259-2521; 2263-2454; 2269-2496; 2280-2524
2303-2684; 2303-2536; 2309-2570; 2319-2442; 2322-2574; 2372-2568; 2382
2610; 2390-2955; 2392-2641; 2393-2638; 2399-3013; 2406-2778; 2424-3023
2435-2616; 2434-2963; 2457-2758; 2446-3021; 2497-2984; 2499-2996; 2545
2835; 2547-2770; 2555-2767; 2578-3020; 2578-2985; 2587-3091; 2591-3023
2606-3067; 2607-3065; 2609-3066; 2611-3062; 2612-3069; 2622-3066; 2628-
3063; 2628-3025; 2633-2721; 2633-2817; 2633-2932; 2633-2901; 2633-3063
2640-3064; 2645-3179; 2646-3203; 2645-2862; 2645-2795; 2646-3056; 2654
3069; 2667-3063; 2685-3061; 2687-2946; 2688-3063; 2691-2937; 2711-3063
2716-2951; 2721-3065; 2721-2994; 2734-2968; 2740-3069; 2742-3009; 2744
3064; 2747-3199; 2757-3056; 2761-3066; 2763-3057; 2764-3063; 2766-3063
2767-3064; 2776-3042; 2782-3064; 2789-3070; 2790-3063; 2793-3021; 2801
3066; 2803-3066; 2829-3063; 2834-3063; 2842-3067; 2844-3063; 2864-2981
2864-3063; 2865-3069; 2865-3070; 2872-3063; 2891-3063; 2920-3060; 2919
3066; 2919-3187; 2920-3063; 2921-3167; 2923-3063; 2937-3057; 2970-3215
2984-3063; 3001-3249; 3028-3217; 3049-3137; 3065-3221; 3113-3224; 3137-3655
44/LG:998845.1:2001MAR30 | | 1-391; 1-291; 17-474; 251-759; 285-730; 311-
585; 317-411; 586-845
45/LG:000014.1:2001MAR30 || 1-595 4-286; 23-593; 336-621; 537-1004; 538-
595; 741-1091
46/LG:000290.9:2001MAR30 | | 1-524; 28-512; 30-318; 60-515; 106-551; 264-
670; 300-461; 300-453; 346-640; 442-964; 687-1331; 775-1211; 819-1024; 870-
1488; 877-1155; 925-1361; 970-1473; 1027-1646; 1091-1662; 1281-1784; 1301-
1772; 1318-1812; 1327-1757; 1387-1769; 1391-1853; 1415-1760; 1478-1846;
1494-1848; 1544-1638
47/LG: 001923.1.2001MAR30 | | 1-235; 14-568; 17-235 310-436; 335-832; 339-
831; 349-507; 365-643; 365-683; 365-484; 369-616; 457-871; 470-908; 485-
753; 489-908; 492-913; 500-826; 510-909; 555-897; 561-820; 566-1071; 572-
949; 581-824; 601-913; 615-1197; 629-912; 677-908 696-1101; 738-1197; 777-
863; 920-1416; 923-1204; 947-1287; 1187-1379; 1314-1437; 1314-1745; 1423
1667; 1454-1623; 1632-1771
48/LG-.008606.21.2001MAR30 | | 1670-2261; 1767-2004; 1555-2004; 1478-1994;
1737-1995; 1746-1995; 1514-1995; 1567-1994; 1889-1972; 1852-1972; 1579-
1972 1602-1967; 1501-1965; 1857-1965; 1800-1965; 1817-1965; 1879-1965
1710-1957; 1905-1959; 1696-1951; 1685-1934; 1424-1928; 1658-1925; 1666 1925; 1589-1912; 1514-1891; 1641-1891; 1596-1854; 1613-1846; 1589-1844; 1570-1832; 1670-1729; 1461-1717; 1361-1717; 1466-1708; 1444-1699; 1333- 1694; 1373-1670; 1412-1654; 1402-1652; 1403-1649; 1063-1614; 1451-1609; 1470-1601; 1358-1597; 1347-1597; 1286-1571; 1306-1570; 1318-1556; 1302- 1534; 1389-1519; 1073-1505; 1071-1488; 1026-1487; 1033-1477; 1033-1465; 1168-1462; 1207-1462; 1152-1458; 1026-1457; 1022-1449; 1033-1435; 1034- 1421; 1062-1419; 1032-1418; 1235-1412; 1034-1412; 1072-1392; 1030-1384; 1033-1373; 1065-1349; 1033-1344; 880-1334; 1042-1333; 1033-1301; 1225-1298; 926-1286; 1029-1257; 1034-1256; 1065-1257; 824-1232; 929-1225; 960-1221; 932-1220; 763-1216; 755-1215; 1026-1213; 935-1212; 657-1189; 742-1182; 710- 1175; 774-1168; 804-1168; 1070-1168; 733-1166; 758-1163; 846-1161; 875- 1161; 940-1161; 745-1161; 770-1161; 927-1161; 767-1159; 1033-1143; 695-
1135; 1018-1130; 565-1122; 613-1123 869-1127; 736-1114; 883-1089; 836- 1086; 802-1083; 540-1045; 955-1019 639-1019; 737-1012; 748-1005; 456-974;
746-951 441-930; 347-916 601-918 840-910; 410-882; 617-880; 642-859; 549-848 625-846; 547-800 473-768 531-765; 524-734; 471-733; 439-712; 175-709 266-670; 439-665; 316-625 435-605; 303-602; 271-591; 395-579; 306-579 379-579; 303-569; 318-555 299-529; 1-526; 400-504; 303-495; 303- 452; 1-418; 303-380; 303-381; 299-378; 63-173; 1-173; 75-173 49/LG:009699.32:2001MAR30 || 200-544; 6-542; 426-542; 234-537; 187-542; 226-543; 93-541; 133-541; 139-542; 88-541; 74-541; 198-540; 165-539; 228- 540; 260-538; 91-539; 101-539; 314-538; 108-539; 83-538; 150-539; 63-539; 320-536; 285-536; 113-536; 158-537; 127-537; 80-536; 208-537; 115-537; 75- Table 3
537; 149-537; 89-536; 81-536; 155-536; 122-536; 124- 536; 118-536; 154-536; 316-536; 97-536; 107-536; 103-536; 450-536; 425- 536; 366-536; 385-536; 149 536; 413-536; 129-536; 428-536; 82-536; 293-535; 94- 534; 78-533; 254-530; 363-529; 65-529; 90-529; 246-527; 75-527; 426-52 5; 162-508; 95 -505; 97-504 162-499; 137-497; 186-497; 316-497; 167-495; 309 -493 ; 208-464; 172-424; 316-423; 132-400; 134-392; 162-386; 1-383; 97-37 9; 141-379; 129-378; 100- 374; 124-360; 119-357; 4-191; 267-533; 2.51-537; 244-.. 537; 240-537; 227-537; 215-536; 199-537; 196-536; 200-540; 199-541; 203 -533 181-536; 177-537;
165-507; 166-536; 159-536 205-541; 185-520; 203 -511 ; 228-537; 333-536; 343-536; 346-538; 354-538 347-527; 406-538; 346 -456 ; 484-536 50/LG: 016723.6 :2001MAR30 I 537-828; 701-814; 52 3-810; 519-812 ; 560-813;
426-812; 398-812 735-812 494-812 736-812; 417 -812 380-810; 580-811; 507-810; 465-810 542-810 721-810 548-810; 453 -810 ; 530-810; 727-810;
536-810 366-810 566-810 667-810 434-810; 580-810; 584-810; 590-810 545-787 545-778 507-763 422-751 480-752; 465-711; 397-669; 398-671 477-653 1-633; 289-599; 282-599; 377-599; 470-592; 1-569; 230-496; 172- 475; 1-429; 1-425; 207-423; 144-419; 1-368; 94-333; 57-313; 141-274; 158- 268; 158-257; 143-249; 31-100
51/LG: 017126.5 :2001MAR30 || 1-323; 1-275; 44-560; 71-290; 123-415; 299-672; 325-749; 391-749; 403-746; 448-1071; 485-748; 653-1195; 786-1379; 798-1198; 826-1198; 874-1178; 925-1395; 989-1152; 1029-1530; 1032-1598; 1104-1293; 1222-1434; 1223-1598; 1285-1598; 1309-1845; 1358-1471; 1502-1619; 1502- 1725; 1660-1895; 1660-2172; 1883-2300; 1883-2135; 1919-2150; 2053-2497; 2048-2459; 2131-2497; 2155-2498; 2155-2500; 2190-2584; 2190-2473; 2195- 2602; 2198-2470; 2409-2842; 2435-2667; 2523-2857; 2562-2857; 2578-2774; 2748-2857 52 /LG: 019362.10 :2001MAR30 [ I 1-274; 1-239; 1 -227; 89-523; 109-624; 166-586;
211-508 225-742; 235-805 235-778; 235-712; 236-805; 235-681 250-5 22;
264-573 268-574; 285-550 293-534; 293-523; 311-569; 313-561 318-5 79;
333-57.7 377-513; 388-653 388-602; 388-578; 392-653; 394-846 404-1 004;
432-1050 : 432-518; 457-702 459-550; 460-655 467-973; 470-745 473- 784;
481-843 481-703; 482-1043 482-731; 488-754; 490-943 489-778 491- 721;
496-684 496-654; 500-706; 503-776; 503-744; 511-744; 512-1095 512 754;
513-756 513-1055; 551133--774466; 518-771; 531-778; 543-778 543-688 545 946;
546-792 550-1086; 555500--883322; 552-800; 559-711; : 563-806; 570-771 576- 772;
578-887 588-993; 594-795; 594-790; 610-935; 612-864; 615-827; 619-8 77;
623-933 627-892; 629-886; 632-909; 634-952; 634-866; 668-1166 668- 1154;
668-978 671-869; 673-1167; 681-981; 686-896; 695-904; 697-938; 699- 936;
700-871; 705-913 704-975; 721-991; 723-889; 739-1099; 741-851; 742- 911; 759-966; 781-1047 ; 783-968; 787-984; 796-1029; 797-1071; 819-1159; 841- 1080; 849-1161; 850-1143; 852-1129; 866-1413; 898-1453; 898-1152; 899-1171; 902-1150; 915-1166; 915-1156; 915-1119; 927-1168; 934-1117; 944-1104; 955- 1162; 957-1169; 957-1096; 963-1166; 984-1532; 973-1163; 975-1150; 982-1150; 983-1162; 986-1222; 991-1150; 998-1171; 998-1150; 998-1146; 1001-1543; 1008-1531; 1008-1150; 1027-1150; 1054-1564; 1064-1373; 1130-1213; 1253- 1716; 1272-1711; 1273-1718; 1273-1596; 1283-1661; 1292-1557; 1297-1711; 1298-1536; 1302-1711; 1301-1586; 1306-1709; 1305-1596; 1303-1572; 1305- 1716; 1305-1709; 1305-1711; 1305-1712; 1305-1665; 1305-1613; 1305-1599; 1305-1455; 1307-1572; 1305-1437; 1305-1442; 1305-1398; 1305-1386; 1305- 1367; 1305-1359; 1305-1668; 1305-1677; 1305-1588; 1305-1503; 1305-1512; 1307-1711; 1308-1596; 1307-1575; 1307-1484; 1309-1711; 1308-1583; 1308- 1578; 1316-1684; 1316-1491; 1318-1711; 1322-1713; 1321-1543; 1322-1446; 1323-1711; 1322-1584; 1322-1571; 1322-1591; 1327-1666; 1327-1601; 1327- 1540; 1331-1714; 1332-1709; 1337-1711; 1340-1601; 1345-1699; 1345-1689; 1345-1582; 1350-1704; 1351-1667; 1356-1616; 1360-1596; 1372-1711; 1374- 1716; 1384-1610; 1387-1699; 1388-1662; 1396-1711; 1395-1596; 1395-1512; 1400-1662; 1404-1674; 1417-1711; 1417-1712; 1419-1711; 1423-1687; 1426- 1711; 1430-1699; 1433-1714; 1436-1715; 1449-1708; 1449-1712; 1455-1685; 1453-1712; 1455-1711; 1466-1711; 1467-1716; 1467-1732; 1468-1676; 1478- 1711; 1479-1717; 1479-1711; 1481-1710; 1488-1711; 1495-1711; 1524-1711; Table 3
1532-1711; 1533-1586; 1542-1712; 1544-1699; 1560-1711; 1564-1699; 1565- 1712; 1589-1711; 1594-1711; 1601-1711
53/LG: 022183.1.-2001MAR30 || 600-1057; 586-820; 607-805; 598-804; 640-802; 73-774; 498-747; 600-741; 600-739; 670-739; 595-644; 1-567; 1-162; 1-151 54/LG:028493.1:2001 AR30 || 1-400; 2-285; 1-301; 10-330; 14-438; 14-127; 14-226; 14-405; 14-218; 16-255; 21-349; 22-262; 27-345; 32-321; 36-186; 36- 163; 36-447; 36-486; 36-195; 36-203; 40-442; 51-423; 54-442; 74-451; 76- 451; 79-440; 102-404; 115-239; 139-442; 146-401; 158-349; 166-442; 210-423; 229-442; 292-359; 301-442; 310-962; 357-962; 384-451; 838-1007; 933-1263; 961-1501; 1225-1424; 1225-1326; 1225-1292; 1230-1374; 1234-1599; 1263-1781; 1377-1654; 1674-2044; 1674-2067; 1697-2057; 1751-1983; 1751-2057 55/LG:034197.1:200lMAR30 || 1-549; 24-537; 38-571; 89-495; 89-421; 109-339; 142-329; 182-410; 179-510; 182-578; 180-409; 193-420; 198-479; 226-579; 224-510; 236-578; 261-578; 344-577 56/LG:054096.31:2001MAR30 II 1-488; 384-654; 524-635; 560-1143; 560-1070;
721-863; 730-1028; 799-1071; 809-1095 848-1465; 872-1157; 897-1202; 920-
1163 1361-1895; 1434-1931 1501-1841 1525- -1969, 1527- -1767 1529- 1785 1535 2043; 1534-1795; 1534 1789; 1534 1761; 1545- -1780; 1557 2073; 1573- 1840 1583-1845; 1587-1848 1595-2089 1599- -1822, 1601- -1871 1616- 1742
1619-1881; 1621-1878; 1631-2176; 1631 2171; 1631- -2147; 1631 1954; 1659
2228 1658-1901; 1667-1849 1672-1954 1672- -2099, 1687- -1927 1691- ■2015
1692-2286; 1696-1930; 1698 1986; 1698 1983; 1698- -1837; 1698 1923; 1700
1981 1709-1963; 1711-1983 1721-2090 1721- -1976, 1721- -1914 1723- ■1973 1741 2033; 1743-1972; 1757 1998; 1764 1939; 1773- -2014; 1780 2054; 1789 2414 1798-2089; 1800-2383 1800-2066 1800- -2005, 1801- -2093 1801- 2415 1807 2084; 1816-2419; 1823 2354; 1821 2093; 1823- -2074; 1825 2067; 1827 2025 1827-1997; 1830-2400 1838-2377 1843- -2087, 1848- -2434 1851- 2090 1858 2124; 1861-2135; 1861 1935; 1870 2415; 1874- -2407; 1873 2140; 1884 2458 1883-2407; 1895-2373 1895-2106 1894- -2370, 1906- -2192 1907- ■2155
1913-2412; 1920-2282; 1920-2133; 1925-2183; 1932-2177; 1936 2421; 1940
2207 1942-2195; 1944-2247 1955-2338 1956-2176; 1957-2106 1961- 2243
1961-2223; 1961-2197; 1961-2186; 1962 2181; 1962-2198; 1967 2399; 1971
2231 1971-2213; 1973-2247 1976-2181 1977-2391; 1980-2418 1980- 2404 1981 2455; 1983-2454; 1983-2452; 1986 2455; 1990-2456; 1993-2458; 1996 2455 1999-2458; 2000-2249 2001-2258 2004-2464; 2004-2458 2006-2460 2006 2209; 2006-2200; 2009 2458; 2011-2458; 2011-2421; 2014-2126; 2017- 2460 2018-2459; 2021-2464 2022-2458 2024-2458; 2025-2268 2026-2234 2027 2272; 2028-2455; 2033 2456; 2033 2458; 2036-2459; 2037-2459; 2037- 2328 2037-2254; 2044-2461 2044-2459 2045- 2456; 2044- 2456 2046-2458 2046 2330; 2049-2460; 2053 2458; 2054 2458; 2054-2463; 2054 2295; 2058 2455 2061-2461; 2063-2459 2067-2458 2067- 2403; 2067- 2375 2069-2452 2070 2458; 2070-2457; 2070-2420; 2070 2416; 2070-2312; 2074 2458; 2076 2458 2078-2459; 2080-2461 2089-2461 2093--2455; 2095- 2354 2097-2460 2104 2532; 2106-2459; 2113 2459; 2114 2458; 2116-2458; 2121 2453; 2121- 2458 2124-2459; 2125-2284 2126-2458 2131- 2458; 2135- 2463 2137-2382
2140-2462; 2147-2458; 2151 2458; 2152 2458; 2155-2462; 2158 2427; 2157-
2371 2158-2458; 2158-2389 2161-2455 2164- 2458; 2166- 2459 2169-2429
2180-2460; 2180-2459; 2183-2453; 2184 2448; 2199-2458; 2201 2455; 2201
2409 2207-2458; 2210-2455 2212-2458 2202- 2419; 2224- 2478 2225-2462
2243 2458; 2258-2438; 2272-2458; 2265-2455; 2284-2458; 2303-2455; 2313-
2458; 22333399--22445588;; 22334422--22445599; 2368-2462
57/LG: 054807.3 :2001MAR30 | | 1-2445; 106-442; 432-655; 441-718; 487-1013;
490-761; 679-974; 680-927; 1030-1429; 1203-1363; 1252-1524; 1328-1740;
1330-1564; 1461-1739; 1574-1734; 1576-1740; 1579-1734; 1637-2195; 2069-
2310; 2072-2368; 2116-2445; 2158-2444; 2180-2445; 2192-2445; 2209-2342;
2319-2445
58/LG: 065873.12 :2001MAR30 || 1-610; 32-437; 36-678; 43-308; 43-279; 67-694;
87-526; 117-729; 128-663; 156-436; 189-756; 193-526; 224-767; 256-715; 260-
755; 297-418; 304-715; 413-526; 444-721; 477-693; 511-1140; 588-712; 614-
707; 614-737; 614-715; 613-715; 630-1243; 629-744; 639-715; 665-715; 844- Table 3
1395; 911-1477; 962-1093; 964-1174; 974-1443; 993-1269; 993-1387; 993-1230; 993-1210; 993-1107; 995-1093; 1005-1164; 1009-1205; 1022-1071; 1022-1399; 1024-1503; 1025-1312; 1038-1298; 1042-1402; 1042-1257; 1058-1203; 1058-
1281; 1069-1269; 1072-1303 1102-1405 1103-1414 1121-1330; 1184-1820 1192-1820; 1223-1820; 1239 1344; 1246 1820; 1250 1820; 1272-1820; 1304- 1840; 1313-1938; 1355-1820 1368-1820 1425-1873 1432-2014; 1450-1681
1490-1758; 1497-1820; 1509-1700; 1521 2062; 1523 1757; 1551-1821; 1557-
1830, 1561- -2155, 1561- -1796 1569-1873 1581-1823 1587-1836; 1594-1816
1620- -2253; 1629- -1862; 1632 1887; 1674 2244; 1674 2174; 1674-1912; 1674-
1836, 1678 -2212, 1680 -2257 1743-2042 1734-2002 1743-1997; 1792-2354
1801- -2337; 1811- -2416; 1810 2324; 1819 2056; 1827 2431; 1846-1950; 1827
2372, 1850- -2302, 1850- -2273 1853-2094 1854-2153 1862-2047; 1866-2080
1880- -2306; 1882- -2160; 1884 2157; 1886 2140; 1902 2455; 1908-2220; 1951
2199 1951 -2219 1952 -2514 1953-2234 1953-2152 1953-2111; 1967-2168
1972- -2026; 1974- -2253; 1999 2204; 2011 2433; 2020 2308; 2027-2294; 2030
2218 2058 -2330 2060- -2314 2031-2507 2086-2670 2086-2307; 2067-2772
2071-2363; 2071-2318; 2078-2380; 2085 2337; 2107 2669; 2108-2395; 2095
2354, 2134 -2351 2101- -2307 2106-2621 2116-2357 2119-2583; 2123-2633
2127- -2585; 2127- -2364; 2133 2690; 2140 2733; 2141-2263; 2169-2598; 2156-
2748, 2156 -2716, 2170- -2429 2170-2391 2172-2625 2189-2440; 2172-2338
2174- -2715; 2184- -2730; 2189 2560; 2188 2437; 2189 2455; 2197-2434; 2206
2490, 2205 -2649, 2211- -2752 2213-2563 2221-2759 2258-2495; 2237-2726
2244- -2846; 2251- -2534; 2255 2726; 2257 2466; 2261 2716; 2268-2769; 2288
2644 2310 -2533 2296- -2724 2304-2732 2303-2668 2303-2544; 2303-2447
2310- -2760; 2310- -2509; 2311 2731; 2312 2541; 2316 2769; 2316-2773; 2325
2515, 2326 -2774, 2325- -2731 2331-2776 2340-2769 2351-2769; 2349-2541
2350- -2602; 2351- -2541; 2354 2771; 2353 2541; 2357-2770; 2359-2773; 2357
2541, 2361 -2773 2362 -2541 2367-2767 2369-2770 2376-2592; 2377-2541
2380- -2770; 2382- -2773; 22338844-2541; 2390 2630; 2393 2651; 2396-2769; 2402
2772 2411 -2707 2417- -2596 2438-2769 2448-2768 2452-2772; 2457-2770
2459- -2768; 2461- -2541; 2463 2773; 2473 2763; 2474-2769; 2473-2730; 2477
2735 2483 -2759 2482 -2769 2499-2741 2508-2769 2517-2741; 2520-2697
2523- -2769; 2538- -2723; 2553 2768; 2555 2769; 2555 2770; 2571-2763; 2580
2730 2577 -2677 2580- -2769 2584-2769; 2586-2740 2587-2769; 2592-2769
2601-2860; 2623-2770; 2638-2727; 2652-2760; 2653-2769; 2704-2769; 2717- 2775; 2718-2768
59/LG:083814.6:200lMAR30 | | 1-272; 69-309; 91-327; 116-352; 118-639; 327- 597; 330-813; 441-777; 539-1086; 547-632; 608-848; 628-1064; 653-983; 663- 892; 667-983; 668-902; 668-1172; 676-976; 682-807; 734-1157; 739-1023; 757- 1000; 790-1045; 814-1061; 825-1189; 916-1429; 934-1211; 955-1093; 980-1365; 980-1227; 1023-1297; 1071-1462; 1082-1333; 1130-1461; 1156-1424; 1156-1389; 1156-1446; 1156-1467; 1192-1381; 1198-1528; 1200-1428; 1201-1406; 1217- 1478; 1218-1537; 1262-1502; 1267-1532; 1306-1580; 1350-1661; 1385-1627; 1392-1661; 1417-2109; 1463-1661; 1473-1674; 1506-1674; 1507-1661; 1515- 1661; 1540-1661; 1570-1661; 1584-1661; 1586-1661; 1614-1673; 1936-2194; 1942-2180; 1945-2178; 1952-2213; 1952-2219; 1963-2149; 1973-2204; 1973- 2193; 1979-2183; 1980-2199; 1980-2043; 1980-2224; 1981-2200; 1983-2199; 1985-2202; 1985-2179; 1985-2209; 2046-2207; 2051-2219
60/LG:093477.1:200lMAR30 | | 1-115; 1-619; 301-656; 387-775; 402-887; 402- 808; 410-775; 601-876; 601-777; 601-831
61/LG: 099572.12 :2001MAR30 | | 1-274; 32-119; 33-2610; 40-114; 46-302; 54- 327; 59-312; 59-174; 61-391; 63-395; 63-346; 69-340; 70-2469; 75-300; 968-
1397; 1283-1892; 1561-1837; 1561-1826; 1565-2164 1584-1857; 1584-1790
1621-2023; 1621-1703; 1722-2018; 1728-2255; 1812-2132; 1819-2011; 1845
2123; 1925-2154; 1979-2240; 1980-2245; 1994-2392 1999-2221; 2006-2577 2006-2532; 2026-2320; 2077-2252; 2173-2668; 2173 2761; 2196-2456; 2258 2509; 2259-2518; 2276-2674; 2304-2618; 2318-2764 2341-2760; 2343-2761 2353-2552; 2369-2607; 2388-2724; 2410-2579; 2468 2752; 2468-2745; 2490 2769; 2492-2697; 2515-3089; 2550-2701; 2571-2665 2571-2921; 2576-2761
2587-2759; 2618-2762; 2670-2911; 2672-2926; 2675-2759; 2800-3264; 2800- Table 3
3027; 2799-2986; 2821-3095; 2850-3119; 2962-3098; 2985-3236; 2985-3200; 3011-3382; 3014-3400; 3014-3313; 3061-3459; 3061-3297; 3082-3349; 3110- 3262; 3115-3361; 3128-3353; 3133-3404; 3150-3402; 3198-3424; 3224-3705; 3241-3500; 3241-3475; 3244-3724; 3249-3531; 3302-3899; 3363-3943; 3387- 3665; 3427-3623; 3428-4014; 3431-3960; 3446-3677; 3457-3527; 3467-3653; 3473-3733; 3474-3745; 3494-3910; 3494-3734; 3500-3751; 3524-3788; 3598- 3866; 3599-3857; 3603-4090; 3603-3750; 3625-3883; 3633-3919; 3666-4152; 3688-3943; 3692-3915; 3708-3977; 3735-3983; 3746-4029; 3746-3988; 3761- 4045; 3768-4101; 3768-3990; 3769-4235; 3777-4005; 3790-4014; 3799-4084; 3802-4010; 3814-4041; 3820-4192; 3821-4068; 3842-4038; 3849-3920; 3856- 4072; 3860-4101; 3882-4132; 3929-4185; 3947-4135; 3951-4219; 3965-4119; 3953-4566; 3971-4569; 3983-4545; 4004-4600; 4003-4532; 4026-4279; 4014- 4381; 4018-4602; 4037-4249; 4030-4383; 4072-4334; 4095-4640; 4111-4641; 4139-4441; 4145-4600; 4148-4559; 4161-4408; 4157-4638; 4166-4631; 4171- 4638; 4185-4509; 4175-4639; 4186-4638; 4188-4634; 4191-4640; 4195-4641; 4196-4641; 4200-4643; 4211-4420; 4222-4640; 4228-4643; 4228-4642; 4228- 4636; 4231-4642; 4231-4640; 4233-4638; 4235-4345; 4237-4639; 4248-4490; 4251-4598; 4253-4522; 4274-4492; 4278-4638; 4282-4642; 4293-4598; 4313- 4542; 4319-4592; 4320-4641; 4334-4590; 4372-4641; 4379-4595; 4386-4637; 4389-4648; 4390-4576; 4409-4619; 4413-4638; 4423-4638; 4441-4640; 4452- 4633; 4455-4630; 4455-4599; 4520-4645; 4528-4643; 4538-4630
62/LG:100396.31:2001MAR30 || 1-175; 25-161; 43-326; 49-487; 49-174; 52-155; 52-228; 61-177; 61-194; 64-489; 64-496; 150-424; 198-365; 244-706; 244-306;
372-881; 393-897; 393-839 393-896; 394-732; 408-872 410-904; 411-862
411-736; 415-736; 438-856 442-877; 443-871; 465-937 482-883; 490-939
515-702; 547-905; 554-879 564-932; 580-939; 605-933 627-876; 678-879
678-921; 699-933; 753-929 828-1129; 828-1183
63 /LG: 1026903.5 :2001MAR30 1-506; 38-428 99-628 132-635; 132-367; 136-
634; 427-802; 427-753; 434-1056; 774-1357; 904-1357
64/LG: 1060168.6 :2001MAR30 1-266; 36-285 95-278 242-443; 242-438; 242-
336
65/LG: 1086906.41 :2001MAR30 1-481; 1-123 37-129; 67-15 : 67-224; 77-135;
77-213; 77-230; 83-265; 95-596 118-701; 136-240; 328-616; 348-601; 350-
604 349-487; 355-576; 399-630 419-777; 431-662; 431-953; 470-739; 473- 681 499-749; 498-875; 517-792 523-1050; 528-633; 546-810; : 616-874; 641- 883 658-1271; 676-920; 759-1277; 769-1002; 771-1335; 771-1010; 771-1276; 777-1174; 852-940; 864-1095; 864-915; 864-1038; 864-1035; 864-977; 864- 1340; 864-1137; 864-1056; 864-1102; 864-1065; 864-1084; 876-1098; 914-1095; 921-1408; 936-1408; 956-1202; 1038-1655; 1107-1357; 1156-1408; 1156-1409; 1156-1415; 1181-1345; 1211-1288; 1260-1408; 1262-1408; 1270-1408; 1277- 1449; 1286-1408; 1306-1408; 1307-1408; 1338-1408; 1595-1655; 1604-1655; 1604-1864
66/LG:1089326.18:200lMAR30 )| 1-652; 110-724; 124-664; 140-291; 564-1203; 696-1252; 1039-1300; 1050-1341; 1050-1343; 1125-1351; 1156-1702; 1176-1451; 1178-1279; 1179-1482; 1196-1413; 1198-1479; 1209-1637; 1209-1452; 1238-
1465 1240-1472; 1368-1800; 1376-1926; 1400-1807; 1439-1722 1491-2129; 1512 1998; 1520-2128; 1595-1664; 1663-1897; 1667-2251; 1674 1924; 1703- 2189 1703-1864; 1714-2346; 1716-1988; 1727-2414; 1731-2099 1783-2393; 1788 2006; 1806-2341; 1871-2361; 1890-2304; 1890-2338; 1905 2377; 1963- 2416 1967-2374; 2001-2416; 2003-2416; 2004-2416; 2018-2416 2035-2416;
2046-2417; 2049-2416; 2049-2423; 2057-2420; 2070-2416; 2090-2416; 2114-
2416; 2115-2419; 2127-2419; 2139-2416; 2158-2416; 2172-2420; 2181-2416;
2210-2416; 2214-2416
67/LG:1090862.32:2001MAR30 || 1-274; 1-212; 1-269; 141-218; 207-400; 209-
614; 247-505; 487-936; 519-936; 705-1330; 793-1339; 819-919; 829-1106; 829-
880; 979-1399; 1012-1500; 1037-1500; 1185-1302; 1293-1671; 1311-1671; 1347-
1633; 1374-1706; 1477-1671; 1477-1683
68/LG:1091941.41:2001MAR30 || 1-146; 8-263; 9-462; 31-243; 34-143; 39-180;
43-186; 44-458; 44-537; 77-334; 82-652; 126-185; 126-464; 126-635; 188-643;
232-643; 236-359; 263-464; 310-782 Table 3
69/LG:1093386.8:2001MAR30 || 1-178; 1-204; 1-221; 10-178; 20-214; 26-178; 39-178; 56-178; 56-200; 56-195; 56-227; 58-174; 67-178; 71-178; 74-609; 75-
609; 79-200; 88-178; 89-203; 89-200; 89-313; 89-217; 91-213; 91-223; 91- 190; 91-200; 91-178; 91-202; 92-198; 115-178; 123-576; 148-197; 207-405;
207-465 209-490 213 - 575 213 -438 214- ■451 216-465; 217-467; 220 476; 227-320 229-531 229- 514 231-475 233- 591 237-611; 241-481; 241-559; 248-611 248-578 248 - 408 249 -692 249- 730 249-625 248-380 248-357; 249-377 257-520 258 - 555 263 -545 259- 346 260-363 263-535 262-485; 263-667 263-668 263 - 587 263 -539 263- 407 263-382 263-376 263-365; 263-363 263-357 263 - •342 268 -807 268- 625 268-522 271-559 272-456; 274-629 274-651 276- 533 283 -499 283- 520 291-530 291-725 294 622; 294-377 314-600 327 - 615 340 -575 364- 793 366-629; 368-618; 378 575; 384-633 416-667 429 - 479 442 -681 453- 595 477-611; 574-812; 626 1016; 628-894 640-825 711- 928 716 -970 758- 1278 786-1278; 786-1265; 906-1184; 920-1173 934-1070; 935-1188; 935-1110; 1008-1320; 1096-1427; 1105 1334;
1140-1347; 1153-1274; 1216-1277; 1331-1615; 1367-1996; 1377-1620; 1379-
1637 1380-1657 1381-1989; 1389-1681 1395-1648; 1405-1856 1427- 1565; 1428 1637; 1440 1586; 1449-2007; 1446 2031; 1451-1994; 1452 2020; 1453 1698 1456-1756 1457-1708; 1461-1822 1488-1603; 1508-1752 1514- 1769 1524 1631; 1540 1993; 1551-1838; 1547-1845; 1549-1996; 1551 2031; 1550 1652 1560-2032 1556-2022 1562-2031 1564-2033; 1565-2031 1565- 2034
1565-2036; 1566 2031 1567 2031; 1573 2033; 1574-1993; 1573 1816; 1573
1804 1575-2032 1578-1825 1582-2036 1583-2032; 1582-1759 1595- 2038 1600 2031; 1595 2032 1606 1810; 1606 1838; 1609-2038; 1610-2031; 1610- 1860 1615-2032 1613-2029 1615-2033 1615-2031; 1616-2015 1617 1977 1616 1859; 1618 2031 1618 1858; 1620 2037; 1622-2032; 1626 2031; 1628 2038 1630-2031 1629-1889 1630-2036 1638-2037; 1643-2029 1644-2029
1645-2039; 1647 2031 1649 2036; 1650 2029; 1652-1903; 1653 2025; 1653
1739 1654-2029 1658-2034 1658-2031 1658-1935; 1659-2031 1665-1914 1667 2031; 1668-2031; 1670-1906; 1671 2050; 1673-1908; 1675 1903; 1676 2031 1683-2035 1680- 1906; 1682- ■2032 1682-2031; 1688-2015 1696 2031 1707 2029; 1720 1935; 1704-2034; 1705 2029; 1705-1961; 1706 2046; 1706 2029 1709-2036 1708- 2031; 1713-■2034 1716-2031; 1718-2031 1721 2031 1720 1851; 1722 2036; 1724-2029; 1734 1987; 1733-2031; 1735 1902; 1743- 2029 1743-2031 1743- 2015; 1746-■1968 1747-2017; 1755-2031 1756-1991
1755-2035; 1769 2016; 1780-1910; 1786 1985; 1786-1956; 1788 2012; 1790
2032 1791-2031 1793- 2029; 1795-■2030 1796-2032; 1806-2011 1813 2031
1814-2030; 1818 2031; 1820-2036; 1820 1976; 1821-2031; 1822 2040; 1828-
2031; 1830-2031 1831-2031; 1835-■2021 1836-2033; 1847-2031 1864 2029
1874-1986; 1876 2031; 1899-2032; 1900 2012; 1905-2031; 1906 2034; 1906
2031; 1935-2037 1938- 2031; 1940- 2031 1940-2028; 1940-1995 1943 2006
1955-2031; 1965-2038
70/LG: 1094187.33: 2001MAR30 I I 1-594 . 1-559; 16-370; 20-378; 77-370; 88-366;
242-309 284-563; 286-568; 302-553 302-416 364-638 372-857; 372-617;
390-634 447-732; 447-742; 458-732 458-717 458-728 458-679; 458-698;
459-731 459-737; 459-719; 459-729 460-754 460-691 460-564; 461-784;
462-697 462-645; 461-563; 462-737 462-714 462-718 462-712; 462-699;
462-701 462-706; 462-682; 462-671 462-661 462-611 465-651; 466-720;
466-712 466-706; 466-702; 466-701 466-699 466-679 466-658; 466-596;
468-765 469-737; 470-688; 470-682 471-720 472-733 472-707; 473-704;
473-670 475-704; 474-681; 475-731 475-720 475-706 475-696; 475-624;
476-761 476-739; 476-731; 476-720 476-707 476-688 477-765; 477-690;
477-648 477-644; 479-720; 483-607 487-718 498-820 498-680; 498-657;
497-783 499-699; 500-735; 511-748 515-763 537-646 554-762; 572-782;
581-851 723-1241; 793-1416; 928-1416; 955-1194; 958-1416; 1093-1234; 1115-
1236
71/LG.-1098692.18.-2001MAR30 | | 1-598; 28-598; 41-310; 47-633; 70-329; 72-
649; 77-603; 77-561; 77-324; 77-312; 77-306; 77-286; 77-204; 77-173; 77-
333; 79-342; 83-670; 84-583; 83-201; 92-184; 94-293; 94-287; 94-230; 94- 151; 95-442; 115-330; 204-262; 203-496; 204-479; 230-493; 233-474; 247-497; Table 3
272-548; 277-632; 282-569; 283-500; 290-53g 288-513; 339-595; 350-628; 352-802; 405-518; 452-585; 471-693; 511-736 516-823; 529-1030; 552-817; 559-823; 575-846; 576-971; 576-814; 580-756 582-1075; 598-657; 617-781; 620-867; 639-912; 699-1000; 715-998; 732-920; 749-1136; 773- 1055; 779-1186; 784-1240; 796-1044; 805-1024; 810-1250; 814-1242; 818-1396; 829-1005; 837- 1105; 838-1019; 840-1250; 925-1136; 974-143g,- 974-1185; 977-1444; 977-1124; 978-1440; 98g-1217; gg7-1440; 1009-1440; 1031-1443; 1041-1270; 1043-1517; 1056-1289; 1064-1370; 1070-1441; 1072-1271; 1076-1343; 1102-1443; 1112- 1436; 1135-1373; 1153-1714; 1161-1440; 1166-1708; 1169-1440; 1175-1435; 1176-1410; 1190-1621; 1196-1499; 1219-1440; 1226-1413; 1227-1440; 1237- 1491; 1268-1436; 1281-1556; 1282-1534; 1290-1754; 1291-1749; 1292-1750; 1293-1749; 1306-1752; 1319-1750; 1326-1715; 1332-1752; 1336-1749; 1339- 1443; 1339-1710; 1347-1485; 1350-1606; 1357-1623; 1357-1736; 1527-1709; 1548-1755; 1549-1749; 1561-1749; 1626-1749; 1626-1746; 1645-1749; 1681-1766 72/LG:1173104.22:2001MAR30 | | 1-308; 1-274; 6-254; 6-368; 10-555; 30-483;
48-298; 57-285; 64-457; 84-340; 100-535 119-200; 127-375 144-540; 145-
438; 190-440; 193-3E 193-511 204-483 221-537; 255-464 257-486; 272-
506; 275-872; 282-527; 293-649 296-526 303-540; 309-547 315-537; 333-
625; 345-551; 387-623; 424-540 430-505 435-623; 436-623 512-623; 659-
854; 659-887; 659-956; 730-984 816-1165 859-1165; 933-1163; 935-1168;
949-1166; 368-529
73/LG:1215335.7:2001MAR30 | | 1-565; 1-491; 1-597; 8-571; 13-100; 14-211;
18-586; 18-211; 19-211; 24-211; 24-575; 43-318; 55-560; 68-565; 88-211;
248-729; 287-546; 289-540; 294-691; 361-649; 391-646; 412-976; 434-1032;
467-1055; 494-731; 551-989; 582-1040; 582-859; 600-841; 615-1255; 638-1242;
652-1299; 682-1212; 705-1263; 732-1255; 736-979; 755-967; 804-1371; 815-
1274; 889-1221; 889-1097; 908-1112; 914-1169; 916-1018; 952-1224; 990-1203;
1000-1466; 1172-1678; 1173-1387; 1173-1342 1287-1488; 1288-1644; 1297-
1892 1383-1925; 1383-1934; 1394r1622 1395-1917; 1400-1935 1400-1627; 1400 1550; 1400-1559; 1400-1626;' 1400 1608 1403-1754; 1403-1599; 1409 1683 1413-1997; 1419-1711; 1419-1681 1424-1708; 1427-1587 1431-1707; 1455 1736; 1471-1675; 1472-1802; 1477 1691 1507-1786; 1516 1941; 1542- 1784 1548-1677; 1554-1681; 1556-1837 1563-1766; 1570-2123 1581-1784; 1586 2192; 1586-1784; 1587-1803; 1621 2159 1650-2160; 1654-1933; 1670 2017 1678-2106; 1687-1895; 1689-1927 1690-1976; 1693-1965 1697-1936; 1698 2021; 1698-1929; 1705-2086; 1721 2007 1721-1987; 1740 2021; 1741- 2013 1743-2292; 1744-1980; 1746-2013 1748-2004; 1750-2031 1750-2027; 1750 1999; 1761-2264; 1761-2029; 1773 2053 1817-2317; 1829 2294; 1831- 2364 1835-2347; 1856-2393; 1878-2129 1883-2295; 1887-2436 1887-2132;
1917-2133; 1922-2188; 1922-2133; 1924-2163 1924-2176; 1924 2082; 1944-
2069 1940- 2253 1940- 2138, 1948 -2057 1962-2567; 1962-2227 1976-2403; 2000 2291; 2010 2251; 2024- -2280; 2024 2269 2028-2088; 2067 2406; 2069- 2403 2071- 2590 2071- 2340, 2073 -2269 2088-2138; 2089-2612 2089-2300; 2093 2293; 2093 2268; 2096- -2145; 2109 2570 2113-2310; 2116 2382; 2119- 2648 2119- •2330 2119- 2405 2120 -2372 2122-2681; 2122-2368 2125-2371; 2126 2372; 2129 2378; 2130- -2434; 2132 2371 2133-2397; 2137 2403; 2135- 2379 2138- 2396 2138- 2391 2166 -2446 2168-2419; 2175-2407 2176-2409; 2181 2447; 2184 2418; 2183- -2373; 2192 2786 2195-2469; 2203 2485; 2206- 2378 2207- 2766 2207- 2533, 2212 -2355 2213-2356; 2214-2741 2214-2552; 2226 2502; 2226 2407; 2229- -2456; 2236 2537 2239-2492; 2262-2647; 2266 2547 2271- •2526 2288- 2836 2292 -2586 2296-2563; 2299-2585 2303-2403; 2331 2609; 2335 2854; 2334- -2615; 2341 2584 2341-2519; 2356 2550; 2365- 2961 2371- 2589 2374- 2624 2396 -2667 2395-2575; 2396-2648 2403-2675;
2405-2644; 2405-2487; 2405-2742; 2405-2655 2408-2987; 2408 2628; 2408-
2642; 2408-2615; 2408-2644; 2411-3009 2418-2596; 2432-2660 2437-2661; 2442-2685; 2445-2846; 2444-3047; 2445 2700 2454-2735; 2454-2699; 2459- 3027; 2457-2736; 2465-2966; 2466-2966 2467-2726; 2478-2713 2491-2684;
2507-3093; 2521-3070; 2521-3045; 2521-2844 2521-2780; 2521 2777; 2525-
3090; 2525-2769; 2533-2820; 2533-2811 2532-2816; 2534-2626 2533-3130;
2533-2653; 2535-2822; 2537-2781; 2537-2768 2546-2904; 2546-2788; 2549- Table 3
3094; 2550-3068; 2554-2859; 2557-2827; 2559-2767; 2565-2903; 2568-2806; 2575-3090; 2577-3094; 2579-2806; 2576-3093; 2588-2836; 2588-2823; 2589- 2851; 2589-2987; 2591-3097; 2601-3129; 2602-3070; 2608-3100; 2616-2844; 2620-2867; 2622-2875; 2628-2924; 2630-2834; 2630-2845; 2630-2852; 2631- 3140; 2648-3087; 2690-3118; 2669-3098; 2676-3138; 2681-3134; 2683-2858; 2689-3134; 2693-3134; 2697-3135; 2697-3152; 2698-2750; 2701-3134; 2703- 3134; 2714-3134; 2716-3134; 2718-3134; 2.721-3134; 2720-2979; 2721-2892; 2734-2968; 2735-3141; 2738-3093; 2744-3134; 2750-3134; 2754-2984; 2756- 3134; 2757-3138; 2756-3125; 2758-3019; 2759-3050; 2764-3125; 2768-3135; 2782-3049; 2788-2959; 2789-3080; 2789-3044; 2792-3061; 2813-3134; 2818- 2965; 2820-3067; 2825-3134; 2828-3128; 2833-3134; 2839-3134; 2833-3099; 2833-3137; 2833-3138; 2836-3117; 2836-3112; 2836-3056; 2842-3140; 2846- 3134; 2846-3065; 2848-3134; 2846-2998; 2858-3087; 2865-3096; 2869-3131; 2894-3134; 2899-3131; 2901-3136; 2906-3134; 2910-3119; 2888-3118; 2917- 3134; 2900-3134; 2956-3134; 2957-3104; 2963-3134; 2966-3030; 2967-3134; 2980-3083; 2981-3125; 2982-3136; 2988-3125; 2993-3125; 2991-3125; 2991- 3094; 2994-3134; 3021-3141; 3025-3134; 3045-3141; 3067-3134; 3084-3134; 3082-3134
74/LG: 1256753.1:2001MAR30 | | 1-570; 70-323; 70-588; 73-411; 149-402; 179-
621; 187-428; 295-543; 299-845; 297-588; 305-449; 324-872; 333-607; 348-
552; 348-725; 351-604; 389-501; 429-678; 431-643; 437-869; 510-757; 551-
780; 561-1069; : 597-858; 621-724; 627-886; 637-1003; 650-921; 681-953; 685-
954; 751-1212; : 793-1034; 793-907; 795-1033; 796-1037; 800-1332; 817-1110; 818-1052; 819-1049; 826-1098; 829-1051; 879-1438; 886-1037; 911-1182; 916- 1152; 933-1185; 984-1183; 1052-1455; 1064-1299; 1085-1438; 1085-1295; 1183- 1345; 1220-1659; 1233-1345; 1242-1345; 1248-1345; 1259-1345; 1283-1725; 1283-1601; 1318-1605; 1326-1877; 1339-1906; 1338-1914; 1336-1967; 1343- 1585; 1348-1638; 1354-1597; 1381-1967; 1380-1968; 1376-1613; 1376-1616; 1404-1816; 1419-1991; 1423-1960; 1436-1903; 1480-2003; 1535-2006; 1537- 1783; 1537-1954; 1537-1994; 1540-1967; 1548-1906; 1559-1964;- 1562-2006; 1563-2006; 1570-2011; 1571-2007; 1571-1849; 1571-2011; 1573-1820; 1576- 1843; 1575-1855; 1575-1938; 1575-1651; 1575-1633; 1575-1655; 1578-2006; 1590-2009; 1590-2006; 1592-1856; 1596-2006; 1596-2008; 1598-2006; 1599- 2010; 1602-2008; 1603-1969; 1605-2006; 1612-1873; 1619-2002; 1621-1839; 1632-2006; 1637-2011; 1638-1941; 1649-2006; 1649-2011; 1657-2006; 1660- 2002; 1663-1898; 1664-2006; 1665-2002; 1675-2006; 1679-2008; 1680-2006; 1685-2006; 1691-1936; 1708-1968; 1708-1937; 1708-2001; 1722-2006; 1725- 2012; 1738-2007; 1738-1965; 1745-2004; 1748-1969; 1758-1975; 1758-2006; 1769-1987; 1769-1952; 1772-1999; 1776-2002; 1792-2006; 1812-2006; 1816- 2007; 1820-2006; 1824-2006; 1826-2009; 1826-2006; 1828-1924; 1835-2002; 1845-1999; 1873-2006; 1885-2006; 1893-2006; 1902-1951; 1923-2000 75/LG.-1326702.10.-2001 AR30 | | 1-445; 1-584; 1-440; 25-218; 60-496; 78-414; 89-312; 89-637; 156-558; 253-776; 305-946; 389-620; 521-1113; 535-1029; 632-1145; .657-1062; 769-1264; 769-1018; 796-946; 820-1458; 1041-1558; 1077- 1589; 1089-1330; 1170-1462; 1218-1506; 1281-1550; 1280-1672; 1280-1527;
1403-1538; 1441-2025; 1774-2317; 2072-4467; 2145-2537; 2145-2785 2170-
2463; 2194-2445; 2200-2777; 2203-2795; 2222-2479; 2346-2558; 2380-2546;
2384-2556; 2390-2655; 2430-3022; 2454-2682; 2446-2702; 2479-2788 2479-
2710; 2510-3093; 2526-2702; 2526-2627; 2559-3183; 2669-2791; 2670-3137;
2681-3189; 2690-3277; 2695-2891; 2698-3259; 2699-2942; 2699-2910 2742-
2903; 2752-3016; 2769-3009; 2779-2929; 2780-3056; 2784-3040; 2855-3100;
2874-3117; 2931-3221; 2935-3164; 2970-3419; 3020-3517; 3021-3294 3029-
3263; 3033-3276; 3039-3228; 3059-3381; 3084-3676; 3096-3314; 3139-3657;
3172-3396; 3177-3437; 3181-3420; 3200-3447; 3254-3563; 3256-3496 3256-
3563; 3266-3536; 3267-3384; 3290-3575; 3314-3776; 3321-3676; 3326-3613; 3358-3889; 3359-3952; 3360-3562; 3360-3500; 3370-3896; 3384-3624 3413-
3692; 3399-3835; 3399-3653; 3410-3676; 3423-3848; 3479-3614; 3527-3804;
3557-3829; 3562-3806; 3576-3797; 3580-3843; 3587-3997; 3587-3826 3595-
4149; 3635-3867; 3646-4278; 3646-4220; 3650-3933; 3680-4217; 3684-4271;
3695-3938; 3761-3950; 3761-4167 ;.3771-3997 ; 3770-4089; 3787-4373 3789- Table 3
3997; 3802-4000 3805-4246 3805 -3997 3821-3997; 3820-3999 3838- 4335; 3859-4011; 3876 4173; 3881 4428; 3892 4381; 3892-4144; 3898 4439; 3900- 4150; 3909-4400 3910-4258 3912-4230 3912-4183; 3911-4169 4047- 4369; 4079-4468; 4093 4473; 4094 4315; 4094 4567; 4094-4560; 4094 4467; 4094- 4466; 4094-4454 4094-4465 4094-4353 4094-4235; 4094-4203 4094- 4236; 4095-4223; 4094 4178; 4094 4464; 4094 4473; 4094-4188; 4108 4511; 4117- 4393; 4118-4226 4119-4465 4135-4430 4172-4397; 4181-4501 4187- 4489; 4187-4450; 4188 4504; 4189 4502; 4197 4501; 4206-4396; 4214 4498; 4227- 4468; 4227-4470 4232-4461 4244-4468 4245-4804; 4248-4526 4263- 4461; 4264-4463; 4281 4468; 4289 4498; 4334 4467; 4338-4502; 4338 4489; 4364- 4775; 4379-4655 4450-4967 4450-4725 4558-4974; 4563-4821 4601- 4866;
4603-4872; 4610-4779; 4620-4944; 4623 4923; 4620-5207; 4646 5172; 4647-
5147; 4651-5084 4654-4895 4670-5200 4695-5280; 4730-4979 4731- 4945; 4737-4971; 4754 5025; 4769 5177; 4769 5088; 4815-5087; 4818 5070; 4827- 5088; 4843-5223 4895-5169 4895-5125 4959-5525; 4960-5048 4968- 5204; 4976-5383; 5022 5278; 5038 5277; 5112-5391; 5128-5369; 5136 5375; 5146- 5436; 5153-5373 5153-5297 5174 •5363 5174-5347; 5253-5563 5342- 5827;
5369-5645; 5382-5578; 5381 5572; 5382-5541; 5382-5838; 5418-5527; 5426-
5680, 5435- -5593 5439- 5714 5439 -5703 5452-5668; 5460-5828 5461- 6070;
5460- -5815; 5469 5691; 5469 5729; 5478 5739; 5483-5724; 5486 5785; 5487-
5713; 5487- -5777 5507- 5711 5515 -5754 5520-6035; 5529-5784 5531- 5692;
5539- -5782; 5542 5796; 5545 5790; 5555-5853; 5556-5815; 5557 5806; 5558-
6084; 5560- -5807 5560- 5795 5570 -5804 5570- -5807, 5581- -5720 5582- 5819;
5590- -6241; 5599 5821; 5601 5862; 5607 6151; 5612- -6013; 5615 5784; 5618-
5868, 5649- -5913 5662- 5913 5676-5791 5686- -5975, 5689- -5864 5690-■5958;
5709- -5997; 5729 5932; 5730 6037; 5734 5999; 5746- -6045; 5748 6089; 5754-
6070, 5780- -6068 5782- 6039 5782-6044 5784- -6002, 5782- -6357 5794-■6184;
5804- -6356; 5808 -5981; 5829 6256; 5832 6151; 5832- -6078; 5832 6071; 5833-
6115, 5835 -6087 5839- 6098 5846-6139 5859- -6168 5863- -6068 5863- 6050;
5864- -6110; 5876 6174; 5883-6106; 5885 6151; 5887- -6133; 5908 6146; 5917-
6219, 5919- -6204 5920-6452 5923-6436 5934- -6096, 5941- -6535 5943- 6478;
5943- -6193; 5949 6190; 5951-6270; 5951 6218; 595-4- -6241; 5964 6051; 5970-
6491, 5970- -6250 5972-6525 5977-6250 6004- -6254, 6020- -6273 6028-■6294;
6031- -6198; 6044 6300; 6050-6574; 6050 6526; 6050- -6304; 6053 6245; 6058-
6377, 6059 -6313 6066-6598 6065-6539 6065- -6310 6066- -6670 6066- 6295;
6071- -6295; 6077 6574; 6081 6295; 6107 6743; 6107- -6350; 6109 6295; 6108-
6302, 6115- -6407 6125-6380 6127-6295 6129- -6295, 6134- -6295 6149- 6424;
6151- -6295; 6164 6387; 6171 6421; 6170-6391; 6185-6700; 6185-6410; 6190-
6451, 6204- -6453 6205-6295 6225 6295 6242-6735; 6247-6664 6246- 6549;
6261- -6395; 6276 6686; 6312 6520; 6316-6736; 6329-6546; 6329 6519; 6331-
6723, 6335 -6743 6341-6576 6341 -6570 6341-6565; 6341-6557 6344-■6743;
6345- -6560; 6348 6774; 6353-6772; 6353 6743; 6365-6776; 6377 6772; 6379-
6621, 6380 -6729 6383-6748; 6383-6715 6383-6677; 6385-6770 6386-•6770;
6388- -6767; 6389 6772; 6389-6745; 6394-6767; 6396-6770; 6401 6770; 6403-
6747, 6404 -6743 6411-6728 6410 -6659; 6416-6575; 6428-6731 6435-■6742;
6435- -6793; 6436 -6743; 6435-6658; 6437-6770; 6438-6745; 6441 6761; 6470-
6744, 6482- -6762 6487-6748 6492 -6764; 6507-6773; 6503-6742 6518-■6723;
6525- -6774; 6550-6692; 6588 6763; 6600-6767; 6601-6694; 2959 3565; 4670-
5323, 2879 -3355 6600-6712 6600 -6770; 5984-6079; 6063-6158
76/LG : 1327239.15 :2001MAR30 II 1- 432; 1-147; 86-382; 91-372; 98-319 ; 135-
437 146-430; 164-668; 164-389; 167-227; 251-398; 251-420 251-690 ; 258- 533 262-506; 271-566; 300-533; 300-678; 301-464; 306-859 312 -448 ; 315- 584 321-615; 343-585; 343-635; 347-570; 347-571 365 -908 365-748 ; 365- 663 390-598; 395-655; 403-713; 419-546; 428-664 436-702 439-645 ; 439- 702 441-728; 442-680; 447-632; 455-659; 464-772 465-1109 ; 465-1071 ; 473- 707 473-705; 475-961; 474-737; 476-707; 477-570 484-747 ; 494-717 ; 496- 700 498-777; 506-745; 508-634; 509-870; 518-788 ; 521-894 ; 520-757 ; 522- 829 524-619; 538-1071; 552-906; 552-770 ; 552-1120 ; 542-863 ; 545-1019 ; 545- 823 548-872; 553-760; 554-796; 554-827 ; 557-951 ; 560-1083 ; 566-1142 ; 581- 758 583-843; 583-836; 590-1191; 597-740 ; 610-856 ; 648-894 ; 661-920 ; 671- Table 3
768; 676-783; 681-984; 681-948; 693-886; 702-960; 704-1127; 706-1002; 722- 1041; 723-1008; 728-918; 748-1024; 760-1021; 789-1041; 780-1372; 782-994; 784-1001; 784-1363; 796-1389; 784-1069; 799-1272; 800-1245; 800-1068; 800- 1089; 806-1092; 840-1385; 840-1186; 856-935; 856-1104; 843-1055; 844-1386; 846-944; 852-1077; 852-1088; 852-1068; 853-1155; 852-1368; 861-1115; 863- 1164; 864-1492; 865-1151; 867-1109; 867-1197; 871-1111; 885-1036; 892-1158; 894-1180; 897-1353; 900-1174; 904-1492; 911-1139; 931-1492; 917-1152; 918- 1492; 928-1374; 934-1347; 937-1362; 941-1263; 940-1217; 946-1215; 949-1391; 959-1108; 963-1353; 973-1195; 987-1353; 988-1063; 988-1300; 996-1230; 996- 1353; 996-1218; 999-1477; 999-1226; 1000-1282; 1002-1353; 1005-1217; 1009- 1353; 1041-1191; 1027-1238; 1028-1486; 1029-1492; 1036-1312; 1037-1495; 1039-1304; 1040-1496; 1043-1292; 1046-1493; 1043-1353; 1050-1492; 1051- 1490; 1057-1311; 1058-1492; 1061-1492; 1064-1492; 1068-1490; 1078-1494; 1083-1282; 1083-1354; 1084-1485; 1092-1311; 1094-1488; 1099-1488; 1095- 1200; 1099-1494; 1098-1485; 1101-1492; 1103-1488; 1104-1311; 1111-1311; 1113-1355; 1113-1491; 1120-1488; 1121-1311; 1123-1492; 1124-1488; 1124- 1492; 1128-1498; 1134-1513; 1141-1489; 1143-1399; 1150-1311; 1154-1493; 1157-1495; 1156-1311; 1164-1494; 1180-1486; 1178-1465; 1181-1493; 1182- 1489; 1192-1488; 1190-1497; 1191-1422; 1204-1477; 1206-1477; 1209-1491; 1206-1492; 1206-1475; 1210-1311; 1216-1311; 1243-1498; 1241-1492; 1240- 1311; 1248-1492; 1255-1499; 1255-1492; 1258-1488; 1275-1467; 1281-1492; 1305-1492; 1373-1492; 1385-1459; 1395-1486; 1411-1494; 1411-1492; 1052- 1421; 1101-1486; 970-1387
77/LG:1327867.15:2001 AR30 | | 1-376; 12-101; 48-687; 239-687; 334-905; 511- 857; 715-956; 759-1317; 1029-1688; 1277-1868; 1304-1688; 1323-1688; 1629-
2082 1788-2196 1861-2124 1895-2137; 1896-2166 1909-2053; 1915-2253; 1937 2201; 1966 2303; 1966 2237; 2077-2282; 2117 2358; 2128-2521; 2170- 2358 2252-2319 2300-2537 2407-2679; 2448-2640 2448-2639; 2454-2560; 2471 2734; 2471 2716; 2490 2733; 2492-2746; 2493-2742; 2498-2810; 2498- 2679 2499-2888 2503-2746 2533-2780; 2534-2675 2550-2955; 2563-2876; 2568 2749; 2569 2733; 2580 2989; 2580-2937; 2584-3113; 2580-2842; 2581- 2877 2581-2815 2583-2821 2612-3191; 2614-2893 2619-2814; 2619-2712;
2625-2896; 2641-2897; 2641 2898; 2647-2998; 2647-3024; 2658-2987; 2659-
2880 2665-2940; 2667-2939 2675-2882; 2676-3107 2677-2967; 2677-3152; 2704 2824; 2722-3184; 2730-2910; 2746-3218; 2743-3024; 2744-3036; 2748- 2971 2750-3005; 2756-3175 2769-3398 2788-2913 2806-3108; 2811-3091 2817 3115; 2839-3356; 2838 3080; 2839 3075; 2842 3069; 2844-3223; 2852 3429 2863-3410; 2860-3287 2860-3147 2861-3120 2862-3309; 2863-3095 2864 3137; 2864-3059; 2868 3124; 2875 3110; 2883 3161; 2892-3159; 2900- 3437 2900-3486; 2903-3201 2935-3113 2936-3193 2961-3517; 2961-3185 2972 3334; 2974-3583; 2976 3209; 2983-3437; 2982-3119; 2986-3247; 2987- 3210 2997-3262; 3014-3208 3014-3529; 3016-3327 3016-3188; 3015-3423;
3022-3380; 3027-3254; 3035-3597; 3035-3300; 3038 3260; 3041-3254; 3043-
3587 3102-3569; 3132-3622 3133-3577; 3135-3406 3139-3602; 3139-3392;
3140-3618; 3144-3615; 3154-3625; 3160-3602; 3166 3452; 3168-3409; 3171-
3621 3173-3620; 3175-3623 3192-3622; 3193-3622 3206-3618; 3210-3620;
3211-3620; 3214-3464; 3216 3501; 3216-3416; 3216-3359; 3217-3485; 3223-
3615 3225-3616; 3225-3623 3234-3498; 3235-3617 3245-3514; 3246-3602; 3252 3619; 3253-3619; 3271 3597; 3265-3622; 3267 3528; 3281-3591; 3274- 3620 3286-3620; 3290-3529 3301-3593; 3298-3619 3312-3606; 3312-3617; 3324 3623; 3343-3619; 3346 3616; 3375-3619; 3376 3580; 3383-3619; 3383- 3603 3384-3619; 3385-3593 3387-3624; 3401-3603 3429-3589; 3434-3617;
3443-3617; 3447-3617; 3450 3629; 3452-3603; 3455 3636; 3464-3631; 3475-
3586 3488-3602; 3495-3602 3501-3620; 3533-3617 3541-3617; 3544-3621
78/LG:1383232.1:2001MAR30 | | 1-144; 7-126; 7-372; 7-374; 7-83; 18-380; 27- 332; 27-528; 59-572; 70-353; 82-589; 179-435; 212-637; 230-611; 236-456; 240-615; 322-620; 340-600; 408-607; 422-607; 422-614; 465-1089; 469-1072; 526-595; 892-1328; 914-1194; 918-1368; 917-1458; 919-1087; 924-1003; 924- 1226; 924-1337; 927-1150; 950-1246; 954-1240; 960-1301; 967-1458; 969-1237; 976-1201; 976-1278; 977-1458; 977-1174; 983-1458; 1011-1180; 1020-1291; Table 3
1045-1458; 1051-1438; 1051-1298; 1087-1458; β 1088-1291; 1088-1314; 1088- 1240; 1088-1347; 1088-1277; 1089-1290; 1095- 1332; 1095-1343; 1118-1458 1123-1251; -1129-1297; 1134-1306; 1140-1350; 1140-1458; 1141-1410; 1159 1398; 1174-1387; 1176-1458; 1189-1414; 1199- 1431; 1199-1458; 1221-1834 1258-1431; 1259-1458; 1265-1429; 1297-1458; 1298-1458; 1322-1458; 1321 1953; 1334-1458; 1338-1458; 1369-1458; 1372- 1458; 1382-1458; 1387-1458 1388-1458; 1404-1458; 1755-2279; 1976-2364 79/LG:1383368.40:2001 AR30 | | 1-492; 10-557; 10-6 03; 23-316; 23-1070; 29- 1272; 29-400; 36-509; 36-276; 36-281; 36-305; 36- 288; 39-678; 38-417; 38- 554; 55-584; 58-338; 59-263; 67-316; 68-263; 68-666; 69-302; 71-276; 76- 403; 76-399; 116-377; 156-355; 217-400; 228-400; 249-494; 258-509; 280-784; 425-509; 425-707; 425-643; 453-831; 512-780; 524- 688; 576-877; 575-875; 592-1073; 599-1070; 602-1068; 606-1069; 618-878; 620-1069; 638-973; 642- 1077; 650-1070; 652-1070; 659-1070; 670-1070; 678 -1070; 692-1070; 705-1070; 708-1070; 709-1073; 725-1070; 728-1071; 751-1070 759-822; 790-855; 798- 1075; 828-1268; 829-1070; 834-1188; 856-1046; 864 -1225; 887-1270; 915-1267; 917-1270; 918-1486; 923-1268; 924-1267; 970-1271 993-1278; 1000-1270; 1018-1273; 1148-1608; 1188-1728; 1231-1762; 1285- 1565 1292-1557; 1298- 1663; 1351-1856; 1395-1560; 1448-1904; 1471-1935 1471-1732 1501-1996 1536-1779; 1538-2011; 1711-1971; 1728-2059; 1781 2335 1781 2016; 1807 2294; 1847-2105; 1950-2205; 2031-2429; 2031-2258 2111-2296 2144-2393 2174-2738; 2174-2459; 2222-2487; 2222-2486; 2278 2577 2279 2861; 2282 2510; 2331-2574; 2379-2626; 2380-2635; 2386-2633 2412-2665 2417-2640 2542-2781;' 2642-3183; 2662-2917; 2686-2955; 2696 3170 2696-2928; 2709 2997; 2752-3013; 2772-3035; 2775-3288; 2776-3289 2801-2928 2819-3112 2898-3288; 2901-3328; 2905-3153; 2905-3330; 2908 3328 2921 3128; 2923 3330; 2936-3328; 3010-3266; 3004-3167; 3032-3280 3032-3332 3042-3271 3043-3265; 3058-3328; 3068-3322; 3069-3328; 3107 3315 3143 3288; 3150 3326; 3150-3328; 3151-3326; 3175-3333; 3207-3337 3207-3298 3244-3328 80/LG:1384477.1:2001MAR30 | | 1-273; 206-365; 206- 696-; 256-661; 259-517 297-552; 638-1222; 642-911; 912-1159; 912-1034; 1004-1262; 1004-1274; 1029- 1104; 1029-1116; 1146-1459; 1221-1659; 1546-1919; 1550-1913; 1603-1913 1630-1721; 1631-1855; 1631-1854; 1631-1899; 1631-1847; 1631-1918; 1631- 1913; 1657-1912; 1679-1913
81/LG:1390822.1:2001MAR30 | | 1-513; 210-773; 722- 1305; 721-1 263; 747-1310; 817-1311; 960-1124; 957-1413; 954-1344; 960-1249; 964-1262; 966-1480; 969- 1490; 973-1263; 986-1211; 993-1533; 990-1225; 993-1526; 993-1228; 995-1230; 993-1566; 995-1220; 1037-1281; 1045-1127; 1097-1702; 1110-1229; 1112-1361; 1116-1413; 1116-1380; 1124-1196; 1132-1574; 1147-1392; 1148-1389; 1148- 1692; 1153-1376; 1154-1296; 1155-1614; 1175-1446 1181-1785 1191-1509; 1197-1509; 1225-1485; 1229-1792; 1231-1691; 1233 1716; 1249 1485; 1259- 1439; 1279-1515; 1295-1542; 1316-1780; 1329-1567 1337-1776 1341-1622; 1344-1591; 1345-1506; 1347-1436; 1349-1558; 1353 1678; 1354 1908; 1366- 1757; 1374-1806; 1375-1622; 1382-1678; 1428-1797 1442-1622 1454-1719; 1474-1939; 1479-2004; 1496-1629; 1520-1862; 1523 1823; 1526 1820; 1525- 1766; 1543-1846; 1543-1856; 1576-1838; 1583-1810 1586-1857 1589-1830; 1601-1698; 1604-1966; 1604-1879; 1604-1842; 1608 1788; 1609 1885; 1623- 1866; 1635-2183; 1637-1850; 1638-1834; 1640-1905 1639-1892 1642-1882; 1641-1908; 1641-1839; 1642-1885; 1641-1853; 1643 1866; 1643-1755; 1644- 1896; 1646-1936; 1646-1905; 1646-1729; 1647-1889 1651-1939 1652-1866; 1652-2174; 1654-2060; 1655-1914; 1655-1898; 1656 2202; 1656 1756; 1658- 1851; 1663-2057; 1661-1936; 1675-1968; 1683-1881 1683-1957 1683-1832; 1692-1936; 1711-2106; 1715-2194; 1718-1778; 1722 1983; 1756 2030; 1761- 1982; 1771-2223; 1777-1988; 1786-1998; 1787-2070 1796-2327 1803-2045; 1803-2096; 1804-2361; 1806-2354; 1806-2060; 1835 2214; 1847-2269; 1855- 2156; 1876-2323;. 1881-2142; 1885-1999; 1901-2059 1903-2252 1910-2465; 1932-2196; 1942-2191; 1944-2184; 1944-2156; 1947-2211; 1947 2172; 1952- 2067; 1956-2244; 1957-2487; 1957-2163; 1952-2363 1976-2224 1988-2519; 1999-2236; 2000-2251; 1994-2492; 2031-2663; 2038 2592; 2041 2278; 2041- 2302; 2045-2524; 2057-2524; 2068-2663; 2088-2366 2104-2557 2109-2609; Table 3
2120- •2327; 2117- -2689; 2119- -2393; 2118- -2383; 2120- -2383; 2123- -2524; 2124-
2377; 2129- -2663, 2132- -2663; 2142- -2422, 2150- -2431, 2155- -2371, 2155- -2689;
2158- -2477; 2170- -2423; 2172- -2524; 2173- -2257; 2176- -2442; 2176- -2446; 2176-
2589; 2188- -2524, 2200- -2460, 2202- -2501, 2204- -2479, 2212- -2460, 2214- -2445;
2217- -2507; 2220- -2505; 2221- -2455; 2223- -2480; 2228- -2704; 22.33- -2457; 2235-
2640; 2253- -2505, 2263- -2642; 2266- -2521, 2268- -2471, 2268- -2866, 2270- -2505;
2272- -2866; 2279- -2854; 2293- -2505; 2298- -2527; 2299- -2503; 2304- -2521; 2308-
2718, 2311- -2521, 2314- -2521, 2316 -2521, 2330 -2521, 2337 -2521, 2344- -2927;
2349- -2590; 2352- -2619; 2352- -2615; 2370- -2640; 2390- -2658; 2399- -2637; 2409-
2661, 2421- -2685, 2427- -2696, 2445- -2991, 2460- -2521, 2461- -2714, 2469- -3026;
2476- -2844; 2490- -3093; 2529- -2763; 2529- -2774; 2531- -2765; 2539- -2742; 2539-
2691, 2539- -2761, 2539- -2737, 2539 -2732, 2545- -2796, 2548- -2689, 2558- -2814;
2557- -2746; 2557- -2842; 2559- -2640; 2571- -2841; 2574- -2894; 2581- -2832; 2616-
2800, 2616- -2886, 2614- -2823, 2625- -2766, 2631- -2881, 2631- -2877, 2643- -2929;
2645- -3003; 2646- -2891; 2650- -2918; 2656- -2989; 2656- -3186; 2653- -2934; 2656-
2902; 2659- -2921, 2670- -2810, 2682- -2977, 2683- -2962, 2689- -2972, 2700- -2925;
2708- -3239; 2716- -3115; 2722- -2945; 2722- -3229; 2726- -3207; 2732- -3206; 2740-
2958, 2742- -3007, 2745- -3020, 2745- -3206, 2750- -3201, 2758- -3243, 2760- -2880;
2763- -3200; 2765- -2970; 2768- -3300; 2768- -3190; 2779- -3267; 2786- -3068; 2787-
3207, 2787- -2944, 2789- -3057, 2790- -3007, 2793- -3042, 2793- -3208, 2797- -3049;
2803- -3102; 2803- -3042; 2803- -3067; 2804- -3054; 2804- -3050; 2807- -3036; 2812-
3011, 2812- -3124, 2814- -3061, 2821 -3123, 2820- -2941, 2822- -3070, 2822 -3073;
2830- -3085; 2832- -3065; 2833- -3027; 2841- -3069; 2845- -3099; 2845- -3080; 2847-
3227, 2856 -3129, 2866- -3092 2867 -3098, 2878- -3366 2884 -3206, 2886- -3068;
2907- -3291; 2908- -3158; 2908- -3115; 2909- -3176; 2910- -3175; 2911- -3036; 2914-
3167, 2916- -3183, 2926- -3182 2932 -3166, 2940- -3186, 2944- -3172, 2949- -3166;
2949- -3159; 2958- -3474; 2968- -3601; 2973- -3246; 2976- -3202; 2978- -3384; 2990-
3540, 2992- -3506, 2993- -3115, 2995- -3266, 3004- -3318 3011- -3500, 3012- -3230;
3015- -3201; 3015- -3291; 3016- -3334; 3016- -3270; 3016- -3306; 3018- -3201; 3018-
3122', 3019- -3583, 3022- -3310, 3023 -3201, 3024- -3201, 3032* -3201, 3033- -3197;
3040- -3262; 3040- -3201; 3040- -3593; 3040- -3305; 3040- -3093; 3053- -3331; 3053-
3340, 3060- -3154, 3061- -3302, 3066- -3201, 3068- -3337, 3072- -3339, 3078- -3201;
3077- -3653; 3077- -3322; 3081- -3304; 3081- -3339; 3089- -3354; 3097- -3550; 3098-
3653 3092 -3414 3107 -3409 3110 -3399 3120 -3354 3120 -3327 3120 -3368;
3121- -3361; 3128- -3655; 3129- -3393; 3130- -3401; 3136- -3387; 3140- -3417; 3144-
3641 3140- -3324 3140 -3371 3140 -3415 3140 -3403 3142 -3444 3142- -3403;
3148- -3200; 3146- -3392; 3147- -3378; 3146- -3389; 3148- -3445; 3150- -3351; 3167-
3615, 3172- -3653, 3179 -3656 3185 -3654, 3186- -3656 3188 -3617 3189 -3619;
3200- -3655; 3205- -3485; 3209- -3423; 3210- -3507; 3215- -3476; 3221- -3481; 3221-
3460, 3223 -3483, 3228 -3460 3228 -3476, 3228 -3435 3228 -3506 3228 -3349;
3228- -3454; 3227- -3425; 3228- -3458; 3228- -3457; 3228- -3358; 3228- -3400; 3232-
3655 3235 -3329 3236 -3470 3239 -3564 3244 -3654 3244 -3489 3246 -3445;
3247- -3639; 3250- -3356; 3253- -3524; 3257- -3448; 3272- -3655; 3275- -3569; 3287-
3410 3288 -3517 3291 -3521 3309 -3517 3312 -3653 3326 -3545 3329 -3545;
3330- -3605; 3335- -3656; 3337- -3539; 3338- -3652; 3345- -3657; 3350- -3653; 3358-
3612 3363 -3616 3363 -3652 3376 -3653 3378 -3651 3382 -3652 3392 -3600;
3403- -3607; 3406- -3651; 3407- -3638; 3408- -3563; 3409- -3591; 3409- -3661; 3419-
3624 3420 -3653 3421 -3653 3433 -3653 3440 -3578 3453 -3651 3469 -3632;
3472- -3650; 3475- -3655; 3475- -3656; 3477- -3655; 3477- -3653; 3477- -3660; 3478-
3655 3483 -3710 3485 -3654 3489 -3653 3494 -3653 3495 -3652 3495 -3647;
3496- -3653; 3499- -3629; 3518- -3651; 3555- -3653; 3565- -3658; 3567- -3653; 3569-
3648 3578 -3657 3585 -3653 3592 -3651 3602 -3655 2539 -2699 2683 -2951;
2631- -2899; 2938- -3206; 2539- -2720; 2881- -3152; 2600- -2738; 2784- -3056; 2557-
2832 2556 -2830 3064 -3201 2805 -3072 2683 -2963 2656 -2936 • 2786 -2910;
2905- -3188; 3644- -3936; 3159- -3293; 2610- -2908; 2793- -3046; 2793- -3016; 2870-
3175 2871 -3183 2804 -3113 2729 -3051 2794 -3134 2864 -3203 2856 -3200;
2853- -3202; 2855- -3206; 2804- -3148; 2853- -3207; 2832- -3207; 2831- -3206; 116-501;
2826- -3202; 2817- -3205; 2817- -3206; 3228- -3640; 3233- -3652; 3215- -3652; 3221-
3652, 3212- -3652, 3218 -3657 3218 -3652 3218 -3648 2790 -3086 2656 -2889;
2849- -3206; 2553- -2744; 2793- -2959; 2828- -3207; 2693- -2959; 3161- -3422; 2912- Table 3
3173 2587-2848; 2844-3098; 3228-3372; 2407-2499 2914-3170; 2563-2740;
2619-2871; 2539-2677; 2957-3206; 2806-3054 3100 3324; 2827-3071; 2581-
2740 2912-3152; 2967-3197; 2793-3025; 2850-3080 2971-3200; 3399-3495;
2982-3206; 2806-3027; 2989-3207; 2786-3001 2994 3201; 2792-2998; 2849-
3046 3644-3814; 3097-3283; 2814-2993; 2349-2499 3120-3291; 2793-2896;
3093-3254; 3228-3385; 3115-3263; 3152-3283 3218-3309; 2845-2962; 2846- 2962 2907-3005; 3227-3307 82/LG: 1398274.13 :2001MAR30 || 1-437; 1 223; 40-297; 53-386; 53 -441 ; 53 -305 ; 53-298; 73-275; 127-214; 200-403; 216-442; 298-555; 345-893; 371-940 ; 381- 527; 410-872; 445-689; 460-617; 479-73 7; 486-693 529-1072; 559-838 ; 571- 1060; 623-839; 664-1100; 701-960; 701- 943; 701-908; 769-1179; 855-1180 ; 975-1492; 978-1169; 978-1072; 983-1072 993-1072 1104-1279; 1120-1356 ; 1149-1567; 1155-1617; 1155-1419; 1213- 1510; 1220-1524; 1250 1433 ; 1260- 1392; 1273-1566; 1298-1550; 1368-1559 1380-1659 1399-1490; 1469-1557 ; 1604-2141; 1625-1868; 1686-1838; 1692 1959; 1693 2043; 1693- 1941 ; 1706- 1895; 1740-2310; 1747-2316; 1768-2042 1778-2077 1780-2316; 1803 -2353 ; 1827-2366; 1846-2389; 1883-2202; 1904 2367; 1904-2139; 1933 2495 ; 1933- 2354; 1952-2162; 1957-2233; 1984-2270 2001- •2080 2014- -2706; 2023 -2303 ; 2030-2412; 2059-2337; 2087-2328; 2136-2420; 2137 2336; 2162- 2303 ; 2165- 2869; 2176-2741; 2176-2722; 2232-2356 2279-2590 2281- -2615; 2284-2463 ; 2287-2540; 2287-2923; 2292-2545; 2296 2503; 2307 2568; 2308- 2565 ; 2319- 2573; 2324-2956; 2333-2583; 2345-2868 2372-•2627 2375 -2642; 2381-2890 ; 2386-2840; 2389-2841; 2410-2650; 2418-2663; 2445 3089; 2452- 3080 ; 2469- 2721; 2472-2860; 2478-2841; 2526-3070 2518-■2801 2520 -2742; 2531-2747 ; 2535-2833; 2572-2821; 2594-2864; 2640-3040; 2640 2901; 2640- 2877 ; 2643- 3039; 2643-2879; 2643-2846; 2643-2833 2645- 2905 2647- -2935; 2658-2911 ; 2660-2934; 2664-2903; 2664-2799; 2681-2950; 2684 2808; 2700- 3231 ; 2700- 2949; 2728-2883; 2734-2853; 2745-2999 2753- 3024 2753- -3012; 2755 -3030 ; 2755-2931; 2766-3000; 2767-2975; 2768 2982; 2779 3280; 2780- 3022 ; 2791- 3018; 2793-3043; 2801-3044; 2804-3350 2804-3076 2808 -2860; 2814-3175 ; 2815-3035; 2816-3072; 2828-2886; 2851 3009; 2853 3117; 2860- 3097 ; 2861- 3418; 2866-3357; 2893-3148; 2904-3184 '2913-3192 2918 -3057; 2921-3136; 2926-3519; 2928-3138; 2934-32Ϊ3; 2940 3035; 2945-3447; 2946- 3332; 2945- 3214; 2955-3214; 2960-3434; 2964-3265 2966-3230 2974-3230; 2979-3465; 3007-3228; 3012-3427; 3013-3573; 3020 3289; 3027-3233; 3032- 3238; 3043- 3508; 3041-3289; 3049-3566; 3052-3465 3053-3599 3065-3465; 3086-3517; 3086-3312; 3092-3324; 3105-3634; 3106-3530; 3117 3384; 3132-3649; 3132- 3400; 3137-3353; 3145-3486; 3158-3730 3179-3735 3182-3375; 3185-3410 ; 3196-3551; 3196-3479; 3212-3474; 3212 3457; 3214 3410; 3215- 3296 ; 3217- 3575; 3218-3727; 3225-3466; 3229-3471 3235-3759 3238-3481; 3247 -3495 ; 3247-3470; 3271-3734; 3271-3731; 3308 3384; 3359 3692; 3527- 3735 ; 3706- 4190; 3706-4106; 3706-3975; 3728-4192 3729-4193 3737-4197; 3737-4193 ; 3739-4197; 3741-4194; 3751-4193; 3753 4193; 3764-4015; 3772- 4196 ; 3777- 4190; 3785-4193; 3789-4190; 3789-4106 3813-4193 3819-4190; 3859-4198 ; 3874-4190; 3875-4190; 3879-4190; 3886 4106; 3900-4194; 3900- 4190 ; 3900- 4195; 3903-4194; 3907-4064; 3910-4190 3911-4054 3921-4193; 3933 -4190 ; 3939-4176; 3951-4198; 3955-4190; 3954 4106; 3973 4189; 3984- 4190 ; 3987- 4194; 3989-4190; 3993-4194; 4030-4190 4059-4186 4099-4191; 4105-4232 ; 4115-4190; 4123-4195; 4121-4189; 4121 4184; 4125-4178; 4131- 4190 ; 1104- 1377; 1111-1298
83/LG:1398646.1:200lMAR30 || 1-2 53; 57-503; 5 7-250; 121-735; 175-440; 213- 441; 265-529; 267-447; 464-1008; 464-1052; 475-723; 475-823; 475-778; 475- 708; 475-709; 475-710; 475-712; 516-606; 526-824; 640-889; 655-903; 818- 1036; 969-1505; 1401-1868; 1403-1622; 1459-1612; 1479-1876; 1503-1771; 1650-1869; 1657-1750; 1681-1861; 1776-2365; 1897-2429; 1897-2191; 1906- 2132; 1906-2016; 1919-2340; 1906-2092; 1906-2033; 1906-2350; 1939-2176; 1963-2164; 1972-2319; 2001-2159; 2014-2545; 2027-2242; 2040-2386; 2045- 2313; 2055-2532; 2074-2269; 2101-2570; 2106-2390; 2117-2510; 2119-2333; 2122-2498; 2122-2404; 2137-2573; 2145-2403; 2148-2390; 2148-2362; 2148- 2339; 2156-2570; 2157-2412; 2157-2529; 2161-2570; 2162-2573; 2163-2574; Table 3
2170-2564; 2169- 2565; 2169 -2436; 2174- 2568; 2179 2579; 2184 2568; 2190 2568; 2193-2574 2198-2454 2207-2465; 2209-2589 2209-2532 2190- 2509 2214-2604; 2213 2746; 2218 -2806; 2226-2445; 2226 2488; 2233 2477; 2235 2564; 2234-2448 2236-2473 2237 2523; 2245-2474 2246-2505 2247-■2474 2245-2455; 2247 2581; 2247 -2429; 2247-2501; 2251 2573; 2253 2491; 2254 2535; 2263-2761 2265-2570 2266-2574; 2253-2564 2275-2700 2296- 2570 2298-2570; 2303 2522; 2316 -2404; 2317-2568; 2319-253.2; 2320-2564; 2322 2570; 2328-2591 2336-2570 2336 2563; 2360-2570 2363-2585 2380-2570 2387-2524; 2389 2618; 2397 -2618; 2406-2596; 2432 25.69; 2446 2577; 2430 2716; 2436-2807 2439-2715 2457 2700; 2492-2568 2476-2715 2476-■2947 2480-2629; 2488-2722; 2499 -2735; 2506-2581; 2526 2771; 2551 3048; 2555 3051; 2636-2700 2629-2916 2629 3048; 2629-2700 2630-2865 2629- 3085 2632-2868; 2632 2892; 2633 -3044; 2635-3099; 2635 3188; 2636 2695; 2638 3050; 2645-2900 2645-2888 2649 3041; 2653-3103 2654-3188 2674- 3092 2668-3091; 2670 2956; 2672 -3181; 2674-3088; 2686-3091; 2699-3243; 2724 2956; 2710-3078 2717-2963 2717-2956; 2722-3088 2724-2952 2724- 2999 2724-2980; 2731 3095; 2741 -3027; 2748-3096; 2765 3096; 2766 3091; 2769 3096; 2777-3094 2780-2983 2789-3071; 2793-3085 2796-3048 2798- 2977 2815-3091; 2872 3091; 2872 -3096; 2868-3094; 2870 3091; 2874-3097; 2888 3091; 2901-3091 2905-3040 2956-3053; 2963-3091 2984-3091 84/LG:1398905.1 2001MAR30 | 1-545; 420-831 ; 420 849; 420-83 3; 435-790; 440-848; 443-689 447-850; 449-707; 507-726 ; 513 771; 515-76 7; 515-856; 532-846; 533-697 ; 536-807; 567-780; 791-1282; 888-1072; 894- 1429; 1017- 1242; 1166-1269; 1344-1465 1402-1463; 1405 1464; 1414-1463; 1013-1349; 1036-1465; 1024-1457 85/LG:1399785.1: 2001 AR30 I 1-592; 243-865; 334- 815; 3 84-1043; 38 9-856; 394-997; 469-995 477-921; 477-688; 603-1040 623 -838; 647-832; 65 7-1046; 660-825; 668-983 ; 668-882; 784-1409; 861-1445; 92 2-1445 ,- 1018-1266 ; 1109- 1384; 1392-1706 1572-1866 1592 -1835 1684- 1886; 1767- 1999 1767- 1881; 1768-2295; 1770 2034; 1777 2408; 1817 2389; 1864-2128; 1864-1983; 1 18892- 2213; 1892-2141 1896-2193 1896- -2023 1935- 2301; 1941- 2148 2011- 2572; 2095-2208; 2123 2741; 2134 2350; 2160 2265; 2166-2768; 2177 2580; 2173- 2415; 2186-2460 2221-2740 2231- -2423 2260- 2503; 2260-2450 2262- 2533; 2270-2502; 2297 2881; 2309 2676; 2309 2502; 2330-2609; 2354-2810; 2348- 2433; 2354-2630 2374-2776 2374- -2676 2399- 2578; 2404- 2652 2413 2735; 2461-2696; 2552-2809; 2553 2951; 2558 3001; 2566-2869; 2577 2812; 2577- 2762; 2580-2822 2584-2768 2589 -2935 2589- 2806; 2606 2763 2604 2836; 2676-3255; 2676 3023; 2682 3232; 2698 2982; 2758-3299; 2802 3094; 2806- 3093; 2815-3087 2817-3077 2911- -3166 2966- 3561; 2996 3251 3029- 3624; 3062-3214; 3067 3509; 3087 3238; 3090 3366; 3093-3336; 3139 3556; 3181- 3542; 3182-3554 3182-3435 3198 -3442 3215- 3395; 3219 3550 3247 3735; 3263-3395; 3264 3550; 3284 ■3547; 3283-3540; 3284-3630; 3288 3802; 3292- 3525; 3311-3548 3323-3542 3353-3557 3373- 3509; 3374 3550 3405 3550; 3428-3502; 3528 3780; 3690 -3937; 3756 4378; 3756-4056; 3758 3917; 3782- 3927; 3805-3919 4066-4637 4067-4477 4079- 4475; 4081 4356 4083 4319; 4083-4142; 4086 4356; 4109 ■4604; 4109 4373; 4120-4594; 4134 4699; 4097- 4610; 4146-4421 4148-4449 4149-4388 4154- 4392; 4154 4391 4182 4449; 4173-4424; 4189 4389; 4189 -4373; 4239-4534; 4241-4839; 4240 4738; 4260- 4804; 4260-4466 4306-4388 4324-4603 4324- 4570; 4327 4767 4332 4431; 4334-4661; 4345-4702; 4345 -4545; 4360-4525; 4388-4903; 4389-4904; 4398- 5040; 4400-4685 4400-4681 4451-4629 4477- 4778; 4482 4749 4485- 4912; 4485-4723; 4491-4728; 4496 -4776; 4516-5121; 4532-4927; 4542 4781; 4551- 5194; 4552-4908 4552-4784 4556-5124 4577-4849; 4577 4867 4584- 4834; 4596-5123; 4624-4856; 4645 -4814; 4645-4800; 4647-4774; 4657 5131; 4685- 5246; 4692-5208 4697-4906 4715-4962 4721-5118; 4721 4934 4729- 4870; 4741-5014; 4748 5014; 4749 -5015; 4752 4900; 4771-5002; 4781-5004; 4781- 4964; 4781-5159 4783-4977 4799-5015 4859 5154; 4877 5476 4880- 5173, 4885-5171; 4886-5164; 4888 •5128; 4900 5168; 4903- 5007; 4906-5179; 4914- 5264; 4918-5156 4921-5472 4929-5211 4938 5296; 4938 5176 4938- 5099; 4940-5209; 4960 5484; 4960 -5237; 4960-5535; 4961- 5609; 4998-5151; 5012- Table 3
5227; 5013-5278; 5016-5578; 5017-5267; 5019-5552; 5019-5278; 5026-5277; 5031-5123; 5034-5318; 5043-5613; 5046-5661; 5044-5302; 5046-5303; 5045- 5273; 5047-5664; 5061-5665; 5060-5507; 5059-5175; 5060-5269; 5060-5266; 5072-5662; 5082-5366; 5083-5308; 5088-5603; 5091-5656; 5091-5322; 5091- 5312; 5094-5336; 5102-5405; 5112-5695; 5117-5380; 5118-5275; 5130-5700; 5152-5425; 5163-5660; 5156-5418; 5158-5662; 5176-5457; 5174-5657; 5183- 5659; 5184-5657; 5190-5621; 5193-5405; 5206-5462; 5213-5705; 5223-5493; 5231-5662; 5228-5514; 5233-5638; 5234-5453; 5230-5494; 5236-5701; 5257- 5663; 5266-5700; 5271-5701; 5274-5704; 5273-5502; 5283-5548; 5283-5516; 5284-5524; 5271-5699; 5285-5697; 5289-5702; 5291-5699; 5292-5700; 5293- 5526; 5298-5707; 5298-5554; 5289-5545; 5302-5587; 5307-5699; 5306-5699; 5309-5532; 5310-5703; 5299-5698; 5315-5625; 5315-5576; 5314-5573; 5317- 5705; 5318-5701; 5318-5700; 5309-5701; 5326-5699; 5313-5701; 5327-5702; 5333-5701; 5333-5700; 5347-5705; 5348-5701; 5337-5701; 5351-5699; 5340- 5703; 5354-5699; 5363-5701; 5365-5653; 5355-5699; 5376-5680; 5372-5701; 5373-5703; 5375-5701; 5380-5701; 5385-5702; 5386-5703; 5397-5706; 5389- 5598; 5405-5701; 5411-5701; 5412-5700; 5418-5548; 5421-5700; 5409-5701; 5436-5696; 5444-5684; 5444-5694; 5445-5699; 5463-5703; 5473-5701; 5481- 5701; 5481-5699; 5492-5699; 5492-5692; 5492-5662; 5494-5697; 5498-5699; 5525-5643; 5527-5650; 5532-5701; 5583-5699; 5591-5660; 5649-5699 86/LG:1446193.10:2001MAR30 | | 1-619; 300-808; 740-1277; 832-1221; 832-1102; 936-1277; 959-1487; 959-1433; 987-1207; 1011-1166; 1067-1270; 1180-1762; 1187-1586; 1205-1505; 1219-1745; 1219-1475; 1289-1780; 1302-1535; 1318-
1606; 1361-1724; 1361-1646 1367-1547; 1370-1648; 1385-1587; 1397-1566 1397-1561; 1397-1692; 1399 1645; 1402-1602; 1402-1577; 1405-1924; 1406- 1893; 1407-1798; 1406-1676 1406-1600; 1406-1561; 1418-1675; 1419-1670 1441-1779; 1445-1825; 1468 1916; 1492-1888; 1549-1849; 1614-1917; 1623 1916; 1623-1906; 1646-1870 1724-2112; 1741-2040; 1749-2003; 1749-1965 1817-2227; 1848-1916; 1921 2251; 1922-2199; 1943-2193; 1998-2496; 2143- 2514; 2143-2341; 2150-2587 2161-2441; 2200-2464; 2229-2668; 2244-2469 2244-2468; 2244-2467; 2262 2841; 2262-2419; 2269-2467;' 2288-2457; 2306 2520; 2309-2570; 2333-2434 2368-2538; 2369-2519; 2373-2563; 2373-2610
2404-2621; 2434-2687; 2440-2898; 2442-2683; 2444-2834; 2466-3014; 2466
2734; 2465-2685; 2493-2970 2510-3021; 2520-3025; 2520-2976; 2520-2739 2525-2755; 2541-2733; 2548 3049; 2548-2788; 2571-3025; 2587-3059; 2602 3063; 2640-2849; 2640-2848 2646-3065; 2651-3065; 2660-3061; 2660-3053
2664-2953; 2667-2862; 2699-3062; 2705-3062; 2705-3059; 2708-3062; 2711 3059; 2713-3061; 2731-2960; 2734-3060; 2738-3062; 2737-3059; 2758-2986; 2780-3062; 2788-3037; 2792-3023; 2799-3051; 2822-3065; 2839-3047; 2839- 3065; 2851-3062; 2859-2936; 2894-3015; 2900-3061; 2910-3054 87/LG:1446210.8:2001MAR30 | | 1485-1790; 1271-1662; 1346-1662; 1156-1506; 1193-1506; 1100-1506; 1276-1505; 1058-1504; 1320-1502; 1061-1502; 1095- 1502; 1102-1502; 1223-1502; 1173-1500; 1359-1498; 1193-1485; 1276-1466; 1072-1465; 1035-1464; 1193-1463; 1185-1451; 1193-1445; 1356-1415; 1172-
1404 943-1370; 967-1366; 1148-1368; 1059-1289; 1004-1255; 650-1238; 980-
1222 909-1189; 918-1181; 946-1165; 1072-1158; 882-1140; 914-1134; 947-
1091 509-1080; 836-1053; 776-992; 608-962; 643-955; 525-939; 527-937; 486-
937 589-934; 512-933 525-932; 553-932; 476- -930; 717-930 508-930; 589-
929 676-928; 467-927 569-928; 515-928; 523- -927; 526-928 659-927; 561-
927 369-927; 635-927 582-926; 534-927; 494- -927; 525-927 526-927; 505-
927 519-927; 521-927 670-927; 657-927; 656- -927; 519-925 470-924; 577-
924 568-923; 594-917 729-918; 685-917; 672- -916; 673-916 • 822-916; 571-
909 305-903; 694-893 310-888; 259-888; 410- -887; 470-887 453-886; 650-
885 261-881; 282-868 624-867; 583-860; 556- -799; 547-786 528-781; 530-
777 493-766; 548-735 458-720; 474-719; 469- -719; 98-716; 427-710; 425-7
440-693; 407-676; 550-673; 357-693; 52-655; 438-654; 407-619; 365-654; 292- 557; 430-558; 305-551; 192-543; 296-519; 319-525; 194-480; 300-474; 222- 362; 110-315; 60-296; 179-254; 1-189
88/LG:1450054.6:2001MAR30 || 1-450; 61-213; 82-413; 84-208; 204-303; 211- 477; 213-673; 245-562; 248-540; 289-809; 294-825; 304-840; 318-595; 335- Table 3
618; 354-590; 373-622; 376-660; 397-638; 397-870; 458-905; 481-920; 487- 913; 487-650; 524-857; 533-1134; 536-776; 564-774; 620-794; 679-867; 722- 1006; 727-906; 755-1050; 814-909; 912-1546; 911-1427; 930-1192; 932-1229; 930-1195; 930-1206; 930-1181; 930-1422; 932-1293; 933-1221; 948-1096; 1008- 1622; 1030-1319; 1040-1281; 1050-1527; 1079-1590; 1091-1589; 3.116-1592; 1117-1567; 1208-1457; 1208-1447; 1208-1442; 1209-1590; 1208-1565; 1267- 1545; 1279-1630; 1288-1633; 1292-1564; 1301-1565; 1300-1599; 1300-1630; 1313-1597; 1313-1544; 1405-1855; 1518-1801; 1554-1633; 1657-1929; 1743- 2336; 1783-2272; 1783-2009; 1783-2008; 1783-1972; 1783-2264; 1783-2348; 1783-2338; 1786-2020; 1965-2372; 1980-2550; 1981-2273; 2165-2412; 2247- 2477; 2319-2901; 2323-2832; 2336-2866; 2372-2489; 2464-2740; 2541-3006; 2546-2822; 2584-2998; 2708-3179; 2982-3353; 2982-3233; 3162-3725; 3246- 3468; 3257-3750; 3257-3501; 3465-3702; 3533-4101; 3753-3859; 3801-4039; 3886-4108; 4052-4640; 4057-4273; 4060-4307; 4557-5009; 4566-5026; 4729- 5265; 4841-5028; 4846-5311; 4985-5532; 4987-5220; 5039-5596; 5051-5493; 5067-5295; 5077-5347
89/LG:1452516.4:2001MAR30 || 1-251; 1-542; 10-606; 18-404; 18-256; 25-249; 47-596; 116-340; 115-372; 118-643; 119-381; 123-385; 156-309; 138-341; 227- 785; 289-787; 266-739; 269-739; 283-607; 284-607; 284-600; 284-598; 327- 828; 378-828; 459-828; 457-892; 587-1195; 587-838; 671-1217; 910-1124; 956- 1359; 1052-1307; 1099-1604; 1099-1384; 1228-1719; 1285-1779; 1285-1750; 1303-1618; 1337-1906; 1353-1774; 1356-1822; 1360-1635; 1360-1813; 1396- 1822; 1448-1818; 1488-1818; 1535-1813
90/LG:1455293.7:2001 AR30 || 1227-1632; 1062-1499; 1174-1498; 1203-1498; 951-1460; 1005-1433; 1167-1417; 1081-1344; 1109-1335; 880-1143; 845-1110; 626-1046; 777-1029; 686-1025; 789-1014; 707-1008; 737-1009; 564-1008; 755-
991 458-973 716-971; 531-959 430-938 395-807; 706-807; 467-805; 410-
803 431-803 482-803; 357-802 337-802 349-802; 380-802; 503-802; 562-
802 284-790 542-785; 588-782 372-780 369-780 337-769; 470-769 429-
767 196-764 164-764; 403-764 478-760 420-737 179-716; 432-708 483-
708 174-700; 447-698; 457-688 211-665 470-671 410-669; 298-577 419-
575 125-561; 61-461; 1-352; 1-237; 61-185
91/LG:1498113 1:2001 AR30 1-652; 65-585
92/LG:1500042 1:2001MAR30 186-562; 228-443; 147-37? 287-341; 271-341;
281-341 232-341; 139-341 266-341 268-341 177-341 221-335 268-335
264-335 228-323; 268-323 263-323 186-323 186-278 268-321 186-276
163-321 186-320; 203-316 263-312 186-267 233-306 213-306 245-306
218-306 194-306; 203-306 255-306 189-306 186-306 1-293; 186-287; 186- 272; 186-251; 270-354 93 /LG: 1500434.4 :2001MAR30 I I -1-180; 1-519; : 1-244; 10-320; 12-157; 24-470; 54-443; 261-733; 261-796; 358-792; 404-519; 407-653; 654-998; 766-1336;
766-1157; 769-1051; 804-1260; 853-1298; 854-1319; 867-1134; 908-1316; 1013
1299 1032-1268; 1059-1288; 1061-1321; 1125-1377; 1233-1357; 1253-1633 1255 1484; 1270-1541; 1496-1961; 1515-1779; 1517-1874; 1556-1759; 1599 1823 1624-2203; 1677-2181; 1680-1901; 1680-1900; 1728-1969; 1736-2247
1736-1958; 1768-2040; 1869-2151; 1885-2359; 1919-2197; 1943-2192; 1977-
2356 1982-2305; 2005-2312; 2030-2308; 2041-2305; 2048-2255; 2068-2332 2091 2350; 2146-2583; 2155-2583; 2254-2765; 2297-2504; 2315-2494; 2335 2609 2341-2953; 2403-2644; 2403-2548; 2473-2726; 2473-2866; 2473-2677 2490 2772; 2528-2822; 2529-2737; 2540-2643; 2580-2808; 2642-2871; 2650 3221 2665-3177; 2667-2896; 2702-2958; 2777-3052; 2824-3061; 2824-3171 2829 3115; 2852-3047; 2886-3171; 2887-3159; 2917-3170; 2925-3245; 2925 3162 2925-3174; 2934-3490; 2952-3193; 2985-3208; 3003-3250; 3012-3263 3015 3312; 3020-3493; 3020-3373; 3023-3466; 3041-3228; 3042-3252; 3042 3423 3042-3228; 3044-3276; 3061-3372; 3089-3320; 3109-3634; 3113-3368 3134 3688; 3133-3369; 3192-3676; 3206-3410; 3246-3670; 3246-3474; 3249- 3712 3250-3713; 3261-3712; 3264-3720; 3265-3676; 3267-3713; 3293-3706 3293 3523; 3293-3746; 3294-3686; 3312-3650; 3334-3717; 3344-3712; 3351- 3712 3353-3732; 3361-3712; 3367-3528; 3370-3581; 3381-3677; 3390-3712
3397-3712; 3398-3706; 3407-3710; 3435-3713; 3449-3749; 3453-3706; 3453- Table 3
3712; 3456-3609; 3474-3707; 3475-3683; 3489-3709; 3501-3713; 3510-3672; 3523-3716; 3589-3672; 3596-3712; 3596-3706; 3605-3704; 3615-3697; 3626- 3710; 3629-3712
94/LG: 1501102.4 :2001MAR30 1-624; 161-682; 550-1130; 698-1209; 834-1279; 847-1100; 631-1173 95/LG =1501768.2 :2001MAR30 I 1-251; 10-257 96/LG: 1502155.6 :2001MAR30 I 1-656; 137-433; 166-714; 167-442; 169-804; 167-714; 167-390; 199-451 214-1032; 279-705; 313-714; 373-789; 395-864; 452-881; 452-822; 453-644 468-930; 510-863; 510-938; 525-714; 736-1205; 511-714; 510-714; 531-691 97/LG: 1512304.2 :2001MAR30 239-837; 472-839; 352-768; 270-747; 15-733; 28-446; 133-426; 1-426; 28-426; 4-426 98/LG: 1512931.11 :2001MAR30 || 617-891; 308-802; 310-802; 506-799; 513-79 8; 574-797; 554-797; 326-796; 378-797; 559-797; 498-796; 436-796; 496-795 397-794; 670-794 373-794; 380-794; 375-794; 455-794; 363-794; 403-792 247-792; 369-721 389-719; 271-719; 290-717; 395-716; 316-716; 371-716
396-716; 461-716; 327-716; 310-712; 465-704; 321-693; 115-690; 173-679 90-
554; 286-534; 121-518; 184-492; 250-491; 153-490; 322-490; 25-490; 224-490;
12-490; 1-476; 84-259; 1-253
99/LG.-155076.18.-2001MAR30 II 4460-4771; 4096-4601; 2331-4600; 4096-4560;
3969-4418; 4297-4346; 3681-4346; 3861-4277 4031-4277; 3986-4275; 3871-
4131 4025-4131; 3656-4099 3868-4099; 3444-4045; 3451-3993; 3746-3958;
3866-3941; 3475-3858; 3555 3831; 3547-3782 3416-3700; 3086-3700; 3036-
3665 3198-3584; 3331-3584 3044-3644; 3038-3641; 3212-3529; 2948-3519; 3252 3518; 3271-3562; 3028 3417; 3264-3416 2872-3272; 3148-3278; 2809- 3321 3038-3248; 2956-3193 2925-3193; 2651-3188; 2964-3188; 2872-3133; 2811 3080; 2665-3061; 2687-2950; 2674-2913 2396-2913; 2555-2847; 2365- 2774 2328-2745; 2365-2745 25.26-2745;- 2373-2714; 2520-2702; 2526-2686;
2538-2684; 2526-2648; 2530 2646; 2369-2508 2088-2504; 2328-2501; 2335-
2501 2042-2501; 2245-2499 2327-2493; 1958-2437; 2335-2424; 2067-2408; 2328 2397; 2043-2397; 2141-2364; 2040-2187 1664-2132; 1611-2082; 1753- 2079 1653-2070; 1599-2068 1606-2065; 1674-2064; 1805-2064; 1649-2063; 1754 2063; 1833-2062; 1609-2062; 1635-2062 1663-2061; 1749-2062; 1854- 2061 1648-2059; 1673-2056 1448-2054; 1462-2053; 1829-2045; 1916-2031; 1563 2023; 1553-2024; 1647-2025; 1392-2022 1642-2016; 1652-1991; 1488- 1955 1614-1960; 1586-1962 1334-1926; 1629-1920; 1366-1917; 1390-1906;
1337-1905; 1505-1875; 1357 1863; 1299-1854 1381-1854; 1287-1832; 1338-
1783 1240-1784; 1492-1783 1372-1763; 1497-1767; 1356-1761; 1534-1740; 1438 1721; 1468-1718; 1264-1711; 1293-170! 1280-1695; 1538-1704; 1366- 1666 1130-1663; 1505-1658 1366-1656; 1378-1648; 1344-1624; 1338-1619; 1318 1613; 1337-1609; 1344 1608; 1357-1602 1341-1589; 1341-1584; 1320- 1577 1038-1568; 1356-1555 1372-1529; 1394-1494; 873-1461; 1181-1455; 1257-1436; 1372-1424; 860-1403; 935-1318; 1090-1318; 1112-1318; 1147-131 1036-1317; 1177-1310; 931-1279; 1113-1278; 989-1268; 1030-1260; 756-1254 872-1216; 815-1042; 667-904; 506-896; 653-866; 261-858; 232-848; 170-791 195-783; 162-754; 571-703; 396-664; 296-575; 1-544; 14-563; 115-337; 1-2 52; 1-35; 1-48; 4536-4757; 4183-4809; 4225-4790; 4559-4769; 4171-4811; 4281- 4814; 4445-4733; 4160-4753; 4188-4769; 4205-4777; 4606-4812; 4479-4731; 4181-4726; 4270-4751; 4469-4736; 4448-4761
100/LG.-159111.41.-2001MAR30 | | 1-3969; 142-503; 234-735; 252-685; 252-507 300-476; 360-981; 360-888; 390-972; 651-1235; 682-899; 730-1170; 771-115 5; 795-1407; 852-1195; 891-1512; 916-1143; 916-1176; 918-1190; 919-1149; 920- 1115; 925-1485; 991-1411; 1041-1466; 1084-1244; 1152-1724; 1204-1692; 1222- 1331; 1220-1677; 1233-1446; 1268-1724; 1299-1450; 1318-1590; 1405-1969; 1489-2081; 1503-2076; 1503-1756; 1568-1767; 1666-2101; 1686-1940; 1689- 1913; 1717-1989; 1736-2072; 1745-2300; 1772-1941; 1775-2244; 1790-2386; 1844-2102; 1916-2192; 1919-2156; 1964-2055; 1977-2216; 1983-2249; 1989- 2079; 2064-2540; 2067-2403; 2067-2297; 2139-2371; 2261-2655; 2261-2553; 2284-2461; 2288-2553; 2313-2577; 2319-2627; 2379-2661; 2396-2641; 2396- 2638; 2514-2809; 2514-2876; 2514-2782; 2532-2772; 2564-2773; 2564-2851; Table 3
2578-2805; 2585-3032; 2594-2861; 2594-2739; 2602-3166; 2645-3099; 2661- 2933; 2663-2887; 2663-2881; 2663-2791; 2665-3231; 2676-2922; 2723-2954; 2732-3020; 2733-3032; 2738-2978; 2753-2993; 2759-3291; 2762-2979; 2775- 3048; 2782-3287; 2791-3379; 2795-3089; 2807-3061; 2807-3069; 2826-2934; 2829-.3104; 2839-3397; 2842-3133; 2879-3407; 2876-3046; 2914-3134; 2937- 3291; 2955-3194; 2980-3373; 2983-3224; 2986-3407; 2986-3238; 3024-3409; 3065-3201; 3072-3235; 3083-3207; 3093-3379; 3094-3243; 3109-3503; 3125- 3197; 3149-3363; 3149-3356; 3162-3813; 3162-3406; 3184-3416; 3205-3400; 3229-3388; 3230-3741; 3242-3513; 3245-3356; 3257-3417; 3263-3501; 3262- 3512; 3277-3532; 3339-3615; 3351-3598; 3466-3932; 3763-3925; 3779-3969; 3858-3928; 3867-3969; 3873-3969; 3934-4391; 3951-4549; 4058-4321; 4058- 4198; 4099-4631; 4154-4711; 4252-4531; 4274-4811; 4282-4896; 4364-4607; 4405-4897; 4418-4546; 4413-4720; 4453-4931; 4455-4718; 4560-4656; 4541- 5144; 4558-4986; 4564-4745; 4572-5078; 4563-4856; 4708-5279; 4690-4913; 4773-5034; 4729-4924; 4776-5273; 4811-5033; 4825-5395; 4825-5241; 4830- 5089; 4849-5093; 4804-5004; 4845-5387; 4911-5184; 4915-5542; 4929-5497; 4969-5274; 4969-5229; 4970-5206; 5018-5419; 4974-5501; 4985-5208; 5011- 5397; 5063-5145; 5026-5428; 4966-5347; 5098-5210; 5018-5253; 5023-5394; 5024-5252; 5085-5595; 5091-5451; 5108-5257; 5059-5218; 5060-5344; 5086- 5333; 5134-5241; 5104-5340; 5152-5373; 5273-5353; 5250-5341; 5297-5353; 5322-5504; 5335-5411; 5387-5466; 5439-5689; 5443-5703; 5464-5642; 5458- 5706; 5509-6097; 5572-6108; 5638-5873; 5630-6220; 5630-5984; 5760-6334; 6114-6332; 6114-6684; 6233-6309; 6270-6804; 6297-6809; 6314-6568; 6420- 6809; 6445-6809; 6601-7147; 6674-6759; 5316-5451; 5316-5632; 4964-5075; 4969-5075; 5334-5512; 5322-5467; 3837-3967
101/LG:170604.1:2001MAR30 | | 1-489; 214-496; 236-501; 238-790; 241-500 102/LG:190477.4:2001MAR30 | | 1-431; 1-118; 1-205; 10-196; 10-513; 21-129; 19-309; 21-361; 26-255; 68-327; 364-972; 407-685; 427-996; 483-1044; 566- 975; 568-834; 639-1130; 644-939; 684-1255; 684-876; 767-1002; 832-1051; 839-1051; 838-1257; 838-1316; 913-1181; 913-1184; 1016-1537; 1065-1303; 1071-1545; 1071-1526; 1231-1630; 1231-1779; 1236-1360; 1270-1779; 1284- 1786; 1320-1788; 1332-1573; 1336-1760; 1370-1686; 1412.-1734; 1418-1824; 1428-1824; 1515-1819; 1558-1819; 1576-1822; 1624-2089; 1936-2481; 1964-2250 103/LG:198087.8:2001MAR30 | | 1-254; 1-491; 19-302; 50-597; 136-623; 157- 427; 177-512; 179-402; 206-405; 319-569; 424-972; 487-987; 646-1051; 650- 1140; 670-1007; 783-1226; 785-1237; 786-1078; 797-1030; 867-1117; 899-1049; 900-1217; 951-1394; 951-1237; 964-1237; 964-1033; 1090-1250; 1116-149! 1131-1356; 1183-1422; 1257-1713; 1257-1646; 1258-1701; 1258-1732; 125! 1737 1258-1651; 1259-1623 1260-1703 1261-1726 1261-1741; 1261-1716 1262 1721; 1262-1717; 1262 1712; 1262 1716; 1262 1705; 1262-1660; 1262 1699 1265-1407; 1288-1575 1300-1889 1302-1731 1307-1667; 1349-1623 1371 1744; 1368-1906; 1410 1604; 1548 1761; 1559 1813; 1599-1822; 1602 2096 1618-1910; 1629-1822 1650-2213 1687-2294 1698-1948; 1740-1997 1741 1796; 1743-2287; 1760 2004; 1785 2223; 1813 2246; 1886-2470; 1886 2248 1886-2201; 1892-2486 1949-2135 1959-2218 1962-2565; 1964-2252 1975 2246; 1983-2390; 2047-2289; 2070-2284; 2082-2301; 2126-2406; 2150- 2305 2171-2455; 2185-2236; 2218-2445 2221-2505; 2226-2904; 2279-2513 2469 3003; 2540-3068; 2540-3045; 2510 3083; 2517-2869; 2527-2942; 2529 3011 2531-2753; 2554-2782; 2557-2786 2568-2959; 2568-2830; 2568-2793
2571-2811; 2575-2961; 2577-2823; 2576-2785; 2580-2847; 2582-2813; 2599-
2814 2599-2856; 2599-2817 2623-2969 2623-2892; 2622-2844; 2629-2912 2633 28761; 2650-2859; 2665 3267; 2671 3094 2682-2938; 2688-2963; 2696 2958 2702-2966; 2703-2958 2709-2930 2713-3009; 2720-3247; 2720-2943 2730 3311; 2735-2972; 2737 2988; 2737 2798 2769-3294; 2774-3046; 2785- 3109 2788-3040; 2789-3061 2838-2985 2842-3266; 2842-3126; 2842-3058 2848 3106; 2848-3096; 2848 2962; 2850 3098 2854-3338; 2859-3317; 2865- 3059 2876-3427; 2881-3124 2882-3134 2884-3068; 2889-3242; 2904-3473 2908 3424; 2908-3138; 2910-3152; 2911-3197; 2911-3180; 2917-3130; 2917- 2974 2919-3177; 2924-3185; 2939-3226 2941-3254; 2952-3217; 2956-3211
2970-3210; 2975-3168; 2976-3449; 2978-3217; 2981-3238; 2997-3280; 2999- Table 3
3242; 3001-3291 3038-3365 3040 -3285 3040-3262; 3041-3229 3045-3296; 3047-3266; 3048 3175; 3052 3304; 3053 3500; 3053-3302; 3055-3326; 3059- 3288; 3073-3311 3077-3327 3092 -3340 3107-3371; 3109-3365 3111-3354; 3119-3600; 3116 3662; 3118 3663; 3122 3263; 3128-3374; 3134-3364; 3136- 3372; 3145-3541 3145-3450 3145 -3386 3147-3435; 3151-3416 ; 3151-3329; 3167-3292; 3175 3444; 3178 3518; 3180-3446; 3183-3371; 3185-3437; 3186- 3371; 3189-3394 3193-3315 3199-3813; 3211-3467; 3212-3841; 3222-3478; 3226-3559; 3226 3467; 3226 3371; 3230-3521; 3230-3512; 3226-3803; 3234- 3592; 3235-3436 3236-3467 3251-3716; 3271-3477; 3272-3519 ; 3276-3403; 3276-3641; 3278 3510; 3286 3815; 3285-3587; 3285-3518; 3292-3774; 3296- 3785; 3296-3556 3298-3545 ; 3301-3511; 3301-3445; 3317-3561 ; 3318-3796; 3323-3804; 3339 3689; 3340 -3584; 3356-3612; 3358-3627; 3370-3841; 3371- 3605; 3371-3841 3373-3844 ; 3381-3841; 3380-3841; 3382-3841 ; 3384-3841; 3385-3846; 3386 3842; 3388 -3846; 3397-3843; 3398-3688; 3398-3658; 3398- 3615; 3406-3817 3406-3839 ; 3407-3839; 3409-3841; 3410-3842 ; 3418-3841; 3420-3837; 3421 3846; 3426 -3841; 3429-3669; 3438-3647; 3431-3845; 3432- 3841; 3438-3684 3440-3801 ; 3439-3726; 3438-3727; 3440-3848 ; 3439-3683; 3446-3841; 3447 3843; 3447 -3698; 3450-3844; 3459-3846; 3460-3843; 3463- 3846; 3463-3838 3463-3845 ; 3470-3639; 3471-3842; 3472-3841 ; 3473-3841; 3474-3844; 3474 3841; 3477 -3735; 3482-3846; 3482-3845; 3483-3841; 3486- 3839; 3488-3841 3491-3839 ; 3494-3722; 3500-3839; 3505-3841 ; 3513-3843; 3513-3841; 3516 3843; 3517 -3838; 3519-3842; 3522-3841; 3526-3841; 3524- 3834; 3534-3834 3535-3841 3536-3841; 3540-3831; 3540-3829 ; 3545-3841; 3549-3803; 3555 3841; 3554 3841; 3559-3841; 3562-3846; 3563-3842; 3565- 3841; 3568-3787 3570-3824 3576-3840; 3577-3841; 3600-3841 ; 3607-3841; 3610-3837; 3617 3845; 3618 -3841; 3628-3840; 3628-3932; 3629-3841; 3632- 3841; 3632-3843 3664-3824 ; 3670-3842; 3671-3846; 3670-3841 ; 3671-3841; 3682-3799; 3690 3874; 3771 -3841; 3772-3838; 3787-3840; 3789-3841 104/LG:198743.2 2001MAR30 I I 1~654; 1-6*53; 134-463; 194-811 ; 194-355; 260- 789; 265-684; 335-647; 399 952; 436-1045; 436-587; 436-855; 451-684; 478- 684; 492-1054; 574-790; 57 6-813; 591-834; 602-890; 722-918; 818-1052; 890- 1139; 896-1423; 978-1461; 981-1150; 1000-1468; 1000-1288;.1053-1510; 1053- 1190; 1061-1602; 1078-1544 1103-1526 1112-1371; 1185-1520 ; 1187-1435; 1192-1563; 1193-1443; 1214 1274; 1216 1731; 1263-1506; 1294-1731; 1289- 1544; 1304-1659; 1327-1594 1339-1529 1383-1618; 1393-1872 ; 1393-1629; 1421-1731; 1447-1848; 1466 -1947; 1479 1686; 1496-1792; 1510-1759; 1555- 1833; 1631-2092; 1648-1908 1659-2144 1668-2106; 1668-1959 ; 1668-1933; 1668-1916; 1720-2190; 1723 1857; 1732-2001; 1742-2142; 1751-1980; 1770- 2003; 1770-1982; 1772-2044 1789 2039 1793 -2046, 1801 -2094 ; 1825-2108; 1849-2309; 1849 2107; 1851 -2089; 1853 2091; 1863- -2142; 1873-2162; 1873- 2141; 1875-2142 1875-2140 1879 2140 1876- -2128, 1939 -2304 1953-2510; 1954-2203; 1973 2230; 1979 2274; 1983 2078; 1986- -2256; 1986 2240; 1991- 2243; 1993-2168 1996-2314 1996 2224 1996- -2201, 2000 -2269 2009-2226; 2010-2285; 2015 2509; 2015 2569; 2014 2217; 2032- -2448; 2032 2257; 2051- 2263; 2052-2124 2060-2299 2062 -2378 2063- -2353, 2063 -2329 2063-2290; 2063-2279; 2064 2522; 2067 2331; 2116 2367; 2160- -2410; 2163-2463; 2163- 2361; 2165-2447 2166-2393 2170 -2415 2202- -2441, 2203- -2742 ; 2214-2415; 2216-2373; 2219 2666; 2219 2454; 2221 2441; 2228- -2521; 2238-2494; 2240- 2441; 2247-2441 2257-2561 2273 -2552 2283 -2441 2288 -2620 ; 2300-3641; 2300-2681; 2303 2679; 2307 2532; 2320 2568; 2324- -2669; 2333-2610; 2339- 2679; 2340-2603 2341-2699 2341 -2612 2343 -2631 2354 -2883 ; 2364-2618; 2369-2632; 2376 2727; 2378 -2839; 2378 2589; 2381- -2641; 2448-2650; 2451- 2877; 2450-2818 2450-2722 ; 2450 -2707 2450 -2699 2461 -2709 ; 2461-2680; 2461-2655; 2461 2589; 2462 -2754; 2463 2743; 2466- -2724; 2484-2738; 2490- 2737; 2491-2581 2497-2814 2521 -2784 2522 -2803, 2523 -2870 ; 2524-2754; 2525-2789; 2551 2822; 2560 -2787; 2560 2786; 2562- -2808; 2562-2805; 2569- 2747; 2578-2813 2579-2808 ; 2594 -2829 2589- -2848, 2613- -2900 ; 2625-2876; 2631-2888; 2637 2863; 2660 -2891; 2661-2893; 2667-2899; 2668-2930; 2671- 2825; 2673-2915 2678-2923 ,- 2678 -3164 2686-3070; 2705-2884 ; 2713-3141;- 2718-2879; 2722 3010; 2722 -3011; 2743-3018; 2743-2985;.2743-2973; 2748- Table 3
2995 2749-3203; 2762-3209 2764-3213 2768-3193; 2770-3017 2770- 3010 2776 2998; 2778-3026; 2794-3059; 2799 3054; 2820-3203; 2824 3394; 2835 3125 2836-2997; 2858-3027 2859-3161 2867-3103; 2879-3095 2882- 3038 2892 3283; 2890-3152; 2910 3143; 2921 3180; 2921-3168; 2924 3117; 2926 3449 2926-3175; 2927-3499 2941-3075 2945-3212; 2946-3152 2947- 3195
2948-3155; 2950-3225; 2956 3234; 2977-3462; 2975-3184; 2988 3228; 2989
3237 2991-3113; 2993-3286 3011-3277 3015-3275; 3018-3294 3021- 3421 3023 3280; 3026-3253; 3036 3267; 3043 3302; 3043-3281; 3043 3289; 3045 3261 3047-3294; 3059-3275 3063-3310 3064-3304; 3066-3351 3066- 3340
3071-3638; 3077-3352; 3077 3310; 3081 3479; 3084-3495; 3085 3350; 3086
3543 3088-3292; 3095-3622 3095-3582 3095-3383; 3096-3357 3097- 3333
3100-3361; 3102-3384; 3104-3594; 3123 3366; 3125-3388; 3141 -3379; 3146
3375 3150-3402; 3164-3596 3164-3391 3164-3375; 3170-3424 3173- 3644 3176 3641; 3176-3412; 3178 3640; 3184-3639; 3193-3641; 3193 -3462; 3196 3646 3196-3599; 3198-3429 3201- -3447 3201- -3410; : 3202- -3641 3202- 3636
3203-3638; 3205-3641; 3205 3647; 3209 3641; 3209- -3387; 3212 3641; 3212
3493 3219 -3639; 3218 -3438 3221- -3646 3223- -3636; : 3223- -3646 3223- 3638 3225 3638; 3226-3638; 3227 3636; 3227 3641; 3231- -3638; 3241 3640; 3247 3647 3249 -3643; 3271 -3505 3273* -3511 3273- -3639; : 3274* -3541 3283- 3537 3284 3566; 3302-3504; 3326 3581; 3326 3545; 3332- -3623; 3332 -3629; 3354 3638 3354 -3579; 3355 -3541 3357- -3637 3357- -3620; : 3359- -3601 3369- ■3618 3369 3608; 3369-3606; 3386 3636; 3391 3590; 3392- -3624; 3400 3504; 3403 3646 3412 -3537; 3425 -3636 3435- -3646 3447- -3641; : 3447- -3640 3448- 3641 3456 3631; 3487-3638; 3487 3602; 3488 3638; 3489- -3643; 3489 3636; 3489 3572 3540 -3646; 3540 -3608 3357- -3638 3360- -3641; : 3356* -3641 3348- 3638 2907 3203; 3324-3638; 2895 3210; 3309 3641; 3297- -3641; 3296 -3639; 3281 3639 3272 -3638; 3267 -3638 3080- -3454 3264- -3636; : 3105- -3489 3241- 3638 3072 3489; 3321-3639; 3334-3641; 3261 3641; 3389- -3638; 3396 -3638; 3418 3641 3411-3646; 3418-3642 3410-3638 3270* -3489; ; 3215- -3405 3462- ■3641 3456 3641; 3215-3400; 2906-3090; 3464-3633; 3489-3638; 3551 -3646; 3550 3641 3409-3489; 3551-3628
* 105/LG: 199194.1:2001MAR30 1-3546; 1-557; 92-570; 124-572 ; 185-511; 261-
570; 325-704; 325-562; 464-820; 693-950; 693-755 1052-1554 ; 1403-1800; 1403-1723; 1403-1471; 1422-1656; 1429-1853; 1448 1809; 1466 -2063; 1469- 1761; 1558-2075; 1547-1806; 1576-2049; 1687-1936 1709-2197 ; 1718-2012; 1729-1994; 1762-1994; 1765-2063; 1779-2021; 1830 2058; 1924 -2225; 1929- 2477; 1929-2264; 1986-2517; 2004-2301; 2040-2301 2048-2182 ; 2123-2306;
2142-2399; 2178-2513; 2180-2581; 2179-2532; 2179-2419; 2201 -2454; 2214-
2486; 2222-2668; 2222-2791; 2222-2525; 2223-2520 2233-2589 ; 2288-2521;
2299-2526; 2359-2955; 2372-2605; 2402-2670; 2404-2652; 2427 -2617; 2448-
2939; 2453-2744; 2457-2757; 2463-2671; 2467-2696 2500-2802 ; 2500-2824; 2509-2732; 2522-3026; 2549-2812; 2553-2807; 2580 3014; 2596 -3234; 2610- 2817; 2626-2761; 2662-2753; 2750-2853; 2781-3298 2781-3031 ; 2873-3092; 2912-3491; 2953-3505; 2971-3204; 2975-3273; 2989 3372; 3005 -3558; 3029- 3535; 3067-3543; 3070-3511; 3070-3539; 3070-3499 3070-3191 ; 3071-3527;
3071-3499; 3071-3355; 3079-3533; 3089-3546; 3098-3541; 3100 -3542; 3100-
3538; 3101-3538; 3107-3368; 3109-3496; 3114-353! 3126-3538; 3131-3400
3143-3538; 3152-3395; 3154-3538; 3156-3546; 3184-3533; 3179 3541; 3181
3477; 3187-3541; 3202-3469; 3216-3544; 3211-3547 3211-3488; 3218-3520
3211-3440; 3224-3518; 3233-3539; 3248-3542; 3255-3512; 3257- 3546; 3264 3534; 3260-3542; 3265-3546; 3266-3455; 3267-3550; 3271-3538; 3274-3535 3291-3538; 3296-3534; 3327-3546; 3328-3542; 3330-3534; 3344- 3538; 3360- ' 3543; 3383-3542; 3386-3538; 3437-3538; 3483-3537 106/LG:200727.6:2001 AR30 | | 982-1425; 986-1131; 689-1042; 705-1042; 583- 1041; 590-1040; 864-1040; 736-1039; 641-1038; 712-1038; 658 -1037; 662-1036; 909-1037; 618-1037; 761-1035; 603-1036; 689-1036; 767-1036; 909-1036; 854- 1036; 670-1036; 582-1035; 687-1034; 730-1035; 775-1034; 621 1034; 602-1034; 656-1023; 662-1013; 656-1012; 655-1006; 653-1003; 656-998; 431-995; 478- 996; 655-988; 466-985; 656-964; 655-915; 656-900; 591-899; 640-865; 359- Table 3
840; 596-821; 596-760; 436- 694 ; 434-678 ; 35 9-678 ; 439- 670; 349-603; 262- 540; 217-490; 110-455; 217- 437 ; 110-348 ; 64-319; 1-253 107 /LG: 201572.20 :2001MAR30 I I 1-643 ; 463 -826; 74 6-1036 979 1596; 1029
1483 1035-1597 1035-1272 1052-1368 1057-1284 1082 1322 1093-■1555
1097-1263; 1097 1653; 1116 1353; 1125 1373; 1142 1689; 1161 1396; 1167
1426 1172-1420 1174-1457 1215-1691 1255-1630 1264 1555 1264-■1556
1297-1499; 1316-1499; 1331 1508; 1355 1612; 1420 -1623; 1512 1636; 1512
1733 1518-2035 1527-1765 1539-1780 1542-2032 ' 1565-2036 1576- 2036
1582-2037; 1600-2074; 1608 2074; 1610 1828; 1617 1901; 1641 1998; 1645
1940 1651-2074 1654-2075 1658-1930 1660-1903 1663-2077 1662- 1964
1676-2074; 1675 2029; 1675 1770; 1689 2074; 1696 1917; 1695 2074; 1695
2079 1695-1911 1695-2031 1695-1941 1695-1914 1697-2074 1697- 1932 1701 1948; 1703 2073; 1705 1990; 1718 2074; 1720 1973; 1720 2074; 1789 2033 1789-2050 1810-2074 1816-2021 1818-2039 1817-2074 1818- 2076 1819 2360; 1821 2074; 1821 2073; 1823 2072; 1823 2074; 1823 2306; 1823 2076 1823-2029 1823-1988 1823-2033 1823-2032 1823-1940 1828- 2074 1833 2074; 1831 2096; 1836 -2026; 1842-2041; 1842 2094; 1843 2364; 1844 2160 1845-2405 1848-2074 1850-2099 1850-2240 1865-2142 1868- 2115
1875-2115; 1881 1937; 1881 2078; 1884 2456; 1884 2186; 1888 2074; 1888
2036 1891-2297 1891-2117 1894-2136 1898-2121 1902-2194 1916- 1993
1930-2074; 1930 2183; 1930 -2069; 1948-2348; 1952 2131; 1966 2188; 1978
2227 1989- •2146 2017-2390 2015 -2280 2017-2302 2042-2393 2072- 2331 2074 2366; 2076 2604; 2112 2384; 2134 2742; 2135 2375; 2136 2404; 2187 2391 2200- 2362 2234-2503 2240 -2494 2246-2545 2278-2435 2280- 2562 2289 2518; 2291 2552; 2309 2915; 2311 2758; 2311 2535; 2314 2567; 2314 2835 2327-2671 2326-2543 2340 -2560 2344-2696 2348-2551 2355- 2576 2355 2574; 2365 2621; 2366 2679; 2379 2659; 2383-2608; 2397 2683; 2413 2692 2437-•2812 2466-2720 2482 -2739 2487-2769 2530-3100 2610- 3112 2611 2915; 2619 3157; 2620 2897; 2636 2898; 2638 2902; 2639 2973; 2640 2870 2647-3168 2657-2864 2663 -2866 2667-2919 2676-2818 2682- 3.045 2693 2946; 2690 2818; 2708 3171; 2716 2955; 2722 2972; 2727 3170; 2731 3197 2738-3260 2740-2966 ' 2743 -2952 2743-2978 2743-3234 2754- 3184 2750 3221; 2752 3215; 2759 3044; 2781-3151; 2777 3219-; 2774 3060; 2777 2930 2800-3260 2823-3266 2826- 2981 2828-3266 2828-3263 2828- 3267 2829 3260; 2836 3076; 2836 2915; 2848 3264; 2853 3260; 2854 3105; 2855 3264 2858-3280 2859-3264 2862- 3109 2862-3260 2863-3263 2865- 3263
2868-3277; 2868-3264; 2869 3277; 2874 3117; 2877 3109; 2882 3263; 2888
2977 2888-3260 2893-3260 2899- 3073 2905-3237 2913-3260 2919-■3246
2924 3265; 2930 3265; 2940 3191; 2940 3260; 2940-3224; 2947 3156; 2947
3260 2948-3259 2959-3263 2972- 3246 2974-3253 2975-3252 2991- 3244
2992 3227; 2997 3260; 3004 3203; 3025 3263; 3036 3264; 3043 3260; 3045
3223 3056-3267 3059-3257 3062-■3263 3064-3264 3065-3263 3070- 3260
3075 3260; 3107-3265; 3145 3492; 3148 3261; 3148 3260; 3170 3260; 3354
3646; 2853-3263 2397-2967 1822- 2060 1821-2056 1867-2073 3031- 3165
2511-2641; 1867-1951
108/LG: 201669.25 :2001MAR30 I I 1-155; 29-3442; 39-3 47; 40-162; 42-7 18; 41-
236; 45-580; 49-390; 101-566 ; 201-771; 245-755; 429-728; 485-667; 525-781;
622-1083; 622-858; 710-945 ; 816-952; 831-1127; 831-1132; 831-1096; 910-
1449; 951-1529; 938-1158; 1012-1334; 1034-1531; 1026-1123; 1146-1772; 1169-
1445; 1187-1800; 1192-1301 ; 1206-1472; 1240-1506; 1254-1859; 1264 1909;
1273-1773; 1287-1748; 1287-1563; 1300-1527; 1311-1586; 1330-1599; 1350
1865; 1353-1889; 1386-1588 ; 1391-1647; 1403-1918; 1419-1688; 1430-1663
1443-1910; 1463-1676; 1473-1720; 1507-1777; 1537-1733;* 1537-1753; 1556
2078; 1562-1788; 1593-1918 ; 1594-1863; 1654-1918; 1806-2016; 1806 1918
1816-1907; 1860-2072; 1860-2017; 1935-2152; 1935-2105; 1994-2363; 2006
2225; 2015-2523; 2020-2436 ; 2097-2569; 2095-2571; 2098-2531; 2098 2503
2098-2366; 2100-2346; 2113-2253; 2119-2572; 2121-2354; 2121-2571; 2122
2575; 2125-2575; 2133-2532 ; 2142-2569; 2143-2368; 2145-2569; 2148 2739
2166-2509; 2166-2411; 2177-2569; 2184-2569; 2203-2570; 2203-2493; 2204
2570; 2211-2570; 2215-2571 ; 2226-2573; 2229-2533; 2241-2572; 2239 2577 Table 3
2242-2571; 2245-2827; 2249-2569; 2251-2572; 2254-2529; 2265-2518; 2279-
2569; 2283-2475; 2284-2517; 2284-2491; 2285-2571; 2298-2572 2325- ■2572 2322-2576; 2325-2576; 2345-2858; 2345-2521; 2348-2631; 2352 2642; 2356 2558; 2369-2700; 2373-2569; 2374-2629; 2375-2570; 2385-2642 2418- 2990 2421-2966; 2433-2569; 2434-2509; 2437-2572; 2441-2836; 2461 2552; 2466 2554; 2494-2642; 2537-2797; 2562-2977; 2564-2840; 2598-2833 2608- ■2946 2617-2863; 2617-2676; 2638-3075; 2647-2888; 2710-2905; 2714 3002; 2714 2944; 2721-2959; 2726-2869; 2736-2897; 2792-2981; 2797-2957 2822- ■3155 2831-3107; 2842-3428; 2846-2985; 2867-3130; 2880-3300; 2880 3076; 2888 3437; 2888-3377; 2891-3108; 2891-2991; 2897-3214; 2912-3122 2941- 3160 2967-3440; 2980-3440; 2981-3439; 2981-3444; 2989-3445; 2992 3440; 2999 3445; 3015-3246; 3022-3442; 3022-3444; 3028-3397; 3031-3451 3034- 3278 3039-3446; 3046-3446; 3046-3447; 3051-3438; 3051-3443; 3066 3440; 3065- 3437; 3069-3322; 3071-3439; 3072-3261; 3073-3447; 3076-3405 3078- •3644
3086-3402; 3092-3440; 3112-3442; 3112-3363; 3126-3279; 3128-3444; 3127- 3448; 3128-3450; 3131-3397; 3133-3440; 3135-3438; 3136-3443; 3135-3419 3139-3442; 3145-3444; 3149-3440; 3160-3290; 3166-3432; 3167-3446; 3167 3436; 3180-3438; 3188-3393; 3190-3438; 3196-3378; 3198-3439; 3206-3443 3227-3442; 3248-3440; 3249-3440; 3251-3433; 3260-3440; 3297-3442; 3389- 3444; 3389-3438; 3390-3444
109/LG:208588.4:2001MAR30 || 1-247; 1-280
110/LG:210412.29:2001MAR30 j| 1-110; 10-164; 18-165; 18-158; 77-332; 77 359; 154-570; 282-729; 354-787; 398-782; 423-782; 590-1120
111/LG:215051.15:2001MAR30 || 1-612; 14-281; 14-521; 16-278; 21-232; 24- 157; 24-322; 44-622; 46-298; 40-488; 40-251; 66-273; 67-547; 67-263; 71- 493; 75-285; 77-510; 81-597; 152-319 176-454; 193-710 309-436; 400-672; 462-1027; 488-678; 504-868; 542-829; 580-777; 611-1179 642-857; 660-1222; 660-1090; 678-925; 718-972; 735-977; 778-971; 756-1004 869-1010; 885-1126;
903-1110; 911-1448; 911-1550; 1034-1375; 1-140; 1382-1667; 1410-1611; 1412-
1643; 1414-1607 1425-1694 1542-1848; 1548-1982 1597-1768 1662-2208 1690-2150; 1691 2150; 1693 2150; 1708-2132; 1735 1981; 1740 2037; 1752- 1997; 1814-2066 1831-2150 1840-2318; 1874-2105 1874-2151 1876-2480 1950-2446; 1952 2373; 1950 2380; 2008-2562; 2108 2551; 2107 2746; 2127- 2523; 2132-2515 2180-2635 2181-2440; 2202-2298 2225-2780 2225-2497 2234-2447; 2265 2783; 2268 2404; 2286-2520; 2315 2492; 2363-2565; 2391 2793; 2395-2840 2395-2662 2409-2633; 2412-2608 2414-2712 2415-2509
2421-2682; 2421-2694; 2424-2732; 2446-2637; 2481-2715; 2484-2717; 2495-
2767; 2527-2703; 2534-2666
112/LG:215475.21:2001MAR30 || 1-477; 1-484; 1-435; 4-488; 194-671; 197-451;
237-773 226-635; 332-927; 335-481; 336-617 341-629; 343-554; 354-481; 363-621 376-629; 383-543; 385-846; 500-965 500-993; 530-1038; 530-1004; 533-769 537-804; 560-1036; 574-1110; 571-997; 580-863; 598-825; 600-1165; 600-814 603-818; 607-981; 607-839; 608-805; 614-1039; 615-901; 626-753; 630-764 637-865; 638-1157; .675-1196; 689-935; 693-1285; 702-860; 706-851; 713-861 716-948; 716-851; 726-936; 794-1060; 797-1141; 807-1006; 811-1007; 819-1001 831-1408; 862-1152; 865-1101; 869-1118; 885-1116; 892-1420; 906- 1474; 906-1163; 926-1506; 926-1155; 930-1296; 944-1184; 964-1508; 964-1273; 968-1512; 967-1138; 994-1254; 1000-1263; 1000-1243; 1012-1194; 1034-1532; 1055-1643; 1055-1678; 1055-1587; 1055-1586; 1064-1280; 1064-1428; 1064- 1295; 1064-1284; 1064-1270; 1064-1272; 1067-1226; 1067-1652; 1071-1313; 1094-1371; 1111-1556; 1114-1732; 1150-1399; 1151-1396; 1159-1717; 1158- 1392; 1159-1367; 1176-1694; 1179-1733; 1184-1459; 1191-1479; 1191-1436; 1203-1316; 1209-1565; 1208-1566; 1216-1476; 1237-1490; 1245-1787; 1250- 1752; 1272-1753; 1272-1752; 1276-1753; 1281-1430; 1285-1561; 1293-1741; 1293-1561; 1306-1615; 1317-1606; 1331-1572; 1335-1618; 1339-1583; 1347- 1565; 1353-1474; 1355-1718; 1358-1634; 1371-1740; 1376-1652; 1377-1839; 1382-1696; 1382-1656; 1384-1977; 1384-1624; 1391-1606; 1394-1894; 1399- 1578; 1408-1581; 1409-1850; 1416-1679; 1425-1731; 1432-1671; 1444-1734; 1447-1987; 1464-1957; 1486-1728; 1490-1726; 1505-2115; 1505-1734; 1507- 1757; 1511-1712; 1516-1955; 1525-1844; 1541-2090; 1541-1771; 1547-1791; Table 3
1553- 2102; 1553- 1781; 1570- 2082; 1579- 2092; 1587- 1833; 1589- 1944; 1589- 1896; 1591- 1789; 1591 -2175; 1601- 1849; 1624- 1789; 1632- 1899; 1635- 2209; 1635-2195; 1652- 1909; 1660-1886; 1661-1878; 1662- 1788; 1662- 1866; 1663- 1922; 1663- 2067; 1670 -2233; 1671- 1921; 1672- 1828; 1672- 1901; 1678- 1903; 1680- 2035; 1683-1827; 1699- 2262; 1699- 1856; 1699-1931; 1709-2217; 1710- 2261; 1709- 1958; 1727 -2261; 1721- 1972; 1725- 2286; 1728- 2024; 1746- 2282; 1750- 2283; 1759- 1988; 1780- 2029; 1802-2075; 1806-2028; 1812-2049; 1830- 2392; 1830- 2093; 1834 -2085; 1837- 2069; 1844- 2022; 1851- 2405; 1851- 2122; 1849-2033; 1858- 2120; 1874- 2501; 1880-2144; 1885-2146; 1885-2390; 1886- 2298; 1887- 2239; 1887 -2075; 1891- 2145; 1891- 2389; 1923- 2192; 1932- 2181; 1931-2179; 1936- 2188; 1952-2390; 1956-2549; 1954-2174; 1971-2207; 1992- 2577; 1992- 2552; 1992 -2291; 1993- 2285; 1994- 2387; 1994- 2290; 1994- 2227; 1996- 2272;' 1996- 2447; 1996- 2381; 1998- 2282; 1996-2463; 1998-2294; 1998- 2179; 2005- 2389; 2006 -2239; 2008- 2240; 2011- 2583; 2016- 2575; 2042- 2300; 2046-2532; 2056-2281; 2057- 2334; 2058-2599; 2059-2310; 2059-2305; 2058- 2121; 2062- 2394; 2076 -2654; 2078- 2365; 2078- 2354; 2087- 2498; 2089- 2360; 2104-2573; 2116- 2729; 2118-2304; 2125-2384; 2144-2590; 2144-2401; 2151- 2404; 2151- 2381; 2162 -2352; 2167- 2437; 2171- 2740; 2178- 2434; 2182- 2703; 2185-2754; 2188- 2727; 2185- 2432; 2188-2447; 2197-2460; 2201-2465; 2201- 2431; 2200- 2522; 2209 -2786; 2211- 2453; 2220- 2728; 2222- 2506; 2249- 2653; 2238-2465; 2252-2630; 2258-2671; 2258-2513; 2259-2523; 2260-2505; 2258- 2527; 2282- 2748; 2282 -2554; 2290- 2411; 2296- 2498; 2298- 2557; 2300- 2557; 2303-2557; 2316- 2583; 2317-2509; 2348-2896; 2347-2608; 2355- 2588; 2362- 2615; 2363- 2653; 2376 -2608; 2385- 2664; 2402- 2605; 2402- 2863; 2399- 3008; 2414-2999; 2422-2995; 2423- 2604; 2427-2973; 2431- 2992; 2430- 2686; 2428- 2668; 2434- 2986; 2435 -2694; 2436- 2640; 2434- 2694; 2434- 2659; 2436- 2697; 2435-2982; 2438-2522; 2441- 2994; 2441-2753; 2441-2702; 2453- 2994; 2458- 2699; 2459- 2719; 2462 -2704; 2465- 2993; 2467- 3055; 2468- •2712; 2470- •2739; 2470-2668; 2483-2911; 2481-2795; 2489-3058; 2484-2691; 2485-2794; 2486- 2838; 2486- 2820; 2486 -2670; 2490- 3100; 2492- 2812; 2500- 3009; 2502- 3019; 2502-2743; 2503-2994; 2505-2768; 2509- 2782; 2519-2779; 2518- 2805; 2517- 3061; -.2522- 2984; 2523 -3074; 2526- 3060; 2521- 2763; 2537- 2992; 2535- 2773; 2536- 2804; 2536-3060; 2537- 3054; 2535- 2818; 2540-2992; 2543-3052; 2544- ■2857; 2546- 2801; 2553 -2730; 2553- 2700; 2557- 2824; 2559- 2835; 2572- 2972; 2573-3021; 2573-3016; 2573- 2994; 2575- 2823; 2575-2839; 2573-2809; 2575- 3030; 2578- 2974; 2578 -2867; 2587- 3013; 2592- 2736; 2608- 2876; 2600- 2675; 2605-2764; 2607-3059; 2607-3052; 2608- 2693; 2615-2846; 2627-2989; 2625- 3100; 2625- 3057; 2628 -2995; 2628- 3055; 2637- 2805; 2638- •3014; 2637- 2917; 2639-3097; 2643- 2903; 2645-3102; 2644- 2900; 2649-3099; 2649-2902; 2651- 3097; 2650- 3099; 2651 -2905; 2655- 3099; 2658- 3101; 2659- •3105; 2660- 3102; 2661-3103; 2662-3100; 2664-3100; 2668-3099; 2669-3103; 2670-3098; 2670- 3104; 2677- 2929; 2684 -3099; 2685- 3105; 2685- 3102; 2687- 3097; 2689- 3100; 2689-3099; 2693-3101; 2697-3098; 2702-3099; 2704-3099; 2704-3103; 2707- 2981; 2707- 3099; 2708 -2987; 2710- 2981; 2711- 3104; 2712- 3103; 2713- 3099; 2721-3099; 2722-3099; 2723-2913; 2724-3100; 2686-3099; 2725-3102; 2727- 3099; 2728- 3004; 2729 -3102; 2730- 3060; 2733- 3099; 2734- •3101; 2734- 2992; 2737-2999; 2743-2982; 2743-2946; 2749-3099; 2749- 3011; 2749- 3016; 2752- 3099; 2759- 2989; 2760 -3036; 2767- 3100; 2766- 3099; 2766- ■3046; 2766- 2979; 2766-2998; 2777-3099; 2795-3385; 2793-3209; 2793- 3054; 2796- 3057; 2798- 3063; 2799- 3043; 2800 -3099; 2801- 3016; 2804- 3074; 2804- •3048; 2809- 3093; 2809-3065; 2809-3164; 2829-3099; 2836-3097; 2854- 3385; 2874- 3039; 2881- 3099; 2890- 3100; 2899 -3099; 2899- 3065; 2900- 3014; 2906- ■3099; 2908- 3099; 2917-3099; 2919- 3069; 2922-3099; 2927-3099; 2929- 3052; 2941- 3097; 2944- 3099; 2949- 3056; 2949 -3104; 2949- 3099; 2950- 3024; 2955- 3099; 2976- 3099; 2978-3061; 2978- 3101; 2985- 3102; 2990- 3099; 3032- 3099; 3051- 3103; 2962- 3097; 2001- 2269; 2202 -2382; 2962- 3099; 2088- 2363; 2032- •2309; 2059- 2347; 2087-2376; 2962- 3100; 2421-2677; 1895- 2199; 2201- 2388; 2431- 2726; 2434- 2702; 2060- 2326; 2421 -2560; 2240- 2381; 2019- 2269; 1919- •2168; 2442- 2560; 2061-2285; 2421-2545; 2890-3099; 2117-2320; 2076- 2261; 2438-2621; 1897- Table 3
2072; 2143-2306 2943-3099; 2058-2210; 2104-2254; 2165-2283; 2424-2540; 2167-2281; 2168 2282; 2120-2182 113/LG:224523.1 2001MAR30 | | 1-113; 5-639; 34-315 114/LG:228186.1 2001 AR30 j j 1-548; 251-836; 354-614; 459-961; 459-686; 544-785; 585-1134; 726-1159; 784-1274; 827-1299; 883-1136; 893-1296; 975-
1364; 1048-1344 1274-1590; 1294-1477; 1310-1675 1355-1619; 1361-1603
1408-1719; 1408-1589; 1413- 1972; 1433-1942; 1530 1988; 1568-1986; 1590-
1988; 1626-1985 1732-1989; 1839-2015; 1909-2023 1948-2515; 1948-2031 1948-2023; 2305 2563; 2332- 2635; 2332-2453; 2332 2384; 2332-2489; 2332- 2448; 2382-2645 2385-2645; 2404-2669; 2418-2930 2441-3026; 2449-2727 2489-2678; 2498 2720; 2498- 2610; 2505-3008; 2505 2738; 2544-3133; 2567- 2850; 2570-2763 2746-3341; 2748-3033; 2756-3275 2771-3015; 2781-3315 2794-2977; 2843 3362; 2832- 3328; 2885-3574; 2903 3256; 2903-3174; 2903- 3124; 2980-3257 3045-3283; 3045-3261; 3063-3217 3100-3568; 3199-3689
3199-3481; 3323-3560; 3326- 3587; 3330-3579; 3340 3594; 3341-3579; 3343 3618; 3344-3568 3347-3778; 3347-3541; 3350-3584 3411-3666; 3441-3718 3448-3574; 3471-3724; 3495 3754; 3502-3761; 3536 3734; 3543-3860; 3557- 3839; 3578-3944 3586-3852; 3617-3923; 3679-4266 3682-4064; 3682-3914
3693-3841; 3699-4307; 3721-3948; 3737-4257; 3737-3999; 3751-4019; 3762-
4300; 3779-4014; 3788-4176 3788-4041; 3788-3920 3788-4311; 3800-4310 3800-4311; 3859-4158; 3890 4350; 3897-4347; 3902 4348; 3906-4351; 3921 4351; 3922-4220; 3927-4349 3932-4347; 3931-4192 3939-4416; 3939-4195 3949-4349; 3951-4347; 3970-4353; 3973-4354; 3973 4152; 4001-4347; 4001- 4348; 4023-4348; 4029-4439 4044-4300; 4047-4273 4062-4329; 4084-4348 4095-4308; 4103-4340; 4119 4348; 4168-4350; 4168 4307; 4187-4350; 4187- 4347; 4200-4348; 4241-4340 4264-4340; 4264-4331 4283-4347; 4377-4591 4425-4706; 4432-4959; 4441 4880; 4467-4695; 4492 4934; 4492-4742; 4531 5120; 4551-4939; 4551-4774 4589-5164; 4676-5122 4682-5159; 4685-5121 4678-5144; 4677-5105; 4677 4969; 4725-5165; 4745-5164; 4746-5164; 4768- 5164; 4769-5165; 4766-5164 4781-5023: 4784-5141 4785-5164; 4800-5018; 4803-5164; 4811-5170; 4820 5167; 4820-5164; 4811 4894; 4830-5141; 4855- 5164; 4866-5165; 4875-5154 4880-5125; 4881-5165 4886-5164; 4887-5164; 4887-5140; 4881-5144; 4921 5144; 4957-5077; 5021-5165 115/LG: 233138.2 :2001MAR30 I 1-4372; 1029-1114; 1216-1596; 1357-1805; 1357- 1624; 1469-1762; 1551-2119 1583-1946; 1584-1974; 1584-2043; 1585-1884; 1586-1880; 1730-2328; 2033 2323; 2089-2295; 2130-2300; 2159-2571; 2177- 2719; 2483-2771; 2533-2759 2534-2825; 2566-2991; 2632-2901; 2635-2896; 2686-2943; 2689-2994; 2792 3256; 2871-3282; 2873-3139; 2924-3290; 2957- 3218; 2966-3483; 2984-3442 3009-3265; 3016-3311; 3036-3395; 3022-3311; 3029-3396; 3039-3289; 3048 3289; 3084-3396; 3088-3395; 3095-3311; 3113- 3311; 3119-3395; 3117-3289 3116-3314; 3120-3401; 3143-3679; 3152-3289; 3157-3424; 3159-3289; 3192 3323; 3200-3465; 3212-3469; 3356-3522; 3358- 3604; 3360-4054; 3431-3886 3433-3680; 3436-3696; 3477-3877; 3527-3815; 3632-3838; 3644-4201; 3644 3902; 3763-4062; 3763-3894; 3764-4099; 3764- 3957; 3812-4337; 3895-4146 3935-4206; 3957-4562; 3958-4372; 3969-4333; 3976-4376; 3976-4228; 4002 4375; 4022-4317; 4043-4308; 4044-4326; 4044- 4372; 4120-4329; 4139-4335 4149-4380; 4159-4597; 4159-4322; 4166-4477; 4198-4475; 4217-4606; 4248 4665; 4254-4626; 4297-4605; 4328-4664; 4333- 4652; 4343-4408; 4357-4664 4423-4665; 4435-4652; 4435-4664; 4436-4626; 4439-4664
116/LG: 234811.10 :2001MAR30 I I 1-421; 83-354; 103-398; 149-440; 149-210; 186-436; 213-395; 271-849; 374-899; 447-686; 448-698; 449-716; 449-731;
449-688 449-943; 451-619 451-678; 451-707; 451-737; 451-727; 451-664; 452-692 452-700; 453-738 455-744; 455-694; 455-969; 456-680; 458-609; 465-944 464-722; 465-676 465-943; 465-973; 465-1003;. 465-671; 465-639; 465-736 465-1005 469-726 471-724; 473-563; 474-653;• 477-722; 479-693; 479-934 481-939 483-896; 501-799; 505-767; 507-960; 504-998; 508-777; 510-771 512-758 516-1000 525-804; 535-648; 544-1043; 559-809; 559-874; 561-685 564-693 568-998; 575-905; 583-855; 585-849; 586-889; 586-795; 593-877 605-855 632-1006 632-874; 639-1037; 639-1023; 641-1037; 648- Table 3
1043; 649-870; 649-922; 651-889; 653-1006; 655-1050; 661-1041; 664-920; 664-1007; 677-1036; 680-1043; 700-930; 700-950; 728-1043; 765-1012; 768- 889; 780-889; 813-1020; 835-1044; 842-1037; 867-1046; 917-992 117/LG:236092.1:2001MAR30 || 1-152; 1-169; 1-285; 37-218; 39-366; 50-332; 100-362; 150-420; 256-466; 283-857; 307-473; 314-674; 314-567; 327-462; 394-636; 394-630; 501-758; 503-803; 506-771; 579-851; 639-837; 663-960; 701-1246; 758-906; 763-911; 774-1183; 785-1008; 790-1028; 830-1397; 858- 1177; 865-1036; 869-1091; 882-1485; 882-1212; 881-1149; 881-1133; 881-1132; 881-1128; 883-1159; 883-1149; 883-1163; 883-1136; 883-1119; 886-1153; 887- 1133; 887-1097; 891-1044; 891-1411; 893-1185; 898-1303; 904-1113; 905-1127; 911-1493; 912-1182; 913-1143; 912-1131; 919-1527; 923-1318; 923-1174; 923- 1181; 935-1105; 943-1171; 944-1178; 945-1199; 947-1218; 967-1236; 983-1076; 992-1284; 998-1252; 1007-1120; 1016-1334; 1016-1369; 1015-1141; 1024-1483; 1024-1271; 1025-1302; 1031-1280; 1033-1327; 1043-1390; 1055-1160; 1057- 1287; 1063-1541; 1066-1351; 1089-1483; 1110-1362; 1111-1414; 1112-1356; 1113-1483; 1114-1389; 1114-1388; 1117-1327; 1120-1551; 1120-1363; 1128- 1372; 1128-1367; 1129-1483; 1133-1406; 1149-1427; 1166-1380; 1189-1435; 1198-1265; 1202-1553; 1207-1466; 1210-1483; 1225-1454; 1270-1597; 1268- 1483; 1271-1538; 1279-1558; 1279-1533; 1290-1541; 1292-1449; 1309-1842; 1308-1523; 1313-1483; 1315-1555; 1329-1940; 1329-1483; 1339-1590; 1341- 1575; 1341-1483; 1352-1538; 1374-1890; 1391-1483; 1422-1684; 1422-1538; 1435-1739; 1485-1956; 1504-1962; 1613-2189; 1614-1965; 1623-1966; 1628- 1956; 1628-1886; 1628-1678; 1653-2140; 1714-1957; 1710-1949; 1721-2181; 1725-1968; 1735-1970; 1737-2007; 1743-2185; 1754-2185; 1757-2186; 1768- 2181; 1771-2192; 1781-2192; 1781-1839; 1781-1837; 1783-1957; 1783-2185; 1783-2183; 1783-2188; 1783-2138; 1783-2120; 1783-1974; 1781-1956; 1781- 1962; 1783-1959; 1783-1962; 1783-1956; 1783-1991; 1783-1933; 1783-1930; ■1783-1919; 1783-2180; 1786-2189; 1783-1942; 1788-2183; 1788-2093; 1791- 2185; 1799-2031; 1799-2045; 1801-2188; 1808-2183; 1818-1874; 1821-2186; 1830-2183; 1837-2116; 1842-2023; 1859-2113; 1871-2182; 1873-2114; 1874- 2185; 1875-2182; 1876-2185; 1876-2184; 1885-2161; 1892-2105; 1901-2185; 1910-2183; 1915-2183; 1931-2183; 1933-2181; 1940-2181; 1942-2175; 1967- 2183; 1968-2179; 1969-2181; 1971-2185; 1971-2181; 1990-2122; 2003-2183; 2009-2185; 2016-2153; 2018-2170; 2063-2142; 2083-2184; 2118-2176 118/LG:236098.12:2001MAR30 || 1-574; 2-798; 6-605; 8-262; 9-388; 12-235; 10-156; 12-271; 16-279; 17-317; 21-262; 24-270; 24-230; 29-270; 32-429; 35- 304; 37-597; 38-147; 40-326; 41-311; 41-355; 62-447; 83-644; 92-356; 170- 434; 249-818; 291-550; 435-723; 449-704; 454-683; 454-641; 466-690; 501- 710; 605-781; 671-798; 676-798; 687-781; 694-798; 695-798; 719-1375; 724- 798; 983-1347; 1054-1358; 1065-1132; 1070-1132; 1079-1196; 1080-1377; 1106- 1417; 1106-1421; 1106-1337; 1106-1288; 1106-1290; 1106-1275; 1106-1253; 1130-1410; 1128-1247; 1142-1418; 1142-1416; 1148-1425; 1317-1894; 132! 1571; 1363-1930; 1370-1630; 1455-1641; 1462-1831; 1462-1796; 1465-1699; 1552-1832; 1553-1832; 1585-1712; 1614-2150; 1703-1988; 1712-2245; 1723- 2172; 1823-2300; 1832-2062; 1836-2117; 1925-2234; 1938-2147; 1940-2135; 1969-2433; 1984-2287; 2000-2464; 2003-2258; 2037-2434; 2064-2662; 2074- 2392; 2109-2295; 2116-2382; 2192-2459; 2215-2825; 2217-2509; 2371-2683; 2395-2857; 2399-2676; 2456-2835; 2473-2727; 2484-2892; 2492-3081; 2511- 2733; 2541-2808; 2583-2816; 2615-3166; 2617-3187; 2630-2904; 2637-2881; 2711-3189; 2713-2987; 2724-2948; 2784-3091; 2786-3038; 2786-3029; 2845- 3439; 2869-3244; 2869-3212; 2869-3119; 2966-3187; 2970-3087; 3032-3632; 3033-3258; 3045-3327; 3067-3239; 3085-3673; 3098-3664; 3124-3664; 3134- 3666; 3139-3405; 3160-3416; 3160-3420; 3190-3666; 3192-3449; 3217-3701; 3226-3492; 3229-3487; 3238-3707; 3249-3661; 3251-3661; 3256-3661; 3260- 3698; 3266-3661; 3267-3661; 3289-3531; 3301-3661; 3302-3703; 3305-3661; 3307-3661; 3311-3703; 3312-3661; 3312-3580; 3323-3556; 3346-3701; 3345- 3606; 3347-3707; 3349-3661; 3351-3707; 3351-3614; 3357-3703; 3371-3661; 3374-3661; 3386-3702; 3384-3703; 3392-3661; 3414-3661; 3417-3698; 3420- 3661; 3423-3661; 3449-3661; 3454-3661; 3458-3661; 3463-3541; 3488-3722; Table 3
3492-3703; 3504-3661; 3505-3701; 3509-3661; 3510-4045; 3644-3701; 3822-
4294; 3904-4395; 3906-4155 3939-4294; 4219-4484 119/LG:236697.15:2001MAR30 I 1-613; 273-507; 280-517 299-540; 305-553; 309-574; 310-527 333-463; 333-459; 310-950 310-523 323-544; 347-862; 339-686; 366-711 366-608; 366-544; 369-612 338800--662244; 381-845; 388-688; 395-634; 395-872 396-636; 397-655; 403-730 402-670 403-647; 403-651; 410-667; 411-787 415-597; 415-954; 419-483 420-761; 421-898; 421-592;
424-590; 426-670; 428-728; 431-703; 444-794; 442-934; 443-850; 446-605; 405-738; 458-811; 416-656; 466-658; 469-591; 470-645; 493-630; 494-658; 520-1153; 550099--665544;; 446677--771155; 471-736; 525-601; 542-838; 544-849; 487-737; 536-1202; 556-852; 509-643; 565-833; 579-857; 595-1163; 595-878; 592-815; 592-854; 592-836; 595-832; 595-828; 601-917; 604-851; 625-1132; 629-877; 633-872; 668-931; 716-843; 672-1155; 691-918; 695-897; 706-866; 723-840; 716-989; 730-1285; 777-1057; 794-1066; 795-1035; 799-1054; 820-1094; 823- 1233; 823-1068; 823-1042; 825-1121; 846-1321; 874-1121; 878-1390; 884-1132; 812-1073; 914-1188; 931-1356; 963-1492; 966-1096; 970-1243; 986-1265; 992- 1273; 992-1272; 1007-1356; 1008-1536; 1008-1393; 1041-1351; 1041-1324; 1043-1601; 1057-1661; 1060-1493; 1058-1612; 1087-1363; 1141-1674; 1151- 1723; 1161-1703; 1168-1464; 1173-1426; 1178-1476; 1186-1466; 1218-1710; 1226-1537; 1228-1708; 1236-1708; 1237-1710; 1255-1707; 1257-1458; 1257- 1430; 1257-1492; 1257-1459; 1265-1524; 1266-1709; 1282-1924; 1291-1703; 1290-1645; 1293-1703; 1301-1703; 1307-1607; 1312-1838; 1317-1703; 1318- 1670; 1318-1563; 1329-1703; 1336-1703; 1338-1703; 1338-1599; 1341-1951; 1340-1608; 1341-1647; 1341-1629; 1351-1643; 1356-1644; 1359-1612; 1365- 1583; 1365-1790; 1378-1709; 1385-1703; 1397-1703; 1403-1785; 1402-1788; 1398-1925; 1403-1818; 1403-1587; 1406-1667; 1419-1690; 1423-1709; 1440- 1924; 1447-1701; 1463-1704; 1465-1694; 1469-1765; 1476-1721; 1480-1573; 1486-1963; 1500-1971; 1500-1966; 1507-1963; 1511-1963;' 1512-1958; 1519- 1965; 1518-1968; 1519-1963; 1523-1966;- 1527-1958; 1530-1703; 1543-1965; 1547-1958; 1548-1970; 1548-1938; 1548-19.65; 1558-1964; 1559-1831; 1562- 1789; 1581-1822; 1585-1958; 1588-1932; 1589-1958; 1589-1703; 1594-1709; 1600-1965; 1604-1893; 1611-1967,-' 1616-1964; ' 1619-1969; 1619-1962; 1619- 1963; 1619-1957; 1619-1865; 1620-1958; 1621-1971; 1625-1954; 1629-1968; 1630-1877; 1630-1861; 1631-1703; 1634-1963; 1637-1970; 1665-1954; 1666- 1963; 1672-1967; 1672-1965; 1677-1948; 1703-1923; 1736-1966; 1768-1971; 1859-1925; 1859-1963; 1862-1968; 1866-1946; 1873-1965; 1874-2020; 1878- 1956;- 1881-1972
120/LG:237503.21:2001MAR30 || 1-593; 181-570; 185-595; 187-465; 270-815; 298-707; 354-573; 404-697; 452-881; 476-956; 485-726; 487-658; 543-807; 587-852; 615-868; 750-1335; 794-1263; 821-913; 836-1062; 863-1439; 878- 1142; 884-1141; 1039-1493; 1045-1402; 1179-1459; 1209-1454; 1225-1516; 1345-1593; 1391-1657; 1430-1490; 1487-1735; 1495-1623; 1525-1697; 1533-
2046; 1754-2018; 1767-2009; 1774-1886; 1786-2035 1910-2484 1914-2318; 1912-2153; 1913-2156; 1919-2026; 1939-2316; 1964 2093; 1967 2315 1985- 2294; 2014-2301; 2146-2589; 2153-2423; 2282-2884 2332-2686 2332-2553; 2345-2607; 2353-2739; 2355-2582; 2357-2675; 2384 2969; 2433 2940 2502- 2845; 2502-2740; 2561-3012; 2561-2754; 2568-3045 2583-2973 2604-2884;
2630-2855; 2847-2978; 2913-3225; 2989-3540; 2989-3222; 3011 3461 3134-
3539; 3163-3553; 3253-3553; 3291-3516; 3314-3553; 3327-3550 3353-3631;
3408-3655; 3418-3631; 3501-3641; 3501-3631; 3506-3631; 3558-3631; 3575-3631
121/LG:238023.7:2001MAR30 | | 1-421; 170-584; 458-807; 626-1191; 754-1034;
755-978; 872-1216; 872-1144; 938-1232 1163-1696 1177-1588; 1200-1487; 1213-1476; 1340-1610; 1446-1864; 1449 1763; 1585 -1796; 1732-2051; 1734- 2252; 1734-1969; 1968-2247; 1968-2436 1968-2221 2097-2630; 2113-2428; 2117-2633; 2120-2626; 2141-2398; 2148-2636; 2166 -2366; 2248-2679; 2317- 2676; 2329-2666; 2401-2568; 2401-2680; 22440055--22668811; 2429-2673; 2549-2673 122/LG:238209.1:2001MAR30 | | 1-298; 1-367; 184-814; 184-784; 197-722; 301- 766; 382-971; 666-723; 702-1152; 702-1348; 735-1364; 760-1005; 759-1197; 794-1323; 817-891; 850-1464; 917-1169; 926-1571; 928-1221; 1001-1581; 1006- 1639; 1279-1843; 1279-1431; 1281-1524; 1283-1569; 1283-1956; 1292-1793; Table 3
1345-1858; 1350-1935; 1376-1635; 1377-1623; 1406-3891; 1539-1592; 1539- 1934; 1662 ■1947; 1674-1892 1681-1874 1709-1851; 1731-2360; 1749-1990; 1859-2120; 1866-2113; 1866-2279; 1875 2498; 1918-2165; 1918-2169; 1996- 2465; 2017 -2206; 2052-2591 2058-2229 2076-2199; 2076-2230; 2110-2525; 2119-2355; 2151-2361; 2158 2275; 2199-2279; 2199-2727; 2228-2832; 2260- 2539; 2301 -2500; 2313-2561 2325-2576 2353-2688; 2347-2967; 2357-2626; 2388-2844; 2421-2682; 2448-2930; 2448 3011; 2450-2699; 2468-2752; 2514- 2603; 2520 -2762; 2541-2809 2545-2819 2572-2849; '2595-2853; 2611-3039; 2646-2852; 2666-2920 ; 2666-3177 ; 2667-2963 ; 2667 -2964 ; 2677-3223 ; 2721- 2970; 2724 -3030 ; 2734-3265 2776-3060 2805-3070; 2807-3060; 2833-3122; 2843-3113; 2846-3079 ; 2846-3145 ; 2880-3132 ; 2903 -3436 ; 2909-3203 ; 2938- 3202; 2944 -3360 ; 2956-3244 2962-3225 2964-3120; 2970- 3469; 2982-3237; 2990-3409; 3004-3243; 3012-3530; 3012 3241; 3018-3273; 3018-3300; 3021- 3128; 3039 -3410; 3053-3251 3071-3245 3104-3241; 3122- 3546; 3160-3392; 3167-3471; 3187-3434; 3188 3750; 3191 3291; 3198-3302; 3203-3454; 3217- 3800; 3233 -3504; 3238-3506 3248-3489 3257-3523; 3260-■3495; 3282-3556; 3284-3845; 3287-3867; 3314-3904; 3354 3725; 3354-3558; 3361-3647; 3363- 3552; 3359 -3856; 3394-3651 3394-3648 3408-3676; 3408- 3640; 3408-3891; 3411-3655; 3414-3711; 3417 3860; 3416 3850; 3419-3.892; 3423-3853; 3426- 3846; 3440 -3827;" 3443-3890 3447-3561 3453-3655; 3457-■3890; 3463-3906; 3466-3891; 3474-3849; 3475-3849; 3475-3813; 3477-3697; 3477-3755; 3490- 3890; 3500 -3889; 3501-3903 3508-3892; 3517-3747; 3518-3850; 3542-3903; 3544-3904; 3545-3886 ; 3585-3801 ; 3605 3895; 3613-3884; 3613-3890; 3623- 3888; 3667 -3908 ; 3697 -3790 ; 3698-3905 3732-3825; 3785-3907; 3794-3880; 3801-3891; 3802-3853 ; 3825-3890 123/LG:238456 . 10 : 2001MAR30 | | 1-237 ; 2-211; 5-311; 8-394; 8-471; 8-274; 11-
182 12 -17 19-552 19-250; 28-373; 30-646; 39-283; 45-231; 50-295 51- 593 50-17 54-252 54-221; 57-316 57-294; 58-239; 59-221; 58-267 292 . 59 -29 59-308 60-164; 61-311 61-328; 61-300; 61-231 62-317 63- 311 67 -35 68-268 75-202 76-343 77-349; 76-231; 78-354 78-326 79- 320 78-30 78-285 79-251 79-345 79-225 79-561; 81-327 80-280 82- 762 82 -38 81-366 81-361 82-352 81-329 83-357; 83-318 82-184 84- 462 84-39 85-325 88-266 91-204 95-651 95-598; 100-327 : 99-336; 101- 367 108-3 55 110-358 108-317 108-197; 110-202; 110-361; 112-355 113- 354 113 -3 22 115-357 118-351 121-386; 124-344; 125-383; 128-540 126- 277 128-3 95 128-363 129-371 132-365; 135-613; 134-373 138-450 140- 328 141-3 61 140-385 150-420 169-425; 178-373; 180-449 186-423 210- 436 211-3 81 235-500 241-814 243-492; 244-315; 241-697 266-822 266- 427 274-4 10 285-702 287-597 285-780; 294-519; 294-496 309-441 325- 501 343 -6 74 345-634; 354-908; 367-900; 374-634; 391-978 391-638 391- 618 394-8 14 399-654; 401-655; 415-808; 414-799; 421-942 431-630 432- 720 443-8 17 455-817; 467-689; 478-751; 480-751; 481-742; 501-724 502- 580 509-1 082 : 526-792; 529-762; 528-656; 529-752; 538-678;: 560-687 : 567- 838 590-8 60; 590-773; 582-857; 582-850; 583-1003; 597-877;; 597-862 ; 589- 833 601-6 75; 593-1055; 608-906; 605-1140; 605-1154; 608-1158; 615-1176; 626-1285; 639-698; 645-907; 652-962; 662-1239; 675-1253; 669-907; 673-1051; 713-1072; 682-920; 694-1114; 694-1225; 694-1162; 689-937; 712-950; 713-883; 717-916; 730-1009; 722-1006; 728-1017; 728-966; 746-1022; 749-1284; 741- 1133; 741-984; 743-987; 749-1026; 768-1042; 770-1002; 773-1031; 778-1010; 796-1232; 796-1284; 809-981; 811-1042; 826-1018; 818-1031; 799-1285; 822- 1252; 824-1290; 827-1112; 826-1288; 828-1284; 813-1241; 830-1284; 821-1284; 830-1289; 827-1288; 816-1192; 831-1284; 834-1290; 834-1287; 837-1290; 838- 1289; 840-1290; 840-1292; 845-1294; 845-1289; 832-1290; 849-1293; 849-1297; 851-1284; 856-1066; 855-1290; 841-1294; 857-1287; 858-1214; 864-1148; 863- 1116; 850-1297; 865-1292; 869-1284; 867-1290; 873-1060; 855-1284; 857-1290; 874-1296; 877-951; 876-1284; 876-1286; 878-1289; 879-1284; 884-1284; 886- 1284; 890-1288; 876-1290; 879-1133; 894-1294; 896-1290; 897-1295; 896-1296; 899-1293; 905-1293; 908-1290; 910-1286; 895-1286; 908-1286; 914-1290; 920- 1127; 937-1253; 938-1290; 941-1283; 941-1286; 947-1290; 937-1297; 939-1284; 954-1289; 972-1283; 1001-1284; 1009-1266; 1009-1161; 995-1282; 1013-1283; Table 3
1026-1285; 1027-1286; 1035-1241; 1034-1294; 1039-1293; 1087-1289; 1090- 1284; 1090-1293; 1036-1141; 1038-1437; 1097-1290; 1099-1180; 1131-1246; 1134-1290; 1138-1284; 1141-1262; 1150-1284; 1155-1283; 1156-1290; 1177- 1287; 1188-1290; 1195-1286; 1233-1290
124/LG:239245.1:2001MAR30 || 1-363; 1-367; 68-119; 76-338; 88-388; 92-314; 116-519; 119-519; 123-370; 123-367; 134-415; 142-519; 143-519; 153-519; 182-460; 204-425; 231-419; 334-519; 340-519; 439-1039; 458-526; 463-519; 797-1402; 826-1056; 836-1014; 840-1062; 850-941; 850-951; 840-1355; 841- 1014; 853-1031; 853-1025; 849-1183; 850-1014; 850-1153; 850-935; 850-925; 850-995; 850-1154; 850-1239; 853-955; 853-1297; 853-1009; 881-1118; 871- 999; 908-1150; 907-1203; 907-1133; 939-1220; 935-1172; 940-1226; 942-1201; 961-1280; 961-1178; 957-1212; 1053-1314; 1058-1543; 1061-1396; 1067-1150; 1067-1266; 1068-1265; 1132-1374; 1148-1445; 1150-1454; 1159-1417; 1168-
1294; 1207- 1455; 1220 -1437 1220- 1815; 1216- 1662 1216-1437 1220- 1325 1225-1406; 1233-1437; 1274 1883; 1304-1823; 1299 1933; 1314 1437; 1329- 1752; 1332- 1437; 1332 -1565 1332- 1845; 1335- 1681 1336-1610 1337- 1708 1340-1437; 1336-1440; 1336 1940; 1339-1855; 1353 1588; 1352 1920; 1366- 1551; 1371- 1956; 1382 -1666 1385- 1611; 1435- 1676 1470-1924 1470-1933 1470-1862; 1471-1701; 1476 1808; 1476-1631; 1478 2010; 1478 1673; 1478 1750; 1478- 1860; 1490 •2056 1490- 1699; 1495- 1702 1495-2051 1503-•1678 1511-1656; 1528-1867; 1550 1795; 1559-1802; 1564 1857; 1568 1896; 1579 2093; 1575- 1841; 1579 ■1997 1581- 2010; 1581- 2117 1581-2102 1581-2074 1587-1849; 1587-1848; 1590 1967; 1610-1874; 1610 1894; 1626 1828; 1643- 2168; 1643- 2167; 1663 •2231 1666- 1984; 1669- 1846 1692-1939 1692- 2185 1699-1809; 1702-1961; 1704 1855; 1708-2337; 1706 1971; 1711 2282; 1713 1939; 1725- 1988; 1739 1955 1739- 1944; 1740- 1988 1753-2031 1763-1941 1769-2018; 1774-1955; 1779 2049; 1785-2027; 1811 2007; 1823-2094; 1828 2106; 1830- 2096; 1834 2118 1866- 2420; 1868- 2157 1870-2211 1875- 2053 1879-2433; 1880-2126; 1901 1996; 1901-2138; 1909 2167; 1915 2213; 1923- 2156; 1939- 2427; 1938 2100 1941- 2117; 1965- 2199 1977-2463 1985-2447
1992-2464; 1992-2203; 1995-2465; 1996-2462; 1998-2227; 1998 2367; 1998
2421; 2006-2464; 2010-2224 2035-2470; 2037-2462 2042-2462 2042-•2463
2045-2448; 2059-2463; 2061-2458; 2066-2263; 2066-2273; 2068 2460; 2070
2465; 2072-2464; 2075-2306 2076-2470; 2076-2468 2078-2467 2079-•2233
2088-2464; 2088-2469; 2092-2449; 2101-2478; 2100 2467; 2116 2421; 2136
2407; 2142-2444; 2154-2463 2155-2426; 2155-2427 2158-2467 2161-•2464
2162-2458; 2174-2464; 2173-2452; 2174-2465; 2176 2463; 2193 2451; 2215
2452; 2228-2470; 2236-2432 2236-2464; 2279-2463 2293-2528 2296-•2464
2302-2463; 2307-2428; 2331-2464; 2353-2464; 2391-2460; 2394-2458
125/LG: 239579.8 :2001MAR30 1-137; 1-166; 13-526; 129-718 : 230-509 239-
446; 245-506; 250-442; 252-556; 253-529; 254-817; 289-422; 325-583 357-
487; 375-474; 377-639; 382-650; 391-636; 395-621; 398-638; 399-668; 412- 733; 414-673; 417-648; 419-961; 430-715; 433-686; 445-647; 454-699; 457- 721; 472-715; 488-791; 499-731; 502-784; 512-921; 511-1079; 511-878; 512- 1004; 515-1129; 522-741; 522-747; 524-754; 527-784; 526-767; 532-748; 544- 1107; 548-1184; 559-820; 577-849; 580-799; 581-816; 595-859; 594-734; 600- 1242; 603-1114; 603-730; 612-1121; 623-1121; 627-1144; 631-877; 650-895; 662-911; 668-756; 670-922; 671-1121; 672-792; 672-917; 677-905; 683-1106; 700-1121; 702-1215; 701-971; 704-1121; 704-979; 705-1121; 708-1121; 712- 924; 720-1118; 743-1199; 730-1259; 730-950; 734-1121; 720-900; 736-1121; 737-946; 728-975; 743-932; 743-997; 743-979; 745-1005; 747-1039; 756-1252; 741-1013; 744-1070; 759-1242; 763-1256; 766-1121; 777-1207; 782-1256; 786-' 1043; 790-1258; 790-1252; 797-1252; 800-1252; 811-1255; 811-1252; 817-1006; 818-1252; 821-1255; 824-1252; 830-1250; 835-1248; 838-1254; 840-1248; 840- 1121; 844-1242; 845-1252; 849-1121; 849-1083; 859-1106; 861-1246; 866-1164; 884-1134; 887-1252; 894-1070; 909-1258; 915-1250; 917-1199; 920-1408; 929- 1208; 931-1252; 931-1216; 936-1255; 949-1252; 949-1244; 951-1242; 952-1121; 953-1252; 953-1242; 957-1247; 963-1256; 965-1222; 970-1256; 979-1246; 976- 1251; 978-1234; 999-1253; 1001-1207; 1007-1253; 1009-1252; 1018-1252; 1017- 1242; 1032-1163; 1049-1234; 1052-1252; 1058-1252; 1072-1252; 1077-1252; Table 3
1094-1250; 1127-1206; 1128-1252; 1132-1252; 1138-1249; 1151-1233; 1183-
1256; 1183-1242; 1183-1241; 1194-1246
126/LG:239601.22:2001MAR30 || 1-198; 10-331; 71-617; 178-601; 178-450; 182-
424 202 - 343 213-564; 214-464 328-593 339- 577 371-602 374-646 376- 632 386 - 672 396-640; 405-880 417-648 418- 906 421-683 426-701 426- 591 451- 706 427-664; 435-713 436-861 437- 695 452-680 449-921 451- 733 453 - ■ 642 453-910; 456-675 462-875 463-707 4 46633--770000;; 464-722 468- 916 468 - ■880 468-877; 472-896; 474-920 475-906 475-781; 475-733 475- 701 475 - 699 477-924; 479-944; 479-883 479-628 482-924; 483-766 491- 920 500 - 779 500-890; 502-918; 502-770 505-801; 508-784; 509-920 511- 918 517 - •916 523-1066; 530-916; 528-801 530-920; 533-921; 532-918; 534- 785 538 - ■921 537-922; 540-918; 548-772 545-918; 561-765; 561-652 561- 646 561 - ■906 563-920 569-918; 570-918 572 -919; 580-921; 582-914 586- 854 593 - •875 597-918 601-915; 603-914 611 -918; 611-915; 616-918 619- 918 633 - •910 635-915 635-1111; 636-915; 63 $-843; 642-916; 644-883 651- 913 666 - 908 669-921 671-918; 677-915 689 -881; 692-874; 694-918; 710- 918 710 - 911 714-918; 716-915; 718-892 728 -918; 752-891; 753-919; 756- 918 765 - 999 779-915; 781-914; 782-886 795 -922; 795-918; 803-918; 807- 822 - 918 331-923; 833-1419; 838-918; 843-1112; 895-1262; 911-1164
1087-1721; 1150-1387; 1269-1613; 1308-1712 1353-1514; 1513-1807; 1515
1700 1528-1631; 1556-1836 1599-1928; 1612-1881 1667-1931 1667-2032 1763 1900; 1994-2529; 2007 2696; 2244-2754 2252 2470; 2256 2771; 2254 2757 2255-2471; 2256-2758 2256-2770; 2256-2537 2256-2462 2263-2393
2277-2482; 2291-2581; 2294 2651; 2294-2676 2294 2674; 2294-2667; 2294
2475 2294-2503; 2313-2792 2314-2651; 2318-2791 2336-2791 2340-2791
2340-2651; 2354-2794; 2382 2687; 2387-2651 2408 2651; 2411 2793; 2413
2796; 2422-2796; 2423-2798 2425-2655; 2425-2606 2427-2636 2461-2796
2473-2651; 2480-2651; 2483-2802; 2520-2789 2532-2790; 2537-2794; 2564-
2796; 2685-2790
127/LG: 240121.1:2001MAR30 || 1-247; 1-67; 1-390; 1-225; 1-425; 2-425; 4- 67;
101-272; 110-360; 110-416; 202-685; 349-639; 349-702; 376-509; 420-597;
517-634; 583-1103; 583-685; 585-685 956-1555; 964-1159; 966-1237; 970-
1228 985-1223; 985-1097; 985.-1082; 987-1066; 988-1351; 1017-1305; 1137- 1580 1137-1383; 1241-1481; 1241-1782; 1251-1425 1258-1591; 1250-1750 1264 1531; 1307-1744; 1309-1556; 1311-1615; 1389-1467; 1389-1520; 1388- 1634 1389-1683; 1433-1690; 1445-1734; 1451-1735 1454-1740; 1492-1698
1534-1792; 1540-1763; 1566-1841; 1583-1870; 1583 1982; 1585-1685; 1650
1846 1659-1821; 1663-1870; 1681-1806; 1704-2082 1715-2140; 1719-2043
1757 -1996 ; 1757 -2291 ; 1766-1992 ; 1775-1957 ; 1777 1920; 1778-2017; 1779
2012 1780-1896; 1785-2148; 1788-2029; 1803-2359 1807-2087; 1814-2083
1829-2103; 1864-2426; 1879-2350; 1885-2150; 1886 2345; 1887-2358; 1888
2356 1896-2352; 1897-2355; 1899-2355; 1933-2157 1935-2358; 1937-2355 1937 2350; 1937-2150; 1938-2315; 1945-2354; 1957 2350; 1958-2357; 1958 2222 1961-2355; 1964-2192; 1967-2355; 1970-2349 1970-2355; 1971-2358 1977 2349; 1984-2355; 1985-2349; 1988-2336; 1991-2350; 1995-2350; 1994 2320 2006-2248; 2015-2472; 2017-2472; 2022-2355 2030-2350; 2031-2356 2049 2356; 2056-2232; 2061-2321; 2068-2470; 2071-2465; 2073-2354; 2076- 2351 2084-2356; 2087-2350; 2090-2357; 2111-2304 2120-2449; 2125-2361
2130-2351; 2135-2350; 2161-2287; 2231-2453; 2253-2453; 2218-2357; 2263- 2453; 2285-2593; 2295-2464; 2321-2695; 2315-2407
128/LG:241110.2:2001MAR30 || 1-256; 29-224; 29-201; 41-327; 56-424; 92-428; 98-180; 271-467; 300-862; 535-1041; 548-817; 548-818; 548-994; 581-810; 611-1185; 611-1171; 663-1265; 731-1290; 784-990; 962-1528; 989-1461; 1136- 1422 1136-1582; 1208-1674; 1247-1648 1334-1582 1334-1783; 1349-1736; 1351-1806; 1357-1802; 1380-1802; 1399 1803; 1408-1802; 1409-1802; 1419- 1764; 1434-1803; 1441-1801; 1449-1929 1447-1603 1465-1805; 1465-1695; 1466-1803; 1468-1731; 1466-1802; 1477-1803; 1496 1803; 1500-1802; 1509- 1768 1510-1803; 1546-1802; 1570-1753 1587-1798 1631-1803; 1664-1803; 1746 1801; 1814-2070; 1818-2063; 1885 2396; 1940 2039; 1945-2189; 1946- 2490 1992-2401; 2115-2706; 2138-2706 2215-2884 2397-2855; 2465-2915; Table 3
2516-2830 ; 2579- 3119; 2659- -3077; 2670- -3214; 2676- 3303; 2759- 3025; 2764
3304; 2777-3272; 2789-3032 2793-3288, 2901 3349; 3007- 3348; 3009- 3349
3172-3553 ; 3174- 3429; 3259- -3502; 3265- -3879; 3352-3496; 3395-3681; 3462
3686; 3475-3737; 3491-3879 3494-3735, 3581 4012; 3583- 4134; 3597- 3796
3629-4130 ; 3645- 3999; 3648- -3907; 3708- -4283; 3712-3799; 3742-4152; 3753
4149; 3768-4182; 3845-4179 3863-4147, 3924 4426; 3928- 4175; 3969- 4180
3991-4161 ; 4100- 4321; 4100- -4173; 4231- -4524; 4237-4755; 4322-4746; 4450
4707; 4471-4746; 4475-4728 4498-4746, 4549 5141; 4549- 4746; 5015- 5403
5019-5195 ; 5019- 5093; 5029- -5502; 5047- -5337; 5131-5389; 5162-5753; 5163
5482; 5168-5425; 5173-5351 5173-5470, 5177 5808; 5202- 5635; 5208- 5631
5360-5538 ; 5399- 5626; 5402- -5870; 5409- -5750; 5497-5761; 5568-5765; 5588
5840; 5629-6181; 5641-6156 5646-5878 5673 6156; 5697- 6149; 5712- 5875
5717-5893 ; 5730- 5956; 5730- -6241; 5766- -6291; 5800-6321; 5835-5940; 5840
6324; 5892-6366; 5920-6324 5942-6362 5958 ■6364; 5982- 6364; 5992- 6350
5993-6238 ; 5993- 6204; 6037- -6324; 6185- -6321; 6199-6348; 6200-6364; 6224
6364; 6312-6364
129/LG:244948.4: 2001MAR30 | 1-586; 1 1-- -223311;; 17 -442 ; 23 -451 ; 30-235 ; 30-492 ;
31-571; 40-425; 31-553; 58- -572; 80-6699_2 >;; 110099 -592 ; 134-574 ; 132 -720 ; 143 -809 ;
177-580; 192-424 ; 215-551; 219-489; 2 222 _44--4 47766 224-469 227-485 227-463
228-434; 229-528 ; 230-532; 229-578; 2213 .11-- 551122 239-749 255-464 250-601
256-643; 262-721 ; 268-453; 293-546; 33C0 )00-- 557744 299-418 304-538 304-432
306-851; 322-605 ; 328-427; 344-663; 33,5 544-- 664488 354-621 357-653 367-492
367-485; 367-525 ; 371-466; 372-703; 33'7 777-- 997788 383-672 383-615 384-483
384-696; 392-474 ; 403-653; 405-616; 44]1 L22-- 666688 431-786 450-724 452-579
454-700; 457-773 ; 461-787; 498-787; 44_9 .88-- 777788 513-978 520-741 544-868
558-834; 563-834 ; 564-810; 573-842; 55'7 722-- 889922 585-832 596-835 597-791
599-843; 599-918 ; 624-898; 628-915; 66:3 522-- •992244 637-1010 645-984; 650-998;
654-948; 654-893 ; 656-911; 652-886; 66<6 544-- 886600 669-847; 674-912; 689-879;
810-1010
130/LG:245378.6: 2001MAR30 I |I 1i--55997 7;; 11(0 )88--770088; 180-576; 3 29-864; 329 -557;
329-546; 333-743 ,- 347-916; 3 35511--991166;; 33.5 511--774422; 384-592; 386-701; 422 -704;
457-704; 472-701 ; 506-1041 ; 660033--11113399;; 661155--775 5; 664-1087 693-1111; 703-901
704-979; 725-858 ; 740-874; 7 77755--11229999;; !8 36622--11119 1; 904-1184 918-1339; 918-
1172 926-1149; 938-1180; 989-1190; 1049-117 0; 1056-1191; 1070-1178; 1100- 1426 1141-1367; 1213-1683 1228-1435; 1231- 1426 1234 1596 1234-1408;
1234-1402; 1235-1536; 1235 1339; 1236-1583; 1234 1366; 1236-1320; 1238-
1698 1270-1428; 1276-1809 1290 1426; 1296 1783 1340-1586 1366-1426'. 1353 1502; 1474-1687; 1550 1955; 1550-1775; 1550-1764; 1559 1771; 1566- 1823 1586-2036; 1604-1820 1616 1987; 1669- 1942 1671-1806 1705-1943 1717 1785; 1718-2193; 1720 1929; 1788-2067; 1798-2204; 1827 2161; 1833- 2398 1855-2107; 1855-2089 1873 2107; 1873- 2032 1877* 2368 1903-2168 1919 2008; 1966-2225; 1984 2545; 2002-2562; 2009 2531; 2013 2544; 2068 2495 2070-2380; 2071-2351 2094 2417; 2097 2576 2097* 2232 2104-2524
2109-2377; 2120-2589; 2121 2594; 2137-2361; 2142 2587; 2155 2576; 2161
2318 2165-2592; 2164-2589 2187 2576; 2196 2567 2206- 2588 2206-2587 2207 2576; 2206-2467; 2209 2587; 2216-2576; 2215 2495; 2242-2550; 2256- 2576 2258-2568; 2264-2735 2298-2585; 2345 2896 2354- -2541 2360 2886
2360-2576; 2383-2914; 2393-2587; 2473-3010; 2473 2576; 2487 2804; 2522
2997 2524-2774; 2560-2819 2600-3028; 2616 2895 2623--'2893 2672 3216 2714 3217; 2729-3175; 2718 3018; 2745-2993; 2740 2942; 2792 3106; 2797 3336 2806-2893; 2807-3184 2823 3413; 2828-3106 2888--3112 2918-3335
2931-3156; 2941-3204; 2948 3222; 2957-3475; 2958 3217; 2978 3240; 2979
3168 2991-3198; 3007-3243 3065 3189; 3087-3342 3093--3299 3112-3517 3112 3367; 3121-3391; 3121 3376; 3121-3373; 3127 3760; 3154 3730; 3158 3761 3175-3651; 3175-3444 3257 3505; 3272-3471 3304--3577 3305-3649 3305 3553; 3317-3558; 3320 3419; 3331-3426; 3334 3523; 3335-3701; 3345- 3606 3341-3968; 3358-3887 3361 3457; 3389-3915 3391- •3675 3400- 4012 3406 4006; 3408-4003; 3414-3849; 3432-3577; 3467 3745; 3479-3651; 3479 3612 3486-3727; 3501-4003 3516 4075; 3568-3916 3570- •3844 3571-3854
3593-3916; 3621-3900; 3622-3900; 3620-3878; 3630-4053; 3630-3808; 3634- Table 3
3898 3643-4187 3655-3919; 3666-4194 3672-3785 3684- 3788 3704- 3825 3716 3934; 3718 4121; 3720-3999; 3725 3996; 3731 3980; 3758 4008; 3746 3982 3746-4023 3766-3962; 3788-4184 3810-4087 3828- 4296 3828- 4027 3833 4084; 3842 4063; 3839-■4074; 3864 4011; 3860 4120; 3863-4059; 3864 4130 3883-4361 3872-4155; 3872-4087 3886-4128 3904- 4480 3905-■4092
3920-4135; 3921 4169; 3925-4463; 3922 4356; 3911 4163; 3924 4548; 3924
4186 3925-4554 3939-4188; 3941-4210 3946-4136 3955- 4466 3938-■4177
3958-4208 ; 3970-4534 ; 3963 4203; 3976-4223; 3989 4219; 3992-4230; 3997
4290 3996-4453 3990-4229; 4021-4267 4024-4232 4024- 4444 4040- 4288
4048-4414; 4053 4265; 4076-■4194; 4085 •4379; 4076 4374; 4089 4534; 4095
4331 4099-4343 4105-4360; 4105-4325 4106-4343 4109- 4352 4112- 4551
4113-4454 ; 4113 4395; 4113-■4370; 4121 ■4395; 4120 4216; 4142-4556; 4143
4534 4150-4710 4150-4396; 4151-4233 4171-4415 4178- 4341 4180- 4740 4191 4451; 4179 4439; 4179-4247; 4196 4411; 4200-4457; 4217-4452; 4222 4501 4235-4755 4234-4516; 4223-4384 4239 -4502 ; 4274- 4754 4280- 4558
4270-4423 ; 4285-4529 ; 4288-4541; 4306 ■4544 ; 4312-4487; 4332 4568; 4320
4561 4368-4545 4362-4743; 4368-4719 4376-4593 ; 4389- 4518 4401- 4561
4390-4659; 4408 4561; 4397-4641; 4408 ■4650 ; 4412-4661; 4414-4772; 4446
4833 4449-4550 4465-5033; 4467-4690 4475-4879 ; 4482- 4718 4475-■4757 4485 4778; 4486 4758; 4494-4782; 4530-4745; 4538-4817; 4544-4744; 4544 4759 4563-5071 4565-5009; 4563-4657; 4564-4886 ; 4567- 5071 4565- 4988 4565 4783; 4565 4748; 4567-4904; 4570-4785; 4571-4846; 4578-4822; 4580 4840 4593-5119 4602-4737; 4595-4937; 4595-4857 ; 4593- 4992 4598- 4847 4604 5075; 4612 4888; 4616-5172; 4618-4882; 4621-4874; 4632-4902; 4644 4860 4647-4917 4645-4914; 4652-5178; 4663-4863 ; 4671- 5178 4693- 4939
4675-5179; 4675-5052; 4678-4960; 4701-4939; 4680-5071; 4680-4904; 4687
5209 4689-4799 4693-5178; 4693-4923 4699-4936 ; 4702- 4990 4704- 5070 4704 5072; 4706 5071; 4707- ■5184 ; 4729-5071 ; 4710-5180; 4712 5179; 4715 5180 4716-4930 4716-5175; 4715-5184; 4723-4961 ; 4725- 5181 4728-■5071
4754-5026; 4734 5180; 4755-5017; 4738-5068; 4745-5178; 4745 5071; 4745
5034 4744-4974 4748-5017; 4753-5018; 4774-5159 ; 4757- 5179 4756-■5178 4761 5179; 4761 5178; 4766-5178; 4767-5181; 4769-5175; 4769-5157; 4774 5179 4774-5178 4772-5178; 4774-5182; 4776-5178 ; 4775- 5159 4777-■5175
4779-5016; 4781 5178; 4777-■5177; 4783-5183; 4783-5069; 4784 5175; 4785
5175 4787-5047 4789-5048; 4810-5182; 4792-5183 ; 4794- 5181 4796-5056 4796 5015; 4795-4977; 4796- 5178; 4815-5054; 4815-5021; 4836-5071; 4820 5180 4820-5073 4821-5178; 4824-5029; 4845-5172 ; 4833- 5178 4855-■5071
4857-5175; 4837 5180; 4841-5181; 4864-5184; 4852-5173; 4854-5178; 4869
5071 4866-5071 4872-5070; 4879-5071 ; 4879-4999 ; 4882- 5175 4886-■5173 4890 5389; 4919-5178; 4919- ■5147 ; 4922 -5166 ; 4927-5183; 4931-5178; 4935 5178 4944-5180 4946-5204; 4948-5178; 4951-5178 ; 4952- 5178 4952-■5151 4950 5071; 4953-5184; 4954-5179; 4959-5178; 4959-5184; 4960 5178; 4962 5166 4963-5061 4962-5069; 4962-5073; 4964-5184 ; 4979- 5181 4994-■5178 4999 5174; 5002 5157; 5015-5178; 5040-5175; 5083-5184; 5098 5166; 5098 5162 5098-5178 4654-4916; 4299-4549; 4897-5071 ; 4859- 5071 4846- 5071 4826 5071; 4820 5071; 4813-5071; 2157-2587; 4861-5071; 4853 5071; 4576 4836 4563-4809 4284-4523; 4946-5071; 4658-4860 ; 4979- 5074 4796-■4985 4777-4935; 4599 4756; 5080- 5166; 3865-3919 131/LG:248203.9 2001MAR30 I | 1-381; 23-620, 52-295 ; 60-161; 63-198; 63-126;
66-150; 66-159; 98-340; 113 -494; 120-350; 178-425; 203-452; 225-463; 233-
514 233-695; 248-613; 263- 484; 265-520; 277-458; : 326-560; 326-617; 326-
864 341-577; 348-539; 385- 635; 429-771; 434-1029; 441-714; 441-676; 462-
958 467-1068, 467-758; 480 -758; 487-746; 491-788; 507-1126, 510-730 ; 519-
727 524-692; 523-726; 534- 1126; 542-1107; 543-755 ; 546-1080; 546-806; 552-
112: L; 549-821, 553-755; 561 -843; 561-1128; 564-734 ; 568-799, 580-701 ; 580-
856 583-767; 587-895; 589- 1168; 589-1003; 590-875 623-877, 624-872 ; 645-
883 646-889; 652-1314; 661 -1065 ; 667-1121, 671-905; 671-92Σ !; 677-1314;
677- -1059; 677- -1130; 685 -112 2; 688-1314; 690-1125; 593-1128; 701-1032 ; 701-
112E 5; 701-1130; 702-963 ; 70 2-756 ,- 704-1129, 707-1125; 711-1131; 734- 1125;
737- -1124; 752- -1034; 754 -113 0; 761-1040; 770-987; 791-1047; 795-1011; 799- Table 3
1040; 799-1124; 805-1061; 805-1127; 807-1125; 814-1074; 835-1125; 840-1120; 841-1069; 841-1008; 852-1125; 854-954; 858-1121; 871-1128; 873-1157; 888- 1120; 896-1205; 898-1094; 905-1130; 905-1064; 907-1130; 923-1090; 923-1127; 924-1121; 926-1125; 928-1077; 931-1219; 940-1127; 942-1121; 966-1159; 977- 1219; 1003-1128; 1016-1123; 1022-1121; 1043-1133; 1052-1198; 1061-1168; 1104-1729; 1104-1721; 1104-1732; 1122-1340; 1163-1342; 1258-1342; 1432-1971 132/LG:249247.1:2001MAR30 | | 1-1913; 1-5.40; 1-578; 1.7-663; 177-768; 186- 1920; 405-977; 441-883; 437-785; 440-702; 524-1048; 562-1193; 568-777; 596- 834; 597-904; 598-875; 630-1125; 634-1107; 647-930; 647-807; 699-929; 718- 930; 737-1095; 747-1354; 785-1043; 787-1296; 788-1246; 808-1049; 814-1329; 820-1069; 831-1477; 832-1087; 838-1322; 861-1079; 895-1084; 914-1448; 914- 1207; 928-1191; 927-1133; 928-1207; 928-1187; 928-1223; 928-1253; 928-1249; 928-1215; 928-1241; 928-1192; 928-1122; 955-1076; 960-1224; 971-1467; 973- 1259; 1004-1265; 1004-1202; 1021-1171; 1025-1277; 1032-1528; 1034-1281; 1040-1246; 1050-1316; 1084-1708; 1089-1317; 1094-1405; 1100-1354; 1102- 1539; 1102-1369; 1102-1377; 1103-1376; 1103-1246; 1108-1336; 1114-1353; 1117-1602; 1125-1736; 1142-1357; 1142-1400; 1154-1696; 1173-1760; 1190- 1416; 1197-1581; 1197-1573; 1201-1778; 1228-1441; 1232-1806; 1232-1482; 1249-1612; 1271-1528; 1274-1814; 1275-1836; 1280-1521; 1287-1570; 1286- 1850; 1290-1550; 1296-1860; 1301-1836; 1310-1877; 1310-1739; 1310-1493; 1319-1606; 1333-1479; 1353-1881; 1353-1812; 1353-1660; 1358-1920; 1369- 1538; 1378-1879; 1389-1563; 1390-1654; 1391-1879; 1395-1623; 1441-1587; 1448-1706; 1449-1913; 1478-1920; 1452-1918; 1452-1885; 1452-1876; 1452- 1672; 1455-1921; 1458-1918; 1464-1920; 1474-1918; 1507-1859; 1477-1732; 1478-1791; 1479-1921; 1481-1921; 1481-1919; 1482-1925; 1485-1928; 1486- 1691; 1487-1852; 1492-1921; 1492-1874; 1492-1848; 1498-1863; 1501-1804; 1507-1863; 1514-1916; 1509-1725; 1512-1591; 1515-1780; 1517-1765; 1518- 2163; 1519-1917; 1526-1913; 1528-1886; 1529-1802; 1532-1792; 1536-1833; 1547-2107; 1546-1633; 1549-1810; 1550-1879; 1555-1919; 1559-1917; 1564- 1799; 1587-1916; 1590-1894; 1591-1924; 1604-1823; 1606-1842; 1608-1841; 1619-1918; 1623-2100; 1632-1923; 1638-1887; 1644-1826; 1646-1926; 1652- 2307; 1653-1771; 1654-1916; 1658-1920; 1665-1891; 1675-1918; 1684-1918; 1685-2293; 1711-1922; 1712-1905; 1724-1911; 1730-1809; 1739-1888; 1778- 1916; 1793-2302; 1794-1925; 1817-1918; 1851-2307; 1858-1923; 2012-2307; 2015-2304; 2022-2305; 2034-2305; 2090-2307
133/LG:267153.16:2001MAR30 | | 1-339; 1-265; 1-308 8-151; 8-226; 8-556; 61- 647; 309-751; 359-650; 375-621; 397-1014; 441-808 482-741; 521-786; 525- 823; 535-796; 541-781; 542-946; 595-890; 594-1074 636-899; 659-1171; 659- 1130; 661-926; 694-1186; 699-967; 724-975; 725-929; 737-989; 737-967; 743- 1240; 743-948; 748-1302; 765-1007; 774-1232; 780-1232; 784-1306; 790-1232; 804-1074; 806-1232; 808-1094; 829-1098; 830-1204; 831-1101; 844-1197; 848- 1235; 871-1432; 874-1146; 874-1157; 910-1571; 912-1406; 916-1232; 930-1250; 930-1087; 940-1234; 963-1263; 979-1536; 986-1222; 1004-1263; 1005-1232; 1035-1480; 1043-1514; 1066-1314; 1071-1600; 1077-1519; 1093-1572; 1100- 1576; 1108-1390; 1127-1372; 1134-1577; 1137-1571; 1141-1571; 1165-1572; 1164-1575; 1173-1463; 1177-1454; 1178-1508; 1179-1232; 1190-1614; 1195- 1571; 1195-1529; 1198-1571; 1196-1561; 1199-1357; 1200-1461; 1211-1575; 1214-1574; 1215-1571; 1221-1573; 1222-1614; 1251-1571; 1260-1574; 1275- 1598; 1275-1531; 1277-1598; 1279-1541; 1304-1579; 1304-1520; 1309-1575; 1309-1568; 1310-1568; 1333-1606; 1363-1601; 1374-1571; 1375-1576; 1410- 1571; 1439-1571; 1468-1689; 1476-1992; 1492-1571; 1524-1598; 1504-1995; 1776-2264; 1820-2230; 1820-2152; 1820-2269; 1868-2049; 1869-2135; 1869- 2220; 1875-2336; 1898-2257; 1912-2389; 1970-2443; 1987-2430; 1988-2430; 2058-2428; 2061-2408; 2131-2270; 2160-2413; 2172-2470; 2171-2828; 2182- 2413; 2183-2414; 2201-2413; 2225-2454; 2230-2428; 2261-2838; 2313-2834; 2347-2984; 2558-2940; 2564-2804; 2576-3169; 2579-2858; 2593-3112; 2602- 2821; 2605-2797; 2605-2663; 2605-2796; 2605-2997; 2605-2737; 2605-2732; 2605-2738; 2605-2829; 2605-2757; 2605-2779; 2621-2877; 2628-3301; 2677- 3185; 2719-3090; 2749-3049; 2762-3230; 2761-3014; 2761-3210; 2791-3028; 2791-3020; 2793-2985; 2821-3067; 2882-3109; 2889-3178; 2892-3135; 2895- Table 3
3142; 2901-3131; 2901-3419; 2911-3153; 2913-3185; 2915-3401; 2920-3080; 2932-3199; 2937-3188; 2954-3198; 2991-3359; 2993-3272; 2999-3249; 3014- 3246; 3065-3408; 3051-3286; 3069-3513; 3095-3513; 3097-3276; 3083-3349; 3104-3336; 3107-3341; 3092-3290; 3152-3305; 3154-3409; 3160-3394; 3154- 3391; 3155-3392; 3156-3407; 3157-3327; 3174-3407; 3159-3461; 3172-3342; 3178-3434; 3179-3588; 3179-3426; 3202-3514; 3190-3514; 3193-3453; 3195- 3522; 3195-3412; 3195-3397; 3199-3458; 3202-3373; 3228-3470; 3236-3465; 3221-3515; 3255-3402; 3244-3522; 3264-3510; 3251-3443; 3262-3522; 3276- 3544; 3276-3491; 3285-3547; 3301-3511; 3307-3544; 3322-3522; 3322-3499; 3339-3511; 3322-3511; 3322-3475; 3322-3513; 3333-3522; 3349-350'8; 3362- 3522; 3365-3513; 3367-3513; 3367-3511; 3373-3450; 3375-3522; 3377-3513; 3390-3513; 3389-3513; 3393-3513; 3393-3511; 3394-3513; 3399-3513; 3406- 3514; 3416-3513; 3419-3511; 3438-3563; 3440-3522; 3443-3522; 3444-3522; 3444-3514; 3446-3522; 3447-3522; 3448-3514; 3451-3513; 3454-3574; 3469- 3522; 3470-3522
134/LG: 291759.5 :2001MAR30 | | 1-560; 1-87; 300-584; 393-606; 393-539 405- 558; 457-1118; 458-671; 481-673; 495-673; 515-907; 532-673; 545-697 557- 673; 596-673; 662-1166; 662-900; 662-898; 679-761; 679-804; 682-962 682- 969; 701-962; 747-906; 747-921; 751-1219; 751-1214; 763-1046; 767-1213; 906-1172; 918-1190; 925-1177; 930-1209; 935-1169; 943-1213; 946-1213; 955- 1018; 955-1218; 956-1218; 957-1113; 960-1216; 963-1211; 963-1213; 963-1124; 963-1217; 963-1218; 963-1049; 963-1117; 963-1036; 964-1056; 964-1215; 964- 1220; 964-1057; 964-1042; 964-1217; 990-1218; 1025-1218; 1025-1219; 1027-
1213; 1028-1178 1028-1179; 1033-1216; 1043-1213; 1153-1218 135/LG:298102.1 :2001MAR30 | | 277-830; 1-389; 156-359 136/LG.-308891.1 :2001MAR30 j j 1-483; 1-658; 414-567 137/LG:312668.4 :2001MAR30 | | 1-248; 1-324; 12-388; 17-610; 42-320; 37-148; 59-454; 44-422; 45-284; 49-259; 48-309; 68-157; 76-293; 167-555; 179-301;
226-772 226-467 273-731 298-438; 356-657 361 800 497 816 506 -750; 506-742 506-736 506-728 506-749; 506-618 506 745 513 949 530 -869; 530-981 530-686 533-824 542-979; 609-947 622-949 622 880 639 -921; 646-979 646-834 658-940 677-913; 677-924 683-861 755 997 758 -979; 781-984 835-984 926-984 927-1161; 984-1331; 1051-1384; 1091-129 0; 1100
1545; 1100-1164; 1100-1346 1101-1433 ; 1105-1164; 1105-1433; 1225- 1344;
1225-1360; 1228- 1503; 1312-1510; 1318-1762; 1330- 1601; 1331-1602; 1335-
1816 1359-1638; 1359-1747; 1370-1643 ; 1371-1831; 1389-1834; 1399- 1876; 1430 1879; 1434-1878; 1437-1872; 1439-1874; 1444- 1879; 1446-1874; 1447- 1829 1448-1876; 1449-1876; 1458-1881 ; 1459-1712; 1476-1874; 1478- 1881; 1482 1876; 1485-1838; 1490-1876; 1497-1879; 1498- 1809; 1510-1876; 1514- 1877 1515-1879; 1517-1879; 1518-1876 ; 1526-1879; 1527-1833; 1528- 1876; 1531 1876; 1556-1875; 1581-1851; 1581-1842; 1597- 1845; 1598-1875; 1622- 1870 1645-1880; 1655-1874; 1680-1878 ; 1730-1876; 1737-1876; 1753 1875;
1791-1880; 1817-1876 138/LG:331642.6: 2001MAR30 | I 1-615; 1-301; 41-303; 108-298; 119-348; 275- 877; 484-718; 682-1268; 691-1260; 691-995; 697-1120; 700-947; 700-1175; 706-985; 731-1238; 886-1618 ; 949-1432; 976-1243; 1104-1630; 1103-1351; 1260-1810; 1313-1871; 1324-1875; 1386-1821; 1395-1831; 1425-1710; 1427- 1715; 1428 171*1; 1429-1702; 1429-1625; 1429-1707; 1428-1703; 1429-1708; 1432-1586; 1600-1891; 1616-1879 139/LG:331 51.12 :2001MAR30 || 1-494; 1-595; 1-639; 3-450; 8-287; 13-525; 18-290; 18 317; 20-240; 21 547; 27-246; 32-296; 38-234; 43-288; 44-245 45- 311; 50-650; 52-648; 55-619; 57-235; 66-626; 110-591; 255-782; 265-553 278-506; 278-538; 315-614; 331-579; 351-725; 388-645; 387-585; 428-928 451-871; 451-611; 548-886; 561-837; 586-849; 597-830; 597-1055; 662-960 688-938; 689-906; 698-969; 704-941; 743-1015; 754-1353; 801-1294; 857-1103; 857-1338; 864-1061; 879-3944; 922-1497; 932-1174; 942-1231; 944-1238; 948- 1220; 951-1208; 1001-1569; 1032-1239; 1041-1338; 1139-1390; 1149-1421; 1149-1364; 1354-1555; 1377-2031; 1425-1698; 1834-1987; 1849-2194; 1852- 2123; 1852-2120; 1855-2100; 1882-2077; 1882-2313; 1882-2081; 1952-2228; 2160-2520; 2177-2604; 2228-2779; 2240-2386; 2242-2342; 2258-2579; 2308- Table 3
2454 2354-2663 2341- 2658 2356-2805 2361-2599 2361-2765 2392- ■2650 2393 2794; 2495 2711; 2516 2611; 2556 2797; 2564 2829; 2664 3009; 2665- 3019 2696-3213 2707- 3226 2764-3020 2766-3315 2779-3035 2785-•3322
2788-3167; 2794 3040; 2843 3110; 2871 3158; 2927-3533; 2933 3505; 2952-
3465 2969- -3215 2971-3219 2971-3192 3008-3495 3010-3277 3005-■3591 3008 3204; 3025 3316; 3034 3525; 3115 3595; 3115 3667; 3131 3369; 3131 3316 3134- -3708 3195-■3743 3231-3738 3265-3532 3299-3836 3298-■3657 3298 3554; 3324 3590; 3337 3590; 3337 3573; 3365 3738; 3444 3904; 3427- 3699 3437- -3741 3435-■3915 3438-3915 3446-3919 3448-3919 3468-•3919 3467 3919; 3472 3935; 3484 3947; 3490 3919; 3493 3919; 3502 3919; 3502- 3834 3503 -3928 3507- 3913 3509-3913 3510-3945 3512-3945 3521- 3766 3531 3928; 3550 3846; 3557 4172; 3560 3928; 3564-3928; 3564-3919; 3593 3935 3609 -3919 3615-3919 3624-3945 3633-3934 3665-3919 3666-3954 3687 3919; 3687 3935; 3710 3919; 3748 3919; 3751 3919; 3771 3928; 3783 3919 3824 -4085 3949-4515 3948-4363 3948-4406 3949-4518 3957-4356 3957 4424; 3957-4419; 3957 -4411; 3968 4357; 3968 4276; 3968 4316; 3968 4415 3968-4245 3968-4441 3968-4427 3968-4233 3968-4420 3968-4359
3968-4358; 3968 4356; 3968 4046; 3968-4425; 3968 4137; 3968 4411; 3968-
4332 3968-4330 3968-4366 3968-4318 3968-4311 3968-4288 3968-4449 3968 4434; 3968 4260; 3968 4253; 3968 4387; 3968-4428; 3968-4417; 3968- 4421 3968-4398 3977-4210 3977-4439 3977-4433 3977-4351 3986-4356
3988-4258; 4004 4222; 4016 -4450; 4019 4515; 4036 4125; 4043 4226; 4053-
4451 4053-4277 4054-4166 4093-4513 4093-4287 4107-4492 4129-4271 4142 4384; 4144-4525; 4239 4472; 4244 4515; 4250 4521; 4258 4495; 4274 4553 4275- ■4521 4287-4521 4303-4508 4336-4886 4335-4461 4337-4514 4375 4525; 4428 4519; 4455 4515; 4694 5273; 4706-5246; 4739-4837; 4750 4837 4764- 4837 4773-4837 4776-4837 4778-4850 4778-4837 4778-4849 5166 5493; 5180 5425; 5175 5458; 5182 5280; 5182 5258; 5184-5266; 5213 5487 5314-5906 5355-5902 5375-5540 5385-5668 5420-5644 5420-5669 5571 5895; 5572 5768; 5649 5944; 5649 -6174; 5710-5922; 5712 5991; 5757 6330 5758-•6315 5758-6054 5760-6189 5761-6009; 5761-6154 5765-6156 5766 6135; 5781-6130; 5793 6072; 5794 5925; 5816-6120; 5816 6101; 5842- 5994 5867-•6116 5869-6126 5918-6137 5948-6202; 5948-6219 5949-6180 5950 6206; 5948 6475; 6050 6295; 6056-6593; 6062- 6271;' 6062-633O; 6106 6655 6116-6196 6143-6290 6144-6597 6286-6501; 6327-6626; 6346-6619
6398-6510; 6415-6615; 6473 -6581; 6516-6629
140/LG: 332414.5 :2001MAR30 I I 1116-156 6; 1097-1566; 1166-1564; 1244-1562; 1226-1561; 1173-1561; 1128 -1561; 1347-1561; 1179-1559; 1464-1557; 1257- 1558; 1154-1556; 1171-1555 1169-1555 ; 1112-1553; 1087-1531; 935-1513; 1210-1512; 1183-1459; 1351 1448; 1216-1432; 1210-1402; 806-1370; 645-1210; 862-1146; 833-1072; 645-77 2; 109-751; 95-670; 69-653; 87-628; 1-501; 70- 499; 110-450; 110-358; 82- 331; 123-329; 69-292; 1-271 141/LG: 332730.12 :2001MAR30 I I 1-1871; 1-246; 101-213; 101-442; 120-464; 156-301; 194-476; 267-605; 316-558; 317-531; 457-691; 467-720; 478-602; 479-736; 549-1012; 608-104 3; 621-893; 624-842; 636-1175; 665-862; 670-906; 710-868; 764-1034; 773-983 ; 926-1129; 929-1373; 930-1372; 936-1361; 945- 1141; 948-1150; 958-1052; 989-1288; 1080-1332; 1086-1618; 1087-1335; 1091- 1267; 1109-1370; 1268-1831 ; 1343-1693 1410-1872 1421-1872; 1439-1864 1442-2042; 1445-1630; 1464 -1864; 1486 1757; 1486 1728; 1486-1871; 1523 1864; 1572-2140; 1576-1778 ; 1585-2005 1755-1870 1789-2048; 1799-2046 1840-2115; 1841-2094; 1891 -2135; 1956 -2216; 1976 2220; 2116-2548; 2166 2652; 2241-2395; 2241-2433 ; 2241-2461 2241-2438 2264-2513; 2283-2482 2313-2484; 2335-2617; 2376 -2559; 2378 2633; 2402 2767; 2418-2762; 2419 2682; 2419-2831; 2459-2703 ; 2479-2759 ; 2479-2755 2486-2822; 2491-2720 2523-3034; 2554-2831; 2554 -2771; 2557 -2856; 2567 2833; 2592-2828; 2599 2973; 2634-2866; 2639-2973 ; 2647-2930 ; 2662-2795 2668-2926; 2670-2928 2713-2917; 2713-3253; 2758 -3032; 2761 3069; 2770 3046; 2803-3368; 2812 3049; 2819-3079; 2837-3213 ; 2855-3308 2865-3321 2879-3127; 2880-3133 2882-3118; 2885-2946; 2920 -3082; 2949 3197; 2953 3211; 2976-3263; 2984 3174; 3000-3203; 3051-3277 ; 3055-3275 3054-3287 3081-3340; 3095-3348 Table 3
3096-3343; 3105-3384; 3120-3374; 3155-3391; 3165-3415; 3167-3433; 3178- 3631; 3187-3447; 3191-3486; 3196-3605; 3213-3353; 3239-3516; 3244-3540; 3256-3525; 3267-3492; 3272-3560; 3292-3898; 3292-3521; 3295-3490; 3296- 3613; 3298-3412; 3300-3769; 3320-3673; 3345-3585; 3345-3862; 3347-3573; 3354-3807; 3388-3653; 3388-3873; 3395-3619; 3401-3681; 3400-3807; 3406- 3687; 3433-3899; 3442-3892; 3444-3901; 3444-3899; 3446-3899; 3445-3899; 3447-3904; 3455-3892; 3455-3906; 3456-3875; 3459-3899; 3471-3862; 3478- 3899; 3480-3899; 3481-3810; 3488-3892; 3494-3899; 3496-3727; 3496-3717; 3500-3899; 3501-3899; 3501-3780; 3504-3643; 3505-3892; 3508-3693; 3512- 3755; 3513-3899; 3524-3899; 3531-3899; 3536-3900; 3538-3900; 3537-3817; 3541-3807; 3542-3892; 3543-3899; 3543-3900; 3542-3904; 3547-3899; 3548- 3737; 3549-3899; 3552-3891; 3573-3899; 3574-3889; 3571-3857; 3576-3901; 3582-3870; 3591-3863; 3595-3899; 3599-3892; 3603-3870; 3632-3901; 3633- 3899; 3634-3861; 3634-3899; 3637-3899; 3665-3862; 3668-3892; 3672-3872; 3676-3892; 3681-3816
142/LG:333062.22:2001MAR30 | | 1-359; 1-472; 1-258 ; 11-85; 10-382; 11-110; 11-397; 24-136; 28-84; 29-79; 29-112; 29-142; 29- 108; 29-104; 29-92; 29-98;
29-89; 29-85 29-127; 30-84; 30-91; 31-84; 188-388; 189-297; 196-646; 199- 298; 199-303 199-281; 199-476; 214-330; 235-497; 258-668; 259-689; 263- 511; 283-462 283-526; 342-604; 402-687; 410-605; 461-517; 603-688 143/LG:335705.2:2001MAR30 | | 1-232; 1-216; 4-517; 7-577; 12-577; 27-346; 31-344; 31-439; 30-413; 31-233; 40-5346; 41-326; .43-477; 47-334; 69-333; 70-199; 69-140; 131-522; 146-733; 277-884; 310-523; 342-838; 358-671; 401- 866; 412-656; 458-961; 458-778; 535-756; 573-867 893-1143; 1160-1659; 1336-1888; 1364-1630; 1443-2106; 1482-1809; 1614 1705; 1619-1744; 1622-
1849; 1626-2176; 1681-1903; 1726-2055 1726-1976 1752-2308 1776-2297;
1949-2214; 1956-2251; 1968-2602; 1974-2602; 1999 2101; 2000 2426; 2052-
2602; 2074-2602; 2101-2631; 2111-2526 2114-2370 2134-2701 2160-2762; 2202-2492; 2211-2665; 2230-2750; 2246 2776; 2324 2821; 2332-2681; 2346- 2587; 2347-2581; 2372-2602; 2389-2941 2392-2644 2407-2671 2415-2854;
2419-2831; 2423-2827; 2420-2847; 2425-2817; 2454 2727; 2477 2732; 2467-
2717 2506-2827; 2525-2814; 2561-2802 2589-3070 2589-2803 2609-3210; 2609 3192; 2609-3214; 2609-3190; 2620 3037; 2612 2727; 2706 2818; 2722- 3158 2742-3003; 2750-3042; 2761-2936 2762-3022 2765-3015 2765-3002; 2767 3324; 2785-3376; 2818-3105; 2854 3063; 2866- 3094; 2927 3184; 2919- 3219 2925-3168; 2926-3204; 2935-3058 3003-3662 3009-3403 3055-3163;
3061-3250; 3068-3654; 3123-3375; 3184-3382; 3193 3531; 3196 3449; 3200-
3415; 3207-3481; 3207-3473; 3217-3458 3220-3467 3220-3466 3222-3544;
3257-3794; 3274-3569; 3285-3675; 3290-3511; 3334 3809; 3322-3540; 3322-
3522; 3367-3525; 3375-3648; 3388-3725 3388-3636 3418-3841 3423-3967; 3429-3676; 3441-3684; 3454-3840; 3467 3787; 3468 3718; 3490-3709; 3495 3712; 3513-3727; 3527-3776; 3539-3803 3540-3796 3555-3930 3543-3844; 3552-3816; 3570-3736; 3570-3732; 3588 3782; 3578 3981; 3578 3875; 3608- 3899; 3617-3808; 3620-4162; 3622-3898 3664-3885 3671-3927 3676-4082; 3707-3927; 3745-3996; 3758-3990; 3759 4098; 3769 4078; 3779-4028; 3804- 4384; 3820-4425; 3811-4087; 3819-4011 3834-4093 3850-4133 3886-4108; 3914-4424; 3901-4112; 3919-4277; 3920 4385; 3907 4144; 3911-4089; 3928- 4233; 3937-4235; 3940-4199; 3942-4222 3975-4248 4007-4391 4051-4391; 4039-4296; 4056-4391; 4058-4391; 4060 4332; 4064 4391; 4070 4391; 4074- 4389; 4063-4391; 4085-4392; 4076-4353 4104-4356 4105-4391 4106-4391; 4109-4391; 4109-4334; 4111-4391; 4118 4336; 4119 4391; 4120-4391; 4111- 4380; 4114-4391; 4133-4391; 4122-4391 4145-4428 4135-4391 4147-4389; 4150-4413; 4154-4391; 4157-4391; 4161 4391; 4166 4389; 4171 4391; 4178- 4391; 4179-4389; 4182-4388; 4184-4391 4180-4389 4197-4378 4202-4391; 4209-4389; 4209-4391; 4203-4391; 4216 4389; 4217- 4391; 4223-4391; 4233- 4391; 4234-4391; 4246-4391; 4268-4382 4259-4547 4276-4391 4267-4545; 4281-4399; 4283-4391; 4303-4391; 4312 4594; 4334- 4391; 4326-4652; 4335- 4580; 4461-5001; 4486-4728; 4486-4678 4486-4668 4486-4628 4486-4598; 4487-4763; 4488-4780; 4491-4744; 4498 4634; 4502 4760; 4504 4779; 4508- 5067; 4515-4725; 4518-4786; 4530-4804 4530-4720 4530-4706 4544-5132; Table 3
4544-4797; 4547-4792; 4548-4655; 4548-4929; 4552-4739; 4556-5039; 4571- 5199; 4573-4744; 4575-4878; 4593-4765; 4593-4842; 4597-4701; 4599-4851; 4611-4879; 4636-4974; 4653-4937; 4665-5284; 4674-4934; 4692-5218; 4702- 4979; 4704-5259;' 4720-4953; 4721-4977; 4724-4995; 4732-4992; 4752-5259; 4753-5202; 4756-4978; 4767-5335; 4767-5287; 4784-5224; 4787-4960; 4796- 5026; 4797-5020; 4800-4981; 4801-5057; 4840-5197; 4840-5045; 4847-5315; 4856-5150; 4869-5068; 4872-5112; 4887-5353; 4892-5340; 4903-5251; 4903- 5141; 4903-5371; 4910-5183; 4911-5356; 4914-5357; 4915-5346; 4919-5351; 4926-5353; 4927-5360; 4929-5177; 4931-5347; 4935-5185; 4939-5179; 4946- 5353; 4946-5355; 4950-5344; 4958-5353; 4960-5353; 4961-5217; 4979-5359; 4979-5354; 4979-5348; 4981-5353; 4985-5353; 4993-5258; 5003-5353; 5006- 5342; 5026-5342; 5032-5346; 5034-5337; 5035-5348; 5039-5346; 5040-5340; 5057-5340; 5079-5341; 5084-5244; 5102-5337; 5125-5353; 5145-5295; 5155- 5340; 5157-5290; 5174-5340; 5174-5336; 5182-5353; 5189-5353; 5210-5371; 5211-5346; 5214-5310; 5219-5353; 5240-5338; 5267-5353; 5271-5340; 5284-5353 144/LG:337930.16:2001MAR30 | | 1-580; 12-580; 19-458; 28-526; 30-438; 33- 270; 41-183; 56-296; 82-686; 124-257; 210-627; 210-459; 271-661; 304-753; 332-626; 506-701; 516-817; 518-769; 558-1126; 565-865; 657-1182; 649-811; 672-1198; 722-1022; 725-1050; 752-1068; 757-1265; 806-1066; 865-1075; 929- 1430; 924-1502; 935-1401; 935-1323; 935-1194; 984-1636; 983-1280; 1038- 1306; 1076-1367; 1081-1211; 1109-1614; 1107-1382; 1108-1382; 1110-1592; 1159-1747; 1185-1346; 1211-1467; 1259-1827; 1260-1827; 1265-1365; 1285- 1520; 1285-1596; 1309-1567; 1386-1650; 1405-1937; 1452-1908;, 1493-1912; 1557-1750; 1666-1813
,145/LG:346481.15:2001MAR30 | | 1-484; 49-416
146/LG:349164.1:2001MAR30 | j 1-446; 1-291; 162-769; 352-945; 433-712; 588- 1066; 624-856; 645-1147; 837-1423; 849-1217; 955-1237; 955-1200; 966-1177;
1015-1400; 1085-159.0; 1088-1415; 1098-1309; 1143-1392; 1154-139! 1186-
1715; 1214-1414 1217-1552 1265-1669 1264-1487 1269-1459; 1310-1641;
1310-1607; 1310-1494; 1371 1927; 1371-1536; 1376 1656; 1384-1597 1433-
1998; 1442-1665 1509-2028 1529-1817 1529-1720 1535-1719; 1542-1771; 1545-2173; 1579 2162; 1600-2099; 1600-1861; 1607-2070; 1609-2028 1624- 1888; 1623-1882 1651-1943 1651-2166 1676-1846 1680-1985; 1705-1895;
1707-2017; 1707-2189; 1730-1993; 1737 2071; 1737-1955; 1737-1954 1741-
2335; 1746-1938 1745-1842 1748-2032 1805-1992 1865-2006; 1868-2146;
1900-2057; 1982 2264; 2014-2082; 2057 2404;' 2057 2333; 2085-2401 2108-
2500; 2108-2366 2116-2813 2149-2453 2170-2695 2179-2413; 2181-2389;
2188-2250; 2213 2523; 2210 2404; 2228-2823; 2228 2795; 2249-2854 2250-
2448; 2256-2460 2256-2880 2270-2541 2270-2454 2359-2869; 2405-2652;
2420-2728; 2426 2663; 2426-2569; 2427 2602; 2437 2867; 2464-2904 2469-
2915; 2470-2869 2473-2906 2476-2902 2485-2906 2487-2905; 2525-2789;
2539-2793; 2539 2769; 2550-2794; 2565-2921; 2605 2906; 2625-2928; 2674-
2913; 2674-2906 2681-2869 2713-2906; 2799-2903; 2832-2906
147/LG:350957.5 2001MAR30 I 1-314; 1-158; 10-322; 1-263; 118-314; 134-652;
134-372; 153-416; 482-848; 491-865; 493-752; 621-833; 683-1139; 752-886;
895-1136; 981-1199
1 14488//L1 ,G0:: 3388335. 51122..88 :2 2000011Mt«ARR3300 | 1- 333 344;; 33-- -220066;; 2 266--115544; ; 56- 593 ; 116 666-- -44333: 3; 117733
4 44455; 1 19922--665. 511;; 220C J0O--338800 220066-- -442222;; 2 21122--444^ 144;; 22116( 5--550044;; 217- 439 ; 222 222-- -66223: 3; 222222
5 54466; 2 22222--440 322;; 2222 322--443333 ; 222222-- -442288;; 2 22222--442_ 377;; 22222; 2--441111;; 222- 369 22 222-- -33558 3; 222222
3 34422; 2 23322--779. 355;; 2231 S22--442233 227799-- -335544;; 3 31100--993: 344;; 33550( 3--995500;; 389- 667 ; 4 L L1166-- -66771. L; 441188
8 81100; 4 45588--777' 755;; 5513 .99--668811 • 552277-- -778800;; 547-693; 844-1373 ; 1175-145Ξ ; 1180-1611
1 11188_9 5-- -11551122;; 1 1118899-- -11440088;; 1 1330055-- -11555533; 1340- -1877; 1351- 1565; 1360- -1627; 1371-
1901, 1378 -1636, 1400- -1841, 1471 -1903 1477- -1962; 1487 -1765; 1488 -1744;
1503- -1751; 1508- -2078; 1539- -1800; 1539- -1755; 1546- -1875; 1558- -1731; 1572-
1801, 1577 -1810, 1576- -1815, 1584 -2184 1603- -1897; 1605 -1747; 1606 -1924;
1607- -1833; 1625- -1892; 1634- -1876; 1635- -1841; 1636- -1891; 1641- -1899; 1656-
1863, 1667- -2104, 1670- -1973, 1671 -1952 1675- -1956; 1686 -1839; 1688 -1976;
1688- -1961; 1689- -1952; 1692- -1946; 1706- -2232; 1706- -1901; 1722- -2246; 1723-
1995, 1731- -1929, 1733- -1942, 1744 -1985 1746- -1992; 1752 -2036; 1758 -2016;
1763- -2000; 1763- -1879; 1767- -2209; 1767- -1996; 1768- -2032; 17 33- -2022; 1783- Table 3
1880 1787-1935; 1804-2071; 1811-2070; 1814-2080; 1827-2153 1822-2054 1872 2049; 1879-2078; 1904-2177; 1909-2134; 1918-2231; 1938 2438; 1961 2471 1970-2359; 1971-2407; 1971-2213; 1972-2414; 1980-2402 1982-2233 1986 2278; 1988-2234; 2022-2432; 2027-2533; 2039-2464; 2039 2324; 2074- 2441 2074-2286; 2082-2543; 2086-2371; 2087-2525; 2090-2562 2090-2308 2098 2326; 2108-2559; 2114-2578; 2116-2574; 2119-2534; 2118 2568; 2118 2564 2127-2570; 2131-2527; 2134-2570; 2135-2523; 2134-2364 2137-2410
2140-2571; 2138 -2518 ; 2142 -2262; 2145- 2570; 2153 -2353; 2156- 2540; 2157
2577 2159 2573 2159-2568 ; 2162 2567; 2162-2569 ; 2176- 2568; 2164-2570
2167-2569; 2170 2569 ; 2171-2569; 2171-2567; 2172-2448; 2179-2408; 2191
2576 2192 2568 2198-2567 ; 2200-2527; 2231-2503 ; 2232- 2499; 2232-2481
2234-2573; 2236 -2570 ; 2237-2556; 2237-2569; 2239-2530; 2256-2567; 2260
2500 2266 2569 2285-2513 ; 2292-2537; 2295-2569 2296-•2569; 2299-2570 2300 2569; 2301 2570 ; 2301 2527; 2304-2574; 2302 2591; 2315-2570; 2317 2572 2322 2570 2331-2570 ; 2335-2568; 2336-2567 2340- 2570; 2340-2842
2359-2565; 2362 2571 ; 2403-2570; 2418-2570; 2419 2570; 2432-2571; 2483-
2569 2519 2569 2578-2839 ; 2583-3015; 2657-3157
149/LG:401 163.1 0:2001 AR30 11 i-276; 72-699 ; 86- 699; 184-869; 205-708; 208- 708; 215-6 64; 2 16-681; 217 -708; 221-690; 226-708 ; 239-708; 251-604; 272- 708; 284-6 26; 3 24-680; 356-708; 456-707; 710-1262; 966-1353; 1016-1299; 1040-1299; 1059 -1597 ; 1121 1390; 1125-1500; 1164 1424; 1170-1427; 1170-
1406; 1185-1706; 1225-1569; 1213-1759; 1243-1891 1279-1503; 1287-1542
1319-1995; 1321-1793; 1486-1837; 1536-1608; 1569 1821; 1539-2149; 1528
2128; 1593-1834; 1607-1869; 1607-1856; 1700-2329 1768-1946; 1833-2338
1863-2216; 1863-2172; 2024-2429; 2032-2248; 2183 2643; 2461-3012; 2461
2908; 2512-2737; 2538-2729; 2542-3183; 2588-2784 2618-2886; 2647-3244
2676-2966; 2692-2971; 2705-3343; 2766-3351; 2774 3071; 2831-3065; 2838
3123; 2861-3120; 2928-3394; 3036-3288; 3039-3412 3060-3302; 3156-3394
3158-3429; 3185-3403; 3192-3282; 3200-3419; 3200 3321; .3213-3489; 3213
3459; 3227-3438; 3237-3494; 3286-3487; 3334-3569 3340-3634; 3343-3884
3364-3908; 3379-3910; 3386-3832; 3388-3644; 3390 3906; 3390-3546; 3409
3879; 3412-3879; 3426-3909; 3429-3879; 3449-3907 3449-3879; 3454-3909
3463-3912; 3472-3548; 3479-3723; 3479-3675; 3501 3748; 3513-3878; 3520-
3869; 35-32-3941; 3549-3873; 3551-3908; 3564-3880 3593-3906; 3597-3906
3634-3769; 3643-3876; 3644-3908; 3681-3869; 3702 3977; 3750-4229; 3750
3988; 3757-3905; 3759-4219; 3762-4071; 3809-3908 3809-3869; 3817-4091
3844-4105; 3881-4162; 3935-4219; 4013-4219; 4017 4219; 4019-4477; 4045-
4219; 4046-4219; 4056-4219 4095-4219; 4127-4219 4146-4219
150/LG: 402133.1:2001 AR30 1-204; 1-134; 8-134 8-466; 89-619; 120-578;
338-902; 382-847; 382-624; 451-688; 484-1114; 728-983; 790-1055; 790-1283;
790-1007; 792-1275; 867-1374; 943-1049; 997-1528 1059-1588; 1096-1633;
1131-1611; 1179-1583; 1208-1553; 1299-1630; 1364 1557; 1388-1611
151/LG:405820.1:2001 AR30 | | 1-428; 1-220; 1-223; 11-67; 11-323; 16-402;
35-234; 121-369; 121-660; 159-759; 196-745 : 201-798; 367-799; 483-605; 578-
909; 580-799; 681-764; 681-792; 711-802
152/LG:405846.1:2001MAR30 | | 1-540; 1-256; 21-605; 38-285; 72-309; 72-493;
77-314; 87-656; 143-513; 156-715; 319-420; 616-1068; 618-889; 863-1042
153/LG:407401.2:2001MAR30 | | 1-652; 162-588; 220-695; 239-795; 406-1012;
642-911; 645-1185; 730-1147; 792-1393; 825-1228; 827-1075; 1081-1202; 1089-
1312; 1111-1369; 1110-1251; 1195-1756; 1202-1504; 1222-1495; 1251-1464;
1261-1684; 1261-1523; 1275-1529; 1313-1724; 1329-1741; 1341-1735; 1361-
1735; 1382-1730; 1388-1723; 1396-1666; 1480-1722; 1482-1651; 1506-1751;
1554-1730; 1639-1891; 1756-2162; 1771-2198; 1818-2059; 1818-2070; 1818-
2067; 1846-1915; 1941-2135; 1942-2217; 1942-2181; 1945-2361; 1946-2100;
1947-2192; 1948-2487; 1949-2236; 1950-2126; 1951-2218; 1951-2210; 1953-
2209; 1954-2201; 1953-2260; 1954-2232; 1957-2454; 1957-2376; 1949-2422;
1964-2200; 1964-2224; 1970-2230; 1980-2531; 1980-2214; 1982-2469; 1987-
2145; 1986-2242; 1989-2200; 2000-2228; 2011-2557; 2011-2525; 2011-2276;
2014-2262; 2013-2240; 2024-2283; 2026-2301; 2032-2308; 2032-2207; 2045-
2279; 2046-2598; 2053-2339; 2057-2330; 2074-2227; 2078-2339; 2079-2349; Table 3
2078-2164; 2091-2324; 2116-2320; 2158-2558; 2159- 2558; 2158 2438; 2163 2638; 2171-2638; 2179-2638; 2188-2636; 2188* •2635; 2189 -2642 2196- •2635 2197-2642; 2197-2604; 2205-2635; 2216-2638; 2217- 2442; 2222 2597; 2224 2662; 2228-2636; 2228-2454; 2230-2632; 2241* 2479; 2242 -2490 2253- 2642 2254-2599; 2258-2635; 2260-2636; 2272-2642; 2269- 2648; 2281 2634; 2281 2641; 2284-2635; 2287-2596; 2289-2539; 2293* •2643; 2294 -2634 2321- 2638 2338-2641; 2340-2635; 2348-2449; 2355-2608; 2355- 2607; 2358 2636; 2370 2632; 2375-2632; 2384-2634; 2384-2626; 2385- 2632; 2385 -2665 2386- 2635 2386-2632; 2389-2635; 2389-2623; 2389-2592; 2389- 2577; 2389 2567; 2393 2623; 2399-2600; 2404-2635; 2404-2615; 2404- •2598; 2412 -2592 2416- 2638 2423-2638; 2423-2632; 2423-2602; 2424-2643; 2442- 2635; 2447 2635; 2481 2634 2525-2635; 2528-2640; 2537-2642 2647; 2551 -2635 2580- 2635 2581-2636
154/LG:408448.10:2001 AR30 | | 1-446; 14-495 ; 72-707; 168-273; 184-442; 212- 757; 216-712; 410-887; 542-749; 549-870; 725-1165; 728-974; 930-1360; 952- 1368; 952-1363; 1096-1610; 1197-1449; 1386- 1677; 1440-1657; 1449-1544; 1463-1814; 1594-1918; 1606-1989; 1606-1862; 1639-1913; 1656-2148; 1676- 1913; 1681-1821; 1797-2058
155/LG:408854.13:2001MAR30 | | 1-261; 1-153; 98-461; 142-545; 353-895; 380- 492; 523-1125; 634-969; 748-1172; 766-1076; 766-1051; 782-1365; 983-1634; 997-1366; 1171-1604; 1364-1585; 1516-1610 156/LG: 411150.14 :2001MAR30 | | 1-661; 45-569 ; 74 254; 86 -587; 130-6 13; 209- 421; 210-390; 214-748; 250-436; 262-516; 306-555 559-783; 575-783 ; 626- 1139; 680-981; 690-927; 696-1273; 798-1372; 800-1258; 806-1096; 87 9-1049; 957-1173; 965-1452; 970-1185; 980-1217; 985-1243 1069 1613; 1247 1499; 1259-1470; 1273-1653; 1273-1548; 1275-1549; 1319 -1540; 1371- 1733; 1372-
1524; 1373-1562; 1379-1661 1422-1887; 1448-1937 1448 1697; 1456- 1697; 1475-1782; 1489-1735; 1489 1745; 1490-1758; 1493 1660; 1532- 1799; 1540- 1767; 1540-1813; 1570-2053 1573-2060; 1578-1823 1583-1828; 1592- 1776;
1605-1776; 1630-1891; 1633-1903; 1635-1902; 1635 1886; 1647- 1902; 1647-
2080; 1665-1902; 1679-2192 1679-2200; 1703-1853 1705 1935; 1713 2164; 1720-2187; 1770-2033; 1773 2192; 1784-1996; 1785 2081; 1792- 1861; 1799- 2408; 1798-2209; 1798-2404 1800-2190; 1801-2073 1808 2418; 1808- 2280; 1819-2051; 1831-2143; 1847 2210; 1890-2187; 1898 2060; 1910- 2188; 1941- 2167; 1943-2412; 1943-2275 1943-2419; 1943-2452 1943 2196; 1949 2168;
1954-2125; 1981-2233; 1991-2276; 1996-2221; 2004 -2455; 2005-2452; 2012-
2396; 2042 2289; 2073-2179 2073-2156; 2073-2157 2073-2186; 2075 2455; 2082-2455; 2084-2455; 2086 2457; 2087-2455; 2116-2276; 2147-2454; 2158- 2417; 2222 2479; 2318-2418 2318-2453; 2332-2417 2332 2455; 2332 2478; 2349-2467 157/LG:4114 66.1:2001MAR30 | 1 2428-2756 S; 205 2-2630; 1859-2459; 1670-2171; 1602-2102; 1692-1933; 1500 -1920; 1744- -1918; 1803-1912; 1221-1730; 1570- 1717; 1145 1708; 1367-1653 ; 1253 -1650, 1430 1652; 1229-1648; 1358-1648; 1294-1648; 1189-1645; 1496 -1646; 1263- -1643; 1193-1642; 1160-1642; 1218- 1642; 1231 1642; 1386-1645 ; 1305 -1645, 1583 -1641; 1590-1641; 1330-1645; 1171-1642; 1236-1642; 1389 -1634; 1145- -1605; 1179-1603; 1069-1603; 1153- 1600; 1039 1601; 1249-1599 ; 1327 -1596; 1122 -1591; 1139-1592; 1305-1585; 1221-1581; 1003-1565; 937- 1539; 1059-1529; 1172-1520; 1255-1492; 1299-1445; 1020-1466; 964-1454; 1161- 1429; 1171-1430; 1214-1403; 1159-1399; 1093-1383; 1345-1418; 1020-1290; 772- 1285; 1041-1285; 853-1276; 1191-1260; 994-1238; 969-1224; 784-1215; 968-12 12; 760-120: ; 1071-1184; 846-1155; 884-1129; 773- 1085; 786-1081; 882-1040; 787-1032; 763-998 682-984; 692-984; 501-984; 733-975; 697-975; 520-973 813-975; 350-933 349-930; 642-902; 347-881;
637-881; 391-874 608-853 630-845 763-842 562-835; 693-830; 516-826;
342-825; 351-810 379-804 342-800 346-794 357-782; 348-783; 350-779;
342-763; 351-760 487-752 351-749 502-748 ; 349-742; 351-740; 334-718;
515-698; 515-691 411-680 354-657 406-643 ; 351-639; 351-637; 309-611;
356-610; 351-595 1-591; 273-549; 299-532; 350-524; 2 57-505; 404-504; 351-
496; 292-481; 347-475; 351-472; 353-428 Table 3
158/LG:413969.68:2001 AR30 || 1-658; 274-628; 344-751; 443-751; 495-748; 668-918; 674-1213; 690-865; 806-865; 813-1281; 813-1254; 905-1571; 1026- 1445; 1033-1597; 1058-1529; 1092-1459; 1092-1551; 1093-1621; 1092-1628; 1092-1511; 1093-1358; 1180-1672; 1187-1437; 1226-1802; 1324-1560; 1333- 1694; 1414-1916; 1440-1795; 1482-1653; 1530-1788; 1581-1964; 1581-1806; 1688-2117; 1860-2113; 1942-2468; 2051-2458; 2075-2290; 2082-2735; 2142- 2730; 2254-2501; 2334-2506; 2348-2538; 2553-2716
159/LG:419641.35:2001MAR30 || 1-515; 5-626; 49-617; 89-352; 90-456; 143- 339; 141-285; 176-452; 207-677; 218-551; 219-447; 222-501; 223-351; 271- 471; 401-974; 431-671; 434-897; 434-882; 502-1043; 506-923; 506-1026; 518- 1136; 520-1099; 535-970; 546-1118; 563-822; 579-890; 584-1092; 611-1070; 619-1070; 624-1068; 629-918; 633-1072; 634-1074; 639-926; 641-1011; 656- 1068; 660-1134; 668-935; 674-1068; 683-1137; 686-1141; 687-1115; 688-1093; 693-947; 694-1148; 704-892; 717-1134; 720-1143; 728-1075; 729-1142; 742- 902; 748-1086; 749-1136; 759-1144; 761-1150; 761-1135; 763-1137; 763-1015; 768-1136; 772-1147; 774-1008; 787-1136; 790-1140; 792-1097; 801-1085; 801- 1100; 817-1069; 820-1138; 822-1137; 825-1141; 825-1171; 829-1067; 841-1139; 841-1169; 859-1136; 862-1121; 862-1144; 866-1144; 868-1138; 874-1140; 876- 1138; 880-1342; 887-1092; 887-1149; 889-1178; 890-1139; 914-1137; 928-1352; 946-1025; 978-1139; 981-1147; 1014-1134; 1041-1150
160/LG:428206.7:2001MAR30 || 1-557; 9-464; 483-976; 483-823; 483-697; 485- 999; 485-864; 507-774; 512-916; 515-954; 570-874; 572-969; 572-694; 631- 991; 636-1013; 710-914; 710-959; 856-1194; 856-1106; 856-1090; 862-1285; 892-1195; 914-1178; 926-1182; 927-1155; 948-1397; 1019-1397; 1018-1402; 1029-1402; 1138-1538; 1156-1396; 1255-1360
161/LG: 430059.1:2001MAR30 1-260; 8-255; 19-217; 36-229; 41-260; 42-262;
64-260; 66-415; 66-248; 69-207; 91-260; 115-363; 116-364; 115-225; 116-273; 116-213 118- 265 118- 414 118-237 127-401; 131-313; 170-444 173-417; 247-497 286- 670 288- 736 288-737 288-588; 288-620; 288-566 288-338; 287-531 306- 484 329- ■570 331-508 349-583; 352-570; 360-590 378-873; 378-620 370- 748 378- 881 391-638 386-644; 389-633; 405-715 411-986; 417-666 417- 557 417- 992 431-720 438-701; 440-1102; 466-590 ; 468-658; 486-830 501- 742 503- 714 522-628 523-1106; 520-1048; 520-808; 519-739; 523-737 531- 783 542- 819 549-786 552-826; 559-820; 578-938 567-844; 583-854 573- 729 577- 806 580-820 591-870; 591-843; 591-715 593-851; 594-871 596- 852 596- 826 600-804 603-768; 614-811; 621-882 611-1157; 636-895 649- 927 649- 784 652-936 652-904; 660-935; 651-948 651-921; 651-893 651- 814 664- •831 667-927 658-1044; 671-867; 664-1177; 665-1255; 666-954 678- 819 671- 953 671-922 673-1281; 676-928; 679-932; 680-935; 681-937 686- 959 687-1114; 699-964; : 702-890; 707-911; 707-980; 719-914; 713-965 714- 905 715-1001; 727-8.31; : 717-1240; 728-1087; 728-867; 729-974; 730-984 731- 1137 733-1016; 736-1003; 736-966; 743-958; 744-1313; 751- 1401; 753-1135; 757-1296; 767-1140; 769-1014; 771-1009; 774-1272; 777-1209; 779-894; 791-1046; 781-1003; 781-964; 784-1002; 776-1338; 802-1219; 802- 1091; 817-1127; 818-1115; 834-1265; 829-1337; 831-1359; 832-1129; 833-1081; 836-1309; 845-1337; 847-1313; 860-1190; 854-1385; 865-1373; 865-1141; 867- 1134; 870-1152; 878-1312; 879-1141; 880-1322; 883-1133; 887-1386; 887-1184; 887-1148; 896-1143; 908-1183; 909-1187; 914-1312; 914-1600; 915-1386; 928- 1386; 930-1388; 930-1285; 931-1385; 932-1388; 933-1384; 934-1389; 942-1385; 954-1121; 959-1386; 958-1383; 968-1383; 969-1221; 970-1392; 972-1387; 973- 1346; 974-1386; 977-1404; 976-1392; 981-1390; 982-1388; 988-1388; 994-1389; 1000-1386; 1003-1244; 1004-1383; 1006-1251; 1015-1387; 1021-1383; 1026- 1385; 1026-1386; 1029-1308; 1029-1350; 1033-1270; 1039-1383; 1046-1388; 1048-1346; 1052-1293; 1053-1294; 1054-1387; 1057-1308; 1058-1368; 1060- 1325; 1063-1385; 1079-1304; 1079-1301; 1080-1341; 1080-1314; 1084-1363; 1084-1333; 1085-1389; 1089-1325; 1102-1635; 1101-1367; 1104-1385; 1103- 1343; 1108-1358; 1109-1385; 1118-1346; 1124-1383; 1138-1376; 1140-1224; 1148-1388; 1147-1385; 1150-1651; 1150-1425; 1156-1351; 1157-1385; 1159- 1383; 1166-1377; 1172-1380; 1180-1347; 1182-1385; 1183-1385; 1186-1278; 1186-1348; 1186-1324; 1188-1385; 1189-1385; 1190-1391; 1194-1651; 1193- Table 3
1373; 1196- -1392; 1200- -1385; 1237- -1385; 1243- -1378; 1244- -1385; 1246- -1474
1248- 1388; 1253- -1705; 1253- 1373; 1256- 1383; 1257- 1385; 1257- -1383; 1258-
1382; 1271- -1847; 1268- -1382; 1280- -1385; 1280- -1378; 1295- -1550; 1295- -1385
1298- 1385; 1298- 1350; 1300- 1385; 1307- 1585; 1307- 1385; 1321- 1385; 1328-
1563; 1330- -1495; 1341- -1846; 1360- -1553; 1366- -1580; 1403- -1642; 1406- -1824
1420- 1891; 1429- 1681; 1440- 1886; 1500- 1793; 1502- 2028; 1527- 1793; 1532-
1889; 1564- -1888; 1575- -1836; 1596- -1849; 1628- -1815; 1680- -2194; 1680- -1922
1680- 1914; 1708- -1999; 1706- 1793; 1706- 1799; 1739- 1942; 1755- 1989; 1795-
1921; 1902- -2056; 1916- -2485; 2021- -2570; 2118- -2305; 2140- -2355; 2141- -2713
2141- -2412; 2141- -2414; 2141- -2327; 2142- -2368; 2143- -2558; 2143- -2464; 2143-
2422; 2143- -2431; 2143- -2419; 2143- -2417; 2143- -2415; 2143- -2414; 2143- -2416
2143- -2409; 2143- -2407; 2143- -2418; 2143- -2405; 2143- -2404; 2143- -2403; 2144-
2405; 2143- -2402; 2143- -2401; 2143- -2399; 2143- -2397; 2143- -2394; 2143- -2396
2143- -2395; 2143- -2389; 2143- -2398; 2143- -2386; 2143- 2384; 2143- -2382; 2143
2378; 2143- -2379, 2143- -2376; 2143- -2374; 2143- -2371; 2143- -2381; 2143- -2370
2143- -2367; 2143- -2360; 2143- -2362; 2143- -2358; 2143- -2348; 2143- -2346; 2143
2344; 2143- -2339, 2143- -2340; 2143- -2332; 2143- -2328; 2143- -2316; 2143- -2288
2143- -2289; 2143- -2229; 2144- -2424; 2143- -2661; 2144- 2567; 2144- -2466; 2144
2438; 2144- -2416, 2144- -2414, 2145- -2415; 2144- -2401; 2144- -2400; 2143- -2406
2144- -2373; 2144- -2355; 2143- -2195; 2145- -2458; 2145- -2437; 2145- -2430; 2145
2423, 2145- -2421, 2145 -2417 2145- -2416, 2145 -2412, 2145- -2411, 2145- -2405
2145- -2403; 2144- -2415; 2145- -2378; 2145- -2368; 2145- -2313; 2145- -2300; 2147
2498, 2146- -2410 2146- -2416 2146- -2404, 2146- -2405, 2146- -2397, 2147- -2670
2148- -2636; 2147- -2445; 2147- -2433; 2147- -2431; 2147- -2432; 2147- -2427; 2147
2426, 2148- -2433 2147 -2414 2147- -2406, 2147- -2407, 2147- -2389, 2147- -2380
2148- -2596; 2148- -2554; 2148- -2423; 2148- -2418; 2148- -2414; 2148- -2411; 2148
2407, 2148- -2401, 2148- -2399, 2148- -2394, 2148- -2395, 2148- -2371; 2148- -2368
2148- -2367; 2148- -2369; 2148- -2360; 2148- -2370; 2148- -2349; 2148- -2343; 2147
2344, 2149- -2743 2150- -2663, 2149- -2486, 2149- -2438, 2149- -2436, 2149- -2489
2149- -241.6; 2149- -2414; 2149- -2402; 2149- -2383; 2149- -2404; 2149- -2363; 2151
2359 2149 -2300 2149 -2495 2150 -2463 2150 -2437 2150 -2430 2150 -2412
2150- -2410; 2150- -2408; 2150- -2411; 2150- -2398; 2150- -2397; 2150- -2394; 2150
2386 2150 -2375 2151 -2380 2150 -2372 2150 -2371 2150 -2360 2150 -2321
2151- -2735; 2151- -2515; 2151- -2434'; 2151- -2433; 2151- -2415; 2151- -2414; 2151
2412 2151 -2403 2151 -2402 2151 -2399 2151 -2396 2151 -2391 2151 -2390
2151- -2332; 2150- -2268; 2152- -2434; 2152- -2414; 2152- -2409; 2152- -2385; 2153
2756 2153 -2412 2153 -2410 2153 -2360 2154 -2438 2154 -2434 2154 -2413
2154- -2403; 2155- -2322; 2156- -2438; 2156- -2430; 2156- -2415; 2157- -2433; 2156
2391 2157 -2449 2157 -2426 2157 -2423 2157 -2415 2157 -2414 2157 -2404
2157- -2395; 2157- -2373; 2157- -2343; 2157- -2312; 2159- -2430; 2159- -2414; 2159
2395 2159 -2387 2159 -2340 2160 -2426 2160 -2414 2160 -2413 2161 -2435
2161- -2413; 2162- -2417; 2162- -2402; 2163- -2637; 2167- -2415; 2165- -2570; 2164
2387 2165 -2416 2166 -2415 2166 -2412 2166 -2398 2166 -2422 2167 -2465
2168- -2356; 2169- -2433; 2170- -2282; 2170- -2420; 2171- -2595; 2173- -2314; 2173
2276 2175 -2460 ; 2177 -2454 2179 -2414 2180 -2676 2183 -2408 2184 -2599
2185- -2290; 2188- -2632; 2189- -2780; 2190- -2674; 2189- -2431; 2191- -2445; 2193
2422 2195 -2463 2199 -2435 2202 -2463 2204 -2633 2208 -2463 2213 -2672
2215- -2464; 2217- -2671; 2225- -2672; 2227- -2468; 2231- -2486; 2233- -2676; 2234
2424 2256 -2675 2262 -2471 2262 -2455 2268 -2672 2274 -2529 2281 -2820
2281- -2560; 2281- -2549; 2287- -2415; 2294- -2572; 2313- -2570; 2317- -2560; 2319
2573 2317 -2821 2322 -2786 2322 -2686 2324 -2786 2326 -2763 2327 -2672
2327- -2631; 2327 -2511; 2329- -2587; 2330 -2383; 2333- -2863; 2332 -2611; 2332
2605 2333 -2589 ; 2333 -2588 2333 -2576 2338 -2600 2347 -2470 2349 -2771
2350- -2793; 2349 -2565; 2369- -2622; 2374 -2660; 2381- -2802; 2382- -2630; 2384
2928 2384 -2662 ; 2384 -2620 2384 -2532 ; 2394 -2668 • 2394 -2666 ; 2396 -2667
2398- -2615; 2405 -3008; 2413- -3009; 2414 -2710; 2414- -2669; 2415 -2513; 2418
2636 2421 -2772 ; 2468 -2744 2471 -2745 2482 -2991 2481 -2753 2488 -2671
2491- -2755; 2497 -2985; 2497- -3007; 2508 -2738; 2510- -2747; 2510 -2761; 2510
2745 2531 -2917 ; 2523 -2753 ; 2530 -2832 ; 2530 -2810 • 2530 -2790 2530 -2788
2532- -2774; 2535 -3007; 2536 -3032; 2544 -2832; 2545- -2671; 2550 -2752; 2565 Table 3
3007; 2564-2991; 2564-2994; 2573-2851; 2574-2803 2575-2820; 2575-2809 2581-3050; 2582-3009; 2586-3029; 2586-3044; 2586 2848; 2590-2875; 2592 2798; 2593-2796; 2602-2855; 2608-3029; 2612-3044 2609-2853; 2610-2861 2611-2928; 2615-3044; 2615-2860; 2616-2886; 2619 3036; 2621-2762; 2621 2813; 2637-3050; 2637-3052; 2692-3053; 2692-3039 2692-3009; 2692-2890 2692-2881; 2695-3044; 2692-2914; 2692-2901; 2695 2786; 2697-2927; 2708 2985; 2730-3029; 2729-2901; 2731-2989; 2813-3048 2167-2435; 2157-2427 2172-2441; 2162-2432; 2708-2979; 2756-3028; 2240 2512; 2189-2462; 2156 2432; 2361-2631; 2174-2455; 2903-3051; 2167-2455 2741-3032; 2168-2460 2145-2438; 2171-2475; 2703-3029; 2684-2947; 2692 3050; 2692-3051; 2692 2995; 2688-3051; 2678-3044; 1478-1882; 2148-2455 2680-3029; 2146-2412 2149-2415; 2174-2438; 2171-2432; 2182-2445; 2151 2413; 2144-2404; 2159 2419; 2155-2413; 2149-2382; 2167-2422; 2175-2429 2152-2405; 2807-3051 2164-2411; 2390-2628; 2172-2422; 2164-2414; 2159 2406; 2151-2382; 2152 2372; 2144-2388; 2234-2478; 2226-2470; 2145-2388 2157-2382; 2149-2385 2151-2387; 2143-2377; 2143-2373; 2172-2382; 2166 2382; 2146-2370; 2888 3017; 2151-2370; 2276-2485; 2358-2576; 2333-2548 2149-2362; 2145-2357 2214-2423; 2154-2361; 2208-2414; 2333-2531; 2741 2935; 2150-2336; 2282- 2466; 2868-3050; 2146-2328; 2875-3051; 2143-2323 2168-2341; 2208-2380 2884-3050; 2148-2284; 2916-3050; 2693-2825; 2825 2945; 2947-3053; 2924- 3029; 2964-3050; 2924-3009; 2982-3051; 2981-3043 2982-3044; 2419-2470 2990-3044
162/LG:448040.3:2001MAR30 || 1-335; 1-366; 1-375; 1-372; 10-335; 12-334;
14-161; 14-260; 15-161; 15-269; 17-161; 19-357; 19-161; 21-359; 22-372; 24-
161; 32-161; 47-161; 55-365; 93-366; 99-372; 158-240; 163-373; 247-507;
247-464; 270-507; 305-507; 455-507
163/LG:451274.1:2001MAR30 || 1-244; 1-397; 1-81; 1-290; 194-479; 194-781;
306-693; 670-909; 670-913; 670-988 ; 702-1281 ; 882-1221; 910-1013; 910-1339;
911-1012; 968-1403; 1070-1306
164/LG:456110.1:2001MAR30 || 1-633; 1-275; 31-671; 33-275; 159-599
165/LG:456954.1:2001MAR30 || 1-552; 1-492; 4-234; 217-728; 255-654
166/LG:474942.12:2001MAR30 || 2547-2602; 2139-2614; 2193-2614; 2201-2614;
2166-2613; 2358-3446; 2173-2613; 2241-2613; 2232-2613; 2267-2613; 2287-
2614,- 2292-2613; 2308-2594 2351-2594; 2432-2663 2384-2594; 2473-2594
2478-2594; 2528-2594; 2284-2597; 2152-2612; 2163-2612; 2167-2612; 2225
2583 2400-2591; 2440-2590 2187-2605; 2291-2608 2192-2607; 2243-2607 2108 2593; 2413-2656; 2299 2655; 2132-2653; 2067-2650; 2111-2644; 2248 2662 2273-2663; 2326-2662 2133-2649; 2352-2635 2026-2623; 2049-2581 2320 2613; 2317-2590; 2428 2660; 2472-2579;.2173-2575; 2509-3073; 2306 2629 2539-3075; 2176-2615 2348-2593; 2540-3046 2317-2586; 2512-2999
2400-2633; 2302-2661; 2322-2652; 2384-2645; 2384 2640; 2420-2623; 2540
2908; 2302-2573; 2567-2902 2346-2613; 2522-2808 2511-2805; 2501-2616
2483-2616; 1995-2624; 2026-2625; 2077-2645; 2028 2624; 2135-2618; 2148
2617; 2561-2637; 2073-2604 2372-2602; 1946-2487 2314-2476; 2337-2476
1991-2439; 2205-2457; 2012-2423; 2185-2427; 1840 2470; 1815-2423; 2130
2403; 2138-2333; 1832-2328 1794-2283; 1994-2236 1582-2170; 1814-2157
1796-2090; 1735-1989; 1716-1983; 1716-1974; 1608-1943; 1683-1932; 1708
1930; 1635-1892; 1679-1887 1664-1877; 1668-1873; 1766-1840; 1773-1840 1223-1758; 1183-1754; 1071-1679; 1149-1658; 1104-1640; 1063-1548; 1304- 1548; 849-1512; 1083-1481; 1104-1481; 1065-1481; 1082-1481; 1246-1478; 866-
1420; 1004-1410; 983-1410; 929-1410 : 907 -1410 ; 1085-1410 ; 1108-1410 ; 873 -
1178; 914-1178; 946-1142; 914-1119; 354-980 ; 360-968 ; 692-925 ; 692-856 ;
686-805; 306-773; 486-771; 692-759; 340-517 ; 192 -384 ; 1-384 ; 1-298 ; 44-296 ;
1-123
167 /LG : 475119 . 14 : 2001MAR30 1-384 ; 126 -376 ; 184-783 ; 210-466 ; 214-781 ;
226-722 227-512 ; 248-545 ; 386-813 ; 386-710 ; 409-866 ; 411-867 ; 418-867 ;
420-874 421-864 ; 433 -827 ; 463 -873 ; 465-872 ; 472 -827 ; 472-639 ; 472-866 ;
500-866 ; 501-870 ; 533-689 ; 536-866 ; 548-866 ; 548-829 ; 549-845 ; 578-864 ;
583 -864 ; 583 -866 ; 611-870 ; 700-877 ; 722-1154 ; 722-979 ; 751-1352 ; 764-978 ; Table 3
889-1377; 938-1236; 953-1120; 1004-1361; 1004-1250; 1072-1394; 1087-1361; 1120-1352; 1274-1360; 1274-1361; 1286-1361
168/LG : 479908.77 :2001MAR30 1-452; 1-237; 51-2 64; 67 -254; 80-273 169/LG : 480127.47 :2001MAR30 1-230; 123-404; 12 3-330; 266-569; 281-569; 297-501; 355-569; 355-573 355-558; 355-489 364 -569; 382-573; 403-555; 402-572; 404-571; 435-569 456-569; 456-530 460 -569; 463-570; 463-569; 463-568; 474-569; 199-330 355-509; 355-488 240 -330; 210-330 170/LG: 481154.12 :2001MAR30 2986-3459; 1-3393; 3079- 3392; 3037-3391;
3007-3387; 3069-3382; 2702-3379; 3045-3384; 2968 -3382; 3078-3384; 2931-
3382 3296-3383; 2865-3382; 3071-3382; 2940-3382 ; 2930 3382; 2965-3382; 2967 3382; 2974-3379; 2975-3382; 2939-3380; 3012 -3380; 3119-3379; 2897- 3381 2948-3379; 2991-3379; 2928-3380; 2929-3379 ; 2975 3379; 3232-3379; 2867 3379; 2957-3379; 2968-3379; 3133-3379; 3148 -3375; 3304-3363; 2967- 3344 2739-3337; 2716-3335; 3171-3335; 2753-3329 ; 2840 3286; 2971-3250; 2853 3069; 1941-2520; 1811-2381; 1852-2291; 1943 -2237; 1984-2211; 1519- 2082 1780-2074; 1519-2049; 1938-2027; 1553-2015 ; 1777 2009; 1460-1998;
1653-1963; 1585-1889; 1603-1869; 1583-1820; 1519 -1805; 1502-1743; 1519- 1731; 1583-1685; 1398-1648; 1314-1577; 1034-1490 ; 1036 1417; 1128-1407; 1128-1388; 1039-1243; 696-1085; 699-983; 734-972 ; 422- 755; 1-599; 385-566; 273-498
171/LG:481414.6:2001MAR30 || 2215-2633; 2242-263 1; 230 8-2631; 2441-2631; 2087-2576; 2332-2562; 2330-2562; 2127-2553; 2331 -2549; 2332-2549; 2444- 2549; 2229-2505; 2207-2472; 2148-2410; 1970-2350 ; 2043-2319; 2097-2318; 1962-2220; 1870-2179; 1785-2130; 1731-2122; 1861 -2122; 1789-2044; 1695- 2042; 1497-1942; 1496-1930; 1496-1928; 1498-1936 ; 1503-1910; 1497-1829; 1499-1764; 1436-1680; 1079-1642; 1498-1633; 1138 -1612; 1354-1612; 1512- 1590; 1081-1538; 1069-1505; 1154-1434; 1159-1432 ; 846-1337; 1223-1325; 749- 1323; 1079-1317 ; 683-1273; 969-1268; 990-1251; 6 48-1148; 943-1135; 760- 1133; 814-1131; 664-1131; 654-1130; 807-1130; 72 1-1130 ; 772-1131; 683-1128; 889-1128; 1072-1128; 681-1119; 726-1100; 830-109 2; 687-1093; 818-1092; 803- 1091; 766-1089; 568-1081; 689-1074; 838-1074; 68 1-1073 ; 537-1063; 491-1041; 797-1034; 743-1013; 730-980; 541-960; 677-943; 5 30-905 ; 656-872; 686-858; 475-823; 500-798; 507-725; 503-709; 462-668; 342 -572; 339-432; 62-432; 116- 431; 7-430; 121-430; 140-429; 337-431; 137-428; 71-431 342-425; 350-425; 99-356; 1-263 172 /LG: 481941.1:2001 AR30 I I 1-393; 35-447; 35-2 97; 67 -389; 67-30 9; 98-351;
122-640 121-305 122-433; 125-431; 125-708; 135 -713; 135-714; 13 8-581; 139-716 143-441 146-732; 166-417; 176-697; 201 -729; 234-3766; 3 02-551; 321-923 484-629 605-1185; 663-1171; 663-827; 6 91-1101; 702-1090 ; 698-952; 711-968 722-1091; 730-1263; 750-1092 857-1290; 859-1096; 859-10 38; 916-
1158; 943-1349; 955-1309; 1015-1518; 1033-1503; 1045-1546; 1094-1 566; 1106-
1349, 1142 -1509, 1161- -1533, 1202- -1596 1202- 1436 ; 1227-1473; 1292 -1523;
1348- -1612; 1354- -1613; 1381- -1479; 1399 1608; 1438 -1692; 1476-1700; 1538-
2165, 1574- -2112, 1586- -1795, 1623- -1901 1661- 1886 ,- 1661-1914; 1704-1972
1711- -2358; 1724- -2232; 1724- -1929; 1757 2203; 1768 -2272; 1774-2348; 1817-
2315 1823 -2056 1851- -2125, 1849 -2127 1868- 2273 ; 1904-2388; 1953-2197
1985- -2565; 1962- -2448; 1974- -2226; 1983 2175; 2048 -2188; 2054-2288; 2063
2376 2094- -2620, 2094- -2377; 2116- -2627 2130- 2415 ,- 2130-2391; 2133-2572
2132- -2373; 2144- -2382; 2149- -2413; 2153 2572; 2189 -2326; 2210-2314; 2225
2449 2323 -2582 2355- -2612, 2360- -2802 2360-2605 ; 2386-2735; 2387-2751
2461- -2740; 2473- -2667; 2491- -2938; 2575 2823; 2648 -2930; 2691-2775; 2694
2979 2719 -2979 2719 -2937, 2751 -2937 2755-2948 ; 2757-3026; 2774 -3087
2774- -3085; 2794- -3029; 2809- -3067; 2814 3289; 2814 -3056; 2815-2965; 2848-
3056 2855 -3405, 2864- -3083, 2868- -3102 2870- 3098 ; 2877-3071; 2880 -3151
2891- -3169; 2914- -3163; 2946- -3167; 2988 3443; 3006 -3274; 3072-3262; 3110
3347 3130 -3232 3155- -3334, 3157 -3431 3168-3692 ; 3186-3454; 3205 -3440
3205- -3439; 3242- -3778; 3231- -3773; 3260 3746; 3277 -3678; 3277-3556; 3282
3561, 3284- -3735, 3285- -3726, 3305- -3763 3305-3770 ; 3331-3753; 3333 -3592
3339-3733; 3341-3480; 3347-3759; 3351-3767; 3357- -3586; 3380-3607; 3398 Table 3
3760; 3413-3598; 3459-3791; 3468-3772; 3492-3675; 3510-3791; 3512-3773; 3519-3726; 3558-3729; 3571-3762; 3598-3791; 3622-3775; 3651-3791 173/LG:887216.4:2001MAR30 | | 1-411; 5-316; 5-414; 5-412; 17-142; 245-534; 289-850; 350-737; 353-633; 373-848; 383-828; 384-848; 385-848; 496-848; 502-809; 568-848; 570-848; 613-848; 699-804
174/LG:899402.3:2001MAR30 | | 1-488; 1-239; 2-291; 8-553; 11-227; 15-240; 56-262; 118-387; 164-517; 168-396; 175-653; 180-686; 220-694; 459-529; 504- 613; 528-938; 546-1053; 629-1059; 704-989; 714-898; 788-1032; 793-1036;
834-1057; 838-1075; 849-1456; 891-1138; 914-1005 916-1350; 921-1196; 962-
1366 962-1061; 965-1213; 968-1250; 1005-1281; 1010-1237; 1035-1433; 1035- 1286 1056-1608; 1064-1298; 1135-1424; 1142-1630 1164-1331 1201-1476; 1239 1510; 1333-1530; 1338-1621; 1359-1614; 1376-1587; 1376 1565; 1377- 1860 1388-1843; 1388-1581; 1391-1810; 1398-1663 1422-1658 1422-1678; 1423 1682; 1441-1720; 1441-1669; 1442-1705; 1448 1743; 1455-1711; 1477- 1935 1477-1716; 1495-2078; 1559-2115; 1566-1687 1576-1872 1581-1831;
1587-1876; 1625-1989; 1625-1812; 1628-1868; 1677-1965; 1682-1951; 1682
1936 1683-2058; 1711-2117; 1716-2190; 1716-1993 1718-2259 1719-2026; 1719 1993; 1727-2291; 1736-2291; 1737-2261; 1743 2293; 1745-2029; 1765- 2291 1770-2028; 1776-2157; 1785-2295; 1789-2363 1804-2331 1841-2323; 1841 2098; 1843-1925; 1850-2026; 1850-2116; 1873 2286; 1884-2291; 1883 2214 1884-2331; 1886-2331; 1887-2174; 1896-2331 1907-2332 1912-2331;
1913-2329; 1918-2157; 1945-2331; 1948-2581; 1966-2331; 196! 2280; 1996-
2331 2003-2331; 2006-2331; 2008-2335; 2011-2277 2015-2338 2018-2401;
2020-2286; 2025-2328; 2042-2328; 2042-2335; 2042-2295; 2043 2331; 2055-
2287 2078- 2325 2078- 2334; 2082- 2391 2086- 2325 2091 -2331 2098-2328; 2110 2331; 2117 2382; 2117-2331; 2131 2331; 2152 2403; 2163 2337; 2171- 2331 2195-•2302 2200-■2454; 2240-2331 2259-2399 2270 -2331 2305-2433; 2327 2625; 2331 2779; 2331- 2778; 2334 2668; 2334 2789; 2334 2661; 2334- 2643 2334-2610 2336- 2712; 2337-2767 2372-2781 2374 -2854 2375-2824; 2377 2585,- 2387 2751; 2398-2740; 2462 2900; 2485 2940; 2485 2708; 2495- 2586 2542- 2827 2546- 2797; 2552- 2825 2566- 2997 2565 -2822 2672-2930; 2694 2990; 2747 2854; 2766- 3369; 2782 3115; 2797 2854; 2812 3042; 2908- 3229 . 2911- 3308 2915-■3201; 2923-•3169 2980-•3227 2992 -3387 2995-3624; 2998 3239; 3032 3294; 3058-3308; 3177 3524; 3180 3740; 3182 3387; 3190- 3550 3192-3504 3194- 3496; 3249-3501 3295- 3417 3336 -3550 3343-3484; 3347 3562; 3374 3596; 3375- 3618; 3394 3624; 3403 3806; 3458 3710; 3480- 3730 3609-3888 3614-•3870; 3701-•3781 3716-3962 3729 -3861 3728-4365; 3738 4314; 3801-4314; 4169-4338; 4169-4359; 4175-4436; 4175 4359; 4175- 4336 4175-4232; 4175-4448; 4175-4443; 4175-4445 4175-4429 4175-4426; 4175 4427; 4175-4421; 4175-4412; 4175-4411; 4176 4319; 4175 4296; 4177- 4474 4177-4536; 4176-4428; 4177-4350; 4210-4762 4255-4768 4348-4807;
4356-4698; 4393-4807; 4392-4807; 4396-4969; 4435 4806; 4445-4675; 4447- 4766 4461-4812; 4470-4811; 4468-4807; 4555-4811; 4562-4807 4588-4812; 4598-4814; 4653-4807; 4671-4807; 4837-5113; 4837-5353; 5083-5471 175/LG:899894.2:2001MAR30 | | 2-398; 1-278; 95-587; 95-324 ;.259-634 ; 294- 819; 320-930; 378-733; 380-471; 407-566; 413-952; 413-669; 437-710; 438- 611; 441-766; 461-1226; 470-743; 486-813; 492-664; 497-697; 509-774; 546- 1072; 568-1166; 586-1074; 631-819; 644-860; 651-1122; 651-892; 685-911; 708-1303; 708-1089; 708-948; 739-1003; 756-1050; 755-1102; 760-1099; 770- 982; 785-989; 795-1092; 797-1002; 802-1308; 840-1325; 840-1324; 843-1274; 843-1073; 851-1163; 854-1112; 866-1196; 866-1156; 872-1057; 881-1431; 910- 1476; 926-1538; 937-1256; 965-1296; 975-1255; 986-1455; 1002-1537; 1022- 1468; 1035-1159; 1042-1248; 1043-1541; 1051-1537; 1065-1538; 1070-1300; 1072-1340; 1072-1532; 1072-1538; 1089-1579; 1104-1578; 1112-1583; 1117- 1538; 1131-1579; 1138-1580; 1143-1579; 1145-1579; 1144-1529; 1151-1583; 1156-1580; 1159-1583; 1159-1579; 1170-1578; 1174-1580; 1175-1579; 1185- 1579; 1199-1582; 1200-1580; 1200-1579; 1205-1530; 1206-1579; 1206-1495; 1210-1579; 1216-1569; 1212-1578; 1222-1579; 1221-1578; 1233-1579; 1243- 1581; 1268-1571; 1268-1579; 1268-1582; 1269-1579; 1272-1579; 1273-1586; 1279-1581; 1288-1576; 1290-1585; 1308-1551; 1308-1514;.1309-1588; 1317- Table 3
1579; 1327-1579; 1335-1576; 1352-1579; 1352 1585; 1369-1497; 1401-1579; 1445-1579; 1451-1579; 1451-1576; 1485-1691 176/LG: 977908.1.2001 AR30 || 1-474; 7-475; 7 -261 8-100; 9-3 36; 80-359; 83- 253; 184-410; 192-424; 267-624; 313-744; 360 -701 374-467; 390-506; 390- 632; 390-692; 390-841; 407-736; 440-736; 445 -682 473-746; 480-704; 514- 730; 611-750; 633-1150; 698-945; 783-1344; 785-1072; 811-1161; 840-1051; 848-1114; 867-1284; 892-1338; 964-1154; .1027-1340; 1029-1506 ; 1042-1160; 1145-1373; 1179-1554; 1189-1465; 1208-1459; 1231-1461; 1254-1804; 1255-
1673; 1324-1669; 1331-1936; 1479-1739 1583 1931 1731- 2231 1746-2161; 1746-1937; 1746-1975; 1746-1860; 1746 2188; 1747 1960; 1752 2319; 1762- 1981; 1770-2076; 1847-2122; 1861-2243 1867 2243 1870- 2068 1871-2131; 1876-2088; 1888-2263; 1906-2446; 1906 2141; 1908 2171; 1917 2321; 2049- 2262; 2049-2479; 2100-2608; 2101-2365 2109-2385 2118- 2360 2154-2607;
2200-2404; 2250-2501; 2252-2448; 2253-2581; 2265 2522; 2291- 2545; 2311-
2551; 2323-2546; 2323-2762; 2369-2947 2376- 2444 2380- 2542 2437-2719;
2437-2601; 2439-2623; 2458-2713; 2460-2929; 2460 2703; 2469 2728; 2476-
2684; 2486 -2682 ; 2498-2813 : 2499 -2810 2500 2610 2524- 2796 2527-2812; 2531-2775; 2532-2800; 2537 -2924; 2559 2873; 2573 3131; 2573- 2826; 2577- 2835; 2587-3071 ; 2595-2857 : 2600 -2689 2603 2990 2603- 2802 2656-2944; 2655-3024; 2666-2933; 2673--2870; 2711 3054; 2735 2848; 2744 3033; 2761- 2988; 2789-3334 ; 2808-3275 : 2811 ■3260 2818- 3349 2821- 3275 2826-3083; 2826-3348; 2829-3338; 2829 -3076; 2833 3062; 2837 3349; 2838- 3199; 2835- 3090; 2853-3308 ; 2855-3344 : 2857 -3343 2881 3144 2883- 3143 2893-3155; 2893-3176; 2897-3113; 2897--3128; 2897 3308; 2898 3167; 2905- 3187; 2907- 3334; 2923-3334 ; 2931-3334 2933 -3334 2940 3334 2943- 3210 2943-3334; 2944-3334; 2950-3334; 2952 -3334; 2953 3334; 2954-3308; 2954-3319; 2962- 3475; 2962-3219 ; 2970-3334 : 2977 -3247 2989 3388 2986-3334 2988-3334; 2989-3334; 2993-3334; 2997 -3334; 3004 3334; 3006-3263; 3008 3350; 3015- 3265; 3015-3272 ; 3022-3641 3024 -3138 3029 3386 3030-3297 3033-3254; 3036-3388; 3041-3343; 3043 -3334; 3055 3334; 3086-3334; 3087-3343; 3088- 3334; 3090-3334 ; 3092-3339 : 3092 •3334 3096- 3341 3102-3642 3110-3334; 3113-3334; 3120-3334; 3143'-3334; 3147 3334; 3159-3681; 3160-3388; 3172- 3334; 3172-3441 ; 3197-3343 : 3199 -3334 3202 3334 3221-3334 3234-3334; 3246-3334; 3326-3389; 3350 -3676; 3353 3679; 3356-3681; 3356-3676; 3356- 3679; 3356-3710 ; .3357-3681 3372 -3677 3371 3645 3382-3679 3390-3552; 3493-3663; 3498-3703; 3498 -3705 177/LG:977929.1 :2001 AR30 11 ι- 78; 24-380; 166-717; 392-812; 392-510 467- 883; 473-699; 530-994; 595 -756; 714-1162; 765-1334; 775-991; 817-1065 838- 1032; 886-1165; 1215-1421; 1281-1474; 1304-1852; 1435-1644; 1437-1669 1453-1776; 1459-1714; 1466 -1744; 1466-1942 1497-1738 1537-2039; 1540-
1834; 1697-1911; 1796-2207 1799-2050; 1817 2050; 1918-2080; 1958-2214 2032-2296; 2087-2702; 2097 2574; 2097-2294 2111-2344 2258-2766; 2364- 2525; 2365-2944; 2372-2636 2435-2701; 2465 2697; 2501-2973; 2548-2974 2549-3004; 2549-2708; 2555 2997; 2575-3018 2578-2887 2598-3003; 2619- 3003; 2625-3005; 2629-3012 2657-3012; 2663 3003; 2672-3005; 2685-3003
2693-3005; 2708-2993; 2716-2974; 2725-2970 2726-2943 2764-3017; 2765- 3005; 2768-3005; 2779-3005; 2780-3002 178/LG:978008.14:2001MAR30 || 1-556; 4-489 185-6 66; 332-4 91 ; 344-781 ; 412 - 985; 509-1119; 546-842; 651-1086; 660-858; 684-1240; 702-1044 ; 760-1401 ; 794-1441; 833-1077; 882-1444; 948-1344; 977-1071; 1035-1480 ; 1035-1267 ; 1062-1543; 1067-1243; 1067-1146; 1103-1370; 1215-1685; 1237 -1854 ; 1247- 1755; 1282-1427; 1299-1565; 1299-1547; 1299-1535; 1299-1774 ; 1387-2060 ; 1405-1660; 1455-1949; 1504-2008; 1520-1761; 1533-2096; 1544-2009 ; 1582- 2050; 1595-1843; 1609-2043; 1617-2047; 1646-2118; 1652-1887 ; 1721-2050 ; 1756-2122; 1759-1946; 1860-2363; 1864-2120; 1867-2158; 1869 -2167 ; 1896- 2381; 1965-2217; 1967-2251; 2014-2228; 2031 2224; 2045-2409 ; 2086-2546 ; 2098-2312; 2113-2621; 2113-2423; 2113-2357; 2114-2374; 2116-2658 ; 2127- 2404; 2126-2382; 2137-2640; 2138-2383; 2139 2457; 2142-2528 ; 2142-2380 ; 2142-2587; 2144-2742; 2150-2463; 2158-2636; 2175-2723; 2217-2636 ; 2237- 2544; 2249-2643; 2250-2643; 2253-2636; 2297-2827; 2315-2883 ; 2414-2646 ; Table 3
2482-2640; 2485-3012; 2472-2833; 2519-2908; 2530-2743; 2558 2781; 2560- 2805; 2590-3227; 2601-2714; 2601-3023; 2631-3215; 2643 -2977 2644- 3103; 2663-2894; 2686-2928; 2859-3033; 2894-3103; 2910-3476; 2925 3248; 2924- 3233; 2979-3129; 2991-3541; 3055-3450; 3079-3351; 3113 -3232 3189- 3372; 3210-3428; 3232-3484; 3268-3822; 3273-3394; 3288-3460; 3299 3458; 3403- 3901; 3524-3800; 3548-3814; 3640-4003; 3655-4251; 3746 •3840 3746- 4042; 3747-4055; 3747-4308; 3752-4300; 3794-4420; 3811-3872; 3876 4057; 3883- 4139; 3908-4392; 3959-4253; 3958-4343; 3966-4194;' 3995 -4259 4007- 4488; 4007-4174; 4039-4500; 4042-4495; 4050-4311; 4053-4275; 4057-4497; 4089-' 4495; 4112-4500; 4112-4407; 4114-4495; 4137-4500; 4158 •4499 4176- 4495; 4215-4375; 4220-4493; 4240-4491; 4242-4480 179/LG:979054.18:2001MAR30 || 1-235; 41-357; 307-759; 327-64 6; 337-956; 340-586; 373-647; 442-647; 501-1029; 505-766; 546-1021 548 1072; 568-758; 594-865; 596-1037; 612-885; 616-1080; 646-967; 661-1035; 672-944; 694-852; 700-1080; 768-1084; 769-1081; 773-1369; 842-1086; 847-1077; 880-1076; 980- 1566; 1020-1549; 1095-1308; 1095-1395; 1096-1445; 1128 1573 1128-1727; 1140-1549; 1142-1528; 1144-1573; 1154-1576; 1159-1405; 1189 1398; 1193- 1576; 1208-1395; 1208-1571; 1215-1764; 1221-1572; 1219-1571 1269-1556; 1274-1571; 1289-1455; 1325-1578; 1338-1492; 1338-1763 1328 1510; 1340- 1482; 1363-1501; 1375-1623; 1407-1575; 1408-1512; 1428-1668 1417-1664; 1417-1564; 1417-1544; 1437-1571; 1451-1571; 1457-1560 1512-1790; 1596- 1983; 1667-2223; 1738-1980; 1757-2228; 1815-2357; 1834-2091 1900-2128; 1991-2146; 2003-2264; 2034-2522; 2035-2250; 2068-2325 2069 2328; 2171- 2248; 2255-2435; 2261-2811; 2273-2762; 2287-2704; 2312-2571 2342-2572; 2350-2564; 2350-2619; 2387-2705; 2402-2978; 2426-2589; 2442-2620; 2451- 3055; 2458-2785; 2464-2745; 2476-3035; 2516-3017; 2516-2757 2535-3020; 2549-2796; 2608-2975; 2639-2758; 2675-3290; 2675-3192; 2682-2909; 2682- 3148; 2686-2910; 2687-3040; 2702-3040; 2703-2883; 2713-2910 2715-3378; '2743-3037; 2840-3171; 2864-3414; 2865-3411; 2897-3411; 2986-3245; 3064- 3446; 3066-3447; 3084-3339; 3084-3449; 3084-3450; 3090 3406 3093-3452; 3097-3347; 3104-3452; 3106-3450; 3128-3454; 3155-3452; 3160 3413; 3178- 3452; 3182-3239; 3188-3451; 3204-3455; 3338-3413; 3345-3450 3345-3445; 3377-3445 180/LG:979185.10:2001MAR30 || 1-637; 1-531; 19-316; 83 -282; 245-701; 382-
652 418- -712 420- -671; 424-739 425-674; 424-652; 428- 713 428-707 429-
697 450- -917 450- -976; 449-687 449-680; 450-584; 453- 714 458-761 458-
689 458- -667 458- -865; 458-830 458-762; 458-732; 458- 719 458-656 458-
890 458- -650 458- -1056 ; 462-698 : 462-677; 462-669; 462 -567; 462-592; 462-
596 462- -565 462- -519; 465-757 465-1108; 469-742; 469 -732; 469-707; 482-
738 499- -858 508- -808; 510-807 510-783, 515-978 515 779 516-765 517-
839 520- -711 529- -902; 531-938 538-832; 535-720 536 795 541-701 543-
761 544- -803 562- -807; 563-806 564-857; 566-763 582- 812 589-1128; 589-
826 592- -888 596- -820; 599-823 600-824; 606-855 614 869 622-860 623-
905 624- -863 625- -891; 625-834 629-903; 630-875 630- 871 632-867 632-
777 640- -862 648- -890; 646-926 646-868; 657-887 666 911 672-806 683-
919 688- -862 690- -952; 690-967 694-911; 697-938 699 887 701-932 701-
832 712- -901 729- -981; 732-869 749-1031; 759-1012; 76 0-9! 33; 764-9-: 18; 764-
886 772- -102: L; 773-100 >; 775-1 02-: L091; 808- -1071;
823-1094; 853-1072; 876-1114; 895-1174; 895-1137; 895 113: l ; 912-10' 78; 914- 1130; 918-1139; 925-1190; 937-1183; 941-1022; 951-1426 ; 9! 55-1235; _ 565-1252; 974-1238; 981-1540; 989-1512; 997-1258; 999-1321; 1006 -1276 1019-1548; 1046-1281; 1070-1248; 1104-1574; 1136-1594; 1135-1593; 1136 1435; 1141-
1596; 1144-1490; 1156-1596 1162-1592; 1182-1581; 1185-1591 1200-1592;
1207-1442; 1207-1439; 1214-1592; 1215-1491; 1215-1480; 1216-1467; 1217
1592; 1235-1593; 1242-1591 1243-1497; 1254-1477; 1256-1432 1260-1464;
1263-1619; 1266-1593; 1270-1603; 1274-1592; 1279-1535; 1280-1576; 1283-
1592; 1283-1563; 1283-1556 1283-1490; 1289-1592; 1289-1561; 1290-1500; 1291-1568; 1296-1596; 1305 1594; 1304-1592; 1315-1593; 1326-1559; 1329- 1592; 1334-1519; 1345-1543 1363-1592; 1375-1575; 1379-1522; 1380-1567; 1382-1595; 1382-1553; 1401-1592; 1416-1592; 1420-1560; 1424-1694; 1437- Table 3
1606; 1441-1592; 1441-1591; 1446-1590; 1448-1592; 1460-1593; 1475-1593; 1481-1588; 1539-1590
181/LG:983654.1:2001MAR30 || 754-1109; 896-1109; 864-1108; 828-1108; 723- 1108; 714-1106; 883-1106; 704-1106; 707-1106; 780-1105; 712-1105; 699-1104; 736-1104; 781-1102; 705-1102; 726-1102; 868-1102; 720-1100; 774-1068; 831- 1068; 715-1067; 519-1064; 713-1063; 714-1060; 494-1059; 833-1054; 714-1052; 908-1051; 850-992; 838-990; 701-988; 720-892; 385-891; 365-582; 308-582; 385-579; 508-564; 228-564; 332-563; 289-564; 239-564; 319-564; 283-564; 416-564; 455-564; 413-564; 19-531; 24-489; 24-468; 24-465; 219-414; 148- 386; 24-380; 24-381; 1-377; 12-377; 24-329; 40-330; 19-275; 24-269; 24-216; 24-209; 24-199; 24-181; 22-123; 25-88; 24-90
182/LG:985092.12:2001MAR30 || 1-117; 1-656; 75-586; 268-778; 360-769; 360- 610; 361-776; 388-731; 435-517; 453-721; 487-779; 492-779; 497-999; 508- 794; 529-784; 606-796; 640-784; 665-1088; 806-1110
183/LG:987396.8:2001MAR30 || 1-383; 123-604; 133-313; 133-391; 134-740; 138-760; 192-389; 211-716; 279-551; 289-371; 336-1038; 460-738; 480-856; 485-1044; 504-731; 521-813; 539-1135; 542-811; 750-867; 784-1338; 903-1135; 906-1125; 906-1296; 1013-1528; 1113-1668; 1173-1725; 1173-1463; 1187-1435; 1339-1698; 1380-1829; 1380-1612; 1545-1848; 1582-1858; 1599-1852; 1615-
1815; 1646-1939; 1692-2058 1692-1957; 1853-2393; 2131-2735; 2197-2771; 2233-2773; 2315-2775; 2321 2731; 2367-2774; 2382-2715; 2404-2774; 2476- 2774; 2484-2767; 2544-2770 2648-2775 184/LG: 987418.10 :2001MAR30 I I 1-475; 132-417; 162-440; 367-611; 367-844; 427-612; 426-1001; 453-708 458-693; 471-586; 474-569; 474-586; 474-756; 474-770; 474-549; 474-876; 474-946; 474-601; 474-833; 474-834; 474-792; 474-552; 474-551; 476-1012 476-586; 492-957; 521-754;: 532-785; 532-900; 591-844; 591-855; 606-847; 603-735; 606-849; 621-901; 638-850; 637-892; 638-1063; 638-833 • 638-842 638-775; 638-777; 638-779; 638-798; 641-835; 645-886; 647-855; 647-844; 647-933; 647-753; 667-944; 671-890; 673-963; 679-1297; 682-980 r 696-820 705-868; 706-973; 708-954; 721-970; 721-1010; 725-1231; 725-1263; 734-1017; 739-998; 743-1018; 752-982; 756-986; 758-985; 772-1342; 775-1247; 782-1006; 786-1052; 789-966; 788-1018; 808-1059; 811- 1062; 813-1111; 816-1361; 818-1006; 819-921; 821-1407; 821-1047; 833-1341; 833-1338; 833-1426; 839-1349; 851-1422; 851-1127; 869-1378; 875-1096; 886- 1362; 897-1024; 897-1253; 897-1078; 910-1202; 908-1056; 909-1203; 920-1383; 921-1389; 921-1180; 932-1383; 930-1208; 945-1382; 945-1207; 951-1163; 951- 1380; 951-1415; 953-1427; 954-1364; 954-1170; 957-1212; 967-1267; 970-1428; 977-1421; 977-1186; 994-1201; 1000-1347; 1001-1421; 1005-1421; 1013-1428; 1022-1339; 1027-1180; 1027-1423; 1029-1423; 1034-1423; 1034-1427; 1037-
1421 1041-1261 ; 1057 -1410 ; 1064-1240 ; 1068-1427 ; 1074-1361 ; 1084-1424
1091-1310 ; 1096-1421 ; 1108-1422 ; 1109-1419 ; 1113 -1429 ; 1113 -1423 ; 1118
1419 1121-1354 ; 1125 -1421 ; 1131-1429 ; 1131-1378 ; 1148-1428 ; 1149-1420 1160 1370 ; 1160-1384 ; 1163 -1421 ; 1166-1407 ; 1169-1407 ; 1171-1416 ; 1171 1426 1174-1376 ; 1178 -1412 ; 1179-1389 ; 1182-1412 ; 1191-1421 ; 1192 -1423 1200 1426 ; 1203-1383 ; 1205-1412 ; 1206-1421 ; 1238-1423; 1240-1422; 1312- 1426 1315-1439 185/LG : 997203 .25 2001MAR30 | I 1-511; 88-291 113-705 115-710; 114-645
119-290 121-396 122-391; 122-378 122-631 124-381; 125-395 128-329 129-404 ; 130-668; 130-379 130-180 135-535; 130-407 133 -402 133 -385 ; 133-37 133-336 135-490 133-618; 134-460 134-433 135-394 134-374; 135-372 134-201 133-717; 133-728; 133 -664 135 -422 135-417; 135-370 136-335 136-370; 135-3867; 137-388 137 -372 ; 137-364; 135-400 140-426 140-395; 141-681; 144-466 150-660 ; 150-608; 152-693 154-702 155-533; 157-745; 189-432 224-779 224-342; 241-384 258-538 322-531; 328-779; 400-732 426-993 499-709; 551-868 554-791 556-724; 560-779;
656-1205; 658-791; 815-1298; 815-1075; 815-1002; 835-1010; 867-1097; 883- 1141; 896-1152; 914-1158; 924-1162; 998-1272; 1029-1305; 1030-1162; 1086- 1273; 1109-1381; 1121-1234; 1181-1455; 1242-1535; 1341-1554; 1539-1980; 1559-2045; 1597-2085; 1698-2010; 1711-1996; 1715-1995; 1750-2206; 1778- Table 3
2035; 1864-2090; 1910-2043 1927-2182 ; 1967 -2532 2029 -2554; 2055 -2323
2058-2257; 2058-2216; 2062-2330; 2083-2335; 2087 2304; 2129-2572; 2132
2384; 2133-2307; 2136-2763 2157-2659 ; 2154-2403 2200 -2422; 2196 -2593 2196-2381; 2176-2444; 2271 2881; 2335-2976; 2362 2880; 2393-2785; 2422 2990; 2423-2709; 2475-2883 2581-2789 ; 2595-2864 2601 -2826; 2605 -2939 2652-3245; 2681-3119; 2717 2960; 2750-3033; 2773 2833; 2784-3084; 2791 2901; 2789-3058; 2789-3060 2832-3222 ; 2860-3417 2888 -3208; 2926 -3186
2927-3199; 2979-3523; 2981-3248; 2984-3247; 3002 3246; 3006-3564; 3012
3239; 3044-3247; 3044-3250 3044-3239 ; 3072-3279 3072 -3330; 3074 -3172 3075-3285; 3077-3339; 3081 3315; 3073-3239; 3094 3395; 3125-3252; 3126 3319; 3116-3418; 3117-3246 3136-3398 ; 3141-3622 3141 -3605; 3147 -3397 3165-3414; 3169-3430; 3170 3403; 3176-3649; 3177 3448; 3180-3523; 3233 3652; 3247-3691; 3246-3492 3260-3674 ; 3260-3542 3260 -3534; 3260 -3489
3260-3488; 3260-3487; 3260-3470; 3260-3452; 3260 3476; 3260-3437; 3278
3759; 3277-3828; 3278-3523 3290-3528 ; 3298-3739 3303 -3517; 3313 -3560
3313-3548; 3325-3733; 3320-3867; 3325-3605; 3325 3606; 3325-3604; 3326
3610; 3326-3591; 3326-3609 3331-3656 3335-3594 3344 -3613; 3344 -3591
3352-3653; 3354-3623; 3360-3598; 3365-3572; 3365 3532; 3365-3529; 3369
3822; 3368-3821; 3378-3868 3382-3639 ; 3382-3859 3385 -3867; 3391 -3520 3398-3865; 3402-3850; 3408 3867; 3408-3865; 3409 3867; 3410-3862; 3410 3861; 3410-3867; 3412-3863 3414-3862 ; 3413-3861 3416 -3867; 3417 -3867 3418-3861; 3420-3837; 3419 3870; 3420-3828; 3420 3811; 3420-3639; 3420 3514; 3421-3864; 3422-3865 3424-3864 3423-3655 3424 -3867; 3424 -3865
3424-3861; 3425-3867; 3425-3868; 3428 3861; 3428 3677; 3429-3861; 3429
3849; 3430-3867; 3432-3641 3435-3712 3435-3784 3435 -3675; 3436 -3710
3436-3660; 3437-3867; 3439-3861; 3439 3547; 3439 3712; 3441-3861; 3443
3804; 3447-3869; 3447-3865 3447-3783 3448-3837 3449 -3822; 3451 -3867
3451-3866; 3463-3867; 3458-3865; 3459 3659; 3460 3866; 3459-3867; 3460
3861; 3471-3867; 3470-3873 3471-3837 3473-3837 3476 -3872; 3480 -3725 3489-3861; 3492-3861; 3490 3861; 3491 3748; 3494 3742; 3507-3866; 3509 3769; 3519-3868; 3525-3867 3528-3852 ,- 3529-3867 3539 -3795; 3539 -3743
3547-3821; 3550-3865; 3552-3831; 3595-3859; 3602 3861; 3616-3859; 3622
3861; 3624-3858; 3632-3858 3636-3862 ; 3639 3861 3644 -3814; 3672 -3858
3673-3788; 3690-3867; 3734-3792; 3745-3864; 3776 3877; 3811-3863; 3555
3835; 3575-3862; 3575-3860 3554-3858 ; 3554 3863 3567 -3859; 3549 -3861 3553-3864; 3539-3863; 3517 3863; 3470-3859; 2163 2597; 3557-3860; 3540 3861; 2328-2789; 3593-3857 3587-3837 ; 3617-3857 3593 -3832; 3647 -3858
3620-3837; 3654-3860; 3655-3861; 3725 3861; 3761 3861
186/LG.-997477.8.-2001 AR30 | 1-215 ; 1 195; 1-464 1-43 7; 195-455; 195-643;
347-761; 356-568; 428-600; 581-746 ; 614-869 ; 685 1190; 687-890; 830-1195;
918-1204
187 /LG: 998855.4 :2001MAR30 | 2-493 ; 1 -646; 1-611; 1-519; 12-644; 151-380;
275-999; 301-451; 378-497; 395-541 ; 393-562; 393-652; 403-881; 405-665;
449-998; 535-883; 536-980; 536-1008 r 574-984; 622-875; 627-992; 628-953;
634-915; 770-984
188/LG:999093.1:2001MAR30 || 1-483; 3 5-567; 47-663; 26 8-626; 268-797; 310-
869; 470-888; 519-1116; 650-1241; 687-1190; 693-973; 7 10-1044; 710-956;
794-1399; 813-1346; 858-1157; 859-1079; 872- 1117; 873- 1135; 904-1128; 961-
1405; 1034-1639; 1227-1792 1238-1890 1280- 1402; 1353 -1719; 1512-1685;
1512-1921; 1512-1742; 1512-1998; 1552 1885; 1593-1941; 1625-1942; 1720-
1956; 1833-2027; 1874-2449 1874-2006; 1885- 2064; 1888 2062; 1899-2166;
2085-2592; 2141-2707; 2220-2364; 2236-2900; 2469-3059; 2533-2965; 2555-
2789; 2555-3024; 2588-3105 2607-3254 ; 2680- 3151; 2694 2959; 2722-2940;
2746-3006; 2754-3300; 2782-3022; 2796-3053; 2874-3103; 2900-3393; 2904-
3154; 2920-3191; 2950-3127 2995-3559 ; 3026- 3292; 3066 3335; 3104-3536;
3104-3293; 3104-3233; 3123-3371; 3178-3443; 3186-3488; 3187-3304; 3188-
3401; 3200-3485; 3247-3743 3260-3551 ; 3277- 3492; 3279 3498; 3283-3506;
3287-3850; 3332-3600; 3338-3642; 3368-3658; 3387-3649; 3485-3679; 3525-
3811; 3549-3799; 3558-4133 3576-3812 ; 3580- 4061; 3581 3699; 3584-3977;
3581-3738; 3611-3952; 3614-3857; 3619-3952; 3623-3742; 3632-3831; 3653- Table 3
3952; 3659-4100; 3674-3943; 3671-4140; 3692 -3952; 3696- •3923; 3703-4141 3686-3942; 3688-3940; 3696-3952; 3696-4142; 3705-4132; 3725-4139; 3710 4139; 3728-3952; 3729-4139; 3741-3943; 3726 -3874; 3744- ■3952; 3741-3984 3741-4132; 3740-4139; 3759-4079; 3779-4145; 3797-4145; 3785-4139; 3823 3952; 3826-4141; 3826-4133; 3864-4112; 3883 -4093; 3886- ■4169; 3885-4140 3895-3952; 4010-4133; 3997-4459; 3998-4249; 4000-4128; 4002-4142; 4010 4132; 4040-4262; 4041-4140; 4041-4442; 4042 -4454; 4057- ■4123; 4067-4133 4223-4663
189/LG:999183.1:2001MAR30 | | 1-509; 11-324; 16-215; 25- 573; 26-347 30- 4439; 33-395; 33-215; 37-215; 133-609; 221- 540; 264-522 ; 264-501; 274-512; 381-771; 409-771; 430-998; 694-770; 701-930 ; 723-1316; 780-1287; 807-1405; 820-1109; 820-1285; 841-1350; 844-1405; 923 -1186 1050 1224 1191- 1419; 1215-1456; 1220-1816; 1329-1605; 1404-1484; 1418 1664; 1563 1906; 1565-
1842; 1569 -1860 1592- •1919 1592-1757 1774-1956 1782-2162 1886- 2149 1981- 2269; 1986 2083; 2028 2550; 2036 2603; 2041 2639; 2042-2634; 2060- 2667; 2068 -2507 2068- 2328 2070-2176 2116-2355 2121- 2584 2125- 2578 2133- 2585; 2183 2582; 2247 2421; 2284-2455; 2324 2823; 2376-2585; 2376 2598; 2424 -3158 2434- •3069 2449-2568 2459-2986 2492 2785 2507 2761 2540- 3169; 2552 2794; 2553 2787; 2553-3128; 2553 3006; 2553 2739; 2576 3189; 2602 -2822 2617- •2788 2640-3283 2647-3150 2679 2932 2689 2973 2692- 2978; 2692 2992; 2698 2848; 2705 2974; 2744-3056; 2778 3074; 2842- 2985; 2842 -3145 2872- ■3057 2872-3354 2872 -3081 2872 3063 2872 3109 2872- 3255; 2872 3195; 2872 3087; 2872-3095; 2883 2932; 2889 3157; 2902 3363; 2923 -3205 2943- •3067 2965-3188 2968 -3177 2999-3400 3015 3283
3015-3216; 3026-3144; 3029-3603; 3034-3321; 3037 3243; 3041 3293; 3050
3302; 3068-3147; 3092-3329 3099-3635 3128 -3414 3137 3600 3145-3391 3167-3418; 3173-3502; 3199 3444; 3201 3448; 3217-3391; 3224 3320; 3226 3501; 3228-3520; 3228-3330 3236-3438 3239 -3502 3240-3498 3254-3546
3255-3511; 3258-3366; 3258-3513; 3259 3504; 3262-3837; 3278 3597; 3278-
3546; 3294-3406; 3300-3509 3302-3561 3323 -3600 3332-3809 3330-3465 3337-3598; 3337-3567; 3360 3861; 3362 3679; 3375-3533; 3376-3956; 3385 3625; 3421-3656; 3456-3675 3456-3877 3462 -3721 3477- 3728 3493-3807 3509-3781; 3549-3807; 3564 3792; 3588 3784; 3604-4166; 3605 3867; 3608- 3919;' 3624-3900; 3611-3976 3625-4039 3631 -3847 3647* 3877 3666-4182
3676-3835; 3683-4119; 3686-3912; 3689 3966; 3689-4090; 3700-4074; 3700-
3919; 3700-4095; 3703-4074 3722-4221 3711 -4183 3715-4301 3733-4250
3735-4206; 3749-3992; 3759-4323; 3772 4029; 3798-4057; 3800-4403; 3803
4050; 3824-4008; 3832-4117 3840-4397 3842 -3964 3844- 4113 3852 4183 3856-3979; 3860-3959; 3868 4111; 3869 4120; 3883 4156; 3884 4177; 3894 4147; 3894-4151; 3894-4152 3896-4140 3913 -4155 3916- 4161 3918 4180 3943-4187; 3951-4432; 3973 4444; 3989-4438; 3991-4439; 3992 4226; 3993 4119; 3993-4254; 4016-4368 4024-4380 4025 -4434 4028- 4442 4030 4441
4032-4295; 4032-4445; 4036-4323; 4036 4438; 4055-4439; 4055 4170; 4056
4394; 4056-4439; 4061-4439 4064-4441 4064 -4439 4062- 4406 4076 4544
4077-4440; 4081-4441; 4084-4441; 4089 4209; 4096-4303; 4103 4441; 4108
4442; 4120-4431; 4115-4343 4116-4439 4117 -4437 4119- 4372 4118 4439 4118-4441; 4122-4478; 4122 4287; 4123 4375; 4124-4390; 4128 4382; 4130 4441; 4130-4365; 4153-4399 4155-4554 4156 -4344 4175 4439 4177-4428 4200-4439; 4208-4422; 4208 4407; 4217 4439; 4225 4439; 4225 4444; 4226 4441; 4226-4437; 4227-4479 4233-4468 4239-4443 4244 4433 4260 4442
4260-4441; 4266-4439; 4267-4439; 4268 4505; 4273 4439; 4279 4439; 4280
4439; 4293-4413; 4300-4589 4340-4585 4354-4835 4359-4439 4365 4441
4382-4554; 4396-4510; 4403 4543; 4409-4552; 4427 4548; 4466 4885; 4466-
4716; 4467-4708; 4521-4846 4530-4769 4572-4892 4602 4869 4605 4878
4605-4875; 4605-4880; 4606 4902; 4606-4883; 4616 4928; 4617 4746; 4722
4889; 4761-4889; 4777-4874 4781-4889 4819-4889 4824-4889 4828 4889
4829-4889
190/LI:1032972.1:2001MAY17 || 1-206; 4-208; 156-476; 219-687; 222-675; 223-
684; 226-705; 226-711; 226-398; 227-678; 228-711; 236-421; 238-530; 239-
476; 238-674; 238-666; 238-595; 238-559; 238-503; 238-468; 238-455; 238- Table 3
439 238-427 238-357; 239-698; 239-689 240-676 239-653; 246-435; 255-
739 260-320 262-985; 261-463; 265-595 268-645 272-746; 274-452; 275-
747 286-714 290-663; 299-688; 298-535 304-462 300-550; 301-527; 304-
526 306-916 315-493; 319-560; 319-578 335-756 335-508; 337-874; 337-
642 337-629 337-653; 337-647; 337-636 338-617 360-620; 365-653; 377-
637 388-882 382-644; 383-631; 387-524 403-877 405-662; 435-887; 414-
672 436-881 435-744; 437-706; 441-978 456-735 459-693; 463-627; 466-
574 468-946 490-978; 501-761; 521-806 524-748 525-781; 537-991; 541-
994 544-807 553-962; 556-993; 559-781 580-915 577-996; 577-992; 580-
993 584-839 596-886; 586-995; 589-992 591-866 589-685; 601-992; 618-
880 624-993 625-1008 ; 628-824 ; 632-998; 644-955; 648-1000; 646-956; 653-
968 653-905 656-906; 656-894; 656-893 656-888 656-963; 660-891; 656-
886 664-895 679-986; 680-917; 711-903 720-992 723-926; 742-992; 744-
993 748-990 752-997; 755-997; 755-992 763-992 769-992; 833-992; 837-
957 851-995 862-996; 686-992
191/ 'LI:17066( 5.6:2001MAY17 | | 1- 240; 63-670; 63-431; 63-612
192/ 'LI: 19704! 3.10:2001MAY17 j | 1 -192; 14- -734; 13-744; 57-453; 66-633 ; 90-
322 150-679 164-747; 169-667; 171-425 183-419 190-639; 212-642; 212-
529 212-461 212-452; 264-452; 270-510 282-569 283-850; 311-470; 319-
572 371-870 414-678; 448-1005 ; 464-715; 477-753; 521-648 556-804 ; 556-
990 574-825 577-733; 593-797; 667-1095; 667-877; 677-1156; 682-937; 687-
128( 3; 687-94: L; 699-946 ; 713-944 ; 720-983; 730-1076; 739-985; 749-1054; 749
975 751-101' 7; 780-1275; 815-1032; 833-1279; 830- -1351; 836- -1099; 861-1053;
864-1125; 889-1166; 906-1265; 925-1267; 931-1494; 953-1178; 963-1234; 972- 1211; 973-1261; 991-1053; 1043-1172; 1051-1306; 1065-1325; 1066-1143; 1074-
1565; 1079- 1154 1082- 1143 1086- 1638 1086-1276 1086-1299 1088-1223 1089-1382; 1090 1330; 1092 1506; 1109 1357; 1113 1400; 1121 1710; 1121 1554; 1121- 1364 1129- 1708 1138- 1402 1143-1530 1143-1426 1155-1559 1156- 1599; 1157 1377; 1165 1440; 1173-1356; 1179 1347; 1181 1567; 1185 •1508; 1201- 1459 1221- 1371 1239- 1721 1241-1720 1248-1488 1248-1366 1270-1795; 1275 1499; 1299 1528; 1309 1579; 1309-1774; 1319-1773; 1336- 1775; 1340- 1624 1340- 1774 ' 1342- 1780 1347-1775; 1348-1927 1348-1603 1356-1599; 1360 1648; 1386-1667; 1400 1643; 1402-2021; 1410 1629; 1414- 1642; 1419- 1750 1429- 1780 1434-1780 1439-1698; 1443-1780 1444-1780 1449-1517; 1465 1730; 1477 1757; 1505 1765; 1507-1780; 1509-1758; 1521 1902; 1521- 1719 1522- 1674 1537-1819 1546-1764; 1548-1778 1552-1855 1554-1780; 1557 1842; 1557 1780; 1559 2174; 1576-1774; 1586-1777; 1587 1857; 1588- 1780 1590- 1777 1592-1780 1593-1779; 1599-1775 1712-1954 1712-1775; 1717 1780; 1743 2147; 1782 2034; 1784-2061; 1804 2408; 1806 2359; 1806-■1941 1806- •1865 1812-•2004 1816-2152; 1825-2129 1825-2101 1825-2060; 1827 2123; 1848-2361; 1835 2105; 1879-2478; 1879 2169; 1907- 2440; 1914-2168 1920- ■2440 1920-2441 1931-2462; 1931-2176 1934-2453 1934-2219; 1946 2402; 1969 2168; 1970 2442; 1985-2454; 1988 2224; 1989- 2441; 1988-2478 2003- •2422 1989-2173 2002-2471; 2008-2471 2012-2075 2023-2441; 2018 2478; 2020 2478; 2022 2477; 2025-2478; 2026-2471; 2029 2471; 2031-2437 2032- ■2479 2036-2471 2035-2436; 2040-2471 2041-2478 2046-2478; 2066 2348; 2066 2343; 2070 2481; 2076-2470; 2077 2478; 2078 2478; 2084-2478 2090- ■2471 2093-2327 2112-2440; 2115-2479 2115-2471 2119-2470; 2119 2345; 2137 2487; 2137 2480; 2140-2471; 2139 2259; 2150 2478; 2150-•2471 2162- 2478 2163-2471 2165-2412; 2166-2479 2167-2471 2158-2380; 2189 2480; 2189 2471; 2196 2471; 2215-2471; 2219 2478; 2220
2437; 2232-2374; 2239-2471; 2284-2478; 2291-2477; 2306-2478 2306-2471
2314-2471; 2303-2478; 2334-2435; 2371-2479; 2415-2478
193/LI:228655.5:2001MAY17 |J 1-447; 261-707; 1-488; 2-448; 1-448; 25-449;
9-208; 80-447; 178-711; 437-688
194/LI:229789.6:2001MAY17 | | 1-851; 65-888; 141-804; 159-724; 208-964; 222-
889; 250-983; 280-968; 313-943; 446-1031; 446-995; 563-931; 572-1146; 638-
932; 700-1353; 732-1182; 832-1182; 999-1176; 999-1182; 999-1146; 999-1104;
1002-1174 Table 3
195/LI:231500.8:2001MAY17 || 377-588; 456-948; 767-1301; 855-1412; 948- 1510; 975-1443; 1102-1443; 1233-1408; 803-1270; 803-1362; 815-1049; 830- 1052; 913-1443; 917-1458; 919-1108; 936-1213; 950-1419; 956-1432; 965-1436; 972-1443; 979-1401; 982-1595; 1039-1408; 1040-1625; 1053-1353; 1103-1442; 1108-1244; 1135-1807; 1135-1312; 1234-1408; 1264-1408; 1-180; 83-519; 153- 720; 368-845; 377-900; 377-862; 377-913; 377-943; 377-594; 377-844; 378- 984; 377-915; 377-847; 377-846; 377-895;. 377-908; 377-823; 377-968; 383- 987; 392-1038; 526-1003; 583-1055; 1329-1408; 588-1101; 629-1046; 791-994 196/LI:253851.26:2001MAY17 || 1653-2247; 1753-2136; 1681-2110; 1899-2110; 1996-2110; 1600-2092; 1812-2057; 1776-2057; 1829-2057; 1782-1915; 1570- 1787; 1595-1778; 1579-1776; 1579-1760; 1555-1740; 1208-1739; 1449-1718; 1324-1714; 1376-1714; 1349-1713; 1398-1713; 480-732; 361-624; 68-601; 120- 590; 194-590; 316-590; 314-577; 174-560; 172-548; 1-490; 176-412; 1449- 1713; 1496-1713; 1444-1710; 1590-1694; 1412-1688; 1450-1685; 1450-1682; 1415-1678; 1169-1677; 1080-1675; 1174-1672; 1181-1673; 1289-1669; 1094- 1641; 1382-1636; 1268-1636; 1410-1598; 1195-1586; 534-765; 516-763; 1310- 1586; 1402-1586; 1339-1583; 1346-1565; 1312-1520; 1207-1483; 1281-1428; 1295-1428; 1123-1421; 1162-1413; 1149-1380; 1165-1364; 1076-1268; 947-1215; 978-1214; 1071-1196; 962-1166; 828-1109; 828-1077; 538-1035; 792-990; 652- 940; 689-940; 663-904; 677-872; 687-870; 375-869; 319-781 197/LI:373302.1:2001MAY17 || 1-563; 23-532; 202-459; 206-824; 729-1163; 729-1371; 1-229; 729-819
198/LI:405707.12:2001MAY17 || 756-1308; 761-1171; 778-1305; 809-1301; 888- 1312; 897-1309; 937-1185; 945-1159; 1025-1325; 533-1302; 539-1325; 533- 1313; 542-1325; 551-1107; 552-1310; 541-1309; 558-1302; 578-1312; 575-1311; 582-1306; 589-1326; 582-1301; 604-1017; 608-1290; 607-974; 611-1157; 611- 1312; 613-1326; 644-885; 637-1304; 651-1316; 646-1318; 639-1312; 652-1309; 656-1323; 657-1315; 656-1334; 662-1325; 667-1309; 674-925; 694-1243; 698- 1244; 722-1307; 727-1305; 376-1320; 454-874; 502-1023; 461-1310; 473-1310; 488-1311; 501-1311; 1-392; 68-792; 126-839; 103-808; 102-789; 105-776; 137- 810; 108-726; 108-811; 107-813; 108-857; 109-857; 109-764; 108-806; 108-
733; 109- -741; 109- -618; 112-829; 112-776; 113-787; 113-822; 113-869; 114-
817; 116- -747; 115- -828; 116-823; 116-844; 127-832; 123-854; 133-833; 124-
757; 121- -787; 125- -801; 128-838; 127-703, 126-864; 127-857; 128-835; 128-
831; 127- -945; 129- -837; 127-839; 127-859; 128-794; 130-894; 130-741; 133-
837; 129- -751; 129- -780; 133-776; 111-1044; 127-885 ; 126-774 ; 136-932 ; 157
459; 266- -992; 377- -1078 ; 36566--11006611 199/LI: 411441.8 :2001MAY17 || 332-539; 347-793; 350-921; 350-871; 362-458; 362-470; 358-880; 362-887; 379-950; 401-990; 396-1018; 399-913; 408-1011; 410-1052; 410-1118; 448-674; 457-1067; 471-998; 856-1174; 485-618; 475-
1225; 495-942; 498-887 505-706; 508- 787; 510-1051; 534-708 ; 534-754; 542- 808; 556-893; 559-1083 575-1245; 607 -954; 604-920; 604-810 ; 597-915; 597- 1207; 598-874; 599-872 601-931; 603- 982; 604-855 ; 609-1180 ; 610-860; 619- 881; 617-825; 624-1283 632-1238; 645 -1072; 645-889; 645-^876; 881-1017; 655-1204; 662-938; 676-1295; 679-1159 ; 684-1071; 692-1301; 697-936; 705- 1175; 709-932; 709-1130; 711-981; 716 -1328; 720-1260; 732-1048; 726-963; 740-1353; 730-1144; 737-1288; 759-976 ; 759-1360; 762-1352; 761-1466; 770- 1381; 775-1192; 788-1353; 778-1280; 7 85-1338; 786 -1300; 800 -1105; 797-1385; 800-1064; 803-959; 829-1298; 830-1100 ; 840-1085; 854-1119; 854-1386; 854- 1287; 884-1462; 919-1461; 932-1415; 9 34-1067; 950 -1440; 973 -1456; 1019- 1415; 1019-1175; 1022-1299; 1028-1149 ; 1109-1245; 1109-1232 ; 1196-1465; 915-1451; 885-1298; 888-1408; 890-149 5; 896-1146; 899-981; 902-1418; 1-495; 9-666; 46-626; 47-643; 74-335; 92-610 ; 92-607; 95 -751; 104- 632; : 111133--778833;;
121-497 176-416; 180-650 183-711; 186-488; 196-442; 196-400; 207-790; 228-702 246-817; 257-810 272-509; 276-600; 288-573; 293-822; 310-613 329-732 329-786; 330-774 329-795; 317-971; 165-749; 186-579; 233-514 282-761 329-618
200/LI:758193.3:2001MAY17 || 1587-1840; 1642-1874; 1678-1940; 1713-1968; 1754-1976; 1825-1980; 1-598; 386-511; 448-680; 509-783; 633-804; 694-947; 715-1269; 757-994; 1390-1649; 1430-1649; 1444-1688; 1456-1666; 1480-1762; Table 3
1498-1626; 1520-1976; 1546-1812; 1577-1968; 57-524; 289-519; 296-516; 323- 701; 326-613; 350-604; 390-659; 403-707; 422-826; 431-709; 449-709; 478- 545; 485-736; 498-762; 543-749; 553-826; 559-827; 587-858; 630-880; 672- 888; 687-1001; 687-932; 694-1184; 699-1212; 702-971; 706-957; 714-968; 715- 980; 715-1003; 738-1047; 738-968; 757-972; 769-1115; 769-1169; 789-1246; 791-1068; 807-1325; 807-1009; 809-929; 824-1036; 829-962; 848-1311; 865- 1231; 879-1133; 888-1185; 891-1128; 898-1164; 922-1086; 929-1435; 941-1197; 945-1228; 947-1213; 956-1188; 961-1172; 972-1228; 975-1115; 991-1123; 993- 1212; 999-1577; 1001-1273; 1006-1273; 1043-1303; 1043-1311; 1045-1606; 1048-1318; 1051-1291; 1051-1565; 1051-1576; 1052-1288; 1055-1266; 1069- 1354; 1075-1528; 1086-1593; 1098-1344; 1102-1372; 1101-1254; 1106-1292; 1113-1359; 1119-1367; 1119-1359; 1123-1321; 1143-1406; 1158-1657; 1158- 1421; 1186-1423; 1194-1460; 1228-1444; 1237-1559; 1248-1869; 1250-1463; 1253-1484; 1253-1486; 1273-1805; 1276-1480; 1283-1543; 1295-1800; 1295- 1462; 1297-1799; 1304-1636; 1305-1568; 1307-1546; 1323-1933; 1325-1595; 1326-1601; 1370-1633; 1378-1953; 1380-1645; 1381-1626; 1383-1937; 1387- 1951; 1393-1995; 1397-1647; 1400-1545; 1428-1645; 1432-1837; 1436-1711; 1435-1706; 1437-1711; 1440-1679; 1445-1944; 1455-1695; 1455-1679; 1455- 1678; 1456-1645; 1466-1748; 1467-1738; 1476-1982; 1482-1881; 1486-1928; 1497-1758; 1498-1731; 1499-1940; 1501-1761; 1506-1980; 1508-1733; 1520- 1799; 1521-1770; 1522-1968; 1537-1981; 1543-1990; 1551-1994; 1552-1976; 1560-1827; 1569-1976; 1580-1836; 1582-1976; 1584-1985; 1587-1837; 1592- 1984; 1596-1974; 1598-1934; 1602-1954; 1606-1984; 1632-2003; 1645-1877; 1648-1920; 1661-1926; 1663-1840; 1674-1986; 1674-1837; 1678-1938; 1677- 1863; 1679-1979; 1687-1941; 1702-1976; 1704-1975; 1731-1983; 1743-1970; 1749-1986; 1748-1959; 1770-1907; 1774-1989; 1774-1976; 1776-1952; 1801- 1979; 1849-1954
201/LI:1028562.3:2001MAY17 | 1| 23-208; 21-208; 22-208; 1-187 202/LI:104650.7:200lMAY17 || 1-411; 1-299; 1-560; 156-423; 235-735; 240- 797; 404-793; 429-592; 1-240; : 1-582; 1-241; 39-282; 46-399; 46-246; 70-302; 70-533; 1-497; 1-541; 1-559; 1-444
203/LI:1094557.4 2001MAY17 326-935; 281-936; 290-934; 374-935; 322-934;
275-934 277-933 281-933; 290-933; 283-930; 308-930 274-936; 235-926; 304-925 275-924 278-924; 290-925; 292-926; 435-920 276-906; 335-736; 322-686 1-681; 7-671; 22-659; 2-652; 19-641; 31-682 8-641; 92-632; 33-
615; 506-584; 1-582; 2-578; 32-579; 46-548; 23-539; 31-438
204/LI:1143528.4 2001MAY17 || 1-474; 1-374; 1-509; 1-233; 40-371; 186-425; 264-460; 325-896 378-912; 378-645; 398-674; 404-954; 562-958; 577-825; 635-879; 725-994 776-893 205/LI:1172210.7 2001MAY17 1450-1804; 1531-1801; 1411-1801; 1450-1801; 1279-1703; 1414-1698; 1253-1404; 876-1368; 515-1113; 515-1115; 515-1024; 168-736; 1-295; 1-294 206/LI:1178659.14:200lMAY17 | | 1847-2379; 1896-2238; 1970-2435 1988-2437;
2033-2435; 2080-2452; 1-539; 3-152 161-781; 187-317; 360-1070; 417-1113; 444-988; 428-967; 440-728; 449-947 452-1000; 452-692; 452-947; 452-931; 452-867; 452-933; 452-823; 452-826 453-1044; 454-1047; 459-1079; 478-926; 486-1111; 502-737; 502-991; 510-1142; 529-681; 522-1135; 526-1166; 548-710; 556-957; 570-1086; 580-1265; 577-1220; 609-1219; 644-1338; 651-1068; 650- 1268; 659-1243; 660-1136; 674-1219; 682-1219; 684-1219; 697-1219; 721-1427; 727-1219; 752-1219; 752-1236; 755-1226; 756-1219; 761-1219; 2125-2395; 2137-2426; 2139-2432; 2140-2432; 2152-2451; 2209-2435; 2237-2435; 2238- 2426; 2263-2507; 2316-2416; 797-1219; 798-1219; 802-1219; 827-1219; 835- 1219; 847-1219; 853-1545; 859-1219; 860-1219; 871-1596; 896-1166; 901-1219; 902-1219; 906-1219; 912-1219; 938-1219; 938-1639; 941-1219; 944-1388; 953- 1219; 961-1469; 961-1660; 965-1219; 963-1229; 965-1266; 965-1264; 980-1507; 2028-2439; 2031-2439; 2045-2438; 2064-2250; 206'6-2426; 2073-2252; 2084- 2435; 2085-2435; 1001-1640; 993-1644; 1009-1219; 1015-1713; 1018-1219; 1073-1627; 1069-1601; 1078-1632; 1096-1766; 1115-1786; 1150-1812; 1162- 1784; 1158-1544; 1333-1901; 1345-1980; 1473-2146; 1505-2076; 1509-1809; 1514-2091; 1510-2046; 1524-2105; 1524-2143; 1526-1957; 1534-1849; 1534- Table 3
2111; 1534-1969; 1534-1942; 1534-1938; 1534-1890; 1534-1880; 1534-1926; 1534-1814; 1534-1792; 1534-1760; 1534-1988; 1552-2215; 1546-2112; 1608- 1862; 1628-1989; 1657-1820; 1648-2170; 1662-2358; 1669-2208; 1677-2285; 1705-2152; 1702-2239; 1682-2298; 1691-2300; 1691-2201; 1696-2174; 1703- 2301; 1704-2251; 1731-2256; 1716-2255; 1770-2346; 1769-2341; 1779-2358; 1789-2353; 1793-2359; 1818-2428; 1816-2435; 1822-2255; 1847-1980; 1865- 2079; 1874-2395; 1896-2415; 1942-2260; 1937-2239; 1941-2394; 1942-2148; 1943-2383; 1975-2438; 1980-2263; 1981-2440; 1983-2442; 1991-2435; 2007- 2438; 2117-2442
207/LI:1983726.3:2001MAY17 || 1-526; 1-618; 1-613; 3-417; 3-607; 3-610; 320-416; 328-435; 465-858
208/LI: 2051495.3 :2001MAY17 || 948-1203; 1009-1203; 1060-1288; 1102-1611; 1495-1685; 1502-1670; 1521-1616; 1596-2117; 1990-2098; 822-1203; 841-1180; 843-1203; 880-1203; 953-1203; 976-1203; 978-1657; 985-1203; 1035-1203; 1049-1609; 1050-1601; 1056-1594; 1066-1203; 1073-1598; 1087-1690; 1087- 1685; 1119-1203; 1137-1707; 1489-1685; 1493-2101; 1495-1628; 1501-1691; 1501-1704; 1501-1688; 1508-1625; 1513-2261; 1521-1669; 1-324; 200-557; 207- 475; 209-384; 316-435; 399-989; 399-982; 399-998; 399-1001; 399-1065; 399- 830; 399-655; 399-890; 423-939; 423-662; 526-1029; 563-1062; 615-1039; 615- 1070; 670-1073; 670-1180; 732-1203; 742-1200; 805-1606; 1522-1628; 1525- 2117; 1528-2088; 1532-1646; 1561-1688; 1562-1628; 1574-1627; 1629-1688; 1633-1688; 1990-2075; 1990-2101; 2004-2116
209/LI: 2117629.1.2001MAY17 || 297-566; 346-880; 346-884; 388-970; 406-994; 434-987; 447-965; 458-958; 527-1128; 532-1123; 558-1107; 567-1039; 580- 1140; 671-1141; 673-1342; 720-1272; 722-978; 797-1233; 797-1010; 861-1203; 988-1139; 4-258; 4-253; 1-672; 1-530; 1-384; 1-604; 13-309; 17-591; 35-653; 79-745; 132-908; 145-788; 185-813; 218-703; 290-841
210/LI:2118007.3:2001MAY17 |) 152-619; 1-529; 1-542; 152-578; 360-1016; 597-1017
211 /LI: 2118292.9 :2001MAY17 || 335-788; 956-1175; 67-689; 335-676; 1-131; 26-720; 66-588; 66-543; 67-541; 70-545; 72-131; 82-131; 335-504; 335-687; 342-435; 335-790; 395-964; 435-965; 527-1127; 932-1221; 956-1561; 993-1286; 994-1231
212/LI:2118733.7:2001 AY17 || 1-783; 1-651; 350-795; 457-876 213/LI:212702.3:2001 AY17 || 1333-1995; 2031-2267; 1334-1517; 1346-1536; 1377-1719; 1371-1913; 1404-1535; 1432-1566; 1433-1689; 1441-1940; 2042- 2299; 1440-1532; 1447-2095; 1451-1742; 2044-2624; 1459-1713; 1460-1692; 1462-1769; 1473-1743; 1504-1963; 1508-1707; 2082-2483; 1530-1705; 2071- 2755; 1544-2111; 1550-1855; 1560-1805; 1584-1854; 1591-1796; 1613-2266; 1621-2123; 1621-1865; 1622-1844; 1624-1870; 1668-2198; 1679-2281; 1694- 2342; 1699-1948; 1703-1894; 1709-2070; 1746-1990; 1748-2015; 1784-2048; 1787-1938; 1788-2359; 1791-2280; 1791-2027; 1806-2106; 1801-2082; 1806- 2310; 1806-2335; 1804-2107; 1806-2280; 1827-2027; 1840-2509; 1846-2017; 1864-2319; 1870-2551; 1885-2099; 1919-2191; 1927-2218; 1937-2139; 1943- 2428; 1944-2379; 1947-2282; 1947-2201; 1963-2116; 1993-2259; 2008-2689; 1-
273 4-245; 8-280; 8-269; 8-250; 9-306; 13-264; 14-282; 17-310; 17-277; 19- 475 19-283; 24-273; 27-297; 29-584; 31-284; 43-300; 144-317; 159-749; 214- 581 212-530; 240-699; 256-695; 256-504; 287-536; 316-807; 347-860; 347- 827 435-742; 447-1032; 531-1028; 573-734; 628-1008; 759-1558; 832-1349; 864-1083; 877-1417; 877-1439; 877-1443; 879-1165; 887-1126; 911-979; 935- 1524; 993-1260; 1002-1249; 1012-1279; 1023-1300; 1039-1357; 1050-1495;
1066-1693; 1084-1757; 1088-1348; 1105-1550; 1141-1576; 1143-1384 1144-
1416; 1144-1380; 1151-1436; 1179-1545; 1225-1838 1256-1371; 1281-1931;
1294-1578; 1294-1544; 1309-1594; 1320-1994; 1324-1852; 2520-2864 2527-
2860; 2530-2854; 2528-2771; 2547-2856; 2547-2877 2554-2830; 2556-2827; 2557-2795; 2560-2792; 2566-2864; 2569-2714; 2570 2710; 2576-2865 2598- 2829; 2600-2870; 2606-2854; 2606-2817; 2606-2859 2623-2870; 2625-2829; 2627-2858; 2643-2864; 2647-2815; 2649-2808; 2666 2858; 2696-2864 2700- 2864; 2719-2994; 2767-3412; 2777-2826; 2977-3093 3215-3955; 3302-3955;
3373-3955; 3572-3841; 3572-3818; 3622-4231; 3754-4009; 2071-2574 2088- Table 3
2359; 2083-2681 2104-2392; 2106-2282; 2112-2230; 2112-2400; 2129-2367; 2141-2413; 2142 -2714; 2153-2476; 2160-2765; 2164-2682; 2167-2865; 2168- 2746; 2189-2416 2189-2436; 2197-2633; 2205-2833; 2444-2834; 2447-2865; 2250-2726; 2448 -2866; 2255-2505; 2454-2864; 2262-2641; 2458-2715; 2261- 2532; 2462-2865 2268-2442; 2276-2807; 2464-2856; 2465-2853; 2277-2780; 2280-2486; 2467 -2862; 2288-2938; 2473-2866; 2474-2864; 2307-2763; 2473- 2732; 2306-2847 2307-2813; 2316-2823; 2325-2833; 2473-2690; 2323-2563; 2332-2821; 2483 -2832; 2343-2582; 2346-2803; 2490-2601; 2361-2611; 2368- 2837; 2375-2829 2374-2864; 2389-2836; 2396-2829; 2400-2871; 2403-2864; 2404-2685; 2415 -2864; 2419-2864; 2419-2862; 2425-2864; 2438-2872; 2440- 2837; 2440-2698 2497-2857; 2502-2854; 2502-2834 214/LI:2207871.10:2001MAY17 | | 68-323; 1-649; 39-640; 70-638; 83-579; 84- 369; 105-402; 202-714; 243-567; 243-670; 266-731; 268-724; 275-724; 277-
731; 278-721; 290-684; 320-730; 322-729; 329-723; 329-496; 329-684; 357- 723; 358-727; 390-546; 393-723; 405-686; 405-723; 406-702; 435-721; 440- 721; 440-731; 468-727; 557-734; 579-836; 579-1011; 608-1209; 621-835; 746- 1234; 795-1093; 798-1223; 810-977; 861-1220; 861-1218; 861-1216; 861-1107; 861-1017; 861-1452; 899-1528; 899-1492; 929-1251; 944-1218; 977-1209; 995- 1573; 1059-1453; 1131-1218; 1131-1217; 1143-1218; 1380-1582; 1380-1888; 1387-1857; 1387-1619; 1454-1884; 1584-1662; 1630-2026 215/LI. -2207876.5. -2001 AY17 | | 1-191
216/LI:2208743.1:2001MAY17 j j 1-590; 12-271; 76-363; ; 107-271; 454-865 217/LI: 2208744.1-.2001MAY17 | j 1258-1311; 1418-1678; 1-253; 155-409; 155- 449; 167-591; 377-535; 377-578; 541-1038; 807-1130; 848-901; 936-1241; 1044-1449; 1147-1470; 1169-1614; 1169-1445
218/LI:230905.3:2001MAY17 | | 1-131; 34-168; 37-299; 38-128; 39-128; 47-128; 51-128; 118-286; 119-286; 120-286; 125-286; 126-286; 126-226; 128-286; 129- 286; 130-286; 134-238; 737-1109; 746-1107; 747-1102; 759-1005; 764-1102; 770-966; 778-1085; 810-1067; 912-1108; 732-964; 734-966; 134-286; 136-286; 138-286; 139-769; 147-286; 148-286; 147-285; 149-305; 152-286; 179-652;
184-831; 181-286; 183-286; 198-286; 226-940; 224-286; 229-830; 225-980;
433-108-2 : 457-755; 552-757; 560-806; 569-1064; 576-868; 577-1093; 577-800;
580-772 584-856; 584-805; 584-1120; 588-1001; 588-933; 588-772; 588-768;
588-697 588-659; 588-682; 588-1060; 591-998; 591-1102; 597-911; 597-819;
597-859 609-1102; 609-886; 616-892; 616-864; 616-853; 617-814; 618-917;
618-810 627-914; 629-873; 634-1107; 635-957; 641-1102; 641-1067; 644-1102;
654-1103 658-1105; 667-906; 668-1101; 670-1102; 670-971; 670-914; 673-
1102; 678-1066; 683-1101; 689-1106; 691-1102; 702-1102; 709-1030; 722-1103; 730-1086
219/LI:235233.95 2001MAY17 1-278; 233-843; 408-921; 493-733 220/LI:235359.24 2001MAY17 637-898; 319-556; 323-910; 333-465; 339-902;
330-594 331- 545 332-602 334-908 333- 492 323- 602 324-778; 340-611 328-520 344- 901 343-845 343-842 345- ■928 344- 865 343-597; 343-584 335-547 346- 592 350-620 353-940 353- ■532 349- 537 353-596; 353-530 343-607 343- 611 355-620 349-613 350- 610 363- 669 351-647; 365-482 356-597 370- 605 371-620 374-623 363- ■610 364- 625 364-590; 365-635 365-632 365- 465 369-613 382-607 371- •604 385-■634 393-664; 393-645 394-539 393- 571 386-688 400-633 403- 579 411- 562 420-721; 416-681 416-664 417- 585 406-628 426-637 449- 723 697- 100 : 271-476; 265-77 263-564 263- 554 263-576 263-561 274- •438 265- 767 265-727 265-725 265-642 265- 536 265-526 265-522 275- •508 267-■534 268-532 267-536 276-495 269- 847 268-759 268-657 269- 651 268--535 277-410 269-565 269-558 271- 586 271-554 271-547 278- 371 272- 576 281-475 272-660 282-518 283- 492 286-497 287-510 286- 871 282- 865 282-626 283-718 283-531 284- 594 284-561 283-545 285- 811 285- 595 285-553 287-875 286-780 286- 607 287-554 287-553 287- •543 286- 542 286-520 286-772 288-554 289- 577 289-532 291-568 305- 484 298- 533 298-925 298-354 304-864 317- 395 309-606 311-589 312- 618 313- 584 318-627 318-567 319-570 1-180; 71-548; 198-452; 197-424; 207-277; 217-464; 218-458; 217-
492; 232-492; 232-466; 233-502; 237-464; 237-446; 237-365; 233-796; 234- Table 3
521 ; 234-516 234- -465 237- -544 ; 250- -506 ; 241- -301 ; 252 -472 ; 252-
379 ; 252-512 252- -508 253 - -500 ; 253-400 255- -500 ; 255- -490 ; 258-518 ; 259-
486 ; 252 -804 252 - -523 252 - -521 ; 250-850 253- -587 ; 253- -532 ; 252-533 ; 262-
516 ; 262-443 263 - -517 263 - -512 ; 263-381 255- -824 ; 265- -507 ; 265-505 ; 265-
501 ; 266-519 265- -379 267 - -461 ; 266-454 267- -397 ; 259- -553 ; 259-541 ; 260-
562 ; 260-535 260- -529 269- -553 ; 261-738 261- -555 ; 270- -441 ; 271-465 ; 266-
495 ; 262-543 262- -466 481- -906 ; 678-837, 677- -946 ; 701- -1006 ; 277-862
221/LI:238365.6:2001MAY17 | | 279-516; 467-724; 585-734; 720-809; 725-801; 1117-1425; 1117-1396; 1134-1389; 1134-1394; 1134-1357; 853-1363; 585-854; 1135-1192; 1-363; 648-1171; 689-1283; 242-616 222/LI:260259.23:2001MAY17 | | 1-133; 29-172
223/LI:321069.2:200lMAY17 || 3325-3625; 3369-3486; 3422-3659; 2280-2530; 2490-2939; 2584-2849; 2613-3197; 2630-2928; 2692-3114; 2791-3188; 2830- 3067; 2884-3442; 2990-3135; 1-315; 5-451; 8-324; 376-942; 866-1396; 881-
1521; 1186-1450; 1206-1823; 1235-1689; 1238-1518; 1441-2060 1480-1672;
1515-1760; 1592-2150; 1797-2027; 1808-2081; 1829-2095; 1867-2197; 1867
2088 1868- 2244 1967- 2245; 2018- •2203 ,- 2072- -2564 ; 2072- 2335 2129-2369; 2129 2268; 2134 2389; 2144-2684; 2146 -2339 ; 2196-2432; 2197 2468; 2206- 2444 2216- 2483 2228- 2519; 2228-2414 ; 2242- -2496 ; 2246- 2340 2264-2464; 2283 2430; 2410 2732; 2432-2638; 2442 -2542 ; 2503-2736; 2506 2746; 2534- 2786 2549- 2804 2574- 2747; 2584-•2789 ; 2598- -2894 ; 2613- 2796 2607-2937; 2613 2981; 2613 3022; 2613-2952; 2613 -2910 ; 2643 -2869; 2672 2942; 2677- 2885 2691-2941 2702- 2939; 2706-■2968 ; 2729 -3024 ; 2751-2965 2791-3074; 2799 3033; 2799 3079; 2828-3076; 2830 -3438 ; 2844-3429; 2862 3055; 2866- 3440 2867- 3090 2953- 3211; 2955-3246 ; 2969- -3404 ; 2987-■3268 3004-3466; 3006 3476; 3014 3479; 3014-3473; 3027 -3476 ; 3031-3473; 3073 3476; 3075- 3344 3077-3473 3078- 3473; 3080-3439 ; 3093- -3479 ; 3100-3480 3109-3412;
3116-3473; 3125-3479; 3134-3476; 3135-3473; 3137-3479; 3146-3398; 3155- 3620; 3159-3528; 3160-3654; 3181-3644; 3197-3402; 3213-3470; 3221-3468: 3249-3466; 3272-3473; 3272-3481; 3287-3473; 3291-3473; 3313-3479; 3320- 3473; 3340-3624; 3347-3620; 3350-3476; 3357-3613; 3359-3608; 3385-3578; 3390-3723; 3390-3715; 3397-3578; 3574-4032; 3779-3835; 3791-4032; 3801-3885 224/LI:331499.8:200lMAY17 | | 1-257; 11-342; 11-411; 11-268; 14-291; 29-647; 30-286; 31-531; 33-356; 36-471; 35-418; 35-240; 36-333; 39-278; 41-206; 47- 289; 49-643; 48-492; 54-319; 56-324; 63-304; 68-324; 68-278; 70-245; 71- 484; 74-327; 89-332; 91-513; 94-339; 111-307; 166-229; 588-979; 634-1227; 704-1186; 712-1253; 722-970; 726-1315; 727-861; 731-1212; 740-1218; 760- 1329; 791-1137; 814-1403; 841-1212; 865-1166; 866-1459; 866-1451; 866-1425; 868-1510; 876-1142; 885-1494; 964-1431; 973-1521; 980-1610; 981-1645; 992- 1600; 1001-1212; 1009-1513; 1023-1183; 1034-1738; 1058-1315; 1090-1522; 1100-1618; 1110-1532; 1117-1538; 1127-1536; 1137-1390; 1138-1462; 1138- 1232; 1141-1504; 1144-1600; 1144-1842; 1227-1467
225/LI:332176.8:2001 AY17 | | 1-415; 1013-1374; 1060-1316; 860-1310; 968- 1309; 907-1308; 1081-1305; 749-1285; 746-1272; 849-1267; 542-1219; 459- 1048; 557-916; 557-776; 403-666; 217-665; 409-660; 157-642; 159-603; 1-599; 284-536; 53-514; 63-514; 191-514
226/LI:333952.7:2001 AY17 | | 1-603; 1-292; 12-211; 12-540; 12-537; 12-500; 12-577; 12-581; 12-613; 12-463; 12-604; 12-428; 12-260; 12-366; 12-578; 63- 535; 119-644; 139-778; 171-456; 243-500; 267-890; 268-497; 292-826; 294- 578; 303-873; 320-884; 345-917; 362-938; 360-888; 364-837; 456-1051; 440- 1060; 501-758; 558-1069; 582-1058; 594-1070; 635-1029; 693-881; 684-1059; 808-1024
227/LI:338428.2:2001MAY17 | | 1-384
228/LI:343869.2:2001MAY17 j j 3155-3475; 3051-3463; 3049-3462; 3254-3463; 3128-3460; 3073-3459; 2980-3458; 3241-3458; 3204-3457; 3187-3456; 3114- 3458; 3172-3457; 3295-3457; 3105-3457; 3110-3457; 3113-3456; 3102-3457; 3058-3455; 2999-3454; 3032-3453; 3103-3453; 3108-3453; 3129-3451; 3148- 3447; 3328-3440; 3186-3440; 3119-3430; 3013-3419; 3105-3418; 2988-3415; 2899-3414; 2964-3408; 3148-3406; 3221-3402; 2928-3400; 3183-3394; 2757- 3407; 2852-3395; 3030-3389; 3149-3389; 2926-3377; 3143-3365; 3223-3361; Table 3
2970-3354; 3106-3334; 3098-3325; 3098-3317; 3040-3302; 2953-3300; 3212- 32 4; 3036-3293; 2728-3287; 3105-3278; 3007-3271; 3039-3254; 2572-3255; 2975-3245; 3046-3233; 2881-3201; 2993-3200; 2974-3194; 2947-3194; 2979- 3183; 2505-3179; 2929-3179; 2746-3178; 2848-3177; 2930-3175; 2873-3175; 3043-3173; 4540-4939; 4619-4g38; 4316-4937; 4607-4936; 4597-4884; 4371- 4867; 4431-4868; 4747-4823; 4470-4770; 4392-4659; 4290-4639; 4237-4622; 4095-4618; 4315-4580; 4223-4530; 3975-4476; 3936-4455; 3874-4439; 4166- 4426; 3874-4395; 4047-4367; 3969-4334; 3846-4322; 3975-4251; 3845-4238; 3936-4217; 3903-4135; 3479-3885; 3531-3865; 3363-3854; 3682-3846; 3507- 3846; 3470-3846; 3529-3822; 3526-3813; 3634-3811; 3507-3705; 3479-3670; 3353-3604; 3034-3601; 3273-3552; 3155-3550; 3027-3541; 3136-3547; 3115- 3548; 3122-3547; 3306-3545; 3172-3543; 3220-3543; 3216-3542; 3363-3542; 3182-3543; 3286-3542; 3265-3542; 3245-3542; 3210-3542; 3130-3540; 3189- 3540; 3157-3541; 3221-3540; 3083-3535; 3082-3534; 3242-3534; 3126-3531; 3293-3531; 3323-3530; 3423-3530; 3283-3530; 3358-3528; 3254-3525; 3094- 3525; 3333-3524; 3460-3523; 3293-3522; 3354-3512; 295g-3504; 3057-3502; 3033-3501; 3057-3500; 320g-3495; 2927-3487; 3055-3482; 4508-4940; 4484- 4940; 4570-4954; 4480-4944; 4486-4943; 4558-4942; 4493-4940; 4679-4940; 1188-1390; 1054-1357; 1086-1363; 1196-1336; 1102-1340; 939-1318; 1075-1279; 998-1262; 800-1259; 1024-1259; 950-1259; 660-1259; 1002-1246; 966-1222; 729-1219; 757-1201; 940-1201; 657-1197; 987-1159; 986-1113; 475-1109; 732- 1070; 488-1070; 476-1068; 732-1064; 549-1004; 754-1015; 832-1014; 686-1009; 783-1004; 798-972; 793-g63; 731-g63; 585-g47; 566-947; 682-926; 401-903; 732-871; 580-876; 601-873; 685-814; 732-807; 732-804; 537-794; 472-655; 391-592; 1-592; 342-578; 465-575; 453-575; 517-575; 520-575; 484-575; 385- 575; 389-575; 450-575; 133-259; 2926-3172; 2745-3158; 2881-3161; 2673-3153; 2944-3136; 2663-3127; 2866-3126; 2636-3118; 2688-3114; 2901-3106; 2799-
3071; 2486-3057; 2779-3057 2728-3056 2697-3045 2670-3035; 2389-302g 2381-3030; 2855-3022; 2737 3022; 2766-3016; 267! 3008; 2402-3004; 2377- 3006; 2547-2995; 2571-2988 2411-2980 2415-2977 2578-2974; 2737-2972 2671-2949; 2678-2939; 2439 2928; 2429 2934; 2649 2925; 2340-2925; 2303 2917; 2673-2920; 2271-2917 2639-2898 2636-2895 2665-2886; 2799-2888
2633-2882; 2379-2876; 2683-2854; 2588 2844; 22'61 2825; 2080-2798; 2587
2795; 2330-2792; 2564-2785 2121-2757 2264-2755 2480-2753; 2384-2742 2678-2735; 2349-2706; 2264 2704; 1958-2667; 2384-2651; 2431-2644; 2285 2637; 2431-2634; 2377-2629 2351-2619 2429-2615 2058-2590; 2284-2559
2330-2553; 2261-2542; 1903-2517; 2341-2450; 1992-2395; 2025-2398; 939-2362;
1979-2108; 1598-2058; 1333-1874; 1659-1872; 1421-1872; 1389-1868; 1406-
1869; 1257-1867; 1258-1867; 1392-1867; 1292-1862; 1630-1863; 1586-1856;
1229-1813; 1243-1821; 1537-1780; 1106-1701; 1021-1655; 1348-1645; 1418-
1645; 1476-1569; 1198-1606; 1259-1512; 941-1511; 1034-1509; 994-1474; 936-
1440; 1160-1415; 1195-1394
229/LI .363532.1:2001MAY17 | | 1-274; 171-303; 171-786; 605-800
230/LI: 398153.37 :2001MAY17 | | 1-658; 3-652; 39-575; 30-616; 39-518; 40-691;
39-522; 39-47O; 39-732; 39-680; 39-607; 39-677; 39-558; 39-532; 39-531; 39-
521; 39-553; 39-479; 39-337; 39-636; 39-623; 54-577; 92-764; 100-863; 129-
654; 204-640; 276-729; 296-763; 39-581
231/LI:416650.1:2001MAY17 | | 1-234; 1-413; 40-413; 53-413; 53-177; 53-284;
53-376; 68-418; 258-693; 53-417; 53-550; 303-554; 53-377
232/LI:444767.32 2001MAY17 || 580-754; 545-1005; 616-867; 598-943; 616-776;
616-906 617-781 618-878; 617-786; 546-989; 546-933; 619-949; 618-1004; 617-828 617-821 546-928; 618-844; 619-906; 618-977; 619-797; 619-1019; 618-943 627-1090 618-873 618-946; 619-921; 619-791; 544-956; 548-920; 548-927 548-945; 547-919; 548-913; 548-1000; 619-969; 547-947; 602-1001; 548-932 548-939 548-943; 619-796; 619-799; 548-950; 619-819; 548-1004; 548-960 548-969 619-822; 619-826; 548-1016; 619-828; 548-968; 548-970; 548-995 619-835 548-996; 548-1005; 619-752; 619-879; 619-688; 619-677;
619-676 619-83g 619-675; 619-883; 619-672; 619-849; 619-706; 619-733; 619-851 6ig-755 619-935; 619-721; 619-749; 619-758; 619-774; 619-777; 619-695 619-778 619-790; 619-792; 619-805; 619-674; .619-687; 619-806; Table 3
619-811; 619-807; 619-853; 619-855; 619-872; 619-871; 619-878; 619-885; 619-757; 619-896; 619-759; 619-902; 620-720; 549-1048; 549-931; 549-1027; 1-259; 41-93; 6-243; 7-387; 13-344; 12-259; 24-347; 28-244; 28-252; 32-259; 34-492; 43-299; 45-130; 48-351; 49-407; 49-162; 52-259; 59-197; 82-259; 90- 259; 97-203; 100-648; 106-377; 107-362; 135-414; 205-466; 295-480; 295-458; 295-483; 295-469; 320-450; 329-1071; 345-550; 353-468; 393-550; 435-764; 401-989; 407-754; 426-754; 432-731; 430-1041; 448-703; 448-990; 469-700; 513-655; 448-767; 476-960; 481-741; 482-756; 437-664; 537-798; 493-708; 493-738; 498-772; 500-734; 506-754; 506-748; 507-710; 510-730; 509-754; 511-751; 512-1004; 507-1099; 548-1072; 518-1178; 526-g45; 526-873; 504-827; 527-710; 506-755; 523-806; 506-681; 506-823; 512-755; 542-754; 546-754; 546-749; 551-721; 550-751; 551-751; 552-713; 553-685; 559-754; 514-1115; 514-1087; 600-855; 569-751; 571-770; 574-754; 576-754; 613-855; 542-942; 542-921; 613-777; 613-910; 543-933; 614-902; 615-842; 544-946; 543-971; 615-885; 616-787; 544-958; 545-945; 605-846; 616-889; 1129-1321; 1132-1357; 1112-1480; 1134-1310; 1132-1409; 1133-1378; 1134-1260; 1135-1456; 1127- 1225; 1190-1336; 1146-1395; 1148-1297; 1151-1387; 1153-1402; 1174-1591; 1161-1377; 1161-1375; 1161-1462; 1161-1404; 1164-1372; 1164-1437; 1164- 1400; 1185-1589; 1136-1376; 1167-1494; 1168-1414; 1168-1422; 1172-1440; 1171-1378; 1173-1408; 1172-1329; 1174-1459; 1198-1610; 1179-1449; 1201- 1589; 1182-1430; 1185-1465; 1185-1450; 1170-1502; 1190-1449; 1195-1425; 1216-1417; 1215-1449; 1219-1592; 1220-1592; 1225-1304; 1211-1434; 1221- 1537; 1186-1466; 1220-1372; 1223-1484; 1227-1357; 1229-1403; 1233-1584; 1233-1379; 1234-1379; 1204-1419; 1224-1360; 1237-1465; 1247-1482; 1282- 15 2; 1264-1483; 1265-1544; 1239-1788; 1292-1564; 1247-1463; 1301-15g8; 1287-1547; 12g2-1544; 12g4-1530; 12g4-1516; 1292-1383; 1299-1527; 1257- 1655; 1299-14g8; 1298-1538; 1304-1608; 1299-1518; 1318-1595; 1336-1592; 1328-1449; 1333-1514; 1320-1449; 1354-1592; 1336-1449; 1356-1589; 1357- 15 2; 1339-1449; 1326-1449; 1332-1449; 1356-1519; 1357-1575; 1356-1494; 1356-1479; 1360-1590; 1360-1592; 1362-1587; 1362-1592; 1365-1592; 1367- 15g2; 1367-1545; 1386-1438; 1386-15g3; 1376-1567; 1376-1560; 1381-1495; 1383-1588; 1386-1588; 1390-15gθ; 1368-1509; 1464-154g,- 1422-15g5; 1407- 15 5; 1409-1567; 1427-1593; 1432-1589; 1421-1592; 1454-1592; 1451-1592; 1465-1592; 1486-1539; 1538-1592; 969-1270; 971-1181; 973-1155; 956-1237; 976-1225; 928-1128; 981-1231; .933-1177; 933-1095; 964-1234; 983-1224; 983- 1245; 966-1555; 964-15g2; g86-1231; 987-1251; 968-1285; 988-1233; 991-1231; 989-1248; 971-1189; 993-1194; 974-1179; 945-1120; 993-1184; 994-1237; 995- 1257; 963-1155; 1009-1553; 996-1246-; 978-1300; 978-1248; 996-1301; 948- 1114; 950-1090; 998-1253; 979-1282; 951-1114; 1067-1317; 1012-1300; 987- 1551; 956-1168; 1036-1227; 1007-1240; 1042-1252; 1013-1251; 1027-1610; 104g-1286; 1000-1322; 1051-1282; 1024-1137; 1024-1273; 1024-1231; 1024- 1232; 1005-1102; 1056-1278; 1026-1286; 980-1095; 1008-1189; 1062-1454; 1043-1573; 1062-1530; 983-1102; 1029-1516; 989-1101; 1020-1562; 1019-1333; 1073-1270; 1058-1555; 1061-1489; .1061-1478; 1046-1318; 1061-1615; 1064- 1551; 1002-1095; 1061-1483; 1004-1325; 1053-1510; 1005-1100; 1005-1101; 1036-1166; 1006-1095; 1056-1259; 1010-1098; 1014-1095; 1015-1101; 1087- 1286; 1077-1323; 1079-1364; 1098-1262; 1080-1365; 1086-1327; 1088-1483; 1083-1232; 1094-1352; 1033-1102; 1094-1341; 1094-1274; 1096-1269; 1099- 1349; 1099-1333; 1102-1335; 1104-1375; 1129-1290; 1102-1326; 1105-1479; 1089-1248; 1055-1128; 1115-1363; 1118-1219; 1123-1390; 895-1182; 895-1331; 895-1154; 895-1118; 895-1119 ; '895-1156; 895-1146; 895-1161; 895-1171; 897- 1119; 897-1180; 897-1161; 898-1061; 914-1173; 881-1214; 920-1015; 897-1131; 898-1147; 898-1048; 917-1180; 898-1234; 917-1167; 898-1235; 917-107g,- 898- 1384; 918-1194; 918-1013; 901-ligθ; g20-1124; 885-lig4; g20-1051; 903-1181; 921-1159; 922-1138; 922-1094; 887-1071; 905-1183; 876-1077; 905-1505; 877- 1118; 906-1063; 907-1165; 908-1154; 908-1131; 908-1524; 908-1149; 911-1074; 928-1039; 910-1166; 911-1195; 930-1155; 911-1151; 930-1154; 912-1170; 910- 1150; 912-1142; 882-1151; 914-1440; 914-1412; 914-1482; 913-1147; 914-1189; 914-1113; 914-1127; 914-1135; 884-1108; 934-1126; 917-1195; 901-1183; 917- 1156; 936-1195; 917-1188; 918-1166; 918-1164; 918-1315; 919-1231; 902-1051; Table 3
919-1184; 902-1193; 920-1461; 920-1056; 920-1153; 920-1591; 923-1195; 923- 1189; 944-1188; 896-1128; 896-1147; 927-1093; 927-1051; 898-1120; 945-1136; 929-1230; 935-1555; 931-1150; 954-1234; 936-1194; 937-1454; 937-1530; 959- 1243; 940-1160; 940-1151; 941-1164; 911-1117; g43-1244; 961-1240; 943-1133; 914-1098; 963-1254; 914-1128; 915-1096; 916-1128; 919-1026; 895-1104; 895- 1135; 895-1134; 895-1040; 895-1113; 895-1167; 876-1136; 895-1151; 880-1427; 877-g66; 896-1117; 884-1425; 897-1142; 898-1060; 897-1160; 898-1083; 897- 1139; 879-1169; 898-1021; 898-1011; 898-1004; 898-978; 898-976; 898-960; 897-1010; 898-1012; 898-1078; 897-1123; 898-1070; 898-1116; 898-1079; 898- 1111; 880-1347; 898-1033; 898-1131; 898-982; 898-1062; 898-1044; 898-983; 898-1073; 898-1090; 898-993; 879-1110; 898-974; 898-1153; 881-1133; 880- 1090; 898-1035; 898-g88; 898-1009; 898-1029; 880-1103; 881-1170; 881-1168; 882-g43; 900-1137; 898-1001; 901-1137; 902-1097; 867-1155; 886-1473; 869- 1170; 885-982; 906-990; 906-1142; 905-1175; 905-981; 906-1155; 891-1197; 908-1145; 908-1079; 908-1248; 908-1192; 908-1090; 908-1135; 908-1130; 909- 1132; 891-1193; 913-1083; 891-1126; 911-1167; 893-1056; 911-1037; 912-1254;
894-1143; 912-1096; 895-1491; 913-1150; 913-1162; 913-1112 895-1053; 895- 1103; 913-1173; 914-1136; 697-923; 789-941; 1-106; 691-926 694-g54; 7g3- 995; 697-973; 698-914; 797-967; 797-990; 699-1211; 701-978 703-1043; 703- 944; 704-976; 804-936; 805-964; 805-989; 709-944; 712-1075 712-1257; 712-
939; 713-949; 715-989; 702-1308; 814-1007; 717-972; 724-987; 727-979; 827- 929; 733-1211; 734-972; 734-949; 773-1260; 738-1229; 738-1211; 738-969; 739-921; 743-1007; 842-984; 751-1006; 752-982; 753-1011; 851-977; 758-1011; 761-1006; 762-980; 766-1008; 769-1015; 771-1211; 776-1211; 776-1006; 778- 1114; 778-1012; 780-1045; 783-1005; 784-1059; 788-1044; 790-989; 793-1223; 795-1045; 799-1037; 79g-1069; 842-1023; 810-1069; 847-1097; 828-1427; 816- 1095; 818-1045; 852-1143; 818-1081; 821-1081; 856-1034; 822-1036; 824-1212 822-1050; 859-1111; 827-1011; 832-1082; 833-1098; 848-1401; 853-1088; 853- 1114; 839-1090; 873-1104; 841-1067; 857-1487; 878-1128; 878-1102; 843-1211 879-1071; 880-1113; 879-1082; 881-1009; 881-1102; 864-1516; 884-1171; 886- 1150; 886-1039; 869-1125; 853-1161; 841-1099; 891-1095; 857-1137; 892-1192 873-1088; 893-10g5; 8g3-1108; 874-107g; 893-1078; 875-1127; 875-1487; 895- 1176; 895-10g2; 8g5-1127; 895-1121; 1299-1433; 888-1187; 928-1141; 932- 1189; 937-1009; 941-1130; 948-1127; 968-1259;- 1408-1527; 631-916; 729-967; 731-956 733-974; 676-754; 641-923; 678-965; 739-1006; 741-973; 742-953; 677-945 741-969; 643-914; 742-959; 743-961; 743-992; 743-989'; 681-1243; 645-927 646-1241; 745-992; 652-829; 789-95g; 745-995; 745-986; 745-978; 649-1248 ; 648-1216; 649-1271; 649-1164; 650-9g5; 752-g92; 654-976; 693-754; 675-1411 : 659-g54; 65g- 27; 758-1000; 662-g22; 661-1205; 760-978; 698-754;
665-921; 702-754; 766-973 755-1403; 672-1080; 674-1174; 676-936; 775-1004; 677-973; 678-953; 775-999 681-1211; 681-967; 684-952 782-964; 684-1161; ,685-941; 668855--993377;; 668877--992299; 686-915; 688-954; 691-967; 788-983; 594-768; 618-754; 597-1238; 639-772; 620-754; 586-984; 639-919 623-751; 641-916; 587-987; 641-901; 624-754; 643-896; 626-754; 636-890; 646-826; 646-877; 646-911; 677-983; 673-839; 609-664; 649-950; 596-1169 651-781; 653-846;
616-1006; 637-1262; 616-686; 557-864; 659-877; 607-1100; 621-722; 621-691;
621-7g3; 687-957; 611-1083; ; 688-879; 648-969; 649-1159; 691-947; 650-754; 627-1026; 692-945; 694-956; ; 654-754; 619-1219; 654-751; 623-1186; 622-1184;
698-958 699-919 699-962 656-754; 723-921; 625-910; 660-754; 663-754; 663-751 727-990 643-844 602-785 549-1002 ; 622-896; : 620-781; 619-782; 620-866 621-866 551-937 622-733 622-918 622-866; 551-1066; 622-828; 623-745 623-865 623-822 623-939 623-899 623-807; 623-709; 624-916; 624-875 626-887; 589-754 625-876 627-858 607-711; 587-1208; 626-867;
556-1088; 591-757; 558-1061; 630-865; 559-979; 520-840; 617-880; 563-1227; 616-909; 618-922; 617-877; 622-844; 619-859; 619-922; 620-877; 603-1178; 603-754; 604-746; 627-802; 624-723; 624-879; 624-864; 628-879; 628-906; 576-1020; 630-875; 631-901; 615-754; 632-856; 633-899; 680-734; 194-259; 1314-1449; 125-228; 1222-1449; 1367-1560; 1360-1560; 1197-1449; 1246-1517; 345-613; 292-600; 1161-1481; 1129-1441; 1221-1560; 1223-1560; 1201-1560; 1188-1560; 1129-1468; 1171-1560; 1129-1488; 1129-1560; 1129-1555; 1129-1553 Table 3
233/LI:759073.1:200lMAY17 || 1-209; 156-684; 155-703; 154-630; 155-653;
155-782; 155-740; 155-772; 155-763; 165-755; 163-494; 167-421; 172-671;
172-479; 175-427; 195-814; 195-727; 229-748; 304-972; 322-900; 392-897;
410-894; 404-855; 435-892; 485-900; 498-894; 496-894; 508-900; 540-1151;
615-1164; 615-1181; 609-1187; 647-1145; 654-1158; 675-1210; 672-1306; 662-
1311; 688-1266; 717-1280; 703-1230; 721-1216; 702-1281; 701-1280; 714-898;
742-1325; 725-1297; 727-1409; 737-1261; 744-1156; 756-1291; 777-1123; 794-
1349; 780-1082; 784-1168; 802-1372; 814-1460; 808-1242; 845-1212; 841-1435;
1093-1310; 1093-1329; 1093-1343; 10g3-1345; 1101-1421; 1093-1181; 1093-
1421; 1157-1712; 1214-1723; 1210-1422; 1228-1422; 1302-1723; 1356-1421;
1648-1730
234/LI: 759902.4 :2001MAY17 || 1-302
235/LI:762268.1:2001MAY17 jj 1-459; 18-575; 34-569; 415-597; 415-988; 414- g85; 671-1340; 712-1333; 1258-1782; 1258-1694; 1258-1759; 1262-1684; 1262-
1694
236/LI: 813699.1.-2001MAY17 | | 1063-1340; 1063-1373; 1063-1324; 1-362; 1-404;
7-511; 7-475; 7-236; 7-377; 7-362; 10-362; 10-248; 45-597; 73-362; 73-597;
74-362; 73-586; 110-596; 113-686; 117-597; 122-684; 123-655; 126-597; 130-
5g7; 130-586 134-362 134-597 134-587 134-586 134-602 134-590 134- 652; 135-696 135-678 145-585 145-362 145-596 145-586 146-648 146- 586; 155-362 158-597 167-686 167-597 167-362 167-623 167-631 167- 596; 170-680 207-680; 215-597; 238-614; 244-825 268-612 267-680 284- 614; 309-680 509-680; 513-737; 534-614; 534-598 534-586 534-825 534- 1136; 534-655 : 538-614; 850-12gg,- 967-1374; 974-1374; 979-1285; 1066-1225; 1063-1157; 1063-1170; 1063-1374; 1063-1280; 263-614; 476-680; 534-653; 935- 1351; 1063-1242
237/LI: 024142.16 :2001MAY17 | | 2223-2725; 234-849; 2347-2749; 1843-2225; 233-831; 306-943; 507-962; 1875-2225; 446-713; 535-967; 679-1400; 725-1038 878-1400; 1237-1401; 1856-2017; 2022-2688; 2074-2746; 2222-2574; 2305-2541 243-791; 414-724; 414-864; 2357-2691; 238-743; 509-942; 1636-1993; 431-946 422-946; 1237-1330; 1880-2541; 1237-1400; 626-960; 455-946; 268-812; 289- 887; 2280-2749; 507-942; 2317-2747; 289-903; 348-857; 335-929; 2415-2716; 301-799; 2232-2707; 2320-2684; 2223-2670; 495-g46; 617-g46; 1821-2378; 340- 943; 287-791; 1519-1926; 961-1400; 1817-2313; 230-719; 301-867; 268-788; 243-790; 297-946; 400-943; 414-906; 348-894; 307-884; 533-1057; 238-712; 238-636; 2301-2632; 238-847; 307-945; 398-711; 257-788; 328-862; 1817-2225; 2223-2643; 2230-2557; 268-856; 1908-2440; 238-737; 268-768; 238-710; 238- 778; 290-812; 1810-2225; 280-853; 319-760; 412-806; 322-920; 276-895; 1- 886; 695-866; 673-840; 510-823; 280-803; 618-763; 10-683; 1003-1399; 837- 1390; 1253-1390; 1200-1393; 685-1401; 610-1392; 1216-1364; 692-1344; 625- 1400; 749-1400; 1064-1400; 988-1400; 1237-1340; 1240-1335; 1237-1320; 601- 1309; 518-1124; 530-1132; 455-1119; 2356-2732; 479-942; 238-787; 414-818; 380-810; 413-946; 297-67g,- 413-857; 301-g59; 353-767; 414-960; 2254-2634; 328-946; 2752-3412; 2956-3426; 2348-2987; 312-893; 1752-2225; 411-819; 2266-2454; 320-889; 268-702; 1921-2440; 335-816; 1765-2225; 281-624; 2744- 3394; 2857-3394; 2836-3389; 2741-3378; 2374-3300; 3036-3302; 2503-3098;
2407-3074; 2305-2962; 2312-2913 2222-2888; 2215-2861; 2216-2835; 2070-
2754; 2216-2751; 2002-2726; 1992-2705; 2328-2700; 2328-2698; 2054-2629;
2328-2598; 2026-2563; 1930-2593 2228-2563; 1910-2573; 1826-2552; 1706-
2437; 1720-2446; 1654-2431; 2032-2401; 2222-2389; 1784-2377; 2078-2363;
1558-2356; 2222-2317; 1583-2274 1504-2017; 1649-2017; 1392-ig71; 1302-
1926; 1325-1778; 667-1537; 2929-3412; 2945-3401; 268-863; 1237-1378; 401- 957; 319-588; 648-946; 422-1038; 1689-2004; 1155-1400; 281-710; 353-789; 291-800; 308-880; 262-931; 413-910; 425-960; 2223-2644; 451-973; 305-765; 335-836; 2274-2634; 538-953; 564-946; 648-861; 238-751; 2258-2662; 380-812; 626-946; 2255-2611; 233-736; 586-946; 299-895; 364-784
238/LI:1018424.4:2001MAY17 || 1-482; 64-468; 69-684; 156-662; 165-358; 276- 646; 391-989; 474-935; 482-802; 537-1017; 676-1359; 685-1288; 685-1177; 688-934; 933-1403; 935-1218; 1083-1500; 1083-1652; 1118-1798; 1295-1846; 1339-2003; 1461-2043; 1457-2065; 1475-1775; 1496-207g; 1527-2077; 1530- Table 3
1935; 1539-1935; 1584-2045 1616-2257; 1630-1904 ; 1657 -2221 1685- -1810;
1688-2222; 1733-2013; 1803-2246; 1816-2424; 1841 -2465; 1871- -2411; 1873-
2248; 1873-2175; 1943-2238 2008-2594; 2053-2546 ; 2104 -2589 2150- -2610;
2150-2416; 2156-2637; 2157-2818; 2158-2414; 2158 -2372; 2158- -2666; 2160-
2268; 2167-2714; 2193-2739 2219-2729; 2318-2546 ; 2331 -2821 2368 -2832; 2402-2503; 2432-2607; 2457 2905; 2501-2710; 2508 -2806; 2508- -2746; 3379- 3450; 3382-3432; 3382-3513 3382-3505; 3382-3475 ; 3390 -3746 33g5- -3536; 3406-3769; 3438-3746; 3452 3746; 3459-3533; 2524 -2956; 2524- -2806; 2541- 2801; 2605-3136; 2658-3073 2656-2908; 2709-3114 ; 2731 -3059 2736- -3118;
2751-2944; 2765-3133; 2821-3125; 2850-3117; 2889 -3152; 2898- -3090; 2944-
3119; 3021-3593; 3134-3308 3136-3306; 3152-3263 ; 3158 -3689 3180- -3308; 3172-3521; 3201-3469; 3292 3433; 3329-3658; 3335 -3533; 3337- -3630; 3339- 3635; 3339-3583; 3340-3629 3340-3619; 3351-3533 ; 3363 -3550 3370- -3533; 3373-3586; 337g-3533; 3379 3490; 3468-3533; 3471 -3533; 3480- -3746; 3510- 3799; 3511-3746; 3535-3746 3542-3746; 3544-3746 ; 3545 -3782, 3558- -3746;
3568-3746; 3607-3746; 3609-3983; 3660-3904; 3663 -3746; 3667- -3983; 3666- 3746; 3689-3746
239/LI: 1085250.6 :2001MAY17 || 954-1413; 983-1543 ; 2367 -2587 2406- -2975; 2389-2958; 2411-2914; 2419-2651; 2429-2582; 909- 1464; 960-1359; 943-1463; 751-1309; 791-1388; 799-1253; 865-1060; 869-1389 ; 894- 1325; g27-1364; 2662- 3107; 4-243; 222-505; 441-1011; 717-1277; 724-13 54; 4- 274; 2488-2928; 2512- 2582; 2605-2776; 2620-2952; 2641-3228; 2658-2901 ; 2441 -2984 1-1673; 1-243; 2-255; 966-1331; 1015-1367; 1056-1340; 1011-1293 ; 1077 -1190 1127- -1560; 1084-1607; 1088-1357; 1095-1339; 1130-1261; 1169 -1418; 1178- -1759; 1256- 1569; 1256-1572; 1270-1572; 1335-1544; 1370-1598 ; 1367 -1518 1454- -1572; 1455-1572; 1453-1515; 1514-1951; 1642-1970; 1745 -1951; 1777- -2459; 1801- 1951; 1895-2631; 2264-2476; 2310-2582; 2316-2596 ; 2332 -23gg 2328 -2692; 2328-2582; 2328-2392; 2332-2560; 2336-2582; 2342 -2975; 2342- -2737; 2354- 2463; 2354-2589; 2354-2633; 2354-2668; 2352-2582 ; 2354 -2gn 2354- -2825; 2354-2774; 2354-2577; 2354-2508; 2354-2456; 2354 -2692; 2720- -2g64; 2775- 3029; 2788-3034; 3045-3219; 3061-3598; 3140-3418 ; 3207 -3440 3238- -3708; 3392-3709; 3392-3635; 3473-4064; 3473-3980; 3473 -3970; 3473- -3700; 3639- 4038; 3639-3866; 3639-3771; 3639-3913; 3640-3814 ; 3645 -4109 3715- -3926; 3726-3940; 3740-4107; 3767-4107; 3837-4088; 3990 -4107,- 4020- -4109; 4043-4107 240/LI:179233.63:2001MAY17 || 1-682; 120-565; 12 7-614; 179-657; 178-1141; 311-957; 422-655; 497-1041
241/LI:2207125.3:2001MAY17 || 1-613; 1-283 242/LI:235153.44:2001MAY17 jj 724-1162; 2619-286 6; 2664-2930; 2751-3026; 2773-3031; 2774-3045; 2831-3089; 1-354; 1-219; 1 -227; 36-182 >; 1-627; 1-417; 3-302; 83-454; 19-1162; 14-342; 117-365; 149-409 ; 200- 390; 241-605; 291- 574; 307-874; 312-365; 346-688; 350-638; 369-94g ; 394- 781; 3g6-665; 440- 838; 451-714; 464-g70; 543-655; 566-737; 571-lθg 6; 573 -842; 591-945; 596- 848; 673-g34; 700-1007; 714-852; 725-1187; 732-g 80; 732-1136; 735- -1165; 754-978; 831-1055; 831-1049; 884-1162; 950-1210; g83-1162; 999-1162; 1015-
1162; 1023-1162 1037-1162; 1048-1162; 1049-1162 ; 1051 -1261 1098- -1756; 1099-1162; 1310 1649; 1461-1649; 1467-1702; 1488 -1727; 1513- -2008; 1520- 1889; 1523-1709 1532-2034; 1532-1657; 1539-1755 ; 1543 -1803, 1665- -1834;
1676-1922; 1718-2288; 1726-2163; 1757-2049; 1779 -2035; 18g8- -2246; 1930- 2135; 2008-2678; 2020-2491; 2099-2537; 2308-2404 ; 2363 -2619 2418 -2976; 2437-2663; 1726-2432; 1858-2367; 1051-1123; 829- 1023; L950-2269; 1944-2308; 1926-2295; 35-529; 1833-2385; 1824-2435 243/LI:007101.10:2001MAY17 || 1984-2085; 1770-20 82; 1738-2082; 1776-2080; 1984-2080; 1738-2076; 1649-2085; 1771-2081; 1695 -2080; 1652-2080; 1676- 2080; 1633-2080; 1804-2079; 1710-2078; 1779-2067 1445-2085; 1470-2080; 1795-2080; 1469-2080; 1480-2080; 1471-2079; 1558 2045; 1427-2043; 1655- 2038; 1594-2037; 1533-2064; 1799-2029; 1555-2055 1684-2049; 1325-2011; 1372-2012; 1476-2005; 1287-2004; 1576-1988; 1313 1979; 1382-1977; 1451- 1975; 1314-1975; 1383-1951; 1739-1955; 1575-1994 1413-1962; 1367-1940; 1470-1979; 1461-1923; 1377-1916; 1472-1914; 1600 1881; 1594-1879; 1243- 1889; 1593-1872; 1448-1841; 1240-1826; 1594-1808 15g7-1803; 1363-1796; Table 3
1550-1803; 1377-1740; 1521-1743; 1215-1693; 1133-1691; 1375-1685; 1422- 1629; 946-1558; 993-1543; 1186-1535; 786-1525; 937-1520; 845-1496; 1079- 1498; 1377-1450; 1090-1373; 1090-1390; 726-1374; 770-1373; 1116-1364; 714- 1358; 1144-1335; 1023-1303; 968-1246; 977-1221; 630-1202; 904-1202; 936- 1192; 674-1140; 457-1092; 639-1089; 332-779; 1-751; 1778-2078; 1792-2029; 1522-2063; 1549-2083; 1563-1789; 1594-1904; 1648-1880; 1684-2047 244/LI: 008541.2 :2001MAY17 || 1-301; 124-811; 124-718; 124-423; 342-899; 390-644; 495-918; 715-1195; 716-1230; 763-1427; 784-12g8; gil-1528; 913- 1515; 949-1434; 961-1619; 981-1534; 983-1121; 1005-1713; 1042-1690; 1133- 1737; 1135-1600; 1134-1602; 1155-1672; 1182-1799; 1227-1707; 1243-1707; 1251-1806; 1277-1707; 1288-1704; 1304-1702; 1324-1707 245/LI: 009658.13 :2001MAY17 || 1-359; 13-466; 17-224; 160-735; 197-464; 237-
483 260-534 262-536 263-541; 270-8g3 300-893 300-689 300-537 302- 834 309-501 315-649 360-641; 377-850 389-856 421-891 440-893 446- 893 448-742 455-896 473-891; 477-893 482-829 489-795 492-893 497- 893 500-827 508-893 506-89g,- 529-895 527-894 528-896 542-893 541- 893 563-727 562-898 568-896 574-898 581-864 588-899 588-893 589- 849 599-893 597-895 611-894 619-8g5 622-893 652-893 657-880 711- 893 711-785 714-893 747-989 754-892 764-893 790-893 854-1151 r 923- 1442 926-1091; 926-1080; 942-1577; 942-127g,- 942-1257; g46-1237; g5g-1225;
961-1113; 968-1243; 982-1196; 1005-1372; 1063-1295; 1082-1307; 1137-1716;
1138-1368; 1191-1486 1196-1418; 1242-1549; 1242-1489 1263-1459; 1263-
1728 1267-1461 1291-1537 1373-1649 1417-1603 1448-1735; 1467-1639 1471 1700; 1488-1736 1490 1675; 149 1748; 1499 1781 1503-1725; 1520 1850 1564-2032 1560-1797 1601-1858 1615-1970 1618-2061; 1617-1956 1619 1947; 1636 1958 1649 2304; 167g 2048; 1682 2044 1697-2280; 1723 2068 1723-2067 1737-1964 1736-2118 1737-2069 3722-4199; 3746-4059
3750-4025; 3760-4059 3788-4084; 3794 4035; 3794 3944 3796-3921; 3798-
4265 3802-4270 3807-4256 3817-4057 3819-426g 3821-4097; 3821-4266 3831 4262; 3840-4262 3858-4265; 3887-4256; 3891 4262 3906-4200; 3938- 4257 3948-4260 3952-4263 3953-4262 3g53-4257 3957-4262; 3956-4262 3971 4263; 3975 4262 3984 4257; 3985 4197; 4054 4268 4000-4247; 4002- 4242 4004-4264 4014-4262 4017-4265 4018-4262 4016-4264; 4019-4262 4013 4198; 4022 4262 4026 4266; 4031 4261; 4032 4263 4034-4206; 4034- 4096 4038-4229 405 -4263 4062-4260 4075-4262 4074-4250; 4102-4262
4115-4201; 4115 4262 4115 4343; 4127 4261; 4139-4263 4141-4197; 4147
4262 4156- 4262 4156-4255 2309-2436 2312-2421 2311-2430; 2325-2468 2328 2616; 2327 2536 2332-2523; 2345 2657; 2362 2601 2365-2434; 2443 2780 2461-■2605 2470-2658 2470-2608 2502-2594 251 -3028 2521-2844 2524 2813; 2556 2688 2565-2793; 2565 2735; 2589-2813 2589-2792; 2604- 2806 2641- 3004 2718-2938 2718-2898 2740-2998 275 -2974 2809-3032 2817 3007; 2821 3077 2823-3142; 2823 3045; 2823 2893 2832-3060; 2845 3144 2851-■3059 2858-3139 2870-3061 2880-3208 287 -3103 2891-3034
2goι 3144; 2905 3233 2922 3149; 2931-3068; 2953 3424 2961-3296; 2961
3230 2961-•3173 2961-3235 3009-3266; 3009-3202 3018-3204; 3023-3512 3034 3250; 3048 3370 3057 3150; 3079-3329; 3085-3388 3086-3339; 3096 3494 30g7-■3305 3099-3432 3098-334g 3127-3284 3143-3431; 3162-3686
3162-3472; 3183 3484 3192 3402; 3202-3589; 3202-3498 3205-3493; 3362
3785 . 3368-3579 3370-3657 3377-3578 3429-3686 3434-3761; 3451-3756 3451 3708; 3480 3721 3485 3742; 3486-3725; 3498 3889 3512-3783; 3513 3828 3539-3794 3572-3896 3588-3921 3590-3857 35gi-3852; 3591-3846 3602 3873; 3615 3955 3626 3864; 3626 3878; 3637 3873 3640-3866; 3641 3807 3651-4135 3651-3910 3655-4223 3657-3777 3718-4223; 3718-3953 1736 2025; 1737-2036 1737 1981; 1736-1970; 1737 1867 1737-2068; 1737- 2027 1737-2020 1752-2300 1772-1979 1779-2110 1781-2089; 1782-2094 1787 2097; 1787 2087 1801 2132; 1801-2234; 1817 2119 1826-2362; 1843 2440 1843-2405 1854-2267 1854-2284 1854-2053 1861-2149; 1861-2095
1861-2083; 1861-2061 1862 2007; 1863-2143; 1871 2131 1875-2145; 1875-
2200 1875-2126 1891-2440 1897-2170 1898-2214 ig46-23g7; 1949-2333
1953-2433; 1954-234! 1962-2279; 1970-2370; 1972-2411 199g-2434; 2003- Table 3
2440; 2016-2617; 2020-2434; 2030-2323; 2037-2436; 2083-2437; 2123-2433; 2127-2429; 2134-2471; 2133-2434; 2133-2421; 2142-2442; 2141-2436; 2142- 2405; 2158-2509; 2167-2434; 2167-2421; 2171-2596; 2193-2557; 2193-2409; 2201-2411; 2203-2616; 2203-2411; 2204-2536; 2218-2536; 2227-2657; 2233- 2532; 2264-2436; 2290-2627; 2290-2536; 2297-2620; 2300-2536; 1737-2200; 476-896; 322-711
246/LI:020012.14:200lMAY17 | | 1134-1317; 1139-1800; 1147-1734; 1163-1755; 1163-1358; 1168-1672; 1171-1729; 1179-1780; 1195-1515; 1286-1814; 1286- 1906; 1357-1928; 1495-1813; 150g-2105; 1599-1856; 1856-2111; 1886-2191; 2038-2669; 2040-2287; 2045-2218; 2074-2303; 2081-2632; 2083-2260; 2093- 2327; 2095-2787; 2105-2337; 2137-2774; 2161-2278; 2165-2739; 2235-2839; 2237-2516; 2238-2365; 2253-2633; 2277-2678; 2277-2482; 2301-2532; 2341- 2441; 2358-2838; 2380-2848; 2384-2848; 2439-2838; 2481-2846; 2479-2549; 2238-2348; 2292-2858; 2415-2863; 2658-3018; 546-1196; 570-846; 992-1305; 1027-1627; 1027-1291; 574-1190; 605-1157; 1030-1693; 1078-1435; 692-1260; 1125-1801; 728-1253; 780-1423; 790-1477; 805-1319; 859-1441; 918-1488; 942- 1457; 959-1459; 1130-1846; 1131-1738; 959-1460; 960-1460; 984-1529; 986- 1272; 1-271; 69-661; 76-325; 128-616; 128-754; 304-909; 334-841; 339-592; 392-1056; 430-1090; 489-1038; 2710-3036; 2754-3007; 2764-3039; 2788-2866; 2807-3039
247/LI:020691.1:2001 AYl7 516-759; 600-759; 1-235; 1-227 29-241; 55-
2g8; 61-237; 61-236; 61-232; 61-226; 61-353; 61-233; 61-217 61-240; 63-
562; 67-226; 72-437; 72-261; 72-518; 72-236; 72-188; 72-202 92-236; 107-
390; 136-594; 137-280; 143-743; 147-747; 163-250; 483-746; 538-587; 538
759; 540-633; 538-766; 602-759; 659-759
248/LI: 021188.12 :2001MAY17 | | 59-307; 60-339 ; 60-296; 61-325; 62-323; 62-
321; 62-301; 67-209; 70-529; 80-340; 116-422 ; 125-384; 121-364; 125-484;
125-423; 125-377; 126-505; 126-507; 138-696; 118822--558877;; 180-281 201-457
201-474; 206-528; 245-484; 243-641; 243-661; 243-715; 245-539 245-760
-248-530; 268-551; 274-697; 287-534; 316-519; 322-578; 324-565 326-519
337-424; 358-602; 359-606; 374-519; 417-511; 433-519; 475-742 534-979
540-1005; 546-757; 546-754; 613-1022; 828-1022; '831-1023; 834-1094; 920-
1094; 920-1088; 920-1087; 924-1088; 926-1088; 926-1096; 929-1096; 935-1086;
935-1088; 936-1093; 938-1088; 938-1093; 938-1033; 938-1094; 938-1095; 1-
370; 4-245; 5-566; 5-292; 5-280; 8-518; 7-497; 6-269; 6-259; 7-285; 7-140;
7-276; 7-224; 8-240; 8-484; 10-607; 10-257; 10-259; 10-253; 10-247; 10-224;
10-217; 10-166; 10-116; 12-254; 11-303; 12-268; 12-261; 12-233; 13-271; 15-
350 13-287; 15-227 14-225; 15-462 15-280; 15-277; 15-266; 16- 176 15- 264 15-263; 15-256 15-166; 15-422 16-308; 16-286; 16-293; 16- 272 16- 242 17-168; 22-281 23-199; 22-322 26-267; 28-281; 29-271; 29- 272 29- 240 30-354; 30-311 32-263; 33-517 36-363; 34-472; 39-488; 35- 328 36- 317 35-94; 41-431; 37-252; 37-223; 0-254; 40-335; 41-285; 44-268; 46-447; 53-287; 54-519; 54-476; 59-520; 59-345; 59-311; g3g-1093; 940-1093; 940- 1092; 943-1093; 94g-1093; 949-1088; 949-1134; 949-1053; 949-1094 ; 950-1094; 949-10g2; g4g-1090; 9.49-1086; 949-1076 249/LI: 021324.4 :2001MAY17 || 1-632; 2 85-940; 482-1054; 601-1089; 601-849; 637-1168; 649-863; 676-1168; 837-1321 971-1507; 972-1083; 980-1493; 985- 1479; 985-1450; 1016-1569; 1041-1601; 1057-1634; 1079-1355; 1079 -1354; 1113-1632; 1122-1606; 1141-1382; 1141 -1530; 1155-1440; 1174-1440 ; 1181- 1560; 1211-1654; 1244-1683; 1258-1648 1260-1532; 1316-1650; 1378-1779; 1379-1648; 1378-1655; 1383-1648; 1383 1644; 1418-1611; 1430-1624 ; 1478- 1648; 1655-2132; 1737-1903; 1738-1902 1739-1903 250/LI: 021834.15.2001MAY17 || 346-565 508-722; 557-998; 660-908 ; 729-958; 944-1092; 984-1310; 1046-1619; 1095-1595; 1129-1571; 1179-1589; 1231-1598; 1247-1465; 1275-1721; 1292-1680; 1417 -1657; 1453-1726; 1459-1748 ; 1480- 1743; 14g7-ig99; 1522-1724; 1589-1728 1-530; 324-615; 332-610; 337-768; 346-669; 385-641; 462-710; 497-1034; 517-784; 528-1058; 535-793; 549-695; 628-1060; 634-1119; 644-922; 645-901; 665-1235; 696-912; 696-957 ; 703-1032; 715-888; 733-972; 734-967; 1291-1521; 1294-1567; 1297-1728; 1295 -1675; 1299-1419; 1302-1727; 1310-1510; 1313 -1697; 1314-1734; .1316-1730 ; 1316- Table 3
1725; 1319-1724; 1319-1726; 1333-1725; 1321-1727; 1324-1726; 1327-1726; 1328-1724; 1328-1726; 1329-1605; 1336-1565; 1348-1733; 1349-1725; 1355- 1724; 1357-1684; 1388-1660; 1389-1638; 1389-1656; 1393-1727; 1391-1730; 1394-1713; 1394-1726; 1396-1687; 1413-1724; 1423-1726; 1442-1670; 1449- 16g4; 1452-1726; 1456-1727; 1458-1727; 1457-1726; 1458-1684; 1461-1731; 1472-1727; 1474-1729; 1479-1727; 1488-1727; 1492-1725; 1493-1724; 1497- 1727; 1497-1622; 1516-1722; 1517-1726; 1519-1728; 1560-1727; 1575-1727; 1576-1727; 1640-1726; 1676-1726; 1735-1996; 1740-2172; 1814-2314; 813-1020; 824-1261; 827-1130; 828-1109; 832-1113; 843-996; 845-1133; 845-1118; 846- 1109; 849-1103; 863-1389; 863-1058; 879-1403; 880-1152; 888-1086; 741-1341; 760-1054; 890-1099; 901-1142; 903-1149; 915-1173; 920-1157; 920-1036; 924- 1366; 924-1153; 925-1189; 940-1179; 940-1037; 762-904; 763-1081; 764-990; 961-1228; 968-1227; 971-1237; 982-1620; 979-1211; 1010-1237; 1029-1206; 1031-1264; 782-1049; 1036-1235; 1061-1334; 1072-1636; 1066-1291; 1075-1388; 1118-1628; 791-1033; 790-1393; 793-1048; 792-998; 798-1056; 1128-1370; 1127-1516; 1128-1564; 1137-1559; 1137-1710; 1139-1390; 1143-1435; 1145- 1391; 1184-1690; 1196-1481; 1196-1621; 1231-1443; 1239-1700; 1243-1528; 1244-1682; 1247-1719; 1255-1483; 1265-1716; 1271-1735; 1273-1731; 1276- 1691; 1275-1725; 1284-1727; 1288-1684; 1291-1727
251/LI:024841.1:2001 AY17 | | 1-885; 131-732; 155-745; 183-819; 181-718; 183-714; 186-851; 214-902; 233-718; 244-878; 251-1055; 298-936; 306-720;
329-916; 336-703; 336-903; 343-796; 358-953; 350-977; 356-1132; 361-1072; 370-712; 363-1023; 370-684 372-g59 415-1023; 419-1190; 459-g39; 487-942; 4g8-g36; 4g7-976; 505-1204 549-836 559-1129; 820-1452; 1198-1729; 1412- 1674; 1423-1899 1573-1826; 1590-1936; 1596-1956 1723-1999 1735-2349
1808-2091 1857 2062; 1921-2188; 1921-2396; 2165 2549; 2314 2827; 2315-
2831; 2338-2588 2342-2876; 2362-2608; 2525-2784 2548-2820 2642-2887
2644-2815 2665-3087; 2664-3178; 2682-2798; 2710-3107; 2728-3273; 2763
3226; 2845-3361 2954-3355; 2957-3171; 2973-3361 2995-3361 2997-3387
2g97-3361 29g7 3335; 2997-3371; 2997-3292; 3001-3292; 3006-3225; 3006
3109; 3007-3360 3017-3361; 3027-3361; 3035-3174 3055-3362 3061-3361
3088-3361 3131-3361; 3158-3361; 3195-3361; 3203-3361; 3221-3361; 3246-
3361; 3260-3361 3290-3362; 3295-3361
252/LI : 025724.12 : 2001MAY17 2978-3524; 2978-3551; 3036-3283; 3047-3307;
3053-3500; 3087-3488; 3115-3396; 3118-3480; 3143-3535 3173-3393; 3176-
3534 3203-3393 3214-3385 3232-3456; 3237-3526; 3234-3529; 3241-3593
3267-3506; 3302 3604; 3335 3529; 3345-3457; 3353-3565 3353-3551; 3354-
3581 1098-1422 1098-1347 1120-1423; 1169-1376; 1169-1391; 1279-1710 1295 1748; 1319-1445; 1416-1611; 1423-1749; 1423-1665 1430-1706; 1429- 1618 1441-1690 1462-1751 1554-1749; 1585-1749; 1633-1749; 1633-2135 1635 1749; 1693 1749; 2053 2318; 2044-2598; 2052-2305 2055-2193; 2055 2375 2055-2143 2055-2189 2055-2116; 2055-2374; 2055-2112; 2065-2340
2065-2323; 2071-2303; 2075-2337; 2084-2347; 2088-2306 2097-218g,- 2167-
3048 2170-3032 2220-2551 2223-2953; 2236-2438; 2236-2427; 2233-2g36
2258-2494; 2262 2430; 2267 2849; 2262-2468; 2273-2508 2278-2628; 2294
2461 2288-2629 2316-2565 2317-2582; 2331-2430; 2408-2994; 2411-2869
2412-2633; 2435 3125; 2434-2993; 2435-2681; 2438-2680 2452-3016; 2459
2737 2462-2736 2466-2860 2471-2713; 2473-3029; 2486-3258; 2485-2952
2486-3026; 2485 2607; 2490 3000; 2490-2762; 2495-2702 2496-3064; 2500
2754 2504-2781 2515-2822 2529-2942; 2527-2755; 2533-2837; 2546-2794 1-
274; 35-516; 54-632; 67-518; 88-523; 108-519; 119-522 119-518; 120-544
142-242; 142-522; 171-433; 173-437; 190-726; 201-635; 203-670; 203-702; 203-645; 208-519; 224-519; 288-815; 315-708; 315-524; 449-776; 489-618; 533-997; 587-744; 589-1042; 655-857; 655-1119; 655-860; 663-1104; 665-1103; 683-8g6; 697-972; 767-1047; 767-1025; 774-1051; 77g~1452; 826-1398; 855- 1020; 902-112g; 925-1281; 949-1051; 975-1259; 985-1607; 1005-1360; 1016- 1305; 1049-1556; 1056-1446; 1064-1332; 1069-1217; 1069-1169; 1091-1385; 1093-1702; 2747-3025; 2759-3005; 2549-277g; 2553-3033; 2558-2707; 2562- 2848; 2595-2807; 2600-2883; 2651-2707; 2701-2843; 2925-3523 Table 3
253 /LI: 029328.2 :2001MAY17 1489-2009; 1525-2050; 1527-2089; 1527-2088; 1528-2208; 1529-1774; 1532- 2037; 1535-2049; 1542-2102; 1549-2038 1562- 2092; 1579-1999; 1584-1948; 1586-1838; 1589-2173; 1607-2220; 1618-2026 1621-2079; 1621-2231; 1624- 2243; 1627-1880; 1635-2060; 1641-2303 1641 2018; 1649-1930; 1673-2345; 1680-2352; 1682-2173; 1680-2254; 1683-1930 1688-2060; 1688-1925; 1711- 1930; 1713-2066; 1716-2354; 1718-2260 1734- 2294; 1733-2309; 1756-2409; 1767-2331; 1768-2448; 1780-1972; 1790-2332 1793-2190; 1802-2066; 1816- 2407; 1817-2037; 1854-2060; 1863-2284 1863- 2223; 1870-2461; 1907-2198; 1907-2090; 1941-2505; 2022-2483; 2042-2655 2044-2483; 2056-2424; 2062- 2489; 2072-2482; 2103-2199; 2103-2424; 2149 2493; 2155-2483; 2159-2563; 2160-2227; 2179-2572; 2179-2443; 2184-2565; 541; 3-519; 59-669; 64-298; 163-407; 193-792; 259-590; 264-497; 285-863; 291-518; 316-858; 353-996; 359-5848; 377-933; 381-640; 482-1039; 497-899; 500-1110; 535-1057; 569-851 ; 615-1039; 618-865; 635-1305; 649-1231; 663- 899; 723-874; 751-1006; 751 -1008; 785-1065; 810-1165; 829-1099; 854-1152; 853-1133; 892-1146; 954-1195; 1037-1175; 1064-1656; 1065-1368; 1079-1605; 1174-1425; 1178-1459; 1185- 1792; 1235-1776; 1249-1840; 1249-1827; 1249-
1579 1249-1478 1249-1479 1259-1455; 1292-1557 1324-1902; 1325-1843 1342 1817; 1349-1968; 1350-2008; 1362-1998; 1385 1969; 1387-2051; 1401 1677 1405-1865 1406-1720 1407-1685; 1421-2001 1477-2023; 4867-5373 4874 5036; 4911-5146; 4911 5131; 4922-5540; 4924 5198; 4924-5ig0; 4943 5036 4944-5200 4944-5180 4946-5338; 4964-5244 4964-5036; 4971-5507 4971 5237; 4977 5412; 4978-5202; 4981-5407; 4987 5215; 5004-5334; 5033- 5515 5060-5267 5062-5274 5072-5616; 5069-5550 5069-5544; 5069-5412 5069 5347; 5069-5350; 5069 5338; 5069-5309; 5079 5350; 5081-5667; 5084- 5308 5085-5386 5088-5582 5089-5642; 5088-5294 50g5-5410; 5102-5200 5108 5539; 5113 5357; 5116 5376; 5118-5679; 5123 5662; 5136-5646; 5142- 5432 5142-5380 5142-5343 5146-5312; 5199-5412 5219-5412; 5220-5412 5222 5412; 5226-5685; 5229-5568; 5229-5527; 5229 5412; 5232-5412; 5233 5412 5234-5515 5234-5514 5238-5678; 5244-5701 5245-5687; 5248-5808
5249-5608; 5250 5582; 5249 5502; 5250-5596; 3645-4230; 3692-3937; 3801
3970 3834-4079 3867-4075 3948-4431; 3953-4395 3953-4387; 3965-4143 3972 4499; 4020 4665; 4021- 4237; 4053-4290; 4079 4349; 4100-4689; 4106 4652 4147-4700 4184-4677 4171-4589; 4219-4486 4235-4541; 4235-4687
4235-4483; 4242 4508; 4253 4501; 4256-4701; 4272-4823; 4275-4451; 4314
4575 4351-4598; 44335533--44558811; 4355-4585; 4403-4528 4442-4688; 4444-4599 4463 4948; 4490-44668877;; 44449922--4687; 4503-4687; 4538 4973; 4544-4996; 4566 4832 4566-4687; 44557700--44881111; 4583-4800; 4584-5036 4593-4799; 4621-4689 4638 5041; 4638-5014; 4638-4861; 4712-5104; 4724 4980; 4725-5021; 4727- 5000 4736-5195; 4736-5036; 4736-5032; 4736-4927 4736-4814; 4736-5206 4741 5036; 4741-4919; 4747-5036; 4749-5213; 4766 5287; 4779-5036; 4781 5356 4781-5051; 4784-5019; 4784-5137; 4787-5231 4787-5296; 4789-5037 4791-5034; 4791-4g45,\ 4805-48g7; 4820-5036; 4836 5045; 4836-5134; 4837
4911 4846-5035 4856-5036 4861-5161; 4861-5156 2196-2747; 2222-2484 2240 2481; 2253 2570; 2261 2770; 2282-2701; 2340-2796; 2343-2574; 2357 2811 2358-2815 2361-2655 2365-2815; 2419-2671 2427-2705; 2444-2795
2448-2809; 2458-2797; 2464-2799; 2498-2802; 2501 2808; 2506-2560; 2524
2816 2553-2808 2558- 2749 2565-2811; 2581-2773 2634-2737; 2642-2802
2746-2994; 2749 3236; 2800 3060; 2857-3354; 2860 3344; 2860-3053; 2860
3044 2860-3021 2868- 3406 2874-3124; 2874-3198 2877-3065; 2939-3148
2953-3183; 2969 3486; 2993 3148; 3004-3306; 3011 3376; 3023-3236; 3048
3346 3082-3464 3139- 3585 3139-3410; 3142-3391 3220-3388; 3220-3363
3326-3901; 3337 3663; 3341- 3571; 3362-3838; 3378 3895; 3407-4042; 3453-
3763 3475-3764 3477- 36g7 3518-3928; 3524-3621 3528-3768; 3610-3862 3643 3862; 5254 56gθ; 5255 5565; 5255-5540; 5255-5506; 5256-5618; 5257- 5685 5265-5702 5264- 5687 5265-5685; 5265-5471 5267-5686; 5271-5423
5274-5560; 5284 5685; 52 o 5682; 5294-5693; 5295 5680; 5298-5682; 5304
5810 5323-5604 533g- 5509 5350-5543; 5385-5673 5409-5870; 5408-5851 5423 5684; 5424 5848; 5425 5649; 5431-5688; 5433 5849; 5433-5844; 5436 5848 5436-5849 5437- 5849 5437-5853; 5438-5848 5454-5854; 5455-5848 Table 3
5454-5677; 5454-5669; 5457-5851; 5457-5848; 5457-5843; 5457-5836; 5457- 5844; 5457-5686; 5457-5685; 5457-5678; 5457-5614; 5457-5583; 5460-5827; 5466-5681; 5466-5678; 5467-5855; 5469-5846; 5472-5683; 5472-5712; 5472- 5699; 5506-5821; 5509-5770; 5510-5844; 5516-5848; 5517-5699; 5526-5854; 5537-5848; 5532-5834; 5537-5691; 5538-5851; 5542-5847; 5541-5848; 5542- 5699; 5544-5848; 5549-5818; 5584-5816; 5590-5844; 5598-5848; 5603-5849; 5611-5848; 5614-5807; 5633-5686; 5655-5839; 5769-5819; 5778-5848; 5797-6001 254/LI: 032171.5 -.2001 AY17 || 1670-2131; 1537-2148; 95-4g3; 1564-2133; 1575- 2148; 1607-2047; 1636-18g3; 1638-1867; 1649-1909; 1658-2090; 1692-2085; 1725-2129; 1742-1838; 1748-2025; 1763-2129; 1770-2040; 1795-2115; 1802- 1912; 1802-2137; 1804-2095; 1849-2013; 1925-2080; 1925-2091; 1962-2125; 1962-2024; 1990-2129; 1-226; 4-307; 5-975; 17-200; 17-597; 30-597; 354-599; 362-830; 443-981; 592-1198; 608-801; 608-1070; 652-821; 929-1249; 954-1213; 983-14g2; 983-1227; 1004-1100; 1026-1266; 1033-ig42; 1067-1832; 1122-1257; 1216-1465; 1299-1713; 1299-1560; 1299-1501; 1434-1587; 1449-2132; 1466- 2149; 1477-1620; 1490-1713; 1490-1745; 1529-2091; 1557-2149 255/LI:035055.1:2001MAY17 | | 975-1174; 1063-1683; 1455-1956; 1498-1965; 1499-1904; 1502-1913; 1711-1936; 1-463; 3-246; 56-614; 57-819; 267-737; 412-967; 412-923; 445-727; 445-1026; 483-918; 927-1174; 927-1167; 927-1178; 969-1613; 975-1181; 975-1198; 975-1564; 975-1599; 977-1174; 1014-1552; 1075-1562; 1096-1724; 1217-1812; 1308-1807; 1461-1920; 1486-1961; 1491- 1955; 1494-1937; 1499-1681; 1499-1836; 1499-1652; 1499-1696; 1499-1803; 1500-1959; 1500-1960; 1502-1800; 1502-1920; 1502-1798; 1595-1798; 1635- 2241; 1708-2027; 1797-1961
256/LI: 036747.17 :2001 AY17 | | 1164-1616; 1224-1488; 1266-1613; 1276-1882; 1292-1563; 1299-1863; 1314-1447; 1336-1667; 1358-1626; 1363-1620; 1395-
1645 1397-1655; 1423-1838; 1437-1703; 2-527; 1-527; 107-328; 110-338; 187- 446; 187-604; 409-974; 412-675; 485-723; 487-1069; 540-1105; 621-887; 904- 12 3 904-1160; 904-1327; 904-1174; 904-1346; 904-1472; 949-1532; 1000- 1511 1016-1426; 1084-159g 1100-1365 1102-1356; 1113-1357; 1113-1637
1116-1365; 1122-1555; 1141-1389; 1152-1378; 1159-1688; 1451-1761; 1456-
1862 1473-1721; 1501-1776; 1511-1863 1527-1855; 1527-1880; 1568-1838 1570 1810; 1578-1842; 1580-1861; 1569 2083; 1592-1876; 1854-1980; 1855 2107 1856-2037; 1865-2118; 1867-2099 1874-2152; 1588-2121; 1591-2064 1629 1923; 1615-2008; 1639-2209; 1640 2094; 1676-1927; 1737-2352; 1740 2167 1739-2424; 1740-2005; 1742-1928 1744-2025; 1756-2094; 1769-2145
1773-2268; 1773-2013; 1784-2291; 1786-2024; 1793-2353; 1793-2330; 1793
2426 1793-2202; 1806-2048 1819-2376 1813-2410 1819-2367; 1833- 2321; 1839 2261; 1919-2096; 1924 2118; 1936 2156; 1917 2338; 1925- 2205; 1936- 2182 1959-2126; 2289-2439 1944-2036 1953-2205 1953-2211; 1980- 2144; 1965 2444; 1970-2286; 1977 2234; i 3 2451; 2021 2340; 2002- 2390; 2017- 2293 2027-2238; 2033-2449 2033-2405 2035-2126 2041-2449; 2043- 2446;
2049-2442; 2063-2451; 2066-2449; 2068 2452; 2096 2401; 2123- 2383; 2369-
2449 2123-2386; 2126-2379; 2156-2392 2378-2449 2157-2449; 2157- 2446; 2158 2442; 2186-2414; 2186-2449; 2188-2449; 2188 -2446; 2199- 244g; 2198- 2258 2285 2444; 621-801; 904-1166; 969-1334; 11 02-1514; 1138-16g2 ; 1205- 1476 1300- 1836; 1383-1894; 1576-2036; 1611-2250 ; 1660-2074; 1740- 2140; 1760 2189; 1786-2042; 1793-2380; 1833-2090; 1856 -2346; 1968- 2100; 1998- 2449 2031- 2449; 2042-2408; 2096-2399; 2136-2410 ; 2186-2400; 2190- 2454; 2328-2449 257/LI:0443 01.2:2001MAY17 | | 398-768; 762-1129; 912-1363; 1047-1608; 1315- 1935; 1605- 1927; 1781-2047; 2034-2397; 2179-2779 ,- 2397-3000; 1-325; 57-565; 57-558; 169 -493; 458-787; 491-938; 696-1019; 707 -1021; 762-941; 762-962; 893-1503; 908-1355; 912-1141; 946-1115; 960-1560 ; 1060-1134; 1159-1422; 1172-1662; 1282-1563; 1365-1705; 1428-1785; 1535 -1756; 1535-1911; 1615- 1788; 1657- 1871; 1714-2136; 1722-2276; 1819-2294 ; 1822-2282; 1822-2333; 1898-2443; 1924-2406; 2050-2485; 2152-2795; 2155 -2792; 2165-2697; 2257- 2775; 2257- 2800; 2271-2770,- 2363-2772; 2452-2897 258/LI.061585.10-.2001MAY17 | | 1-731; 6-604; 11-3 12; 14-513; 14-295; 22-432; 129-762; 223-786; 358-844; 637-1111; 709-1382; 729-1371; 851-1108; 912- Table 3
1514; 1203-1771; 1266-1525; 1429-1874; 1524-1874; 1612-1871; 1706-2042; 1706-1939; 1746-1848; 1780-2057; 1835-2045; 1987-2262; 2008-2262; 2086-2470 259/LI:066742.21:2001MAY17 || 2603-2818; 2687-2954; 2724-2957; 2814-3092; 2883-3164; 2952-3213; 3555-3879; 3591-3912; 3615-3903; 3650-3907; 3676-
3915; 3709-3909; 3763-3915; 3902-4322 4081-4267; 2982-3435; 2982-3376; 2982-3148; 2984-3131; 3006-3482; 3006 3457; 3006-3249; 3018-3154; 3026- 3300; 3048-3288; 3088-3320; 3091-3328 3093-3340; 3121-3379; 3135-3753; 3155-3691; 3169-3546; 3180-3413; 3182 3331; 3200-3367; 3202-3494; 3202- 3429; 3201-3362; 3223-3521; 3262-3655 3290-3594; 3305-3883; 3315-3542; 3326-3730; 3326-3601; 3334-3592; 3341 3907; 3341-3614; 3341-3600; 3341- 3599; 3331-3515; 3363-3651; 3356-3502 3403-3912; 3414-3707; 3423-3908; 3426-3703; 3431-3873; 3443-3886; 3443 3658; 3443-3643; 3433-3502; 3445- 3538; 3448-3655; 3449-3860; 3463-3912 3493-3786; 3512-3916; 3513-3918; 3514-3912; 3514-3916; 3520-3923; 3524 3793; 3525-3766; 3528-3909; 3528- 3770; 3528-3764; 3536-3915; 3541-3gi5 3544-3923; 3549-3810; 3574-3912; 3580-3874; 3581-3918; 3590-3918; 3597 3916; 3597-3911; 3598-3912; 3598- 3845; 3617-3889; 3620-3917; 3622-3872 3649-3769; 3655-3922; 3654-3912; 3670-3852; 3675-3912; 3676-3914; 3676 3880; 3676-3879; 3680-3917; 3680- 3988; 3712-3856; 3722-3896; 3724-3920 3738-3912; 3780-3914; 3797-3916; 3800-3917; 3850-3912; 3902-4334; 4014 4461; 4029-4462; 4049-4462; 4081- 4551; 4096-4462; 4143-4430; 4208-4611 4466-4749; 740-1156; 740-928; 744-
925; 750-1009; 766-1373; 809-1064; 825-1157; 838-1062; 842-1058; 847-1430;
848-g24; 858-1060; 85g-1080; 897-1223 928-1154; 956-1162; 978-1217; 1027-
1157; 1030-1156 1100-1754; 1111-1342 1166-1337; 1198-1587; 1198-1414; 1238-1486; 1243 1478; 1356-1761; 1374-1758; 1390-1501; 1390-1642; 1423- 1809; 1442-1986 1442-1934; 1442-1838 1442- -1692, 1486- -2020, 1498- -1718; 1520-1664; 1520 1623; 1554-1976; 1557 1770; 1599- -1863; 1614- -1978; 1630- 1883; 1650-2146 1672-1967; 1731-2085 1817 -2264, 1823- -2040, 1871- -2088;
1930-2407; 1946-2504; 1981-2223; 1982 2239; 2019- -2289; 2043- -2495; 2044-
2495; 2107-2495 2116-2488; 2141-2638 2141- -2383, 2143- -2387, 2171- -2413;
2201-2403; 2207-2432; 2218-2488; 2261 2495; 2264- -2548; 2286- -2543; 2286-
2401; 2317-2608 2332-2586; 2332-2578 2332 -2443, 2339 -2465, 2350 -2538; 2365-2620; 2381 2643; 2385-2495; 2395 2691; 2398- -2707; 2441- -2704; 2498- 2764; 2505-2757 2515-3041; 2514-2779 2552 -3041, 2552- -3040, 2563- -2764;
2596-2946; 2597-2881; 2609-2866; 2639 2868; 2661- -2947; 2680- -2951; 2714-
2995; 2713-3040 2713-2988; 2715-2997 2734 -3003, 2757 -3001 2803- -3072; 2807-3006; 2824 3145; 2830-3088; 2857 3152; 2876- -3156; 2881- -3343; 2887- 2957; 2888-3385 2905-3146; 2938-3210 2973 -3139 2980 -3222 1-638; 83-664
33-660; 83-605; 104-396; 122-405; 123-537; 180-570; 184-739; 184-781; 187-
812 187-475 193- -488 222-496; 263-803; 274-886; 287-884; 291-542; 314- 727 318-730 328- -886 335-598; 347-906; 354-885; 357-599; 361-703; 364- 969 364-881 364- -623 363-609; 365-887; 369-899; 370-887; 390-663; 399- 673 395-660 412- -670 441188--667733; 441177--665599; 431-707; 434-643; 448-675; 455- 659 456-925 455- -719 445588--992255; 446644--992255; 465-925; 469-925; 483-926; 491- 925 491-659 494- -930 449944--992255; 449955--992255; 498-1124 496-925 ; 499-945 ; 503 897 505-954 511- -928 519-925 520-985 520 520-767; 520-736; 557- 925 562-983 562- -929 568-925 567-925 576 -1118 ; 589-957 ; 616-845 ; 621 925 627-924 628- -991 632-930 632-927 689 -1153 ; 700-924 ; 705-1009 ; 705- 938 706-1161 ; 712-964 ; 714-1157 ; 719-995 ; 719-927 ; 725-1158 ; 727-914 ; 729- 991 731-1162 ; 738-981 ; 1362-1521 ; 2530-3027 ; 1644-1798 ; 1365-1526 ; 987- 1241 1478-1760 ; 3535-3828 ; 3142-3443 ; 1411- 1758 ; 3540-3911 ; 2185-2602 ; 3417-3856 ; 2074-2629 ; 1117-1719 ; 3431-4039; 2285-2892 ; 2170-2795 ; 3293- 3912 ; 3130-3764 ; 3194-3850 ; 1031-1158 260/LI : 075492 .206 : 2001MAY17 | | 93-456 ; 10 1-2 13 ; 100-317 ; 100-338 ; 105-374 ;
105-346; 110-355; 113-456 126-377 ; 126-324 ; 132-394 ; 149-587 ; 149-422 ;
160-399 ; 163-431 ; 196-416 194-438 ; 195-705 ; 196-638 ; 198-624 ; 196-349 ;
196-414 ; 196-434 ; 196-438 196-334; 207-465 ; 210-463 ; 211-460 ; 214-441;
219-457 ; 290-456 ; 294-492 345-612 ; 347-609 ; 358-630 ; 382-456 ; 424-929 ;
524-789 ; 535-701 ; 535-657 606-1125 ; 634-738 ; 669-1091 ; 700-1222 ; 851-1113 ;
897-1130; 914-1146 ; 954-1429 ; 954-1428 ; 1-456 ; 32-466 ; 30-523 ; 38-301 ; 39- Table 3
315; 57-317; 64-343; 66-342; 65-376; 64-323; 74-456; 87-480; 92-313; 984-
1246; 1144-1224; 196-428; 733-888; 669-889 1038-1240; 697-929; 121-194 261/LI:090782.3:2001MΛY17 | | 1-700; 22-689 1-664; 1-491; 1-567; 1-487; 1- 244; 1-530; 1-543; 44-361; 44-439; 97-645; 224-757; 259-478; 280-764; 387- 747; 430-748; 430-747; 430-1132; 445-1116; 447-753; 462-682; 469-652; 489-. 656; 505-1159; 510-755; 546-1098; 547-1262 615-1284; 639-1283; 968-1705; 985-1670; 1017-1685; 1017-1416; 1017-1483; 1017-1392; 1017-1355; 1017-1359; 1017-1312; 1017-1292; 1017-1167; 1031-1651; 1030-1428; 1071-1647; 1077-
1647; 1101-1785; 1201-1861; 1205-1972; 1251-1886; 1265-1663 1290-1942; 1300-1708; 1322-1689; 1328-1970; 1337-1878; 1348-2050; 1347 1812; 1356- 1995; 1364-1935; 1365-1855; 1382-1755; 1409-2083; 1418-2149 1447-1993;
1562-2025; 1573-1681; 1580-2294; 1585-2121; 1668-1966; 1685-2407; 1705- 2265; 1783-2361; 1795-1952; 1799-2101; 1809-2376; 1849-2308; 1877-2361; 1927-2361; 1938-2340; 2116-2287
262/LI:1031308.1:2001MAYl7 | | 8-646; 16-646; 6-367; 13-695; 16-509; 16-611; 16-664; 15-484; 20-572; 1-594; 20-485; 17-690; 16-560; 34-635; 48-730; 82- 491; 101-506; 108-426; 109-426; 129-660; 140-709; 151-716; 258-809; 267- 563; 267-675; 269-778; 540-753; 618-997; 639-997; 837-1029; 837-1280; 1162- 1577; 1452-1754; 1499-1755; 1604-2163; 1607-1846; 1864-2249; 1864-2005; 1866-2115; 1994-2412; 1994-2097; 2177-2640; 2209-2417
263/LI:1054377.1:2001MAY17 | | 1-647; 569-892; 574-656; 581-916; 599-797; 599-659; 755-902; 755-1385; 756-1359; 901-1504; 982-1341; 1107-1215 264/LI:1072074.10:2001MAY17 I I 11-496; 11-476; 11-468; 11-467; 11-457; 11-
456; 11-454; 11-434; 11-394; 11-486; 11-381; 11-319; 11-268; 1111--776677;; 1111--
257; 14-626; 11-655; 11-433; 11-426; 13-557; 12-471; 12-418; 3322--669966;; 2222--
710; 12-643; 59-623; 41-486; 55-551; 57-696; 66-690; 89-763; 111100--774433;; 115522--
651; 152-673; 202-472; 228-737; 231-729; 271-892; 315-1007; 332255--667744;; 332288--
697; 367-869; 439-1092; 462-676; 542-1177; 502-896; 606-977; 558800--11002277;; 661188-
1338 ; 580-1026; 628-1264; 641-1156; 644-1149; 644-1146-,- 659-1223; 660-1224
723- 1244; 691-1163; 691-1164; 801-1375; 808-1372; 869-1619; 923-1413; 942-
1159 ; 931-1576; 930-1417; 933-1417; 927-1354; 952-1796; 977-1279; 956-1495
978- L657; 1052-1657; 1058-1656; 1061-1656; 1098-1640; 1220-1843; 1196-1866
1204 -1481; 1265-1608; 1243-1871; 1296-1759; 1349-1870; 1371-1611; 1372-
1599 ,- 1377-1639; 1379-1611; 1415-2048; 1425-1872; 1464-1953; 1485-2146;
1509 -2158; 1526-2214; 1595-2155; 1682-2186; 1696-1858; 1698-1959; 1706-
2340 ; 1709-1965; 1711-2077; 1720-2071; 1720-1954; 1720-1938; 1720-1917;
1727 -2242; 1730-2209; 1738-2256; 1744-2268; 1749-1965; 1-645; 11-623; 11-
502; 11-260; 11-589; 1-745; 11-573; 1-454; 6-609; 11-335; 11-552; 11-682;
11-645; 11-615; 11-722; 11-511; 11-555; 11-520; 11-528; 11-658; 11-530; 11
364; 11-701; 11-595; 11-686; 11-660; 11-714; 11-593; 11-599; 11-642; 11-
549; 11-670; 11-5.08; 11-495; 11-483; 2713-3074; 2717-3056; 2694-3063; 2721
3064 2719-2977; 2720-3066 2701-3062; 2709-2842; 2709-3063; 2713-3063 2716 3052; 2718-3061; 2710 3063; 2721-3065; 2746-3056; 2745-3016; 2745 2996 2744-2971; 2724-2908 2747-3063; 2750-3052; 2755-3065; 2755-3063 2746 3060; 2806-3059; 2809 3063; 2811-2953; 2814-3029; 2822-3059; 2819 3063 2845-3063; 2846-3052 2855-3064; 2878-2991; 2886-2945; 2888-3063 2892 3030; 2858-3001; 2919-3063; 2988-3052; 2991-3052; 2993-3052; 3000 3058 2526-2814; 2526-2795 2531-2767; 2558-2991; 2558-2743; 2562-3014
2562-2803; 2562-2789; 2550 2809; 2574-3026; 2553-2808; 2578-3079; 2585
3062 2593-3028 2599-3060 2606-2844; 2614-3063; 2614-3059; 2594-2875 2618 2967; 2619 2754; 2597 3062; 2602-2962; 2605-2813; 2603-3059; 2604 3059 2632-2817 2639-3055 2641-3060; 2645-3052; 2623-3052; 2688-3102 2651 3059; 2652 3063; 2632 2887; 2655-3063; 2657-2865; 2634-3063; 2640- 3063 2664-3062 2642-3025 2671-2961; 2647-3061; 2670-3072; 2673-3060 2672 3063; 2673 3061; 2675 3027; 2678-3052; 2682-3028; 2683-3064; 2684 3065 2685-3066 2687-3069 2686-3052; 2687-3022; 2691-3063; 2688-3057 2689 3059; 2669 2921; 2671 3061; 2695-3056; 2701-3068; 2707-2980; 2685- 3055 2710-3059 2687-3052 2193-2471; 2194-2450; 2206-2601; 2281-2435
2281-2754; 2288-2515; 2288-2601; 2288-2525; 2288-2512; 2288-2486; 2288
2469 2288-2435; 2304-2964 2330-2608; 2332-2980; 2336-2802; 2341-2622 Table 3
2524-2800 ; 2351-2554 ; 2351-2828 ; 2353- 2592; 2379-2914; 2384-2954; 2362- 2686 ; 2387-2700 ; 2389 -2942 2367-2621; 2367 2442; 2394-2607; 2405-2766; 2407 -2579 ; 2408-2807 ; 2409-2620; 2409-2562; 2411-2952; 2399-2955; 2525- 2808 ; 2389-2714 ; 2413 -2672 2420-2691; 2549-3023; 2408-2883; 2416-3035; 2449-3019 ; 2447-2695 ; 2455-2750; 2455- 2653; 2457-2726; 2445-3047; 2470- 3033 ; 2475-2709 ; 2479 -2823 2483-2727; 2449-2969; 2449-2999; 2488-2816; 2472 -2986 ; 2472 -3039 ; 2473 3061; 2481-3016; 2527-2609; 2510-2778; 2533- 3017 ; 2524-2857 ; 2524 -2790 2524-2822; 2524-2816; 1765-1974; 1782-2008; 1784-2085 ; 1787 -2017 ; 1789 2256; 1792- 2266; 1791-2036; 1793-2091; 1793- 2075 ; 1798-2018 ; 1805 -2218 1810-2266; 1815 2112; 1822-2110; 1827-2026; 1843 -2113 ; 1842 -2036 ; 1845-2266; 1846- 2256; 1846-2378; 1845-2018; 1846- 2090 ; 1854-2266 ; 1856 -2031 1876-2009; 1874-2066; 1894-2005; 1908-2266; 1909-2177 ; 1931-2438 ; 1931-2182; 1934-2061; 2161-2395; 1941-2187; 2175- 2384 ; 1941-2184 ; 1942 -2237 1945-2241; 1970 2182; 1975-2218; 2189-2256; 2003 -2451 ; 1983 -2239 ; 1985-2236; 1988-2511; 1988-2214; 1983-2170; 2005- 2266 ; 2017 -2256 ; 2037-2268; 2041-2256; 2069-2536; 2191-2689; 2052-2388; 2052-2256 ; 2053 -2295 ; 2055-2449; 2057-2253; 2083-2238; 2092-2352; 2103- 2693 ; 2129-2680 ; 2110-2354; 2124-2582; 2136-2417; 2153-2401 265 /LI . 1072889 . 15 : 2001MAY17 I I 1945-2057; 1950-2076; 1951-2079; 1951-2076;
1980-2082 1983-2076; 1985-2076; 1985 2073; 1985-2040; 1988-2051; 2000- 2076; 201 -2083; 2011-2080 1942-2076 1763- 2076 1766-2076 1765-1896 1767-2081 1769-2074; 1775-2080; 1779 2032; 1780 1947; 1788 2074; 1788 2076; 178 -2060; 1791 2013 1792-2062 1797-2070 1800-2076 1801-2036 1800-2080 1814-2061; 1822 2080; 1831-2030; 1831 2001; 1833 2057; 1835
1903; 1835-2077; 1836- 2076 1838-2074 1840-2075 1841-2077 1851-2056
1858-2076 1859-2075; 1865 2084; 1865 2021; 1867 2085; 1866 2076; 1873
2076; 1875-2076; 1876- 2076 1876-2080 1880 2066 1881-2078 1885-2097
1892-2076 1907-2006; 1909-2079; 1909 2074; 1919 2015; 1921-2076; 1944 2077; 166 -2038; 1663 $--1903 1671-2076 1673 2083 1675 -2076 1674-1934 1683-2082 1688-2074; 1689 2074; 1692 2076; 1694 2081; 1695 2074; 1697- 1948; 1698-2070; 1720-1948 1728-2080 1725-1951 1727 -2077 1727-2076
1733-2060 1741-2076; 1752-2074; 1749 2079; 1750 2074; 1750-2006; 1698-
1784 ; 1751-2091 ; 1699- 2074 1701-2076 1751-2074 1754 -2081 1703-2079;
1765-1980 1703-2076; 1753 2076; 1703 1980; 1704 2076; 1710 1959; 1712-
2076 ; 1715-1951 ; 1716* 2095 1718-1953 1758-2079 1757 -2078 1761-2076;
1301-1603 1302-1536; 1313 1536; 1316 1588; 1322 1569; 1331 1729; 1331-
1504 ; 1338-1721 ; 1340- 1535 1352-1581 1367-1585 1376 -1660 1396-1561;
1391-1647 1408-1600; 1412-2041; 1431 1876; 1431-1588; 1433 1582; 1422-
1665; 1430-1764; 1424-1682 1425-1702 1426- 2034 1434 -1726 1441-1835;
1440-1693 1450-1901; 1473-1682; 1482 1592; 1484 1757; 1472 1610; 1481- 1752; 148 -1631; 1496-1744; 1494-2052 1491-2076 1509 -2076 1497-2065; 1498-1743 1501-1801; 1502-1753; 1506 1867; 1538 1845; 1528 2033; 1533-
1648; 1542-1743; 1553- 1797 1559-1814 1569-1676 1585 2038 1596-2076;
1595-2015 1595-1697; 1607 2076; 1610 2076; 1610 2079; 1610 2081; 1611-
2076; 1612-2076; 1618* 2078 1619-2038 1618-1861 1618 1849 1620-2077;
1623-1870 1627-2081; 1628-2077; 1627-1804; 1640-2083; 1645 2076; 1640-
2077; 1651-1855; 1651-1883 1654-2083 1655- 2076 1655 1905 1658-2074;
1660-2076 1660-2078; 1662-2022; 1661-1904; 976-1313; 981-1582; 981-1218; 981-1234; 981-1156; 1005-1111; 1027-1309; 1029-1586; 1029-1292; 1029-1286; 1029-1270 1032-1325; 1034-1266; 1047-1210; 1047-1572; 1051-1553; 1053-
1341; 1053-1313; 1055-1324; 1056-1283 1054-1365; 1069 -1249; 1080-1337;
1083-1408 1088-1337; 1092-1408; 1093 1326; 1095-1512; 1097 -1279 ; 1106-
1354; 1100-1355; 1112-1354; 1119-1531 1117-1315; 1121 -1235 ; 1124-1319 ;
1134-1351 1142-1491; 1142-1472; 1151 1668; 1148-1470; 1144-1429 ; 1144-
1364; 1153-1674; 1153-1598; 1151-1379 1148-1489; 1153 -1570 ; 1147 -1365 ;
1151-1410 1151-1386; 1170-1666; 1154 1371; 1154-1325; 1165-1598 ; 1158-
1366; 1157-1292; 1170-1679; 1186-1305 1170 1314; 1175 -1325 ; 1177 -1628 ;
1187-1460 1186-1392; 1190-1521; 1197 1381; 1198-1468; 1199-1461 ; 1199-
1450; 1201-1486; 1200-1465; 1198-1445 1199 1495; 1199 -1320 ; 1202-1445 ;
1203-1484 1211-1477; 1217-1780; 1217 1482; 1217-1459; 1217 -1441 ; 1216- Table 3
1498; 1234-1554; 1242-1492; 1243-1356; 1252-1480; 1252-1504; 1254-1525; 1256-1533; 1258-1612; 1257-1526; 1258-1534; 1260-1527; 1259-1503; 1259- 1464; 1262-1323; 1265-1490; 1265-1415; 1273-1486; 1291-1571; 339-773; 342- 425; 342-670; 362-648; 375-663; 388-623; 400-655; 416-666; 426-623; 414- 677; 432-681; 464-715; 477-527; 483-1150; 501-643; 495-666; 525-659; 536- 609; 556-1154; 572-1191; 574-874; 580-1058; 598-1132; 597-858; 606-873; 622-859; 614-1047; 631-1191; 635-1132; 636-869; 653-1045; 660-910; 660-884; 674-1062; 676-940; 664-922; 667-909; 672-908; 688-872; 676-894; 677-1294; 679-900; 690-930; 738-1112; 739-1131; 743-1027; 759-974; 764-1016; 761- 1006; 767-823; 774-1073; 787-1054; 795-1379; 806-1324; 809-1088; 809-1085; 809-1033; 833-1324; 833-1311; 839-1214; 840-1375; 840-1264; 842-1161; 852- 1100; 842-1375; 853-1359; 855-1125; 858-1130; 861-1129; 875-1032; 864-914; 871-1438; 877-1120; 897-1156; 900-1469; 915-1104; 904-1142; 921-1139; 921- 1100; 922-1198; 922-1136; 912-1153; 925-1293; 918-1177; 931-1221; 940-1172; 943-1221; 943-1190; 952-1221; 953-1232; 956-1282; 951-1450; 952-1230; 967- 1213; 966-1055; 971-1192; 973-1216; 975-1211; 965-1400; 967-1396; 967-1443; 966-1219; 980-1116; 972-1536; 1-445; 1-177; 45-185; 66-179; 66-186; 66-207; 66-423; 66-180; 66-193; 66-177; 66-178; 66-176; 66-364; 68-177; ; 129-448;
191-313 193-569; 224-441 239- 436 255- 453 255-513; 257-538 261-623; 261-486 262-499; 265-515 268- 524 277- 562 277-579; 264-513 279-523; 281-639 289-607 296-626 296- 456 296- 428 296-405; 297-740 297-778; 297-673 297-425 303-400 289- 529 305- 568 306-603; 307-394 308-411; 311-583 310-533 311-382 296- 410 311- 635 311-607; 311-587 311-566; 311-524 311-493 311-449 311- 455 311-■430 311-424; 311-413 311-405; 311-392 311-390 311-432 311- 411 311-•567 311-362; 316-558 316-570; 319-607 320-504 308-568 322- 677 322-•699 311-492; 324-581 331-547; 328-595 331-568 339-578 170-■233 226-■309 266/LI:1077480.1 2001MAY17 1289-1454; 1034-1384; 671-1375; 671-765-; 477- 743; 1-743
267/LI:1079555.1:2001MAY17 || 856-1334; 519-1295; 4-1132; 409-1064; 724- 1049; 670-1049; 564-1047; 604-1046; 747-1046; 879-1045; 826-1046; 801-1046; 491-1046; 591-1030; 460-1030; 453-1022; 427-977; 466-964; 674-957; 450-932; 394-947; 444-945; 212-945; 793-930; 688-864; 437-805; 528-791; 238-779; 279-748; 1-743; 620-703; 93-682; 179-620; 377-541; 379-484; 1-426; 169-396 268/LI:1084992.28:2001MAY17 || 221-782; 412-791; 525-785; 652-783; 1-537; 1-255
269/LI:1085472.5:2001MAY17 || 1-386; 1-548; 68-694; 179-606; 204-866; 323- 636; 427-849; 445-998; 458-998; 491-856; 497-786; 791-1209; 845-1234; 899- 1521; 985-1154; 990-1217; 1009-1207; 1045-1548; 1049-1651; 1049-1445; 1128-
1625; 1130-1261 1186- -1724 , 1188- -1421 , 1240- -1573 , 1290- -1594 , 1305- -1572 1371-1990; 1460 1951 ; 1554- -1724 ; 1564- -2136 ; 1702 - -2133 ; 1744- -2140 ; 1751 2270; 1782-2258 1792- -2253 , 1809- -2085 1836- -2253 1904- -2253 , 1929- -2253 1952-2253; 2090 2694 ; 2097 - -2253 ; 2097- -2688 ; 2179- -2253 ; 2415- -2823 ; 2546 2861; 2550-2949 2550- -2672 , 2550- -3074 , 2550- -2935 , 2550- -2878 , 2550- -2761 2550-2748; 2550 2738 ; 2550- -2727 ; 2550- -2658 ; 2550- -2645 ; 2550- -2626 ; 2550 2604; 2550-2616 2550- -3028 , 2550- -2736 , 2571- -2815 , 2577 - -3174 , 2577 - -2724 2598-3145; 2604 2992 ; 2617 - -3022 ; 2617 - -3103 ; 2625- -3277 ; 2647- -2919 ; 2717 2874; 2720-2938 2766- -3170 , 2766 -3014 2769- -3254 2769- -3011 2772- -3063 2787-2937; 4024 4573 ; 4024- -4761 ; 4029- -4283 ; 4146- -4762 ; 4162 - -4761 ; 4208 4762; 4267-4771 4279- -4755 4287 -4762 4291 -4771 4329 -4762 4382 -4627 4442-4763; 4503 4771 ; 4516- -4637 ; 2798- -3416 ; 2808- -3023 ; 2819 - -3043 ; 2827 3131; 2830-3199 2846- -3083 2866 -3428 2889 -3145 2906 -3520 2925 -3122
2936-3414; 2951-3185; 2974-3216; 2986-3238; 2997-3131; 2999-3271; 3004
3149; 3025-3407 3068-3505; 3068-3325; 3070-3539; 3072-3325; 3073-3446
3074-3567; 3077-3230; 3090-3542; 3091-3421; 3136-3368; 3143-3410; 3171-
3629; 3171-3380 3173-3403; 3194-3477; 3214-3901; 3219-3411; 3223-3500 3231-3620; 3231 3487; 3233-3455; 3275-3523; 3291-3715; 3297-3770; 3307 3699; 3322-3604 3321-3562; 3357-3522; 3367-3701; 3384-3810; 3389-3804
3390-3594; 3393-4007; 3395-3836; 3411-3729; 3419-3952; 3433-4009; 3432
3619; 3442-3580 3452-3957; 3475-3734; 3479-4005; 3521-3735; 3535-3812 Table 3
3561-3810; 3562-3799; 3564-4032; 3564-3819; 3571-3821; 3571-4052; 3578- 4045; 3579-4101; 3582-4040; 3581-3963; 3589-4047; 3584-3866; 3586-4044; 3587-3834; 3589-4044; 3589-4040; 3599-4045; 3601-4043; 3604-4045; 3606- 4006; 3606-4043; 3607-4045; 3607-4037; 3609-3879; 3611-4045; 3611-3969; 3611-4040; 3613-4045; 3549-3833; 3569-3944; 3560-3964; 3561-3971; 3570- 3968; 3647-3935; 3576-3970; 3580-3974; 3581-3966; 3582-3969; 3591-4063; 3660-4103; 3597-3969; 3597-3920; 3600-4027; 3604-3881; 3650-4004; 3688- 4183; 3655-3932; 3656-3904; 3695-3930; 3664-3900;' 3665-3970; 3670-4009; 3704-3824; 3677-3937; 3721-3989; 3733-3952; 3680-3981; 3707-3980; 3709- 4004; 3746-4331; 3718-4004; 3720-4103; 3718-3965; 3718-3964; 3705-3972; 3714-3967; 3767-4004; 3768-4009; 3770-4007; 3799-4004; 3819-4009; 3831- 4009; 3831-4008; 3809-3981; 3879-4046; 3883-4150; 3834-3981; 3839-3980; 3848-3986; 3991-4296
270/LI:1086800.7:200lMAYl7 | | 1704-1842; 1867-2393; 1976-2237; 2086-2372; 2216-2493; 2334-2697; 2407-2693; 2511-2634; 3256-3736; 3388-3891; 3637- 3868; 3771-4053; 3854-4253; 4175-4688; 4220-4714; 4331-4717; 4396-4963; 4436-4692; 4448-4802; 4507-4778; 4551-4989; 4874-4995; 1-625; 31-518; 31- 296; 53-191; 184-445; 396-784; 419-967; 419-914; 423-637; 534-1058; 610- 1075; 610-961; 626-913; 756-1380; 1035-1615; 1384-2032; 1403-2002; 1404- 2020; 1403-1983; 1403-1665; 1403-1552; 1403-1587; 1407-1809; 1407-1667; 1410-1694; 1584-2069; 1616-2187; 1704-2158; 1704-2121; 1704-2137; 1704- 1891; 1757-2505; 1765-2191; 1808-2263; 1843-2212; 1879-1997; 1896-2443; 1924-2136; 1928-2161; 1984-2484; 2020-2681; 2019-2484; 2073-2611; 2107- 2496; 2116-2484; 2117-2491; 2198-2497; 2216-2473; 2218-2484; 2261-2539; 2271-2626; 2331-2489; 2342-2825; 2342-2680; 2383-2484; 2435-2991; 2408- 2697; 2402-3179; 2463-2694; 2466-3125; 2587-3163; 2630-3211; 2666-3298; 2805-3054; 2805-3046; 2808-3005; 2808-3021; 2898-3393; 3020-3278; 3030- 3307; 3179-3456; 3188-3462; 3279-3465; 3319-3451; 3323-3456; 3353-3820; 3389-3456; 3587-3840; 3612-3879; 3615-3825; 3627-3893; 3643-3918; 3663- 3901; 3672-3975; 3692-3948;. 3783-4173; 3783-4154; 3783-4024; 3838-4061; 3854-4007; 4163-4647; 4174-4581; 4174-4530; 4174-4365; 4183-4829; 4206- 4470; 4215-4723; 4215-4639; 4228-4421; 4229-4681; 4245-4483; 4316-4745; 4361-4800; 4369-4910; 4371-4959; 4380-4955; 4382-4664; 4406-4927; 4428- 4943; 4434-4799; 4434-4911; 4441-4983; 4464-4917; 4474-4987; 4481-4939; 4481-5008; 4495-4995; 4522-4968; 4534-4993; 4535-4980; 4541-4995; 4552- 4996; 4554-4983; 4554-4947; 4554-4789; 4555-4990; 4577-4989; 4594-4995; 4597-4995; 4612-4996; 4619-4954; 4617-4931; 4622-4853; 4624-4948; 4624- 4995; 4651-5006; 4655-4995; 4657-4989; 4663-5013; 4682-5002; 4730-4997; 4730-4993; 4783-4983; 4783-4955; 4784-4990; 4785-4999; 4785-4995; 4796- 4962; 4798-4995; 4831-4997; 4846-4995; 4929-4993
271/LI:1089871.9:2001MAY17 | | 4627-4883; 4631-4802; 4642-4889; 4642-5009; 4644-4879; 4690-4893; 4694-4965; 4699-4880; 4700-4886; 4703-4964; 4709- 4878; 4733-5267; 4744-5011; 4744-5260; 4768-5001; 4770-5058; 4770-4961; 4791-5401; 4788-5261; 4794-5069; 4801-5012; 4835-5115; 4879-5435; 4879- 5112; 4883-5162; 4941-5117; 4951-5245; 4956-5496; 4956-5399; 4956-5065; 4971-5065; 4973-5182; 4980-5266; 5079-5520; 5084-5367; 5139-5397; 5143- 5416; 5169-5442; 5179-5659; 5179-5425; 5186-5467; 5115-5480; 5231-5518; 5234-5428; 5237-5622; 5245-5539; 5246-5777; 5246-5738; 5257-5420; 5264- 5511; 5278-5671; 5314-5584; 5320-5777; 5329-5777; 5330-5595; 5338-5782; 5360-5779; 5373-5629; 5382-5632; 5382-5595; 5403-5873; 5410-5666; 5425- 5687; 5450-5828; 5473-5871; 5482-5872; 5488-5869; 5492-5743; 5523-5785.; 3338-3825; 3396-3806; 3408-3653; 3407-3643; 3408-3929; 3408-3636; 3417- 3550; 3427-3748; 3479-3756; 3486-3721; 3570-3834; 3643-4076; 3654-3929; 3705-4174; 3736-4206; 3736-4264; 3774-4340; 3782-3900; 3813-4356; 3830- 4129; 3840-4354; 3840-4103; 3851-4081; 3858-4112; 3868-4103; 3871-4145; 3880-4171; 3887-4185; 3890-4447; 3921-4182; 3920-4164; 3921-4164; 3926- 4219; 3938-4182; 3944-4405; 3950-4477; 3965-4221; 3983-4416; 3983-4190; 3983-4388; 3983-4128; 3985-4209; 3986-4131; 3987-4446; 3989-4199; 3990- 4425; 3991-4276; 3996-4263; 4001-4190; 4003-4190; 4003-4276; 4015-4265; 4025-4264; 4105-4407; 4106-4274; 4106-4346; 4134-4357; 4175-4409; 4178- Table 3
4409; 4185-4598; 4207-4309; 4220-4453; 4309-4468; 4336-4717; 4350-4730; 4389-4845; 4415-4696; 4423-4886; 4484-4890; 4491-4856; 4498-4751; 4506- 4966; 4509-4960; 4527-4886; 4559-4886; 4558-4799; 4567-4890; 4627-4964; 1- 611; 377-936; 378-936; 378-933; 378-922; 378-836; 416-764; 533-889; 561- 1193; 649-1195; 734-4886; 756-936; 810-900; 872-936; 886-1444; 1237-1724; 1292-1662; 1292-1564; 1479-1751; 1672-2337; 1672-2247; 1810-2037; 1834- 2210; 1858-2063; 1947-2071; 1950-2239; 2067-2407; 2177-2758; 2204-2466; 2269-2872; 2271-2515; 2349-2946; 2464-2893; 2518-2738; 2535-2975; 2612- 3053; 2615-2860; 2617-3140; 2653-2894; 3001-3452; 3035-3503; 3065-3556; 3078-3396; 3153-3402; 3197-3613; 3198-3526; 3300-3554; 3308-3512; 1-118; 1301-1923; 1823-2370; 1950-2111; 2311-2952; 2608-2868; 2757-3232; 3153- 3614; 3311-3553; 3999-4321; 4056-4296; 4172-4678; 4214-4658; 4380-4845; 4495-4886; 4554-4960; 5246-5501; 5319-5525; 5356-5827; 5384-5779; 5480- 5777; 5523-5771; 5707-5783; 5546-5813; 5554-5832; 5562-5777; 5583-5766; 5606-5872; 5676-5916; 5713-5917; 5684-5766; 5726-5899
272/LI:110297.6:2001MAY17 | | 1525-1784; 1712-2149; 1806-2044; 1851-2020; 1916-2149; 1996-2242; 2036-2397; 2103-2402; 2177-2345; 2279-2391; 1-391; 82-368; 82-321; 162-720; 196-457; 323-569; 459-679; 535-832; 555-1149; 555- 1147; 564-795; 564-1051; 565-1015; 564-1004; 564-1013; 564-1155; 564-1074; 564-1038; 564-977; 565-1173; 564-1198; 584-1195; 639-935; 642-850; 659- 1181; 698-1172; 882-1457; 887-1413; 930-1453; 930-1537; 941-1464; 944-1374; 943-1504; 949-1519; 947-1612; 994-1631; 1025-1646; 1057-1146; 1098-1533; 1098-1468; 1103-1292; 1115-1728; 1120-1694; 1149-1650; 1226-1800; 1246- 1503 1288-1928; 1301-1783; 1306-1857; 1315-1784; 1350-1737; 1352-1465; 1356 1985; 1357-1898; 1363-1784; 1388-1784; 1424-1933; 1433-1733; 1494- 1727 1524-1939; 1532-1784; 1533-2006; 1568-1784; 1568-1968; 1673-1862; 1787 2339; 1806-2347; 1806-2397; 1806-2149; 1836-2091; 1845-2149; 1845- 2148 1858-2020; 1879-2354; 1879-2361; 1892-2342; 1923-2149; 1930-2403; 1930 2179; 1944-2207; 1992-2374; 2012-2265; 2022-2397; 2024-2404; 2027- 2291 2036-2394; 2044-2397; 2077-2397; 2119-2354; 2119-2402; 2149-2391; 2160-2391; 2188-2399; 2199-2359; 2206-2400; 2206-2395; 2239-2402 273/LI:1143463.8:2001MAY17 | | 890-1571; 1047-1621; 1103-1767; 1190-1540; 1296-1935; 2170-2329; 3274-3650; 3419-3486; 3462-3638; 3659-3773; 3843- 4062; 3906-4171; 4263-4519; 4304-4670; 4355-4622; 4412-4677; 4445-5117; 4488-4666; 4757-4941; 4759-5133; 4811-5128; 4842-5067; 4847-5081; 4879- 5128; 4885-5300; 4928-5340; 5068-5515; 5068-5323; 5069-5490; 5162-5569; 5173-5540; 5214-5360; 79-784; 170-809; 173-817; 207-813; 241-738; 274-872; 279-815; 315-432; 362-977; 360-999; 376-768; 386-1176; 393-1075; 397-1042; 473-1144; 528-1193; 587-1284; 626-1212; 630-1249; 1-522; 650-1193; 654- 1193; 692-1418; 728-827; 1-219; 16-281; 748-1328; 783-1340; 803-1450; 15- 642; 839-1432; 15-320; 850-1294; 15-611; 10-419; 16-594; 893-1572; 965- 1643; 994-1193; 989-1598; 1055-1693; 1060-1299; 17-240; 1071-1561; 1077- 1621; 1092-1441; 17-285; 1113-1806; 1131-1884; 18-305; 1165-1302; 1176- 1410; 1193-1760; 1200-1638; 1217-1775; 1223-1848; 1269-1869; 1299-1883; 1317-2032; 1360-1690; 18-209; 28-548; 35-479; 37-507; 39-646; 5234-5631; 5237-5631; 5241-5742; 5246-5807; 5252-5631; 5284-5631; 5286-5840; 5293- 5616; 5300-5480; 5317-5616; 5347-5620; 5349-5622; 5356-5772; 5369-5738; 5374-5768; 5400-5564; 5406-5617; 5463-5779; 5481-5616; 5497-5617; 5706- 5768; 5009-5128; 5016-5563; 5018-5455; 5019-5576; 5019-5455; 5023-5300; 5029-5393; 5038-5302; 5059-5627; 5068-5459; 5068-5495; 5068-5507; 5068- 5494; 5068-5285; 5068-5517; 5068-5286; 5068-5428; 5068-5496; 5068-5445; 5068-5539; 5068-5485; 5068-5556; 5068-5426; 5069-5550; 5068-5498; 5068- 5497; 5068-5484; 5068-5345; 5068-5583; 5068-5408; 5069-5566; 5068-5492; 5068-5551; 5069-5514; 5140-5302; 5147-5629; 5152-5626; 5162-5370; 5162- 5591; 5164-5568; 5162-5275; 5176-5736; 5187-5631; 5214-5325; 5214-5631; 5215-5563; 5221-5566; 4609-5064; 4629-4871; 4629-4873; 4704-5029; 4704- 5164; 4720-5128; 4729-4979; 4730-5147; 4730-5128; 4489-4669; 4730-4996; 4730-5009; 4757-4993; 4757-5294; 4759-5003; 4492-4728; 4759-5149; 4515- 4853; 4514-4984; 4760-5129; 4765-5231; 4805-5218; 4810-5228; 4809-5011; 4820-5343; 4821-5056; 4831-5219; 4841-5069; 4843-5032; 4844-5305; 4845- Table 3
5128; 4846-5224 4847-5128; 4858-5219 4877-5128 4879-5129; 4878-5128; 4517-4821; 4881 5303; 4881-5219; 4885 5128; 4516 4676 4903-5128; 4907- 5302; 4939-5393 4950-5298; 4972-5325 4529-4812 4566-4855; 4586-5087; 4602-4860; 4992 5302; 5009-5263; 3915-4140; 3917 4098 3924-4109; 4098- 4441; 4099-4457 3935-4225; 4119-4307 4122-4644 4122-4711; 3959-4298; 3963-4468; 4151 4263; 4014-4633; 4016 4203; 4157-4310 4029-4204; 4045- 4194; 4046-4428 4056-4496; 4159-4611 4080-4674 4092-4350; 4096-4323; 4099-4458; 4159 4538; 4159-4633; 4162 4376; 4201-4659 4226-4509; 4235- 4777; 4235-4510 4236-4480; 4243-4494 4269-4669 4273-4518; 4271-4446; 4288-4547; 4291 4676; 4305-4568; 4312-4619; 4334-4614 4347-4713; 4357- 4613; 4357-4419 4384-4457; 4411-4523 4419-4909 4431-4673; 4441-4662; 4445-4994; 4456 4676; 4470-4641; 4473 4710; 4480-4950 4486-5061; 2177- 2624; 2184-2627 2188-2583; 2203-2623 2223-2625 2251-2624; 2258-2618;
2266-2575; 2315-2624; 2321-2618; 2332 2676; 2397-2637 2409-2624; 2409-
2622; 2425- 2624 2440-2612; 2471-2617 2569-2849 2569-2754; 2569-3071; 2585-3166; 2696 2899; 2734-2949; 2739-3036; 2744 3133 2883-3116; 2916- 3146; 2916- 3142 2947-3158; 3008-3612 •3027-3165 3139-3307; 3147-3240; 3152-3690; 3156 3599; 3161-3491; 3163 3446; 3210-3456 3242-3321; 3310- 3942; 3399- 3596 3418-3486; 3443-3697 3453-3684 3461-4098; 3488-3754; 3503-3740; 3572 4219; 3685-3829; 3695 3932; 3707-3901 3727-3927; 3843- 4099; 3848- 4072 3855-4091; 3886-3976 3900-4128 1370-1621; 1393-2015; 1399-1941; 1405 1790; 1419-2044; 1434-1851; 1446 1829 1451-1934; 1470- 1711; 1487-•2053 1497-1885; 1502-2054; 1515-2281 1532-2178; 1561-2215; 1571-2033; 1573 1852; 1613-2149; 1620- 2123; 1722 2127 1733-2151; 1758- 2357; 1743-•2369 1811-2352; 1837-2240; 1892-2133 1933-2520; 1965-2630; 1977-2559; 1998 2486; 2007-2346; 2019- 2628; 2024 2217 2029-2662; 2030- 2300; 2072-•2617 2121-2579; 2139-2622; 2152-2625 2155-2622; 2163-2622; 2167-2624; 2174-2618; 1360-1566; 2173-2329
274/LI.-1144466.1.-2001 ΑY17 | | 1052-1581; 1154-1455; 1232-1689; 1319-1664; 1458-1678; 1530-1620; 1965-2223; 1973-2194; 1980-2191; 2115-2167; 1-193; 1- 444; 134-707; 148-659; 154-715; 295-446; 407-818; 458-1048; 458-881; 458- 870; 458-1015; 458-875; 458-792; 458-939; 458-905; 458-984; 458-934; 458- 986; 458-1008; 460-659; 498-768; 611-1099; 608-1286; 607-1089; 655-1315; 656-1275; 660-1253; 670-939; 670-947; 671-1350; 671-1263; 670-1302; 670- 1192; 670-1152; 670-1160; 670-1081; 671-1271; 671-1238; 674-998; 701-1257; 712-951; 718-1205; 723-1226; 735-1252; 744-1260; 768-1359; 767-1367; 815- 1426; 857-1500; 885-1515; 892-1513; 955-1158; 973-1563; 996-1580; 1013- 1458; 1020-1561; 1023-1311; 1023-1307; 1056-1710; 1050-1563; 1053-1580; 1104-1532; 1106-1523; 1134-1372; 1176-1543; 1219-1679; 1227-1664; 1217- 1578; 1232-1487; 1277-1662; 1290-1678; 1310-1664; 1329-1664; 1391-1664; 1425-1679; 1445-2076; 1459-1664; 1451-1580; 1467-1664; 1483-1679; 1495- 2041; 1546-1664; 1690-2093; 1958-2182; 1960-2194; 1968-2223; 1973-2173; 1973-2218; 1973-2204; 1973-2201; 1980-2030; 1980-2188; 1980-2099; 2069- 2200; 2078-2207; 2099-2201; 2143-2201
275/LI:1170624.2:2001MAY17 | | 1-468; 30-523; 30-579; 30-657; 176-365; 237- 799; 257-538; 386-799; 502-903; 631-1136
276/LI.-1171602.39.-2001MAY17 | | 1-191; 1-196; 1-214; 30-703; 120-700; 378- 606
277/LI:1182361.3:2001MAY17 | | 1-600; 1-260; 2-221; 1-605; 1-621; 1-483; 1- 484; 1-475; 1-377; 1-537; 1-635; 39-694; 56-441; 73-651; 196-750; 165-674; 164-669; 210-695; 234-511; 284-737
278/LI-.1188194.15:2001MAY17 | | 705-994; 746-1005; 1317-1629; 1317-1613; 1317-1377; 1317-1428; 1-588; 18-604; 74-533; 202-793; 207-804; 240-804; 260-448; 276-448; 316-841; 313-930; 317-1030; 317-829; 344-911; 336-973; 343-1008; 347-993; 347-448; 379-946; 634-1003; 628-1007; 727-903; 731-962; 734-1002; 733-1011; 746-998; 747-1012; 746-1007; 746-797; 746-1011; 755- 996; 764-1005; 764-1037; 764-995; 764-1010; 764-996; 764-1004; 764-961; 764-906; 764-904; 764-867; 764-863; 764-1074; 765-1007; 760-991; 761-1422; 764-1105; 764-997; 772-900; 764-979; 764-994; 754-994; 769-1404; 772-1030; 772-1369; 772-1004; 783-1016; 780-1011; 798-1004; 801-1004; 810-1377; 808- Table 3
1002; 809-1020; 815-1011; 808-1430; 815-1016; 817-994; 828-1011; 835-1483; 847-1356; 846-1518; 862-1460; 874-1002; 879-1508; 881-1476; 891-1019; 892- 994; 891-1382; 893-1525; 895-1492; 911-1437; 908-1515; 907-1464; 917-1529; 915-1603; 928-1411; 933-994; 936-1410; 939-1002; 953-1460; 963-1549; 962- 1503; 1150-1591; 1308-1707; 1311-1808; 1312-1664; 1311-1871; 1311-1870; 1316-1459; 1317-1389; 1317-1836; 1317-1679; 1317-1767; 1317-1516; 1317- 1797; 1317-1653; 1317-1383; 1317-1372; 1317-1590; 1317-1579; 1317-1568; 1317-1622; 1356-1807; 1384-1988; 1414-1771; 1593-1717
279/LI: 1189195.7 -.2001MAY17 || 740-1224; 756-965; 791-1418; 801-1021; 811- 1419; 913-1507; 973-1484; 1012-1117; 1024-1420; 1024-1245; 1029-1234; 1035- 1470; 1146-1726; 1203-1459; 1212-1491; 1225-1756; 1226-1612; 1226-1584; 1277-1498; 1417-1623; 1481-1722; 1488-1722; 1558-1722; 1558-1984; 1578- 1810; 1686-1953; 1-350; 38-602; 38-573; 38-565; 38-429; 38-299; 49-685; 93- 186; 96-517; 104-610; 112-352; 177-655; 178-710; 178-576; 188-646; 188-603;
206-673 206-681 206-474; 207-648; 212-657 238-613 238-677; 238-671
238-672 238-664 238-668; 238-535; 238-450 240-596 240-414; 264-821
330-694 344-892 346-887 346-733 349-919 360-978 373-841; 379-981
388-949 388-845 391-845 409-816 434-824 437-939 448-845; 456-953
458-887 476-919 471-848 472-951 478-937 479-755 480-845; 485-907
492-950 493-844 515-966 537-950 539-1212; 549-938; 552-951; 560-1004;
559-913 564-828 580-950 597-1116 632-1214; 646-963; 651-1224; 650-1084;
674-1117; 690-1187; 695-1120; 696-1224; 699-1102; 703-1121; 711-1223; 716-
1240
280/LI:1190092.13:2001MAY17 || 1-488
281/LI:1190318.4:2001MAY17 || 301-467; 302-466; 394-1014; 394-944; 412-
1025; 451-985; 494-1066; 508-1105; 519-1107; 528-1105; 541-1110; 581-1063;
585-1105; 614-1122; 634-1077; 639-1105; 639-1106; 640-1098; 641-1105; 646-
1105; 642-844; 646-1104; 656-1122; 660-1105; 671-1105; 672-1104; 673-1122;
679-1077; 680-1105; 678-1105; 680-1125; 692-1105; 698-1105; 703-1105; 717-
1123; 721-1113; 742-1105; 799-1105; 824-1105; 842-1113; 871-1108; 870-1106;
886-1051; 937-1102; 936-1101; 1-562; 19-560; 19-559; 19-544; 19-416; 19-
395; 65-556; 119-644; 137-679; 227-379; 242-729; 242-673; 245-733; 249-463;
248-799; 269-532; 269-531; 269-810 272-547; 284-596
282/LI: 144233.1:2001MAY17 ]| 1-235 1-242; 1-232; 87-723
283/LI:154608.1:2001MAY17 || 1-239 1-255; 1-463; 53-341; 83-374; 228-754;
228-384; 299-730; 537-757; 612-922
284/LI:170101.1:2001MAY17 || 1-193; 80-578; 80-360; 164-575; 166-438; 352-
539; 472-1085; 492-578; 492-564; 492-926; 663-889; 680-1160; 812-1100; 840-
1012; 840-999; 854-993; 975-1160; 979-1127
285/LI: 180043.1:2001MAY17 || 1-624; 695-1070; 560-689; 563-685; 590-991;
590-1121; 592-858; 634-924; 686-1082; 744-1082; 747-1070; 868-1070; 914-
1070
286/LI:193050.1:2001MAY17 || 1-637; 34-637; 48-637; 294-782; 327-567; 414-
556; 414-877; 562-1043; 575-796; 862-1182; 884-1011; 898-1040; 933-1197;
1083-1488; 1121-1378; 1121-1483; 1330-1489; 1330-1487; 1407-1487; 1426-
1475; 1426-1912; 1791-2085; 1793-1960; 1793-1898; 1793-1953; 1793-2259;
1793-2141; 1797-1884; 1803-2017; 1822-2101; 1822-2217; 1847-2288; 1857-
2309; 1872-2332; 1886-2330; 1888-2183; 1896-2328; 1898-2322; 1916-2328;
1967-2321; 1976-2320; 1981-2301; 2000-2233; 2032-2322; 2055-2295; 2084-
2323; 2137-2324; 2154-2321
287/LI:197477.31:2001MAY17 | | 1-598; 185-392; 185-607; 439-1303; 452-1155;
520-707; 643-1353; 823-1155; 1022-1292; 1029-1220; 1121-1694; 1177-1735;
1186-1495; 1249-1746; 1254-1654; 1315-1694; 1320-1744; 1320-1820; 1323-
1703; 1336-1889; 1357-1740; 1358-1704; 1359-1703; 1416-1879; 1370-1650;
1378-1810; 1379-1951; 1391-1900; 1419-1892; 1445-1654; 1443-1582; 1444-
1810; 1450-1959; 1454-1909; 1459-1906; 1461-1901; 1466-1729; 1468-1907;
1469-1967; 1473-1909; 1475-1943; 1475-1820; 1479-1753; 1485-1741; 1485-
1772; 1486-1737; 1490-1947; 1492-1942; 1494-1946; 1495-1755; 1495-1739;
1498-1950; 1502-1950; 1507-1947; 1509-1777; 1514-1949; 1516-1907; 1516-
1794; 1519-1764; 1525-1941; 1535-1953; 1536-1793; 1557-1947; 1559-1822; Table 3
1561-1937; 1573-1945; 1576-1654; 1581-1944; 1585-1945; 1594-1834; 1595- 1946; 1597-1852; 1599-1784; 1605-1950; 1610-1947; 1609-1936; 1619-1947; 1620-1938; 1620-1796; 1646-1950; 1745-1939; 1454-1845; 1453-1929; 1151- 1835; 1399-1826; 1485-1948
288/LI:199639.12:2001MAYl7 || 1332-1596; 1340-1629; 1387-1792; 1385-1843; 1394-1700; 447-681; 1396-1700; 1401-1791; 1402-1701; 1405-1701; 473-709; 1406-1798; 1411-1697; 1418-1856; 1414-1700; 1415-1791; 1415-1751; 521-733; 724-1252; 1418-1788; 791-1067; 953-1132; 956-1071; 1060-1465; 1060-1253; 1086-1696; 1148-1253; 1156-1765; 1180-1272; 1182-1272; 1185-1597; 1418- 1730; 1418-1728; 1191-1682; 1207-1540; 1216-1677; 388-489; 403-669; 406- 508; 411-655; 412-687; 416-668; 417-785; 428-858; 428-743; 430-732; 441- 1231; 1-354; 25-343; 114-638; 160-659; 209-459; 359-611; 387-735; 388-591; 388-522; 1794-1951; 1804-2061; 1808-2365; 1811-2044; 1817-2098; 1820-2340; 1825-2321; 1834-2082; 1841-2125; 1852-2040; 1858-2079; 1858-2069; 1878- 2128; 1883-2128; 1903-2134; 1903-2196; 1915-2163; 1922-2144; 1924-2379; 1926-2376; 1928-2379; 1931-2130; 1944-2186; 1947-2337; 1952-2375; 1958- 2376; 1960-2147; 1961-2376; 1970-2376; 1964-2398; 1965-2398; 1984-2376; 1988-2375; 2000-2381; 2011-2381; 2060-2373; 2142-2389; 2188-2310; 2258- 2376; 2317-2369; 1418-1703; 1418-1701; 1418-1698; 1418-1697; 1418-1564; 1418-1692; 1418-1828; 1418-1682; 1422-1649;, 1429-1609; 1418-1674; 1418- 1604; 1418-1557; 1435-1734; 1418-1525; 1418-1516; 1436-1704; 1436-1699; 1442-2048; 1448-1716; 1451-1869; 1456-1703; 1456-1702; 1456-1663; 1453- 2049; 1464-1779; 1469-1858; 1418-1481; 1470-1663; 1475-1663; 1493-1663; 1470-1873; 1495-1760; 1500-1663; 1507-1866; 1509-2010; 1527-2168; 1537- 1831; 1551-1697; 1470-1831; 1471-1700; 1472-1841; 1564-1758; 1567-1792; 1569-2175; 1581-1819; 1585-1865; 1591-1810; 1591-2114; 1616-1706; 1633- 2201; 1636-1855; 1670-2126; 1674-2101; 1679-2276; 1685-1860; 1687-2299; 1688-2257; 1692-1865; 1709-2120; 1709-1959; 1746-1863; 1746-1823; 1.756- 2008; 1762-2113; 1795-2244
289/LI: 200058.6 :2001MAY17 I I 28-527; 1-506; 1021-1647; 1143-1639; 1069- •1610; 839-1434; 1018-1397; 733-1395; 896-1233; 927-1233; 777-1225; 799- 1226; 710-1135; 710-1121; 404-1013; 633-1010; 461-996; 710-939; 260-928; 484-908; 381-898; 293-867; 353-851; 363-840; 275-835; 175-785; 120-770; 172-757; 299-751; 147-645; 26-587; 81-577; 1-566 290/LI:201374.23:2001MAY17 I I 1-607; 1-532; 64-422
291/LI:201824.1:2001MAY17 | | 5-492; 1143-1421; 1435-1606; 2079-2282; 2079- 2263; 2104-2443; 2208-2634; 2343-2587; 2468-2726; 2509-2734; 2629-2870; 2747-3031; 2787-3010; 2884-3294; 2952-3185; 3099-3702; 3141-3465; 3224- 3380; 3437-3717; 3526-3717; 3584-3743; 1-492; 267-966; 268-726; 268-829; 582-1277; 671-1407; 753-1267; 758-1340; 885-1494; 885-1075; 903-1443; 913- 1547; 930-1213; 936-1422; 1020-1615; 1024-1472; 1043-1573; 1133-1398; 1151- 1606; 1253-1518; 1343-1606; 1433-1606; 1529-2176; 1552-1988; 1555-1935;
2079-2407; 2079-2301 2079-2299; 2079-2265; 2079-2260; 2079-2296 2079
2238; 2079-2261; 2079-2198; 2079-2276; 2090-2174; 2104-2408; 2111-2410
2164-2392; 2179-2448 2317-2798; 2317-2544; 2332-2797; 2332-2404 2354
2583; 2358-2964; 2358-2639; 2440-3035; 2460-2758; 2460-2729; 2475-2702
2484-2726; 2494-2748 2494-3135; 2566-2814; 2586-2743; 2599-2887 2621
2849; 2637-2893; 2642-3088; 2642-2850; 2659-2939; 2673-2746; 2702-2970
2708-2882; 2757-3268 2787-3174; 2806-3203; 2802-2947; 2818-3239 2818
3101; 2904-3220; 2911-3162; 2923-3155; 2952-3367; 2968-3236; 2982-3205
3003-3298; 3011-3202 3024-3234; 3101-3370; 3102-3380; 3112-3309 3130
3711; 3135-3386; 3143-3424; 3168-3678; 3202-3707; 3224-3429; 3227-3501
3265-3561; 3280-3745 3280-3742; 3285-3738; 3286-3696; 3291-3752 3297-
3744; 3301-3530; 3307-3713; 3308-3749; 3322-3743; 3325-3590; 3329-3749
3349-3712; 3356-3644 3356-3627; 3384-3738; 3400-3738; 3413-3753 3412
3654; 3419-3741; 3429-3743; 3429-3689; 3436-3729; 3436-3726; 3472-3743
3475-3735; 3494-3738 3505-3716; 3559-3722; 3563-3761; 3578-3749; 3579- 3747; 3589-3738; 3599-3743; 3660-3738
292/LI:201989.11:2001MAY17 || 780-1316; 876-1306; 907-1332; 916-1293; 959- 1306; 989-1311; 1034-1307; 1121-1293; 827-1436; 631-1368; 1132-1330; 1113- Table 3
1327; 628-1324; 1204-1319; 1074-1318; 750-1323; 1001-1315; 1065-1311; 862- 1310; 915-1309; 942-1311; 851-1309; 693-1310; 967-1309; 808-1306; 905-1308; 907-1308; 948-1306; 970-1308; 1014-1306; 1026-1306; 1241-1306; 1247-1306; 910-1307; 970-1307; 885-1306; 972-1306; 1113-1311; 852-1305; 951-1301; 946- 1301; 900-1298; 898-1298; 757-1307; 947-1295; 989-1294; 911-1293; 1011- 1292; 733-1312; 812-1298; 940-1291; 1116-1288; 959-1282; 863-1298; 1109- 1286; 691-1247; 1013-1241; 1091-1240; 1045-1235; 538-1183; 914-1160; 1012- 1135; 565-1127; 783-1110; 584-1110; 495-1042; 810-1007; 453-998; 520-989; 625-989; 528-980; 768-970; 705-923; 440-896; 253-893; 428-887; 722-877; 590-874; 288-860; 365-848; 599-838; 585-805; 729-793; 457-786; 577-773; 630-770; 538-709; 43-604; 217-494; 19-454; 20-454; 19-397; 276-359; 14-292; 12-264; 1-262; 73-260; 19-210
293/LI: 2035159.1:2001MAY17 | | 1-619; 75-734; 507-733; 507-716; 540-733; 608-733
294/LI: 204818.10 :2001MAY17 | | 1-556; 124-700; 151-400; 151-361; 159-725; 209-556; 293-830; 335-789; 374-614; 544-1070; 544-768; 621-917; 638-919; 689-924; 740-1303; 961-1446; 983-1137; 407-659
295/LI:2048337.1:2001MAY17 | | 1390-2016; 1400-2016; 1533-2016; 1444-2014; 1339-1958; 1123-1780; 1567-2016; 1469-2018; 1629-2040; 1701-2163; 1709- 2128; 1752-2123; 1639-2121; 1699-2121; 1775-2121; 1886-2121; 1653-2119; 1515-2110; 1699-2108; 1493-2104; 1508-2104; 1466-2101; 1527-2077; 1599- 2049; 1451-2049; 1494-1770; 1204-1758; 1128-1649; 1203-1479; 755-1302; 503- 923; 575-883; 574-883; 238-865; 306-871; 239-867; 341-863; 239-779; 129- 778; 239-776; 130-739; 73-730; 124-725; 194-715; 99-708; 44-709; 49-691; 239-641; 239-617; 145-551; 1-531; 239-459; 239-369; 22-252; 77-163 296/LI-.2049697.4:2001MAY17 | | 1052-1314; 1267-1501; 1270-1970; 1282-1501; 1-298; 11-349; 203-660; 214-709; 233-571; 235-345; 237-642; 238-558; 256- 642; 274-518; 301-874; 419-651; 424-893; 440-894; 457-889; 470-886; 479- 906; 483-796; 485-894; 563-886; 565-888; 604-893; 625-893; 636-890; 810- 1002; 958-1306; 1023-1270; 1030-1333; 1164-1392; 1177-1367; 1187-1501; 1222-1500; 1262-1501; 1270-1453; 1270-1907; 1270-1898; 1270-1501; 1270- 1905; 1271-1501; 1282-1500; 1314-1481; 1335-1404'; 1409-1501; 1437-1501; 1452-1907'; 1447-2049; 1663-2102; 1685-2100; 1794-2094; 1795-2094; 1801- 2109; 1812-2060; 1815-2094; 1815-2098; 1815-1978; 1815-1905; 1819-2000; 1819-2097; 1831-2097; 1893-2097; 1919-2047; 1942-2097 297/LI:2050808.19:2001MAY17 | | 783-1021; 867-1215; 896-1203; 913-1239; 1055-1238; 798-1234; 931-1241; 981-1241; 794-1240; 801-1239; 801-1238; 889- 1238; 1125-1238; 806-1237; 943-1237; 731-1231; 803-1223; 813-1223; 877- 1218; 813-1222; 942-1218; 756-1217; 745-1217; 848-1217; 478-1213; 911-1213; 804-1213; 797-1213; 814-1213; 840-1213; 808-1213; 1080-1204; 812-1210; 768- 1206; 796-1206; 912-1203; 772-1202; 1044-1200; 690-1198; 786-1183; 937- 1179; 838-1158; 746-1115; 706-1113; 684-1106; 706-1109; 706-1105; 705-1096;
706-1097; 619-1081; 785-1063; 427-1048; 711-1015 747-994 433-909; 657-
881, 545-887; 433-860; 433-850; 535-836; 285-832 380-842 201-818; 581-
823 476-754; 373-747; 180-740; 200-713; 304-704 201-704 179-698; 180-
695 352-690; 228-689; 413-688; 130-685; 226-665 400-633 372-642; 87-56!
15-575; 1-568 ; 284-497; 180-470 180-449; 214-462 ; 361-424 : 179-362; 192-
330 180-320; 6-140; 19-91
298/LI:209773.25:2001MAY17 || 197-960; 415-1089; 1-950; 248-892; 504-776 299/LI:2117881.32:2001MAYl7 j| 1-620; 330-757; 836-1181; 182-743; 182-782; 182-699; 182-425; 209-814; 314-694; 317-445; 399-617; 563-792; 739-1296; 781-1257; 965-1222; 965-1268; 986-1205; 999-1280
300/LI:2118140.9:2001MAY17 || 452-891; 463-581; 513-1164; 820-1411; 994- 1449; 1113-1706; 1335-1697; 1396-1697; 1465-1697; 1590-1697; 1-580; 1-130; 2-576; 4-580; 3-112; 2-567; 12-576; 13-581; 33-576; 37-579; 41-512; 67-581; 63-583; 63-576; 420-577; 439-580; 439-581; 445-581; 452-943; 452-1038; 452- 580; 452-828; 452-706; 452-936; 455-572; 452-990; 460-580; 463-580; 476- 1333; 512-1119; 531-1128; 578-780; 598-788; 659-898; 820-1407; 878-1378; 933-1547; 954-1421; 1014-1591; 1009-1546; 1038-1657; 1029-1307; 1054-1621; 1146-1461; 1158-1699; 1279-1697; 1308-1697; 1366-1697; 1373-1697; 1393- Table 3
1845; 1395-1697; 1401-1702; 1413-1738; 1428-1697; 1433-1697; 1465-1688;
1526-1697; 1569-1697; 1573- 1697; 1576-1697
301/LI: 2118151.15 :2001MAY17 | | 6118-6612; 6123-6601; 6130-6604; 6157-6327;
6184-6875; 6190-6435; 6201- 6575; 6213-6321; 6223-6874; 6273-6566; 6278-
6863 6285-6813; 6286-6828; 6295-6790 6319-6838; 6414-6842; 6409-6874;
6412 6878; 3068-3447; 3067- 3331; 3110 3447; 3115-3441; 3115-3394; 3117-
3363 3130-3445; 3135-3369; 3137-3399 3155-3321; 3281-3795; 3370-3445;
3390-3928; 3478-3775; 3483-3963; 3483 3714; 3564-3736; 3566-4077; 3583- 3687; 3587-4106; 3609-4157; 3626-4335 3688-3928; 3720-3982; 3724-4285;
3726-4288; 3840-4413; 3867-4298; 3889-4384; 3925-4260; 3922-4362; 3922-
4431 3921-4357; 3979-4153; 3981- 4457 3993-4235; 4033-4316; 4088-4332;
4088-4810; 4144-4737; 4187- 4809; 4195 4422; 4197-4810; 4209-4891; 4200-
4810 4207- •4767 4239- 4810; 4265- 4810 4270-4487; 4271-4810; 4281-4810; 4306 4810; 4358 4810; 4359- 4784; 4365 4810; 4371-4810; 4543-4735; 4550- 4809 4561- 5165 4598- 4704; 4632- 4928 4771-5156; 4881-5174; 4883-5128; 4979 5320; 4987 -5489; 4987- 5587; 5351 5928; 5426-5852; 5426-5775; 5508- 6121 5545- ■5814 5743- 5922; 5760- 6030 5799-6041; 5809-6125; 5812-6557; 5812 6462; 5817 -6090; 5820- 6089; 5879 6280; 5882-6373; 5882-6366; 5891- 6336 5891- 6281 5899- 6240; 5902- 6079 5902-6295; 5902-6386; 5902-6490; 5902 6353; 2634 3181; 2674- 3241; 2677 3136; 2686-3190; 5902-6468; 5902- 6230 5903- ■6435 5909- 6160; 5909- 6181 5909-6313; 5942-6458; 5963-6309; 5964 6429; 5974 6487; 6012- 6469; 6016-6434; 6023-6615; 6073-6600; 6087- 6522 6094- 6568 6105- ■6241; 2919- -3294 2924-3350 2930-3331; 2933-3337; 2936 3150; 2947 -3425; 2964- 3221; 2670 2950; 2693-3312; 2704-3233 2748- 3010 2751- ■3298 2734- •2989; 2770- -2933 2779-3360 2780-3292; 2793-3353; 2800 3363; 2819 -3342; 2844- 3061; 2855 3062; 2858 3294; 2864-3330 2853- 2971 2889- ■3328 2895- 3158; 2903- -3125 2906-3357 2908-3347; 5902-6326; 5902 6368; 5902 6430; 5902- 6378; 5902 6532; 2223 2769; 2237-2624 2251- 2821 2259- 2886 2264- 2618; 2300 -2907 2341-2572 2355-2558; 2351-2598;
2361-2651; 2443-2647; 2456- 3118; 2478 2834; 2483-2711; 2483-3123; 5618-
5875 5812-6300; 5879-6345; 5898- -6343 1-6874; 1420-1812; 1453-1698; 1545- 1887 1723-1885; 1902-2171; 1925- -2353 1930-2119; 1935-2184; 1937-2170; 1971 2318; 2005-2297; 2038-2294; 2036-2562; 2.044-2612; 2060-2320; 2066 2322 2093-2668; 2110-2341; 2099-2684 2129-2414; 2163-2346; 2158-2810; 2171 2665; 2190-2341; 2474- 3150; 2533 2978; 2561-3119; 2574-3092; 2575- 2772 2571-3153; 2630-3086; 2631-2796 2618-2922; 2618-3260; 2630-2764;
6419-6882; 6427-6713; 6435-6874; 6482 6874; 6484-6705; 6494-6836; 6496-
; 6507-6882 2964-3160; 2964-3176; 2975-3363; 2978-3227; 2997-3447; 3010-3279; 3024 3337; 3027-3448; 3034-3451; 3036-
3445 6586-6847; 6582-6870; 6586-6840 6582-6882; 6586-6879; 6590-6874;
6613-6882; 6651-6875; 6700-6877; 6789-6876; 6508-6882; 6509-6876; 6538
6874; 6542-6874; 6561-6880; 6563-6878; 6570-6880; 6570-6870; 6576-6815 302/LI: 2118324.9 :2001MAY17 II 2737-2927; 2754-3347; 2914-3173; 2924-2994; 2941-3178; 2994-3539; 2995- 3232; 2999-3224; 3010-3271; 3042-3216; 3081- 3302; 3149-3463; 3151-3446 3151-3431; 3151-3432; 3151-3409; 3151-3375; 3157-3409; 3185-3410; 3224- 3601; 3224-3453; 3268-3547; 3292-3749; 3312- 3674; 3342-3446; 3389-3567 3399-3651; 3496-3902; 3524-3741; 3532-3686; 3536-3687; 3595-4059; 3595 3764; 3687-4145; 3690-4123; 3690-4109; 3691- 3904; 3691-4142; 3693-4042 3700-4316; 3702-3821; 3702-3783; 3702-3834; 3721-3954; 3753-4325; 3759 4028; 3773-4028; 3783-3982; 3795-4032; 3803- 4112; 3812-4059; 3815-4218 3815-4304; 3840-4365; 3840-4022; 3859-4183; 3870-4131; 3870-4163; 3874- 4166; 3882-4156; 3889-4450; 3890-4110; 3892- 4167; 3903-4150; 3905-4171 3905-4323; 3905-4174; 3928-4100; 3985-4200; 3987-4327; 4036-4682; 4042- 4264; 4054-4330; 4068-4693; 4094-4356; 4150- 4408; 4166-4416; 4189-4455 4216-4496; 4216-4615; 4227-4491; 4245-4695; 4250-4689; 4261-4515; 4266 4735; 4277-4721; 4279-4693; 4281-4732; 4288- 4730; 4292-4696; 4297-4590 4314-4693; 4325-4496; 4368-4732; 4369-4732; 4372-4619; 4372-4626; 4373- 4730; 4432-4733; 4434-4691; 4288-4738; 4364- 4732; 4408-4732; 1-406; 1206-1459; 1586-2175; 2456-2997; 2530-2959; 2651- 2845; 3903-4330; 3955-4211; 4047-4320; 4160-4433; 4241-4678; 4277-4560; Table 3
4440-4732; 4457-4734; 4470-4735; 4518-4732; 4520-4730; 4527-4627; 4542- 4729; 4553-4720; 4558-4732; 4589-4730; 4619-4734; 4644-4720; 239-799; 569- 1097; 754-1293; 763-876; 847-978; 867-1358; 1141-1491; 1204-1576; 1292- 1842; 1382-1567; 1454-1778; 1477-1721; 1588-1848; 1618-2041; 1656-2174; 1889-2449; 2000-2557; 2456-2978; 2456-2822; 2456-2984; 2486-3051; 2530- 2995; 2580-3154; 2608-2873; 2615-3061; 2695-2975
303/LI:2118368.12:2001MAY17 | | 1-308; 1-181; 3-171; 3-160; 12-338; 17-269; 18-312; 19-272; 25-324; 69-728; 170-827; 168-731; 180-782; 190-374; 244- 456; 184-442; 206-838; 206-637; 228-892; 240-815; 268-915; 324-924; 319- 845; 334-915; 336-535; 340-544; 345-850; 351-895; 368-1025; 360-974; 379- 618; 388-894; 393-931; 395-894; 401-916; 481-814; 474-939; 483-1167; 482- 1084; 491-1040; 499-1075; 493-1102; 499-1090; 502-1031; 501-1069; 499-1154; 498-1057; 506-1081; 522-1032; 513-1090; 521-1095; 520-1093; 527-1103; 531- 1096; 531-1121; 538-952; 541-1076; 542-1097; 545-1246; 552-1120; 556-999; 561-1048; 582-879; 583-797; 577-1262; 580-1198; 591-1175; 598-1118; 613- 1015; 620-1201; 634-1026; 643-1110; 646-775; 647-904; 665-1171; 665-905; 707-1140; 702-766; 755-1301; 796-1098; 844-1070; 900-1359
304/LI:2119448.5:200lMAYl7 | | 1-595; 34-346; 65-540; 247-537; 382-806; 382- 765; 759-1546; 1076-1357; 1076-1454; 1098-1462; 1098-1397; 1099-1397; 1104- 1693; 1208-1364; 1232-1397; 1281-1510; 1281-1582; 1322-1585; 1424-1532; 1489-1861; 1772-2299; 1780-2250; 1811-2263; 1824-2302; 2005-2623; 2020-. 2622; 2080-2648; 2145-2436; 1658-2127; 1960-2387; 2145-2516; 2152-2732; 2396-3015; 2436-2679; 2451-2679; 2662-3286; 2713-3362
305/LI:212023.7:2001MAY17 || 1-675; 1-441; 90-677; 85-621; 176-709; 201- 824; 216-832; 269-716; 272-900; 285-620; 353-943; 358-879; 411-992; 413- 868; 429-1013; 481-989; 534-1147; 580-953; 591-950; 593-707; 718-1299; 735- 1075; 735-1097; 737-1046; 737-905; 758-1134; 760-1184; 773-1418; 781-878; 805-969; 860-1094; 876-1432; 984-1454; 999-1454; 1015-1458; 1036-1455; 104-8-13O2; 1092-1450; 1099-1454; 1148-1448; 1154-1472 ;.1154-1469; 1171- 1409; 1184-1454; 1192-1472; 1262-1456; 1323-1472; 1369-1474
306/LI: 2120556.1:2001MAY17 | | 1-407; 293-592; 294-593; 295-792; 300-509; . 305-819; 327-492; 329-878; 335-792; 447-508; 580-1019; 586-774; 694-1031; 715-1052; 721-1160; 739-1127; 878-1221; 712-1042 30'7/LI: 2121577.3 :2001MAY17 | | 1-219; 1-213; 163-219
308/LI:2123395.11:2001MAY17 j | 2356-2648; 2439-2646; 2382-2448; 2409-2652; . 1-616; 357-758; 362-561; 365-908; 375-981; 408-936; 440-656; 440-589; 445- 687; 447-722; 453-931; 489-1107; 520-785; 534-1105; 549-1032; 576-841; 589- 1127; 594-990; 618-944; 630-1110; 670-1183; 692-1151; 699-1134; 708-964; 708-946; 727-1336; 736-1151; 754-1161; 776-1152; 778-1153; 787-1036; 797- 1161; 807-1403; 824-1098; 836-1130; 836-992; 838-1148; 840-990; 842-1166; 842-1106; 859-1161; 879-1161; 882-1058; 923-1154; 930-1161; 936-1164; 1021- 1148; 1030-1166; 1030-1152; 1033-1240; 1136-1643; 1136-1389; 1369-1632; 1384-1624; 1389-1584; 1389-1582; 1464-1582; 1498-1954; 1497-1794; 1630- 2198; 1687-1971; 1774-2247; 1778-2062; 1811-2253; 1811-2007; 1816-2253; 1819-2200; 2025-2649; 2072-2609; 2080-2589; 2092-2583; 2092-2253; 2180- 2632; 2181-2594; 2196-2651; 2216-2631; 2221-2530; 2222-2626; 2223-2441; 2225-2651; 2262-2554; 2280-2588; 2289-2583; 2300-2549; 2300-2550; 2318-2646 309/LI:2123452.9:2001MAY17 | | 1084-1283; 1-452; 1-691; 1-449; 1-185; 16- 527; 3-278; 5-273; 7-190; 5-266; 7-187; 9-579; 9-580; 9-214; 9-205; 9-263; 9-557; 10-581; 10-202; 10-571; 14-240; 16-253; 18-421; 18-360; 17-229; 18- 420; 18-191; 18-174; 18-159; 21-71; 21-603; 26-366; 1-244; 2-259; 29-597; 5-216; 4-231; 10-603; 11-539; 19-443; 21-200; 72-323; 102-626; 111-348;
124-384; 124-361; 122-556; 144-440; 145-326; 144-562; 149-323; 159-449;
145-413; 183-465; 209-477; 252-785; 264-822; 268-838; 268-799; 281-595;
348-581; 353-796; 353-551; 402-821; 401-642; 404-836; 404-682; 421-681;
443-693; 448-678; 450-717; 460-794; 465-662; 466-743; 471-1107; 474-751;
491-1048; 523-824; 545-1200; 581-887; 584-823; 589-883; 599-854; 613-925;
624-906; 637-893; 628-1251; 635-1220; 654-1133; 654-898; 657-1211; 663-
1178; 663-938; 663-911; 663-869; 680-916; 695-1205; 703-796; 709-1225; 720-
917; 756-841; 757-990; 758-982; 773-1248; 773-1192; 773-1026; 771-1242; Table 3
786-1248; 791-1241; 791-1242; 792-1044; 792-1025; 797-1100; 815-1244; 825- 1250; 829-1244; 829-1026; 829-1018; 829-984; 829-881; 831-1254; 836-1251; 840-1245; 840-941; 851-966; 863-977; 885-1244; 896-1298; 897-1159; 913- 1244; 928-1215; 930-1213; 931-1210; 937-1528; 950-1245; 938-1111; 952-1149; 996-1242; 997-1239; 985-1208; 1055-1244; 1061-1421; 1061-1302; 1140-1247; 1140-1217; 1208-1450; 1231-1806; 1654-2044; 1726-1891; 1730-2042; 1754- 2059; 1821-2044; 1834-2044; 1939-2044; 1953-2044
310/LI: 2164109.1:2001MAY17 1-462 311/LI: 2168320.1.-2001MAY17 1-518 312/LI: 2173577.1:2001MAY17 1-582 313/LI: 2179256.1:2001MAY17 1-631 314/LI:2180388.1:2001MAY17 1-648 315/LI: 2199713.8 :2001MAY17 849-1361; 861-1089; 897-1088; 911-1088; 921- 1264; 1-347; 1-177; 1-85; -557; 7-190; 7-120; 13-302; 131-355; 222-485;
248-744; 260-439; 270-538; 304-747; 366-949; 399-991; 968-1235; 848-1073; 848-1051; 848-1048; 921-992; 921-983; 927-1317; 957-1083; 406-602; 457-734; 473-1022; 512-744; 519-627; 526-624; 533-1050; 623-1088; 634-988; 634-1088; 635-815; 639-1091; 749-1081; 749-982; 837-1300; 837-983; 848-1317; 848- 1105; 1035-1371; 1046-1158; 1046-1227; 1146-1317; 1163-1317; 1168-1317; 1183-1317; 1185-1297; 1187-1262; 1212-1599; 1216-1317; 1252-1748; 1267- 1617; 1306-1361; 1497-1722; 1497-1773; 1499-1822
316/LI:2200587.2:2001MAY17 || 421-530; 425-527; 363-525; 425-524; 417-512; 375-512; 444-510; 425-510; 352-510; 375-509; 425-509; 425-506; 444-506; 392-505; 380-501; 425-501; 1-501; 422-495; 375-495; 407-495; 392-495; 378- 495; 434-495; 444-495; 383-495; 402-495; 190-482; 375-476; 375-461; 1-454; 368-444; 375-440; 451-530; 474-530; 469-530; 431-530; 47-163; 441-530; 1- 213; 457-527; 351-530; 451-521; 1-198; 1-149; 359-530 14-193 : 442-510; 450-510; 451-509; 366-530; 479-530; 471-529; 476-530; 47-134; 24-114; 375- 751; 444-530
317/LI:2200761.12:2001MAY17 || 1-648; 14-462; 16-404; 16-143; 37-681; 90- 664; 116-664; 170-684; 174-462; 192-663; 214-831; 230-664; 244-664; 243- 664; 258-872; 330-9,96; 342-971; 383-462; 413-860; 444-1160; 476-990; 478- 1123; 487-1094; 512-1113; 523-1101; 528-1094; 527-1062; 550-909 318/LI:2203624.1:2001MAY17 || 1-290; 1-165; 5-192 ; ' 10-550 ; 10-165; 34-192;' 40-504; 40-208; 40-165; 369-497; 379-727; 484-727; 575-1127; 588-727; 597- 1114; 597-727; 597-740; -597-1107; 608-729; 1051-1109
319/LI:220495.9:2001MAY17 || 1-626; 8-656; 582-816; 582-941; 653-916; 656- 854; 688-1032; 808-1080; 808-1082; 835-1039; 871-1178; 920-1521; 981-1236; 983-1391; 998-1570; 1016-1633; 1077-1592; 1080-1625; 1128-1538; 1128-1271; 1150-1562; 1163-1588; 1177-1853; 1174-1738; 1192-1368; 1205-1393; 1240-
1698; 1273-1798 1279-1553; 1302-1734; 1304-1733; 1314-1720; 1323-1758;
1333-1702; 1367-1741; 1405-1606; 1403-1666; 1422-1596; 1422-1735; 1422-
1697; 1422-1692 1429-1699; 1521-1735; 1563-1683; 1598-1730; 1620-1860;
1651-1856; 1663 2114; 1771-1984; 1913-2237; 2071-2693; 2111-2592; 2333-
2832; 2480-2787 2490-3039; 2609-3103; 2650-2936
320/LI: 2205532.1:2001MΛY17 1-761; 58-680; 104-751; 389-1094; 481-1197;
507-1189; 909-1145; 1-536; 768-1221
321/LI: 2206277.1:2001MAY17 | | 1-359 ; 57-325 ; 115-324 133-357 133-323
133-364; 144-323 147-323 ; 155-363 ; 155-341 ; 155-323 155-282 169-763
210-323; 265-323 269-325; 542-935 ; 542-927 ; 542-828 542-797 542-683
558-810; 558-904 582-854; 652-917 ; 729-931 ; 780-944; 790-1102; 835-904
322/LI 2207765.8 2001MAY17 I I 520-1155 ; 42-686 ; 1--601
323/LI 2208404.4 2001MAY17 j j 1-344 324/LI 2208715.3 2001MAY17 I j 1-712 325/LI 2208766.2 2001MAY17 j j 1-2505 ; 1-237 ; 6-248 ; 120-865 ; 166-241 ; 552- 827 ; 566-773 ; 566-1062 ; 566-629 ; 566-994 ; 566-913 ; 565-829 ; 566-803 ; 566- 732 ; 566-731 ; 566-725; 566-712 ; 566-706 ; 566-703 ; 566-687 ; 593-755; 601- 1153 ; 615-1091 ; 619-734 ; 639-915 ; 667-923 ; 685-1172 ; 685-1122 ; 686-931 ; 703-829 ; 721-1408 ; 732-986 ; 736-1260 ; 739-1150 ; 742-1412 ; 744-912 ; 791- 1043 ; 791-1030 ; 801-1014 ; 820-929 ; 821-1086 ; 826-1129 ; 827-1187 ; 827-1032 ; Table 3
828-1054; 843-1101; 850-1072; 879-1138; 898-1198; 905-1422; 928-1206; 949- 1518; 951-1280; 975-1202; 976-1205; 976-1427; 976-1173; 978-1276; 979-1275; 1000-1548; 1034-1260; 1034-1362; 1074-1260; 1085-1260; 1090-1344; 1090-
1302; 1100-1707; 1118-1409 1121-1705; 1133-1429 1135-1436; 1152-1719; 1154-1261; 1168-1415; 1168 1380; 1170-1430; 1176-1723; 1179-1417; 1184- 1641; 1188-1434; 1194-1720 1195-1638; 1194-1436 1291-1673; 1291-179! 1291-1779; 1291-1762; 1291 1714; 1291-1581; 1291-1567; 1291-1542; 1291- 1481; 1291-1471; 1291-1526 1291-1437; 1291-1531 1295-1751; 1304-1650; 1308-1541; 1312-1605; 1323 1925; 1337-1815; 1346 1607; 1356-1832; 1358- 1641; 1360-1725; 1372-1991 1389-1718; 1395-1655 1405-1631; 1406-1933;
1406-1723; 1420-1966; 1436-1725; 1441-1689; 1441 1675; 1454-1795; 1462-
1738; 1462-1534; 1465-1711 1467-2003; 1471-2061 1476-1850; 1483-1726; 1484-1724; 1486-1745; 1497 2001; 1500-2061; 1506 1681; 1518-1810; 1518- 1776; 1517-2209; 1532-1810 1574-1994; 1587-1837 1594-2225; 1610-1887;
1616-2051; 1626-1905; 1629-1872; 1636-2103; 1636 1864; 1636-1855; 1666-
1938; 1666-1917; 1666-1908 1675-1956; 1675-1930 1685-1951; 1692-2072; 1692-1958; 1694-1972; 1698 2103; 1698-1921; 1698 2121; 1701-1949; 1720- 2090; 1721-1971; 1722-2000 1723-1999; 1725-1963 1726-1935; 1740-1972; 1740-1959; 1744-1936; 1757 2024; 1765-2039; 1767-2024; 1784-2003; 1787- 2321; 1789-1971; 1790-2045 1793-2343; 1799-1940 1802-2260; 1816-2081;
1824-2438; 1819-2059; 1824-2401; 1836-2389; 1859 2441; 1859-2102; 1878-
2400; 1873-2175; 1873-2149 1872-2088; 1877-2087 1881-2280; 1895-2143; 1897-2206; 1905-2496; 1906 2458; 1908-2466; 1916-2158; 1925-2329; 1926- 2177; 1931-2455; 1937-2128 1958-2457; 1959-2249 1966-2249; 1969-2245;
1968-2282; 1971-2144; 1971-2249; 1987-2454; 1992 2286; 1995-2272; 2008-
2281; 2013-2456; 2013-2457 2014-2301; 2018-2283 2019-2297; 2024-2500; 2027-2496; 2028-2496; 2033 2280; 2044-2355; 2046-2501; 2051-2332; 2055- 2499; 2054-2346; 2056-2496 2062-2489; 2066-2499 2070-2506; 2072-2500; 2072-2359; 2075-2420; 2075 2419; 2080-2497; 2080 2445; 2091-2496; 2089- 2507; 2095-2498; 2106-2361 2109-2265; 2117-2496 2118-2372; 2121-2496; 2121-2457; 2123-2445; 2128 2496; 2138-2498; 2140 2496; 2141-2499; 2141- 2498; 2159-2394; 2160-2505 2169-2500; 2175-2500 2173-2386; 2183-2497; 2192-2433; 2192-2432; 2202 2503; 2205-2457; 2211 2496; 2241-2496; 2254- 2505; 2255-2496; 2254-2503 2260-2494; 2252-2411 2266-2496; 2268-2495; 2274-2361; 2281-2446; 2289 2496; 2307-2407; 2316-2496; 2317-2451; 2318- 2499; 2356-2497; 2361-2505 2390-2500; 2411-2505 326/LI : 2209636.3 :2001MAY17 I I 181-331; 355-530; 881-1147; 1192-1648; 1-247;
97-594; 168-390; 168-331; 168-766; 262-331; 262-391; 381-974; 649-956; 802- 1035; 881-1448; 881-1175; 914-1139; 948-1120; 1006-1420; 1059-1466; 1211- 1373; 1233-1420; 1335-1850 327/LI:221864.68:200lMAY17 | | 1-549
328/LI:229267.1:200lMAY17 | | 1-330; 63-323; 63-309; 63-293; 63-288; 114- 730; 171-330; 174-330; 249-773; 554-943; 567-1003; 565-1013; 640-977; 640- 1033; 640-987; 648-935; 648-936; 652-1009; 665-941; 861-1401; 907-1537; 951-1409; 952-1525; 959-1374; 1317-1853; 1317-1511; 1317-1476; 1317-1636; 1317-1537; 1326-1775; 1326-1727; 1403-1773; 1452-2093; 1463-1934; 1463- 2115; 1530-2198; 1538-2056; 1558-2202; 1565-2205; 1602-2166; 1602-2174; 1750-2206; 1823-2366; 1906-2217; 2012-2566; 2111-2674; 2138-2699; 2268- 2685; 2284-2784; 2295-2763; 2295-2576; 2303-2504; 2441-2763; 2471-2722; 2473-2763; 2654-2763
329/LI:229648.2:2001MAY17 | | 1-606; 13-470; 168-808; 169-792; 176-761; 166- 601; 236-883; 226-831; 253-779; 287-796; 313-1024; 332-915; 380-1130; 403- 591; 480-1071; 481-1094; 521-641; 535-1130; 541-1187; 583-1135; 583-778; 594-1218; 603-1122; 612-1321; 721-1388; 715-967; 726-1361; 737-1373; 761- 1033; 814-1254; 815-1313; 847-1471; 862-1475; 878-1399; 900-1501; 919-1530; 912-1385; 914-1105; 929-1636; 969-1226; 973-1387; 973-1206; 1001-1283; 1008-1356; 1075-1809; 1102-1631; 1113-1738; 1201-1471; 1240-1385; 1295- 1631; 1295-1865; 1298-1588; 1365-1701; 1454-2078; 1459-1641; 1460-1836; 1616-1903; 1670-2028; 1684-2378; 1702-2398; 1756-2037; 1750-1996; 1753- 2018; 1753-2010; 1760-2454; 1810-2295; 1989-2186; 2027-2554; 2037-2291; Table 3
2038-2269; 2111-2369; 2138-2501; 2140-2634; 2140-2404; 2141-2665; 2144- 2630; 2143-2629; 2148-2327; 2156-2628; 2152-2416; 2217-2629; 2224- 2668; 2224-2471; 2283-2352; 2297-2669; 2342-2675 : 2367-2632; 2416-2665; 2419- 2670; 2458-2669; 2573-2668
330/LI:231016.1:2001MAY17 || 1-559; 6-236; 170-788; 170-314; 608-1 082; 607 967; 619-739; 637-1076; 741-1080 331/LI:231140.5:2001MAY17 || 1-486; 1-419; 2-395; 24-486; 41-486; 42-506;
7-265; 52-486; 52-439; 52-425; 7-486; 52-396; 52-581; 7-353; 52-33 9; 53- 483; 7-249; 53-486; 53-506; 83-486; 109-486; 112-486; 121-486; 122 -486; 149-391; 189-486; 202-486; 203-486; 258-436; 273-486; 281-483; 290 -486; 315-486; 323-751; 338-766; 8-573; 407-751; 9-486; 654-751; 654-720 ; 654- 735; 659-751; 678-1377; 684-751; 684-749; 684-741; 24-506 332/LI:231695.14:2001MAYl7 || 22-789; 1-636; 22-549 333/LI:232846.24:2001MAYl7 jj 4293-4575; 4294-4575; 4294-4569; 429 5-4576; 4299-4572; 4298-4547; 4301-4569; 4302-4555; 4302-4559; 4302-4533; 4303-
4569 4304-4569; 4302-4569; 4304-4547 4308-4564 4309-4567; 4312 4570; 4313 4561; 4313-4590; 4315-4569; 4316 4444; 4321 4575; 4323-4470; 4321- 4569 4324-4577; 4325-4612; 4326-4574 4325-4547 4334-4513; 4337 4573; 4337 4569; 4341-4569; 4342-4565; 4343-4523; 4345 4564; 4344-4575; 4346- 4947 4349-4569; 4349-4575; 4354-4569 4354-4545 4362-4562; 4360- 4569; 4361 4569; 4362-4572; 4363-4575; 4364 4575; 4362 4532; 4364-4565; 4366- 4424 4365-4569; 4366-4570; 4368-4572 4371-4493 4378-4559; 4391 4565; 4399 4569; 4400-4570; 4402-4575; 4409 4581; 4423 4569; 4491-4569; 4495- 4569 4510-4572; 4518-4569; 4521-4572 4674-5173 4677-5131; 4677 5136; 4677 4819; 4678-4965; 4686-5143; 4681 4953; 4681 4944; 4681-4755; 4683- 4969 4681-5073; 4683-4968; 4681-4910 4681-5067 4681-5050; 4681 5117;
4679-5406; 4681-4733; 4683-5090; 4681 5011; 4686 5139; 4686-5127; 4686-
4864 4686-4986; 4686-4854; 4687-5046 4692-5015 4691-5145; 4697 5100; 4702 4790; 4695-5144; 4700-4942; 4717 4775; 4719-5177; 4720-5177; 4719- 4985 4721-5231; 4722-4967; 4722-5299 4722-5008 4734-5013; 4742- 5081;
4765-5036; 4761-4975; 4782-5204; 4794-5050; 4805 5034; 4815-5021; 4822-
5298 4184-4571; 4190-4565; 4187-4574 -4186-4571 4187-4565; 4198 4563; 4199 4571; 4199-4569; 4200-4431; 4205 4569; 4205-4312; 4208-4589; 4208- 4569 4208-4444; 4207-4403; 4209-4433 4209-4425 4208-4449; 4212- 4576; 4212 4456; 4212-4476; 4213-4569; 4215 4347; 4215-4515; 4215-4525; 4215- 4541 4216-4457; 4217-4574; 4217-4569 4220-4570 4219-4562; 4224- 4578; 4220 4569; 4223-4570; 4223-4565; 4225 4382; 4230-4564; 4227-4516; 4228- 4576 4229-4550; 4230-4539; 4233-4437 4238-4413 4239-4417; 4240- 4529; 4241 4575; 4243-4573; 4243-4547; 4244 4575; 4247 4569; 4243-4470; 4247- 4487 4247-4568; 4233-4431; 4250-4552 4250-4541 4250-4569; 4251- 4492; 4253 4572; 4251-4446; 4254-4528; 4253 4569; 4253 4524; 4254-4492; 4254- 4483 4259-4562; 4257ι-4511; 4258-4569 4258-4565 4264-4569; 4267- -4510; 4267 4568; 4268-4572; 4270-4575; 4269-4485; 4271-4572; 4273-4526; 4273- 4570 4272-4575; 4276-4572; 4280-4350 4281-4533 4281- -4450, 4283 -4497; 4282 4569; 4288-4569; 4290-4565; 2705 3230; 2721 2963; 2726- -2883; 2731- 3215 2734-3142; 2739-3350; 2741-2934 2753-3226 2780- -2915, 2790 3327; 2804 3166; 2803-3002; 2813-3003; 2827-3071; 2826 3092; 2841- -2950; 2845- 3393 2910-3164; 2921-3091; 2921-3211 2925-3174 2931- -3482, 2933 -3468; 2934 3074; 2935-3439; 2941-3002; 2941 3482; 2941 3155; 2941- -3179; 2941- 3200 2941-3251; 2941-3447; 2941-3399 2941-3460 2941 -3469 2941 -3478; 2941 3239; 2945-3439; 2949-3189; 2951 -3218; 2957 3210; 2966- -3205; 2986- 3288 3016-3118; 3015-3233; 3020-3465 3021-3289 3025 -3242 3024 -3326; 3025 3154; 3025-3255; 3025-3247; 3025 3447; 3025-3203; 3028-3482; 3031- 3271 3032-3240; 3034-3198; 3037-3283 3037-3487 3038-3478; 3049- -3462; 3058 3206; 3060-3473; 3074-3580; 3076-3609; 3084 3657; 3086-3293; 3087- 3362 3088-3618; 3091-3494; 3079-3698 3098-3617 3106-3373; 3133- -3677; 3138 -3619; 3141-3390; 3125-3598; 3131 3485; 3138-3854; 3141-3442; 3142- 3689 3142-3343; 3144-3602; 3148-3380 3155-3389 3158-3744; 3159- -3250; 3176 3442; 3181-3614; 3173-3602; 3176 3696; 3177 3599; 3176-3389; 3195- 3260 3186-3469; 3188-3617; 3192-3468 3192-3419 3195τ3444; 3213* -3426; Table 3
4003- 4328; 4012 4269; 4015 4257; 4007 4266; 4017 4173; 4026> 4487; 4026 4259; 4024-•4528 4025- 4318 4027- 4294 4029- 4'269 4029- 4537 4032- 4347 4036-4310; 4038 4320; 4044 4548; 4043 4569; 4047 4250; 4052' 4366; 4058 4560; 4059--4270 4060- 4330 4062- 4331 4061- 4306 4065- 4556 4062- 4246 4079-4575; 4082 4320; 4093 4356; 4095- 4346; 4096 4444; 4096' 4373; 4099 4289; 4100*-4334 4102- 4330 4103-■4354 4104- 4386 4105- 4561 4105- 4376 4109-4569; 4107 4569; 4108 4545; 4109 4282; 4111 4571; 4110- 4337; 4111 4417; 4111--4376 4119-4576 4121-■4393 4126- 4493 4121- 4360 4126- 4574 4125-4569; 4127 4241; 4127 4571; 4127- 4541; 4127 4321; 4127- 4573; 4127 4384; 4130*-4569 4129-4361 4129-4379 4129- 4409 4131- 4569 4133- 4378 4133-4675; 4142 4485; 4144 4572; 4143 4565; 4144 4574; 4146- 4361; 4148 4569; 4148--4526 4149-4418 4151-4571 4152- 4574 4158- 4504 4161- 4569 4161-4383; 4162 4565; 4162 4572; 4163- 4569; 4187 4476; 4164- 4569; 4165 4346; 4167--4569 4167-4575 4168-4529 4168- 4569 4174- 4575 4170- 4391 4171-4456; 4171 4390; 4171 4569; 4172 4569; 4175 4422; 4173- 4571; 4173 4574; 4174--4342 4175-4432 4178-•4561 4176- 4569 4177- 4419 4177- 4567 4181-4535; 4185 4561; 4182 4565; 4184 4460; 4185 4573; 4184- 4416; 4187 4570; 3833--4086 3824- 3975 3835- 4070 3839- 4357 3836- 4051 3829- 4019 3841-4107; 3843 4300; 3845 4176; 3847 4405; 3856 4396; 3849 4336; 3866 4064; 3872--4193 3883-4304 3883-4160 3883- 4158 3883- 4307 3882- 4148 3884-4066; 3885 4155; 3888 4459; 3888 4458; 3891 4274; 3892 4172; 3892 4158; 3892--4142 3897- 4169 3901- 4190 3899- 4498 3901- 4103 3901- 4461 3902-4206; 3892 4282; 3907 4546; 3907 4261; 3910 4200; 3898 4250; 3916 4168; 3923--4556 3926-4508 3924-■4540 3925- 4157 3928- 4154 3929- 4348 3940-4393; 3928 4513; 3935 4106; 3935 4176; 3928 4007; 3942 4528; 3944 4466; 3947--4178 3950-4506 3953-■4204 3954- 4230 3958- 4573 3963- 4516 3951-4253; 3970 4043; 3972 4539; 3971 4262; 3971 4237; 3980 4462; 3975 4490; 3976 -4299 3978-4167 3978-4221 3970-4228 3988- 4574 3989- 4188 3980-4226; 3990 4244; 3990 4223; 3993 4501; 3993 4565; 3998 4492; 3996 4264; 3988 -4251 3997-4238 3999-•4529 4000-4229 4001- 4283 4003- 4245 4004-4268; 3997 4213; 4007 4569; 4007 4264; 4007 4302; 4008 4189; 4008 4241; 4008 -4266 4000-4257 4008-4238 4009-•4303 4008-4511 4012-■4290 4011-4249; 1808 1932; 1951 2212; 2073 4569; 2233 2818; 2476 2722; 2533 3201; 2569--2700 2612- 3002 4729- 5247 4785- 4956 4824- 5097 5342- 5515 2136-2575; 3601 3821; 3603 4159; 3610 3892; 3609 4110; 3610 3837; 3610 4132; 3612 -3866 3614-3855 3618- 3836 3619-3885 3622- 4208 3621- 3813 3621-4179; 3625 •3710; 3625 3802; 3633 3850; 3633 4221; 3624 4295; 3639 3882; 3627 -3838 3656-•3847 3662-•4157 3663-3927 3663- 3884 3668- 3848 3669-3930; 3673 •4030; 3685 4177; 3692 4207; 3687 3838; 3706 3883; 3708 4004; 3708 -3902 3720- 3863 3719-■3932 3716-4097 3724- 4234 3727- 4002 3730-4097; 3724 3986; 3737 4009; 3727 4025; 3728 3980; 3742 3993; 3750 4316; 3756 -3925 3758-3999 3747-■4022 3750-4389 3773-■4225 3766- 4328 3767-3892; 3768 •4341; 3768 4058; 3770 4330; 3770 3965; 3770 4302; 3774 3892; 3774 -4324 3774-•4318 3774-•3939 3777-4357 3776- 4298 3778- 4041 3780-4356; 3785 4044; 3775 4030; 3788 4052; 3798 4314; 3801 4163; 3796 3981; 3814 -3963 3817-4276 3816-■4102 3807-4365 3819-■4084 3817-4351 3812-3962; 3825 4440; 3830 3916; 3830 4074; 3208 3377; 3224 3761; 3216 3469; 3219 -3459 3225-3482 3229-•3617 3237-3462 3238-3482 3263-•3718 3253-3620; 3263 3444; 3268 3485; 3278 3482; 3278 3567; 3300 3559; 3291 3482; 3291 -3771 3314-3590 3316-•3565 3319-•3575 3330-3564 3327-•3975 3342-3617; 3330 3856; 3349 3701; 3335 3482; 3336 3604; 3356 3628; 3359 3713; 3346 -3897 3348-•3624 3354-•3779 3356-3609 3357-3917 3360-•3621 3375-3597; 3370 3598; 3387 3628; 3393 •3585; 3385 3655; 3402 3482; 3391 3920; 3395 -3638 3395-3649 3395-3842 3388-3871 3413-■3677 3413-3482 3400-3647; 3421 3684; 3424 3871; 3406 4134; 3441 3673; 3451 3677; 3452 4133; 3453 -3710 3457-3987 3472-•3670 3495-3552 3497-3730 3515-■3672 3515-3691; 3515 3688; 3502 4119; 3502 3848; 3515 3618; 3510 3779; 3515 3699; 3515 -3645 3515-3929 3515-3731 3516-4028 3531-3781 3517-3699 3529-3764; 3530 3775; 3531 3743; 3533 •3710; 3534 ■3816; 3534 3787; 3533 3781; 3537 -3805 3536-3628 3553-•3701 3540-3840 3540-3825 3541-3691 Table 3
3545-3798; 3546-3804; 3548-3847; 3548-3817; 3550-3792; 3550-3708; 3553- 3811; 3558-3956; 3558-4139; 3566-3841; 3566-3859; 3576-3846; 3584-3698; 3585-3817; 3592-4092; 3592-3813; 3593-4201; 3598-3809; 3600-3840; 4827- 5072; 4828-5067; 4843-5057; 4847-5336; 4848-5120; 4849-5084; 4856-5090; 4859-5090; 4867-5151; 4917-5474; 4932-5473; 4954-5271; 4957-5221; 4958- 5187; 4961-5478; 4978-5381; 4982-5254; 4984-5257; 4990-5208; 5008-5479; 5012-5478; 5017-5269; 5028-5486; 5032-5478; 5039-5222; 5043-5183; 5043- 5310; 5050-5311; 5077-5315; 5087-5369; 5089-5298;' 5092-5362; 5101-5369; 5126-5478; 5130-5515; 5136-5392; 5137-5415; 5169-5333; 5175-5474; 5177- 5457; 5184-5435; 5185-5457; 5187-5448; 5205-5473; 5206-5441; 5219-5475; 5235-5478; 5238-5472; 5243-5478; 5244-5491; 5250-5473; 5267-5487; 5279- 5478; 5288-5515; 5295-5478; 5300-5465; 5316-5477; 5330-5973; 5336-5513; 5337-5478; 5339-5478; 5371-5480; 5415-5478; 5416-5546; 423-857; 456-719; 525-1139; 525-663; 560-856; 600-856; 620-830; 632-859; 656-790; 665-919; 696-1158; 696-969; 730-1177; 741-4569; 774-1158; 793-1158; 826-1159; 831- 1159; 842-1177; 846-1195; 869-1184; 869-1139; 870-1391; 873-1079; 902-1059; 1189-1663; 1188-1245; 1188-1554; 1189-1606; 1189-1565; 1195-1631; 1198- 1637; 1196-1604; 1197-1607; 1197-1769; 1197-1776; 1197-1661; 1197-1675; 1197-1486; 1197-1633; 1197-1827; 1198-1697; 1197-1684; 1203-1713; 1203- 1694; 1209-1656; 1206-1633; 1206-1622; 1206-1580; 1216-1687; 1227-1633; 1291-1483; 1291-1479; 1326-1392; 1353-1934; 1361-1667; 1393-1921; 1393- 1923; 1404-1650; 1408-1526; 1413-1683; 1425-1752; 1501-1906; 1547-1645; 1597-2126; 1603-1999; 1603-1699; 1611-2192; 1659-2189; 1672-2222; 1720- 2147; 1721-2178; 1740-2190; 1755-2274; 1760-2208; 1760-2032; 1766-1824; 1768-2190; 1782-2282; 1791-2028; 1794-1930; 1791-2305; 1825-2357; 1837- 2052; 1883-2076; 1937-2174; 1970-2557; 1983-2544; 2024-2266; 2043-2602; 2096-2365; 2129-2685; .2143-2782; 2146-2899; 2171-2347; 2242-2856; 2255- 2816; 2374-2637; 2442-3006; 2482-2859; 2507-3002; 2509-3002; 2517-2768; 2541-3002; 2546-3009; 2550-2961; 2553-3002; -2565-3002; 2577-3184; 2600- 3002; 2610-2922; 2612-3169; 2622-2891; 2647-3230; 1-220; 1-535; 20-92-; 24- 560; 102-447; 223-773; 271-525; 271-837; 305-562; 320-579; 348-831; 364- 747; 380-638; 405-856; 1732-1977; 993-1099; 2588-2783; 900-1158; 877-1158; 4259-4575; 5122-5476; 4103-4515; 1195-1669; 1197-1676; 4022-4560; 4702- 5275; 2218-2777; 868-1491
334/LI:233411.11:2001MAY17 | | 2092-2274; 2158-2646; 2194-2476; 1050-1533; 1050-1572; 1050-1538; 1050-1576; 1095-1576; 1096-1576; 1139-1576; 1175-
1518; 1175-1514 1175-1494; 1193-1576; 1205-1844; 1214-1406; 1297-1870 1299-1896; 1300 1572; 1305-1882; 1322-1789; 1328-1826; 1344-1617; 1353 1574; 1398-2011 1417-1570; 1420-2052; 1458-1576; 1471-1576; 1474-2092 1487-1576; 1488 1576; 1495-2116; 1495-1763; 1499-1960; 1506-1843; 1507 1790; 1697-2162 1705-2162; 1705-1780; 1705-2159; 1705-2144; 1705-2184
1705-2001; 1705-2070; 1705-1895; 1705-2284; 1705-1843; 1705-1864; 1705
1871; 1705-2064 1705-1817; 1705-2199; 1728-2173; 1730-1951; 1755-2178
1781-2434; 1783-1975; 1803-2033; 1818-2085; 1821-2421; 1826-2467; 1869
2580; 1835-1936 1837-2099; 1840-2007; 1844-2052; 1844-2228; 1845-2207 1850-2190; 1860 2135; 1871-2168; 1874-2157; 1880-2066; 1901-2193; 1918- 2375; 1957-2234 1967-2554; 1987-2544; 1989-2232; 2003-2375; 2014-2354 2015-2139; 2019 2325; 2020-2374; 2023-2514; 2036-2265; 2037-2683; 2043 2735; 2048-2287 2062-2678; 2066-2550; 2072-2327; 2073-2268; 2077-2200
2083-2331; 2116-2725; 2132-2624; 2141-2498; 2152-2616; 2178-2474; 2176- 2576; 2188-2497; 2186-2702; 1-274; 5-251; 19-425; 28-617; 29-302; 30-307; 45-290; 52-308; 52-326; 79-309; 111-324; 300-524; 470-1066; 487-784; 538- 721; 591-852; 631-735; 741-857; 749-1292; 766-891; 786-1085; 786-1399; 827- 1142; 834-926; 867-1327; 930-1328; 1050-1314; 1050-1548; 1050-1544; 1050- 1542; 1050-1308; 3558-3702; 3631-3701; 3449-3701; 2575-2751; 2599-2887; 2597-2744; 2600-3034; 2597-3216; 2599-2881; 2640-3217; 2640-2936; 2650- 2890; 2650-2899; 2656-3314; 2662-2748; 2675-3140; 2681-3217; 2680-2867; 2691-3140; 2718-3133; 2728-3140; 2730-3147; 2740-3036; 2754-2980; 2778- 3148; 2780-2994; 2787-3217; 2791-3019; 2791-3206; 2805-3354; 2812-3102; 2817-3141; 2819-3141; 2819-3055; 2826-3141; 2830-3060; 2838-3136; 2857- Table 3 3137; 2870-3087; 2870-3075; 2870-3082; 2875-3509 2882-3217; 2892-3404;
2906-3138; 2927-3141 2927-3257; 2926-3148; 2930 3141; 2932-3141; 2957-
3260; 2973-3602; 3005-3377; 3012-3141; 3029-3259 3055-3328; 3058-3307;
3085-3639; 3118-3279 3132-3634; 3132-3671; 3192-3653; 3222-3476; 3236
3696; 3241-3699; 3248-3704; 3253-3701; 3261-3709 3266-3701; 3280-3700;
3335-3697; 3343-3694 3350-3703; 3359-3701; 3384-3652; 3419-3701; 3430-
3678; 2195-2870; 2195-2415; 2195-2313; 2211-2719 2571-3090; 2233-2707;
2247-2599; 2251-2592 2258-2730; 2270-2502; 2274-2748; 2275-2749; 2285-
2550; 2292-2694; 2295-2751; 2295-2748; 2299-2747 2302-2748 2304-2747;
2305-2765; 2305-2751 2306-2748; 2308-2571; 2314 2608; 2321 2593; 2321-
2706; 2322-2753; 2332-2607; 2335-2735; 2338-2627 2345-2751 2574-2627;
2349-3021; 2354-2632 2362-2753; 2363-2754; 2365 2680; 2364 3021; 2383-
2701; 2392-2680; 2403-2681; 2407-2748; 2411-2748 2423-2627 2422-2710;
2427-2627; 2428-2963 2431-2672; 2437-2748; 2439 2748; 2441 2748; 2447-
2957; 2451-2691; 2460-3072; 2467-3051; 2477-2627 2477-2680 2480-2751;
2483-2626; 2497-3036; 2499-2824; 2500-2746; 2503-2741; 2505-2744; 2528- 2744; 2543-3192; 2567-2808
335/LI:233545.13:2001MAYl7 | | 428-687; 431-678; 433-717; 433-708; 433-863; 466-748; 501-774; 523-1109; 523-1085; 523-1030; 523-943; 521-1206; 523-746; 550-1028; 550-1089; 555-805; 554-817; 559-980; 559-716; 561-943; 566-1153; 570-793; 590-878; 596-776; 600-929; 607-949; 611-1129; 611-878; 618-882; 630-1148; 630-863; 630-858; 633-828; 637-1156; 647-924; 650-881; 658-919; 661-868; 669-893; 683-951; 689-945; 689-1121; 693-919; 692-932; 697-911; 699-1318; 698-912; 717-906; 723-832; 736-1176; 765-1045*; 778-960; 783-1340 793-1024; 807-1056; 829-1144; 829-1026; 831-1214; 832-1111; 837-1096; 838- 1034; 842-1135; 854-1402; 865-1121; 889-1121; 900-1068; 905-1327; 920-1016 926-1025; 926-1418; 926-1407; 926-1345; 926-1291; 925-1092; 926-1024; 926- 1295; 926-1080; 933-1120; 946-1108; 956-1088; 959-1177; 968-1233; 968-1204 969-1203; 970-1220; 970-1210; 971-1223; 1012-1449; 1069-1311; 1073-1715; 1109-1171; 1117-1172; 1119-1751; 1119-1739; 1119-1773; 1119-1768; 1132- 1663; 1132-1395; 1130-1379; 1139-1449 ;' 1139-1419; 1149-1405; 1160-1381; 1168-1792; 1168-1631; 1168-1451; 1170-1418; 1-377; 1-527; 92-613; 181-676; 276-825; 295-907; 303-919; 326-651; 328-607; 346-630; 392-595; 1206-1511; 1222-1699; 1220-1444; 1222-1479; 1224-1512; 1224-1499; 1223-1312; 1229- 1598; 1234-1382; 1241-1517; 1248-1391; 1248-1475; 1250-1510; 1256-1394; 1259-1801; 1257-1429; 1274-1574; 1279-1809; 1280-1519; 1285-1418; 1292- 1894; 1297-1392; 1325-1421; 1326-1558; 1327-1894; 1325-1549; 1343-1894; 1381-1858; 1430-1513; 1432-1894; 1548-1785; 1548-1795; 1581-1769 336/LI:234671.101:200lMAY17 I ] 1-615; 1-218; 11-449; 17-259; 69-278 116-
264 187-423; 188-440 188-442; 189-510; 189-457; 214-460; 214-450; 265- 826 266-772; 283-555 298-834; 306-506; 311-581; 343-474; 371-842; 408- 664 438-717; 440-825 460-789; 468-789; 473-694; 530-779; 532-781; 728- 1211; 760-1184; 807-1188; 807-1187; 823-1241; 826-1236; 899-1232; 899-1235; 899-1240; 899-1105; 899-1007; 906-1188; 914-1205; 913-1191; 915-1164; 928- 1185; 968-1256; 969-1190; 987-1233; 995-1230; 1022-1234; 1069-1239; 1090- 1237; 1100-1239; 1124-1236
337/LI:236098.14:2001MAYl7 || 3109-3374; 2794-3286; 2796-3045; 2829-3184; 1735-2329; 1759-2009; 1759-2227; 1759-2102; 1856-2077; 1860-1977; 1922- 2522; 2382-2593; 2394-2551; 2395-2591; 2399-2551; 2400-2935; 2534-2591; 2712-3184; 2128-2597; 2139-2551; 2141-2551; 2146-2551; 2150-2588; 2156- 2551; 2157-2551; 2179-2421; 2191-2551; 2192-2593; 2195-2551; 2197-2551; 2201-2593; 2202-2551; 2202-2470; 2213-2446; 2236-2591; 1-297; 182-299; 217- 461; 252-820; 416-915; 504-1040; 569-1201; 593-878; 602-1135; 613-1062;
713-1190; 726-1007; 815-1124; 828-1037; 830-1025 859-1323; 874-1177; 890-
1354; 893-1148; 927-1324; 954-1552; 964-1282; 999-1185; 1006-1272; 1058
1741; 1082-1349; 1105-1715; 1107-1399; 1261-1573 1285-1747; 1289-1566; 1346-1725; 1363-1617; 1923-2148; 1935-2217; 1957 2129; 2378-2612; 2235- 2496; 2237-2597; 2239-2551; 2241-2597; 2241-2504 2247-2593; 2261-2551; 2264-2551; 2276-2592; 2274-2593; 2282-2551; 2304 2551; 2307-2588; 2310- 2551; 2313-2551; 2339-2551; 2344-2551; 2348-2551 2353-2431; 2029-2295; Table 3
2050-2306; 2050-2310; 2080-2556; 2082-2339; 2107-2591; 2116-2382; 2119- 2377; 1975-2563; 1988-2554; 2014-2554; 2024-2556; 1676-1928; 1676-1919; 1374-1782; 1382-1971; 1401-1623; 1431-1698; 1473-1706; 1505-2056; 1507- 2077; 1520-1794; 1527-1771; 1601-2079; 1603-1877; 1614-1838; 1674-1981 338/LI:236196.15:2001MAY17 || 1579-1788; 1040-1404; 1040-1429; 1051-1631; 1038-1255; 1055-1267; 1058-1255; 1062-1380; 1073-1322; 1075-1361; 1077- 1336; 1087-1350; 1089-1413; 1090-1342; 1100-1372; 1102-1363; 1112-1687; 1112-1535; 1126-1391; 1138-1374; 1142-1411; 1158-1411; 1165-1376; 1157- 1747; 1174-1746; 1173-1369; 1191-1785; 1194-1717; 1209-1485; 1213-1503; 1214-1466; 1204-1747; 1227-1527; 1227-1477; 1225-1739; 1240-1623; 1250- 1738; 1271-1790; 1272-1511; 1288-1429; 1276-1787; 1285-1785; 1284-1784; 1286-1785; 1317-1552; 1318-1565; 1319-1455; 1308-1789; 1322-1587; 1311- 1568; 1318-1571; 1316-1786; 1320-1785; 1320-1739; 1320-1477; 1321-1791; 1321-1784; 1320-1574; 1322-1591; 1323-1611; 1321-1580; 1326-1790; 1328- 1597; 1333-1423; 1333-1433; 1338-1785; 1348-1783; 1338-1789; 1339-1791; 1348-1791; 1349-1791; 1350-1785; 1355-1784; 1357-1790; 1361-1792; 1361- 1785; 1363-1785; 1367-1785; 1367-1788; 1377-1782; 1376-1532; 1380-1785; 1381-1785; 1384-1786; 1386-1786; 1407-1628; 1407-1677; 1416-1791; 1418- 1790; 1420-1783; 1427-1712; 1428-1792; 1429-1785; 1430-1785; 1431-1786; 1435-1785; 1438-1785; 550-845; 567-720; 570-866; 572-834; 567-957; 589-808; 595-836; 597-1195; 600-881; 599-905; 586-808; 607-841; 609-846; 597-876; 615-1252; 621-1188; 622-876; 637-900; 647-1106; 647-896; 649-845; 660-915; 668-1260; 662-1259; 697-1152; 680-1407; 691-960; 704-1259; 709-1338; 718- 1146; 716-972; 722-1058; 727-952; 734-1139; 738-998; 739-981; 743-981; 746- 1134; 746-873; 746-984; 748-1026; 758-1319; 758-1031; 774-946; 775-970; 783-1040; 798-1183; 817-1081; 822-1051; 841-1117; 825-1088; 846-1110; 868- 1158; 869-1148; 871-1151; 873-1068; 861-1127; 876-1134; 878-1211; 878-1136; 881-1138; 885-1461; 885-1124; 885-1362; 884-1132; 885-1131; 876-1089; 897- 1134; 903-1248; 903-1135; 904-1171; 921-1145; 922-1461; 922-1166; 922-1138; 955-1264; 955-1477; 955-1171; 955-1182; 957-1232; 958-1240; 960-1120,-.962-
1208 966-1213; 972-1226; 1009-1493; 975-1484; 966-1226; 982-1182; 993-
1484 994-1489; 1001-1244; 1003-1234; 994-1220; 1009-1274; 1021-1218; 1007-
1288 1022-1181; 1030-1512; 1030-1297; 1036-1310; 1038-1224; 263-700; 262-
363 263-900; 263-819 262-678 262-507 263-330; 264-601; 267-482 267-
549 267-900; 271-447 268-353 273-793 273-583; 273-483; 273-457 273-
443 273-430 273-863 273-738 273-442 279-955 295-583; 285-904 287-
542 289-435 290-941 299-575 299-580 303-854 302-980; 310-1062 ; 307-
906 321-665 322-580 324-573 326-888 326-576 329-597; 335-574; 365-
900 351-757 365-610 374-776 384-776 392-776 413-672; 418-704; 434-
561 434-1171; 447-763; 448-741; 452-965; 458-873; 465-573; 475-1144; 489-
759 484-718; 517-702; 521-797; 512-967; 513-821; 519-987; 537-863; 528-
986 528-1163; 553-775; 559-799; 1-478; 1-427; 1-380; 1-443; 1-416; 1-589;
1-386; 1-524; 1-158; 104-561; 200-560; 240-788; 243-649; 262-311; 249-818;
249-485 259-461 263-596; 252-510 253-799 ; 253-602 ; 253-792 262-463 ; 257-542 257-583 257-531; 257-570 260-593 ; 262-602 ; 260-612 262-739 ; 262-369 261-330 262-704; 262-546 262-435 ; 262-329 ; 262-796 1440-1834 ;
1460-1750; 1460 -1745; 1460 -1731; 1453-1736; 1454-1738 ; 1457-1741 ; 1466- 1834; 1498 1785 ; 1500-1785 ; 1487-1783; 1496 -1698 ; 1518-1809 ; 1531-1763 ; 1534-1790; 1536-1779; 1538-1783; 1542-1785; 1541-1785 ; 1546-1754 ; 1550- 1790; 1556 -1772 ; 1557-1785 ; 1564 1792; 1567 -1782 ; 1567-1785 ; 1572-1843 ; 1569-1785; 1580-1792; 1582-1787; 1584-1792; 1600-1785 ; 1618-1785 ; 1635- 1736; 1647 -1841 ; 1651-1785 ,- 1709-1782 339/LI:237 086.1 -2001MAY17 | I 919- 1075; 920- 1118 ; 933-1140 ; 934-1118 ; 934- 1066; 934- 1140; 1-176; 7-660; 16 176; 80-176 ; 530-1074 ; 705-1114 340/LI:238 585.30-.2001MAY17 51; 4-206; 157-337 341/LI:238 672.6 :2001MAY17 I j 712-1012; 526- 1001 ; 639-1192 ; 556-1123 ; 734- 1092; 568- 1060; 638-1059; 781-1057; 954-1056 ; 604-1054; 838-1054; 927-1054 ; 888-1054; 643-1051; 682-10 51; 665-1050; 768 -1015 ; 278-971 ; 659-963 ; 355- 949; 274-6 00; 366-589; 355 574; 274-534; 1- 507 Table 3
342/LI:239579.9:2001MAY17 | | 1612-2056; 1619-2053; 1618-1807; 1622-2056; 1625-2053; 1631-2051; 1636-2049; 1641-1922; 1641-2049; 1646-2053; 1650- 1922; 1650-1884; 1660-1907; 1662-2047; 1667-1965; 1685-1935; 1688-2053; 1695-1871; 1710-2059; 1716-2051; 1718-2000; 1721-2209; 1730-2009; 1732- 2053; 1732-2017; 1737-2056; 1750-2045; 1752-2043; 1753-1922; 1754-2053; 1754-2043; 1758-2048; 1764-2057; 1766-2023; 1771-2057; 1780-2047; 1777- 2052; 1779-2035; 1800-2054; 1802-2008; 1808-2054; 1810-2053; 1819-2053; 1818-2043; 1833-1964; 1850-2035; 1853-2053; 1859-2053; 1873-2053; 1878- 2053; 1895-2051; 1928-2007; 1929-2053; 1933-2053; 1939-2050; 1952-2034; 1984-2043; 1984-2057; 1984-2042; 1995-2047; 1313-1805; 1316-1930; 1323- 1548; 1323-1542; 1328-1585; 1325-1555; 1327-1568; 1333-1549; 1345-1908; 1354-1912; 1360-1621; 1378-1650; 1382-1617; 1381-1600; 1395-1535; 1396- 1660; 1401-2043; 1404-1531; 1404-1915; 1413-1922; 1424-1922; 1428-1945; 1432-1678; 1451-1696; 1463-1712; 1469-1557; 1472-1922; 1473-1593; 1478- 1706; 1484-1907; 1501-1922; 1503-2016; 1505-1922; 1505-1780; 1506-1922; 1509-1922; 1513-1725; 1521-1701; 1544-2000; 1521-1919; 1531-1751; 1535- 1922; 1537-1922; 1546-1806; 1548-1840; 1557-2053; 1557-2024; 1560-2043; 1564-2057; 1567-1922; 1583-2057; 1587-1844; 1591-2059; 1591-2053; 1598- 2053; 1601-2053; 1612-2053; 1312-1880; 224-347; 235-495; 247-515; 247-722;
254-526 258-502; 261-489 264-802; 280-903; 293-626; 296-524; 299-850; 321-649 341-839; 352-708 355-616; 411-684; 412-721; 414-639; 416-698; 433-659 495-691; 502-736 999-1234; 1002-1266; 515-674; 522-829; 1014- 1276; 1022-1289; 532-669; 542-823; 545-902; 549-789; 550-707; 550-912; 553- 956; 557-803; 558-799; 575-831; 580-851; 580-837; 592-881; 601-856; 602- 826; 634-842; 636-750; 640-1162; 661-1243; 666-891; 668-936; 677-1216; 684- 885; 684-1250; 700-1167; 707-940; 738-1055; 737-940; 769-940; 777-1210; 787-1062; 804-969; 804-1086; 806-1076; 806-1166; 816-1327; 839-1093; 842- 1051; 866-1160; 873-1129; 911-1094; 935-1179; 955-1250; 956-1288; 965-1175; 965-1169; 965-1236; 965-1111; 968-1282; 975-1238; 974-1551; 984-1221; 990- 1204; 995-1200; 995-1211; 996-1086; 996-1233; 2-520; 1-583; 38-656; 38-667; 69-693; 76-600; 78-384; 83-310; 101-614; 109-448; 119-387; 149-381; 205- 452; 211-504; 1023-1270; 1030-1283; 1031-1310; 1040-1247; 1046-1307; 1051- 1243; 1053-1357; 1054-1330; 1055-1618; 1090-1223; 1126-1384; 1138-1264; 1158-1288; 1178-1440; 1183-1451; 1192-1437; 1196-1422; 1199-1439; 1200- 1469; 1213-1534; 1215-1474; 1218-1449; 1220-1762; 1231-1516; 1234-1487; 1246-1448; 1255-1500; 1258-1522; 1273-1516; 1289-1592; 1300-1532; 1303- 1585; 1313-1722; 1312-1679
343/LI.-239720.1:2001MAYl7 | | 174-663; 375-786; 459-831; 582-770; 645-908; 787-1490; 883-1159; 1014-1550; 1145-1782; 1160-1394; 3034-3295; 3065-3329; 3143-3622; 3174-3623; 3182-3469; 3184-3620; 3200-3403; 3210-3619; 3236- 3532; 3249-3619; 3271-3529; 3287-3540; 3314-3597; 3359-3503; 3396-3621; 1- 294; 1-517; 1-607; 9-581; 27-698; 32-119; 36-632; 164-533; 166-402; 183- 766; 190-602; 226-792; 234-548; 339-1024; 382-751; 405-776; 413-1049; 458- 1059; 477-973; 489-985; 576-1101; 582-854; 582-1137; 583-1164; 591-781; 629-1206; 669-1298; 682-865; 725-1138; 760-1326; 820-1504; 842-1355; 844- 1095; 849-1389; 898-1506; 898-1419; 930-1502; 944-1571; 984-1601; 1027-
1488; 1109- 1821 1144- 1818 1123- 1688 1147- 1826; 1158- 1716 1158-1416 1157- 1616; 1197 1450; 1211 1554; 1220 1745; 1223- 1547; 1261 1571; 1251 1813; ^SO1732 1297- 1757 1297- 1802 1314- 1681; 1314- 1576 1297-1692 1293- WS?; 1345 1818; 1385 2022; 1406 1619; 1435- 1850; 1547 1783; 1606 1783; 1714- 2255 1797- 2373 2173- 2765 2676- 2943; 2677- 2976 2679-2978 2679- 2945; 2699 2961; 2699 3021; 2699 2869; 2699- 2956; 2699 2860; 2699 2897; 2699- ■2765 2699- 2756 2699- 2757 2699- 2979; 2699- 2909 2699-3263 2699- 2859; 2699 3156; 2699 2855; 2699 3043; 2699- 3050; 2699 3237; 2699- 2867; 2699- ■3096 2699- 2863 2701- 3000 2701- 2756; 2793- 2986 2804-2901 2845- 3111; 2880 3154; 2881 3010; 2884 3241; 2884- 2984; 2901 3126; 2902 3330; 2903- 3099 2909- 3101 2924- 3092 2928- 3453; 2938- 3149 2945-3191
2970-3507; 2975-3518; 2984-3516; 2991-3519; 2994-3165; 3008-3092; 3016
3581; 3018-3365; 3018-3103; 3038-3582; 3045-3594; 3052-3576 3058-3468
3097-3614; 3112-3303; 3130-3619; 3138-3577; 3154-3623; 3162-3619; 3163- Table 3
3614; 3168-3622; 3173-3580; 3182-3589; 3175-3619; 3177-3432; 3182-3583; 3182-3599; 3183-3619; 3182-3462; 3184-3619; 3187-3632; 3191-3619; 3202- 3621; 3202-3478; 3204-3499; 3208-3619; 3218-3612; 3230-3614; 3235-3619; 3236-3619; 3236-3614; 3238-3622; 3239-3619; 3244-3494; 3246-3599; 3250- 3620; 3252-3620; 3255-3620; 3257-3445; 3280-3614; 3281-3598; 3281-3599; 3281-3614; 3284-3619; 3299-3619; 3299-3579; 3299-3506; 3320-3580; 3341- 3619; 3346-3573; 3357-3623; 3374-3578; 3376-3480; 3378-3622; 3382-3607; 3406-3619; 3436-3528; 3443-3619; 3515-3614; 3521-3619
344/LI:240037.6:2001MAYl7 | | 21-584; 319-1012; 366-490; 389-952; 406-722; 484-909; 555-1005; 586-1040; 821-1037; 1-220; 17-98; 32-282; 33-292; 34- 374; 36-240; 81-347; 368-742; 365-829; 363-1011; 366-785; 366-820; 366-869; 374-982; 384-893; 384-694; 390-885; 393-712; 403-891; 403-1017; 410-1026; 450-951; 480-1041; 484-910; 499-999; 518-781; 538-821; 542-1023; 558-1023; 553-1022; 569-1022; 574-909; 573-740; 588-967; 591-959; 591-1036; 680-1025 345/LI:243900.7:2001MAY17 | | 838-1158; 838-1146; 838-1116; 838-1143; 840- 1144; 839-1056; 841-1061; 875-1103; 1072-1143; 411-970; 436-712; 486-754; 556-1157; 731-1054; 835-1079; 837-1125; 887-1155; 388-966; 402-1083; 408- 862; 408-837; 408-942; 408-653; 408-92-5; 408-553; 408-952; 408-958; 408- 1061; 408-688; 408-959; 408-917; 408-970; 408-566; 408-909; 408-953; 408- 976; 408-866; 409-505; 412-652; 412-685; 427-720; 428-,658; 467-754; 1-330; 467-729; 468-710; 469-728; 1-228; 113-330; 211-369; 477-696; 322-617; 387- 641; 503-581; 506-945; 506-798; 544-1204; 634-1167; 640-1139; 709-1180; 710-1156; 777-1177; 814-1177; 819-1167; 823-1062; 833-1177; 835-1084; 835- 1096; 835-1087; 837-1145
346/LI:244378.1:2001 AYl7 | | 254-637; 340-561.; 421-932; 1416-1645; 1473- 1714; 1510-2248; 1531-2027; 1554-2241; 1567-1957; 1595-2071; 1621-2216; 1- 535; 178-744; 254-815; 254-713; 255-563; 271-763; 271-557; 313-805; 313- 556; 328-681; 338-415; 340-524; 349-612; 366-872; 384-558; 438-905; 438- 804; 476-689; 562-1072; 604-1017; 630-1093; 633-1180; 669-1284; 705-1047; 771-1242; 771-982; 775-1249; 830-1343; 838-1368; 863-1094; 869-1368; 879- ' 1450; 886-1381; 896-1727; 896-1458; 896-1157; 896-1439; 908-1369; 906-1186; 913-1153; 914-1545; 949-1430; 975-1483; 1001-1579; 1001-1244; 1010-1450; 1021-1450; 1041-1587; 1074-1704; 1030-1767; 1074-1698; 1074-1711; 1074- 1743; 1074-1757; 1074-1236; 1074-1781; 1074-1692; 1074-1777; 1074-1747; 1074-1738; 1076-1327; 1078-1690; 1083-1526; 1082-1752; 1108-1472; 1127-
1638 1126-1615; 1131-1311; 1160-1687; 1173-1740; 1173-1397; 1194-1697;
1194-1817; 1199-1657; 1202-1458; 1216-1896; 1228-1378; 1231-1491; 1236-
1497 1235-1655; 1276-1750; 1278-1725; 1286-2050; 1290-1810; 1290-1809;
1309-1902; 1314-1838; 1335-1787; 1345-1607; 1347-1991; 1365-1639; 1365-
1970 1363-1882; 1382-1627; 1393-1639; 1397-1905; 1405-1997; 1410-1953;
1414-2242; 1415-2173; 1433-1980; 1430-1901; 1452-1969; 1473-1879; 1486- 2276; 1480-1795; 1481-2001; 1508-2151; 1510-1967; 1510-1827; 1510-1730; 1510-1623; 1529-1680; 1537-1865; 1556-2197; 1531-2249; 1535-2061; 1553- 2281; 1570-2252; 1560-2073; 1559-2252; 1568-2249; 1565-2131; 1583-2248; 1590-2249; 1600-2249; 1594-2207; 1618-2199; 1616-2249; 1619-1883; 1621- 2249; 1620-2041; 1638-2252; 1628-2249; 1646-2272; 1659-2246; 1655-1811; 1662-2249; 1675-1925; 1699-2249; 1687-2249; 1693-2224; 1707-1932; 1710- 1964; 1742-1900; 1750-2122; 1749-1866; 1754-2191; 1754-2412; 1764-2197; 1784-2255; 1787-2242; 1803-2073; 1805-2214; 1812-2253; 1816-2028; 1841- 2255; 1843-2259; 1838-2248; 1848-2217; 1866-2019; 1861-2259; 1864-2254; 1901-2126; 1904-2254; 1912-2249; 1940-2248; 1951-2206; 1957-2250; 1984- 2239; 1973-2168; 1982-2254; 1999-2385; 2009-2148; 2058-2250; 2055-2257; 2082-2213; 2088-2385; 2105-2259; 2088-2212; 2128-2257; 2133-2256; 2145- 2208; 2187-2385; 2182-2254; 2281-2385; 2286-2385; 2286-2479 347/LI:245500.3:200lMAYl7 | | 2482-2901; 2487-2718; 2487-2960; 2488-2790; 2491-2905; 2494-2955; 2493-2907; 2493-2730; 2497-2789; 2498-2905; 2504- 2899; 2508-2733; 2509-2911; 2515-2953; 2515-2844; 2515-2897; 2515-2904; 2515-2956; 2516-2902; 2519-2905; 2519-2755; 2520-2763; 2520-2758; 2520- 2785; 2521-2962; 2521-2707; 2522-2646; 2522-2722; 2522-2779; 2525-2906; 2526-2752; 2526-2704; 2526-2783; 2528-2955; 2528-2774;. 2528-2953; 2529- Table 3
2905 2537- -2813 2540- 2905; 2544- 2955; 2545- -2667 2546- 2823 2546- 2800;
2548* 2955; 2552' 2955; 2553-2908; 2555-2773; 2557 2955; 2558- 2811; 2558-
2879 2561--2832 2561- 2771; 2562- 2962; 2562 -2955 2563- 2905 2564- 2967;
2567* 2953; 2568 2955; 2569-2783; 2569-2851; 2570 2955; 2572- 2957; 2573-
2955 2575--2843 2577- 2955; 2578- 2906; 2583--2919 2585- 2881 2589- 2741;
2588- 2956; 2589 2771; 2591-2955; 2335-2867; 2337 2862; 2337- 2867; 2341-
2905 2341*-2910 2346- 2596; 2348- 2621; 2350--2794 2351- 2607 2353- 2597;
2356* 2631; 2359 2593; 2359-2611; 2360-2612; 2360 2633; 2360- 2650; 2360-
2616 2361*-2634 2360- 2521; 2362- 2863; 2362--2595 2364- 2836 2367- 2855;
2373* 2619; 2372 2636; 2381-2646; 2382-2911; 2383 2913; 2384- 2961; 2384-
2830 2385*-2916 2393- 2656; 2397- 2468; 2398--2885 2400- 2655 2415- 2953;
2400 2646; 2401 2688; 2401-2621; 2402-2659; 2402 2947; 2408- 2861; 2408-
2719 2412--2660 2417- 2655; 2419- 2660; 2423--2662 2424- 2905 2428- 2905;
2433 2870; 2433 2621; 2435-2904; 2436-2705; 2436 2678; 2437- 2795; 2438-
2663 2439--2905 2440- 2905; 2444- 2920; 2446--2575 2450- 2643 2450- 2905;
2450 2593; 2452 2908; 2452-2905; 2455-2902; 2460 2911; 2462- 2639; 2462-
2718 2461--2702 2465- 2908; 2466- 2907; 2468--2708 2468- 2742 2477- 2893;
2479* 2688; 2479 2710; 2481-2649; 2481-2746; 2482 2902; 2486- 2917; 2486-
3065 2032--2269 2032-2312; 2034- 2294; 2035--2176 2038- 2297 2046- 2328;
2045 2262; 2046 2335; 2048-2125; 2052-2291; 2052 2281; 2061- 2318; 2064-
2411 2067--2310 2071- 2327; 2076- 2334; 2081^-2259 2082- 2304 2082- 2676;
2083 2631; 2090 2280; 2093-2363; 2099-2312; 2100 2369; 2110 2480; 2109-
2356 2112'-2329 2112-2405; 2114- 2645; 2114'-2348 2117- 2373 2117- 2385;
2117 2184; 2119 2386; 2118-2402; 2120-2402; 2125 2389; 2126 2374; 2131-
2365 2133 -2377 2133-2412; 2136-2371; 2140 -2401 2144- 2402 2145-•2401;
2152 2684; 2153 2434; 2155-2875; 2156-2389; 2158 2395; 2164 2449; 2169-
2801 2177--2402 2177-■2409; 2180- 2437; 2180'-2285 2180- 2432 2180-2415;
2185 2337; 2187 2724; 2190-2437; 2190-2855; 2196 2390; 2212 2854; 2215-
2411 2215--2472 2217-•2715; 2222- 2476; 2225--2832 2232- 2498 2234- 2510;
2242 2457; 2247. 2868; 2247-2802; 2247-2867; 2248 2533; 2255 2324; 2254-
2902 2261'-2528 2261-2488; 2263- 2537; 2267'-2529 2279- 2584 2304- 2751;
2306 2571; 2307 2507; 2307-2583; 2308-2558; 2307 2598; 2309 2593; 2311-
2831 2311'-2421 2311-2867; 2311- 2811; 2311--2574 2312- 2487 2313-2851;
2314 2534; 2317 2527; 2319-2614; 2320-2581; 2322 2558; 2329 2599; 2331-
2533 2332^-2559 1577-1765; 1583-1817; 1603 -2078 1618- 1908 1644- 1877;
1655 1908; 1669 1857; 1672-1903; 1675-1879; 1678 1839; 1675 1909; 1675-
2187 1675 -1927 1677-•1940; 1685-•2215; 1691 -1971 1694- 1953 1713- 2016;
1714 1961; 1715 1958; 1725-2255; 1728-1923; 1731 2030; 1731 1973; 1732-
1984 1736 -1977 1736-■2035; 1741-•2057; 1748 -2273 1749- 2008 1759-2010;
1761 2028; 1762 2305; 1765-2027; 1767-2154; 1768 1992; 1769 2007; 1769-
2029 1788 -2032 1795-2013; 1800-2055; 1807 -2058 1815-2014 1826-2073;
1834 2268; 1838 1978; 1859-2059; 1852-1919; 1857 2298; 1867 2151; 1867-
2124 1871 -2096 1870*■2120; 1873-•2141; 1874 -2032 1876-2117 1885-2300;
1885 2095; 1885 2512; 1890-2177; 1901-2148; 1901 2164; 1907 2139; 1911-
2179 1911--2065 1912-■2146; 1918-•2410; 1928 -2208 1929- 2045 1936-2169;
1942 2200; 1943 2203; 1948-2192; 1949-2160; 1953 2171; 1958 2214; 1979-
2138 1982 -2217 1983-•2250; 1985-•2258; 1986 -2039 1993- 2212 2002- 2232;
2003 2254; 2003 2277; 2005-2243; 2006-2258; 2007 2257; 2009 2293; 2012-
2406 2017 -2252 2028-■2480; 2028-2275; 2028 -2291 2029-■2275 2030-2572;
2031 2241; llll 1268; 1117-1368; 1116-1719; 1123 1327; 1123 1401; 1125-
1278 1127 -1362 1128-1618; 1131-•1400; 1135 -1428 1149-■1461 1149-1360;
1154 1368; 1164 1673; 1171-1413 ; 1176-1287; 1182 1418; 1198 -1801; 1196-
1451 1210 -1496 1214-1498; 1222-1621; 1234 -1507 1238-■1513 1241-1390;
1267 1522; 1271 1503; 1274-1848; 1272-1415; 1273 1534; 1273 1412; 1278-
1486 1277 -1484 1280--1465; 1297-•1766; 1315 -1573 1327-■1594 1347-1594;
1353 1606; 1368 1641; 1372-1618; 1379-1947; 1381 1954; 1385 1645; 1389-
1628 1391 -1499 1414--1674; 1414-•1670; 1415 -1539 1429-•1888 1427-1699;
1433 1516; 1436 1675; 1437-1772; 1436-1700; 1438 1659; 1439 •1618; 1443-
2051 1444 -1705 1454--1701; 1460-•1613; 1463 -1703 1465-•1660 1469-1763;
1471 1686; 1471 1718; 1475-1768; 1480-1771; 1483 1736; 1487 1649; 1489- Table 3
1585; 1500-1763; 1505-1776; 1507-1699; 1509-1770; 1510-1768; 1510-1745; 1511-1664; 1512-1768; 1512-1754; 1513-1785; 1516-1780; 1528-1771; 1538- 1735; 1538-1731; 1538-1705; 1549-1800; 1563-2131; 1576-1828; 1576-1811; 1580-1835; 1583-1835; 1581-1842; 1587-2115; 1589-1879; 1583-2332; 1595- 2188; 1595-2955; 1604-2174; 1607-1873; 1610-1839; 1613-1842; 1618-1882; 1641-2202; 1641-1872; 1641-1863; 1644-1885; 1648-1900; 1650-1922; 1653- 1768; 1654-1932; 555-1119; 557-1162; 558-1094; 560-1138; 559-644; 563-793; 567-939; 573-1157; 575-1004; 616-917; 619-761; 627-884; 627-875; 633-892; 649-904; 628-1095; 633-903; 652-1252; 658-786; 656-1261; 660-837; 664-917; 674-1314; 680-1318; 682-1331; 688-1297; 696-1321; 697-810; 704-840; 707- 1118; 704-972; 715-1102; 717-1335; 732-1279; 718-918; 737-890; 749-989; 750-1033; 753-1168; 755-1046; 755-1001; 756-1038; 750-883; 771-1245; 775- 1067; 782-1344; 781-1009; 775-922; 784-1053; 807-1346; 793-1045; 793-964; 818-1038; 823-1301; 858-965; 871-1108; 880-1337; 885-1495; 888-1154; 888- 1108; 890-1142; 900-1139; 900-1099; 901-1145; 903-1148; 909-1156; 880-1224; 915-1417; 917-1479; 923-1138; 923-1116; 924-1189; 925-1200; 932-1170; 933- 1487; 932-1245; 934-1151; 935-1182; 942-1532; 948-1378; 952-1369; 953-1528; 953-1456; 956-1211; 971-1058; 975-1266; 1012-1433; 1017-1264; 1017-1271; 1025-1205; 1028-1277; 1040-1256; 1041-1255; 1054-1552; 1056-1269; 1080- 1306; 1089-1346; 1110-1561; 1110-1349; 1-281; 28-621; 170-625 196-660
200-429 201-696 212-697 212-668 225-784 225-637 233-785 241-647 250-794 250-813 283-629 294-840 294-384 345-799 341-644 343-707 375-912 379-673 380-877 394-706 395-752 403-675 423-747 456-584 459-705 475-712 475-940 475-699 488-717 488-752 500-668 506-756 508-1024. 520-662 526-660 526-1176; 535-1046; 539-782; 549-819; 2721-
2903 2722-2962; 2736-2955 2738-2905; 2743-2957 2769-2875; 2778-2885; 2783 2907 2784-3012; 2788-2894; 2793-2905; 2829 2955; 2839-2955; 2848- 2907 2853-2955; 2868-2958 2884-3153; 2893-2955 3037-3158; 2593-2903;
2594-2820 2594-2842; 2595 2955; 2596-2905; 2597-2899 ;.2600-2846 ; 2601-
2879 2601-2877; 2602-2955 2602-2905; 2603-2967 2606-2955; 2607-2955;
2607-2868 2607-2913; 2607 2896; 2609-2840; 2609 2883; 2615-2862 2616-
2959 2622-2952; 2620-2892 2621-2891; 2628-2905 2629-2887; 2630-2908;. 2630 2754 2630-2906; 2631-2942; 2633-2907; 2635 2955; 2634-2950 2637- 2899 2644-2953; 2645-2871 2644-2932; 2652-2905 2650-2962; 2652-2965; 2653 2823 2657-2955; 2657 2911; 2658-2961; 2657 2904; 2660-2905 2662- 2913 2664-2951; 2663-2905 2663-2930; 2665-2915 2674-2958; 2675-2957; 2678 2926; 2683-2952; 2685 2955; 2687-2932; 2688 2962; 2694-2955 2701- 2947 2701-2901; 2701-2955 2704-2906; 2706-2955 2721-2904; 618-888; 1136- 1558 927-1380; 1489-2103
348/LI:245982.24:2001MAY17 | | 1569-2192; 1576-1734; 1578-2092; 1588-1865; 1596-2103; 1596-1849; 1596-2043; 1602-1997; 1602-1874; 1604-1856; 1565- 2129; 1617-2175; 1616-1733; 1627-2128; 1630-1874; 1634-1733; 1639-2168; 1642-1733; 1642-2164; 1642-2201; 1642-2176; 1642-2170; 1642-1881; 1642- 1854; 1647-1931; 1647-2015; 1653-1912; 1654-2046; 1654-1908; 1656-1920; 1656-1868; 1656-1732; 1656-1733; 1656-2097; 1657-1940; 1672-2084; 1682- 1940; 1682-1926; 1712-2156; 484-1040; 563-1143; 571-1047; 583-842; 587- 1095; 656-1321; 683-1188; 684-1177; 719-1290; 754-1340; 771-990; 771-1019; 798-1340; 805-1059; 828-1448; 853-1382; 884-1439; 883-1171; 919-1331; 944- 1659; 948-1488; 926-1518; 966-1539; 973-1436; 940-1500; 941-1501; 978-1536; 968-1334; 990-1379; 1085-1474; 1091-1277; 1089-1722; 1119-1368; 1121-1358; 1128-1358; 1130-1232; 1159-1447; 1190-1807; 1248-1516; 1180-1302; 1206- 1483; 1286-1505; 1272-1900; 18-80; 12-109; 1562-1620; 1565-2095; 1-625; 209-844; 269-807; 345-980; 1793-2193; 1793-1924; 1793-2199; 1793-2143; 1793-1952; 1793-1847; 1793-1966; 1794-2044; 1793-2004; 1744-2196; 1747-
1989; 1748-2193; 1749-2198 1753-2173; 1753-2199; 1758-2201; 1793-2014; 1795-1913; 1796-2194; 1801 1969; 1801-2042; 1801-2078; 1808-2156; 1759- 2050; 1808-2053; 1811-2193 1812-2193; 1817-1988; 1819-2197; 1817-1989;
1821-2197; 1821-2193; 1824-2081; 1825-2009; 1759-1974; 1763-2164; 1766-
2193; 1767-2196; 1771-2074 1769-2197; 1772-2024; 1780-2025; 1781-2153;
1782-2197; 1783-2197; 1787-2197; 1786-2183; 1793-1955; 1793-1990; 1793- Table 3
2194; 1829-2193; 1834-2099; 1847-2196; 1859-2198; 1864-2193; 1864-2132
1866-2099; 1866-2097; 1866-2115; 1867-2197; 1867- 2194; 1872-2195; 1874
2132; 1874-2201; 1874-2112; 1878-2137; 1879-2029; 1881-2197; 1895-2197
1897-2196; 1898-2201; 1905-2216; 1905-2081; 1905- 2134; 1912-2196; 1919-
2174; 1925-2199; 1923-2198; 1925-2368; 1935-2049; 1956-2193; 1959-2243
1960-2232; 1961-2196; 1968-2375; 2002-2196; 2054-2193; 2084-2176; 2087-2192
349/LI: 246054.1.2001MAY17 | | 489-687; 514-783; 576-851; 600-874; 658-872;
710-916; 819-1215; 903-1200; 947-1488; 1328-1609; 1374-1630; 1420-1630;
1500-1636; 1-256; 1-557; 2-230; 23-383; 41-230; 42-230; 235-568; 249-568;
256-350; 258-516; 283-555 295- 546 301-479; 280-362 301-389 301-414;
301-429; 301-430; 301-433 301- 443 301-449; 301-444 301-537 301-450;
301-460; 301-519 301-423 301- 506 301-630; 301-461 301-610 301-579;
301-428; 301-517 305-596 313- 556 317-630; 318-672 321-738 331-426;
335-575; 337-557 337-572 338- 880 338-577 338-836 344-713 344-585;
344-803; 346-596 349-714 352- 609 361-605 372-536 396-868 404-636;
419-550; 457-876 455-805 467- 871 474-749 478-653 501-917 505-907;
508-915; 512-912 512-797 523- 912 537-781 555-845 562-820 579-912;
589-838; 590-766; 597-942 601- •869 626-757 629-845 630-1077 : 665-913;
672-897; 708-907; 710-944 710- 912 710-875 710-873 777-912; 799-962;
841-1127 856-1203; 877-1072; 879-1162; 910-1170; 930-1199; 942-1183; 947-
1194; 958-1161; 976-1137; 977-1194; 978-1167,- 982 .-1162 992- -1554; 1005-
1136; 1010-1223; 1016-1303; 1019-1267; 1020- -1246; 1033- -1317, 1042- -1615;
1057-1606; 1062-1588; 1133- -1296; 1139-1631; 1158- -1629; 1160- -1296; 1170-
1632; 1168-1630; 1170-1347, 1174-1645; 1174- -1635, 1177- -1631 1182- -1630;
1189-1630; 1191-1630; 1202- -1638; 1204-1630; 1206- -1638; 1208- -1630; 1209-
1630; 1231-1631; 1233-1634, 1231-1357; 1250- -1477, 1259- -1636 1264- -1630;
1268-1632; 1271-1618; 1276- -1634; 1285-1498; 1285- -1630; 1296- -1623; 1299-
1588; 1311-1630; 1327-1619, 1334-1630; 1335- -1630, 1340- -1631 1354- -1630;
1374-16-23; 1380-1844; 1391- -1633; 1412-1631; 1417- -1630; 1429- -1623; 1433-
1630; 1441-1630; 1448-1636, 1520-1609; 1623 -1883
350/LI:256051.229:2001MAY17 | | 644-771; 656 -771; 524-771; 681-771 720-771;
535-771; 299-694; 294-653; 1-399; 242-399; 294-399; 114-371 1-207
351/LI 260629.7:2001MAY17' | 1-145; 19-145
352/LI 272723.1:2001MAY17 j 1-386; 7-391; : 2 27788--77E9 )55;; 2277!8 3--886633; 227799--:3 38866
353/LI 272766.1:2001MAY17 j 1-662; 1-112; 4 -* 14411--88"7 733;; 5577(0 3--995577
354/LI 275726.1:2001MAY17 j 1-157; 1-583; . 1 L--9977;; 11--555544; 44--99'7 7;; 3333--.9 577;; 445511--
594; 456-591; 456-521
355/LI : 276815.1 : 2001MAY17 | 1 1--225500;; 4488--445555;; 4488--55Ϊ9 )88
356/LI 283562.5:2001MΛY17 | 1 1--558844;; 335522--880077; ; 336677-- -888877;; .5 58844--1122 33355;; 990 366--11553377;; 1192-1669; 1339-1548; 1540-1824; 262-667; 297-515; 313-980; 352-622; 364- 938; 364-873; 367-975; 367-965; 367-979; 454-1036; 558-1236; 569-1230; 571- 1227; 639-1227; 660-1234; 775-1036; 822-1319; 906-1441; 1059-1583; 1059-
1585; 1059-1618; 1272-1498; 1274-1485 1333-1669 1335-1958; 1385-1510 1525-1968; 1525-1922; 1528-1805; 1528 1809; 1567-2204; 1595-1838; 1597- 1753; 1675-2166; 1674-2357; 1689-2259 1688-1915 1758-2216; 1758-2376
1776-2093; 1776-2028; 1777-2080; 1782-2073; 1782 2066; 1774-2018; 1783
1993; 1826-2406; 1839-2097 1839-2266 1814-2431 1817-2314; 1822-1974 1829-1970; 1894-2533; 1924 2534; 1916 2151; 1919 2585; 1976-2570; 2018 2564; 2049-2539; 2066-2638 2053-2661 2128-2742 2128-2344; 2161-2759 2157-2851; 2169-2738; 2202 2576; 2222 2860; 2257 2759; 2283-2885; 2330- 2929; 2353-2747; 2417-3003 2471-2746 2550-3096 2418-2692; 2437-2640 2442-2653; 2445-2709; 2451 3078; 2468 2968; 2587-3217; 2593-2842; 2713 3314; 2751-3003; 2754-3288 2755-3318 2761-2994 2765-3262; 2762-2940
2792-2878; 2807-3361; 2827-3375; 2841-3361; 2844 3378; 2887-3377; 2895
3364; 2922-3313; 2928-3361; 2935-3362 2934-3152 2968-3198; 2990-3364
2993-3361; 3081-3317; 3118-3361; 3155-3285; 3167-3361; 3265-3378; 3288-3359 357/LI: 289066.15 :2001MAY17 | | 2967-3112; 2107-2266; 2143-2303; 2102-2253; 2086-2268;' 2114-2268; 2096-2268; 2098-2286; 2123-2256; 2136-2268; 2109- 2267; 2109-2272; 2109-2266; 2109-2268; 2134-2268; 2138-2266; 2158-2272; 2161-2254; 2169-2268; 2174-2267; 2170-2252; 2200-2265; 2164-2220; 2210- Table 3
2266; 2312- -2962, 2378- -2949 2495-3172; 2513-2782 2553-2803 2585-3134;
2586- -2834; 2600- -3223; 2603 3073; 2628-3233; 2643-3145; 2648 2769; 2659-
2930, 2666 -2905 2699 -2994 2700-2939; 2700-2993 2700-2863 2716-3248;
2716- -2937; 2722- -3251; 2728 2945; 2727-2953; 2733-3251; 2746 3150; 2757-
3243, 2761 -3025, 2774 -3248 2775-3048; 2781-3251 2781-3248 2785-3211;
2785- -3046; 2786- -3248; 2785 3072; 2787-3050; 2790 3248; 2804 3247; 2809-
33224499, 2 2880088--22885588,; 22882200 -3251 2825-3068; 1712-1976 1721-1903 1754-2114; 1730 2301; 1757-2031; 1735-1912; 1739-1967; 1742-1958; 1773 2047; 1754- 1928 1760-2267; 1774-2043 1770-1958; 1798-2259 1800-2011 1801-2100; 1814 2062; 1805-2192; 1805-2076; 1808-2300; 1827 1977; 1827 2010; 1844- 2392 1833-2307; 1824 -2093 1839-2301; 1853-2132 1826-2115 1843-2301; 1846 2225; 1839-2300; 1839 2261; 1856-2301; 1858 2303; 1847 -2305; 1863- 2280 1864-2307; 1865 -2301 1866-2299; 1858-2103 1859-2278 1860-2296;
1874-2307; 1890-2325; 1880 2282; 1868-2302; 1869 2312; 1885 2282; 1878-
2303 1891-2305; 1894 2307 1885-2304; 1900-2299 1893-2278 1893-2304; 1898 2301; 1913-2307; 1903-2308; 1930-2182; 1907 2166; 1923 -2301; 1912- 2319 1927-2259; 1914 -2250 1938-2300; 1926-2287 1924-2191 1926-2306;
1941-2210; 1929-2306; 1934 2303; 1949-2305; 1945 2314; 1945 -2227; 1960-
2301 1950-2278; 1951-2301 1953-2261; 1956-2119 1959-2300 1946-2258;
1952-2240; 2006-2314; 2006 2263; 1987-2272; 1990-2261; 1995 2266; 2002-
2223 2002-2217; 2005-2245 2040-2288; 2008-2229 2052-2271 2071-2284; 2054 2295; 2060-2298; 2064 2298; 2059-2324; 2077-2270; 2111 2247; 2078- 2256 2113-2318; 2119-2318 2084-2266; 2122-2321 2097-2281 2102-2250; 2102 2224; 1086-1328; 1090 1332; 1094-1255; 1112-1371; 1112 -1231; 1101- 1556 1107-1561; 1132-1380 1137-1376; 1145-1341 1152-1394 1132-1538;
1147-1483; 1154-1541; 1162 1406; 1162-1341; 1162 1691; 1163 1761; 1165-
1316 1168-1414; 1177-1462 1177-1423; 1178-1432 1180-1386 1183-1413; 1188 1519; 1197-1333; 1214 1511; 1215-1472; 1237 1514; 1245 1529; 1265- 1846 1278-1524; 1314-1958 1294-1551; 1294-1428 1317-1547 1317-1566;
1321-1782; 1320-1818; 1336 1582; 1340-1977; 1345 1745; 1352 1603; 1353-
1621 1353-1613; 1363-1614 1363-1609; 1369-1621 1370-1649 1374-1660; 1386 1584; 1389-1722; 1431 1789; 1409-2035; 1410 1996; 1428 1958; 1428- 1602 1428-2075; 1430-1929 1440-1674; 1470-2009 1472-1731 1448-1735; 1466 2019; 1500-2050; 1478 1727; 1503-1776; 1506 1797; 1485 1729; 1486- 1647 1486-1583; 1494-1731 1502-1937; 1535-1810 1511-1717 1537-2070;
1514-1753; 1543-1984; 1550 1768; 1568-1816; 1568 1788; 1544 1851; 1546-
1811 1554-1738; 1582 -1809 1588-2220; 1564-1916 1572-2195 1568-2043; 1593 1836; 1595-1774; 1606 1809; 1586-2218; 1627 1733; 1606 2108; 1633- 1834 1627-1899; 1634-1931 1657-2154; 1650-1871 1671-2154 1644-2203,
1664-1889; 1695-2272; 1698-2266; 1712-2237; 1703 2284; 1712 2249; 1709-
2172; 1709-1841; 1709 -1974 1693-1950; 1712-1942 1-555; 29 569; 107-570;
316-564; 316-537; 416 -649; 447-677; 577-1269; 591-866; 590- 1000; 591-929;
594-870; 594-936; 593 -722; 595-725; 596-997; 596-816; 596-8 81; 596-1016;
596-1015; 596-982; 596-772; 596-841; 596-900; 596-995; 596- 807; 607-870;
614-1009; 615-822; 615-880; 615-1084; 619-1105; 636-1113; 6 48-1179; 653-
933; 655-902; 658-946 ; 658-889; 664-870; 672-965; 688-896; 715-1006; 719-
984; 743-946; 765-1327; 765-1343; 810-1048; 892-1198; 893-1 066; 921-1186;
901-1168; 905-1028; 963-1117; 946-1402; 977-1247; 987-1208; 967-1531; 967-
1501 1004-1213; 1027 -1277; 1004-1532; 1007-1158; 1043-1292 1057-1347;
1073 1356; 2836-3249; 2839-3248; 2847-3249; 2849-3246; 2855 3249; 2858-
3248 2871-3106; 2873 -3091; 2896-3251; 2898-3120; 2906-3251 2924-3174;
2936 3160; 2941-3210; 2941-3172; 2942-3250; 2953-3251; 2953 -3244; 2953-
3248 2956-3248; 2958 -3186; 2965-3247; 2966-3246; 2970-3181 2977-3231;
2981 3231; 2985-3218; 2992-3246; 2997-3254; 3033-3202; 3043 -3248; 3055-
3249 3080-3248; 3139 -3248; 653-914; 670-886; 719-989; 885 1138; 946-1155; 971-1197; 1007-1348; 1067-1292; 1569-1828; 1590-2135; 1620- 1764; 1649-2099; 1674-1949; 1709-2299; 1712-2279; 2831-3046; 2852-3256; 2895 3248; 2934- 3159; 2944-3246; 2957 -3249; 2980-3043; 3006-3218; 3134-3251 40-465; 780- 1118; 596-1080; 671-1239; 719-1338 Table 3
358 /LI : 331040 . 17 2001MAY17 610-825; 615-835; 660-842; 602-792; 604-812;
709- 839 728-838 740-943 776-838 602-846; 1-320; 1-265; 27-606; 114-429; 114- 394 138-508 143-427 151-438 171-726; 174-604; 204-839; 193-766; 213- 517 218-800 224-657 257-784 257-812; 258-673; 295-633; 300-550 300- 862 303-592 324-585 331-511 341-838 354-838; 357-615 361-500 374- 840 370-651 375-798 374-838 377-802 380-838; 392-642 407-841 422- 841 426-574 441-841 442-850 444-841 445-841; 449-852 453-844 451- 841 456-676 457-847 479-841 488-838 493-841; 506-841; 506-732 505- 647 511-844 528-848 528-838 549-841 569-841; 590-827; 597-841
359/LI:332414.5: 2001MAY17 I 1-550 1-600; 68-669; 159-429; 227-450; 228- 657; 240-489; 25 3-828; 268-608; 268-516; 267-908; 281-487; 436-1056; 490- 1073; 481-1079; 509-1090; 522-1079; 507-1100; 536-1093; 535-1040 541-1127 ; 544-1162; 548-12 05; 556-1069; 595-1231; 604-1134; 615-1121; 615-1486; 655 1217; 679-1217; 682-1273; 701-1090; 725-1402; 713-1384; 710-1251 721-1405 ; 754-1097; 785-1312; 800-1018; 769-1642; 802-1441; 964-1527; 1093 1670 ; 1160-1724; 1184-1697; 1245-1689; 1255-1723; 1270-1710; 1274-1723 1286- 1718; 1312-1713; 1324-1721 ; 1327-1712 ; 1329-1712 ; 1331-1718 ; 1337-1716 ; 1341-1616; 1367- 1658 ; 1367 -1678 ; 1373 -1589 ; 1383 -1718 ; 1401-1719 ; 1414- 1715; 1504-1718; 1621-1714 360/LI:332730.16 2001MAY17 i| 1338-1533; 1411-1523; 1411-1752; 1430-1774; 1448-1621; 1504 1786; 1577-1915; 1626-1868; 1627-1841; 1767-2001; 1777-
2030 1788- 1912; 1789-2046 1859-2322; 1918-2353; 1931-2203 1934-2152 1946 2485; 1975-2172; 1980 2216; 2020-2178; 2074-2344; 2083 2293; 2236 2439 2239-2683; 2240-2682 2246-2671; 2255-2451; 2258-2460 2268-2362 2390 2642; 2396-2928; 2397 2645; 2401-2577; 2419-2680; 2578 3141; 2653- 3003 2720- 3182; 2731-3182 2749-3174; 2752-3352; 2755-2940 2769-3391 2769 3365; 2774-3174; 2796 3067; 2796-3038; 2796-3181; 2833 3174; 2875 3131 2882- 3450; 2886-3088 2895-3315; 3065-3180; 3Q99-3358 3109-3356 3150 3425; 3151- 3404; 3201-3445; 3266-3526; 3286-3530; 3426-3858; 3476 3962 3551- 3771; 3551-3705 3551-3748; 3551-3743; 3574-3823 3593-3792 3623 3794; 3645- 3927; 3686-3869; 3688-3943; 3712-4077; 3728 4072; 3729 3992 3729- 4141; 3741-4043 .3769-4013; 3789-4069; .3789-4065 3796-4132 3801 4030; 3833- 4344; 3864 4081; 3864-4141; 3868-4608; 3867 4166; 3877 4143 3902- 4138; 3909-4283 3944-4176; 3949-4283; 3957-4240 3972-4105
3978-4236; 3980-4238; 4023-4563; 4023-4227; 4068-4342; 4071 4379; 4080
4356; 4113-4678; 4122-4359 4129-4389; 4147-4523; 4165-4618; 4175-4631 4189-4437; 1-693 ; 11-242; 63-358; 229-781; 243-568; 311-494; 415-631; 443- 844; 462-652; 538-1071; 546-886; 580-899; 677-1020; 682-1168; 714-1260; 728-1151; 728-1270; 737-1059; 746-965; 850-1490; 891-1270; 976-1403; 1003- 1401; 1013-1404 1022-1608; 1025-1227; 1025-1435; 1036-1412; 1048-1256; 1055-1404; 1066 1401; 1073-1270; 1080-1403; 1066-3181; 1083-1404; 1089- 1366; 1092-1322 1092-1363; 1087-1629; 1143-1412; 1181-1270; 1180-1443; 1178-1556; 1195 1363; 1190-1397; 1286-1598; 4811-5090; 4814-4953; 4815- 5202; 4818-5003 4822-5065; 4823-5209; 4834-5209; 4841-5209; 4846-5210; 4847-5127; 4848 5210; 4851-5130; 4851-5117; 4852-5202; 4853-5209; 4853- 5210; 4852-5214 4857-5209; 4858-5047; 4859-5209; 4862-5201; 4883-5209; 4884-5209; 4881 5167; 4886-5211; 4892-5180; 4901-5173; 4905-5209; 4909- 5202; 4913-5180 4942-5211; 4943-5209; 4944-5209; 4944-5171; 4947-5209; 4975-5172; 4978-5202; 4982-5182; 4986-5202; 4991-5126; 4190-4443; 4192- 4428; 4195-4256 4230-4392; 4259-4507; 4263-4521; 4286-4573; 4294-4484; 4310-4513; 4361 4587; 4365-4585; 4364-4597; 4391-4650; 4405-4658; 4406- 4653; 4415-4694 4430-4684; 4465-4701; 4475-4725; 4477-4743; 4488-4941; 4497-4757; 4501 4796; 4523-4663; 4549-4826; 4554-4850; 4566-4835; 4577- 4802; 4582-4870 4602-5208; 4602-4831; 4605-4800; 4606-4923; 4608-4722; 4610-5079; 4630 4983; 4655-5172; 4655-4895; 4657-4883; 4664-5117; 4698- 4963; 4698-5183 4705-4929; 4710-5117; 4711-4991; 4716-4997; 4743-5209; 4752-5212; 4754-5211; 4754-5209; 4755-5209; 4756-5209; 4757-5214; 4765- 5215; 4765-5216 4766-5185; 4769-5209; 4781-5172; 4788-5209; 4790-5209; 4791-5120; 4798 5202; 4800-5209; 4804-5209; 4806-5027; 4806-5037; 4810- 5209; 4811-5209 Table 3
361/LI:333849.21:2001MAY17 | | 1-566
362/LI:337038.15:200lMAY17 | j 2690-2744; 2697-3054; 2719-3077; 2719-2965; 2723-3281; 2723-3016; 2728-3014; 2746-3247; 2945-3050; 2954-3085; 2998- 3134; 3013-3526; 3059-3604; 3915-4090; 3950-4157; 3963-4053; 3971-4239; 3606-3910; 3651-4040; 3651-3915; 3678-3977; 3713-3982; 3873-4529; 2490- 2545; 2495-2545; 4159-4676; 4201-4449; 4209-4640; 4243-4648; 4243-4494; 4243-4640; 4265-4503; 4277-4530; 4283-4811; 4326-4867; 4343-4593; 2664- 2832; 2673-3057; 2681-3057; 2681-3052; 2681-3028; 2681-3013; 2681-2753; 2681-2752; 2681-3174; 2681-2984; 2686-3079; 2690-2897; 2690-2782; 3091- 3452; 3178-3644; 3194-3644; 4042-4458; 4043-4332; 4097-4600; 4109-4393: 4109-4511; 3566-3895; 3365-3643; 3366-3646; 3416-3643; 3444-3594; 3451- 3633; 3453-3642; 3463-3812; 3463-3799; 3471-4016; 3474-3840; 3476-3845; 3488-3643; 3360-3629; 1-5249; 1-546; 42-653; 56-479; 192-512; 392-891; 394- 891; 418-891; 434-891; 439-847; 461-553; 477-614; 510-847; 515-891; 534- 847; 535-885; 579-883; 596-650; 634-889; 674-758; 719-987; 774-863; 796-
1035 1205-1455; 1452-1902 1650-1948; 1659-2077; 1718-1987; 1719-1977 1756 2203; 1762-1911; 1763 1974; 1780-2190; 1801-2202; 1863-2126; 1867- 2425 1868-2059; 1965-2271 1991-2205; 1996-2245; 2007-2570; 2008-2419 2066 2269; 2134-2545; 2134-2374; 2142-2545; 2159-2415; 2174-2545; 2196- 2545 2247-2545; 2262-2545 2268-2542 2267-2498; 2271-2545; 2271-2473; 2279 2523; 2361-2783; 2378 2545; 2453-2545; 2746-2989; 2746-2938 2746- 2833 2746-2806; 2749-3307 2830-3077 2830-3098; 2830-3083; 2830-3051; 2851 3077; 2856-3125; 3209 3642; 3222 3641; 3234-3644; 3273-3888 2509- 2579 2606-3051; 2622-3077 2640-2790 2656-2806; 4355-4591; 4366-4879; 4380 4638; 4385-4881; 4426 4708; 4433 4672; 4458-4921; 4465-4918 4468- 4698 4518-4900; 4534-4928 4546-4928 4547-4689; 4568-4923; 4589-4887;
4593-4919; 4602-4923; 4609 4928; 4609-4919; 4668-4923; 4735-4928 4779- 5205; 4806-5068; 4848-5244 4859-4919 4971-5244 363 /LI: 337606.6 :2001MAY17 I 1-424; 234-433; 234-456; 234-631; 234-647; 277-631; 292-631; 355-631; 468-631; 473-631 364/LI:338032.10:2001MAY17 I I 1-394; 28-408 365/LI:339265.16:200lMAY17 j j 675-1064; 949-1207; 1142-1469; 1278-1636;
1527-2001; 2259- 2699; 2775-3542; 2964-3271; 3400-3625; 1-255; 156-614; 178- 879; 187-630; 207-852; 257-614; 264-596; 276-875; 281-630; 314-630; 417- 910; 660-1064; 671-1064; 739-1064; 805-1225; 891-1471; 902-1458; 984-1172; 1102-1469; 1102- 1467; 1102-1476; 1115-1589; 1192-1438; 1200-1458; 1223- 1664; 1248-1469; 1280-1373; 1287-1439; 1360-1916; 1486-2091; 1569-1828; 1608-2156; 1814- 2458; 1916-2435; 2076-2449; 2281-2842; 2283-2530; 2311- 2748; 2727-3147; 2775-3149; 2780-3271; 2802-3189; 2842-3097; 3205-3473; 3245-3384; 3248- 3824; 3257-3744; 3400-3684; 3407-3548; 3452-3811 366/LI:344646.4: 2001MAY17 | | 1586-1767; 1597-1793; 1597-1796; 1599-1760; 1124-1362; 1134- 1363; 1149-1387; 1530-1754; 634-898; 658-925; 709-990; 725- 960; 730-1222; 1 857; 306-541; 309-710; 320-768; 320-769; 348-756; 348-565; 369-633; 371-768 ; 388-707; 399-801; 410-739; 425-719; 467-708; 488-811; 496-811; 498-813 ; 509-1176; 511-1088; 553-814; 557-777; 567-856; 593-1215; 732-1001; 730-1390; 749-1112; 790-1147; 790-983; 795-1127; 802-1146; 814- 1292; 816-1225; 834-1059; 835-1049; 908-1149; 921-1352; 922-1181; 917-1630; 944-1234; 944-1308; 956-1064; 960-1225; 965-1681; 986-1221; 986-1556; 1012- 1287; 1013-1233; 1031-1141; 1038-1654; 1048-1229; 1048-1322; 1053-1318; 1071-1374; 1075- 1513; 1075-1338; 1076-1727; 1106-1578; 1230-1720; 1259- 1448; 1261-1715; 1264-1720; 1266-1715; 1266-1723; 1272-1518; 1279-1756; 1279-1755; 1284- 1760; 1288-1760; 1295-1719; 1298-1754; 1300-1755; 1301- 1760; 1301-1757; 1306-1761; 1310-1761; 1310-1758; 1309-1757; 1312-1759; 1315-1759; 1317- 1786; 1317-1754; 1318-1761; 1335-1760; 1337-1761; 1343- 1760; 1341-1720; 1345-1755; 1348-1760; 1349-1629; 1352-1761; 1355-1538; 1359-1754; 1363- 1752; 1375-1760; 1378-1760; 1381-1758; 1382-1752; 1386- 1759; 1389-1768; 1391-1723; 1394-1769; 1394-1718; 1397-1627; 1399-1759; 1400-1661; 1412- 1655; 1430-1758; 1430-1600; 1437-1758; 1438-1549; 1438- 1760; 1446-1757; 1466-1770; 1468-1658; 1483-1761; 1487-1754; 1513-1760; 1515-1759; 1515- 1760; 1520-1764; 1520-1760 Table 3
367/LI : 347393 .7 : 2001MAY17 | | 1-380 ; 923-1312 ; 1044-1315 ; 103-283 ; 224-843 ;
528-1153 ; 803-1010 ; 804-1340 ; 909-1315 ; 930-1343 ; 953-1349 ; 1022-1299 ;
1029-1251; 1162-1349; 1181-1349
368/LI: 348107.36 :2001MAY17 || 1-492; 1-499; 3-492; 1-219; 4-492; 3-219; 4-
219
369/LI: 351120.6.-2001 AY17 || 2875-3280; 1-245; 12-454; 12-173; 12-124; 38-
555; 58-577; 139-426; 178-682 ; 178-419; 186-688; 296-518; 296-426; 320-613;
327-737; 401-810; 430-680; 430-604; 433-541; 506-742; 519-737; 531-1173;
627-1087 ; 2737-3047 ; 2740-2941 ; 2749-3043 ; 2752-3047 ; 2755-3003 ; 2770-2935 ;
2770-2863 ; 2792-3047 ; 2792-3043 ; 2800-3043 ; 2807-2972 ; 904-1038 ; 905-1374 ;
911-1165 ; 921-1183 ; 896-1106 ; 728-1338 ; 730-1360 ; 740-1256 ; 761-1055 ; 819-
1112 819-1122; 820-1125; 830-1066; 834-1371; 838-1087; 845-1116; 850-1100;
60-1117 ; 861-1144 ; 863-1490 ; 862-1114 ; 871-1144 ; 879-996 ; 891-1135 ; 896-
1120 925-1042; 944-1356; 950-1042; 966-1032; 973-1455; 981-1249; 994-1574; 1122 1585; 1123-1593; 1131-1339; 1134-1586; 1133-1588; 1137-1407; 1139- 1588 1145-1592; 1145-1401 1146-1451 1150-1592 1159-1588 1159-1587; 1159 1556; 1159-1547; 1161 1371; 1161 1409; 1859 2093 ; 1862 2110; 1862- 2076 1861-2107; 1863-2090 1865-2124 1865-2162 1865-2076 1865-2073; 1864 2143; 1866-2124; 1867 2354; 1867 2017; 1866 2100 ; 1869 2114; 1869- 2085 2634-3070; 2638-3043 2649-3043 2661-3043 2663-3043 2679-3044; 2684 3047; 2689-3043; 2698-3043; 2707 3046; 2713 3042 ; 2720 3047; 2721- 3047 2722-3061; 2723-3044 2731-3034 2886-3043 2886-3295 2897-3043;
2947-3047; 2960-3034; 3054 3206; 2848 3280; 2849 3280 ; 2849 3094; 2849-
3260 2850-3241; 2852-3047 2857-3044 2859-3240 2883-3043 1491-1723; 1505 1724; 1519-1594; 1522 1590; 1527-1585; 1540-2053; 1688 1979; 1692- 1933 1699-1922; 1718-1982 1722-1959 1858-2228 1859-2140 1220-1587;
1226-1503; 1233-1484; 1239-1586; 1238 1479; 1244-1582; 1245 1532; 1248-
1584 1248-1824; 1248-1587 1249-1591 1253-1587 1255-1587 1259-1588; 1259 1518; 1275-1723; 1288-1592; 1297 1493; 1296 1585 ; 1296 1546; 1303- 1587 1314-1587; 1325-1587 1326-1592 1339-1587 1343-1576 1343-1572; 1343 1567; 1343-1548; 1355-1587; 135C 1587; 1356 1589 ; 1360 1587; 1362- 1519 1364-1587; 1366-1570 1373-1587 1374-1587 1379-1803 1379-1587; 1455 1585; 1462-1723; 1462-1588; 1466-1586; 1477 1590; 1490-1587; 1491 1841 1495-1841; 1379-1549 1380-1587 1382-1587 1383-1588 1382-1579 1384 1590; 1390-1587; 1401-1587; 1451 1841; 1410 1723; 1433 1588; 1436 1587 1436-1585; 1446-1585 2219-2760 2219-2456 2257-2496 2261-2536 2279 2537; 2282-2514; 2301 2534; 2348 2593; 2356 2886; 2355 2602; 2364 2633 2368-2562; 2287-2475 2301-2574 2374-2748 2016-2292 2021-2298 2022 2253; 2031-2331; 2035-2186; 2065 2333; 2080 2657; 2095 2350; 2110- 2517 2119-2703; 2129-2368 2140-2371 2150-2386 2170-2408 2180-2276
2209-2454; 2885-2968; 2659 3041; 2587 3045; 2596-3006; 2601-3044; 2602
2810 2608-3041; 2621-3043 2624-3043 2626-2904 2626- 2894 2630-3043 2631 3041; 2631-3042; 2377-2594; 2377 2535; 2388 2901; 2406 2684; 2411 2576 2432-2721; 2442-2749 2446-3047 2462-2627 2476- 2723 2488-2749 2488 2696; 2500-2720; 2510-3049; 2524 3043; 2536 2792; 2542 2856; 2547 2810 2564-3046; 2570-3042 2575-3046 2580-2944 2586- 3046 1163-1451 1167 1587; 1168-1252; 1174-1593; 1176-1591; 1179 1589; 1179 1588; 1181 1587 1182-1589; 1182-1416 1182-1413 1183-1587 1183- 1585 1184-1588 1198 1588; 1201-1587; 1203 1319; 1206 1463 ; 1206 1452; 1210 1442; 1220 1588 1000-1535; 1014-1298 1029-1268 1034-1315 1037-■1546 1040-1506 1049 1552; 1051-1301; 1073 1544; 1075 1557 ; 1075 1368; 1077-1548; 1079 1412 1100-1242; 1100-1426 1100-1381 1100-1364 1100-•1352 1121-1730
1869-2071; 1869-2228; 1869-2149; 1869 2101 ; 1869 2109; 1869 2011; 1872
2055 1872-2034; 1872-2033 1872-2023 1872-2134 1872-2108 1872-2063 1872 2052; 1872-2088; 1879-2113; 1883-2131; 1883 -2360; 1885 1972; 1887- 2395 1900-1966; 1945-2436 1948-2161; 1958-2224 1998-■2319 1999-2272
1998-2258; 922-1175; 973-1241; 994-1140; 1037-1165; 1075-1339; 1087-1477; 1112-1590; 1121-1587; 1142-1587; 1159-1411; U59-1445; 1464-1590; 2209- 2382; 2312-2741; 2364-2600; 2571-2847; 2591-2900; 2616-3047; 2661-3045; 1923-2492; 12-134; 2832-2968; 2657-2936; 12-303; 3-290; 2721-3041; 2544- Table 3
2937; 2599-3038; 2602-3046; 2291-2743; 2479-2937; 2285-2743; 2590-3041; 2580-3047; 93-596; 2437-2997; 2065-2630; 2058-2663; 2406-3047 370/LI:358762.41:2001MAYl7 || 668-795; 671-789; 524-762; 552-754; 481-636; 476-574; 476-528; 1-528; 668-1054; 704-1037; 734-1037; 644-1037; 666-1018; 483-1011; 668-967; 668-918; 1311-1684; 668-863; 1307-1655; 1087-1655; 1357- 1643; 1004-1579; 670-798; 924-1178; 724-1126
371/LI:363003.48:2001MAY17 || 720-1034; 758-1030; 764-1038; 770-1030; 772- 933; 774-1033; 784-1031; 795-1033; 805-1029; 808-1015; 809-962; 815-1037; 822-1033; 831-1031; 852-1036; 865-990; 872-1031; 872-1033; 875-1034; 892- 1033; 894-1029; 907-1032; 913-1032; 919-1033; 918-1044; 923-1031; 983-1033; 543-820; 558-748; 565-1033; 565-1031; 566-863; 570-1033; 572-1033; 573- 1033; 578-790; 581-1033; 582-1036; 583-1033; 584-1030; 588-1035; 590-1036; 592-1039; 594-1033; 587-1033; 595-1038; 595-1031; 608-816; 608-817; 608- 860; 622-1033; 622-851; 623-1037; 625-1033; 631-914; 632-831; 634-883; 636- 986; 643-1031; 643-1033; 643-876; 645-866; 644-896; 651-1033; 653-1035; 654-1032; 657-1014; 658-1039; 658-937; 661-1034; 661-1030; 663-1030; 668- 1033; 669-1036; 669-1034; 671-1033; 672-1034; 673-1030; 679-1033; 687-898; 687-881; 688-991; 688-889; 688-886; 689-1034; 690-996; 696-960; 728-1031; 729-1033; 734-1036; 734-1033; 734-986; 737-992; 737-1035; 737-969; 750- 1036; 753-1033; 756-1034; 69-652; 339-700; 337-993; 342-638; 348-1023; 353-
525; 353-817 353-613; 353-606; 353-589; 353-419; 355-599 356-579 360- 827; 360-499 360-494; 360-415; : 357-603; 360-527; 360-542 360-522 360-
511; 360-469 360-635; 360-610; 360-597; 367-612; 364-623 364-608 365- 628; 366-594 366-852; 371-995; ; 371-649; 371-594 372-609 373-556 374- 538; 372-521 374-477; 371-692; : 374-548; 372-641 378-614; 380-640 382- 597; 385-440 384-579; 388-567; ; 398-956; 405-713 405-505; 413-1034; 414- 969; 424-954 434-717; 437-709; 440-957; 450-810 475-820; 475-724; 476- 991; 477-991 480-741; 507-687; ; 511-721; 523-653 524-778; 531-1011; 534- 1030;: 1-530; 657-811; 243-333; 638-1031; 658-1031 607-1031 372/LI:370899.6:2001MAY17 | | 2425-2623; 2434-2623; 2438-2701; 2443-2714; 2501-3079; 2501-3073; 2529-2997; 2425-2551; 2529-3006; 2545-3002; 2553- 2999; 2576-3153; 2603-2996; 2639-2999; 2642-3183; 2696-2992; 2723-2979; 2776-2981; 3123-3648; 3352-3639; 3352-3649; 1-494; 18-447; 24-554; 26-661; 27-293; 31-567; 48-338; 49-296; 54-303; 153-770; 221-813; 267-604; 279-371; 295-525; 316-636; 352-531; 385-786; 417-830; 462-677; 498-694; 498-891; 507-1001; 513-919; 529-749; 539-609; 586-834; 593-1103; 641-1082; 643-1031; 642-995; 663-1157; 751-1145; 752-1267; 803-1084; 872-1457; 881-1085; 889- 1141; 959-1181; 1031-1490; 1031-1492; 1036-1493; 1041-1492; 1056-1454; 1060-1493; 1061-1495; 1062-1493; 1067-1432; 1073-1494; 2367-2616; 1075- 1493; 1079-1493; 1081-1498; 1084-1496; 1087-1434; 1090-1497; 1090-1499; 1093-1493; 1092-1497; 1093-1492; 1094-1493; 1097-1491; 1096-1459; 1097- 1493; 1101-1490; 1102-1493; 1106-1495; 1108-1499; 1115-1492; 1122-1457; 1129-1336; 1129-1346; 1129-1492; 1130-1495; 1141-1387; 1145-1375; 1156- 1493; 1168-1498; 1188-1490; 1200-1459; 1205-1493; 1207-1494; 1235-1493; 1256-1500; 1258-1493; 1315-1614; 1372-1692; 1376-1493; 1391-1496; 1517- 1813; 1517-1807; 1530-1646; 1530-1649; 1528-1664; 1530-1985; 1530-1716; 1537-1802; 1547-1976; 1547-1852; 1561-1778; 1621-1963; 1651-2422; 1857- 2165; 1903-2149; 1907-2126; 1912-2079; 1930-2197; 1930-2203; 1990-2266; 2007-2540; 2007-2186; 2036-2506; 2050-2608; 2128-2571; 2131-2398; 661-869; 857-1110; 1022-1492; 1050-1490; 1072-1495; 588-1023 373/LI:376470.1:2001MAY17 | | 1-544; 1-88; 379-544
374/LI: 400961.18 :2001MAY17 j | 1468-1821; 1751-1821; 1640-1807; 1152-1768; 1185-1638; 1037-1610; 1153-1594; 1117-1550; 1192-1542; 1110-1514; 1263- 1513; 1275-1489; 1110-1476; 1284-1473; 1260-1471; 1219-1455; 1182-1452; 1217-1449; 1103-1443; 1202-1437; 1109-1422; 1192-1424; 1107-1417; 1112- 1418; 1122-1417; 1163-1397; 1160-1393; 1179-1393; 1163-1382; 1134-1379; 1106-1374; 1198-1369; 1120-1365; 1111-1362; 1106-1363; 1187-1363; 1102- 1358; 1111-1356; 1111-1355; 1111-1352; 1108-1351; 1104-1339; 1109-1336; 1106-1335; 1112-1334; 1111-1333; 1109-1331; 1100-1330; 1114-1329; 1123- 1330; 1111-1326; 1111-1312; 1111-1309; 1108-1307; 1110-1282; 1110-1278; Table 3
906-1254; 1111-1247; 1100-1234; 1119-1217; 849-1173; 886-1170; 655-1165; 696-1164; 757-1164; 791-1164; 732-1163; 699-1163; 663-1163; 770-1163; 763- 1162; 863-1163; 847-1162; 739-1162; 715-1162; 707-1162; 837-1162; 989-1161; 702-1160; 843-1160; 763-1160; 712-1159; 767-1159; 715-1159; 697-1159; 675- 1159; 773-1157; 711-1157; 883-1157; 758-1157; 790-1158; 687-1157; 715-1157; 871-1157; 821-1158; 804-1157; 856-1157; 729-1157; 706-1157; 1058-1157; 798- 1157; 797-1157; 884-1157; 1064-1157; 658-1157; 1073-1157; 793-1157; 1081- 1157; 790-1157; 787-1157; 786-1157; 784-1157; 774-1157; 762-1157; 770-1157; 769-1157; 767-1157; 764-1157; 923-1157; 763-1157; 806-1157; 823-1157; 821- 1157; 705-1157; 746-1157; 788-1157; 720-1157; 736-1157; 813-1157; 733-1157; 1012-1157; 860-1156; 1074-1155; 705-1155; 714-1155; 707-1155; 853-1155; 782-1150; 890-1148; 945-1145; 870-1142; 855-1139; 1020-1137; 772-1136; 1011-1135; 813-1131; 698-1130; 741-1122; 603-1121; 715-1119; 701-1119; 543- 1118; 913-1118; 619-1118; 675-1117; 715-1112; 704-1109; 546-1105; 581-1104; 671-1096; 750-1089; 611-1090; 640-1088; 775-1084; 841-1084; 816-1084; 760- 1079; 703-1059; 550-1058; 760-1055; 792-1054; 813-1054; 626-1052; 589-1052; 472-1005; 756-1001; 738-993; 554-984; 813-966; 732-964; 772-960; 728-955;
728-953; 533-948 728-944; 691-931; 715-927; 693-922; 680-917; 658-914; 663-900; 685-898 650-898; 665-876; 605-865; 608-845; 288-845; 626-792; 231-725; 226-685 304-566; 32-390; 27-284; 21-273; 13-272; 1-240 375/LI:404482.20 2001MAY17 | | 1874-2107; 1987-2190; 2398-2649; 2535-2773;
2606-3094; 2627-2877; 2664-3125; 2704-2986; 2733-3131; 2754-3131; 1-609; 1-
598; 1-754; 1-265; 5-117; 46-320; 162-426; 182-754; 187-433 248-531; 283-
359; 404-659; 448-818; 550-792; 603-818; 605-977 687-947; 717-1267; 939- 1393; 1059-1297; 1059-1242; 1111-1359; 1290-1753 1290-1524 1482-2072;
1510-1691 1516-2098; 1574-1877; 1578-1878; 1657 1961; 1663-2188; 1665
2076; 1669-1864; 1814-2121; 1874-2195; 1913-2195 1919-2131 1928-2141;
1987-2397 2098-2373; 2309-2532; 2309-2486; 2309 2399; 2420 2675; 2427-
2909; 2477-2770; 2528-3071; 2553-3095; 2565-3120 2565-3106 2613-3214;
2621-3082 2602-2848; 2627-3028; 2609-2859; 2613 3002; 2628 3096; 2660-
2974; 2671-3134; 2678-3131; 2687-3125; 2680-3131 2657-3116 2658-3031;
2705-3131 2710-3134; 2721-3136; 2734-3125; 2710 2852; 2737 3132; 2738-
3132; 2738-3084; 2746-3131; 2759-3152; 2771-3022 2773-3132 2782-3131;
•2794-3066 2798-2984; 2807-3093; 2828-3131; 2808 3030; 2841 3245; 2850-
3245; 2862-3110; 2988-3131; 3012-3131; 3016-3130 3026-3123 3055-3125; 3196-3604 3203-3253; 3211-3462 376/LI: 405985.1:2001 AY17 || 94-645; 285-905; 346-831; 594-887; 597-911; 664-1222; 664-1018; 687-1273; 713-960; 936-1212; 1-653; 247-499; 254-557; 267-532; 285-600; 298-598; 331-827; 334-615
377/LI:406389.1:2001MAY17 || 1-479; 10-577; 10-469; 390-667; 402-715; 418- 738; 514-740; 649-910; 654-936; 697-1069; 700-967; 927-1213; 929-1464; 1130-1515; 1146-1557; 1148-1583; 1152-1668; 1185-1561; 1224-1557; 1249- 1867; 1249-1555; 1273-1557; 1400-1561; 1449-1516
378/LI:406833.1:200lMAY17 || 1892-2135; 1955-2223; 1-517; 52-337; 72-616; 76-389; 96-384; 99-632; 105-371; 181-379; 186-576; 189-358; 230-843; 372- 737; 372-496; 449-662; 464-938; 477-957; 522-786; 540-774; 540-724; 568-
1007; 568-765; 570-771; 630-1052; 696-905; 718-937; 743-983 746-901; 747-
1017; 773-1005; 773-1293; 851-1466; 854-1121; 934-1209; 1007-1318; 1028
1633; 1112-1633; 1120-1647; 1163-1383 1181-1470; 1275-1671 1272-1545; 1277-1630; 1277-1855; 1277-1777; 1280 1367; 1282-1557; 1350 2098; 1364- 1564; 1400-1633; 1416-2051; 1510-1971 1513-1633; 1517-1970 1539-1633; 1551-2108; 1568-2033; 1646-1899; 1660 2191; 1772-2010; 1786 2226; 1786- 2136; 1853-2113; 1863-2040; 1870-2424 1877-2140; 1896-2452 1910-2455; 1945-2184; 1954-2511; 1971-2409; 1971 2222; 2033-2278; 2092 2250; 2092- 2431; 2114-2361; 2118-2337; 2131-2340 2134-2421; 2144-2366 2175-2387; 2211-2500; 2232-2909; 2267-2542; 2280 2736; 2295-2901; 2305 2880; 2324- 2868; 2326-2870; 2327-2806; 2330-2873 2332-2807; 2341-2493 2353-2627; 2357-2408; 2376-2812; 2376-2618; 2400 2573; 2409-2909; 2414 2851; 2436- 2653; 2436-2733; 2437-2706; 2438-2865 2441-2910; 2440-2903 2448-2907;
2456-2708; 2456-2912; 2462-2911; 2475-2901; 2480-2905; 2480-2912; 2480- Table 3
2909; 2490-2909; 2498-2927; 2501-2869; 2509-2905; 2513-2905; 2554-2905; 2566-2912; 2579-2862; 2674-2861; 2690-2924; 2699-2927; 2702-2901; 2707- 2859; 2724-2853; 2731-2912
379/LI: 407921.3 :2001MAY17 | | 3156-3405; 3164-3595; 3183-3412; 3279-3881; 3384-3920; 3415-3829; 3477-3920; 3517-3844; 3517-3747; 3540-4032; 3618- 3885; 3683-3812; 3841-4130; 3858-4099; 3882-4375; 3882-4376; 3922-4520; 3945-4051; 3965-4132; 3976-4349; 3999-4178; 4033-4323; 4070-4672; 4188- 4487; 4188-4630; 4188-4778; 4188-4416; 4188-4622; 4239-4726; 4244-4493; 4252-4532; 4259-4834; 4291-4908; 4323-4571; 4328-4755; 4328-4598; 4335- 4572; 4371-4552; 4406-4982; 4435-4500; 4525-5044; 4575-4643; 4601-4847; 4668-5242; 4732-5331; 4764-5168; 4765-5331; 4792-5032; 4820-5209; 4821- 5219; 4890-5192; 4895-5149; 4949-5122; 4974-5207; 4980-5331; 4993-5254; 5034-5173'; 5043-5306; 5048-5552; 5053-5191; 5058-5158; 5058-5208; 5088- 5224; 5100-5547; 5101-5585; 5135-5589; 5144-5590; 5150-5593; 5163-5586; 5181-5585; 5201-5585; 5210-5586; 5215-5586; 5215-5587; 5217-5592; 5221- 5589; 1-539; 48-541; 271-418; 362-712; 443-832; 551-1267; 629-1189; 646- 1242; 646-1238; 795-1450; 857-1250; 870-1284; 914-1281; 972-1289; 992-1286; 1053-1486; 1085-1657; 1220-1675; 1221-1598; 1424-1994; 1611-2016; 1611- 2011; 1613-1936; 1701-1921; 1744-2249; 1819-2349; 2254-2811; 2364-2587; 2373-2825; 2373-2909; 2563-2756; 2719-2999; 2755-3216; 2841-3141; 2845- 3512; 2942-3048; 2944-3048; 2950-3048; 2953-3048; 2960-3468; 2972-3298; 2972-3048; 3044-3634; 3054-3304; 3130-3535; 3130-3422; 5230-5411; 5230- 5541; 5230-5583; 5230-5318; 5240-5589; 5240-5549; 5253-5592; 5258-5585; 5261-5583; 5268-5585; 5269-5587; 5275-5574; 5289-5585; 5294-5416; 5293- 5592; 5296-5586; 5307-5513; 5316-5586; 5327-5576; 5331-5586; 5331-5577; 5331-5547; 5352-5576; 5374-5586; 5383-5588; 5390-5583; 5397-5587; 5409- 5585; 5504-5586
380/LI: 409078.54 :2001MAY17 1 I 1-612; 375-623; 404-950; 421-621; 423-810; 425-609; 495-1086; 613-922; 691-1013; 742-1103; 893-1137; 917-1229; 1051- 1342; 1100-1339; 1100-1293; 1112-1404; 1114-1189; 1138-1189; 1282-1917; 1431-1797; 1620-2067; 1872-2070; 1930-2064; 1930-2027; 1987-2256; 2164- 2636; 2183-2846; 2183-2706; 2183-2969; 2183-3076; 2185-2398; 2438-3031; 2471-3075; 2493-3242; 2500-3294; 2548-3209; 2581-3449; 2597-3158; 2662- 3495; 2662-3399; 2678-3140; 2704-3401; 2703-3496; 2713-3336; 2759-3619; 2837-3561; 2863-3477; 2854-3603; 2846-3457; 2877-3028; 2968-3581; 3049- 3728; 3070-3358
381/LI:423601.6: 2001MAY17 | | 691-1245; 1049-1186; 804-1181; 779-1180; 790- 1179; 830-1179; 839-1179; 1062-1177; 934-1177; 615-1132; 823-1121; 655- 1114; 956-1104; 768-1088; 721-1044; 582-1043; 791-987; 823-983; 666-957; 348-777; 76-748; 1-748
382/LI:425024.5 2001MAY17 709-907; 933-1141; 1058-1585; 1193-1334; 1193- 1746; 1195-1413 1205-1767; 1213-1461 1217-1751 1253-1540; 1261-1510;
1264-1510; 1428-1746; 1-544; 40-697; 60-608; 279 -916; 635-1151
383/LI:427909.29:2001MAY17 708-942 2330-2735 2330-2697; 2332-2738;
2330-2500; 2334-2738 2335-2741; 2335 2694; 2338 2735; 2347-2735; 2347-
2615; 2347-2535; 2352-2736; 2353 2735 2354-2735 2354-2703; 2359-2735;
2359-2610; 2359-2619 2359-2733; 2361-22660055;; 22336622-2735; 2364-2735; 2364-
2734; 2365-2729; 2366-2735; 2366-2618 2367-2735 2370-2729; 2368-2614;
2373-2717; 2329-2378 2329-2380; 2376-2735; 2376 2739; 2376-2738; 2379-
2729; 2384-2651; 2385-2636; 2386-2606; 2387-2735 2389-2692; 2393-2735;
2394-2739; 2396-2735; 2418-2739; 2420-2685; 2427-2733; 2432-2691; 2433
2735; 2436-2735; 2439-2734; 2441-2901; 2445-2739 2448-2733; 2448-2735; 2448-2702; 2448-2670; 2448-2634; 2448-2943; 2460 2737; 2459-2733; 2460- 2735; 2461-2741; 2462-2735; 2464-2735; 2466-2736 2468-2730; 2469-2729; 2489-2735; 2494-2735; 2496-2734; 2497-2735; 2499 2735; 2500-2737; 2502- 2739; 2502-2729; 2507-2658; 2518-2729; 2523-2729 2528-2754; 2528-2735; 1911-2165; 1919-2351; 1923-2146; 1928-2485; 1956 2222; 1960-2174; 1961- 2217; 1968-2247; 1975-2227; 1978-2084; 1981-2222 1986-2246; 2005-2279; 2022-2300; 2026-2285; 2026-2246; 2049-2591; 2051 2318; 2051-2300; 2054- 2264; 2065-2313; 2069-2222; 2086-2191; 2100-2273 2100-2217; 2109-2595; Table 3
2111-2650; 2111-2347; 2121-2635; 2116-2222; 2118-2335; 2122-2403; 2153- 2375; 2163-2657; 2168-2428; 2177-2440; 2203-2735; 2209-2697; 2213-2690; 2239-2743; 2239-2735; 2239-2500; 2244-2735; 2249-2741; 2255-2508; 2259- 2684; 2267-2542; 2269-2529; 2276-2735; 2279-2735; 2280-2735; 2280-2503; 2283-2738; 2285-2729; 2287-2735; 2287-2374; 2290-2735; 2293-2542; 2296- 2742; 2297-2740; 2295-2735; 2302-2733; 2305-2544; 2309-2735; 2311-2735; 2312-2735; 2313-2736; 2314-2741; 2314-2736; 2319-2735; 2317-2738; 2318- 2735; 2318-2741; 2319-2729; 2320-2735; 2320-2742; 2320-2741; 2320-2739; 2322-2736; 2322-2735; 2326-2735; 2329-2735; 2545-2730; 2551-2735; 2563- 2737; 2570-2731; 2570-2740; 2570-2735; 2570-2739; 2578-2736; 2579-2733; 2580-2735; 2581-2729; 2599-2724; 2611-2735; 2612-2735; 2614-2735; 2639- 2735; 2661-2735; 2707-2768; 2711-2768; 2806-3069; 2840-3100; 2842-3140; 2876-3134; 2891-2956; 3000-3311; 3074-3334; 3083-3350; 3171-3427; 3173- 3353; 3257-3765; 1016-1290; 1028-1282; 1037-1240; 1049-1258; 1056-1269; 1062-1256; 1074-1317; 1087-1310; 1101-1315; 1232-1497; 1288-1499; 1309- 1812; 1361-1554; 1442-1787; 1445-1742; 1485-1751; 1489-1752; 1494-1755; 1517-1807; 1524-1804; 1533-1817; 1544-1734; 1499-1599; 1545-1790; 1554- 1820; 1556-1815; 1556-1811; 1565-1852; 1570-1829; 1576-1829; 1577-1815; 1596-1832; 1599-1816; 1609-1760; 1614-1873; 1622-1913; 1625-1745; 1631- 1829; 1641-1929; 1646-1916; 1672-1874; 1690-1900; 1699-1968; 1708-1883; 1713-1886; 1721-1986; 1751-2023; 1751-2018; 1784-2187; 1784-1961; 1781- 2109; 1799-2072; 1801-2060; 1802-2262; 1802-2288; 1805-1945; 1806-1992; 1808-2051; 1809-2063; 1811-2097; 1814-2063; 1814-2074; 1823-2074; 1828- 2065; 1839-2104; 1840-2105; 1842-1974; 1866-2347; 1869-2070; 1889-2173; 1900-2173; 1908-2155; 1908-2176; 604-860; 607-979; 617-828; 619-849; 620- 878; 627-732; 661-1109; 660-967; 663-941; 673-737; 674-898; 694-850; 704- 896; 664-905; 707-934; 669-1178; 709-941; 674-1316; 674-1169; 680-1207; 693-937; 694-937; 698-823; 698-999; 698-1055; 699-985; 700-1167; 703-1266; 773-1334; 778-1334; 868-1161; 789-1003; 861-1107; 828-1408; 840-1014; 346- 602; 348-907; 362-629; 360-622; 871-1277; 913-1166; 884-1281; 884-1142; 893-1190; 954-1487; 936-1276; 948-1208; 380-793; 389-887; 389-512; 404-987; 407-904; 413-859; 415-905; 413-689; 414-646; 414-638; 414-636; 417-670; 440-987; 444-712; 445-732; 455-685; 461-588; 463-981; 464-640; 467-743; 467-720; 472-753; 474-694; 487-760; 490-727; 506-983; 504-761; 508-763; 510-769; 513-725; 518-759; 523-976; 526-929; 527-756; 529-799; 529-628; 533-770; 539-819; 539-755; 541-769; 542-762; 546-783; 553-938; 553-777; 558-749; 564-712; 566-708; 568-864; 576-727; 586-745; 586-746; 588-829; 590-951; 590-840; 592-976; 593-834; 596-800; 1034-1197; 959-1241; 1068- 1162; 993-1260; 1050-1370; 1013-1285; 18-237; 133-749; 159-751; 228-858; 263-772; 262-777; 266-775; 270-635; 294-826; 295-861; 295-597; 300-542; 301-353; 308-745; 314-803; 1-628; 316-564; 335-961
384/LI:428198.20:2001MAY17 || 1696-2142; 2315-2802; 2343-2538; 2556-2871; 2702-2871; 2706-2829; 2720-2877; 2780-2871; 1-441; 4-208; 4-206; 284-507; 292-885; 323-673; 347-630; 390-940; 393-720; 401-940; 420-947; 535-810; 544-802; 551-828; 569-774; 570-837; 592-902; 603-915; 603-894; 638-949; 679-922; 709-897; 725-988; 728-936; 739-1016; 783-1121; 835-1020; 835-1070; 870-1137; 914-1446; 922-1188; 937-1217; 938-1446; 944-1257; 945-1193; 945- 1398; 987-1218; 999-1250; 1018-1366; 1091-1357; 1096-1357; 1096-1673; 1129- 1409; 1191-1333; 1237-1553; 1237-1496; 1237-1403; 1240-1526; 1252-1529; 1252-1508; 1261-1707; 1261-1524; 1272-1512; 1275-1509; 1320-1496; 1380- 1654; 1382-1654; 1381-1653; 1381-1509; 1402-1991; 1416-1629; 1426-1972; 1450-1701; 1451-1688; 1469-2104; 1498-2101; 1521-1803; 1541-2025; 1541- 1811; 1543-1832; 1543-1765; 1544-2113; 1544-1808; 1558-1789; 1559-1805; 1571-2103; 1579-1847; 1601-2038; 1601-2039; 1603-2104; 1603-1877; 1611- 2142; 1667-1915; 1660-2145; 1668-2141; 1669-2145; 1673-1892; 1674-2102; 1677-2103; 1691-2142; 1692-2138; 1692-1906; 1699-2104; 1699-2142; 1699- 2098; 1706-2143; 1710-1989; 1721-1973; 1728-2142; 1743-2142; 1744-2145; 1749-2142; 1757-2097; 1779-2099; 1779-2027; 1779-2138; 1801-2037; 1819- 2101; 1826-1971; 1830-2119; 1832-2138; 1832-2065; 1833-2143; 1846-2137; 1852-2311; 1871-2146; 1876-2123; 1881-2142; 284-727; 361-542; 534-789; Table 3
1883-2142; 1888-2143; 1898-2314; 1898-2179; 1901-2140; 1903-2133; 1903- 2070; 1919-2138; 1920-2142; 1921-2137; 1924-2134; 1925-2141; 1938-2044; 1961-2261; 1973-2142; 1975-2142; 1986-2138; 1998-2142; 2031-2142; 2044- 2142; 2049-2142; 2049-2119; 2049-2100; 2059-2442; 2083-2142; 2189-2541; 2202-2408; 2266-2538; 1701-2149; 1688-2136; 121-724
385/LI:429738.6:200lMAYl7 | | 1-571; 16-303; 27-571; 175-604; 175-416; 217- 766; 363-591; 558-1187; 558-1164; 756-1249 386/LI:449437.1:200l AYl7 | | 528-838; 1-642
387/LI:459269.25:2001MAYl7 j | 699-1074; 715-1078; 714-1078; 736-1078; 743- 1076; 751-1078; 755-1075; 777-1078; 791-1078; 798-1074; 798-1078; 798-994; 830-1069; 839-1075; 862-1078; 883-1375; 913-1078; 917-1077; 1012-1077; 1014-1078; 1050-1400; 1060-1568; 1073-1304; 1076-1617; 1144-1401; 1150- 1703; 1226-1690; 1299-1580; 1302-1533; 1449-1690; 1455-1690; 1517-1923; 1760-1884; 1-621; 1-311; 20-338; 61-566; 184-338; 184-337; 263-338; 425- 1014; 478-1073; 484-957; 483-730; 498-910; 498-591; 498-761; 501-843; 502- 802; 502-652; 502-891; 505-759; 506-633; 509-961; 510-1070; 507-1059; 511- 989; 532-966; 542-974; 543-1039; 564-837; 564-814; 567-884; 554-1079; 596- 840; 599-1036; 603-1078; 610-1037; 615-1079; 620-854; 638-1078; 644-1075; 658-891; 673-1072; 679-1084; 689-1078; 691-994
388/LI:464206.1:200lMAY17 | | 2504-2794; 2520-2796; 2606-2828; 2657-2776; 1- 286; 1-637; 30-262; 108-263; 111-541; 184-521; 116-277; 190-400; 236-757; " 246-678; 244-714; 302-480; 262-871; 271-865; 271-836; 272-837; 286-837; 286-836; 287-838; 311-782; 311-823; 399-840; 417-850; 499-1144; 1078-1676; 1082-1475; 1099-1667; 1104-1533; 1155-1798; 1196-1725; 1201-1734; 1219- 1734; 1250-2033; 1264-1572; 1461-1840; 1510-1774; 1569-2025; 1857-2469; 1946-2476; 2302-2594; 2302-2600; 2302-2503; 2503-2585
389/LI:465821.2:2001MAYl7 | 1-126; 1-221; 1-411; 1-412; 5-412; 10-108; 14- 617; 12-412; 15-221; 16-221 18-221; 19-221; 23-412; 20-221 21-170; 38-
229 26-341; 33-221; 29-514 35-221; 36-352; 34-412; 36-578 33-355; 36- 221 37-221; 37-110; 38-501 35-226; 32-515; 36-346; 39-221 37-379; 35- 350 38-131; 37-416; 39-233 36-481; 38-295; 49-221; 71-654 125-221; 131- 487 157-729 156-221 242-334; 267-732, 267-733; 267-450; 267-443; 283- 554 309-551 309-545 322-566; 322-499; 331-864; 348-623; 371-895; 368- 677 390-819 458-992 476-860; 498-861; 500-816; 501-751; 519-781; 522- 856 598-807 599-874 661-1305; 670-860; ; 722-914; 732-857; 738-928; 739 858 794-895 815-895 830-946; 838-895; 951-1401; 1188-1430; 1192-1434;
1192-1522; 1219-1376; 1224-1300; 1228-1708; 1228-1430; 1228-1408; 1228- 1394; 1229-1430; 1240-1430; 1263-1363; 1268-1402; 1320-1896; 1325-1430; 1477-1944; 1551-1921; 1571-1931; 1591-1876; 1595-1802; 1601-1817; 1600- 1715; 1601-1916; 1601-1822; 1601-1717; 1601-1654; 1610-1880; 1611-1943; 1626-1945; 1631-1899; 1631-1872; 1644-1881; 1664-1962; 1664-1937; 1664- 1942; 1664-1934; 1664-1921; 1678-1922; 1679-1907; 1679-1933; 1694-1943; 1704-1932; 1751-1903; 1754-1953; 1758-1942; 1836-1942; 1855-1942 390/LI:474414.28:2001MAY17 | | 2866-3268; 2196-2695; 1-477; 3-473; 137-788; 550-1170; 573-1079; 584-912; 593-1034; 631-1163; 641-894; 642-921; 649- 1120; 651-922; 670-1159; 668-927; 674-1193; 679-928; 707-1329; 716-1376; 721-1015; 743-959; 753-1337; 763-1029; 770-945; 799-1221; 798-1187; 812- 1059; 820-1187; 839-966; 867-1300; 877-1507; 879-1158; 892-1468; 918-1187; 921-1184; 923-1158; 926-1064; 938-1187; 939-1514; 959-1426; 969-1239; 999- 1313; 1012-1469; 1012-1070; 1014-1270; 1032-1467; 1051-1507; 1064-1510; 1070-1507; 1084-1506; 1092-1511; 1092-1512; 1097-1514; 1097-1511; 1098- 1512; 1098-1406; 1101-1507; 1105-1510; 1106-1506; 1108-1367; 1117-1290; 1132-1507; 1136-1438; 1137-1509; 1149-1502; 1146-1506; 1148-1449; 1148- 1435; 1148-1507; 1149-1503; 1150-1505; 1150-1497; 1149-1465; 1150-1385; 1156-1507; 1162-1507; 1165-1503; 1175-1508; 1193-1508; 1203-1505; 1204- 1470; 1201-1401; 1223-1503; 1231-1399; 1226-1506; 1245-1506; 1247-1561; 1247-1422; 1254-1493; 1257-1514; 1263-1487; 1264-1321; 1270-1537; 1283- 1502; 1287-1507; 1288-1507; 1308-1834; 1319-1504; 1330-1507; 1333-1505; 1363-1504; 1381-1908; 1400-1751; 1397-1482; 1401-1502; 1431-1507; 1460- 1708; 1457-1741; 1474-1730; 1507-1817; 1518-1771; 1523-1957; 1523-2030; Table 3
1523-1752; 1539-1780; 1532-1972; 1548-1862; 1536-2139; 1571-1757; 1594 2183; 1663-2136; 1687-2003; 1713-1941; 1721-2345; 1747-2044; 1759-2029 1792-1956; 1804-2071; 1838-2154; 1878-2125; 1952-2496; 1963-2147; 1965 2103; 1981-2373; 1992-2299; 2001-2553; 2001-2499; 2001-2123; 2087-2474 2102-2385; 2125-2393; 2136-2240; 2192-2475; 2201-2478; 2223-2523; 2257 2853; 2293-2557; 2298-2493; 2301-2533; 2313-2474; 2335-2597; 2344-2590 2347-2719; 2356-2607; 2371-3546; 2372-2761; 2389-2760; 2394-2696; 2404 2598; 2405-2561; 2417-2696; 2446-2695; 2449-2988; 2490-2627; 2521-2744 2523-2825; 2526-2752; 2534-2818; 2570-2815; 2580-2841; 2613-2856; 2659 3237; 2705-2942; 2727-2994; 2834-3382; 2835-3086; 2841-3139; 2880-3518 2890-3451; 2890-3153; 2891-3095; 2911-3014; 2925-3476; 2924-3297; 2966 3170; 2976-3413; 2978-3261; 2978-3251; 2979-3182; 3037-3427; 3038-3271 3044-3297; 3045-3501; 3051-3142; 3058-3438; 3060-3337; 3061-3327; 3067 3337; 3070-3338; 3072-3552; 3077-3339; 3078-3380; 3084-3549; 3102-3346 3108-3563; 3108-3269; 3111-3553; 3115-3549; 3116-3553; 3121-3546; 3123 3552; 3124-3346; 3131-3549; 3135-3548; 3137-3387; 3141-3549; 3151-3553 3159-3449; 3158-3455; 3166-3544; 3174-3547; 3176-3546; 3179-3546; 3177 3439; 3182-3551; 3181-3284; 3182-3546; 3184-3546; 3184-3641; 3184-3642 3184-3601; 732-1331; 792-1012; 863-1142; 905-1480; 938-1447; 991-1238; 1032-1468; 3112-3359; 3129-3549; 3145-3546; 3171-3552; 3180-3538; 3183 3553; 3184-3395; 3184-3369; 3186-3548; 3184-3388; 3189-3645; 3188-3448 3189-3549; 3198-3546; 3198-3427; 3204-3444; 3226-3731; 3229-3626; 3234 3494; 3241-3549; 3242-3554; 3248-3544; 3246-3543; 3243-3551; 3246-3549 3248-3558; 3250-3553; 3264-3519; 3271-3549; 3274-3817; 3286-3784; 3297 3577; 3304-3544; 3308-3556; 3327-3546; 3337-3595; 3338-3506; 3341-3549 3351-3546; 3366-3882; 3428-3564; 3442-3651; 3452-3550; 3479-3694; 3487 3547; 3658-4217; 2917-3464; 1079-1505; 2342-2809; 1020-1536; 2658-3225 2328-2892; 1676-1767; 1676-2017; 2235-2849
391/LI .-474435.14. -2001MAY17 | | 1387-2006; 1394-1653; 1402-16 42; 1413-1645; 1427-1630; 1432-1645; 1434-1645; 1437-1608; 1455-1736; 1457 -1672; 1461-
1756; 1475-1953; 1475-1645; 1489-2033 1505-1792; 1510-1748 ; 1513-1728;
1525-1781; 1533-2198; 1547-2101; 1551-2084; 1557-2073; 1590 2085; 1642-
2159; 1662-2084 1663-2072; 1666-2083 1666-2085; 1667-2084 1667-2089; 1667-2078; 1667 2051; 1667-1913; .1667 1867; 1667-1851; 1667 1886; 1670- 2084; 1673-2082 1677-2090; 1676-2087 1680-2080; 1683-2081 1686-2087; 1686-2085; 1710 1855; 1715-1863; 1715 1997; 1725-2024; 1744 -2081; 1745- 1967; 1747-2090 1750-2088; 1755-2009 1762-2065; 1763-1896 ; 1777-2089; 1782-2048; 1788 2238; 1789-1984; 1794 2093; 1794-2081; 1795 -2086; 1798- 1934; 1800-2059 1800-2020; 1803-2084 1802-2084 237-739 238-398 241-
629; 242-637; 243-637; 255-632; 261-457 264-835 271-478 275-637 284- 634; 284-637; 290-723; 305-637; 306-626 318-626 328-636 329-632 337- 629; 369-616; 373-629; 414-634; 447-615 453-636 460-623 472-731 563- 731; 612-1186; 718-815; 718-833; 740-828; 763-823; 1096-155 8; 1099-1794; 1116-1645; 1116-1544; 1116-1466; 1116-1372; 1119-1354; 1131 -1404; 1131- 1380; 1131-1334; 1131-1320; 1131-1294; 1131-1285; 1131-1271 ; 1131-1237; 1131-1217; 1131-1252; 1134-1312; 1157-1505; 1148-1746; 1161 -1745; 1183- 1395; 1164-1742; 1198-1772; 1215-1414; 1224-1477; 1257-1621 ; 1276-1557; 1299-1878; 1325-1880; 1324-1812; 1324-1545; 1324-1532; 1365 -1578; 1372- 1661; 1372-1706; 1-223; 19-289; 43-491; 45-621; 51-584; 51 574; 51-566; 51
534 51-522; 51-505 51-456; 51-412 51-396; 51-220; 51-213 ; 51-207; 51- 128 51-603; 51-601 51-607; 51-527 51-447; 51-309; 51-288 ; 51-268; 51- 241 51-546; 51-489 60-349; 73-446 82-2087; 82-390; 82-33 9; 83-617; 84- 638 90-448; 89-416 92-533; 95-350 95-348; 96-348; 100-69 5; 99-355; 99- 415 100-356; 103-161; 108-339; 104-349; 104-326 110-683; 106-337; 107- 189 107-425; 109-462; 112-638; 112-180; 113-374 114-669; 117-212; 117- 315 124-382; 131-434; 133-360; 146-376; 161-639 180-439; 183-639; 185- 704 187-739; 185-411; 194-639; 196-639; 224-629 233-629; 1811-2084; 1818 2084; 1821-2085; 1843-1902; 1844-2084; 1846-2119; 1847-2120 ; 1851-2084; 1872-2084; 1905-2082; 1907-2084; 1916-2435; 1935-2076; 1947 -2087; 1951- 2087; 1952-2091; 1976-2100; 1999-2596; 2035-2091; 2058-2472 ; 2060-2 2303; Table 3
2060-2301; 2070-2538; 2071-2476; 2072-2535; 2073-2334; 2124-2542; 2129-
2535; 2146-2544; 2181-2538; 2182-2604 2185-2542; 2185-2551; 2185-2441 2185-2346; 2186-2629; 2186-2331; 2186 2255; 2186-3483; 2191-2545; 2192 2509; 2299-2507; 2501-2804; 2612-3053 2613-3053; 2628-3191; 2720-3066 2933-3249; 2945-3186; 2988-3347; 3066 3419; 3072-3363; 3080-3483; 3092 3271; 3123-3364; 3138-3461; 3208-3483 3225-3469; 3232-3469; 3242-3483 3309-3436; 3326-3443; 3373-3483; 3379 3483; 3403-3483; 3415-3483; 1950 2040; 1133-1414; 1736-2287; 2768-3335 1764-2342 '
392/LI:474458.11:2001MAY17 || 2214-2323; 2214-2322; 2214-2300; 2214-2504;
2216-2546 1452-1872; 1453-1875; 1454-1872; 1456-1873; 1467-1863; 1467-
1752; 1473-1856; 1474-1873 1480-1719 1487-1876; 1487-1870; 1492-1872
1492-1775 1496-1823; 1506 1875'; 1512 1874; 1515-1871; 1515-1744; 1517
1815; 1517-1740; 1537-1870 1536-1872 1541-1856; 1550-1869; 1549-1832
1552-1854 1551-1829; 1555 1872; 1556 1877; 1556-1822; 1560-1870; 1559
1793; 1568-1814; 1573-1874 1580-1874 1579-1825; 1581-2033; 1581-1844
1582-1853 1584-1868; 1584 1864; 1586 1872; 1587-1873; 1591-1862; 1595
1872; 1609-1872; 1619-1872 1617-1872 1617-1845; 1617-2071; 1625-1871
1631-1872 1632-1870; 1632 1868; 1649 2027; 1649-1840; 1649-1836; 1656-
1989; 1664-2029; 1666-1939 1666-1937 1666-1877; 1670-1876; 1671-1875
1683-1873 1685-1872; 1701 1904; 1706-1843; 1707-1962; 1714-2289; 1715-
1872; 1723-1994; 1739-1974 1739-1864 1744-2307; 1750-1973; 1754-2029
1754-2036 1759-2035; 1765 1864; 1772-2024; 1774-2275; 1781-1910; 1784
1869; 1789-2019; 1794-2042 1794-1872 1796-2045; 1799-2030; 1812-2255
1813-2299 1819-2030; 181c 1930; 1823 2034; 1831-2030; 1832-2040; 1840-
2364; 1842-2360; 1842-2326 1869-2030 1883-1961; 1884-2029; 1889-2029
1892-2030 1898-2034; 1917 2030; 1919 2332; 1919-2029; 1922-2029; 1923
2374; 1928-2384; 1931-2540 1933-2412 1936-2504; 1943-2029; 1951-2505
1962-2029 1975-2404; 2075 2401; 2111 2524; 2117-2543; 2130-2538; 2137
2405; 2144-2558; 2151-2404 2155-2549 2154-2538; 2157-2405; 2160-2538
2159-2404 2164-2538; 2166 2412; 2167 2363-; 2173-2388; 2175-2374; 2177-
2549; 2181-2543; 2181-2404 2185-2542 2187-2274; 2191-2564; 2202-2542
2205-2513 2204-2413; 2214 2545; 2214 2542; 2214-2540; 2214-2538; 2214
2410; 2214-2407; 2214-2404 2214-2403 2214-2402; 2214-2393; 2214-2374
'2214-2373 2214-2357; 2214-2330; 10151254; 1017-1251; 1018-1406; 1020
1261; 1022-1266; 1021-1251 1022-1369 1023-1617; 1030-1194; 1035-1251
1039-1251 1041-1536; 1054 1404; 1070 1561; 1070-1470; 1070-1251; 1076
1251; 1077-1264; 1079-1539 1082-1623 1082-1251; 1086-1344; 1086-1262
1089-1482 1096-1251; 1106 1251; 1114 1577; 1114-1221; 1117-1673; 1117-
1663; 1118-1395; 1125-1341 1125-1406 1127-1605; 1139-1439; 1145-1589
1148-1686 1164-1689; 1163 1557; 1165 1367; 1172-1447; 1173-1413; 1187-
1421; 1192-1251; 1195-1468 1201-1468 1201-1398; 1278-1772; 1281-1626
1281-1836 1281-1490; 1281 1483; 1281-1442; 1281-1441; 1302-1827; 1304-
1832; 1309-1792; 1309-1478 1311-1580 1312-1798; 1330-1831; 1336-1638
1335-1534 1336-1600; 1341 1836; 1346 1762; 1349-1689; 1357-1627; 1370
1454; 1371-1653; 1376-1927 1376-1582 1378-1872; 1400-1874; 1405-1777
1407-1873 1409-1864; 1410 1870; 1412 1877; 1422-1693; 1423-1871; 1434-
1864; 1433-1691; 1437-1906 1438-1715 1446-1870; 1447-1528; 1450-1869
1449-1753 428-972; 431-642; 432-659; 466-667; 468-1009; 492-1022; 496-
1068; 523-813; 525-832; 539-1100; 547-683; 549-650; 552-763; 554-1012; 560-
1125; 563-1119; 565-1110; 574-1007; 577-1183; 586-856 592-1136; 600-1118;
600-1111; 601-975; 606-850; 609-766; 625-724; 625-892 626-859; 648-803;
648-723; 658-921; 668-1024; 679-934; 682-859; 686-927 693-1193; 693-935;
696-847; 705-977; 706-925; 729-846; 730-842; 736-1182 738-1182; 746-1251;
746-980; 752-1242; 765-1000; 782-904; 809-1030; 818-1152; 829-1172; 839-
935; 847-1103; 848-1082; 855-927; 894-1238; 905-1152; 911-1091; 910-1411;
924-1179; 925-1443; 929-1134; 931-2552; 957-1200; 964-1490; 981-1513; 983-
1221; 988-1246; 993-1535; 993-1158; 996-1237; 999-1510; 1000-1271; 999-
1240; 1000-1179; 1009-1322; 1011-1220; 1-574; 22-302; 108-455; 213-913;
225-904; 223-773; 319-888; 320-871; 329-645; 336-746; 342-643; 355-578;
380-624; 2231-2545; 2237-2546; 2241-2538; 2253-2540; 2251-2538; 2255-2404; Table 3
2262-2545; 2266-2376; 2267-2549; 2269-2499; 2273-2529; 2309-2545; 2315-
2551; 2347-2404; 2426-2542
393/LI: 477127.18 :2001MAY17 | | 1660-2087; 1688-2086; 1709-1885; 1725-2084;
1732-2050; 1738-2081; 1734-2081; 1765-2084; 1767-2050; 1775-2081 1784-
1994; 1783-2081; 1787-2079; 1795-2081; 1805-2050; 1831-2018 1930-20-81; 1933-2079; 1937-2081; 1938-2084; 1939-2081; 1939-2086; 1939 2087 1939- 2078; 1960-2081; 1986-2268; 2032-2526; 2032-2544; 2032-2473 2032-2465;
2032-2522; 2032-2347; 2032-2285; 2074-2577; 2142-2358; 2150-2626 2150-
2371; 2166-2460 2228-2812; 2258-2827; 2260-2868; 2275-2966 2288-2736; 2290-2826; 2303 2547; 2304-2826; 2314-2861; 2315-2894; 2329 2570 2336- 2911; 2338-2780 2338-2558; 2339-2496; 2365-2737; 2404-2872 2404-2772; 2407-2650; 2422 2688; 2444-2671; 2468-2751; 2468-2744; 2470 2659 2491- 2716; 2544-2732 2580-3171; 3158-3295; 3170-3302; 3239-3302 3083-3302; 3146-3300; 3056 3302; 2779-3367; 2811-3056; 2815-3265; 2823 3259 2826- 3300; 2832-3263 2838-3308; 2838-3303; 2841-3300; 2842-3136 2842-3127;
2842-3119; 2842-3140; 2842-3164; 2843-3136; 2843-3121; 2845-3150 2845-
3145; 2845-3139; 2845-3131; 2845-3129; 2845-3302; 2858-3305 2868-3300;
2872-3302; 2881-3305; 2883-3303; 2890-3300; 2724-3202; 2724-2988 2728-
3260; 1-284; 27-342; 77-649; 107-585; 142-590; 178-757; 208-355; 245-835;
271-781; 293-850 308-821 320-531 329-593 332-606; 343-453; 359-616 365-630; 372-834 385-852 392-847 410-853 440-850; 468-854; 476-854 492-841; 491-689 508-661 505-837 505-617 507-850; 519-673; 527-788 536-851; 536-630 538-851; 553-814; 552-852 592-856; 621-850; 636-850
650-853; 652-851 676-854; 700-1084; 735-1009; 735-850; 748-850; 755-1066; 796-1219; 871-1202; 872-1216; 870-1520; 878-1362; 902-1184; 902-1148; 895- 1523; 907-1508; 1036-1589; 1095-1482; 1090-1330; 1103-1614; 1132-1410; 1205-1520; 1212-1450; 1211-1694; 1213-1446; 1217-1625; 1217-1330; 1218- 1531; 1237-1511; 1239-1447; 1239-1685; 1297-1780; 1354-1601; 1375-1667; 1385-1769; 1410-1872; 1418-1681; 1443-1885; 1458-1782; 1464-1567; 1473- 1687; 1489-1772; 1492-1779; 1501-1773; 1562-1765; 1562-1736; 1571-1752; 1581-1843; 1583-2054; 1583-1813; 1596-1885; 1612-2042; 1636-2086; 1639- 1862; 1641-2087; 1647-1786; 1654-1873; 1654-1850; 2889-3304; 2933-3302; 2935-3302; 2942-3215; 2942-3370; 2970-3302; 2982-3302; 3012-3227; 3040- 3302; 3040-3262; 945-1559; 2438-2993; 1350-1585; 2859-3307; 2438-2704; 1164-1672 394/LI:480375.55:2001MAY17 | | 1142-1601; 1161-1348; 1180-1394; 1184-1646;
1200-1537; 1277-1640; 1281-1336; 1316-1640 1341-1696; 1374-1640; 1404-
1542; 1416-1532; 1430-1640; 1430-1643; 1436-1628; 1440-1659; 1441-1560;
1444-1607; 1457-1696; 1457-1530; 1471-1640 1471-1628; 1471-1596; 1471-
1582; 1503-1664; 1526-1717; 1535-2021; 1539-2131; 1539-1735; 1539-1791;
1566-1751; 1593-1836; 1606-2156; 1653-1866 1673-1928; 1707-2156; 1720-
2172; 1767-1993; 1771-2052; 1771-2050; 1792-2156; 1820-2418; 1862-2143; 1885-2158; 1894-2097; 1917-2156; 1979-2128; 2012-2156; 2056-2156; 2074- 2156; 2083-2156; 2086-2156; 2088-2156; 183-652; 193-366; 230-617; 288-566; 289-591; 307-764; 320-782; 320-718; 396-891; 407-603; 462-1036; 521-809; 539-738; 598-849; 619-779; 635-912; 658-917; 672-945; 704-1330; 758-988; 782-1037; 832-1077; 866-1084; 891-1532; 891-1163; 898-1147; 910-1538; 919- 1160; 929-1202; 933-1532; 962-1530; 965-1532; 978-1568; 978-1439; 978-1221; 982-1532; 1007-1531; 1006-1308; 1030-1585; 1034-1318; 1069-1298; 1080-1532; 1078-1600; 1082-1175; 1094-1333; 1095-1335; 1105-1593; 1-255; 13-293; 17- 289; 19-326; 23-283; 29-369; 42-523; 72-266; 68-347; 120-417; 121-638; 122- 369; 121-366; 138-366; 145-369
395/LI:480467.24:2001MΛY17 | | 12-318; 12-394; 12-273; 12-266; 27-289; 73- 307; 130-393; 206-438; 265-565; 358-633; 505-617; 914-1375; 1022-1375; 1265-1333; 12-614; 18-310; 26-503; 39-435; 55-311; 58-528; 71-382; 90-642; 109-373; 118-565; 128-570; 137-635; 139-568; 151-396; 166-321; 182-461; 216-532; 235-565; 258-521; 264-726; 267-566; 291-567; 296-423; 355-645; 359-635; 382-553; 416-729; 450-700; 471-572; 596-654; 631-1296; 902-1215; 902-1338; 929-1214; 956-1210; 959-1351; 1018-1370; 1063-1320; 1106-1348; 1118-1231; 1138-1372; 1272-1374; 1-481; 12-481; 3-524; 12-521; 12-615; 12- Table 3
572 ; 12-559 ; 12- -264 12- -631 ; 12- -494 ; 12-557 ; 12-505; 12-458 12-207 ; 12-
173 ; 12 -261 ; 12- -560 12- -338 ; 12- -206 12-324 ; 12-213; 12-312 12-608 ; 12-
309 ; 12-575 ; 12 - -267 12- -237 ; 12- -306 12-304 ; 12-269; 12-296 12-298 ; 12-
292 ; 12 -286 ; 12- -289 12- -288 ; 12- -250 12 -254 ; 12-290; 12-285 12 -255 ; 12 -
272 ; 12 -257 ; 12- -282 12- -271 ; 12 - -268 12-311 ; 1127-1213 ; 1161-1213 ; 12 -493 ;
687-1301
396/LI: 80587.1 : 2001 AY17 I 903 -1488 ; 991-1538 ; 2528-2995 ; 2916-3232 ;
3323-3695; 1-620 185-304; 186-405 ; 196-869 ; 271-788 ; 271-857 ; 272 -670 ; 325-867; 325-778 325-848 ; 325-879 ; 326-903 ; 325-893 ; 325-825 ; 325-852 ;
325-891 326-879 326-942 ; 356-640; 363-879; 375-1056 ; 402-887 ; 400-961 ; 400-687 411-887 414-887 ; 423-1055; 448-821;r 450-878; 451-879; 485-737; 534-887 563-863 634-1520; 604-983; 604-879; : 604-1080; 604-887; 612-879; 614-794 629-903 640-1244; 711-929; 725-1245; 749-1259; 788-1552; 765- 1249; 825-1544; 853-1274; 862-1484; 868-1542; 880-1357; 883-1566; 874-1491; 888-1406; 888-1503; 893-1384; 901-1438; 941-1314; 955-1314; 977-1544; 981- 1235; 1008-1314; 1006-1406; 984-1495; 1002-1458; 1006-1505; 1036-1692; 1025-1694; 1014-1312; 1034-1658; 1022-1458; 1027-1555; 1057-1672; 1073-
1318; 1063-1220; 1050-1659; 1076-1317 1117-1373 1113-1538; 1141-1869
1131-1652; 1134-1669; 1134-1584; 1134-1427; 1134 1436; 1134-1671; 1148-
1812; 1172-1682; 1176-1765; 1163-1538 1207-1747 1195-1777; 1214-1813 1221-1934; 1209-1422; 1212-1703; 1220 1428; 1243-1802; 1245-1827; 1246 1743; 1262-1493; 1272-1971; 1295-1841 1316-1637 1319- 1924; 1329- 1506 1333-1982; 1363-1958; 1401-1937; 1404 1889; 1407 1795; 1407-1825; 1423 1658; 1421-1801; 1422-1931; 1462-1538 1471-1753 1481- 1738; 1476- 2080 1487-1910; 1487-1965; 1521-1767; 1511 1970; 1521 2169; 1549-2070; 1562- 1655; 1560-2137; 1562-1960; 1562-2113 1562-2020 1565- 1842; 1569- 2204 1575-1975; 1579-2073; 1587-2053; 1626 2235; 1626 2192; 1632-1876; 1636 2141; 1652-1919; 1658-2147; 1670-2148 1730-1964 1762- 1960; 1784- 2183
1795-2220; 1801-1995; 1803-2388; 1809-2148; 1822 2140; 1837-2189; 1855 2192; 1877-2175; 1876-2148; 1893-2142 ;, 1895-2190 1894- 2179; 1925- 2190 1928-2176; 1935-2190; 1937-2152; 1961-2175; 1970 2186; 1978-2190; 1995
2190; 2016-2190; 2075-2175; 2071-2688; 2075-2189 2114- 2189; 2129- 2190
2494-2616; 2499-2691; 2499-2583; 2499--2650; 2.499 2646; 2499-2752; 2502
2714; 2504-2649; 2504-2658; 2504-2689; 2504-2628 2538- 2682; 2769- 2848
2835-3231; 2884-3400; 2988-3182; 3126-3421; 3122-3348; 3297-3421; 3352-
3421; 3355-3421; 3368-3418; 3467-3708
397/LI:480798.13:2001MAYl7 || 1-328; 2-180; 2-462; 2-369; 2-324; 2-250; 3-
490; 2-367; 12-512; 1-362; 1-321; 2-473; 2-421; 2-470; 2-466; 2-329; 2-465;
2-225; 3-572; 2-499 2-432; 2-512; 2-418; 11-289; 3-453; 8-410; 12-376; 26-
292 20-407; 27-514 25-483; 25-455; 25-464; 30-436; 42-471; 31-495; 44- 462 26-493; 33-453 33-447; 46-626; 62-531; 82-312; 96-514; 106-329; 158- 457 180-470; 204-444 220-510; 207-453; 233-493; 257-525; 261-452; 306- 866 313-855; 324-789 336-628; 330-623; 331-581; 355-866; 339-433; 355- 613 360-558; 365-528 33-417; 1415-1636; 1419-1638; 1422-1699; 1425-1942;
1425-2000; 1427-1816; 1431-1630; 1433-1721 1447-1675; 1465-1544; 1474-
1754; 1478-1895; 1481-1697; 1511-1964 1511-1718 1517-1654; 1519-1990 1522-1718; 1534-1673; 1539-1715; 1682 1844 1682 1802; 1545-1799; 1549 1834; 1554-1797; 1565-1735; 1603-1912 1613-1849 1628-2184; 1646-1859
1647-1818; 1777-2219; 1717-2224; 1900-2460 1902 2121; 1921-2297; 1938-
2456; 1968-2567; 1987-2429; 1991-2592; 1992-2652 2051-2501; 2054-2584 2135-2441; 2105-2379; 2152-2262; 2107- 2392 2096-2289; 2118-2403; 2163- 2433; 2162-2362; 2187-2549; 2163-2580; 2188-2492 2188-2708; 2197-2715 2197-2471; 38-537; 47-471; 2183-2681; 1-448; 1-239; 1-472; 1-227; 1-213; 1- 402; 1-258; 1-442; 1-407; 2-258; 1-431; 1-248; 18-258; 20-438; 1-242; 2- 426; 5-435; 6-382; 1-379; 1-343; 1-364; 21-413; 1-141; 1-346; 1-356; 1-222; 1-296; 39-295; 18-312; 14-330; 42-292; 1144-1228; 1151-1678; 1156-1441; 1158-1448; 1163-1463; 1164-1402; 1167-1279; 1177-1452; 1183-1718; 1183- 1409; 1182-1415; 1186-1432; 1186-1399; '1190-1432; 1216-1603; 1203-1704; 1200-1659; 1201-1441; 1201-1448; 1202-1448; 1201-1434; 1202-1329; 1204- 1674; 1202-1562; 1208-1405; 1213-1708; 1234-1602; 1233-1394; 1233-1330; Table 3
1233-1294; 1215-1446; 1213-1466; 1213-1448; 1222-1448; 1228-1456; 1232- 1413; 1230-1409; 1232-1448; 1234-1448; 1234-1402; 1256-1655; 1260-1545; 1238-1427; 1239-1447; 1241-1448; 1241-1447; 1244-1405; 1248-1745; 1247- 1409; 1275-1767; 1253-1448; 1255-1448; 1266-1446; 1267-1448; 1267-1452; 1293-1561; 1271-1501; 1272-1546; 1272-1455; 1274-1448; 1275-1449; 1274- 1409; 1277-1638; 1278-1544; 1280-1448; 1285-1445; 1291-1448; 1296-1402; 1297-1535; 1298-1553; 1300-1448; 1301-1448; 1306-1854; 1309-1586; 1312- 1530; 1311-1448; 1312-1411; 1314-1514; 1320-1711; 1326-1483; 1324-1451; 1351-1538; 1334-1448; 1334-1626; 1336-1558; 1341-1612; 1341-1443; 1343- 1571; 1343-1561; 1343-1625; 1349-1701; 1350-1450; 1351-1448; 1351-1829; 1365-1718; 1365-1738; 1372-1635; 1374-1448; 1380-1623; 1389-1448; 1391- 1448; 1391-1642; 1536-1765; 1399-1448; 977-1513; 977-1448; 978-1414; 979- 1451; 977-1410; 989-1408; 990-1384; 1026-1406; 993-1280; 994-1117; 996- 1204; 998-1448; 1000-1448; 1002-1599; 1003-1409; 1004-1412; 1006-1261; 1019-1279; 1025-1386; 1025-1253; 1030-1448; 1031-1448; 1030-1450; 1032- 1117; 1034-1450; 1034-1276; 1034-1270; 1034-1252; 1034-1240; 1036-1469; 1038-1451; 1039-1303; 1039-1256; 1040-1408; 1042-1597; 1043-1303; 1044- 1450; 1046-1296; 1055-1321; 1053-1333; 1056-1412; 1057-1277; 1060-1375; 1059-1310; 1063-1448; 1066-1448; 1066-1409; 1067-1692; 1067-1453; 1070- 1455; 1077-1409; 1101-1408; 1130-1568; 1121-1413; 1126-1691; 1137-1448; 1140-1448; 1140-1385; 1144-1551; 1144-1448; 1144-1451; 1144-1295; 1144-
1280 1144-1360; 369-557; 378-582; 378-537; 382-598; 397-663; 409-692; 409-
872 428-832 431-688; 434-832; 435-821; 434-754; 434-772 442-706; 434-
574 451-691 442-620; 494-744; 494-673; 505-759; 516-699 526-792; 527-
800 528-789 536-810; 538-837; 545-790; 549-912; 549-609 551-803, 557-
867 557-809 973-1333; 559-867; 559-705; 567-835 566-723 : 579-825; 593-
839 600-880 614-887; 609-812; 612-842; 647-910; 663-890; 676-804; 689-
939 678-1117 682-1117; 729-811; 748-1009; 835-995; 861-1404; 850-1386; 946-1213; 933-1425; 957-1448; 939-1410; 942-1477; 949-1410; 959-1411; 973- 1386; 326-615; 351-849; 378-904; 2175-2526; 2194-2462; 329-661; 2-363; 11- 412; 3-411; 7-416; 20-483; 11-493; 16-506; 11-531
398/LI: 81203.14 :2001MAY17 | | 1502-1776; 1511-2084; 1517-1801; 1524-1800; 1556-2376; 1561-2454; 1565-1895; 1564-1768; 1570-1784; 1578-2361; 1600-
1879; 1635-1877; 1649-1930; 1641-2458; 1647-1774; 1656-1859 1663-2216; 1679-2285; 1674-1877; 1680-1896; 1684-2536; 1679-1877; 1747 2026; 1757- 2536; 1765-2604; 1763-2110; 1771-2199; 1780-1988; 1782-2020 1783-2069;
1786-2058; 1789-2373; 1790-2029; 1784-2482; 1791-2114; 1791-2022; 1798
2179; 1807-2485; 1811-2513; 1814-2080; 1814-2100; 1827-2444 1827-2412;
1837 2562; 1833-2114; 1834-2106; 1836-2385; 1837-2325; 1837-2518; 1837-
2475 1837-2544; 1837-2073; 1839-2106; 1841-2097; 1843-2124; 1843-2120;
1843 -2092; 1852-2465; 1854-2357; 1854-2122; 1866-2146; 1879-2658; 1879-
2682 ,- 1910-2410; 1922-2387; 1924-2457; 1926-2524; 1-565; 1-491; 1-597; 18-
586; 24-575; 55-560; 68-565; 289-540; 294-691; 533-1101; 543-735; 744-1314;
754 1121; 850-1152; 956-1242; 976-1471; 975-1877; 1000-1815; 1018-1253;
1045 -1908; 1094-1703; 1188-2008; 1191-2064; 1262-2029; 1267-2160; 1289-
2121 1306-2150; 1309-1968; 1313-2040; 1334-2162; 1374-2039; 1375-2249;
1387 2058; 1390-1985; 1442-2378; 1455-2186; 1471-2334; 1476-2018; 1476-
2027 1479-2203; 1487-1715; 1488-2010; 1493-2028; 1493-1720; 1493-2223;
1496 1847; 1496-1692; 1506-2090; 2275-2888; 2276-2466; 2281-2880; 2284-
2805 2296-2578; 2300-2859; 2300-2626; 2319-2500; 2307-2834; 2307-2645;
2313 2676; 2316-2846; 2319-2595; 2320-2838; 2329-2630; 2332-2585; 2333-
2600 2364-2619; 2355-2740; 2359-2640; 2381-2933; 2385-2679; 2389-2656; 2392-2678; 2396-2496; 2424-2702; 2427-2708; 2434-2677; 2434-2612; 2449-
2643 2474-2910; 2489-2760; 2488-2668; 2498-2835; 2498-2748; 2501-2735;
2501-2737; 2514-3152; 2540-3248; 2538-2793; 2547-2792; 2547-2828; 2556- 2759; 2584-2777; 2606-3248; 2629-3238; 2619-2767; 2626-2746; 2716-3238; 2783-3231; 2930-3254; 2929-3252; 3042-3247; 3102-3238; 3180-3247; 3195- 3247; 1931-2440; 1933-2537; 1971-2222; 1976-2388; 1980-2225; 2000-2524; 2004-2888; 2010-2226; 2015-2281; 2015-2226; 2017-2175; 2020-2626; 2022- 2651; 2037-2257; 2033-2346; 2033-2231; 2055-2660; 2058-2320; 2104-2691; Table 3
2093-2384; 2098-2636; 2103-2344; 2125-2835; 2117-2373; 2117-2362; 2135- 2757; 2135-2651; 2150-2830; 2163-2401; 2162-2496 2164-2815; 2160-2499; 2164-2683; 2166-2362; 2182-2393; 2186-2386; 2186 2361; 2189-2238; 2181- 2695; 2182-2705; 2182-2563; 2206-2403; 2194-2882 2212-2498; 2212-2423;
2199-3000; 2199-2741; 2202-2663; 2215-2461; 2209-2475; 2212-2741; 2215- 2774; 2213-2465; 2218-2464; 2219-2465; 2222-2471; 2223-2527; 2225-2464; 2226-2490; 2228-2472; 2231-2489; 2231-2484; 2238-2882; 2259-2539; 2261- 2512; 2274-2540; 2268-2500; 2269-2502; 857-1132
399/LI: 481237.11 -.2001MAY17 j | 2075-2224; 2126-2235; 2146-2509; 2154-2224; 2154-2213; 2330-2535; 2331-2525; 1128-1657; 1133-1254; 1172-1383; 1176- 1456; 1187-1436; 1187-1437; 1193-1437; 1193-1694; 1209-1435; 1216-1418; 1230-1498; 1255-1709; 1269-1553; 1282-1904; 1282-1489; 1286-1436; 1285- 1358; 1302-1717; 1310-1543; 1317-1709; 1352-1853; 1352-1898; 1353-1668; 1369-1842; 1371-1612; 1386-1611; 1406-1727; 1413-1650; 1436-1751; 1440- 1687; 1466-1682; 1466-1657; 1472-2044; 1473-1708; 1475-2079; 1475-1735; 1491-1766; 1516-1756; 1520-2065; 1526-1760; 1526-1900; 1544-2080; 1542- 2105; .1544-1859; 1544-2037; 1551-1775; 1549-1738; 1551-1790; 1572-1821; 1585-1849; 1602-1877; 1606-2015; 1606-1832; 1613-1954; 1621-1821; 1626- 1927; 1626-1883; 1642-1791; 1665-2183; 1670-2186; 1673-1936; 1677-2231; 1680-1930; 1690-1943; 1694-2244; 1697-2187; 1715-1940; 1719-2006; 1731- 1899; 1732-2021; 1738-2210; 1764-2033; 1767-2232; 1773-1940; 1775-2213; 1778-2217; 1780-2044; 1782-2226; 1784-2228; 1785-2225; 1785-2228; 1787- 2233; 1793-2224; 1795-2227; 1809-2226; 1816-2243; 1820-2226; 1823-2057; 1836-2213; 1835-2073; 1836-2100; 1843-2232; 1856-2225; 1861-2122; 1861- 2042; 1874-2042; 1874-2190; 1876-2048; 1878-2224; 1883-2225; 1894-2226; 1897-2189; 1899-2217; 1902-2223; 1902-2127; 1942-2172; 1953-2212; 1954- 2226; 1967-2207; 2019-2226; 2026-2193; 2030-2244; 2031-2212; 2036-2225;
2073-2217; 609-712; 617-895; 627-1072; 637-692; 651-1076; 655-954; 659-904; 659-1123; 659-900; 665-892; 665-867; 665-821; 666-936; 676-994; 685-931; 701-893; 702-937; 720-1100; 735-1018; 736-910; 763-1178; 763-911; 763-910; 763-912; 763-1120; 763-875; 761-876; 765-1092; 778-946; 777-1016; 779-1110; 780-1072; 834-1072; 834-931; 852-1209; 868-1379; 875-1172; 879-1171; 881- 1025; 941-1464; 946-1211; 947-1353; 962-1380; 956-1278; 959-1379; 962-1379; 967-1381; 992-1379; 994-1439; 994-1401; 994-1368; 994-1195; 994-1165; 994- 1379; 997-1189; 996-1379; 1001-1253; 1022-1589; 1029-1588; 1031-1335; 1031- 1597; 1034-1274; 1047-1326; 1063-1379; 1065-1146; 1067-1348; 1076-1383; 1076-1315; 1083-1356; 1095-1327; 1115-1227; 1122-1350; 1123-1218; 1126- 1381; 1796-2217; 1825-2092; 1849-2186; 1875-2217; 1894-2071; 1924-2162;
2004-2217; 2044-2185; 1-271; 20-243; 21-243 161-643; 176-643; 184-643;
228-733 374-633; 396-732 432-692; 460-851 480-904 482-783; 486-577 494-731 506-653; 519-795 520-618; 522-918 525-613 526-734; 526-731 526-653 526-642; 526-735 526-732; 526-733; 528-731 528-645; 528-620; 528-653 528-590; 528-738 528-646; 538-879; 541-727 541-738; 541-645; 541-629 541-1047; 543-880 ; 543-641; 543-645; 543-652; 557-740; 565-643; 576-738 577-731; 586-834
400/LI:481368.12:200lMAY17 | | 909-1346; 908-1532; 2312-2678; 2315-2479; 2317-2725; 2294-2703; 2298-2703; 2331-2726; 2338-2726; 2332-2734; 2339- 2731; 2349-2716; 2355-2526; 2370-2734; 2399-2725; 2389-2631; 2395-2725; . 2436-2698; 2450-2725; 2430-2725; 2445-2734; 2454-2733; 2493-2725; 2522- 2725; 2495-2724; 2551-2720; 2566-2734; 906-1502; 906-1594; 919-1504; 2164- 2462; 2170-2726; 2181-2511; 2159-2729; 2164-2726; 2196-2725; 2183-2726; 2204-2725; 2194-2726; 2201-2726; 2237-2514; 920-1465; 930-1414; 77-223; 77- 142; 225-571; 263-680; 279-998; 287-776; 316-801; 321-747; 308-979; 313- 768; 324-919; 328-903; 346-686; 346-758; 346-916; 346-747; 372-730; 355- 1040; 373-842; 377-971; 391-840; 386-956; 394-1035; 393-923; 415-743; 439- 1110; 454-1082; 1-665; 11-472; 27-579; 451-1069; 27-595; 36-577; 456-1162; 36-616; 493-1098; 536-1092; 536-1125; 36-460; 36-605; 36-556; 36-565; 36- 480; 540-1093; 549-1132; 549-1151; 574-1207; 588-1160; 588-1182; 611-1233; 597-1132; 601-1148; 600-1130; 630-1286; 653-1261; 676-1381; 664-1272; 671- 1346; 668-1360; 669-1390; 680-1275; 690-1328; 703-1141;. 706-1334; 710-1245; Table 3
36-220; 723-990; 746-1319; 749-1425; 798-1274; 763-1356; 766-1370; 770- 1391; 772-1440; 781-1475; 36-198; 36-270; 36-619; 127-910; 1814-2439; 1217-
1906; 1223-1728; 1226-1866 1228-1898 1256-1795; 1229-1906; 1233-1905; 1248-1868; 1260-1947; 1272 1938; 1299 1755; 1285-1835; 1291-1831; 1310- 1978; 1330-1713; 1339-1866 1818-2444 1826-2469; 1842-2094; 1857-2079; 1404-1927; 1392-2134; 1413 1908; 1415 1472; 1414-2056; 1424-2070; 1450- 1706; 1434-2107; 1442-2091 1460-1976 1450-1847; 1450-2092; 1450-2089; 1466-2149; 1467-2043; 1469 2113; 1471 2113; 1477-2080; 1478-2095; 1485- 2160; 1487-2150; 1502-2114 1506-2081 1519-2132; 1534-2102; 1541-1928;
1549-2104; 1552-2183; 1554-2202; 1559-2090; 946-1318; 938-1198; 1193-1823; 950-1601; 950-1559; 955-1641; 955-1499; 957-1562; 965-1627; 970-1654; 1001-
1629 1004 -1508 969-1588; 1005-1385; 1036- 1571; 1043- 1739; 1049-1577; 1063 1564; 1047 1691 1082-1747; 1112-1618; 1123-1778; 1124 1634; 1129- 1780 1138 -1732 1115-1818 ; 1214-1660; 1158-1719 ; 1157-1844 1169-1719; 1168 1837; 1172 1748 1179-1741; 1179-1655; 1189-1741; 1171 1777; 1192- 1948 1880 -2078 1867-2442 ; 1866-2579; 1876-2483 ; 1884-2640 1886-2554; 1897 2156; 1902 2727 1933-2449; 1936-2280; 1941-2629; 1949 2335; 1986- 2505 1986 -2188 1855-2350 ; 1983-2725; 1986-2351 ; 2041-2637 2066-2726; 2079 2597; 2081 -2646 2091-2726; 2097-2726; 2109-2726; 2142 2687; 2140- 2393 2130 -2726 2156-2424 1563-1734; 1567-2096 ; 1569-2170 1576-1803; 1602 2070; 1592 -2143 1592-2134; 1602-1828; 1608-2184; 1614 2241; 1629- 2200 1639 -2164 1642-2338 ; 1654-2214; 1665-2287 ; 1671-2312 1674.-2327; 1694 2478; 1706 -2227 1722-2157; 1721-2297; 1722-2259; 1736 2382; 1743- 2374 1787 -2502 1762-2455 ; 1801-2453; 1839-2042 ; 2263-2521 2246-2726; 2269 2533; 2252 -2869 2277-2749; 2277-2546; 2277-2545; 2253 2716; 2259- 2725 2286 2735 2287-2733 ; 2301-2644; 2307-2725 2305-2726 2312-2725; 2312 2606; 1364 -1617 1364 1595; 1349-2058; 1363 -1800; 1352 2067; 1367- 1990 • 1357 -2093 1359-1873 ,-.1368-2008; 1406-1889 ; 785-1340; 787-1263; 791- 1512 790 1270; 813-1236; 810-1415; 816-1296; 825-1440 ; 829 1333; 834-1436;
839-1402; 850-1459; 874-1448; 879-1419; 887-1578; 891-1564; 905-1581; 1328- 1989; 1347-1999; 1377-2005; 1358-2126; 2263-2517; 2239-2377; 2251-2725; 2251-2417; 2157-2412; 2159-2386; 2159-2384; 2165-2725; 2138-2726; 2162- 2726; 445-1096; 513-1126; 565-1046; 600-1042; 631-1183; 674-1328; 704-1287; 749-1281; 778-1321
401/LI:482301.8:2001MAY17 | | 85-519; 213-848; 392-524; 392-590; 407-516; 426-1137; 433-1063; 444-876; 444-1025; 460-1056; 490-975; 499-1148; 554- 850; 577-1147; 592-774; 635-753; 645-1167; 645-1186; 660-1121; 701-1269; 741-957; 754-1341; 798-1167; 834-1445; 879-1377; 904-1174; 917-1514; 975- 1617; 999-1553; 1029-1270; 1034-1087; 1113-1361; 1168-1845; 1180-1526; 1188-1711; 1225-1846; 1237-1678; 1496-1878; 1511-1821; 1525-1789; 1540- 1863; 1570-1838; 1583-1824; 1602-1861; 1651-1868; 1722-1865; 1-559; 1-101; 1-598; 176-448; 182-909; 162-770; 209-896; 306-845; 392-754; 392-635; 411- 1014; 365-1104; 408-1017; 392-947; 392-1031; 433-1017; 432-607; 392-885; 432-498; 392-455; 433-978; 444-1002; 444-565; 402-760; 444-803; 392-984; 434-1018; 407-1001; 407-1085; 416-1156; 425-1018; 464-1095; 441-1017; 444- 733; 444-912; 444-972; 434-1038; 445-665; 434-1164; 449-756; 444-951; 469- 1018; 478-1178; 495-804; 495-803; 487-1152; 485-1191; 504-844; 511-950; 543-1111; 508-1107; 515-1008; 527-773; 523-750; 530-1149; 554-762; 529-865; 568-713; 558-1144; 575-825; 578-1325; 600-964; 590-822; 582-1226; 589-1137; 602-1189; 621-1238; 603-1336; 634-848; 635-890; 637-1041; 639-1174; 642- 1214; 661-1193; 650-1172; 650-1160; 660-938; 660-1258; 680-1344; 690-1255; 695-1302; 707-1174; 722-1292; 728-1393; 739-1250; 740-1378; 745-1224; 748- 1333; 752-1122; 765-993; 766-1288; 786-1349; 794-1041; 848-1117; 835-1531; 845-1390; 827-1098; 849-1342; 853-1561; 862-1417; 875-1458; 875-1408; 858- 1184; 858-1029; 880-1581; 891-1239; 916-1628; 875-1099; 909-1094; 890-1145; 891-1102; 913-1301; 906-1152; 936-1515; 931-1118; 938-1202; 954-1194; 976- 1213; 963-1227; 986-1468; 991-1271; 993-1585; 1005-1568; 1003-1667; 1018- 1542; 1041-1704; 1032-1484; 1028-1570; 1049-1328; 1051-1624; 1054-1616; 1097-1584; 1110-1784; 1101-1375; 1105-1530; 1104-1579; 1124-1809; 1108- 1322; 1113-1639; 1136-1696; 1136-1814; 1162-1778; 1186-1870; 1198-1763; Table 3
1171-1535; 1179-1530; 1181- 1413; 1210-1751; 1190-1331; 1203 1556; 1192 1401; 1212-1759; 1213-1468; 1214-1807; 1234-1823; 1225-1882 1230- 1846 1236-1858; 1237-1412; 1217- 1847; 1263-1812; 1251-1846; 1260 1823; 1246 1714; 1283-1713; 1286-1839; 1295-1859; 1281-1836; 1293-1850 1274- 1871 1270-1714; 1298-1850; 1331-1478; 1332-1861; 1345-1745; 1323 1851; 1319 1916; 1340-1875; 1362-1645; 1373-1597; 1375-1847; 1358-1857 1381- 1626 1382-1619; 1364-1865; 1366-1861; 1371-1861; 1392-1867; 1353 1471; 1394 1857; 1397-1867; 1374-1813; 1399-1851; 1402-1860;' 1364-1616 1413- 1859 1425-1851; 1406-1859; 1407-1861; 1409-1863; 1431-1851; 1413 1851; 1432 1645; 1413-1861; 1434-1697; 1418-1815; 1439-1813; 1426-1859 1447- 1861 1448-1866; 1451-1851; 1432-1861; 1453-1851; 1440-1831; 1446 1859; 1452 1854; 1470-1864; 1451-1858; 1454-1862; 1475-1851; 1456-1863 1460- 1858 1481-1857; 1480-1793; 1504-1851; 1496-1861; 1518-1754; 1503 1860; 1506 1824; 1512-1851; 1536-1759; 1523-1862; 1540-1783; 1525-1822 1545- 1835 1532-1857; 1552-1859; 1535-1789; 1524-1667; 1549-1857; 1571 1850; 1571 1857; 1574-1624; 1575-1859; 1596-1852; 1597-1864; 1586-1859 1596- 1862 1620-1861; 1625-1861; 1639-1905; 1655-1864; 1644-1740; 1659-1861; 1689 1862; 1720-1859; 1733-1843; 1760-1861; 1790-1865; 1787-1857 402 /LI: 482482.29 :2001MAY17 |j 1-590; 326-792; 394-902; 527-7 39 ; 541-1099 ; 542-703; 394-633; 445-726; 500-908; 579-870; 649-1159; 693-964 ; 711-1067 ; 735-989; 737-976; 776-1008; 807-1095 403 /LI: 758877.26 :2001MAY17 I I 1954-2115; 1-675; 90-341 90-346 ; 90-262 ; 483-1018; 483-711; 483-1046 ; 483-972; 483-1117; 483-1052 ; 533-1026 ; 598- 1151; 651-1211; 694-888; 748-1258; 755-1274; 815-1226 838-1226 ; 892 -1230 ; 904-1484; 907-1548; 918-1230; 941-1230; 965-1562; 972 1554 ; 1006-1608 ; 1027-1564; 1070-1735; 1075-1588; 1108-1196; 1116-1639 1120-1230 ; 1135- 1652; 1138-1823; 1164-1858; 1178-1673; 1178-1830; 1207 1833 ; 1432 -1652 ; 1433-1652; 1433-1580; 1433-1892; 1712.-2128; 1734-1986 1740-2128 ; 1747- 2128; 1774-2131; 1830-2134 404/LI : 791042.1 : 2001MAY17 1-114; 1-468; 1 14-431; 190-454; 190-512; 194-
534 198-622 ; 198-504 198-339; 198-338; 198-350 198-609 198-612; 198- 608 198-611 ; 198-566 198-534; 199-534; 198-670 201-321 201-534; 205- 534 208-534; 210-458 251-534; 255-321; 264-534 286-812 343-856; 354- 788 415-865; 434-916 440-913; 499-608; 624-913 696-836 701-913; 738- 929 778-1029; 778-836; 778-856; 782-1036; 7 15-836; 823-1286; 894-1284; 946-1281; 958-1283; 1154-1653; 1154-1256 405/LI: 808999.26 :2001MAY17 I I 4581-5217; 4638-5181; 46! 6-511 0; 473 6-5205; 4862-5266; 4941-5482; 5251-5537;' 5254-5541; 4530-5274; 4573- 5186; 3432- 3881; 3432-3678; 3507-3742; 3548-3976; 3706-3925; 3708- 3923; 3711- 3912; 3713-3821; 3713-3973; 3713-3923; 3713-3918; 3713-3915; 3715-3880; 3759- 3858; 3761-3930; 3814-4328; 3859-4393; 3919-4393; 4076-■4325; 4129 4634; 4153-4555; 4197-4768; 4395-4923; 4446-4923; 4455-4697; 3223-3777; 3228- 3727; 3228-3293; 3251-3426; 3267-3500; 3269-3591; 3300-■3742; 3306 3407; 3352-3742; 3352-3620; 3363-3742; 2186-2361; 2193-2365; 2206-2291; 2218- 2686; 2233-2461; 2244-2722; 2244-2575; 2244-2486; 2244- 2461; 2245 2615; 2247-2541; 2262-2860; 2260-2371; 2280-2451; 2285-2453; 2313-2512; 2324- 2829; 2324-2576; 2328-2550; 2374-2859; 2372-2611; 2375- 2828; 2469- 2962; 2483-2828; 2488-2941; 2495-2964; 2500-2962; 2501-2963; 2502-2960; 2508- 2966; 2513-2949; 2516-2966; 2516-2781; 2522-2931; 2520-•2958; 2544 2951; 2546-2950; 2555-2631; 2562-2838; 2586-2961; 2592-2928; 2599-2965; 2603- 2958; 2600-2962; 2613-2863; 2613-2876; 2625-2767; 2633- 2936; 2653 2962; 2670-2922; 2681-2962; 2684-2960; 2709-2963; 2726-2961; 2752-2964; 2756- 2962; 2757-2959; 2768-2962; 2796-2962; 2802-2962; 2905-■3478; 2905 3448; 2913-3151; 3012-3591; 3030-3638; 3064-3636; 1784-2028; 1803-2418; 1814- 2087; 1815-2304; 1819-2211; 1796-2396; 1816-1969; 1825- 2329; 1849 2095; 1894-2290; 1882-2360; 1897-2156; 1899-2183; 1889-2470; 1889-2479; 1892- 2321; 1895-2472; 1897-2209; 1901-2033; 1922-2168; 1914-■2563; 1914 2337; 1917-2329; 1920-2121; 1936-2201; 1936-2402; 1939-2584; 1949-2016; 1950- 2439; 1947-2577; 1951-2236; 1958-2244; 1962-2245; 1966-■2221; 1982- 2573; 2007-2253; 1991-2414; 1991-2278; 2007-2222; 2008-2403; 2017-2292; 2017- Table 3
2245; 2021-2322; 2024-2236; 2029-2324; 2042-2318; 2042-2310; 2046-2686; 2046-2352; 2055-2673; 2060-2.583; 2060-2587; 2083-2580; 2098-2452;" 2111- 2368; 2121-2513; 2121-2330; 2130-2504; 2132-2380; 2132-2373; 2132-2422; 2135-2380; 2146-2276; 2149-2417; 2152-2412; 2154-2289; 2156-2409; 2179- 2500; 2176-2605; 1271-1869; 1274-1869; 1284-1829; 1319-1557; 1333-1587; 1342-1951; 1344-1613; 1364-1538; 1351-1941; 1351-1602; 1377-2039; 1382- 1972; 1387-2015; 1391-1927; 1391-1933; 1391-1654; 1394-1778; 1394-1719; 1411-1991; 1412-1743; 1417-1692; 1418-1685; 1447-2086; 1450-1741; 1434- 1505; 1487-1945; 1486-1954; 1489-1772; 1491-1780; 1508-1970; 1498-2051; 1499-2022; 1528-1746; 1532-1770; 1555-1801; 1566-1905; 1572-2082; 1574- 2110; 1589-2174; 1583-1872; 1583-1769; 1583-1822; 1610-2112; 1598-1903; 1606-1749; 1614-1719; 1635-2232; 1667-2038; 1653-1932; 1657-1828; 1657- 1954; 1672-1916; 1696-2120; 1698-2205; 1725-2367; 1712-1891; 1741-2046; 1745-1810; 1746-2022; 1746-2011; 1747-1970; 1747-1894; 1749-2040; 1770- 2175; 1780-2020; 1800-2307; 1799-1925; 791-1146; 801-1042; 807-1437; 785- 1397; 813-1297; 844-1141; 881-1055; 894-1168; 897-1298; 920-1188; 924-1213; 925-1157; 927-1556; 939-1251; 945-1275; 946-1208; 955-1482; 956-1130; 957- 1302; 952-1506; 970-1595; 975-1587; 981-1569; 989-1147; 1004-1561; 990- 1436; 990-1218; 1031-1541; 1040-1402; 1047-1441; 1047-1636; 1047-1572; 1049-1400; 1054-1484; 1060-1355; 1040-1247; 1040-1245; 1062-1505; 1047- 1260; 1087-1584; 1098-1357; 1105-1333; 1119-1350; 1143-1389; 1146-1511; 1146-1459; 1147-1562; 1146-1308; 1129-1603; 1146-1735; 1169-1398; 1182- 1586; 1183-1822; 1172-1790; 1215-1912; 1214-1749; 1198-1645; 1205-1681; 1236-1470; 1236-1873; 1249-1881; 1263-1902; 1266-1710; 1268-1768; 1-144; 3- 507; 42-608; 146-587; 146-566; 147-598; 753-1316; 146-543; 147-587; 149- 538; 147-512; 155-705; 156-788; 174-767; 183-649; 184-649; 186-569; 186- 457; 198-647; 203-717; 214-527; 287-540; 301-770; 334-600; 346-777; 357- 836; 358-539; 360-600; 369-915; 369-927; 377-842; 386-600; 412-653; 433- 1112; 457-755; 489-841; 606-1038; 608-812; 608-1148; 615-1162; 626-778; 616-844; 651-1212; 667-1076; 687-1191; 689-1248; 690-1106; 698-1118; 704- 9.82; 721-1024; 726-939; 727-1197; 742-1331; 763-1209; 756-1004; 784-946; 4643-4977; 3509-3742; 3509-4008
406/LI:815715.10:2001MAY17 690-1152; 716-1133 732-1150; 1-537; 1-516;
1-507; 3-216; 129-577; 163-577 221-57*7; 256-577 256-573; 267-577; 273- 590; 273-616; 273-587; 280-428 280-411; 309-809 344-657; 353-576; 367- 596; 379-637; 401-498; 410-970 418-938; 431-584 493-1065; 502-1139; 527- 791; 520-577; 545-1024; ' 561-674 ; 579-1047; 576-1116 554-654; 573-878; 606- 1114; 609-1119; 609-795; 603-1115; 611-937; 615-889 638-856; 641-914; 641- 899; 641-1158; 698-1149; 698-1157; 709-1093; 717-897; 719-1062; 699-938; 726-1151; 730-1045; 714-938; 736-1151; 736-1047; 736-847; 735-1152; 736- 1077; 736-1169; 736-1132; 736-1154; 736-1153; 736-1045; 736-1150; 736-920;
736-1109; 736-1115; 736-846; 736-795; 736-934 736-1075; 736-1046; 738-897 736-1080; 736-835; 736-897; 741-897; 744-1150 725-897; 757-1139; 750-1157 736-905; 756-1161; 736-877; 754-1037; 736-868 740-871; 762-1080; 766-1169 766-1110; 773-1153; 773-1152; 778-938; 778-1022; 780-938; 792-1152; 813- 1149; 822-1082; 834-1047; 835-1067; 853-1150; 855-1153; 862-1092; 846-1054; 877-1150; 948-1153; 949-1148; 972-1139; 972-1107; 972-1151; 972-1082; 972- 1112; 972-1150; 972-1155; 981-1134; 965-1149; 968-1152; 1009-1082 407/LI:902980.16:2001MΛYl7 || 1-401; 1-160; 22-267; 22-414; 267-1069; 426- 1099; 671-1137; 804-1192; 831-1352; 875-1311; 1091-1521; 1100-1357; 1159- 1491; 1159-1388; 1165-1451; 1172-1622; 1180-1430; 1359-1656; 1396-1557 1422-1912; 1422-1678; 1429-1748; 1473-1677; 1575-1991; 1627-1922; 1751 2306; 1760-2174; 1762-2018; 1769-2183; 1779-2241; 1783-2241; 1821-2042 1837-2217; 1865-2129; 1904-2221; 1917-2244; 1930-2244; 1976-2238; 1995 2245; 2022-2339; 2027-2292; 2049-2564; 2060-2345; 2061-2301; 2080-2572 2088-2576; 2094-2168; 2097-2249; 2105-2320; 2117-2248; 2172-2513; 2191 2303; 2331-2874; 2335-2843; 2335-2438; 2335-2777; 2335-2614; 2335-2703 2335-2688; 3137-3411; 3171-3382; 3212-3426; 3219-3406; 3240-3573; 3240 3477; 3446-3590; 2449-2736; 2455-2773; 2474-2905; 2475-2683; 2482-2874 2503-2784; 2509-2982; 2527-3006; 2529-2810; 2548-3017; 2551-2793; 2562 Table 3
3026; 2574- -2868; 2582- -3076, 2612- -3074; 2446- -2726; 2446- -2716, 2448- -2719;
2449- -2705; 2448- -2759; 2448- -2717; 2335- -2536; 2335- -2538; 2335- -2533; 2335-
2499, 2335- -2475; 2335- -2528, 2335 -2417, 2335- -2401, 2343 -2604 2343 -2580;
2346- -2848; 2349- -2488; 2354- -2772; 2358- -2821; 2335- -2701; 2335- -2659; 2335-
2660, 2335- -2618; 2335- -2623 2335 -2612, 2335- -2606, 2335 -2602 2335 -2573;
2335- -2577; 2335- -2509; 2335- -2453; 2361- -2756; 2362- -2913; 2361- -2598; 2363-
2945 2363 -2934; 2360- -2629 2366 -2912, 2386- -2660, 2401 -2502 2415 -2909;
2419- -2919; 2357- -2597; 2428- -2981; 2430- -2649; 2432- -2899; 2615- -2915; 2633-
3211, 2636- -3240; 2639- -3182, 2646- -3055; 2646- -3079; 2647- -3094, 2648 -3087;
2649- -3198; 2651- -3058; 2658- -3080; 2664- -3080; 2668- -3082; 2673- -3001; 2673-
2936 2673 -2910; 2678- -3165 2678 -3065, 2684- -3101, 2703- -3248, 2742 -2936;
2746- -2992; 2763- -3032; 2763- -3006; 2817- -3086; 2816- -3175; 2856- -3249; 2874-
3218, 288i -3082; 2889- -3372, 2903 -3082, 2908- -3378; 2934- -3309, 2935- -3190;
2943- -3425; 2960- -3419; 2966- -3420; 3001- -3295; 3007- -3423; 3012- -3379; 3016-
3420, 3022- -3420; 3092- -3402, 3098- -3353; 3121- -3420; 3126- -3406, 3126- -3419
408/LI: 903196.25 :2001MAY17 II i-: 201; " '-605; 11-296; 13- -587; 18-668; 20-266;
29-260; 33 -270; 82-677; 81- -285; L08-364; 127-336, 155-: 300; 157-411; 159-
415; 206-455; 240-841 375- -458; 458-1068; 606-80S ; 621- -1085, 745-: L312; 776-
1391, 803-1142; 804-1199; 803-1111; 887-1437; 91S -1577 987- -1562; 1000-
1562, 1002- -1257; 1018- -1252, 1043- -1548; 1084- -1337; 1121- -1322, 1142- -1396;
1200- -1419; 1224- -1786; 1335- -1435; 1337- -1643; 1388- -1965; 1467- -1744; 1487-
1783 2781 -3012, 2792- -3230 2791 -3218, 2799- -3012, 2827 -2995 2834 -2966;
2861- -3162; 2986- -3258; 3074- -3642; 3087- -3613; 3087- -3559; 3087- -3256; 3300-
3667, 3354 -3673, 3354- -3631 3404 -3657, 3516- -3664, 1488 -1655 1489 -2147;
1559- -1829; 1566- -2124; 1598- -1857; 1646- -2106; 1646- -1899; 1646- -1885; 1675-
2184, 1676 -1950, 1697- -1964 1706 -1935, 1725- -2120, 1732- -1986 1732 -2301;
1732- -1976; 1831- -2192; 1857- -1975; 1875- -2362; 2743- -2972; 2750- -3006; 2752-
2901 2770 -3009; 1910- -2206 1910 -2129, 1939- -2114, 1947- -2308, 1950 -2200;
1955- -2195; 1992- -2245; 2006- -2523; 2022- -2693; 2094- -2478; 2108- -2728; 2116-
2573 2116 -2394 2154- -2441 2162 -2574, 2172 -2395 2175 -2590 2180 -2426;
2179- -2378; 2182- -2465; 2185- -2576; 2214- -2394; 2242- -2459; 2265- -2801; 2294-
2475 2294 -2465, 2294- -2855 2294 -2529, 2294- -2525, 2319 -2591 2342 -2589;
2348- -2589; 2349- -2589; 2361- -2972; 2371- -2590; 2377- -2661; 2394- -2887; 2434-
3011 2440 -2681, 2498 -2983 2517 -3012 2519 -3004 2524 -3013 2524 -3028;
.2527- -2898; 2532- -2974; 2560- -2968; 2565- -2973; 2578- -3004; 2577- -2820; 2591-
3004 2594 -3004, 2595- -3004 2594- -2883, 2604- -3007, 2603 -3013, 2608 -3012;
2609- -2987; 2617- -3013; 2617- -2839; 2618- -2972; 2622- -2863; 2624- -2992; 2639-
2885 2650 -3003, 2664- -2863 2670 -3005, 2677- -3009, 2682 -2996 2691 -3009;
2696- -2963; 2712- -3012; 2714- -2958;' 2730- -2975; 2738- -2985
409/LI: 903914.10 :2001MAY17 || 2784-3328; 2785-3382; 2843-3494; 2830-3357;
2869- -3227; 2878- -3483; 2875- -3088; 2887- -3157; 2905- -3175; 2905- -3148; 2920-
3212 2920 -3214 2952 -3205 2966 -3472 2966- -3261, 2993 -3262 3001 -3635;
3022- -3241; 3039- -3505; 3062- -3612; 3067- -3248; 3067- -3390; 3091- -3329; 3157-
3467 3157 -3459 3157 -3422 3158 -3462 3159 -3469, 3227 -3392 3260 -3424;
3262- -3510; 3538- -4132; 3541- -4211; 3591- -4008; 3633- -4206; 3942- -4174; 3946-
4186 3952 -4191 3958- -4216 3958 -4184, 3958- -4181, 3958 -4140 3958 -4103;
3958- -4088; 3958- -4092; 3958- -4076; 3958- -4064; 3958- -4057; 3958- -4044; 3958-
4028 3958 -4077, 3994 -4250 4136 -4310, 4157- -4351, 4186 -4370 4187 -4439;
4206- -4354; 4328- -4586; 4387- -4778; 4456- -4803; 4647- -4988; 982-1304; 383-1322;
983-1320; 383-1381; 983-1294; 983-1301; 984- -1301, 983- L293; 983-1303; 986-
1227 1041 -1313 1031 -1321 1053 -1322, 1079 -1304, 1101 -1614 1103 -1351;
1116- -1325; 1128- -1325; 1207- -1635; 1267- -1541; 1319- -1757; 1446- -1909; 1467-
2026 1476 -1969 1548 -1925 1656 -1724 1693 -2235 1752 -2347 1752 -2196;
1842- -2229; 1849- -2236; 1965- -2435; 1965- -2537; 1970- -2451; 1965- -2380; 1977-
2166 1994 -2280, 2073- -2701 2075 -2327, 2109- -2679, 2186 -2418 2186 -2616;
2202- -2545; 2211- -2496; 2227- -2425; 2290- -2831; 2307- -2568; 2349- -2677; 2358-
2791 2410 -2674 2410 -2927 2419 -2989 2445 -2728, 2450 -2709 2471 -2904;
2457- -3110; 2468- -2756; 2486- -2656; 2498- -2833; 2515- -3073; 2515- -2763; 2517-
2614 2546 -3170, 2557- -3114 2573 -2835, 2609 -2863, 2643 -3225 2645 -3060;
2651- -3142; 2654- -2935; 2640- -3234; 2662- -3191; 2662- -2822; 2671- -3240; 2689- Table 3
3231 : 2724-3262; 2729-3234; 2752-3329; 2775-3235; 2776-3289; 1-249; 116-
440 309-859; 365-871; 394-859; 455-820; 473-859; 489-734; 492-846; 496-
766 496-745; 523-859 524-783; 530-804; 555-859; 572-1221; 587-1182; 611-
864 612-886; 612-859 614-859; 617-1239; 638-906 t 665-859; 667-859; 672-
859 673-859; 677-859 699-859; 703-859; 713-859; 726-859; 729-859; 730-
859 755-859; 771-859 778-859; 795-1291; 806-1316; 920-1304; 912-1319;
915-1322; 926-1322; 916-1322; 932-1304; 937-1322; 945-1322; 952-1301; 949- 1322; 963-1322; 964-1301; 966-1304; 972-1298; 982-1290; 982-1301; 979-1305; 979-1322; 982-1322; 983-1304
410/LG: 006764.2. -2001JU 22 | | 1-290; 138-447; 197-590; 199-440; 237-435; 441-582; 452-716; 488-710; 488-912; 530-803; 554-804; 712-954; 712-1116; 748-1062; 836-1031; 896-1154; 919-1308; 942-1579; 1097-1516; 1162-1353; 1170-1353; 1266-1617; 1255-1577; 1339-1610; 1382-1610
411/LG: 014704.8 -.2001JUN22 | | 1-743; 81-239; 442-550; 486-912; 527-815; 527- 793; 602-898; 659-961; 814-1064; 840-1408; 851-1398; 873-1135; 949-1433; 949-1182; 997-1180; 1007-1323; 1007-1185; 1081-1394; 1097-1360; 1097-1356; 1097-1354; 1124-1358; 1161-1410; 1172-1559; 1172-1562; 1172-1382; 1187- 1539; 1187-1420; 1329-1625; 1463-1912; 1467-1672; 1481-1735; 1485-1646; 1493-1592; 1495-1810; 1496-1905; 1501-1912; 1506-1908; 1518-1796; 1519- 1896; 1519-1723; 1532-1698; 1538-1796; 1545-1911; 1548-1855; 1560-1907; 1569-1905; 1571-1842; 1605-1906; 1624-1885; 1685-1930; 1729-1924; 1734- 1925; 1748-1844; 1772-1930; 1790-1930; 1790-1907; 1799-1907; 1804-1907; 1813-1907; 1813-1891; 1813-1863; 1813-1930; 1817-1941 412/LG:1447607.7:2001JUN22 I I 1-542; 1-529; 1-523; 1-367; 75-504; 75-540;
153-418 160-606; 196-390; 282-520; 282-493; 282-472; 299-892; 459-718; 469-539 486-723; 495-1008; 539-1084; 540-777; 544-769; 555-816; 587-761; 626-847 694-1008; '696-991; 696-976; 696-977; 696-954; 696-920; 702-954; 730-955 769-1146; 769-998; 775-945; 813-1092; 857-1219; 934-1112; 944-
1196; 1041-1447; 1069-1286; 1077-1231; 1081-1232 1140-1604; 1140-1309
1232-1690 1235-1668; 1235-1654; 1236-1687 ;' 1236 1449; 1238-1587; 1245
1861; 1247-1366; 1247-1328; 1247-1379; 1266-1499 1298-1870; 1304-1573
1318-1573 1328-1527; 1340-1577; 1348-1657; 1357 1604; 1360-1849; 1360-
1763; 1385-1910; 1385-1567; 1404-1728; 1415-170! 1415-1676; 1419-1711
1427-1701 1434-1995; 1435-1655; 1437-1712; 1448 1875; 1448-1695; 1450
1868; 1450-1719; 1450-1716; 1473-1645; 1500-1756 1530-1745; 1532-1872
1539-2128 1581-2227; 1587-1809; 1592-1865; 1599 1875; 1613-2238; 1639
1901; 1695-1953; 1705-1978; 1711-1961; 1734-2000 1761-2041; 1761-2160
1772-2036 1786-2223; 1790-2240; 1795-2234; 1806 2060; 1811-2280; 1818
2239; 1822-2266; 1822-2105; 1824-2238; 1826-2277 1833-2275; 1833-2283
1837-2241 1842-2135; 1859-2238; 1870-2041; 1909 2277; 1913-2277; 1914-
2277; 1917-2171; 1917-2164; 1918-2275; 1953-2277 1977-2278; 1979-2236 1985-2277; 2002-2279; 2015-2280; 2063-2277; 2065 2275; 2072-2172; 2087 2274; 2098-2265; 2103-2277; 2134-2275; 2164-2279 2189-2265 413/LG:1455032.3:2001JU 22 II 1-473; 1-590; 1-306 98-306; 146-589; 186-
382 230-725; 248-648; 333-625 336-635; 347-609 308-549 354-648; 365- 656 325-557; 367-648; 338-521 352-540; 433-648 439-825 453-699; 459- 697 471-725; 499-589; 480-723 482-653; 484-648 486-649 498-648; 501- 622 505-745; 541-642; 557-990 567-824; 567-794 575-868; 576-910; 581- 809 584-884; 586-861; 587-1061; 588-648; 589-648 591-739; 592-806; 594- 1076 594-1120; 596-1026; 596-831; 597-846; 599-856; 598-1143; 602-897;
600-1005; 601-835; 602-1105; 603-805; 603-868; 603-889; 603-846; 603-840;
603-829; 603-826; 603-820; 603-947; 604-898; 604-900 604-838; 605-1036;
605-841; 605-815; 605-894; 606-908; 606-861; 606-858 607-870; 607-852;
607-846; 607-780; 606-866; 607-905; 609-862; 609-793 610-869; 610-849;
610-829; 612-832; 607-720; 607-726; 611-895; 612-857 612-858; 608-817;
612-1160; 612-1137; 612-1108; 611-1003; 612-931; 612-887; 612-883; 612-894;
612-875; 612-863; 612-851; 612-859; 612-848; 612-846; 612-836; 612-823;
612-820; 612-814; 614-1072; 614-828; 612-805; 612-736; 612-980; 612-893;
613-854; 613-849; 613-841; 612-879; 613-870; 614-943; 614-902; 614-854;
614-824; 615-896; 615-870; 614-889; 616-870; 613-863; 614-861; 618-867; Table 3
617-1180; 620-904; 621-897; 623-868; 621-1043; 622-1026; 623-778; 624-860; 626-803; 627-936; 624-712; 628-1182; 629-738; 634-744; 635-1145; 635-898;
635-969; 640-892; 640-878; 641-854; 643-950; 643-745; 644-849; 645-803; 648-1181; 648-928; : 648-888; 649-1127; 648-1148; 651-909; 653-931; 654-938; 664-1059; 664-884; : 667-1056; 675-932; 677-889; 678-906; 689-935; 689-890; 696-748; 708-899; 703-994; 703-1189; 705-991; 706-1132; 706-912; 708-1181; 714-1169; 717-1172; 717-1018; 718-1072; 720-1182; 722-1182; 724-976; 727- 852; 729-909; 729-1187; 739-1186; 742-1066; 744-945; 744-1188; 744-1181; 745-1184; 745-1181; 746-1188; 747-1189; 748-828; 749-1181; 755-1181; 757- 1180; 757-1183; 758-997; 767-1086; 771-1188; 772-1186; 774-1113; 775-1031; 775-1181; 776-1027; 777-1181; 778-1183; 781-1180; 784-1180; 782-1054; 784- 1181; 782-950; 786-1038; 786-1069; 784-1007; 789-1181; 788-997; 789-1060; 791-1181; 791-1166; 794-1183; 793-1183; 795-1181; 802-998; 803-1165; 802- 1187; 803-1093; 806-1182; 806-972; 810-1057; 810-1183; 811-1039; 811-1183; 811-1180; 812-1022; 812-1182; 813-1140; 814-1106; 814-1181; 817-1181; 818- 1181; 824-1109; 828-968; 829-1146; 832-1165; 834-1086; 836-1181; 837-1172; 838-1119; 842-1057; 850-1183; 851-1181; 861-1181; 864-1086; 865-1185; 870- 1070; 880-1125; 881-1159; 885-1182; 887-1199; 888-1181; 895-1184; 895-1171; 901-1168; 898-1043; 899-1180; 902-1130; 911-1159; 915-1090; 918-1175; 919- 1172; 919-1119; 919-1144; 921-1187; 927-1184; 927-1172; 927-1078; 940-1181; 941-1172; 943-1183; 943-1172; 952-1181; 954-1185; 954-1184; 961-1188; 963- 1129; 967-1185; 971-1172; 977-1183; 983-1183; 982-1052; 996-1180; 1000- 1183; 1009-1183; 1017-1181; 1023-1181; 1030-1175; 1057-1183; 1061-1201; 1082-1183; 1085-1181; 1105-1184; 1118-1172; 1123-1183 414/LG:1501898.18:2001JUN22 | | 584-1074; 200- -933 370- -921 272- -923 470-
874; 524- -874 626- -874 454- -873 454-870; 733- -882 625- -878 585- -877 458-
876; 575- -875 463- -874 506- -874 674-874; 709- -874 472- -874 484- -875 513-
869; 494- -870 458- -870 590- -870 310-873; 413- -869 454 -869 473- -869 504-
869; ■459- -869 648- -869 699- -869 701-869; 708- -869 730 -869 746- -869 491-
869; 498- -869 470- -867 537- -867 604-867; 528- -875 436- -875 454- -860 702-
874; 308- -859 780- -858 523- -872 546-872; 492- -856 ■ 641- -856 767- -856 564-
870; 503- -869 493- -869 805- -869 535-868; 439- -867 489- -864 541- -860 608-
843; 307- -838 314- -836 292- -830 685-828; 499- -827 246 -824 232- -823 221-
822; 264- -808 228- -791 187- -780 581-792; 279- -758 176- -749 176- -744 486-
745; 491- -744 582- -743 434- -730 268-731; 432- -729 449- -719 203- -699 472-
699; 441- -682 312- -636 276- -626 307-620; 357- -595 20-. 593; 129-. 592; 77-59
321-591; 365-586; 357-576; 330-575; 1-570; 310-585; 394-562; 15-558; 357- 552; 46-547; 15-529; 188-524; 128-531; 258-516; 264-513; 258-508; 310-504; 20-497; 158-485; 15-484; 210-472; 15-471; 350-442; 154-434; 15-418; 15-377; 227-359; 15-357; 15-209; 1-175; 15-173; 77-160; 15-155; 15-153; 15-152; 15- 149; 15-148; 15-142; 15-137; 15-126; 15-120; 15-113; 15-104; 15-96; 15-71 415/LG:1502692.5:2001JUN22 || 1-548; 1-615; 135-489; 160-798; 175-444; 187-
630; 187-473 244-487; 247-409; 248-539; 248 -457; 259-756 259-593; 270-
385; 274-991 274-992; 277-783; 329-844; 298-772; 308-882 337-593; 353-
977; 383-658 395-789; 418-675; 443-685; 447-666; 466-974 476-1065; 481-
710; 491-738 491-683; 524-1041; 533-1060; 550-923; 550-765; 572-977; 573- 1038; 548-1068; 581-960; 584-1040; 600-1079; 605-1039; 616-1032; 581-1068; 621-1081; 579-804; 580-828; 626-1080; 637-886; 638-846; 640-705; 641-1078; 644-1082; 647-1078; 615-841; 680-1076; 684-1078; 691-1019; 695-945; 699- 999; 708-910; 711-1078; 741-895; 737-1080; 752-1076; 755-1078; 757-1052; 761-1076; 760-1067; 766-1038; 773-1073; 773-999; 781-1076; 791-1006; 760- 1076; 797-1080; 811-1078; 816-1076; 823-1078 ; 858-1078; 866-1078; 878-1078; 904-1072; 906-1078; 931-1083; 974-1078 416/LG:208949.8:2001JUN22 || 1-482; 38-482; 117-484; 124-452; 125-482; 136- 488; 272-482; 272-458; 322-484; 322-482; 446 -760 417/LG: 240501.10 :2001JUN22 || 494-1240; 912- 1170; 891-1111; 705-1110; 891- 1064; 508-1063; 487-881; 341-747; 1-710; 149 -419; 341-414; 1171-1238; 603- 1157; 1171-1235 Table 3
418/LG-.329228.27-.2001JUN22 || 1-524; 83-296; 85-486; 181-420; 243-808; 295- 667; 295-549; 295-513; 399-659; 429-839; 440-836; 440-530; 533-967; 603- 1033; 613-897; 704-942; 794-1179; 855-1528; 887-1232
419/LG:337056.11:2001JU 22 I I 1-603; 1-684 420/LG:346663.9:200lJU 22 | j 1-277; 20-567; 383-943; 383-526; 383-1081; 434-1006; 454-906; 560-974; 729-1333; 758-1014; 785-1013; 1092-1337 421/LG:7685586.2:2001JUN22 || 1-367; 1-583; 12-585; 80-585; 100-585 422 /LG: 407730.13 :2001JUN22 j j 1-489 423/LG:025465.5:200lJUN22 I I 1-142; 41-816; 141-395; 153-712; 160-412; 161- 417; 165-411; 163-408; 165-293; 177-411; 182-366; 201-649; 201-416; 206- 676; 417-1016; 636-1125; 636-885; 636-869; 654-1007; 782-1213; 807-1263; 917-1355; 920-1206; 921-1058; 931-1311; 933-1230; 991-1608; 997-1231; 1052- 1571; 1059-1264; 1058-1619; 1060-1845; 1157-1625; 1171-1622; 1189-1440; 1211-1630; 1260-1619; 1285-1752; 1398-1707; 1453-1693; 1524-1892; 1537- 1854; 1604-1795; 1604-1786; 1614-2078; 1615-1798; 1660-2075; 1662-2175; 1822-2111; 1881-2126; 1952-2023; 1960-2085; 1976-2062 424/LG:054509.14:2001JUN22 II 1-279; 100-673; 200-446; 358-671; 408-876;
508-2210; 451-661; 615-836 618-1158; 816-1066; 825-1071; 877-1054; 896-
1162 912-1515; 922-1146; 922-1175; 925-1171; 971-1058; 1040-1550; 105! 1612 1113-1777; 1132-1630 1148-1420; 1149-1771; 1176-1630; 1199-1739;
1207-1778 1219-1638; 1295-1547; 1332-2127; 1334-1874; 1346-1920; 1355-
2133 1360-2122; 1372-1571 1391-1678; 1402-2130; 1437-1890; 1439-1910; 1439 1697 1440-1981; 1441-1550; 1452-1605; 1455-2131; 1459-1715; 1465- 1762 1483-2134; 1488-1764 1489-1963; 1496-2121; 1513-1820 1513-1772; 1513 1751 1513-2102; 1542 2132; 1541-1786; 1553-1841; 1588 2129; 1595- 1833 1597-1845; 1597-1800 1600-1797; 1614-1812; 1617-2162 1621-1855; 1625 1856 1644-1923; 1649 2072; 1657-2202; 1656-1855; 1661 2147; 1676- 1932 1678-2027; 1678-1783 1681-2250; 1695-2043; 1699-1876 1691-2157; 1702 1923 1702-2169; 1724 2168; 1730-2080; 1732-2159; 1732 1977; 1733- 2167 1741-2213; 1742-2167 1770-2104; 1775-1968; 1776-2206 1783-2205; 1790 2188 1798-2207; 1807-2047; 1809-2206; 1819-2210; 1821-2310; 1823- 2097 1824-2307; 1835-2204 1852-2201; 1864-2189; 1872-2165; 1872-2206; 1872 2207 1891-2101; 1908 2206; 1908-2129; 1908-2160; 1924-2204; 1919- 2167 1921-2126; 1949-2203 1961-2228; 1964-2235; 1973-2210; 1975-2189; 1980 2141 1979-2210; 1981 2164; 1980-2164; 1997-2207; 2000-2206; 2031- 2306 2031-2426; 2051-2206 2056-2206; 2061-2198; 2068-2159; 2073-2204;
2088-2330 2142-2206; 2149-2592; 2161-2399; 2197-2429; 2197-2656; 2197-
2727 2197-2456; 2298-2877 2321-2557; 2321-2567; 2322-2607; 2323-2597; 2342 2617 2345-2609; 2445 2655; 2472-2612; 2545-2989; 2545-2787; 2547- 2865 2586-3085; 2597-3085 2600-3088; 2638-3174; 2637-2844; 2685-3176; 2688-3164; 2814-3214; 2900-3215; 3015-3201; 3155-3403 425/LG:1067876.1:2001_JUN22 | | 1-287; 5-247; 151-524; 185-647 426/LG:1327699.55:2001JUN22 j | 1-272
427/LG:1482904.10:2001JU 22 j j 1-618; 151-794; 186-747; 189-536; 249-747; 270-747; 471-1077; 1037-1606; 1106-1624; 1106-1359; 1109-1447; 1185-1438; 1215-1657; 1223-1464; 1331-1579; 1335-1881; 1333-1624; 1341-1485; 1360- 1908; 1369-1643; 1384-1761; 1384-1588; 1387-1640; 1425-1537; 1465-1714; 1467-1679; 1473-1905; 1546-1793; 1587-1816; 1597-2105; 1633-1894; 1657- 1760; 1663-1922; 1673-2039; 1686-1957; 1717-1989; 1721-1990; 1787-2248; 1829-2070; 1829-1943; 1831-2069; 1832-2073; 1836-2368; 1853-2146; 1854- 2088; 1855-2085; 1862-2134; 1865-2087; 1915-2474; 1922-2073; 1947-2218; 1952-2188; 1969-2221; 2020-2219; 2067-2325; 2089-2304; 2131-2299; 2147- 2425; 2147-2333; 2149-2320; 2168-2580; 2178-2406; 2198-2381; 2226-2381; 2255-2519; 2256-2695; 2264-2960; 2284-2381; 2286-2381; 2291-2381; 2299- 2552; 2299-2522; 2304-2537; 2319-2761; 2319-2637; 2354-2641; 2362-2913; 2375-2942; 2372-2436; 2374-2950; 2372-3003; 2379-2621; 2384-2674; 2390- 2633; 2417-3003; 2416-3004; 2412-2652; 2412-2649; 2440-2852; 2455-3027; 2459-2996; 2472-2939; 2516-3039; 2571-3042; 2573-2990; 2573-3030; 2573- 2819; 2576-3003; 2584-2942; 2595-3045; 2595-3000; 2598-3042; 2606-3047; 2607-3043; 2607-2885; 2607-3047; 2609-2856; 2611-2891; 2611-2687; 2611- Table 3
2691; 2611-2669; 2611-2974; 2612-2879; 2626-3045; 2626-3042; 2628-2892; 2632-3044; 2632-3042; 2634-3042; 2635-3046; 2639-3038; 2641-3042; 2648- 2909; 2655-3038; 2657-2875; 2673-3047; 2674-2977; 2685-3042; 2685-3047; 2693-3042; 2696-3038; 2699-2934; 2701-3038; 2715-3044; 2716-3042; 2721- 3042; 2758-3042; 2761-3048; 2774-3043; 2805-3042; 2805-3023; 2805-2988; 2805-2970; 2808-3035; 2810-3043; 2812-3038; 2828-3042; 2834-3043; 2860- 3042; 2862-3045; 2862-3042; 2864-2960; 2871-3038; 2909-3042; 2938-2987; 2959-3036
428/LG: 222317.4 :2001JUN22 | | 1-256 1-252 429/LG:332701.3:2001JUN22 j j 1-368 184-566; 260-572; 277-532; 277-741; 282-740; 290-477 ;■ 290-391 ; 290-395 290-698; 290-702; 290-716; 290-351; 298-567; 335-565; 349-700; 354-572 602-1197; 730-964; 730-1073; 747-833; 787-984; 787-1054; 797-1059; 921-1369; 936-1180; 950-1208; 958-1216; 1016-
1519 1018- 1270 1043- 1277 1062- 1325 1062- 1310; 1101- 1490; 1120- 1330; 1134 1352; 1134 1415; 1135 1480; 1134 1477; 1135-1378; 1135- 1425; 1144- 1674 1134- 1492 1135- 1431 1134- 1527 1135- 1471; 1176- 1611; 1219- 1388; 1241 1485; 1297 1571; 1294 1612; 1333 1760; 1378-1961; 1434-1628; 1497- 2105 1497- 2024 1530- 1838 1550- 1787 1575- 2103; 1575- 1808; 1755- 2019; 1755 2366; 1741 2138; 1800 2041; 1807 2095; 1858-2246; 1859-2056; 1946- 2201 1971- 2109 1988- 2485 1988- 2214 2045- 2619; 2073- 2310; 2086- 2713; 2092 2603; 2101 2370; 2101 2550; 2110 2649; 2110- 2726; 2155-2431; 2159- 2592 2160- 2353 2204- 2818 2213- 2709 2213- 2439; 2275- 2504; 2277- 2568; 2287 2811; 2304 2583; 2308 2762; 2312 2510; 2319- 2932; 2337-2872; 2337- 2601 2363- 2806 2364- 2608 2370- 2894 2370- 2881; 2376- 2920; 2378- 2843; 2387 2639; 2437 2916; 2440 2663; 2444 2697; 2444-2909; 2450- 2919; 2457- 2908 2458- 2921 2460- 2916 2464- 2916 2468- 2918; 2472- 2935; 2473- 2919; 2474 2932; 2476 2922; 2480 2885; 2484 2935; 2485- 2911; 2488-2915; 2486- 2910 2490- 2893 2504- 2911 2512- 2944 2515- 2920; 2525- 2936; 2536- 2838; 2539 2945; 2554 2911; 2594 2915; 2598 2920; 2595-2911; 2602- 2769; 2600- 2922 2601- 29.36 2605- 2918 2608- 2932 2612- 2959; 2612- 2894; 2612- 2834; 2615 2918; 2621 2906; 2619 2910; 2621 2882; 2621- 2924; 2621-2879; 2629- 2918 2631- 2911 2640- 2911 2650- 2911 2649- •2816; 2653'- -2911; 2663- 2918;
2678-2920; 2686-2906; 2692-2873; 2721-2906; 2731-2876; 2741-2940; 2754-
2911; 2758-2936; 2759-2926; 2761-2920; 2767-3396; 2767-3254; 2777-2906;
2793-3212; 2794-3176; 2796-2918; 2839-3217; 2853-2921; 2936-3396; 29^77-
3208; 2977-3209; 2979-3597; 3067-3412; 3138-3538; 3246-3583; 3284-3471;
3287-4626; 3287-3650; 3300-3782; 3304-3999; 3323-3821; 3336-3415; 3355-
3583; 3415-3821; 3424-4202; 3424-3583; 3529-3821; 3560-3837; 3605-3973;
3620-3802; 3648-4275; 3653-4291; 3962-4220
430/LG:369881.5:2001JUN22 | | 1009-1307; 903-1306; 920-1305; 892-1305; 1013-
1305; 1068-1305; 1127-1305; 691-1261; 777-1247; 778-1199; 556-1200; 563-
1197; 706-1175; 595-1139; 377-1089; 549-1052; 488-963; 667-959; 263-912;
592-849; 549-791; 380-688; 449-679; 408-631; 392-573; 273-570; 1-550; 1-
488; 1-463
431/LG:404381.2:2001JUN22 | | 1-175; 5-616; 233-818; 233-409; 234-475; 406-
690; 426-653; 500-750; 568-983; 676-912; 761-1201; 765-974; 807-1375; 907-
1120; 909-1360; 946-1399; 952-1399; 1007-1256; 1102-1399; 1216-1399; 1221-
1284
432/LG:405709.2:2001JUN22 | | 2-151; 1-284; 7-144; 26-294; 137-341; 139-341;
157-341; 210-341; 219-341
433/LG:406664.17:2001JUW22 | | 1-220
434/LG:7670681.1:2001JU 22 j j 1-64.9
435/LG: 7687404.1:2001JUN22 j j 1-589; 345-684; 453-864; 533-1112
436/LG:7690030.24:200UUN22 | | 1-387
437/LG:7690229.3:2001JU 22 | j 1-506; 183-671; 183-409
438/LG:7690533.16:200lJUN22 j | 1-378; 239-840; 240-488; 392-944; 657-905;
661-849; 844-1156; 855-1114; 889-1182; 1004-1186
439/LG:7691131.2:2001JUN22 | | 1-555; 1-281; 172-500; 337-555; 438-899; 440-
900; 472-733; 473-899; 481-897; 579-899; 583-994; 692-902
440/LG: 7692559.6 :2001JUN22 | | 1-717; 220-462; 392-476 Table 3
441/LG:7684866.10:2001JUN22 | | 14-230; 1-239; 1-513
442/LG: 002106.5 :2001JUN22 | | 1-322; 7-258; 23-82; 24-564; 32-572; 43-297;
68-293; 367-628; 367-653; 601-872; 601-948; 637-1117; 642-1104; 690-1111;
955-1102; 963-1527; 979-1647; 988-1221
443/LG:004064.1:200lJUN22 | | 1-582; 464-885; 496-1007; 547-970; 554-938;
556-813; 622-1007; 622-889; 622-888; 752-966
444/LG: 007916.8 :2001JUN22 | | 945-1497; 989-1464; 694-1266; 646-1265; 642-
1252; 871-1214; 858-1140; 832-1139; 832-1118; 193-792; 227-764; 439-623;
105-593; 233-463; 1-346
445/LG:014719.14:2001JUN22 | | 1-244; 1-444; 72-590; 73-308; 103-582; 111-
340; 480-1013; 548-884; 573-1192; 638-906; 658-1284; 727-1291; 747-992;
1014-1534; 1040-1526; 1182-1462; 1218-1813; 1273-1689; 1265-1836; 1273-
1614 1273-1819; 1279-1836 1288-1453; 1315-1836; 1344-1913; 1396-1927 1443 1992; 1443-1695; 1457-2004; 1465-1756; 1470-2021; 1494-1943; 1535 1883 1586-1852; 1600-1705 1628-2242; 1672-2163; 1745-2316; 1813-2328 1843 2356; 1837-2357; 1839-2115; 1843-2207; 1843-2425; 1843-2426; 1843- 2453 1843-2400; 1843-2401 1843-2276; 1843-2458; 1843-2433; 1843-2366 1844 2311; 1845-2390; 1931-2329; 1936-2328; 2125-2439; 2163-2768; 2223 2440 2234-2741; 2418-2859 2418-2750; 2418-2668; 2494-2858; 2498-2859; 2543 2853; 2572-2812; 2592 2872; 2598-2814; 2608-2672; 2633-2858; 2665- 2900 2762-2903; 2759-2853 2766-2881; 2774-2858; 2787-2858 446/LG: 021763.31 :2001JUN22 | | 1-466; 2-497; 1-591; 11-391; 11-248; 12-216; 12-517; 12-324; 19-268; 21-255; 21-229; 32-122; 33-302; 34-331; 34-221; 49- 382; 50-260; 50-244; 55-301; 57-301; 60-339; 60-564; 62-517; 63-280; 121-
553; 140-624 140-374 140-349; 140-343 140-302 140-293 140-281; 147-
761; 174-438 176-638 208-526; 215-666 223-330 236-517 240-63?; 257-
702; 269-458 269-670 281-517; 279-641 284-496 292-517 291-517; 308-
499; 333-517
447 /LG: 025397.1:2001JUN22 1-737; 4-249; 23-680 65-571; 120-607; 124-
445; 392-459; 421-609; 426-684; 451-575; 594-943; 602-984; 673-799; 720-
969; 797-1221; 846-1029; 855-1070; 890-1097; 890-1359; 1102-1339; 1102- 1272; 1107-1319; 1109-1296; 1145-1296; 1154-1340; 1173-1319; 1207-1319
1226-1319 1226-1710; 1632-1866; 1631-1905; 1632-2071; 1632-1830; 1632-
1761; 1632-1697; 1659-2112; 1677-1872; 1677-1788; 1687-1944; 1692-1989
1755-2297 1755-2369; 1755-2291; 1766-2328; 1775-2074; 1795-2095; 1827-
2126; 1831-2399; 1838-2088; 1863-2353; 1939-2102; 1945-2199; 1956-2468
1961-2130 1981-2080; 1986-2262; 2080-2218; 2158-2608; 2093-2589; 2107-
2592; 2107-2547; 2107-2378; 2110-2387; 2116-2617; 2156-2624; 2174-2632
2184-2349 2186-2632; 2197-2628; 2201-2632; 2274-2597; 2274-2513; 2256
2632; 2261-2641; 2273-2628; 2273-2555; 2294-2632; 2303-2617; 2305-2633 2312-2628; 2314-2632; 2317-2628; 2344-2795; 2356-2623; 2378-2628; 2386- 2637; 2503-2639
448/LG:029880.20:2001JUN22 | | 1-609; 360-1090; 523-1088; 965-1532; 1347- 1933; 1459-1792; 1572-1958; 1610-2111; 1708-1893; 2034-2536; 2046-2427; 2076-2333; 2123-2633; 2163-2696; 2180-2645; 2187-2474; 2188-2440; 2228- 2808; 2228-2755; 2254-2510; 2271-2561; 2275-2756; 2275-2794; 2276-2874; 2276-2520; 2286-2538; 2303-2569; 2302-2540; 2321-2876; 2324-2606; 2338- 2578; 2350-2856; 2350-2630; 2383-2694; 2444-2881; 2442-2845; 2445-2705; 2450-2987; 2453-2673; 2497-2778; 2526-2672; 2529-2847; 2539-3191; 2537- 2729; 2539-2821; 2559-2849; 2605-3052; 2605-2685; 2681-2828; 2692-2882; 2705-2845; 2803-3049; 2818-3095; 2818-2935; 2857-3131; 2980-3229 449/LG:040422.37:2001JUN22 | | 1-2729; 712-974; 987-1079; 988-1504; 988- 1394; 997-1545; 995-1663; 997-1527; 1004-1459; 1006-1475; 1006-1427; 1006- 1457; 1008-1496; 1023-1288; 1016-1477; 1015-1453; 1026-1428; 1033-1333; 1036-1405; 1046-1318; 1046-1486; 1046-1479; 1046-1478; 1046-1477; 1046- 1476; 1046-1473; 1046-1467; 1046-1459; 1046-1458; 1046-1456; 1046-1453; 1046-1452; 1046-1485; 1046-1432; 1046-1429; 1046-1428; 1046-1427; 1046- 1404; 1046-1399; 1046-1354; 1046-1305; 1046-1303; 1046-1286; 1046-1287; 1046-1279; 1053-1416; 1054-1514; 1063-1495; 1070-1249; 1082-1304; 1107- 1276; 1098-1336; 1098-1530; 1098-1490; 1098-1484; 1118-1388; 1140-1625; Table 3
1128-1329; 1144-1465; 1151-1420; 1155-1538; 1201-1560; 1230-1455; 1235-
1482; 1249-1432; 1262-1738; 1267-1380; 1349-1552 1357-1574; 1420-1919; 1454-1537; 1488-1884; 1501-2247; 1551-2217; 1566 2243; 1566-2230; 1571- 2262; 1586-2109; 1589-1842; 1603-1881; 1605-2242 1606-1881; 1617-1901;
1631-2166; 1644-2148; 1660-2208; 1653-2241; 1674-2222; 1701-2208; 1705-
2211; 1776-2329; 1797-2319; 1801-1897; 1814-2309 1822-2320; 1831-2219; 1831-2123; 1833-2130; 1834-2090; 1836-2088; 1861 2122; 1843-2086; 1856- 2319; 1863-2321; 1866-2321; 1872-2327; 1880-2305 1897-2304; 1900-2314; 1913-2323; 1931-2274; 1935-2303; 1935-2295; 1937 2327; 1945-2172; 1950- 2319; 1965-2322; 1966-2309; 1985-2224; 1987-2215 1988-2312; 1987-2250; 1989-2219; 2002-2319; 2011-2312; 2014-2271; 2017 2280; 2018-2163; 2019- 2277; 2020-2303; 2027-2306; 2023-2319; 2028-2325 2028-2317; 2041-2328; 2038-2319. 2043-2141; 2043-2315; 2050-2317; 2055 2300; 2056-2312; 2058- 2476; 2058-2309; 2059-2329; 2058-2317; 2070-2319 2071-2314; 2081-2314; 2114-2654; 2117-2318; 2119-2328; 2118-2309; 2120 2316; 2159-2299; 2159-
2312; 2160-2245; 2166-2313; 2230-2312; 2230-2471; 2274-2471; 2299-2459; 2322-2559; 2395-2813; 2400-2675; 2428-2685; 2668-3196
450/LG:065935.11:200UU 22 | | 1-557; 127-707; 127-257; 528-1090; 774-1356; 882-1480; 894-1448; 894-1572; 910-1271; 1033-1571; 1071-1628; 1436-2080; 1497-1572; 1595-1834; 1596-2047; 1596-1828; 1687-1945; 1954-2550; 1972-
2550; 2000-2445; 2038-2473; 2338-2896 2450-2752; 2509-3079; 2533-2700; 2592-2899; 2627-3001; 2672-2929; 2702 2951; 2732-2899; 2748-2971; 2754- 2900; 2757-3051; 2821-3258; 2824-3080 2834-3275; 2834-3090; 2873-3455;
2895-3084; 2931-3164; 2964-3426; 3002-3217; 3058-3326; 3108-3340; 3115
3318, 3125 -3362, 3152- -3547, 3200- -3468 3231-3412; 3269-3497; 3275-3542
3282- -3530; 3321- -3547; 3333- -3708; 3333 3545; 3352-3547; 3358-3641; 3415
3725, 3427 -3602, 3455- -3740, 3456- -3802 3456-3763; 3475-3976; 3551-3804
3558- -4020; 3559- -4014; 3561- -4014; 3570 4014; 3569-4014; 3571-3786; 3571-
3787, 3572 -4019 3572 -3778 3573- -4018 3575-4018; 3575-4000; 3575-3863
3576- -3974; 3575- -3797; 3575- -3775; 3577 4018; 3580-4138; 3580-3766; 3586
4014, 3597 -4014 3601 -4019 3607 -4017 3611-4018; 3614-4014; 3614-4017
3614- -4015; 3618- -4019; 3619- -4015; 3697 4022; 3706-4014; 3711-3999; 3732-
3947, 3738 -4015, 3740 -4020, 3742- -4020 3787-4014; 3796-4021; 3815-3993
3828- -4014; 3871- -3993; 3878- -4347; 3891 4347; 3897-4352; 3905-4293; 3938
4014, 3987 -4351, 3994- -4347, 4035- -4353 4093-4347
451/LG:074381.1 ;2001JUN22 866-1265 878-1265; 815-1265; 842-1263; 1102- 1262; 1187-1262 ; 852-1262; '856-1261; 955-1260; 1016-1260; 837-1260; 835- 1260; 885-1260 888-1260; 846-1260; 980-1260; 1088-1260; 951-1260; 860- 1260; 788-1256 1065-1256; 791-1254; 892-1252; 995-1252; 819-1247; 760- 1223; 790-1220 759-1220; 612-1177; 597-1161; 871-1107; 799-1062; 802-1045;
819-1044; 744-1023; 803-1017; 723-988; 610-969; 812-965; 727-961; 689-943;
678-935; 800-909; 634-907; 678-902; 638-854; 618-838; 610-836; 618-822;
610-815; 245-767; 610-741; 610-732; 610-699; 255-455; 300-456; 1-433; 1-252
452/LG:083814.6:2001JUN22 | | 1-383; 1-241; 16-247; 16-530; 20-117; 59-299;
117-781; 230-500; 297-537; 319-555; 344-580; 346-866; 555-824; 558-1040;
668-1004; 766-1313; 774-859; 835-1075; 855-1291; 880-1210; 884-1554; 890-
1119; 894-1210; 895-1399; 895-1129; 903-1203; 909-1034; 961-1384; 966-1250;
984-1227; 1017-1272; 1041-1288; 1052-1416; 1143-1657; 1161-1438; 1182-1320;
1207-1593; 1207-1454; 1250-1525; 1298-1690; 1309-1561; 1372-1889; 1357-
1689; 1383-1652; 1383-1695; 1383-1674 1383-1617; 1419-1609 1425-1756;
1427-1656; 1428-1634; 1444-1706; 1445 1765; 1489-1730; 1494-1760; 1516
1889; 1534-1808; 1578-1889; 1613-1855 1620-1889; 1645-2337 1691-1889;
1703-2391; 1701-1902; 1734-1902; 1735- 1889; 1743-1889; 1768-1889; 1798
1889; 1812-1889; 1814-1889; 1842-1901; 2164-2422; 2170-2408 2173-2406;
2180-2447; 2180-2441; 2191-2377; 2201- 2432; 2201-2421; 2207 2411; 2208-
2427; 2208-2271; 2208-2452; 2209-2428; 2211-2427; 2213-2430 2213-2407;
2214-2412; 2213-2437; 2274-2435; 2279-2447
453/LG: 090985.1.-2001JUN22 | | 1-616; 1-508; 14-114
454/LG:093750.2:200UUN22 | j 1-438; 1-565; 9-406; 11-406; 431-668; 524-811;
623-845; 633-829; 636-885; 670-1111; 689-1110; 772-1024; 896-1234 Table 3
455/LG:1013708.26:200UUN22 | | 1176-1675; 1164-1620; 857-1344; 888-1050; 709-1048; 593-1046; 839-1045; 825-1046; 869-1045; 864-1045; 928-1045; 745- 1045; 705-1045; 867-1045; 642-1045; 865-1045; 742-1045; 665-1045; 744-1043; 580-1043; 640-1042; 879-1042; 829-1040; 744-1039; 634-1039; 743-1036; 747- 1035; 752-1022; 662-942; 652-837; 525-734; 415-685; 221-495; 148-493; 149-
476; 40-449; 121-412; 170-316; 11-196 1-178 456/LG: 1022283.8 :2001JUN22 || 1-4090; 503-1073; 930-1489; 1138-1690; 1316-
1592 1505-2283; 1522-1804; 1566-2048 1562-2157 1576-2155 1604-2157; 1615 2157; 1752-2079; 1761-1828; 1695-2264; 1678-2060; 1747 2500; 1883- 2147 1880-2169; 1933-2225; 1967-2150 2054-2403 2048-2688 2030-2265;
2125-2685; 2189-2369; 2180-2832; 2201-2836; 2263-2403; 2263 2472; 2332-
2532 2442-2888; 3295-3519; 3318-3868 3344-3863 3345-3785 3345-3805; 3351 3875;' 3366-3996; 3375-3915; 3378 3905; 3422 3991; 3446 3909; 3455- 3989 3462-4084; 3466-4019; 3470-3965 3477-3843 3478-3682 3483-3902; 3498 4053; 3522-3981; 3580-4086; 3580 4039; 3580 4059; 3580 4054; 3580- 4056 3580-4053; 3580-4051; 3580-3689 3580-4080 3580-3853 3593-3685;
3596-3836; 3604-4090; 3600-3865; 3600 4090; 3608 4090; 3609 3868; 3614-
4090 3614-3976; 3614-3860; 3615-3833 3625-4090 3626-4090 3625-4077; 3632 4092; 3638-4093; 3639-4090; 3639 3952; 3644 4083; 3647 3878; 3650- 4096 3651-4080; 3653-4052; 3660-4090 3663-4096 3664-4087 3662-4056;
3667-4080; 3667-4091; 3668-4052; 3669 3914; 3668-4089; 3673 4054; 3677-
4090 3683-4090; 3683-4042; 3682-4040 3686-4090 3685-3911 3687-4089;
3686-3919; 3689-4092; 3685-4047; 3688 3858; 3693-4090; 3695 4089; 3696-
4090 3697-4090; 3701-4090; 3706-4051 3711-4090 3713-4093 3713-4090; 3715 4090; 3718-3970; 3719-4046; 3724-4090; 3724-4091; 3728-4090; 3727 4049 3730-4090; 3728-4050; 3731-4090 3732- -4093 3733-4090 3732-4052;
3736-4081; 3733-3993; 3739-4091; 3739 4087; 3742 3957; 3752-4089; 3756-
4189 3756-4041; 3757-4087; 3757-3861 3764- -4090 3765-3990 3765-4091;
3766-4090; 3770-4019; 3771-4090; 3772 4050; 3773 4088; 3776-4047; 3777-
4093 3777-4090; 3780-4090; 3782-3897 3781- -3982 3785-4090 3788-4090;
37-89-4090; 3792-4058; 3793-4051; 3793 4052; 3793 4049; 3793-4045; 3793-
4026 3797- 4050 ; 3799- 4090 3799- 4081 3801- -4090 3803-4052 3804-4089; 3806 4084; 3805-4051; 3806 4093; 3806 4090; 3807 4051; 3808-4090; 3818- 4050 3824- 4000 ; 3822- 4191 3847- 4090 3852- -4089 3878-4080 3886-4080; 3894 4090; 3901-4038; 3902 4030; 3902 4080; 3903 4090; 3906-4090; 3910- 4093 3910- 4090 ; 3921- 4090 3926- 4553 3925- -4030 3926-4090 3931-4058; 3931 4090; 3934-4094; 3949 4089; 3954 4082; 3991 4163; 4082-4380; 4096- 4234 4100- 4337 ; 4100- 4473 4105- 4390 4106- -4611 4108-4674 4112-4536; 4112 4492; 4112-4332; 4112 4334; 4112 4293; 4112 4289; 4112-4283; 4119- 4719 4122- 4558 ; 4120- 4641 4140- 4396 4177- -4667 4204-4790 4204-4667; 4207 4651; 4217-4481; 4217 4470; 4222 4421; 4230 4660; 4245 4526; 4252- 4487 4256- 4775 ; 4264- 4510 4275- 4590 4288* -4802 4296-4518 4301-4558; 4312 4896; 4316-4742; 4336 4867; 4360 4652; 4393 4671; 4402-4798; 4402- 4565 4414-■4477 ; 4415-■4920 4426-■4915 4427- -4940 4439-4677 4440-4653; 4440 4902; 4506-4965; 4551-4968; 4569-4828; 4580 4846; 4603 4848; 4629- 4891 4633-5207; 4636-4860 4637-4869 4645-4856 4682-4957 4691-4925; 4698 5268; 4732-4962; 4741 5328; 4759 5057; 4759-4991; 4771 4872; 4803- 5039 4814-5087; 4822-5451 4827-5067 4828-5066 4830-5102 4860-5278; 4886 5106; 4889-5137; 4893 5246; 4894 5205; 4902 5105; 4908 5454; 4928- 5152 4941-5537; 4947-5438 4953-5603 4965-5539 4963-5171 4964-5246; 4976 5579; 4993-5251; 5015 5559; 5013 5224; 5022 5259; 5025 5429; 5025- 5252 5041-5702; 5054-5533 5063-5314 5088-5627 5089-5533 5106-5370;
5129-5624; 5129-5691; 5121-5405; 5123 5236; 5125 5361; 5129 5374; 5129-
5369 5135-5391; 5181-5417; 5194-5814 5194-5617 5195-5473 5214-5595; 5214 5339; 5221-5443; 5219-5328; 5258 5796; 5236-5464; 5255-5511; 5266- 5723 5266-5514; 5269-5540; 5271-5558 5271-5637 5276-5549 5277-5494; 5289 5679; 5297-5828; 5344-5895; 5332 5539; 5334 5588; 5350 5547; 5350- 5494 5344-5608; 5362-5572; 5352-5604 5352-5600 5352-5594 5359-5911; 5359 5632; 5389-6031; 5372-6087; 5389 5828; 5390 5618; 5403-5633; 5418- 5836 5420-5708; 5473-5708; 5469-5623 5473-5632 5475-5746 5477-5719; Table 3
5476-5958; 5484 5722; 5488 5708; 5497-5708; 5489- 6056; 5488 6141; 5504- 5714; 5496-6029 5519-5683 5531-5708; 5538-5708; 5563-5708 5561-5830 5581-5816; 5601-5846; 5601 5848; 5606-5851; 5618-5871; 5621 5848; 5630- 5873; 5630-5822 5636-5963 5641 5889; 5644-5900; 5737-6018 5742-6141 5742-5892; 5748-5990; 5748-5929; 5752-6163; 5754-6225; 5754 -5971; 5754 5933; 5754-5926 5754-5915 5755-6196; 5755-6019; 5755-6027 5755-5993 5755-5958; 5757 5965; 5762-5997; 5762-5942; 5762-6052; 5766 6206; 5766- 6024; 5768-6013 5769-6031 5769 6020; 5771-5974; 5775-6002 5780-6038 5785-6016; 5796 6206; 5796 6015; 5797-6033; 5785-6073; 5799 6059; 5801 6013; 5805-6063 5853-6349 5827-6083; 5830-6011; 5859-6248 5860-6169 5861-6122; 5863 6143; 5864 6098; 5865-6115; 5879-6131; 5904 6362; 5907 6187; 5911-6357 5913-6479 5909-6180; 5912-6171; 5912-6111 5913-6184 5921-6348; 5926 6037; 5939 6211; 5941-6214; 5943-6208; 5946 6110; 5953 6012; 5962-6206 5971-6245 5972-6206; 5974-6193; 5981-6206 5983-6209 5983-6200; 5983-6193; 5988 6204; 5984-6206; 5984-6203; 5997 6468; 5988 6213; 5988-6206 5986-6137 5993-6164; 6002-6566; 6002-6206 6004-6211 6006-6206; 6006-6205; 6012 6440; 6009-6210; 6011-6206; 6028 -6205; 6036 6586; 6036-6298 6048-6224 6086-6289; 6055-6223; 6068-6353 6071-6666 6071-6324; 6071 6313; 6082 6487; 6074-6205; 6074-6438; 6079 6431; 6085 6342; 6086-6322 6098-6222 6096-6347; 6100-6512; 6113-6195 6111-6424 6112-6347; 6132 6677; 6219 6669; 6197-6520; 6231-6596; 6221 6673; 6222 6695; 6225-6627 6224-6712 6224-6636; 6224-6464; 6225-6755 6225-6775 6225-6673; 6225 6660; 6225-6535; 6227-6753; 6227-6603; 6228 6656; 6228- 6427; 6231-6678 6228-6355 6225-6579; 6231-6346; 6249-6310 6256-6738 6249-6793; 6262 6795; 6260 6531; 6260-6528; 6262-6754; 6261 6510; 6261 6507; 6262-6557 6262-6473 6266-6540; 6253-6649; 6278-6451 6280-6451 6281-6909; 6281-6541; 6282 6498; 6288-6753; 6340-6899; 6300 -6561; 6307- 6469; 6304-6749 6306-6415 6316-6785; 6322-6511; 6323-6624 ; 6325-6793 6330-6758; 6335 6790; 6334 6608; 6337-6790; 6325-6398; 6342 -6731; 6342 6599; 6342-6593 6343-6750 6345-6632; 6346-6649; 6334-6499 ; 6348-6790 6350-6793; 6354-6792; 6354 6758; 6360-6610; 6309-6601; 6368 -6792; 6368 6791; 6373-6593 6374-6796 6378-6792; 6377-6668; 6377-6626 6380-6800 6379-6792; 6381 6658; 6367-6601; 6381-6792; 6386-6602; 6376 6587; 6376 6476; 6392-6789 6392-6653 6392-6625; 6391-6622; 6393-6792 6392-6683 6394-6792; 6394 6747; 6394 6609; 6396-6753; 6398-6518; 6402 -6756; 6387 6489; 6405-6793 6407-6792 6407-6660; 6410-6792; 6413-6791 6414-6743 6416-6665; 6416 6796; 6416 6808; 6418-6793; 6422-6792; 6426 -6709; 6427 6792; 6427-6794 6429-6743 6437-6792; 6439-6793; 6439-6695 6453-7019 6452-6793; 6452 6792; 6463 6792; 6462-6754; 6462-6706; 6463 -6756; 6465 6755; 6468-6797 6475-6756 6476-6720; 6477-6708; 6478-6798 6478-6782 6480-6785; 6481 6792; 6481-6758; 6482-6757; 6482-6735; 6483 6787; 6483 6734; 6486-6707 6487-6792 6487-6790; 6488-6707; 6494-6792 6495-6792 6496-6792; 6496-6757; 6497-6797; 6497-6782; 6501-6757; 6502 6760; 6501 6782; 6509-6798 6522-6792 6539-6792; 6540-6793; 6541-6792 6545-6767 6553-6792; 6571 6792; 6571 6790; 6579-7171; 6591-6710; 6595 -6769; 6596- 6796; 6596-6792 6606-6792 6610-6798; 6611-6792; 6611-6743 6617-6792 6624-6785; 6624 6792; 6634-6799; 6635-6795; 6638-6798; 6643 6792; 6647 6796; 6656-6758 6667-6796 6671-6785; 6689-6792; 6696-6793 6704 6792 6715-6785; 6721-6785; 6722-6785; 6730-6785; 6780-7171; 6723 -6793 457/LG:1034386.1:2001JUN22 2-1037; 617-967; 254-958; 2 54-348 ; 1-326 458/LG:1045617.36:2001JUN2 I I 87 2 li 1 287; 2-204 4-668; 190-753 ; 319-826; 434- 729; 515-1167 459/LG:1063303. 1-.2001JUN22 || 1-280; 54-636; 145-368; 202-758; 30 6-798 321-580; 323-799; 392-669; 410-651; 509-1329; 707-790; 1065-1296; 1065- 1285; 1065-1210 ; 1065-1212; 1065-1158; 1065-1146; 1065-1143; 1065-1142 1065-1135; 1065-1134; 1065-1126; 1065-1116; 1067-1347; 1068-1290; 1068- 1278; 1071-1307 ; 1076-1587; 1076-1322; 1090-1373; 1093-1359; 1094-1333 1094-1235; 1097-1586; 1097-1279; 1097-1248; 1097-1246; 1097-1151; 1097 1250; 1099-1336 ; 1099-1292; 1101-1355; 1102-1342; 1104-1201; 1120-1288 1120-1282; 1120-1237; 1120-1204; 1125-1488; 1152-1397; 1158-1385; 1177- Table 3
1456; 1218-1305; 1390-1560; 1423-1624; 1451-1708; 1499-1727; 1087-1165; 1083-1162; 1453-1569; 1312-1556; 1420-1665; 1244-1541; 1435-1718; 1260-
1582; 459-798; 1373-1727; 1274-1727; 1161-1703; 1072-1709 460/LG: 1094200.1:2001JUN22 II 1-706; 28-242; 43-222; 36-339; 37-255; 43-
590; 43-577 43-542; 43-317; 43-303 43-253 43-238; 43-223; 43-114; 47-
590; 49-621 52-307; 54-311; 57-303 59-303 62-303; 65-279; 80-532; 81-
267; 82-285 82-352; 84-382; 88-386 99-319 171-740; 195-795; 202-481;
211-766; 211-390; 211-441; 219-609; 219-586 252-567; 261-426; 320-803;
352-805; 360-806; 360-811; 373-959; 389-831; 398-831; 401-694; 412-787;
416-807; 417-656; 429-932; 438-806; 445-803; 445-733; 453-833; 463-878;
462-679; 464-829; 506-1156; 506-759 ; 529-1038; 529-806; 529-984; 545-829;
556-830; 566-1042; 587-1229; 589-1074; 598-806; 601-833; 607-914; 608-873;
611-1074 615-1074; 621-1119; 621-896; 634-1079; 639-1073; 649-1095; 664- 784; 733-1117; 752-1100; 778-1051; 784-1059; 797-1091; 809-1053; 818-1037; 818-1221; 842-1093; 857-1060; 860-1073; 860-1120; 865-1113; 873-1124; 885- 1264; 895-1148; 905-1160; 937-1074; 947-1031; 969-1093; 976-1150; 979-1224; 990-1127; 995-1093; 1025-1234; 1062-1141; 1071-1141; 1090-1506; 1176-1334; 1174-1644; 1215-1746; 1212-1628; 1217-1484; 1217-1478; 1226-1413; 1236-
1370; 1237-1781; 1237-1746 1237-1692; 1237-1609; 1237-1602; 1237-1592 1237-1506; 1237-1456; 1237 1461; 1237-1382; 1237-1360; 1237-1359; 1237 1334; 1237-1297; 1237-1291 1242-1554; 1256-1506; 1268-1761; 1268-1645
1300-1733; 1289-1592; 1296-1546; 1342-1510; 1350-1640; 1372-1658; 1379
1969; 1384-1670; 1384-1909 1392-1686; 1408-1814; 1412-1547; 1438-1668
1445-1711; 1446-1706; 1449-1570; 1457-1657; 1459-1671; 1459-1582; 1466
1730; 1470-1710; 1471-1645 1476-1760; 1476-1736; 1476-1732; 1476-1729 1476-1719; 1476-1710; 1479 1721; 1485-1619; 1491-1677; 1502-1704; 1506 1705; 1525-1656; 1526-1804 1539-1844; 1539-1834; 1539-1799; 1541-2147
1541-1851; 1541-1830; 1579-1794; 1579-2175; 1581-1802; 1623-1853; 1624
1905; 1636-1821; 1655-2212 •1661- 2168; 1660 -1882 1680 -2110 1662* -1916 1678-2205; 1678-2174; 1676 2093; 1682-1903; 1704 1970; 1712 2167; 1715 2024; 1719-1923; 1721-1971 1724- 1969; 1725-2011 1729 -1982 1746--2198 1746-2014; 1747-2093; 1752 2209; 1754-2212; 1760 2212; 1763 2212; 17.63 2215; 1766-2214; 1769-2206 1776- 2205; 1776-1884 1777 -2215 1784--2206 1789-2215; 1791-2093; 1794 2093; 1796-1988; 1796 1944;' ' 1802 2093; 1821 2159; 1821-2205; 1817-2093 1821- 2075; 1835-2217 1838 2085 1839'-2063 1844-2104; 1846-2093; 1851 2093; 1851-2085; 1865 2116; 1874 2209; 1878 2085; 1896-2147; 1917-2093 1919- 2093; 1925-2216 1940 2093 1944'-2093 1946-2093; 1967-2093; 1977 2109; 1975-2093; 1976-2093; 1996 2085; 1998 2093; 2031-2085; 2031-2093 2036- 2197; 2042-2093 2044 -2093 2063 -2160 2063-2212; 2076-2164; 2098 2147; 2105-2212; 2107-2683; 2167 2341; 2167 2520; 2602-3185; 2707-2823 2758- 3142; 2760-3017 2911 3177 461/LG: 1099249.19.-2001JU 22 1- 544; 1-265 ; 290 540; 290-5 35; 397-59!
535-783; 612-881; 699-964; 706-964; 833-1450; 839-1095; 861-1413; 1022- 1306; 1194-1353; 1205-1368; 1255-1738; 1280-1777; 1281-1778; 1281-1724; 1283-1534; 1307-1736; 1319-1778; 1319-1535; 1327-1778; 1343-1778; 1389- 1624; 1392-1845; 1425-1839; 1430-1738; 1435-1541; 1432-1777; 1467-1727; 1565-1842; 1568-1840; 1602-1797; 1602-1672; 1615-1843
462 /LG: 110667.1:2001JU 22 || 1-592; 225-785; 495-1121; 753-810; 948-1590; 1427-1933; 1427-1893; 1530-2069; 1698-2091; 1721-2054; 1721-2066; 1814- 2069; 1853-2054; 1930-2581; 2016-2573; 2496-2567
463/LG:1132386.20:2001JUN22 || 1-365; 1-476; 14-256; 89-588; 215-797; 290- 793; 290-729; 292-538; 445-738; 538-1195; 620-803; 721-1334; 929-1420; 929- 1506; 929-1271; 954-1543; 1134-1550; 1154-1550; 1197-1467; 1216-1766; 1395-
1663; 1512-1881; 1536-2021 1567-1804; 1567-1711 1586-2084; 1592-2138 1628-1892; 1639-2064; 1639 1845; 1639-2026; 1639 2138; 1652-2140; 1744- 2033; 1767-2057; 1768-1856 1798-2061; 1817-2363 1853-2114; 1856-2149
1853-2132; 1856-2151; 1879-2156; 1879-2145; 1885-2154; 1905-2168; 1949
2160; 1954-2676; 2007-2286 2020-2122; 2028-2287 2034-2692; 2036-2311
2059-2323; 2080-2653; 2095-2345; 2098-2304; 2127 2411; 2142-2467; 2158
2422; 2170-2279; 2170-2337 2182-2916; 2193-2812 2204-2706; 2206-2418 Table 3
2216-2627; 2216-2470; 2246 -2531; 2262-2470; 2299-2532; 2301-2548; 2301- 2531; 2303-2552; 2303-2734 2305-2555; 2309-2573; 2309-2528 2310-2632 2325-2818; 2327-2641; 2332 -2645; 2357-2600; 2364-2901; 2375-3016; 2373 2596; 2378-2620; 2377-2617 2392-2661; 2393-2954; 2393-2657 2399-2641 2420-2715; 2424-2732; 2429 ■2854; 2447-3013; 2454-2717; 2481 2734; 2484 2729; 2497-2759; 2523-3015 2522-2960; 2551-3014; 2553-2719 2556-2812 2556-2778; 2560-3081; 2572 •2820; 2575-2829; 2576-3010; 2585-2847; 2594- 2916; 2611-3040; 2623-2827 ; 2629-2908; 2630-3137;' 2630-2965 2633- 2896 2634-2868; 2634-2864; 2634 -3040; 2636-2884; 2650-2927; 2659 2969; 2670 2944; 2670-2887; 2670-2889 ; 2672-2951; 2681-2943; 2683-2917 2730- 2872 2734-2894; 2750-3030; 2752 -3046; 2763-3299; 2771-3299; 2774 2958; 2770 3302; 2776-3037; 2775-3014 ; 2775-2960; 2776-3025; 2797-3018 2820- 2984 2821-3107; 2824-3115; 2826 -3101; 2828-3598; 2833-3103; 2837 3263; 2839 3162; 2855-3362; 2855-3065 ; 2865-3129; 2867-3128; 2879-3063 2883- 3411 2885-3133; 2887-3159; 2887 -3139; 2897-3474; 2896-3118; 2910 3187; 2923 3198; 2924-3204; 2941-3497 ,- 2938-3193; 2951-3491; 2951-3208 2968- 3234 2969-3175; 2971-3200; 2979 -3223; 2989-3461; 2983-3519; 2987 3517; 2990 3291; 2990-3301; 2991-3286 ; 2993-3430; 2993-3242; 2993-3239 2994- 3250 2998-3546; 2999-3187; 2999 -3185; 3005-3231; 3010-3224; 3015 3538; 3015 3219; 3015-3134; 3017-3228 ; 3027-3504; 3033-3454; 3037-3518 3038- 3440 3043-3558; 3043-3492; 3041 -3293; 3062-3518; 3079-3529; 3068 3285; 3068- 3290; 3179-3438; 3068-3286 ; 3183-3560; 3068-3273; 3188-3563 3193- 3482 3075-3349; 3085-3315; 3198 -3459; 3088-3519-; 3089-3558; 3087 3298; 3199- 3560; 3101-3561; 3202-3561 ,- 3203-3557; 3103-3510; 3206-3487 3210- -3454 3104-3567; 3108-3563; 3124 -3555; 3214-3541; 3160-3570; 3222 3543; 3228 3498; 3136-3558; 3251-3563 ; 3142-3443; 3142-3568; 3255-3536 3142- 3560 3257-3447; 3142-3553; 3142 -3524; 3260-3516; 3148-3455; 3266 3535; 3146 3512; 3270-3560; 3148-3557 ; 3289-3516; 3290-3558; 3305-3561 3148- 3518 3309-3568; 3148-3413; 3322 -3556; 3149-3407; 3330-3562; 3350-3566; 3361 3561; 3383-3561; 3152-3357 ; 33-86-3563; 3171-3406; 3388-3561 3391-3558 3177-3320; 3418-3568; 3435 -3559; 3444-3561; 3446-3558; 3454 3558; 3459- 3566; .3459-3558; 3459-3561 ,- 3462-3568; 3464-3561; 3441-3558 3466-3558 3470-3561; 3496-3568; 3502 -3561 464/LG: 116015.2 :2001JUN22 I I 1-119; 1-535; 27-264 : 27-228 42-409; 59-131; 60-204; 87-362; 91-264;.94 -399; 139-247; 195-685; 210-445 210-441; 217- 396; 229-517; 240-469; 242 -514; 330-542; 335-561; 335-546 431-874; 431- 643; 505-1287; 508-741; 52 7-774; 530-660; 563-881 ; 564-744 567-685; 568- 1023; 587-748; 604-1045; 6 28-1095; 631-1095; 645-1099; 646- 1098; 648-718; 657-1095; 667-1098; 669-1092; 689-1096; 707-1097; 721-1092; 739-1092; 744- 1475; 753-1065; 755-1083; 775-1093; 777-1035; 785-1075; 806-1092; 824-1099; 828-1095; 837-1095; 837-1061; 848-1091; 866-1447; 866-1008; 873-1053; 889- 1098; 900-1160; 907-1096; 913-1302; 965-1233; 1031-1105; 1049-1118; 1049- 1177; 1206-1528; 1206-1562 ; 1215-1455; 1218-1724; 1232-1496; 1305-1556; 1411-1962; 1414-1650; 1425 -1697; 1432-1972; 1504-1766; 1597-1889; 1604- 1860; 1652-1890; 1654-1948 ; 1651-1972; 1670-1972; 1681-2135; 1683-1940; 1704-1959; 1706-1997; 1708 -2136; 1745-2028; 1773-2134; 1775-1972; 1847- 2134; 1855-2134; 1891-2115 ; 1893-2134; 1902-2464; 1913-2118; 1967-2126; 1995-2703; 2011-2520; 2029 -2126; 2374-2763; 2376-2795; 2402-2484; 2404- 2643; 2421-2865; 2428-2827 ; 2442-2723; 2455-3042; 2473-2990; 2513-2774; 2545-2799; 2545-2800; 25.72 -3066; 2575-2714; 2579-2804; 2643-2893; 2671- 2909; 2711-3057; 2711-2952 ; 2717-3332; 2718-2962; 2725-3057; 2736-2951; 2738-2959; 2756-3057; 2763 -3319; 2759-3057; 2790-3057; 2825-3041; 2826- 3315; 2832-3057; 2839-2908 ; 2839-3089; 2840-3057; 2850-3188; 2887-3057; 2907-3057; 2928-3057; 2933 -3057; 2944-3310; 2964-3057; 2967-3057; 2970- 3057; 2980-3058; 1-162; 6- 77 465/LG: 1173104.15 :2001JUN22 | | 1-448; 81-473; 149-450; 156-536: 159-444;
164-477; 176-401 199-406 198-461 198-433; 199-348; 199-392 200-422;
201-428; 205-470 208-632 209-424 211-292; 221-368; 223-632 224-282;
229-631; 232-625 238-599 238-457 241-538; 259-675; 257-615 260-502;
260-493; 273-625 279-544 282-627 283-715; 291-632; 298-820 300-810; Table 3
310-476; 312-498; 313-610; 323-547; 331-540; 345-608; 369-513; 377-542; 497-582; 537-1106; 575-1187; 1096-1557; 1096-1380; 1096-1367; 1323-1550; 1047-1255 466/LG:12 85109 .14:2001JUN22 | | 1-212; 6-49 7; 97-676; 284-8 99; 297-777; 438- 726; 466- 661; 471-735; 492-1081 ; 496-972; 503-694; 503-594 ; 503-593; 503-
910; 503 720; 504-724; 503-675 503-621 04-732; 505-614; 505-851; 505- 922; 505- 658; 505-643; 505-567 505-617 05-641; 518-830; 517-727; 517- 673; 517- 576; 517-620; 518-610 518-907 20-792; 523-1048 ; 524-764; 524- 766; 524- 1045; 534-1121; 535-837; 534-822; 545-638; 550-843; 559-1115; 563- 813; 562- 804; 562-803; 572-819; 612-881; 614-855; 613-879; 617-850; 641- 1209; 641 -914; 658-1200; 689-979; 709-1337 ; 716-937; 718-1042; 737-1010;
738-1346; 787- 1037; 788-1111; 789-1077; 806-968; 819-956; 821-1180; 822- 1081; 830 -1400 826-1122; 831-1073; 843-1081; 873-1080; 877-1409; 887-1417; 889-1147; 896 1324; 892-1452; 910-1171; 935-1446; 939-1168 955-1440; 998-
1318; 1004-1437; 1023-1438; 1023-1439 1035-1280; 1039-1437; 1044-1441
1066-1276; 1075-1438; 1075-1333; 1077-1440; 1081-1451; 1094-1367; 1094-
1289; 1095-1451; 1101-1188; 1102-1411 1102-1362; 1101-1353; 1101-1260 1103-1285; 1105-1438; 1120-1374; 1126 1437; 1146-1327; 1156-1422; 1160 1440; 1160-1439; 1163-1345; 1186-1442 1222-1449; 1234-1437; 1237-1438
1257-1336; 1259-1336; 1264-1445; 1275-1437; 1304-1449; 1332-1451 467/LG:131477.11:2001JUN22 | | 1-550; 211-715; 428-1164; 512-1148; 539-1065;
674-1285; 678-1167; 712-1172; 724-1263; 727-1263 801-1107; 1012-1263; 1090-1370; 1192-1425; 1192-1638; 1212-1717; 1249 1512; 1280-4394; 1357-
1923; 1460-1692 1566-1719; 1580-1832; 1686-2266 1721-2178; 1737-2245 1765-1984; 1934 2305; 1955-2304; 1966-2225; 2094 2304; 2114-2394; 2255 2756; 2255-2789 2281-2774; 2351-2618; 2439-2698 2509-2623; 2511-3100
2525-2975; 2533-2984; 2540-2754; 2565-3029; 2567-2769; 2572-2799; 2648
3299; 2659-2797 2661-2897; 2729-2996; 2785-3091 2796-3078; 2796-3040
2833-3064; 2847-3060; 2888-3163; 2911-3122; 2960-3302;' 2963-3302; 2996
3238; 3031-3302 3036-3277; 3045-3555; 3081-3334 3091-3333; 3092-3557
3098-3368; 3143-3329; 3147-3249; 3153-3691; 3161 3759;' 3188-3756; 3207
3472; 3244-3698 3294-3764; 3298-3761; 3301-3763 3300-3717; 3319-3760 3319-3700; 3319 3763; 3321-3732; 3324-3763; 3324-3475; 3324-3685; 3324- 3760; 3328-3760 3337-3740; 3345-3560; 3354-3760 3381-3761; 3381-3760
3395-3741; 3397-3655; 3401-4010; 3407-3549; 3411 3760; 3415-3765; 3417
3689; 3417-3760 3417-3763; 3424-3720; 3432-3761 3451-3757; 3450-3657 3471-3762; 3539 3738; 3541-3721; 3541-3760; 3564 3731; 3565-4204; 3567 3760; 3578-3761 3596-3760; 3711-3760; 3774-4008 3786-4039; 3866-4081 3890-4456; 3970 4296; 3971-4521; 4033-4283; 4058 4351; 4141-4413; 4159 4781; 4182-4423 4182-4553; 4259-4501; 4271-4425 4331-4806; 4676-4923 4708-4982; 4718 4802; 4728-4960; 4735-4990; 4779-4996; 4782-4996; 4804- 4996; 4813-5260 4815-4996; 4848-4996; 4904-4996 5192-5510; 5196-5380
5196-5415; 5197-5283; 5197-5392; 5197-5411; 5197 5471; 5216-5703; 5216
5460; 5222-5517 5224-5633; 5260-5599; 5266-5744 5298-5425; 5397-5660
5561-5750
468/LG: 1333618.1: 2001JUN22 489-1081; 1-670
469/LG: 1347760.16: 2001JUN22 ' 1-648; 359-927; 539-907; 873-1491; 906-1382;
950-1582; 969-1469; 972-1570; 975-1570; 985-1530; 1052-1642; 1052-1303
1083-1673; 1092-1628; 1092-1634; 1113-1444; 1119- 1700; 1151-1442; 1151
1762; 1188-1646; 1187-1655; 1209-1671; 1190-1473: 1192-1481; 1199-1752
1200-1723; 1256-1502; 1246-1862; 1267-1606; 1273- 1783; 1275-1811; 1284
1573; 1307-1450; 1358-1655; 1358-1529; 1365-1793; 1373-1617; 1413-1592
1446-1511; 1447-1723; 1447-1712; 1448-1671; 1448- 1595; 1450-1741; 1485
1729; 1517-1670; 1550-1796; 1583-2061; 1598-1857; 1600-1884; 1600-1777
1650-1717; 1851-2447; 1851-2463; 2161-2420; 2172-2472; 2304-2468; 2319-
2439; 2111-2462
470/LG: 1383039.369 :2001JUN22 | | 1-593; 1-586; 1-489; 112-481; 112-620; 112-
625; 294-635; 419-1151; 684-938
471/LG: 1383313.3 :2001JUN22 | | 1-564; 250-701; 251-515; 371-922; 474-1070;
555-1218; 572-1153; 592-1084; 669-1077; 697-1004; 719-1270; 721-1031; 722- Table 3
1031; 743-1010; 767-1118; 793-1050; 806-1105; 813-1106; 815-1347; 836-1388; 858-1294; 954-1165; 993-1478; 1028-1487; 1028-1266; 1037-1232; 1053-1259; 1075-1639; 1086-1172; 1089-1295; 1136-1418; 1152-1300; 1159-1590; 1160-
1445; 1191-1453 1197-1766; 1292-1779 1382-1610 1385-1997; 1389-1864; 1391-1633; 1394 1997; 1409-1610; 1419 1997; 1427 1858; 1440-1780; 1509- 1997; 1533-3316 1560-1896; 1572-1870 1577-1730 1580-2182; 1595-1995; 1595-1856; 1645 2165; 1644-1868; 1660-2124; 1670-1730; 1756-1977; 1774- 2026; 1776-2012 1777-1835; 1792-2186 1792-2154 1792 -1991 1792- -1972;
1792-1889; 1792-1863; 1792-1854; 1793 2013; 1836 2322; 1839- -2457; 1839-
2333; 1839-2206 1840-2456; 1840-2332 1840-2334 1848 -2339, 1849- -2333;
1862-2336; 1886-2437; 1903-2192; 1920 2003; 1923 2372; 1922- -2017; 1924-
2301; 1924-2158 1931-3311; 1937-2146 1940-2421 1945 -2221, 1946- -2226;
1946-2162; 2009-2571; 2013-2265; 2014 2261; 2031 2542; 2040- -2323; 2057-
2550; 2069-2200 2076-2399; 2076-2272 2082-2311 2090 -2334 2094 -2220; 2121-2698; 2122 2424; 2122-2391; 2125-2385; 2139 2361; 2159- -2429; 2161- 2423; 2166-2400 2169-2492; 2170-2441 2198-2453 2202- -2588 2219- -2631;
2253-2723; 2255-2740; 2282-2547; 2304 2609; 2353 2618; 2364- -2609; 2365-
2592; 2367-2914 2397-2659; 2412-2654 2413-2526 2423- -2819 2427- -2486;
2436-2722; 2438-2710; 2439-2673; 2440-2595; 2441 2687; 2459- -2760; 2466-
2708; 2467-3018 2469-2760; 2472-2800 2485-2666 2488 -2946 2488 -2751;
2491-3009; 2525-2743; 2533-2654; 2557 2824; 2560 3054; 2570- -2830; 2579-
3136; 2587-3242 2589-2743; 2591-3176 2594-2914 2597 -2743 2599 -2743;
2607-2678; 2623-3127; 2628-2854; 2629 2861; 2657 3351; 2667- -3256; 2685-
3060; 2687-2944 2687-3273; 2687-2923 2689-3274 2694 -3232 2752 -3271; 2754-2985; 2762 3197; 2766-3148; 2766 2995; 2766 2992; 2766- -2972; 2766- 2930; 2766-2982 2780-3307; 2780-3020 2789-3275 2789 -3271 2792 -3055;
2799-3045; 2821-3271; 2821-3069; 2822 3307; 2821 3307; 2837- -3101; 2843-
3080; 2843-2959 2857-3319; 2858-3278 2858-3307 2860 -3317 2864 -3319;
2863-3307; 2865-3314; 2866-3314; 2866 3308; 2866 3123; 2866- -3003; 2869-
3315; 2872-3311 2877-3316 2880-3316 2888-3003 2888 -3330 2899 -3307; 2897-3319; 2904 3311; 2906 3311; 2907 3314; 2909-3317; 2909-3273; 2910- 3176; 2919-3278 2916-3315 2928-3314 2938-3083 2940-3306; 2943-3317; 2942-3311; 2945 3200; 2962 3071; 2962 3307; 2961 3237; 2970-3311; 2974- 3206; 2975-3311 2984-3253 2988-3311 2997-3312 2999-3314; 3005-3311; 3008-3308; 3008 3315; 3015 3316; 3015 3311; 3020 3311; 3021-3274; 3026- 3297; 3036-3311 3042-3150 3047-3244 3065-3292 3065-3317; 3069-3271; 3069-3311; 3072 3312; 3075 3275; 3077 3299; 3084 3307; 3089-3315; 3093- 3316; 3095-3307 3117-3316; 3150-3318 3165-3263 3174-3320; 3180-3310; 3192-3261; 3204-3316; 3230-3311 472/LG: 1384075.8 :2001JUN22 | | 1-500 1-486; 1-388; 3-586; 2-424; 6-464; 10- 347; 19-451; 28-484; 28-452; 28-446 28-485; 28-488; 28-490; 28-361; 41- 441; 60-407; 64-496; 71-646; 75-510 240-688; 240-863; 250-863; 331-780;
575-1099; 858-1260; 986-1224; 1034-1759; 1051-1687; 1052-1668; 1206-1762;
1378-1608; 1396-1918; 1415-1918; 1701-2003; 1730-2360; 1854-2316 1928-
2395; 1932-2436 1932-2202; 1946-2199 1949-2180 1948-2145; 1951-2399; 1954-2105; 1954 -2175; 1954-2181; 1954 2161; 1954-2439; 1954-2213 1954- 2045; 1954-2263 1954-2231; 1954-2335 1954-2295 1955-2285; 1954-2123; 1954-2005; 1954 -2111; 1954-2104; 1954 2435; 1954 2318; 1954-2094 1954- 2400; 1954-2004 1955-2434; 1955-2372 1962-2417 1964-2231; 1972-2429; 1976-2403; 1980-2430; 1981-2432; 1982 2435; 1981 2186; 1984-2435 1985-
2435; 1986-2386; 1988-2435; 1989-2359 1995-2435 1997-2435; 1997-2431;
2009-2439; 2003- 2437; 2006-2436; 2009-2360; 2009 2431; 2012-2217 2031-
2432; 2034-2435; 2043-2426; 2051-2390 2053-2439 2061-2305; 2080-2435;
2107-2428; 2127- 2437; 2150-2440; 2154 2392; 2166-2427; 2245-2359 2262-
2428; 2268-2419; 2289-2428; 2315-2428 2339-2432 2355-2436
473/LG:1384155.1:2001JUN22 || 1-124; 1-339; 25-470; 27-173; 38-333; 40-147;
40-218; 40-139; 40-175; 40-375; 40-125; 40-377; 40-475; 40-415; 63-426; 64-
518; 64-523; 92-349; 106-269; 133-383; 137-389; 145-410; 217-591; 217-429;
221-479; 228-489; 236-620; 243-445; 248-422; 249-437; 272-366; 292-567;
294-882; 294-514; 314-866; 317-560; 320-562; 324-863; 323-651; 368-644; Table 3
380-865; 391-844; 405-892; 455-907 456-903 461-907; 477-909 492-904 494-905; 500-904; 503-904; 504-910 505-907 506-916; 508-904 511-905 535-876; 562-884; 585-904; 595-907 601-904 607-866; 615-858 641-848 669-855; 671-904; 677-904; 692-909 719-879 719-904; 726-879 730-904 741-902; 804-1386; 835-904 474/LG:1385280.12:2001JUN22 507-838; 545-834; 486-824; 614-819; 497-821;
393-820 404- -820 419- -820; 487- -820; 743- -820; 295- -819 365-819 395-819 422-819 419* -819 424- -819; 594- -819; 505- -815; 373- -818 486-818 517-817 602-817 271- -817 366- -817; 368- -816; 373- -817; 501- -817 622-817 645-817 398-816 399 -816 393- -816; 421- -816; 435- -816; 451- -816 463-816 472-816 474-816 492 -816 501- -816; 527- -816; 542- -816; 524- -816 570-816 658-816 709-816 722 -816 416- -816; 363- -816; 455- -812; 389- -812 405-812 524-812 535-810 620 -810 287- -808; 493- -803; 631- -791; 271- -789 581-789 325-778 489-779 433 -776 391- -768; 303- -734; 355- -716; 271- -712 543-698 139-628 352-621 331 -610 276- -561; 1 188--_5 56655;; 227722--15 55511;; 2 28877--!5 54455;; 271-523; 278-522; 314- 500; 22-472; 60-465; 73-457; 126-420; 134-410; 147-408; 272-402; 266-398; 173-393; 126-376; 274-372; 121-375; 121-373; 4-269; 60-279; 1-257; 9-240 475/LG:1390535.25:2001JUN22 |) 1-130; 45-137; 49-349; 54-333; 56-393; 54- 268; 84-168; 185-423; 214-456; 390-452; 396-452; 364-456; 56-200; 54-189; 46-186; 51-212; 46-218; 46-229; 78-284; 196-420; 310-359; 47-284; 49-297 476/LG:1397047.1:2001JUN22 || 1-586; 66-408; 145-723; 145-575; 407-1147; 458-1146; 629-1143; 1060-1525
477/LG:1398646.15:2001JUN22 | | 1606-2246; 1606-2092; 1527-1972; 1335-1886; 1100-1644; 1036-1589; 1055-1589; 1073-1582; 1275-1498; 1269-1495; 1075- 1493; 1271-1492; 1302-1492; 1364-1492; 1054-1504; 1036-1500; 1273-1497; 1149-1497; 1166-1497; 1170-1497; 1132-1496; 1178-1495; 1087-1492; 1273- 1492; 1069-1492; 1167-1492; 1216-1492; 1385-1492; 1289-1492; 1075-1489; 1123-1489; 1030-1486; 1194-1486; 1111-1479; 902-1476; 1190-1472; 1306-1441; 928-1467; 1357-1454; 956-1452; 1039-1451; 952-1449; 1030-1449; 1197-1449; 1034-1445; 1050-1442; 813-1433; 1142-1428; 662-1417; 620-1401; 890-1395; 842-1399; 1125-1400; 891-1384; 883-1396; 886-1389; 757-1379; 1028-1390; 1181-1384; 1125-1381; 1199-1378; 1125-1353; 1118-1364; 1071-1357; 1119- 1357; 877-1348; 1030-1317; 1046-1301; 1033-1293; 1046-1289; 1033-1269; 1031-1266; 837-1208; 618-1207; 927-1172; 751-1155; 900-1136; 889-1123; 831- 1117; 877-1116; 840-1116; 795-1102; 1030-1101; 1037-1101; 676-1101; 1037-
1096; 858-1101; 786-1019; 793-1019; 866-1009; 881-1030; 798-1019; 790-1019; 807-997; 729-992; 847-978 - 652-974; 562-974; 697-971; 737-964; 723-971; 737-971; 761-971; 781-971; 833-970; 721-965; 720-933; 788-925; 545-804; 717-805; 506-791; 519-734; 159-633; 385-625; 297-591; 43-589; 1-589; 362-
583; 339-576; 300-574; 363-564; 401-559; 306-532; 300-527; 291-514; 1-506; 306-416; 291-397; 10-233; 10-163
478/LG: 1446193.10 :2001JUN22 || 1-619; 300-808; 740-1277; 832-1221; 832- 1102; 936-1277; 959-1487; 959-1433; 987-1207; 1011-1166; 1067-1270; 1180-
1762; 1187-1586; 1205-1505; 1219-1745 1219-1475 1289-1780; 1302-1535; 1318-1606; 1361-1724; 1361-1646; 1367 1547; 1370-1648; 1385-1587; 1397- 1566; 1397-1561; 1397-1692; 1399-1645 1402-1602 1402-1577; 1405-1924; 1407-1798; 1406-1600; 1406-1561; 1406 1893; 1406 1676; 1418-1675; 1419- 1670; 1441-1779; 1445-1825; 1468-1916 1492-1888 1549-1849; 1614-1917; 1623-1916; 1623-1906; 1646-1870; 1724 2112; 1741-2040; 1749-2003; 1749- 1965; 1817-2227; 1826-2489; 1848-1916 1921-2251 1922-2199; 1943-2193; 1998-2496; 2143-2514; 2143-2341; 2150 2587; 2161 2441; 2178-2913; 2200- 2464; 2229-2668; 2244-2469; 2244-2468 2244-2467 2262-2841; 2262-2419; 2269-2467; 2284-2957; 2288-2457; 2306 2520; 2309 2570; 2333-2434; 2368- 2538; 2369-2519; 2373-2563; 2373-2610 2400-2876 2404-2621; 2434-2687;
2440-2898; 2442-2683; 2444-2834; 2465-2685; 2466 3014; 2466-2734; 2493-
2970 2510-3021; 2520-3025; 2520-2739 2520-2976 2525-2755; 2541-2733; 2548 3049; 2548-2788; 2571-3025; 2587 3059; 2602 3063; 2640-2849; 2640- 2848 2646-3065; 2651-3065; 2660-3061 2660-3053 2664-2953; 2667-2862; 2699 3062; 2705-3062; 2705-3059; 2708 3062; 2711 3059; 2713-3061; 2731- 2960 2734-3060; 2738-3062; 2737-3059 2758-2986 2780-3062; 2788-3037; Table 3
2792-3023 ; 2799-3051 ; 2822-3065 ; 2839-3065 ; 2839-3047 ; 2851-3062 ; 2859- 2936 ; 2894-3015 ; 2900-3061 ; 2910-3054 ; 2914-3279 ; 2964-3279 ; 3052-3318 ; 3076-3361 ; 3099-3319 ; 3115-3279 ; 3165-3279 ; 3199-3685 ; 3201-3482 ; 3363- 3836 ; 3363-3545 ; 3383-3472 ; 3389-3905 ; 3389-3545 ; 3484-3913 ; 3495-3913 ; 3608-4027 ; 3616-3901 ; 3648-4115 ; 3659-4115 ; 3814-4050
479/LG: 1446405.14 : 2001JUN22 | | 1-450 ; 61-213 ; 82-413 ; 84-208 ; 204-303 ; 211- 477 ; 213-673 ; 245-562 ; 248-540 ; 289-809 ; 294-825 ; 304-840 ; 318-595 ; 335- 618 ; 354-590 ; 373-622 ; 376-660 ; 397-870 ; 397-638 ; 458-905 ; 481-920 ; 487- 913 ; 487-650 ; 524-857 ; 533-1134 ; 536-776 ; 564-774 ; 620-794 ; 679-867 ; 722- 1006 ; 727-906 ; 755-1050 ; 814-909 ; 912-1546 ; 911-1427 ; 930-1422 ; 932-1229 ;
930-1206 ; 930-1195 ; 930-1192 ; 930-1181 ; 932-1293 933-1221; 948-1096; 1008-
1622; 1030-1319 1040-1281 1050-1527; 1079-1590 1091-1589 1116-1592; 1117-1567; 1208 1565; 1208 1457; 1208-1447; 1208 1442; 1209 1590; 1267- 1545; 1279-1630 1288-1633 1292-1564; 1301-1565 1300-1630 1300-1599; 1313-1597; 1313 1544; 1405 1855; 1518-1801; 1554 1633; 1657-1929; 1743 2336; 1783-2272 1783-2338 1783-2348; 1783-2264 1783-2009 1783-2008; 1783-1972; 1786 2020; 1965 2372; 1980-2550; 1981-2273; 2165 2412; 2247- 2477; 2319-2901 2323-2832 2336-2866; 2372-2489 2372-2454 2464-2740; 2541-3006; 2546 2822; 2584 2998; 2708-3179; 2982 3353; 2982-3233; 3162 3725; 3246-3468 3257-3750 3257-3501; 3465-3702 3533- ■4101 3753-3859; 3801-4039; 3886 4108; 4052 4641; 4057-4273; 4060 4308; 4158 4834; 4558- 5010; 4567-5027 4730-5266 4842-5029; 4847-5312 4986-■5533 4988-5221; 5040-5597; 5052 5494; 5046 5804; 5068-5296; 5078 5348; 5133 10336; 5491- 6116; 5785-6234 5785-6150 5794-6365; 5797-5986 5802-•6344 5935-6475;
5950-6299; 5952-6248; 6000-6567; 6019-6606; 6068 6293; 6091 6682; 6219-
6669; 6282-6568 6282-6508 6376-6666; 6424-6793 6425-■6716 6434-6573; 6468-7022; 6524 6757; 6534 6793; 6558-7090; 6565 6790; 6576 7168; 6628- 6871; 6706-7073 6807-7074 6812-7084; 6857-7220 6937-•7193 6993-7508; 6993-7261; 7066 7180; 7070 7326; 7097-7692; 7099 7373; 7189 7385; 7198- 7682; 7259-7512 7345-7622 7389-7855; 7391-7676 7489-■7917 7564-8135; 7568-7861; 7585 7740; 7588 7825; 7617-7845; 7663-8046; 7804 8527; 7939- 8477; 7956-8479 8092-8526 8092-8241; 8106-8345 8124-8314 8156-8479; 8164-8508; 8210 8482; 8227 8671; 8266-8718; 8286-8451; 8342-8588; 8358 8793; 8358-8591 8429-8699 8429-8647; 8446-8558 8531-8719 8537-8780;
8537-8699; 8659-9150; 8664 8907; 8700-8969; 8703-9099; 8719 9012; 8743-
9010; 8749-9015 8820-8937 8821-9376; 8861-9097 8887-9110 8931-9491; 8943-8997; 8955 9261; 8963-9514; 8980-9369; 8980-9228; 8993 9541; 9005- 9473; 9005-9453 9027-9410 9026-9125; 9027-9267 9046-9485 9063-9322; 9067-9305; 9071 9533; 9070-9323; 9119-9414; 9123 9423; 9159 9341; 9161- 9402; 9194-9444 9196-9426 9235-9475; 9257-9525 9257-9517 9277-9530; 9306-9533; 9321 9800; 9321 9694; 9321-9533; 9334-9541; 9347 9635; 9349- 9649; 9373-9726 9373-9651 9424-9545; 9424-9526 9427-9522 9429-9531; 9464-9683; 9467 9687; 9470 9737; 9475-9707; 9477 9721; 9555 9805; 9556- 9809; 9560-9869 9563-9680 9567-9797; 9567-9786 9567-9741 9567-9821; 9567-9729; 9567 9764; 9575-9911; 9581-9971; 9579 9865; 9586 9841; 9589- 9844; 9596-9867 9596-9843 9597-9847; 9601-9777; 9634-9773 9640-9899; 9642-9944; 9642-9896; 9643-9917; 9649-10056; 9652-9940; 9681-9881; 9689- 9986; 9696-10122; 9693-9951; 9699-10169; 9698-9921; 9699-9963; 9716-10252; 9719-9973; 9724-10148; 9741-9964; 9745-9977; 9750-10311; 9752-10030; 9754-
10126; 9758-10293 9760-9991; 9761-10298; 9761-10189; 9769-10234; 9769-
10308; 9777-10296 9790-10037; 9795-10293; 9797-10254; 9805-10021; 9806-
10231; 9817-10001 9852-10336 9853-10231; 9859-10336: 9861-10336; 9862-
10275; 9870-10339 9871-10292 9880-10336; 9886-10337; 9895-10122; 9897-
10336; 9897-10343 9900-10333 9906-10342; 9911-10340; 9913-10300; 9919-
10338; 9922-10085 9927-10339 9934-10219; 9931-10339; 9936-10336; 9939-
10336; 9947-10341 9953-10337 9954-10336; 9959-10336; 9960-10333; 9964-
10170; 9975-10336 9976-10248; 9978-10232; 9982-10342; 9982-10333; 9984-
10341; 9985-10336 9995-10233; 10005-10336; 10004-10336; 10011-10299; 10011-10336; 10011-10237; 10023-10336; 10029-10336; 10040-10336; 10048- 10336; 10055-10333; 10061-10337; 10065-10336; 10069-10224; 10079-10325; Table 3
10086-10336; 10090-10303; 10098- 10336; 10100-10316; 10100-10336; 10107- 10264; 10111-10336; 10118-10229; 10135-10212; 10139-10336; 10147,-10336; 10151-10336; 10155-10336; 10200- 10335; 10212-10340; 10254-10338; 10256- 10332; 10257-10339 480/LG:1448148.1:2001JUW22 || 1- 417; 39-440; 60-289; 255-505; 436-998; 436- 701; 549-780; 754-961; 799-1053; 834-1410; 1108-1733; 1127-1593; 1127-1590; 1129-1584; 1215-1538; 1250-1379; 1256-15.75; 1281-1584; 1315-1583; 1420- 1585; 1420-1583
481/LG: 1452619.13 :2001JUN22 || 1 -167; 4-484; 310-576; 350-563; 350-584; 350-790; 672-1040; 820-1091; 858 -1082 482/LG: 1452783.22 :2001JUN22 || 1 -7068 1-6434; 44 482; 188- 3168; 514-847; 697-1324; 702-1344; 706-913; 721 -1175 873-1331; 1168- 1798; 1193-1798; 1261-1797; 1293-1798; 1413-1676; 1740 2349; 1744-2165; 1915-2545; 2211- 2724; 2239-2867; 2601-3129; 2849 -2997 3192-3426 3207-3926 ; 3261-3834; 3261-3735; 3261-4006; 3537-3967; 3742 4106; 3742 3941; 3748-4265; 3763- 4156; 3752-4161; 3886-4319; 4043 -4422 4284-4584 4400-4669 ; 4626-4884; 4682-5232; 4692-4844; 4744-5335; 4783 5136; 4783 5050; 4789-5380; 4961- 5355; 4965-5364; 5024-5358; 5034 -5174 5046-5281 5154 5376 ; 5208-5364; 5238-5355; 5246-5826; 5249-5364; 5274 5364; 5615 5793; 5634-5845; 5637- 5980; 5637-5989; 5637-5748; 5659 -6146 5687-6109 5687-6123 ; 5766-6045; 5776-6261; 5773-6390; 5805-6367; 5810 5970; 5838 6238; 5876-6146; 5918- 6380; 5945-6218; 5978-6434; 6054 -6512 6054-6315 6064-6596 ; 6234-6690; 6295-6357; 6316-6619; 6416-6658; 6475 6804; 6480 6968; 6483-6982; 6445- 6963; 6462-6960; 6524-7042; 6469 -6901 6508-7069 6486-6921 ; 6491-6979; 6497-6739; 6487-6966; 6517-6785; 6550 7030; 6550 6962; 6557-6974; 6557- 6835; 6576-6990; 6587-6991; 6593 -6931 6596-7032 6607-7034 ; 6617-6997; 6617-7040; 6620-6873; 6637-7041; 6638 7034; 6638 7032; 6642-7026; 6643- 6991; 6703-6926; 6717-6940; 6791 -7073 6795-7045 6808-7258 ; 6820-7054; 6826-7032; 6839-7077; 6857-7095; 6864 7087; 6871-7013; 6917-6987; 6883- 7093; 6905-7093; 6904-7066; 6919 -6997 6927-7042 6938-7030 ; 6938-7042; 6938-7002; 6941-7042; 34-500 483/LG:1453417.5:2001JUN22 || 1- 503; 1-630; 167-7 75; 228-773; 745-1291; 1219-1673; 1230-1599; 1230-1702; 1423- -1670; 1461- 1656 1492-1772; 1522-
1702; 1522-1759; 1522-1932 1744 -1928 1761 2015 1780-2037; 1787-2121; 1848-2120; 1908-2531; 2072 2640; 2105- -2356; 2110 2401 2148-2386; 2176- 2735; 2197-2363; 2243-2529 2245 -2441 2286 -2620 2361-2579; 2378-2991;
2454-2587; 2577-2858; 2587-2908; 2871- -3120; 2975 3252 2978-3254; 3003- 3458; 3003-3254; 3004-3268; 3075 -3612 3078 -3310 3262-3585; 3307-3588; 3323-3620; 3330-3588; 3330-3557; 3339- -3588; 3339-3592; 3357-3588; 3460-3588 484/LG:1455222.23:2001JUN22 || 1 -449; 1-286 ; 223-741; 223-511; 606-837; 606-1117; 610-840; 666-937; 1053 -1316 1066 -1338; 1195-1485; 1202-1741; 1213-1749; 1240-1750; 1256-1415; 1260- -1493; 1260-1790; 1405-1728; 1466- 1773; 1537-1790; 1571-1790; 1636 -1711 485/LG:149121.8:2001JUN22 || 1-7 69 120-337 120- 269; 184-79 8; 296-773; 321-822; 357-771; 381-780; 415-732 417-642 422-516; 422-773; 466-1014; 496-739; 505-858; 508-779; 562-8 54 587-741 636-861; 643-864; 665-998; 679-1306; 709-766; 735-1103; 787 1025; 838-1388; 887-1007; 887-1014; 1218- 1672; 1218-1601; 1228-1402; 1248 1751; 1248-1627 1248-1349 1255-1517; 1255-1513; 1257-1537; 1257-1607; 1257-1562; 1257 1437; 1257 1432; 1257- 1409; 1257-1403; 1257-1399; 1257 -1396; 1257-1345 1257-1326 1257-1321; 1257-1314; 1260-1525; 1260-1482; 1260-1450; 1262 1514; 1267 1629; 1267- 1625; 1274-1841; 1278-1523; 1278 -1478; 1278-1463 1282-1488 1286-1431; 1290-1675; 1300-1577; 1325-1842; 1329-1699; 1336-1829; 1338 1586; 1357- 1920; 1366-1534; 1386-1554; 1401 1661; 1411-1624 1414-1740 1416-1607; 1450-1854; 1451-1755; 1473-1846; 1473-1727; 1477 1775; 1484 1936; 1487- 1755; 1493-2063; 1507-1817; 1509 -1885; 1522-2152 1525-1735 1551-1730; 1556-1770; 1558-1862; 1561-2143; 1574-1956; 1591 2149; 1593 1841; 1596- 2118; 1603-1767; 1610-2229; 1611 1874; 1619-1977 1623-1984 1629-2093; 1637-1899; 1657-1749; 1672-1935; 1674-2046; 1674 2074; 1680-1933; 1680- 1839; 1681-1967; 1683-1941; 1684 -2130; 1684-1764 1684-1967 1707-2095 ; Table 3
1708-2095; 1710-1989; 1710- 2265; 1716 1963; 1721- 1976; 1721 1992; 1734
1942; 1745-2309 1757-2026; 1761- 2006 1764- 2157; 1767-2222 1767-2164 1777-2324; 1787 2009; 1789- 1981; 1792 2091; 1792- 2349; 1794 2108; 1802 2012; 1812-2091 1828-2055; 1830- 1994 1838-•2322; 1837-2174 1853-■2142
1853-2146; 1858-2113; 1862 2114; 1909 2035; 1914-2202; 1939 2193; 1941
2075; 1941-2221 1953-2199; 1955- 2161 1958-•2239; 1958-•2207 1959-•2403
1969-2254; 1977-2199; 1984-2443; 1984 2408; 1985-2301; 1984 2195; 1984
2208; 1986-2214 1988-2262; 1989- 2294 1990-•2260; 1994-2523 2002-2441
1998-2146; 2001-2390; 2006 2421; 2010 2104; 2013-2117; 2014 2254; 2014
2240; 2013-2391 2027-2518; 2028- 2182 2040- 2511; 2040- 2369 2040- 2295 2040-2293; 2040 2291; 2040-2283; 2040 2282; 2040-2273; 2040 2270; 2040 2184; 2040-2179 2040-2257; 2040- 2250 2040-■2244; 2040- 2256 2040- 2290 2040-2328; 2056 2308; 2064-2551; 2064 2317; 2079-2444; 2089 2295; 2090 2340; 2116-2552 2116-2458; 2133- 2670 2141- 2345; 2155-2431 2157- 2405
2162-2267; 2165-2486; 2171 2418; 2186 2645; 2181-2392; 2185 2718; 2185
2496 2188-2644 2189-2730; 2189- 2789 2189- 2739; 2208-2801 2208- 2439 2211 2463; 2213 2437; 2217-2489; 2235 3003; 2234-2709; 2241 2456; 2261 2536 2266-2858 2268-2577; 2268- 2561 2270-2506; 2276-•2561 2278- 2551 2286 2929; 2281 2822; 2282-2486; 2284 2835; 2291-2854; 2292 2590; 2299 2890 2305-2874 2305-2538; 2321- 2868 2332- 2777; 2352-2904 2356- 2929
2358-2769; 2366-2883; 2368 2463; 2369 2835; 2373-2665; 2385 2689; 2395
2678; 2406-2615 2408-2617; 2415- 2931 2414-2916; 2418-2914 2429- 2905
2436-2915; 2441-2889; 2441 2732; 2442 2749; 2443-2732; 2444 2690; 2446
2580; 2451-2929 2458-2918; 2459- 2929 2462-2927; 2467-2925 2470- 2932
2475-2931; 2475-2897; 2474 2567; 2476 2929; 2477-2929; 2478 2890; 2481
2929 2483-2936; 2486-2933 2490- 2933 2503-2929; 2504-2930 2504- 2925 2505 2925; 2509-2691; 2511-2764; 2511 2760; 2513-2802; 2515 2933; 2517 2928 2516-2929; 2520-2935 2526- 2942 2530-2929; 2534-2922 2536-■2929 2545 2936; 2546-2933; 2547-2925; 2547 2852; 2547-2784; 2550 2933; 2550 2820 ,2550-2781; 2564-2931 2554- 2845 2558-2929; 2560-•2929 2562-■2870
2562-2832; 2573-2784; 2575 2930; 2576 2918; 2577-2929; 2578 2998; 2583
2825 2584-2890; 2583-2848 2587- 2843 2588-2838; 2591-2934 2598- 2932 2600 2927; 2603-2934; 2604 2929; 2607 2926; 2609-2927; 2610 2929; 2611 2936 2613-2929; 2613-2823 2614- 2929 2614-2936; 2628-2933 2642- 2929 2639 2929; 2671-2928; 2669 2911; 2673 2929; 2676- 2925; 2684 2933; 2684 2902 2685-2947; 2688-2936 2728- 2936 2667-2812; 2737-2929 2740- 2929 2685 2812; 2761-2935; 2765 2888; 2771 2870; 2771- 2929; 2772 2929; 2778 2918 2786-3385; 2815-2929 2827- 2936 2837-2928; 3021-3756 3021- 3596
3124-3733; 3127-3431; 3342- 3885; 3380 3631; 3484- 3878; 3534 3997; 3760
3968 3810-3997
486/LG:1500175.18:2001JUN22 I 1-228 17-247 25 -345; 27-221; 29-576; 29-
275; 35-616; 34-290 35-292 39-286 40-260; 35 251; 40-652; 42-285; 51-
777; 53-338; 53-309 53-220 55-268 61-369; 60 304; 62-323; 65-227; 69-
523; 69-298; 70-305 69-314 69-316 70-389; 79- 396; 88-361; 94-337; 95-
565; 94-282; 95-312 96-360 99-689 120-432 129-498; 131-242; 207-660;
207- 288 209-618; 249-470 248-1912 248-514; 257-514; 258-545; 259-544; 261- 524 262-507; 264-488 265-562; 265-835; 267 -349; 266-620; 267-523; 268- 429 270-628 272-523 272-510; 275-826; 276 -763; 277-508; 279-740; 279- 700 280-590 281-513 282-571; 283-561; 283 -544; 297-671; 306-466; 308- 755 308-564 319-796 321-834; 358-605; 363 -605; 369-640; 380-657; 397- 955 421-739 448-567 452-905; 452-690; 452 -710; 453-738; 452-582; 464- 906 477-730; 476-622 515-730; 516-761; 521 -745; 542-1022; 547-1162; 557- 821 567-906; 596-1050; 609-931; 616-877 621-918; 635-907; 636-847; 639- 918 645-869; 651-959; 681-883; 690-778; 701 -1137; 729-1005; 742-1296; 749- 966 826-1087; 844-1299 ; 844-1088; 848-1153; 849-1111; 859-1126; 869- 1388; 868-1297; 895-1177; 907-1147; 915-1174; 928-1212; 937-1440; 958-1263; 965-1202; 967-1507; 986-1231; 992-1240; 992-1426 ; 1000-1417; 1007-1267; 1013-1244; 1015-1543; 1013- 1480; 1015-1236; 1016 -1296; 1037-1567; 1038- 1304; 1043-1294; 1050-1296; 1064-1332; 1063-1307 ; 1066-1267; 1066-1308; 1068-1349; 1073-1207; 1073- 1287; 1081-1567; 1092 -1323; 1099-1543; 1105- Table 3
1351; 1102-1261; 1118-1317; 1124-1256; 1131-1374; 1151-1453; 1153-1500; 1153-1533; 1198-1818; 1212-1436; 1224-1794; 1222-1505; 1236-1513; 1237- 1419; 1239-1572; 1266-1806; 1270-1856; 1271-1531; 1295-1588; 1299-1527; 1282-1823; 1282-1503; 1313-1876; 1317-1874; 1317-1868; 1317-1671; 1318- 1912; 1319-1542; 1329-1873; 1329-1869; 1328-1653; 1335-1866; 1347-1864; 1352-1792; 1371-1500; 1389-1543; 1396-1543; 1402-1543; 1406-1909; 1426- 1543; 1427-1912; 1432-1805; 1438-1912; 1438-1914; 1440-1912; 1441-1912; 1442-1911; 1441-1871; 1441-1688; 1441-1543; 1448-1909; 1451-1917; 1454- 1917; 1457-1912; 1459-1911; 1486-1915; 1487-1906; 1487-1841; 1490-1913; 1579-1911; 1585-1804; 1593-1911; 1597-1671; 1603-1909; 1603-1910; 1605- 1868; 1616-1908; 1722-1920; 1722-1912; 1722-1913; 1722-1917; 1722-1846; 1722-1916; 1722-1915; 1722-1909; 1722-1897; 1722-1860; 1722-1853; 1722- 1927; 1726-1910; 1751-1884; 1756-1815; 1762-1914; 1766-1877; 1771-1868; 1786-1912; 1799-1864
487/LG: 1500434.6 :2001JUN22 || 1-519; 41-388; 71-404; 106-450; 176-904; 182- 519; 359-831; 359-895; 456-890; 502-617; 505-751; 752-1097; 865-1435; 865- 1256; 868-1150; 903-1359; 952-1397; 953-1418; 966-1233; 1007-1415; 1112- 1398; 1131-1367; 1158-1387; 1160-1420; 1224-1476; 1332-1456; 1352-1732; 1354-1583; 1369-1640; 1382-1962; 1595-2060; 1614-1878; 1616-1973; 1655- 1858; 1698-1922; 1723-2302; 1776-2280; 1779-2000; 1779-1999; 1827-2068; 1835-2346; 1835-2057; 1867-2139; 1968-2250; 1984-2458; 2018-2296; 2042- 2291; 2076-2455; 2081-2404; 2104-2411; 2129-2407; 2140-2404; 2147-2354; 2167-2431; 2190-2449; 2245-2682; 2254-2682; 2353-2864; 2396-2603; 2414- 2593; 2434-2708; 2440-3052; 2502-2743; 2502-2647; 2572-2825; 2572-2965; 2572-2776; 2589-2871; 2627-2921; 2628-2836; 2639-2742; 2679-2907; 2741- 2970; 2749-3320; 2764-3276; 2766-2995; 2801-3057; 2876-3151; 2923-3160; 2923-3270; 2928-3214; 2951-3146; 2985-3270; 2986-3258; 3016-3269; 3024- 3344; 3024-3261; 3024-3273; 3033-3589; 3051-3292; 3084-3307; 3102-3349; 3111-3362; 3114-3411; 3119-3592; 3119-3472; 3122-3565; 3134-3706; 3140- 3327; 3141-3351; 3141-3522; 3141-3327; 3143-3375; 3160-3471; 3188-3419; 3208-3792; 3208-3733; 3212-3467; 3232-3468; 3233-3787; 3291-3775; 3305- 3509; 3345-3573; 3345-3769; 3348-3811; 3349-3812; 3360-3811; 3363-3819; 3364-3775; 3366-3812; 3392-3805; 3392-3622; 3392-3845; 3393-3785; 3411- 3749; 3433-3816; 3443-3811; 3450-3811; 3452-3831; 3460-3811; 3466-3627; 3469-3680; 3480-3776; 3489-3811; 3496-3811; 3497-3805; 3506-3809; 3534- 3812; 3548-3848; 3552-3805; 3552-3811; 3555-3708; 3573-3806; 3574-3782; 3588-3808; 3600-3812; 3609-3771; 3622-3815; 3688-3771; 3695-3811; 3695- 3805; 3704-3803; 3714-3796; 3725-3809; 3728-3811
488/LG:1501550.19:2001JUN22 || 4601-4881; 4617-4869; 4551-4846; 4571-4846; 4520-4845; 4694-4845; 4242-4839; 4245-4839; 4605-4811; 4570-4808; 4069- 4685; 4144-4623; 4494-4623; 4149-4568; 4041-4565; 4161-4562; 4181-4559; 4301-4559; 4066-4530; 4183-4388; 3897-4384; 3857-4377; 4138-4364; 3883- 4325; 4148-4282; 3881-4259; 3650-4206; 3725-4174; 3726-4165; 3857-4159; 3607-4110; 3845-4094; 3629-4039; 3864-3964; 3866-3964; 3837-3938; 3333- 3778; 3280-3651; 3157-3651; 3295-3645; 3314-3644; 3184-3620; 3191-3646; 3243-3644; 3203-3643; 3255-3641; 3136-3595; 3297-3580; 2938-3544; 2957- 3504; 3255-3502; 3248-3497; 2956-3486; 2640-3257; 2792-3226; 2728-3152; 2578-3114; 2728-3010; 2798-3008; 2235-2816; 2582-2798; 2300-2779; 2468- 2705; 2302-2571; 2305-2554; 1951-2524; 2120-2421; 2164-2421; 2165-2421; 2130-2363; 2130-2308; 1650-2202; 1625-2057; 1485-2018; 1481-2018; 1606- 1895; 1108-1697; 1220-1532; 1253-1386; 911-1380; 1220-1348; 926-1329; 686- 1180; 594-1091; 719-1091; 722-1091; 846-1091; 903-1091; 1030-1091; 1031- 1091; 691-1091; 539-1074; 540-1072; 463-1072; 588-1050; 562-1045; 635-1029; 747-955; 688-851; 560-832; 449-705; 1-559; 403-558; 235-540; 352-542 489/LG:1501923.26:2001JUN22 || 262-612; 1-421; 1-414; 1-412; 1-392; 1-344; 1-308; 1-283
490/LG: 150960.9 :2001JUN22 || 1-525; 47-546; 96-346; 125-255; 246-498; 274- 622; 275-478; 275-409; 275-376; 290-556; 293-395; 298-542; 299-574; 303- 555; 304-672; 315-745; 315-630; 317-619; 335-923; 334-568; 335-931; 360- 596; 368-613; 408-620; 435-706; 442-1021; 485-794; 487-751; 490-710; 493- Table 3
676; 493-1021; 493-715; 523-901; 552-753; 581-648; 583-896; 580-789; 603- 1162; 611-786; 630-1001; 651-896; 678-958; 709-969; 728-1169; 735-1209; 735-987; 741-1014; 804-1074; 807-1012; 835-1014; 844-1023; 847-962; 951- 1358; 951-1144; 968-1121; 977-1193; 1039-1144; 1071-1163; 1073-1163; 1076- 1490; 1098-1433; 1099-1163; 1107-1570; 1225-1489; 1233-1522; 1280-1685; 1278-1736; 1287-1593; 1289-1593; 1294-1684; 1295-1594; 1298-1594; 1299- 1691; 1304-1590; 1307-1593; 1308-1684; 1308-1644; 1311-1457; 1311-141! 1311-1409; 1311-1374; 1311-1672; 1311-1681; 1311-1623; 1311-1596; 1311- 1594; 1311-1591; 1311-1590; 1311-1585; 1311-1575; 1311-1567; 1311-1497; 1311-1450; 1315-1542; 1312-1998; 1328-1627; 1329-1597; 1329-1592; 1341- 1609; 1344-1762; 1349-1596; 1349-1595; 1349-1556; 1357-1672; 1362-1751; 1363-1766; 1363-1724; 1363-1556; 1364-1593; 1365-1734; 1368-1556; 1386- 1556; 1388-1653; 1393-1556; 1400-1759; 1402-1902; 1430-1724; 1444-1590; 1457-1651; 1460-1685; 1474-1712; 1478-1758; 1484-2006; 1484-1703; 1509- 1599; 1529-1748; 1545-2247; 1563-2018; 1567-1993; 1578-1753; 1581-2149; 1585-1758; 1602-2012; 1602-1851; 1639-1756; 1639-1716; 1649-1900; 1655- 2005; 1688-2136; 1687-1843; 1697-1953; 1704-1936; 1710-1990; 1713-2231; 1718-2212; 1727-1974; 1734-2017; 1745-1932; 1751-1971; 1751-1961; 1775- 2020; 1795-2026; 1795-2088; 1807-2055; 1814-2036; 1816-2270; 1818-2267; 1820-2270; 1823-2022; 1836-2078; 1839-2228; 1844-2266; 1850-2267; 1852- 2039; 1853-2267; 1856-2289; 1857-2289; 1876-2267; 1880-2266; 1892-2272; 1903-2272; 1952-2264; 2034-2280; 2208-2260
491/LG: 182744.29 :2001JUN22 | | 1-543; 1-577; 5-272; 5-273; 28-566; 386-842; 386-626; 386-565; 386-546; 386-437; 425-641; 431-810; 431-728; 502-956; 534-956; 598-1062; 611-1056; 612-1059; 618-1267; 618-1059; 684-1059; 802- 1019; 908-1457; 1061-1555; 1063-1294; 1107-1284; 1227-1705; 1291-1908; 1461-2077; 1927-2158 492/LG: 197166.1:2001JUN22 | | 1-256
493/LG:197455.5:2001JU 22 | j 3-490; 3-399; 1-410; 28-220; 34-526; 48-796.; 77-2.93; 80-362; 95-612; 311-582; 507-1141; 533-1176; 682-1034 494/LG: 198251.8 :2001JUN22 | | 1-558; 86-619; 104-623; 104-608; 105-383; 108-
368; 113-661 120-277; 125-519; 136-594; 147-681; 160-514; 170-689; 181-
459; 191-250 240-538; 310-605; 310-593; 312-431; 312-444; 322-484; 343-
•681-; 343-576 357-503; 416-671; 416-674; 475-664; 558-1146; 564-816;' 576-
825; 618-922 679-935; 788-931; 993-1519; 1010-1608; 1023-1283; 1023-1678; 1042-1292; 1046-1301; 1051-1549; 1052-1324; 1052-1337; 1053-1323; 1059- 1680; 1071-1610; 1070-1706; 1069-1706; 1076-1312; 1083-1678; 1081-1317; 1101-1364; 1100-1531; 1112-1681; 1111-1343; 1114-1420; 1124-1393; 1129- 1708; 1143-1425; 1145-1712; 1145-1753; 1156-1420; 1159-1435; 1175-1443; 1179-1751; 1179-1442; 1182-1746; 1187-1620; 1191-1769; 1197-1765; 1200- 1441; 1202-1531; 1203-1454; 1206-1514; 1209-1492; 1211-1425; 1209-1493; 1213-1425; 1220-1743; 1224-1463; 1227-1702; 1231-1504; 1235-1753; 123! 1785; 1243-1427; 1244-1495; 1264-1562; 1268-1520; 1274-1476; 1276-1526; 1281-1486; 1295-1523; 1301-1733; 1309-1750; 1315-1538; 1320-1595; 1321- 1784; 1326-1784; 1332-1784; 1333-1789; 1333-1551; 1337-1791; 1344-1791; 1345-1739; 1355-1710; 1354-1770; 1354-1614; 1356-1784; 1357-1607; 1358- 1784; 1364-1784; 1365-1606; 1367-1784; 1374-1787; 1376-1784; 1377-1787; 1382-1628; 1386-1785; 1386-1639; 1394-1784; 1415-1784; 1420-1784; 1440- 1786; 1439-1686; 1440-1697; 1448-1790; 1452-1746; 1455-1757; 1465-1784; 1465-1739; 1465-1692; 1465-1691; 1468-1784; 1469-1713; 1475-1789; 1485- 1789; 1485-1738; 1485-1723; 1488-1740; 1488-1703; 1492-1734; 1494-1762; 1496-1789; 1497-1790; 1497-1784; 1513-1758; 1521-1782; 1534-1774; 1549- 1774; 1549-1765; 1553-1784; 1562-1787; 1567-1790; 1589-1789; 1592-1784; 1592-1776
495/LG: 200149.3 :2001JUN22 | | 1-581; 172-279; 205-760; 212-423; 231-811; 233-838; 232-950; 233-535; 236-475; 234-562; 241-809; 246-514; 255-403; 687-942; 882-1368; 884-1185; 887-1081; 906-1098; 1019-1493; 1024-1202; 1112-1370; 1209-1503; 1209-1518; 1247-1612; 1263-1520; 1302-1773; 1320- 1860; 1344-1767; 1342-1923; 1371-3563; 1376-1618; 1467-1728; 1471-1553; 1472-1730; 1480-1766; 1482-1586; 1483-1879; 1489-1586; 1502-1877; 1573- Table 3
2137; 1639-1833; 1642-1826; 1856-2196; 1891-2174; 2051 -2283 2051 2246 2058-2409; 2058-2303; 2064-2306; 2107-2480; 2115-2372; 2127-2700; 2146 2409; 2205-2438; 2379-2937; 2532-2757; 2562-2824; 2564 3071 2598 2901 2603-2857; 2610-3221; 2612-3047; 2612-2819; 2621-2805; 2627-2938; 2656- 3037; 2662-3077; 2667-3034; 2667-2876; 2693-2944; 2719 3198 2745 -2959 2781-3015; 2815-3245; 2816-3074; 2847-3448; 2849-3101; 2864-3300; 2864- 3090; 2890-3059; 2890-2977; 2894-3217; 2902-3183; 2902 3477 2902 -3497 2902-3148; 2912-3233; 2917-3087; 2926-3477; 2956-3292; 2974-3206; 2975 3074; 2982-3248; 2985-3505; 2987-3163; 2995-3101; 2994 3448 2994 -3347 2994-3333; 3007-3269; 3024-3431; 3024-3281; 3052-3307; 3066-3524; 3063 3563; 3118-3377; 3120-3296; 3124-3320; 3134-3376; 3135 -3362 3139 -3614 3139-3360; 3148-3619; 3154-3601; 3161-3427; 3179-3563; 3183-3762; 3210- 3578; 3229-3372; 3232-3563; 3240-3563; 3240-3468; 3267 -3738 3288 -3563 3292-3777; 3297-3780; 3299-3563; 3308-3779; 3309-3778; 3310 3784; 3315 3587; 3321-3563; 3323-3784; 3323-3783; 3327-3784; 3332 -3600 3343 -3783 3344-3777; 3347-3781; 3347-3785; 3355-3713; 3358-3782; 3358-3733; 3362 3563; 3368-3781; 3367-3784; 3391-3780; 3389-3781; 3399 -3781 3410 -3740 3427-3699; 3429-3782; 3446-3781; 3446-3782; 3462-3563; 3479 3779; 3478 3781; 3491-4117; 3494-3779; 3505-3781; 3506-3781; 3512 -3796 3656 3782 3663-3777; 3663-3781; 3663-3783; 3681-3733; 3686-3779; 3852-4117 496/LG:203483.3:2001JUN22 || 1-505; 87-799; 245-719; 3 16-726; 361 -596; 598- 1159; 686-1341; 718-1252; 723-1005; 884-1570; 977-1470 ; 981-1491; 1052- 1578; 1163-1492; 1273-1865; 1397-1869; 1486-1621; 1602 -1884 ; 1602-1969; 1650-1904; 1726-1908; 1726-1905; 1834-1892; 1834-1889; 1834-1905 497/LG:209701.7:2001JUN22 || 1-254; 20-305; 42-601; 33 9-902 ; 511- 1000; 550- 753; 578-850; 586-1025; 678-1042; 723-1186; 723-983; 7 78-924; 907-1211; 938-1387; 956-1337; 979-1512; 1316-1533; 1316-1488 498/LG:210614.1:2001JUN22 || 1-262; 1-422; 14-258 ; 21- 435; 190-869; 769- 1177;' 771-876; 782-1188; 914-1177; 966-1177 499/LG:210672.1:2001JUN22 || 1-266; 16-487; 16-30 5; 16-3 09; 16-228 ; 16-212; 27-214;' 123-645; 125-395; 154-788; 154-320; 191-359; 338-877; 391- 919; 464- 893; 566-1102; 588-836; 606-855; 1047-1194; 1145-1650; 1145-1253; 1462- 1645; 1486-2160; 1489-1758; 1526-1994; 1638-2339; 1931-2384; 2325- 2424 500/LG: 215051.10 :2001JUN22 | | 1-538; 1-640; 472-757; 500-701; 502- 733; 504- 697; 515-784; 632-938; 638-1072; 687-858; 752-1298; 780-1240; 781- 1240; 783-1240; 798-1222; 825-1071; 830-1127; 842-1087; 904-1156; 921-12 40; 930- 1408; 964-1241; 964-1195; 966-1570; 1040-1536; 1042-1463 ; 1040-147 0; 1098- 1652; 1182-1343; 1197-1836; 1198-1641; 1217-1613; 1222-1605; 1270- 1725; 1271-1530; 1293-1534; 1314-1578; 1315-1587; 1324-1537; 1341-1952; 1342 1584; 1354-1555; 1358-1494; 1381-2107; 1376-1610; 1397-2100; 1496- 1583 1562-2189; 1573-1860; 1588-2016; 1612-2147; 1618-2152; 1626-2148; 1684- 1913; 1703-1874; 1709-2125; 1732-1931; 1739-2185; 1738-2185; 1747- 2191 1754-2185; 1789-2185; 1793-2189; 1795-2189; 1835-2087; 1886-2185; 1895- 2183; 2000-2188; 2043-2185; 2069-2185; 1653-2189; 1743-2185; 1691- 2035 2010-2170; 1655-2189; 1185-1470 501/LG:218989.3:2001JUN22 || 1-96; 1-520; 4 -515; 5-593; 17-402; 75-641; 75- 655; 179-716; 230-768; 289-520; 292-578; 423-716; 502-568; 503-568; 497- 583; 504-595; 504-583; 504-617; 504-561; 504-560; 504-559; 504-557; 465- 712; 517-574; 519-590
502/LG:228107.11:2001JUN22 || 1-482; 1-355; 1-455 ; 1-277 ; 1-138 ; 7-233 ; 20- 397; 20-292; 134-350; 149-471; 221-451; 390 -843 ; 410-923 ; 538-1101'; 659- 1151; 684-937; 770-892; 889-1047; 998-1593; 1000-1181 ; 1060-1506 ; 1269- 1863; 1274-1657; 1403-1966; 1589-2241; 1655 -2134 ; 2002-2293 ; 2042-2242 ; 2096-2292; 2096-2428; 2162-2336; 2327-2966; 2454-2854 ; 2500-2770 ; 2673- 2852; 2733-3282; 2860-3085; 2969-3087; 2975 -3085 ; 3032-3087
503/LG: 231016.1:2001JUN22 I 1-619 ; 1-145 ; 439-913 ; 450-570 ; 455-735 ; 468- 907; 572-911
504/LG: 235943.60 :2001JUN22 | I 1-438 ; 16-383 285-422 ; 306-848 ; 313-549 ; 334-608; 334-833; 445-700; 449-918 ; 465-758 468-603 ; 477-771 ; 478-762 ; 494-613; 518-782; 543-1050; 545-784 ; 571-823 ; 572-838 ; 579-1090 ; 594-1046 ; Table 3
612-852; 620-887; 650-862; 650-791; 666-1088; 667-1088; 675-1091; 705-1090; 748-1089; 796-955; 799-1087; 817-1088; 817-1080; 833-1083; 854-1089; 861- 1080; 860-1081; 975-1081
505/LG:235970.14:200UUN22 || 1648-2041; 1648-2039; 1598-2038; 1594-2035; 1940-1993; 1629-1939; 1594-1925; 1429-1671; 948-1547; 1409-1485; 1134-1443; 1221-1439; 983-1433; 986-1436; 1125-1436; 1218-1436; 1056-1434; 1323-1433; 1202-1429; 985-1429; 978-1429; 997-1429; 1011-1429; 1051-1429; 1059-1429; 1045-1429; 1100-1429; 1124-1429; 1163-1429; 1221-1429; 1253-1429; 1273- 1429; 1274-1429; 1109-1429; 1245-1429; 1314-1429; 1086-1427; 1074-1427; 1173-1427; 1264-1424; 1220-1420; 964-1417; 975-1415; 1167-1415; 942-1402; 1221-1404; 1218-1402; 809-1385; 724-1404; 844-1394; 826-1390; 964-1388; 861-1386; 876-1386; 775-1386; 884-1383; 882-1381; 816-1379; 1286-1380; 945- 1378; 838-1377; 1100-1372; 784-1358; 818-1357; 945-1344; 992-1340; 875-
1336; 957-1323; 762-1317; 1087-1322; 665-1300; 1047-1285; 1048-1276; 988-
1279; 1020-1274;: 988-1272; 997-1258; 990-1246; 960-1236; 951-1227; 972-
1224; 952-1213; 1132-1210; 1038-1174; 629-1154; 871-1154-; 913-1148; 909-
1142; 637-1134; 544-1118; 881-1113; 859-1094; 589-1088; 836-1091; 602-1086;
913-1085; 568-1082; 807-1071; 495-1066; 497-1066; 837-1067; 632-1059; 803-
1058; 653-1042; 496-1034; 470-1023; 495-1014; 752-1004; 419-987; 416-986;
727-962 503-970; 706-955 428-944; 817-941; 661-924; 589-913 386-906 436-902 437-863; 286-849 370-831; .624-810; 310-803; 614-799 582-795 547-792 542-789; 560-786 617-774; 339-771; 512-756; 547-748 468-746 544-744 497-744; 456-704 1-549
506/LG: 236697.15 :2001JUN22 || 1901-2047; 1646-1996; 1908-1999; 1527-1998;
1648-1998; 1795-1998; 1575-1997; 1664-1997; 1545-1995; 1656-1995; 1699-
1994; 1889-1995; 1638-1994; 1763-1993; 1527-1993; 1550-1993 1575- 1992 1643-1991; 1627-1992; 1699-1992; 1900-1992; 1546-1992; 1534 1990; 1538 1990; 1646-1990; 1693-1990; 1570-1992; 1585-1991; 1661-1990 1886- 1990 1513-1990; 1546-1990 ;' 1699-1990 ; 1646-1989; 1612-1985; 1539 1985; 1647- 1985; 1574-1985; 1616-1985; 1554-1985; 1905-1983; 1646-1984 1652- 1981 1692-1981; 1368-1978; 1704-1975; 1761-1975; 1635-1973; 1893 1973; 1575 1965; 1615-1959; 1467-1951; 1309-1951; 1425-1952; 1886-1952 1730- 1950 1631-1920; 1657-1904; 1449-1891; 1223-1889; 1646-189'2; 1375 1887; 1657 1888; 1339-1865; 1349-1855; 1586-1858; 1608-1849; 1430-1845 1589- 1816 1429-1815; 1392-1818; 1430-1812; 1503-1748; 1419-1793; 1496 1792; 1178 1750; 1276-1743; 1245-1737; 1264-1737; 1621-1736; 1305-1736 1227-■1736 1293-1736; 1405-1736; 1255-1735; 1263-1735; 1282-1734; 1450 1736; 1490 1731; 1344-1730; 1356-1730; 1363-1730; 1365-1730; 1412-1730 1351- 1730 1616-1730; 1188-1730; 1318-1730; 1328-1730; 1320-1730; 1424 1730; 1557 1730; 1474-1728; 1492-1721; 1446-1717; 1106-1716; 1168-1701 1345-■1697 1433-1694; 1084-1688; 1368-1674; 1317-1672; 1378-1670; 1364 1657; 1368 1656; 1085-1639; 1386-1639; 1367-1635; 1334-1634; 1365-1626 1070-•1628
1430-1614; 1383-1611; 1392-1610; 1507-1600; 1345-1590; 1338-1572; 1328
1565; 1364-1573; 1483-1567; 1281-1522; 1292-1551; 1292-1540 1247-1512
1294-1511 1397-1527; 1410-1536; 1347-1546; 909-1547; 1298-1511; 1277-149! 1006-1521 1108-1455; 1213-1455; 1277-1455; 1209-1452 : 1197-1441; 976-1440 1133-1433 1186-1426; 949-1426; 1185-1425; 1166-1424; 1091-1419; 1151-1419 1174-1418 1170-1418; 1155-1411; 1089-1464; 1224-1406; 905-1443; 1362-1426
1054-1401 961-1439; 1229-1400; 1231-1397; 1151-1395; 1093-1393; 1118-1390
1022-1379 887-1379; 1018-1425; 1216-1375; 1010-1363; 1163-1355; 1230-1352
1176-1351 1191-1328; 1164-1327; 715-1348; 1167-1312; 1092-1340; 1071-1335
1278-1354 1029-1326; 1019-1324; 657-1322; 1016-1312; 1035-1303; 1011-1289
705-1274 990-1273; 1050-1273;' 1010-1276; 1032-1276; 1036-1272; 1040-1273;
942-1258 1017-1264; 727-1237; 982-1228; 996-1235; 936-1200; 1067-1194;
720-1187 704-1187; 941-1168; 962-1164; 982-1142; 1025-1142; 870-1143; 574- 1129; 802-1082; 793-1065; 824-1064; 805-1060; 765-1039; 626-1036; 791-1036; 817-1036; 738-1034; 538-1013; 738-985; 469-981; 727-975; 786-1047; 671-945; 503-928; 367-896; 763-893; 594-873; 586-867; 587-867; 503-852; 323-851 466-851; 535-818; 485-817; 566-816; 366-799; 496-772; 495-735; 379-724 574-708; 464-698; 470-694; 451-693; 432-693; 395-691; 433-686; 383-681 Table 3
393-673; 419-652 ; 458-629 ; 387-628 ; 61-490 ; 22-473 ; 1-433 ; 128-386 ; 156-
385; 102 3-379; 15 6-234 ; 156-228
507/LG:2 338576.3: 2001JUN22 I I 1-455 ; 190-452
508/LG:2 338602.2: 2001JUN22 j j 1-187 ; 1-559 ; 2-289 ; 2-270 ; 13-390 ; 15-283 ;
16-269; 16-166; 17-282 ; 17-108 ; 21-1294 ; 21-207 ; 23-278 ; 45-542 ; 33-276 ;
34-583; 34-293; 34-276 ; 34-273 ; 36-271 ; 34-263 ; 34-243 ; 35-304 ; 38-579 ; 36-
321; 36- -310 36- 307; 36-298 36-294 36-288 36-291; 36-151; 37-356; 36
290 37 -260 37- 243; 37-154 38-345 38-314 38-296;' 38-297; 38-289; 38 283 38 -294 39- 342; 39-304 39-310 39-284 39-272; 39-263; 39-241; 39 204 42 -143 4 411-- 321; 41-617 41-339 41-283 41-308; 41-276; 44-572; 45 519 43 -280 4400-- 288; 43-432 43-398 43-310 43-273; 43-249; 43-214; 43 170 44 -286 4455-- 601; 45-297 45-288 45-280 42-302; 46-301; 46-298; 48 461 49 -305 4477-- 276; 49-338 49-332 49-306 49-312; 49-248; 49-247; 50 343 50 -339 5500-- 326; 50-320 50-269 51-560 51-359; 52-357; 52-298; 54 295 53 -283 5544-- 260; 54-321 54-296 58-249 60-272; 62-376; 62-314; 62 307 67 -692 6699-- 581; 71-311 73-249 88-632 104-293 112-41C ); 132-320;
157-676 157-361 ; 169 -680 181-437 180-358 192-568 232-83C ); 271-795; 273-546 280-512 ; 280 -776 280-548 298-540 355-600 356-61" ; 358-617; 363-605 371-485 387 -608 394-687 400-609 412-639 426-60: ; 433-641; 435-541 440-766 477 -674 490-931; 490-741 504-1062; 508-636; 513-655
514-785; 535-723 525 -773 525-725; 535-819 548-956 5 54455--8877"7 ';; 554477--881122;;
548-796; 548-776 572 -1081; 566-768 567-821; 608-844; 611-855; 626-1187;
617-836; 622-902 641 -925; 646-856; 651-880; 666-1264; 660-875; 683-955;
685-937; 703-1264; 692-946; 708-1290; 699-858; 703-960; 723-1292; 734-1262
739-1262 748-1041; 759-1019; 770-1078; 771-1069; 773-1019; 774-1264; 774- 1002 774-1071; 774-1064; 774-1044; 774-1015; 774-1014; 775-1261; 775-1043
775- 042; 775-1029; 775-1022; 776-1058; 777-1048; 778-1271; 779-1262; 779- 1016 780-1317; 781-1278; .780-1051; 781-1046; 781-1047; 781-1025; 787-1056
777-910; 789-1208 789-1064; 795-1275; 796-1086; 796-1032; 796-1026; 803-
1208 804-1194; 807-1005; 807-1056; 848-1293; 848-1210; 851-1300; 850-1294
355-1295; 853-1300; 856-1302; 858-1309; 859-1287; 863-1316; 865-1300; 877-
1185 885-1294; 895-1300; 897-1302; 910-1300; 912-1300; 918-1263; 918-1180
923-1303; 925-1300; 926-1295; 928-1294; 934-1303; 938-1244; 945-1163; 951- 1233; 964-1238; 974-1303; 974-1228; 977-1279; 998-1266; 1001-1294; 1011- 1252; 1034-1311 1032-1285; 1033-1200 1040-1252; 1045-1300 1045-1470; 1072-1285; 1079 1300; 1092-1294 1100 1300; 1118-1412; 1121-1295; 1124 1306; 1137-1300 1144-1241; 1155-1266 1168-1450; 1180-1300 1190-1303; 1194-1301; 1199- 1454; 1206-1288 1207 1495; 1212-1394; 1226-1486; 1233 1300; 1233-1294 1257-1306; 1312-1486 1380-1892; 1772-1962 1778-2265; 1778-2016; 1780 1951; 1792-2309 1792 2215; 1792-2034; 1793 1970; 1792- 1960; 1792-1897 1799-2210; 1800-2124 1800-1936; 1801-2207 1801-2060; 1803-2036; 1808- 2001; 1808-1943 1828-2076; 1828-2075; 1836 2106; 1853- 1943; 1863-2090; 1876-2130; 1876-2075 1900-2011 1900-2139 1905-2198;
1910-2147; 1941-2213; 1982-2221 2001 2249; 2010 2304; 2023 2287; 2057-
2525; 2060-2528; 2061-2530; 2062-2316 2065-2529 2073-2539 2076-2525; 2076-2313; 2077- 2535; 2081-2529; 2081 2539; 2085 2523; 2100 2525; 2104- 2532; 2107-2525; 2108-2528; 2114-2528 2113-2532 2119-2525 2121-2521; 2123-2528; 2134- 2532; 2146-2222 2150-2557; 2151-2525; 2151 2332; 2162- 2544; 2164-2528; 2172-2525; 2175-2525 2179-2624; 2187-2630 2188-2582; 2237-2525; 2252- 2544; 2263-2533 2271 2521; 2271-2529; 2316-2677; 2329- 2525; 2336-2624; 2349-2532; 2371-2525 2448-2847 509/LG:241291.46 :2001JUW22 || 1-147; 94-641; 190-508; 203-354; 221-287; 262-392; 311-622 ; 477-932; 539-1821; 545-1102; 589-1101; 596-1233; 603- 1133; 614-1207; 615-1204; 625-1190; 631-1231; 647-1157; 659-1282; 666-1289 674-1287; 679-12 54; 681-1199; 682-1208 682-1048; 682-1163; 695-1495; 702- 1316; 700-1195; 703-1320; 703-1196; 722-1286; 731-1358; 733-1285; 737-1286 739-1353; 733-13 53; 739-1003; 761-1287 763-1411; 769-1226; 768-1319; 773- 1402; 773-1220; 790-1231; 796-1445; 806-1353; 808-1427; 812-1418; 814-1137 818-1216; 826-13 95; 844-1376; 856-1474 859-1341; 861-1398; 871-1491; 877- 1302; 878-1294; 880-1338; 881-1497; 881-1452; 886-1352; 887-1452; 887-1354 Table 3
890-1467 ; 893 -1173 ; 895-1353 ; 896-1429 ; 897-1473 ; 899-1397 ; 902-1479 ; 908-
1161 896-1508; 910-1424; 911-1517; 908-1176; 911-1475; 912-1437; 913-1424;
918-1180 ; 918-1166 ; 919-1031 ; 918-996 ; 918-1174 ; 920-1521 ; 924-1176 ; 925-
1083 931-1227; 934-1476; 938-1507; 941-1611; 941-1548; 942-1454; 941-1316;
947-1235 ; 948-1195 ; 950-1473 ; 962-1513 ; 958-1429 ; 957-1352 ; 961-1435 ; 963-
1479 964-1559; 964-1414; 977-1483; 984-1517; 987-1377; 985-1219; 989-1231;
989-1269 ; 991-1235 ; 993-1255 ; 991-1251 ; 1004-1126 ; 997-1554 990-1597; 992-
1597 1007-1524 1015-1216; 1006-1258 1016-1293;' 1003-1581 1016-1256;
1010-1584; 1006-1424; 1010-1475; 1028-1521; 1030-1314; 1022 1621; 1035-
1288 1037-1565 1038-1521; 1039-1431 1060-1448; 1059-1475 1048-1613; 1061 1475; 1048 1611; 1047-1727; 1046 1613; 1051-1471; 1067 1200; 1055- 1655 1076-1367 1065-1629; 1084-1281 1074-1667; 1075-1654 1078-1601; 1078 1714; 1079 1586; 1092-1295; -1082 1598; 1095-1474; 1083 1662; 1110- 1596 1092-1595 1111-1236; 1101-1634 1101-1708; 1101-1655 1113-1390; 1105 1588; 1117 1416; 1130-1507; 1116-1285; 1124-1474; 1118 1611; 1124- 1653 1124-1635 1123-1764; 1129-1577 1132-1594; 1139-1666 1143-1766; 1155 1703; 1144 1691; 1146-1437; 1152 1274; 1155-1761; 1157 1695; 1163- 1835 1164-1746 1166-1797; 1168-1757 1168-1718; 1168-1594 1170-1754; 1177 1696; 1174 1447; 1179-1815; 1179-1827; 1188-1738; 1187 1790; 1187- 1708 1188-1621 1186-1840; 1191-1446 1213-1704; 1206-1730 1205-1862; 1211 1752; 1215 1661; 1219-1581; 1217-1846; 1222-1602; 1226 1844; 1234- 1835 1243-1609 1237-1735; 1238-1626 1238-1659; 1241-1463 1241-1602; 1241 1717; 1247 1622; 1246-1887; 1252 1896; 1261-1504; 1264 1856; 1273- 1486 1281-1387 1284-1856; 1284-1852 1287-1605; 1289-1915 1291-1853; 1293 1620; 1296 1607; 1295-1860; 1296 1872; 1296-1914; 1301 1613; 1301- 1619 1308-1846 1311-1909; 1318-1878 1320-1856; 1322-1858 1319-1581; 1324 1937; 1324 1558; 1331-1877; 1332 1885; 1343-1858; 1347 1860; 1347- 1779 1354-1925 1360-1853; 1371-1588 1373-1860; 1386-1497 1368-1877; 1378 1516; 1382-1885; 1403-1621; 1402 1599; 1418-1779; 1420 1818; 1442- 1901 1498-1761 1497-1621; 1506-1864 1510-1752; 1531-1795 1524-1876; 1528 1776; 1546 1820; 1544-1769; 1555-1833; 1562-1820; 1574 1820; 1589- 2045 1616-2053 1628-1820; 1643-1824 1640-1849; 1705-1865 1762-2327; 1809 1861; 1851 2150; 1859-2112; 1846 2427; 1881-2036; 1883-2043; 1884 2450 1868-2314 1886-2113; 1893-1973 1894-2119; 1884-2375 1910-2187;
1910-2164; 1903 2441; 1922-2184; 1923 2149; 1934-2167; 1941-2436; 1934
2173 1942-2323 1946-2210; 1946-2179 1947-2191; 1951-2197 1946- 2374; 1963 2204; 1963 2202; 1947-2552; 1951-2541; 1969-2226; 1969 2209; 1973- 2216 1957-2421 1976-2284; 1978-2247 1978-2270; 1979-2257 1980- 2248;
1980-2128; 1982 2261; 1983-2213; 1985 2215; 1986-2237; 1986 2215; 1987-
2267 1987-2225 1987-2216; 1987-2247 1987-2209; 1987-2240 1987-■2239; 1987 2208; 1987 2206; 1987-2210; 1987 2250; 1988-2239; 1988 2237; 1988- 2212 1988-2243 1989-2202; 1993-2211 1993-2237; 1995-2347 1994- 2505; 2035 2632; 1995 2247; 1995-2343; 1995-2198; 1995-2192; 1995 2224; 1996- 2255 1995-2250 1996-2232; 1995-2249 1996-2249; 2001-2456 1997- 2058; 1997 2252; 1996-2230; 1997-2269; 1997-2255; 1998-2246; 1997 2248; 1998- 2173 1983-2446 1999-2266; 2001-2259 1983-2318; 2001-2184 2001- 2213; 2001 2235; 1989 2540; 2005-2205; 2005-2289; 2007-2259; 2006-2297; 1991 2269 2011-2256 1993-2438; 2012-2117 1995-2341; 2012-2266 2013- -2270
1998-2556; 1999 2543; 2015-2251; 2001 2397; 2001-2594; 2001 2481; 2017-
2256 1999-2343 2004-2251; 2005-2259 2005-2591; 2006-2326 2006- -2479
2006-2454; 2005 2066; 2006-2453; 2023-2262; 2022-2224; 2008 2297; 2025
2298 2024-2209 2008-2255; 2008-2276 2026-2164; 2025-2285 2010- -2299
2015-2591; 2031 2209; 2033-2209; 2017-2338; 2016-2261; 2038 2244; 2039
2327 2021-2229 2022-2568; 2022-2274 2022-2302; 2048-2218 2038- -2168 2023 -2269; 2023-2275; 2023-2483; 2039 2210; 2039-2237; 2023 2328; 2023 2239 2023-2234 2025-2553; 2025-2269 2026-2678; 2024-2270 2027- -2174
2026-2261; 2045 2292; 2029-2263; 2047-2303; 2031-2539; 2031 2635; 2031
2294 2031-2457 2048-2305; 2031-2264 2032-2384; 2048-2233 2048- -2301 2032 2598; 2048 2282; 2048-2291; 2048 2222; 2031-2301; 2048 2276; 2048 2209 2048-2237 2031-2275; 2049-2298 2048-2206; 2048-2174 2049- -2286 Table 3
2031- 2252; 2033- 2298; 2048- -2197; 2049- -2291; 2050- -2286; 2031- -2632; 2050-
2373; 2050- -2250; 2050- -2303, 2050- -2271; 2049- -2214, 2050- -2295, 2032- -2277;
2050- -2293; 2051- -2202; 2051- -2299; 2051- -2324; 2050- -2309; 2051- -2294; 2036-
2291; 2053- -2224; 2037- -2361, 2053- -2304; 2053- -2145, 2038 -2284, 2038- -2296;
2040- -2292; 2052- -2480; 2055- -2117; 2041- -2293; 2041- -2262; 2039- -2290; 2041-
2269; 2041- -2264; 2042- -2621, 2042- -2209; 2042- -2287; 2057- -2253, 2042- -2271;
2041- -2297; 2042- -2291; 2042- -2593; 2043- -2239; 2042- -2267; 2043- -2274; 2042-
2298, 2047- -15476; 2044-2337; 2044-230C ); 2044-2288; 2042-2288; 2042-2279;
2042- -2270; 2044- -2309; 2045- -2302; 2048- -2286; 2045- -2313; 2045- -2265; 2045-
2493, 2046- -2299; 2048- -2493, 2047- -2301; 2048- -2662; 2047- -2272, 2047- -2252;
2048- -2296; 2048- -2269; 2048- -2300; 2047- -2298; 2048- -2306; 2048- -2512; 2048-
2302; 2048- -2268; 2048- -2304, 2048- -2278; 2048- -2253; 2048- -2259; 2048- -2297;
2048- -2313; 2048- -2498; 2049- -2311; 2049- -2615; 2050- -2324; 2066- -2300; 2048-
2287, 2048- -2256, 2066- -2301, 2051- -2325, 2051- -2307, 2051- -2337, 2051- -2289;
2051- -2311; 2052- -2284; 2052- -2118; 2069- -2340; 2052- -2568; 2052- -2308; 2052-
2299, 2052- -2291; 2053- -2263, 2051- -2304; 2055- -2196; 2052- -2274; 2053- -2338;
2055- -2609; 2053- -2325; 2055- -2337; 2057- -2209; 2055- -2290; 2070- -2297; 2056-
2604 2053- -2337, 2060 -2647 2060- -2330; 2062- -2673, 2062- -2307, 2062- -2303;
2063- -2131; 2080- -2163; 2067- -2305; 2067- -2195; 2067- -2316; 2069- -2343; 2069-
2329, 2068- -2311, 2069- -2579, 2070- -2326, 2069- -2272, 2069- -2295, 2070- -2373;
2069- -2327; 2069- -2326; 2078- -2595; 2069- -2328; 2069- -2256; 2072- -2373; 2071-
2346, 2087- -2294, 2073- -2727 2072- -2553; 2072- -2326, 2073- -2563, 2072- -2363;
2072- -2414; 2071- -2255; 2072- -2356; 2074- -2360; 2074- -2290; 2091- -2322; 2076-
2346 2077 -2421, 2077 -2326 2079- -2399, 2077- -2318 2077 -2255 2079- -2328;
2080- -2339; 2081- -2338; 2081- -2571; 2083- -2304; 2082- -2426; 2098- -2154; 2085-
2270, 2087- -2190, 2087- -2308 2087- -2306, 2088- -2199, 2090- -2393, 2092- -2636;
2091- -2347; 2092- -2677; 2094- -2349; 2092- -2248; 2093- -2304; 2094- -2278; 2094-
2341 2096 -2326 2098 -2382 2098 -2383, 2101 -2576 2101 -2423 2103- -2380;
2121- -2220; 2121- -2346; 2112- -2345; 2127- -2346; 2114- -2384; 2114- -2366; 2130-
2264 2120 -2265 2120 -2343 2120- -2333, 2121 -2364 2123 -2406 2126- -2755;
2127- -2361; 2129- -2378; 2129- -2362; 2161- -2241; 2145- -2347; 2150- -2345; 2152-
2398 .2158- -2441, 2154- -2398 2157- -2332, 2157- -2360, 2163 -2375, 2159- -2440;
2162- -2735; 2160- -2418; 2168- -2613; 2167- -2611; 2183- -2317; 2185- -2655; 2174-
2698 2174 -2422 2175 -2683 2188 -2594 2183 -2440 2182 -2353 2184 -2476;
2188- -2706; 2188- -2382; 2188- -2656; 2192- -2466; 2199- -2456; 2205- -2769; 2205-
2636 2207 -2325 2204 -2458 2205- -2483 2206 -2481, 2206 -2442 2211- -2742;
2209- -2457; 2215- -2483; 2215- -2455; 2217- -2476; 2218- -2419; 2215- -2290; 2227-
2523, 2227 -2421, 2245 -2484, 2248- -2824, 2247- -2564, 2250 -2896, 2251- -2394;
2248- -2430; 2247- -2512; 2248- -2431; 2252- -2736; 2253- -2521; 2254- -2607; 2255-
2514 2256 -2415 2257 -2792 2254 -2458 2256 -2492 2256 -2500 2263 -2842;
2270- -2802; 2271- -2758; 2270- -2829; 2268- -2562; 2278- -2337; 2279- -2483; 2278-
2493 2282 -2590 2282 -2535 2283 -2537 2301 -2457 2285 -2723 2285- -2549;
2282- -2609; 2282- -2542; 2285- -2558; 2288- -2639; 2288- -2399; 2293- -2531; 2295-
2392 2295 -2477 2296 -2533 2295 -2525 2297 -2545 2300 -2457 2300- -2506;
2305- -2399; 2307- -2730; 2305- -2535; 2307- -2592; 2314- -2556; 2310- -2464; 2312-
2554 2313 -2755 2314 -2558 2312 -2553 2315 -2556 2321 -2880 2320- -2600;
2322- -2550; 2323- -2466; 2323- -2555; 2324- -2862; 2322- -2563; 2327- -2424; 2333-
2449 2329 -2560 2336 -2870 2337 -2477 2339 -2578, 2344 -2720 2345- -2713;
2346- -2602; 2345- -2468; 2345- -2578; 2353- -2756; 2353- -2612; 2354- -2863; 2354-
2864 • 2354 -2591 2352 -2579 2352 -2576 2352 -2544 2357 -2627 2358 -2440;
2359- -2843; 2358- -2573; 2362- -2602; 2362- -2612; 2372- -2858; 2363- -2615; 2361-
2469 2369 -2570 2369 -2464 2371 -2545 2368 -2569 2370 -2579 2372 -2971;
2376- -2539; 2375- -2623; 2376- -2620; 2377- -2505; 2377- -2509; 2376- -2583; 2375-
2594 2377 -2605 2375 -2598 2377 -2607 2379 -2932 2380 -2620 2377 -2532;
2382- -2637; 2387- -2911; 2388- -2616; 2389- -2585; 2390- -2633; 2390- -2791; 2390-
2888 2390 -2840 2390 -2598 2406 -2515 2377 -3005 2407 -2515 2394 -2626;
2401- -2610; 2403- -2622; 2406- -2692; 2406- -2613; 2415- -2796; 2419- -2633; 2419-
2621 2418 -2561 2419 -2661 2420 -2667 2419 -2589 2421 -2680 2424 -2554;
2429- -2646; 2429- -2636; 2429- -2706; 2429- -2642; 2430- -2660; 2437- -2645; 2441-
2693 2442 -2664 2440 -2586 2450 -2522 2452 -2679 2453 -2626 2454 -2592; Table 3
2457 2770; 2457 2708; 2461- 2681; 2461 2731; 2467 2864; 2471 2639; 2476 2572 2479 -2567 2479- 2626; 2481- 2673 2481- 2698 2486- 2608 2494- 2738 2498 2879; 2528 2832; 2524-2724; 2524 2681; 2528 2635; 2517 2851; 2537 2647 2539 -2772 2539- 2777; 2542- 2647 2547- 2796 2559- 2835 2560- 2617 2568 2701; 2572 2818; 2580- 2663; 2590 2788; 2603 2840; 2605 2713; 2605 2837 2610 -2856 2612- 2865; 2615- 2832 2616- 2821 2616- 2754 2616- 2822 2634 2815; 2636 2852; 2628-2975; 2646 2756; 2657 3048; 2783 3016; 2799 3370 2799 -3074 2839- 3089; 2843- 3029 2853- 3071 2854- 3216 2858- 3102 2858 3076; 2865 3019; 2866-3120; 2866 3019; 2868 3018; 2885 3052; 2884 3123 2889 -3129 2900- 3044; 2922- 3164 2922- 3161 2934- 3198 2925- 3162 2948 3158; 2953 3077; 2961- 3100; 3024 3528; 3017 3207; 3020 3190; 3035 3255 3048 -3677 3034- 3107; 3051- 3277 3054- 3352 3055- 3520 3055- 3588 3057 3616; 3057 3530; 3063- 3531; 3064 3231; 3068 3452; 3069 3655; 3055 3352 3068 -3629 3064- 3152; 3079- 3587 3081- 3207 3082- 3333 3085- 3466 3085 3529; 3086 3560; 3089- 3354; 3103 3414; 3090 3531; 3096 3518; 3085 3405 3100 -3436 3112- 3378; 3116- 3370 3121- 3503 3127- 3532 3132- 3381 3141 3377; 3120 3400; 3146- 3528; 3157 3518; 3157 3489; 3163 3529; 3165 3526 3152 -3263 3171- 3398; 3174- 3425 3174- 3520 3173- 3433 3177- 3468 3178 3440; 3178 3418; 3182- 3282; 3183 3526; 3190 3405; 3190 3520; 3179 3520 3192 -3348 3210- 3414; 3208- 3427 3209- 3529 3209- 3525 3211- 3313 3213 3526; 3189 3489; 3215- 3432; 3215 3449; 3217 3495; 3216 3520; 3218 3526 3218 -3450 3218- 3445; 3194- 3399 3219- 3532 3224- 3494 3228- 3469 3232 3519; 3233 3498; 3225- 3485; 3237 3528; 3239 3526; 3219 3417; 3233 3395 3244 -3530 3266- 3514; 3268- 3526 3268- 3533 3271- 3527 3259- 3479 3286 3526; 3268 3433; 3295-3916; 3296 3520; 3301 3535; 3306 3528; 3305 3540 3309 -3575 3309- 3529; 3308- 3528 3316- 3522 3319- 3528 3326- 3526 3326 3520; 3307 3527; 3332-3525; 3334 3530; 3337 3501; 3339 3520; 3340 3524 3343 -3535 3347- 3521; 3349- 3526 3349- 3430 3349- 3533 3340- 3467 3341 3620; 3355 3532; 3357-3530; 3355 3526; 3356 3526; 3356 3533; 3358 3520 3358 -3531 3366- 3841; 3359- 3531 3361- 3492 3361- 3526 3363- 3520 3366 3838; 3367 3508; 3366-3533; 3366 3526; 3368 3531; 3366 3528; 3368 3535 3368 -3543 3368- 3513; 3377- 3520 3368- 3478 3383- 3526 3361- 3496 3384 3519; 3386 3523; 3393-3458; 3400 3526; 3409 3526; 3416 3526; 3418 3641 3418 -3529 3419- 3524; 3396- 3527 3418- 3526 3425- 3520 3432- 3590 3438 3526; 3440 3528; 3442-3526; 3441 3610; 3444 3529; 3446 3525; 3438 3529 3453 -3535 3454- 3520; 3454- 3525 3455- 3526 3460- 3526 3463- 3526 3465 3712; 3470 3520; 3470- 3531; 3482 4005; 3513 4172; 3513 3816; 3526 3808 3544 -4158 3578- 4114; 3586- 3849 3627- 4111 3642- 4040 3688- 3889 3693 3792; 3694 3970; 3706-4167; 3706 3959; 3748 4295; 3762 4279; 3775 3881 3813 -4412 3828- 3913; 3845- 4153 3848- 4122 3847- 4001 3858- 3989 3864 4493; 3869 4462; 3880-4314; 3887 4416; 3890 4151; 3896 4361; 3913 4463 3925 -4435 3927- 4228; 3932- 4007 3940- 4363 3968- 4453 3990- 4647 4005 4281; 4023 4243; 4031-4119; 4036 4283; 4050 4468; 4066 4691; 4105 4380 4108 -4158 4118- 4634; 4118- 4398 4159- 4707 4161- 4453 4158- 4788 4176 4457; 4184 4683; 4221-4797; 4224 4775; 4233 4816; 4236 4528; 4238 4521 4238 -4459 4238- 4385; 4294- 4781 4301- 4491 4303- 4574 4316- 4647 4322 4537; 4326 4587; 4331- 4582; 4344 4583; 4344 4609; 4378 4651; 4390 4664 4410 -4935 4408- 4478; 4410- 4634 4409- 4944 4410- 4931 4428- 4625 4428 4662; 4429 4707; 4493-4768; 4493 4766; 4501 4746; 4535 4904; 4549 4780 4552 -5142 4553- 5024; 4555- 5000 4558- 4773 4571- 4712 4574- 4819 4596 5160; 4603 4766; 4602- 4845; 4610 4829; 4620 4893; 4623 4969; 4631 5114 4631 -4840 4632- 4883; 4632- 5104 4640- 5005 4662- 4903 4686- 4957 4697 4890; 4736 5233; 4785- 5048; 4790 5025; 4800 5023; 4809 5246; 4805 5438 4820 -5088 4829- 5087; 4829- 5059 4836- 5331 4856- 4996 4889- 5082 4891 5040; 4891 5035; 4894- 5478; 4904 5263; 4904 5122; 4909 5028; 4922 5090 4940 -5545 4936- 5355; 4943- 5143 4945- 5177 4958- 5200 4958- 5196 4968 5275; 4974 5272; 4975- 5463; 4981 5322; 4995 5286; 4995 5285; 5033 5263 5060 -5213 5059- 5196; 5061- 5719 5072- 5306 5076- 5308 5085- 5175 5086 5341; 5097 5283; 5098- 5426; 5104 5315; 5098 5365; 5128 5297; 5135 5488 5148 -5508 5158- 5762; 5165- 5428 5174- 5431 5193- 5474 5198- 5411 Table 3
5200 5426; 5200- 5516; 5201 5505; 5206-5542; 5209-5468; 5216-5452; 5210-
5487 5242-5485; 5243 5499 5248 5460; 5263-5927; 5283-5749; 5278-5543;
5283 5676; 5289-5771; 5308 5852; 5309-5835; 5323-5797; 5323-5635; 5323-
5834 5326-5621; 5331 5834 5350 5692; 5362-5728; 5354-5794; 5357-5835;
5355-5851; 5365-5736; 5369 5835; 5376-5834; 5377-5632; 5395-5834; 5400-
5790 5408-5834; 5407 5934 5414 5835; 5425-5836; 5424-5837; 5428-5680;
5429-5836; 5430- 5839; 5434 5834; 5435-5704; 5439-5835; 5439-5790; 5440-
5711 5441-5918; 5484-5835 5490-5834; 5493-5836; 5496-6049; 5498-5749;
5507 5836; 5514-5840; 5524 5836; 5545-6065; 5547-5805; 5554-5708; 5564-
6050 5564-5789; 5573-5840 5591 5835; 5594-5872; 5597-6074; 5602-6085;
5605-5834; 5620- 6051; 5649-5823; 5653-5904; 5654-5854; 5670-5935; 5673-
5935 5670-6190; 5671-6162 5690 6237; 5694-5757; 5697-5936; 5700-5835;
5722 5980; 5731-5938; 5749 5835; 5770-5841; 5771-6332; 5804-6224; 5823-
6028 5847-5924; 5884-6239 5906 6471; 5915-6220; 5936-6482; 5956-6311;
5972-6177; 5981-6200; 5992 6238; 6004-6482; 6007-6261; 6042-6601; 6053-
6298 6054-6240; 6104-6482 6105 6283; 6105-6574; 6152-6482; 6211-6711;
6211 6462; 6212-6457; 6215 6480; 6229-6826; 6242-6401; 6244-6765; 6247-
6813 6272-6745; 6277-6356 6298 6581; 6326-6867; 6330-6826; 6330-6786;
6340 6395; 6345- 6482; 6347-6780; 6361-6482; 6377-6482; 6385-6782; 6397-
6469 6427-6482; 6524-6803 6522 6779; 6524-7074; 6525-6736; 6526-6806;
6526 6749; 6524-7138; 6531 6584; 6531-6726; 6642-6862; 6642-6997; 6660-
6924 6660-7194; 6660-6886 6660 7063; 6661-6816; 6665-7061; 6697-7137;
6704 6879; 6712-6931; 6715 7231; 6722-7305; 6727-7270; 6737-7262; 6737-
7233 6739-7087; 6750-6998 6776-7210; 6823-7253; 6840-7094; 6915-7449;
6919-7509; 6914-7273; 6973-7206; 7010-7509; 7000-7061; 7151-7373; 7297-
7725 7317-7542; 7314-7959 7346-7916; 7388-7825; 7481-7916; 7485-7870;
7495-7916; 7503-7949; 7596-7802; 7596-8026; 7628-7868; 7650-7916; 7732-
7916 7769-7949; 7848-8141 2107-2350; 2017-2302; 2387-2610; 2010-2069;
3458 3526; 2048-2293; 3460 3529; 7848-7916; 3461-3526; 3466-3529; 3466-
3528 2397-2457; 3469-3528 3467-3523: 3470-3526; 3461-3514; 3473-3526;
2033-2127; 3471-3520; 2674 2767; 3428-3520; 7827-7916; 2816-2903; 3433-
3520 3443-3529; 2215 2300 1832 1917; 3446-3529; 7319-7375; 2048-2126;
3447 3525; 2671-2748; 7841 7916; 3433-3510; 3453-3526; 2002-2076; 2697-
2756 2038-2147; 1898 1969 2167-2272; 3419-3525; 2978-3083; 2028-2120;
3425-3526; 7814-7916; 1995 2096; 3429-3527; 3415-3514; 3428-3526; 3429-
3526 2840-2935; 3430 3526 3309-3405; 960-1055; 3428-3522; 3284-3409; 571-
696; 2059-2182; 3179-3301; 3407-3529; 3431-3530; 3408-3529; 2543-2663;
3408-3526; 3084-3203; 2898-3012; 2876-2989; 7596-7709; 2692-2804; 2059-
2172 2910-3021; 3130-3256 2831-2943; 2517-2635; 3397-3507; 3299-3412;
2042 2158; 2048-2185; 3386 3524; 3121-3258; 2994-3130; 1378-1513; 2884-
3018 3394-3526; 2723-2856 3271-3403; 3398-3529; 7784-7916; 3397-3527;
2757 2884; 3117-3246; 2207-2336; 3260-3389; 3394-3523; 2356-2483; 3124-
3251 2573-2722; 2856-3005 3362-3509; 3378-3526; 7795-7943; 888-1035;
3383-3529; 2958-3104; 3383-3527; 2310-2453; 3384-3529; 2069-2212; 3268-
3411 3385-3529; 2956-3095 3383-3525; 2865-3005; 2050-2189; 2351-2490;
3387 3526; 3193-3332; 2800 2958; 3085-3242; 3201-3358; 3194-3351; 3371-
3526 3364-3520; 1963-2098 3109-3264; 2540-2693; 2889-3032; 2848-3000;
3325 3477; 3369-3520; 3375-3526; 2868-3019; 2094-2244; 3373-3520; 2885-
3054 3355-3523; 3359-3529 3358-3526; 3357-3526; 1518-1684; 3359-3526;
3358 3524; 2842-3008; 3361 3529; 1988-2154; 2353-2517; 3092-3258; 3020-
3185 2955-3120; 3032-3196 3275-3436; 2843-3006; 2855-3018; 3362-3523;
3156 3317; 3359-3520; 3365 3520; 3352-3529; 2279-2455; 1863-2039; 2501-
2677 3351-3526; 3357-3531 2557-2731; 3355-3527; 2051-2224; 3266-3439;
2018 2190; 2282-2454; 2025-2196; 2147-2318; 2312-2483; 2844-3014; 7630-
7800 2891-3062; 3359-3527 2025 2195; 2371-2540; 3343-3526; 2739-2921;
3352-3526; 1988-2170; 2697 2878; 2279-2459; 2059-2239; 2209-2389; 3366-
3529 2780-2959; 3226-3405 2050 2228; 2247-2424; 2033-2211; 3222-3399;
2480 2671; 2023-2214; 2959-3149; 3336-3526; 2063-2253; 2734-2924; 2024-
2199 2812-3001; 3337-3526 3338 3526; 2777-2966; 3330-3520; 2978-3165;
3339 3526; 3333-3519; 3334 3520; 2364-2549; 3341-3526; 2464-2648; 3327- Table 3
3523; 3346- -3531; 2820- -3015; 1680-1866 ; 2815-3009 ; 7755-7948 3196 -3390;
2138- -2332; 2048- -2242; 3189- 3376 ; 2147-2341 ; 2442-2635 ; 7870 7959; 3336-
3529; 1988- -2180; 3346- -3526; 2054-2246 ; 2184-2375 ; 2974-3175 3157-3359;
2598- -2799; 2280- -2480; 2161- 2361; 2963-3163 ; 3329-3529 ; 3045 3245; 2146-
2345; 3321- -3520; 2959- -3155; 3212-3411; 3183-3382 3060-3259 2537-2736;
2011- -2209; 2225- -2422; 2068-2265; 1994-2190; 2219 2415; 3329-3526; 3224-
3420, 2130- -2326, 2068- -2259; 3321-3526; 2842-3047 7762-7959 3324-3529;
3107- -3311; 2028- -2233; 1940-2144; 3222-3425; 3329 3528; 2131 2324; 2564-
2767, 2977- -3180, 3324- -3526; 2254-2456; 1997-2199 3328-3529 7139-7340;
2404- -2605; 7618- -7819; 1980-2181; 3325-3530; 2424 2633; 2772 2981; 2778-
2987, 3311- -3520, 2042- -2254; 3064-3273; 2360-2568 2001-2209 2048-2258;
2431- -2639; 3152- -3360; 2045-2251; 3313-3520; 2048 2254; 2086-2293; 2165-
2372, 2811- -3017, 2141- -2347; 7137-7205; 3107-3320 2038-2251 3229-3430;
1921- -2134; 2050- -2263; 2053-2265; 3309-3520; 1654 1857; 2049-2261; 7769-
7959, 2993- -3205, 3291- -3502; 2188-2399; 3318-3529 3308-3519 1879-2089;
2131- -2341; 3063- -3273; 2703- 2913; 2677-2887; 2390-2600; 2417 2626; 3198-
3415, 3027- -3244, 3310- -3526; 2801-3017 3109-3325 2751-2965 2125-2336;
3149- -3364; 3305- -3520; 2253-2468; 1989 2203 3190 3403; 7351-7571; 2139-
2359, 3307- -3526, 2048- -2267; 2158-2376 2052-2270 2051-2269 2288-2506;
3308- -3526; 2126- -2344; 2139-2356; 2001 2219 3244 3461; 3222 3445; 2161-
2384, 2969- -3191, 2114- -2337; 2418-2640 2736-2958 3356-3528 2865-3087;
3189- -3406; 2218- -2440; 2279-2500; 2323 2544 3059 3270; 2254-2475; 2786-
3007, 3306- -3526, 3104- -3324; 3197-3422 1951-2176 2721-2947 2690-2915;
2104- -2329; 3167- -3392; 2084-2309; 2129 2354; 2045 2269; 3167 3391; 2888-
3112, 2001- -2225 3301- -3525; 2080-2304 2215-2439 2033-2256 2025-2248;
1986- -2210; 3229- -3451; 1912-2141; 3304-3532 3296-3524; 1926-2154; 3009-
3237, 2955- -3181, 2000- -2227; 789-1017; 3276 3503; 2023-2250; 1659-1871;
2557- -2783; 2048- -2274; 2117-2348; 3274-3505 2041-2272; 2057-2287; 2039-
2269, 3188- -3417, 2904- -3134; 2137-2367; 2040-2269 2452- 2681 3005 3234;
2116- -2345; 2923- •3152; 2559-2788; 3295-3524; 2106 2335; 2557 2786; 3095-
3328 2157 -2390 2570 -2801; 1636-1857; 2522-2755 2050-•2283 2902 3135;
2130- -2363; 2712- -2947; 2131-2363; 2258-2490; 2947 3179; 2045 2277; 2961-
3193 2361 -2592 3085 -3316; 2033-2264; 2327-2562 2048-■2283 2295 2530;
2732- -2967; 2733- -2968; 2248-2483; 2923-3158; 1910 2145; 2077 2311; 3295-
3529 3065 -3299 3286 -3520; 1653-1871; 2778-3012 3291- 3525 2635 2869;
2527- -2761; 2385- -2612; 2418-2652; 3292-3526; 1679 1901; 2091 2325; 2255-
2489 3218 -3453 2872 -3102; 2031-2265; 2077-2310 7418-•7657 3086 3323;
2744- -2981; 2455- -2693; 3236-3473; 2539-2776; 2016 2253; 2253 2490; 2420-
2657 2044 -2281 3118 -3354; 1949-2185; 2457-2693 2496-■2733 2665 2901;
3552- -3788; 2462- -2698; 2376- 2612; 2068-2304; 2098-2331; 3055 3294; 2918-
3157 2749 -2988 2028 -2267; 2050-2289; 2463-2702; 1994-2233 2127 2365;
2085- -2323; 3079- -3317; 2157-2395; 2561-2799; 2985-3223; 2780 3018; 3033-
3271 2476 -2714 3288 -3526; 2051-2290; 2013-2251; 2642-2883 2625 2867;
2167- -2408; 3105- -3346; 2678-2919; 2888-3129; 2247-2488; 894-1107; 2098-2339;
2616- -2857; 2958- -3199; 3288-3527; 2956-3196; 2991-3227; 2865-3108; 2052-
2294 1631 -1859 2138 -2381; 3283-3526; 2303-2546; 2027-2269; 2280 2522;
698-936; 2048-2290; 2979-3221; 2023-2266; 2042-2283; 1630-1859; 2126-2371;
2155- -2400; 2590- -2835; 3289-3530; 2042-2286; 2764-3008; 3260-3505; 2161-
2405 2130 -2374 2165 -2409; 3282-3526; 2143-2387 3140-3384 2039-2283;
3191- -3435; 2444- -2688; 3270-3513; 2732-2974; 2533 2774; 1949 2196; 3194-
3441 2914 -3158 2483 -2730; 2322-2568; 3001-3247 2040-2287 2213-2459;
1918- -2162; 2048- -2294; 3280-3526; 2184-2430; 2593 2839; 2203 2440; 2295-
2540 2884 -3129 2109 -2357; 3254-3502; 2950-3198 2235-2483 2098-2346;
2019- -2267; 2050- -2298; 3211- 3459; 1895-2143; 3037-3237; 2071 2318; 3271-
3519 2003 -2250 3283 -3531; 2302-2549; 2734-2981 2868-3115 1987-2234;
2217- -2464; 2751- -2981; 2204- 2456; 7438-7571; 2980-3230; 3078-3327; 2050-
2299 3123 -3372 3261 -3511; 3065-3314; 2378-2626; 2114-2363; 2706-2945;
2051- -2300; 2681- -2931; 2599-2847; 2853-3105; 2943-3195; 3084-3337; 2079-
2330 2700 -2952 3112 -3363; 2581-2832; 3221-3472; 2090-2341; 2098-2348;
2001- -2252; 2813- -3064; 2522-2773; 2642-2893; 3270-3521; ■ 2085-2335; 2065- Table 3
2315, 2069- -2319, 3279 -3529, 2154- -2404 2024 -2274 2058 -2311, 2699 -2953;
3245- -3499; 2561- -2814; 3089- -3343; 2948- -3201; 2833- -3085; 3273- -3526; 1979-
2232, 3222- -3475, 2041- -2294, 1998- -2250, 2044 -2296 2070 -2322, 2094 -2346;
2989- -3241; 2069- -2321; 2050- -2302; 3279- -3527; 2076- -2328; 2450- -2702; 3019-
3271, 2279- -2529 3250 -3502, 3010- -3266 2143 -2398 2734 -2980, 2006 -2261;
2042- -2297; 3176- -3422; 3259- -3511; 2621- -2876; 2819- -3074; 2987- -3242; 1987-
2242, 2749- -3000, 2009 -2264, 2526- -2780 2563 -2817 2051- -2305, 3079- -3333;
3278- -3527; 2098- -2352; 2164- -2418; 2104- -2362; 3006- -3264; 2103- -2357; 2951-
3209, 2199 -2452 2169 -2426, 2141- -2398 2139 -2396 2251- -2508, 2152- -2409;
7596- -7743; 2059- -2315; 2085- -2341; 1956- -2212; 2099- -2355; 506-762; 2365-2621;
2776- -3023; 2153- -2412; 2268- -2523; 2139- -2398; 2249- -2501; 2058- -2318; 2084-
2343, 2973- -3232, 2053- -2313, 2045- -2304, 2911- -3170, 2328- -2587, 2253- -2512;
2052- -2311; 3182- -3440; 2070- -2329; 2041- -2299; 2041- -2273; 2757- -3018; 1615-
1863 1987 -2248 3265 -3526, 2582- -2843 2063 -2323 3134- -3380, 1897- -2136;
2049- -2310; 2442- -2702; 1965- -2225; 458-721; 2537-2796; 2041-2304; 2886-3149;
2207- -2470; 2478- -2741; 2098- -2361; 2080- -2342; 2140- -2391; 2756- -3018; 3263-
3525, 2282 -2544, 2681 -2939, 3058- -3320, 2087- -2349, 2888- -3149, 2036- -2298;
2792- -3039; 3153- -3414; 2980- -3241; 2096- -2361; 2377- -2642; 1920- -2185; 2744-
3008, 1942- -2207, 2027 -2291, 2373- -2636, 2251 -2515, 1980- -2245, 7137- -7261;
2207- -2469; 2665- -2928; 2981- -3248; 2395- -2662; 2098- -2365; 2122- -2388; 2451-
2718 2032 -2298 2885 -3151 2329- -2595 2751 -3017 2459- -2725, 2072 -2338;
2024- -2290; 2050- -2315; 2025- -2290; 2099- -2364; 2072- -2337; 2268- -2533; 2079-
2344 2052 -2321 2295 -2564 2350- -2620 2419 -2688 2695- -2963, 2743 -3011;
1949- -2217; 2427- -2695; 2057- -2325; 2153- -2421; 3106- -3374; 2077- -2345; 2371-
2638, 1988- -2255, 2384 -2651, 7297- -7564, 2106- -2373, 2612- -2879, 1619- -1872;
2824- -3091; 2025- -2292; 2039- -2310; 2069- -2339; 2138- -2409; 1978- -2249; 2260-
2530 2104 -2374 2087 -2357 2039- -2309 1978 -2248 2050- -2320 2044 -2314;
2048- -2318; 2954- -3224; 2028- -2297; 3264- -3526; 2211- -2480; 2152- -2420; 1598-
1861 2330- -2600 1982 -2251 2438- -2711 2054 -2327 2374- -2635 2217 -2489;
2743- -3015; 2064- -2334; 2461- -2733; 2775- -3047; 2025- -2296; 7755- -7860; 1427-
1697 3266 -3526, 2139 -2410 2962- -3233 3145 -3416 2437- -2708 2049 -2320;
2048- -2319; 3143- -3416; 1992- -2267; 2050- -2325; 2351- -2626; 3252- -3526; 2051-
2'326 2457- -2731, 115- 389; 3184-3458; 1991-2265; 2852-3126; 2248-2522;' 3167
3441 2377 -2651 2294 -2566 2045 -2318 1979 -2252 '2421 -2694 3260 -3526;
•1988- -2265; 2098- -2375; 2071- -2348; 3001- -3278; 2183- -2453; 2120- -2397; 2255-
2531 2359 -2636 2559 -2836 2062- -2338 2324 -2600 2049 -2325 2038 -2314;
2025- -2301; 2736- -3012; 2297- -2573; 2086- -2359; 1988- -2263; 2051- -2327; 2048-
2328, 2217- -2496, 2953- -3233, 2321- -2599, 3240- -3514, 3093- -3372, .2482- -2761;
2049- -2328; 2048- -2327; 2050- -2329; 2052- -2331; 2145- -2424; 2918- -3198; 3179-
3458 2525 -2803 2103 -2381 1983 -2261 2323 -2601 2073 -2351 2841 -3118;
3242- -3520; 1987- -2265; 2026- -2303; 2903- -3180; 3107- -3386; 2052- -2329; 3251-
3526 3255 -3531 2042 -2324 2016 -2298 2737 -3019 3244 -3526 2055 -2336;
3245- -3526; 2417- -2698; 3181- -3462; 1621- -1889; 2040- -2321; 2051- -2332; 3155-
3437 3183 -3464, 2037 -2322 2374 -2659 3149 -3434 3028 -3313 2080 -2364;
3240- -3521; 2016- -2300; 2526- -2810; 3026- -3310; 2052- -2336; 2071- -2354; 3151-
3434 3243 -3526, 2145- -2428 2033- -2315, 2053 -2336, 2064 -2352 2204- -2492;
2016- -2304; 3086- -3372; 2070- -2357; 2097- -2384; 2008- -2295; 3240- -3526; 2171-
2457 3156 -3442, 2053 -2339 7595- -7870 1588 -1861, 2910- -3196 2097- -2383;
2984- -3270; 3243- -3529; 2050- -2336; 3089- -3375; 2733- -3019; 2089- -2375; 2134-
2426 1978 -2269 3060 -3351 2050 -2342 2099 -2391 1979 -2270 2860 -3151;
2379- -2670; 2099- -2392; 3037- -3327; 2756- -3046; 3085- -3375; 2956- -3245; 3237-
3526, 2222 -2512, 3238- -3524 2067 -2356 2815 -3104 2053 -2350 2515 -2812;
2833- -3128; 2044- -2340; 3228- -3521; 2006- -2302; 2049- -2345; 1579- -1860; 2663-
2959 2321 -2613 2050 -2345 3233 -3528 3231 -3526 3142 -3437 2050 -2346;
2042- -2337; 2342- -2636; 2114- -2408; 3180- -3474; 2074- -2368; 2312- -2605; 1610-
1851 1999 -2286, 3231 -3524 3231 -3523 2374 -2667 3130 -3423 1946 -2239;
7389- -7694; 2024- -2328; 2328- -2630; 2122- -2424; 2564- -2865; 2279- -2579; 1988-
2289, 3066- -3366, 2733- -3032, 2479- -2777, 3183- -3481, 7619 -7916 2025 -2322;
3216- -3526; 3159- -3468; 3090- -3399; 1977- -2286; 2049- -2357; 2044- -2352; 2220-
2490, 3222- -3529, 2050 -2355 2154 -2458; 2129 -2432 3223 -3526 2778 -3081; Table 3
3212-3527; 3207- 3526; 3208 3526; 3212 3531; 3209 -3526; 2098 2412; 2145-
2458 3215-3526 3192-3526 1551 -1866 2254-2565 ; 2127 -2453 2037-2369; 2052 2383; 3201 3526; 2074-2400; 2166 2490; 1525-1853; 3198 3521; 2072- 2398 3198-3526 2206-2510 2070 -2394 1576-1880 ; 2059 -2383 2099-2422; 1944 2268; 1555 1866; 2139 2447; 1580 1881; 2219-2538; 3177 3526; 3079- 3423 7446-7791 3184-3527 3182 -3529 3179-3526 3185 -3527 3185-3529; 2781 3126; 2374 2705; 3188-3527; 2483 2819; 1544-1872; 3187 3526; 3188- 3526 2152-2490 3191-3527 2981 -3168 1946-2278 ; 3162 -3529 3193-3527; 3159 3526; 3159 3509; 2157 2523; 3169 3531; 7596-7959; 1537 1883; 3163- 3526 3169-3527 6914-7061 1529 -1872 1946-2304 1524 -1870 3057-3409;
1637-1970; 2487- 2788; 2978 3363; 3026 3411; 3142-3526; 3145 3526; 2559-
2939 3146-3526; 3148-3524 3153 -3528 3151-3526 ; 3143 -3517 1601-1965;
3126-3530; 7545- 7916; 3073 3458; 3103 3506; 3122-3524; 3128 3530; 3117-
3520 3127-3527; 3084-3467 3126 -3526 3133-3527 ; 3130 -3529 3133-3529; 2054 2442; 2537-2931; 3138-3528; 1494- 1862; 3143-3526; 2779-3169; 3139- 3526 3030-3413; 3057-3413 3116--3530 3119-3528 ; 3110 -3526 3113-3526; 3115 3526; 3120-3531; 3118-3529; 2379 2789; 3116-3526; 3008 3416; 3119- 3526 3125-3526; 3125-3527 3514 -3920 3120-3526 ; 3124 -3529 2827-3273; 3079 3522; 3082-3517; 2995 3435; 1938 2377; 2978-3417; 2049 2490; 3090- 3529 3091-3526; 3094-3526 3021 -3447 3090-3520 ; 2518 -2945 3097-3526;
3100-3531; 1929- 2357; 7292 7571; 2062 2489; 3107-3530; 3098 3512; 3109-
3528 1547-2036; 2980-3469 3068 -3468 2235-2717 ; 2047 -2517 3017-3494; 1899 2374; 2042-2518; 3059-3529; 2364 2835; 2590-3059; 2278-2747; 3269- 3739 3057-3515; 2063-2521 2083 -2514 541-993; 3074-3 527; 1885-2335; 2472- 2923 3075-3526; 2107-2555 2977 -3423 3078-3526 ; 2091 -2634 7245-7571;
2067-2604; 2031* 2566; 2223-2757; 2867 3404; 2067-2596; 2515-3041; 2419-
2945 2067-2593; 1995-2520 2118 -2647 2992-3510 2920 3437 2048-2564;
2093-2608; 2023* 2538; 2049-2564; 2120 2633; 2047 2554; 2088 2579; 1943-
2306 6998-7469; 2303-2789 2410 -2911 1899-2399 2323 2819 2371-2867;
2069-2567; 1994- 2479; 1943-2329; 2369 2864; 2141 2738; 2061 2644; 2129-
2719 2083-2660; 2946-3528 2048 -2635 2675-3244 7259 7571 1957-2525; 2821 3384; 7229-7571; 2136-2692; 1988 2550; 1884 2452; 2044 2605; 7060- 7534 2301-2854; 2215-2766 1976 -2516 2079-2634 2083 2634 2717-3266; 7596 7889; 7137-7511; 1815-3518; 2038 2651; 2092 2712; 2049 2664; 7227- 7571 880-1483; 2081-2682
510/LG-.241742.1: 2001JUN22 I I 1-6 14; 1 618; 9-126; 523-1068; 691-12 91; 887-
1291 1120-1688; 1157-1625 1355-2040 ; 1429-2031; 1553-2038; 1668- 2031; 1678 1871; 1726-2237; 1897 2391; 1903-2268; 1919-2258; 2240-2758; 2369- 2608 2456-3039; 2544-2765 2597-2813 ; 2674-2996; 2938-3195; 3002- 3407;
3002-3224; 3026- 3532; 3040-3566; 3062-3458; 3091-3359; 3094-3457; 3107-
3318 3107-3692 3193-3719 3194-3802 ; 3298-3492; 3352-3904; 3353- 3876; 3392 3932; 3455 3947; 3437-3621; 3445-3947; 3491-3679; 3494-4094; 3535- 4080 3552-3794 3567-4052 3597-4180 ; 3724-4166; 3715-4273; 3717 3977; 3719 3899; 3731-3796; 3775-3931; 3813-4164; 3822-4499; 3904-4173; 3964- 4135 3948-4166 3966-4346 4032-4166 ; 4042-4425; 4083-4300; 4086 4166; 4116 4352; 4190 4448; 4190 4449; 4190-4329; 4197-4351; 4201-4478; 4202- 4530 4203-4434 4203-4326 4207-4857 ; 4215-4469; 4219-4795; 4301 4755; 4300 4522; 4337 4511; 4337-4523; 4365-4887; 4367-4622; 4367-4522; 4373- 4523 4432-4505 4467-4987 4534-4973 4547-5110; 4547-5124; 4553 4608; 4557 4850; 4564 4813; 4565-5111; 4568 5018; 4568-5068; 4567-4802; 4567- 4770 4568-4714 4568-4631 4569-4803 4593-4742; 4684-4962; 4694 4962; 4714 4924; 4723 5035; 4771-5086; 4771 5080; 4771-5079; 4771-5076; 4773- 5058 4774-5056 4782-5041 4792-5040 4812-5366; 4813-5100; 4814- 5230; 4813 5078; 4815 5025; 4816 5466; 4829 4935; 4846-5071; 4856- 5371; 4865- 5444 4865-5118 4865-5107 4892-5606 4901-5312; 4917-5092; 4946 5224; 4953 5227; 4963 5070; 4971 5565; 4968 5158; 4969-5076; 4976-5465; 4981- 5605 4991-5254 4998-5243 5015-5266 5027-5249; 5029-5485; 5057 5309; 5067 5643; 5085-5540; 5099-5627; 5099 -5331; 5107-5649; 5124-5533; 5133- 5647 5132-5400 5190-5611 5216-5695 ; 5238-5695; 5243-5676; 5245- 5684;
5254-5689; 5263- 5682; 5272-5696; 5272 -5682; 5275- 5698; 5289-5689; 5289- Table 3
5676; 5312-5676; 5316-5695; 5341-5676; 5345-5690; 5348-5639; 5348-5422; 5355-5699; 5357-5614; 5361-5675; 5366-5695; 5377-5620; 5381-5681; 5389- 5698; 5391-5682; 5392-5682; 5395-5687; 5411-5615; 5424-5695; 5431-5677; 5441-5713; 5441-5681; 5454-5561; 5454-5696; 5463-5699; 5464-5692; 5467- 5682; 5492-5698; 5536-5683; 5541-5692; 5544-5689; 5555-5682; 5558-5674; 5565-5671
511/LG: 244520.33 -.2001JUN22 | I 1-602 ; 2 25-857; 318-742; 355-610; 370-627; 392-723; 533-862; 585-713; 810-1052 512/LG: 247556.1:2001JUN22 | I 1-242 513/LG:247792.5:2001JUN22 | j 1599-1922 ; 1440-1913 ; 1619-1913; 1561 -1911; 1449-1909; 1642-1911; 1807- 1909 ; 1314-1895; 1391-1893; 1412-1829; 1532- 1738; 1514-1697; 1379-1696; 1480-1696 ; 1493-1695; 1430-1695; 1481- 1695; 1430-1694; 1459-1657; 1057- 1656 ; 1476-1654; 1476-1619; 1022-1609; 888-1593; 1041-1586; 1314-1492; 1218- 1467 ; 1218-1430; 1173-1421; 657-1206; 6 53-1204; 385-940; 532-759; 1-670; 175-618 ; 406-595; 412-525; 175-454 514/LG: 253580.6 :2001JUN22 | 1-589 ; 133-541; 219-594; 219-473; 235 1280; 236-815; 284-856; 319-601; 335-573 ; 389-802; 353-633; 386-630; 425-877; 440-955; 509-1063; 574-946; 586-1046 ; 609-1052; 678-902; 699-966; 701-827; 742-919; 833-1224; 869-1080 875-1270 904-1337; 918-1336; 919-1259; 955-
1206 957 -1386 ; 957 -1247 ; 9 62-1248 ; 1 26-1345; 1026-1247; 1030-1296; 1042- 1334 1042-1345 ; 1045-1278 1074-1441 1076-1335 1096-1382 1107-1348; 1110 1669 ; 1113 -1343 ; 1126-1355; 1160 1426; 1171 1650; 1171 1432; 1174- 1447 1178-1353 ; 1182-1477 1183-1342 1200-1450 1204-1428 1209-1341; 1214 1474 ; 1224-1478 ; 1225-1351; 1228 1518; 1243 1696; 1268 1319; 1279- 1505 1280-1507 ; 1281-1554 1311-1388 1351-1629 1359-1696 1364-1798; 1365 1604 ; 1367 -1603 ; 1367 -1598; 1367 1584; 1367 1585; 1371-1600; 1376- 1616 1387-1585 ; 1390-1633 1394-1638 1407-1557 1410-1650 1418 1687;
1423-1690; 1430-1694; 1440 1803; 1463 1705; 1473 1690; ■ 1489 1651; 1522-
1795 1522-1754 ; 1529-1819 1529-1782 1530-1794 1543-1783 1545 1834; 1547 1825 ; 1550-1767 ; 1557 1829; 1559 1813; 1560-1811; 1561 1822; 1567- 1840 1570-1853 ; 1575-2002 1579-1852 1586-1852 1586-1854 1592 1915; 1632 1869 ; 1633 -1856 ; 1633 -1826; 1636-1855; 1645-1909; 1646 1875; 1646- 1866 1649-2225 ; 1649-1922 1666-2129 1670-1883 1670-1858 1672 1936; 1678 1964 ; 1679-1904 ; 1683-1897; 1684 1923; 1685 1902; 1686 1748; 1689- 1947 1693-2195 ; 1701-2245 1701-1966 1702-1995 1711-1955 1714 2024;
1723-1945; 1742-1892; 1748 2318; 1748 1893; 1754 2283; 1753 1995; 1754-
1995 1755- -1959 , 1757 -1968 1758-1965 1759-2047 1759-2025 1784 2297; 1787 1992 ; 1787- -1991 ; 1787 1989; 1787 1957; 1802 1973; 1803 2180; 1814- 2183 1818- -2058 ; 1822- -2074 1825-2102 1829-2051 1831-2059 1837-2095; 1839 2144 ; 1841- -2071 ; 1844 2092; 1846-2017; 1845 2011; 1852-2238; 1852- 2122 1852- -2103 , 1852 -2094 1857-2102 1859-2786 1859- -2147 1863 2128; 1870 2157 ; 1877 - -2436 ; 1884 2114; 1886 2035; 1892 2232 ; 1894 2490; 1894- 2125 1895- -2006 , 1896 -2238 1912-2542 1919-2181 1919- -2153 1921-2177; 1922 2204 ; 1929- -2181 ; 1937 2184; 1943 2058; 1947 2218 ; 1962 2106; 1963- 2223 1976 -2106 1980 -2242 2001-2272 2026-2321 2028 -2287 2031 2298; 2036 2360 ; 2037- -2304 ; 2037 2265; 2041 2561; 2041- 2273 ; 2041 2274; 2049- 2711 2049 -2496 , 2071 -2311 2077-2314 2078-2341 2077- -2266 2083 2503;
2085-2337 ; 2087-2495 ; 2087-2364; 2088 2495; 2091 2356 ; 2095 2355; 2104-
2364 . 2108-2359 ; 2110-2243 2111-2388 2115-2680 2119- -2266 2125 2603;
2136-2387 ; 2138-2437 ; 2154-2359; 2158 2495; 2175- 2748 ; 2180 2459; 2180-
2446 2183 -2786 ; 2178-2445 2193-2461 2197-2747 2210 -2475 2211 2445; 2212 2453 ; 2221-2465 ; 2235 2484; 2239-2529; 2242 2530 ; 2243 2518; 2244- 2553 2258-2783 ; 2261-2496 2265-2553 2271-2525 2271 -2521 2271 2510;
2273 -2526 ; 2274-2506 ; 2279-2376; 2281 2726; 2289- 2744; 2293-2547; 2312-.
2565 2316-2748 ; 2319-2542 2323-2520 2323-2786 2323-2610 2324 2783;
2331-2785 ; 2337-2783 ; 2341 2783; 2343 2786; 2342-2783; 2359 2785; 2347-
2790 2350-2791 ; 2350-2789 2353-2793 2355-2438 2356-2783 2357 2792; 2365 2792 ; 2365-2783 ; 2366 2459; 2366 2664; 2368-2615; 2368 2565; 2369- 2786 2371-2788 ; 2371-2576 2372-2576 2373-2640 2375-2750 2377-2786;
2378-2452 ; 2379-2597 ; 2380-2576; 2382 2630; 2389 2576; 2392-2786; 2396- Table 3
2782; 2398-2576; 2399-2789; 2412-2786; 2412-2618 2414-2767; 2414-2786
2414-2642 2421-2699; 2424-2611; 2426-2783; 2431 2799; 2431-2781; 2438
2786; 2438-2636; 2446-2784; 2448-2731; 2448-2680 2451-2644; 2463-2671
2466-2782 2466-2662; 2470-2779; 2467-2786; 2467-2662; 2471-2787; 2472
2786; 2483-2755; 2490-2787; 2492-2758; 2491-2746 2493-2783; 2492-2714
2494-2729 2495-3040; 2497-2745; 2497-2742; 2497 2786; 2499-2783; 2500
2753; 2500-2576; 2502-2553; 2504-2788; 2505-2782 2507-2731; 2517-2738
2520-2772 2524-2703; 2534-2780; 2549-2786; 2549 2763; 2552-2671; 2565-
3046; 2572-2782; 2577-3077; 2577-2852; 2610-2783 2622-2781; 2637-3080
2637-2913 2647-3081; 2650-3081; 2667-2786; 2668 2786; 2671-3068; 2673
2783; 2714-2783; 2731-2786; 2758-3027; 2803-3408 2811-3081; 2840-3071
2845-3091 2952-3187; 2988-3274; 2988-3084; 3316-3588; 3316-3713 ;' 3618-4172
515/LG:291759.5:2001JUN22 || 1-264; 67-386; 107-386; 113-368; 113-324; 113-
213; 113-285 113-241; 113-202; 113-503; 113-446; 113-175; 113-449; 113-
206; 113-170 118-192; 116-517; 117-389; 129-364; 124-550; 152-633; 156-
633; 179-619 216-532; 245-321; 272-857; 288-542; 345-621; 399-916; 399-
654; 402-663 411-593; 437-652; 512-649; 533-1107; 606-660; 569-647; 847-
1131; 940-1153; 940-1086; 952-1105; 1004-1665; 1005-1218; 1028-1220; 1042-
1220; 1062-1454; 1079-1220 1092-1244; 1104-1220; 1143-1220; 1209-1445; 1209-1447; 1209-1713; 1226 1308; 1226-1351; 1229-1509; 1229-1516; 1248- 1509; 1294-1453; 1294-1468 1298-1766; 1298-1761; 1310-1593; 1314-1760; 1453-1719; 1465-1737; 1472 1724; 1477-1756; 1482-1716; 1485-1760; 1490- 1760; 1493-1760; 1501-1765 1502-1765; 1502-1565; 1503-1765; 1504-1660; 1507-1763; 1510-1594; 1510 1664; 1510-1671; 1510-1760; 1510-1583; 1510- 1758; 1510-1765; 1510-1764 1510-1596; 1511-1762; 1511-1603; 1511-1767; 1511-1764; 1537-1765; 1572 1766; 1572-1765; 1574-1760; 1575-1725; 1575- 1726; 1580-1763; 1590-1760 1700-1765 516/LG: 298226.1:2001JUN22 I 539-1158; 983-1158; 78-629; 1-619; 1-605; 323* 578; 1-554 517/LG: 306342.1:2001JUN22 1-752; 166-239; 575-697; 655-943
518/LG: 327144.5 :2001JUN22 1-264; 86-694; 181-682; 182-405; 227-848; 267-
673; 268-400; 558-1036; 561-816; 770-985; 774-1477; 776-1033; 913-1515;
962-1142; 1025-1346; 1025-1283; 1034-1343; 1112-1359; 1194-1252; 1428-2037;
1542-1917; 1621-1930; 1626-1887; 1630-1922; 1626-1888; 1659-1888; 1668-
1963 1644-1888; 1649-1879 1652-1773; 1658-1900; 1668-1871 1702-1888 1726 1968; 1727-2000; 1732 1888; 1704-1838; 1709-1888; 1710-1983; 1710- 1978 1728-2237; 1742-1894 1732-2255; 1744-2034; 1752-188! 1753-1924
1754-2006; 1728-1976; 1756 1990; 1750-2181; 1752-2168; 1764-2010; 1754
2348 1758-2126; 1780-2028 1781-1888; 1771-2146; 1784-2034 1758* -2174
1759-2173; 1759-1887; 1790 1937; 1791-1949; 1781-2176; 1764 1888; 1801
1888 1801-1887; 1803-1888 1778-2047; 1783-1991; 1783-2339 1804* -2243 1821 2073; 1796-1888; 1799-2073; 1821-2308; 1835-2374; 1820 2064; 1820- 1888 1822-1989; 1822-1919 1832-2090; 1832-2118; 1832-2081 1867- -2264 1908 1993; 1876-2235; 1882 2114; 1902-2181; 1888-2387; 1907 2355; 1913- 2151 1906-2465; 1906-2129 1907-2187; 1907-2153; 1907-2117 1913* -2121 1913 2096; 1942-2175; 1927 2116; 1945-2182; 1952-2239; 1958 2312; 1956 2187 1960-2233; 1966-2382 1982-2478; 1958-2195; 1964-2570 1982* -2370 1971 2186; 1990-2211; 1991-2214; 1993-2186; 1978-2238; 1997 2333; 1996 2234 1997-2238; 1997-2119 1998-2669; 1994- ■2600; 1997-2592 2016 -2417 2016 2295; 2036-2572; 2027 2669; 2017-2187; 2041-2642; 2049 2301; 2049 2334 2049-2328; 2075-2665 2075-2593; 2075- •2208; 2093-2350 2095 -2364
2099-2327; 2100-2327; 2090 2567; 2090-2304; 2090-2570; 2118 2322; 2120-
2658 2123-2672; 2148-2640 2138-2662; 2160- ■2402; 2143-2671 2164 -2392
2165-2381; 2157-2700; 2174 2706; 2175-2421; 2203-2665; 2204 2486; 2207-
2342 2218-2703; 2232-2706 2236-2698; 2222- ■2424; 2222-2439 2239 -2563
2224-2594; 2244-2333; 2248 2696; 2249-2696; 2257-2706; 2258 2437; 2245
2703 2245-2709; 2264-2707 2251-2698; 2252- ■2703; 2253-2464 2254 -2703
2272-2698; 2272-2707; 2257-2703; 2274-2703; 2259-2502; 2280 2698; 2282
2696 2283-2698; 2288-2696 2284-2514; 2295-2696; 2297-2368 2298 -2707
2284-2511; 2301-2698; 2285-2704; 2286-2703; 2303-2707; 2288-2653; 2305- Table 3
2698; 2307-2698; 2309-2698; 2311-2703; 2296-2703; 2329-2703; 2333-2706; 2335-2619; 2336-2698; 2341-2706; 2342-2427; 2347-2703; 2349-2688; 2352- 2706; 2356-2693; 2359-2707; 2361-2669; 2361-2635; 2362-2703; 2346-2604; 2364-2611; 2365-2492; 2353-2587; 2376-2701; 2377-2710; 2365-2703; 2382- 2704; 2385-2703; 2387-2704; 2403-2703; 2410-2703; 2403-2701; 2413-2703; 2413-2605; 2417-2696; 2431-2682; 2433-2663; 2417-2661; 2475-2698; 2498- 2701; 2499-2703; 2515-2703; 2567-2703; 2571-2707; 2561-2678; 2586-2707; 2602-2703; 2619-2704; 2203-2409; 2201-2362; 1758-1864; 2003-2601; 1938- 2600; 693-1162; 662-1125; 685-1157; 2249-2703; 699-1154; 707-1162; 859- 1166; 713-1166; 2368-2691; 2309-2701; 2314-2708; 749-1161; 2285-2694; 2246- 2704; 625-1147
519/LG: 331499.8 :200UUN22 | | 1-257; 11-342; 11-411; 11-268; 14-291; 30-735; 29-646; 30-286; 31-531; 33-356; 36-471; 35-418; 35-240; 36-333; 39-278; 41- 206; 47-289; 54-319; 56-324; 63-304; 71-484; 68-324; 68-278; 70-245; 70- 679; 74-327; 89-332; 91-513; 94-339; 111-307; 166-229; 250-695; 293-741; 308-877; 382-715; 383-646; 492-690; 517-787; 573-941; 633-1226; 641-1031; 641-857; 721-969; 726-860; 733-980; 739-1217; 759-1211; 790-1136; 864-1165; 865-1458; 865-1450; 865-1424; 875-1141; 979-1609; 1000-1211; 1022-1182; 1040-1628; 1038-1628; 1057-1314; 1089-1521; 1099-1628; 1099-1617; 1109- 1531; 1126-1535; 1136-1389; 1137-1461; 1137-1231; 1143-1843; 1226-1466; 1528-2127; 1789-2303; 1827-2081; 1844-2169; 2069-2317; 2161-2405; 2188- 2551; 2259-2423; 2296-2404; 2326-2404; 2328-2437
520/LG: 331582.12 :2001JUN22 | | 1-568; 1-544; 34-543; 41-261; 42-275; 96-588; 111-391; 134-453; 133-582; 183-586; 228-528; 279-583; 294-542; 294-558; 301-519; 301-501; 301-582; 306-502; 317-583; 317-596; 355-582; 451-583; 530-797; 530-581; 593-1158; 613-854; 615-888; 660-911; 694-1128; 710-1130; 743-1023; 773-1060; 775-1066; 799-1084; 802-997; 802-995; 821-903; 830- 1081; 839-1016; 908-1324;' 1041-1609; 1048-1557; 1048-1553; 1073-1396; 1117-
1619; 1224- -1497; 1230- -1724; : 1247- -1680; : 1247- -1527; 1247- -1487 1247-1441
1250- -1651; 1305- -1587; 1308- -1874; 1351- -1635; 1369- -2151; 1554 1862; 1554
1701; ; 1547- -1898; 1573- -2354; : 1576- -1857; : 1587- -2044; : 1614- -1784 1617-1943
1627- -1889; 1638- -2174; 1638- -2091; 1638- -1843; 1638- -1832; 1638 1810; 1656
1949; ; 1679- -2111; 1678- -1879; : 1690- -1816; : 1706- -2095; : 1707- -1924 1710-2052
1739- -1983; 1741- -1974; 1745- -2010; 1763- -2286; 1823- -2069; 1825 2445; 1827
2504; 1833- -2441; 1836- -2462; : 1860- -2026; : 1868- -2437; : 1870- -2418 1881-2485
1891- -2524; 1918- -2152; 1919- -2489; 1923- -2140; 1928- -2203; 1940 2262; 1946-
2069; : 1957- -2304; ; 1988- -2134; : 2021- -2297; 2055- -2249; : 2068- -2536 2077-2524
2089- -2522; 2102- -2524; 2103- -2530; 2113- -2527; 2114- -2423; 2114 2367; 2115
2480; : 2121* -2452; : 2126* -2360;r 2138* -2529;r 2142- -2518; : 2143* -2445 2161-2368
2165-2426; 2166-2524; 2166-2416; 2171-2524; 2188-2533; 2188-2518; 2197- 2536; 2207-2516; 2215-2519; 2215-2516; 2234-2530; 2241-2476; 2252-2524; 2267-2524; 2269-2523; 2325-2518; 2330-2522; 2330-2515; 2333-2524; 2334- 2531; 2356-2525; 2358-2545; 2395-2554; 2447-2522
521/LG:333017.12:2001JUN22 || 76-559; 102-555; 100-555; 184-553; 237-552; 247-552; 357-552; 75-552; 326-552; 351-552; 1-547; 92-547; 113-547; 220- 547; 262-547; 249-544; 235-542; 263-542; 177-536; 255-501; 262-488; 1-466; 150-387; 51-342
522/LG:334438.8:200lJU 22 || 1-596; 158-348; 214-735; 214-686; 242-604; 320-506; 321-592; 396-770; 431-700; 478-741; 496-701; 503-739; 505-737; 506-739; 579-864; 625-750; 637-890; 645-747; 715-1276; 778-833; 1067-1538; 1214-1646; 1282-1646; 1284-1549; 1378-1647; 1429-1646; 1445-1566; 1486- 1686; 1544-1649
523/LG:337835.7:200lJU 22 || 1-435; 15-132; 24-221; 24-284; 31-273; 36-456; 36-259; 41-149; 44-321; 64-669; 81-168; 83-613; 92-323; 124-353; 133-359; 177-455; 177-457; 189-457; 371-1046; 380-965; 380-629; 380-458; 497-1081; 548-772; 595-1079; 625-1002; 652-1120; 654-1116; 659-1116; 668-1116; 683- 1118; 691-1078; 694-1119; 719-1121; 721-1118; 722-1116; 726-850; 730-1119; 792-1113; 836-1123; 847-1116; 930-1112; 1011-1114
524/LG:346536.12:2001JUN22 || 1-635; 3-129; 7-249; 20-269; 21-589; 20-659; 24-524; 31-374; 34-284; 48-580; 48-284; 53-106; 58-284; 55-530; 85-465; 85- Table 3
330; 86-341; 114-331; 147-423; 159-431; 189-409; 201-824; 245-459; 284-733; 295-888; 340-731; 368-953; 456-789; 484-969; 610-1085; 659-1179; 860-1024; 960-1576; 975-1190; 981-1569; 987-1355; 1018-1630; 1028-1578; 1066-1397; 1088-1387; 1253-1476; 1265-1483; 1419-1968; 1444-1924; 1447-1712; 1479- 1764; 1526-1794; 1564-1798; 1564-2093; 1603-1922; 1603-1875; 1612-1815; 1687-2260; 1832-2372; 1840-2110; 1924-2412; 1942-2412; 1956-2183; 1958- 2198; 2002-2517; 2024-2627; 2025-2721; 2033-2336; 2033-2237; 2036-2299; 2059-2294; 2061-2667; 2063-2341; 2068-2513; 2073-2707; 2074-2441; 2091- 2417; 2093-2417; 2095-2411; 2095-2231; 2099-2313; 2107-2665; 2106-2674; 2142-2507; 2158-2722; 2232-2487; 2255-2772; 2282-2572; 2286-2571; 2305- 2363; 2338-2441; 2340-2561; 2378-2740; 2381-2523; 2413-3030; 2437-2724; 2447-2786; 2455-2724; 2468-2945; 2486-2900; 2495-2680; 2555-2719; 2571- 2840; 2577-3085; 2584-2760; 2614-2875; 2622-2821; 2649-2943; 2671-2939; 2671-2902; 2696-2889; 2697-2995; 2723-3084; 2724-3147; 2725-3146; 2757- 3003; 2760-3288; 2777-3146; 2780-3146; 2803-3070; 2810-3146; 2814-3146; 2832-3427; 2861-3114; 2871-3145; 2876-3139; 2892-3167; 2916-3165; 2943- 3188; 2947-3286; 2953-3453; 2957-3084; 2957-3037; 2972-3447; 2997-3245; 2997-3164; 3018-3258; 3028-3298; 3046-3281; 3078-3317; 3084-3316; 3085- 3171; 3099-3316; 3111-3316; 3115-3316; 3124-3566; 3131-3316; 3134-3316; 3135-3316; 3136-3321; 3159-3316; 3163-3316; 3165-3316; 3199-3314 525/LG:348117.5:2001JUN22 | | 1-260; 100-491; 98-494; 121-265; 160-708; 348- 878; 453-630; 458-893; 489-781; 510-809; 510-830; 510-778; 525-897; 527- 705; 528-777; 532-881; 549-814; 585-783; 624-885; 636-902; 648-912; 669- 896; 689-896; 691-1174; 713-893; 715-896; 747-896; 765-895; 772-896; 780- 896; 805-896; 838-896; 1046-1182; 1048-1182; 1082-1182; 1084-1218; 1089- 1499; 1089-1203; 1091-1182; 1109-1182; 1111-1182; 1385-1828; 1388-1828; 1389-1643; 1389-1885; 1411-1642; 1420-1540; 1420-1879; 1420-1727; 1420- 1655; 1420-1530; 1421-1474; 1421-1565; 1423-1849; 1424-1917; 1424-1825; 1425-1644; 1429-1831; 1438-1644; 1440-1644; 1447-1913; 1447-1810; 1447- 1828; 1447-1794; 1447-1825;. 1447-1644; 1457-1781; 1457-1644; 1464-1898; 1483-1878; 1484-1926; 1486-1566; 1519-1828; 1526-1644; 1532-1957; 1538- 1956; 1536-1644; 1539-1644; 1544-1958; 1548-1962; 1553-1957; 1558-1821; 1588-1644; 1636-1934; 1651-1746; 1686-1954; 1684-1746; 1688-1957; 1804- 1955; 1836-1953; 1885-1958
526/LG:350407.22:200UUN22 | | 143-434; 164-434; 182-434; 8-433; 154-428; 170-428; 266-428; 303-428; 170-423; 218-429; 154-415; 170-411; 1-410; 146- 403; 103-403; 177-403; 170-398; 159-394; 1-393; 299-393; 170-389; 191-384; 114-375; 170-373; 170-370; 203-364; 170-331; 154-330; 8-328; 154-322; 1- 318; 170-289; 170-286; 170-260; 8-224 527/LG: 373219.13 :200UUN22 | | 1-547; 26-383; 70-605; 72-247; 95-264; 131-
692 197-449; 229-384; 321-573; 366-622; 384-826; 384-656; 413-728; 446-
925 467-622; 467-924; 467-885; 475-1002; 482-650; 484-945; 486-750; 538- 874 564-711; 706-1279; 715-970; 730-1274; 741-1389; 744-1147; 788-989;
890-1068; 902-1082; 925-1116; 939-1375; 961-1407; 1027-1290 1032-1342
1032-1558; 1060-1340; 1062-1114; 1143-1407; 1197-1407 1246 1407; 1273
1677; 1273-1532; 1430-1698; 1437-1609; 1446-1749; 1486-2104 1536-1754
1562-1824; 1561-2263; 1573-1821; 1578-1820; 1579-1828 1605 1791; 1608-
1856; 1614-1918; 1617-1844; 1638-1818; 1642-2191; 1642-1860 1650-2193
1661-1904; 1664-1893; 1699-1979; 1699-1972; 1727-1997 1727 2197; 1739-
2140; 1739-1994; 1741-1995; 1742-2003; 1742-2001; 1743-1822 1781-1999
1835-1905; 1840-2076; 1850-2271; 1881-2123; 1883-2394 1903 2156; 1913-
2084; 1915-2195; 1923-2156; 1939-2187; 1998-2275; 2001-2222 2007-2193
2014-2305; 2035-2556; 2045-2311; 2047-2303; 2053-2325 2058-2456; 2066
2312; 2066-2304; 2099-2369; 2112-2316; 2140-2374; 2142-2648 2147-2400
2150-2433; 2152-2423; 2165-2395; 2199-2736; 2199-2308 2204 2463; 2206-
2446; 2225-2463; 2253-2959; 2247-2647; 2247-2463; 2250-2463 2252-2650
2253-2647; 2253-2724; 2285-2647; 2285-2575; 2323-2464 2325-2568; 2368-
2463; 2368-2643; 2381-2586; 2397-2628; 2411-2658; 2414-2463 2422-2742
2481-2645; 2481-2650; 2481-2647; 2481-2897; 2484-2893 2484 2897; 2503
2896; 2508-2896; 2509-2647; 2511-2636; 2521-2754; 2523-2890 2531-2639 Table 3
2540-2761; 2550-2647; 2555- ■2850; 2560-2645; 2570-2891; 2589-2897; 2590- 2871; 2664-2896; 2667-2896; 2667-2886; 2667-2736; 2667-2834; 2670-2896; 2675-2896; 2672-2893; 2699-■2895; 2704-2891; 2710-2798; 2712-2857; 2711- 2891; 2712-2886; 2754-2896; 2751-2902; 2776-2886; 2777-2877; 2786-2893 528/LG:375048.15:2001JUN22 || 1-207; 25-778; 240-511; 274-645; 274-826; 276-603; 277-550; 283-480; 298-571; 302-547; 335-516; 338-623; 518-1032; 529-848; 529-804; 531-835; 531-802; 531-771; 532-803; 536-802; 536-785; 651-1168; 651-890; 711-961; 723-1343; 734-1224; 734-977; 820-1056; 823- 1275; 841-1244; 897-1351; 904-1387; 912-1355; 942-1325; 946-1385; 999-1388; 1021-1389; 1061-1387; 1080-1384; 1151-1414; 1183-1387; 1185-1350; 1276- 1728; 1316-1478; 1413-2081; 1505-1804; 1756-2215; 1877-2202; 1880-2160; 2060-2771; 2115-2499; 2158-2727; 2162-2728; 2395-2499; 2395-2456; 2395- 2549; 2430-2499; 2495-2821; 2495-2636; 2527-2668; 2536-2793; 2536-2816; 2645-2845; 2755-3010; 2940-3178; 3004-3217; 3183-3414; 3313-3401; 3346- 3756; 3349-3584; 3411-3767; 3441-3847; 3458-3932; 3587-3933; 3608-3929; 3613-3876; 3626-3929; 3717-3933; 3718-3886; 3727-3930; 3727-3872; 3728- 3892; 3753-3921 529/LG:400114.3:200lJUN22 | | 1-577; 1-511; 1-429; 286-708; 412-964; 901- 1312; 1115-1724; 1613-1672; 1620-1899; 1620-1738; 1624-1959; 1624-1960; 1627-1943; 1627-1787; 1813- 2325; 1950-2565; 1989-2565; 2016-2558; 2043- 2632; 2344-2604; 2529-3124; 2528-3199; 2634-3189; 2632-2888; 2739-3244; 2748-3249
530/LG: 400652.1:2001JUN22 | I 1-7 13; 5 -428; 38-411; 38-261; 76-739; 79-324; 640-1214; 961-1384; 961-1586; 1105-1363; 1108-1479; 1349-2088; 1376-2051; 1421-1586; 1480-1653; 1560-2145; 1709 -2412; 1752-2163; 1794-2123 1818- 2163; 1920-2145; 1923-2226; 1936-2516 1936-2223; 1936-2119 1949-2159; 1949-2516; 2273-2518; 2281-2749; 2362-2900; 2511-3117; 2527 2989 2527- 2720; 2571-2740; 2751-2901; 2848-3168 2873-3132; 2902-3411 2902-3146; 2923-3019; 2945-3185; 3041-3176; 3135 3384; 3218-3632; 3218 3479 3218- 3420; 3353-3506; 3396-3539; 3409-3632 3409-3664; 3448-4010 3526-3966; 3555-3812; 3557-3786; 3568-3828; 3577 4009; 3611-4004; 3644 4048 3661- 3757; 3667-3946; 3670-4053; 3682-4048 3689-3959; 3714-4034 3721-3831; 3721-4056; 3724-3989; 3768-3932; 3844 -4010; 3844-3999; 3881-4048 3881- 4044; 3881-3943; 3909-4048 531/LG: 401313.10: 2001 UN22 || 1-532; 272-750; 272-765; 474-1 014; 474-749; 545-697; 666-934; 691-908; 772-1348; 869-1364; 904-1164; 923-1333; 985- 1422; 992-1425; 1101-1425; 1120-1425; 1215-1425; 1215-1419 532/LG: 406389.1:2001JUN22 I 1-479; 10-577; 10-469; 390-667; 402-715; 418- 738; 514-740; 649-910; 654-936; 697-1068; 700-967; 927-1213; 929-1464; 1146-1557; 1148-1583; 1152-1668; 1158-1495; 1185-1561; 1224-1557; 1249- 1865; 1249-1555; 1273-1557; 1400-1561; 1449-1516; 1684-2152; 1785-2219; 1830-2335; 1897-2308; 1897-2219; 1937-2316; 2051-2305 533/LG:406595.2:2001JUN22 | I 1-549; 1-496; 192-658; 192-543; 192-43 3 ; 208- 495; 208-388; 294-953; 617-1189; 976-1238; 976-1125; 976-1160; 980- 1240 ; 980-1382; 983-1267; 1189-1760; 1277-1731; 1277-1694; 1277-1464; 127 7-1415 ;
1338-1764; 1452-1570 1469-2016; 1501-1734; 1549-1810; 1557-2057; 1 593 -
2254; 1592-2057 1646-2184 1659-1945; 1680-2069; 1689-2057 1690-2 064 ; 1771-2070; 1789 2046 1789-2066; 1789-2016; 1791-2057; 1834 2112 ; 1 904- 2062; 1907-2270 1915-2398 1915-2253; 1956-2057; 2008-2564 1980-2 266 ; 1981-2270; 2036 2267 2084-2207; 2107-2740; 2160-2736; 2203- 2784 ; 2 239- 2871; 2378-2627 2378-2536 2381-2578; 2381-2594; 2471-2966 2593 -2 851 ;
2603-2880; 2752-3029 2761-3035; 2852-3038; 2892-3024; 2896 3029 ; 2 926-
3393; 2961-3437 2962-3029 3160-3413; 3181-3428; 3185-3611 3188-3 398 ;
3200-3466; 3210-3441 3216-3491; 3236-3474; 3245-3548; 3265 3521 ; 3 344-
3626; 3356-3746; 3356-3727; 3356-3597; 3411-3634; 3427-3826 3427-3 580 ; 3520-3775; 3674-3788; 3710-4024; 3713-3991; 3728-3924 534/LG:410628.21:2001JUN22 1-277; 88-346; 102-609; 145-59 6 ; 145-369 ; 249-346; 400-595; 504-588 535/LG:413583.15:2001 UN22 | | 1-209 ; 20-488 ; 18-572 ; 35-262 ; 35-296 ; 44- 509; 42-470; 52-543; 168-574 ; 178-643 ; 205-411 ; 274-519 ; 298-662 ; 348-663 ; Table 3
350-656; 351-667; 362-555; 385-769; 411-789; 621-898; 751-1253; 805-1115; 805-1119; 821-1064; 1047-1515; 1050-1302; 1050-1490; 1075-1625; 1169-1438; 1175-1673; 1205-1694; 1205-1611; 1294-1987; 1391-1764; 1396-1963; 1416- 1946; 1436-1878; 1436-1660; 1453-1844; 1458- 1629; 1458-1835 1465-1579; 1490-1767; 1533-1806; 1564-2128; 1581-1682; 1581-1824; 1617-1764; 1628 1764; 1657-1898; 1657-1895; 1783-1922; 1797- 2586; 1849-2483 1876-2473; 1890-2483; 2015-2483; 2022-2130; 2024-2289; 2041-2431; 2048 2518; 2058- 2522; 2059-2518; 2063-2519; 2065-2522; 2062-2516; 2071-2508 2076-2520; 2087-2516; 2101-2527; 2157-2528; 2210-2516; 2214-2510; 2232 2444; 2330- 2395; 2421-3105; 2428-3019; 2513-3132; 2554-3041; 2583-3132 2663-3224; 2666-2762; 2665-3183; 2665-3250; 2715-3289; 2813-2989; 2813 3357; 2824- 3437; 2981-3118; 3026-3238; 3038-3291; 3107-3304; 3208-3360 1917-2504 536/LG: 419641.35 :2001JUN22 | | 1-110; 1-345; 3-706; 16-587; 40-133; 61-611; 347-958; 647-909; 653-1332; 669-802; 683-888 ; 718-1365; 733-1039; 775-1361; 837-1031; 965-1532; 989-1096; 989-1058; 1001-1291; 1007-1074; 1061-1318; 1074-1540; 1086-1307; 1087-1285; 1108-1405; 1137-1421; 1151-1634; 1180- 1847; 1225-1321; 1230-1464; 1238-1529; 1327-. 1486, 1375- -1850, 1485- -2082; 1557-1839; 1564-1786; 1564-1817; 1564-2106; 1566- -1773; 1564- -1801; 1571- 1647; 1583-1845; 1637-1828; 1664-1920; 1812- 2112, 1847- -2044, 1950- -2464; 1954-2575; 1998-2566; 2092-2288; 2156-2626; 2167- -2500; 2168- -2396; 2171- 2450; 2172-2300; 2201-2520; 2297-2947; 2350- 2923, 2380 -2620, 2383- -2831; 2383-2846; 2426-2626; 2451-2992; 2455-2975; 2455- -2872; 2467- -3085; 2469- 3048; 2484-2919; 2495-3067; 2497-2940; 2512- 2771, 2524 -3007, 2528- -2839; 2533-3041; 2560-3019; 2568-3019; 2573-3017; 2578- -2867; 2582- -3021; 2583- 3023; 2588-2875; 2590-2960; 2603-3094; 2605- 3017 2609 -3083 2610- -3091; 2617-2884; 2620-3090; 2621-3089; 2623-3017; 2632- -3086; 2634- -3091; 2635- 3090; 2636-3064; 2637-3042; 2643-3097; 2642- 2896, 2653 -2841 2666- -3083; .2669-3092; 2677-3024; 2678-3091; 2691-2851,-' 2697- -3035; 2698- -3085; 2708- 3093; 2710-3084; 2710-3099; 2712-2964; 2712- 3086 2717 -3085 2721 -3096; 2723-2957; 2736-3085; 2739-3089; 2741-3046; 2745- -2844; 2750- -3034; 2750- 3049; 2766-3018; 2769-3087; 2771-3086; 2774- 3090 2774 -3120 2778- -3016; 2790-3088; 2790-3118; 2808-3085; 2811-3093; 2811- -3070; 2815- -3093; 2817- 3087; 2823-3089; 2825-3087; 2829-3291; 2836- 3098 2836 -3041 2838 -3127; 2839-3088; 2863-3086; 2877-3301; 2895-2974; 2927-3088; 2930-3096; 2963- 3083; 2990-3099
537/LG:420759.4:2001JUN22 | | 1-221; 1-377 538/LG:425448.18:2001JUN22 | | 3962-4500; 416 4-4488; 4103-4461; 3905-4330; 4030-4330; 3710-4324; 3820-4187; 3903-4184; 3507-4036; 3233-3674; 3403- 3640; 3195-3628; 3298-3541; 3049-3387; 3034- 3373; 3033-3347; 3036-3235; 2750-3224; 3036-3198; 3081-3197; 2917-3181; 2816-3150; 2910-3143; 2917- 3143; 2752-3137; 2613-3135; 2767-3136; 2825- 3113; 2835-3113; 2877-3113; 2809-3111; 2657-3008; 2711-3004; 2424-2978; 2497-2934; 2320-2872; 2323- 2845; 2576-2831; 2267-2745; 2366-2639; 2147- 2561; 2303-2542; 2284-2498; 2168-2477; 2214-2475; 1791-2425; 2139-2411; 2053-2406; 1947-2364; 1996- 2308; 2095-2308; 1834-2292; 2005-2267; 1833- 2221; 2018-2210; 1935-2190; 1970-2123; 1833-2077; 1668-2064; 1735-2052; 1789-2049; 1814-2010; 1660- 1956; 1747-1948; 1752-1948; 1627-1906; 1634- 1873; 1413-1851; 1629-1837; 1726-1832; 1664-1827; 1493-1804; 1582-1802; 1538-1781; 1490-1768; 1488- 1747; 1124-1701; 1408-1690; 1396-1682; 1144- 1660; 1116-1656; 1424-1608; 1080-1605; 1327-1548; 1081-1539; 1064-1509; 1114-1507; 1105-1503; 1079- 1494; 1075-1481; 1189-1473; 1077-1470; 1187- 1471; 1081-1465; 1327-1463; 1070-1445; 1079-1442; 1075-1441; 1079-1441; 1079-1432; 1074-1429; 1157- 1413; 1093-1412; 1078-1411; 1132-1401; 1094- 1398; 1079-1386; 1326-1383; 1093-1369; 1098-1367; 1208-1364; 1079-1358; 1277-1355; 1102-1347; 1085-
1262; 774-1157; 1070-1150 741-966; 637-963; 714-962; 722-962; 716-962; 723-962; 736-962; 788-961 774-960; 579-959 773-959; 659-958; 737-958;
503-957 533-957 604-957 641-957; 571-957 530-955; 575-956; 600-956; 643-956 647-956 653-956 619-956; 668-956 721-956; 727-956; 766-955; 825-955 629-956 477-956; 568-954; 569-954; 612-954; 625-954; 642-954; 689-956 805-954; 807-954; 506-953; 531-952; 543-952; 553-956; 559-954; Table 3
564- 953 579-954 646-954; 506-952 545- 952 719- 953 615- -952 586-952 641- 950 599-951 661-950; 723-951 753- 950 499- 948 574 -948 661-948 680- 948 730-948 776-948; 629-947 542- 948 719- 947 731--945 544-946 705- 940 445-935 542-930; 275-926 275- 915 553- 909 677--906 603-903 626- 902 505-887 676-890; 317-886 583- 885 188- 881 328 -881 468-879 629 - 880 596-880 334-878; 562-874 274-■872 400- 869 567 -870 445-869 635- 865 632 -860 305-857; 619-858 398-■849 273- 854 324 -852 552-848 613 - 828 531-804; 552-793; 541-787 509- 782 607- 703 404--699 428-692 429- 687 413-683; 247-682; 434-679 399- 657 380- 644 506--634 358-614 389 - 609 333-589; 222-542 241-481 309- 448 134- 403 265--386 1-345; 77- 295; 86-190
539/LG: 435717.5 :2001JUN22 1-144; 7-374; 7-372; 7-126; 7-83; 18-380; 27- 528; 27-332; 59-572; 70-353; 82-589 : 179-435; 212-637; 230-611; 236-456; 240-615; 322-620; 340-600; 408-607; 422-614; 422-607; 465-1089; 469-1072; 526-595; 892-1328; 914-1194; 918-1368; 917-1458; 919-1087; 924-1003; 924- 1337; 924-1226; 924-1305; 927-1150; 950-1246; 954-1240; 960-1301; 967-1458; 976-1278; 976-1201; 976-1199; 977-1458; 977-1174; 983-1458; 1011-1180;
1020-1291; 1045-1458; 1051-1438; 1051-1298; 1087-1458 1088-1347; 1088-
1314; 1088-1291; 1088-1277; 1088-1240; 1089-1290; 1095-1343; 1095-1332
1118-1458; 1123-1251; 1129-1297; 1134-1306; 1140-1350 1140-1458; 1141
1410; 1159-1398; 1174-1387; 1176-1458; 1189-1414; 1199-1458; 1199-1431
1221-1834; 1258-1431; 1259-1458; 1265-1429; 1297-1458 1298-1458; 1321
1954; 1322-1458; 1334-1458; 1338-1458; 1369-1458; 1372-1458; 1382-145!
1387-1458; 1388-1458; 1404-1458; 1724-2252; 1718-2264 1716-2231; 1721 2250; 1720-2316; 1724-2242; 1726-2080; 1716-1957; 172 -1979; 1726-2051 1726-1885; 1726-1828; 1726-1818; 1726-1778; 1729-1844 1744-2315; 1735-
1973; 1737-1841; 1738-2003; 1755-1! 1755-2290; 1755-2259; 1755-2229
1755-2169; 1743-1930; 1755-2280; 1745-1996; 1762-2339 1755-2021; 1755
2005; 1755-1990; 1755-1808; 1760-1961; 1760-1890; 1763-2040; 1775-2059
1796-2322; 1785-2078; 1785-2073; 1799-2344; 1805-2365 1790-2085; 1792
2013; 1811-1997; 1809-2183; 1812-2268; 1828-2320; 1827-2254; 1816-2073
1816-2042; 1821-2066; 1821-1950; 1846-2121; 1848-2329 1849-2152; 1866 2324; 1867-2338; 1883-2332; 1893-2389; 1901-2139; 188 -2116; 1931-2364 1943-2207; 1947-2363; 1953-2365; 1958-2369; 1977-2365 1981-2367; 1992
2364; 1993-2289; 1995-2368; 1997-2368; 1998-2363; 2001-2364; 2003-2368
2003-2365; 2006-2204; 2020-2368; 2021-2357; 2025-2363 2026-2301; 2027
2284; 2031-2273; 2041-2365; 2049-2368; 2050-2369; 2050-2366; 2060-2179
2064-2366; 2063-2287; 2069-2365; 2073-2217; 2110-2365 2118-2365; 2123
2370; 2123-2368; 2123-2332; 2145-2368; 2147-2366; 2154-2365; 2159-2370
2168-2363; 2186-2369; 2189-2364; 2216-2336; 2229-2365; 2233-2365; 2243-
2368; 2255-2365
540/LG:441159.31:200lJUN22 || 1-453; 384-956; 384-667 512-765; 546-774;
565-765; 565-892; 565-774; 565-762; 572-905; 602-759; 621-863; 629-956;
632-759; 665-754; 665-716; 686-929; 746-979; 789-1022 799-1062; 810-1216;
831-1205; 831-1194; 846-1075; 863-1034; 899-1151; 899-1130; 921-1174; 936
1169; 941-1161; 942-1149; 978-1097; 981-1206; 1018-1246; 1041-1636; 1091-
1343 ; 1109-1604 ; 1100-1516 1100-1262 ; 1141-1390 ; 1168-1467 ; 1174-1468 1174-1458 ; 1194-1418 ; 1194 1629 1266-1600; 1284-1680; 1284-1399; 1307 1455 ; 1320-1559 ; 1349-1566 1404-1597; 1450-2031; 1450-1730; 1451-1530 1451-1772 ; 1478-1938 ; 1505 1666 1603-1829; 1618-1844; 1623-2142; 1626 2164 ; 1667-2062 ; 1667-1968 1718-2276; 1722-1938; 1750-2269; 1761-2044
1794-2312 ; 1805-2050 ; 1807-2088 1807-2073; 1825-2287; 1831-2292; 1833-
2287 ; 1833 -2313 ; 1833-2247 1862-2316; 1871-2314; 1874-2227; 1878-2310 1882-2312 ; 1883 -2310 ; 1901 2043 1903-2292; 1912-2310; 1917-2312; 1922 2288 ; 1920-2306 ; 1923 -2312 1922-2260; 1932-2311; 1939-2317; 1953-2270
1967-2310 ; 1986-2312 ; 1991-2315 1991-2308; 1993-2315; 2015-2310; 2041-
2312 ; 2074-2308 ; 2089-2314 2090-2310; 2100-2310; 2122-2260; 2122-2229
2195-2310; 2214-2268; 2239-2505; 2072-2200; 1948-2287; 1847-2287; 668-1150 541/LG:461375.2:2001JUN22 || 1-635; 115-586; 107-506; 123-400; 151-261; 137-791; 143-326; 246-938; 354-972; 496-631; 612-1166; 708-1202; 822-1050; Table 3
825-1341; 1020-1271; 1256-1668; 1259-1394; 1346-1580; 1464-1748; 1478-2009; 1547-1993; 1575-1764; 1608-1818; 1615-1870; 1615-1896; 1617-2081; 1620-
2083; 1682- -1990; 1689- -4242; : 1708- -2221 1744-2179 1815-2256; 1866-2119
1888- -3431; 1900- -2332; 1993- -2590; 2028 2301; 2101 2239; 2102-2704; 2108-
2315; 2109- -2529; 2110- -2363; : 2126- -2677 2157-2420 2168-2464; 2200-2769
2207- -2756; 2254- -2571; 2284- -2567; 2298 2850; 2312 2808; 2391-2743; 2424
2895; 2440- -3033; 2524- -3246; : 2617- -2877 2653-3039 2662-3215; 2673-2896
2687- -2902; 2706- -2902; 2706- -3259; 2720 2962; 2737 3045; 2778-2949; 2785-
3026; 2853- -3036; 2882- -3165; : 2911- -3172 2915-3205 2960-3157; 2960-3243
2960- -3234; 2965- -3328; 2982- -3422; 3022 3100; 3088 3634; 3116-3599; 3117-
3627; : 3119- -3300; 3124- -3216; : 3146- -3663 3146-3404 3151-3392; 3155-3446
3167- -3676; 3172- -3612; 3183- -3244; 3185 3451; 3187 3733; 3187-3853; 3217
3694; ' 3216- -3609; 3234- -3723; : 3234- -3477 3246-3516 3291-3657; 3325-3535
3492- -3774; 3514- -3731; 3528- -3579; 3542 3815; 3557-4005; 3564-4166; 3566-
3853; : 3579- -3818; ; 3593- -4143; ; 3594- -4147 3604-4136 3608-4198; 3635-4150
3738- -4171; 3752- -3907; 3784- -4242; 3784 3860; 3802-4060; 3818-4059; 3830
4234; ; 3834- -4188; ' 3837- -4293; : 3849- -4242 3858-4236; 3864-4242; 3862-4232;
3863- -4242; 3884- -4248; 3917- -4286; 3949 4227; 3962-4286; 3966-4242; 3970-
4291; ; 3975- -4217; 3993- -4157; : 4015- -4252 4078-4286; 4089-4525; 4099-4214;
4098- -4284; 4102- -4243; 4118- -4242; 4143 4303; 4144-4507; 4187-4528; 4344-
4727; 4382- -4841; 4380- -4842; : 4612- -4842 4747-5226; 4747-4836
542/LG: 474674.34 :2001JUN22 1 I 1 I 5533'7 7--885533 386-852; 585-850; 508-851; 606-848;
4 49966--E8 34488;; 55(0 333--8844E8 3;; 505- -848; 553311--88'4 188;; 5572-848 523-848; 601-848; 619-847;
4 49933--!8 34444;; 55:3 366--884444 L;; 535* -844; 665588--88:1 L55;; 5599-809 592-803; 543-787; 506-768;
5 50066--7" 76655;; 55:2 288--776644 I;; 535* -761; 449933--77!5 522;; 5506-749 507-737; 556-708; 102-519;
443; 36-311; 46-309
543 /LG: 81414.8 :2001JUN22 2528-2946; 2754-2944; 2555-2944; 2621-2944;
2400-2889; 2643-2875; 2645-2875; 2440-2866; 2644-2862; 2645-2862; 2757-
2862; 2542-2818; 2520-2785; 2461-2723 2283-2663; 2356-2632; 2410-2631; 2275-2533; 1881-2501; 2183-2492; 2098 2443; 2174-2435; 2044-2435; 2102- 2357; 2008-2355; 1810-2255; 1809-2241 1809-2243; 1811-2249; 1816-2223; 1809-2202; 1810-2142; 1812-2077; 1749 1993; 1392-1955; 1811-1946; 1667- 1925; 1451-1925; 1825-1903; 1394-1851 1382-1818; 1467-1747; 1472-1745; 1159-1650; 1536-1638 1062-1636; 1392-1630; 996-1586; 1282-1581; 1303-1564; 961-1461; 1256-1448; 1073-1446; 977-1444; 1085-1444; 1127-1444; 967-1443; 1034-1443; 991-1443; 1120-1443; 1202-1441; 996-1441; 1385-1441; 994-1432; 1039-1413; 1000-1406 : 1131-1405 1143-1405; 1116-1404; 1079-1402; 881-1394; 1002-1387; 1151-1387 994-1386; 850-1376; 804-1354; 1110-1347; 1056-1326; 1118-1286; 854-1273; 1047-1269; 990-1256; 810-1243; 1005-1219; 843-1218; 969-1185; 999-1171; 788-1136; 13-1111; 820-1038; 816-1022; 775-981; 655-
885; 81- 11; 373 -746; 360-746; 652-745; 372-745; 452-744; 317-744; 389-744;
354-744; 389-738 ; 300-732; 354-706; 257-705; 170-705; 275-702; 412-669;
235-667; 41-645; 174-640; 448-616; 1-609; 348-608; 354-596; 236-527; 1-521;
382-514; 366-501
544/LG: 7669276.1:2001JUN22 I I 1-607
545/LG: 7677848.1:2001JU 22 j j 1-329
546/LG : 7684981.3 :2001JUN22 jj 1-386; 3-140; 6-387; 6-243; 262-511; 290-533;
308-386; 437-738; 448-738; 444-612; 481-755; 493-738; 541-727; 587-1087;
603-985; 646-1165; 697-968 798-988; 945-1472; 990-1518; 1022-1206; 1136-
1457; 1199-1510; 1203-1814; 1387-1699; 1424-1669; 1492-1779; 1507-1951; 1515-1805; 1544-1602; 1718-2133; 1761-2160; 1764-2138; 1764-2135; 2036-2155
547 /LG: 7685048.6 :2001JUN22 I I 1-541; 133-369; 133-380 548/LG: 7688302.1:2001JU 22 j j 1-359; 57-325; 115-324; 133-357 133-323 133-364; 144-323; 147-323 155-363; 155-341; 155-323; 155-282 169-763 207-773; 210-323; 265-323 269-325; 542-927; 542-828; 542-683 558-810 558-904; 582-854; 652-917 729-931 549/LG:7690463.3 :2001JUN22 I I 1-593; 36-570; 115-361; 292-559; 294-592; 306-469; 306-559; 330-559; 339-559; 425-559; 455-575; 516-1013; 676-1000; 711-962; 791-1089; 809-1050; 813-1198; 815-1189; 836-1170; 836-1199; 836- 1155; 836-1084; 836-1055; 836-1013; 836-974; 836-918; 855-1132; 860-1114; Table 3
864-990; 886-1158; 891-1202; 892-1194; 898-1010; 914-1130; 916-1200; 942-
1196; 942-1194; 942-1158; 1026-1203; 1026-1090; 1085-1186; 1096-1198; 1116-
1198
550/LG:7691479.5:2001JUN22 || 1-599
551/LG:7691527.4:2001JUN22 jj 1-261; 48-129; 50-328; 51-136; 57-293; 58-
310; 58-577; 58-764; 58-551; 58-272; 66-364; 66-357; 68-318; 68-310; 73-
340; 77-344; 120-376; 129-327; 165-388; 202-662; 408-649
552/LG:7691663.1:200UUN22 | | 1-680; 38-172; 61-172; 461-666; 468-665; 477-
613; 495-730; 521-713; 619-782; 621-782; 621-759; 628-782; 637-782; 655-
782; 658-782; 688-797; 689-782; 691-775; 695-782; 706-782; 716-795; 721-
782; 722-782
553/LG:7691854.1:2001JU 22 | | 602-896; 620-896; 646-896; 756-832; 529-755;
1-606; 244-472; 1-111
554/LG:7692235.2:2001JUN22 || 1-629; 276-779
555/LG:7692239.1:2001JUN22 j j 1-598; 33-533; 70-338; 136-407; 181-715; 204-
411; 205-411; 207-520; 209-508; 212-757; 212-411; 214-411; 216-554; 228-
411; 229-411; 243-765; 474-761; 508-744; 644-706; 663-852; 683-1077; 692-
843; 804-1153; 804-1050; 926-1229; 1106-1597; 1185-1661; 1330-1661; 1428-
1657; 1475-1654; 1481-1648
556/LG:7692575.1.-2001JUN22 || 1-247; 97-594; 168-390; 168-331; 168-766;
181-331; 262-331; 262-391; 355-530; 364-492; 381-974; 422-858; 549-848;
649-956; 802-1035; 851-1366; 881-1447; 881-1147; 948-1120; 1059-1466; 1211-
1373; 1237-1625; 1452-1748; 1452-1512; 1452-1975; 1465-1582
557/LG: 7692742.1:2001JUN22 || 1-262; 1-601; 35-239; 35-244; 189-280; 228-
285; 504-682; 526-718
558/LG:7693942.1:2001JUN22 | | 1-545; 9-315; 122-245; 126-393; 312-557; 379-
1027 401-563; 420-1078; .421-545; 474-924; 474-557; 636-1080; 656-1050;
664-1151; 829-1123; 832-1124; 836-1103; 840-1167; 840-1125; 857-1169; 858-
1020 857-951; 858-907; 858-1270; 858-1172; 858-1124; 858-1067; 858-1037;
858-996; 858-964; 859-1163; 887-1158; 893-1168; 979-1167; 979-1128; 992- 1156; 1062-1140; 1077-1511; 1097-1359; 1334-1909; 1334-1897; 1337-1603; 1349-1889; 1354-1469; 1711-2256; 1815-2255; 1924-2148; 1932-2236; 1972- 2362; 2008-2358; 2038-2358 '
559/LG:899248.22:2001JUN22* | | 1-597 ;' 1-542 ; 106-701; 109-645; 106-643; 292- 576; 400-861; 405-658; 487-633; 487-929; 487-1249; 524-820; 526-820; 756- 814; 854-1425; 863-1249; 1720-1944; 1042-1249; 1371-1855; 1432-1940; 1537- 2138; 1657-1890; 1674-2199; 1740-2021; 1825-1908; 1909-2324; 1910-2199; 1908-2418; 1934-2518; 1948-2477; 2148-2381; 2178-2686; 2178-2417; 2180- 2583; 2180-2426; 2242-2778; 2336-2958; 2358-2917; 2368-2668; 2412-2658; 2412-2626; 2412-2625; 2493-2733
560/LG:979051.25:2001JU 22 | | 1-747; 11-337; 229-764; 341-768; 345-575; 472-922; 477-1110; 497-1049; 506-763; 542-824; 542-838; 542-827; 545-827; 577-839; 631-898; 671-1193; 680-866; 722-1018; 757-1046; 757-1045; 760- 1026; 765-1172; 765-991; 770-1246; 781-1284; 805-1338; 812-1089; 842-1006; 845-1335; 863-1315; 879-1398; 880-1137; 903-1315; 926-1470; 930-1344; 931- 1145; 932-1201; 943-1545; 948-1475; 1031-1329; 1035-1316; 1020-1370; 1072- 1320; 1100-1377; 1112-1239; 1117-1306; 1119-1408; 1121-1345; 1121-1339; 1129-1347; 1129-1232; 1126-1778; 1153-1440; 1159-1395; 1161-1459; 1168- 1669; 1187-1807; 1183-1721; 1183-1415; 1190-1516; 1188-1306; 1207-1387; 1214-1435; 1218-1466; 1220-1485; 1221-1369; 1224-1792; 1235-1557; 1257- 1470; 1264-1817; 1289-1724; 1297-1677; 1297-1586; 1329-1673; 1345-1586; 1346-1514; 1365-1478; 1355-1526; 1369-1589; 1370-1677; 1388-1565; 1405- 1732; 1421-1840; 1423-1986; 1447-1942; 1451-1628; 1467-1639; 1481-1958; 1498-1767; 1504-2020; 1507-1951; 1513-1779; 1513-1768; 1530-1966; 156! 1780; 1569-1968; 1580-1958; 1588-1886; 1595-1974; 1615-1888; 1619-1985; 1619-1860; 1625-1874; 1626-2130; 1634-1960; 1652-1806; 1658-2125; 1664- 1748; 1673-2283; 1675-1754; 1689-1970; 1711-1843; 1726-2025; 1727-1995; 1729-1953; 1740-2027; 1749-2004; 1772-1986; 1774-1938; 1797-2322; 1798- 2047; 1809-2201; 1810-2038; 1810-2030; 1812-2359; 1815-2075; 1833-2185; 1840-2387; 1839-2128; 1840-2078; 1841-2452; 1849-2085; 1856-2448; 1870- Table 3
2093 1885-2151; 1886-2149 ; 1895 -2175 ; 1895 -1997 1897- -2466 1912- •2337 1912 2216; 1916-2167; 1932 -2476; 1951 -2500; 1967 2551; 1986 2247; 1989 2131 1999-2183; 2006-2260 ; 2045 -2312 ; 2049 -2272 2051- -2266 2055-2367 2056 2289; 2061-2217; 2062 -2296; 2064 -2482; 2064 2319; 2076 2366; 2078 2227 2083-2316; 2085-2363 ; 2093 -2569 ; 2093 -2290 2109- -2383 2114-■2212 2120 2227; 2142-2580; 2142 -2407; 2147 -2227; 2154 2403; 2154 2492; 2187 2421 2201-2454; 2204-2442 ; 2205 -2331 ; 2217 -2405 2240- -2609 2275-•2645 2276 2738; 2278-2702; 2287 -2703; 2292 -2737; 2292 2568; 2299 2732; 2299 2557 2300-2731; 2322-2731 ; 2326 -2643 ; 2344 -2730 2348- -2713 2355- 2681
2374-2645; 2377-2585; 2404 -2672; 2428 -2702; 2469 2713; 2480 2832; 2482
2731 2499-2732; 2548-2827 ; 2548 -2765 ; 2564 -2730 2564- -2797 2567-•2695 2583 2829; 2583-2880; 2583 -2823; 2583 -2721; 2585 2641; 2585 2821; 2592 2826 2598-3270; 2601-2832 ; 2606 -3017 ; 2607 -2713 2644- -2882 2649- 2829 2667 2878; 2690-2825; 2699 -2825; 2703 -3228; 2723 2963; 2766 2825; 2768 2826 2768-2825; 2940-3457 ; 3024 -3643 ; 3082 -3698 3094- -3699 3096-3420 3108 3461; 3110-3633; 3112 -3461; 3119 -3446; 3120 3461; 3120 3343; 3130 3543 3130-3340; 3141-3235 ; 3137 -3231 ; 3142 -3638 3142- -3426 3141- 3396
3142-3520; 3142-3469; 3142 -3422; 3142 -3444; 3142 3358; 3142 3352; 3142 3349; 3142-3346; 3142-3326 ; 3142 -3317 ; 3142 -3318 3142- -3305 3142-3303 3142-3285; 3142-3284; 3142 -3282; 3142 -3273; 3142 3254; 3142 3251; 3142 3244; 3142-3242; 3142-3234 ; 3142 -3235 ; 3142 -3228 3142- -3231 3142-3224 3142-3222; 3142-3245; 3142 -3209; 3142 -3197; 3143 3347; 3148 3414; 3149 3417; 3151-3384; 3169-3450 ; 3170 -3731 ; 3170 -3410 3180- -3411 3183-•3762 3187-3436; 3197-3378; 3200 -3424; 3201 -3433; 3225 3474; 3237 3506; 3242 3797; 3243-3443; 3243-3467 ; 3244 -3453 ; 3244 -3590 3251- -3453 3256-3453 3260-3868; 3270-3420; 3271 -3496; 3284 -3503; 3285 3594; 3285 3513; 3322 3783; 3339-3801; 3340-3801 ; 3349 -3593 ; 3349 -3554 3353- -3801 3357-•3801 3362-3728; 3363-3595; 336.4 -3808; 3368 -3801; 3380 3466; 3385 3808; 3390 3456; 3405-3716; 3408-3801 ; 3415 -3801 ; 3418 -3681 3420- -3719 3430-3697 3450-3800; 3497-3737; 3497 -3779; 3512 -3801; 3527 3803; 3562 3797; 3578 3787; 3581-4011; 3588-3716 ; 3602 -3805 ; 3718 -3801 3782- -3941 3872-•4132 3947-4198; 3998-4435; 4118 -4723; 4259 -4776; 4258 4435; 4494 4981; 4499 4981; 4526-5111 561/LG: 979054.18 :2001 UN22 II i- 453; 1-227; 21-34 0; 31- -650; 34-2 80; 67-341; 136-341; 195-723; 199-460; 240-7 15; 2 42-766 ; 262-452; 288-5 59; 2 90-731; 306-579; 310-774; 340-661; 340-5 35; 3 55-729 ; 366-638; 388-5 46; 3 94-774; 462-778; 463-775; 467-1061 ; 536- 780; 541-771; 574-770; 674- 1258; 714-1241; 749-1250; 787-1087; 787-10 00; 78 8-113 7; 820-1265 820- 1419; 832-1241; 834- 1220; 836-1265; 846-1268; 851-10 97; 8 81-1090; 88 -1268 ; 900 1087 ; 900-1263; 907-1456; 913-1264; 911-12 63; 96 1-124 8; 966-1263 981 1147; 1017 -1270; 1030-1184; 1030-1455; 1020 -1202; 1032 -1174; 1055 1193 1067 -1315 ; 1099- 1267; 1100-1204; 1120-1360 ; 1109 -1356 ; 1109-1256 1109 -1236 1129-1263; 1143-1263; 1149-1252; 1204 -1482; 1288 -1675; 1359 1915 1430 1672 ; 1449- 1920; 1507-2049; 1526-1783 ; 1592 -1820 ; 1683-1838 1695 -1956 1726-2214; 1727-1942; 1760-2017; 1761 -2020; 1863 -1940; 1947 2127; 1953 2503 ; 1965- 2454; 1979-2396; 2004-2263 ; 2034 -2264 ; 2042-2311 2042 -2256 2079-2397; 2094-2670; 2118-2281; 2134 -2312; 2143 -2747; 2150 2477; 2168 2727 ; 2208- 2709; 2208-2449; 2227-2712 ; 2241 -2488 ; 2300-2667 2331 -2450 2367-2982; 2367-2884; 2374-2601; 2374 -2840; 2378 -2602; 2379 2732; 2394 2732 ; 2395- 2575; 2407-3070; 2405-2602 ; 2435 -2729 ; 2456-3036 2532 -2863 2557-3103; 2556-3106; 2589-3103; 2678 -2937; 2758 -3139; 2756 3138; 2776 3031 ; 2776- 3142; 2776-3141; 2782-3098 ,- 2785 -3144 ; 2789-3039 2796 -3144 2798-3142; 2820-3146; 2847-3144; 2852 -3105; 2870 -3144; 2874-2931; 2880 3143 ; 2896- 3147; 3030-3105; 3037-3142 ; 3037 -3137 ; 3069-3137 562 /LG: 979415.1:2001JUN22 II ι- 42; 1 -403; 48-313 ; 130-402; 178-508; 379- 812; 611-972; 643-811; 649 -935; 650-8 24; 651-926; 665-1244; 688-811; 847- 1246; 967-1204; 1014-1555; 1014- 1632; 1110-1628; 1188-1445; 1221-2002; 1525-2039; 1574-2138; 1574 -1893; 1869 -2099; 1998- 2137; 2021-2308; 2064- 2568; 2378-2619; 2463-2987 ; 2775 -3042 ; 2783-3239; 2782-3209; 2782-3018; 2782-3057; 2782-3028; 2797 -3243; 2815 -3017; 2998- 3209;.3054-3261; 3054- Table 3
3514; 3254-3713; 3254-3531; 3261-3670; 3263-3447; 3263-3435; 3284-3491; 3308-3541; 3345-3526; 3382-3786; 3386-3669; 3426-3959; 3427-3786; 3430- 3785; 3437-3783; 3483-3742; 3588-3734; 3799-4372; 3811-4031; 3875-4533; 3875-4503; 3879-4445; 3889-4153; 3904-4182; 4043-4273; 4073-4521; 4138- 4312; 4291-4476; 4399-4656; 4442-4996; 4603-4997
563/LG:980685.1:2001JUN22 || 1-257; 4-146; 30-377; 42-101; 132-522; 140- 345; 149-759; 152-340; 303-899; 312-557; .313-778 ; 294-403; 333-764; 368- 711; 376-594; 493-638; 604-1099; 1029-1522; 1042-1601; 1200-1373; 1213-
1455; 1269-1925; 1294-1533 1294-1851; 1309-1599; 1312-1539; 1549-2214 1566-1637; 1585-1880; 1587 1797; 1623-1900; 1622-1847; 1624-1934; 1643 2079; 1877-2303; 1878-2527 1884-2003; 1900-2462; 1908-2330; 1911-2564
1977-2431; 2006-2592; 2014-2565; 2037-2218; 2099-2599; 2112-2480; 2160-
2635; 2161-2639 2173-2639 2174-2639; 2178-2633; 2194-2640; 2202-2608; 2267-2566; 2357 2643; 2366 2640; 2369-2639; 2382-2565; 2430-2632; 2520- 2610; 2540-2642 2597-3070 2677-2892; 2678-2892; 2677-3183; 2818-3098; 2916-3444; 3142 3439; 3160 3381; 3226-3658; 3227-3485; 3276-3444; 3303- 3481; 3303-3845 3324-3486 3337-3592; 3359-3605; 3359-3636; 3384-3481; 3503-3760; 3609 3762; 3618 3883; 3664-3943; 3684-4124; 3746-4167; 3753- 3998; 3773-3861 3833-4168 3932-4170; 4052-4171 564/LG: 981272.6 :2001JUN22 || 1334-1514; 1317-1493; 1341-1483; 1173-1480; 1421-1480; 952-1480; 999-1451; 999-1309; 999-1176; 465-998; 456-951; 674- 951; 414-793; 264-644; 365-641; 317-641; 500-640; 432-631; 253-597; 256- 518; 1-502; 269-486; 1-366; 256-325; 1-146
565/LG:982723.4:2001JUN22 | | 1-559; 354-781; 711-1070; 711-1043; 711-799; 727-1014; 727-979; 978-1232; 979-1175; 996-1533; 1022-1231; 1177-1583; 1265-1565; 1264-1985; 1349-2036; 1352-1595; 1352-1577; 1381-1604; 1388- 1577;. 1403-1577; 1455-1577; 1474-1577; 1487-1577; 1491-1582; 1527-1577; 1871-2242; 1873-2183 ;■ 1872-2146 ; 1879-2149; 1885-2095; 1885-2017; 1885- 1975; 1904-2073; 1944-2285; 1946-2166; 1995-2231; 2000-2284; 2057-2243; 2123-2309
566/LG: 982915.8 :2001JUN22 | | 1-626; 78-621; 97-626; 106-625; 132-659; 167- 710; 331-730; 392-808; 416-622; 423-903; 435-969; 459-1008; 498-667;- 563- 814; 612-1074; 761-1365; 785-1274; 8*13-1023; 835-1074; 865-1219; 916-1048; 965-14*37; 1221-1488; 13.54-1638; 1473-1990; 1473-2184; 1512-1621; 1723-2314; 1736-2349; 1793-2370; 1800÷2370; 2013-2405; 2013-2305; 2015-2277; 2044- 2681; 2224-2716; 2224-2836; 2304-7584; 2317-2950; 2514-2745; 2680-3373; 2721-2891; 2723-2993; 2761-3429; 2820-3373; 2872-3517; 3006-3723; 3296- 3638; 3388-3638; 3447-3923; 3450-3968; 3483-3750; 3501-3960; 3567-3923; 3612-3730; 3768-4439; 3850-4134; 3911-4055; 3945-4123; 3961-4571; 4331- 4826; 4334-4631; 4403-4616; 4522-5066; 4703-5129; 4801-5379; 4810-5335; 4839-4947; 5018-5344; 5024-5589; 5059-5626; 5070-5724; 5201-5474; 5225- 5429; 5244-5834; 5258-5492; 5318-5814; 5355-5938; 5376-5605; 5478-5564; 5552-6106; 5776-6455; 5993-6396; 6035-6431; 6035-6171; 6039-6350; 6164- 6553; 6289-6448; 6356-6954; 6423-6580; 6437-6722; 6539-6851; 6557-6794; 6575-6767; 6672-6900; 6712-6826; 6712-6955; 6751-7329; 6806-7105; 6864- 7088; 6868-7415; 6891-6978; 6907-7415; 6944-7126; 6963-7254; 7041-7546; 7048-7483; 7047-7314; 7085-7359; 7129-7522; 7163-7584; 7177-7584; 7181- 7584; 7179-7423; 7202-7584; 7210-7415; 7249-7584; 7249-7585; 7260-7542; 7272-7536; 7275-7584; 7276-7535; 7275-7528; 7365-7584; 7428-7584; 7431-7584 567/LG:987785.10:2001JUN22 | | 1-244; 208-496; 387-701; 406-1032; 491-1098; 637-1127; 649-836; 661-927; 666-950; 674-793; 701-1201; 719-946; 721-1015; 905-1145; 905-1198; 930-1098; 986-1429; 1058-1566; 1062-1429; 1079-1198; 1093-1198; 1105-1184; 1123-1446; 1124-1417; 1124-1431; 1126-1434; 1306- 1414; 1306-1484; 1306-1412; 1306-1453; 1306-1478; 1306-1395; 1306-1438; 1306-1429; 1314-1429; 1317-1941; 1341-1429; 1338-1426; 1341-1842; 1339- 1429; 1362-1432; 1393-2033; 1459-2038; 1678-2029; 1696-1909; 1718-2072; 1717-2005; 1722-2072; 1726-2072; 1726-2071; 1726-2044; 1730-2020; 1730- 2072; 1730-2094; 1733-1953; 1733-1956; 1735-1955; 1740-2072; 1742-2072; 1748-2031; 1747-2072; 1748-1852; 1748-2072; 1748-1809; 1748-1808; 1748- 2033; 1748-1844; 1748-1799; 1748-2063; 1748-2067; 1748-1969; 1748-2029; Table 3
1748-1834; 1748-1843; 1748-2053; 1748-1826; 1748-1822; 1748-2095; 1748- 1817; 1748-1816; 1748-1936; 1748-2066; 1748-1856; 1749-2093; 1757-2072 1758-2028; 1763-2147; 1763-2072; 1765-1971; 1765-2072; 1768-2072; 1769- 2072; 1788-2018; 1788-2072; 1789-1960; 1797-1909; 1808-2072; 1809-2072 1807-2072; 1811-2072; 1813-2072; 1821-2066; 1822-2072; 1835-1908; 1847 1966; 1837-2000; 1838-2072; 1839-2054; 1845-2054; 1854-2072; 1854-2095 1853-2140; 1855-2072; 1856-1966; 1862-2072; 1863-2072; 1876-2072; 1879 2072; 1880-2140; 1880-2120; 1883-2072; 1889-2072; 1906-2072; 1911-2072 1912-2120; 1913-2137; 1930-2072; 1967-2072; 1966-2145; 1969-2072; 1976 2112; 1997-2072; 2005-2072; 2022-2072; 2079-2420; 2088-2608; 2088-2476 2088-2431; 2108-2525; 2108-2616; 2108-2490; 2108-2491; 2108-2536; ' 2108- 2361; 2108-2453; 2108-2461; 2108-2468; 2108-2476; 2108-2390; 2108-2489 2108-2420; 2108-2433; 2108-2431; 2108-2434; 2108-2526; 2108-2409; 2108 2432; 2108-2515; 2108-2394; 2108-2438; 2108-2211; 2108-2212; 2108-2370 2121-2515; 2113-2210; 2118-2496; 2138-2734; 2176-2734; 2221-2348; 2226 2501; 2248-2418; 2293-2513; 2307-2513; 2374-2585; 2471-2734
Table 4
SEQ ID NO: Template ID Tissue Distribution
1 LG:1041015.22:2001MAR30 Endocrine System - 31%, Exocrine Glands - 31%, Hemic and Immune System - 23%
2 LG:106877.10:2001MAR30 Unclassified/Mixed - 19%, Exocrine Glands - 13%, Male Genitalia - 12%
3 LG:1138554.16:2001MAR30 Sense Organs - 23%, Germ Cells - 13%, Embryonic Structures - 11%
4 LG:1383277.7:2001MAR30 Urinary Tract - 33%, Unclassified/Mixed - 23%, Digestive System - 13%, Endocrine System - 13%
5 LG:1397614.15:2001MAR30 Urinary Tract - 18%, Nervous System - 15%, Exocrine Glands - 11%
6 LG:1399315.8:2001MAR30 Unclassified/Mixed - 30%, Respiratory System - 11%, Connective Tissue - 10%
7 LG: 198782.1.2001MAR30 Embryonic Structures - 10%
8 LG:236046.1:2001MAR30 Connective Tissue - 15%, Germ Cells - 12%, Endocrine System - 11%
9 LG:332122.6:2001MAR30 Musculoskeletal System - 15%, Cardiovascular System - 13%, Respiratory System - 13%
10 LG:345320.16:2001MAR30 Hemic and Immune System - 24%, Liver - 19%, Unclassified/Mixed - 14%
11 LG:350827.10:2001MAR30 Germ Cells - 17%
12 LG:399901.5:2001MAR30 Germ Cells - 16%, Unclassified/Mixed - 15%, Embryonic Structures - 14%
13 LG:404563.1:2001MAR30 Liver - 29%, Unclassified/Mixed - 15%
14 LG:977812.15:2001MAR30 Nervous System - 47%, Respiratory System - 17%, Embryonic Structures - 15%, Endocrine System - 15%
J 15 LG:983810.1:2001MAR30 Sense Organs - 33%, Nervous System - 31% o
16 LG:984488.1:2001MAR30 Sense Organs - 39%, Unclassified/Mixed - 27%
17 LG:011606.1:2001MAR30 Exocrine Glands - 24%, Pancreas - 18%, Male Genitalia - 14%
18 LG:025465.5:2001MAR30 Embryonic Structures - 16%, Cardiovascular System - 13%, Germ Cells - 13%
19 LG:025724.10:2001MAR30 Skin - 23%, Pancreas - 11%
20 LG:1095426.1:2001MAR30 Germ Cells - 31%, Unclassified/Mixed - 13%, Respiratory System - 12%
21 LG:1132418.1:2001MAR30 Liver - 90%, Nervous System - 10%
22 LG: 1377900.14:2001MAR30 Hemic and Immune System - 15%, Embryonic Structures - 11%, Endocrine System - 11%, Pancreas - 11%
23 LG:1383812.1:2001MAR30 Nervous System - 35%, Unclassified/Mixed - 33%, Male Genitalia - 23%
24 LG: 1468687.1.2001MAR30 Pancreas - 100%o
25 LG:1505513.1:2001MAR30 Digestive System - 29%, Respiratory System - 29%, Nervous System - 29%
26 LG:178823.9:2001MAR30 Connective Tissue - 14%, Exocrine Glands - 10%
27 LG:198342.3:2001MAR30 widely distributed
28 LG:210672.1:2001MAR30 Female Genitalia - 26%, Nervous System - 24%, Connective Tissue - 21%
29 LG:212823.8:2001MAR30 Unclassified/Mixed - 29%, Urinary Tract - 29%, Digestive System - 17%, Nervous System - 17%
30 LG:220495.9:2001MAR30 Unclassified/Mixed - 17%, Skin - 12%
31 LG:238262.1:2001MAR30 Embryonic Structures - 18%, Liver - 15%, Sense Organs - 11%
32 LG:239410.21 :2001MAR30 Digestive System - 31%, Male Genitalia - 23%
Figure imgf000406_0001
o
-lη -t in w ∞ Oi O *- 1 M co -* <-> vo c- o <Λ O *— -d v co co co co co co co -<d- *^ ^o ^ κn ι aM κc -ιr- κnr) θn it~~ ∞n σn --' κtΩ κ c
CΛ Table 4
SEQ ID NO: Template ID Tissue Distribution
64 LG:1060168.6:2001MAR30 Hemic and Immune System - 50%, Male Genitalia - 33%, Nervous System - 17%
65 LG: 1086906.41 :2001MAR30 Exocrine Glands - 16%, Connective Tissue - 14%, Respiratory System - 10%
66 LG:1089326.18:2001MAR30 Unclassified Mixed - 33%, Digestive System - 17%, Nervous System - 14%
67 LG:1090862.32:2001MAR30 Unclassified/Mixed - 25%, Female Genitalia - 21%, Respiratory System - 13%
68 LG:1091941.41:2001MAR30 Connective Tissue - 37%, Liver - 17%, Embryonic Structures - 17%
69 LG:1093386.8:2001MAR30 Embryonic Structures - 16%
70 LG:1094187.33:2001MAR30 Hemic and Immune System - 18%
71 LG:1098692.18:2001MAR30 Digestive System - 31%, Liver - 19%, Skin - 11%
72 LG: 1173104.22:2001MAR30 Sense Organs - 18%, Liver - 13%, Germ Cells - 10%
73 LG:1215335.7:2001MAR30 Embryonic Structures - 11%
74 LG:1256753.1:2001MAR30 Embryonic Structures - 13%, Female Genitalia - 10%
75 LG: 1326702.10:2001MAR30 Connective Tissue - 15%, Cardiovascular System - 11%, Embryonic Structures - 10%
76 LG:1327239.15:2001MAR30 Sense Organs - 19%, Respiratory System - 13%
77 LG:1327867.15:2001MAR30 Embryonic Structures - 13%, Nervous System - 10%
78 LG:1383232.1:2001MAR30 Sense Organs - 21%, Skin - 18%, Exocrine Glands - 12%
79 LG:1383368.40:2001MAR30 Respiratory System - 11%
80 LG:1384477.1:2001MAR30 Endocrine System - 31%, Liver - 17%, Urinary Tract - 13%
81 LG:1390822.1:2001MAR30 widely distributed
82 LG: 1398274.13 :2001MAR30 Skin - 15%
83 LG:1398646.1:2001MAR30 Unclassified/Mixed - 18%
84 LG:1398905.1:2001MAR30 Unclassified/Mixed - 22%, Nervous System - 13%, Musculoskeletal System - 10%, Digestive System - 10%
85 LG:1399785.1:2001MAR30 Embryonic Structures - 11%
86 LG:1446193.10:2001MAR30 Sense Organs - 34%
87 LG:1446210.8:2001MAR30 Skin - 16%, Pancreas - 11%
88 LG:1450054.6:2001MAR30 Sense Organs - 14%, Unclassified/Mixed - 12%
89 LG: 1452516.4:2001MAR30 Unclassified Mixed - 23%, Skin - 12%, Connective Tissue - 12%
90 LG:1455293.7:2001MAR30 Endocrine System - 19%, Respiratory System - 16%, Urinary Tract - 14%
91 LG:1498113.1:2001MAR30 Liver - 100%
92 LG: 1500042.1 :2001MAR30 Female Genitalia - 44%, Exocrine Glands - 19%, Respiratory System - 14%
93 LG: 1500434.4:2001MAR30 Stomatognathic System - 22%, Sense Organs - 18%
94 LG:1501102.4:2001MAR30 Embryonic Structures - 45%, Liver - 21%, Musculoskeletal System - 14%
95 LG: 1501768.2:2001MAR30 Digestive System - 50%, Respiratory System - 50%
Table 4
SEQ ID NO: Template ID Tissue Distribution
96 LG:1502155.6:2001MAR30 Liver - 24%, Female Genitalia - 24%, Embryonic Structures - 12%
97 LG:1512304.2:2001MAR30 Unclassified/Mixed - 27%, Connective Tissue - 27%, Cardiovascular System - 15%, Endocrine System - 15%
98 LG:1512931.11:2001MAR30 Unclassified/Mixed - 38%, Embryonic Structures - 13%, Urinary Tract - 11%
99 LG:155076.18:2001MAR30 Respiratory System - 13%, Endocrine System - 12%
100 LG:159111.41:2001MAR30 Germ Cells - 15%, Connective Tissue - 10%
101 LG:170604.1:2001MAR30 Respiratory System - 50%, Urinary Tract - 30%, Female Genitalia - 20%
102 LG:190477.4:2001MAR30 Sense Organs - 28%, Unclassified/Mixed - 14%
103 LG:198087.8:2001MAR30 Embryonic Structures - 12%, Unclassified/Mixed - 10%, Nervous System - 10%
104 LG:198743.2:2001MAR30 Unclassified/Mixed - 12%, Nervous System - 11%
105 LG:199194.1:2001MAR30 Sense Organs - 16%, Embryonic Structures - 13%
106 LG:200727.6:2001MAR30 Unclassified/Mixed - 22%, Germ Cells - 12%
107 LG:201572.20:2001MAR30 widely distributed
108 LG:201669.25:2001MAR30 Digestive System - 10%, Pancreas - 10%
109 LG:208588.4:2001MAR30 Digestive System - 100%
110 LG:210412.29:2001MAR30 Respiratory System - 30%, Embryonic Structures - 27%, Musculoskeletal System - 18%
111 LG:215051.15:2001MAR30 Nervous System - 11%, Skin - 10%, Urinary Tract - 10%
112 LG:215475.21:2001MAR30 Embryonic Structures - 20%
113 LG:224523.1:2001MAR30 Respiratory System - 67%, Nervous System - 33%
114 LG:228186.1:2001MAR30 Germ Cells - 17%, Urinary Tract - 11%
115 LG:233138.2:2001MAR30 Cardiovascular System - 15%
116 LG:234811.10:2001MAR30 Liver - 38%
117 LG:236092.1:2001MAR30 Urinary Tract - 14%, Embryonic Structures - 14%, Germ Cells - 13%
118 LG:236098.12:2001MAR30 Unclassified/Mixed - 11%
119 LG:236697.15:2001MAR30 Sense Organs - 15%
120 LG:237503.21:2001MAR30 Sense Organs - 42%
121 LG:238023J:2001MAR30 Exocrine Glands - 22%, Unclassified Mixed - 18%, Nervous System - 15%
122 LG:238209.1:2001MAR30 Skin - 16%
123 LG:238456.10:2001MAR30 Germ Cells - 14%, Endocrine System - 12%, Urinary Tract - 10%
124 LG:239245.1:2001MAR30 Musculoskeletal System - 11%, Sense Organs - 11%
125 LG:239579.8:2001MAR30 Embryonic Structures - 12%, Cardiovascular System - 10%
126 LG:239601.22:2001MAR30 Embryonic Structures - 13%, Unclassified/Mixed - 12%
127 LG:240121.1:2001MAR30 Unclassified/Mixed - 21%, Skin - 16%
Table 4
SEQ ID NO: Template ID Tissue Distribution
128 LG:241110.2:2001MAR30 Stomatognathic System - 16%, Urinary Tract - 13%, Respiratory System - 11%
129 LG:244948.4:2001MAR30 Skin - 18%
130 LG:245378.6:2001MAR30 Exocrine Glands - 10%
131 LG:248203.9:2001MAR30 Unclassified/Mixed - 13%
132 LG:249247.1:2001MAR30 Cardiovascular System - 18%, Nervous System - 18%
133 LG:267153.16:2001MAR30 Germ Cells - 16%
134 LG:291759.5:2001MAR30 Connective Tissue - 17%, Germ Cells - 11%, Digestive System - 10%, Endocrine System - 10%
135 LG:298102.1:2001MAR30 Male Genitalia - 67%, Nervous System - 33%
136 LG:308891.1:2001MAR30 Endocrine System - 80%, Nervous System - 20%
137 LG:312668.4:2001MAR30 Unclassified Mixed - 21%, Female Genitalia - 11%
138 LG:331642.6:2001MAR30 Connective Tissue - 60%
139 LG:331851.12:2001MAR30 Unclassified/Mixed - 15%, Sense Organs - 11%
140 LG:332414.5:2001MAR30 Germ Cells - 35%, Hemic and Immune System - 13%, Unclassified/Mixed - 11%
141 LG:332730.12:2001MAR30 Unclassified/Mixed - 12%
142 LG:333062.22:2001MAR30 Hemic and Immune System - 83%, Exocrine Glands - 13%
143 LG:335705.2:2001MAR30 widely distributed
144 LG:337930.16:2001MAR30 Skin - 58%, Stomatognathic System - 31%
145 LG:346481.15:2001MAR30 Female Genitalia - 50%, Digestive System - 50%
146 LG:349164.1:2001MAR30 Stomatognathic System - 27%, Cardiovascular System - 22%, Musculoskeletal System - 11%
147 LG:350957.5:2001MAR30 Germ Cells - 49%, Female Genitalia - 20%
148 LG:383512.8:2001MAR30 Nervous System - 11%, Liver - 11%
149 LG:401163.10:2001MAR30 Liver - 23%, Hemic and Immune System - 13%
150 LG:402133.1:2001MAR30 Unclassified/Mixed - 23%, Nervous System - 23%, Respiratory System - 16%
151 LG:405820.1:2001MAR30 Unclassified/Mixed - 26%, Liver - 18%, Connective Tissue - 14%
152 LG:405846.1:2001MAR30 Male Genitalia - 58%, Female Genitalia - 17%, Nervous System - 17%
153 LG:407401.2:2001MAR30 Germ Cells - 36%
154 LG:408448.10:2001MAR30 Unclassified/Mixed - 28%, Germ Cells - 19%, Skin - 12%
155 LG:408854.13:2001MAR30 Musculoskeletal System - 21%, Cardiovascular System - 14%, Digestive System - 14%, Endocrine System - 14%
156 LG:411150.14:2001MAR30 Urinary Tract - 13%
157 LG:411466.1:2001MAR30 Unclassified/Mixed - 25%, Germ Cells - 14%, Female Genitalia - 10%
158 LG:413969.68:2001MAR30 Respiratory System - 20%, Embryonic Structures - 19%, Digestive System - 14%
159 LG:419641.35:2001MAR30 Unclassified/Mixed - 14%, Respiratory System - 10%
Figure imgf000410_0001
Q o o
Figure imgf000410_0002
W oo Table 4
SEQ ID NO: Template ID Tissue Distribution
192 L 197048.10.2001MAY17 Skin - 16%, Endocrine System - 11%
193 LI:228655.5:2001MAY17 Unclassified/Mixed - 48%, Pancreas - 23%, Exocrine Glands - 20%
194 LI:229789.6:2001MAY17 Female Genitalia - 42%, Digestive System - 33%, Hemic and Immune System - 17%
195 LI:231500.8:2001MAY17 Endocrine System - 26%, Hemic and Immune System - 23%, Digestive System - 23%
196 LI:253851.26:2001MAY17 Endocrine System - 38%, Male Genitalia - 13%, Female Genitalia - 11%
197 LI:373302.1:2001MAY17 Exocrine Glands - 56%, Female Genitalia - 22%, Nervous System - 22%
198 LI:405707.12:2001MAY17 Nervous System - 28%, Connective Tissue - 24%, Endocrine System - 17%
199 LI:411441.8:2001MAY17 Nervous System - 61%, Skin - 17%, Pancreas - 11%
200 LI:758193.3:2001MAY17 Urinary Tract - 18%, Nervous System - 15%, Exocrine Glands - 11%
201 LI:1028562.3:2001MAY17 Unclassified/Mixed - 100%
202 LI:104650.7:2001MAY17 Nervous System - 63%, Urinary Tract - 25%, Female Genitalia - 13%
204 LI:1143528.4:2001MAY17 Respiratory System - 35%, Unclassified/Mixed - 27%, Hemic and Immune System - 16%
205 LI:1172210.7:2001MAY17 Endocrine System - 26%, Musculoskeletal System - 21%, Connective Tissue - 21%
206 LI:1178659.14:2001MAY17 Germ Cells - 30%, Urinary Tract - 14%, Nervous System - 12%
207 LI:1983726.3:2001MAY17 Unclassified/Mixed - 97%
208 LI:2051495.3:2001MAY17 Sense Organs - 41%, Embryonic Structures - 26%
209 LI:2117629.1:2001MAY17 Urinary Tract - 33%, Nervous System - 33%, Hemic and Immune System - 17%, Male Genitalia - 17%
210 LI:2118007.3:2001MAY17 Nervous System - 100%
211 LI:2118292.9:2001MAY17 Connective Tissue - 26%, Male Genitalia - 19%, Exocrine Glands - 19%
212 LI:2118733.7:2001MAY17 Connective Tissue - 100%
213 LI:212702.3:2001MAY17 Germ Cells - 13%, Nervous System - 11%, Unclassified/Mixed - 11%
214 LI:2207871.10:2001MAY17 Germ Cells - 34%, Endocrine System - 15%, Male Genitalia - 14%
215 LI:2207876.5:2001MAY17 Nervous System - 100%
216 LI:2208743.1:2001MAY17 Sense Organs - 67%, Urinary Tract - 17%, Endocrine System - 11%
217 LI:2208744.1:2001MAY17 Female Genitalia - 43%, Connective Tissue - 32%, Endocrine System - 11%
218 LI:230905.3:2001MAY17 Skin - 13%, Cardiovascular System - 12%, Embryonic Structures - 11%
219 LI:235233.95:2001MAY17 Embryonic Structures - 56%, Cardiovascular System - 22%, Hemic and Immune System - 11%, Male Genitalia - 11%
220 LI:235359.24:2001MAY17 Male Genitalia - 16%, Endocrine System - 13%, Liver - 12%
221 LI:238365.6:2001MAY17 Nervous System - 57%, Hemic and Immune System - 43%
223 LI:321069.2:2001MAY17 Urinary Tract - 14%, Unclassified/Mixed - 11%
224 LI:331499.8:2001MAY17 Respiratory System - 13%, Male Genitalia - 13%, Exocrine Glands - 12%
225 LI:332I76.8:2001MAY17 Germ Cells - 27%, Unclassified/Mixed - 18%, Exocrine Glands - 11%, Endocrine System - 11%
Table 4
SEQ ID NO: Template ID Tissue Distribution
226 LI:333952.7:2001MAY17 Respiratory System - 69%, Hemic and Immune System - 31%
228 LI:343869.2:2001MAY17 widely distributed
229 LI:363532.1:2001MAY17 Digestive System - 67%, Nervous System - 33%
231 LI:416650.1:2001MAY17 Cardiovascular System - 47%, Connective Tissue - 41%, Digestive System - 12%
232 LI:444767.32:2001MAY17 Musculoskeletal System - 19%, Hemic and Immune System - 11%
233 LI:759073.1:2001MAY17 Exocrine Glands - 45%, Respiratory System - 15%, Hemic and Immune System - 15%
234 LI:759902.4:2001MAY17 Skin - 100%
235 LI:762268.1:2001MAY17 Pancreas - 84%
236 LI:813699.1:2001MAY17 Endocrine System - 40%, Liver - 26%, Respiratory System - 14%, Female Genitalia - 14%
237 LI:024142.16:2001MAY17 Sense Organs - 40%, Pancreas - 13%
238 LI:1018424.4:2001MAY17 Connective Tissue - 12%, Nervous System - 11%
239 LI:1085250.6:2001MAY17 Cardiovascular System - 25%, Embryonic Structures - 22%, Respiratory System - 12%
241 LI:2207125.3:2001MAY17 Male Genitalia - 100%
242 LI:235153.44:2001MAY17 Connective Tissue - 18%, Embryonic Structures - 11%
*. 243 LI:007101.10:2001MAY17 Germ Cells - 25%, Connective Tissue - 23%
° 244 LI:008541.2:2001MAY17 Unclassified/Mixed - 39%, Exocrine Glands - 24%, Female Genitalia - 18%
245 LI:009658.13:2001MAY17 Embryonic Structures - 70%
246 LI:020012.14:2001MAY17 Germ Cells - 33%
247 LI:020691.1:2001MAY17 Female Genitalia - 78%, Digestive System - 22%
248 LI:021188.12:2001MAY17 Respiratory System - 18%, Female Genitalia - 12%
249 LI:021324.4:2001MAY17 Endocrine System - 37%, Liver - 18%, Nervous System - 15%
250 LI:021834.15:2001MAY17 Liver - 15%, Nervous System - 11%
251 LI:*024841.1:2001MAY17 Hemic and Immune System - 17%, Connective Tissue - 14%, Pancreas - 10%
252 LI:025724.12:2001MAY17 Skin - 17%, Pancreas - 11%
253 LI:029328.2:2001MAY17 Germ Cells - 13%
254 LI:032171.5:2001MAY17 Skin - 15%, Urinary Tract - 11%, Hemic and Immune System - 11%
255 LI:035055.1:2001MAY17 Musculoskeletal System - 30%, Respiratory System - 28%, Endocrine System - 20%
256 LI:036747.17:2001MAY17 Skin - 13%, Hemic and Immune System - 12%
257 LI:044301.2:2001MAY17 Urinary Tract - 28%, Unclassified/Mixed - 17%, Nervous System - 12%
258 LI:061585.10:2001MAY17 Embryonic Structures - 27%, Respiratory System - 18%
259 LL066742.21 :2001MAY17 widely distributed
260 LI:075492.206:2001MAY17 Liver - 15%
Table 4
SEQ ID NO: Template ID Tissue Distribution
261 LI:090782.3:2001MAY17 Musculoskeletal System - 39%, Exocrine Glands - 28%, Cardiovascular System - 22%
262 LI:1031308.1:2001MAY17 Germ Cells - 52%, Endocrine System - 23%
263 LI:1054377.1:2001MAY17 " Exocrine Glands - 29%, Digestive System - 24%, Urinary Tract - 24%
264 LI:1072074.10:2001MAY17 Endocrine System - 10%
265 LI:1072889.15:2001MAY17 Embryonic Structures - 13%
266 LI: 1077480. 2001MAY17 Urinary Tract - 86%, Digestive System - 14%
267 LI:1079555.1:2001MAY17 Pancreas - 37%, Unclassified/Mixed - 12%
268 LI:1084992.28:2001MAY17 Digestive System - 75%, Female Genitalia - 25%
269 LI:1085472.5:2001MAY17 Urinary Tract - 18%, Exocrine Glands - 14%, Female Genitalia - 11%
270 LI:1086800J:2001MAYI7 Urinary Tract - 12%, Embryonic Structures - 10%
271 LI:1089871.9:2001MAY17 Cardiovascular System - 12%
272 LI:110297.6:2001MAY17 Endocrine System - 14%, Unclassified/Mixed - 11%, Embryonic Structures - 10%
273 LI:1143463.8:2001MAY17 Germ Cells - 18%, Skin - 16%
274 LI:1144466.1:2001MAY17 Embryonic Structures - 41%
275 LI:1170624.2:2001MAY17 Endocrine System - 45%, Digestive System - 18%, Hemic and Immune System - 18%, Nervous System - 18%
: 276 LI:1171602.39:2001MAY17 Liver - 90%, Nervous System - 10%
277 LI:1182361.3:2001MAY17 Connective Tissue - 100%
278 LI:1188194.15:2001MAY17 Embryonic Structures - 38%, Musculoskeletal System - 36%
279 LI:1189195J:2001MAY17 Germ Cells - 46%, Respiratory System - 12%
280 LI:1190092.13:2001MAY17 Hemic and Immune System - 100%
281 LI:1190318.4:2001MAY17 Germ Cells - 61%
282 LI: 144233. 2001MAY17 Unclassified/Mixed - 42%, Urinary Tract - 33%, Hemic and Immune System - 17%
283 LI: 154608. L2001MAY17 Urinary Tract - 33%, Hemic and Immune System - 25%, Nervous System - 25%
284 LI:170101.1:2001MAY17 Urinary Tract - 33%, Respiratory System - 33%, Exocrine Glands - 21%
285 LI:180043. L2001MAY17 Pancreas - 45%, Endocrine System - 41%, Hemic and Immune System - 14%
286 LI:193050.1:2001MAY17 Urinary Tract - 28%, Nervous System - 21%, Exocrine Glands - 15%
287 LI:197477.31:2001MAY17 Embryonic Structures - 18%, Sense Organs - 14%, Hemic and Immune System - 12%
288 LI: 199639.12:2001MAY17 Skin - 15%, Sense Organs - 11%
289 LI:200058.6:2001MAY17 Urinary Tract - 35%, Unclassified/Mixed - 22%, Hemic and Immune System - 22%, Male Genitalia - 22%
290 LI:201374.23:2001MAY17 Unclassified/Mixed - 71%, Digestive System - 29%
291 LI:201824.1:2001MAY17 Musculoskeletal System - 13%, Cardiovascular System - 12%, Exocrine Glands - 11%
292 LI:201989.11:2001MAY17 Germ Cells - 23%, Unclassified/Mixed - 22%, Digestive System - 10%
Table 4
SEQ ID NO: Template ID Tissue Distribution
293 LI:2035159.1:2001MAY17 Pancreas - 71%, Female Genitalia - 14%, Male Genitalia - 14%
294 LI:204818.10:2001MAY17 Skin - 29%, Endocrine System - 16%, Urinary Tract - 15%
295 LI:2048337.1:2001MAY17 Stomatognathic System - 30%, Endocrine System - 13%, Sense Organs - 13%
296 LI:2049697.4:2001MAY17 Embryonic Structures - 25%, Germ Cells - 19%
297 LI:2050808.19:2001MAY17 Liver - 24%, Embryonic Structures - 13%, Respiratory System - 12%
298 LI:209773.25:2001MAY17 Male Genitalia - 100%
299 LI:2117881.32:2001MAY17 Sense Organs - 82%
300 LI:2118140.9:2001MAY17 Liver - 47%, Digestive System - 21%, Respiratory System - 16%
301 LL2118151.15:2001MAY17 Unclassified/Mixed - 15%, Germ Cells - 15%
302 LI:2118324.9:2001MAY17 Germ Cells - 15%, Female Genitalia - 12%
303 LI:2118368.12:2001MAY17 Musculoskeletal System - 20%, Pancreas - 14%, Liver - 13%
304 LI:2119448.5:2001MAY17 Stomatognathic System - 58%, Embryonic Structures - 16%
305 LI:212023.7:2001MAY17 Germ Cells - 51%, Pancreas - 12%
306 LI:2120556.1:2001MAY17 Sense Organs - 36%, Unclassified/Mixed - 12%, Pancreas - 12%
307 LI:2121577.3:2001MAY17 Skin - 76%, Endocrine System - 24%
308 LI:2123395.11:2001MAY17 Unclassified/Mixed - 13%, Female Genitalia - 11%, Embryonic Structures - 11%
309 LI:2123452.9:2001MAY17 Exocrine Glands - 14%, Musculoskeletal System - 11%
310 LI:2164109.1:2001MAY17 Hemic and Immune System - 100%
311 LI:2168320.1:2001MAY17 Digestive System - 100%
312 LI:2173577.1:2001MAY17 Male Genitalia - 100%
313 LI:2179256.1:2001MAY17 Unclassified/Mixed - 100%
314 LI:2180388.1:2001MAY17 Male Genitalia - 100%
315 LI:2199713.8:2001MAY17 Urinary Tract - 28%, Endocrine System - 11%, Male Genitalia - 10%
316 LI:2200587.2:2001MAY17 Female Genitalia - 49%, Respiratory System - 18%, Exocrine Glands - 12%
317 LI:2200761.12:2001MAY17 Nervous System - 100%
318 LI:2203624.1:2001MAY17 Respiratory System - 19%, Endocrine System - 19%, Exocrine Glands - 19%
319 LI:220495.9:2001MAY17 Embryonic Structures - 12%, Liver - 11%
320 LI:2205532.1:2001MAY17 Liver - 64%, Respiratory System - 21%, Hemic and Immune System - 14%
321 LI:2206277.1:2001MAY17 Embryonic Structures - 29%, Skin - 24%, Musculoskeletal System - 15% 323 LI:2208404.4:2001MAY17 Nervous System - 100%
325 LI:2208766.2:2001MAY17 Stomatognathic System - 21%, Embryonic Structures - 11%
326 LI:2209636.3:2001MAY17 Exocrine Glands - 23%, Urinary Tract - 20%, Nervous System - 20%
Table 4
SEQ ID NO: Template ID Tissue Distribution
328 LI:229267.1:2001MAY17 Hemic and Immune System - 100%
329 LI:229648.2:2001MAY17 Nervous System - 77%, Endocrine System - 19%
330 LI:231016.1:2001MAY17 Digestive System - 36%, Respiratory System - 27%, Hemic and Immune System - 18%, Male Genitalia - 18%
331 LI:231140.5:2001MAY17 Embryonic Structures - 30%, Hemic and Immune System - 16%, Urinary Tract - 12%, Cardiovascular System - 12%
333 LI:232846.24:2001MAY17 widely distributed
334 LI:233411.11:2001MAY17 Nervous System - 10%
335 LI:233545.13:2001MAY17 Liver - 17%, Endocrine System - 11%, Musculoskeletal System - 10%
336 LI:234671.101:2001MAY17 Sense Organs - 29%
337 LI:236098.14:2001MAY17 Unclassified/Mixed - 14%
338 LI:236196.15:2001MAY17 Endocrine System - 15%, Musculoskeletal System - 15%, Exocrine Glands - 11%
339 LI:237086.1:2001MAY17 Exocrine Glands - 33%, Urinary Tract - 27%, Hemic and Immune System - 20%, Nervous System - 20%
340 LI:238585.30:2001MAY17 Female Genitalia - 50%, Hemic and Immune System - 50%
341 LI:238672.6:2001MAY17 Germ Cells - 21%, Urinary Tract - 19%, Exocrine Glands - 14%
342 LI:239579.9:2001MAY17 Sense Organs - 11%, Connective Tissue - 11%, Cardiovascular System - 10%
^ 343 LI:239720.1:2001MAY17 Unclassified/Mixed - 16%, Nervous System - 16%, Endocrine System - 12% w 344 LI:240037.6:2001MAY17 Urinary Tract - 33%, Exocrine Glands - 17%, Liver - 11%
345 LI:243900J:2001MAY17 Stomatognathic System - 34%, Male Genitalia - 16%, Skin - 15%
346 LI:244378.1:2001MAY17 Skin - 12%, Sense Organs - 12%
347 LI:245500.3:2001MAY17 Cardiovascular System - 13%
348 LI:245982.24:2001MAY17 widely distributed
349 LI:246054.1:2001MAY17 Stomatognathic System - 13%, Urinary Tract - 11%
350 LI:256051.229:2001MAY17 Exocrine Glands - 22%, Cardiovascular System - 17%, Digestive System - 17%
351 LI:260629.7:2001MAY17 Unclassified/Mixed - 100%
352 LI:272723.1:2001MAY17 Cardiovascular System - 67%, Hemic and Immune System - 33%
353 LI:272766.1:2001MAY17 Digestive System - 50%, Hemic and Immune System - 50%
354 LI:275726.1:2001MAY17 Cardiovascular System - 67%, Nervous System - 33%
355 LI:276815.1:2001MAY17 Endocrine System - 71%, Female Genitalia - 29%
356 LI:283562.5:2001MAY17 Sense Organs - 27%, Germ Cells - 13%, Unclassified/Mixed - 12%
357 LI:289066.15:2001MAY17 Sense Organs - 14%
358 LI:331040.17:2001MAY17 Unclassified Mixed - 12%, Sense Organs - 12%
359 LI:332414.5:2001MAY17 Germ Cells - 35%, Hemic and Immune System - 12%, Unclassified/Mixed - 12%
360 LI:332730.16:2001MAY17* widely distributed
Table 4
SEQ ID NO: Template ID Tissue Distribution
362 LI:337038.15:2001MAY17 Germ Cells - 19%
363 LI:337606.6:2001MAY17 Germ Cells - 77%
364 LI:338032.10:2001MAY17 Nervous System - 100%
365 LI:339265.16:2001MAY17 Germ Cells - 29%, Nervous System - 17%, Urinary Tract - 13%
366 LI:344646.4:2001MAY17 Sense Organs - 23%, Connective Tissue - 12%, Respiratory System - 11%, Unclassified/Mixed - 11%
367 LI:347393.7:2001MAY17 Embryonic Structures - 24%, Cardiovascular System - 20%, Connective Tissue - 17%
369 LI:351120.6:2001MAY17 widely distributed
370 LI:358762.41:2001MAY17 Cardiovascular System - 40%, Endocrine System - 19%, Embryonic Structures - 13%
371 LI:363003.48:2001MAY17 Male Genitalia - 15%
372 LI:370899.6:2001MAY17 Embryonic Structures - 14%, Skin - 13%, Unclassified/Mixed - 12%
373 LI:376470.1:2001MAY17 Hemic and Immune System - 100%
374 LI:400961.18:2001MAY17 Skin - 16%, Embryonic Structures - 13%
375 LI:404482.20:2001MAY17 Hemic and Immune System - 13%, Connective Tissue - 11%, Exocrine Glands - 11%
376 LI:405985.1:2001MAY17 Nervous System - 69%, Female Genitalia - 31%
^ 377 LI:406389.1:2001MAY17 Embryonic Structures - 44%, Nervous System - 24%, Respiratory System - 11%, Male Genitalia - 11%
S 378 LI:406833.1:2001MAY17 Musculoskeletal System - 16%, Unclassified/Mixed - 15%, Urinary Tract - 10%
379 LI:4D7921.3:2001MAY17 Germ Cells - 29%
380 LI:409078.54:2001MAY17 Male Genitalia - 24%, Skin - 20%, Liver - 11%
381 LI:423601.6:2001MAY17 Hemic and Immune System - 21%, Musculoskeletal System - 13%, Connective Tissue - 13%
382 LI:425024.5:2001MAY17 Skin - 31%, Pancreas - 19%, Exocrine Glands - 17%
383 LI:427909.29:2001MAY17 Stomatognathic System - 10%
384 LI:428198.20:2001MAY17 Digestive System - 17%, Male Genitalia - 15%, Urinary Tract - 14%
385 LI:429738.6:2001MAY17 Nervous System - 45%, Respiratory System - 27%, Hemic and Immune System - 27%
386 LI:449437.1:2001MAY17 Female Genitalia - 50%, Hemic and Immune System - 50%
387 LI:459269.25:2001MAY17 Sense Organs - 16%, Digestive System - 11%, Nervous System - HΨo, Connective Tissue - 11%
388 LI:464206.1:2001MAY17 Germ Cells - 20%, Connective Tissue - 13%, Endocrine System - 13%
389 LI:465821.2:2001MAY17 Liver - 16%, Musculoskeletal System - 12%
390 LI:474414.28:2001MAY17 Embryonic Structures - 12%
391 L 474435.14:2001MAY17 Germ Cells - 10%
392 LI:474458.11:2001MAY17 widely distributed
393 LI:477127.18:2001MAY17 Hemic and Immune System - 13%
394 LI:480375.55:2001MAY17 Germ Cells - 14%, Digestive System - 12%
Table 4
SEQ ID NO: Template ID Tissue Distribution
395 LI:480467.24:2001MAY17 Skin - 34%, Connective Tissue - 16%, Nervous System - 11%
396 LI:480587.1:2001MAY17 widely distributed
397 LI:480798.13:2001MAY17 Sense Organs - 16%
398 LI:481203.14:2001MAY17 Exocrine Glands - 16%
399 LI:481237.11:2001MAY17 Embryonic Structures - 14%, Unclassified/Mixed - 12%
400 LI:481368.12:2001MAY17 Pancreas - 14%, Hemic and Immune System - 11%, Urinary Tract - 10%
401 LI:482301.8:2001MAY17 Germ Cells - 13%
402 LI:482482.29:2001MAY17 Musculoskeletal System - 30%, Endocrine System'- 20%, Connective Tissue - 15%
403 LI:758877.26:2001MAY17 Pancreas - 26%, Respiratory System - 13%, Unclassified/Mixed - 13%, Exocrine Glands - 13%
404 LI:791042.1:2001MAY17 Embryonic Structures - 28%, Male Genitalia - 28%, Urinary Tract - 22%
405 LI:808999.26:2001MAY17 widely distributed
406 LI:815715.10:2001MAY17 Hemic and Immune System - 13%, Unclassified/Mixed - 12%
407 LI:902980.16:2001MAY17 Sense Organs - 15%, Connective Tissue - 13%
408 LI:903196.25:2001MAYI7 Sense Organs - 15%, Exocrine Glands - 11% 409 LI:903914.10:2001MAY17 Unclassified Mixed - 15%, Nervous System - 12%, Connective Tissue - 12% 410 LG:006764.2:2001IUN22 Unclassified/Mixed - 24%, Respiratory System - 18%, Embryonic Structures - 16%, Male Genitalia - 16%
411 LG:014704.8:2001JUN22 Germ Cells - 13%, Female Genitalia - 11%, Liver - 10%
412 LG: 1447607.7:2001IUN22 Stomatognathic System - 16%, Germ Cells - 14%, Female Genitalia - 10%
413 LG:1455032.3:2001JUN22 Skin - 10%
414 LG:1501898.18:2001JUN22 Germ Cells - 23%, Urinary Tract - 12%, Connective Tissue - 11%
415 LG: 1502692.5:2001 JUN22 Sense Organs - 15%, Embryonic Structures - 11%
416 LG:208949.8:2001JUN22 Unclassified/Mixed - 60%, Exocrine Glands - 19%, Urinary Tract - 17%
417 LG:240501.10:2001 JUN22 Embryonic Structures - 43%, Hemic and Immune System - 14%, Nervous System - 14%
418 LG:329228.27:2001JUN22 Musculoskeletal System - 27%, Liver - 20%, Exocrine Glands - 18%
419 LG:337056.11:2001IUN22 Liver - 100%
420 LG:346663.9:2001IUN22 Endocrine System - 33%, Unclassified/Mixed - 22%, Female Genitalia - 15%, Cardiovascular System - 15%
421 LG:7685586.2:2001JUN22 Unclassified Mixed - 76%, Cardiovascular System - 24%
422 LG:407730.13:2001JUN22 Sense Organs - 100%
423 LG:025465.5:2001JUN22 Embryonic Structures - 15%, Urinary Tract - 15%, Cardiovascular System - 12%
424 LG:054509.14:2001JUN22 Germ Cells - 13%
425 LG:1067876.1:2001JUN22 Unclassified/Mixed - 55%, Female Genitalia - 36%
426 LG: 1327699.55:2001 JUN22 Exocrine Glands - 100%
Table 4
SEQ ID NO: Template ID Tissue Distribution
427 LG:1482904.10:2001JUN22 Embryonic Structures - 13%, Female Genitalia - 11%
428 LG:222317.4:2001 JUN22 Female Genitalia - 50%, Digestive System - 50%
429 LG:332701.3:2001IUN22 Unclassified Mixed - 14%
430 LG:369881.5:2001JUN22 Skin - 51%, Unclassified/Mixed - 23%
431 LG:404381.2:2001 JUN22 Endocrine System - 24%, Pancreas - 24%, Nervous System - 21%
432 LG:405709.2:2001JUN22 Endocrine System - 39%, Connective Tissue - 30%, Hemic and Immune System - 17%
433 LG.-406664.17:2001 JUN22 Hemic and Immune System - 100%
434 LG:7670681.1:2001JUN22 Musculoskeletal System - 100%
435 LGJ687404.1 :2001 JUN22 Female Genitalia - 40%, Endocrine System - 40%, Digestive System - 20%
436 LG:7690030.24:2001JUN22 Hemic and Immune System - 100%
437 LG:7690229.3:2001JUN22 Unclassified/Mixed - 86%, Nervous System - 14%
438 LG:7690533.16:2001 JUN22 Pancreas - 30%, Musculoskeletal System - 20%, Male Genitalia - 20%
439 LG:7691131.2:2001JUN22 Unclassified/Mixed - 53%, Pancreas - 19%
440 LG:7692559.6:2001IUN22 Musculoskeletal System - 55%, Endocrine System - 36%
*. 441 LG:7684866.10:2001IUN22 Female Genitalia - 100% σ 442 LG:002106.5:2001JUN22 Musculoskeletal System - 28%, Liver - 21%, Respiratory System - 16%
443 LG. 04064.1 :2001 JUN22 Urinary Tract - 70%, Male Genitalia - 20%, Hemic and Immune System - 10%
444 LG:007916.8:2001JUN22 Female Genitalia - 32%, Liver - 26%, Digestive System - 12%, Endocrine System - 12%
445 LG:014719.14:2001JUN22 Skin - 16%, Nervous System - 14%, Female Genitalia - 12%
446 LG.-021763.31 :2001 JUN22 Urinary Tract - 17%, Male Genitalia - 14%, Cardiovascular System - 13%
447 LG:025397.1:2001 JUN22 Musculoskeletal System - 31%, Sense Organs - 14%, Endocrine System - 12%
448 LG:029880.20:2001JUN22 Sense Organs - 24%, Digestive System - 14%, Nervous System - 13% .
449 LG:040422.37:2001IUN22 Germ Cells - 18%, Unclassified/Mixed - 13%
450 LG:065935.11:2001JUN22 Unclassified/Mixed - 13%, Germ Cells - 13%, Sense Organs - 12%
451 LG:074381.1:2001JUN22 Unclassified/Mixed - 21%, Female Genitalia - 12%, Germ Cells - 11%, Endocrine System - 11%
452 LG:083814.6:2001IUN22 Embryonic Structures - 15%
453 LG:090985.1:2001 JUN22 Digestive System - 100%
454 LG:093750.2:2001JUN22 Connective Tissue - 33%, Female Genitalia - 19%, Urinary Tract - 14%
455 LG: 1013708.26:2001 JUN22 Skin - 27%, Unclassified/Mixed - 16%, Embryonic Structures - 12%
456 LG:1022283.8:2001JUN22 Skin - 11%
457 LG:1034386.1:2001IUN22 Urinary Tract - 83%, Digestive System - 17%
458 LG: 1045617.36:2001 JUN22 Liver - 47%, Cardiovascular System - 21%, Endocrine System - 21%
Table 4
SEQ ID NO: Template ID Tissue Distribution
459 LG:1063303.1:2001JUN22 Embryonic Structures - 21%, Connective Tissue - 15%, Nervous System - 11%
460 LG: 1094200.1 :2001 JUN22 Germ Cells - 23%, Unclassified/Mixed - 11%
461 LG:1099249.19:2001JUN22 Connective Tissue - 22%, Unclassified/Mixed - 21%, Urinary Tract - 15%
462 LG:110667.1:2001JUN22 Liver - 38%, Nervous System - 29%, Respiratory System - 21%
463 LG:1132386.20:2001IUN22 Nervous System - 13%, Embryonic Structures - 11%, Sense Organs - 11%
464 LG:116015.2:2001JUN22 Sense Organs - 21%, Germ Cells - 15%
465 LG:1173104.15:2001JUN22 Liver - 15%, Female Genitalia - 12%, Embryonic Structures - 11%
466 LG:1285109.14:2001IUN22 Germ Cells - 16%, Cardiovascular System - 14%, Connective Tissue - 12%
467 LG:131477.11:2001JUN22 Sense Organs - 21%, Germ Cells - 11%
468 LG:1333618.1:2001JUN22 Female Genitalia - 50%, Respiratory System - 50%
469 LG: 1347760.16:2001 JUN22 Connective Tissue - 14%, Embryonic Structures - 13%, Nervous System - 12%
470 LG:1383039.369:2001JUN22 Embryonic Structures - 64%, Hemic and Immune System - 21%, Digestive System 14%
471 LG:1383313.3:2001JUN22 Germ Cells - 18%, Nervous System - 16%
472 LG: 1384075.8:2001 JUN22 Unclassified/Mixed - 25% 473 LG:1384155.1:2001JUN22 Embryonic Structures - 13% 474 LG: 1385280.12:2001IUN22 Unclassified/Mixed - 30%, Embryonic Structures - 13%
475 LG:1390535.25:2001IUN22 Female Genitalia - 17%, Connective Tissue - 15%, Musculoskeletal System - 14%
476 LG:1397047.1:2001JUN22 Unclassified/Mixed - 50%, Female Genitalia - 33%, Male Genitalia - 17%
477 LG:1398646.15:2001IUN22 Skin - 15%, Female Genitalia - 14%, Unclassified/Mixed - 10%
478 LG:1446193.10:2001JUN22 Sense Organs - 29%
479 LG: 1446405.14:2001 JUN22 Unclassified Mixed - 10%
480 LG:1448148.1:2001JUN22 Unclassified/Mixed - 22%, Male Genitalia - 18%, Urinary Tract - 17%
481 LG: 1452619.13:2001IUN22 Exocrine Glands - 67%, Female Genitalia - 17%
482 LG: 1452783.22:2001 JUN22 Respiratory System - 14%, Embryonic Structures - 12%, Female Genitalia - 10%
483 LG: 1453417.5:2001 JUN22 Nervous System - 32%, Skin - 19%, Endocrine System - 18%
484 LG:1455222.23:2001JUN22 Embryonic Structures - 37%, Pancreas - 18%, Exocrine Glands - 16%
485 LG:149121.8:2001JUN22 widely distributed
486 LG:1500175.18:2001JUN22 Sense Organs - 27%
487 LG: 1500434.6:2001 JUN22 Stomatognathic System - 21%, Sense Organs - 18%
488 LG: 1501550.19:2001 JUN22 Urinary Tract - 34%, Sense Organs - 14%
489 LG:1501923.26:2001JUN22 Liver - 64%, Nervous System - 36%
490 LG: 150960.9:2001 JUN22 Skin - 14%, Unclassified Mixed - 10%
Table 4
SEQ ID NO: Template ID Tissue Distribution
491 LG: 182744.29:2001 JUN22 Respiratory System - 20%, Pancreas - 18%, Nervous System - 16%
492 LG:197166.1:2001JUN22 Nervous System - 100%
493 LG:197455.5:2001IUN22 Exocrine Glands - 50%, Nervous System - 21%, Endocrine System - 17%
494 LG:198251.8:2001IUN22 Sense Organs - 19%, Nervous System - 14%
495 LG:200149.3:2001JUN22 Germ Cells - 16%, Skin - 15%, Connective Tissue - 12%
496 LG:203483.3:2001JUN22 Unclassified/Mixed - 23%, Exocrine Glands - 14%, Digestive System - 14%
497 LG:209701.7:2001JUN22 Nervous System - 34%, Connective Tissue - 24%, Respiratory System - 17%
498 LG:210614.1:2001IUN22 Hemic and Immune System - 50%, Digestive System - 33%, Nervous System - 17%
499 LG:210672.1:2001JUN22 Female Genitalia - 22%, Nervous System - 22%, Connective Tissue - 17%
500 LG:215051.10:2001JUN22 Unclassified/Mixed - 21%, Nervous System - 14%
501 LG:218989.3:2001JUN22 Embryonic Structures - 21%, Skin - 16%, Female Genitalia - 11%, Pancreas - 11%
502 LG:228107.11 :2001IUN22 Nervous System - 13%, Pancreas - 13%, Male Genitalia - 13%
503 LG:231016.1:2001JUN22 Digestive System - 57%, Male Genitalia - 29%, Hemic and Immune System - 14%
504 LG:235943.60:2001IUN22 Pancreas - 28%, Female Genitalia - 14%, Respiratory System - 12%
^ 505 LG.-235970.14:2001IUN22 Stomatognathic System - 15%
∞ 506 LG:236697.15:2001JUN22 Sense Organs - 14%
507 LG:238576.3:2001IUN22 Embryonic Structures - 90%, Nervous System - 10%
508 LG:238602.2:2001JUN22 widely distributed
509 LG:241291.46:2001IUN22 widely distributed
510 LG:241742.1:2001IUN22 widely distributed
511 LG:244520.33:2001JUN22 Pancreas - 36%, Cardiovascular System - 28%, Hemic and Immune System - 16%
512 LG:247556.1:2001TUN22 Exocrine Glands - 100%
513 LG:247792.5:2001JUN22 Germ Cells - 47%
514 LG:253580.6:2001JUN22 widely distributed
515 LG:291759.5:2001IUN22 Embryonic Structures - 14%, Connective Tissue - 12%, Digestive System - 12%
516 LG:298226.1:2001 JUN22 Musculoskeletal System - 52%, Embryonic Structures - 39%
517 LG:306342.1 :2001IUN22 Endocrine System - 44%, Hemic and Immune System - 33%, Male Genitalia - 22%
518 LG:327144.5:2001IUN22 Germ Cells - 16%, Unclassified/Mixed - 14%, Hemic and Immune System - 11%
519 LG:331499.8:2001 JUN22 Skin - 13%, Unclassified Mixed - 12%, Exocrine Glands - 11%
520 LG:331582.12:2001JUN22 Embryonic Structures - 50%
521 LG:333017.12:2001JUN22 Germ Cells - 49%, Unclassified/Mixed - 15%
522 LG:334438.8:2001IUN22 Urinary Tract - 19%, Connective Tissue - 15%, Cardiovascular System - 12%
Table 4
SEQ ID NO: Template ID Tissue Distribution
523 LG:337835.7:2001JUN22 Germ Cells - 32%, Skin - 21%
524 LG:346536.12:2001JUN22 Nervous System - 10%
525 LG:348117.5:2001JUN22 Urinary Tract - 19%, Musculoskeletal System - 12%, Female Genitalia - 11%
526 LG:350407.22:2001JUN22 Urinary Tract - 17%, Female Genitalia - 16%, Digestive System - 12%
527 LG:373219.13:2001JUN22 Respiratory System - 17%, Exocrine Glands - 11%
528 LG:375048.15:2001 JUN22 Sense Organs - 18%, Male Genitalia - 18%, Urinary Tract - 13%
529 LG:400114.3:2001 JUN22 Skin - 24%, Digestive System - 19%, Respiratory System - 17%
530 LG.400652.1:2001 JUN22 Skin - 19%, Cardiovascular System - 12%, Digestive System - 10%
531 LG:401313.10:2001JUN22 Nervous System - 35%, Embryonic Structures - 29%, Unclassified/Mixed - 19%
532 LG:406389.1:2001IUN22 Embryonic Structures - 38%, Nervous System - 35%, Respiratory System - 10%
533 LG:406595.2:2001JUN22 Sense Organs - 15%, Urinary Tract - 13%, Embryonic Structures - 11%
534 LG:410628.21:2001JUN22 Digestive System - 33%, Male Genitalia - 33%, Hemic and Immune System - 25%
535 LG:413583.15:2001JUN22 Stomatognathic System - 23%, Sense Organs - 13%
536 LG:419641.35:2001 JUN22 Unclassified/Mixed - 13%
* 537 LG:420759.4:2001JUN22 Urinary Tract - 100%
« 538 LG:425448.18:2001IUN22 Sense Organs - 15%, Embryonic Structures - 10%
539 LG:435717.5:2001JUN22 Skin - 13%, Sense Organs - 12%, Endocrine System - 11%
540 LG:441159.31:2001 JUN22 Unclassified/Mixed - 18%, Urinary Tract - 15%
541 LG:461375.2:2001JUN22 Embryonic Structures - 16%, Connective Tissue - 13%
542 LG:474674.34:2001JUN22 Liver - 23%, Endocrine System - 17%, Germ Cells - 14%
543 LG:481414.8:2001JUN22 Unclassified/Mixed - 16%
544 LG:7669276.1:2001JUN22 Nervous System - 100%
545 LG:7677848.1:2001JUN22 Cardiovascular System - 100%
546 LG:7684981.3:2001JUN22 Nervous System - 19%, Liver - 12%, Male Genitalia - 12%
547 LG:7685048.6:2001JUN22 Hemic and Immune System - 50%, Nervous System - 50%
548 LG:7688302.1:2001JUN22 Skin - 30%, Embryonic Structures - 20%, Musculoskeletal System - 13%
549 LG:7690463.3:2001JUN22 Liver - 17%, Urinary Tract - 17%, Exocrine Glands - 12%
550 LG:7691479.5:2001IU 22 Hemic and Immune System - 100%
551 LG:7691527.4:2001JUN22 Nervous System - 26%, Respiratory System - 20%, Musculoskeletal System - 17%
552 LG:7691663.1:2001JUN22 Embryonic Structures - 20%, Pancreas - 20%, Liver - 19%, Male Genitalia - 19%
553 LG:7691854.1:2001JUN22 Liver - 32%, Unclassified/Mixed - 21%, Musculoskeletal System - 21%
554 LG:7692235.2:2001JUN22 Hemic and Immune System - 100%
Table 4
SEQ ID NO: Template ID Tissue Distribution
555 LGJ692239.1:2001 JUN22 Exocrine Glands - 20%, Digestive System - 17%, Nervous System - 14%
556 LG:7692575.1:2001JUN22 Sense Organs - 69%
557 LG:7692742.1:2001JUN22 Nervous System - 50%, Female Genitalia - 33%, Hemic and Immune System - 17%
558 LG:7693942.1 :2001IUN22 Musculoskeletal System - 19%, Exocrine Glands - 15%, Embryonic Structures - 14%
559 LG:899248.22:2001IUN22 Musculoskeletal System - 34%, Embryonic Structures - 14%, Connective Tissue - 10%
560 LG:979051.25:2001JUN22 Liver - 11%
561 LG:979054.18:2001IUN22 Nervous System - 14%, Sense Organs - 12%, Embryonic Structures - 11%
562 LG:979415.1:2001JUN22 Skin - 37%, Sense Organs - 27%
563 LG:980685.1:2001JUN22 Digestive System - 12%, Female Genitalia - 11%, Hemic and Immune System - 11%
564 LG:981272.6:2001JUN22 Unclassified Mixed - 29%, Female Genitalia - 16%, Connective Tissue - 16%
565 LG:982723.4:2001IUN22 Embryonic Structures - 21%, Hemic and Immune System - 17%, Digestive System - 15%
566 LG:982915.8:2001JUN22 Digestive System - 14%
567 LG:987785.10:2001IUN22 Sense Organs - 14%, Pancreas - 12%, Unclassified/Mixed - 12%
6 o
Table 5
SEQ ID NO: Frame Length Start Stop GI Number Probability Score Annotation
587 1 335 112 1116 gl6550386 1.00E-154 unnamed protein product
587 1 335 112 1116 gl2836009 1.00E-120 evidence:NAS~hypothetical protein-putative
587 1 335 112 1116 g296164 3.00E-09 156 kDa Protein
591 3 180 3 542 g13325269 4.00E-77 Similar to RIKEN cDNA 2400006N03 gene
591 3 180 3 542 g12845621 3.00E-62 data source:SPTR, source key:Q9W704, evidence:ISS~putative~related to XENOPUS RPA INTERACTING PROTEIN ALPHA
591 3 180 3 542 g5262751 2.00E-31 Xenopus RPA interacting protein alpha
592 2 263 2 790 g12847529 l.OOE-101 data source:SPTR, source key:Q15546, evidence:ISS~homolog to MONOCYTE TO MACROPHAGE DIFFERENTIATION PROTEIN-putative
592 2 263 2 790 gl2836289 l.OOE-101 data source:SPTR, source key:Q15546, evidence:ISS~homolog to MONOCYTE TO MACROPHAGE DIFFERENTIATION PROTEIN-putative
592 2 263 2 790 gl8314462 l.OOE-101 monocyte to macrophage differentiation-associated
594 1 162 547 1032 gl2846755 7.00EJ0 data source:SPTR, source key:Q9H5H0, evidence:ISS~homolog to CDNA: FLJ23445 FIS, CLONE HSI01721~putative ^ 594 1 162 547 1032 gl2840994 7.00E-70 data source:SPTR, source key:Q9H5H0, evidence:ISS~homoIog to CDNA: FLI23445 FIS, CLONE HSI01721~putative
594 1 162 547 1032 gl2837553 7.00EJ0 data source:SPTR, source key:Q9H5H0, evidence:ISS~homolog to CDNA: FLJ23445 FIS, CLONE HSI01721~putative
595 2 127 143 523 g7689013 1.00E-56 uncharacterized hematopoietic stem/progenitor cells protein MDS033
595 2 127 143 523 gl6307000 1.00E-56 uncharacterized hematopoietic stem/progenitor cells protein MDS033
595 2 127 143 523 gl2841276 5.00E-55 data source:SPTR, source key:Q9NZ42, evidence:ISS~homolog to UNCHARACTERIZED HEMATOPOIETIC STEM/PROGENITOR CELLS PROTEIN MDS033~putative
596 3 392 99 1274 gl2018147 2.00E-07 vegetative cell wall protein gpl
596 3 392 99 1274 gl4571744 8.00E-07 probable protease 1 like protein
596 3 392 99 1274 gl5213204 4.00E-06 unknown
599 2 239 392 1108 g12845540 1.00EJ9 data source:SPTR, source key:Q9HA82, evidence:ISS~homolog to CDNA FLJ12089 FIS, CLONE HEMBB 1002550, WEAKLY SIMILAR TO HYPOTHETICAL UOG-I
599 2 239 392 1108 gl3936285 1.00E-79 TRH4
599 2 239 392 1108 gl4715021. 4.00E-62 Similar to RIKEN cDNA 2310081H14 gene
601 2 584 2 1753 g14042044 0 unnamed protein product
601 2 584 2 1753 gl5779199 0 NG22 protein
601 2 584 2 1753 g4529890 0 NG22
Table 5
SEQ ID NO: Frame Length Start Stop Gl Number Probability Score Annotation
602 3 454 3 1364 gl4272810 0 unnamed protein product
602 3 454 3 1364 gl2804631 0 golgi membrane protein GP73
602 3 454 3 1364 g7271867 0 golgi membrane protein GP73
603 3 88 408 671 g10944516 2.00E-34 dJ408B20.2 (novel 7 transmembrane receptor (rhodopsin family) (olfactory receptor like) protein (hs6Ml-32))
603 3 88 408 671 g18480408 1.00E-26 olfactory receptor MOR256-11
603 3 88 408 671 gl8480406 3.00E-26 olfactory receptor MOR256-10
604 167 76 576 gl4278719 2.00E-88 B cell crosslinked IgM-activating sequence protein
604 167 76 576 gl3591714 2.00E-88 immunoglobulin superfamily receptor translocation associated protein 2c
604 167 76 576 gl3591712 2.00E-88 immunoglobulin superfamily receptor translocation associated protein 2b
605 156 1 468 gl6041100 8.00E-89 hypothetical protein
605 156 1 468 g4454851 8.00E-89 protein phosphatase 2A BR gamma subunit
605 156 1 468 g619215 2.00E-88 protein phosphatase 2A1 B gamma subunit
608 178 130 663 gl5523799 2.00E-79 unnamed protein product j 608 178 130 663 g16551407 2.00E-44 unnamed protein product
J 608 178 130 663 g2992628 4.00E-15 putative seven pass transmembrane protein
611 3 110 3 332 g14043139 2.00E-61 RIKEN cDNA 2610511F20 gene
611 3 110 3 332 gl2848653 l.OOE-59 data source:SPTR, source key Q9UK27, evidence:ISS~homolog to LEUCINE-RICH REPEATS CONTAINING F-BOX PROTEIN FBL3~putative
611 3 110 3 332 g7022695 3.00E-45 unnamed protein product
612 3 429 3 1289 gl5930223 0 poliovirus receptor
612 3 429 3 1289 g7798736 0 poliovirus receptor
612 3 429 3 1289 gl90205 0 poliovirus receptor
613 2 176 2 529 g7259234 1.00E-17 contains transmembrane (TM) region
613 2 176 2 529 gl2837694 1.00E-17 MRNA, COMPLETE CDS, CLONE: l-107~data source:SPTR, source key:Q9JMG4, evidence:ISS~putative
613 2 176 2 529 gl2861877 1.00E-17 MRNA, COMPLETE CDS, CLONE: l-107~data source:SPTR, source key:Q9JMG4, evidence:ISS~putative
614 1 80 514 753 g3002527 2.00E-10 neuronal thread protein AD7c-NTP
614 1 80 514 753 g18490197 4.00E-10 Unknown (protein for MGC23782)
614 1 80 514 753 g6650810 6.00E-10 PRO 1902
615 1 280 1 840 g7242977 1.00E-142 KIAA1311 protein
Table 5
SEQ ID NO: Frame Length Start Stop Gl Number Probability Sc Annotation
615 1 280 1 840 gl4042145 1.00E-45 unnamed protein product
615 1 280 1 840 gl4041949 2.00E-45 unnamed protein product
624 3 133 390 788 gl4189960 3.00E-25 PRO0764
624 3 133 390 788 gl5214765 8.00E-23 Similar to hypothetical protein
624 3 133 390 788 g9280152 2.00E-20 unnamed portein product
626 1 372 214 1329 gl3543940 0 Similar to RIKEN cDNA 2610017G09 gene
626 1 372 214 1329 gl4035978 0 unnamed protein product
626 1 372 214 1329 g14272784 0 unnamed protein product
627 2 167 1559 2059 gl1493483 1.00E-20 PRO2550
627 2 167 1559 2059 g7020440 1.00E-19 unnamed protein product
627 2 167 1559 2059 gl872200 2.00E-18 alternatively spliced product using exon 13A
628 2 272 1262 2077 gl2654109 l.OOE-100 PRO0659 protein
628 2 272 1262 2077 g6690250 l.OOE-100 PRO0659
629 1 207 604 1224 gl4717079 l.OOE-110 dJ469A13.2 (Novel protein)
> > 629 1 207 604 1224 gl2857138 1.00E-71 data source:SPTR, source key:Q9H8P4, evidence:ISS~homolog to CDNA FLI13346 FIS, CLONE OVARC1002107~putative
629 1 207 604 1224 gl2839239 1.00E-71 data source:SPTR, source key:Q9H8P4, evidence.TSS-homolog to CDNA FLJ 13346 FIS, CLONE OVARC1002107~putative
630 2 207 2 622 g14717079 2.00E-82 dI469A13.2 (Novel protein)
630 2 207 2 622 gl2839239 3.00E-47 data source:SPTR, source key:Q9H8P4, evidence:ISS~homolog to CDNA FLI13346 FIS, CLONE OVARC1002107~putative
630 207 622 gl2857255 3.00E-47 data source:SPTR, source key:Q9H8P4, evidence:ISS~homolog to CDNA FLI13346 FIS, CLONE OVARC1002107~putative
631 3 81 234 476 gl0437569 2.00E-18 unnamed protein product
631 3 81 234 476 gl0437485 4.00E-17 unnamed protein product
631 3 81 234 476 gl4189960 6.00E-17 PRO0764
632 1 792 73 2448 g2232150 0 FYN binding protein
632 1 792 73 2448 g2078273 0 SLP-76 associated protein
632 1 792 73 2448 g7416993 0 EVH1 domain binding protein
638 2 134 515 916 gl2851779 3.00E-24 evidence:NAS~hypothetical protein-putative
638 2 134 515 916 gl2836995 1.00E-23 evidence:NAS~hypothetical protein-putative
640 3 110 3 332 gl3937933 6.00E-08 Unknown (protein for IMAGE:3838856)
Table 5
SEQ ID NO: Frame Length Start Stop GlNumber Probability Score Annotation
643 2 307 2 922 g16740557 1.00E-165 Similar to hypothetical protein FLJ10134
643 2 307 2 922 gl4035908 1.00E-165 unnamed protein product
643 2 307 2 922 gl7390505 1.00E-131 Similar to hypothetical protein FLJ10134
644 3 138 405 818 g12805623 9.00E-06 Unknown (protein for MGC:8183)
645 1 584 181 1932 gl4549207 0 URAX1
645 1 584 181 1932 g17907795 0 TGF-beta induced apotosis protein 3
645 1 584 181 1932 g17049034 0 unnamed protein product
646 2 123 125 493 gl3276669 2.00E-53 hypothetical protein
647 2 917 2 2752 gl4041780 0 AKAP-2 protein
647 2 917 2 2752 g4589472 0 KIAA0920 protein
647 2 917 2 2752 gl7384432 0 bA151F5.1.1 (A kinase (PRKA) anchor protein 2)
649 2 181 92 634 gl0433669 1.00E-49 unnamed protein product
649 2 181 92 634 gl4133229 1.00E-49 KIAA0999 protein
650 1 124 562 933 gl2698182 1.00E-29 hypothetical protein 650 1 124 562 933 g7020440 7.00E-24 unnamed protein product 650 1 124 562 933 gl1493483 3.00E-23 PRO2550
651 2 331 65 1057 g14290590 0 Similar to CGI-62 protein
651 2 331 65 1057 g4929593 0 CGI-62 protein
651 2 331 65 1057 gl2854328 5.00E-43 data source:SPTR, source key:Q9Y372, evidence:ISS~homolog to CGI-62 PROTEIN-putative
652 2 120 1394 1753 gl6041152 2.00E-10 hypothetical protein
652 2 120 1394 1753 gl0435380 3.00E-07 unnamed protein product
653 1 212 25 660 g2665836 1.00E-103 dynein light intermediate chain 2
653 1 212 25 660 g2618478 l.OOE-100 dynein light intermediate chain 53/55
653 1 212 25 660 g2618484 l.OOE-100 dynein light intermediate chain 53/55
655 2 184 668 1219 gl0436645 1.00E-93 unnamed protein product
655 2 184 668 1219 gl3905156 6.00E-61 Unknown (protein for MGC: 11798)
655 2 184 668 1219 g7243155 3.00E-60 KIAA1387 protein
657 2 115 890 1234 g6691806 7.00E-16 alternatively spliced form
657 2 115 890 1234 gl2007315 1.00E-09 unknown
658 1 207 136 756 gl4248997 1.00E-89 lung seven transmembrane receptor 1
658 1 207 136 756 gl0047325 1.00E-82 KIAA1624 protein
658 1 207 136 756 gl4248999 2.00E-62 lung seven transmembrane receptor 2
Table 5
SEQID NO: Frame Length Start Stop Gl Number Probability Score Annotation
660 1 166 175 672 gl4272514 1.00E-76 unnamed protein product
660 1 166 175 672 gl2845046 7.00E-76 data source:SPTR, source key:077262, evidence:ISS~putative~related to EG:22E5.9 PROTEIN
660 1 166 175 672 gl2848539 7.00E-76 data source:SPTR, source key:077262, evidence:ISS~putative~reIated to EG:22E5.9 PROTEIN
661 2 1435 2 4306 g4432953 0 annexin V-binding protein (ABP-10)
661 2 1435 2 4306 gl0438646 1.00E-140 unnamed protein product
661 2 1435 2 4306 gl 1994784 2.00E-50 gene_id:T19N8.6~unknown protein
662 3 398 3 1196 gl4017883 0 KIAA 1833 protein
662 3 398 3 1196 g15617725 7.00E-31 Hypothetical protein C34G6.1
662 3 398 3 1196 g7105685 7.00E-31 Hypothetical protein C34G6.1
663 2 162 122 607 gl6554238 3.00E-72 unnamed protein product
663 2 162 122 607 gl5620835 3.00EJ2 KIAA1888 protein
663 2 162 122 607 gl7223620 3.00E-72 ATP-binding cassette A5
664 1 130 115 504 g203072 6.00E-70 0-44 protein
664 1 130 115 504 gl2848292 1.00E-69 data source.-SPTR, source key:P38718, evidence:ISS~homolog to 0-44 PROTEIN-putative 5 664 1 130 115 504 gl7390760 1.00E-69 RIKEN cDNA 2610205H19 gene Λ 666 3 241 3 725 gl4198207 2.00E-83 Similar to CG4452 gene product
666 3 241 3 725 g4200234 4.00E-77 hypothetical protein
666 3 241 3 725 g4200238 3.00EJ2 hypothetical protein
668 85 255 g18027778 1.00E-29 unknown
668 85 255 gl5485600 1.00E-29 putative alpha mannosyltransferase
668 85 255 g12804615 1.00E-29 Unknown (protein for MGC:3136)
669 240 720 g9857700 5.00E-93 myeloid cell leukemia protein 1
669 240 720 g8388943 5.00E-93 myeloid cell differentiation protein
669 240 720 g7582272 5.00E-93 Mcl-1 delta S/TM
670 61 63 245 g8248885 3.00E-30 metallothionein-I gene transcription activator
670 61 63 245 g717187 8.00E-30 RNA polymerase II
670 61 63 245 gl7390349 8.00E-30 polymerase (RNA) II (DNA directed) polypeptide K (7.0kD)
671 129 3 389 gl2848031 4.00E-48 evidence:NAS~hypothetical protein-putative
671 129 3 389 gl2718388 1.00E-13 conserved hypothetical protein
671 129 3 389 g9758240 2.00E-08 emblCAB61034.1~gene_id:K3K7.8~similar to unknown protein
672 383 438 1586 g6808038 0 hypothetical protein
672 383 438 1586 g5081610 1.00E-179 huntington yeast partner C
Table 5
SEQID NO: Frame Length Start Stop Gl Number Probability Score Annotation
672 3 383 438 1586 gl0440161 1.00E-179 unnamed protein product
673 3 417 2553 3803 g7243185 0 KIAA1402 protein
673 3 417 2553 3803 gl8043971 0 Unknown (protein for IMAGE:3987018)
673 3 417 2553 3803 gl5426519 1.00E-130 hypothetical protein FLJ22678
674 3 89 396 662 g7022185 5.00E-11 unnamed protein product
674 3 89 396 662 gl6549259 3.00E-09 unnamed protein product
674 3 89 396 662 gl8203809 3.00E-09 Unknown (protein forMGC:19764)
675 3 466 1080 2477 g17046100 0 ATP-binding cassette protein
675 3 466 1080 2477 g17223620 0 ATP-binding cassette A5
675 3 466 1080 2477 g4240130 2.00E-66 KIAA0822 protein
676 2 290 2 871 g4160666 1.00E-161 NG,NG-dimethylarginine dimethylaminohydrolase
676 2 290 2 871 gl0279810 1.00E-160 unnamed protein product
676 2 290 2 871 gl2845868 1.00E-152 data soιirce:MGD, source key:MGI:1916469, evidence:ISS~dimethylarginine dimethylaminohydrolase l~putative fe 679 2 303 80 988 gl3544020 ' 1.00E-162 Similar to RIKEN cDNA 6030457N17 gene
* 679 2 303 80 988 gl2833947 1.00E-112 data source:Pfam, source key:PF01754, evidence:ISS~hypothetical A20-like zinc finger containing protein-putative
679 2 303 80 988 g7299642 3.00E-15 CG5333 gene product
680 1 233 667 1365 g16877144 1.00E-121 Unknown (protein for MGC:10135)
680 1 233 667 1365 gl4041999 1.00E-121 unnamed protein product
680 1 233 667 1365 gl4042471 1.00E-121 unnamed protein product
681 3 495 363 1847 g7959331 0 KIAA1532 protein
681 3 495 363 1847 g2959559 0 fos39554_l
681 3 495 363 1847 gl8314468 1.00E-113 Unknown (protein for IMAGE:4825062)
682 1 54 118 279 gl8044412 7.00E-06 Similar to KIAA0475 gene product
682 1 54 118 279 g3413912 7.00E-06 KIAA0475 protein
684 1 441 28 1350 gl3936285 1.00E-168 TRH4
684 1 441 28 1350 gl2845540 1.00E-168 data source:SPTR, source key:Q9HA82, evidence:ISS~homolog to CDNA FLJ12089 FIS, CLONE HEMBB 1002550, WEAKLY SIMILAR TO HYPOTHETICAL UOG-1
684 1 441 28 1350 g15077841 5.00E-86 Trhl
688 2 467 92 1492 g6330019 0 KIAA 1145 protein
688 2 467 92 1492 gl3874437 l.OOE-133 cerebral protein-11
Table 5
SEQ ID NO: Frame Length Start Stop Gl Number Probability Score Annotation
688 2 467 92 1492 g6634047 1.00E-133 KIAA0481 protein
691 205 25 639 gl2539946 1.00E-108 unnamed protein product
691 205 25 639 gl2001948 1.00E-108 My004 protein
691 205 25 639 gl2539948 1.00E-102 unnamed protein product
692 238 484 1197 gl3543615 1.00E-131 Unknown (protein for MGC: 14607)
692 238 484 1197 gl3111774 1.00E-131 Similar to steroidogenic acute regulatory protein related
692 238 484 1197 g4309949 1.00E-131 similar to MLN 64; similar to 138027 (PID:g2135214)
693 3 313 3 941 g6808093 1.00E-130 hypothetical protein
693 3 313 3 941 g4263043 1.00E-14 putative calcium channel
693 3 313 3 941 g4206210 1.00E-14 putative calcium channel
694 2 95 2 286 gl6550068 3.00E-40 unnamed protein product
694 2 95 2 286 gl2834087 7.00E-38 evidence:NAS~hypothetical protein-putative
694 2 95 2 286 g7292012 2.00E-13 CGI 3907 gene product
695 2 196 110 697 gl0438063 8.00E-74 unnamed protein product 695 2 196 110 697 gl5277443 5.00E-63 Unknown (protein for MGC: 19083)
695 2 196 110 697 gl8027352 2.00E-14 unknown
696 3 352 162 1217 gl4603078 0 Similar to RIKEN cDNA 4931428D14 gene
696 3 352 162 1217 gl2845936 1.00E-174 evidence:NAS~hypothetical protein-putative
696 3 352 162 1217 g13543107 1.00E-173 RIKEN cDNA 4931428D14 gene
702 3 152 498 953 g16549297 2.00E-92 unnamed protein product
702 3 152 498 953 g18204863 2.00E-92 hypothetical protein MGC3020
702 3 152 498 953 gl2653557 7.00E-92 Unknown (protein for MGC:3020)
703 3 84 96 347 gl8314565 2.00E-41 Similar to signal recognition particle 9kD
703 3 84 96 347 gl8490251 3.00E-21 signal recognition particle 9kD
703 3 84 96 347 gl5929315 3.00E-21 signal recognition particle 9kD
704 3 107 3993 4313 gl2006055 2.00E-56 DC42
706 3 362 246 1331 g3283879 0 unknown
706 3 362 246 1331 g6978018 0 SCHIP-1
706 3 362 246 1331 g6978022 0 SCHIP-1-D241/253
707 2 317 377 1327 gl 1610570 0 MOP-5
707 2 317 377 1327 gl4042766 0 unnamed protein product
707 2 317 377 1327 g6942315 1.00E-180 hypothetical protein SBBI88
Table 5
SEQ ID NO: Frame Length Start Stop Gl Number Probability Score Annotation
708 2 101 11 313 g7770147 6.00E-16 PRO 1847
708 2 101 11 313 g!0437752 6.00E-15 unnamed protein product
708 2 101 11 313 g6650810 3.00E-14 PRO1902
709 116 271 618 gl6041132 9.00E-12 hypothetical protein
709 116 271 618 gl0435559 l.OOE-11 unnamed protein product
709 116 271 618 gl0799024 2.00E-10 HC6
711 201 1 603 g7020571 l.OOE-101 unnamed protein product
711 201 1 603 gl2002684 l.OOE-101 chromosome 9 open reading frame 6
711 201 1 603 gl6041813 1.00E-101 hypothetical protein FLJ20457
713 3 563 3 1691 gl6516599 0 unnamed protein product
713 3 563 3 1691 gl6516597 0 unnamed protein product
713 3 563 3 1691 g4159682 0 Phosphatidylglycerophosphate synthase
714 2 373 119 1237 gl2847516 1.00E-125 data source.-SPTR, source key:Q9PTD5, evidence:ISS~putative~related to KIAA0009 PROTEIN
714 2 373 119 1237 gl7512323 1.00E-124 Similar to RIKEN cDNA 2610016C23 gene 714 2 373 119 1237 gl2855709 1.00E-124 data source:SPTR, source key:Q15390, evidence:ISS~homolog to HYPOTHETICAL PROTEIN KIAA0009~putative in 2 912 2 2737 gl 136436 0 KIAA0188
111 2 912 2 2737 g7264655 0 Lpinl
717 2 912 2 2737 gl2859810 0 data source:MGD, source key.MGI: 1891340, evidence:ISS~lipin l~putative
718 2 601 2 1804 g10954048 9.00E-24 ovarian fibroin-like substance- 1
718 2 601 2 1804 g!59712 3.00E-23 dragline silk fibroin
718 2 601 2 1804 gl7063211 3.00E-23 dragline silk protein
720 3 132 768 1163 gl6550108 9.00E-22 unnamed protein product
720 3 132 768 1163 gl3624461 9.00E-22 dI259A10.1 (ssDNA binding protein (SEB4D))
720 3 132 768 1163 g8895698 6.00E-18 RRM-containing protein SEB-4
723 1 332 1156 2151 gl5214686 4.00E-81 Unknown (protein for AGE:4537124)
723 1 332 1156 2151 gl2858533 2.00E-30 data source:SPTR, source key:Q9V540, evidence:ISS~putative~related to CG8058 PROTEIN
725 2 219 2 658 gl3488609 1.00E-114 GAJ
725 2 219 2 658 gl2847934 1.00E-102 data source:SPTR, source key:Q09739, evidence:ISS~putative~related to HYPOTHETICAL 24.2 KDA PROTEIN C13A11.03 IN CHROMOSOME I
725 2 219 2 658 g984224 2.00E-31 hypothetical coiled-coil protein
726 3 208 126 749 gl7862302 8.00E-24 LD21733p
Table 5
SEQ ID NO: Frame Length Start Stop Gl Number Probability Score Annotation
726 3 208 126 749 g7299099 8.00E-24 CG8379 gene product
727 2 470 2 1411 g13559033 0 bAHM20.3.1 (novel protein similar to. Pleurodeles waltlii RAP55 protein, isoform 1)
727 2 470 2 1411 gl3559032 1.00E-138 bAHM20.3.2 (novel protein similar to Pleurodeles waltlii RAP55 protein, isoform 2)
727 2 470 2 1411 gl6877144 4.00E-94 Unknown (protein for MGC: 10135)
728 3 212 3 638 gl6551687 1.00E-106 unnamed protein product
728 3 212 3 638 gl3442784 1.00E-106 DRCTNNB1A
728 3 212 3 638 gl7511709 1.00E-106 down-regulated by Ctnnbl, a
729 2 115 1289 1633 g3413884 4.00E-60 KIAA0461 perotein
729 2 115 1289 1633 g5101774 4.00E-60 KIAA0461/245 protein
729 2 115 1289 1633 g927300 9.00E-05 ORF; similar to.Drosophila supressor of hairy wing protein, Swiss-Prot Accession Number
730 2 599 5 1801 gl5208233 0 hypothetical protein
730 2 599 5 1801 gl5080468 2.00E-68 Similar to RIKEN cDNA 1110018J12 gene
730 2 599 5 1801 gl2834655 1.00E-62 data source:SPTR, source key:P11055, evidence:ISS~homolog to MYOSIN HEAVY CHAIN, FAST SKELETAL MUSCLE, EMBRYONIC (MUSCLE EMBRYONIC MYOSIN HEAVY fe CHAIN) (SMHCE)-putative
* 733 1 313 1 939 gl3625166 1.00E-171 RALBP1"
733 1 313 1 939 gl5706481 1.00E-171 Unknown (protein for MGC: 16228)
733 1 313 1 939 g2677843 1.00E-163 RalBPl-associated EH domain protein Repsl
734 ' 2 254 83 844 12654495 1.00E-128 Unknown (protein for IMAGE:2822295)
■ 734 2 254 83 844 gl3279332 1.00E-128 Unknown (protein for IMAGE:2822295)
734 2 254 83 844 gl3879370 2.00E-58 Unknown (protein for MGC.7867)
735 3 137 294 704 17221829 3.00E-41 TDC1
735 3 137 294 704 gl4602501 3.00E-41 hypothetical protein DKFZp566I133
735 3 137 294 704 gl3185293 3.00E-41 unnamed protein product
738 1 147 142 582 g9104819 4.00E-05 hypothetical protein
739 3 194 3 584 g3738323 9.00E-67 hypothetical protein
739 3 194 3 584 g7269951 3.00E-53 putative protein
739 3 194 3 584 gI3111782 4.00E-20 Similar to HSPC171 protein
744 1 607 940 2760 g7959271 0 KIAA1505 protein
744 1 607 940 2760 g9929955 1.00E-148 hypothetical protein
744 1 607 940 2760 gl5208049 1.00E-127 hypothetical protein
746 3 224 192 863 g6330331 1.00E-112 KIAA1189 protein
Table 5
SEQ ID NO: Frame Length Start Stop Gl Number Probability Score Annotation
746 3 224 192 863 gl2861409 5.00E-46 data source:SPTR, source key:Q9ULNl, evidence:ISS- -homolog to KIAA1189 PROTEIN (FRAGMENT)~putative
748 1 311 781 1713 gl0436681 1.00E-177 unnamed protein product
748 1 311 781 1713 g5912126 1.00E-176 hypothetical protein
749 3 307 252 1172 gl2698087 1.00E-180 KIAA1771 protein
749 3 307 252 1172 g 16550229 1.00E-179 unnamed protein product
749 3 307 252 1172 g 14597918 1.00E-151 human CLASP-3
751 1 491 274 1746 g 16553996 0 unnamed protein product
751 1 491 274 1746 gl0438804 1.00E-130 unnamed protein product
751 1 491 274 1746 gl 3938187 1.00E-130 hypothetical protein FLI22419
752 3 545 324 1958 gl6878013 0 chromosome 12 open reading frame 22
752 3 545 324 1958 gl2274931 0 hypothetical protein
752 3 545 324 1958 gl 8146658 0 TGF-beta induced apotosis protein 12
754 1 123 223 591 gl0799024 5.00E-15 HC6 fe 754 1 123 223 591 gl0436743 3.00E-14 unnamed protein product
° 754 1 123 223 591 gl 8027740 l.OOE-11 unknown
755 2 71 575 787 g 16550881 4.00E-05 unnamed protein product
756 3 193 174 752 gl7512047 l.OOE-110 Unknown (protein for MGC:20579)
756 3 193 174 752 gl3365915 5.00E-39 hypothetical protein
756 3 193 174 752 g7020988 3.00E-38 unnamed protein product
757 2 202 452 1057 gl6553318 6.00E-95 unnamed protein product
757 2 202 452 1057 g 13097084 5.00E-18 Unknown (protein for MGC:7041)
757 2 202 452 1057 g6807802 1.00E-07 hypothetical protein
760 3 438 285 1598 g434765 0 ORF
760 3 438 285 1598 gl2804871 0 nucleolar phosphoprotein pi 30
760 3 438 285 1598 g663008 0 nucleolar phosphoprotein pl30
763 2 595 653 2437 gl 0047245 0 KIAA1585 protein
763 2 595 653 2437 g7022646 8.00E-97 unnamed protein product
763 2 595 653 2437 g3377722 1.00E-14 male-specific lethal-2
764 3 947 3 2843 g7243155 0 KIAA1387 protein
764 3 947 3 2843 gl3623235 0 Similar to hypothetical protein FLI20707
764 3 947 3 2843 gl3905156 0 Unknown (protein for MGC: 11798)
Table 5 ID NO: Frame Length Start Stop Gl Number I 'robability Score Annotation 76 2 68 2 205 gl8480246 3.0OE-3O olfactory receptor MOR138-3 76 2 68 2 205 gl5293707 7.00E-26 olfactory receptor 76 2 68 2 205 g9652309 6.00E-21 M12 odorant receptor 77 3 184 21 572 gl3560108 l.OOE-101 bA261Nl 1.2.1 (novel protein, isoform 1) 77 3 184 21 572 gl2837694 7.00E-81 MRNA, COMPLETE CDS, CLONE:l-107~data source:SPTR, source key:Q9JMG4, evidence:ISS~putative 77 3 184 21 572 g7259234 7.00E-81 contains transmembrane (TM) region 78 3 166 6 503 g5869925 4.00E-24 olfactory receptor 78 3 166 6 503 gl8479780 4.00E-24 olfactory receptor MOR262-4 78 3 166 6 503 g8919697 4.00E-24 olfactory receptor 79 2 210 14 643 gl2853606 6.00E-57 data source:SPTR, source key:044231, evidence:ISS~putative~related to OUTER ARM DYNEIN LIGHT CHAIN 1 79 2 210 14 643 gl2840067 1.00E-52 data source:SPTR, source key:044231, evidence:ISS~putative~related to OUTER ARM DYNEIN LIGHT CHAIN 1 79 2 210 14 643 g2760163 2.00E-24 outer arm dynein light chain 1 80 2 109 644 970 gl3276655 2.00E-25 hypothetical protein 80 2 109 644 970 gl7028424 7.00E-25 Similar to calcium/calmodulin-dependent protein kinase kinase 1, alpha 80 2 109 644 970 gl8308166 7.00E-25 calcium/calmodulin-dependent protein kinase kinase alpha 81 1 130 1 390 g6705973 3.00E-05 pBS4A5 81 1 130 1 390 gl4789624 3.00E-O5 Unknown (protein for MGC: 18335) 81 1 130 1 390 g3738263 3.00E-05 cytochrome P-450 82 3 224 186 857 g4062502 1.00E-121 ProW protein homolog 82 3 224 186 857 gl787165 1.00E-121 putative transport system permease protein 82 3 224 186 857 g4583569 1.00E-113 putative aliphatic sulfonate transport membrane component 83 2 91 1724 1996 gl6549456 4.00E-18 unnamed protein product 83 2 91 1724 1996 gl8027424 5.00E-16 unknown 83 2 91 1724 1996 gl2698155 2.00E-14 hypothetical protein 84 3 185 3 557 g16553692 1.00E-103 unnamed protein product 84 3 185 3 557 gl6580688 2.00E-98 hypothetical protein 84 3 185 3 557 g14091950 7.00E-56 L-threonine 3-dehydrogenase 87 1 227 76 756 gl6554793 2.00E-05 no on or off transient A 87 1 227 76 756 g16554785 2.00E-05 no on or off transient A
Table 5
SEQ ID NO: Frame Length Start Stop Gl Number Probability Score Annotation
787 227 76 756 gl6554787 2.00E-05 no on or off transient A
788 70 2479 2688 gl6924282 8.00E-21 Unknown (protein for MGC:27375)
788 70 2479 2688 gl0336831 5.00E-19 IgA regulatory protein
790 45 55 189 gl6878329 9.00E-08 Unknown (protein for MGC:29628)
790 45 55 189 gl2804415 9.00E-08 Similar to hypothetical protein FLI10891
790 45 55 189 g7023216 9.00E-08 unnamed protein product
792 3 109 141 467 g2587027 2.00E-20 HERV-E envelope glycoprotein
792 3 109 141 467 g2587024 2.00E-20 HERV-E envelope glycoprotein
792 3 109 141 467 gl049232 8.00E-19 HERV-E envelope protein
793 2 145 920 1354 g2587027 2.00E-21 HERV-E envelope glycoprotein
793 2 145 920 1354 g2587024 2.00E-21 HERV-E envelope glycoprotein
793 2 145 920 1354 gl049232 2.00E-19 HERV-E envelope protein
794 2 56 233 400 g6690227 1.00E-13 PRO0478
794 2 56 233 400 gl86774 3.00E-10 zinc finger protein ; 794 2 56 233 400 g9929995 1.00E-09 hypothetical protein
796 3 288 108 971 14249961 1.00E-109 Similar to hypothetical protein AB030201
796 3 288 108 971 gl4789776 8.00E-87 Similar to hypothetical protein AB030201
796 3 288 108 971 g7259296 2.00E-86 contains transmembrane (TM) region
797 2 103 953 1261 g16553789 2.00E-12 unnamed protein product
797 2 103 953 1261 g11493409 6.00E-08 PRO0898 -
797 2 103 953 1261 gl6877294 1.00E-07 Similar to hypothetical protein PRO 1722
800 249 577 1323 gl0435262 1.00E-139 unnamed protein product
800 249 577 1323 gl6877653 1.00E-138 Similar to KIAA0643 protein
800 249 577 1323 g3327100 1.00E-109 KIAA0643 protein
802 102 214 519 gl3506805 5.00E-48 thy ic stromal co-transporter
802 102 214 519 gl6550334 1.00E-47 unnamed protein product
802 102 214 519 g8131858 1.00E-38 putative thymic stromal co-transporter TSCOT
804 266 777 1574 g9963761 3.00E-23 cd003 protein
805 63 289 477 gl4249973 4.00E-14 Similar to hypothetical protein PRO 1722
805 63 289 477 gl8490197 7.00E-14 Unknown (protein for MGC:23782)
805 63 289 477 g6650810 1.00E-13 PRO1902
806 122 495 860 g15667843 1.00E-48 melanin-concentrating hormone receptor MCH-R2
Table 5
SEQ ID NO: Frame Length Start Stop Gl Number Probability Score Annotation
806 3 122 495 860 gl4164383 1.00E-48 G protein-coupled receptor
806 3 122 495 860 g13604342 1.00E-48 G protein-coupled receptor MCH2
814 2 717 2 2152 gl6041704 0 hypothetical protein FLJ23322
814 2 717 2 2152 gl0438323 0 unnamed protein product
814 2 717 2 2152 gl0439967 0 unnamed protein product
815 1 153 508 966 g6172225 1.00E-92 ST2V
815 1 153 508 966 g220077 7.00E-54 ST2 protein
815 1 153 508 966 g5456908 7.00E-54 ST2L
816 2 146 92 529 gl2850332 1.00E-34 Protein phosphatase 2C containing protein-data source:Pfam, source key:PF00481, evidence:ISS~putative
816 2 146 92 529 gl6552416 6.00E-16 unnamed protein product
817 3 131 216 608 gl2852098 1.00E-60 data source:SPTR, source key:014563, evidence:ISS~homolog to GLUTAMYL-TRNA SYNTHETASE (FRAGMENT)~putative
817 3 131 216 608 g7294109 5.00E-35 CG4573 gene product fe 817 3 131 216 608 g2688265 5.00E-27 glutamyl-tRNA synthetase (gltX) ω 819 1 453 1 1359 gl4042460 0 unnamed protein product
819 1 453 1 1359 gl3623647 0 Similar to RIKEN cDNA 2700091N06 gene
819 1 453 1 1359 gl2849446 1.00E-170 evidence:NAS~hypothetical protein-putative
820 3 288 594 1457 gl2836212 2.00E-64 evidence:NAS~hypothetical protein-putative
820 3 288 594 1457 g18043476 2.00E-64 RIKEN cDNA 1200015A19 gene
820 3 288 594 1457 gl7512106 8.00E-31 Similar to RIKEN cDNA 1200015A19 gene
822 3 282 804 1649 g11990420 1.00E-149 MOP-3
822 3 282 804 1649 g7022892 1.00E-149 unnamed protein product
822 3 282 804 1649 gl8606385 1.00E-148 hypothetical protein FLJ10701
824 2 149 2 448 g9501799 7.00E-76 mitochondrial import receptor Tom22
824 2 149 2 448 gl0716801 7.00EJ6 Tom22
824 2 149 2 448 gl0437092 7.00E-76 unnamed protein product
827 1 195 1 585 g6808095 7.00E-81 hypothetical protein
827 1 195 1 585 g4589678 7.00E-81 KIAA1014 protein
827 1 195 1 585 gl0434696 6.00E-76 unnamed protein product
829 2 429 2 1288 gl0862874 0 dI927M24.2 (KIAA1219)
829 2 429 2 1288 g6330590 1.00E-162 KIAA1219 protein
Table 5.
SEQ ID NO: Frame Length Start Stop Gl Number Probability Score Annotation
829 2 429 2 1288 gl7391470 7.00E-95 Unknown (protein for IMAGE:4693777)
830 2 65 2 196 gl4388555 1.00E-33 hypothetical protein
830 2 65 2 196 gl2854823 2.00E-22 data source:SPTR, source key:Q9W232, evidence:ISS~putative~related to CG17807 PROTEIN
830 2 65 2 196 g7959173 1.00E-07 KIAA1456 protein
832 2b 90 1130 1399 g3002527 2.00E-22 neuronal thread protein AD7c-NTP
832 2b 90 1130 1399 gl6877294 3.00E-22 Similar to hypothetical protein PRO 1722
832 2b 90 1130 1399 gl0439739 5.00E-22 unnamed protein product
835 3 367 369 1469 gl2855517 1.00E-162 data source:SPTR, source key:Q9VS60, evidence:ISS~putative~related to CG8576 PROTEIN
835 3 367 369 1469 gl8044462 1.00E-131 Unknown (protein for MGC:30540)
835 3 367 369 1469 g14035948 6.00E-93 unnamed protein product
838 1 207 340 960 gl6553789 5.00E-13 unnamed protein product
838 1 207 340 960 gl1493409 1.00E-12 PRO0898
838 1 207 340 960 g7770147 2.00E-12 PRO 1847
839 2 90 578 847 gl6566353 2.00E-11 putative ion channel protein CATSPER2 variant 1 fe 839 2 90 578 847 gl6566356 2.00E-11 putative ion channel protein CATSPER2 variant 2
* 839 2 90 578 847 gl6566350 3.00E-10 putative ion channel protein CATSPER2
840 2 122 305 670 gl0437485 1.00E-28 unnamed protein product
840 2 122 305 670 gl0437569 1.00E-27 unnamed protein product
840 2 122 305 670 g7020625 1.00E-26 unnamed protein product
841 2 107 128 448 g3413912 2.00E-37 KIAA0475 protein
841 2 107 128 448 g18044412 9.00E-36 Similar to KIAA0475 gene product
841 2 107 128 448 g13278492 1.00E-05 Unknown (protein for MGC:7673)
•843 3 91 702 974 g12698182 l.OOE-ll hypothetical protein
843 3 91 702 974 gl6552221 2.00E-11 unnamed protein product
843 3 91 702 974 gl4198309 4.00E-11 Similar to proline-serine-threonine phosphatase-interacting protein 2
844 2 285 2 856 g9255809 1.00E-149 PMEPA1 protein
844 2 285 2 856 gl5824469 1.00E-149 solid tumor-associated 1 protein
844 2 285 2 856 gl6303742 1.00E-149 SfAGl/PMEPAl
847 2 363 2 1090 gl4714684 1.00E-166 Unknown (protein for IMAGE:3482764)
847 2 363 2 1090 g12850324 1.00E-165 data source:SPTR, source key:Q9VS51, evidence:ISS~putative~related to CG8596 PROTEIN
847 2 363 2 1090 gl7861694 5.00E-50 GH22722p
848 2 745 1220 3454 g7243081 0 KIAA1350 protein
Table 5
SEQ ID NO: Frame Length Start Stop Gl Number Probability Score Annotation
848 2 745 1220 3454 gl8490104 0 Unknown (protein for IMAGE.4236151)
848 2 745 1220 3454 gl6924225 1.00E-108 Unknown (protein for MGC:22206)
849 2 134 746 1147 gl2005635 2.00E-73 AD031
850 1 976 1 2928 gl0434944 0 unnamed protein product
850 1 976 1 2928 g7300581 1.00E-125 CG4845 gene product
850 1 976 1 2928 gl5145395 3.00E-52 Hypothetical protein R13F6.10
853 2 155 239 703 gl6566353 3.00E-65 putative ion channel protein CATSPER2 variant 1
853 2 155 239 703 gl6566356 3.00E-65 putative ion channel protein CATSPER2 variant 2
853 2 155 239 703 gl6566350 8.00E-26 putative ion channel protein CATSPER2
854 163 10 498 g9837292 2.00E-24 C-type lectin
854 163 10 498 g6651065 2.00E-24 lectin-like NK cell receptor LLT1
854 163 10 498 g18044358 2.00E-24 Similar to lectin-like NK cell receptor
855 123 199 567 g12844231 2.00E-39 evidence:NAS~putative~unclassifiable
855 123 199 567 g517115 5.00E-16 KIAA0032 fe 855 123 199 567 gl2856817 6.00E-16 Regulator of chromosome condensation (RCC1) containing protein-data source:InterPro, source key:IPR000408, evidence:ISS~putative
856 3 138 3 416 gl7390179 5.00E-61 Similar to RIKEN cDNA 9030409E16 gene
856 3 138 3 416 gl2858225 5.00E-59 evidence:NAS~hypothetical protein-putative
856 3 138 3 416 g7303701 1.00E-07 CGI 2341 gene product
858 2 300 50 949 g12654927 1.00E-132 Unknown (protein for MGC:5509)
858 2 300 50 949 gl3905264 1.00E-112 Similar to hypothetical protein MGC5509
858 2 300 50 949 g9022437 2.00E-19 ashwin
860 2 70 383 592 g12698182 2.00E-15 hypothetical protein
860 2 70 383 592 g7021164 9.00E-14 unnamed protein product
860 2 70 383 592 gl6876883 l.OOE-10 Unknown (protein for AGE:4075924)
862 73 295 513 gl6549456 2.00E-19 unnamed protein product
862 73 295 513 g7959267 4.00E-16 KIAA1503 protein
862 73 295 513 gl8027424 1.00E-15 unknown
864 206 394 1011 g13623425 3.00E-54 Similar to KIAA0445 gene product
864 206 394 1011 gl5620903 6.00E-46 KIAA1922 protein .
864 206 394 1011 g8979803 5.00E-45 dJ37C10.5 (KIAA0445)
866 3 87 3 263 gl2804713 3.00E-39 Unknown (protein for MG 2492)
Table 5
SEQ ID NC ': Frame Length Start Stop Gl Number Probability Score Annotation
866 3 87 3 263 g12847677 9.00E-30 data source:SPTR, source key:Q9U5I9, evidence:ISS~putative~related to CENTRIN,
866 3 87 3 263 gl2848210 1.00E-29 data source:SPTR, source key:Q9U5J0, evidence:ISS~putative~related to PUTATIVE CENTRIN (FRAGMENT)
867 2 149 89 535 g4200446 3.00E-51 FYVE finger-containing phosphoinositide kinase
868 2 445 2 1336 g7295961 1.00E-117 CG9867 gene product
868 2 445 2 1336 gl6182556 1.00E-117 GH05422p
868 2 445 2 1336 g3947579 1.00E-30 predicted using Genefinder
869 2 216 224 871 gl633564 1.00E-102 C8
869 2 216 224 871 gl2803453 1.00E-102 Similar to gene rich cluster, C8 gene
869 2 216 224 871 gl2805099 2.00E-63 gene rich cluster, C8 gene
870 3 77 132 362 g10440282 3.00E-12 unnamed protein product
870 3 77 132 362 gl4388331 2.00E-09 hypothetical protein
870 3 77 132 362 g16552221 4.00E-09 unnamed protein product
872 3 402 90 1295 g8102033 0 TRF2-interacting telomeric RAP1 protein fe 872 3 402 90 1295 gl3543358 0 TRF2-interacting telomeric RAP1 protein
872 3 402 90 1295 g13325304 0 TRF2-interacting telomeric RAP1 protein
873 3 86 3 260 g3395506 7.00E-30 dJ511E16.2 (putative protein based on ESTs)
873 3 86 3 260 gl8606260 6.00E-23 Similar to hypothetical protein dI511E16.2
874 2 144 212 643 gl2833402 2.00E-47 evidence:NAS~hypothetical protein-putative
874 2 144 212 643 g12843375 2.00E-47 evidence:NAS~hypothetical protein-putative
875 3 279 192 1028 gl4495648 1.00E-158 Unknown (protein for MGC: 15606)
875 3 279 192 1028 gl6549254 1.00E-158 unnamed protein product
875 3 279 192 1028 gl2859694 6.00E-38 data source:SPTR, source key:Q05004, evidence:ISS~homolog to BRUSH BORDER 61.9 KDA PROTEIN PRECURSOR-putative
876 2 69 2 208 gl3624098 7.00E-16 cervical cancer 1 protooncogene protein p40
876 2 69 2 208 gl6588706 3.00E-15 cervical cancer protooncogene-2 protein
876 2 69 2 208 gl5077022 1.00E-13 cervical cancer receptor
877 1 116 973 1320 gl6566359 2.00E-11 putative ion channel protein CATSPER2 variant 3
877 1 116 973 1320 gl6566353 2.00E-11 putative ion channel protein CATSPER2 variant 1
877 1 116 973 1320 gl6566356 2.00E-11 putative ion channel protein CATSPER2 variant 2
878 2 618 2 1855 g6329755 0 KIAA1126 protein
878 2 618 2 1855 g4680229 4.00E-52 DNb-5
Table 5
SEQ ID NO: Frame Length Start Stop Gl Number Probability Score Annotation
878 2 618 2 1855 g15004313 2.00E-40 membrane-associated transporter protein B
880 2 197 65 655 gl2653037 4.00EJ0 Unknown (protein for IMAGE:3355813)
880 2 197 65 655 gl5209730 2.00E-66 unnamed protein product
880 2 197 65 655 gl2861881 4.00E-42 evidence:NAS~hypothetical protein-putative
881 3 132 2412 2807 g2852636 7.00E-05 unknown
882 2 197 56 646 gl3937819 l.OOE-101 Unknown (protein for MGC: 12335)
882 2 197 56 646 g4468307 9.00E-95 dI413H6.1.1 (hamster Androgen-dependent Expressed Protein LIKE PUTATIVE protein)
882 2 197 56 646 gl91315 5.00E-66 androgen-dependent expressed protein
885 3 220 426 1085 gl8043306 1.00E-92 RIKEN cDNA 1810033 A06 gene
885 3 220 426 1085 gl2841374 1.00E-92 data source:SPTR, source key:Q9NRU6, evidence:ISS~homolog to human X 009 PROTEIN-putative
885 3 220 426 1085 g7301782 7.00E-34 CG2006 gene product
886 2 365 2 1096 g17390000 0 Similar to RIKEN cDNA 5730455013 gene
886 2 365 2 1096 gl2857019 1.00E-112 data source:SPTR, source key :081652, evidence:ISS~putative~related to PHYB 1
& 886 2 365 2 1096 gl4189976 l.OOE-111 PR02972
J 887 3 109 48 374 gl0437569 4.00E-28 unnamed protein product
887 3 109 48 374 gl0437485 3.00E-26 unnamed protein product
887 3 109 48 374 g9280152 3.00E-25 unnamed portein product
888 106 43 360 gl0437485 2.00E-15 unnamed protein product
888 106 43 360 gl4043141 1.00E-14 Unknown (protein for MGC: 15483)
888 106 43 360 g10441877 3.00E-14 unknown
889 157 112 582 g10434098 1.00E-07 unnamed protein product
889 157 112 582 g18027726 3.00E-07 unknown
889 157 112 582 g854065 7.00E-06 U88
890 99 262 558 gl0435559 6.00E-16 unnamed protein product
890 99 262 558 gl0437485 2.00E-15 unnamed protein product
890 99 262 558 g9280152 2.00E-14 unnamed portein product
891 89 193 459 gl4189960 7.00E-18 PRO0764
891 89 193 459 g8980667 2.00E-17 PADI-H protein
891 89 193 459 gl0437569 8.00E-17 unnamed protein product
892 118 844 1197 ,g2072957 1.00E-08 p40
892 118 844 1197 g2072966 2.00E-08 p40
Table 5
SEQ ID NO: Frame Length Start Stop Gl Number Probability Score Annotation 892 1 1 18 844 1 197 g337663 9.00E-08 ORF1 ; putative 893 170 1 5 51100 g10802923 4.00E-08 SecY-independent transporter protein 893 170 1 551100 g5869819 2.00E-07 NADH-ubiquinone oxidoreductase subunit 1 893 170 1 5 51100 gl3359187 8.00E-07 KIAA 1657 protein 896 238 392 1105 g12845540 1.00E-67 data source:SPTR, source key:Q9HA82, evidence:ISS~homolog to CDNA FLU2089 FIS, CLONE HEMBB 1002550, WEAKLY SIMILAR TO HYPOTHETICAL UOG-1
896 2 238 392 1105 gl3936285 1.00E-67 TRH4 896 2 238 392 1105 gl4715021 3.00E-50 Similar to RIKEN cDNA 2310081H14 gene 897 3 131 381 773 g3176973 9.00E-33 BCE-1 : 898 3 62 300 485 gl6550580 3.00E-11 unnamed protein product 898 3 62 300 485 g6690248 7.00E-10 PRO0657 898 3 62 300 485 g288145 1.00E-09 put. ORF 900 2 64 2 193 gl7390202 3.00E-28 Similar to RIKEN cDNA 2510005D08 gene 900 2 64 2 193 gl4035896 3.00E-28 unnamed protein product ω 900 2 64 2 193 gl2848605 1.00E-23 data source:SPTR, source key:Q21541, evidence:ISS~putative~related to M142.5 PROTEIN oo 901 1 95 58 342 gl0436992 5.00E-41 unnamed protein product 901 1 95 58 342 gl3784943 5.00E-35 Unknown (protein for MGC: 11761) 902 3 122 192 557 g6650810 2.00E-26 PRO 1902 902 3 122 192 557 gl2698182 2.00E-22 hypothetical protein 902 3 122 192 557 gl6553789 9.00E-22 unnamed protein product 908 1 94 94 375 gl7390188 7.00E-47 Similar to RIKEN cDNA 1110058L19 gene 908 1 94 94 375 g12841765 9.00E-32 data source:SPTR, source key:Q9VLU6, evidence:ISS~putative~related to CG7224 PROTEIN 908 1 94 94 375 gl2835436 9.00E-32 data source:SPTR, source key:Q9VLU6, evidence:ISS-putative~related to CG7224 PROTEIN 910 3 1027 6 3086 g4240311 0 KIAA091 1 protein 910 3 1027 6 3086 gl 1558246 0 calsyntenin-1 protein 910 3 1027 6 3086 gl 1558248 0 calsyntenin-1 protein 911 3 190 3 572 gl4036042 1.00E-104 unnamed protein product 911 3 190 3 572 gl8088345 2.00E-91 Similar to RIKEN cDNA 1110066C01 gene 911 3 190 3 572 gl2849796 8.00EJ8 data source:SPTR, source key:Q9NZE8, evidence:ISS~homolog to MITOCHONDRIAL 39S RIBOSOMAL PROTEIN L35 (MRP-L35)~putative
912 549 1649 gl5277565 0 RIKEN cDNA 2510039018 gene 912 549 1649 gl2846932 0 data source-.SPTR, source key.Q9VQ60, evidence:ISS-putative~related to CG7289 PROTEIN
Table 5
SEQ ID NO: Frame Length Start Stop Gl Number Probability Score Annotation
912 3 549 3 1649 gl3325391 1.00E-138 Similar to RIKEN cDNA 2510039018 gene
913 3 194 225 806 gl3543692 1.00E-87 COBW-like protein
913 3 194 225 806 gl3177623 1.00E-87 dopamine-responsive protein
913 3 194 225 806 gl5488579 1.00E-87 COBW-like protein
916 2 58 338 511 g6690248 6.00E-05 PRO0657
917 2 81 53 295 gl2053359 6.00E-07 hypothetical protein
918 2 248 296 1039 gl8490618 1.00E-142 Similar to RIKEN cDNA 1700048E23 gene
918 2 248 296 1039 gl2839952 1.00E-117 data source:SPTR, source key:073884, evidence:ISS~putative~related to PUTATIVE PHOSPHATASE
918 2 248 296 1039 g3218467 6.00E-57 putative phosphatase
919 2 128 542 925 g14042106 4.00E-72 unnamed protein product
920 3 439 231 1547 g7023022 5.00E-88 unnamed protein product
920 3 439 231 1547 gl4030861 2.00E-36 paraneoplastic neuronal antigen MAI
920 3 439 231 1547 gl8478557 9.00E-36 paraneoplastic onconeuronal protein MAI 921 2 193 149 727 gl2746410 5.00E-35 coenzyme A diphosphatase
921 2 193 149 727 gl2836479 7.00E-35 data source:MGD, source key:MGI: 1914778, evidence:ISS~nudix (nucleoside diphosphate linked moiety X)-type motif 7~putative
921 2 193 149 727 gl2847124 2.00E-33 data source:MGD, source key:MGI:1914778, evidence:ISS~nudix (nucleoside diphosphate linked moiety X)-type motif 7~putative
922 3 305 3 917 gl6024938 4.00E-46 4-lBB-mediated signaling molecule
922 3 305 3 917 gl2845847 3.00E-34 evidence:NAS~hyρothetical protein-putative
922 3 305 3 917 18490950 2.00E-33 RIKEN cDNA 2410005L11 gene
923 2 142 1244 1669 g6562162 1.00E-71 hypothetical protein
923 2 142 1244 1669 g695370 1.00E-46 thyroid receptor interactor
923 2 142 1244 1669 g3193258 1.00E-46 proteasome subunit SUG1
927 3 76 309 536 gl2698192 3.00E-07 hypothetical protein
927 3 76 309 536 gl6550881 5.00E-07 unnamed protein product
927 3 76 309 536 g15929032 6.00E-06 Similar to RIKEN cDNA 9430029K10 gene
931 2 75 62 286 gl0437485 5.00E-10 unnamed protein product
931 2 75 62 286 gl6041132 9.00E-10 hypothetical protein
931 2 75 62 286 g7020625 1.00E-09 unnamed protein product
934 3 554 3 1664 g6599215 0 hypothetical protein
Table 5
SEQ ID NO: Frame Length Start Stop Gl Number Probability Score Annotation
934 3 554 3 1664 g7023623 0 unnamed protein product
934 3 554 3 1664 g3549261 1.00E-13 interaptin
935 3 266 1698 2495 g7019969 1.00E-149 unnamed protein product
935 3 266 1698 2495 g12805451 1.00E-106 Similar to hypothetical protein FLJ20093
935 3 266 1698 2495 gl0438722 7.00E-89 unnamed protein product
937 1 205 277 891 gl2847516 1.00E-60 data source:SPTR, source key:Q9PTD5, evidence:ISS~putative~related to KIAA0009 PROTEIN
937 1 205 277 891 gl2855709 3.00E-60 data source:SPTR, source key:Q15390, evidence:ISS~homolog to HYPOTHETICAL PROTEIN KIAA0009~putative
937 1 205 277 891 gl7512323 6.00E-59 Similar to RIKEN cDNA 2610016C23 gene
938 2 227 386 1066 gl6550264 1.00E-112 unnamed protein product
938 2 227 386 1066 g16924243 1.00E-72 Unknown (protein for IMAGE:4049523)
938 2 227 386 1066 gl504016 4.00E-09 no similarities to reported gene products
939 3 81 3 245 g14717079 1.00E-40 dJ469A13.2 (Novel protein)
939 3 81 3 245 gl2857138 1.00E-21 data source:SPTR, source key:Q9H8P4, evidence:ISS~homoIog to CDNA FLJ13346 FIS, fc CLONE OVARC 1002107~putative
° 939 3 81 3 245 gl2839239 1.00E-21 data source:SPTR, source key:Q9H8P4, evidence:ISS~homolog to CDNA FLI13346 FIS, CLONE OVARC 1002107~putative
940 1 646 1 1938 gl3111835 0 hypothetical protein FLI20333
940 1 646 1 1938 g7243047 0 KIAA1333 protein
940 1 646 1 1938 g7020359 0 unnamed protein product
943 3 335 3 1007 g6330416 0 KIAA1201 protein
943 3 335 3 1007 gl5559417 3.00E-66 Unknown (protein for MGC:20455)
.943 3 335 3 1007 g7959333 3.00E-66 KIAA1533 protein
945 2 154 50 511 gl4043111 4.00E-28 Similar to ubiquitin associated and SH3 domain containing, A
945 2 154 50 511 gl6304176 4.00E-28 nm23-ρhosphorylated unknown substrate
945 2 154 50 511 g7799912 l.OOE-11 UBASH3A protein
947 3 121 432 794 gl915967 2.00E-62 small acidic protein
947 3 121 432 794 gl6741003 2.00E-62 small acidic protein
947 3 121 432 794 gl3937979 2.00E-62 small acidic protein
948 3 137 888 1298 gl 1493508 4.00E-29 PRO0522
' 948 3 137 888 1298 gl5080674 4.00E-18 RanBPM
948 3 137 888 1298 gl3194576 4.00E-18 RANBPM
Table 5
SEQ ID NO: Frame Length Start Stop Gl Number Probability Score Annotation
950 1 127 202 582 gl6553676 4.00E-63 unnamed protein product
950 1 127 202 582 gl2847853 3.00E-15 data source:MGD, source key:MGI:l 100877, evidence:ISS~putative-transforming growth factor beta regulated gene 1
951 2 74 65 286 g16549456 1.00E-15 unnamed protein product
951 2 74 65 286 gl5680195 2.00E-13 Similar to hypothetical protein FLJ11267
951 2 74 65 286 g7023820 2.00E-13 unnamed protein product
953 3 196 144 731 gl5012072 6.00E-93 Similar to DKFZP566K023 protein
953 3 196 144 731 g7018410 6.00E-93 hypothetical protein
953 3 196 144 731 gl3559035 9.00E-92 dJ586015.1 (hypothetical 22.1 KDA protein)
954 2 349 2 1048 gl4017777 0 MEGF10 protein (KIAA1780)
954 2 349 2 1048 gl7017251 5.00E-43 MEGF12
954 2 349 2 1048 gl7386053 5.00E-43 Jedi protein
955 2 359 2 1078 gl2405521 4.00E-68 unnamed protein product
955 2 359 2 1078 g18606449 2.00E-59 germ cell-specific gene 1 955 2 359 2 1078 g12839367 9.00E-37 data source:MGD, source key :MGI: 1194499, evidence:ISS~germ cell-specific gene l~putative
956 2 380 155 1294 gl4017869 0 KIA A 1826 protein
956 2 380 155 1294 gl5928503 0 Similar to KIAA1826 protein
956 2 380 155 1294 gl4042730 5.00E-98 unnamed protein product
959 3 115 333 677 gl6550502 2.00E-51 unnamed protein product
959 3 115 333 677 gl4290546 2.00E-51 Similar to RIKEN cDNA 2410003C20 gene
959 3 115 333 677 gl2804121 2.00E-51 Unknown (protein for IMAGE:3954132)
962 3 74 2505 2726 gl0433567 1.00E-08 unnamed protein product
962 3 74 2505 2726 gl8490197 3.00E-08 Unknown (protein for MGC:23782)
962 3 74 2505 2726 gl2698182 5.00E-08 hypothetical protein
964 1 111 250 582 gl0437569 8.00E-20 unnamed protein product
964 1 111 250 582 gl4189960 4.00E-19 PRO0764
964 1 111 250 582 gl5214765 9.00E-19 Similar to hypothetical protein
969 2 216 2 649 g307155 4.00E-97 MAC30
969 2 216 2 649 gl7390346 3.00E-84 Unknown (protein for MGC:25841)
969 2 216 2 649 g3831458 6.00E-08 hypothetical protein
970 3 109 102 428 g4200241 5.00E-26 hypothetical protein
970 3 109 102 428 gl2248791 3.00E-20 syntaxin 12
Table 5
SEQ ID NO: Frame Length Start Stop Gl Number Probability Score Annotation
970 3 109 102 428 gl4715019 3.00E-20 Unknown (protein for MGC:6471)
974 3 565 240 1934 gl4278953 0 Mid- 1 -related chloride channel 1
974 3 565 240 1934 g13096892 0 Similar to KIAA0761 protein
974 3 565 240 1934 g4588787 0 unknown
975 2 352 2 1057 gl8088178 1.00E-134 Unknown (protein for IMAGE:3882977)
975 2 352 2 1057 gl0636484 4.00E-81 polyglutamine-containing protein
975 2 352 2 1057 gl4017947 4.00E-81 KIAA1865 protein
976 1 349 976 2022 gl4549207 0 URAX1
976 1 349 976 2022 gl7907795 0 TGF-beta induced apotosis protein 3
976 1 349 976 2022 gl7049034 0 unnamed protein product
978 3 274 2046 2867 g7020399 1.00E-58 unnamed protein product
978 3 274 2046 2867 gl0435659 1.00E-17 unnamed protein product
978 3 274 2046 2867 gl7132941 2.00E-11 ORF_ID:alr3807~hypothetical protein
983 3 839 18 2534 gl0880933 0 putative prostate cancer susceptibility protein HPC2 ELAC2 fc 983 3 839 18 2534 gl2804973 0 putative prostate cancer susceptibility protein
N 983 3 839 18 2534 gl3278771 0 putative prostate cancer susceptibility protein
985 3 196 570 1157 g12005505 1.00E-107 AD029
985 3 196 570 1157 gl2697953 1.00E-106 KIAA1704 protein
985 3 196 570 1157 g7920153 7.00E-93 lipopolysaccharide specific response-7 protein
986 2 755 2 2266 g7022590 0 unnamed protein product
986 2 755 2 2266 gl0435073 0 unnamed protein product
986 2 755 2 2266 g7959163 0 KIAA1452 protein
1001 3 335 252 1256 gl6550386 1.00E-154 unnamed protein product
1001 3 335 252 1256 gl2836009 1.00E-120 evidence:NAS~hypotheticaI protein-putative
1001 3 335 252 1256 g296164 3.00E-09 156 kDa Protein
1002 3 168 744 1247 gl2002207 6.00E-98 chymotrypsin-Iike protein
1002 3 168 744 1247 g6581056 4.00E-95 CHORD containing protein- 1
1002 3 168 744 1247 gl7390873 6.00E-92 RIKEN cDNA 1110001009 gene
1003 1 172 112 627 g2587027 1.00E-19 HERV-E envelope glycoprotein
1003 1 172 112 627 g2587024 1.00E-19 HERV-E envelope glycoprotein
1003 1 172 112 627 gl049232 5.00E-17 HERV-E envelope protein
1005 3 123 1155 1523 gl3276669 2.00E-53 hypothetical protein
Table 5
SEQID NO: Frame Length Start Stop GlNumber Probability Score Annotation
1008 1 154 247 708 gl7430957 9.00E-17 HYPOTHETICAL TRANSMEMBRANE PROTEIN
1008 1 154 247 708 g3594 1.00E-09 carboxypeptidase s
1008 1 154 247 708 gl008367 1.00E-09 ORF YIL172w
1009 2 270 2 811 gl7512162 1.00E-153 Unknown (protein for MGC:29802)
1009 2 270 2 811 g15082287 1.00E-153 Unknown (protein for IMAGE:3502817)
1009 2 270 2 811 g2522348 4.00E-46 Na/taurocholate cotransporting polypeptide 1
1013 2 109 140 466 g2587027 2.00E-20 HERV-E envelope glycoprotein
1013 2 109 140 466 g2587024 2.00E-20 HERV-E envelope glycoprotein
1013 2 109 140 466 gl049232 8.00E-19 HERV-E envelope protein
1014 3 69 30 236 g6114601 7.00E-24 stromal antigen 3, (STAG3)
1014 3 69 30 236 gl3195163 4.00E-10 stromal antigen 3
1014 3 69 30 236 g3090423 3.00E-08 stag3
1017 3 118 3 356 gl4009459 1.00E-06 protocadherin-betal 1
1017 3 118 3 356 g5457029 1.00E-06 protocadherin beta 11 fc 1017 3 118 3 356 g5457035 4.00E-06 protocadherin beta 14
1019 2 138 98 511 gl6550813 9.00E-42 unnamed protein product
1019 2 138 98 511 g2792016 1.00E-40 olfactory receptor
1019 2 138 98 511 g4092819 1.00E-40 BC319430_5
1020 1 359 163 1239 gl5131403 2.00E-80 dJ85M6.3 (similar to testis-specific protein PBS 13)
1020 1 359 163 1239 g7023926 2.00E-80 unnamed protein product
1020 1 359 163 1239 gl7426495 4.00E-60 bA353I17.2 (testis specific protein similar to TCP11 (t-complex 11 (a murine top homolog)))
1021 2 79 188 424 g7020440 6.00E-20 unnamed protein product
1021 2 79 188 424 g6690252 5.00E-16 PRO0663
1021 2 79 188 424 gl6552221 1.00E-15 unnamed protein product
1022 2 380 2 1141 g6683126 1.00E-128 KIAA0339 protein
1022 2 380 2 1141 gl7016489 3.00E-18 wsv091
1022 2 380 2 1141 g9837385 3.00E-18 retinitis pigmentosa GTPase regulator-like protein
1023 3 594 216 1997 g15990553 1.00E-173 Unknown (protein for MGG23445)
1023 3 594 216 1997 gl6041702 1.00E-122 Unknown (protein for MGC: 17998)
1023 3 594 216 1997 g7295275 1.00E-36 CG8616 gene product
1024 3 233 3 701 gl4272632 1.00E-126 unnamed protein product
1024 3 233 3 701 gl6551700 1.00E-108 unnamed protein product
Table 5
SEQ ID NO: Frame Length Start Stop Gl Number Probability Score Annotation
1024 3 233 3 701 gl2843884 1.00E-79 evidence:NAS~hypothetical protein-putative
1025 3 325 3 977 gl2654711 1.00E-178 Unknown (protein for MGC:3169)
1025 3 325 3 977 gl0438670 1.00E-178 unnamed protein product
1025 3 325 3 977 gl5928500 1.00E-163 Similar to hypothetical protein MGC3169
1026 2 256 908 1675 gl5079262 1.00E-44 Unknown (protein for IMAGE:3154539)
1026 2 256 908 1675 g13544043 2.00E-23 Unknown (protein for IMAGE:3627317)
1026 2 256 908 1675 gl2003980 2.00E-23 spinster-like protein
1027 1 260 610 1389 gl8043473 1.00E-106 DP-ribosylation-like factor 6 interacting protein 6
1027 1 260 610 1389 gl2854930 1.00E-105 DP-ribosylation-like factor 6 interacting protein 6~data source:MGD, source key:MGI:1929507, evidence:IS S~putati ve
1027 1 260 610 1389 gl2846953 1.00E-103 DP-ribosylation-like factor 6 interacting protein 6~data source:MGD, source key :MGI: 1929507, evidence:ISS~putative
1030 3 207 831 1451 gl4717079 l.OOE-110 dJ469A13.2 (Novel protein)
1030 3 207 831 1451 gl2857138 1.00E-71 data source:SPTR, source key:Q9H8P4, evidence:ISS~homolog to CDNA FLJ 13346 FIS, CLONE OVARC 1002107~putative
1030 3 207 831 1451 gl2839239 1.00EJ1 data source:SPTR, source key:Q9H8P4, evidence:ISS~homolog to CDNA FLI13346 FIS, CLONE OVARC1002107~putative
1032 3 313 30 968 gl4198207 1.00E-179 Similar to CG4452 gene product
1032 3 313 30 968 g4200234 1.00E-176 hypothetical protein
1032 3 313 30 968 g4200238 1.00E-154 hypothetical protein
1033 1 91 472 744 g9967222 3.00E-22 hypothetical protein
1034 1 561 1 1683 g3882183 0 KIAA0731 protein
1034 1 561 1 1683 g7022373 5.00E-56 unnamed protein product
1034 1 561 1 1683 gl0726821 9.00E-32 larp gene product
1035 3 91 288 560 gl2698182 l.OOE-11 hypothetical protein
1035 3 91 288 560 gl6552221 2.00E-11 unnamed protein product
1035 3 91 288 560 gl4198309 4.00E-11 Similar to proline-serine-threonine phosphatase-interacting protein 2
1037 79 928 1164 g288145 8.00E-08 put. ORF
1037 79 928 1164 g6690248 1.00E-07 PRO0657
1037 79 928 1164 g9955914 6.00E-06 platelet glycoprotein VI-3
1038 213 1 639 gl2847051 1.00E-107 evidence.NAS-hypothetical protein-putative
1038 213 1 639 gl6549898 1.00E-107 unnamed protein product
Table 5
SEQ ID NO: Frame Length Start Stop Gl Number Probability Score Annotation
1038 1 213 1 639 g16877037 3.00E-71 Similar to RIKEN cDNA 2600001B 17 gene
1039 3 148 450 893 gl4042588 2.00E-54 unnamed protein product
1039 3 148 450 893 gl4042283 2.00E-54 unnamed protein product
1039 3 148 450 893 gl4035872 2.00E-54 unnamed protein product
1042 1 305 70 984 g16307277 1.00E-140 putative protein tyrosine kinase
1042 1 305 70 984 gl4715460 1.00E-140 Nori-2p
1042 1 305 70 984 g9588402 1.00E-140 dJ28H20.2 (novel protein)
1043 3 162 3 488 gl8490805 2.00E-93 hypothetical protein SP192
1043 3 162 3 488 gl0503966 2.00E-93 unknown
1043 3 162 3 488 gl0437401 2.00E-93 unnamed protein product
1045 3 1093 3 3281 g5733726 0 gamma-synergin
1045 3 1093 3 3281 g5733728 0 gamma-synergin
1045 3 1093 3 3281 g7341344 0 gamma-synergin
1047 1 515 721 2265 gl2804973 0 putative prostate cancer susceptibility protein fc 1047 1 515 721 2265 gl0880933 0 putative prostate cancer susceptibility protein HPC2/ELAC2
1047 1 515 721 2265 g13278771 0 putative prostate cancer susceptibility protein
1048 3 104 762 1073 g12849011 3.00E-17 Zinc finger, C2H2 type containing protein-data source:Pfam, source key:PF00096, evidence:ISS~putative
1049 3 177 3 533 g12844368 7.00E-82 evidence:NAS~hypotheticaI protein-putative
1049 3 177 3 533 gl3358924 2.00EJ9 hypothetical protein
1049 3 177 3 533 gl3623489 5.00E-26 Unknown (protein for IMAGE:4109498)
1050 2 330 2 991 gl0436267 1.00E-178 unnamed protein product
1050 2 330 2 991 gl6359295 1.00E-152 Similar to hypothetical protein FLJ13955
1050 2 330 2 991 g5459205 6.00E-75 dI462023.2 (novel protein)
1052 3 206 3 620 gl2834129 1.00E-105 data source:SPTR, source key:Q9VEZ4, evidence:ISS~putative~reIated to CG5013 PROTEIN
1052 3 206 3 620 gl2855876 1.00E-57 Beta defensin containing protein-data source:Pfam, source key:PF00711, evidence:ISS~putative
1052 3 206 3 620 g7300099 2.00E-42 CG5013 gene product
1057 2 3021 2 9064 g7243035 0 KIAA1327 protein
1057 2 3021 2 9064 g2384711 0 antigen containing epitope to monoclonal antibody MMS-85/12
1057 2 3021 2 9064 gl0438646 0 unnamed protein product
1058 1 168 70 573 g10047243 2.00E-63 KIAA1584 protein
1058 1 168 70 573 g6468312 2.00E-38 hypothetical protein
Table 5
SEQ ID NO: Frame Length Start Stop Gl Number Probability Score Annotation
1058 1 168 70 573 g7019973 2.00E-38 unnamed protein product
1060 3 1036 3 31 10 g7271 03 0 DWF-1
1060 3 1036 3 31 10 g7141 125 0 Ellis-van Creveld syndrome protein
1060 3 1036 3 31 10 g7141 127 0 Ellis-van Creveld syndrome protein
1061 3 470 159 1568 g9828190 0 FLAMINGO 1
1061 3 470 159 1568 gl665821 0 Similar to D.melanogaster cadherin-related tumor suppressor
1061 3 470 159 1568 g6681360 1.00E-176 MEGF3
1062 1 194 556 1137 gl4133213 7.00E-33 KIAA0732 protein
1064 3 389 3 1169 g4884468 1.00E-159 hypothetical protein
1064 3 389 3 1169 gl5929494 1.00E-141 Unknown (protein for MGC: 10151)
1064 3 389 3 1169 gl 8380937 1.00E-128 Unknown (protein for MGC:4713)
1065 2 235 119 823 gl4198207 4.00E-69 Similar to CG4452 gene product
1065 2 235 119 823 g4200234 8.00E-63 hypothetical protein
1065 2 235 119 823 g4200238 5.00E-58 hypothetical protein fc 1069 1 212 1285 1920 gl0504263 1.00E-114 betaPix-b
* 1069 1 212 1285 1920 g 10504266 1.00E-1 14 betaPix-c
1069 1 212 1285 1920 gl5420378 1.00E-61 betaPix-d
1071 2 284 170 1021 gl3442786 1.00E-107 Drctnnbla
1071 2 284 170 1021 g 16551687 1.00E-106 unnamed protein product
1071 2 284 " 170 1021 gl7511709 1.00E-106 down-regulated by Ctnnbl, a
1073 1 304 226 1137 gl3625186 1.00E-173 RNA binding protein
1073 1 304 226 1137 gl4042167 1.00E-172 unnamed protein product
1073 1 304 226 1137 gl2853682 1.00E-154 data source:SPTR, source key:P10962, evidence:ISS~putative~related to MAK16 PROTEIN
1074 2 434 86 1387 gl2846470 0 data source:SPTR, source key:O46078, evidence:ISS~putative~related to EG:39E1.1 PROTEIN (CGI 1596 PROTEIN)
1074 2 434 86 1387 gl0728401 8.00E-88 EG:39E1.1 gene product
1074 2 434 86 1387 gl5292213 8.00E-88 LD42227p
1075 99 124 420 gl5620859 2.00E-44 KIAA1900 protein
1075 99 124 420 gl 6549994 2.00E-44 unnamed protein product
1076 84 397 648 g299471 1.00E-08 X-linked retinopathy protein
1076 84 397 648 gl2698182 5.00E-08 hypothetical protein
1076 84 397 648 gl0433567 4.00E-07 unnamed protein product
Table 5
SEQ ID NO: Frame Length Start Stop Gl Number Probability Score Annotation
1078 3 146 3 440 gl3359183 4.00E-27 KIAA1655 protein
1078 3 146 3 440 gl 0439739 3.00E-24 unnamed protein product
1078 3 146 3 440 gl4249973 2.00E-23 Similar to hypothetical protein PR01722
1079 2 208 143 766 gl4574118 1.00E-17 Hypothetical protein F22B7.10
1079 2 208 143 766 g 16553246 3.00E-15 unnamed protein product
1079 2 208 143 766 g7293494 9.00E-06 CG6659 gene product
1081 2 54 305 466 g6690248 3.00E-10 PRO0657
1081 2 54 305 466 gl6550580 1.00E-08 unnamed protein product
1081 2 54 305 466 g288145 1.00E-08 put. ORF
1084 1 111 892 1224 g4309949 5.00E-39 similar to MLN 64; similar to 138027 (PID:g2135214)
1084 1 111 892 1224 gl3111774 5.00E-39 Similar to steroidogenic acute regulatory protein related
1084 1 111 892 1224 gl3543615 5.00E-39 Unknown (protein for MGC: 14607)
1088 3 375 792 1916 gl2655913 0 sprouty-4A
1088 3 375 792 1916 g4850326 1.00E-169 sprouty-4 1088 3 375 792 1916 g5917720 1.00E-169 sprouty 4
^ 1090 1 46 1 138 gl2852725 4.00E-06 data source:SPTR, source key:Q9VBLl, evidence:ISS~putative~related to CG5901 PROTEIN
1091 3 227 186 866 gl0041644 1.00E-34 unnamed protein product
1091 3 227 186 866 gl0041654 1.00E-34 unnamed protein product
1091 3 227 186 866 g 10041649 3.00E-30 unnamed protein product
1093 3 101 552 854 g7770147 6.00E-16 PR01847
1093 3 101 552 854 gl0437752 6.00E-15 unnamed protein product
1093 3 101 552 854 g6650810 3.00E-14 PRO1902
1094 1 126 619 996 gl6041152 2.00E-16 hypothetical protein
1094 1 126 619 996 gl0435380 2.00E-09 unnamed protein product
1095 2 67 194 394 g522145 4.00E-07 B-cell growth factor
1097 3 430 39 1328 gl6877653 0 Similar to KIAA0643 protein
1097 3 430 39 1328 g3327100 0 KIAA0643 protein
1097 3 430 39 1328 g 10435262 l .OOE-138 unnamed protein product
1 101 3 224 288 959 g 12855287 3.00E-65 evidence:NAS~hypothetical protein-putative
1101 3 224 288 959 g4200330 8.00E-22 dI821Dl l .l (PUTATIVE protein)
1 102 2 958 164 3037 gl6306780 0 Unknown (protein for IMAGE:3461401)
1102 2 958 164 3037 g!6552089 0 unnamed protein product
Table 5
SEQID NO: Frame Length Start Stop Gl Number Probability Sc Annotation
1102 2 958 164 3037 gl2857435 1.00E-105 evidence:NAS~putative~unclassifiable
1106 3 302 210 1115 gl4272790 1.00E-156 unnamed protein product
1106 3 302 210 1115 gl5209786 1.00E-146 unnamed protein product
1106 3 302 210 1115 g7303350 1.00E-12 CGI 2251 gene product
1107 3 312 72 1007 gl5079708 1.00E-151 Similar to KIAA0514 gene product
1107 3 312 72 1007 g3043552 1.00E-151 KIAA0514 protein
1108 1 402 910 2115 gl4388555 0 hypothetical protein
1108 1 402 910 2115 gl2854823 8.00E-96 data source:SPTR, source key:Q9W232, evidence:ISS~putative~related to CG 17807 PROTEIN
1108 1 402 910 2115 g7291441 6.00E-89 CG17807 gene product
1110 2 359 2 1078 g12405521 4.00E-68 unnamed protein product
1110 2 359 2 1078 g18606449 2.00E-59 germ cell-specific gene 1
1110 2 359 2 1078 gl2839367 9.00E-37 data source.MGD, source key:MGI:l 194499, evidence:ISS~germ cell-specific gene l~putative llll 1 287 1 861 gl4714684 1.00E-135 Unknown (protein for IMAGE:3482764) llll 1 287 1 861 gl2850324 1.00E-134 data source:SPTR, source key:Q9VS51, evidence:ISS-putative~related to CG8596 PROTEIN fc llll 1 287 1 861 gl7861694 1.00E-29 GH22722p
1112 2 62 308 493 gl2963869 2.00E-24 gene trap ankyrin repeat containing protein
1112 2 62 308 493 gl0438501 7.00E-07 unnamed protein product
1112 2 62 308 493 g7020282 1.00E-05 unnamed protein product
1113 3 396 480 1667 g14250716 2.00E-17 Unknown (protein for MGC:13310)
1113 3 396 480 1667 gl6877906 1.00E-16 Unknown (protein for DVIAGE:3344281)
1113 3 396 480 1667 gl5030268 1.00E-13 Unknown (protein for MGC9923)
1114 3 962 3 2888 gl3625166 0 RALBP1
1114 3 962 3 2888 gl5706481 0 Unknown (protein for MGC: 16228)
1114 3 962 3 2888 g2677843 0 RalBPl-associated EH domain protein Repsl
1115 97 291 g3047242 1.00E-13 melastatin
1115 97 291 g3243075 2.00E-13 melastatin 1
1115 97 291 g8131903 2.00E-06 transient receptor potential-related protein
1116 211 633 gl304179 2.00E-05 fibrinogen A-alpha-chain
1116 211 633 g3789960 2.00E-05 fibrinogen A-alpha chain
1116 211 633 g531261 5.00E-05 5E5 antigen
1117 124 562 933 gl2698182 1.00E-29 hypothetical protein
1117 124 562 933 g7020440 7.00E-24 unnamed protein product
Table 5
SEQID NO: Frame Length Start Stop Gl Number Probability Score Annotation
1117 124 562 933 gl 1493483 3.00E-23 PRO2550
1118 142 61 486 gl4041976 1.00E-38 unnamed protein product
1118 142 61 486 g5689553 1.00E-38 KIAA1108 protein
1118 142 61 486 g988221 2.00E-35 Tbcl
1119 1294 184 4065 g7228149 0 ATFa-associated factor
1119 1294 184 4065 g7022872 0 unnamed protein product
1119 1294 184 4065 g5101772 0 p621
1120 3 188 3 566 gl2804117 7.00E-39 Unknown (protein for MGC: 11276)
1120 3 188 3 566 gl2652917 1.00E-26 Unknown (protein for MGQ2694)
1120 3 188 3 566 gl2851605 3.00E-26 DNA segment, Chr 7, Wayne State University 86, expressed-data source:MGD, source key :MGI: 106442, evidence:ISS~putative
1121 1 177 43 573 gl1932167 2.00E-40 dJ659I19.1 (KIAA0435 protein)
1121 1 177 43 573 g2662151 2.00E-40 KIAA0435
1123 3 80 48 287 gl0433567 8.00E-09 unnamed protein product fc 1123 3 80 48 287 gl0440282 8.00E-07 unnamed protein product
* 1123 3 80 48 287 gl4388331 8.00E-07 hypothetical protein
1124 3 507 552 2072 gl6549800 0 unnamed protein product
1124 3 507 552 2072 g12852088 1.00E-138 data source:SPTR, source key:Q14699, evidence.TSS-homolog to HYPOTHETICAL PROTEIN KIAA0084 (HA2022) (FRAGMENT)-putative
1124 3 507 552 2072 g577299 7.00E-61 The ha2022 gene product is novel,
1125 2 114 119 460 gl4139788 2.00E-46 unnamed protein product
1125 2 114 119 460 gl2405797 2.00E-46 unnamed protein product
1125 2 114 119 460 gl2405805 2.00E-46 unnamed protein product
1126 3 62 300 485 gl6550580 3.00E-11 unnamed protein product
1126 3 62 300 485 g6690248 7.00E-10 PRO0657
1126 3 62 300 485 g288145 1.00E-09 put. ORF
1128 54 436 597 gl0435738 1.00E-08 unnamed protein product
1128 54 436 597 gl4042822 3.00E-07 unnamed protein product
1128 54 436 597 g2810991 6.00E-07 KRAB-zinc finger protein KZF-1
1129 181 34 576 g4205084 4.00E-40 WW domain binding protein-1
1129 181 34 576 14603081 4.00E-40 Similar to WW domain binding protein 1
1129 181 34 576 gl8044295 2.00E-38 Similar to WW domain binding protein 1
Table 5
SEQ ID NO: Frame Length Start Stop Gl Number Probability Score Annotation
1131 2 107 569 889 g5726235 2.00E-19 unknown protein U5/2
1132 2 115 434 778 g7544146 2.00E-28 vanilloid receptor type 1 like protein 1
1132 2 115 434 778 g6782444 2.00E-28 vanilloid receptor splice variant
1132 2 115 434 778 g5263196 2.00E-28 stretch-inhibitable nonselective channel (SIC)
1133 180 154 693 g7243155 6.00E-82 KIAA1387 protein
1133 180 154 693 gl3623235 5.00E-21 Similar to hypothetical protein FLI20707
1133 180 154 693 gl3905156 5.00E-21 Unknown (protein for MGC: 11798) 1135 57 328 498 g10437485 9.00E-10 unnamed protein product
1135 57 328 498 g7020292 1.00E-09 unnamed protein product
1135 57 328 498 g9280152 1.00E-08 unnamed portein product
1136 3 129 405 791 gl0439739 6.00E-26 unnamed protein product
1136 3 129 405 791 gl3359183 1.00E-25 KIAA1655 protein
1136 3 129 405 791 g3002527 2.00E-25 neuronal thread protein AD7c-NTP
1137 1 546 1321 2958 gl3158006 0 unnamed protein product S 1137 1 546 1321 2958 gl3158008 0 unnamed protein product
1137 1 546 1321 2958 gl7225574 0 LIM domain only 7
1138 2 199 668 1264 gl0438571 3.00E-97 unnamed protein product
1142 3 398 504 1697 g10436616 1.00E-129 unnamed protein product
1142 3 398 504 1697 g14286252 5.00E-71 Similar to hypothetical protein FLJ14213
1142 3 398 504 1697 g10503959 l .OOE-58 unknown
1145 2 1711 1151 6283 g7959279 0 KIAA1509 protein
1145 2 1711 1151 6283 gl0434073 0 unnamed protein product
1145 2 1711 1151 6283 g6563224 1.00E-142 unknown
1146 2 314 227 1168 gl1342658 1.00E-158 transmembrane chemokine CXCL16
1146 2 314 227 1168 gl4042031 1.00E-156 unnamed protein product
1146 2 314 227 1168 gl1139544 1.00E-146 SRPSOX
Figure imgf000452_0001
TABLE 6
Program Description Reference Parameter Threshold ABIFACTURA A program that removes vector sequences and masks Applied Biosystems, Foster City, CA. ambiguous bases in nucleic acid sequences.
ABI/PARACEL FDF A Fast Data Finder useful in comparing and annotating Applied Biosystems, Foster City, CA; Paracel Mismatch <50% amino acid or nucleic acid sequences. Inc., Pasadena, CA.
ABI AutoAssembler A program that assembles nucleic acid sequences. Applied Biosystems, Foster City, CA. BLAST A Basic Local Alignment Search Tool useful in sequence Altschul, S.F. et al. (1990) J. Mol. Biol.215:403- ESTs: Probability value= 1.0E-8 or less; similarity search for amino acid and nucleic acid 410; Altschul, S.F. et al. (1997) Nucleic Acids Full Length sequences: Probability sequences. BLAST includes five functions: blastp, Res. 25:3389-3402. value= l.OE-10 or less blastn, blastx, tblastn, and tblastx.
FASTA A Pearson and Lipman algorithm that searches for Pearson, W.R. and DJ. Lipman (1988) Proc. ESTs: fasta E value=1.06E-6; Assembled similarity between a query sequence and a group of Natl. Acad Sci. USA 85:2444-2448; Pearson, ESTs: fasta Identity= 95% or greater and sequences of the same type. FASTA comprises as least W.R. (1990) Methods Enzymol. 183:63-98; and Match length=200 bases or greater; fastx five functions: fasta, tfasta, fastx, tfastx, and ssearch. Smith, T.F. and M.S. Waterman (1981) Adv. E value=1.0E-8 or less; Full Length Appl. Math.2:482-489. sequences: fastx score=100 or greater
BLIMPS A BLocks IMProved Searcher that matches a sequence Henikoff, S. and J.G. Henikoff (1991) Nucleic Probability value= 1.0E-3 or less against those in BLOCKS, PRINTS, DOMO, PRODOM, Acids Res. 19:6565-6572; Henikoff, J.G. and S. and PFAM databases to search for gene families, Henikoff (1996) Methods Enzymol.266:88- 105; sequence homology, and structural fingerprint regions, and Attwood, T.K. et al. (1997) J. Chem. Inf.
Comput. Sci. 37:417-424.
HMMER An algorithm for searching a query sequence against Krogh, A. et al. (1994) J. Mol. Biol. 235:1501- PFAM hits: Probability value= 1.0E-3 or hidden Markov model (HMM)-based databases of 1531; Sonnhammer, E.L.L. et al. (1988) Nucleic less; protein family consensus sequences, such as PFAM. Acids Res.26:320-322; Durbin, R. et al. (1998) Signal peptide hits: Score= 0 or greater
Our World View, in a Nutshell, Cambridge Univ.
Press, pp. 1-350.
TABLE 6
Program Description Reference Parameter Threshold ProfileScan An algorithm that searches for structural and sequence Gribskov, M. et al. (1988) CABIOS 4:61-66; Normalized quality score≥GCG-specified motifs in protein sequences that match sequence patterns Gribskov, M. et al. (1989) Methods Enzymol. "HIGH" value for that particular Prosite defined in Prosite. 183:146-159; Bairoch, A. et al. (1997) Nucleic motif. Generally, score=l .4-2.1.
Acids Res. 25:217-221.
Phred A base-calling algorithm that examines automated Ewing, B. et al. (1998) Genome Res. 8:175-185; sequencer traces with high sensitivity and probability. Ewing, B. and P. Green (1998) Genome Res. 8:186-194.
Phrap A Phils Revised Assembly Program including SWAT Smith, T.F. and M.S. Waterman (1981) Adv. Score= 120 or greater; and CrossMatch, programs based on efficient Appl. Math. 2:482-489; Smith, T.F. and M.S. Match length= 56 or greater implementation o the Smith-Waterman algorithm, Waterman (1981) J. Mol. Biol. 147:195-197; useful in searching sequence homology and assembling and Green, P., University of Washington, DNA sequences. Seattle, WA.
Consed A graphical tool for viewing and editing Phrap Gordon, D. et al. (1998) Genome Res. 8:195- assemblies. 202.
SPScan A weight matrix analysis program that scans protein Nielson, H. et al. (1997) Protein Engineering Score=3.5 or greater sequences for the presence of secretory signal peptides. 10:1-6; Claverie, J.M. and S. Audic (1997) CABIOS 12:431-439.
TMAP A program that uses weight matrices to delineate Persson, B. and P. Argos (1994) J. Mol. Biol. transmembrane segments on protem sequences and 237:182-192; Persson, B. and P. Argos (1996) determine orientation. Protein Sci. 5:363-371.
TMHMMER A program that uses a hidden Markov model (HMM) to Sonnhammer, E.L. et al. (1998) Proc. Sixth Intl. Conf. delineate transmembrane segments on protein sequences On Intelligent Systems for Mol. Biol., Glasgow et al., and determine orientation. eds., The Am. Assoc. for Artificial Intelligence (AAAI) Press, Menlo Park, CA, and MIT Press, Cambridge, MA, pp. 175-182.
Motifs A program that searches amino acid sequences for Bairoch, A. et al. (1997) Nucleic Acids Res. patterns that matched those defined in Prosite. 25:217-221; Wisconsin Package Program Manual, version 9, page M51-59, Genetics Computer Group, Madison, WI.

Claims

CLAIMS What is claimed is:
1. An isolated polynucleotide selected from the group consisting of:
5 a) a polynucleotide comprising a pol nucleotide sequence selected from the group consisting of NO: 1-567, b) a polynucleotide comprising a naturally occurring pol nucleotide sequence at least about 90% identical to a polynucleotide sequence selected from the group consisting of NO:l-567, c) a polynucleotide complementary to the polynucleotide of a), 0 d) a polynucleotide complementary to the polynucleotide of b), and e) an RNA equivalent of a)-d).
2. An isolated polynucleotide of claim 1, comprising a pol nucleotide sequence selected from the group consisting of SEQ ID NO:l-567. 5
3. An isolated polynucleotide comprising at least about 60 contiguous nucleotides of a polynucleotide of claim 1.
4. A composition for the detection of expression of secretory polynucleotides comprising at o least one of the polynucleotides of claim 1 and a detectable label.
5. A method for detecting a target polynucleotide in a sample, said target polynucleotide having a sequence of a polynucleotide of claim 1, the method comprising: a) amplifying said target polynucleotide or fragment thereof using polymerase chain reaction 5 amplification, and b) detecting the presence or absence of said amplified target pol nucleotide or fragment thereof, and, optionally, if present, the amount thereof.
6. A method for detecting a target polynucleotide in a sample, said target polynucleotide o comprising a sequence of a polynucleotide of claim 1, the method comprising: a) hybridizing the sample with a probe comprising at least about 20 contiguous nucleotides comprising a sequence complementary to said target polynucleotide in the sample, and which probe specifically hybridizes to said target polynucleotide, under conditions whereby a hybridization complex is formed between said probe and said target polynucleotide or fragments thereof, and 5 b) detecting the presence or absence of said hybridization complex, and, optionally, if present, the amount thereof.
7. A method of claim 5, wherein the probe comprises at least about 30 contiguous nucleotides.
5
8. A method of claim 5, wherein the probe comprises at least about 60 contiguous nucleotides.
9. A recombinant pol nucleotide comprising a promoter sequence operably linked to a o polynucleotide of claim 1.
10. A cell transformed with a recombinant pol nucleotide of claim 9.
11. A transgenic organism comprising a recombinant polynucleotide of claim 9. 5
12. A method for producing a secretory polypeptide, the method comprising: a) culturing a cell under conditions suitable for expression ofthe secretory polypeptide, wherein said cell is transformed with a recombinant polynucleotide of claim 9, and b) recovering the secretory polypeptide so expressed. 0
13. A purified secretory polypeptide (SPTM) encoded by at least one of the polynucleotides of claim 2.
14. An isolated antibody which specifically binds to a secretory polypeptide of claim 13. 5
15. A method of identifying a test compound which specifically binds to the secretory polypeptide of claim 13, the method comprising: a) providing a test compound; b) combining the secretory polypeptide with the test compound for a sufficient time and o under suitable conditions for binding; and c) detecting binding of the secretory polypeptide to the test compound, thereby identifying the test compound which specifically binds the secretory polypeptide.
16. A microarray wherein at least one element of the microarray is a polynucleotide of claim 5 3.
17. A method for generating a transcript image of a sample which contains polynucleotides, the method comprising: a) labeling the polynucleotides of the sample, b) contacting the elements of the microarray of claim 16 with the labeled polynucleotides of the sample under conditions suitable for the formation of a hybridization complex, and c) quantifying the expression of the polynucleotides in the sample.
18. A method for screening a compound for effectiveness in altering expression of a target polynucleotide, wherein said target polynucleotide comprises a polynucleotide sequence of claim 1, the method comprising: a) exposing a sample comprising the target polynucleotide to a compound, under conditions suitable for the expression of the target polynucleotide, b) detecting altered expression of the target polynucleotide, and c) comparing the expression ofthe target pol nucleotide in the presence of varying amounts of the compound and in the absence of the compound.
19. A method for assessing toxicity of a test compound, said method comprising: a) treating a biological sample containing nucleic acids with the test compound; b) hybridizing the nucleic acids of the treated biological sample with a probe comprising at least about 20 contiguous nucleotides of a polynucleotide of claim 1 under conditions whereby a specific hybridization complex is formed between said probe and a target polynucleotide in the biological sample, said target polynucleotide comprising a polynucleotide sequence of a polynucleotide of claim 1 or fragment thereof; c) quantifying the amount of hybridization complex; and d) comparing the amount of hybridization complex in the treated biological sample with the amount of hybridization complex in an untreated biological sample, wherein a difference in the amount of hybridization complex in the treated biological sample is indicative of toxicity of he test compound.
20. An aπay comprising different nucleotide molecules affixed in distinct physical locations on a solid substrate, wherein at least one of said nucleotide molecules comprises a first oligonucleotide or polynucleotide sequence specifically hybridizable with at least about 30 contiguous nucleotides of a target polynucleotide, said target polynucleotide having a sequence of claim 1.
21. An array of claim 20, wherein said first oligonucleotide or polynucleotide sequence is completely complementary to at least about 30 contiguous nucleotides of said target polynucleotide.
22. An aπay of claim 20, wherein said first oligonucleotide or polynucleotide sequence is completely complementary to at least about 60 contiguous nucleotides of said target pol nucleotide
23. An aπay of claim 20, which is a microaπay.
24. An array of claim 20, further comprising said target polynucleotide hybridized to said first oligonucleotide or polynucleotide.
25. An aπay of claim 20, wherein a linker joins at least one of said nucleotide molecules to said solid substrate.
26. An aπay of claim 20, wherein each distinct physical location on the substrate contains multiple nucleotide molecules having the same sequence, and each distinct physical location on the substrate contains nucleotide molecules having a sequence which differs from the sequence of nucleotide molecules at another physical location on the substrate.
27. An isolated polypeptide selected from the group consisting of: a) a polypeptide comprising an amino acid sequence selected from the group consisting of SEQ ID NO.568-1146, b) a naturally occurring polypeptide comprising an amino acid sequence at least about 90% identical to an amino acid sequence selected from the group consisting of SEQ ID NO:568-l 146, c) a biologically active fragment of a polypeptide having an amino acid sequence selected from the group consisting of SEQ ID NO:568-1146, and d) an immunogenic fragment of a polypeptide having an amino acid sequence selected from the group consisting of SEQ ID NO.568-1146.
28. An isolated polypeptide of claim 27, comprising a polypeptide sequence selected from the group consisting of SEQ ID NO.568-1146.
PCT/US2002/009921 2001-03-29 2002-03-27 Secretory molecules WO2002083876A2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
EP02739118A EP1409504A2 (en) 2001-03-29 2002-03-27 Secretory molecules
CA002447212A CA2447212A1 (en) 2001-03-29 2002-03-27 Secretory molecules
AU2002311791A AU2002311791A1 (en) 2001-03-29 2002-03-27 Secretory molecules

Applications Claiming Priority (16)

Application Number Priority Date Filing Date Title
US28006701P 2001-03-29 2001-03-29
US28006801P 2001-03-29 2001-03-29
US60/280,068 2001-03-29
US60/280,067 2001-03-29
US29128001P 2001-05-16 2001-05-16
US60/291,280 2001-05-16
US29182901P 2001-05-17 2001-05-17
US29184901P 2001-05-17 2001-05-17
US60/291,829 2001-05-17
US60/291,849 2001-05-17
US29942801P 2001-06-19 2001-06-19
US60/299,428 2001-06-19
US30000101P 2001-06-20 2001-06-20
US29977601P 2001-06-20 2001-06-20
US60/300,001 2001-06-20
US60/299,776 2001-06-20

Publications (2)

Publication Number Publication Date
WO2002083876A2 true WO2002083876A2 (en) 2002-10-24
WO2002083876A3 WO2002083876A3 (en) 2004-02-19

Family

ID=27575326

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2002/009921 WO2002083876A2 (en) 2001-03-29 2002-03-27 Secretory molecules

Country Status (4)

Country Link
EP (1) EP1409504A2 (en)
AU (1) AU2002311791A1 (en)
CA (1) CA2447212A1 (en)
WO (1) WO2002083876A2 (en)

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003059948A1 (en) * 2002-01-15 2003-07-24 Medigene Ag Dilated cardiomyopathy associated gene-2 (dcmag-2): a cytoplasmatic inducer of sarcomeric remodeling in cardiomyocytes
WO2004009819A2 (en) * 2002-07-23 2004-01-29 Delta Biotechnology Limited Polypeptides with a signal sequence comprising an fivsi motif and olynucleotides encoding therefor
WO2005003336A2 (en) 2003-07-07 2005-01-13 Universiteit Utrecht Holding B.V. Newly identified cholinephosphotransferases and ethanolaminephosphotransferases
US6924358B2 (en) 2001-03-05 2005-08-02 Agensys, Inc. 121P1F1: a tissue specific protein highly expressed in various cancers
US7244827B2 (en) 2000-04-12 2007-07-17 Agensys, Inc. Nucleic acid and corresponding protein entitled 24P4C12 useful in treatment and detection of cancer
WO2009054471A1 (en) * 2007-10-25 2009-04-30 Toray Industries, Inc. Immune response inducer
WO2009054475A1 (en) * 2007-10-25 2009-04-30 Toray Industries, Inc. Method for detection of cancer
US7537896B2 (en) 2000-01-28 2009-05-26 Henry M. Jackson Foundation For The Advancement Of Military Medicine Androgen-regulated PMEPA1 gene and polypeptides
JP2009120596A (en) * 2007-10-25 2009-06-04 Toray Ind Inc Immunity-inducing agent
US7601825B2 (en) 2001-03-05 2009-10-13 Agensys, Inc. Nucleic acid and corresponding protein entitled 121P1F1 useful in treatment and detection of cancer
US7696336B2 (en) 2002-08-16 2010-04-13 Agensys, Inc. Nucleic acids and corresponding proteins entitled 251P5G2 useful in treatment and detection of cancer
EP2333112A2 (en) 2004-02-20 2011-06-15 Veridex, LLC Breast cancer prognostics
US20110288031A1 (en) * 2002-05-31 2011-11-24 The Gov't of the U.S.A. as represented by the Secretary of the Dep't of Health and Human Service Identification of a novel bhd gene
US9382318B2 (en) 2012-05-18 2016-07-05 Amgen Inc. ST2 antigen binding proteins

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DATABASE GENBANK [Online] 07 July 2000 WATERSON R.H.: 'The sequence of homo sapiens clone', XP002964529 Retrieved from NCBI Database accession no. (AC023786) *
DATABASE GENBANK [Online] 10 August 2000 'National Cancer Institute, Cancer Genome Anatomy Project (CGAP), Tumor Gene Index', XP002964530 Retrieved from NCBI Database accession no. (BE552030) *

Cited By (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7537896B2 (en) 2000-01-28 2009-05-26 Henry M. Jackson Foundation For The Advancement Of Military Medicine Androgen-regulated PMEPA1 gene and polypeptides
US7244827B2 (en) 2000-04-12 2007-07-17 Agensys, Inc. Nucleic acid and corresponding protein entitled 24P4C12 useful in treatment and detection of cancer
US8039603B2 (en) 2001-03-05 2011-10-18 Agensys, Inc. Nucleic acid and corresponding protein entitled 121P1F1 useful in treatment and detection of cancer
US7892548B2 (en) 2001-03-05 2011-02-22 Agensys, Inc. 121P1F1: a tissue specific protein highly expressed in various cancers
US7601825B2 (en) 2001-03-05 2009-10-13 Agensys, Inc. Nucleic acid and corresponding protein entitled 121P1F1 useful in treatment and detection of cancer
US6924358B2 (en) 2001-03-05 2005-08-02 Agensys, Inc. 121P1F1: a tissue specific protein highly expressed in various cancers
US7309585B2 (en) 2001-03-05 2007-12-18 Agensys, Inc. 121P1F1: a tissue specific protein highly expressed in various cancers
WO2003059948A1 (en) * 2002-01-15 2003-07-24 Medigene Ag Dilated cardiomyopathy associated gene-2 (dcmag-2): a cytoplasmatic inducer of sarcomeric remodeling in cardiomyocytes
US8865880B2 (en) * 2002-05-31 2014-10-21 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Identification of a novel BHD gene
US20110288031A1 (en) * 2002-05-31 2011-11-24 The Gov't of the U.S.A. as represented by the Secretary of the Dep't of Health and Human Service Identification of a novel bhd gene
WO2004009819A3 (en) * 2002-07-23 2004-03-25 Delta Biotechnology Ltd Polypeptides with a signal sequence comprising an fivsi motif and olynucleotides encoding therefor
US9133265B2 (en) 2002-07-23 2015-09-15 Novozymes Biopharma Dk A/S Gene and polypeptide sequences
GB2406571A (en) * 2002-07-23 2005-04-06 Delta Biotechnology Ltd Polypeptides with a signal sequence comprising an fivsi motif and olynucleotides encoding therefor
US8258102B2 (en) 2002-07-23 2012-09-04 Novozymes Biopharma Dk A/S Gene and polypeptide sequences
GB2406571B (en) * 2002-07-23 2007-02-21 Delta Biotechnology Ltd Gene and polypeptide sequences
WO2004009819A2 (en) * 2002-07-23 2004-01-29 Delta Biotechnology Limited Polypeptides with a signal sequence comprising an fivsi motif and olynucleotides encoding therefor
US7696336B2 (en) 2002-08-16 2010-04-13 Agensys, Inc. Nucleic acids and corresponding proteins entitled 251P5G2 useful in treatment and detection of cancer
US8604169B2 (en) 2002-08-16 2013-12-10 Agensys, Inc. Nucleic acids and corresponding proteins entitled 251P5G2 useful in treatment and detection of cancer
WO2005003336A2 (en) 2003-07-07 2005-01-13 Universiteit Utrecht Holding B.V. Newly identified cholinephosphotransferases and ethanolaminephosphotransferases
WO2005003336A3 (en) * 2003-07-07 2005-09-29 Univ Utrecht Holding Bv Newly identified cholinephosphotransferases and ethanolaminephosphotransferases
EP2333112A2 (en) 2004-02-20 2011-06-15 Veridex, LLC Breast cancer prognostics
WO2009054471A1 (en) * 2007-10-25 2009-04-30 Toray Industries, Inc. Immune response inducer
US9249409B2 (en) 2007-10-25 2016-02-02 Toray Industries, Inc. Method for detection of cancer
JP2013101149A (en) * 2007-10-25 2013-05-23 Toray Ind Inc Cancer detecting method
JP2013101148A (en) * 2007-10-25 2013-05-23 Toray Ind Inc Cancer detecting method
CN101842113A (en) * 2007-10-25 2010-09-22 东丽株式会社 Immune response inducer
JP5439815B2 (en) * 2007-10-25 2014-03-12 東レ株式会社 Cancer detection method
JP2009120596A (en) * 2007-10-25 2009-06-04 Toray Ind Inc Immunity-inducing agent
KR20150041808A (en) * 2007-10-25 2015-04-17 도레이 카부시키가이샤 Method for detection of cancer
WO2009054475A1 (en) * 2007-10-25 2009-04-30 Toray Industries, Inc. Method for detection of cancer
JP2013101147A (en) * 2007-10-25 2013-05-23 Toray Ind Inc Cancer detecting method
KR101633351B1 (en) 2007-10-25 2016-06-27 도레이 카부시키가이샤 Method for detection of cancer
US10493136B2 (en) 2007-10-25 2019-12-03 Toray Industries, Inc. Immune response inducer
US9504737B2 (en) 2007-10-25 2016-11-29 Toray Industries, Inc. Immune response inducer
US10493138B2 (en) 2007-10-25 2019-12-03 Toray Industries, Inc. Immune response inducer
US10493137B2 (en) 2007-10-25 2019-12-03 Toray Industries, Inc. Immune response inducer
US10227414B2 (en) 2012-05-18 2019-03-12 Amgen Inc. ST2 antigen binding proteins
US9982054B2 (en) 2012-05-18 2018-05-29 Amgen Inc. ST2 antigen binding proteins
US9382318B2 (en) 2012-05-18 2016-07-05 Amgen Inc. ST2 antigen binding proteins
US11059895B2 (en) 2012-05-18 2021-07-13 Amgen Inc. ST2 antigen binding proteins
US11965029B2 (en) 2012-05-18 2024-04-23 Amgen Inc. ST2 antigen binding proteins

Also Published As

Publication number Publication date
WO2002083876A3 (en) 2004-02-19
CA2447212A1 (en) 2002-10-24
AU2002311791A1 (en) 2002-10-28
EP1409504A2 (en) 2004-04-21

Similar Documents

Publication Publication Date Title
WO2002079449A2 (en) Molecules for disease detection and treatment
EP1409504A2 (en) Secretory molecules
CA2427010A1 (en) Transporters and ion channels
US20060216706A1 (en) Proteins associated with cell growth, differentiation, and death
US20030215822A1 (en) Secreted proteins
JP2004533222A (en) Immunoglobulin superfamily proteins
US20050027103A1 (en) Structural and cytoskeleton-associated protein
CA2419943A1 (en) Secretory molecules
CA2420983A1 (en) Molecules for disease detection and treatment
WO2003062385A2 (en) Secretory molecules
WO2002024895A2 (en) Transcription factors and zinc finger proteins
US20070225218A1 (en) Extracellular Messengers
EP1263949A2 (en) Secretory polypeptides and corresponding polynucleotides
US20040106125A1 (en) Neurotransmission-associated proteins
US6962799B2 (en) Microtubule-associated proteins and tubulins
EP1409677A2 (en) Receptors and membrane-associated proteins
US20050064543A1 (en) Secreted proteins
US20040171012A1 (en) Nucleic acid-associated proteins
CA2410679A1 (en) Secretion and trafficking molecules
WO2002055738A2 (en) Molecules for disease detection and treatment
EP1472285A2 (en) Secretory molecules
WO2000075298A2 (en) Molecules for disease detection and treatment
US20040097707A1 (en) Receptors and membrane-associated proteins
US20050186569A1 (en) Nucleic acid-associated proteins
WO2001011032A1 (en) Secretory molecules

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2002739118

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2447212

Country of ref document: CA

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWP Wipo information: published in national office

Ref document number: 2002739118

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 2002739118

Country of ref document: EP

NENP Non-entry into the national phase in:

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP